{"records": [{"_id": "10031-OMIM:250250", "condition": {"condition_name": "CARTILAGE-HAIR HYPOPLASIA; CHH", "freq_per_birth": "Cartilage-hair hypoplasia occurs most often in the Old Order Amish population, where it affects about 1 in 1,300 newborns. In people of Finnish descent, its incidence is approximately 1 in 20,000. Outside of these populations, the condition is rare, and its specific incidence is not known. It has been reported in individuals of European and Japanese descent.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ANAUXETIC DYSPLASIA 1; ANXD1", "CARTILAGE-HAIR HYPOPLASIA; CHH", "Omenn syndrome", "METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS; MDWH"]}, "gene information": {"db_hgnc_gene_id": 10031.0}, "interventions": [{"int_description_1": "Installation of middle ear ventilation tubes"}, {"int_description_2": "Prednisolone"}, {"int_description_3": "Prednisone", "timeframe_int3": "Days or Weeks", "age_use_int3": "Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Human immunoglobulin G"}, {"int_description_5": "Rituximab"}, {"int_description_6": "Alemtuzumab", "timeframe_int6": "Hours", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Clarithromycin"}, {"int_description_8": "Cyclosporine"}, {"int_description_9": "Somatotropin"}, {"int_description_10": "Carbamazepine"}, {"int_description_11": "Cyclophosphamide"}, {"int_description_12": "Busulfan"}, {"int_description_13": "Melphalan"}, {"int_description_14": "Thiotepa"}, {"int_description_15": "Doxorubicin"}, {"int_description_16": "Trimethoprim"}, {"int_description_17": "Sulfamethoxazole"}, {"int_description_18": "Vincristine", "timeframe_int18": "Hours", "age_use_int18": "Neonate,Infant,Child", "contra_int18": "No", "qualscale_reclass_drug18": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug18": "Effective / Ameliorative"}, {"int_description_19": "Treosulfan"}, {"int_description_20": "Methotrexate"}, {"int_description_21": "Fludarabine"}, {"int_description_22": "Bleomycin"}, {"int_description_23": "Valaciclovir"}, {"int_description_24": "Mycophenolate mofetil"}, {"int_description_25": "Methylprednisolone"}, {"int_description_26": "Infliximab"}, {"int_description_27": "Deferoxamine"}, {"int_description_28": "Deferasirox"}, {"int_description_29": "Deferiprone"}, {"int_description_30": "Anti-thymocyte globulin"}, {"int_description_31": "Regramostim"}, {"int_description_32": "Human interleukin-2"}, {"int_description_33": "Filgrastim"}, {"int_description_34": "Blood cell transfusions"}, {"int_description_35": "Immunoglobulin replacement therapy"}, {"int_description_36": "Adenoidectomy"}, {"int_description_37": "Antrostomy"}, {"int_description_38": "Bone marrow transplantation", "timeframe_int38": "Days or Weeks,Years", "age_use_int38": "Infant,Child", "qualscale_reclass_drug38": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug38": "Effective / Ameliorative"}, {"int_description_39": "Caldwell-Luc operation"}, {"int_description_40": "Corrective osteotomy"}, {"int_description_41": "Hematopoietic stem cell transplantation (HSCT)", "timeframe_int41": "Days or Weeks,Years", "age_use_int41": "Infant,Child", "contra_int41": "No", "qualscale_reclass_drug41": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug41": "Effective / Ameliorative"}, {"int_description_42": "Nasal polyps operation"}, {"int_description_43": "Small bowel resection"}, {"int_description_44": "Splenectomy"}, {"int_description_45": "Surgical realignment of the lower extremities"}, {"int_description_46": "Tonsillectomy"}, {"int_description_47": "Vocal cord polyp operation"}], "references": [{"pmid_title_1": "A Systematic Review on Predisposition to Lymphoid (B and T cell) Neoplasias in Patients With Primary Immunodeficiencies and Immune Dysregulatory Disorders (Inborn Errors of Immunity).", "pmid_1": 31057537.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Frontiers in immunology"}, {"pmid_title_2": "Diffuse large B-cell lymphoma chemotherapy reveals a combined immunodeficiency syndrome in cartilage hair hypoplasia.", "pmid_2": 29688570.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Swiss medical weekly"}, {"pmid_title_3": "Diversity of Pubertal Development in Cartilage-Hair Hypoplasia; Two Illustrative Cases.", "pmid_3": 29462708.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Journal of pediatric and adolescent gynecology"}, {"pmid_title_4": "Variable phenotype of severe immunodeficiencies associated with RMRP gene mutations.", "pmid_4": 25663137.0, "pmid_date_4": 2015.0, "pmid_journal_4": "Journal of clinical immunology"}, {"pmid_title_5": "Cartilage hair hypoplasia: characteristics and orthopaedic manifestations.", "pmid_5": 25764362.0, "pmid_date_5": 2015.0, "pmid_journal_5": "Journal of children's orthopaedics"}, {"pmid_title_6": "Phenotypic variations of cartilage hair hypoplasia: granulomatous skin inflammation and severe T cell immunodeficiency as initial clinical presentation in otherwise well child with short stature.", "pmid_6": 24217815.0, "pmid_date_6": 2014.0, "pmid_journal_6": "Journal of clinical immunology"}, {"pmid_title_7": "Cartilage-hair hypoplasia: follow-up of immunodeficiency in two patients.", "pmid_7": 24402619.0, "pmid_date_7": 2014.0, "pmid_journal_7": "Journal of clinical immunology"}, {"pmid_title_8": "Hypoplastic anemia in cartilage-hair hypoplasia-balancing between iron overload and chelation.", "pmid_8": 23140882.0, "pmid_date_8": 2013.0, "pmid_journal_8": "The Journal of pediatrics"}, {"pmid_title_9": "Treatment of cartilage-hair hypoplasia with recombinant human growth hormone.", "pmid_9": 24330304.0, "pmid_date_9": 2013.0, "pmid_journal_9": "Pediatrics international : official journal of the Japan Pediatric Society"}, {"pmid_title_10": "Granulomatous inflammation in cartilage-hair hypoplasia: risks and benefits of anti-TNF-\u03b1 mAbs.", "pmid_10": 21714993.0, "pmid_date_10": 2011.0, "pmid_journal_10": "The Journal of allergy and clinical immunology"}, {"pmid_title_11": "Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation.", "pmid_11": 20375313.0, "pmid_date_11": 2010.0, "pmid_journal_11": "Blood"}, {"pmid_title_12": "Immunologic and clinical features of 25 Amish patients with RMRP 70 A-->G cartilage hair hypoplasia.", "pmid_12": 19150606.0, "pmid_date_12": 2009.0, "pmid_journal_12": "Clinical immunology (Orlando, Fla.)"}, {"pmid_title_13": "Diffuse lymphoplasmacytic bronchiolitis in cartilage-hair hypoplasia.", "pmid_13": 18280854.0, "pmid_date_13": 2008.0, "pmid_journal_13": "The Journal of pediatrics"}, {"pmid_title_14": "Bone marrow transplantation for cartilage-hair-hypoplasia.", "pmid_14": 17041608.0, "pmid_date_14": 2006.0, "pmid_journal_14": "Bone marrow transplantation"}, {"pmid_title_15": "The natural history of severe anemia in cartilage-hair hypoplasia.", "pmid_15": 16097009.0, "pmid_date_15": 2005.0, "pmid_journal_15": "American journal of medical genetics. Part A"}, {"pmid_title_16": "An effective case of growth hormone treatment on cartilage-hair hypoplasia.", "pmid_16": 15780958.0, "pmid_date_16": 2005.0, "pmid_journal_16": "Bone"}, {"pmid_title_17": "Granulocyte colony-stimulating factor-responsive chronic neutropenia in cartilage-hair hypoplasia.", "pmid_17": 15167352.0, "pmid_date_17": 2004.0, "pmid_journal_17": "Journal of pediatric hematology/oncology"}, {"pmid_title_18": "Growth hormone treatment in cartilage-hair hypoplasia: effects on growth and the immune system.", "pmid_18": 14960021.0, "pmid_date_18": 2004.0, "pmid_journal_18": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_19": "Treatment with recombinant IL-2 for recurrent respiratory infection in a case of cartilage-hair hypoplasia with autoimmune hemolytic anemia.", "pmid_19": 10633276.0, "pmid_date_19": 2000.0, "pmid_journal_19": "Journal of bone and mineral metabolism"}, {"pmid_title_20": "Cartilage-hair hypoplasia--clinical manifestations in 108 Finnish patients.", "pmid_20": 8444246.0, "pmid_date_20": 1993.0, "pmid_journal_20": "European journal of pediatrics"}]}, {"_id": "10031-OMIM:250460", "condition": {"condition_name": "METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS; MDWH", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ANAUXETIC DYSPLASIA 1; ANXD1", "METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS; MDWH", "Omenn syndrome", "CARTILAGE-HAIR HYPOPLASIA; CHH"]}, "gene information": {"db_hgnc_gene_id": 10031.0}, "interventions": [{"int_description_1": "Treosulfan"}, {"int_description_2": "Fludarabine"}, {"int_description_3": "Anti-thymocyte globulin"}, {"int_description_4": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_5": "Surgeries for leg deformity"}], "references": [{"pmid_title_1": "'Metaphyseal dysplasia without hypotrichosis' can present with late-onset extraskeletal manifestations.", "pmid_1": 31413121.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Journal of medical genetics"}]}, {"_id": "10031-OMIM:607095", "condition": {"condition_name": "ANAUXETIC DYSPLASIA 1; ANXD1", "freq_per_birth": "Anauxetic dysplasia is a very rare disorder; its prevalence is unknown.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS; MDWH", "ANAUXETIC DYSPLASIA 1; ANXD1", "Omenn syndrome", "CARTILAGE-HAIR HYPOPLASIA; CHH"]}, "gene information": {"db_hgnc_gene_id": 10031.0}, "interventions": [{"int_description_1": "Fuse malformed cervical vertebrae in infancy"}, {"int_description_2": "Simultaneous bilateral proximal femoral valgus osteotomies"}, {"int_description_3": "Temporary hemiepiphyseodesis with two-hole plates of distal femoral and proximal tibial growth plates"}], "references": [{"pmid_title_1": "Cartilage-Hair Hypoplasia - Anauxetic Dysplasia Spectrum Disorders", "pmid_1": 22420014.0, "pmid_date_1": 2020.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Axial correction of the lower limb deformities in a girl with anauxetic dysplasia.", "pmid_2": 22528854.0, "pmid_date_2": 2014.0, "pmid_journal_2": "Musculoskeletal surgery"}]}, {"_id": "10301-OMIM:612562", "condition": {"condition_name": "DIAMOND-BLACKFAN ANEMIA 7", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["DIAMOND-BLACKFAN ANEMIA 7"]}, "gene information": {"db_hgnc_gene_id": 10301.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks", "age_use_int31": "Child", "contra_int31": "Yes", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Methotrexate"}, {"int_description_33": "Fludarabine"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil", "timeframe_int45": "Days or Weeks,Years", "age_use_int45": "Child", "contra_int45": "No", "qualscale_reclass_drug45": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug45": "Effective / Ameliorative"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Effective / Ameliorative"}, {"int_description_55": "Cisplatin"}, {"int_description_56": "Muplestim"}, {"int_description_57": "Filgrastim", "timeframe_int57": "Years", "contra_int57": "No", "qualscale_reclass_drug57": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug57": "Curative"}, {"int_description_58": "Total body irradiation"}, {"int_description_59": "Radiotherapy"}, {"int_description_60": "red blood cells transfusion"}, {"int_description_61": "Thoracoabdominal irradiation"}, {"int_description_62": "Total lymphoid irradiation"}, {"int_description_63": "Above-knee amputation"}, {"int_description_64": "Bone marrow transplantation"}, {"int_description_65": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_66": "laparotomy, tumor dissection"}, {"int_description_67": "limb-salvage surgery"}, {"int_description_68": "Maxillectomy"}, {"int_description_69": "umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "How I manage children with Diamond-Blackfan anaemia.", "pmid_2": 30515771.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_3": 31916719.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Turk J Pediatr"}, {"pmid_title_4": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_4": 31355022.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Case Rep Hematol"}, {"pmid_title_5": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_5": 30811439.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PLoS One"}, {"pmid_title_6": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_6": 30881276.0, "pmid_date_6": 2019.0, "pmid_journal_6": "EJIFCC"}, {"pmid_title_7": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_7": 31208452.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Med Case Rep"}, {"pmid_title_8": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_8": 31574871.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_9": 30411682.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Curr Gene Ther"}, {"pmid_title_10": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_10": 29222242.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_11": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_11": 28623394.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Ann Hematol"}, {"pmid_title_12": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_12": 27882484.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Int J Hematol"}, {"pmid_title_13": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_13": 27537786.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Eur J Haematol"}, {"pmid_title_14": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_14": 28602958.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_15": 27082377.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Blood Cancer"}, {"pmid_title_16": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_16": 26872907.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Int J Hematol"}, {"pmid_title_17": "Pure red cell aplasia.", "pmid_17": 27881371.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Pure red cell aplasia.", "pmid_18": 27913462.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_19": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_19": 27329125.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Int J Hematol"}, {"pmid_title_20": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_20": 26496000.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_21": 25492299.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_22": 25963299.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Am J Hematol"}, {"pmid_title_23": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_23": 24611452.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_24": 24296492.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Biol Blood Marrow Transplant"}, {"pmid_title_25": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_25": 23795277.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Mediterr J Hematol Infect Dis"}, {"pmid_title_26": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_26": 22619618.0, "pmid_date_26": 2012.0, "pmid_journal_26": "ScientificWorldJournal"}, {"pmid_title_27": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_27": 23016900.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Br J Haematol"}, {"pmid_title_28": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_28": 24744655.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Turk J Haematol"}, {"pmid_title_29": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_29": 21062271.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Clin Exp Immunol"}, {"pmid_title_30": "How I treat Diamond-Blackfan anemia.", "pmid_30": 20651069.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Blood"}, {"pmid_title_31": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_31": 20655265.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Transfus Clin Biol"}, {"pmid_title_32": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_32": 20190482.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Intern Med"}, {"pmid_title_33": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_33": 19415275.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Ann Hematol"}, {"pmid_title_34": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_34": 18164793.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_35": 18671700.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Br J Haematol"}, {"pmid_title_36": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_36": 18028431.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Eur J Haematol"}, {"pmid_title_37": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_37": 18776763.0, "pmid_date_37": 2008.0, "pmid_journal_37": "J Pediatr Hematol Oncol"}, {"pmid_title_38": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_38": 18331650.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_39": "Deferasirox.", "pmid_39": 17353569.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Am J Health Syst Pharm"}, {"pmid_title_40": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_40": 17414568.0, "pmid_date_40": 2007.0, "pmid_journal_40": "J Pediatr Hematol Oncol"}, {"pmid_title_41": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_41": 17663681.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_42": 17562599.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Haematologica"}, {"pmid_title_43": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_43": 17312003.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Blood"}, {"pmid_title_44": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_44": 17921858.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_45": 16679921.0, "pmid_date_45": 2006.0, "pmid_journal_45": "J Pediatr Hematol Oncol"}, {"pmid_title_46": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_46": 17325961.0, "pmid_date_46": 2006.0, "pmid_journal_46": "Hematology"}, {"pmid_title_47": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_47": 16317735.0, "pmid_date_47": 2006.0, "pmid_journal_47": "Pediatr Blood Cancer"}, {"pmid_title_48": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_48": 16785135.0, "pmid_date_48": 2006.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_49": 16304857.0, "pmid_date_49": 2005.0, "pmid_journal_49": "J Pak Med Assoc"}, {"pmid_title_50": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_50": 16291361.0, "pmid_date_50": 2005.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_51": 15692602.0, "pmid_date_51": 2005.0, "pmid_journal_51": "Hematol J"}, {"pmid_title_52": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_52": 16041310.0, "pmid_date_52": 2005.0, "pmid_journal_52": "Biol Blood Marrow Transplant"}, {"pmid_title_53": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_53": 15813920.0, "pmid_date_53": 2005.0, "pmid_journal_53": "Eur J Haematol"}, {"pmid_title_54": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_54": 15795909.0, "pmid_date_54": 2005.0, "pmid_journal_54": "Am J Hematol"}, {"pmid_title_55": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_55": 14984172.0, "pmid_date_55": 2004.0, "pmid_journal_55": "J Trop Pediatr"}, {"pmid_title_56": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_56": 15220956.0, "pmid_date_56": 2004.0, "pmid_journal_56": "Bone Marrow Transplant"}, {"pmid_title_57": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_57": 14979474.0, "pmid_date_57": 2004.0, "pmid_journal_57": "Int J Hematol"}, {"pmid_title_58": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_58": 15382270.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatr Blood Cancer"}, {"pmid_title_59": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_59": 18521394.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Sarcoma"}, {"pmid_title_60": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_60": 14608205.0, "pmid_date_60": 2003.0, "pmid_journal_60": "J Pediatr Hematol Oncol"}, {"pmid_title_61": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_61": 12359817.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_62": 12351372.0, "pmid_date_62": 2002.0, "pmid_journal_62": "Blood"}, {"pmid_title_63": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_63": 12022425.0, "pmid_date_63": 2002.0, "pmid_journal_63": "J Trop Pediatr"}, {"pmid_title_64": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_64": 12142794.0, "pmid_date_64": 2002.0, "pmid_journal_64": "J Pediatr Hematol Oncol"}, {"pmid_title_65": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_65": 11313667.0, "pmid_date_65": 2001.0, "pmid_journal_65": "Bone Marrow Transplant"}, {"pmid_title_66": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_66": 11196268.0, "pmid_date_66": 2001.0, "pmid_journal_66": "J Pediatr Hematol Oncol"}, {"pmid_title_67": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_67": 11563769.0, "pmid_date_67": 2001.0, "pmid_journal_67": "J Pediatr Hematol Oncol"}, {"pmid_title_68": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_68": 10779036.0, "pmid_date_68": 2000.0, "pmid_journal_68": "J Pediatr Hematol Oncol"}, {"pmid_title_69": "Diamond-Blackfan anemia.", "pmid_69": 10698294.0, "pmid_date_69": 2000.0, "pmid_journal_69": "Curr Opin Hematol"}, {"pmid_title_70": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_70": 10673683.0, "pmid_date_70": 2000.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_71": 27263505.0, "pmid_date_71": 2000.0, "pmid_journal_71": "Turk J Haematol"}, {"pmid_title_72": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_72": 10714760.0, "pmid_date_72": 2000.0, "pmid_journal_72": "J Pediatr Endocrinol Metab"}, {"pmid_title_73": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_73": 10397110.0, "pmid_date_73": 1999.0, "pmid_journal_73": "AJR Am J Roentgenol"}, {"pmid_title_74": "Bone marrow transplantation in non-malignant disorders.", "pmid_74": 9916644.0, "pmid_date_74": 1998.0, "pmid_journal_74": "Bone Marrow Transplant"}, {"pmid_title_75": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_75": 8846147.0, "pmid_date_75": 1996.0, "pmid_journal_75": "J Pediatr Hematol Oncol"}, {"pmid_title_76": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_76": 8606629.0, "pmid_date_76": 1996.0, "pmid_journal_76": "Medicine (Baltimore)"}, {"pmid_title_77": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_77": 8625135.0, "pmid_date_77": 1995.0, "pmid_journal_77": "Cancer"}, {"pmid_title_78": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_78": 7691318.0, "pmid_date_78": 1993.0, "pmid_journal_78": "Stem Cells"}, {"pmid_title_79": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_79": 3109937.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Eur J Haematol"}, {"pmid_title_80": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_80": 13105384.0, "pmid_date_80": 1953.0, "pmid_journal_80": "Arch Dis Child"}]}, {"_id": "10306-OMIM:615550", "condition": {"condition_name": "DIAMOND-BLACKFAN ANEMIA 12", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["DIAMOND-BLACKFAN ANEMIA 12"]}, "gene information": {"db_hgnc_gene_id": 10306.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Hours,Days or Weeks", "age_use_int31": "Child", "contra_int31": "Yes", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Methotrexate", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Fludarabine"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole", "timeframe_int54": "Hours,Days or Weeks,Years", "age_use_int54": "Neonate,Infant,Child", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Effective / Ameliorative"}, {"int_description_55": "Cisplatin"}, {"int_description_56": "Muplestim"}, {"int_description_57": "Filgrastim", "timeframe_int57": "Days or Weeks,Years", "age_use_int57": "Infant,Child", "contra_int57": "No", "qualscale_reclass_drug57": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug57": "Curative"}, {"int_description_58": "Total body irradiation"}, {"int_description_59": "Radiotherapy"}, {"int_description_60": "red blood cells transfusion"}, {"int_description_61": "Thoracoabdominal irradiation"}, {"int_description_62": "Total lymphoid irradiation"}, {"int_description_63": "Above-knee amputation"}, {"int_description_64": "Bone marrow transplantation"}, {"int_description_65": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_66": "laparotomy, tumor dissection"}, {"int_description_67": "limb-salvage surgery"}, {"int_description_68": "Maxillectomy"}, {"int_description_69": "umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "How I manage children with Diamond-Blackfan anaemia.", "pmid_2": 30515771.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_3": 31916719.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Turk J Pediatr"}, {"pmid_title_4": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_4": 31355022.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Case Rep Hematol"}, {"pmid_title_5": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_5": 30811439.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PLoS One"}, {"pmid_title_6": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_6": 30881276.0, "pmid_date_6": 2019.0, "pmid_journal_6": "EJIFCC"}, {"pmid_title_7": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_7": 31208452.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Med Case Rep"}, {"pmid_title_8": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_8": 31574871.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_9": 30411682.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Curr Gene Ther"}, {"pmid_title_10": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_10": 29222242.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_11": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_11": 28623394.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Ann Hematol"}, {"pmid_title_12": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_12": 27882484.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Int J Hematol"}, {"pmid_title_13": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_13": 27537786.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Eur J Haematol"}, {"pmid_title_14": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_14": 28602958.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_15": 27082377.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Blood Cancer"}, {"pmid_title_16": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_16": 26872907.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Int J Hematol"}, {"pmid_title_17": "Pure red cell aplasia.", "pmid_17": 27881371.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Pure red cell aplasia.", "pmid_18": 27913462.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_19": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_19": 27329125.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Int J Hematol"}, {"pmid_title_20": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_20": 26496000.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_21": 25492299.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_22": 25963299.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Am J Hematol"}, {"pmid_title_23": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_23": 24611452.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_24": 24296492.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Biol Blood Marrow Transplant"}, {"pmid_title_25": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_25": 23795277.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Mediterr J Hematol Infect Dis"}, {"pmid_title_26": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_26": 22619618.0, "pmid_date_26": 2012.0, "pmid_journal_26": "ScientificWorldJournal"}, {"pmid_title_27": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_27": 23016900.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Br J Haematol"}, {"pmid_title_28": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_28": 24744655.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Turk J Haematol"}, {"pmid_title_29": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_29": 21062271.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Clin Exp Immunol"}, {"pmid_title_30": "How I treat Diamond-Blackfan anemia.", "pmid_30": 20651069.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Blood"}, {"pmid_title_31": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_31": 20655265.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Transfus Clin Biol"}, {"pmid_title_32": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_32": 20190482.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Intern Med"}, {"pmid_title_33": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_33": 19415275.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Ann Hematol"}, {"pmid_title_34": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_34": 18164793.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_35": 18671700.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Br J Haematol"}, {"pmid_title_36": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_36": 18028431.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Eur J Haematol"}, {"pmid_title_37": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_37": 18776763.0, "pmid_date_37": 2008.0, "pmid_journal_37": "J Pediatr Hematol Oncol"}, {"pmid_title_38": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_38": 18331650.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_39": "Deferasirox.", "pmid_39": 17353569.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Am J Health Syst Pharm"}, {"pmid_title_40": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_40": 17414568.0, "pmid_date_40": 2007.0, "pmid_journal_40": "J Pediatr Hematol Oncol"}, {"pmid_title_41": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_41": 17663681.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_42": 17562599.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Haematologica"}, {"pmid_title_43": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_43": 17312003.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Blood"}, {"pmid_title_44": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_44": 17921858.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_45": 16679921.0, "pmid_date_45": 2006.0, "pmid_journal_45": "J Pediatr Hematol Oncol"}, {"pmid_title_46": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_46": 17325961.0, "pmid_date_46": 2006.0, "pmid_journal_46": "Hematology"}, {"pmid_title_47": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_47": 16317735.0, "pmid_date_47": 2006.0, "pmid_journal_47": "Pediatr Blood Cancer"}, {"pmid_title_48": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_48": 16785135.0, "pmid_date_48": 2006.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_49": 16304857.0, "pmid_date_49": 2005.0, "pmid_journal_49": "J Pak Med Assoc"}, {"pmid_title_50": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_50": 16291361.0, "pmid_date_50": 2005.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_51": 15692602.0, "pmid_date_51": 2005.0, "pmid_journal_51": "Hematol J"}, {"pmid_title_52": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_52": 16041310.0, "pmid_date_52": 2005.0, "pmid_journal_52": "Biol Blood Marrow Transplant"}, {"pmid_title_53": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_53": 15813920.0, "pmid_date_53": 2005.0, "pmid_journal_53": "Eur J Haematol"}, {"pmid_title_54": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_54": 15795909.0, "pmid_date_54": 2005.0, "pmid_journal_54": "Am J Hematol"}, {"pmid_title_55": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_55": 14984172.0, "pmid_date_55": 2004.0, "pmid_journal_55": "J Trop Pediatr"}, {"pmid_title_56": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_56": 15220956.0, "pmid_date_56": 2004.0, "pmid_journal_56": "Bone Marrow Transplant"}, {"pmid_title_57": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_57": 14979474.0, "pmid_date_57": 2004.0, "pmid_journal_57": "Int J Hematol"}, {"pmid_title_58": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_58": 15382270.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatr Blood Cancer"}, {"pmid_title_59": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_59": 18521394.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Sarcoma"}, {"pmid_title_60": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_60": 14608205.0, "pmid_date_60": 2003.0, "pmid_journal_60": "J Pediatr Hematol Oncol"}, {"pmid_title_61": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_61": 12359817.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_62": 12351372.0, "pmid_date_62": 2002.0, "pmid_journal_62": "Blood"}, {"pmid_title_63": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_63": 12022425.0, "pmid_date_63": 2002.0, "pmid_journal_63": "J Trop Pediatr"}, {"pmid_title_64": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_64": 12142794.0, "pmid_date_64": 2002.0, "pmid_journal_64": "J Pediatr Hematol Oncol"}, {"pmid_title_65": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_65": 11313667.0, "pmid_date_65": 2001.0, "pmid_journal_65": "Bone Marrow Transplant"}, {"pmid_title_66": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_66": 11196268.0, "pmid_date_66": 2001.0, "pmid_journal_66": "J Pediatr Hematol Oncol"}, {"pmid_title_67": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_67": 11563769.0, "pmid_date_67": 2001.0, "pmid_journal_67": "J Pediatr Hematol Oncol"}, {"pmid_title_68": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_68": 10779036.0, "pmid_date_68": 2000.0, "pmid_journal_68": "J Pediatr Hematol Oncol"}, {"pmid_title_69": "Diamond-Blackfan anemia.", "pmid_69": 10698294.0, "pmid_date_69": 2000.0, "pmid_journal_69": "Curr Opin Hematol"}, {"pmid_title_70": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_70": 10673683.0, "pmid_date_70": 2000.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_71": 27263505.0, "pmid_date_71": 2000.0, "pmid_journal_71": "Turk J Haematol"}, {"pmid_title_72": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_72": 10714760.0, "pmid_date_72": 2000.0, "pmid_journal_72": "J Pediatr Endocrinol Metab"}, {"pmid_title_73": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_73": 10397110.0, "pmid_date_73": 1999.0, "pmid_journal_73": "AJR Am J Roentgenol"}, {"pmid_title_74": "Bone marrow transplantation in non-malignant disorders.", "pmid_74": 9916644.0, "pmid_date_74": 1998.0, "pmid_journal_74": "Bone Marrow Transplant"}, {"pmid_title_75": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_75": 8846147.0, "pmid_date_75": 1996.0, "pmid_journal_75": "J Pediatr Hematol Oncol"}, {"pmid_title_76": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_76": 8606629.0, "pmid_date_76": 1996.0, "pmid_journal_76": "Medicine (Baltimore)"}, {"pmid_title_77": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_77": 8625135.0, "pmid_date_77": 1995.0, "pmid_journal_77": "Cancer"}, {"pmid_title_78": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_78": 7691318.0, "pmid_date_78": 1993.0, "pmid_journal_78": "Stem Cells"}, {"pmid_title_79": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_79": 3109937.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Eur J Haematol"}, {"pmid_title_80": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_80": 13105384.0, "pmid_date_80": 1953.0, "pmid_journal_80": "Arch Dis Child"}]}, {"_id": "10310-OMIM:618310", "condition": {"condition_name": "DIAMOND-BLACKFAN ANEMIA 18", "alternate_names": ["DIAMOND-BLACKFAN ANEMIA 18"]}, "gene information": {"db_hgnc_gene_id": 10310.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "Yes", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Methotrexate", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Fludarabine"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole", "timeframe_int54": "Hours,Days or Weeks,Years", "age_use_int54": "Neonate,Infant,Child", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Effective / Ameliorative"}, {"int_description_55": "Cisplatin"}, {"int_description_56": "Muplestim"}, {"int_description_57": "Filgrastim", "timeframe_int57": "Days or Weeks,Years", "age_use_int57": "Infant,Child", "contra_int57": "No", "qualscale_reclass_drug57": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug57": "Curative"}, {"int_description_58": "Total body irradiation"}, {"int_description_59": "Radiotherapy"}, {"int_description_60": "red blood cells transfusion"}, {"int_description_61": "Thoracoabdominal irradiation"}, {"int_description_62": "Total lymphoid irradiation"}, {"int_description_63": "Above-knee amputation"}, {"int_description_64": "Bone marrow transplantation"}, {"int_description_65": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_66": "laparotomy, tumor dissection"}, {"int_description_67": "limb-salvage surgery"}, {"int_description_68": "Maxillectomy"}, {"int_description_69": "umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "How I manage children with Diamond-Blackfan anaemia.", "pmid_2": 30515771.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_3": 31916719.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Turk J Pediatr"}, {"pmid_title_4": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_4": 31355022.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Case Rep Hematol"}, {"pmid_title_5": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_5": 30811439.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PLoS One"}, {"pmid_title_6": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_6": 30881276.0, "pmid_date_6": 2019.0, "pmid_journal_6": "EJIFCC"}, {"pmid_title_7": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_7": 31208452.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Med Case Rep"}, {"pmid_title_8": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_8": 31574871.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_9": 30411682.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Curr Gene Ther"}, {"pmid_title_10": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_10": 29222242.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_11": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_11": 28623394.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Ann Hematol"}, {"pmid_title_12": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_12": 27882484.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Int J Hematol"}, {"pmid_title_13": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_13": 27537786.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Eur J Haematol"}, {"pmid_title_14": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_14": 28602958.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_15": 27082377.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Blood Cancer"}, {"pmid_title_16": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_16": 26872907.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Int J Hematol"}, {"pmid_title_17": "Pure red cell aplasia.", "pmid_17": 27881371.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Pure red cell aplasia.", "pmid_18": 27913462.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_19": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_19": 27329125.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Int J Hematol"}, {"pmid_title_20": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_20": 26496000.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_21": 25492299.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_22": 25963299.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Am J Hematol"}, {"pmid_title_23": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_23": 24611452.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_24": 24296492.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Biol Blood Marrow Transplant"}, {"pmid_title_25": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_25": 23795277.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Mediterr J Hematol Infect Dis"}, {"pmid_title_26": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_26": 22619618.0, "pmid_date_26": 2012.0, "pmid_journal_26": "ScientificWorldJournal"}, {"pmid_title_27": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_27": 23016900.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Br J Haematol"}, {"pmid_title_28": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_28": 24744655.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Turk J Haematol"}, {"pmid_title_29": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_29": 21062271.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Clin Exp Immunol"}, {"pmid_title_30": "How I treat Diamond-Blackfan anemia.", "pmid_30": 20651069.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Blood"}, {"pmid_title_31": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_31": 20655265.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Transfus Clin Biol"}, {"pmid_title_32": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_32": 20190482.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Intern Med"}, {"pmid_title_33": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_33": 19415275.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Ann Hematol"}, {"pmid_title_34": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_34": 18164793.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_35": 18671700.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Br J Haematol"}, {"pmid_title_36": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_36": 18028431.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Eur J Haematol"}, {"pmid_title_37": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_37": 18776763.0, "pmid_date_37": 2008.0, "pmid_journal_37": "J Pediatr Hematol Oncol"}, {"pmid_title_38": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_38": 18331650.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_39": "Deferasirox.", "pmid_39": 17353569.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Am J Health Syst Pharm"}, {"pmid_title_40": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_40": 17414568.0, "pmid_date_40": 2007.0, "pmid_journal_40": "J Pediatr Hematol Oncol"}, {"pmid_title_41": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_41": 17663681.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_42": 17562599.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Haematologica"}, {"pmid_title_43": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_43": 17312003.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Blood"}, {"pmid_title_44": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_44": 17921858.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_45": 16679921.0, "pmid_date_45": 2006.0, "pmid_journal_45": "J Pediatr Hematol Oncol"}, {"pmid_title_46": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_46": 17325961.0, "pmid_date_46": 2006.0, "pmid_journal_46": "Hematology"}, {"pmid_title_47": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_47": 16317735.0, "pmid_date_47": 2006.0, "pmid_journal_47": "Pediatr Blood Cancer"}, {"pmid_title_48": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_48": 16785135.0, "pmid_date_48": 2006.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_49": 16304857.0, "pmid_date_49": 2005.0, "pmid_journal_49": "J Pak Med Assoc"}, {"pmid_title_50": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_50": 16291361.0, "pmid_date_50": 2005.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_51": 15692602.0, "pmid_date_51": 2005.0, "pmid_journal_51": "Hematol J"}, {"pmid_title_52": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_52": 16041310.0, "pmid_date_52": 2005.0, "pmid_journal_52": "Biol Blood Marrow Transplant"}, {"pmid_title_53": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_53": 15813920.0, "pmid_date_53": 2005.0, "pmid_journal_53": "Eur J Haematol"}, {"pmid_title_54": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_54": 15795909.0, "pmid_date_54": 2005.0, "pmid_journal_54": "Am J Hematol"}, {"pmid_title_55": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_55": 14984172.0, "pmid_date_55": 2004.0, "pmid_journal_55": "J Trop Pediatr"}, {"pmid_title_56": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_56": 15220956.0, "pmid_date_56": 2004.0, "pmid_journal_56": "Bone Marrow Transplant"}, {"pmid_title_57": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_57": 14979474.0, "pmid_date_57": 2004.0, "pmid_journal_57": "Int J Hematol"}, {"pmid_title_58": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_58": 15382270.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatr Blood Cancer"}, {"pmid_title_59": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_59": 18521394.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Sarcoma"}, {"pmid_title_60": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_60": 14608205.0, "pmid_date_60": 2003.0, "pmid_journal_60": "J Pediatr Hematol Oncol"}, {"pmid_title_61": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_61": 12359817.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_62": 12351372.0, "pmid_date_62": 2002.0, "pmid_journal_62": "Blood"}, {"pmid_title_63": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_63": 12022425.0, "pmid_date_63": 2002.0, "pmid_journal_63": "J Trop Pediatr"}, {"pmid_title_64": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_64": 12142794.0, "pmid_date_64": 2002.0, "pmid_journal_64": "J Pediatr Hematol Oncol"}, {"pmid_title_65": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_65": 11313667.0, "pmid_date_65": 2001.0, "pmid_journal_65": "Bone Marrow Transplant"}, {"pmid_title_66": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_66": 11196268.0, "pmid_date_66": 2001.0, "pmid_journal_66": "J Pediatr Hematol Oncol"}, {"pmid_title_67": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_67": 11563769.0, "pmid_date_67": 2001.0, "pmid_journal_67": "J Pediatr Hematol Oncol"}, {"pmid_title_68": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_68": 10779036.0, "pmid_date_68": 2000.0, "pmid_journal_68": "J Pediatr Hematol Oncol"}, {"pmid_title_69": "Diamond-Blackfan anemia.", "pmid_69": 10698294.0, "pmid_date_69": 2000.0, "pmid_journal_69": "Curr Opin Hematol"}, {"pmid_title_70": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_70": 10673683.0, "pmid_date_70": 2000.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_71": 27263505.0, "pmid_date_71": 2000.0, "pmid_journal_71": "Turk J Haematol"}, {"pmid_title_72": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_72": 10714760.0, "pmid_date_72": 2000.0, "pmid_journal_72": "J Pediatr Endocrinol Metab"}, {"pmid_title_73": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_73": 10397110.0, "pmid_date_73": 1999.0, "pmid_journal_73": "AJR Am J Roentgenol"}, {"pmid_title_74": "Bone marrow transplantation in non-malignant disorders.", "pmid_74": 9916644.0, "pmid_date_74": 1998.0, "pmid_journal_74": "Bone Marrow Transplant"}, {"pmid_title_75": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_75": 8846147.0, "pmid_date_75": 1996.0, "pmid_journal_75": "J Pediatr Hematol Oncol"}, {"pmid_title_76": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_76": 8606629.0, "pmid_date_76": 1996.0, "pmid_journal_76": "Medicine (Baltimore)"}, {"pmid_title_77": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_77": 8625135.0, "pmid_date_77": 1995.0, "pmid_journal_77": "Cancer"}, {"pmid_title_78": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_78": 7691318.0, "pmid_date_78": 1993.0, "pmid_journal_78": "Stem Cells"}, {"pmid_title_79": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_79": 3109937.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Eur J Haematol"}, {"pmid_title_80": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_80": 13105384.0, "pmid_date_80": 1953.0, "pmid_journal_80": "Arch Dis Child"}]}, {"_id": "10327-OMIM:614900", "condition": {"condition_name": "DIAMOND-BLACKFAN ANEMIA 11", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["DIAMOND-BLACKFAN ANEMIA 11"]}, "gene information": {"db_hgnc_gene_id": 10327.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "Yes", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Methotrexate", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "No", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Fludarabine"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole", "timeframe_int54": "Hours,Days or Weeks,Years", "age_use_int54": "Neonate,Infant,Child", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Effective / Ameliorative"}, {"int_description_55": "Cisplatin"}, {"int_description_56": "Muplestim"}, {"int_description_57": "Filgrastim", "timeframe_int57": "Days or Weeks,Years", "age_use_int57": "Infant,Child", "contra_int57": "No", "qualscale_reclass_drug57": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug57": "Curative"}, {"int_description_58": "Total body irradiation"}, {"int_description_59": "Radiotherapy"}, {"int_description_60": "red blood cells transfusion"}, {"int_description_61": "Thoracoabdominal irradiation"}, {"int_description_62": "Total lymphoid irradiation"}, {"int_description_63": "Above-knee amputation"}, {"int_description_64": "Bone marrow transplantation"}, {"int_description_65": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_66": "laparotomy, tumor dissection"}, {"int_description_67": "limb-salvage surgery"}, {"int_description_68": "Maxillectomy"}, {"int_description_69": "umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "How I manage children with Diamond-Blackfan anaemia.", "pmid_2": 30515771.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_3": 31916719.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Turk J Pediatr"}, {"pmid_title_4": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_4": 31355022.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Case Rep Hematol"}, {"pmid_title_5": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_5": 30811439.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PLoS One"}, {"pmid_title_6": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_6": 30881276.0, "pmid_date_6": 2019.0, "pmid_journal_6": "EJIFCC"}, {"pmid_title_7": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_7": 31208452.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Med Case Rep"}, {"pmid_title_8": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_8": 31574871.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_9": 30411682.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Curr Gene Ther"}, {"pmid_title_10": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_10": 29222242.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_11": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_11": 28623394.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Ann Hematol"}, {"pmid_title_12": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_12": 27882484.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Int J Hematol"}, {"pmid_title_13": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_13": 27537786.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Eur J Haematol"}, {"pmid_title_14": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_14": 28602958.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_15": 27082377.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Blood Cancer"}, {"pmid_title_16": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_16": 26872907.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Int J Hematol"}, {"pmid_title_17": "Pure red cell aplasia.", "pmid_17": 27881371.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Pure red cell aplasia.", "pmid_18": 27913462.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_19": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_19": 27329125.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Int J Hematol"}, {"pmid_title_20": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_20": 26496000.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_21": 25492299.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_22": 25963299.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Am J Hematol"}, {"pmid_title_23": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_23": 24611452.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_24": 24296492.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Biol Blood Marrow Transplant"}, {"pmid_title_25": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_25": 23795277.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Mediterr J Hematol Infect Dis"}, {"pmid_title_26": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_26": 22619618.0, "pmid_date_26": 2012.0, "pmid_journal_26": "ScientificWorldJournal"}, {"pmid_title_27": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_27": 23016900.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Br J Haematol"}, {"pmid_title_28": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_28": 24744655.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Turk J Haematol"}, {"pmid_title_29": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_29": 21062271.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Clin Exp Immunol"}, {"pmid_title_30": "How I treat Diamond-Blackfan anemia.", "pmid_30": 20651069.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Blood"}, {"pmid_title_31": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_31": 20655265.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Transfus Clin Biol"}, {"pmid_title_32": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_32": 20190482.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Intern Med"}, {"pmid_title_33": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_33": 19415275.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Ann Hematol"}, {"pmid_title_34": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_34": 18164793.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_35": 18671700.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Br J Haematol"}, {"pmid_title_36": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_36": 18028431.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Eur J Haematol"}, {"pmid_title_37": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_37": 18776763.0, "pmid_date_37": 2008.0, "pmid_journal_37": "J Pediatr Hematol Oncol"}, {"pmid_title_38": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_38": 18331650.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_39": "Deferasirox.", "pmid_39": 17353569.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Am J Health Syst Pharm"}, {"pmid_title_40": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_40": 17414568.0, "pmid_date_40": 2007.0, "pmid_journal_40": "J Pediatr Hematol Oncol"}, {"pmid_title_41": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_41": 17663681.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_42": 17562599.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Haematologica"}, {"pmid_title_43": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_43": 17312003.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Blood"}, {"pmid_title_44": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_44": 17921858.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_45": 16679921.0, "pmid_date_45": 2006.0, "pmid_journal_45": "J Pediatr Hematol Oncol"}, {"pmid_title_46": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_46": 17325961.0, "pmid_date_46": 2006.0, "pmid_journal_46": "Hematology"}, {"pmid_title_47": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_47": 16317735.0, "pmid_date_47": 2006.0, "pmid_journal_47": "Pediatr Blood Cancer"}, {"pmid_title_48": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_48": 16785135.0, "pmid_date_48": 2006.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_49": 16304857.0, "pmid_date_49": 2005.0, "pmid_journal_49": "J Pak Med Assoc"}, {"pmid_title_50": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_50": 16291361.0, "pmid_date_50": 2005.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_51": 15692602.0, "pmid_date_51": 2005.0, "pmid_journal_51": "Hematol J"}, {"pmid_title_52": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_52": 16041310.0, "pmid_date_52": 2005.0, "pmid_journal_52": "Biol Blood Marrow Transplant"}, {"pmid_title_53": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_53": 15813920.0, "pmid_date_53": 2005.0, "pmid_journal_53": "Eur J Haematol"}, {"pmid_title_54": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_54": 15795909.0, "pmid_date_54": 2005.0, "pmid_journal_54": "Am J Hematol"}, {"pmid_title_55": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_55": 14984172.0, "pmid_date_55": 2004.0, "pmid_journal_55": "J Trop Pediatr"}, {"pmid_title_56": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_56": 15220956.0, "pmid_date_56": 2004.0, "pmid_journal_56": "Bone Marrow Transplant"}, {"pmid_title_57": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_57": 14979474.0, "pmid_date_57": 2004.0, "pmid_journal_57": "Int J Hematol"}, {"pmid_title_58": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_58": 15382270.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatr Blood Cancer"}, {"pmid_title_59": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_59": 18521394.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Sarcoma"}, {"pmid_title_60": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_60": 14608205.0, "pmid_date_60": 2003.0, "pmid_journal_60": "J Pediatr Hematol Oncol"}, {"pmid_title_61": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_61": 12359817.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_62": 12351372.0, "pmid_date_62": 2002.0, "pmid_journal_62": "Blood"}, {"pmid_title_63": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_63": 12022425.0, "pmid_date_63": 2002.0, "pmid_journal_63": "J Trop Pediatr"}, {"pmid_title_64": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_64": 12142794.0, "pmid_date_64": 2002.0, "pmid_journal_64": "J Pediatr Hematol Oncol"}, {"pmid_title_65": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_65": 11313667.0, "pmid_date_65": 2001.0, "pmid_journal_65": "Bone Marrow Transplant"}, {"pmid_title_66": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_66": 11196268.0, "pmid_date_66": 2001.0, "pmid_journal_66": "J Pediatr Hematol Oncol"}, {"pmid_title_67": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_67": 11563769.0, "pmid_date_67": 2001.0, "pmid_journal_67": "J Pediatr Hematol Oncol"}, {"pmid_title_68": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_68": 10779036.0, "pmid_date_68": 2000.0, "pmid_journal_68": "J Pediatr Hematol Oncol"}, {"pmid_title_69": "Diamond-Blackfan anemia.", "pmid_69": 10698294.0, "pmid_date_69": 2000.0, "pmid_journal_69": "Curr Opin Hematol"}, {"pmid_title_70": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_70": 10673683.0, "pmid_date_70": 2000.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_71": 27263505.0, "pmid_date_71": 2000.0, "pmid_journal_71": "Turk J Haematol"}, {"pmid_title_72": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_72": 10714760.0, "pmid_date_72": 2000.0, "pmid_journal_72": "J Pediatr Endocrinol Metab"}, {"pmid_title_73": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_73": 10397110.0, "pmid_date_73": 1999.0, "pmid_journal_73": "AJR Am J Roentgenol"}, {"pmid_title_74": "Bone marrow transplantation in non-malignant disorders.", "pmid_74": 9916644.0, "pmid_date_74": 1998.0, "pmid_journal_74": "Bone Marrow Transplant"}, {"pmid_title_75": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_75": 8846147.0, "pmid_date_75": 1996.0, "pmid_journal_75": "J Pediatr Hematol Oncol"}, {"pmid_title_76": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_76": 8606629.0, "pmid_date_76": 1996.0, "pmid_journal_76": "Medicine (Baltimore)"}, {"pmid_title_77": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_77": 8625135.0, "pmid_date_77": 1995.0, "pmid_journal_77": "Cancer"}, {"pmid_title_78": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_78": 7691318.0, "pmid_date_78": 1993.0, "pmid_journal_78": "Stem Cells"}, {"pmid_title_79": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_79": 3109937.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Eur J Haematol"}, {"pmid_title_80": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_80": 13105384.0, "pmid_date_80": 1953.0, "pmid_journal_80": "Arch Dis Child"}]}, {"_id": "10328-OMIM:617408", "condition": {"condition_name": "DIAMOND-BLACKFAN ANEMIA 16", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["DIAMOND-BLACKFAN ANEMIA 16"]}, "gene information": {"db_hgnc_gene_id": 10328.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "Yes", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Methotrexate", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Fludarabine"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole", "timeframe_int54": "Hours,Days or Weeks,Years", "age_use_int54": "Neonate,Infant,Child", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Effective / Ameliorative"}, {"int_description_55": "Cisplatin"}, {"int_description_56": "Muplestim"}, {"int_description_57": "Filgrastim", "timeframe_int57": "Days or Weeks,Years", "age_use_int57": "Infant,Child", "contra_int57": "No", "qualscale_reclass_drug57": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug57": "Curative"}, {"int_description_58": "Total body irradiation"}, {"int_description_59": "Radiotherapy"}, {"int_description_60": "red blood cells transfusion"}, {"int_description_61": "Thoracoabdominal irradiation"}, {"int_description_62": "Total lymphoid irradiation"}, {"int_description_63": "Above-knee amputation"}, {"int_description_64": "Bone marrow transplantation"}, {"int_description_65": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_66": "laparotomy, tumor dissection"}, {"int_description_67": "limb-salvage surgery"}, {"int_description_68": "Maxillectomy"}, {"int_description_69": "umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "How I manage children with Diamond-Blackfan anaemia.", "pmid_2": 30515771.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_3": 31916719.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Turk J Pediatr"}, {"pmid_title_4": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_4": 31355022.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Case Rep Hematol"}, {"pmid_title_5": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_5": 30811439.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PLoS One"}, {"pmid_title_6": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_6": 30881276.0, "pmid_date_6": 2019.0, "pmid_journal_6": "EJIFCC"}, {"pmid_title_7": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_7": 31208452.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Med Case Rep"}, {"pmid_title_8": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_8": 31574871.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_9": 30411682.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Curr Gene Ther"}, {"pmid_title_10": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_10": 29222242.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_11": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_11": 28623394.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Ann Hematol"}, {"pmid_title_12": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_12": 27882484.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Int J Hematol"}, {"pmid_title_13": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_13": 27537786.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Eur J Haematol"}, {"pmid_title_14": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_14": 28602958.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_15": 27082377.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Blood Cancer"}, {"pmid_title_16": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_16": 26872907.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Int J Hematol"}, {"pmid_title_17": "Pure red cell aplasia.", "pmid_17": 27881371.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Pure red cell aplasia.", "pmid_18": 27913462.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_19": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_19": 27329125.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Int J Hematol"}, {"pmid_title_20": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_20": 26496000.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_21": 25492299.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_22": 25963299.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Am J Hematol"}, {"pmid_title_23": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_23": 24611452.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_24": 24296492.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Biol Blood Marrow Transplant"}, {"pmid_title_25": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_25": 23795277.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Mediterr J Hematol Infect Dis"}, {"pmid_title_26": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_26": 22619618.0, "pmid_date_26": 2012.0, "pmid_journal_26": "ScientificWorldJournal"}, {"pmid_title_27": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_27": 23016900.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Br J Haematol"}, {"pmid_title_28": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_28": 24744655.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Turk J Haematol"}, {"pmid_title_29": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_29": 21062271.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Clin Exp Immunol"}, {"pmid_title_30": "How I treat Diamond-Blackfan anemia.", "pmid_30": 20651069.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Blood"}, {"pmid_title_31": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_31": 20655265.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Transfus Clin Biol"}, {"pmid_title_32": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_32": 20190482.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Intern Med"}, {"pmid_title_33": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_33": 19415275.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Ann Hematol"}, {"pmid_title_34": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_34": 18164793.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_35": 18671700.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Br J Haematol"}, {"pmid_title_36": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_36": 18028431.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Eur J Haematol"}, {"pmid_title_37": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_37": 18776763.0, "pmid_date_37": 2008.0, "pmid_journal_37": "J Pediatr Hematol Oncol"}, {"pmid_title_38": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_38": 18331650.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_39": "Deferasirox.", "pmid_39": 17353569.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Am J Health Syst Pharm"}, {"pmid_title_40": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_40": 17414568.0, "pmid_date_40": 2007.0, "pmid_journal_40": "J Pediatr Hematol Oncol"}, {"pmid_title_41": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_41": 17663681.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_42": 17562599.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Haematologica"}, {"pmid_title_43": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_43": 17312003.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Blood"}, {"pmid_title_44": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_44": 17921858.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_45": 16679921.0, "pmid_date_45": 2006.0, "pmid_journal_45": "J Pediatr Hematol Oncol"}, {"pmid_title_46": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_46": 17325961.0, "pmid_date_46": 2006.0, "pmid_journal_46": "Hematology"}, {"pmid_title_47": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_47": 16317735.0, "pmid_date_47": 2006.0, "pmid_journal_47": "Pediatr Blood Cancer"}, {"pmid_title_48": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_48": 16785135.0, "pmid_date_48": 2006.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_49": 16304857.0, "pmid_date_49": 2005.0, "pmid_journal_49": "J Pak Med Assoc"}, {"pmid_title_50": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_50": 16291361.0, "pmid_date_50": 2005.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_51": 15692602.0, "pmid_date_51": 2005.0, "pmid_journal_51": "Hematol J"}, {"pmid_title_52": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_52": 16041310.0, "pmid_date_52": 2005.0, "pmid_journal_52": "Biol Blood Marrow Transplant"}, {"pmid_title_53": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_53": 15813920.0, "pmid_date_53": 2005.0, "pmid_journal_53": "Eur J Haematol"}, {"pmid_title_54": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_54": 15795909.0, "pmid_date_54": 2005.0, "pmid_journal_54": "Am J Hematol"}, {"pmid_title_55": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_55": 14984172.0, "pmid_date_55": 2004.0, "pmid_journal_55": "J Trop Pediatr"}, {"pmid_title_56": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_56": 15220956.0, "pmid_date_56": 2004.0, "pmid_journal_56": "Bone Marrow Transplant"}, {"pmid_title_57": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_57": 14979474.0, "pmid_date_57": 2004.0, "pmid_journal_57": "Int J Hematol"}, {"pmid_title_58": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_58": 15382270.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatr Blood Cancer"}, {"pmid_title_59": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_59": 18521394.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Sarcoma"}, {"pmid_title_60": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_60": 14608205.0, "pmid_date_60": 2003.0, "pmid_journal_60": "J Pediatr Hematol Oncol"}, {"pmid_title_61": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_61": 12359817.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_62": 12351372.0, "pmid_date_62": 2002.0, "pmid_journal_62": "Blood"}, {"pmid_title_63": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_63": 12022425.0, "pmid_date_63": 2002.0, "pmid_journal_63": "J Trop Pediatr"}, {"pmid_title_64": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_64": 12142794.0, "pmid_date_64": 2002.0, "pmid_journal_64": "J Pediatr Hematol Oncol"}, {"pmid_title_65": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_65": 11313667.0, "pmid_date_65": 2001.0, "pmid_journal_65": "Bone Marrow Transplant"}, {"pmid_title_66": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_66": 11196268.0, "pmid_date_66": 2001.0, "pmid_journal_66": "J Pediatr Hematol Oncol"}, {"pmid_title_67": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_67": 11563769.0, "pmid_date_67": 2001.0, "pmid_journal_67": "J Pediatr Hematol Oncol"}, {"pmid_title_68": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_68": 10779036.0, "pmid_date_68": 2000.0, "pmid_journal_68": "J Pediatr Hematol Oncol"}, {"pmid_title_69": "Diamond-Blackfan anemia.", "pmid_69": 10698294.0, "pmid_date_69": 2000.0, "pmid_journal_69": "Curr Opin Hematol"}, {"pmid_title_70": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_70": 10673683.0, "pmid_date_70": 2000.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_71": 27263505.0, "pmid_date_71": 2000.0, "pmid_journal_71": "Turk J Haematol"}, {"pmid_title_72": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_72": 10714760.0, "pmid_date_72": 2000.0, "pmid_journal_72": "J Pediatr Endocrinol Metab"}, {"pmid_title_73": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_73": 10397110.0, "pmid_date_73": 1999.0, "pmid_journal_73": "AJR Am J Roentgenol"}, {"pmid_title_74": "Bone marrow transplantation in non-malignant disorders.", "pmid_74": 9916644.0, "pmid_date_74": 1998.0, "pmid_journal_74": "Bone Marrow Transplant"}, {"pmid_title_75": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_75": 8846147.0, "pmid_date_75": 1996.0, "pmid_journal_75": "J Pediatr Hematol Oncol"}, {"pmid_title_76": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_76": 8606629.0, "pmid_date_76": 1996.0, "pmid_journal_76": "Medicine (Baltimore)"}, {"pmid_title_77": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_77": 8625135.0, "pmid_date_77": 1995.0, "pmid_journal_77": "Cancer"}, {"pmid_title_78": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_78": 7691318.0, "pmid_date_78": 1993.0, "pmid_journal_78": "Stem Cells"}, {"pmid_title_79": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_79": 3109937.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Eur J Haematol"}, {"pmid_title_80": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_80": 13105384.0, "pmid_date_80": 1953.0, "pmid_journal_80": "Arch Dis Child"}]}, {"_id": "10344-OMIM:618312", "condition": {"condition_name": "DIAMOND-BLACKFAN ANEMIA 19", "alternate_names": ["DIAMOND-BLACKFAN ANEMIA 19"]}, "gene information": {"db_hgnc_gene_id": 10344.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "Yes", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Methotrexate", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Fludarabine"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole", "timeframe_int54": "Hours,Days or Weeks,Years", "age_use_int54": "Neonate,Infant,Child", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Effective / Ameliorative"}, {"int_description_55": "Cisplatin"}, {"int_description_56": "Muplestim"}, {"int_description_57": "Filgrastim", "timeframe_int57": "Days or Weeks,Years", "age_use_int57": "Infant,Child", "contra_int57": "No", "qualscale_reclass_drug57": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug57": "Curative"}, {"int_description_58": "Total body irradiation"}, {"int_description_59": "Radiotherapy"}, {"int_description_60": "red blood cells transfusion"}, {"int_description_61": "Thoracoabdominal irradiation"}, {"int_description_62": "Total lymphoid irradiation"}, {"int_description_63": "Above-knee amputation"}, {"int_description_64": "Bone marrow transplantation"}, {"int_description_65": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_66": "laparotomy, tumor dissection"}, {"int_description_67": "limb-salvage surgery"}, {"int_description_68": "Maxillectomy"}, {"int_description_69": "umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "How I manage children with Diamond-Blackfan anaemia.", "pmid_2": 30515771.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_3": 31916719.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Turk J Pediatr"}, {"pmid_title_4": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_4": 31355022.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Case Rep Hematol"}, {"pmid_title_5": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_5": 30811439.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PLoS One"}, {"pmid_title_6": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_6": 30881276.0, "pmid_date_6": 2019.0, "pmid_journal_6": "EJIFCC"}, {"pmid_title_7": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_7": 31208452.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Med Case Rep"}, {"pmid_title_8": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_8": 31574871.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_9": 30411682.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Curr Gene Ther"}, {"pmid_title_10": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_10": 29222242.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_11": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_11": 28623394.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Ann Hematol"}, {"pmid_title_12": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_12": 27882484.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Int J Hematol"}, {"pmid_title_13": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_13": 27537786.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Eur J Haematol"}, {"pmid_title_14": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_14": 28602958.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_15": 27082377.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Blood Cancer"}, {"pmid_title_16": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_16": 26872907.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Int J Hematol"}, {"pmid_title_17": "Pure red cell aplasia.", "pmid_17": 27881371.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Pure red cell aplasia.", "pmid_18": 27913462.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_19": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_19": 27329125.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Int J Hematol"}, {"pmid_title_20": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_20": 26496000.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_21": 25492299.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_22": 25963299.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Am J Hematol"}, {"pmid_title_23": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_23": 24611452.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_24": 24296492.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Biol Blood Marrow Transplant"}, {"pmid_title_25": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_25": 23795277.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Mediterr J Hematol Infect Dis"}, {"pmid_title_26": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_26": 22619618.0, "pmid_date_26": 2012.0, "pmid_journal_26": "ScientificWorldJournal"}, {"pmid_title_27": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_27": 23016900.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Br J Haematol"}, {"pmid_title_28": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_28": 24744655.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Turk J Haematol"}, {"pmid_title_29": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_29": 21062271.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Clin Exp Immunol"}, {"pmid_title_30": "How I treat Diamond-Blackfan anemia.", "pmid_30": 20651069.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Blood"}, {"pmid_title_31": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_31": 20655265.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Transfus Clin Biol"}, {"pmid_title_32": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_32": 20190482.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Intern Med"}, {"pmid_title_33": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_33": 19415275.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Ann Hematol"}, {"pmid_title_34": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_34": 18164793.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_35": 18671700.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Br J Haematol"}, {"pmid_title_36": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_36": 18028431.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Eur J Haematol"}, {"pmid_title_37": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_37": 18776763.0, "pmid_date_37": 2008.0, "pmid_journal_37": "J Pediatr Hematol Oncol"}, {"pmid_title_38": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_38": 18331650.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_39": "Deferasirox.", "pmid_39": 17353569.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Am J Health Syst Pharm"}, {"pmid_title_40": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_40": 17414568.0, "pmid_date_40": 2007.0, "pmid_journal_40": "J Pediatr Hematol Oncol"}, {"pmid_title_41": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_41": 17663681.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_42": 17562599.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Haematologica"}, {"pmid_title_43": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_43": 17312003.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Blood"}, {"pmid_title_44": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_44": 17921858.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_45": 16679921.0, "pmid_date_45": 2006.0, "pmid_journal_45": "J Pediatr Hematol Oncol"}, {"pmid_title_46": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_46": 17325961.0, "pmid_date_46": 2006.0, "pmid_journal_46": "Hematology"}, {"pmid_title_47": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_47": 16317735.0, "pmid_date_47": 2006.0, "pmid_journal_47": "Pediatr Blood Cancer"}, {"pmid_title_48": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_48": 16785135.0, "pmid_date_48": 2006.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_49": 16304857.0, "pmid_date_49": 2005.0, "pmid_journal_49": "J Pak Med Assoc"}, {"pmid_title_50": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_50": 16291361.0, "pmid_date_50": 2005.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_51": 15692602.0, "pmid_date_51": 2005.0, "pmid_journal_51": "Hematol J"}, {"pmid_title_52": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_52": 16041310.0, "pmid_date_52": 2005.0, "pmid_journal_52": "Biol Blood Marrow Transplant"}, {"pmid_title_53": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_53": 15813920.0, "pmid_date_53": 2005.0, "pmid_journal_53": "Eur J Haematol"}, {"pmid_title_54": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_54": 15795909.0, "pmid_date_54": 2005.0, "pmid_journal_54": "Am J Hematol"}, {"pmid_title_55": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_55": 14984172.0, "pmid_date_55": 2004.0, "pmid_journal_55": "J Trop Pediatr"}, {"pmid_title_56": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_56": 15220956.0, "pmid_date_56": 2004.0, "pmid_journal_56": "Bone Marrow Transplant"}, {"pmid_title_57": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_57": 14979474.0, "pmid_date_57": 2004.0, "pmid_journal_57": "Int J Hematol"}, {"pmid_title_58": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_58": 15382270.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatr Blood Cancer"}, {"pmid_title_59": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_59": 18521394.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Sarcoma"}, {"pmid_title_60": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_60": 14608205.0, "pmid_date_60": 2003.0, "pmid_journal_60": "J Pediatr Hematol Oncol"}, {"pmid_title_61": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_61": 12359817.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_62": 12351372.0, "pmid_date_62": 2002.0, "pmid_journal_62": "Blood"}, {"pmid_title_63": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_63": 12022425.0, "pmid_date_63": 2002.0, "pmid_journal_63": "J Trop Pediatr"}, {"pmid_title_64": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_64": 12142794.0, "pmid_date_64": 2002.0, "pmid_journal_64": "J Pediatr Hematol Oncol"}, {"pmid_title_65": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_65": 11313667.0, "pmid_date_65": 2001.0, "pmid_journal_65": "Bone Marrow Transplant"}, {"pmid_title_66": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_66": 11196268.0, "pmid_date_66": 2001.0, "pmid_journal_66": "J Pediatr Hematol Oncol"}, {"pmid_title_67": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_67": 11563769.0, "pmid_date_67": 2001.0, "pmid_journal_67": "J Pediatr Hematol Oncol"}, {"pmid_title_68": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_68": 10779036.0, "pmid_date_68": 2000.0, "pmid_journal_68": "J Pediatr Hematol Oncol"}, {"pmid_title_69": "Diamond-Blackfan anemia.", "pmid_69": 10698294.0, "pmid_date_69": 2000.0, "pmid_journal_69": "Curr Opin Hematol"}, {"pmid_title_70": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_70": 10673683.0, "pmid_date_70": 2000.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_71": 27263505.0, "pmid_date_71": 2000.0, "pmid_journal_71": "Turk J Haematol"}, {"pmid_title_72": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_72": 10714760.0, "pmid_date_72": 2000.0, "pmid_journal_72": "J Pediatr Endocrinol Metab"}, {"pmid_title_73": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_73": 10397110.0, "pmid_date_73": 1999.0, "pmid_journal_73": "AJR Am J Roentgenol"}, {"pmid_title_74": "Bone marrow transplantation in non-malignant disorders.", "pmid_74": 9916644.0, "pmid_date_74": 1998.0, "pmid_journal_74": "Bone Marrow Transplant"}, {"pmid_title_75": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_75": 8846147.0, "pmid_date_75": 1996.0, "pmid_journal_75": "J Pediatr Hematol Oncol"}, {"pmid_title_76": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_76": 8606629.0, "pmid_date_76": 1996.0, "pmid_journal_76": "Medicine (Baltimore)"}, {"pmid_title_77": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_77": 8625135.0, "pmid_date_77": 1995.0, "pmid_journal_77": "Cancer"}, {"pmid_title_78": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_78": 7691318.0, "pmid_date_78": 1993.0, "pmid_journal_78": "Stem Cells"}, {"pmid_title_79": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_79": 3109937.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Eur J Haematol"}, {"pmid_title_80": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_80": 13105384.0, "pmid_date_80": 1953.0, "pmid_journal_80": "Arch Dis Child"}]}, {"_id": "10345-OMIM:612528", "condition": {"condition_name": "DIAMOND-BLACKFAN ANEMIA 5", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["DIAMOND-BLACKFAN ANEMIA 5"]}, "gene information": {"db_hgnc_gene_id": 10345.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "Yes", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Methotrexate", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Fludarabine"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole", "timeframe_int54": "Hours,Days or Weeks,Years", "age_use_int54": "Neonate,Infant,Child", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Effective / Ameliorative"}, {"int_description_55": "Cisplatin"}, {"int_description_56": "Muplestim"}, {"int_description_57": "Filgrastim", "timeframe_int57": "Days or Weeks,Years", "age_use_int57": "Infant,Child", "contra_int57": "No", "qualscale_reclass_drug57": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug57": "Curative"}, {"int_description_58": "Total body irradiation"}, {"int_description_59": "Radiotherapy"}, {"int_description_60": "red blood cells transfusion"}, {"int_description_61": "Thoracoabdominal irradiation"}, {"int_description_62": "Total lymphoid irradiation"}, {"int_description_63": "Above-knee amputation"}, {"int_description_64": "Bone marrow transplantation"}, {"int_description_65": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_66": "laparotomy, tumor dissection"}, {"int_description_67": "limb-salvage surgery"}, {"int_description_68": "Maxillectomy"}, {"int_description_69": "umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "How I manage children with Diamond-Blackfan anaemia.", "pmid_2": 30515771.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_3": 31916719.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Turk J Pediatr"}, {"pmid_title_4": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_4": 31355022.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Case Rep Hematol"}, {"pmid_title_5": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_5": 30811439.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PLoS One"}, {"pmid_title_6": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_6": 30881276.0, "pmid_date_6": 2019.0, "pmid_journal_6": "EJIFCC"}, {"pmid_title_7": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_7": 31208452.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Med Case Rep"}, {"pmid_title_8": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_8": 31574871.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_9": 30411682.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Curr Gene Ther"}, {"pmid_title_10": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_10": 29222242.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_11": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_11": 28623394.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Ann Hematol"}, {"pmid_title_12": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_12": 27882484.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Int J Hematol"}, {"pmid_title_13": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_13": 27537786.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Eur J Haematol"}, {"pmid_title_14": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_14": 28602958.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_15": 27082377.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Blood Cancer"}, {"pmid_title_16": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_16": 26872907.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Int J Hematol"}, {"pmid_title_17": "Pure red cell aplasia.", "pmid_17": 27881371.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Pure red cell aplasia.", "pmid_18": 27913462.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_19": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_19": 27329125.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Int J Hematol"}, {"pmid_title_20": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_20": 26496000.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_21": 25492299.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_22": 25963299.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Am J Hematol"}, {"pmid_title_23": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_23": 24611452.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_24": 24296492.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Biol Blood Marrow Transplant"}, {"pmid_title_25": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_25": 23795277.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Mediterr J Hematol Infect Dis"}, {"pmid_title_26": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_26": 22619618.0, "pmid_date_26": 2012.0, "pmid_journal_26": "ScientificWorldJournal"}, {"pmid_title_27": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_27": 23016900.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Br J Haematol"}, {"pmid_title_28": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_28": 24744655.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Turk J Haematol"}, {"pmid_title_29": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_29": 21062271.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Clin Exp Immunol"}, {"pmid_title_30": "How I treat Diamond-Blackfan anemia.", "pmid_30": 20651069.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Blood"}, {"pmid_title_31": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_31": 20655265.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Transfus Clin Biol"}, {"pmid_title_32": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_32": 20190482.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Intern Med"}, {"pmid_title_33": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_33": 19415275.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Ann Hematol"}, {"pmid_title_34": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_34": 18164793.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_35": 18671700.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Br J Haematol"}, {"pmid_title_36": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_36": 18028431.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Eur J Haematol"}, {"pmid_title_37": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_37": 18776763.0, "pmid_date_37": 2008.0, "pmid_journal_37": "J Pediatr Hematol Oncol"}, {"pmid_title_38": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_38": 18331650.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_39": "Deferasirox.", "pmid_39": 17353569.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Am J Health Syst Pharm"}, {"pmid_title_40": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_40": 17414568.0, "pmid_date_40": 2007.0, "pmid_journal_40": "J Pediatr Hematol Oncol"}, {"pmid_title_41": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_41": 17663681.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_42": 17562599.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Haematologica"}, {"pmid_title_43": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_43": 17312003.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Blood"}, {"pmid_title_44": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_44": 17921858.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_45": 16679921.0, "pmid_date_45": 2006.0, "pmid_journal_45": "J Pediatr Hematol Oncol"}, {"pmid_title_46": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_46": 17325961.0, "pmid_date_46": 2006.0, "pmid_journal_46": "Hematology"}, {"pmid_title_47": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_47": 16317735.0, "pmid_date_47": 2006.0, "pmid_journal_47": "Pediatr Blood Cancer"}, {"pmid_title_48": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_48": 16785135.0, "pmid_date_48": 2006.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_49": 16304857.0, "pmid_date_49": 2005.0, "pmid_journal_49": "J Pak Med Assoc"}, {"pmid_title_50": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_50": 16291361.0, "pmid_date_50": 2005.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_51": 15692602.0, "pmid_date_51": 2005.0, "pmid_journal_51": "Hematol J"}, {"pmid_title_52": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_52": 16041310.0, "pmid_date_52": 2005.0, "pmid_journal_52": "Biol Blood Marrow Transplant"}, {"pmid_title_53": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_53": 15813920.0, "pmid_date_53": 2005.0, "pmid_journal_53": "Eur J Haematol"}, {"pmid_title_54": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_54": 15795909.0, "pmid_date_54": 2005.0, "pmid_journal_54": "Am J Hematol"}, {"pmid_title_55": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_55": 14984172.0, "pmid_date_55": 2004.0, "pmid_journal_55": "J Trop Pediatr"}, {"pmid_title_56": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_56": 15220956.0, "pmid_date_56": 2004.0, "pmid_journal_56": "Bone Marrow Transplant"}, {"pmid_title_57": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_57": 14979474.0, "pmid_date_57": 2004.0, "pmid_journal_57": "Int J Hematol"}, {"pmid_title_58": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_58": 15382270.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatr Blood Cancer"}, {"pmid_title_59": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_59": 18521394.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Sarcoma"}, {"pmid_title_60": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_60": 14608205.0, "pmid_date_60": 2003.0, "pmid_journal_60": "J Pediatr Hematol Oncol"}, {"pmid_title_61": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_61": 12359817.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_62": 12351372.0, "pmid_date_62": 2002.0, "pmid_journal_62": "Blood"}, {"pmid_title_63": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_63": 12022425.0, "pmid_date_63": 2002.0, "pmid_journal_63": "J Trop Pediatr"}, {"pmid_title_64": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_64": 12142794.0, "pmid_date_64": 2002.0, "pmid_journal_64": "J Pediatr Hematol Oncol"}, {"pmid_title_65": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_65": 11313667.0, "pmid_date_65": 2001.0, "pmid_journal_65": "Bone Marrow Transplant"}, {"pmid_title_66": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_66": 11196268.0, "pmid_date_66": 2001.0, "pmid_journal_66": "J Pediatr Hematol Oncol"}, {"pmid_title_67": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_67": 11563769.0, "pmid_date_67": 2001.0, "pmid_journal_67": "J Pediatr Hematol Oncol"}, {"pmid_title_68": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_68": 10779036.0, "pmid_date_68": 2000.0, "pmid_journal_68": "J Pediatr Hematol Oncol"}, {"pmid_title_69": "Diamond-Blackfan anemia.", "pmid_69": 10698294.0, "pmid_date_69": 2000.0, "pmid_journal_69": "Curr Opin Hematol"}, {"pmid_title_70": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_70": 10673683.0, "pmid_date_70": 2000.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_71": 27263505.0, "pmid_date_71": 2000.0, "pmid_journal_71": "Turk J Haematol"}, {"pmid_title_72": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_72": 10714760.0, "pmid_date_72": 2000.0, "pmid_journal_72": "J Pediatr Endocrinol Metab"}, {"pmid_title_73": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_73": 10397110.0, "pmid_date_73": 1999.0, "pmid_journal_73": "AJR Am J Roentgenol"}, {"pmid_title_74": "Bone marrow transplantation in non-malignant disorders.", "pmid_74": 9916644.0, "pmid_date_74": 1998.0, "pmid_journal_74": "Bone Marrow Transplant"}, {"pmid_title_75": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_75": 8846147.0, "pmid_date_75": 1996.0, "pmid_journal_75": "J Pediatr Hematol Oncol"}, {"pmid_title_76": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_76": 8606629.0, "pmid_date_76": 1996.0, "pmid_journal_76": "Medicine (Baltimore)"}, {"pmid_title_77": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_77": 8625135.0, "pmid_date_77": 1995.0, "pmid_journal_77": "Cancer"}, {"pmid_title_78": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_78": 7691318.0, "pmid_date_78": 1993.0, "pmid_journal_78": "Stem Cells"}, {"pmid_title_79": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_79": 3109937.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Eur J Haematol"}, {"pmid_title_80": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_80": 13105384.0, "pmid_date_80": 1953.0, "pmid_journal_80": "Arch Dis Child"}]}, {"_id": "10360-OMIM:612561", "condition": {"condition_name": "DIAMOND-BLACKFAN ANEMIA 6", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["DIAMOND-BLACKFAN ANEMIA 6"]}, "gene information": {"db_hgnc_gene_id": 10360.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Hours,Days or Weeks,Years", "age_use_int31": "Infant,Child", "contra_int31": "Yes", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Methotrexate", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Fludarabine"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole", "timeframe_int54": "Hours,Days or Weeks,Years", "age_use_int54": "Neonate,Infant,Child", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Effective / Ameliorative"}, {"int_description_55": "Cisplatin"}, {"int_description_56": "Muplestim"}, {"int_description_57": "Filgrastim", "timeframe_int57": "Days or Weeks,Years", "age_use_int57": "Infant,Child", "contra_int57": "No", "qualscale_reclass_drug57": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug57": "Curative"}, {"int_description_58": "Total body irradiation"}, {"int_description_59": "Radiotherapy"}, {"int_description_60": "red blood cells transfusion"}, {"int_description_61": "Thoracoabdominal irradiation"}, {"int_description_62": "Total lymphoid irradiation"}, {"int_description_63": "Above-knee amputation"}, {"int_description_64": "Bone marrow transplantation"}, {"int_description_65": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_66": "laparotomy, tumor dissection"}, {"int_description_67": "limb-salvage surgery"}, {"int_description_68": "Maxillectomy"}, {"int_description_69": "umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "How I manage children with Diamond-Blackfan anaemia.", "pmid_2": 30515771.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_3": 31916719.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Turk J Pediatr"}, {"pmid_title_4": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_4": 31355022.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Case Rep Hematol"}, {"pmid_title_5": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_5": 30811439.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PLoS One"}, {"pmid_title_6": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_6": 30881276.0, "pmid_date_6": 2019.0, "pmid_journal_6": "EJIFCC"}, {"pmid_title_7": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_7": 31208452.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Med Case Rep"}, {"pmid_title_8": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_8": 31574871.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_9": 30411682.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Curr Gene Ther"}, {"pmid_title_10": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_10": 29222242.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_11": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_11": 28623394.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Ann Hematol"}, {"pmid_title_12": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_12": 27882484.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Int J Hematol"}, {"pmid_title_13": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_13": 27537786.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Eur J Haematol"}, {"pmid_title_14": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_14": 28602958.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_15": 27082377.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Blood Cancer"}, {"pmid_title_16": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_16": 26872907.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Int J Hematol"}, {"pmid_title_17": "Pure red cell aplasia.", "pmid_17": 27881371.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Pure red cell aplasia.", "pmid_18": 27913462.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_19": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_19": 27329125.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Int J Hematol"}, {"pmid_title_20": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_20": 26496000.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_21": 25492299.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_22": 25963299.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Am J Hematol"}, {"pmid_title_23": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_23": 24611452.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_24": 24296492.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Biol Blood Marrow Transplant"}, {"pmid_title_25": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_25": 23795277.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Mediterr J Hematol Infect Dis"}, {"pmid_title_26": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_26": 22619618.0, "pmid_date_26": 2012.0, "pmid_journal_26": "ScientificWorldJournal"}, {"pmid_title_27": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_27": 23016900.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Br J Haematol"}, {"pmid_title_28": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_28": 24744655.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Turk J Haematol"}, {"pmid_title_29": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_29": 21062271.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Clin Exp Immunol"}, {"pmid_title_30": "How I treat Diamond-Blackfan anemia.", "pmid_30": 20651069.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Blood"}, {"pmid_title_31": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_31": 20655265.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Transfus Clin Biol"}, {"pmid_title_32": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_32": 20190482.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Intern Med"}, {"pmid_title_33": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_33": 19415275.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Ann Hematol"}, {"pmid_title_34": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_34": 18164793.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_35": 18671700.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Br J Haematol"}, {"pmid_title_36": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_36": 18028431.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Eur J Haematol"}, {"pmid_title_37": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_37": 18776763.0, "pmid_date_37": 2008.0, "pmid_journal_37": "J Pediatr Hematol Oncol"}, {"pmid_title_38": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_38": 18331650.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_39": "Deferasirox.", "pmid_39": 17353569.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Am J Health Syst Pharm"}, {"pmid_title_40": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_40": 17414568.0, "pmid_date_40": 2007.0, "pmid_journal_40": "J Pediatr Hematol Oncol"}, {"pmid_title_41": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_41": 17663681.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_42": 17562599.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Haematologica"}, {"pmid_title_43": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_43": 17312003.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Blood"}, {"pmid_title_44": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_44": 17921858.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_45": 16679921.0, "pmid_date_45": 2006.0, "pmid_journal_45": "J Pediatr Hematol Oncol"}, {"pmid_title_46": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_46": 17325961.0, "pmid_date_46": 2006.0, "pmid_journal_46": "Hematology"}, {"pmid_title_47": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_47": 16317735.0, "pmid_date_47": 2006.0, "pmid_journal_47": "Pediatr Blood Cancer"}, {"pmid_title_48": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_48": 16785135.0, "pmid_date_48": 2006.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_49": 16304857.0, "pmid_date_49": 2005.0, "pmid_journal_49": "J Pak Med Assoc"}, {"pmid_title_50": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_50": 16291361.0, "pmid_date_50": 2005.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_51": 15692602.0, "pmid_date_51": 2005.0, "pmid_journal_51": "Hematol J"}, {"pmid_title_52": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_52": 16041310.0, "pmid_date_52": 2005.0, "pmid_journal_52": "Biol Blood Marrow Transplant"}, {"pmid_title_53": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_53": 15813920.0, "pmid_date_53": 2005.0, "pmid_journal_53": "Eur J Haematol"}, {"pmid_title_54": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_54": 15795909.0, "pmid_date_54": 2005.0, "pmid_journal_54": "Am J Hematol"}, {"pmid_title_55": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_55": 14984172.0, "pmid_date_55": 2004.0, "pmid_journal_55": "J Trop Pediatr"}, {"pmid_title_56": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_56": 15220956.0, "pmid_date_56": 2004.0, "pmid_journal_56": "Bone Marrow Transplant"}, {"pmid_title_57": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_57": 14979474.0, "pmid_date_57": 2004.0, "pmid_journal_57": "Int J Hematol"}, {"pmid_title_58": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_58": 15382270.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatr Blood Cancer"}, {"pmid_title_59": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_59": 18521394.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Sarcoma"}, {"pmid_title_60": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_60": 14608205.0, "pmid_date_60": 2003.0, "pmid_journal_60": "J Pediatr Hematol Oncol"}, {"pmid_title_61": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_61": 12359817.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_62": 12351372.0, "pmid_date_62": 2002.0, "pmid_journal_62": "Blood"}, {"pmid_title_63": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_63": 12022425.0, "pmid_date_63": 2002.0, "pmid_journal_63": "J Trop Pediatr"}, {"pmid_title_64": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_64": 12142794.0, "pmid_date_64": 2002.0, "pmid_journal_64": "J Pediatr Hematol Oncol"}, {"pmid_title_65": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_65": 11313667.0, "pmid_date_65": 2001.0, "pmid_journal_65": "Bone Marrow Transplant"}, {"pmid_title_66": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_66": 11196268.0, "pmid_date_66": 2001.0, "pmid_journal_66": "J Pediatr Hematol Oncol"}, {"pmid_title_67": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_67": 11563769.0, "pmid_date_67": 2001.0, "pmid_journal_67": "J Pediatr Hematol Oncol"}, {"pmid_title_68": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_68": 10779036.0, "pmid_date_68": 2000.0, "pmid_journal_68": "J Pediatr Hematol Oncol"}, {"pmid_title_69": "Diamond-Blackfan anemia.", "pmid_69": 10698294.0, "pmid_date_69": 2000.0, "pmid_journal_69": "Curr Opin Hematol"}, {"pmid_title_70": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_70": 10673683.0, "pmid_date_70": 2000.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_71": 27263505.0, "pmid_date_71": 2000.0, "pmid_journal_71": "Turk J Haematol"}, {"pmid_title_72": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_72": 10714760.0, "pmid_date_72": 2000.0, "pmid_journal_72": "J Pediatr Endocrinol Metab"}, {"pmid_title_73": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_73": 10397110.0, "pmid_date_73": 1999.0, "pmid_journal_73": "AJR Am J Roentgenol"}, {"pmid_title_74": "Bone marrow transplantation in non-malignant disorders.", "pmid_74": 9916644.0, "pmid_date_74": 1998.0, "pmid_journal_74": "Bone Marrow Transplant"}, {"pmid_title_75": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_75": 8846147.0, "pmid_date_75": 1996.0, "pmid_journal_75": "J Pediatr Hematol Oncol"}, {"pmid_title_76": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_76": 8606629.0, "pmid_date_76": 1996.0, "pmid_journal_76": "Medicine (Baltimore)"}, {"pmid_title_77": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_77": 8625135.0, "pmid_date_77": 1995.0, "pmid_journal_77": "Cancer"}, {"pmid_title_78": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_78": 7691318.0, "pmid_date_78": 1993.0, "pmid_journal_78": "Stem Cells"}, {"pmid_title_79": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_79": 3109937.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Eur J Haematol"}, {"pmid_title_80": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_80": 13105384.0, "pmid_date_80": 1953.0, "pmid_journal_80": "Arch Dis Child"}]}, {"_id": "1037-OMIM:612924", "condition": {"condition_name": "HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4", "freq_per_birth": "The incidence of atypical hemolytic-uremic syndrome is estimated to be 1 in 500,000 people per year in the United States. The atypical form is probably about 10 times less common than the typical form.", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4"]}, "gene information": {"db_hgnc_gene_id": 1037.0}, "interventions": [{"int_description_1": "Prednisone"}, {"int_description_2": "Dexamethasone"}, {"int_description_3": "Labetalol"}, {"int_description_4": "Doxazosin"}, {"int_description_5": "Amlodipine", "timeframe_int5": "Hours,Days or Weeks,Years", "age_use_int5": "Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Eculizumab"}, {"int_description_7": "Basiliximab"}, {"int_description_8": "Etanercept"}, {"int_description_9": "Cyclosporine"}, {"int_description_10": "Metronidazole"}, {"int_description_11": "Sirolimus"}, {"int_description_12": "Piperacillin"}, {"int_description_13": "Captopril"}, {"int_description_14": "Tazobactam"}, {"int_description_15": "Ciprofloxacin"}, {"int_description_16": "Ceftriaxone"}, {"int_description_17": "Nifedipine"}, {"int_description_18": "Vincristine"}, {"int_description_19": "Fluconazole"}, {"int_description_20": "Tacrolimus"}, {"int_description_21": "Azathioprine"}, {"int_description_22": "Mycophenolate mofetil"}, {"int_description_23": "Lansoprazole"}, {"int_description_24": "Methylprednisolone"}, {"int_description_25": "Corticosteroids"}, {"int_description_26": "Iron"}, {"int_description_27": "Calcium carbonate"}, {"int_description_28": "Alginic acid", "timeframe_int28": "Hours,Days or Weeks", "age_use_int28": "Infant,Child", "contra_int28": "No", "qualscale_reclass_drug28": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug28": "Effective / Ameliorative"}, {"int_description_29": "Meningococcal vaccine"}, {"int_description_30": "Serine protease inhibitor", "timeframe_int30": "Hours,Days or Weeks", "age_use_int30": "Child", "contra_int30": "No", "qualscale_reclass_drug30": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug30": "Effective / Ameliorative"}, {"int_description_31": "Sodium bicarbonate"}, {"int_description_32": "Hemodialysis"}, {"int_description_33": "Peritoneal dialysis"}, {"int_description_34": "Plasma exchange"}, {"int_description_35": "Transfusion with packed red cells"}, {"int_description_36": "Bilateral nephrectomy", "timeframe_int36": "Days or Weeks,Years", "age_use_int36": "Infant,Child", "contra_int36": "No", "qualscale_reclass_drug36": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug36": "Effective / Ameliorative"}, {"int_description_37": "Kidney transplantation", "timeframe_int37": "Hours,Days or Weeks", "age_use_int37": "Infant,Child", "contra_int37": "No", "qualscale_reclass_drug37": "Case report(s)", "rev1_eff_reclass_drug37": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "A complement factor B mutation in a large kindred with atypical hemolytic uremic syndrome.", "pmid_1": 24906628.0, "pmid_date_1": 2014.0, "pmid_journal_1": "Journal of clinical immunology"}, {"pmid_title_2": "Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft.", "pmid_2": 22591029.0, "pmid_date_2": 2012.0, "pmid_journal_2": "Transplant international : official journal of the European Society for Organ Transplantation"}, {"pmid_title_3": "Complement deficiency states and associated infections.", "pmid_3": 21624663.0, "pmid_date_3": 2011.0, "pmid_journal_3": "Molecular immunology"}, {"pmid_title_4": "Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy.", "pmid_4": 21643943.0, "pmid_date_4": 2011.0, "pmid_journal_4": "Pediatric nephrology (Berlin, Germany)"}, {"pmid_title_5": "Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome.", "pmid_5": 22287852.0, "pmid_date_5": 2011.0, "pmid_journal_5": "Clinical pharmacology : advances and applications"}, {"pmid_title_6": "An adult with acute poststreptococcal glomerulonephritis complicated by hemolytic uremic syndrome and nephrotic syndrome.", "pmid_6": 16183409.0, "pmid_date_6": 2005.0, "pmid_journal_6": "American journal of kidney diseases : the official journal of the National Kidney Foundation"}, {"pmid_title_7": "Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency.", "pmid_7": 10344366.0, "pmid_date_7": 1999.0, "pmid_journal_7": "Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"}, {"pmid_title_8": "Human complement factor H deficiency associated with hemolytic uremic syndrome.", "pmid_8": 9848786.0, "pmid_date_8": 1998.0, "pmid_journal_8": "Journal of the American Society of Nephrology : JASN"}]}, {"_id": "10383-OMIM:613308", "condition": {"condition_name": "DIAMOND-BLACKFAN ANEMIA 9", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["DIAMOND-BLACKFAN ANEMIA 9"]}, "gene information": {"db_hgnc_gene_id": 10383.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Methotrexate", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "Yes", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Fludarabine"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole", "timeframe_int54": "Hours,Days or Weeks,Years", "age_use_int54": "Neonate,Infant,Child", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Effective / Ameliorative"}, {"int_description_55": "Cisplatin"}, {"int_description_56": "Muplestim"}, {"int_description_57": "Filgrastim", "timeframe_int57": "Days or Weeks,Years", "age_use_int57": "Infant,Child", "contra_int57": "No", "qualscale_reclass_drug57": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug57": "Curative"}, {"int_description_58": "Total body irradiation"}, {"int_description_59": "Radiotherapy"}, {"int_description_60": "red blood cells transfusion"}, {"int_description_61": "Thoracoabdominal irradiation"}, {"int_description_62": "Total lymphoid irradiation"}, {"int_description_63": "Above-knee amputation"}, {"int_description_64": "Bone marrow transplantation"}, {"int_description_65": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_66": "laparotomy, tumor dissection"}, {"int_description_67": "limb-salvage surgery"}, {"int_description_68": "Maxillectomy"}, {"int_description_69": "umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "How I manage children with Diamond-Blackfan anaemia.", "pmid_2": 30515771.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_3": 31916719.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Turk J Pediatr"}, {"pmid_title_4": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_4": 31355022.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Case Rep Hematol"}, {"pmid_title_5": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_5": 30811439.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PLoS One"}, {"pmid_title_6": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_6": 30881276.0, "pmid_date_6": 2019.0, "pmid_journal_6": "EJIFCC"}, {"pmid_title_7": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_7": 31208452.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Med Case Rep"}, {"pmid_title_8": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_8": 31574871.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_9": 30411682.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Curr Gene Ther"}, {"pmid_title_10": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_10": 29222242.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_11": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_11": 28623394.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Ann Hematol"}, {"pmid_title_12": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_12": 27882484.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Int J Hematol"}, {"pmid_title_13": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_13": 27537786.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Eur J Haematol"}, {"pmid_title_14": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_14": 28602958.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_15": 27082377.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Blood Cancer"}, {"pmid_title_16": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_16": 26872907.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Int J Hematol"}, {"pmid_title_17": "Pure red cell aplasia.", "pmid_17": 27881371.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Pure red cell aplasia.", "pmid_18": 27913462.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_19": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_19": 27329125.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Int J Hematol"}, {"pmid_title_20": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_20": 26496000.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_21": 25492299.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_22": 25963299.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Am J Hematol"}, {"pmid_title_23": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_23": 24611452.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_24": 24296492.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Biol Blood Marrow Transplant"}, {"pmid_title_25": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_25": 23795277.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Mediterr J Hematol Infect Dis"}, {"pmid_title_26": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_26": 22619618.0, "pmid_date_26": 2012.0, "pmid_journal_26": "ScientificWorldJournal"}, {"pmid_title_27": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_27": 23016900.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Br J Haematol"}, {"pmid_title_28": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_28": 24744655.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Turk J Haematol"}, {"pmid_title_29": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_29": 21062271.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Clin Exp Immunol"}, {"pmid_title_30": "How I treat Diamond-Blackfan anemia.", "pmid_30": 20651069.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Blood"}, {"pmid_title_31": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_31": 20655265.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Transfus Clin Biol"}, {"pmid_title_32": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_32": 20190482.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Intern Med"}, {"pmid_title_33": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_33": 19415275.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Ann Hematol"}, {"pmid_title_34": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_34": 18164793.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_35": 18671700.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Br J Haematol"}, {"pmid_title_36": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_36": 18028431.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Eur J Haematol"}, {"pmid_title_37": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_37": 18776763.0, "pmid_date_37": 2008.0, "pmid_journal_37": "J Pediatr Hematol Oncol"}, {"pmid_title_38": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_38": 18331650.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_39": "Deferasirox.", "pmid_39": 17353569.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Am J Health Syst Pharm"}, {"pmid_title_40": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_40": 17414568.0, "pmid_date_40": 2007.0, "pmid_journal_40": "J Pediatr Hematol Oncol"}, {"pmid_title_41": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_41": 17663681.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_42": 17562599.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Haematologica"}, {"pmid_title_43": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_43": 17312003.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Blood"}, {"pmid_title_44": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_44": 17921858.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_45": 16679921.0, "pmid_date_45": 2006.0, "pmid_journal_45": "J Pediatr Hematol Oncol"}, {"pmid_title_46": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_46": 17325961.0, "pmid_date_46": 2006.0, "pmid_journal_46": "Hematology"}, {"pmid_title_47": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_47": 16317735.0, "pmid_date_47": 2006.0, "pmid_journal_47": "Pediatr Blood Cancer"}, {"pmid_title_48": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_48": 16785135.0, "pmid_date_48": 2006.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_49": 16304857.0, "pmid_date_49": 2005.0, "pmid_journal_49": "J Pak Med Assoc"}, {"pmid_title_50": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_50": 16291361.0, "pmid_date_50": 2005.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_51": 15692602.0, "pmid_date_51": 2005.0, "pmid_journal_51": "Hematol J"}, {"pmid_title_52": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_52": 16041310.0, "pmid_date_52": 2005.0, "pmid_journal_52": "Biol Blood Marrow Transplant"}, {"pmid_title_53": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_53": 15813920.0, "pmid_date_53": 2005.0, "pmid_journal_53": "Eur J Haematol"}, {"pmid_title_54": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_54": 15795909.0, "pmid_date_54": 2005.0, "pmid_journal_54": "Am J Hematol"}, {"pmid_title_55": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_55": 14984172.0, "pmid_date_55": 2004.0, "pmid_journal_55": "J Trop Pediatr"}, {"pmid_title_56": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_56": 15220956.0, "pmid_date_56": 2004.0, "pmid_journal_56": "Bone Marrow Transplant"}, {"pmid_title_57": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_57": 14979474.0, "pmid_date_57": 2004.0, "pmid_journal_57": "Int J Hematol"}, {"pmid_title_58": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_58": 15382270.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatr Blood Cancer"}, {"pmid_title_59": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_59": 18521394.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Sarcoma"}, {"pmid_title_60": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_60": 14608205.0, "pmid_date_60": 2003.0, "pmid_journal_60": "J Pediatr Hematol Oncol"}, {"pmid_title_61": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_61": 12359817.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_62": 12351372.0, "pmid_date_62": 2002.0, "pmid_journal_62": "Blood"}, {"pmid_title_63": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_63": 12022425.0, "pmid_date_63": 2002.0, "pmid_journal_63": "J Trop Pediatr"}, {"pmid_title_64": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_64": 12142794.0, "pmid_date_64": 2002.0, "pmid_journal_64": "J Pediatr Hematol Oncol"}, {"pmid_title_65": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_65": 11313667.0, "pmid_date_65": 2001.0, "pmid_journal_65": "Bone Marrow Transplant"}, {"pmid_title_66": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_66": 11196268.0, "pmid_date_66": 2001.0, "pmid_journal_66": "J Pediatr Hematol Oncol"}, {"pmid_title_67": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_67": 11563769.0, "pmid_date_67": 2001.0, "pmid_journal_67": "J Pediatr Hematol Oncol"}, {"pmid_title_68": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_68": 10779036.0, "pmid_date_68": 2000.0, "pmid_journal_68": "J Pediatr Hematol Oncol"}, {"pmid_title_69": "Diamond-Blackfan anemia.", "pmid_69": 10698294.0, "pmid_date_69": 2000.0, "pmid_journal_69": "Curr Opin Hematol"}, {"pmid_title_70": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_70": 10673683.0, "pmid_date_70": 2000.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_71": 27263505.0, "pmid_date_71": 2000.0, "pmid_journal_71": "Turk J Haematol"}, {"pmid_title_72": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_72": 10714760.0, "pmid_date_72": 2000.0, "pmid_journal_72": "J Pediatr Endocrinol Metab"}, {"pmid_title_73": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_73": 10397110.0, "pmid_date_73": 1999.0, "pmid_journal_73": "AJR Am J Roentgenol"}, {"pmid_title_74": "Bone marrow transplantation in non-malignant disorders.", "pmid_74": 9916644.0, "pmid_date_74": 1998.0, "pmid_journal_74": "Bone Marrow Transplant"}, {"pmid_title_75": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_75": 8846147.0, "pmid_date_75": 1996.0, "pmid_journal_75": "J Pediatr Hematol Oncol"}, {"pmid_title_76": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_76": 8606629.0, "pmid_date_76": 1996.0, "pmid_journal_76": "Medicine (Baltimore)"}, {"pmid_title_77": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_77": 8625135.0, "pmid_date_77": 1995.0, "pmid_journal_77": "Cancer"}, {"pmid_title_78": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_78": 7691318.0, "pmid_date_78": 1993.0, "pmid_journal_78": "Stem Cells"}, {"pmid_title_79": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_79": 3109937.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Eur J Haematol"}, {"pmid_title_80": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_80": 13105384.0, "pmid_date_80": 1953.0, "pmid_journal_80": "Arch Dis Child"}]}, {"_id": "10389-OMIM:618313", "condition": {"condition_name": "DIAMOND-BLACKFAN ANEMIA 20", "alternate_names": ["DIAMOND-BLACKFAN ANEMIA 20"]}, "gene information": {"db_hgnc_gene_id": 10389.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Methotrexate", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "Yes", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Fludarabine"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole", "timeframe_int54": "Hours,Days or Weeks,Years", "age_use_int54": "Neonate,Infant,Child", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Effective / Ameliorative"}, {"int_description_55": "Cisplatin"}, {"int_description_56": "Muplestim"}, {"int_description_57": "Filgrastim", "timeframe_int57": "Days or Weeks,Years", "age_use_int57": "Infant,Child", "contra_int57": "No", "qualscale_reclass_drug57": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug57": "Curative"}, {"int_description_58": "Total body irradiation"}, {"int_description_59": "Radiotherapy"}, {"int_description_60": "red blood cells transfusion"}, {"int_description_61": "Thoracoabdominal irradiation"}, {"int_description_62": "Total lymphoid irradiation"}, {"int_description_63": "Above-knee amputation"}, {"int_description_64": "Bone marrow transplantation"}, {"int_description_65": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_66": "laparotomy, tumor dissection"}, {"int_description_67": "limb-salvage surgery"}, {"int_description_68": "Maxillectomy"}, {"int_description_69": "umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "How I manage children with Diamond-Blackfan anaemia.", "pmid_2": 30515771.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_3": 31916719.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Turk J Pediatr"}, {"pmid_title_4": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_4": 31355022.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Case Rep Hematol"}, {"pmid_title_5": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_5": 30811439.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PLoS One"}, {"pmid_title_6": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_6": 30881276.0, "pmid_date_6": 2019.0, "pmid_journal_6": "EJIFCC"}, {"pmid_title_7": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_7": 31208452.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Med Case Rep"}, {"pmid_title_8": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_8": 31574871.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_9": 30411682.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Curr Gene Ther"}, {"pmid_title_10": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_10": 29222242.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_11": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_11": 28623394.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Ann Hematol"}, {"pmid_title_12": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_12": 27882484.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Int J Hematol"}, {"pmid_title_13": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_13": 27537786.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Eur J Haematol"}, {"pmid_title_14": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_14": 28602958.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_15": 27082377.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Blood Cancer"}, {"pmid_title_16": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_16": 26872907.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Int J Hematol"}, {"pmid_title_17": "Pure red cell aplasia.", "pmid_17": 27881371.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Pure red cell aplasia.", "pmid_18": 27913462.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_19": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_19": 27329125.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Int J Hematol"}, {"pmid_title_20": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_20": 26496000.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_21": 25492299.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_22": 25963299.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Am J Hematol"}, {"pmid_title_23": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_23": 24611452.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_24": 24296492.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Biol Blood Marrow Transplant"}, {"pmid_title_25": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_25": 23795277.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Mediterr J Hematol Infect Dis"}, {"pmid_title_26": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_26": 22619618.0, "pmid_date_26": 2012.0, "pmid_journal_26": "ScientificWorldJournal"}, {"pmid_title_27": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_27": 23016900.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Br J Haematol"}, {"pmid_title_28": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_28": 24744655.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Turk J Haematol"}, {"pmid_title_29": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_29": 21062271.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Clin Exp Immunol"}, {"pmid_title_30": "How I treat Diamond-Blackfan anemia.", "pmid_30": 20651069.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Blood"}, {"pmid_title_31": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_31": 20655265.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Transfus Clin Biol"}, {"pmid_title_32": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_32": 20190482.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Intern Med"}, {"pmid_title_33": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_33": 19415275.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Ann Hematol"}, {"pmid_title_34": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_34": 18164793.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_35": 18671700.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Br J Haematol"}, {"pmid_title_36": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_36": 18028431.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Eur J Haematol"}, {"pmid_title_37": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_37": 18776763.0, "pmid_date_37": 2008.0, "pmid_journal_37": "J Pediatr Hematol Oncol"}, {"pmid_title_38": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_38": 18331650.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_39": "Deferasirox.", "pmid_39": 17353569.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Am J Health Syst Pharm"}, {"pmid_title_40": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_40": 17414568.0, "pmid_date_40": 2007.0, "pmid_journal_40": "J Pediatr Hematol Oncol"}, {"pmid_title_41": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_41": 17663681.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_42": 17562599.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Haematologica"}, {"pmid_title_43": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_43": 17312003.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Blood"}, {"pmid_title_44": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_44": 17921858.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_45": 16679921.0, "pmid_date_45": 2006.0, "pmid_journal_45": "J Pediatr Hematol Oncol"}, {"pmid_title_46": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_46": 17325961.0, "pmid_date_46": 2006.0, "pmid_journal_46": "Hematology"}, {"pmid_title_47": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_47": 16317735.0, "pmid_date_47": 2006.0, "pmid_journal_47": "Pediatr Blood Cancer"}, {"pmid_title_48": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_48": 16785135.0, "pmid_date_48": 2006.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_49": 16304857.0, "pmid_date_49": 2005.0, "pmid_journal_49": "J Pak Med Assoc"}, {"pmid_title_50": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_50": 16291361.0, "pmid_date_50": 2005.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_51": 15692602.0, "pmid_date_51": 2005.0, "pmid_journal_51": "Hematol J"}, {"pmid_title_52": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_52": 16041310.0, "pmid_date_52": 2005.0, "pmid_journal_52": "Biol Blood Marrow Transplant"}, {"pmid_title_53": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_53": 15813920.0, "pmid_date_53": 2005.0, "pmid_journal_53": "Eur J Haematol"}, {"pmid_title_54": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_54": 15795909.0, "pmid_date_54": 2005.0, "pmid_journal_54": "Am J Hematol"}, {"pmid_title_55": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_55": 14984172.0, "pmid_date_55": 2004.0, "pmid_journal_55": "J Trop Pediatr"}, {"pmid_title_56": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_56": 15220956.0, "pmid_date_56": 2004.0, "pmid_journal_56": "Bone Marrow Transplant"}, {"pmid_title_57": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_57": 14979474.0, "pmid_date_57": 2004.0, "pmid_journal_57": "Int J Hematol"}, {"pmid_title_58": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_58": 15382270.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatr Blood Cancer"}, {"pmid_title_59": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_59": 18521394.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Sarcoma"}, {"pmid_title_60": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_60": 14608205.0, "pmid_date_60": 2003.0, "pmid_journal_60": "J Pediatr Hematol Oncol"}, {"pmid_title_61": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_61": 12359817.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_62": 12351372.0, "pmid_date_62": 2002.0, "pmid_journal_62": "Blood"}, {"pmid_title_63": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_63": 12022425.0, "pmid_date_63": 2002.0, "pmid_journal_63": "J Trop Pediatr"}, {"pmid_title_64": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_64": 12142794.0, "pmid_date_64": 2002.0, "pmid_journal_64": "J Pediatr Hematol Oncol"}, {"pmid_title_65": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_65": 11313667.0, "pmid_date_65": 2001.0, "pmid_journal_65": "Bone Marrow Transplant"}, {"pmid_title_66": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_66": 11196268.0, "pmid_date_66": 2001.0, "pmid_journal_66": "J Pediatr Hematol Oncol"}, {"pmid_title_67": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_67": 11563769.0, "pmid_date_67": 2001.0, "pmid_journal_67": "J Pediatr Hematol Oncol"}, {"pmid_title_68": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_68": 10779036.0, "pmid_date_68": 2000.0, "pmid_journal_68": "J Pediatr Hematol Oncol"}, {"pmid_title_69": "Diamond-Blackfan anemia.", "pmid_69": 10698294.0, "pmid_date_69": 2000.0, "pmid_journal_69": "Curr Opin Hematol"}, {"pmid_title_70": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_70": 10673683.0, "pmid_date_70": 2000.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_71": 27263505.0, "pmid_date_71": 2000.0, "pmid_journal_71": "Turk J Haematol"}, {"pmid_title_72": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_72": 10714760.0, "pmid_date_72": 2000.0, "pmid_journal_72": "J Pediatr Endocrinol Metab"}, {"pmid_title_73": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_73": 10397110.0, "pmid_date_73": 1999.0, "pmid_journal_73": "AJR Am J Roentgenol"}, {"pmid_title_74": "Bone marrow transplantation in non-malignant disorders.", "pmid_74": 9916644.0, "pmid_date_74": 1998.0, "pmid_journal_74": "Bone Marrow Transplant"}, {"pmid_title_75": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_75": 8846147.0, "pmid_date_75": 1996.0, "pmid_journal_75": "J Pediatr Hematol Oncol"}, {"pmid_title_76": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_76": 8606629.0, "pmid_date_76": 1996.0, "pmid_journal_76": "Medicine (Baltimore)"}, {"pmid_title_77": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_77": 8625135.0, "pmid_date_77": 1995.0, "pmid_journal_77": "Cancer"}, {"pmid_title_78": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_78": 7691318.0, "pmid_date_78": 1993.0, "pmid_journal_78": "Stem Cells"}, {"pmid_title_79": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_79": 3109937.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Eur J Haematol"}, {"pmid_title_80": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_80": 13105384.0, "pmid_date_80": 1953.0, "pmid_journal_80": "Arch Dis Child"}]}, {"_id": "10397-OMIM:612527", "condition": {"condition_name": "DIAMOND-BLACKFAN ANEMIA 4", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["DIAMOND-BLACKFAN ANEMIA 4"]}, "gene information": {"db_hgnc_gene_id": 10397.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Methotrexate", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "Yes", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Fludarabine"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole", "timeframe_int54": "Hours,Days or Weeks,Years", "age_use_int54": "Neonate,Infant,Child", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Effective / Ameliorative"}, {"int_description_55": "Cisplatin"}, {"int_description_56": "Muplestim"}, {"int_description_57": "Filgrastim", "timeframe_int57": "Days or Weeks,Years", "age_use_int57": "Infant,Child", "contra_int57": "No", "qualscale_reclass_drug57": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug57": "Curative"}, {"int_description_58": "Total body irradiation"}, {"int_description_59": "Radiotherapy"}, {"int_description_60": "red blood cells transfusion"}, {"int_description_61": "Thoracoabdominal irradiation"}, {"int_description_62": "Total lymphoid irradiation"}, {"int_description_63": "Above-knee amputation"}, {"int_description_64": "Bone marrow transplantation"}, {"int_description_65": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_66": "laparotomy, tumor dissection"}, {"int_description_67": "limb-salvage surgery"}, {"int_description_68": "Maxillectomy"}, {"int_description_69": "umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "How I manage children with Diamond-Blackfan anaemia.", "pmid_2": 30515771.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_3": 31916719.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Turk J Pediatr"}, {"pmid_title_4": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_4": 31355022.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Case Rep Hematol"}, {"pmid_title_5": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_5": 30811439.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PLoS One"}, {"pmid_title_6": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_6": 30881276.0, "pmid_date_6": 2019.0, "pmid_journal_6": "EJIFCC"}, {"pmid_title_7": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_7": 31208452.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Med Case Rep"}, {"pmid_title_8": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_8": 31574871.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_9": 30411682.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Curr Gene Ther"}, {"pmid_title_10": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_10": 29222242.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_11": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_11": 28623394.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Ann Hematol"}, {"pmid_title_12": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_12": 27882484.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Int J Hematol"}, {"pmid_title_13": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_13": 27537786.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Eur J Haematol"}, {"pmid_title_14": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_14": 28602958.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_15": 27082377.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Blood Cancer"}, {"pmid_title_16": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_16": 26872907.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Int J Hematol"}, {"pmid_title_17": "Pure red cell aplasia.", "pmid_17": 27881371.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Pure red cell aplasia.", "pmid_18": 27913462.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_19": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_19": 27329125.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Int J Hematol"}, {"pmid_title_20": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_20": 26496000.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_21": 25492299.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_22": 25963299.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Am J Hematol"}, {"pmid_title_23": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_23": 24611452.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_24": 24296492.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Biol Blood Marrow Transplant"}, {"pmid_title_25": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_25": 23795277.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Mediterr J Hematol Infect Dis"}, {"pmid_title_26": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_26": 22619618.0, "pmid_date_26": 2012.0, "pmid_journal_26": "ScientificWorldJournal"}, {"pmid_title_27": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_27": 23016900.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Br J Haematol"}, {"pmid_title_28": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_28": 24744655.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Turk J Haematol"}, {"pmid_title_29": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_29": 21062271.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Clin Exp Immunol"}, {"pmid_title_30": "How I treat Diamond-Blackfan anemia.", "pmid_30": 20651069.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Blood"}, {"pmid_title_31": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_31": 20655265.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Transfus Clin Biol"}, {"pmid_title_32": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_32": 20190482.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Intern Med"}, {"pmid_title_33": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_33": 19415275.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Ann Hematol"}, {"pmid_title_34": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_34": 18164793.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_35": 18671700.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Br J Haematol"}, {"pmid_title_36": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_36": 18028431.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Eur J Haematol"}, {"pmid_title_37": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_37": 18776763.0, "pmid_date_37": 2008.0, "pmid_journal_37": "J Pediatr Hematol Oncol"}, {"pmid_title_38": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_38": 18331650.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_39": "Deferasirox.", "pmid_39": 17353569.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Am J Health Syst Pharm"}, {"pmid_title_40": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_40": 17414568.0, "pmid_date_40": 2007.0, "pmid_journal_40": "J Pediatr Hematol Oncol"}, {"pmid_title_41": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_41": 17663681.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_42": 17562599.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Haematologica"}, {"pmid_title_43": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_43": 17312003.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Blood"}, {"pmid_title_44": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_44": 17921858.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_45": 16679921.0, "pmid_date_45": 2006.0, "pmid_journal_45": "J Pediatr Hematol Oncol"}, {"pmid_title_46": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_46": 17325961.0, "pmid_date_46": 2006.0, "pmid_journal_46": "Hematology"}, {"pmid_title_47": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_47": 16317735.0, "pmid_date_47": 2006.0, "pmid_journal_47": "Pediatr Blood Cancer"}, {"pmid_title_48": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_48": 16785135.0, "pmid_date_48": 2006.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_49": 16304857.0, "pmid_date_49": 2005.0, "pmid_journal_49": "J Pak Med Assoc"}, {"pmid_title_50": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_50": 16291361.0, "pmid_date_50": 2005.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_51": 15692602.0, "pmid_date_51": 2005.0, "pmid_journal_51": "Hematol J"}, {"pmid_title_52": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_52": 16041310.0, "pmid_date_52": 2005.0, "pmid_journal_52": "Biol Blood Marrow Transplant"}, {"pmid_title_53": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_53": 15813920.0, "pmid_date_53": 2005.0, "pmid_journal_53": "Eur J Haematol"}, {"pmid_title_54": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_54": 15795909.0, "pmid_date_54": 2005.0, "pmid_journal_54": "Am J Hematol"}, {"pmid_title_55": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_55": 14984172.0, "pmid_date_55": 2004.0, "pmid_journal_55": "J Trop Pediatr"}, {"pmid_title_56": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_56": 15220956.0, "pmid_date_56": 2004.0, "pmid_journal_56": "Bone Marrow Transplant"}, {"pmid_title_57": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_57": 14979474.0, "pmid_date_57": 2004.0, "pmid_journal_57": "Int J Hematol"}, {"pmid_title_58": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_58": 15382270.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatr Blood Cancer"}, {"pmid_title_59": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_59": 18521394.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Sarcoma"}, {"pmid_title_60": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_60": 14608205.0, "pmid_date_60": 2003.0, "pmid_journal_60": "J Pediatr Hematol Oncol"}, {"pmid_title_61": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_61": 12359817.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_62": 12351372.0, "pmid_date_62": 2002.0, "pmid_journal_62": "Blood"}, {"pmid_title_63": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_63": 12022425.0, "pmid_date_63": 2002.0, "pmid_journal_63": "J Trop Pediatr"}, {"pmid_title_64": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_64": 12142794.0, "pmid_date_64": 2002.0, "pmid_journal_64": "J Pediatr Hematol Oncol"}, {"pmid_title_65": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_65": 11313667.0, "pmid_date_65": 2001.0, "pmid_journal_65": "Bone Marrow Transplant"}, {"pmid_title_66": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_66": 11196268.0, "pmid_date_66": 2001.0, "pmid_journal_66": "J Pediatr Hematol Oncol"}, {"pmid_title_67": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_67": 11563769.0, "pmid_date_67": 2001.0, "pmid_journal_67": "J Pediatr Hematol Oncol"}, {"pmid_title_68": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_68": 10779036.0, "pmid_date_68": 2000.0, "pmid_journal_68": "J Pediatr Hematol Oncol"}, {"pmid_title_69": "Diamond-Blackfan anemia.", "pmid_69": 10698294.0, "pmid_date_69": 2000.0, "pmid_journal_69": "Curr Opin Hematol"}, {"pmid_title_70": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_70": 10673683.0, "pmid_date_70": 2000.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_71": 27263505.0, "pmid_date_71": 2000.0, "pmid_journal_71": "Turk J Haematol"}, {"pmid_title_72": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_72": 10714760.0, "pmid_date_72": 2000.0, "pmid_journal_72": "J Pediatr Endocrinol Metab"}, {"pmid_title_73": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_73": 10397110.0, "pmid_date_73": 1999.0, "pmid_journal_73": "AJR Am J Roentgenol"}, {"pmid_title_74": "Bone marrow transplantation in non-malignant disorders.", "pmid_74": 9916644.0, "pmid_date_74": 1998.0, "pmid_journal_74": "Bone Marrow Transplant"}, {"pmid_title_75": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_75": 8846147.0, "pmid_date_75": 1996.0, "pmid_journal_75": "J Pediatr Hematol Oncol"}, {"pmid_title_76": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_76": 8606629.0, "pmid_date_76": 1996.0, "pmid_journal_76": "Medicine (Baltimore)"}, {"pmid_title_77": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_77": 8625135.0, "pmid_date_77": 1995.0, "pmid_journal_77": "Cancer"}, {"pmid_title_78": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_78": 7691318.0, "pmid_date_78": 1993.0, "pmid_journal_78": "Stem Cells"}, {"pmid_title_79": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_79": 3109937.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Eur J Haematol"}, {"pmid_title_80": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_80": 13105384.0, "pmid_date_80": 1953.0, "pmid_journal_80": "Arch Dis Child"}]}, {"_id": "10402-OMIM:105650", "condition": {"condition_name": "DIAMOND-BLACKFAN ANEMIA 1", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["DIAMOND-BLACKFAN ANEMIA 1"]}, "gene information": {"db_hgnc_gene_id": 10402.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Methotrexate", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "Yes", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Fludarabine"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole"}, {"int_description_55": "Corticotherapy"}, {"int_description_56": "Cisplatin"}, {"int_description_57": "Muplestim"}, {"int_description_58": "Glucocorticoid therapy"}, {"int_description_59": "Iron chelation therapy"}, {"int_description_60": "Steroids", "timeframe_int60": "Hours,Days or Weeks,Years", "age_use_int60": "Neonate,Infant,Child", "contra_int60": "No", "qualscale_reclass_drug60": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug60": "Effective / Ameliorative"}, {"int_description_61": "Filgrastim"}, {"int_description_62": "Gene therapy"}, {"int_description_63": "Total body irradiation"}, {"int_description_64": "Blood transfusions", "timeframe_int64": "Days or Weeks,Years", "age_use_int64": "Infant,Child", "contra_int64": "No", "qualscale_reclass_drug64": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug64": "Curative"}, {"int_description_65": "Radiotherapy"}, {"int_description_66": "red blood cells transfusion"}, {"int_description_67": "Thoracoabdominal irradiation"}, {"int_description_68": "Total lymphoid irradiation"}, {"int_description_69": "Above-knee amputation"}, {"int_description_70": "Bone marrow transplantation"}, {"int_description_71": "Hematopoietic stem cell transplantation"}, {"int_description_72": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_73": "laparotomy, tumor dissection"}, {"int_description_74": "limb-salvage surgery"}, {"int_description_75": "Maxillectomy"}, {"int_description_76": "umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "Diamond-Blackfan Anemia", "pmid_2": 20301769.0, "pmid_date_2": 2019.0, "pmid_journal_2": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_3": "How I manage children with Diamond-Blackfan anaemia.", "pmid_3": 30515771.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Br J Haematol"}, {"pmid_title_4": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_4": 31916719.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Turk J Pediatr"}, {"pmid_title_5": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_5": 31355022.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Case Rep Hematol"}, {"pmid_title_6": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_6": 30811439.0, "pmid_date_6": 2019.0, "pmid_journal_6": "PLoS One"}, {"pmid_title_7": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_7": 30881276.0, "pmid_date_7": 2019.0, "pmid_journal_7": "EJIFCC"}, {"pmid_title_8": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_8": 31208452.0, "pmid_date_8": 2019.0, "pmid_journal_8": "J Med Case Rep"}, {"pmid_title_9": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_9": 31574871.0, "pmid_date_9": 2019.0, "pmid_journal_9": "Medicine (Baltimore)"}, {"pmid_title_10": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_10": 30411682.0, "pmid_date_10": 2018.0, "pmid_journal_10": "Curr Gene Ther"}, {"pmid_title_11": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_11": 29222242.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_12": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_12": 28623394.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Ann Hematol"}, {"pmid_title_13": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_13": 27882484.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Int J Hematol"}, {"pmid_title_14": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_14": 27537786.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Eur J Haematol"}, {"pmid_title_15": "Lymphoblastoid cell lines from Diamond Blackfan anaemia patients exhibit a full ribosomal stress phenotype that is rescued by gene therapy.", "pmid_15": 28931864.0, "pmid_date_15": 2017.0, "pmid_journal_15": "Sci Rep"}, {"pmid_title_16": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_16": 28602958.0, "pmid_date_16": 2017.0, "pmid_journal_16": "Biol Blood Marrow Transplant"}, {"pmid_title_17": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_17": 27082377.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Pediatr Blood Cancer"}, {"pmid_title_18": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_18": 26872907.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Int J Hematol"}, {"pmid_title_19": "Pure red cell aplasia.", "pmid_19": 27881371.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Blood"}, {"pmid_title_20": "Pure red cell aplasia.", "pmid_20": 27913462.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_21": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_21": 27329125.0, "pmid_date_21": 2016.0, "pmid_journal_21": "Int J Hematol"}, {"pmid_title_22": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_22": 26496000.0, "pmid_date_22": 2016.0, "pmid_journal_22": "Pediatr Blood Cancer"}, {"pmid_title_23": "Glucocorticoids improve erythroid progenitor maintenance and dampen Trp53 response in a mouse model of Diamond-Blackfan anaemia.", "pmid_23": 26305041.0, "pmid_date_23": 2015.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_24": 25492299.0, "pmid_date_24": 2015.0, "pmid_journal_24": "Pediatr Blood Cancer"}, {"pmid_title_25": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_25": 25963299.0, "pmid_date_25": 2015.0, "pmid_journal_25": "Am J Hematol"}, {"pmid_title_26": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_26": 24611452.0, "pmid_date_26": 2014.0, "pmid_journal_26": "Br J Haematol"}, {"pmid_title_27": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_27": 24296492.0, "pmid_date_27": 2014.0, "pmid_journal_27": "Biol Blood Marrow Transplant"}, {"pmid_title_28": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_28": 23795277.0, "pmid_date_28": 2013.0, "pmid_journal_28": "Mediterr J Hematol Infect Dis"}, {"pmid_title_29": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_29": 22619618.0, "pmid_date_29": 2012.0, "pmid_journal_29": "ScientificWorldJournal"}, {"pmid_title_30": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_30": 23016900.0, "pmid_date_30": 2012.0, "pmid_journal_30": "Br J Haematol"}, {"pmid_title_31": "The Czech National Diamond-Blackfan Anemia Registry: clinical data and ribosomal protein mutations update.", "pmid_31": 22381658.0, "pmid_date_31": 2012.0, "pmid_journal_31": "Blood Cells Mol Dis"}, {"pmid_title_32": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_32": 24744655.0, "pmid_date_32": 2012.0, "pmid_journal_32": "Turk J Haematol"}, {"pmid_title_33": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_33": 21062271.0, "pmid_date_33": 2011.0, "pmid_journal_33": "Clin Exp Immunol"}, {"pmid_title_34": "How I treat Diamond-Blackfan anemia.", "pmid_34": 20651069.0, "pmid_date_34": 2010.0, "pmid_journal_34": "Blood"}, {"pmid_title_35": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_35": 20655265.0, "pmid_date_35": 2010.0, "pmid_journal_35": "Transfus Clin Biol"}, {"pmid_title_36": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_36": 20190482.0, "pmid_date_36": 2010.0, "pmid_journal_36": "Intern Med"}, {"pmid_title_37": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_37": 19415275.0, "pmid_date_37": 2009.0, "pmid_journal_37": "Ann Hematol"}, {"pmid_title_38": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_38": 18164793.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Blood Rev"}, {"pmid_title_39": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_39": 18671700.0, "pmid_date_39": 2008.0, "pmid_journal_39": "Br J Haematol"}, {"pmid_title_40": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_40": 18028431.0, "pmid_date_40": 2008.0, "pmid_journal_40": "Eur J Haematol"}, {"pmid_title_41": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_41": 18776763.0, "pmid_date_41": 2008.0, "pmid_journal_41": "J Pediatr Hematol Oncol"}, {"pmid_title_42": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_42": 18331650.0, "pmid_date_42": 2008.0, "pmid_journal_42": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_43": "Deferasirox.", "pmid_43": 17353569.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Am J Health Syst Pharm"}, {"pmid_title_44": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_44": 17414568.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_45": 17663681.0, "pmid_date_45": 2007.0, "pmid_journal_45": "Pediatr Transplant"}, {"pmid_title_46": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_46": 17562599.0, "pmid_date_46": 2007.0, "pmid_journal_46": "Haematologica"}, {"pmid_title_47": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_47": 17312003.0, "pmid_date_47": 2007.0, "pmid_journal_47": "Blood"}, {"pmid_title_48": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_48": 17921858.0, "pmid_date_48": 2007.0, "pmid_journal_48": "J Pediatr Hematol Oncol"}, {"pmid_title_49": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_49": 16679921.0, "pmid_date_49": 2006.0, "pmid_journal_49": "J Pediatr Hematol Oncol"}, {"pmid_title_50": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_50": 17325961.0, "pmid_date_50": 2006.0, "pmid_journal_50": "Hematology"}, {"pmid_title_51": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_51": 16317735.0, "pmid_date_51": 2006.0, "pmid_journal_51": "Pediatr Blood Cancer"}, {"pmid_title_52": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_52": 16785135.0, "pmid_date_52": 2006.0, "pmid_journal_52": "Haematologica"}, {"pmid_title_53": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_53": 16304857.0, "pmid_date_53": 2005.0, "pmid_journal_53": "J Pak Med Assoc"}, {"pmid_title_54": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_54": 16291361.0, "pmid_date_54": 2005.0, "pmid_journal_54": "J Pediatr"}, {"pmid_title_55": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_55": 15692602.0, "pmid_date_55": 2005.0, "pmid_journal_55": "Hematol J"}, {"pmid_title_56": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_56": 16041310.0, "pmid_date_56": 2005.0, "pmid_journal_56": "Biol Blood Marrow Transplant"}, {"pmid_title_57": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_57": 15813920.0, "pmid_date_57": 2005.0, "pmid_journal_57": "Eur J Haematol"}, {"pmid_title_58": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_58": 15795909.0, "pmid_date_58": 2005.0, "pmid_journal_58": "Am J Hematol"}, {"pmid_title_59": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_59": 14984172.0, "pmid_date_59": 2004.0, "pmid_journal_59": "J Trop Pediatr"}, {"pmid_title_60": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_60": 15220956.0, "pmid_date_60": 2004.0, "pmid_journal_60": "Bone Marrow Transplant"}, {"pmid_title_61": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_61": 14979474.0, "pmid_date_61": 2004.0, "pmid_journal_61": "Int J Hematol"}, {"pmid_title_62": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_62": 15382270.0, "pmid_date_62": 2004.0, "pmid_journal_62": "Pediatr Blood Cancer"}, {"pmid_title_63": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_63": 18521394.0, "pmid_date_63": 2004.0, "pmid_journal_63": "Sarcoma"}, {"pmid_title_64": "RNA and protein evidence for haplo-insufficiency in Diamond-Blackfan anaemia patients with RPS19 mutations.", "pmid_64": 15384984.0, "pmid_date_64": 2004.0, "pmid_journal_64": "Br J Haematol"}, {"pmid_title_65": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_65": 14608205.0, "pmid_date_65": 2003.0, "pmid_journal_65": "J Pediatr Hematol Oncol"}, {"pmid_title_66": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_66": 12359817.0, "pmid_date_66": 2002.0, "pmid_journal_66": "Pediatrics"}, {"pmid_title_67": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_67": 12351372.0, "pmid_date_67": 2002.0, "pmid_journal_67": "Blood"}, {"pmid_title_68": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_68": 12022425.0, "pmid_date_68": 2002.0, "pmid_journal_68": "J Trop Pediatr"}, {"pmid_title_69": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_69": 12142794.0, "pmid_date_69": 2002.0, "pmid_journal_69": "J Pediatr Hematol Oncol"}, {"pmid_title_70": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_70": 11313667.0, "pmid_date_70": 2001.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_71": 11196268.0, "pmid_date_71": 2001.0, "pmid_journal_71": "J Pediatr Hematol Oncol"}, {"pmid_title_72": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_72": 11563769.0, "pmid_date_72": 2001.0, "pmid_journal_72": "J Pediatr Hematol Oncol"}, {"pmid_title_73": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_73": 10779036.0, "pmid_date_73": 2000.0, "pmid_journal_73": "J Pediatr Hematol Oncol"}, {"pmid_title_74": "Diamond-Blackfan anemia.", "pmid_74": 10698294.0, "pmid_date_74": 2000.0, "pmid_journal_74": "Curr Opin Hematol"}, {"pmid_title_75": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_75": 10673683.0, "pmid_date_75": 2000.0, "pmid_journal_75": "Bone Marrow Transplant"}, {"pmid_title_76": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_76": 27263505.0, "pmid_date_76": 2000.0, "pmid_journal_76": "Turk J Haematol"}, {"pmid_title_77": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_77": 10714760.0, "pmid_date_77": 2000.0, "pmid_journal_77": "J Pediatr Endocrinol Metab"}, {"pmid_title_78": "Diamond-Blackfan anemia: report of seven further mutations in the RPS19 gene and evidence of mutation heterogeneity in the Italian population.", "pmid_78": 11112378.0, "pmid_date_78": 2000.0, "pmid_journal_78": "Blood Cells Mol Dis"}, {"pmid_title_79": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_79": 10397110.0, "pmid_date_79": 1999.0, "pmid_journal_79": "AJR Am J Roentgenol"}, {"pmid_title_80": "Bone marrow transplantation in non-malignant disorders.", "pmid_80": 9916644.0, "pmid_date_80": 1998.0, "pmid_journal_80": "Bone Marrow Transplant"}, {"pmid_title_81": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_81": 8846147.0, "pmid_date_81": 1996.0, "pmid_journal_81": "J Pediatr Hematol Oncol"}, {"pmid_title_82": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_82": 8606629.0, "pmid_date_82": 1996.0, "pmid_journal_82": "Medicine (Baltimore)"}, {"pmid_title_83": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_83": 8625135.0, "pmid_date_83": 1995.0, "pmid_journal_83": "Cancer"}, {"pmid_title_84": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_84": 7691318.0, "pmid_date_84": 1993.0, "pmid_journal_84": "Stem Cells"}, {"pmid_title_85": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_85": 3109937.0, "pmid_date_85": 1987.0, "pmid_journal_85": "Eur J Haematol"}, {"pmid_title_86": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_86": 13105384.0, "pmid_date_86": 1953.0, "pmid_journal_86": "Arch Dis Child"}]}, {"_id": "10411-OMIM:610629", "condition": {"condition_name": "DIAMOND-BLACKFAN ANEMIA 3", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["DIAMOND-BLACKFAN ANEMIA 3"]}, "gene information": {"db_hgnc_gene_id": 10411.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Methotrexate", "timeframe_int32": "Days or Weeks", "age_use_int32": "Child", "contra_int32": "Yes", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Fludarabine"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole", "timeframe_int54": "Hours,Days or Weeks,Years", "age_use_int54": "Neonate,Infant,Child", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Effective / Ameliorative"}, {"int_description_55": "Cisplatin"}, {"int_description_56": "Muplestim"}, {"int_description_57": "Filgrastim", "timeframe_int57": "Days or Weeks,Years", "age_use_int57": "Infant,Child", "contra_int57": "No", "qualscale_reclass_drug57": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug57": "Curative"}, {"int_description_58": "Total body irradiation"}, {"int_description_59": "Radiotherapy"}, {"int_description_60": "red blood cells transfusion"}, {"int_description_61": "Thoracoabdominal irradiation"}, {"int_description_62": "Total lymphoid irradiation"}, {"int_description_63": "Above-knee amputation"}, {"int_description_64": "Bone marrow transplantation"}, {"int_description_65": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_66": "laparotomy, tumor dissection"}, {"int_description_67": "limb-salvage surgery"}, {"int_description_68": "Maxillectomy"}, {"int_description_69": "umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "How I manage children with Diamond-Blackfan anaemia.", "pmid_2": 30515771.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_3": 31916719.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Turk J Pediatr"}, {"pmid_title_4": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_4": 31355022.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Case Rep Hematol"}, {"pmid_title_5": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_5": 30811439.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PLoS One"}, {"pmid_title_6": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_6": 30881276.0, "pmid_date_6": 2019.0, "pmid_journal_6": "EJIFCC"}, {"pmid_title_7": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_7": 31208452.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Med Case Rep"}, {"pmid_title_8": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_8": 31574871.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_9": 30411682.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Curr Gene Ther"}, {"pmid_title_10": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_10": 29222242.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_11": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_11": 28623394.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Ann Hematol"}, {"pmid_title_12": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_12": 27882484.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Int J Hematol"}, {"pmid_title_13": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_13": 27537786.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Eur J Haematol"}, {"pmid_title_14": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_14": 28602958.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_15": 27082377.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Blood Cancer"}, {"pmid_title_16": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_16": 26872907.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Int J Hematol"}, {"pmid_title_17": "Pure red cell aplasia.", "pmid_17": 27881371.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Pure red cell aplasia.", "pmid_18": 27913462.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_19": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_19": 27329125.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Int J Hematol"}, {"pmid_title_20": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_20": 26496000.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_21": 25492299.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_22": 25963299.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Am J Hematol"}, {"pmid_title_23": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_23": 24611452.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_24": 24296492.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Biol Blood Marrow Transplant"}, {"pmid_title_25": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_25": 23795277.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Mediterr J Hematol Infect Dis"}, {"pmid_title_26": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_26": 22619618.0, "pmid_date_26": 2012.0, "pmid_journal_26": "ScientificWorldJournal"}, {"pmid_title_27": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_27": 23016900.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Br J Haematol"}, {"pmid_title_28": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_28": 24744655.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Turk J Haematol"}, {"pmid_title_29": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_29": 21062271.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Clin Exp Immunol"}, {"pmid_title_30": "How I treat Diamond-Blackfan anemia.", "pmid_30": 20651069.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Blood"}, {"pmid_title_31": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_31": 20655265.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Transfus Clin Biol"}, {"pmid_title_32": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_32": 20190482.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Intern Med"}, {"pmid_title_33": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_33": 19415275.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Ann Hematol"}, {"pmid_title_34": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_34": 18164793.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_35": 18671700.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Br J Haematol"}, {"pmid_title_36": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_36": 18028431.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Eur J Haematol"}, {"pmid_title_37": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_37": 18776763.0, "pmid_date_37": 2008.0, "pmid_journal_37": "J Pediatr Hematol Oncol"}, {"pmid_title_38": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_38": 18331650.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_39": "Deferasirox.", "pmid_39": 17353569.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Am J Health Syst Pharm"}, {"pmid_title_40": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_40": 17414568.0, "pmid_date_40": 2007.0, "pmid_journal_40": "J Pediatr Hematol Oncol"}, {"pmid_title_41": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_41": 17663681.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_42": 17562599.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Haematologica"}, {"pmid_title_43": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_43": 17312003.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Blood"}, {"pmid_title_44": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_44": 17921858.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_45": 16679921.0, "pmid_date_45": 2006.0, "pmid_journal_45": "J Pediatr Hematol Oncol"}, {"pmid_title_46": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_46": 17325961.0, "pmid_date_46": 2006.0, "pmid_journal_46": "Hematology"}, {"pmid_title_47": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_47": 16317735.0, "pmid_date_47": 2006.0, "pmid_journal_47": "Pediatr Blood Cancer"}, {"pmid_title_48": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_48": 16785135.0, "pmid_date_48": 2006.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_49": 16304857.0, "pmid_date_49": 2005.0, "pmid_journal_49": "J Pak Med Assoc"}, {"pmid_title_50": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_50": 16291361.0, "pmid_date_50": 2005.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_51": 15692602.0, "pmid_date_51": 2005.0, "pmid_journal_51": "Hematol J"}, {"pmid_title_52": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_52": 16041310.0, "pmid_date_52": 2005.0, "pmid_journal_52": "Biol Blood Marrow Transplant"}, {"pmid_title_53": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_53": 15813920.0, "pmid_date_53": 2005.0, "pmid_journal_53": "Eur J Haematol"}, {"pmid_title_54": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_54": 15795909.0, "pmid_date_54": 2005.0, "pmid_journal_54": "Am J Hematol"}, {"pmid_title_55": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_55": 14984172.0, "pmid_date_55": 2004.0, "pmid_journal_55": "J Trop Pediatr"}, {"pmid_title_56": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_56": 15220956.0, "pmid_date_56": 2004.0, "pmid_journal_56": "Bone Marrow Transplant"}, {"pmid_title_57": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_57": 14979474.0, "pmid_date_57": 2004.0, "pmid_journal_57": "Int J Hematol"}, {"pmid_title_58": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_58": 15382270.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatr Blood Cancer"}, {"pmid_title_59": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_59": 18521394.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Sarcoma"}, {"pmid_title_60": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_60": 14608205.0, "pmid_date_60": 2003.0, "pmid_journal_60": "J Pediatr Hematol Oncol"}, {"pmid_title_61": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_61": 12359817.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_62": 12351372.0, "pmid_date_62": 2002.0, "pmid_journal_62": "Blood"}, {"pmid_title_63": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_63": 12022425.0, "pmid_date_63": 2002.0, "pmid_journal_63": "J Trop Pediatr"}, {"pmid_title_64": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_64": 12142794.0, "pmid_date_64": 2002.0, "pmid_journal_64": "J Pediatr Hematol Oncol"}, {"pmid_title_65": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_65": 11313667.0, "pmid_date_65": 2001.0, "pmid_journal_65": "Bone Marrow Transplant"}, {"pmid_title_66": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_66": 11196268.0, "pmid_date_66": 2001.0, "pmid_journal_66": "J Pediatr Hematol Oncol"}, {"pmid_title_67": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_67": 11563769.0, "pmid_date_67": 2001.0, "pmid_journal_67": "J Pediatr Hematol Oncol"}, {"pmid_title_68": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_68": 10779036.0, "pmid_date_68": 2000.0, "pmid_journal_68": "J Pediatr Hematol Oncol"}, {"pmid_title_69": "Diamond-Blackfan anemia.", "pmid_69": 10698294.0, "pmid_date_69": 2000.0, "pmid_journal_69": "Curr Opin Hematol"}, {"pmid_title_70": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_70": 10673683.0, "pmid_date_70": 2000.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_71": 27263505.0, "pmid_date_71": 2000.0, "pmid_journal_71": "Turk J Haematol"}, {"pmid_title_72": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_72": 10714760.0, "pmid_date_72": 2000.0, "pmid_journal_72": "J Pediatr Endocrinol Metab"}, {"pmid_title_73": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_73": 10397110.0, "pmid_date_73": 1999.0, "pmid_journal_73": "AJR Am J Roentgenol"}, {"pmid_title_74": "Bone marrow transplantation in non-malignant disorders.", "pmid_74": 9916644.0, "pmid_date_74": 1998.0, "pmid_journal_74": "Bone Marrow Transplant"}, {"pmid_title_75": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_75": 8846147.0, "pmid_date_75": 1996.0, "pmid_journal_75": "J Pediatr Hematol Oncol"}, {"pmid_title_76": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_76": 8606629.0, "pmid_date_76": 1996.0, "pmid_journal_76": "Medicine (Baltimore)"}, {"pmid_title_77": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_77": 8625135.0, "pmid_date_77": 1995.0, "pmid_journal_77": "Cancer"}, {"pmid_title_78": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_78": 7691318.0, "pmid_date_78": 1993.0, "pmid_journal_78": "Stem Cells"}, {"pmid_title_79": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_79": 3109937.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Eur J Haematol"}, {"pmid_title_80": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_80": 13105384.0, "pmid_date_80": 1953.0, "pmid_journal_80": "Arch Dis Child"}]}, {"_id": "10414-OMIM:613309", "condition": {"condition_name": "DIAMOND-BLACKFAN ANEMIA 10", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["DIAMOND-BLACKFAN ANEMIA 10"]}, "gene information": {"db_hgnc_gene_id": 10414.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Methotrexate", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "Yes", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Fludarabine"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole", "timeframe_int54": "Hours,Days or Weeks,Years", "age_use_int54": "Neonate,Infant,Child", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Effective / Ameliorative"}, {"int_description_55": "Cisplatin"}, {"int_description_56": "Muplestim"}, {"int_description_57": "Filgrastim", "timeframe_int57": "Days or Weeks,Years", "age_use_int57": "Infant,Child", "contra_int57": "No", "qualscale_reclass_drug57": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug57": "Effective / Ameliorative"}, {"int_description_58": "Total body irradiation"}, {"int_description_59": "Radiotherapy"}, {"int_description_60": "red blood cells transfusion"}, {"int_description_61": "Thoracoabdominal irradiation"}, {"int_description_62": "Total lymphoid irradiation"}, {"int_description_63": "Above-knee amputation"}, {"int_description_64": "Bone marrow transplantation"}, {"int_description_65": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_66": "laparotomy, tumor dissection"}, {"int_description_67": "limb-salvage surgery"}, {"int_description_68": "Maxillectomy"}, {"int_description_69": "umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "How I manage children with Diamond-Blackfan anaemia.", "pmid_2": 30515771.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_3": 31916719.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Turk J Pediatr"}, {"pmid_title_4": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_4": 31355022.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Case Rep Hematol"}, {"pmid_title_5": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_5": 30811439.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PLoS One"}, {"pmid_title_6": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_6": 30881276.0, "pmid_date_6": 2019.0, "pmid_journal_6": "EJIFCC"}, {"pmid_title_7": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_7": 31208452.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Med Case Rep"}, {"pmid_title_8": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_8": 31574871.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_9": 30411682.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Curr Gene Ther"}, {"pmid_title_10": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_10": 29222242.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_11": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_11": 28623394.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Ann Hematol"}, {"pmid_title_12": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_12": 27882484.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Int J Hematol"}, {"pmid_title_13": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_13": 27537786.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Eur J Haematol"}, {"pmid_title_14": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_14": 28602958.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_15": 27082377.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Blood Cancer"}, {"pmid_title_16": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_16": 26872907.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Int J Hematol"}, {"pmid_title_17": "Pure red cell aplasia.", "pmid_17": 27881371.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Pure red cell aplasia.", "pmid_18": 27913462.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_19": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_19": 27329125.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Int J Hematol"}, {"pmid_title_20": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_20": 26496000.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_21": 25492299.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_22": 25963299.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Am J Hematol"}, {"pmid_title_23": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_23": 24611452.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_24": 24296492.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Biol Blood Marrow Transplant"}, {"pmid_title_25": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_25": 23795277.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Mediterr J Hematol Infect Dis"}, {"pmid_title_26": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_26": 22619618.0, "pmid_date_26": 2012.0, "pmid_journal_26": "ScientificWorldJournal"}, {"pmid_title_27": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_27": 23016900.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Br J Haematol"}, {"pmid_title_28": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_28": 24744655.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Turk J Haematol"}, {"pmid_title_29": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_29": 21062271.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Clin Exp Immunol"}, {"pmid_title_30": "How I treat Diamond-Blackfan anemia.", "pmid_30": 20651069.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Blood"}, {"pmid_title_31": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_31": 20655265.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Transfus Clin Biol"}, {"pmid_title_32": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_32": 20190482.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Intern Med"}, {"pmid_title_33": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_33": 19415275.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Ann Hematol"}, {"pmid_title_34": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_34": 18164793.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_35": 18671700.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Br J Haematol"}, {"pmid_title_36": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_36": 18028431.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Eur J Haematol"}, {"pmid_title_37": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_37": 18776763.0, "pmid_date_37": 2008.0, "pmid_journal_37": "J Pediatr Hematol Oncol"}, {"pmid_title_38": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_38": 18331650.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_39": "Deferasirox.", "pmid_39": 17353569.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Am J Health Syst Pharm"}, {"pmid_title_40": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_40": 17414568.0, "pmid_date_40": 2007.0, "pmid_journal_40": "J Pediatr Hematol Oncol"}, {"pmid_title_41": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_41": 17663681.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_42": 17562599.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Haematologica"}, {"pmid_title_43": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_43": 17312003.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Blood"}, {"pmid_title_44": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_44": 17921858.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_45": 16679921.0, "pmid_date_45": 2006.0, "pmid_journal_45": "J Pediatr Hematol Oncol"}, {"pmid_title_46": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_46": 17325961.0, "pmid_date_46": 2006.0, "pmid_journal_46": "Hematology"}, {"pmid_title_47": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_47": 16317735.0, "pmid_date_47": 2006.0, "pmid_journal_47": "Pediatr Blood Cancer"}, {"pmid_title_48": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_48": 16785135.0, "pmid_date_48": 2006.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_49": 16304857.0, "pmid_date_49": 2005.0, "pmid_journal_49": "J Pak Med Assoc"}, {"pmid_title_50": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_50": 16291361.0, "pmid_date_50": 2005.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_51": 15692602.0, "pmid_date_51": 2005.0, "pmid_journal_51": "Hematol J"}, {"pmid_title_52": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_52": 16041310.0, "pmid_date_52": 2005.0, "pmid_journal_52": "Biol Blood Marrow Transplant"}, {"pmid_title_53": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_53": 15813920.0, "pmid_date_53": 2005.0, "pmid_journal_53": "Eur J Haematol"}, {"pmid_title_54": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_54": 15795909.0, "pmid_date_54": 2005.0, "pmid_journal_54": "Am J Hematol"}, {"pmid_title_55": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_55": 14984172.0, "pmid_date_55": 2004.0, "pmid_journal_55": "J Trop Pediatr"}, {"pmid_title_56": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_56": 15220956.0, "pmid_date_56": 2004.0, "pmid_journal_56": "Bone Marrow Transplant"}, {"pmid_title_57": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_57": 14979474.0, "pmid_date_57": 2004.0, "pmid_journal_57": "Int J Hematol"}, {"pmid_title_58": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_58": 15382270.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatr Blood Cancer"}, {"pmid_title_59": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_59": 18521394.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Sarcoma"}, {"pmid_title_60": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_60": 14608205.0, "pmid_date_60": 2003.0, "pmid_journal_60": "J Pediatr Hematol Oncol"}, {"pmid_title_61": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_61": 12359817.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_62": 12351372.0, "pmid_date_62": 2002.0, "pmid_journal_62": "Blood"}, {"pmid_title_63": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_63": 12022425.0, "pmid_date_63": 2002.0, "pmid_journal_63": "J Trop Pediatr"}, {"pmid_title_64": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_64": 12142794.0, "pmid_date_64": 2002.0, "pmid_journal_64": "J Pediatr Hematol Oncol"}, {"pmid_title_65": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_65": 11313667.0, "pmid_date_65": 2001.0, "pmid_journal_65": "Bone Marrow Transplant"}, {"pmid_title_66": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_66": 11196268.0, "pmid_date_66": 2001.0, "pmid_journal_66": "J Pediatr Hematol Oncol"}, {"pmid_title_67": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_67": 11563769.0, "pmid_date_67": 2001.0, "pmid_journal_67": "J Pediatr Hematol Oncol"}, {"pmid_title_68": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_68": 10779036.0, "pmid_date_68": 2000.0, "pmid_journal_68": "J Pediatr Hematol Oncol"}, {"pmid_title_69": "Diamond-Blackfan anemia.", "pmid_69": 10698294.0, "pmid_date_69": 2000.0, "pmid_journal_69": "Curr Opin Hematol"}, {"pmid_title_70": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_70": 10673683.0, "pmid_date_70": 2000.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_71": 27263505.0, "pmid_date_71": 2000.0, "pmid_journal_71": "Turk J Haematol"}, {"pmid_title_72": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_72": 10714760.0, "pmid_date_72": 2000.0, "pmid_journal_72": "J Pediatr Endocrinol Metab"}, {"pmid_title_73": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_73": 10397110.0, "pmid_date_73": 1999.0, "pmid_journal_73": "AJR Am J Roentgenol"}, {"pmid_title_74": "Bone marrow transplantation in non-malignant disorders.", "pmid_74": 9916644.0, "pmid_date_74": 1998.0, "pmid_journal_74": "Bone Marrow Transplant"}, {"pmid_title_75": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_75": 8846147.0, "pmid_date_75": 1996.0, "pmid_journal_75": "J Pediatr Hematol Oncol"}, {"pmid_title_76": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_76": 8606629.0, "pmid_date_76": 1996.0, "pmid_journal_76": "Medicine (Baltimore)"}, {"pmid_title_77": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_77": 8625135.0, "pmid_date_77": 1995.0, "pmid_journal_77": "Cancer"}, {"pmid_title_78": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_78": 7691318.0, "pmid_date_78": 1993.0, "pmid_journal_78": "Stem Cells"}, {"pmid_title_79": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_79": 3109937.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Eur J Haematol"}, {"pmid_title_80": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_80": 13105384.0, "pmid_date_80": 1953.0, "pmid_journal_80": "Arch Dis Child"}]}, {"_id": "10416-OMIM:617409", "condition": {"condition_name": "DIAMOND-BLACKFAN ANEMIA 17", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["DIAMOND-BLACKFAN ANEMIA 17"]}, "gene information": {"db_hgnc_gene_id": 10416.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Methotrexate", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "Yes", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Fludarabine"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole", "timeframe_int54": "Hours,Days or Weeks,Years", "age_use_int54": "Neonate,Infant,Child", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Effective / Ameliorative"}, {"int_description_55": "Cisplatin"}, {"int_description_56": "Muplestim"}, {"int_description_57": "Filgrastim", "timeframe_int57": "Days or Weeks,Years", "age_use_int57": "Infant,Child", "contra_int57": "No", "qualscale_reclass_drug57": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug57": "Curative"}, {"int_description_58": "Total body irradiation"}, {"int_description_59": "Radiotherapy"}, {"int_description_60": "red blood cells transfusion"}, {"int_description_61": "Thoracoabdominal irradiation"}, {"int_description_62": "Total lymphoid irradiation"}, {"int_description_63": "Above-knee amputation"}, {"int_description_64": "Bone marrow transplantation"}, {"int_description_65": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_66": "laparotomy, tumor dissection"}, {"int_description_67": "limb-salvage surgery"}, {"int_description_68": "Maxillectomy"}, {"int_description_69": "umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "How I manage children with Diamond-Blackfan anaemia.", "pmid_2": 30515771.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_3": 31916719.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Turk J Pediatr"}, {"pmid_title_4": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_4": 31355022.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Case Rep Hematol"}, {"pmid_title_5": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_5": 30811439.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PLoS One"}, {"pmid_title_6": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_6": 30881276.0, "pmid_date_6": 2019.0, "pmid_journal_6": "EJIFCC"}, {"pmid_title_7": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_7": 31208452.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Med Case Rep"}, {"pmid_title_8": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_8": 31574871.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_9": 30411682.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Curr Gene Ther"}, {"pmid_title_10": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_10": 29222242.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_11": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_11": 28623394.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Ann Hematol"}, {"pmid_title_12": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_12": 27882484.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Int J Hematol"}, {"pmid_title_13": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_13": 27537786.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Eur J Haematol"}, {"pmid_title_14": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_14": 28602958.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_15": 27082377.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Blood Cancer"}, {"pmid_title_16": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_16": 26872907.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Int J Hematol"}, {"pmid_title_17": "Pure red cell aplasia.", "pmid_17": 27881371.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Pure red cell aplasia.", "pmid_18": 27913462.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_19": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_19": 27329125.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Int J Hematol"}, {"pmid_title_20": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_20": 26496000.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_21": 25492299.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_22": 25963299.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Am J Hematol"}, {"pmid_title_23": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_23": 24611452.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_24": 24296492.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Biol Blood Marrow Transplant"}, {"pmid_title_25": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_25": 23795277.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Mediterr J Hematol Infect Dis"}, {"pmid_title_26": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_26": 22619618.0, "pmid_date_26": 2012.0, "pmid_journal_26": "ScientificWorldJournal"}, {"pmid_title_27": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_27": 23016900.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Br J Haematol"}, {"pmid_title_28": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_28": 24744655.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Turk J Haematol"}, {"pmid_title_29": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_29": 21062271.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Clin Exp Immunol"}, {"pmid_title_30": "How I treat Diamond-Blackfan anemia.", "pmid_30": 20651069.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Blood"}, {"pmid_title_31": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_31": 20655265.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Transfus Clin Biol"}, {"pmid_title_32": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_32": 20190482.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Intern Med"}, {"pmid_title_33": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_33": 19415275.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Ann Hematol"}, {"pmid_title_34": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_34": 18164793.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_35": 18671700.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Br J Haematol"}, {"pmid_title_36": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_36": 18028431.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Eur J Haematol"}, {"pmid_title_37": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_37": 18776763.0, "pmid_date_37": 2008.0, "pmid_journal_37": "J Pediatr Hematol Oncol"}, {"pmid_title_38": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_38": 18331650.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_39": "Deferasirox.", "pmid_39": 17353569.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Am J Health Syst Pharm"}, {"pmid_title_40": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_40": 17414568.0, "pmid_date_40": 2007.0, "pmid_journal_40": "J Pediatr Hematol Oncol"}, {"pmid_title_41": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_41": 17663681.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_42": 17562599.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Haematologica"}, {"pmid_title_43": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_43": 17312003.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Blood"}, {"pmid_title_44": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_44": 17921858.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_45": 16679921.0, "pmid_date_45": 2006.0, "pmid_journal_45": "J Pediatr Hematol Oncol"}, {"pmid_title_46": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_46": 17325961.0, "pmid_date_46": 2006.0, "pmid_journal_46": "Hematology"}, {"pmid_title_47": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_47": 16317735.0, "pmid_date_47": 2006.0, "pmid_journal_47": "Pediatr Blood Cancer"}, {"pmid_title_48": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_48": 16785135.0, "pmid_date_48": 2006.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_49": 16304857.0, "pmid_date_49": 2005.0, "pmid_journal_49": "J Pak Med Assoc"}, {"pmid_title_50": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_50": 16291361.0, "pmid_date_50": 2005.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_51": 15692602.0, "pmid_date_51": 2005.0, "pmid_journal_51": "Hematol J"}, {"pmid_title_52": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_52": 16041310.0, "pmid_date_52": 2005.0, "pmid_journal_52": "Biol Blood Marrow Transplant"}, {"pmid_title_53": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_53": 15813920.0, "pmid_date_53": 2005.0, "pmid_journal_53": "Eur J Haematol"}, {"pmid_title_54": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_54": 15795909.0, "pmid_date_54": 2005.0, "pmid_journal_54": "Am J Hematol"}, {"pmid_title_55": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_55": 14984172.0, "pmid_date_55": 2004.0, "pmid_journal_55": "J Trop Pediatr"}, {"pmid_title_56": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_56": 15220956.0, "pmid_date_56": 2004.0, "pmid_journal_56": "Bone Marrow Transplant"}, {"pmid_title_57": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_57": 14979474.0, "pmid_date_57": 2004.0, "pmid_journal_57": "Int J Hematol"}, {"pmid_title_58": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_58": 15382270.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatr Blood Cancer"}, {"pmid_title_59": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_59": 18521394.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Sarcoma"}, {"pmid_title_60": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_60": 14608205.0, "pmid_date_60": 2003.0, "pmid_journal_60": "J Pediatr Hematol Oncol"}, {"pmid_title_61": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_61": 12359817.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_62": 12351372.0, "pmid_date_62": 2002.0, "pmid_journal_62": "Blood"}, {"pmid_title_63": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_63": 12022425.0, "pmid_date_63": 2002.0, "pmid_journal_63": "J Trop Pediatr"}, {"pmid_title_64": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_64": 12142794.0, "pmid_date_64": 2002.0, "pmid_journal_64": "J Pediatr Hematol Oncol"}, {"pmid_title_65": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_65": 11313667.0, "pmid_date_65": 2001.0, "pmid_journal_65": "Bone Marrow Transplant"}, {"pmid_title_66": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_66": 11196268.0, "pmid_date_66": 2001.0, "pmid_journal_66": "J Pediatr Hematol Oncol"}, {"pmid_title_67": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_67": 11563769.0, "pmid_date_67": 2001.0, "pmid_journal_67": "J Pediatr Hematol Oncol"}, {"pmid_title_68": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_68": 10779036.0, "pmid_date_68": 2000.0, "pmid_journal_68": "J Pediatr Hematol Oncol"}, {"pmid_title_69": "Diamond-Blackfan anemia.", "pmid_69": 10698294.0, "pmid_date_69": 2000.0, "pmid_journal_69": "Curr Opin Hematol"}, {"pmid_title_70": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_70": 10673683.0, "pmid_date_70": 2000.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_71": 27263505.0, "pmid_date_71": 2000.0, "pmid_journal_71": "Turk J Haematol"}, {"pmid_title_72": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_72": 10714760.0, "pmid_date_72": 2000.0, "pmid_journal_72": "J Pediatr Endocrinol Metab"}, {"pmid_title_73": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_73": 10397110.0, "pmid_date_73": 1999.0, "pmid_journal_73": "AJR Am J Roentgenol"}, {"pmid_title_74": "Bone marrow transplantation in non-malignant disorders.", "pmid_74": 9916644.0, "pmid_date_74": 1998.0, "pmid_journal_74": "Bone Marrow Transplant"}, {"pmid_title_75": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_75": 8846147.0, "pmid_date_75": 1996.0, "pmid_journal_75": "J Pediatr Hematol Oncol"}, {"pmid_title_76": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_76": 8606629.0, "pmid_date_76": 1996.0, "pmid_journal_76": "Medicine (Baltimore)"}, {"pmid_title_77": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_77": 8625135.0, "pmid_date_77": 1995.0, "pmid_journal_77": "Cancer"}, {"pmid_title_78": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_78": 7691318.0, "pmid_date_78": 1993.0, "pmid_journal_78": "Stem Cells"}, {"pmid_title_79": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_79": 3109937.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Eur J Haematol"}, {"pmid_title_80": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_80": 13105384.0, "pmid_date_80": 1953.0, "pmid_journal_80": "Arch Dis Child"}]}, {"_id": "10418-OMIM:606164", "condition": {"condition_name": "DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS"]}, "gene information": {"db_hgnc_gene_id": 10418.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Methotrexate", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "Yes", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Fludarabine"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole", "timeframe_int54": "Hours,Days or Weeks,Years", "age_use_int54": "Neonate,Infant,Child", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Effective / Ameliorative"}, {"int_description_55": "Cisplatin"}, {"int_description_56": "Muplestim"}, {"int_description_57": "Filgrastim", "timeframe_int57": "Days or Weeks,Years", "age_use_int57": "Infant,Child", "contra_int57": "No", "qualscale_reclass_drug57": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug57": "Curative"}, {"int_description_58": "Total body irradiation"}, {"int_description_59": "Radiotherapy"}, {"int_description_60": "red blood cells transfusion"}, {"int_description_61": "Thoracoabdominal irradiation"}, {"int_description_62": "Total lymphoid irradiation"}, {"int_description_63": "Above-knee amputation"}, {"int_description_64": "Bone marrow transplantation"}, {"int_description_65": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_66": "laparotomy, tumor dissection"}, {"int_description_67": "limb-salvage surgery"}, {"int_description_68": "Maxillectomy"}, {"int_description_69": "umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "How I manage children with Diamond-Blackfan anaemia.", "pmid_2": 30515771.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_3": 31916719.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Turk J Pediatr"}, {"pmid_title_4": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_4": 31355022.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Case Rep Hematol"}, {"pmid_title_5": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_5": 30811439.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PLoS One"}, {"pmid_title_6": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_6": 30881276.0, "pmid_date_6": 2019.0, "pmid_journal_6": "EJIFCC"}, {"pmid_title_7": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_7": 31208452.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Med Case Rep"}, {"pmid_title_8": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_8": 31574871.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_9": 30411682.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Curr Gene Ther"}, {"pmid_title_10": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_10": 29222242.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_11": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_11": 28623394.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Ann Hematol"}, {"pmid_title_12": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_12": 27882484.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Int J Hematol"}, {"pmid_title_13": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_13": 27537786.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Eur J Haematol"}, {"pmid_title_14": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_14": 28602958.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_15": 27082377.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Blood Cancer"}, {"pmid_title_16": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_16": 26872907.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Int J Hematol"}, {"pmid_title_17": "Pure red cell aplasia.", "pmid_17": 27881371.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Pure red cell aplasia.", "pmid_18": 27913462.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_19": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_19": 27329125.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Int J Hematol"}, {"pmid_title_20": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_20": 26496000.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_21": 25492299.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_22": 25963299.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Am J Hematol"}, {"pmid_title_23": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_23": 24611452.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_24": 24296492.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Biol Blood Marrow Transplant"}, {"pmid_title_25": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_25": 23795277.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Mediterr J Hematol Infect Dis"}, {"pmid_title_26": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_26": 22619618.0, "pmid_date_26": 2012.0, "pmid_journal_26": "ScientificWorldJournal"}, {"pmid_title_27": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_27": 23016900.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Br J Haematol"}, {"pmid_title_28": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_28": 24744655.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Turk J Haematol"}, {"pmid_title_29": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_29": 21062271.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Clin Exp Immunol"}, {"pmid_title_30": "How I treat Diamond-Blackfan anemia.", "pmid_30": 20651069.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Blood"}, {"pmid_title_31": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_31": 20655265.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Transfus Clin Biol"}, {"pmid_title_32": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_32": 20190482.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Intern Med"}, {"pmid_title_33": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_33": 19415275.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Ann Hematol"}, {"pmid_title_34": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_34": 18164793.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_35": 18671700.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Br J Haematol"}, {"pmid_title_36": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_36": 18028431.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Eur J Haematol"}, {"pmid_title_37": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_37": 18776763.0, "pmid_date_37": 2008.0, "pmid_journal_37": "J Pediatr Hematol Oncol"}, {"pmid_title_38": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_38": 18331650.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_39": "Deferasirox.", "pmid_39": 17353569.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Am J Health Syst Pharm"}, {"pmid_title_40": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_40": 17414568.0, "pmid_date_40": 2007.0, "pmid_journal_40": "J Pediatr Hematol Oncol"}, {"pmid_title_41": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_41": 17663681.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_42": 17562599.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Haematologica"}, {"pmid_title_43": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_43": 17312003.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Blood"}, {"pmid_title_44": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_44": 17921858.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_45": 16679921.0, "pmid_date_45": 2006.0, "pmid_journal_45": "J Pediatr Hematol Oncol"}, {"pmid_title_46": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_46": 17325961.0, "pmid_date_46": 2006.0, "pmid_journal_46": "Hematology"}, {"pmid_title_47": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_47": 16317735.0, "pmid_date_47": 2006.0, "pmid_journal_47": "Pediatr Blood Cancer"}, {"pmid_title_48": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_48": 16785135.0, "pmid_date_48": 2006.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_49": 16304857.0, "pmid_date_49": 2005.0, "pmid_journal_49": "J Pak Med Assoc"}, {"pmid_title_50": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_50": 16291361.0, "pmid_date_50": 2005.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_51": 15692602.0, "pmid_date_51": 2005.0, "pmid_journal_51": "Hematol J"}, {"pmid_title_52": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_52": 16041310.0, "pmid_date_52": 2005.0, "pmid_journal_52": "Biol Blood Marrow Transplant"}, {"pmid_title_53": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_53": 15813920.0, "pmid_date_53": 2005.0, "pmid_journal_53": "Eur J Haematol"}, {"pmid_title_54": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_54": 15795909.0, "pmid_date_54": 2005.0, "pmid_journal_54": "Am J Hematol"}, {"pmid_title_55": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_55": 14984172.0, "pmid_date_55": 2004.0, "pmid_journal_55": "J Trop Pediatr"}, {"pmid_title_56": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_56": 15220956.0, "pmid_date_56": 2004.0, "pmid_journal_56": "Bone Marrow Transplant"}, {"pmid_title_57": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_57": 14979474.0, "pmid_date_57": 2004.0, "pmid_journal_57": "Int J Hematol"}, {"pmid_title_58": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_58": 15382270.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatr Blood Cancer"}, {"pmid_title_59": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_59": 18521394.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Sarcoma"}, {"pmid_title_60": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_60": 14608205.0, "pmid_date_60": 2003.0, "pmid_journal_60": "J Pediatr Hematol Oncol"}, {"pmid_title_61": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_61": 12359817.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_62": 12351372.0, "pmid_date_62": 2002.0, "pmid_journal_62": "Blood"}, {"pmid_title_63": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_63": 12022425.0, "pmid_date_63": 2002.0, "pmid_journal_63": "J Trop Pediatr"}, {"pmid_title_64": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_64": 12142794.0, "pmid_date_64": 2002.0, "pmid_journal_64": "J Pediatr Hematol Oncol"}, {"pmid_title_65": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_65": 11313667.0, "pmid_date_65": 2001.0, "pmid_journal_65": "Bone Marrow Transplant"}, {"pmid_title_66": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_66": 11196268.0, "pmid_date_66": 2001.0, "pmid_journal_66": "J Pediatr Hematol Oncol"}, {"pmid_title_67": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_67": 11563769.0, "pmid_date_67": 2001.0, "pmid_journal_67": "J Pediatr Hematol Oncol"}, {"pmid_title_68": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_68": 10779036.0, "pmid_date_68": 2000.0, "pmid_journal_68": "J Pediatr Hematol Oncol"}, {"pmid_title_69": "Diamond-Blackfan anemia.", "pmid_69": 10698294.0, "pmid_date_69": 2000.0, "pmid_journal_69": "Curr Opin Hematol"}, {"pmid_title_70": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_70": 10673683.0, "pmid_date_70": 2000.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_71": 27263505.0, "pmid_date_71": 2000.0, "pmid_journal_71": "Turk J Haematol"}, {"pmid_title_72": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_72": 10714760.0, "pmid_date_72": 2000.0, "pmid_journal_72": "J Pediatr Endocrinol Metab"}, {"pmid_title_73": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_73": 10397110.0, "pmid_date_73": 1999.0, "pmid_journal_73": "AJR Am J Roentgenol"}, {"pmid_title_74": "Bone marrow transplantation in non-malignant disorders.", "pmid_74": 9916644.0, "pmid_date_74": 1998.0, "pmid_journal_74": "Bone Marrow Transplant"}, {"pmid_title_75": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_75": 8846147.0, "pmid_date_75": 1996.0, "pmid_journal_75": "J Pediatr Hematol Oncol"}, {"pmid_title_76": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_76": 8606629.0, "pmid_date_76": 1996.0, "pmid_journal_76": "Medicine (Baltimore)"}, {"pmid_title_77": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_77": 8625135.0, "pmid_date_77": 1995.0, "pmid_journal_77": "Cancer"}, {"pmid_title_78": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_78": 7691318.0, "pmid_date_78": 1993.0, "pmid_journal_78": "Stem Cells"}, {"pmid_title_79": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_79": 3109937.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Eur J Haematol"}, {"pmid_title_80": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_80": 13105384.0, "pmid_date_80": 1953.0, "pmid_journal_80": "Arch Dis Child"}]}, {"_id": "10419-OMIM:615909", "condition": {"condition_name": "DIAMOND-BLACKFAN ANEMIA 13", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["DIAMOND-BLACKFAN ANEMIA 13"]}, "gene information": {"db_hgnc_gene_id": 10419.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Methotrexate", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "Yes", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Fludarabine"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole", "timeframe_int54": "Hours,Days or Weeks,Years", "age_use_int54": "Neonate,Infant,Child", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Contraindicated"}, {"int_description_55": "Cisplatin"}, {"int_description_56": "Muplestim"}, {"int_description_57": "Filgrastim", "timeframe_int57": "Days or Weeks,Years", "age_use_int57": "Infant,Child", "qualscale_reclass_drug57": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug57": "Curative"}, {"int_description_58": "Total body irradiation"}, {"int_description_59": "Radiotherapy"}, {"int_description_60": "red blood cells transfusion"}, {"int_description_61": "Thoracoabdominal irradiation"}, {"int_description_62": "Total lymphoid irradiation"}, {"int_description_63": "Above-knee amputation"}, {"int_description_64": "Bone marrow transplantation"}, {"int_description_65": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_66": "laparotomy, tumor dissection"}, {"int_description_67": "limb-salvage surgery"}, {"int_description_68": "Maxillectomy"}, {"int_description_69": "umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "How I manage children with Diamond-Blackfan anaemia.", "pmid_2": 30515771.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_3": 31916719.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Turk J Pediatr"}, {"pmid_title_4": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_4": 31355022.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Case Rep Hematol"}, {"pmid_title_5": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_5": 30811439.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PLoS One"}, {"pmid_title_6": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_6": 30881276.0, "pmid_date_6": 2019.0, "pmid_journal_6": "EJIFCC"}, {"pmid_title_7": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_7": 31208452.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Med Case Rep"}, {"pmid_title_8": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_8": 31574871.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_9": 30411682.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Curr Gene Ther"}, {"pmid_title_10": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_10": 29222242.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_11": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_11": 28623394.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Ann Hematol"}, {"pmid_title_12": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_12": 27882484.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Int J Hematol"}, {"pmid_title_13": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_13": 27537786.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Eur J Haematol"}, {"pmid_title_14": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_14": 28602958.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_15": 27082377.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Blood Cancer"}, {"pmid_title_16": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_16": 26872907.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Int J Hematol"}, {"pmid_title_17": "Pure red cell aplasia.", "pmid_17": 27881371.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Pure red cell aplasia.", "pmid_18": 27913462.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_19": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_19": 27329125.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Int J Hematol"}, {"pmid_title_20": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_20": 26496000.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_21": 25492299.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_22": 25963299.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Am J Hematol"}, {"pmid_title_23": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_23": 24611452.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_24": 24296492.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Biol Blood Marrow Transplant"}, {"pmid_title_25": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_25": 23795277.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Mediterr J Hematol Infect Dis"}, {"pmid_title_26": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_26": 22619618.0, "pmid_date_26": 2012.0, "pmid_journal_26": "ScientificWorldJournal"}, {"pmid_title_27": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_27": 23016900.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Br J Haematol"}, {"pmid_title_28": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_28": 24744655.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Turk J Haematol"}, {"pmid_title_29": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_29": 21062271.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Clin Exp Immunol"}, {"pmid_title_30": "How I treat Diamond-Blackfan anemia.", "pmid_30": 20651069.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Blood"}, {"pmid_title_31": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_31": 20655265.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Transfus Clin Biol"}, {"pmid_title_32": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_32": 20190482.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Intern Med"}, {"pmid_title_33": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_33": 19415275.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Ann Hematol"}, {"pmid_title_34": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_34": 18164793.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_35": 18671700.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Br J Haematol"}, {"pmid_title_36": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_36": 18028431.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Eur J Haematol"}, {"pmid_title_37": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_37": 18776763.0, "pmid_date_37": 2008.0, "pmid_journal_37": "J Pediatr Hematol Oncol"}, {"pmid_title_38": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_38": 18331650.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_39": "Deferasirox.", "pmid_39": 17353569.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Am J Health Syst Pharm"}, {"pmid_title_40": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_40": 17414568.0, "pmid_date_40": 2007.0, "pmid_journal_40": "J Pediatr Hematol Oncol"}, {"pmid_title_41": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_41": 17663681.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_42": 17562599.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Haematologica"}, {"pmid_title_43": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_43": 17312003.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Blood"}, {"pmid_title_44": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_44": 17921858.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_45": 16679921.0, "pmid_date_45": 2006.0, "pmid_journal_45": "J Pediatr Hematol Oncol"}, {"pmid_title_46": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_46": 17325961.0, "pmid_date_46": 2006.0, "pmid_journal_46": "Hematology"}, {"pmid_title_47": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_47": 16317735.0, "pmid_date_47": 2006.0, "pmid_journal_47": "Pediatr Blood Cancer"}, {"pmid_title_48": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_48": 16785135.0, "pmid_date_48": 2006.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_49": 16304857.0, "pmid_date_49": 2005.0, "pmid_journal_49": "J Pak Med Assoc"}, {"pmid_title_50": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_50": 16291361.0, "pmid_date_50": 2005.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_51": 15692602.0, "pmid_date_51": 2005.0, "pmid_journal_51": "Hematol J"}, {"pmid_title_52": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_52": 16041310.0, "pmid_date_52": 2005.0, "pmid_journal_52": "Biol Blood Marrow Transplant"}, {"pmid_title_53": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_53": 15813920.0, "pmid_date_53": 2005.0, "pmid_journal_53": "Eur J Haematol"}, {"pmid_title_54": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_54": 15795909.0, "pmid_date_54": 2005.0, "pmid_journal_54": "Am J Hematol"}, {"pmid_title_55": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_55": 14984172.0, "pmid_date_55": 2004.0, "pmid_journal_55": "J Trop Pediatr"}, {"pmid_title_56": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_56": 15220956.0, "pmid_date_56": 2004.0, "pmid_journal_56": "Bone Marrow Transplant"}, {"pmid_title_57": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_57": 14979474.0, "pmid_date_57": 2004.0, "pmid_journal_57": "Int J Hematol"}, {"pmid_title_58": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_58": 15382270.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatr Blood Cancer"}, {"pmid_title_59": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_59": 18521394.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Sarcoma"}, {"pmid_title_60": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_60": 14608205.0, "pmid_date_60": 2003.0, "pmid_journal_60": "J Pediatr Hematol Oncol"}, {"pmid_title_61": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_61": 12359817.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_62": 12351372.0, "pmid_date_62": 2002.0, "pmid_journal_62": "Blood"}, {"pmid_title_63": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_63": 12022425.0, "pmid_date_63": 2002.0, "pmid_journal_63": "J Trop Pediatr"}, {"pmid_title_64": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_64": 12142794.0, "pmid_date_64": 2002.0, "pmid_journal_64": "J Pediatr Hematol Oncol"}, {"pmid_title_65": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_65": 11313667.0, "pmid_date_65": 2001.0, "pmid_journal_65": "Bone Marrow Transplant"}, {"pmid_title_66": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_66": 11196268.0, "pmid_date_66": 2001.0, "pmid_journal_66": "J Pediatr Hematol Oncol"}, {"pmid_title_67": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_67": 11563769.0, "pmid_date_67": 2001.0, "pmid_journal_67": "J Pediatr Hematol Oncol"}, {"pmid_title_68": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_68": 10779036.0, "pmid_date_68": 2000.0, "pmid_journal_68": "J Pediatr Hematol Oncol"}, {"pmid_title_69": "Diamond-Blackfan anemia.", "pmid_69": 10698294.0, "pmid_date_69": 2000.0, "pmid_journal_69": "Curr Opin Hematol"}, {"pmid_title_70": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_70": 10673683.0, "pmid_date_70": 2000.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_71": 27263505.0, "pmid_date_71": 2000.0, "pmid_journal_71": "Turk J Haematol"}, {"pmid_title_72": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_72": 10714760.0, "pmid_date_72": 2000.0, "pmid_journal_72": "J Pediatr Endocrinol Metab"}, {"pmid_title_73": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_73": 10397110.0, "pmid_date_73": 1999.0, "pmid_journal_73": "AJR Am J Roentgenol"}, {"pmid_title_74": "Bone marrow transplantation in non-malignant disorders.", "pmid_74": 9916644.0, "pmid_date_74": 1998.0, "pmid_journal_74": "Bone Marrow Transplant"}, {"pmid_title_75": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_75": 8846147.0, "pmid_date_75": 1996.0, "pmid_journal_75": "J Pediatr Hematol Oncol"}, {"pmid_title_76": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_76": 8606629.0, "pmid_date_76": 1996.0, "pmid_journal_76": "Medicine (Baltimore)"}, {"pmid_title_77": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_77": 8625135.0, "pmid_date_77": 1995.0, "pmid_journal_77": "Cancer"}, {"pmid_title_78": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_78": 7691318.0, "pmid_date_78": 1993.0, "pmid_journal_78": "Stem Cells"}, {"pmid_title_79": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_79": 3109937.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Eur J Haematol"}, {"pmid_title_80": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_80": 13105384.0, "pmid_date_80": 1953.0, "pmid_journal_80": "Arch Dis Child"}]}, {"_id": "10440-OMIM:612563", "condition": {"condition_name": "DIAMOND-BLACKFAN ANEMIA 8", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["DIAMOND-BLACKFAN ANEMIA 8"]}, "gene information": {"db_hgnc_gene_id": 10440.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Methotrexate", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "Yes", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Fludarabine"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole", "timeframe_int54": "Hours,Days or Weeks,Years", "age_use_int54": "Neonate,Infant,Child", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Effective / Ameliorative"}, {"int_description_55": "Cisplatin"}, {"int_description_56": "Muplestim"}, {"int_description_57": "Filgrastim", "timeframe_int57": "Days or Weeks,Years", "age_use_int57": "Infant,Child", "contra_int57": "No", "qualscale_reclass_drug57": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug57": "Curative"}, {"int_description_58": "Total body irradiation"}, {"int_description_59": "Radiotherapy"}, {"int_description_60": "red blood cells transfusion"}, {"int_description_61": "Thoracoabdominal irradiation"}, {"int_description_62": "Total lymphoid irradiation"}, {"int_description_63": "Above-knee amputation"}, {"int_description_64": "Bone marrow transplantation"}, {"int_description_65": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_66": "laparotomy, tumor dissection"}, {"int_description_67": "limb-salvage surgery"}, {"int_description_68": "Maxillectomy"}, {"int_description_69": "umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "How I manage children with Diamond-Blackfan anaemia.", "pmid_2": 30515771.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_3": 31916719.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Turk J Pediatr"}, {"pmid_title_4": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_4": 31355022.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Case Rep Hematol"}, {"pmid_title_5": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_5": 30811439.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PLoS One"}, {"pmid_title_6": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_6": 30881276.0, "pmid_date_6": 2019.0, "pmid_journal_6": "EJIFCC"}, {"pmid_title_7": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_7": 31208452.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Med Case Rep"}, {"pmid_title_8": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_8": 31574871.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_9": 30411682.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Curr Gene Ther"}, {"pmid_title_10": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_10": 29222242.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_11": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_11": 28623394.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Ann Hematol"}, {"pmid_title_12": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_12": 27882484.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Int J Hematol"}, {"pmid_title_13": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_13": 27537786.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Eur J Haematol"}, {"pmid_title_14": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_14": 28602958.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_15": 27082377.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Blood Cancer"}, {"pmid_title_16": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_16": 26872907.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Int J Hematol"}, {"pmid_title_17": "Pure red cell aplasia.", "pmid_17": 27881371.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Pure red cell aplasia.", "pmid_18": 27913462.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_19": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_19": 27329125.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Int J Hematol"}, {"pmid_title_20": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_20": 26496000.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_21": 25492299.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_22": 25963299.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Am J Hematol"}, {"pmid_title_23": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_23": 24611452.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_24": 24296492.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Biol Blood Marrow Transplant"}, {"pmid_title_25": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_25": 23795277.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Mediterr J Hematol Infect Dis"}, {"pmid_title_26": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_26": 22619618.0, "pmid_date_26": 2012.0, "pmid_journal_26": "ScientificWorldJournal"}, {"pmid_title_27": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_27": 23016900.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Br J Haematol"}, {"pmid_title_28": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_28": 24744655.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Turk J Haematol"}, {"pmid_title_29": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_29": 21062271.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Clin Exp Immunol"}, {"pmid_title_30": "How I treat Diamond-Blackfan anemia.", "pmid_30": 20651069.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Blood"}, {"pmid_title_31": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_31": 20655265.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Transfus Clin Biol"}, {"pmid_title_32": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_32": 20190482.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Intern Med"}, {"pmid_title_33": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_33": 19415275.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Ann Hematol"}, {"pmid_title_34": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_34": 18164793.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_35": 18671700.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Br J Haematol"}, {"pmid_title_36": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_36": 18028431.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Eur J Haematol"}, {"pmid_title_37": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_37": 18776763.0, "pmid_date_37": 2008.0, "pmid_journal_37": "J Pediatr Hematol Oncol"}, {"pmid_title_38": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_38": 18331650.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_39": "Deferasirox.", "pmid_39": 17353569.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Am J Health Syst Pharm"}, {"pmid_title_40": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_40": 17414568.0, "pmid_date_40": 2007.0, "pmid_journal_40": "J Pediatr Hematol Oncol"}, {"pmid_title_41": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_41": 17663681.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_42": 17562599.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Haematologica"}, {"pmid_title_43": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_43": 17312003.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Blood"}, {"pmid_title_44": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_44": 17921858.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_45": 16679921.0, "pmid_date_45": 2006.0, "pmid_journal_45": "J Pediatr Hematol Oncol"}, {"pmid_title_46": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_46": 17325961.0, "pmid_date_46": 2006.0, "pmid_journal_46": "Hematology"}, {"pmid_title_47": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_47": 16317735.0, "pmid_date_47": 2006.0, "pmid_journal_47": "Pediatr Blood Cancer"}, {"pmid_title_48": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_48": 16785135.0, "pmid_date_48": 2006.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_49": 16304857.0, "pmid_date_49": 2005.0, "pmid_journal_49": "J Pak Med Assoc"}, {"pmid_title_50": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_50": 16291361.0, "pmid_date_50": 2005.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_51": 15692602.0, "pmid_date_51": 2005.0, "pmid_journal_51": "Hematol J"}, {"pmid_title_52": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_52": 16041310.0, "pmid_date_52": 2005.0, "pmid_journal_52": "Biol Blood Marrow Transplant"}, {"pmid_title_53": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_53": 15813920.0, "pmid_date_53": 2005.0, "pmid_journal_53": "Eur J Haematol"}, {"pmid_title_54": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_54": 15795909.0, "pmid_date_54": 2005.0, "pmid_journal_54": "Am J Hematol"}, {"pmid_title_55": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_55": 14984172.0, "pmid_date_55": 2004.0, "pmid_journal_55": "J Trop Pediatr"}, {"pmid_title_56": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_56": 15220956.0, "pmid_date_56": 2004.0, "pmid_journal_56": "Bone Marrow Transplant"}, {"pmid_title_57": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_57": 14979474.0, "pmid_date_57": 2004.0, "pmid_journal_57": "Int J Hematol"}, {"pmid_title_58": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_58": 15382270.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatr Blood Cancer"}, {"pmid_title_59": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_59": 18521394.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Sarcoma"}, {"pmid_title_60": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_60": 14608205.0, "pmid_date_60": 2003.0, "pmid_journal_60": "J Pediatr Hematol Oncol"}, {"pmid_title_61": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_61": 12359817.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_62": 12351372.0, "pmid_date_62": 2002.0, "pmid_journal_62": "Blood"}, {"pmid_title_63": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_63": 12022425.0, "pmid_date_63": 2002.0, "pmid_journal_63": "J Trop Pediatr"}, {"pmid_title_64": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_64": 12142794.0, "pmid_date_64": 2002.0, "pmid_journal_64": "J Pediatr Hematol Oncol"}, {"pmid_title_65": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_65": 11313667.0, "pmid_date_65": 2001.0, "pmid_journal_65": "Bone Marrow Transplant"}, {"pmid_title_66": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_66": 11196268.0, "pmid_date_66": 2001.0, "pmid_journal_66": "J Pediatr Hematol Oncol"}, {"pmid_title_67": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_67": 11563769.0, "pmid_date_67": 2001.0, "pmid_journal_67": "J Pediatr Hematol Oncol"}, {"pmid_title_68": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_68": 10779036.0, "pmid_date_68": 2000.0, "pmid_journal_68": "J Pediatr Hematol Oncol"}, {"pmid_title_69": "Diamond-Blackfan anemia.", "pmid_69": 10698294.0, "pmid_date_69": 2000.0, "pmid_journal_69": "Curr Opin Hematol"}, {"pmid_title_70": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_70": 10673683.0, "pmid_date_70": 2000.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_71": 27263505.0, "pmid_date_71": 2000.0, "pmid_journal_71": "Turk J Haematol"}, {"pmid_title_72": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_72": 10714760.0, "pmid_date_72": 2000.0, "pmid_journal_72": "J Pediatr Endocrinol Metab"}, {"pmid_title_73": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_73": 10397110.0, "pmid_date_73": 1999.0, "pmid_journal_73": "AJR Am J Roentgenol"}, {"pmid_title_74": "Bone marrow transplantation in non-malignant disorders.", "pmid_74": 9916644.0, "pmid_date_74": 1998.0, "pmid_journal_74": "Bone Marrow Transplant"}, {"pmid_title_75": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_75": 8846147.0, "pmid_date_75": 1996.0, "pmid_journal_75": "J Pediatr Hematol Oncol"}, {"pmid_title_76": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_76": 8606629.0, "pmid_date_76": 1996.0, "pmid_journal_76": "Medicine (Baltimore)"}, {"pmid_title_77": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_77": 8625135.0, "pmid_date_77": 1995.0, "pmid_journal_77": "Cancer"}, {"pmid_title_78": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_78": 7691318.0, "pmid_date_78": 1993.0, "pmid_journal_78": "Stem Cells"}, {"pmid_title_79": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_79": 3109937.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Eur J Haematol"}, {"pmid_title_80": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_80": 13105384.0, "pmid_date_80": 1953.0, "pmid_journal_80": "Arch Dis Child"}]}, {"_id": "10483-OMIM:145600", "condition": {"condition_name": "MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1"]}, "gene information": {"db_hgnc_gene_id": 10483.0}, "interventions": [{"int_description_1": "Dantrolene", "timeframe_int1": "Hours", "age_use_int1": "Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Intraoperative Presentation of Malignant Hyperthermia (Confirmed by RYR1 Gene Mutation, c.7522C>T; p.R2508C) Leads to Diagnosis of King-Denborough Syndrome in a Child With Hypotonia and Dysmorphic Features: A Case Report.", "pmid_1": 27918309.0, "pmid_date_1": 2017.0, "pmid_journal_1": "A A Case Rep"}]}, {"_id": "10585-OMIM:604403", "condition": {"condition_name": "GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2", "freq_per_birth": "GEFS+ is a rare condition. Its prevalence is unknown.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["MIGRAINE, FAMILIAL HEMIPLEGIC, 3; FHM3", "GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2", "EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6"]}, "gene information": {"db_hgnc_gene_id": 10585.0}, "interventions": [{"int_description_1": "Ezogabine"}, {"int_description_2": "Carbamazepine"}, {"int_description_3": "Ethosuximide", "timeframe_int3": "Days or Weeks", "age_use_int3": "Infant", "contra_int3": "No", "qualscale_reclass_drug3": "Cohort study or studies", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Valproic acid", "timeframe_int4": "Hours", "age_use_int4": "Infant", "contra_int4": "Yes", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Lamotrigine"}, {"int_description_6": "Phenytoin"}, {"int_description_7": "Ranolazine"}], "references": [{"pmid_title_1": "<i>SCN1A</i> Seizure Disorders", "pmid_1": 20301494.0, "pmid_date_1": 2019.0, "pmid_journal_1": "GeneReviews\u00ae"}, {"pmid_title_2": "Dravet Syndrome: An Overview.", "pmid_2": 31497436.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Cureus"}, {"pmid_title_3": "Rescuable folding defective NaV1.1 (SCN1A) mutants in epilepsy: properties, occurrence, and novel rescuing strategy with peptides targeted to the endoplasmic reticulum.", "pmid_3": 25576396.0, "pmid_date_3": 2015.0, "pmid_journal_3": "Neurobiology of disease"}, {"pmid_title_4": "Ranolazine selectively blocks persistent current evoked by epilepsy-associated Na\u03bd1.1 mutations.", "pmid_4": 20735403.0, "pmid_date_4": 2010.0, "pmid_journal_4": "Br J Pharmacol"}, {"pmid_title_5": "Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus.", "pmid_5": 21156207.0, "pmid_date_5": 2010.0, "pmid_journal_5": "Neurobiol Dis"}, {"pmid_title_6": "Increased neuronal firing in computer simulations of sodium channel mutations that cause generalized epilepsy with febrile seizures plus.", "pmid_6": 14702334.0, "pmid_date_6": 2004.0, "pmid_journal_6": "Journal of neurophysiology"}, {"pmid_title_7": "Functional effects of two voltage-gated sodium channel mutations that cause generalized epilepsy with febrile seizures plus type 2.", "pmid_7": 11567038.0, "pmid_date_7": 2001.0, "pmid_journal_7": "J Neurosci"}]}, {"_id": "10585-OMIM:607208", "condition": {"condition_name": "EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["MIGRAINE, FAMILIAL HEMIPLEGIC, 3; FHM3", "EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6", "GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2"]}, "gene information": {"db_hgnc_gene_id": 10585.0}, "interventions": [{"int_description_1": "Mechanical ventilation", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Vagus nerve stimulation"}, {"int_description_3": "Ketogenic diet", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Clobazam", "timeframe_int4": "Days or Weeks,Years", "age_use_int4": "Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Cohort study or studies", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Fenfluramine", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Clonazepam"}, {"int_description_7": "Cannabidiol"}, {"int_description_8": "Topiramate", "timeframe_int8": "Days or Weeks", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Atropine"}, {"int_description_10": "Methscopolamine", "timeframe_int10": "Days or Weeks", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Methylatropine", "timeframe_int11": "Hours,Days or Weeks", "age_use_int11": "Neonate,Infant,Child", "contra_int11": "No", "qualscale_reclass_drug11": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "Levetiracetam"}, {"int_description_13": "Carbamazepine"}, {"int_description_14": "Zonisamide", "timeframe_int14": "Days or Weeks", "age_use_int14": "Neonate,Infant,Child", "contra_int14": "No", "qualscale_reclass_drug14": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}, {"int_description_15": "Valproic acid", "timeframe_int15": "Days or Weeks", "age_use_int15": "Neonate,Infant,Child", "contra_int15": "No", "qualscale_reclass_drug15": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug15": "Effective / Ameliorative"}, {"int_description_16": "Lamotrigine"}, {"int_description_17": "Phenytoin", "timeframe_int17": "Days or Weeks,Years", "age_use_int17": "Infant,Child", "contra_int17": "No", "rev1_eff_reclass_drug17": "Effective / Ameliorative"}, {"int_description_18": "Stiripentol", "timeframe_int18": "Days or Weeks,Years", "age_use_int18": "Infant,Child", "contra_int18": "No", "qualscale_reclass_drug18": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug18": "Effective / Ameliorative"}, {"int_description_19": "Potassium bromide"}, {"int_description_20": "Phenobarbital"}], "references": [{"pmid_title_1": "<i>SCN1A</i> Seizure Disorders", "pmid_1": 20301494.0, "pmid_date_1": 2019.0, "pmid_journal_1": "GeneReviews\u00ae"}, {"pmid_title_2": "Time of Day and a Ketogenic Diet Influence Susceptibility to SUDEP in <i>Scn1a</i> <sup><i>R1407X</i>/+</sup> Mice.", "pmid_2": 30984098.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Front Neurol"}, {"pmid_title_3": "Dravet Syndrome: An Overview.", "pmid_3": 31497436.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Cureus"}, {"pmid_title_4": "Severe peri-ictal respiratory dysfunction is common in Dravet syndrome.", "pmid_4": 29329111.0, "pmid_date_4": 2018.0, "pmid_journal_4": "J Clin Invest"}, {"pmid_title_5": "Pathogenesis and new candidate treatments for infantile spasms and early life epileptic encephalopathies: A view from preclinical studies.", "pmid_5": 25968935.0, "pmid_date_5": 2015.0, "pmid_journal_5": "Neurobiol Dis"}]}, {"_id": "10585-OMIM:609634", "condition": {"condition_name": "MIGRAINE, FAMILIAL HEMIPLEGIC, 3; FHM3", "freq_per_birth": "The worldwide prevalence of familial hemiplegic migraine is unknown. Studies suggest that in Denmark about 1 in 10,000 people have hemiplegic migraine and that the condition occurs equally in families with multiple affected individuals (familial hemiplegic migraine) and in individuals with no family history of the condition (sporadic hemiplegic migraine). Like other forms of migraine, familial hemiplegic migraine affects females more often than males.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6", "MIGRAINE, FAMILIAL HEMIPLEGIC, 3; FHM3", "GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2"]}, "gene information": {"db_hgnc_gene_id": 10585.0}, "interventions": [{"int_description_1": "Topiramate"}, {"int_description_2": "Levetiracetam", "timeframe_int2": "Days or Weeks", "age_use_int2": "Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Lacosamide", "timeframe_int3": "Days or Weeks", "age_use_int3": "Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Valproic acid", "timeframe_int4": "Days or Weeks", "age_use_int4": "Child", "contra_int4": "Yes", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Ranolazine"}], "references": [{"pmid_title_1": "Familial Hemiplegic Migraine", "pmid_1": 20301562.0, "pmid_date_1": 2015.0, "pmid_journal_1": "GeneReviews\u00ae"}, {"pmid_title_2": "Ranolazine selectively blocks persistent current evoked by epilepsy-associated Na\u03bd1.1 mutations.", "pmid_2": 20735403.0, "pmid_date_2": 2010.0, "pmid_journal_2": "Br J Pharmacol"}]}, {"_id": "10588-OMIM:607745", "condition": {"condition_name": "SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11", "SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3", "EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1"]}, "gene information": {"db_hgnc_gene_id": 10588.0}, "interventions": [{"int_description_1": "Topiramate"}, {"int_description_2": "Levetiracetam"}, {"int_description_3": "Oxcarbazepine", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Carbamazepine", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Valproic acid"}, {"int_description_6": "Phenytoin", "timeframe_int6": "Hours,Days or Weeks", "age_use_int6": "Neonate,Infant", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Sodium channel blockers"}, {"int_description_8": "Phenobarbital", "timeframe_int8": "Hours,Days or Weeks", "age_use_int8": "Neonate,Infant", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "<i>SCN1A</i> Seizure Disorders", "pmid_1": 20301494.0, "pmid_date_1": 2019.0, "pmid_journal_1": "GeneReviews\u00ae"}, {"pmid_title_2": "Phenotypic spectrum and genetics of SCN2A-related disorders, treatment options, and outcomes in epilepsy and beyond.", "pmid_2": 31904126.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Epilepsia"}, {"pmid_title_3": "Further corroboration of distinct functional features in SCN2A variants causing intellectual disability or epileptic phenotypes.", "pmid_3": 30813884.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Molecular medicine (Cambridge, Mass.)"}, {"pmid_title_4": "Integration of biological/pathophysiological contexts to help clarify genotype-phenotype mismatches in monogenetic diseases. Childhood epilepsies associated with SCN2A as a case study.", "pmid_4": 29307654.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Biochemical pharmacology"}, {"pmid_title_5": "Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance.", "pmid_5": 23360469.0, "pmid_date_5": 2013.0, "pmid_journal_5": "Epilepsia"}]}, {"_id": "10588-OMIM:613721", "condition": {"condition_name": "EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3", "EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11", "EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1"]}, "gene information": {"db_hgnc_gene_id": 10588.0}, "interventions": [{"int_description_1": "Vagus nerve stimulation", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Clobazam"}, {"int_description_3": "Corticotropin", "timeframe_int3": "Days or Weeks,Years", "age_use_int3": "Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Clonazepam", "timeframe_int4": "Days or Weeks,Years", "age_use_int4": "Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Nitrazepam"}, {"int_description_6": "Propranolol"}, {"int_description_7": "Topiramate"}, {"int_description_8": "Midazolam", "timeframe_int8": "Days or Weeks,Years", "age_use_int8": "Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Case report(s)", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Levetiracetam"}, {"int_description_10": "Dalfampridine"}, {"int_description_11": "Oxcarbazepine"}, {"int_description_12": "Lidocaine", "timeframe_int12": "Hours,Days or Weeks", "age_use_int12": "Neonate,Infant", "contra_int12": "No", "qualscale_reclass_drug12": "Case report(s)", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Mexiletine"}, {"int_description_14": "Carbamazepine"}, {"int_description_15": "Lacosamide"}, {"int_description_16": "Pyridoxine", "timeframe_int16": "Days or Weeks,Years", "age_use_int16": "Infant,Child", "contra_int16": "No", "qualscale_reclass_drug16": "Case report(s)", "rev1_eff_reclass_drug16": "Effective / Ameliorative"}, {"int_description_17": "Zonisamide"}, {"int_description_18": "Vigabatrin", "timeframe_int18": "Hours,Days or Weeks", "age_use_int18": "Neonate,Infant", "contra_int18": "No", "qualscale_reclass_drug18": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug18": "Effective / Ameliorative"}, {"int_description_19": "Valproic acid"}, {"int_description_20": "Lamotrigine"}, {"int_description_21": "Phenytoin", "timeframe_int21": "Days or Weeks,Years", "age_use_int21": "Infant,Child", "contra_int21": "No", "qualscale_reclass_drug21": "Case report(s)", "rev1_eff_reclass_drug21": "Effective / Ameliorative"}, {"int_description_22": "Corticotherapy"}, {"int_description_23": "Benzodiazepine", "timeframe_int23": "Hours,Days or Weeks", "age_use_int23": "Neonate,Infant", "contra_int23": "No", "qualscale_reclass_drug23": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug23": "Effective / Ameliorative"}, {"int_description_24": "Sodium channel blockers"}, {"int_description_25": "Phenobarbital"}], "references": [{"pmid_title_1": "<i>SCN1A</i> Seizure Disorders", "pmid_1": 20301494.0, "pmid_date_1": 2019.0, "pmid_journal_1": "GeneReviews\u00ae"}, {"pmid_title_2": "Phenotypic spectrum and genetics of SCN2A-related disorders, treatment options, and outcomes in epilepsy and beyond.", "pmid_2": 31904126.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Epilepsia"}, {"pmid_title_3": "Progress in Understanding and Treating SCN2A-Mediated Disorders.", "pmid_3": 29691040.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Trends in neurosciences"}, {"pmid_title_4": "Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.", "pmid_4": 28379373.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Brain : a journal of neurology"}, {"pmid_title_5": "Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia.", "pmid_5": 26645390.0, "pmid_date_5": 2016.0, "pmid_journal_5": "Journal of neurology"}, {"pmid_title_6": "A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline.", "pmid_6": 15028761.0, "pmid_date_6": 2004.0, "pmid_journal_6": "The Journal of neuroscience : the official journal of the Society for Neuroscience"}]}, {"_id": "10590-OMIM:617935", "condition": {"condition_name": "EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4"]}, "gene information": {"db_hgnc_gene_id": 10590.0}, "interventions": [{"int_description_1": "Oxcarbazepine", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Carbamazepine", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Phenobarbital", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Various anticonvulsant medications were tried with limited success"}], "references": [{"pmid_title_1": "SCN3A deficiency associated with increased seizure susceptibility.", "pmid_1": 28235671.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Neurobiology of disease"}, {"pmid_title_2": "Novel SCN3A variants associated with focal epilepsy in children.", "pmid_2": 24157691.0, "pmid_date_2": 2014.0, "pmid_journal_2": "Neurobiology of disease"}]}, {"_id": "10591-OMIM:168300", "condition": {"condition_name": "PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC", "freq_per_birth": "Paramyotonia congenita is an uncommon disorder; it is estimated to affect fewer than 1 in 100,000 people.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["NORMOKALEMIC PERIODIC PARALYSIS", "PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC", "HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2", "MYOTONIA, POTASSIUM-AGGRAVATED", "HYPERKALEMIC PERIODIC PARALYSIS; HYPP", "MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16"]}, "gene information": {"db_hgnc_gene_id": 10591.0}, "interventions": [{"int_description_1": "Pacemaker"}, {"int_description_2": "Salbutamol", "timeframe_int2": "Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Lidocaine"}, {"int_description_4": "Mexiletine"}, {"int_description_5": "Carbamazepine"}, {"int_description_6": "Hydrochlorothiazide", "timeframe_int6": "Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Case report(s)", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Acetazolamide"}, {"int_description_8": "Chlorothiazide"}, {"int_description_9": "Flecainide"}, {"int_description_10": "Ranolazine"}, {"int_description_11": "Potassium chloride"}, {"int_description_12": "Potassium"}, {"int_description_13": "\u03b1-[(2-methylphenoxy)methyl]-benzenemethanamine (Me7)"}], "references": [{"pmid_title_1": "Prolonged attacks of weakness with hypokalemia in SCN4A-related paramyotonia congenita.", "pmid_1": 30028520.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Muscle & nerve"}, {"pmid_title_2": "Whole-Body Muscle MRI in Patients with Hyperkalemic Periodic Paralysis Carrying the SCN4A Mutation T704M: Evidence for Chronic Progressive Myopathy with Selective Muscle Involvement.", "pmid_2": 26256659.0, "pmid_date_2": 2015.0, "pmid_journal_2": "Journal of clinical neurology (Seoul, Korea)"}, {"pmid_title_3": "Imaging alterations in skeletal muscle channelopathies: a study in 15 patients.", "pmid_3": 27199537.0, "pmid_date_3": 2015.0, "pmid_journal_3": "Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology"}, {"pmid_title_4": "Clinical experience with long-term acetazolamide treatment in children with nondystrophic myotonias: a three-case report.", "pmid_4": 25042881.0, "pmid_date_4": 2014.0, "pmid_journal_4": "Pediatric neurology"}, {"pmid_title_5": "Severe phenotypes of paralysis periodica paramyotonia are associated with the Met1592Val mutation in the voltage-gated sodium channel gene (SCN4A) in a Chinese family.", "pmid_5": 21665479.0, "pmid_date_5": 2011.0, "pmid_journal_5": "Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia"}, {"pmid_title_6": "Ranolazine block of human Na v 1.4 sodium channels and paramyotonia congenita mutants.", "pmid_6": 21317558.0, "pmid_date_6": 2011.0, "pmid_journal_6": "Channels (Austin, Tex.)"}, {"pmid_title_7": "Preferred mexiletine block of human sodium channels with IVS4 mutations and its pH-dependence.", "pmid_7": 15864116.0, "pmid_date_7": 2005.0, "pmid_journal_7": "Pharmacogenetics and genomics"}, {"pmid_title_8": "Different flecainide sensitivity of hNav1.4 channels and myotonic mutants explained by state-dependent block.", "pmid_8": 14608015.0, "pmid_date_8": 2004.0, "pmid_journal_8": "The Journal of physiology"}, {"pmid_title_9": "Severe infantile hyperkalaemic periodic paralysis and paramyotonia congenita: broadening the clinical spectrum associated with the T704M mutation in SCN4A.", "pmid_9": 12933953.0, "pmid_date_9": 2003.0, "pmid_journal_9": "Journal of neurology, neurosurgery, and psychiatry"}, {"pmid_title_10": "Gating of myotonic Na channel mutants defines the response to mexiletine and a potent derivative.", "pmid_10": 11723275.0, "pmid_date_10": 2001.0, "pmid_journal_10": "Neurology"}, {"pmid_title_11": "Paramyotonia congenita: genotype to phenotype correlations in two families and report of a new mutation in the sodium channel gene.", "pmid_11": 8902732.0, "pmid_date_11": 1996.0, "pmid_journal_11": "Journal of the neurological sciences"}, {"pmid_title_12": "Two human paramyotonia congenita mutations have opposite effects on lidocaine block of Na+ channels expressed in a mammalian cell line.", "pmid_12": 8910215.0, "pmid_date_12": 1996.0, "pmid_journal_12": "The Journal of physiology"}]}, {"_id": "10591-OMIM:170500", "condition": {"condition_name": "HYPERKALEMIC PERIODIC PARALYSIS; HYPP", "freq_per_birth": "Hyperkalemic periodic paralysis affects an estimated 1 in 200,000 people.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["NORMOKALEMIC PERIODIC PARALYSIS", "HYPERKALEMIC PERIODIC PARALYSIS; HYPP", "HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2", "MYOTONIA, POTASSIUM-AGGRAVATED", "PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC", "MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16"]}, "gene information": {"db_hgnc_gene_id": 10591.0}, "interventions": [{"int_description_1": "Pacemaker", "timeframe_int1": "Hours", "age_use_int1": "Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Cardbohydrate rich, potassium free diet", "timeframe_int2": "Hours", "age_use_int2": "Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Salbutamol", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Prednisone", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Child", "contra_int4": "No", "qualscale_reclass_drug4": "Cohort study or studies", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Hydrochlorothiazide"}, {"int_description_6": "Acetazolamide"}, {"int_description_7": "Chlorothiazide"}, {"int_description_8": "Diclofenamide"}, {"int_description_9": "Azathioprine", "timeframe_int9": "Hours", "age_use_int9": "Child", "contra_int9": "No", "qualscale_reclass_drug9": "Case report(s)", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Calcium gluconate"}, {"int_description_11": "Diuretics"}, {"int_description_12": "Glucocorticoid therapy"}, {"int_description_13": "Thiazide diuretic"}, {"int_description_14": "Mild exercise"}], "references": [{"pmid_title_1": "Lower-extremity magnetic resonance imaging in patients with hyperkalemic periodic paralysis carrying the SCN4A mutation T704M: 30-month follow-up of seven patients.", "pmid_1": 30172468.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Neuromuscular disorders : NMD"}, {"pmid_title_2": "Hyperkalemic Periodic Paralysis", "pmid_2": 20301669.0, "pmid_date_2": 2016.0, "pmid_journal_2": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_3": "Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis.", "pmid_3": 26865514.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Neurology"}, {"pmid_title_4": "Whole-Body Muscle MRI in Patients with Hyperkalemic Periodic Paralysis Carrying the SCN4A Mutation T704M: Evidence for Chronic Progressive Myopathy with Selective Muscle Involvement.", "pmid_4": 26256659.0, "pmid_date_4": 2015.0, "pmid_journal_4": "Journal of clinical neurology (Seoul, Korea)"}, {"pmid_title_5": "Imaging alterations in skeletal muscle channelopathies: a study in 15 patients.", "pmid_5": 27199537.0, "pmid_date_5": 2015.0, "pmid_journal_5": "Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology"}, {"pmid_title_6": "Severe phenotypes of paralysis periodica paramyotonia are associated with the Met1592Val mutation in the voltage-gated sodium channel gene (SCN4A) in a Chinese family.", "pmid_6": 21665479.0, "pmid_date_6": 2011.0, "pmid_journal_6": "Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia"}, {"pmid_title_7": "Familial hyperkalemic periodic paralysis caused by a de novo mutation in the sodium channel gene SCN4A.", "pmid_7": 22253644.0, "pmid_date_7": 2011.0, "pmid_journal_7": "Korean journal of pediatrics"}, {"pmid_title_8": "Beneficial effect of albuterol in congenital myasthenic syndrome with epsilon-subunit mutations.", "pmid_8": 21721016.0, "pmid_date_8": 2011.0, "pmid_journal_8": "Muscle & nerve"}, {"pmid_title_9": "Disappearance of episodic weakness during pregnancy in hyperkalemic periodic paralysis from the SCNA4 mutation T704M.", "pmid_9": 19741438.0, "pmid_date_9": 2009.0, "pmid_journal_9": "The neurologist"}, {"pmid_title_10": "Hyperkalaemia in a tetraplegic adolescent due to de novo sodium channel mutation.", "pmid_10": 17804458.0, "pmid_date_10": 2008.0, "pmid_journal_10": "Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"}, {"pmid_title_11": "Severe infantile hyperkalaemic periodic paralysis and paramyotonia congenita: broadening the clinical spectrum associated with the T704M mutation in SCN4A.", "pmid_11": 12933953.0, "pmid_date_11": 2003.0, "pmid_journal_11": "Journal of neurology, neurosurgery, and psychiatry"}, {"pmid_title_12": "Paramyotonia congenita: genotype to phenotype correlations in two families and report of a new mutation in the sodium channel gene.", "pmid_12": 8902732.0, "pmid_date_12": 1996.0, "pmid_journal_12": "Journal of the neurological sciences"}, {"pmid_title_13": "Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysis.", "pmid_13": 8388676.0, "pmid_date_13": 1993.0, "pmid_journal_13": "Annals of neurology"}]}, {"_id": "10591-OMIM:170600", "condition": {"condition_name": "NORMOKALEMIC PERIODIC PARALYSIS", "alternate_names": ["HYPERKALEMIC PERIODIC PARALYSIS; HYPP", "NORMOKALEMIC PERIODIC PARALYSIS", "HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2", "MYOTONIA, POTASSIUM-AGGRAVATED", "PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC", "MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16"]}, "gene information": {"db_hgnc_gene_id": 10591.0}, "interventions": [{"int_description_1": "High sodium diet"}, {"int_description_2": "Budesonide", "timeframe_int2": "Days or Weeks", "age_use_int2": "Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Hydrochlorothiazide", "timeframe_int3": "Days or Weeks", "age_use_int3": "Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Acetazolamide"}, {"int_description_5": "Metformin"}, {"int_description_6": "Acetylsalicylic acid", "timeframe_int6": "Days or Weeks", "age_use_int6": "Child", "contra_int6": "No", "qualscale_reclass_drug6": "Case report(s)", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Normal saline solution", "timeframe_int7": "Hours", "age_use_int7": "Child", "contra_int7": "No", "qualscale_reclass_drug7": "Case report(s)", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Successful treatment of normokalemic periodic paralysis with hydrochlorothiazide.", "pmid_1": 29907477.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Brain & development"}, {"pmid_title_2": "Familial Normokalemic Periodic Paralysis Associated With Mutation in the <i>SCN4A</i> p.M1592V.", "pmid_2": 29930533.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Frontiers in neurology"}, {"pmid_title_3": "Mutations of sodium channel alpha-subunit genes in Chinese patients with normokalemic periodic paralysis.", "pmid_3": 18046642.0, "pmid_date_3": 2008.0, "pmid_journal_3": "Cellular and molecular neurobiology"}]}, {"_id": "10591-OMIM:608390", "condition": {"condition_name": "MYOTONIA, POTASSIUM-AGGRAVATED", "freq_per_birth": "This condition appears to be rare; it has been reported in only a few individuals and families worldwide.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["HYPERKALEMIC PERIODIC PARALYSIS; HYPP", "MYOTONIA, POTASSIUM-AGGRAVATED", "HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2", "NORMOKALEMIC PERIODIC PARALYSIS", "PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC", "MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16"]}, "gene information": {"db_hgnc_gene_id": 10591.0}, "interventions": [{"int_description_1": "Mask ventilation"}, {"int_description_2": "Desipramine", "timeframe_int2": "Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Oxcarbazepine"}, {"int_description_4": "Mexiletine"}, {"int_description_5": "Carbamazepine", "timeframe_int5": "Days or Weeks,Years", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Quinidine", "timeframe_int6": "Days or Weeks,Years", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Case report(s)", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Acetazolamide"}, {"int_description_8": "Flecainide"}, {"int_description_9": "Hydroquinidine"}, {"int_description_10": "Lamotrigine", "timeframe_int10": "Hours", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Case report(s)", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Tocainide"}, {"int_description_12": "Phenytoin"}, {"int_description_13": "Barbiturates"}, {"int_description_14": "Penicilline"}, {"int_description_15": "Thiazide diuretic"}, {"int_description_16": "Laryngomalacia surgery"}], "references": [{"pmid_title_1": "Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate.", "pmid_1": 30611854.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Pharmacological research"}, {"pmid_title_2": "Flecainide-Induced Brugada Syndrome in a Patient With Skeletal Muscle Sodium Channelopathy: A Case Report With Critical Therapeutical Implications and Review of the Literature.", "pmid_2": 29899727.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Frontiers in neurology"}, {"pmid_title_3": "Myotonia permanens with Nav1.4-G1306E displays varied phenotypes during course of life.", "pmid_3": 29774303.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology"}, {"pmid_title_4": "Flecainide-Responsive Myotonia Permanens With SNEL Onset: A New Case and Literature Review.", "pmid_4": 26944947.0, "pmid_date_4": 2016.0, "pmid_journal_4": "Pediatrics"}, {"pmid_title_5": "Mutations in SCN4A: a rare but treatable cause of recurrent life-threatening laryngospasm.", "pmid_5": 25311598.0, "pmid_date_5": 2014.0, "pmid_journal_5": "Pediatrics"}, {"pmid_title_6": "Diagnosis and outcome of SCN4A-related severe neonatal episodic laryngospasm (SNEL): 2 new cases.", "pmid_6": 23958773.0, "pmid_date_6": 2013.0, "pmid_journal_6": "Pediatrics"}, {"pmid_title_7": "Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy.", "pmid_7": 23052413.0, "pmid_date_7": 2013.0, "pmid_journal_7": "European journal of clinical pharmacology"}]}, {"_id": "10591-OMIM:613345", "condition": {"condition_name": "HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2", "freq_per_birth": "Although its exact prevalence is unknown, hypokalemic periodic paralysis is estimated to affect 1 in 100,000 people. Men tend to experience symptoms of this condition more often than women.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["HYPERKALEMIC PERIODIC PARALYSIS; HYPP", "HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2", "MYOTONIA, POTASSIUM-AGGRAVATED", "NORMOKALEMIC PERIODIC PARALYSIS", "PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC", "MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16"]}, "gene information": {"db_hgnc_gene_id": 10591.0}, "interventions": [{"int_description_1": "Pacemaker", "timeframe_int1": "Days or Weeks", "age_use_int1": "Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Low carbohydrate/sodium, high potassium diet", "timeframe_int2": "Days or Weeks", "age_use_int2": "Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Spironolactone"}, {"int_description_4": "Eplerenone", "timeframe_int4": "Days or Weeks", "age_use_int4": "Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Bumetanide"}, {"int_description_6": "Triamterene", "timeframe_int6": "Days or Weeks", "age_use_int6": "Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Hydrochlorothiazide", "timeframe_int7": "Days or Weeks", "age_use_int7": "Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline"}, {"int_description_8": "Acetazolamide"}, {"int_description_9": "Diclofenamide", "timeframe_int9": "Days or Weeks", "age_use_int9": "Child", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Potassium chloride"}, {"int_description_11": "Potassium", "timeframe_int11": "Days or Weeks", "age_use_int11": "Child", "contra_int11": "No", "qualscale_reclass_drug11": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "Potassium-sparing diuretics", "timeframe_int12": "Days or Weeks", "age_use_int12": "Child", "contra_int12": "No", "qualscale_reclass_drug12": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Hypokalemic Periodic Paralysis", "pmid_1": 20301512.0, "pmid_date_1": 2018.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Prolonged attacks of weakness with hypokalemia in SCN4A-related paramyotonia congenita.", "pmid_2": 30028520.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Muscle & nerve"}, {"pmid_title_3": "Bumetanide prevents transient decreases in muscle force in murine hypokalemic periodic paralysis.", "pmid_3": 23427324.0, "pmid_date_3": 2013.0, "pmid_journal_3": "Neurology"}, {"pmid_title_4": "Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype.", "pmid_4": 22094484.0, "pmid_date_4": 2011.0, "pmid_journal_4": "Neurology"}, {"pmid_title_5": "Atypical arrhythmic complications in familial hypokalemic periodic paralysis.", "pmid_5": 19708131.0, "pmid_date_5": 2009.0, "pmid_journal_5": "Journal of cardiovascular medicine (Hagerstown, Md.)"}, {"pmid_title_6": "The genotype and clinical phenotype of Korean patients with familial hypokalemic periodic paralysis.", "pmid_6": 18162704.0, "pmid_date_6": 2007.0, "pmid_journal_6": "Journal of Korean medical science"}]}, {"_id": "10591-OMIM:614198", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16", "freq_per_birth": "The prevalence of congenital myasthenic syndrome is unknown. At least 600 families with affected individuals have been described in the scientific literature.", "pattern_of_inheritance": "Autosomal dominant==Autosomal recessive", "alternate_names": ["HYPERKALEMIC PERIODIC PARALYSIS; HYPP", "MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16", "MYOTONIA, POTASSIUM-AGGRAVATED", "NORMOKALEMIC PERIODIC PARALYSIS", "PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC", "HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2"]}, "gene information": {"db_hgnc_gene_id": 10591.0}, "interventions": [{"int_description_1": "Ventilation", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Myasthenic syndrome caused by mutation of the SCN4A sodium channel.", "pmid_1": 12766226.0, "pmid_date_1": 2003.0, "pmid_journal_1": "Proceedings of the National Academy of Sciences of the United States of America"}]}, {"_id": "10593-OMIM:113900", "condition": {"condition_name": "PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A", "freq_per_birth": "The prevalence of progressive familial heart block is unknown. In the United States, about 1 in 5,000 individuals have complete heart block from any cause; worldwide, about 1 in 2,500 individuals have complete heart block.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["CARDIOMYOPATHY, DILATED, 1E; CMD1E", "PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A", "ATRIAL FIBRILLATION, FAMILIAL, 10; ATFB10", "LONG QT SYNDROME 3; LQT3", "VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1; VF1", "BRUGADA SYNDROME 1; BRGDA1", "SICK SINUS SYNDROME 1; SSS1"]}, "gene information": {"db_hgnc_gene_id": 10593.0}, "interventions": [{"int_description_1": "Epinephrine"}, {"int_description_2": "Dobutamine"}, {"int_description_3": "Isoprenaline"}, {"int_description_4": "Dopamine"}, {"int_description_5": "Aminophylline"}, {"int_description_6": "Atropine"}, {"int_description_7": "Procainamide", "timeframe_int7": "Hours", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Pacemaker implantation"}], "references": [{"pmid_title_1": "2018 ACC/AHA/HRS Guideline on the\u00a0Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society.", "pmid_1": 30412710.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Journal of the American College of Cardiology"}, {"pmid_title_2": "Anaesthetic management of pacemaker implantation in a child with dilated cardiomyopathy and acquired complete atrioventricular heart block.", "pmid_2": 31772403.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Indian journal of anaesthesia"}, {"pmid_title_3": "Utility of isoproterenol in unmasking latent escape rhythm in pacemaker dependent patients undergoing pacemaker replacement.", "pmid_3": 18308011.0, "pmid_date_3": 2008.0, "pmid_journal_3": "The American journal of cardiology"}, {"pmid_title_4": "Paradoxical effect of isoprenaline infusion.", "pmid_4": 16216767.0, "pmid_date_4": 2005.0, "pmid_journal_4": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology"}, {"pmid_title_5": "A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation.", "pmid_5": 12569159.0, "pmid_date_5": 2003.0, "pmid_journal_5": "The Journal of clinical investigation"}, {"pmid_title_6": "Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block.", "pmid_6": 11804990.0, "pmid_date_6": 2002.0, "pmid_journal_6": "Circulation"}, {"pmid_title_7": "Cardiac conduction defects associate with mutations in SCN5A.", "pmid_7": 10471492.0, "pmid_date_7": 1999.0, "pmid_journal_7": "Nature genetics"}, {"pmid_title_8": "Procainamide administration during electrophysiology study--utility as a provocative test for intermittent atrioventricular block.", "pmid_8": 2462213.0, "pmid_date_8": 1988.0, "pmid_journal_8": "Pacing and clinical electrophysiology : PACE"}, {"pmid_title_9": "Bedside evaluation of atrioventricular block with narrow QRS complexes: usefulness of carotid sinus massage and atropine administration.", "pmid_9": 7064840.0, "pmid_date_9": 1982.0, "pmid_journal_9": "The American journal of cardiology"}]}, {"_id": "10593-OMIM:601144", "condition": {"condition_name": "BRUGADA SYNDROME 1; BRGDA1", "freq_per_birth": "The exact prevalence of Brugada syndrome is unknown, although it is estimated to affect 5 in 10,000 people worldwide.  This condition occurs much more frequently in people of Asian ancestry, particularly in Japanese and Southeast Asian populations.Although Brugada syndrome affects both men and women, the condition appears to be 8 to 10 times more common in men.  Researchers suspect that testosterone, a sex hormone present at much higher levels in men, may account for this difference.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["CARDIOMYOPATHY, DILATED, 1E; CMD1E", "BRUGADA SYNDROME 1; BRGDA1", "ATRIAL FIBRILLATION, FAMILIAL, 10; ATFB10", "LONG QT SYNDROME 3; LQT3", "VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1; VF1", "PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A", "SICK SINUS SYNDROME 1; SSS1"]}, "gene information": {"db_hgnc_gene_id": 10593.0}, "interventions": [{"int_description_1": "Implantable cardioverter defibrillator (ICD)", "timeframe_int1": "Hours", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Placement of a temporary pacemaker"}, {"int_description_3": "Isoprenaline"}, {"int_description_4": "Procainamide", "timeframe_int4": "Hours", "age_use_int4": "Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Pilsicainide"}, {"int_description_6": "Verapamil", "timeframe_int6": "Hours,Days or Weeks", "age_use_int6": "Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Quinidine"}, {"int_description_8": "Epicardial Substrate Ablation"}], "references": [{"pmid_title_1": "Non-invasive assessment of the arrhythmogenic substrate in Brugada syndrome using signal-averaged electrocardiogram: clinical implications from a prospective clinical trial.", "pmid_1": 31647530.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology"}, {"pmid_title_2": "Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.", "pmid_2": 28500178.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Circulation. Arrhythmia and electrophysiology"}, {"pmid_title_3": "Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation.", "pmid_3": 26291334.0, "pmid_date_3": 2015.0, "pmid_journal_3": "Circulation. Arrhythmia and electrophysiology"}, {"pmid_title_4": "ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene.", "pmid_4": 24439875.0, "pmid_date_4": 2014.0, "pmid_journal_4": "International journal of cardiology"}, {"pmid_title_5": "Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium.", "pmid_5": 21403098.0, "pmid_date_5": 2011.0, "pmid_journal_5": "Circulation"}, {"pmid_title_6": "Identification of six novel SCN5A mutations in Japanese patients with Brugada syndrome.", "pmid_6": 21321465.0, "pmid_date_6": 2011.0, "pmid_journal_6": "International heart journal"}, {"pmid_title_7": "Monomorphic ventricular tachycardia due to Brugada syndrome successfully treated by hydroquinidine therapy in a 3-year-old child.", "pmid_7": 16426410.0, "pmid_date_7": 2006.0, "pmid_journal_7": "Journal of cardiovascular electrophysiology"}, {"pmid_title_8": "Efficacy of quinidine in high-risk patients with Brugada syndrome.", "pmid_8": 15381640.0, "pmid_date_8": 2004.0, "pmid_journal_8": "Circulation"}, {"pmid_title_9": "Electrical storm in Brugada syndrome successfully treated using isoprenaline.", "pmid_9": 15018871.0, "pmid_date_9": 2004.0, "pmid_journal_9": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology"}, {"pmid_title_10": "Hydroquinidine therapy in Brugada syndrome.", "pmid_10": 15145111.0, "pmid_date_10": 2004.0, "pmid_journal_10": "Journal of the American College of Cardiology"}]}, {"_id": "10593-OMIM:601154", "condition": {"condition_name": "CARDIOMYOPATHY, DILATED, 1E; CMD1E", "freq_per_birth": "It is estimated that 750,000 people in the United States have dilated cardiomyopathy; roughly half of these cases are familial.", "pattern_of_inheritance": "Autosomal dominant==X-linked dominant==Autosomal recessive", "alternate_names": ["BRUGADA SYNDROME 1; BRGDA1", "CARDIOMYOPATHY, DILATED, 1E; CMD1E", "ATRIAL FIBRILLATION, FAMILIAL, 10; ATFB10", "LONG QT SYNDROME 3; LQT3", "VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1; VF1", "PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A", "SICK SINUS SYNDROME 1; SSS1"]}, "gene information": {"db_hgnc_gene_id": 10593.0}, "interventions": [{"int_description_1": "Cardiac Assist Devices (Mechanical Hearts)"}, {"int_description_2": "Implantable Cardiac Defibrillator (ICD)"}, {"int_description_3": "Pacemakers"}, {"int_description_4": "Heparin"}, {"int_description_5": "Isosorbide dinitrate"}, {"int_description_6": "Norepinephrine"}, {"int_description_7": "Dopamine"}, {"int_description_8": "Carvedilol"}, {"int_description_9": "Spironolactone"}, {"int_description_10": "Losartan"}, {"int_description_11": "Metoprolol"}, {"int_description_12": "Eplerenone"}, {"int_description_13": "Candesartan", "timeframe_int13": "Days or Weeks", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Tolvaptan"}, {"int_description_15": "Bisoprolol"}, {"int_description_16": "Amiodarone"}, {"int_description_17": "Sotalol"}, {"int_description_18": "Ivabradine"}, {"int_description_19": "Bumetanide"}, {"int_description_20": "Valsartan"}, {"int_description_21": "Digoxin"}, {"int_description_22": "Furosemide", "timeframe_int22": "Days or Weeks", "age_use_int22": "Neonate,Infant,Child", "contra_int22": "No", "qualscale_reclass_drug22": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug22": "Effective / Ameliorative"}, {"int_description_23": "Hydralazine"}, {"int_description_24": "Ramipril"}, {"int_description_25": "Trandolapril"}, {"int_description_26": "Enalapril"}, {"int_description_27": "Lisinopril", "timeframe_int27": "Days or Weeks", "age_use_int27": "Neonate,Infant,Child", "contra_int27": "No", "qualscale_reclass_drug27": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug27": "Effective / Ameliorative"}, {"int_description_28": "Captopril"}, {"int_description_29": "Dofetilide"}, {"int_description_30": "Quinidine"}, {"int_description_31": "Acetazolamide"}, {"int_description_32": "Enoxaparin"}, {"int_description_33": "Torasemide"}, {"int_description_34": "Etacrynic acid"}, {"int_description_35": "Flecainide"}, {"int_description_36": "Rosuvastatin"}, {"int_description_37": "Sacubitril"}, {"int_description_38": "Milrinone"}, {"int_description_39": "Propafenone"}, {"int_description_40": "Metolazone"}, {"int_description_41": "Warfarin"}, {"int_description_42": "Heart Transplantation"}], "references": [{"pmid_title_1": "Heart rate manipulation in dilated cardiomyopathy: Assessing the role of Ivabradine.", "pmid_1": 29716702.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Indian heart journal"}, {"pmid_title_2": "Rapid and effective response of the R222Q SCN5A to quinidine treatment in a patient with Purkinje-related ventricular arrhythmia and familial dilated cardiomyopathy: a case report.", "pmid_2": 29871609.0, "pmid_date_2": 2018.0, "pmid_journal_2": "BMC medical genetics"}, {"pmid_title_3": "2017 ACC Expert Consensus Decision Pathway for Optimization of Heart\u00a0Failure Treatment: Answers to 10\u00a0Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.", "pmid_3": 29277252.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Journal of the American College of Cardiology"}, {"pmid_title_4": "Multifocal atrial and ventricular premature contractions with an increased risk of dilated cardiomyopathy caused by a Na<sub>v</sub>1.5 gain-of-function mutation (G213D).", "pmid_4": 29506689.0, "pmid_date_4": 2018.0, "pmid_journal_4": "International journal of cardiology"}, {"pmid_title_5": "Does Lowering Heart Rate Improve Outcomes in Children With Dilated\u00a0Cardiomyopathy and Chronic\u00a0Heart Failure?", "pmid_5": 28859791.0, "pmid_date_5": 2017.0, "pmid_journal_5": "Journal of the American College of Cardiology"}, {"pmid_title_6": "Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure.", "pmid_6": 28859790.0, "pmid_date_6": 2017.0, "pmid_journal_6": "Journal of the American College of Cardiology"}, {"pmid_title_7": "Tolvaptan: A Novel Diuretic in Heart Failure Management.", "pmid_7": 27403182.0, "pmid_date_7": 2016.0, "pmid_journal_7": "The journal of Tehran Heart Center"}, {"pmid_title_8": "2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.", "pmid_8": 27206819.0, "pmid_date_8": 2016.0, "pmid_journal_8": "European heart journal"}, {"pmid_title_9": "I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.", "pmid_9": 25179314.0, "pmid_date_9": 2015.0, "pmid_journal_9": "Cardiology journal"}, {"pmid_title_10": "Ivabradine might improve exercise capacity in dilated cardiomyopathy in comparison with bisoprolol: assessment with the ergospirometry test.", "pmid_10": 24774739.0, "pmid_date_10": 2014.0, "pmid_journal_10": "Revista espanola de cardiologia (English ed.)"}, {"pmid_title_11": "Angiotensin-neprilysin inhibition versus enalapril in heart failure.", "pmid_11": 25176015.0, "pmid_date_11": 2014.0, "pmid_journal_11": "The New England journal of medicine"}, {"pmid_title_12": "Ivabradine improves heart rate variability in patients with nonischemic dilated cardiomyopathy.", "pmid_12": 25119894.0, "pmid_date_12": 2014.0, "pmid_journal_12": "Arquivos brasileiros de cardiologia"}, {"pmid_title_13": "2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.", "pmid_13": 23747642.0, "pmid_date_13": 2013.0, "pmid_journal_13": "Journal of the American College of Cardiology"}, {"pmid_title_14": "Mechanical circulatory support for advanced heart failure: patients and technology in evolution.", "pmid_14": 22412091.0, "pmid_date_14": 2012.0, "pmid_journal_14": "Circulation"}, {"pmid_title_15": "Eplerenone in patients with systolic heart failure and mild symptoms.", "pmid_15": 21073363.0, "pmid_date_15": 2011.0, "pmid_journal_15": "The New England journal of medicine"}, {"pmid_title_16": "Ivabradine, a novel heart rate slower: is it a sword of double blades in patients with idiopathic dilated cardiomyopathy?", "pmid_16": 21712169.0, "pmid_date_16": 2011.0, "pmid_journal_16": "Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology"}, {"pmid_title_17": "Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial.", "pmid_17": 21111980.0, "pmid_date_17": 2010.0, "pmid_journal_17": "Journal of cardiac failure"}, {"pmid_title_18": "Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.", "pmid_18": 20801500.0, "pmid_date_18": 2010.0, "pmid_journal_18": "Lancet (London, England)"}, {"pmid_title_19": "Comparison of dopamine and norepinephrine in the treatment of shock.", "pmid_19": 20200382.0, "pmid_date_19": 2010.0, "pmid_journal_19": "The New England journal of medicine"}, {"pmid_title_20": "Comparison of Dopamine and Norepinephrine in the treatment of shock.", "pmid_20": 21977124.0, "pmid_date_20": 2010.0, "pmid_journal_20": "Maedica"}, {"pmid_title_21": "Sleep apnoea in patients with heart failure: part II: therapy.", "pmid_21": 19913772.0, "pmid_date_21": 2009.0, "pmid_journal_21": "Archives of cardiovascular diseases"}, {"pmid_title_22": "The management of acute heart failure and diuretic therapy.", "pmid_22": 19142155.0, "pmid_date_22": 2009.0, "pmid_journal_22": "American journal of therapeutics"}, {"pmid_title_23": "Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial.", "pmid_23": 19922995.0, "pmid_date_23": 2009.0, "pmid_journal_23": "Lancet (London, England)"}, {"pmid_title_24": "Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.", "pmid_24": 19406272.0, "pmid_date_24": 2009.0, "pmid_journal_24": "The American journal of cardiology"}, {"pmid_title_25": "Rosuvastatin in older patients with systolic heart failure.", "pmid_25": 17984166.0, "pmid_date_25": 2007.0, "pmid_journal_25": "The New England journal of medicine"}, {"pmid_title_26": "Cardiomyopathy, familial dilated.", "pmid_26": 16839424.0, "pmid_date_26": 2006.0, "pmid_journal_26": "Orphanet journal of rare diseases"}, {"pmid_title_27": "Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.", "pmid_27": 15659722.0, "pmid_date_27": 2005.0, "pmid_journal_27": "The New England journal of medicine"}, {"pmid_title_28": "Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.", "pmid_28": 15492298.0, "pmid_date_28": 2004.0, "pmid_journal_28": "Circulation"}, {"pmid_title_29": "Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.", "pmid_29": 15533851.0, "pmid_date_29": 2004.0, "pmid_journal_29": "The New England journal of medicine"}, {"pmid_title_30": "A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home.", "pmid_30": 15454175.0, "pmid_date_30": 2004.0, "pmid_journal_30": "The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation"}, {"pmid_title_31": "Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease.", "pmid_31": 12679756.0, "pmid_date_31": 2003.0, "pmid_journal_31": "American heart journal"}, {"pmid_title_32": "Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.", "pmid_32": 12595851.0, "pmid_date_32": 2003.0, "pmid_journal_32": "American heart journal"}, {"pmid_title_33": "Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.", "pmid_33": 12390947.0, "pmid_date_33": 2002.0, "pmid_journal_33": "Circulation"}, {"pmid_title_34": "Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors.", "pmid_34": 12392830.0, "pmid_date_34": 2002.0, "pmid_journal_34": "Journal of the American College of Cardiology"}, {"pmid_title_35": "Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in MEDical patients with ENOXaparin (MEDENOX) trial.", "pmid_35": 11206019.0, "pmid_date_35": 2000.0, "pmid_journal_35": "The American journal of cardiology"}, {"pmid_title_36": "Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.", "pmid_36": 10714728.0, "pmid_date_36": 2000.0, "pmid_journal_36": "JAMA"}, {"pmid_title_37": "The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.", "pmid_37": 10023943.0, "pmid_date_37": 1999.0, "pmid_journal_37": "Lancet (London, England)"}, {"pmid_title_38": "Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.", "pmid_38": 10486417.0, "pmid_date_38": 1999.0, "pmid_journal_38": "The New England journal of medicine"}, {"pmid_title_39": "Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction.", "pmid_39": 10091816.0, "pmid_date_39": 1999.0, "pmid_journal_39": "Journal of the American College of Cardiology"}, {"pmid_title_40": "Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.", "pmid_40": 10587334.0, "pmid_date_40": 1999.0, "pmid_journal_40": "Circulation"}, {"pmid_title_41": "The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.", "pmid_41": 10471456.0, "pmid_date_41": 1999.0, "pmid_journal_41": "The New England journal of medicine"}, {"pmid_title_42": "Diuretic therapy.", "pmid_42": 9691107.0, "pmid_date_42": 1998.0, "pmid_journal_42": "The New England journal of medicine"}, {"pmid_title_43": "Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction.", "pmid_43": 9525542.0, "pmid_date_43": 1998.0, "pmid_journal_43": "Journal of the American College of Cardiology"}, {"pmid_title_44": "Ventricular dysfunction and the risk of stroke after myocardial infarction.", "pmid_44": 8995087.0, "pmid_date_44": 1997.0, "pmid_journal_44": "The New England journal of medicine"}, {"pmid_title_45": "Effect of antithrombotic therapy on risk of sudden coronary death in patients with congestive heart failure.", "pmid_45": 9104905.0, "pmid_date_45": 1997.0, "pmid_journal_45": "The American journal of cardiology"}, {"pmid_title_46": "A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy.", "pmid_46": 8789442.0, "pmid_date_46": 1996.0, "pmid_journal_46": "Human molecular genetics"}, {"pmid_title_47": "Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.", "pmid_47": 7539890.0, "pmid_date_47": 1995.0, "pmid_journal_47": "The New England journal of medicine"}, {"pmid_title_48": "Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)", "pmid_48": 7914611.0, "pmid_date_48": 1994.0, "pmid_journal_48": "Lancet (London, England)"}, {"pmid_title_49": "Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial.", "pmid_49": 1545080.0, "pmid_date_49": 1992.0, "pmid_journal_49": "Journal of the American College of Cardiology"}, {"pmid_title_50": "Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.", "pmid_50": 2057034.0, "pmid_date_50": 1991.0, "pmid_journal_50": "The New England journal of medicine"}, {"pmid_title_51": "Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group.", "pmid_51": 2447297.0, "pmid_date_51": 1988.0, "pmid_journal_51": "JAMA"}, {"pmid_title_52": "Low dose heparin for prevention of deep vein thrombosis and pulmonary embolism in medical patients.", "pmid_52": 3306913.0, "pmid_date_52": 1987.0, "pmid_journal_52": "Scottish medical journal"}, {"pmid_title_53": "Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).", "pmid_53": 2883575.0, "pmid_date_53": 1987.0, "pmid_journal_53": "The New England journal of medicine"}, {"pmid_title_54": "Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.", "pmid_54": 3520315.0, "pmid_date_54": 1986.0, "pmid_journal_54": "The New England journal of medicine"}]}, {"_id": "10593-OMIM:603829", "condition": {"condition_name": "VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1; VF1", "pattern_of_inheritance": "Autosomal dominant, Not applicable", "alternate_names": ["BRUGADA SYNDROME 1; BRGDA1", "VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1; VF1", "ATRIAL FIBRILLATION, FAMILIAL, 10; ATFB10", "LONG QT SYNDROME 3; LQT3", "CARDIOMYOPATHY, DILATED, 1E; CMD1E", "PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A", "SICK SINUS SYNDROME 1; SSS1"]}, "gene information": {"db_hgnc_gene_id": 10593.0}, "interventions": [{"int_description_1": "Epinephrine"}, {"int_description_2": "Amiodarone"}, {"int_description_3": "Procainamide"}, {"int_description_4": "Lidocaine"}, {"int_description_5": "Magnesium sulfate"}, {"int_description_6": "Disopyramide"}, {"int_description_7": "Ajmaline"}, {"int_description_8": "Implantable Cardio-Defibrillator"}, {"int_description_9": "Pacemaker implantation"}], "references": [{"pmid_title_1": "Epinephrine", "pmid_1": 29489283.0, "pmid_date_1": 2020.0}, {"pmid_title_2": "Refractory ventricular arrhythmias during aortic valve replacement and cardiac artery bypass requiring 16 attempts of electrical cardioversion: a case report.", "pmid_2": 32783130.0, "pmid_date_2": 2020.0, "pmid_journal_2": "JA clinical reports"}, {"pmid_title_3": "Refractory ventricular fibrillation in patient taking Lamictal.", "pmid_3": 29703563.0, "pmid_date_3": 2018.0, "pmid_journal_3": "The American journal of emergency medicine"}, {"pmid_title_4": "Cohort of Patients Referred for Brugada Syndrome Investigation in an Electrophysiology Service - 19-Year Registry.", "pmid_4": 29898017.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Arquivos brasileiros de cardiologia"}, {"pmid_title_5": "Amiodarone Versus Lidocaine for Pediatric Cardiac Arrest Due to Ventricular Arrhythmias: A Systematic Review.", "pmid_5": 28009655.0, "pmid_date_5": 2017.0, "pmid_journal_5": "Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies"}, {"pmid_title_6": "A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome.", "pmid_6": 10940383.0, "pmid_date_6": 2000.0, "pmid_journal_6": "FEBS letters"}]}, {"_id": "10593-OMIM:603830", "condition": {"condition_name": "LONG QT SYNDROME 3; LQT3", "freq_per_birth": "Romano-Ward syndrome is the most common form of inherited long QT syndrome, which affects an estimated 1 in 2,000 people worldwide. Long QT syndrome may actually be more common than this estimate, however, because some people never experience any symptoms associated with arrhythmia and therefore may not be diagnosed.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["BRUGADA SYNDROME 1; BRGDA1", "LONG QT SYNDROME 3; LQT3", "ATRIAL FIBRILLATION, FAMILIAL, 10; ATFB10", "VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1; VF1", "CARDIOMYOPATHY, DILATED, 1E; CMD1E", "PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A", "SICK SINUS SYNDROME 1; SSS1"]}, "gene information": {"db_hgnc_gene_id": 10593.0}, "interventions": [{"int_description_1": "Propranolol"}, {"int_description_2": "Metoprolol"}, {"int_description_3": "Atenolol"}, {"int_description_4": "Nadolol"}, {"int_description_5": "Lidocaine"}, {"int_description_6": "Eleclazine"}, {"int_description_7": "Mexiletine"}, {"int_description_8": "Flecainide"}, {"int_description_9": "Ranolazine", "timeframe_int9": "Days or Weeks", "age_use_int9": "Child", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Beta-blockers"}, {"int_description_11": "Implantable cardioverter-defibrillator"}, {"int_description_12": "Pacemaker implantation"}], "references": [{"pmid_title_1": "Lidocaine attenuation testing: An in\u00a0vivo investigation of putative LQT3-associated variants in the SCN5A-encoded sodium channel.", "pmid_1": 28412158.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Heart rhythm"}, {"pmid_title_2": "Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: A meta-analysis.", "pmid_2": 29059199.0, "pmid_date_2": 2017.0, "pmid_journal_2": "PloS one"}, {"pmid_title_3": "Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study.", "pmid_3": 27566755.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Circulation"}, {"pmid_title_4": "Pronounced Shortening of QT Interval With Mexiletine Infusion Test in Patients With Type 3 Congenital Long QT Syndrome.", "pmid_4": 26632536.0, "pmid_date_4": 2016.0, "pmid_journal_4": "Circulation journal : official journal of the Japanese Circulation Society"}, {"pmid_title_5": "Congenital long QT syndromes: prevalence, pathophysiology and management.", "pmid_5": 25288402.0, "pmid_date_5": 2014.0, "pmid_journal_5": "Paediatric drugs"}, {"pmid_title_6": "Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome.", "pmid_6": 18662191.0, "pmid_date_6": 2008.0, "pmid_journal_6": "Journal of cardiovascular electrophysiology"}, {"pmid_title_7": "Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial.", "pmid_7": 16274417.0, "pmid_date_7": 2005.0, "pmid_journal_7": "Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc"}, {"pmid_title_8": "Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation.", "pmid_8": 11333173.0, "pmid_date_8": 2001.0, "pmid_journal_8": "Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc"}, {"pmid_title_9": "Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy.", "pmid_9": 8521555.0, "pmid_date_9": 1995.0, "pmid_journal_9": "Circulation"}]}, {"_id": "10593-OMIM:608567", "condition": {"condition_name": "SICK SINUS SYNDROME 1; SSS1", "freq_per_birth": "Sick sinus syndrome accounts for 1 in 600 patients with heart disease who are over age 65. The incidence of this condition increases with age.", "pattern_of_inheritance": "Autosomal dominant==Autosomal recessive", "alternate_names": ["BRUGADA SYNDROME 1; BRGDA1", "SICK SINUS SYNDROME 1; SSS1", "ATRIAL FIBRILLATION, FAMILIAL, 10; ATFB10", "VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1; VF1", "CARDIOMYOPATHY, DILATED, 1E; CMD1E", "PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A", "LONG QT SYNDROME 3; LQT3"]}, "gene information": {"db_hgnc_gene_id": 10593.0}, "interventions": [{"int_description_1": "Epinephrine"}, {"int_description_2": "Methoxamine"}, {"int_description_3": "Isoprenaline"}, {"int_description_4": "Theophylline"}, {"int_description_5": "Propranolol"}, {"int_description_6": "Pindolol"}, {"int_description_7": "Losartan"}, {"int_description_8": "Atropine"}, {"int_description_9": "Digoxin"}, {"int_description_10": "Quinidine", "timeframe_int10": "Hours,Days or Weeks", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Cohort study or studies", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Cilostazol"}, {"int_description_12": "Warfarin", "timeframe_int12": "Hours", "age_use_int12": "Neonate,Infant,Child", "qualscale_reclass_drug12": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Pacemaker implantation"}], "references": [{"pmid_title_1": "Efficacy of cilostazol for sick sinus syndrome to avoid permanent pacemaker implantation: A retrospective case-control study.", "pmid_1": 30982679.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Journal of cardiology"}, {"pmid_title_2": "Beneficial effects of losartan for prevention of paroxysmal atrial fibrillation in patients with sick sinus syndrome: analysis with memory function of pacemaker.", "pmid_2": 25787020.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Heart and vessels"}, {"pmid_title_3": "Perioperative management of hereditary arrhythmogenic syndromes.", "pmid_3": 22499746.0, "pmid_date_3": 2012.0, "pmid_journal_3": "British journal of anaesthesia"}, {"pmid_title_4": "Diagnosis and treatment of sick sinus syndrome.", "pmid_4": 12725451.0, "pmid_date_4": 2003.0, "pmid_journal_4": "American family physician"}, {"pmid_title_5": "Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A).", "pmid_5": 14523039.0, "pmid_date_5": 2003.0, "pmid_journal_5": "The Journal of clinical investigation"}, {"pmid_title_6": "Advances in pacing for the patient with sick sinus syndrome.", "pmid_6": 9132078.0, "pmid_date_6": 1997.0, "pmid_journal_6": "Current opinion in cardiology"}, {"pmid_title_7": "Effects of permanent pacemaker and oral theophylline in sick sinus syndrome the THEOPACE study: a randomized controlled trial.", "pmid_7": 9236443.0, "pmid_date_7": 1997.0, "pmid_journal_7": "Circulation"}, {"pmid_title_8": "[Sick sinus syndrome discovered after induction of general anesthesia in a patient with normal preoperative Holter ECG].", "pmid_8": 7933475.0, "pmid_date_8": 1994.0, "pmid_journal_8": "Masui. The Japanese journal of anesthesiology"}, {"pmid_title_9": "Comparison of effects of propranolol versus pindolol on sinus rate and pacing frequency in sick sinus syndrome.", "pmid_9": 8420236.0, "pmid_date_9": 1993.0, "pmid_journal_9": "The American journal of cardiology"}, {"pmid_title_10": "Heart rate responses to autonomic drugs in sick sinus syndrome--correlation with syncope and electrophysiologic data.", "pmid_10": 2010943.0, "pmid_date_10": 1991.0, "pmid_journal_10": "Japanese circulation journal"}, {"pmid_title_11": "Assessment of oral quinidine effects on sinus node function in sick sinus syndrome patients.", "pmid_11": 7055049.0, "pmid_date_11": 1982.0, "pmid_journal_11": "American heart journal"}]}, {"_id": "10596-OMIM:614558", "condition": {"condition_name": "EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13; EIEE13", "freq_per_birth": "There are at least 140 individuals with SCN8A-related epilepsy with encephalopathy. This condition is estimated to account for 1 percent of all cases of epilepsy with encephalopathy.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13; EIEE13", "SEIZURES, BENIGN FAMILIAL INFANTILE, 5; BFIS5"]}, "gene information": {"db_hgnc_gene_id": 10596.0}, "interventions": [{"int_description_1": "Vagus nerve stimulation", "timeframe_int1": "Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Ketogenic diet", "timeframe_int2": "Days or Weeks,Years", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Clobazam", "timeframe_int3": "Days or Weeks,Years", "age_use_int3": "Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Levodopa"}, {"int_description_5": "Oxitriptan"}, {"int_description_6": "Amitriptyline"}, {"int_description_7": "Carvedilol"}, {"int_description_8": "Topiramate"}, {"int_description_9": "Levetiracetam", "timeframe_int9": "Days or Weeks", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Case report(s)", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Nilvadipine"}, {"int_description_11": "Oxcarbazepine", "timeframe_int11": "Days or Weeks", "age_use_int11": "Neonate,Infant,Child", "contra_int11": "No", "qualscale_reclass_drug11": "Case report(s)", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "Carbamazepine", "timeframe_int12": "Days or Weeks", "age_use_int12": "Neonate,Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Case report(s)", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Lacosamide", "timeframe_int13": "Days or Weeks", "age_use_int13": "Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Case report(s)", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Zonisamide"}, {"int_description_15": "Valproic acid"}, {"int_description_16": "Lamotrigine"}, {"int_description_17": "Phenytoin", "timeframe_int17": "Days or Weeks,Years", "age_use_int17": "Infant,Child", "contra_int17": "No", "qualscale_reclass_drug17": "Case report(s)", "rev1_eff_reclass_drug17": "Still in Trials / Unproven"}, {"int_description_18": "Cannabinoids", "timeframe_int18": "Days or Weeks,Years", "age_use_int18": "Neonate,Infant,Child", "contra_int18": "No", "qualscale_reclass_drug18": "Case report(s)", "rev1_eff_reclass_drug18": "Effective / Ameliorative"}, {"int_description_19": "Corticotherapy"}, {"int_description_20": "GS967"}, {"int_description_21": "Immunoglobulins"}, {"int_description_22": "Prax330", "timeframe_int22": "Days or Weeks", "age_use_int22": "Neonate,Infant,Child", "contra_int22": "No", "qualscale_reclass_drug22": "Case report(s)", "rev1_eff_reclass_drug22": "Effective / Ameliorative"}, {"int_description_23": "Sodium channel blockers"}, {"int_description_24": "Phenobarbital"}], "references": [{"pmid_title_1": "Clinical study of 19 patients with SCN8A-related epilepsy: Two modes of onset regarding EEG and seizures.", "pmid_1": 31026061.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Epilepsia"}, {"pmid_title_2": "The spectrum of intermediate SCN8A-related epilepsy.", "pmid_2": 30968951.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Epilepsia"}, {"pmid_title_3": "A single-center SCN8A-related epilepsy cohort: clinical, genetic, and physiologic characterization.", "pmid_3": 31402610.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Ann Clin Transl Neurol"}, {"pmid_title_4": "Prax330 reduces persistent and resurgent sodium channel currents and neuronal hyperexcitability of subiculum neurons in a mouse model of SCN8A epileptic encephalopathy.", "pmid_4": 31278928.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Neuropharmacology"}, {"pmid_title_5": "A comprehensive approach to identifying repurposed drugs to treat SCN8A epilepsy.", "pmid_5": 29574705.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Epilepsia"}, {"pmid_title_6": "The novel sodium channel modulator GS-458967 (GS967) is an effective treatment in a mouse model of SCN8A encephalopathy.", "pmid_6": 29782051.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Epilepsia"}, {"pmid_title_7": "<i>SCN8A</i>-Related Epilepsy with Encephalopathy", "pmid_7": 27559564.0, "pmid_date_7": 2016.0, "pmid_journal_7": "GeneReviews\u00ae"}, {"pmid_title_8": "Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: A potential treatment target?", "pmid_8": 26647175.0, "pmid_date_8": 2016.0, "pmid_journal_8": "Molecular genetics and metabolism"}, {"pmid_title_9": "Recurrent and Non-Recurrent Mutations of SCN8A in Epileptic Encephalopathy.", "pmid_9": 26029160.0, "pmid_date_9": 2015.0, "pmid_journal_9": "Front Neurol"}, {"pmid_title_10": "Electroclinical features of epileptic encephalopathy caused by SCN8A mutation.", "pmid_10": 25951352.0, "pmid_date_10": 2015.0, "pmid_journal_10": "Pediatrics international : official journal of the Japan Pediatric Society"}, {"pmid_title_11": "SCN8A mutations in Chinese children with early onset epilepsy and intellectual disability.", "pmid_11": 25785782.0, "pmid_date_11": 2015.0, "pmid_journal_11": "Epilepsia"}, {"pmid_title_12": "A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy.", "pmid_12": 24874546.0, "pmid_date_12": 2014.0, "pmid_journal_12": "Neurobiol Dis"}, {"pmid_title_13": "Convulsive seizures and SUDEP in a mouse model of SCN8A epileptic encephalopathy.", "pmid_13": 25227913.0, "pmid_date_13": 2014.0, "pmid_journal_13": "Hum Mol Genet"}]}, {"_id": "10596-OMIM:617080", "condition": {"condition_name": "SEIZURES, BENIGN FAMILIAL INFANTILE, 5; BFIS5", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["SEIZURES, BENIGN FAMILIAL INFANTILE, 5; BFIS5", "EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13; EIEE13"]}, "gene information": {"db_hgnc_gene_id": 10596.0}, "interventions": [{"int_description_1": "Oxcarbazepine"}, {"int_description_2": "Carbamazepine"}, {"int_description_3": "Phenobarbital"}], "references": [{"pmid_title_1": "Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation.", "pmid_1": 26677014.0, "pmid_date_1": 2016.0, "pmid_journal_1": "Annals of neurology"}]}, {"_id": "10599-OMIM:264350", "condition": {"condition_name": "PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE", "freq_per_birth": "PHA1 is a rare condition that has been estimated to affect 1 in 80,000 newborns.", "pattern_of_inheritance": "Autosomal recessive, Autosomal dominant", "alternate_names": ["LIDDLE SYNDROME 3", "PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE", "BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2"]}, "gene information": {"db_hgnc_gene_id": 10599.0}, "interventions": [{"int_description_1": "Peritoneal dialysis", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant", "contra_int1": "Yes", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Dietary potassium restriction"}, {"int_description_3": "Salbutamol"}, {"int_description_4": "Beclomethasone dipropionate"}, {"int_description_5": "Fludrocortisone"}, {"int_description_6": "Hydroxyprogesterone"}, {"int_description_7": "Montelukast"}, {"int_description_8": "Domperidone"}, {"int_description_9": "Ranitidine", "timeframe_int9": "Hours,Days or Weeks", "age_use_int9": "Neonate,Infant", "contra_int9": "No", "qualscale_reclass_drug9": "Case report(s)", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Cromoglicic acid", "timeframe_int10": "Hours,Days or Weeks,Years", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Case report(s)", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Carbenoxolone"}, {"int_description_12": "Indomethacin"}, {"int_description_13": "Hydrochlorothiazide"}, {"int_description_14": "Phenoxymethylpenicillin"}, {"int_description_15": "Hydrocortisone"}, {"int_description_16": "Flucloxacillin", "timeframe_int16": "Hours,Days or Weeks,Years", "age_use_int16": "Neonate,Infant,Child", "contra_int16": "No", "qualscale_reclass_drug16": "Case report(s)", "rev1_eff_reclass_drug16": "Effective / Ameliorative"}, {"int_description_17": "Omeprazole", "timeframe_int17": "Hours", "age_use_int17": "Neonate,Infant,Child", "contra_int17": "No", "qualscale_reclass_drug17": "Case report(s)", "rev1_eff_reclass_drug17": "Effective / Ameliorative"}, {"int_description_18": "Sodium citrate", "timeframe_int18": "Hours", "age_use_int18": "Neonate,Infant,Child", "contra_int18": "No", "qualscale_reclass_drug18": "Case report(s)", "rev1_eff_reclass_drug18": "Effective / Ameliorative"}, {"int_description_19": "Sevelamer", "timeframe_int19": "Hours,Days or Weeks,Years", "age_use_int19": "Neonate,Infant,Child", "contra_int19": "No", "qualscale_reclass_drug19": "Cohort study or studies", "rev1_eff_reclass_drug19": "Effective / Ameliorative"}, {"int_description_20": "Tolevamer"}, {"int_description_21": "Calcium carbonate"}, {"int_description_22": "Sodium chloride"}, {"int_description_23": "Calcium gluconate", "timeframe_int23": "Hours,Days or Weeks,Years", "age_use_int23": "Neonate,Infant,Child", "contra_int23": "No", "qualscale_reclass_drug23": "Cohort study or studies", "rev1_eff_reclass_drug23": "Effective / Ameliorative"}, {"int_description_24": "Gaviscon"}, {"int_description_25": "Insulin"}, {"int_description_26": "Sodium bicarbonate"}, {"int_description_27": "D-glucose"}, {"int_description_28": "Ion exchange resins"}], "references": [{"pmid_title_1": "Pseudohypoaldosteronism type 1: clinical features and management in infancy.", "pmid_1": 24616761.0, "pmid_date_1": 2013.0, "pmid_journal_1": "Endocrinol Diabetes Metab Case Rep"}, {"pmid_title_2": "Pseudohypoaldosteronism type 1: management issues.", "pmid_2": 23680607.0, "pmid_date_2": 2013.0, "pmid_journal_2": "Indian Pediatr"}, {"pmid_title_3": "Life threatening hyperkalemia in a neonate with pseudo-hypoaldosteronism.", "pmid_3": 22764468.0, "pmid_date_3": 2012.0, "pmid_journal_3": "J Pak Med Assoc"}, {"pmid_title_4": "A homozygous missense mutation in SCNN1A is responsible for a transient neonatal form of pseudohypoaldosteronism type 1.", "pmid_4": 21653223.0, "pmid_date_4": 2011.0, "pmid_journal_4": "Am J Physiol Endocrinol Metab"}, {"pmid_title_5": "Critical points in the management of pseudohypoaldosteronism type 1.", "pmid_5": 21750640.0, "pmid_date_5": 2011.0, "pmid_journal_5": "J Clin Res Pediatr Endocrinol"}, {"pmid_title_6": "Pseudohypoaldosteronism type 1 in an infant.", "pmid_6": 21789870.0, "pmid_date_6": 2011.0, "pmid_journal_6": "Ceylon Med J"}, {"pmid_title_7": "Autosomal dominant pseudohypoaldosteronism type 1 with a novel splice site mutation in MR gene.", "pmid_7": 19912655.0, "pmid_date_7": 2009.0, "pmid_journal_7": "BMC Nephrol"}, {"pmid_title_8": "Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.", "pmid_8": 16972228.0, "pmid_date_8": 2007.0, "pmid_journal_8": "Hum Mutat"}, {"pmid_title_9": "Recurrence of the R947X mutation in unrelated families with autosomal dominant pseudohypoaldosteronism type 1: evidence for a mutational hot spot in the mineralocorticoid receptor gene.", "pmid_9": 16757525.0, "pmid_date_9": 2006.0, "pmid_journal_9": "J Clin Endocrinol Metab"}, {"pmid_title_10": "Identification of a novel mutation in the human mineralocorticoid receptor gene in a german family with autosomal-dominant pseudohypoaldosteronism type 1: further evidence for marked interindividual clinical heterogeneity.", "pmid_10": 12679457.0, "pmid_date_10": 2003.0, "pmid_journal_10": "J Clin Endocrinol Metab"}, {"pmid_title_11": "Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism.", "pmid_11": 12788847.0, "pmid_date_11": 2003.0, "pmid_journal_11": "J Clin Endocrinol Metab"}, {"pmid_title_12": "Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds.", "pmid_12": 11344206.0, "pmid_date_12": 2001.0, "pmid_journal_12": "J Clin Endocrinol Metab"}, {"pmid_title_13": "Compound heterozygous mutations in the gamma subunit gene of ENaC (1627delG and 1570-1G-->A) in one sporadic Japanese patient with a systemic form of pseudohypoaldosteronism type 1.", "pmid_13": 11231969.0, "pmid_date_13": 2001.0, "pmid_journal_13": "J Clin Endocrinol Metab"}, {"pmid_title_14": "A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.", "pmid_14": 11134129.0, "pmid_date_14": 2000.0, "pmid_journal_14": "J Clin Endocrinol Metab"}, {"pmid_title_15": "Lung symptoms in pseudohypoaldosteronism type 1 are associated with deficiency of the alpha-subunit of the epithelial sodium channel.", "pmid_15": 10586178.0, "pmid_date_15": 1999.0, "pmid_journal_15": "J Pediatr"}]}, {"_id": "10599-OMIM:613021", "condition": {"condition_name": "BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["LIDDLE SYNDROME 3", "BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2", "PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE"]}, "gene information": {"db_hgnc_gene_id": 10599.0}, "interventions": [{"int_description_1": "PEP therapy using flutter"}, {"int_description_2": "PEP with Acapella device"}, {"int_description_3": "Beclomethasone dipropionate"}, {"int_description_4": "Fluticasone propionate"}, {"int_description_5": "Clarithromycin"}, {"int_description_6": "Colistin"}, {"int_description_7": "Budesonide"}, {"int_description_8": "Tobramycin"}, {"int_description_9": "Erythromycin"}, {"int_description_10": "Azithromycin"}, {"int_description_11": "Roxithromycin"}, {"int_description_12": "Ciprofloxacin"}, {"int_description_13": "Aztreonam"}, {"int_description_14": "Amoxicillin"}, {"int_description_15": "Itraconazole"}, {"int_description_16": "Gentamicin"}, {"int_description_17": "Atorvastatin"}, {"int_description_18": "Formoterol"}, {"int_description_19": "Alvelestat"}, {"int_description_20": "Carbocisteine"}, {"int_description_21": "Acetylcysteine"}, {"int_description_22": "AZD5069"}, {"int_description_23": "Mannitol"}, {"int_description_24": "Sodium chloride"}, {"int_description_25": "PD (position not disclosed) with forced expiration"}, {"int_description_26": "Pulmonary rehabilitation"}, {"int_description_27": "Lung transplantation"}, {"int_description_28": "VATS lobectomy and general lobectomy"}], "references": [{"pmid_title_1": "Inhaled corticosteroids for bronchiectasis.", "pmid_1": 29766487.0, "pmid_date_1": 2018.0, "pmid_journal_1": "The Cochrane database of systematic reviews"}, {"pmid_title_2": "Lung transplantation for non-cystic fibrosis bronchiectasis.", "pmid_2": 27215505.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Respiratory medicine"}, {"pmid_title_3": "Management of bronchiectasis in adults.", "pmid_3": 25792635.0, "pmid_date_3": 2015.0, "pmid_journal_3": "The European respiratory journal"}, {"pmid_title_4": "Airway clearance techniques for bronchiectasis.", "pmid_4": 26591003.0, "pmid_date_4": 2015.0, "pmid_journal_4": "The Cochrane database of systematic reviews"}, {"pmid_title_5": "Long-term macrolides for non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis.", "pmid_5": 24417869.0, "pmid_date_5": 2014.0, "pmid_journal_5": "Respirology (Carlton, Vic.)"}, {"pmid_title_6": "Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial.", "pmid_6": 24717640.0, "pmid_date_6": 2014.0, "pmid_journal_6": "The Lancet. Respiratory medicine"}, {"pmid_title_7": "The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.", "pmid_7": 25458200.0, "pmid_date_7": 2014.0, "pmid_journal_7": "The Lancet. Respiratory medicine"}, {"pmid_title_8": "Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials.", "pmid_8": 25154045.0, "pmid_date_8": 2014.0, "pmid_journal_8": "The Lancet. Respiratory medicine"}, {"pmid_title_9": "Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection.", "pmid_9": 24625200.0, "pmid_date_9": 2014.0, "pmid_journal_9": "American journal of respiratory and critical care medicine"}, {"pmid_title_10": "The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis--a randomised controlled trial.", "pmid_10": 24731015.0, "pmid_date_10": 2014.0, "pmid_journal_10": "Respiratory research"}, {"pmid_title_11": "Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis.", "pmid_11": 23433769.0, "pmid_date_11": 2013.0, "pmid_journal_11": "Respiratory medicine"}, {"pmid_title_12": "Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.", "pmid_12": 23532241.0, "pmid_date_12": 2013.0, "pmid_journal_12": "JAMA"}, {"pmid_title_13": "Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.", "pmid_13": 23532242.0, "pmid_date_13": 2013.0, "pmid_journal_13": "JAMA"}, {"pmid_title_14": "Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial.", "pmid_14": 23681906.0, "pmid_date_14": 2013.0, "pmid_journal_14": "Thorax"}, {"pmid_title_15": "Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis.", "pmid_15": 23429964.0, "pmid_date_15": 2013.0, "pmid_journal_15": "Chest"}, {"pmid_title_16": "Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults.", "pmid_16": 22564014.0, "pmid_date_16": 2012.0, "pmid_journal_16": "Respirology (Carlton, Vic.)"}, {"pmid_title_17": "Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.", "pmid_17": 22901887.0, "pmid_date_17": 2012.0, "pmid_journal_17": "Lancet (London, England)"}, {"pmid_title_18": "A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis.", "pmid_18": 22717535.0, "pmid_date_18": 2012.0, "pmid_journal_18": "Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society"}, {"pmid_title_19": "Clinical efficacy and safety of budesonide-formoterol in non-cystic fibrosis bronchiectasis.", "pmid_19": 21778259.0, "pmid_date_19": 2012.0, "pmid_journal_19": "Chest"}, {"pmid_title_20": "Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.", "pmid_20": 22744718.0, "pmid_date_20": 2012.0, "pmid_journal_20": "American journal of respiratory and critical care medicine"}, {"pmid_title_21": "A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis.", "pmid_21": 22947443.0, "pmid_date_21": 2012.0, "pmid_journal_21": "Respiratory medicine"}, {"pmid_title_22": "The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis.", "pmid_22": 22349069.0, "pmid_date_22": 2012.0, "pmid_journal_22": "Respiratory medicine"}, {"pmid_title_23": "A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis.", "pmid_23": 20870753.0, "pmid_date_23": 2011.0, "pmid_journal_23": "American journal of respiratory and critical care medicine"}, {"pmid_title_24": "Effects of pulmonary rehabilitation in bronchiectasis: A retrospective study.", "pmid_24": 21339371.0, "pmid_date_24": 2011.0, "pmid_journal_24": "Chronic respiratory disease"}, {"pmid_title_25": "Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis.", "pmid_25": 22018993.0, "pmid_date_25": 2011.0, "pmid_journal_25": "Respiratory medicine"}, {"pmid_title_26": "Video-assisted thoracic surgery for bronchiectasis.", "pmid_26": 21172520.0, "pmid_date_26": 2011.0, "pmid_journal_26": "The Annals of thoracic surgery"}, {"pmid_title_27": "Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis.", "pmid_27": 16476120.0, "pmid_date_27": 2006.0, "pmid_journal_27": "Journal of clinical pharmacy and therapeutics"}, {"pmid_title_28": "Inhaled steroids improve quality of life in patients with steady-state bronchiectasis.", "pmid_28": 16434174.0, "pmid_date_28": 2006.0, "pmid_journal_28": "Respiratory medicine"}, {"pmid_title_29": "Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis.", "pmid_29": 10934074.0, "pmid_date_29": 2000.0, "pmid_journal_29": "American journal of respiratory and critical care medicine"}, {"pmid_title_30": "A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.", "pmid_30": 10717010.0, "pmid_date_30": 2000.0, "pmid_journal_30": "The New England journal of medicine"}, {"pmid_title_31": "Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study.", "pmid_31": 9163637.0, "pmid_date_31": 1997.0, "pmid_journal_31": "The European respiratory journal"}, {"pmid_title_32": "Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation.", "pmid_32": 3787536.0, "pmid_date_32": 1986.0, "pmid_journal_32": "Thorax"}, {"pmid_title_33": "Nebulized amoxicillin in chronic purulent bronchiectasis.", "pmid_33": 4053147.0, "pmid_date_33": 1985.0, "pmid_journal_33": "Clinical therapeutics"}]}, {"_id": "10599-OMIM:618126", "condition": {"condition_name": "LIDDLE SYNDROME 3", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2", "LIDDLE SYNDROME 3", "PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE"]}, "gene information": {"db_hgnc_gene_id": 10599.0}, "interventions": [{"int_description_1": "Low sodium diet", "timeframe_int1": "Hours,Days or Weeks,Years", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "Yes", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Amiloride", "timeframe_int2": "Hours,Days or Weeks,Years", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "Yes", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Triamterene", "timeframe_int3": "Hours,Days or Weeks,Years", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "A Missense Mutation in the Extracellular Domain of <i>\u03b1</i>ENaC Causes Liddle Syndrome.", "pmid_1": 28710092.0, "pmid_date_1": 2017.0, "pmid_journal_1": "J Am Soc Nephrol"}, {"pmid_title_2": "A novel epithelial sodium channel gamma-subunit de novo frameshift mutation leads to Liddle syndrome.", "pmid_2": 17634077.0, "pmid_date_2": 2007.0, "pmid_journal_2": "Clin Endocrinol (Oxf)"}, {"pmid_title_3": "Liddle's syndrome associated with a point mutation in the extracellular domain of the epithelial sodium channel gamma subunit.", "pmid_3": 12473862.0, "pmid_date_3": 2002.0, "pmid_journal_3": "J Hypertens"}, {"pmid_title_4": "Genotype-phenotype analysis of a newly discovered family with Liddle's syndrome.", "pmid_4": 9350583.0, "pmid_date_4": 1997.0, "pmid_journal_4": "J Hypertens"}, {"pmid_title_5": "Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome.", "pmid_5": 7550319.0, "pmid_date_5": 1995.0, "pmid_journal_5": "Nat Genet"}, {"pmid_title_6": "A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity.", "pmid_6": 8524790.0, "pmid_date_6": 1995.0, "pmid_journal_6": "Proc Natl Acad Sci U S A"}, {"pmid_title_7": "The effect of triamterene and sodium intake on renin, aldosterone, and erythrocyte sodium transport in Liddle's syndrome.", "pmid_7": 6262354.0, "pmid_date_7": 1981.0, "pmid_journal_7": "J Clin Endocrinol Metab"}]}, {"_id": "10600-OMIM:177200", "condition": {"condition_name": "LIDDLE SYNDROME 1", "freq_per_birth": "Liddle syndrome is a rare condition, although its prevalence is unknown. The condition has been found in populations worldwide.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE", "LIDDLE SYNDROME 1", "BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1"]}, "gene information": {"db_hgnc_gene_id": 10600.0}, "interventions": [{"int_description_1": "Low sodium diet", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "Yes", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Amiloride", "timeframe_int2": "Hours,Days or Weeks,Years", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "Yes", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Triamterene", "timeframe_int3": "Hours,Days or Weeks,Years", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "A Missense Mutation in the Extracellular Domain of <i>\u03b1</i>ENaC Causes Liddle Syndrome.", "pmid_1": 28710092.0, "pmid_date_1": 2017.0, "pmid_journal_1": "J Am Soc Nephrol"}, {"pmid_title_2": "A novel epithelial sodium channel gamma-subunit de novo frameshift mutation leads to Liddle syndrome.", "pmid_2": 17634077.0, "pmid_date_2": 2007.0, "pmid_journal_2": "Clin Endocrinol (Oxf)"}, {"pmid_title_3": "Liddle's syndrome associated with a point mutation in the extracellular domain of the epithelial sodium channel gamma subunit.", "pmid_3": 12473862.0, "pmid_date_3": 2002.0, "pmid_journal_3": "J Hypertens"}, {"pmid_title_4": "Genotype-phenotype analysis of a newly discovered family with Liddle's syndrome.", "pmid_4": 9350583.0, "pmid_date_4": 1997.0, "pmid_journal_4": "J Hypertens"}, {"pmid_title_5": "Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome.", "pmid_5": 7550319.0, "pmid_date_5": 1995.0, "pmid_journal_5": "Nat Genet"}, {"pmid_title_6": "A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity.", "pmid_6": 8524790.0, "pmid_date_6": 1995.0, "pmid_journal_6": "Proc Natl Acad Sci U S A"}, {"pmid_title_7": "The effect of triamterene and sodium intake on renin, aldosterone, and erythrocyte sodium transport in Liddle's syndrome.", "pmid_7": 6262354.0, "pmid_date_7": 1981.0, "pmid_journal_7": "J Clin Endocrinol Metab"}]}, {"_id": "10600-OMIM:211400", "condition": {"condition_name": "BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE", "BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1", "LIDDLE SYNDROME 1"]}, "gene information": {"db_hgnc_gene_id": 10600.0}, "interventions": [{"int_description_1": "PEP therapy using flutter"}, {"int_description_2": "PEP with Acapella device"}, {"int_description_3": "Beclomethasone dipropionate"}, {"int_description_4": "Fluticasone propionate"}, {"int_description_5": "Clarithromycin"}, {"int_description_6": "Colistin"}, {"int_description_7": "Budesonide"}, {"int_description_8": "Tobramycin"}, {"int_description_9": "Erythromycin"}, {"int_description_10": "Azithromycin"}, {"int_description_11": "Roxithromycin"}, {"int_description_12": "Ciprofloxacin"}, {"int_description_13": "Aztreonam"}, {"int_description_14": "Amoxicillin"}, {"int_description_15": "Itraconazole"}, {"int_description_16": "Gentamicin"}, {"int_description_17": "Atorvastatin"}, {"int_description_18": "Formoterol"}, {"int_description_19": "Alvelestat"}, {"int_description_20": "Carbocisteine"}, {"int_description_21": "Acetylcysteine"}, {"int_description_22": "AZD5069"}, {"int_description_23": "Mannitol"}, {"int_description_24": "Sodium chloride"}, {"int_description_25": "PD (position not disclosed) with forced expiration"}, {"int_description_26": "Pulmonary rehabilitation"}, {"int_description_27": "Lung transplantation"}, {"int_description_28": "VATS lobectomy and general lobectomy"}], "references": [{"pmid_title_1": "Inhaled corticosteroids for bronchiectasis.", "pmid_1": 29766487.0, "pmid_date_1": 2018.0, "pmid_journal_1": "The Cochrane database of systematic reviews"}, {"pmid_title_2": "Lung transplantation for non-cystic fibrosis bronchiectasis.", "pmid_2": 27215505.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Respiratory medicine"}, {"pmid_title_3": "Management of bronchiectasis in adults.", "pmid_3": 25792635.0, "pmid_date_3": 2015.0, "pmid_journal_3": "The European respiratory journal"}, {"pmid_title_4": "Airway clearance techniques for bronchiectasis.", "pmid_4": 26591003.0, "pmid_date_4": 2015.0, "pmid_journal_4": "The Cochrane database of systematic reviews"}, {"pmid_title_5": "Long-term macrolides for non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis.", "pmid_5": 24417869.0, "pmid_date_5": 2014.0, "pmid_journal_5": "Respirology (Carlton, Vic.)"}, {"pmid_title_6": "Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial.", "pmid_6": 24717640.0, "pmid_date_6": 2014.0, "pmid_journal_6": "The Lancet. Respiratory medicine"}, {"pmid_title_7": "The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.", "pmid_7": 25458200.0, "pmid_date_7": 2014.0, "pmid_journal_7": "The Lancet. Respiratory medicine"}, {"pmid_title_8": "Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials.", "pmid_8": 25154045.0, "pmid_date_8": 2014.0, "pmid_journal_8": "The Lancet. Respiratory medicine"}, {"pmid_title_9": "Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection.", "pmid_9": 24625200.0, "pmid_date_9": 2014.0, "pmid_journal_9": "American journal of respiratory and critical care medicine"}, {"pmid_title_10": "The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis--a randomised controlled trial.", "pmid_10": 24731015.0, "pmid_date_10": 2014.0, "pmid_journal_10": "Respiratory research"}, {"pmid_title_11": "Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis.", "pmid_11": 23433769.0, "pmid_date_11": 2013.0, "pmid_journal_11": "Respiratory medicine"}, {"pmid_title_12": "Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.", "pmid_12": 23532241.0, "pmid_date_12": 2013.0, "pmid_journal_12": "JAMA"}, {"pmid_title_13": "Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.", "pmid_13": 23532242.0, "pmid_date_13": 2013.0, "pmid_journal_13": "JAMA"}, {"pmid_title_14": "Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial.", "pmid_14": 23681906.0, "pmid_date_14": 2013.0, "pmid_journal_14": "Thorax"}, {"pmid_title_15": "Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis.", "pmid_15": 23429964.0, "pmid_date_15": 2013.0, "pmid_journal_15": "Chest"}, {"pmid_title_16": "Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults.", "pmid_16": 22564014.0, "pmid_date_16": 2012.0, "pmid_journal_16": "Respirology (Carlton, Vic.)"}, {"pmid_title_17": "Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.", "pmid_17": 22901887.0, "pmid_date_17": 2012.0, "pmid_journal_17": "Lancet (London, England)"}, {"pmid_title_18": "A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis.", "pmid_18": 22717535.0, "pmid_date_18": 2012.0, "pmid_journal_18": "Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society"}, {"pmid_title_19": "Clinical efficacy and safety of budesonide-formoterol in non-cystic fibrosis bronchiectasis.", "pmid_19": 21778259.0, "pmid_date_19": 2012.0, "pmid_journal_19": "Chest"}, {"pmid_title_20": "Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.", "pmid_20": 22744718.0, "pmid_date_20": 2012.0, "pmid_journal_20": "American journal of respiratory and critical care medicine"}, {"pmid_title_21": "A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis.", "pmid_21": 22947443.0, "pmid_date_21": 2012.0, "pmid_journal_21": "Respiratory medicine"}, {"pmid_title_22": "The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis.", "pmid_22": 22349069.0, "pmid_date_22": 2012.0, "pmid_journal_22": "Respiratory medicine"}, {"pmid_title_23": "A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis.", "pmid_23": 20870753.0, "pmid_date_23": 2011.0, "pmid_journal_23": "American journal of respiratory and critical care medicine"}, {"pmid_title_24": "Effects of pulmonary rehabilitation in bronchiectasis: A retrospective study.", "pmid_24": 21339371.0, "pmid_date_24": 2011.0, "pmid_journal_24": "Chronic respiratory disease"}, {"pmid_title_25": "Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis.", "pmid_25": 22018993.0, "pmid_date_25": 2011.0, "pmid_journal_25": "Respiratory medicine"}, {"pmid_title_26": "Video-assisted thoracic surgery for bronchiectasis.", "pmid_26": 21172520.0, "pmid_date_26": 2011.0, "pmid_journal_26": "The Annals of thoracic surgery"}, {"pmid_title_27": "Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis.", "pmid_27": 16476120.0, "pmid_date_27": 2006.0, "pmid_journal_27": "Journal of clinical pharmacy and therapeutics"}, {"pmid_title_28": "Inhaled steroids improve quality of life in patients with steady-state bronchiectasis.", "pmid_28": 16434174.0, "pmid_date_28": 2006.0, "pmid_journal_28": "Respiratory medicine"}, {"pmid_title_29": "Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis.", "pmid_29": 10934074.0, "pmid_date_29": 2000.0, "pmid_journal_29": "American journal of respiratory and critical care medicine"}, {"pmid_title_30": "A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.", "pmid_30": 10717010.0, "pmid_date_30": 2000.0, "pmid_journal_30": "The New England journal of medicine"}, {"pmid_title_31": "Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study.", "pmid_31": 9163637.0, "pmid_date_31": 1997.0, "pmid_journal_31": "The European respiratory journal"}, {"pmid_title_32": "Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation.", "pmid_32": 3787536.0, "pmid_date_32": 1986.0, "pmid_journal_32": "Thorax"}, {"pmid_title_33": "Nebulized amoxicillin in chronic purulent bronchiectasis.", "pmid_33": 4053147.0, "pmid_date_33": 1985.0, "pmid_journal_33": "Clinical therapeutics"}]}, {"_id": "10600-OMIM:264350", "condition": {"condition_name": "PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE", "freq_per_birth": "PHA1 is a rare condition that has been estimated to affect 1 in 80,000 newborns.", "pattern_of_inheritance": "Autosomal recessive, Autosomal dominant", "alternate_names": ["BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1", "PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE", "LIDDLE SYNDROME 1"]}, "gene information": {"db_hgnc_gene_id": 10600.0}, "interventions": [{"int_description_1": "Peritoneal dialysis", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant", "contra_int1": "Yes", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Dietary potassium restriction"}, {"int_description_3": "Salbutamol"}, {"int_description_4": "Beclomethasone dipropionate"}, {"int_description_5": "Fludrocortisone"}, {"int_description_6": "Hydroxyprogesterone"}, {"int_description_7": "Montelukast"}, {"int_description_8": "Domperidone"}, {"int_description_9": "Ranitidine", "timeframe_int9": "Hours,Days or Weeks", "age_use_int9": "Neonate,Infant", "contra_int9": "No", "qualscale_reclass_drug9": "Case report(s)", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Cromoglicic acid", "timeframe_int10": "Hours,Days or Weeks,Years", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Case report(s)", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Carbenoxolone"}, {"int_description_12": "Indomethacin"}, {"int_description_13": "Hydrochlorothiazide"}, {"int_description_14": "Phenoxymethylpenicillin"}, {"int_description_15": "Hydrocortisone"}, {"int_description_16": "Flucloxacillin", "timeframe_int16": "Hours,Days or Weeks,Years", "age_use_int16": "Neonate,Infant,Child", "contra_int16": "No", "qualscale_reclass_drug16": "Case report(s)", "rev1_eff_reclass_drug16": "Effective / Ameliorative"}, {"int_description_17": "Omeprazole", "timeframe_int17": "Hours", "age_use_int17": "Neonate,Infant,Child", "contra_int17": "No", "qualscale_reclass_drug17": "Case report(s)", "rev1_eff_reclass_drug17": "Effective / Ameliorative"}, {"int_description_18": "Sodium citrate", "timeframe_int18": "Hours", "age_use_int18": "Neonate,Infant,Child", "contra_int18": "No", "qualscale_reclass_drug18": "Case report(s)", "rev1_eff_reclass_drug18": "Effective / Ameliorative"}, {"int_description_19": "Sevelamer", "timeframe_int19": "Hours,Days or Weeks,Years", "age_use_int19": "Neonate,Infant,Child", "contra_int19": "No", "qualscale_reclass_drug19": "Cohort study or studies", "rev1_eff_reclass_drug19": "Effective / Ameliorative"}, {"int_description_20": "Tolevamer"}, {"int_description_21": "Calcium carbonate"}, {"int_description_22": "Sodium chloride"}, {"int_description_23": "Calcium gluconate", "timeframe_int23": "Hours,Days or Weeks,Years", "age_use_int23": "Neonate,Infant,Child", "contra_int23": "No", "qualscale_reclass_drug23": "Cohort study or studies", "rev1_eff_reclass_drug23": "Effective / Ameliorative"}, {"int_description_24": "Gaviscon"}, {"int_description_25": "Insulin"}, {"int_description_26": "Sodium bicarbonate"}, {"int_description_27": "D-glucose"}, {"int_description_28": "Ion exchange resins"}], "references": [{"pmid_title_1": "Pseudohypoaldosteronism type 1: clinical features and management in infancy.", "pmid_1": 24616761.0, "pmid_date_1": 2013.0, "pmid_journal_1": "Endocrinol Diabetes Metab Case Rep"}, {"pmid_title_2": "Pseudohypoaldosteronism type 1: management issues.", "pmid_2": 23680607.0, "pmid_date_2": 2013.0, "pmid_journal_2": "Indian Pediatr"}, {"pmid_title_3": "Life threatening hyperkalemia in a neonate with pseudo-hypoaldosteronism.", "pmid_3": 22764468.0, "pmid_date_3": 2012.0, "pmid_journal_3": "J Pak Med Assoc"}, {"pmid_title_4": "A homozygous missense mutation in SCNN1A is responsible for a transient neonatal form of pseudohypoaldosteronism type 1.", "pmid_4": 21653223.0, "pmid_date_4": 2011.0, "pmid_journal_4": "Am J Physiol Endocrinol Metab"}, {"pmid_title_5": "Critical points in the management of pseudohypoaldosteronism type 1.", "pmid_5": 21750640.0, "pmid_date_5": 2011.0, "pmid_journal_5": "J Clin Res Pediatr Endocrinol"}, {"pmid_title_6": "Pseudohypoaldosteronism type 1 in an infant.", "pmid_6": 21789870.0, "pmid_date_6": 2011.0, "pmid_journal_6": "Ceylon Med J"}, {"pmid_title_7": "Autosomal dominant pseudohypoaldosteronism type 1 with a novel splice site mutation in MR gene.", "pmid_7": 19912655.0, "pmid_date_7": 2009.0, "pmid_journal_7": "BMC Nephrol"}, {"pmid_title_8": "Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.", "pmid_8": 16972228.0, "pmid_date_8": 2007.0, "pmid_journal_8": "Hum Mutat"}, {"pmid_title_9": "Recurrence of the R947X mutation in unrelated families with autosomal dominant pseudohypoaldosteronism type 1: evidence for a mutational hot spot in the mineralocorticoid receptor gene.", "pmid_9": 16757525.0, "pmid_date_9": 2006.0, "pmid_journal_9": "J Clin Endocrinol Metab"}, {"pmid_title_10": "Identification of a novel mutation in the human mineralocorticoid receptor gene in a german family with autosomal-dominant pseudohypoaldosteronism type 1: further evidence for marked interindividual clinical heterogeneity.", "pmid_10": 12679457.0, "pmid_date_10": 2003.0, "pmid_journal_10": "J Clin Endocrinol Metab"}, {"pmid_title_11": "Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism.", "pmid_11": 12788847.0, "pmid_date_11": 2003.0, "pmid_journal_11": "J Clin Endocrinol Metab"}, {"pmid_title_12": "Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds.", "pmid_12": 11344206.0, "pmid_date_12": 2001.0, "pmid_journal_12": "J Clin Endocrinol Metab"}, {"pmid_title_13": "Compound heterozygous mutations in the gamma subunit gene of ENaC (1627delG and 1570-1G-->A) in one sporadic Japanese patient with a systemic form of pseudohypoaldosteronism type 1.", "pmid_13": 11231969.0, "pmid_date_13": 2001.0, "pmid_journal_13": "J Clin Endocrinol Metab"}, {"pmid_title_14": "A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.", "pmid_14": 11134129.0, "pmid_date_14": 2000.0, "pmid_journal_14": "J Clin Endocrinol Metab"}, {"pmid_title_15": "Lung symptoms in pseudohypoaldosteronism type 1 are associated with deficiency of the alpha-subunit of the epithelial sodium channel.", "pmid_15": 10586178.0, "pmid_date_15": 1999.0, "pmid_journal_15": "J Pediatr"}]}, {"_id": "10602-OMIM:264350", "condition": {"condition_name": "PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE", "freq_per_birth": "PHA1 is a rare condition that has been estimated to affect 1 in 80,000 newborns.", "pattern_of_inheritance": "Autosomal recessive, Autosomal dominant", "alternate_names": ["LIDDLE SYNDROME 2", "PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE", "BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3"]}, "gene information": {"db_hgnc_gene_id": 10602.0}, "interventions": [{"int_description_1": "Peritoneal dialysis", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant", "contra_int1": "Yes", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Dietary potassium restriction"}, {"int_description_3": "Salbutamol"}, {"int_description_4": "Beclomethasone dipropionate"}, {"int_description_5": "Fludrocortisone"}, {"int_description_6": "Hydroxyprogesterone"}, {"int_description_7": "Montelukast"}, {"int_description_8": "Domperidone"}, {"int_description_9": "Ranitidine", "timeframe_int9": "Hours", "age_use_int9": "Neonate,Infant", "contra_int9": "No", "qualscale_reclass_drug9": "Case report(s)", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Cromoglicic acid", "timeframe_int10": "Hours,Days or Weeks,Years", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Case report(s)", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Carbenoxolone"}, {"int_description_12": "Indomethacin"}, {"int_description_13": "Hydrochlorothiazide"}, {"int_description_14": "Phenoxymethylpenicillin"}, {"int_description_15": "Hydrocortisone"}, {"int_description_16": "Flucloxacillin", "timeframe_int16": "Hours,Days or Weeks,Years", "age_use_int16": "Neonate,Infant,Child", "contra_int16": "No", "qualscale_reclass_drug16": "Case report(s)", "rev1_eff_reclass_drug16": "Effective / Ameliorative"}, {"int_description_17": "Omeprazole", "timeframe_int17": "Hours", "age_use_int17": "Neonate,Infant,Child", "contra_int17": "No", "qualscale_reclass_drug17": "Case report(s)", "rev1_eff_reclass_drug17": "Effective / Ameliorative"}, {"int_description_18": "Sodium citrate", "timeframe_int18": "Hours", "age_use_int18": "Neonate,Infant,Child", "contra_int18": "No", "qualscale_reclass_drug18": "Case report(s)", "rev1_eff_reclass_drug18": "Effective / Ameliorative"}, {"int_description_19": "Sevelamer", "timeframe_int19": "Hours,Days or Weeks,Years", "age_use_int19": "Neonate,Infant,Child", "contra_int19": "No", "qualscale_reclass_drug19": "Cohort study or studies", "rev1_eff_reclass_drug19": "Effective / Ameliorative"}, {"int_description_20": "Tolevamer"}, {"int_description_21": "Calcium carbonate"}, {"int_description_22": "Sodium chloride"}, {"int_description_23": "Calcium gluconate", "timeframe_int23": "Hours,Days or Weeks,Years", "age_use_int23": "Neonate,Infant,Child", "contra_int23": "No", "qualscale_reclass_drug23": "Cohort study or studies", "rev1_eff_reclass_drug23": "Effective / Ameliorative"}, {"int_description_24": "Gaviscon"}, {"int_description_25": "Insulin"}, {"int_description_26": "Sodium bicarbonate"}, {"int_description_27": "D-glucose"}, {"int_description_28": "Ion exchange resins"}], "references": [{"pmid_title_1": "Pseudohypoaldosteronism type 1: clinical features and management in infancy.", "pmid_1": 24616761.0, "pmid_date_1": 2013.0, "pmid_journal_1": "Endocrinology, diabetes & metabolism case reports"}, {"pmid_title_2": "Pseudohypoaldosteronism type 1: management issues.", "pmid_2": 23680607.0, "pmid_date_2": 2013.0, "pmid_journal_2": "Indian pediatrics"}, {"pmid_title_3": "Life threatening hyperkalemia in a neonate with pseudo-hypoaldosteronism.", "pmid_3": 22764468.0, "pmid_date_3": 2012.0, "pmid_journal_3": "JPMA. The Journal of the Pakistan Medical Association"}, {"pmid_title_4": "A homozygous missense mutation in SCNN1A is responsible for a transient neonatal form of pseudohypoaldosteronism type 1.", "pmid_4": 21653223.0, "pmid_date_4": 2011.0, "pmid_journal_4": "American journal of physiology. Endocrinology and metabolism"}, {"pmid_title_5": "Critical points in the management of pseudohypoaldosteronism type 1.", "pmid_5": 21750640.0, "pmid_date_5": 2011.0, "pmid_journal_5": "Journal of clinical research in pediatric endocrinology"}, {"pmid_title_6": "Pseudohypoaldosteronism type 1 in an infant.", "pmid_6": 21789870.0, "pmid_date_6": 2011.0, "pmid_journal_6": "The Ceylon medical journal"}, {"pmid_title_7": "Autosomal dominant pseudohypoaldosteronism type 1 with a novel splice site mutation in MR gene.", "pmid_7": 19912655.0, "pmid_date_7": 2009.0, "pmid_journal_7": "BMC nephrology"}, {"pmid_title_8": "Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.", "pmid_8": 16972228.0, "pmid_date_8": 2007.0, "pmid_journal_8": "Human mutation"}, {"pmid_title_9": "Recurrence of the R947X mutation in unrelated families with autosomal dominant pseudohypoaldosteronism type 1: evidence for a mutational hot spot in the mineralocorticoid receptor gene.", "pmid_9": 16757525.0, "pmid_date_9": 2006.0, "pmid_journal_9": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_10": "Identification of a novel mutation in the human mineralocorticoid receptor gene in a german family with autosomal-dominant pseudohypoaldosteronism type 1: further evidence for marked interindividual clinical heterogeneity.", "pmid_10": 12679457.0, "pmid_date_10": 2003.0, "pmid_journal_10": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_11": "Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism.", "pmid_11": 12788847.0, "pmid_date_11": 2003.0, "pmid_journal_11": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_12": "Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds.", "pmid_12": 11344206.0, "pmid_date_12": 2001.0, "pmid_journal_12": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_13": "Compound heterozygous mutations in the gamma subunit gene of ENaC (1627delG and 1570-1G-->A) in one sporadic Japanese patient with a systemic form of pseudohypoaldosteronism type 1.", "pmid_13": 11231969.0, "pmid_date_13": 2001.0, "pmid_journal_13": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_14": "A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.", "pmid_14": 11134129.0, "pmid_date_14": 2000.0, "pmid_journal_14": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_15": "Lung symptoms in pseudohypoaldosteronism type 1 are associated with deficiency of the alpha-subunit of the epithelial sodium channel.", "pmid_15": 10586178.0, "pmid_date_15": 1999.0, "pmid_journal_15": "The Journal of pediatrics"}]}, {"_id": "10602-OMIM:613071", "condition": {"condition_name": "BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["LIDDLE SYNDROME 2", "BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3", "PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE"]}, "gene information": {"db_hgnc_gene_id": 10602.0}, "interventions": [{"int_description_1": "PEP therapy using flutter"}, {"int_description_2": "PEP with Acapella device"}, {"int_description_3": "Beclomethasone dipropionate"}, {"int_description_4": "Fluticasone propionate"}, {"int_description_5": "Clarithromycin"}, {"int_description_6": "Colistin"}, {"int_description_7": "Budesonide"}, {"int_description_8": "Tobramycin"}, {"int_description_9": "Erythromycin"}, {"int_description_10": "Azithromycin"}, {"int_description_11": "Roxithromycin"}, {"int_description_12": "Ciprofloxacin"}, {"int_description_13": "Aztreonam"}, {"int_description_14": "Amoxicillin"}, {"int_description_15": "Itraconazole"}, {"int_description_16": "Gentamicin"}, {"int_description_17": "Atorvastatin"}, {"int_description_18": "Formoterol"}, {"int_description_19": "Alvelestat"}, {"int_description_20": "Carbocisteine"}, {"int_description_21": "Acetylcysteine"}, {"int_description_22": "AZD5069"}, {"int_description_23": "Mannitol"}, {"int_description_24": "Sodium chloride"}, {"int_description_25": "PD (position not disclosed) with forced expiration"}, {"int_description_26": "Pulmonary rehabilitation"}, {"int_description_27": "Lung transplantation"}, {"int_description_28": "VATS lobectomy and general lobectomy"}], "references": [{"pmid_title_1": "Inhaled corticosteroids for bronchiectasis.", "pmid_1": 29766487.0, "pmid_date_1": 2018.0, "pmid_journal_1": "The Cochrane database of systematic reviews"}, {"pmid_title_2": "Lung transplantation for non-cystic fibrosis bronchiectasis.", "pmid_2": 27215505.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Respiratory medicine"}, {"pmid_title_3": "Management of bronchiectasis in adults.", "pmid_3": 25792635.0, "pmid_date_3": 2015.0, "pmid_journal_3": "The European respiratory journal"}, {"pmid_title_4": "Airway clearance techniques for bronchiectasis.", "pmid_4": 26591003.0, "pmid_date_4": 2015.0, "pmid_journal_4": "The Cochrane database of systematic reviews"}, {"pmid_title_5": "Long-term macrolides for non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis.", "pmid_5": 24417869.0, "pmid_date_5": 2014.0, "pmid_journal_5": "Respirology (Carlton, Vic.)"}, {"pmid_title_6": "Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial.", "pmid_6": 24717640.0, "pmid_date_6": 2014.0, "pmid_journal_6": "The Lancet. Respiratory medicine"}, {"pmid_title_7": "The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.", "pmid_7": 25458200.0, "pmid_date_7": 2014.0, "pmid_journal_7": "The Lancet. Respiratory medicine"}, {"pmid_title_8": "Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials.", "pmid_8": 25154045.0, "pmid_date_8": 2014.0, "pmid_journal_8": "The Lancet. Respiratory medicine"}, {"pmid_title_9": "Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection.", "pmid_9": 24625200.0, "pmid_date_9": 2014.0, "pmid_journal_9": "American journal of respiratory and critical care medicine"}, {"pmid_title_10": "The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis--a randomised controlled trial.", "pmid_10": 24731015.0, "pmid_date_10": 2014.0, "pmid_journal_10": "Respiratory research"}, {"pmid_title_11": "Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis.", "pmid_11": 23433769.0, "pmid_date_11": 2013.0, "pmid_journal_11": "Respiratory medicine"}, {"pmid_title_12": "Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.", "pmid_12": 23532241.0, "pmid_date_12": 2013.0, "pmid_journal_12": "JAMA"}, {"pmid_title_13": "Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.", "pmid_13": 23532242.0, "pmid_date_13": 2013.0, "pmid_journal_13": "JAMA"}, {"pmid_title_14": "Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial.", "pmid_14": 23681906.0, "pmid_date_14": 2013.0, "pmid_journal_14": "Thorax"}, {"pmid_title_15": "Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis.", "pmid_15": 23429964.0, "pmid_date_15": 2013.0, "pmid_journal_15": "Chest"}, {"pmid_title_16": "Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults.", "pmid_16": 22564014.0, "pmid_date_16": 2012.0, "pmid_journal_16": "Respirology (Carlton, Vic.)"}, {"pmid_title_17": "Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.", "pmid_17": 22901887.0, "pmid_date_17": 2012.0, "pmid_journal_17": "Lancet (London, England)"}, {"pmid_title_18": "A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis.", "pmid_18": 22717535.0, "pmid_date_18": 2012.0, "pmid_journal_18": "Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society"}, {"pmid_title_19": "Clinical efficacy and safety of budesonide-formoterol in non-cystic fibrosis bronchiectasis.", "pmid_19": 21778259.0, "pmid_date_19": 2012.0, "pmid_journal_19": "Chest"}, {"pmid_title_20": "Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.", "pmid_20": 22744718.0, "pmid_date_20": 2012.0, "pmid_journal_20": "American journal of respiratory and critical care medicine"}, {"pmid_title_21": "A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis.", "pmid_21": 22947443.0, "pmid_date_21": 2012.0, "pmid_journal_21": "Respiratory medicine"}, {"pmid_title_22": "The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis.", "pmid_22": 22349069.0, "pmid_date_22": 2012.0, "pmid_journal_22": "Respiratory medicine"}, {"pmid_title_23": "A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis.", "pmid_23": 20870753.0, "pmid_date_23": 2011.0, "pmid_journal_23": "American journal of respiratory and critical care medicine"}, {"pmid_title_24": "Effects of pulmonary rehabilitation in bronchiectasis: A retrospective study.", "pmid_24": 21339371.0, "pmid_date_24": 2011.0, "pmid_journal_24": "Chronic respiratory disease"}, {"pmid_title_25": "Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis.", "pmid_25": 22018993.0, "pmid_date_25": 2011.0, "pmid_journal_25": "Respiratory medicine"}, {"pmid_title_26": "Video-assisted thoracic surgery for bronchiectasis.", "pmid_26": 21172520.0, "pmid_date_26": 2011.0, "pmid_journal_26": "The Annals of thoracic surgery"}, {"pmid_title_27": "Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis.", "pmid_27": 16476120.0, "pmid_date_27": 2006.0, "pmid_journal_27": "Journal of clinical pharmacy and therapeutics"}, {"pmid_title_28": "Inhaled steroids improve quality of life in patients with steady-state bronchiectasis.", "pmid_28": 16434174.0, "pmid_date_28": 2006.0, "pmid_journal_28": "Respiratory medicine"}, {"pmid_title_29": "Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis.", "pmid_29": 10934074.0, "pmid_date_29": 2000.0, "pmid_journal_29": "American journal of respiratory and critical care medicine"}, {"pmid_title_30": "A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.", "pmid_30": 10717010.0, "pmid_date_30": 2000.0, "pmid_journal_30": "The New England journal of medicine"}, {"pmid_title_31": "Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study.", "pmid_31": 9163637.0, "pmid_date_31": 1997.0, "pmid_journal_31": "The European respiratory journal"}, {"pmid_title_32": "Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation.", "pmid_32": 3787536.0, "pmid_date_32": 1986.0, "pmid_journal_32": "Thorax"}, {"pmid_title_33": "Nebulized amoxicillin in chronic purulent bronchiectasis.", "pmid_33": 4053147.0, "pmid_date_33": 1985.0, "pmid_journal_33": "Clinical therapeutics"}]}, {"_id": "10602-OMIM:618114", "condition": {"condition_name": "LIDDLE SYNDROME 2", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3", "LIDDLE SYNDROME 2", "PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE"]}, "gene information": {"db_hgnc_gene_id": 10602.0}, "interventions": [{"int_description_1": "Low sodium diet", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "Yes", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Amiloride", "timeframe_int2": "Hours,Days or Weeks,Years", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "Yes", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Triamterene", "timeframe_int3": "Hours,Days or Weeks,Years", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Cadaveric renal transplant"}], "references": [{"pmid_title_1": "A Missense Mutation in the Extracellular Domain of <i>\u03b1</i>ENaC Causes Liddle Syndrome.", "pmid_1": 28710092.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Journal of the American Society of Nephrology : JASN"}, {"pmid_title_2": "A novel epithelial sodium channel gamma-subunit de novo frameshift mutation leads to Liddle syndrome.", "pmid_2": 17634077.0, "pmid_date_2": 2007.0, "pmid_journal_2": "Clinical endocrinology"}, {"pmid_title_3": "Liddle's syndrome associated with a point mutation in the extracellular domain of the epithelial sodium channel gamma subunit.", "pmid_3": 12473862.0, "pmid_date_3": 2002.0, "pmid_journal_3": "Journal of hypertension"}, {"pmid_title_4": "Genotype-phenotype analysis of a newly discovered family with Liddle's syndrome.", "pmid_4": 9350583.0, "pmid_date_4": 1997.0, "pmid_journal_4": "Journal of hypertension"}, {"pmid_title_5": "Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome.", "pmid_5": 7550319.0, "pmid_date_5": 1995.0, "pmid_journal_5": "Nature genetics"}, {"pmid_title_6": "A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity.", "pmid_6": 8524790.0, "pmid_date_6": 1995.0, "pmid_journal_6": "Proceedings of the National Academy of Sciences of the United States of America"}, {"pmid_title_7": "The effect of triamterene and sodium intake on renin, aldosterone, and erythrocyte sodium transport in Liddle's syndrome.", "pmid_7": 6262354.0, "pmid_date_7": 1981.0, "pmid_journal_7": "The Journal of clinical endocrinology and metabolism"}]}, {"_id": "10817-OMIM:617575", "condition": {"condition_name": "NEPHROTIC SYNDROME, TYPE 14", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["NEPHROTIC SYNDROME, TYPE 14"]}, "gene information": {"db_hgnc_gene_id": 10817.0}, "interventions": [{"int_description_1": "Hemodialysis"}, {"int_description_2": "Total parenteral nutrition"}, {"int_description_3": "Fingolimod"}, {"int_description_4": "Hydrocortisone"}, {"int_description_5": "Enzyme replacement therapy"}, {"int_description_6": "Pharmacological chaperones"}, {"int_description_7": "Substrate reduction therapy"}, {"int_description_8": "CRISPR-Cas9"}], "references": [{"pmid_title_1": "Fifty years of lyase and a moment of truth: sphingosine phosphate lyase from discovery to disease.", "pmid_1": 30635364.0, "pmid_date_1": 2019.0, "pmid_journal_1": "J Lipid Res"}, {"pmid_title_2": "Advances in Sphingolipidoses: CRISPR-Cas9 Editing as an Option for Modelling and Therapy.", "pmid_2": 31771289.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Int J Mol Sci"}, {"pmid_title_3": "SGPL1 Deficiency: A Rare Cause of Primary Adrenal Insufficiency.", "pmid_3": 30517686.0, "pmid_date_3": 2019.0, "pmid_journal_3": "J Clin Endocrinol Metab"}, {"pmid_title_4": "Recent advances and novel treatments for sphingolipidoses.", "pmid_4": 28857617.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Future Med Chem"}, {"pmid_title_5": "Deficiency of the sphingosine-1-phosphate lyase SGPL1 is associated with congenital nephrotic syndrome and congenital adrenal calcifications.", "pmid_5": 28181337.0, "pmid_date_5": 2017.0, "pmid_journal_5": "Hum Mutat"}]}, {"_id": "10820-OMIM:308240", "condition": {"condition_name": "LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1", "freq_per_birth": "XLP1 is estimated to occur in about 1 per million males worldwide. XLP2 is less common, occurring in about 1 per 5 million males.", "pattern_of_inheritance": "X-linked recessive", "alternate_names": ["LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1"]}, "gene information": {"db_hgnc_gene_id": 10820.0}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Prednisone", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Dexamethasone"}, {"int_description_4": "Ganciclovir", "timeframe_int4": "Hours", "age_use_int4": "Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Human immunoglobulin G"}, {"int_description_6": "Antithymocyte immunoglobulin (rabbit)", "timeframe_int6": "Days or Weeks", "age_use_int6": "Infant,Child", "contra_int6": "Yes", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Rituximab"}, {"int_description_8": "Alemtuzumab"}, {"int_description_9": "Vedolizumab"}, {"int_description_10": "Adalimumab"}, {"int_description_11": "Cyclosporine"}, {"int_description_12": "Muromonab"}, {"int_description_13": "Cyclophosphamide"}, {"int_description_14": "Busulfan"}, {"int_description_15": "Melphalan"}, {"int_description_16": "Thiotepa"}, {"int_description_17": "Doxorubicin"}, {"int_description_18": "Mercaptopurine", "timeframe_int18": "Hours", "age_use_int18": "Neonate,Infant,Child", "contra_int18": "No", "qualscale_reclass_drug18": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug18": "Effective / Ameliorative"}, {"int_description_19": "Mesalazine", "timeframe_int19": "Hours", "age_use_int19": "Neonate,Infant,Child", "contra_int19": "No", "qualscale_reclass_drug19": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug19": "Effective / Ameliorative"}, {"int_description_20": "Sulfasalazine"}, {"int_description_21": "Vincristine"}, {"int_description_22": "Treosulfan"}, {"int_description_23": "Methotrexate"}, {"int_description_24": "Fludarabine"}, {"int_description_25": "Etoposide"}, {"int_description_26": "Tacrolimus"}, {"int_description_27": "Foscarnet"}, {"int_description_28": "Acyclovir"}, {"int_description_29": "Azathioprine", "timeframe_int29": "Hours", "age_use_int29": "Neonate,Infant,Child", "contra_int29": "No", "qualscale_reclass_drug29": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug29": "Effective / Ameliorative"}, {"int_description_30": "Mycophenolate mofetil"}, {"int_description_31": "Hydrocortisone"}, {"int_description_32": "Tocilizumab"}, {"int_description_33": "Methylprednisolone"}, {"int_description_34": "Infliximab"}, {"int_description_35": "Emapalumab"}, {"int_description_36": "Cefotaxime"}, {"int_description_37": "Total body irradiation"}, {"int_description_38": "Total parental nutrition", "timeframe_int38": "Days or Weeks", "age_use_int38": "Infant,Child", "contra_int38": "No", "qualscale_reclass_drug38": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug38": "Curative"}, {"int_description_39": "Allogeneic stem cell transplantation"}, {"int_description_40": "Colectomy"}, {"int_description_41": "Diverting ileostomy"}, {"int_description_42": "Surgical management"}], "references": [{"pmid_title_1": "Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis.", "pmid_1": 32374962.0, "pmid_date_1": 2020.0, "pmid_journal_1": "N Engl J Med"}, {"pmid_title_2": "Hematopoietic Stem Cell Transplantation for XIAP Deficiency in Japan.", "pmid_2": 27815752.0, "pmid_date_2": 2017.0, "pmid_journal_2": "J Clin Immunol"}, {"pmid_title_3": "Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study.", "pmid_3": 28935695.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Blood"}, {"pmid_title_4": "Progressive reduction of circulating B lymphocytes in patients with X-linked lymphoproliferative disease (XLP).", "pmid_4": 27220551.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Br J Haematol"}, {"pmid_title_5": "Novel Mutations in SH2D1A Gene in X-linked Lymphoproliferative Syndrome, Diagnosed After B-Cell Non-Hodgkin Lymphoma.", "pmid_5": 28267077.0, "pmid_date_5": 2017.0, "pmid_journal_5": "J Pediatr Hematol Oncol"}, {"pmid_title_6": "Symptomatic males and female carriers in a large Caucasian kindred with XIAP deficiency.", "pmid_6": 25943627.0, "pmid_date_6": 2015.0, "pmid_journal_6": "J Clin Immunol"}, {"pmid_title_7": "Cerebral Vasculitis in X-linked Lymphoproliferative Disease Cured by Matched Unrelated Cord Blood Transplant.", "pmid_7": 26433589.0, "pmid_date_7": 2015.0, "pmid_journal_7": "J Clin Immunol"}, {"pmid_title_8": "A de novo whole gene deletion of XIAP detected by exome sequencing analysis in very early onset inflammatory bowel disease: a case report.", "pmid_8": 26581487.0, "pmid_date_8": 2015.0, "pmid_journal_8": "BMC Gastroenterol"}, {"pmid_title_9": "BIRC4 Mutation: An Important Rare Cause of Uveitis.", "pmid_9": 26513308.0, "pmid_date_9": 2015.0, "pmid_journal_9": "J Clin Rheumatol"}, {"pmid_title_10": "A female patient with incomplete hemophagocytic lymphohistiocytosis caused by a heterozygous XIAP mutation associated with non-random X-chromosome inactivation skewed towards the wild-type XIAP allele.", "pmid_10": 25744037.0, "pmid_date_10": 2015.0, "pmid_journal_10": "J Clin Immunol"}, {"pmid_title_11": "Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes.", "pmid_11": 23131490.0, "pmid_date_11": 2013.0, "pmid_journal_11": "Blood"}, {"pmid_title_12": "Interleukin-21 overexpression dominates T cell response to Epstein-Barr virus in a fatal case of X-linked lymphoproliferative syndrome type 1.", "pmid_12": 23467775.0, "pmid_date_12": 2013.0, "pmid_journal_12": "Clin Vaccine Immunol"}, {"pmid_title_13": "X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.", "pmid_13": 20926771.0, "pmid_date_13": 2011.0, "pmid_journal_13": "Blood"}, {"pmid_title_14": "Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature.", "pmid_14": 15908972.0, "pmid_date_14": 2005.0, "pmid_journal_14": "Bone Marrow Transplant"}, {"pmid_title_15": "Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation.", "pmid_15": 12239144.0, "pmid_date_15": 2002.0, "pmid_journal_15": "Blood"}]}, {"_id": "10856-OMIM:222900", "condition": {"condition_name": "SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL"]}, "gene information": {"db_hgnc_gene_id": 10856.0}, "interventions": [{"int_description_1": "Sucrose and starch restricted diet", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Sacrosidase"}, {"int_description_3": "Prebiotics (poorly digestible carbohydrates)", "timeframe_int3": "Days or Weeks,Years", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Probiotics", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Parenteral nutrition"}], "references": [{"pmid_title_1": "The Role of Disaccharidase Deficiencies in Functional Abdominal Pain Disorders-A Narrative Review.", "pmid_1": 30501067.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Nutrients"}, {"pmid_title_2": "Relationships among Dietary Intakes and Persistent Gastrointestinal Symptoms in Patients Receiving Enzyme Treatment for Genetic Sucrase-Isomaltase Deficiency.", "pmid_2": 29311037.0, "pmid_date_2": 2018.0, "pmid_journal_2": "J Acad Nutr Diet"}, {"pmid_title_3": "The multiple roles of sucrase-isomaltase in the intestinal physiology.", "pmid_3": 26812950.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Mol Cell Pediatr"}, {"pmid_title_4": "Congenital sucrase-isomaltase deficiency: diagnostic challenges and response to enzyme replacement therapy.", "pmid_4": 26163121.0, "pmid_date_4": 2015.0, "pmid_journal_4": "Arch Dis Child"}, {"pmid_title_5": "Congenital sucrase-isomaltase deficiency: identification of a common Inuit founder mutation.", "pmid_5": 25452324.0, "pmid_date_5": 2015.0, "pmid_journal_5": "CMAJ"}, {"pmid_title_6": "Congenital sucrase-isomaltase deficiency: an under-diagnosed disease in Chinese children.", "pmid_6": 24433566.0, "pmid_date_6": 2014.0, "pmid_journal_6": "BMC Pediatr"}, {"pmid_title_7": "Congenital sucrase-isomaltase deficiency:  heterogeneity of inheritance, trafficking, and function of an intestinal enzyme complex.", "pmid_7": 23103643.0, "pmid_date_7": 2012.0, "pmid_journal_7": "J Pediatr Gastroenterol Nutr"}, {"pmid_title_8": "Congenital sucrase-isomaltase deficiency:  diet assessment and education guidelines.", "pmid_8": 23103652.0, "pmid_date_8": 2012.0, "pmid_journal_8": "J Pediatr Gastroenterol Nutr"}, {"pmid_title_9": "Clinical aspects and treatment of congenital sucrase-isomaltase deficiency.", "pmid_9": 23103658.0, "pmid_date_9": 2012.0, "pmid_journal_9": "J Pediatr Gastroenterol Nutr"}, {"pmid_title_10": "Congenital sucrase-isomaltase deficiency presenting with failure to thrive, hypercalcemia, and nephrocalcinosis.", "pmid_10": 12014995.0, "pmid_date_10": 2002.0, "pmid_journal_10": "BMC Pediatr"}, {"pmid_title_11": "Glucose polymer as a cause of protracted diarrhea in infants with unsuspected congenital sucrase-isomaltase deficiency.", "pmid_11": 8648532.0, "pmid_date_11": 1996.0, "pmid_journal_11": "J Pediatr"}, {"pmid_title_12": "Congenital sucrase-isomaltase deficiency.", "pmid_12": 8576798.0, "pmid_date_12": 1995.0, "pmid_journal_12": "J Pediatr Gastroenterol Nutr"}]}, {"_id": "10922-OMIM:610021", "condition": {"condition_name": "HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7", "freq_per_birth": "Congenital hyperinsulinism affects approximately 1 in 50,000 newborns. This condition is more common in certain populations, affecting up to 1 in 2,500 newborns.", "pattern_of_inheritance": "Autosomal dominant==Autosomal recessive", "alternate_names": ["HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7"]}, "gene information": {"db_hgnc_gene_id": 10922.0}, "interventions": [{"int_description_1": "Glucagon", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Octreotide", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Cohort study or studies", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Diazoxide", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Cohort study or studies", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Avexitide", "timeframe_int4": "Hours", "age_use_int4": "Neonate,Infant,Child", "qualscale_reclass_drug4": "Cohort study or studies", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Dasiglucagon", "timeframe_int5": "Hours", "age_use_int5": "Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Glucagon analogue linked to a human immunoglobulin Fc fragment monotherapy"}, {"int_description_7": "Recombinant human monoclonal antibody to insulin receptor monotherapy"}, {"int_description_8": "D-glucose"}, {"int_description_9": "Restrictive pancreatic resection (laparoscopy)"}], "references": [{"pmid_title_1": "A Novel Intragenic <i>SLC16A1</i> Mutation Associated With Congenital Hyperinsulinism.", "pmid_1": 28491926.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Global pediatric health"}]}, {"_id": "10935-OMIM:618049", "condition": {"condition_name": "PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2"]}, "gene information": {"db_hgnc_gene_id": 10935.0}, "interventions": [{"int_description_1": "Nasogastric tube"}, {"int_description_2": "Levodopa"}, {"int_description_3": "Pyridoxine", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Pramipexole"}, {"int_description_5": "Carbidopa"}, {"int_description_6": "Leucovorin"}], "references": [{"pmid_title_1": "Brain dopamine-serotonin vesicular transport disease presenting as a severe infantile hypotonic parkinsonian disorder.", "pmid_1": 26497564.0, "pmid_date_1": 2016.0, "pmid_journal_1": "Journal of inherited metabolic disease"}, {"pmid_title_2": "Brain dopamine-serotonin vesicular transport disease and its treatment.", "pmid_2": 23363473.0, "pmid_date_2": 2013.0, "pmid_journal_2": "The New England journal of medicine"}]}, {"_id": "10936-OMIM:617239", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC; CMS21", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC; CMS21"]}, "gene information": {"db_hgnc_gene_id": 10936.0}, "interventions": [{"int_description_1": "Mechanical ventilation"}, {"int_description_2": "Ephedrine"}, {"int_description_3": "Amifampridine", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Pyridostigmine"}, {"int_description_5": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "How chromosomal deletions can unmask recessive mutations? Deletions in 10q11.2 associated with CHAT or SLC18A3 mutations lead to congenital myasthenic syndrome.", "pmid_1": 29130637.0, "pmid_date_1": 2018.0, "pmid_journal_1": "American journal of medical genetics. Part A"}, {"pmid_title_2": "The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes.", "pmid_2": 29874875.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Int J Mol Sci"}, {"pmid_title_3": "Vesicular acetylcholine transporter defect underlies devastating congenital myasthenia syndrome.", "pmid_3": 28188302.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Neurology"}, {"pmid_title_4": "Variants in SLC18A3, vesicular acetylcholine transporter, cause congenital myasthenic syndrome.", "pmid_4": 27590285.0, "pmid_date_4": 2016.0, "pmid_journal_4": "Neurology"}]}, {"_id": "10969-OMIM:212140", "condition": {"condition_name": "CARNITINE DEFICIENCY, SYSTEMIC PRIMARY", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["CARNITINE DEFICIENCY, SYSTEMIC PRIMARY"]}, "gene information": {"db_hgnc_gene_id": 10969.0}, "interventions": [{"int_description_1": "Levocarnitine", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "D-glucose"}, {"int_description_3": "Frequent feeding", "timeframe_int3": "Hours,Days or Weeks,Years", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Systemic Primary Carnitine Deficiency", "pmid_1": 22420015.0, "pmid_date_1": 2016.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Primary systemic carnitine deficiency: a Turkish case with a novel homozygous SLC22A5 mutation and 14 years follow-up.", "pmid_2": 26030785.0, "pmid_date_2": 2015.0, "pmid_journal_2": "J Pediatr Endocrinol Metab"}, {"pmid_title_3": "Analysis of genetic mutations in Chinese patients with systemic primary carnitine deficiency.", "pmid_3": 25132046.0, "pmid_date_3": 2014.0, "pmid_journal_3": "Eur J Med Genet"}, {"pmid_title_4": "SLC22A5 mutations in a patient with systemic primary carnitine deficiency: the first Korean case confirmed by biochemical and molecular investigation.", "pmid_4": 23090741.0, "pmid_date_4": 2012.0, "pmid_journal_4": "Ann Clin Lab Sci"}]}, {"_id": "10979-OMIM:615182", "condition": {"condition_name": "COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD", "freq_per_birth": "2-hydroxyglutaric aciduria is a rare disorder. D-2-HGA and L-2-HGA have each been reported to affect fewer than 150 individuals worldwide. Combined D,L-2-HGA appears to be even rarer, with only about a dozen reported cases.", "pattern_of_inheritance": "Autosomal dominant==Autosomal recessive", "alternate_names": ["COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD", "MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23"]}, "gene information": {"db_hgnc_gene_id": 10979.0}, "interventions": [{"int_description_1": "Intubation"}, {"int_description_2": "Mechanical ventilation"}, {"int_description_3": "Ventilation"}, {"int_description_4": "Clonazepam"}, {"int_description_5": "Na-K-citrate", "timeframe_int5": "Hours", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Gastrostomy tube"}, {"int_description_7": "Tracheotomy"}], "references": [{"pmid_title_1": "An overview of combined D-2- and L-2-hydroxyglutaric aciduria: functional analysis of CIC variants.", "pmid_1": 29238895.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Journal of inherited metabolic disease"}, {"pmid_title_2": "Expanding the Clinical Spectrum of Mitochondrial Citrate Carrier (SLC25A1) Deficiency: Facial Dysmorphism in Siblings with Epileptic Encephalopathy and Combined D,L-2-Hydroxyglutaric Aciduria.", "pmid_2": 25614306.0, "pmid_date_2": 2015.0, "pmid_journal_2": "JIMD reports"}, {"pmid_title_3": "Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders.", "pmid_3": 25473036.0, "pmid_date_3": 2014.0, "pmid_journal_3": "Science translational medicine"}, {"pmid_title_4": "Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission.", "pmid_4": 26870663.0, "pmid_date_4": 2014.0, "pmid_journal_4": "Journal of neuromuscular diseases"}, {"pmid_title_5": "Agenesis of corpus callosum and optic nerve hypoplasia due to mutations in SLC25A1 encoding the mitochondrial citrate transporter.", "pmid_5": 23393310.0, "pmid_date_5": 2013.0, "pmid_journal_5": "Journal of medical genetics"}, {"pmid_title_6": "Challenging colonic polyposis pedigrees: differential diagnosis, surveillance, and management concerns.", "pmid_6": 14734220.0, "pmid_date_6": 2004.0, "pmid_journal_6": "Cancer genetics and cytogenetics"}]}, {"_id": "10979-OMIM:618197", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23", "COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD"]}, "gene information": {"db_hgnc_gene_id": 10979.0}, "interventions": [{"int_description_1": "Ephedrine"}, {"int_description_2": "Salbutamol"}, {"int_description_3": "Amifampridine", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Pyridostigmine", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Acetylcholinesterase inhibitors"}, {"int_description_6": "Tracheotomy"}], "references": [{"pmid_title_1": "Congenital myasthenic syndrome with mild intellectual disability caused by a recurrent SLC25A1 variant.", "pmid_1": 31527857.0, "pmid_date_1": 2020.0, "pmid_journal_1": "European journal of human genetics : EJHG"}, {"pmid_title_2": "Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission.", "pmid_2": 26870663.0, "pmid_date_2": 2014.0, "pmid_journal_2": "Journal of neuromuscular diseases"}, {"pmid_title_3": "Agenesis of corpus callosum and optic nerve hypoplasia due to mutations in SLC25A1 encoding the mitochondrial citrate transporter.", "pmid_3": 23393310.0, "pmid_date_3": 2013.0, "pmid_journal_3": "Journal of medical genetics"}]}, {"_id": "10983-OMIM:605814", "condition": {"condition_name": "CITRULLINEMIA, TYPE II, NEONATAL-ONSET", "freq_per_birth": "Type I citrullinemia is the most common form of the disorder, affecting about 1 in 57,000 people worldwide. Type II citrullinemia is found primarily in the Japanese population, where it occurs in an estimated 1 in 100,000 to 230,000 individuals. Type II also has been reported in other populations, including other people from East Asia, the Middle East, the United States, and the United Kingdom.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["CITRULLINEMIA, TYPE II, NEONATAL-ONSET"]}, "gene information": {"db_hgnc_gene_id": 10983.0}, "interventions": [{"int_description_1": "Lactose-free therapeutic formulas"}, {"int_description_2": "Lipid and protein-rich low-carbohydrate diet"}, {"int_description_3": "Supplement diet with fat-soluble vitamins", "timeframe_int3": "Days or Weeks,Years", "age_use_int3": "Neonate,Infant", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Still in Trials / Unproven"}, {"int_description_4": "Arginine"}, {"int_description_5": "Proline", "timeframe_int5": "Days or Weeks,Years", "age_use_int5": "Neonate,Infant", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Pyruvic acid", "timeframe_int6": "Hours,Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Phenylbutyric acid", "timeframe_int7": "Days or Weeks", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Glycerol phenylbutyrate"}, {"int_description_9": "Medium-chain triglycerides"}, {"int_description_10": "Heterologous human adult liver-derived progenitor cells", "timeframe_int10": "Hours,Days or Weeks", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Human heterologous liver cells (for infusion)", "timeframe_int11": "Days or Weeks,Years", "age_use_int11": "Neonate,Infant,Child", "contra_int11": "No", "qualscale_reclass_drug11": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "Orthotopic liver transplantation (OLT)"}], "references": [{"pmid_title_1": "Current treatment for citrin deficiency during NICCD and adaptation/compensation stages: Strategy to prevent CTLN2.", "pmid_1": 31255436.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Molecular genetics and metabolism"}, {"pmid_title_2": "Citrin Deficiency", "pmid_2": 20301360.0, "pmid_date_2": 2017.0, "pmid_journal_2": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_3": "Circulating tricarboxylic acid cycle metabolite levels in citrin-deficient children with metabolic adaptation, with and without sodium pyruvate treatment.", "pmid_3": 28041819.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Molecular genetics and metabolism"}, {"pmid_title_4": "Effectiveness of Medium-Chain Triglyceride Oil Therapy in Two Japanese Citrin-Deficient Siblings: Evaluation Using Oral Glucose Tolerance Tests.", "pmid_4": 28003588.0, "pmid_date_4": 2016.0, "pmid_journal_4": "The Tohoku journal of experimental medicine"}, {"pmid_title_5": "Clinical, molecular and functional investigation on an infant with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD).", "pmid_5": 24586645.0, "pmid_date_5": 2014.0, "pmid_journal_5": "PloS one"}, {"pmid_title_6": "Medium-chain triglyceride supplementation under a low-carbohydrate formula is a promising therapy for adult-onset type II citrullinemia.", "pmid_6": 27896073.0, "pmid_date_6": 2014.0, "pmid_journal_6": "Molecular genetics and metabolism reports"}, {"pmid_title_7": "Citrin deficiency in a Romanian child living in Spain highlights the worldwide distribution of this defect and illustrates the value of nutritional therapy.", "pmid_7": 23835251.0, "pmid_date_7": 2013.0, "pmid_journal_7": "Molecular genetics and metabolism"}, {"pmid_title_8": "Treatment with lactose (galactose)-restricted and medium-chain triglyceride-supplemented formula for neonatal intrahepatic cholestasis caused by citrin deficiency.", "pmid_8": 23430852.0, "pmid_date_8": 2012.0, "pmid_journal_8": "JIMD reports"}, {"pmid_title_9": "Liver transplantation for an infant with neonatal intrahepatic cholestasis caused by citrin deficiency using heterozygote living donor.", "pmid_9": 19413723.0, "pmid_date_9": 2010.0, "pmid_journal_9": "Pediatric transplantation"}, {"pmid_title_10": "Citrin deficiency and current treatment concepts.", "pmid_10": 20233664.0, "pmid_date_10": 2010.0, "pmid_journal_10": "Molecular genetics and metabolism"}, {"pmid_title_11": "[Therapeutic approaches for patients with adult-onset type II citrullinemia (CTLN2): effectiveness of treatment with low-carbohydrate diet and sodium pyruvate].", "pmid_11": 21921468.0, "pmid_date_11": 2010.0, "pmid_journal_11": "Rinsho shinkeigaku = Clinical neurology"}, {"pmid_title_12": "Living donor liver transplantation for type II citrullinemia from a heterozygous donor.", "pmid_12": 19260507.0, "pmid_date_12": 2008.0, "pmid_journal_12": "Hepato-gastroenterology"}, {"pmid_title_13": "Treatment of a citrin-deficient patient at the early stage of adult-onset type II citrullinaemia with arginine and sodium pyruvate.", "pmid_13": 18958581.0, "pmid_date_13": 2008.0, "pmid_journal_13": "Journal of inherited metabolic disease"}, {"pmid_title_14": "Citrin deficiency: a novel cause of failure to thrive that responds to a high-protein, low-carbohydrate diet.", "pmid_14": 17332192.0, "pmid_date_14": 2007.0, "pmid_journal_14": "Pediatrics"}, {"pmid_title_15": "Feasibility of auxiliary partial orthotopic liver transplantation from living donors for patients with adult-onset type II citrullinemia.", "pmid_15": 15048800.0, "pmid_date_15": 2004.0, "pmid_journal_15": "Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society"}, {"pmid_title_16": "Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.", "pmid_16": 15050979.0, "pmid_date_16": 2004.0, "pmid_journal_16": "Molecular genetics and metabolism"}, {"pmid_title_17": "Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease.", "pmid_17": 12787807.0, "pmid_date_17": 2003.0, "pmid_journal_17": "Hepatology research : the official journal of the Japan Society of Hepatology"}, {"pmid_title_18": "A novel inborn error of metabolism detected by elevated methionine and/or galactose in newborn screening: neonatal intrahepatic cholestasis caused by citrin deficiency.", "pmid_18": 12692712.0, "pmid_date_18": 2003.0, "pmid_journal_18": "European journal of pediatrics"}, {"pmid_title_19": "Neonatal intrahepatic cholestasis caused by citrin deficiency: severe hepatic dysfunction in an infant requiring liver transplantation.", "pmid_19": 12424587.0, "pmid_date_19": 2002.0, "pmid_journal_19": "European journal of pediatrics"}, {"pmid_title_20": "Infantile citrullinemia caused by citrin deficiency with increased dibasic amino acids.", "pmid_20": 12409267.0, "pmid_date_20": 2002.0, "pmid_journal_20": "Molecular genetics and metabolism"}, {"pmid_title_21": "Living-related liver transplantation for type II citrullinemia using a graft from heterozygote donor.", "pmid_21": 11211185.0, "pmid_date_21": 2001.0, "pmid_journal_21": "Transplantation"}, {"pmid_title_22": "Type II (adult onset) citrullinaemia: clinical pictures and the therapeutic effect of liver transplantation.", "pmid_22": 11606680.0, "pmid_date_22": 2001.0, "pmid_journal_22": "Journal of neurology, neurosurgery, and psychiatry"}]}, {"_id": "10985-OMIM:238970", "condition": {"condition_name": "HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME", "freq_per_birth": "Ornithine translocase deficiency is a very rare disorder. More than 100 affected individuals have been described in the scientific literature.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME"]}, "gene information": {"db_hgnc_gene_id": 10985.0}, "interventions": [{"int_description_1": "Low protein diet and carnitine supplementation"}, {"int_description_2": "Low protein diet and citrulline supplementation", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Low protein diet and creatine supplementation"}, {"int_description_4": "Low protein diet and Essential amino acids (EAAs) supplementation", "timeframe_int4": "Hours", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Low protein diet and lysine supplementation", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Soybean oil"}, {"int_description_7": "Arginine"}, {"int_description_8": "L-Lysine"}, {"int_description_9": "Benzoic acid", "timeframe_int9": "Days or Weeks,Years", "age_use_int9": "Neonate,Infant,Child", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Phenylbutyric acid"}, {"int_description_11": "Glycerol phenylbutyrate"}, {"int_description_12": "Levocarnitine"}, {"int_description_13": "Creatine"}, {"int_description_14": "Citrulline"}, {"int_description_15": "Phenylacetic acid", "timeframe_int15": "Days or Weeks", "age_use_int15": "Neonate,Infant,Child", "contra_int15": "No", "qualscale_reclass_drug15": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug15": "Effective / Ameliorative"}, {"int_description_16": "D-glucose", "timeframe_int16": "Hours", "age_use_int16": "Neonate,Infant,Child", "contra_int16": "No", "qualscale_reclass_drug16": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug16": "Effective / Ameliorative"}, {"int_description_17": "Heterologous human adult liver-derived progenitor cells", "timeframe_int17": "Hours,Days or Weeks", "age_use_int17": "Neonate,Infant,Child", "contra_int17": "No", "qualscale_reclass_drug17": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug17": "Effective / Ameliorative"}, {"int_description_18": "Hemodialysis"}, {"int_description_19": "Orthotopic liver transplantation (OLT)"}], "references": [{"pmid_title_1": "Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome", "pmid_1": 22649802.0, "pmid_date_1": 2020.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision.", "pmid_2": 30982989.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Journal of inherited metabolic disease"}, {"pmid_title_3": "Urea cycle disorders-update.", "pmid_3": 31110235.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Journal of human genetics"}, {"pmid_title_4": "Phase I/II Trial of Liver-derived Mesenchymal Stem Cells in Pediatric Liver-based Metabolic Disorders: A Prospective, Open Label, Multicenter, Partially Randomized, Safety Study of One Cycle of Heterologous Human Adult Liver-derived Progenitor Cells (HepaStem) in Urea Cycle Disorders and Crigler-Najjar Syndrome Patients.", "pmid_4": 30801523.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Transplantation"}, {"pmid_title_5": "Evaluation of dietary treatment and amino acid supplementation in organic acidurias and urea-cycle disorders: On the basis of information from a European multicenter registry.", "pmid_5": 30734935.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Journal of inherited metabolic disease"}, {"pmid_title_6": "[Clinical diagnosis and treatment of three cases with hyperornithinemia-hyperammonemia-homocitrullinuria syndrome].", "pmid_6": 28592010.0, "pmid_date_6": 2017.0, "pmid_journal_6": "Zhonghua er ke za zhi = Chinese journal of pediatrics"}, {"pmid_title_7": "Guidelines for acute management of hyperammonemia in the Middle East region.", "pmid_7": 27099506.0, "pmid_date_7": 2016.0, "pmid_journal_7": "Therapeutics and clinical risk management"}, {"pmid_title_8": "Efficacy and safety of i.v. sodium benzoate in urea cycle disorders: a multicentre retrospective study.", "pmid_8": 27663197.0, "pmid_date_8": 2016.0, "pmid_journal_8": "Orphanet journal of rare diseases"}, {"pmid_title_9": "The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.", "pmid_9": 25874378.0, "pmid_date_9": 2015.0, "pmid_journal_9": "Orphanet journal of rare diseases"}, {"pmid_title_10": "Creatine metabolism in urea cycle defects.", "pmid_10": 22644604.0, "pmid_date_10": 2012.0, "pmid_journal_10": "Journal of inherited metabolic disease"}, {"pmid_title_11": "Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome with stroke-like imaging presentation: clinical, biochemical and molecular analysis.", "pmid_11": 17825324.0, "pmid_date_11": 2008.0, "pmid_journal_11": "Journal of the neurological sciences"}, {"pmid_title_12": "Neonatal onset of hyperornithinemia-hyperammonemia-homocitrullinuria syndrome with favorable outcome.", "pmid_12": 9329423.0, "pmid_date_12": 1997.0, "pmid_journal_12": "The Journal of pediatrics"}]}, {"_id": "11005-OMIM:606777", "condition": {"condition_name": "GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1", "freq_per_birth": "GLUT1 deficiency syndrome is a rare disorder. Approximately 500 cases have been reported worldwide since the disorder was first identified in 1991. In Australia, the prevalence of the disorder has been estimated at 1 in 90,000 people. However, researchers suggest that the disorder may be underdiagnosed, because many neurological disorders can cause similar symptoms.", "pattern_of_inheritance": "Autosomal dominant==Autosomal recessive", "alternate_names": ["EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12", "GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1", "GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2"]}, "gene information": {"db_hgnc_gene_id": 11005.0}, "interventions": [{"int_description_1": "Ketogenic diet"}, {"int_description_2": "Caffeine"}, {"int_description_3": "Topiramate"}, {"int_description_4": "Acetazolamide"}, {"int_description_5": "Zonisamide"}, {"int_description_6": "Valproic acid", "timeframe_int6": "Hours", "age_use_int6": "Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Lipoic acid"}, {"int_description_8": "Phenobarbital"}], "references": [{"pmid_title_1": "Glucose Transporter Type 1 Deficiency Syndrome", "pmid_1": 20301603.0, "pmid_date_1": 2018.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}]}, {"_id": "11005-OMIM:612126", "condition": {"condition_name": "GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2", "pattern_of_inheritance": "Autosomal dominant, Not applicable", "alternate_names": ["EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12", "GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2", "GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1"]}, "gene information": {"db_hgnc_gene_id": 11005.0}, "interventions": [{"int_description_1": "Ketogenic diet"}, {"int_description_2": "Caffeine"}, {"int_description_3": "Topiramate"}, {"int_description_4": "Levetiracetam"}, {"int_description_5": "Acetazolamide"}, {"int_description_6": "Zonisamide"}, {"int_description_7": "Valproic acid"}, {"int_description_8": "Lamotrigine", "timeframe_int8": "Hours", "age_use_int8": "Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Acetylcholinesterase inhibitors"}, {"int_description_10": "Lipoic acid"}, {"int_description_11": "Phenobarbital"}], "references": [{"pmid_title_1": "Glucose Transporter Type 1 Deficiency Syndrome", "pmid_1": 20301603.0, "pmid_date_1": 2018.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "A 23 years follow-up study identifies GLUT1 deficiency syndrome initially diagnosed as complicated hereditary spastic paraplegia.", "pmid_2": 27725288.0, "pmid_date_2": 2016.0, "pmid_journal_2": "European journal of medical genetics"}, {"pmid_title_3": "GLUT1 deficiency syndrome into adulthood: a follow-up study.", "pmid_3": 24413642.0, "pmid_date_3": 2014.0, "pmid_journal_3": "Journal of neurology"}, {"pmid_title_4": "Partial effectiveness of acetazolamide in a mild form of GLUT1 deficiency: a pediatric observation.", "pmid_4": 23649827.0, "pmid_date_4": 2013.0, "pmid_journal_4": "Movement disorders : official journal of the Movement Disorder Society"}]}, {"_id": "11005-OMIM:614847", "condition": {"condition_name": "EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2", "EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12", "GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1"]}, "gene information": {"db_hgnc_gene_id": 11005.0}, "interventions": [{"int_description_1": "Atkins diet"}, {"int_description_2": "Ketogenic diet"}, {"int_description_3": "Levetiracetam"}, {"int_description_4": "Ethosuximide", "timeframe_int4": "Hours", "age_use_int4": "Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Antiepileptic drugs"}], "references": [{"pmid_title_1": "<i>CHD2</i>-Related Neurodevelopmental Disorders", "pmid_1": 26677509.0, "pmid_date_1": 2015.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "The role of SLC2A1 mutations in myoclonic astatic epilepsy and absence epilepsy, and the estimated frequency of GLUT1 deficiency syndrome.", "pmid_2": 26537434.0, "pmid_date_2": 2015.0, "pmid_journal_2": "Epilepsia"}]}, {"_id": "1101-OMIM:155255", "condition": {"condition_name": "MEDULLOBLASTOMA", "pattern_of_inheritance": "Not applicable", "alternate_names": ["PROSTATE CANCER", "MEDULLOBLASTOMA", "PANCREATIC CANCER, SUSCEPTIBILITY TO, 2", "FANCONI ANEMIA, COMPLEMENTATION GROUP D1", "WILMS TUMOR 1", "BREAST CANCER", "BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2"]}, "gene information": {"db_hgnc_gene_id": 1101.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Prednisone"}, {"int_description_3": "Sonidegib"}, {"int_description_4": "Lomustine"}, {"int_description_5": "Temozolomide"}, {"int_description_6": "Cyclophosphamide"}, {"int_description_7": "Carboplatin"}, {"int_description_8": "Melphalan"}, {"int_description_9": "Ifosfamide"}, {"int_description_10": "Thiotepa"}, {"int_description_11": "Topotecan"}, {"int_description_12": "Vincristine"}, {"int_description_13": "Methotrexate"}, {"int_description_14": "Cytarabine"}, {"int_description_15": "Irinotecan"}, {"int_description_16": "Etoposide"}, {"int_description_17": "Hydroxyurea"}, {"int_description_18": "Methylprednisolone", "timeframe_int18": "Days or Weeks", "age_use_int18": "Neonate,Infant,Child", "contra_int18": "No", "qualscale_reclass_drug18": "Case report(s)"}, {"int_description_19": "Vismodegib"}, {"int_description_20": "Cisplatin"}, {"int_description_21": "Bevacizumab", "timeframe_int21": "Days or Weeks", "age_use_int21": "Neonate,Infant,Child", "contra_int21": "No", "qualscale_reclass_drug21": "Case report(s)", "rev1_eff_reclass_drug21": "Effective / Ameliorative"}, {"int_description_22": "Craniospinal irradiation"}, {"int_description_23": "Hyperfractionated accelerated radiotherapy (HART)"}, {"int_description_24": "Autologous stem cell transplantation"}, {"int_description_25": "Surgical resection of tumor"}], "references": [{"pmid_title_1": "EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma.", "pmid_1": 31797797.0, "pmid_date_1": 2019.0, "pmid_journal_1": "The Lancet. Oncology"}, {"pmid_title_2": "Post-treatment maturation of medulloblastoma in children: two cases and a literature review.", "pmid_2": 30270802.0, "pmid_date_2": 2018.0, "pmid_journal_2": "The Journal of international medical research"}, {"pmid_title_3": "Management and treatment of children with medulloblastoma in Serbia, a middle-income country.", "pmid_3": 30358225.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Journal of B.U.ON. : official journal of the Balkan Union of Oncology"}, {"pmid_title_4": "Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).", "pmid_4": 29016837.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Neuro-oncology"}, {"pmid_title_5": "Metachronous Medulloblastoma in a Child With Successfully Treated Neuroblastoma: Case Report and Novel Findings of DNA Sequencing.", "pmid_5": 29891519.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Journal of the National Comprehensive Cancer Network : JNCCN"}, {"pmid_title_6": "Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma.", "pmid_6": 28605510.0, "pmid_date_6": 2017.0, "pmid_journal_6": "Neuro-oncology"}, {"pmid_title_7": "Medulloblastoma.", "pmid_7": 26336203.0, "pmid_date_7": 2016.0, "pmid_journal_7": "Journal of child neurology"}, {"pmid_title_8": "Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.", "pmid_8": 26169613.0, "pmid_date_8": 2015.0, "pmid_journal_8": "Journal of clinical oncology : official journal of the American Society of Clinical Oncology"}, {"pmid_title_9": "Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience.", "pmid_9": 23296323.0, "pmid_date_9": 2013.0, "pmid_journal_9": "Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery"}, {"pmid_title_10": "Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study.", "pmid_10": 23857707.0, "pmid_date_10": 2013.0, "pmid_journal_10": "Neuro-oncology"}]}, {"_id": "1101-OMIM:194070", "condition": {"condition_name": "WILMS TUMOR 1", "freq_per_birth": "Wilms tumor is the most common kidney cancer in children. In Europe and North America, Wilms tumor affects 1 in 10,000 children. In the United States, 500 children develop Wilms tumor each year. The incidence of Wilms tumor seems to vary among populations, with African Americans having a higher-than-average risk of developing this cancer and Asians having a lower-than-average risk.Wilms tumor rarely develops in adults; only about 300 such cases have been described.", "pattern_of_inheritance": "Autosomal dominant, Not inherited, X-linked dominant", "alternate_names": ["MEDULLOBLASTOMA", "WILMS TUMOR 1", "PANCREATIC CANCER, SUSCEPTIBILITY TO, 2", "FANCONI ANEMIA, COMPLEMENTATION GROUP D1", "PROSTATE CANCER", "BREAST CANCER", "BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2"]}, "gene information": {"db_hgnc_gene_id": 1101.0}, "interventions": [{"int_description_1": "Dactinomycin"}, {"int_description_2": "Temozolomide"}, {"int_description_3": "Cyclophosphamide"}, {"int_description_4": "Carboplatin"}, {"int_description_5": "Ifosfamide"}, {"int_description_6": "Topotecan"}, {"int_description_7": "Doxorubicin"}, {"int_description_8": "Vincristine"}, {"int_description_9": "Irinotecan"}, {"int_description_10": "Etoposide"}, {"int_description_11": "MK-1775", "timeframe_int11": "Days or Weeks", "age_use_int11": "Neonate,Infant,Child", "contra_int11": "No", "qualscale_reclass_drug11": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "Bevacizumab", "timeframe_int12": "Days or Weeks", "age_use_int12": "Neonate,Infant,Child", "qualscale_reclass_drug12": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Radiation therapy"}, {"int_description_14": "Nephrectomy"}], "references": [{"pmid_title_1": "Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study.", "pmid_1": 32134700.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Journal of clinical oncology : official journal of the American Society of Clinical Oncology"}, {"pmid_title_2": "Preclinical evaluation of the combination of AZD1775 and irinotecan against selected pediatric solid tumors: A Pediatric Preclinical Testing Consortium report.", "pmid_2": 31975571.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Pediatric blood & cancer"}, {"pmid_title_3": "Pharmacotherapeutic Management of Wilms Tumor: An Update.", "pmid_3": 30604241.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Paediatric drugs"}, {"pmid_title_4": "Vincristine, Irinotecan, and Bevacizumab in Relapsed Wilms Tumor With Diffuse Anaplasia.", "pmid_4": 28859044.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Journal of pediatric hematology/oncology"}, {"pmid_title_5": "Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.", "pmid_5": 29659330.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Journal of clinical oncology : official journal of the American Society of Clinical Oncology"}, {"pmid_title_6": "Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study Group.", "pmid_6": 29077255.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Pediatric blood & cancer"}, {"pmid_title_7": "Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.", "pmid_7": 29211618.0, "pmid_date_7": 2018.0, "pmid_journal_7": "Journal of clinical oncology : official journal of the American Society of Clinical Oncology"}, {"pmid_title_8": "Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol.", "pmid_8": 29089605.0, "pmid_date_8": 2017.0, "pmid_journal_8": "Nature reviews. Urology"}, {"pmid_title_9": "Management of Wilms Tumor: ICMR Consensus Document.", "pmid_9": 28367612.0, "pmid_date_9": 2017.0, "pmid_journal_9": "Indian journal of pediatrics"}, {"pmid_title_10": "Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532.", "pmid_10": 27811504.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Annals of surgery"}, {"pmid_title_11": "Treatment of multiply relapsed wilms tumor with vincristine, irinotecan, temozolomide and bevacizumab.", "pmid_11": 24115645.0, "pmid_date_11": 2014.0, "pmid_journal_11": "Pediatric blood & cancer"}, {"pmid_title_12": "A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors.", "pmid_12": 23894304.0, "pmid_date_12": 2013.0, "pmid_journal_12": "PloS one"}, {"pmid_title_13": "Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study.", "pmid_13": 17634492.0, "pmid_date_13": 2007.0, "pmid_journal_13": "Journal of clinical oncology : official journal of the American Society of Clinical Oncology"}]}, {"_id": "1101-OMIM:605724", "condition": {"condition_name": "FANCONI ANEMIA, COMPLEMENTATION GROUP D1", "pattern_of_inheritance": "X-linked recessive, Autosomal recessive", "alternate_names": ["MEDULLOBLASTOMA", "FANCONI ANEMIA, COMPLEMENTATION GROUP D1", "PANCREATIC CANCER, SUSCEPTIBILITY TO, 2", "WILMS TUMOR 1", "PROSTATE CANCER", "BREAST CANCER", "BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2"]}, "gene information": {"db_hgnc_gene_id": 1101.0}, "interventions": [{"int_description_1": "Healthy diet"}, {"int_description_2": "Oxandrolone"}, {"int_description_3": "Danazol"}, {"int_description_4": "Testosterone propionate"}, {"int_description_5": "Oxymetholone"}, {"int_description_6": "Metenolone"}, {"int_description_7": "Calcium"}, {"int_description_8": "Prednisone"}, {"int_description_9": "Dexamethasone"}, {"int_description_10": "Insulin aspart"}, {"int_description_11": "Medroxyprogesterone acetate"}, {"int_description_12": "Tretinoin"}, {"int_description_13": "Eltrombopag"}, {"int_description_14": "Levothyroxine"}, {"int_description_15": "Estradiol"}, {"int_description_16": "Cetuximab"}, {"int_description_17": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_18": "Alemtuzumab"}, {"int_description_19": "Coenzyme M"}, {"int_description_20": "Cyclosporine"}, {"int_description_21": "Dactinomycin"}, {"int_description_22": "Sirolimus"}, {"int_description_23": "Somatotropin"}, {"int_description_24": "Vitamin D"}, {"int_description_25": "Cyclophosphamide"}, {"int_description_26": "Carboplatin"}, {"int_description_27": "Busulfan"}, {"int_description_28": "Ifosfamide"}, {"int_description_29": "Thiotepa"}, {"int_description_30": "Doxorubicin"}, {"int_description_31": "Fluorouracil", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Mercaptopurine", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Neonate,Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Trimethoprim"}, {"int_description_34": "Sulfamethoxazole"}, {"int_description_35": "Gemcitabine"}, {"int_description_36": "Vincristine"}, {"int_description_37": "Methotrexate"}, {"int_description_38": "Fludarabine"}, {"int_description_39": "Cytarabine"}, {"int_description_40": "Irinotecan"}, {"int_description_41": "Daunorubicin"}, {"int_description_42": "Etoposide"}, {"int_description_43": "Idarubicin"}, {"int_description_44": "Tacrolimus"}, {"int_description_45": "Acyclovir"}, {"int_description_46": "Quercetin"}, {"int_description_47": "Tioguanine"}, {"int_description_48": "Mycophenolate mofetil"}, {"int_description_49": "Tranexamic acid"}, {"int_description_50": "Hydroxyurea"}, {"int_description_51": "Methylprednisolone"}, {"int_description_52": "Methyltestosterone"}, {"int_description_53": "Leucovorin"}, {"int_description_54": "Vinorelbine"}, {"int_description_55": "Deferasirox"}, {"int_description_56": "Deferiprone"}, {"int_description_57": "Co-trimoxazole"}, {"int_description_58": "Asparaginase Escherichia coli"}, {"int_description_59": "Cisplatin"}, {"int_description_60": "Antilymphocyte immunoglobulin (horse)"}, {"int_description_61": "Norethandrolone"}, {"int_description_62": "Phosphorus"}, {"int_description_63": "GM-CSF (granulocyte-macrophage colony-stimulating factor)"}, {"int_description_64": "rh-SOD"}, {"int_description_65": "Bevacizumab"}, {"int_description_66": "Filgrastim"}, {"int_description_67": "Amifostine"}, {"int_description_68": "Radiation therapy", "timeframe_int68": "Days or Weeks,Years", "age_use_int68": "Child", "contra_int68": "No", "qualscale_reclass_drug68": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug68": "Effective / Ameliorative"}, {"int_description_69": "Total abdominal radiation"}, {"int_description_70": "Total body irradiation"}, {"int_description_71": "Total lymphoid irradiation"}, {"int_description_72": "Transfusion of blood products"}, {"int_description_73": "Bone marrow transplantation"}, {"int_description_74": "Hematopoietic stem cell transplantation"}, {"int_description_75": "Surgery for polydactyly, carpectomy"}, {"int_description_76": "Surgical intervention"}, {"int_description_77": "\u042burgical tumor removement"}], "references": [{"pmid_title_1": "Gingival Bleeding in a Child with Fanconi Anemia: A Case Report and Literature Review.", "pmid_1": 32231808.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Case Rep Dent"}, {"pmid_title_2": "Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.", "pmid_2": 29668547.0, "pmid_date_2": 2019.0, "pmid_journal_2": "J Pediatr Hematol Oncol"}, {"pmid_title_3": "Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.", "pmid_3": 31192125.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Front Oncol"}, {"pmid_title_4": "Fanconi anemia: a single center experience of a large cohort.", "pmid_4": 31990462.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Turk J Pediatr"}, {"pmid_title_5": "Therapeutic research in the crystal chromosome disease Fanconi anemia.", "pmid_5": 30389152.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Mutat Res Genet Toxicol Environ Mutagen"}, {"pmid_title_6": "Oral cancer in Fanconi anemia: Review of 121 cases.", "pmid_6": 29650274.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Crit Rev Oncol Hematol"}, {"pmid_title_7": "Essential Role of BRCA2 in Ovarian Development and Function.", "pmid_7": 30207912.0, "pmid_date_7": 2018.0, "pmid_journal_7": "N Engl J Med"}, {"pmid_title_8": "Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.", "pmid_8": 29203412.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Biol Blood Marrow Transplant"}, {"pmid_title_9": "How I manage patients with Fanconi anaemia.", "pmid_9": 28474441.0, "pmid_date_9": 2017.0, "pmid_journal_9": "Br J Haematol"}, {"pmid_title_10": "Eltrombopag for the treatment of aplastic anemia: current perspectives.", "pmid_10": 27695288.0, "pmid_date_10": 2016.0, "pmid_journal_10": "Drug Des Devel Ther"}, {"pmid_title_11": "Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.", "pmid_11": 27246371.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Biol Blood Marrow Transplant"}, {"pmid_title_12": "Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.", "pmid_12": 26900943.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Pediatr Hematol Oncol"}, {"pmid_title_13": "Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.", "pmid_13": 26657402.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Eur J Med Genet"}, {"pmid_title_14": "Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.", "pmid_14": 25575015.0, "pmid_date_14": 2015.0, "pmid_journal_14": "J Clin Endocrinol Metab"}, {"pmid_title_15": "Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.", "pmid_15": 25862235.0, "pmid_date_15": 2015.0, "pmid_journal_15": "Ann Hematol"}, {"pmid_title_16": "Alternative donor hematopoietic cell transplantation for Fanconi anemia.", "pmid_16": 25824692.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Blood"}, {"pmid_title_17": "Fanconi anemia and solid malignancies in childhood: a national retrospective study.", "pmid_17": 25381700.0, "pmid_date_17": 2015.0, "pmid_journal_17": "Pediatr Blood Cancer"}, {"pmid_title_18": "Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.", "pmid_18": 25531282.0, "pmid_date_18": 2015.0, "pmid_journal_18": "Bone Marrow Transplant"}, {"pmid_title_19": "Clear cell sarcoma of the kidney in a child with Fanconi anemia.", "pmid_19": 24735155.0, "pmid_date_19": 2014.0, "pmid_journal_19": "Pediatr Dev Pathol"}, {"pmid_title_20": "Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.", "pmid_20": 25085358.0, "pmid_date_20": 2014.0, "pmid_journal_20": "Haematologica"}, {"pmid_title_21": "Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.", "pmid_21": 24019220.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Management of dental extraction in a female patient with fanconi anemia.", "pmid_22": 25628690.0, "pmid_date_22": 2014.0, "pmid_journal_22": "J Dent (Tehran)"}, {"pmid_title_23": "Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature.", "pmid_23": 22965917.0, "pmid_date_23": 2013.0, "pmid_journal_23": "Head Neck"}, {"pmid_title_24": "Deferasirox therapy in children with Fanconi aplastic anemia.", "pmid_24": 22510772.0, "pmid_date_24": 2012.0, "pmid_journal_24": "J Pediatr Hematol Oncol"}, {"pmid_title_25": "Fatal course of tonsillar squamous cell carcinoma associated with Fanconi anaemia: a mini review.", "pmid_25": 21925890.0, "pmid_date_25": 2012.0, "pmid_journal_25": "J Craniomaxillofac Surg"}, {"pmid_title_26": "Treatment of the bone marrow failure in Fanconi anemia patients with danazol.", "pmid_26": 22178060.0, "pmid_date_26": 2012.0, "pmid_journal_26": "Blood Cells Mol Dis"}, {"pmid_title_27": "Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing.", "pmid_27": 21519011.0, "pmid_date_27": 2011.0, "pmid_journal_27": "J Clin Oncol"}, {"pmid_title_28": "Successful treatment of esophageal squamous cell carcinoma in a patient with Fanconi anemia.", "pmid_28": 20410055.0, "pmid_date_28": 2010.0, "pmid_journal_28": "Jpn J Clin Oncol"}, {"pmid_title_29": "Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.", "pmid_29": 19564748.0, "pmid_date_29": 2009.0, "pmid_journal_29": "J Pediatr Hematol Oncol"}, {"pmid_title_30": "Treatment with deferiprone for iron overload alleviates bone marrow failure in a Fanconi anemia patient.", "pmid_30": 19814681.0, "pmid_date_30": 2009.0, "pmid_journal_30": "Hemoglobin"}, {"pmid_title_31": "Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.", "pmid_31": 18302713.0, "pmid_date_31": 2008.0, "pmid_journal_31": "Br J Haematol"}, {"pmid_title_32": "Thrombocytopenia in the neonate.", "pmid_32": 18433954.0, "pmid_date_32": 2008.0, "pmid_journal_32": "Blood Rev"}, {"pmid_title_33": "Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.", "pmid_33": 18379369.0, "pmid_date_33": 2008.0, "pmid_journal_33": "J Thorac Oncol"}, {"pmid_title_34": "Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function.", "pmid_34": 18623197.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Pediatr Blood Cancer"}, {"pmid_title_35": "Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.", "pmid_35": 18831513.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Cancer"}, {"pmid_title_36": "Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.", "pmid_36": 17950918.0, "pmid_date_36": 2007.0, "pmid_journal_36": "Biol Blood Marrow Transplant"}, {"pmid_title_37": "Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.", "pmid_37": 17038525.0, "pmid_date_37": 2007.0, "pmid_journal_37": "Blood"}, {"pmid_title_38": "Chemotherapy for myeloid malignancy in children with Fanconi anemia.", "pmid_38": 16609946.0, "pmid_date_38": 2007.0, "pmid_journal_38": "Pediatr Blood Cancer"}, {"pmid_title_39": "A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.", "pmid_39": 17096012.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Leukemia"}, {"pmid_title_40": "HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.", "pmid_40": 18022575.0, "pmid_date_40": 2007.0, "pmid_journal_40": "Biol Blood Marrow Transplant"}, {"pmid_title_41": "Anesthesia and Fanconi anemia: a case report and review of literature.", "pmid_41": 16918663.0, "pmid_date_41": 2006.0, "pmid_journal_41": "Paediatr Anaesth"}, {"pmid_title_42": "Squamous cell carcinoma of the hypopharynx in a young woman with Fanconi's anemia.", "pmid_42": 17308840.0, "pmid_date_42": 2006.0, "pmid_journal_42": "Braz J Otorhinolaryngol"}, {"pmid_title_43": "Squamous cell vulvar carcinoma associated with Fanconi's anemia: a case report.", "pmid_43": 11975685.0, "pmid_date_43": 2002.0, "pmid_journal_43": "Int J Gynecol Cancer"}, {"pmid_title_44": "Growth hormone deficiency caused by pituitary stalk interruption in Fanconi's anemia.", "pmid_44": 11148528.0, "pmid_date_44": 2001.0, "pmid_journal_44": "J Pediatr"}, {"pmid_title_45": "Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.", "pmid_45": 9658728.0, "pmid_date_45": 1998.0, "pmid_journal_45": "Haematologica"}, {"pmid_title_46": "Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.", "pmid_46": 8781414.0, "pmid_date_46": 1996.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.", "pmid_47": 7644282.0, "pmid_date_47": 1995.0, "pmid_journal_47": "Pediatr Nurs"}, {"pmid_title_48": "Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.", "pmid_48": 8283365.0, "pmid_date_48": 1994.0, "pmid_journal_48": "J Pediatr"}, {"pmid_title_49": "A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia.", "pmid_49": 8280614.0, "pmid_date_49": 1993.0, "pmid_journal_49": "Br J Haematol"}, {"pmid_title_50": "Fanconi's anemia. A family study with 20-year follow-up including associated breast pathology.", "pmid_50": 6478420.0, "pmid_date_50": 1984.0, "pmid_journal_50": "Cancer"}, {"pmid_title_51": "Multiple hepatic tumors and peliosis hepatis in Fanconi's anemia treated with androgens.", "pmid_51": 199056.0, "pmid_date_51": 1977.0, "pmid_journal_51": "Am J Dis Child"}, {"pmid_title_52": "Hepatic lesions in patients treated with synthetic anabolic steriods.", "pmid_52": 185239.0, "pmid_date_52": 1976.0, "pmid_journal_52": "J Clin Pathol"}, {"pmid_title_53": "The defective absorption of phosphorus and calcium and the effect of vitamin D in the Fanconi syndrome.", "pmid_53": 13610080.0, "pmid_date_53": 1958.0, "pmid_journal_53": "Guys Hosp Rep"}]}, {"_id": "11022-OMIM:300896", "condition": {"condition_name": "CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M", "freq_per_birth": "SLC35A2-CDG is a rare disorder. At least nine affected individuals have been described.", "pattern_of_inheritance": "X-linked dominant", "alternate_names": ["CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M"]}, "gene information": {"db_hgnc_gene_id": 11022.0}, "interventions": [{"int_description_1": "Nasogastric tube"}, {"int_description_2": "Levothyroxine"}, {"int_description_3": "Furosemide"}, {"int_description_4": "Acetaminophen"}, {"int_description_5": "Gastrostomy tube"}], "references": [{"pmid_title_1": "Mosaicism of the UDP-Galactose transporter SLC35A2 in a female causing a congenital disorder of glycosylation: a case report.", "pmid_1": 29907092.0, "pmid_date_1": 2018.0, "pmid_journal_1": "BMC medical genetics"}]}, {"_id": "11036-OMIM:606824", "condition": {"condition_name": "GLUCOSE/GALACTOSE MALABSORPTION; GGM", "freq_per_birth": "Glucose-galactose malabsorption is a rare disorder; only a few hundred cases have been identified worldwide. However, as many as 10 percent of the population may have a somewhat reduced capacity for glucose absorption without associated health problems.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["GLUCOSE/GALACTOSE MALABSORPTION; GGM"]}, "gene information": {"db_hgnc_gene_id": 11036.0}, "interventions": [{"int_description_1": "Carbohydrate-free formula", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Galactomin19"}, {"int_description_3": "Lactose-free cow's milk"}, {"int_description_4": "Rehydration", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Nutrition management of congenital glucose-galactose malabsorption: Case report of a Chinese infant.", "pmid_1": 31415402.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Medicine (Baltimore)"}, {"pmid_title_2": "Multiple sequence variations in SLC5A1 gene are associated with glucose-galactose malabsorption in a large cohort of Old Order Amish.", "pmid_2": 20486940.0, "pmid_date_2": 2011.0, "pmid_journal_2": "Clinical genetics"}]}, {"_id": "11051-OMIM:614618", "condition": {"condition_name": "HYPEREKPLEXIA 3; HKPX3", "freq_per_birth": "The exact prevalence of hereditary hyperekplexia is unknown. This condition has been identified in more than 150 individuals worldwide.", "pattern_of_inheritance": "Autosomal dominant==Autosomal recessive", "alternate_names": ["HYPEREKPLEXIA 3; HKPX3"]}, "gene information": {"db_hgnc_gene_id": 11051.0}, "interventions": [{"int_description_1": "Clobazam", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Clonazepam", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Nitrazepam", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Levetiracetam", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Cognitive behavior therapy\u00a0(CBT)"}, {"int_description_6": "Physical Exercise Training"}], "references": [{"pmid_title_1": "Hereditary Hyperekplexia Overview", "pmid_1": 20301437.0, "pmid_date_1": 2019.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "The P429L loss of function mutation of the human glycine transporter 2 associated with hyperekplexia.", "pmid_2": 31370103.0, "pmid_date_2": 2019.0, "pmid_journal_2": "The European journal of neuroscience"}, {"pmid_title_3": "Novel mutations in <i>SLC6A5</i> with benign course in hyperekplexia.", "pmid_3": 31604777.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Cold Spring Harbor molecular case studies"}, {"pmid_title_4": "Startles, Stiffness, and SLC6A5: Do You Know the Condition?", "pmid_4": 29478738.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Pediatric neurology"}, {"pmid_title_5": "Hyperekplexia: Report on phenotype and genotype of 16 Jordanian patients.", "pmid_5": 27843043.0, "pmid_date_5": 2017.0, "pmid_journal_5": "Brain & development"}, {"pmid_title_6": "Genotype-phenotype correlations in hyperekplexia: apnoeas, learning difficulties and speech delay.", "pmid_6": 24030948.0, "pmid_date_6": 2013.0, "pmid_journal_6": "Brain : a journal of neurology"}, {"pmid_title_7": "Hyperekplexia: treatment of a severe phenotype and review of the literature.", "pmid_7": 21515498.0, "pmid_date_7": 2011.0, "pmid_journal_7": "The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques"}, {"pmid_title_8": "Clonazepam is an effective treatment for hyperekplexia due to a SLC6A5 (GlyT2) mutation.", "pmid_8": 19562758.0, "pmid_date_8": 2009.0, "pmid_journal_8": "Movement disorders : official journal of the Movement Disorder Society"}]}, {"_id": "11117-OMIM:253300", "condition": {"condition_name": "SPINAL MUSCULAR ATROPHY, TYPE I", "freq_per_birth": "Spinal muscular atrophy affects 1 per 8,000 to 10,000 people worldwide. Spinal muscular atrophy type I is the most common type, accounting for about half of all cases. Types II and III are the next most common and types 0 and IV are rare.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["SPINAL MUSCULAR ATROPHY, TYPE II", "SPINAL MUSCULAR ATROPHY, TYPE I", "SPINAL MUSCULAR ATROPHY, TYPE III"]}, "gene information": {"db_hgnc_gene_id": 11117.0}, "interventions": [{"int_description_1": "Mechanical insufflation-exsufflation (cough assist)"}, {"int_description_2": "Nasogastric tube"}, {"int_description_3": "Non-invasive positive pressure ventilation", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Oralnasal suction"}, {"int_description_5": "Calcium"}, {"int_description_6": "Glycopyrronium"}, {"int_description_7": "Nusinersen"}, {"int_description_8": "Vitamin D"}, {"int_description_9": "Riluzole"}, {"int_description_10": "Ceftriaxone"}, {"int_description_11": "Vorinostat"}, {"int_description_12": "Trichostatin A"}, {"int_description_13": "Palivizumab"}, {"int_description_14": "Onasemnogene abeparvovec", "timeframe_int14": "Days or Weeks", "age_use_int14": "Neonate,Infant", "contra_int14": "No", "qualscale_reclass_drug14": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}, {"int_description_15": "Nebulized bronchodilators"}, {"int_description_16": "Manual chest physiotherapy"}, {"int_description_17": "Posterior spine fusion"}, {"int_description_18": "Tracheotomy"}], "references": [{"pmid_title_1": "Nusinersen as a Therapeutic Agent for Spinal Muscular Atrophy.", "pmid_1": 32233169.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Yonsei Med J"}, {"pmid_title_2": "Spinal Muscular Atrophy", "pmid_2": 20301526.0, "pmid_date_2": 2019.0, "pmid_journal_2": "GeneReviews\u00ae"}, {"pmid_title_3": "Drug treatment for spinal muscular atrophy type I.", "pmid_3": 31825542.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Cochrane Database Syst Rev"}, {"pmid_title_4": "Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care.", "pmid_4": 29290580.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Neuromuscular disorders : NMD"}, {"pmid_title_5": "Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics.", "pmid_5": 29305137.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Neuromuscular disorders : NMD"}, {"pmid_title_6": "Treatment Advances in Spinal Muscular Atrophy.", "pmid_6": 28983837.0, "pmid_date_6": 2017.0, "pmid_journal_6": "Curr Neurol Neurosci Rep"}, {"pmid_title_7": "Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy.", "pmid_7": 29091557.0, "pmid_date_7": 2017.0, "pmid_journal_7": "The New England journal of medicine"}, {"pmid_title_8": "Small Molecules in Development for the Treatment of Spinal Muscular Atrophy.", "pmid_8": 27490705.0, "pmid_date_8": 2016.0, "pmid_journal_8": "Journal of medicinal chemistry"}, {"pmid_title_9": "Spinal Muscular Atrophy.", "pmid_9": 26515624.0, "pmid_date_9": 2015.0, "pmid_journal_9": "Neurol Clin"}]}, {"_id": "11117-OMIM:253400", "condition": {"condition_name": "SPINAL MUSCULAR ATROPHY, TYPE III", "freq_per_birth": "Spinal muscular atrophy affects 1 per 8,000 to 10,000 people worldwide. Spinal muscular atrophy type I is the most common type, accounting for about half of all cases. Types II and III are the next most common and types 0 and IV are rare.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["SPINAL MUSCULAR ATROPHY, TYPE II", "SPINAL MUSCULAR ATROPHY, TYPE III", "SPINAL MUSCULAR ATROPHY, TYPE I"]}, "gene information": {"db_hgnc_gene_id": 11117.0}, "interventions": [{"int_description_1": "Salbutamol"}, {"int_description_2": "Nusinersen", "timeframe_int2": "Days or Weeks,Years", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Somatotropin"}, {"int_description_4": "Gabapentin"}, {"int_description_5": "Valproic acid"}, {"int_description_6": "Phenylbutyric acid"}, {"int_description_7": "Acetylcarnitine"}, {"int_description_8": "Hydroxyurea"}, {"int_description_9": "Creatine"}, {"int_description_10": "Olesoxime"}, {"int_description_11": "Thyrotrophin releasing hormone"}], "references": [{"pmid_title_1": "Drug treatment for spinal muscular atrophy types II and III.", "pmid_1": 32006461.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Cochrane Database Syst Rev"}, {"pmid_title_2": "Nusinersen as a Therapeutic Agent for Spinal Muscular Atrophy.", "pmid_2": 32233169.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Yonsei Med J"}, {"pmid_title_3": "Spinal Muscular Atrophy", "pmid_3": 20301526.0, "pmid_date_3": 2019.0, "pmid_journal_3": "GeneReviews\u00ae"}, {"pmid_title_4": "Treatment Advances in Spinal Muscular Atrophy.", "pmid_4": 28983837.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Curr Neurol Neurosci Rep"}, {"pmid_title_5": "Spinal Muscular Atrophy.", "pmid_5": 26515624.0, "pmid_date_5": 2015.0, "pmid_journal_5": "Neurol Clin"}]}, {"_id": "11117-OMIM:253550", "condition": {"condition_name": "SPINAL MUSCULAR ATROPHY, TYPE II", "freq_per_birth": "Spinal muscular atrophy affects 1 per 8,000 to 10,000 people worldwide. Spinal muscular atrophy type I is the most common type, accounting for about half of all cases. Types II and III are the next most common and types 0 and IV are rare.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["SPINAL MUSCULAR ATROPHY, TYPE III", "SPINAL MUSCULAR ATROPHY, TYPE II", "SPINAL MUSCULAR ATROPHY, TYPE I"]}, "gene information": {"db_hgnc_gene_id": 11117.0}, "interventions": [{"int_description_1": "Salbutamol"}, {"int_description_2": "Nusinersen", "timeframe_int2": "Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Somatotropin"}, {"int_description_4": "Gabapentin"}, {"int_description_5": "Valproic acid"}, {"int_description_6": "Phenylbutyric acid"}, {"int_description_7": "Acetylcarnitine"}, {"int_description_8": "Hydroxyurea"}, {"int_description_9": "Creatine"}, {"int_description_10": "Onasemnogene abeparvovec"}, {"int_description_11": "Olesoxime"}, {"int_description_12": "Thyrotrophin releasing hormone"}], "references": [{"pmid_title_1": "Drug treatment for spinal muscular atrophy types II and III.", "pmid_1": 32006461.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Cochrane Database Syst Rev"}, {"pmid_title_2": "Nusinersen as a Therapeutic Agent for Spinal Muscular Atrophy.", "pmid_2": 32233169.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Yonsei Med J"}, {"pmid_title_3": "Spinal Muscular Atrophy", "pmid_3": 20301526.0, "pmid_date_3": 2019.0, "pmid_journal_3": "GeneReviews\u00ae"}, {"pmid_title_4": "The Effectiveness and Value of Treatments for Spinal Muscular Atrophy.", "pmid_4": 31778620.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Journal of managed care & specialty pharmacy"}, {"pmid_title_5": "Treatment Advances in Spinal Muscular Atrophy.", "pmid_5": 28983837.0, "pmid_date_5": 2017.0, "pmid_journal_5": "Curr Neurol Neurosci Rep"}, {"pmid_title_6": "Spinal Muscular Atrophy.", "pmid_6": 26515624.0, "pmid_date_6": 2015.0, "pmid_journal_6": "Neurol Clin"}]}, {"_id": "11132-OMIM:616330", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18"]}, "gene information": {"db_hgnc_gene_id": 11132.0}, "interventions": [{"int_description_1": "Amifampridine", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Procaine"}, {"int_description_3": "Procainamide"}, {"int_description_4": "Ciprofloxacin"}, {"int_description_5": "Quinidine"}, {"int_description_6": "Chloroquine"}, {"int_description_7": "Fluoxetine"}, {"int_description_8": "Phenytoin"}, {"int_description_9": "Acetylcholinesterase inhibitors"}], "references": [{"pmid_title_1": "The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes.", "pmid_1": 29874875.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Int J Mol Sci"}, {"pmid_title_2": "Congenital Myasthenic Syndromes", "pmid_2": 20301347.0, "pmid_date_2": 2016.0, "pmid_journal_2": "GeneReviews\u00ae"}]}, {"_id": "1122-OMIM:253260", "condition": {"condition_name": "BIOTINIDASE DEFICIENCY", "freq_per_birth": "Profound or partial biotinidase deficiency occurs in approximately 1 in 60,000 newborns", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["BIOTINIDASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 1122.0}, "interventions": [{"int_description_1": "Biotin", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Genotypic and phenotypic correlations of biotinidase deficiency in the Chinese population.", "pmid_1": 30616616.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Orphanet journal of rare diseases"}, {"pmid_title_2": "Irreversibility of Symptoms with Biotin Therapy in an Adult with Profound Biotinidase Deficiency.", "pmid_2": 28220409.0, "pmid_date_2": 2017.0, "pmid_journal_2": "JIMD reports"}, {"pmid_title_3": "A treatable cause of myelopathy and vision loss mimicking neuromyelitis optica spectrum disorder: late-onset biotinidase deficiency.", "pmid_3": 28281033.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Metabolic brain disease"}, {"pmid_title_4": "Outcomes of oral biotin treatment in patients with biotinidase deficiency - Twenty years follow-up.", "pmid_4": 28649539.0, "pmid_date_4": 2015.0, "pmid_journal_4": "Molecular genetics and metabolism reports"}, {"pmid_title_5": "Biotinidase deficiency: clinical and genetic studies of 38 Brazilian patients.", "pmid_5": 25174816.0, "pmid_date_5": 2014.0, "pmid_journal_5": "BMC medical genetics"}]}, {"_id": "11301-OMIM:618752", "condition": {"condition_name": "NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT; SCN8", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT; SCN8"]}, "gene information": {"db_hgnc_gene_id": 11301.0}, "interventions": [{"int_description_1": "Lipase substitution", "timeframe_int1": "Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Granulocyte colony-stimulating factor", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Cohort study or studies", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Allogeneic hematopoietic cell transplantation", "timeframe_int3": "Days or Weeks", "age_use_int3": "Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Cohort study or studies", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Cord blood transplantation"}, {"int_description_5": "Hematopoietic stem cell transplantation", "timeframe_int5": "Days or Weeks", "age_use_int5": "Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Cohort study or studies", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Septal defect surgery"}], "references": [{"pmid_title_1": "Congenital Neutropenia and Rare Functional Phagocyte Disorders in Children.", "pmid_1": 31030818.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Hematology/oncology clinics of North America"}, {"pmid_title_2": "Mutations in the <i>SRP54</i> gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome.", "pmid_2": 29914977.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Blood"}, {"pmid_title_3": "Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like features.", "pmid_3": 28972538.0, "pmid_date_3": 2017.0, "pmid_journal_3": "J Clin Invest"}]}, {"_id": "1133-OMIM:300755", "condition": {"condition_name": "AGAMMAGLOBULINEMIA, X-LINKED", "freq_per_birth": "XLA occurs in approximately 1 in 200,000 newborns.", "pattern_of_inheritance": "X-linked recessive", "alternate_names": ["AGAMMAGLOBULINEMIA, X-LINKED"]}, "gene information": {"db_hgnc_gene_id": 1133.0}, "interventions": [{"int_description_1": "Human immunoglobulin G", "timeframe_int1": "Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Piperacillin"}, {"int_description_3": "Tazobactam"}, {"int_description_4": "Trimethoprim"}, {"int_description_5": "Sulfamethoxazole"}, {"int_description_6": "Meropenem"}, {"int_description_7": "Amoxicillin"}, {"int_description_8": "Ceftriaxone"}, {"int_description_9": "Clavulanic acid"}, {"int_description_10": "Vancomycin"}, {"int_description_11": "Acyclovir"}, {"int_description_12": "Mannitol"}, {"int_description_13": "Fresh frozen plasma transfusion"}, {"int_description_14": "Vacuum assisted closure (VAC)"}, {"int_description_15": "Haematopoietic stem cell transplantation"}], "references": [{"pmid_title_1": "Plasma therapy leads to an increase in functional IgA and IgM concentration in the blood and saliva of a patient with X-linked agammaglobulinemia.", "pmid_1": 31122289.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Journal of translational medicine"}, {"pmid_title_2": "Delayed diagnosis of X-linked agammaglobulinaemia in a boy with recurrent meningitis.", "pmid_2": 31830942.0, "pmid_date_2": 2019.0, "pmid_journal_2": "BMC neurology"}, {"pmid_title_3": "Pseudomonas aeruginosa severe skin infection in a toddler with X-linked agammaglobulinemia due to a novel BTK mutation.", "pmid_3": 30882382.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Le infezioni in medicina"}, {"pmid_title_4": "Long-Term Efficacy and Safety of Hizentra\u00ae in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 Trials.", "pmid_4": 30415311.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Journal of clinical immunology"}, {"pmid_title_5": "Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label study.", "pmid_5": 29522908.0, "pmid_date_5": 2018.0, "pmid_journal_5": "European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences"}, {"pmid_title_6": "X-Linked Agammaglobulinaemia: Outcomes in the modern era.", "pmid_6": 28729230.0, "pmid_date_6": 2017.0, "pmid_journal_6": "Clinical immunology (Orlando, Fla.)"}, {"pmid_title_7": "Gastrointestinal Manifestations in X-linked Agammaglobulinemia.", "pmid_7": 28236219.0, "pmid_date_7": 2017.0, "pmid_journal_7": "Journal of clinical immunology"}, {"pmid_title_8": "X-linked agammaglobulinemia - first case with Bruton tyrosine kinase mutation from Pakistan.", "pmid_8": 28304004.0, "pmid_date_8": 2017.0, "pmid_journal_8": "JPMA. The Journal of the Pakistan Medical Association"}, {"pmid_title_9": "X-Linked Agammaglobulinemia", "pmid_9": 20301626.0, "pmid_date_9": 2016.0, "pmid_journal_9": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_10": "Enteroviruses in X-Linked Agammaglobulinemia: Update on Epidemiology and Therapy.", "pmid_10": 26883540.0, "pmid_date_10": 2016.0, "pmid_journal_10": "The journal of allergy and clinical immunology. In practice"}, {"pmid_title_11": "X-linked Agammaglobulinemia.", "pmid_11": 26909497.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Indian journal of pediatrics"}, {"pmid_title_12": "Efficacy and safety of Gammaplex(\u00ae) 5% in children and adolescents with primary immunodeficiency diseases.", "pmid_12": 26696596.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Clinical and experimental immunology"}, {"pmid_title_13": "Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity.", "pmid_13": 26873735.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Journal of hematology & oncology"}, {"pmid_title_14": "Mortality and morbidity in patients with X-linked agammaglobulinaemia.", "pmid_14": 24485939.0, "pmid_date_14": 2015.0, "pmid_journal_14": "Allergologia et immunopathologia"}, {"pmid_title_15": "Successful hematopoietic cell transplantation in a patient with X-linked agammaglobulinemia and acute myeloid leukemia.", "pmid_15": 25900577.0, "pmid_date_15": 2015.0, "pmid_journal_15": "Pediatric blood & cancer"}, {"pmid_title_16": "X linked agammaglobulinemia: a single centre experience from India.", "pmid_16": 23873299.0, "pmid_date_16": 2014.0, "pmid_journal_16": "Indian journal of pediatrics"}, {"pmid_title_17": "Pulmonary complications in patients with antibody deficiency.", "pmid_17": 21339034.0, "pmid_date_17": 2011.0, "pmid_journal_17": "Allergologia et immunopathologia"}, {"pmid_title_18": "Efficacy, safety, and pharmacokinetics of a 10% liquid immune globulin preparation (GAMMAGARD LIQUID, 10%) administered subcutaneously in subjects with primary immunodeficiency disease.", "pmid_18": 21424824.0, "pmid_date_18": 2011.0, "pmid_journal_18": "Journal of clinical immunology"}, {"pmid_title_19": "Efficacy and safety of Hizentra(\u00ae) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy.", "pmid_19": 21705277.0, "pmid_date_19": 2011.0, "pmid_journal_19": "Clinical immunology (Orlando, Fla.)"}, {"pmid_title_20": "Clinical and molecular analysis of 49 patients with X-linked agammaglobulinemia from a single center in Argentina.", "pmid_20": 18677443.0, "pmid_date_20": 2009.0, "pmid_journal_20": "Journal of clinical immunology"}, {"pmid_title_21": "Familial hemophagocytic lymphohistiocytosis in two brothers with X-linked agammaglobulinemia.", "pmid_21": 18421721.0, "pmid_date_21": 2008.0, "pmid_journal_21": "Pediatric blood & cancer"}, {"pmid_title_22": "Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study.", "pmid_22": 12217331.0, "pmid_date_22": 2002.0, "pmid_journal_22": "Clinical immunology (Orlando, Fla.)"}]}, {"_id": "11359-OMIM:201710", "condition": {"condition_name": "LIPOID CONGENITAL ADRENAL HYPERPLASIA", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["LIPOID CONGENITAL ADRENAL HYPERPLASIA"]}, "gene information": {"db_hgnc_gene_id": 11359.0}, "interventions": [{"int_description_1": "Fludrocortisone", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Hydrocortisone", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Hormone replacement therapy (estrogen & progesterone)"}, {"int_description_4": "Hormone replacement therapy"}], "references": [{"pmid_title_1": "Nonclassic congenital lipoid adrenal hyperplasia diagnosed at 17 months in a Korean boy with normal male genitalia: emphasis on pigmentation as a diagnostic clue.", "pmid_1": 32252217.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Ann Pediatr Endocrinol Metab"}, {"pmid_title_2": "Impaired cognitive function in women with congenital adrenal hyperplasia.", "pmid_2": 16449336.0, "pmid_date_2": 2006.0, "pmid_journal_2": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_3": "Mechanism for the development of ovarian cysts in patients with congenital lipoid adrenal hyperplasia.", "pmid_3": 10700722.0, "pmid_date_3": 2000.0, "pmid_journal_3": "European journal of endocrinology"}, {"pmid_title_4": "Spontaneous puberty in 46,XX subjects with congenital lipoid adrenal hyperplasia. Ovarian steroidogenesis is spared to some extent despite inactivating mutations in the steroidogenic acute regulatory protein (StAR) gene.", "pmid_4": 9077535.0, "pmid_date_4": 1997.0, "pmid_journal_4": "J Clin Invest"}, {"pmid_title_5": "The pathophysiology and genetics of congenital lipoid adrenal hyperplasia.", "pmid_5": 8948562.0, "pmid_date_5": 1996.0, "pmid_journal_5": "The New England journal of medicine"}]}, {"_id": "11367-OMIM:245590", "condition": {"condition_name": "GROWTH HORMONE INSENSITIVITY SYNDROME WITH IMMUNE DYSREGULATION 1, AUTOSOMAL RECESSIVE", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["GROWTH HORMONE INSENSITIVITY SYNDROME WITH IMMUNE DYSREGULATION 1, AUTOSOMAL RECESSIVE"]}, "gene information": {"db_hgnc_gene_id": 11367.0}, "interventions": [{"int_description_2": "Prednisone"}, {"int_description_3": "Dexamethasone"}, {"int_description_4": "Mecasermin rinfabate"}, {"int_description_5": "Levothyroxine"}, {"int_description_6": "Human immunoglobulin G"}, {"int_description_7": "Cyclosporine"}, {"int_description_8": "Sirolimus"}, {"int_description_9": "Somatotropin"}, {"int_description_10": "Tacrolimus", "timeframe_int10": "Days or Weeks", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Case report(s)", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Acyclovir"}, {"int_description_12": "Antibiotics"}, {"int_description_13": "Immunosuppressants"}, {"int_description_14": "Extracorporeal membrane oxygenation"}], "references": [{"pmid_title_1": "Human growth disorders associated with impaired GH action: Defects in STAT5B and JAK2.", "pmid_1": 33122102.0, "pmid_date_1": 2021.0, "pmid_journal_1": "Molecular and cellular endocrinology"}, {"pmid_title_2": "Developmental Adaptive Immune Defects Associated with STAT5B Deficiency in Three Young Siblings.", "pmid_2": 33090292.0, "pmid_date_2": 2021.0, "pmid_journal_2": "Journal of clinical immunology"}, {"pmid_title_3": "Signal transducer and activator of transcription 5B deficiency due to a novel missense mutation in the coiled-coil domain.", "pmid_3": 30205186.0, "pmid_date_3": 2019.0, "pmid_journal_3": "J Allergy Clin Immunol"}, {"pmid_title_4": "A novel missense mutation in the SH2 domain of the STAT5B gene results in a transcriptionally inactive STAT5b associated with severe IGF-I deficiency, immune dysfunction, and lack of pulmonary disease.", "pmid_4": 22419735.0, "pmid_date_4": 2012.0, "pmid_journal_4": "J Clin Endocrinol Metab"}, {"pmid_title_5": "The STAT5b Pathway Defect and Autoimmunity.", "pmid_5": 22912632.0, "pmid_date_5": 2012.0, "pmid_journal_5": "Front Immunol"}, {"pmid_title_6": "STAT5b deficiency: an unsuspected cause of growth failure, immunodeficiency, and severe pulmonary disease.", "pmid_6": 21414633.0, "pmid_date_6": 2011.0, "pmid_journal_6": "J Pediatr"}, {"pmid_title_7": "STAT5b deficiency: lessons from STAT5b gene mutations.", "pmid_7": 21396575.0, "pmid_date_7": 2011.0, "pmid_journal_7": "Best Pract Res Clin Endocrinol Metab"}, {"pmid_title_8": "A novel STAT5B mutation causing GH insensitivity syndrome associated with hyperprolactinemia and immune dysfunction in two male siblings.", "pmid_8": 20538865.0, "pmid_date_8": 2010.0, "pmid_journal_8": "Eur J Endocrinol"}, {"pmid_title_9": "Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation.", "pmid_9": 17030597.0, "pmid_date_9": 2006.0, "pmid_journal_9": "Pediatrics"}, {"pmid_title_10": "Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation.", "pmid_10": 16787985.0, "pmid_date_10": 2006.0, "pmid_journal_10": "J Clin Endocrinol Metab"}, {"pmid_title_11": "Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b.", "pmid_11": 15827093.0, "pmid_date_11": 2005.0, "pmid_journal_11": "J Clin Endocrinol Metab"}, {"pmid_title_12": "Growth hormone insensitivity resulting from post-GH receptor defects.", "pmid_12": 15135774.0, "pmid_date_12": 2004.0, "pmid_journal_12": "Growth Horm IGF Res"}]}, {"_id": "11429-OMIM:603552", "condition": {"condition_name": "HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4; FHL4", "freq_per_birth": "Familial hemophagocytic lymphohistiocytosis occurs in approximately 1 in 50,000 individuals worldwide.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4; FHL4"]}, "gene information": {"db_hgnc_gene_id": 11429.0}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Dexamethasone"}, {"int_description_3": "Human immunoglobulin G"}, {"int_description_4": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_5": "Cyclosporine"}, {"int_description_6": "Methotrexate", "timeframe_int6": "Hours", "age_use_int6": "Infant,Child", "contra_int6": "No", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Etoposide"}, {"int_description_8": "Anti-infective therapy"}, {"int_description_9": "Broad-spectrum antibiotics"}, {"int_description_10": "Corticotherapy"}, {"int_description_11": "HLH-2004 treatment protocol", "timeframe_int11": "Hours", "age_use_int11": "Infant,Child", "contra_int11": "No", "qualscale_reclass_drug11": "Cohort study or studies", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "Hematopoietic stem cell transplantation", "timeframe_int12": "Days or Weeks", "age_use_int12": "Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug12": "Curative"}, {"int_description_13": "Stem cell transplantation"}], "references": [{"pmid_title_1": "Characterization of a novel splicing mutation in UNC13D gene through amplicon sequencing: a case report on HLH.", "pmid_1": 29157204.0, "pmid_date_1": 2017.0, "pmid_journal_1": "BMC Med Genet"}, {"pmid_title_2": "An N-Terminal Missense Mutation in STX11 Causative of FHL4 Abrogates Syntaxin-11 Binding to Munc18-2.", "pmid_2": 24459464.0, "pmid_date_2": 2014.0, "pmid_journal_2": "Front Immunol"}, {"pmid_title_3": "Approach to hemophagocytic syndromes.", "pmid_3": 22160031.0, "pmid_date_3": 2011.0, "pmid_journal_3": "Hematology. American Society of Hematology. Education Program"}, {"pmid_title_4": "Novel syntaxin 11 gene (STX11) mutation in three Argentinean patients with hemophagocytic lymphohistiocytosis.", "pmid_4": 19967551.0, "pmid_date_4": 2010.0, "pmid_journal_4": "Journal of clinical immunology"}, {"pmid_title_5": "Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients.", "pmid_5": 17525286.0, "pmid_date_5": 2007.0, "pmid_journal_5": "Blood"}, {"pmid_title_6": "Spectrum and clinical implications of syntaxin 11 gene mutations in familial haemophagocytic lymphohistiocytosis: association with disease-free remissions and haematopoietic malignancies.", "pmid_6": 16582076.0, "pmid_date_6": 2006.0, "pmid_journal_6": "J Med Genet"}]}, {"_id": "11445-OMIM:613101", "condition": {"condition_name": "HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5", "freq_per_birth": "Familial hemophagocytic lymphohistiocytosis occurs in approximately 1 in 50,000 individuals worldwide.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5"]}, "gene information": {"db_hgnc_gene_id": 11445.0}, "interventions": [{"int_description_1": "Total parenteral nutrition"}, {"int_description_2": "Prednisolone"}, {"int_description_3": "Dexamethasone"}, {"int_description_4": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_5": "Cyclosporine", "timeframe_int5": "Days or Weeks", "age_use_int5": "Infant,Child", "qualscale_reclass_drug5": "Cohort study or studies", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Methotrexate"}, {"int_description_7": "Etoposide"}, {"int_description_8": "HLH-2004 treatment protocol", "timeframe_int8": "Hours", "age_use_int8": "Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Cohort study or studies", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Allogeneic matched bone marrow transplantation", "timeframe_int9": "Days or Weeks", "age_use_int9": "Infant,Child", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Curative"}, {"int_description_10": "Hematopoietic stem cell transplantation", "timeframe_int10": "Days or Weeks", "age_use_int10": "Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug10": "Curative"}], "references": [{"pmid_title_1": "Type 5 Familial Hemophagocytic Lymphohistiocytosis in a Seven-year-old Girl Post Second Bone Marrow Transplantation with Failure to Thrive: STXBP2 Novel Mutation.", "pmid_1": 31807395.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Cureus"}, {"pmid_title_2": "Approach to hemophagocytic syndromes.", "pmid_2": 22160031.0, "pmid_date_2": 2011.0, "pmid_journal_2": "Hematology. American Society of Hematology. Education Program"}]}, {"_id": "11573-OMIM:276600", "condition": {"condition_name": "TYROSINEMIA, TYPE II", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["TYROSINEMIA, TYPE II"]}, "gene information": {"db_hgnc_gene_id": 11573.0}, "interventions": [{"int_description_1": "Low protein"}, {"int_description_2": "Phenylalanine/tyrosine-restricted diet"}, {"int_description_3": "Etretinate", "timeframe_int3": "Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Omega-3 fatty acids", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Familial Richner-Hanhart syndrome: Report of a sibling with incomplete presentation.", "pmid_1": 32713067.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Dermatol Ther"}, {"pmid_title_2": "Whole-exome sequencing identifies a homozygous pathogenic variant in <i>TAT</i> in a girl with palmoplantar keratoderma.", "pmid_2": 31799120.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Mol Genet Metab Rep"}, {"pmid_title_3": "Aminoacidopathies: Prevalence, Etiology, Screening, and Treatment Options.", "pmid_3": 29094226.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Biochem Genet"}, {"pmid_title_4": "Photophobia accompanied by painful plantar punctate hyperkeratotic patches: Tyrosinemia type 2.", "pmid_4": 29480263.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Indian J Ophthalmol"}, {"pmid_title_5": "Herpetiform keratitis and palmoplantar hyperkeratosis: warning signs for Richner-Hanhart syndrome.", "pmid_5": 27832414.0, "pmid_date_5": 2017.0, "pmid_journal_5": "J Inherit Metab Dis"}, {"pmid_title_6": "Palmoplantar hyperkeratosis with a linear disposition along dermatoglyphics: a clue for an early diagnosis of tyrosinemia type II.", "pmid_6": 28166616.0, "pmid_date_6": 2017.0, "pmid_journal_6": "G Ital Dermatol Venereol"}, {"pmid_title_7": "Tyrosinemia type II: Mutation update, 11 novel mutations and description of 5 independent subjects with a novel founder mutation.", "pmid_7": 28255985.0, "pmid_date_7": 2017.0, "pmid_journal_7": "Clin Genet"}, {"pmid_title_8": "Richner-Hanhart syndrome (tyrosinemia type II).", "pmid_8": 29360903.0, "pmid_date_8": 2017.0, "pmid_journal_8": "Cutis"}, {"pmid_title_9": "Tyrosinemia type II: Novel mutations in TAT in a boy with unusual presentation.", "pmid_9": 27285949.0, "pmid_date_9": 2016.0, "pmid_journal_9": "Pediatr Int"}, {"pmid_title_10": "Novel and recurrent mutations in the TAT gene in Tunisian families affected with Richner-Hanhart syndrome.", "pmid_10": 23954227.0, "pmid_date_10": 2013.0, "pmid_journal_10": "Gene"}, {"pmid_title_11": "Isolated corneal pseudodendrites as the initial manifestation of tyrosinemia type II in monozygotic twins.", "pmid_11": 22588828.0, "pmid_date_11": 2012.0, "pmid_journal_11": "J Pediatr Ophthalmol Strabismus"}, {"pmid_title_12": "Tyrosinemia type II (Richner-Hanhart syndrome): a new mutation in the TAT gene.", "pmid_12": 21145993.0, "pmid_date_12": 2011.0, "pmid_journal_12": "Eur J Med Genet"}, {"pmid_title_13": "A large TAT deletion in a tyrosinaemia type II patient.", "pmid_13": 21636300.0, "pmid_date_13": 2011.0, "pmid_journal_13": "Mol Genet Metab"}, {"pmid_title_14": "Richner-Hanhart syndrome (tyrosinemia type II): a case report of delayed diagnosis with pseudodendritic corneal lesion.", "pmid_14": 22389994.0, "pmid_date_14": 2011.0, "pmid_journal_14": "Turk J Pediatr"}, {"pmid_title_15": "Identification of two new mutations in the TAT gene in a Danish family with tyrosinaemia type II.", "pmid_15": 18945316.0, "pmid_date_15": 2009.0, "pmid_journal_15": "Br J Dermatol"}, {"pmid_title_16": "Richner-Hanhart syndrome detected by expanded newborn screening.", "pmid_16": 18577048.0, "pmid_date_16": 2008.0, "pmid_journal_16": "Pediatr Dermatol"}, {"pmid_title_17": "The genetic tyrosinemias.", "pmid_17": 16602095.0, "pmid_date_17": 2006.0, "pmid_journal_17": "Am J Med Genet C Semin Med Genet"}, {"pmid_title_18": "Tyrosinaemia type II with diffuse plantar keratoderma and self-mutilation.", "pmid_18": 16309482.0, "pmid_date_18": 2006.0, "pmid_journal_18": "Clin Exp Dermatol"}, {"pmid_title_19": "Richner-Hanhart syndrome: report of a case with a novel mutation of tyrosine aminotransferase.", "pmid_19": 16318910.0, "pmid_date_19": 2006.0, "pmid_journal_19": "J Dermatol Sci"}, {"pmid_title_20": "Richner Hanhart syndrome.", "pmid_20": 16514229.0, "pmid_date_20": 2006.0, "pmid_journal_20": "Indian J Pediatr"}, {"pmid_title_21": "Clinical and mutational investigations of tyrosinemia type II in Northern Tunisia: identification and structural characterization of two novel TAT mutations.", "pmid_21": 16574453.0, "pmid_date_21": 2006.0, "pmid_journal_21": "Mol Genet Metab"}, {"pmid_title_22": "Richner-Hanhart syndrome (tyrosinemia II): early diagnosis of an incomplete presentation with unusual findings.", "pmid_22": 16780475.0, "pmid_date_22": 2006.0, "pmid_journal_22": "Pediatr Dermatol"}, {"pmid_title_23": "Corneal lesion as the initial manifestation of tyrosinemia type II.", "pmid_23": 16863017.0, "pmid_date_23": 2006.0, "pmid_journal_23": "J Chin Med Assoc"}, {"pmid_title_24": "TAT gene mutation analysis in three Palestinian kindreds with oculocutaneous tyrosinaemia type II; characterization of a silent exonic transversion that causes complete missplicing by exon 11 skipping.", "pmid_24": 16917729.0, "pmid_date_24": 2006.0, "pmid_journal_24": "J Inherit Metab Dis"}, {"pmid_title_25": "Plantar keratoderma: a manifestation of tyrosinemia type II (Richner-Hanhart syndrome).", "pmid_25": 16270769.0, "pmid_date_25": 2005.0, "pmid_journal_25": "Ann Saudi Med"}, {"pmid_title_26": "Tyrosinemia type II: nine cases of ocular signs and symptoms.", "pmid_26": 11589874.0, "pmid_date_26": 2001.0, "pmid_journal_26": "Am J Ophthalmol"}, {"pmid_title_27": "Tyrosinemia type II: Report of the first four cases in Saudi Arabia.", "pmid_27": 17344737.0, "pmid_date_27": 1998.0, "pmid_journal_27": "Ann Saudi Med"}, {"pmid_title_28": "Richner-Hanhart syndrome: importance of early diagnosis and early intervention.", "pmid_28": 8912606.0, "pmid_date_28": 1996.0, "pmid_journal_28": "J Am Acad Dermatol"}, {"pmid_title_29": "Richner-Hanhart syndrome (tyrosinaemia-II) (report of four cases without ocular involvement).", "pmid_29": 6453606.0, "pmid_date_29": 1981.0, "pmid_journal_29": "Br J Dermatol"}]}, {"_id": "11577-OMIM:302060", "condition": {"condition_name": "BARTH SYNDROME; BTHS", "freq_per_birth": "Barth syndrome is estimated to affect 1 in 300,000 to 400,000 individuals worldwide. More than 150 cases have been described in the scientific literature.", "pattern_of_inheritance": "X-linked recessive", "alternate_names": ["BARTH SYNDROME; BTHS"]}, "gene information": {"db_hgnc_gene_id": 11577.0}, "interventions": [{"int_description_1": "Ventilation"}, {"int_description_2": "Bezafibrate"}, {"int_description_3": "Alprostadil"}, {"int_description_4": "Digoxin"}, {"int_description_5": "Furosemide", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Captopril"}, {"int_description_7": "Levocarnitine"}, {"int_description_8": "ACE inhibitors"}, {"int_description_9": "Tetrastearoyl cardiolipin"}, {"int_description_10": "Digitalis"}, {"int_description_11": "Diuretics"}, {"int_description_12": "Granulocyte colony-stimulating factor", "timeframe_int12": "Days or Weeks,Years", "age_use_int12": "Neonate,Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Inotropic agents"}, {"int_description_14": "Gene therapy"}, {"int_description_15": "Progressive exercise resistance training", "timeframe_int15": "Days or Weeks,Years", "age_use_int15": "Infant,Child", "contra_int15": "No", "qualscale_reclass_drug15": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug15": "Effective / Ameliorative"}, {"int_description_16": "Cardiac transplant"}], "references": [{"pmid_title_1": "Increased mtDNA Abundance and Improved Function in Human Barth Syndrome Patient Fibroblasts Following AAV-<i>TAZ</i> Gene Delivery.", "pmid_1": 31336787.0, "pmid_date_1": 2019.0, "pmid_journal_1": "International journal of molecular sciences"}, {"pmid_title_2": "Barth syndrome: mechanisms and management.", "pmid_2": 31239752.0, "pmid_date_2": 2019.0, "pmid_journal_2": "The application of clinical genetics"}, {"pmid_title_3": "Barth syndrome associated with compound hemizygosity and heterozygosity of the TAZ and LDB3 genes.", "pmid_3": 17394203.0, "pmid_date_3": 2007.0, "pmid_journal_3": "American journal of medical genetics. Part A"}, {"pmid_title_4": "Xq28-linked noncompaction of the left ventricular myocardium: prenatal diagnosis and pathologic analysis of affected individuals.", "pmid_4": 9332651.0, "pmid_date_4": 1997.0, "pmid_journal_4": "American journal of medical genetics"}, {"pmid_title_5": "Barth syndrome: clinical observations and genetic linkage studies.", "pmid_5": 8042670.0, "pmid_date_5": 1994.0, "pmid_journal_5": "American journal of medical genetics"}, {"pmid_title_6": "Possible X linked congenital mitochondrial cardiomyopathy in three families.", "pmid_6": 8487269.0, "pmid_date_6": 1993.0, "pmid_journal_6": "Journal of medical genetics"}]}, {"_id": "g", "condition": {"condition_name": "ACTH DEFICIENCY, ISOLATED", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ACTH DEFICIENCY, ISOLATED"]}, "gene information": {"db_hgnc_gene_id": 11596.0}, "interventions": [{"int_description_1": "Hydrocortisone"}, {"int_description_2": "Cortisol therapy"}, {"int_description_3": "Glucocorticoid therapy", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Central adrenal insufficiency in children and adolescents.", "pmid_1": 30086867.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Best practice & research. Clinical endocrinology & metabolism"}, {"pmid_title_2": "A Novel <i>TBX19</i> Gene Mutation in a Case of Congenital Isolated Adrenocorticotropic Hormone Deficiency Presenting with Recurrent Respiratory Tract Infections.", "pmid_2": 28458651.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Front Endocrinol (Lausanne)"}, {"pmid_title_3": "Phenotypic homogeneity and genotypic variability in a large series of congenital isolated ACTH-deficiency patients with TPIT gene mutations.", "pmid_3": 22170728.0, "pmid_date_3": 2012.0, "pmid_journal_3": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_4": "Congenital isolated adrenocorticotropin deficiency: an underestimated cause of neonatal death, explained by TPIT gene mutations.", "pmid_4": 15613420.0, "pmid_date_4": 2005.0, "pmid_journal_4": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_5": "Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency.", "pmid_5": 12651888.0, "pmid_date_5": 2003.0, "pmid_journal_5": "Genes & development"}]}, {"_id": "11621-OMIM:600496", "condition": {"condition_name": "MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3", "freq_per_birth": "MODY is estimated to account for 1 to 3 percent of all cases of diabetes.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3", "Hyperinsulinism due to HNF1A deficiency"]}, "gene information": {"db_hgnc_gene_id": 11621.0}, "interventions": [{"int_description_1": "Liraglutide", "timeframe_int1": "Days or Weeks", "age_use_int1": "Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Insulin glargine"}, {"int_description_3": "Glyburide"}, {"int_description_4": "Gliclazide"}, {"int_description_5": "Glimepiride"}, {"int_description_6": "Metformin"}, {"int_description_7": "Glipizide"}], "references": [{"pmid_title_1": "Mexican Carriers of the <i>HNF1A</i> p.E508K Variant Do Not Experience an Enhanced Response to Sulfonylureas.", "pmid_1": 29844095.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Diabetes care"}, {"pmid_title_2": "Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort.", "pmid_2": 26479152.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Diabetic medicine : a journal of the British Diabetic Association"}, {"pmid_title_3": "Mody-3: novel HNF1A mutation and the utility of glucagon-like peptide (GLP)-1 receptor agonist therapy.", "pmid_3": 24014008.0, "pmid_date_3": 2014.0, "pmid_journal_3": "Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists"}, {"pmid_title_4": "A family with a novel termination mutation in hepatic nuclear factor 1\u03b1 in maturity-onset diabetes of the young type 3 which is unresponsive to sulphonylurea therapy.", "pmid_4": 24642958.0, "pmid_date_4": 2014.0, "pmid_journal_4": "Hormone research in paediatrics"}, {"pmid_title_5": "Response to oral gliclazide in a pre-pubertal child with hepatic nuclear factor-1 alpha maturity onset diabetes of the young.", "pmid_5": 21242637.0, "pmid_date_5": 2011.0, "pmid_journal_5": "Annals of Saudi medicine"}]}, {"_id": "11621-ORPHA:324575", "condition": {"condition_name": "Hyperinsulinism due to HNF1A deficiency", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["Hyperinsulinism due to HNF1A deficiency", "MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3"]}, "gene information": {"db_hgnc_gene_id": 11621.0}, "interventions": [{"int_description_1": "Diazoxide", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Frequent feeding"}], "references": [{"pmid_title_1": "High Incidence of Heterozygous ABCC8 and HNF1A Mutations in Czech Patients With Congenital Hyperinsulinism.", "pmid_1": 26431509.0, "pmid_date_1": 2015.0, "pmid_journal_1": "J Clin Endocrinol Metab"}]}, {"_id": "11633-OMIM:616941", "condition": {"condition_name": "AGAMMAGLOBULINEMIA 8, AUTOSOMAL DOMINANT", "alternate_names": ["AGAMMAGLOBULINEMIA 8, AUTOSOMAL DOMINANT"]}, "gene information": {"db_hgnc_gene_id": 11633.0}, "interventions": [{"int_description_1": "Human immunoglobulin G", "timeframe_int1": "Days or Weeks"}, {"int_description_2": "Aggressive antibiotic therapy"}, {"int_description_3": "Vorhyaluronidase alfa"}], "references": [{"pmid_title_1": "Agammaglobulinemia", "pmid_1": 32310401.0, "pmid_date_1": 2020.0}, {"pmid_title_2": "Homozygous transcription factor 3 gene (TCF3) mutation is associated with severe hypogammaglobulinemia and B-cell acute lymphoblastic leukemia.", "pmid_2": 28532655.0, "pmid_date_2": 2017.0, "pmid_journal_2": "The Journal of allergy and clinical immunology"}]}, {"_id": "11653-OMIM:275350", "condition": {"condition_name": "TRANSCOBALAMIN II DEFICIENCY", "freq_per_birth": "The prevalence of transcobalamin deficiency is unknown. At least 45 affected individuals have been described in the medical literature.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["TRANSCOBALAMIN II DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 11653.0}, "interventions": [{"int_description_1": "Hydroxocobalamin", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Cyanocobalamin", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Mecobalamin"}, {"int_description_4": "Folic acid", "timeframe_int4": "Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Red cell blood transfusion"}], "references": [{"pmid_title_1": "Different Presentations of Patients with Transcobalamin II Deficiency: A Single-Center Experience from Turkey", "pmid_1": 30185401.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Turkish journal of haematology : official journal of Turkish Society of Haematology"}, {"pmid_title_2": "Transcobalamin deficiency: vitamin B<sub>12</sub> deficiency with normal serum B<sub>12</sub> levels.", "pmid_2": 31666257.0, "pmid_date_2": 2019.0, "pmid_journal_2": "BMJ case reports"}, {"pmid_title_3": "Vacuolization of Myeloid Lineage and Multilineage Dysplasia in a Case of Transcobalamin II Deficiency.", "pmid_3": 30369758.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion"}, {"pmid_title_4": "Congenital Transcobalamin II Deficiency: A Rare Entity with a Broad Differential.", "pmid_4": 29132166.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Klinische Padiatrie"}, {"pmid_title_5": "Novel Mutation in an Indian Patient with Transcobalamin II Deficiency.", "pmid_5": 25947267.0, "pmid_date_5": 2015.0, "pmid_journal_5": "Indian journal of pediatrics"}, {"pmid_title_6": "Transcobalamin II Deficiency in Four Cases with Novel Mutations.", "pmid_6": 25914105.0, "pmid_date_6": 2015.0, "pmid_journal_6": "Turkish journal of haematology : official journal of Turkish Society of Haematology"}, {"pmid_title_7": "Transcobalamin (TC) deficiency and newborn screening.", "pmid_7": 22167278.0, "pmid_date_7": 2012.0, "pmid_journal_7": "Journal of inherited metabolic disease"}, {"pmid_title_8": "Transcobalamin deficiency caused by compound heterozygosity for two novel mutations in the TCN2 gene: a study of two affected siblings, their brother, and their parents.", "pmid_8": 20607612.0, "pmid_date_8": 2010.0, "pmid_journal_8": "Journal of inherited metabolic disease"}]}, {"_id": "11782-OMIM:605407", "condition": {"condition_name": "SEGAWA SYNDROME, AUTOSOMAL RECESSIVE", "freq_per_birth": "Dopa-responsive dystonia is estimated to affect 1 per million people worldwide. However, the disorder is likely underdiagnosed because the condition may not be identified in people with mild symptoms, or it may be misdiagnosed in people who have symptoms similar to other movement disorders.", "pattern_of_inheritance": "Autosomal recessive, Autosomal dominant, Autosomal recessive", "alternate_names": ["SEGAWA SYNDROME, AUTOSOMAL RECESSIVE"]}, "gene information": {"db_hgnc_gene_id": 11782.0}, "interventions": [{"int_description_1": "Levodopa", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Metoclopramide"}, {"int_description_3": "Biperiden", "timeframe_int3": "Days or Weeks", "age_use_int3": "Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Benserazide", "timeframe_int4": "Days or Weeks", "age_use_int4": "Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Selegiline", "timeframe_int5": "Days or Weeks", "age_use_int5": "Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Dopa-Responsive Dystonia in Han Chinese Patients: One Novel Heterozygous Mutation in GTP Cyclohydrolase 1 (GCH1) and Three Known Mutations in TH.", "pmid_1": 29405179.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Med Sci Monit"}, {"pmid_title_2": "Tyrosine Hydroxylase Deficiency", "pmid_2": 20301610.0, "pmid_date_2": 2017.0, "pmid_journal_2": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_3": "Brain catecholamine depletion and motor impairment in a Th knock-in mouse with type B tyrosine hydroxylase deficiency.", "pmid_3": 26276013.0, "pmid_date_3": 2015.0, "pmid_journal_3": "Brain"}, {"pmid_title_4": "Tyrosine hydroxylase deficiency in Taiwanese infants.", "pmid_4": 22264700.0, "pmid_date_4": 2012.0, "pmid_journal_4": "Pediatr Neurol"}, {"pmid_title_5": "Expanding phenotype and clinical analysis of tyrosine hydroxylase deficiency.", "pmid_5": 20823027.0, "pmid_date_5": 2011.0, "pmid_journal_5": "J Child Neurol"}, {"pmid_title_6": "Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis.", "pmid_6": 20430833.0, "pmid_date_6": 2010.0, "pmid_journal_6": "Brain"}, {"pmid_title_7": "Levodopa-responsive infantile parkinsonism due to a novel mutation in the tyrosine hydroxylase gene and exacerbation by viral infections.", "pmid_7": 15747353.0, "pmid_date_7": 2005.0, "pmid_journal_7": "Mov Disord"}]}, {"_id": "11784-OMIM:612926", "condition": {"condition_name": "HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6", "freq_per_birth": "The incidence of atypical hemolytic-uremic syndrome is estimated to be 1 in 500,000 people per year in the United States. The atypical form is probably about 10 times less common than the typical form.", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6", "THROMBOPHILIA DUE TO THROMBOMODULIN DEFECT"]}, "gene information": {"db_hgnc_gene_id": 11784.0}, "interventions": [{"int_description_1": "Prednisone"}, {"int_description_2": "Dexamethasone"}, {"int_description_3": "Labetalol"}, {"int_description_4": "Doxazosin"}, {"int_description_5": "Amlodipine", "timeframe_int5": "Days or Weeks", "age_use_int5": "Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Eculizumab"}, {"int_description_7": "Basiliximab"}, {"int_description_8": "Etanercept"}, {"int_description_9": "Cyclosporine"}, {"int_description_10": "Metronidazole"}, {"int_description_11": "Sirolimus"}, {"int_description_12": "Piperacillin"}, {"int_description_13": "Captopril"}, {"int_description_14": "Tazobactam"}, {"int_description_15": "Ciprofloxacin"}, {"int_description_16": "Ceftriaxone"}, {"int_description_17": "Nifedipine"}, {"int_description_18": "Vincristine"}, {"int_description_19": "Fluconazole"}, {"int_description_20": "Tacrolimus"}, {"int_description_21": "Azathioprine"}, {"int_description_22": "Mycophenolate mofetil"}, {"int_description_23": "Lansoprazole"}, {"int_description_24": "Methylprednisolone"}, {"int_description_25": "Corticosteroids"}, {"int_description_26": "Iron"}, {"int_description_27": "Calcium carbonate"}, {"int_description_28": "Alginic acid"}, {"int_description_29": "Meningococcal vaccine"}, {"int_description_30": "Serine protease inhibitor"}, {"int_description_31": "Sodium bicarbonate"}, {"int_description_32": "Hemodialysis"}, {"int_description_33": "Peritoneal dialysis"}, {"int_description_34": "Plasma exchange"}, {"int_description_35": "Transfusion with packed red cells"}, {"int_description_36": "Bilateral nephrectomy"}, {"int_description_37": "Kidney transplantation", "timeframe_int37": "Days or Weeks", "age_use_int37": "Child", "contra_int37": "No", "qualscale_reclass_drug37": "Cohort study or studies", "rev1_eff_reclass_drug37": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "A complement factor B mutation in a large kindred with atypical hemolytic uremic syndrome.", "pmid_1": 24906628.0, "pmid_date_1": 2014.0, "pmid_journal_1": "J Clin Immunol"}, {"pmid_title_2": "Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft.", "pmid_2": 22591029.0, "pmid_date_2": 2012.0, "pmid_journal_2": "Transpl Int"}, {"pmid_title_3": "Complement deficiency states and associated infections.", "pmid_3": 21624663.0, "pmid_date_3": 2011.0, "pmid_journal_3": "Mol Immunol"}, {"pmid_title_4": "Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy.", "pmid_4": 21643943.0, "pmid_date_4": 2011.0, "pmid_journal_4": "Pediatr Nephrol"}, {"pmid_title_5": "Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome.", "pmid_5": 22287852.0, "pmid_date_5": 2011.0, "pmid_journal_5": "Clin Pharmacol"}, {"pmid_title_6": "An adult with acute poststreptococcal glomerulonephritis complicated by hemolytic uremic syndrome and nephrotic syndrome.", "pmid_6": 16183409.0, "pmid_date_6": 2005.0, "pmid_journal_6": "Am J Kidney Dis"}, {"pmid_title_7": "Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency.", "pmid_7": 10344366.0, "pmid_date_7": 1999.0, "pmid_journal_7": "Nephrol Dial Transplant"}, {"pmid_title_8": "Human complement factor H deficiency associated with hemolytic uremic syndrome.", "pmid_8": 9848786.0, "pmid_date_8": 1998.0, "pmid_journal_8": "J Am Soc Nephrol"}]}, {"_id": "11908-OMIM:174810", "condition": {"condition_name": "FAMILIAL EXPANSILE OSTEOLYSIS; FEO", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7", "FAMILIAL EXPANSILE OSTEOLYSIS; FEO", "PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2"]}, "gene information": {"db_hgnc_gene_id": 11908.0}, "interventions": [{"int_description_1": "Etidronic acid"}, {"int_description_2": "Human calcitonin"}, {"int_description_3": "Pamidronic acid"}, {"int_description_4": "Alendronic acid"}, {"int_description_5": "Salmon calcitonin"}, {"int_description_6": "Osteotomy"}], "references": [{"pmid_title_1": "Intragenic SNP haplotypes associated with 84dup18 mutation in TNFRSF11A in four FEO pedigrees suggest three independent origins for this mutation.", "pmid_1": 17447113.0, "pmid_date_1": 2007.0, "pmid_journal_1": "Journal of bone and mineral metabolism"}, {"pmid_title_2": "Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis.", "pmid_2": 12568416.0, "pmid_date_2": 2003.0, "pmid_journal_2": "Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research"}, {"pmid_title_3": "Familial expansile osteolysis (excessive RANK effect) in a 5-generation American kindred.", "pmid_3": 11889411.0, "pmid_date_3": 2002.0, "pmid_journal_3": "Medicine"}]}, {"_id": "11908-OMIM:602080", "condition": {"condition_name": "PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2", "freq_per_birth": "Classic Paget disease of bone occurs in approximately 1 percent of people older than 40 in the United States. Scientists estimate that about 1 million people in this country have the disease. It is most common in people of western European heritage.Early-onset Paget disease of bone is much rarer. This form of the disorder has been reported in only a few families.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7", "PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2", "FAMILIAL EXPANSILE OSTEOLYSIS; FEO"]}, "gene information": {"db_hgnc_gene_id": 11908.0}, "interventions": [{"int_description_1": "Etidronic acid"}, {"int_description_2": "Denosumab", "timeframe_int2": "Days or Weeks,Years", "age_use_int2": "Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Still in Trials / Unproven"}, {"int_description_3": "Human calcitonin"}, {"int_description_4": "Zoledronic acid"}, {"int_description_5": "Pamidronic acid"}, {"int_description_6": "Alendronic acid"}, {"int_description_7": "Risedronic acid"}, {"int_description_8": "Ibandronate"}, {"int_description_9": "AMGN-0007"}, {"int_description_10": "Intramedullary nails"}], "references": [{"pmid_title_1": "Juvenile Paget disease.", "pmid_1": 29080812.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Metabolism: clinical and experimental"}, {"pmid_title_2": "Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene.", "pmid_2": 12929927.0, "pmid_date_2": 2003.0, "pmid_journal_2": "Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research"}]}, {"_id": "11908-OMIM:612301", "condition": {"condition_name": "OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7", "freq_per_birth": "Autosomal dominant osteopetrosis is the most common form of the disorder, affecting about 1 in 20,000 people. Autosomal recessive osteopetrosis is rarer, occurring in an estimated 1 in 250,000 people.Other forms of osteopetrosis are very rare. Only a few cases of intermediate autosomal osteopetrosis and OL-EDA-ID have been reported in the medical literature.", "pattern_of_inheritance": "Autosomal dominant==Autosomal recessive==X-linked recessive", "alternate_names": ["PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2", "OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7", "FAMILIAL EXPANSILE OSTEOLYSIS; FEO"]}, "gene information": {"db_hgnc_gene_id": 11908.0}, "interventions": [{"int_description_1": "Calcium"}, {"int_description_2": "Prednisolone", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Dexamethasone"}, {"int_description_4": "Human immunoglobulin G", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Midazolam"}, {"int_description_6": "Metronidazole"}, {"int_description_7": "Vitamin D", "timeframe_int7": "Days or Weeks", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Case report(s)", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Calcitriol"}, {"int_description_9": "Levetiracetam"}, {"int_description_10": "Ceftriaxone"}, {"int_description_11": "Vancomycin"}, {"int_description_12": "Cord-blood transplant"}, {"int_description_13": "Hematopoietic stem cell transplantation", "timeframe_int13": "Days or Weeks", "age_use_int13": "Neonate,Infant", "contra_int13": "No", "qualscale_reclass_drug13": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Tracheostomy"}], "references": [{"pmid_title_1": "Brain Abscess in a Patient with Osteopetrosis: A Rare Complication.", "pmid_1": 32840095.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Journal of clinical research in pediatric endocrinology"}, {"pmid_title_2": "RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations.", "pmid_2": 22271396.0, "pmid_date_2": 2012.0, "pmid_journal_2": "Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research"}, {"pmid_title_3": "Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations.", "pmid_3": 18606301.0, "pmid_date_3": 2008.0, "pmid_journal_3": "American journal of human genetics"}]}, {"_id": "11920-OMIM:601859", "condition": {"condition_name": "AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME", "freq_per_birth": "ALPS is a rare disorder; its prevalence is unknown.", "pattern_of_inheritance": "Autosomal recessive, Autosomal dominant", "alternate_names": ["AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME"]}, "gene information": {"db_hgnc_gene_id": 11920.0}, "interventions": [{"int_description_1": "Sirolimus", "timeframe_int1": "Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Pentostatin"}, {"int_description_3": "Pyrimethamine"}, {"int_description_4": "Sulfadoxine"}, {"int_description_5": "Blood transfusion"}, {"int_description_6": "Haematopoietic stem cell transplantation", "timeframe_int6": "Days or Weeks,Years", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Case report(s)", "rev1_eff_reclass_drug6": "Curative"}], "references": [{"pmid_title_1": "Rare splicing defects of FAS underly severe recessive autoimmune lymphoproliferative syndrome.", "pmid_1": 28668589.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Clinical immunology (Orlando, Fla.)"}, {"pmid_title_2": "Use of Sirolimus (Rapamycin) for Treatment of Cytopenias and Lymphoproliferation Linked to Autoimmune Lymphoproliferative Syndrome (ALPS). Two Case Reports.", "pmid_2": 28234735.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Journal of pediatric hematology/oncology"}, {"pmid_title_3": "Immunomodulatory drugs in autoimmune lymphoproliferative syndrome (ALPS).", "pmid_3": 21674759.0, "pmid_date_3": 2012.0, "pmid_journal_3": "Pediatric blood & cancer"}, {"pmid_title_4": "Pentostatin for treatment of refractory autoimmune lymphoproliferative syndrome.", "pmid_4": 21495163.0, "pmid_date_4": 2011.0, "pmid_journal_4": "Pediatric blood & cancer"}, {"pmid_title_5": "Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome.", "pmid_5": 19208097.0, "pmid_date_5": 2009.0, "pmid_journal_5": "British journal of haematology"}]}, {"_id": "12362-OMIM:191100", "condition": {"condition_name": "TUBEROUS SCLEROSIS 1; TSC1", "freq_per_birth": "Tuberous sclerosis complex affects about 1 in 6,000 people.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["FOCAL CORTICAL DYSPLASIA, TYPE II; FCORD2", "TUBEROUS SCLEROSIS 1; TSC1", "LYMPHANGIOLEIOMYOMATOSIS; LAM"]}, "gene information": {"db_hgnc_gene_id": 12362.0}, "interventions": [{"int_description_1": "Sirolimus", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Celecoxib"}, {"int_description_3": "Vigabatrin", "timeframe_int3": "Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Simvastatin"}, {"int_description_5": "Everolimus", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Infant,Child", "contra_int5": "No", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Anticonvulsants", "timeframe_int6": "Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "mTOR inhibitors", "timeframe_int7": "Hours,Days or Weeks", "age_use_int7": "Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Epilepsy surgery"}], "references": [{"pmid_title_1": "Tuberous Sclerosis Complex", "pmid_1": 20301399.0, "pmid_date_1": 2020.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Genetic Etiologies, Diagnosis, and Treatment of Tuberous Sclerosis Complex.", "pmid_2": 31018109.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Annual review of genomics and human genetics"}, {"pmid_title_3": "Tuberous sclerosis complex.", "pmid_3": 27226234.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Nature reviews. Disease primers"}]}, {"_id": "12362-OMIM:607341", "condition": {"condition_name": "FOCAL CORTICAL DYSPLASIA, TYPE II; FCORD2", "alternate_names": ["LYMPHANGIOLEIOMYOMATOSIS; LAM", "FOCAL CORTICAL DYSPLASIA, TYPE II; FCORD2", "TUBEROUS SCLEROSIS 1; TSC1"]}, "gene information": {"db_hgnc_gene_id": 12362.0}, "interventions": [{"int_description_1": "Sirolimus", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Infant,Child", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Everolimus", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia.", "pmid_1": 28215400.0, "pmid_date_1": 2017.0, "pmid_journal_1": "American journal of human genetics"}, {"pmid_title_2": "Minute amounts of hamartin wildtype rescue the emergence of tuber-like lesions in conditional Tsc1 ablated mice.", "pmid_2": 27425891.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Neurobiology of disease"}]}, {"_id": "12363-OMIM:607341", "condition": {"condition_name": "FOCAL CORTICAL DYSPLASIA, TYPE II; FCORD2", "alternate_names": ["TUBEROUS SCLEROSIS 2; TSC2", "FOCAL CORTICAL DYSPLASIA, TYPE II; FCORD2", "LYMPHANGIOLEIOMYOMATOSIS; LAM"]}, "gene information": {"db_hgnc_gene_id": 12363.0}, "interventions": [{"int_description_1": "Sirolimus", "timeframe_int1": "Days or Weeks", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia.", "pmid_1": 28215400.0, "pmid_date_1": 2017.0, "pmid_journal_1": "American journal of human genetics"}]}, {"_id": "12363-OMIM:613254", "condition": {"condition_name": "TUBEROUS SCLEROSIS 2; TSC2", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["FOCAL CORTICAL DYSPLASIA, TYPE II; FCORD2", "TUBEROUS SCLEROSIS 2; TSC2", "LYMPHANGIOLEIOMYOMATOSIS; LAM"]}, "gene information": {"db_hgnc_gene_id": 12363.0}, "interventions": [{"int_description_1": "Propranolol"}, {"int_description_2": "Sirolimus", "timeframe_int2": "Days or Weeks", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Celecoxib", "timeframe_int3": "Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Cohort study or studies", "rev1_eff_reclass_drug3": "Still in Trials / Unproven"}, {"int_description_4": "Vigabatrin", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Simvastatin"}, {"int_description_6": "Everolimus"}, {"int_description_7": "Anticonvulsants", "timeframe_int7": "Hours,Days or Weeks", "age_use_int7": "Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Corticotherapy"}, {"int_description_9": "mTOR inhibitors"}, {"int_description_10": "Phorbol 12-myristate 13-acetate"}, {"int_description_11": "Ablative therapy"}, {"int_description_12": "Embolization"}, {"int_description_13": "Epilepsy surgery"}, {"int_description_14": "Kidney-sparing resection"}, {"int_description_15": "Nephrectomy"}], "references": [{"pmid_title_1": "Tuberous Sclerosis Complex", "pmid_1": 20301399.0, "pmid_date_1": 2020.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Tuberous sclerosis complex: Recent advances in manifestations and therapy.", "pmid_2": 28667702.0, "pmid_date_2": 2017.0, "pmid_journal_2": "International journal of urology : official journal of the Japanese Urological Association"}, {"pmid_title_3": "Tuberous sclerosis complex.", "pmid_3": 27226234.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Nature reviews. Disease primers"}, {"pmid_title_4": "Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development.", "pmid_4": 27494029.0, "pmid_date_4": 2016.0, "pmid_journal_4": "PLoS genetics"}, {"pmid_title_5": "Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.", "pmid_5": 15851026.0, "pmid_date_5": 2005.0, "pmid_journal_5": "Cell"}]}, {"_id": "12518-ORPHA:276556", "condition": {"condition_name": "Hyperinsulinism due to UCP2 deficiency", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["Hyperinsulinism due to UCP2 deficiency", "Congenital isolated hyperinsulinism"]}, "gene information": {"db_hgnc_gene_id": 12518.0}, "interventions": [{"int_description_1": "High-carbohydrate and low-protein diet", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Diazoxide"}, {"int_description_3": "Starch, corn", "timeframe_int3": "Days or Weeks", "age_use_int3": "Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Diagnosis and management of hyperinsulinaemic hypoglycaemia.", "pmid_1": 30086874.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Best Pract Res Clin Endocrinol Metab"}, {"pmid_title_2": "[Clinical features and genetic analysis of seven patients with congenital hyperinsulinism].", "pmid_2": 30098243.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Zhonghua Yi Xue Yi Chuan Xue Za Zhi"}, {"pmid_title_3": "Congenital Hyperinsulinism: Diagnosis and Treatment Update.", "pmid_3": 29280746.0, "pmid_date_3": 2017.0, "pmid_journal_3": "J Clin Res Pediatr Endocrinol"}, {"pmid_title_4": "Novel Hypoglycemia Phenotype in Congenital Hyperinsulinism Due to Dominant Mutations of Uncoupling Protein 2.", "pmid_4": 27967291.0, "pmid_date_4": 2017.0, "pmid_journal_4": "J Clin Endocrinol Metab"}, {"pmid_title_5": "Congenital Hypoglycemia Disorders: New Aspects of Etiology, Diagnosis, Treatment and Outcomes: Highlights of the Proceedings of the Congenital Hypoglycemia Disorders Symposium, Philadelphia April 2016.", "pmid_5": 27753189.0, "pmid_date_5": 2017.0, "pmid_journal_5": "Pediatr Diabetes"}, {"pmid_title_6": "Molecular mechanisms of congenital hyperinsulinism.", "pmid_6": 25733449.0, "pmid_date_6": 2015.0, "pmid_journal_6": "J Mol Endocrinol"}, {"pmid_title_7": "The Diagnosis and Management of Hyperinsulinaemic Hypoglycaemia.", "pmid_7": 26316429.0, "pmid_date_7": 2015.0, "pmid_journal_7": "J Clin Res Pediatr Endocrinol"}, {"pmid_title_8": "Persistent hyperinsulinaemic hypoglycaemia in infancy.", "pmid_8": 24931352.0, "pmid_date_8": 2014.0, "pmid_journal_8": "Semin Pediatr Surg"}, {"pmid_title_9": "Genotype and phenotype correlations in 417 children with congenital hyperinsulinism.", "pmid_9": 23275527.0, "pmid_date_9": 2013.0, "pmid_journal_9": "J Clin Endocrinol Metab"}, {"pmid_title_10": "Hyperinsulinaemic hypoglycaemia: genetic mechanisms, diagnosis and management.", "pmid_10": 22231386.0, "pmid_date_10": 2012.0, "pmid_journal_10": "J Inherit Metab Dis"}, {"pmid_title_11": "Hyperinsulinaemic hypoglycaemia:genetic mechanisms, diagnosis and management.", "pmid_11": 23032149.0, "pmid_date_11": 2012.0, "pmid_journal_11": "J Clin Res Pediatr Endocrinol"}, {"pmid_title_12": "Congenital hyperinsulinism: current trends in diagnosis and therapy.", "pmid_12": 21967988.0, "pmid_date_12": 2011.0, "pmid_journal_12": "Orphanet J Rare Dis"}, {"pmid_title_13": "Mutations in UCP2 in congenital hyperinsulinism reveal a role for regulation of insulin secretion.", "pmid_13": 19065272.0, "pmid_date_13": 2008.0, "pmid_journal_13": "PLoS One"}]}, {"_id": "12642-OMIM:618323", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC"]}, "gene information": {"db_hgnc_gene_id": 12642.0}, "interventions": [{"int_description_1": "Pyridostigmine", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes.", "pmid_1": 29874875.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Int J Mol Sci"}, {"pmid_title_2": "Homozygous mutations in VAMP1 cause a presynaptic congenital myasthenic syndrome.", "pmid_2": 28253535.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Ann Neurol"}]}, {"_id": "12731-OMIM:300299", "condition": {"condition_name": "NEUTROPENIA, SEVERE CONGENITAL, X-LINKED", "freq_per_birth": "The incidence of severe congenital neutropenia is estimated to be 1 in 200,000 individuals.", "pattern_of_inheritance": "X-linked recessive, Autosomal dominant, Autosomal recessive", "alternate_names": ["THROMBOCYTOPENIA 1", "NEUTROPENIA, SEVERE CONGENITAL, X-LINKED", "WISKOTT-ALDRICH SYNDROME"]}, "gene information": {"db_hgnc_gene_id": 12731.0}, "interventions": [{"int_description_1": "Antibiotic prophylaxis", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Granulocyte colony-stimulating factor", "timeframe_int2": "Days or Weeks", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "<i>WAS</i>-Related Disorders", "pmid_1": 20301357.0, "pmid_date_1": 2016.0, "pmid_journal_1": "GeneReviews\u00ae"}, {"pmid_title_2": "A large kindred with X-linked neutropenia with an I294T mutation of the Wiskott-Aldrich syndrome gene.", "pmid_2": 19006568.0, "pmid_date_2": 2009.0, "pmid_journal_2": "British journal of haematology"}]}, {"_id": "12731-OMIM:301000", "condition": {"condition_name": "WISKOTT-ALDRICH SYNDROME", "freq_per_birth": "The estimated incidence of Wiskott-Aldrich syndrome is between 1 and 10 cases per million males worldwide; this condition is rarer in females.", "pattern_of_inheritance": "X-linked", "alternate_names": ["THROMBOCYTOPENIA 1", "WISKOTT-ALDRICH SYNDROME", "NEUTROPENIA, SEVERE CONGENITAL, X-LINKED"]}, "gene information": {"db_hgnc_gene_id": 12731.0}, "interventions": [{"int_description_1": "Laminar flow cabin"}, {"int_description_2": "Germ-deficient diet"}, {"int_description_3": "Prednisolone"}, {"int_description_4": "Betamethasone"}, {"int_description_5": "Clobetasol"}, {"int_description_6": "Romiplostim"}, {"int_description_7": "Eltrombopag"}, {"int_description_8": "Aminocaproic acid"}, {"int_description_9": "Rituximab"}, {"int_description_10": "Cyclosporine"}, {"int_description_11": "Cyclophosphamide"}, {"int_description_12": "Busulfan"}, {"int_description_13": "Vincristine"}, {"int_description_14": "Methotrexate"}, {"int_description_15": "Vancomycin"}, {"int_description_16": "Gentamicin"}, {"int_description_17": "Tacrolimus"}, {"int_description_18": "Acyclovir"}, {"int_description_19": "Azathioprine"}, {"int_description_20": "Hydrocortisone"}, {"int_description_21": "Tranexamic acid"}, {"int_description_22": "Methylprednisolone", "timeframe_int22": "Hours,Days or Weeks", "age_use_int22": "Neonate,Infant,Child", "contra_int22": "No", "qualscale_reclass_drug22": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug22": "Effective / Ameliorative"}, {"int_description_23": "Phenytoin"}, {"int_description_24": "Methimazole"}, {"int_description_25": "Antibiotic/Antiviral/Antifungal prophylaxis"}, {"int_description_26": "Antifungicides"}, {"int_description_27": "Fluocinolone"}, {"int_description_28": "Human interleukin-2", "timeframe_int28": "Years", "age_use_int28": "Child", "contra_int28": "No", "qualscale_reclass_drug28": "Case report(s)", "rev1_eff_reclass_drug28": "Still in Trials / Unproven"}, {"int_description_29": "Intravenous immunoglobulin therapy"}, {"int_description_30": "Mercaptoethansulphate"}, {"int_description_31": "Subcutaneous immunoglobulin"}, {"int_description_32": "Topical emollient"}, {"int_description_33": "Stem cell gene therapy"}, {"int_description_34": "Disinfectant baths"}, {"int_description_35": "Platelet transfusion"}, {"int_description_36": "Bone marrow transplantation"}, {"int_description_37": "Hematopoietic stem cell transplantation"}, {"int_description_38": "Splenectomy", "timeframe_int38": "Days or Weeks", "age_use_int38": "Neonate,Infant,Child", "contra_int38": "No", "qualscale_reclass_drug38": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug38": "Curative"}], "references": [{"pmid_title_1": "Mechanisms of increased mitochondria-dependent necrosis in Wiskott-Aldrich syndrome platelets.", "pmid_1": 31278208.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Haematologica"}, {"pmid_title_2": "How I manage patients with Wiskott Aldrich syndrome.", "pmid_2": 30864154.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.", "pmid_3": 29086100.0, "pmid_date_3": 2018.0, "pmid_journal_3": "J Clin Immunol"}, {"pmid_title_4": "Posttransplant cyclophosphamide for haploidentical stem cell transplantation in children with Wiskott-Aldrich syndrome.", "pmid_4": 29745014.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Pediatr Blood Cancer"}, {"pmid_title_5": "<i>WAS</i>-Related Disorders", "pmid_5": 20301357.0, "pmid_date_5": 2016.0, "pmid_journal_5": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_6": "Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopenia.", "pmid_6": 26224646.0, "pmid_date_6": 2015.0, "pmid_journal_6": "Blood"}, {"pmid_title_7": "Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.", "pmid_7": 24622513.0, "pmid_date_7": 2014.0, "pmid_journal_7": "Sci Transl Med"}, {"pmid_title_8": "Outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome.", "pmid_8": 22426750.0, "pmid_date_8": 2012.0, "pmid_journal_8": "Bone Marrow Transplant"}, {"pmid_title_9": "Stem-cell gene therapy for the Wiskott-Aldrich syndrome.", "pmid_9": 21067383.0, "pmid_date_9": 2010.0, "pmid_journal_9": "N Engl J Med"}, {"pmid_title_10": "Autoimmune thyroiditis after bone marrow transplantation in a boy with Wiskott-Aldrich syndrome.", "pmid_10": 12468924.0, "pmid_date_10": 2002.0, "pmid_journal_10": "J Pediatr Hematol Oncol"}]}, {"_id": "12731-OMIM:313900", "condition": {"condition_name": "THROMBOCYTOPENIA 1", "freq_per_birth": "The estimated incidence of X-linked thrombocytopenia is between 1 and 10 per million males worldwide; this condition is rarer among females.", "pattern_of_inheritance": "X-linked recessive", "alternate_names": ["WISKOTT-ALDRICH SYNDROME", "THROMBOCYTOPENIA 1", "NEUTROPENIA, SEVERE CONGENITAL, X-LINKED"]}, "gene information": {"db_hgnc_gene_id": 12731.0}, "interventions": [{"int_description_1": "Eltrombopag"}, {"int_description_2": "Corticotherapy"}, {"int_description_3": "Intravenous immunoglobulin therapy"}, {"int_description_4": "Platelet transfusion"}, {"int_description_5": "Hematopoietic stem cell transplantation", "timeframe_int5": "Days or Weeks", "age_use_int5": "Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Curative"}], "references": [{"pmid_title_1": "Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopenia.", "pmid_1": 26224646.0, "pmid_date_1": 2015.0, "pmid_journal_1": "Blood"}, {"pmid_title_2": "Hematopoietic Stem Cell Transplantation for X-Linked Thrombocytopenia With Mutations in the WAS gene.", "pmid_2": 25388447.0, "pmid_date_2": 2015.0, "pmid_journal_2": "J Clin Immunol"}, {"pmid_title_3": "Wiskott-Aldrich syndrome mutation in two Turkish siblings with X-linked thrombocytopenia.", "pmid_3": 27264129.0, "pmid_date_3": 2011.0, "pmid_journal_3": "Turk J Haematol"}, {"pmid_title_4": "Recurrent V75M mutation within the Wiskott-Aldrich syndrome protein: description of a homozygous female patient.", "pmid_4": 15946311.0, "pmid_date_4": 2005.0, "pmid_journal_4": "Eur J Haematol"}]}, {"_id": "12765-OMIM:601705", "condition": {"condition_name": "T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY", "freq_per_birth": "T-cell immunodeficiency, congenital alopecia, and nail dystrophy is a rare disorder. It has been diagnosed in only a few individuals, almost all of whom are members of a large extended family from a community in southern Italy.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY", "T-CELL LYMPHOPENIA, INFANTILE, WITH OR WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT"]}, "gene information": {"db_hgnc_gene_id": 12765.0}, "interventions": [{"int_description_1": "Mechanical ventilation"}, {"int_description_2": "Oxygen therapy"}, {"int_description_3": "Prednisone"}, {"int_description_4": "Human immunoglobulin G"}, {"int_description_5": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_6": "Daclizumab"}, {"int_description_7": "Cyclosporine"}, {"int_description_8": "Amphotericin B"}, {"int_description_9": "Cyclophosphamide"}, {"int_description_10": "Ethambutol"}, {"int_description_11": "Trimethoprim"}, {"int_description_12": "Sulfamethoxazole"}, {"int_description_13": "Vincristine"}, {"int_description_14": "Rifampicin"}, {"int_description_15": "Itraconazole"}, {"int_description_16": "Pentamidine"}, {"int_description_17": "Streptomycin"}, {"int_description_18": "Acyclovir"}, {"int_description_19": "Methylprednisolone"}, {"int_description_20": "Steroids"}, {"int_description_21": "Thyroid hormone"}, {"int_description_22": "Irradiated blood transfusions"}, {"int_description_23": "Red blood cell transfusions"}, {"int_description_24": "Hematopoietic stem cell transplantation", "timeframe_int24": "Days or Weeks", "age_use_int24": "Neonate,Infant", "contra_int24": "No", "qualscale_reclass_drug24": "Case report(s)", "rev1_eff_reclass_drug24": "Effective / Ameliorative"}, {"int_description_25": "Thymic transplantation", "timeframe_int25": "Days or Weeks", "age_use_int25": "Neonate,Infant", "qualscale_reclass_drug25": "Case report(s)", "rev1_eff_reclass_drug25": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Epstein-Barr virus associated with high-grade B-cell lymphoma in nude severe combined immunodeficiency.", "pmid_1": 31151968.0, "pmid_date_1": 2019.0, "pmid_journal_1": "BMJ Case Rep"}, {"pmid_title_2": "Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis.", "pmid_2": 31447097.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Am J Hum Genet"}, {"pmid_title_3": "FOXN1 compound heterozygous mutations cause selective thymic hypoplasia in humans.", "pmid_3": 31566583.0, "pmid_date_3": 2019.0, "pmid_journal_3": "J Clin Invest"}, {"pmid_title_4": "FOXN1 Deficiency: from the Discovery to Novel Therapeutic Approaches.", "pmid_4": 28932937.0, "pmid_date_4": 2017.0, "pmid_journal_4": "J Clin Immunol"}, {"pmid_title_5": "FOXN1 deficient nude severe combined immunodeficiency.", "pmid_5": 28077132.0, "pmid_date_5": 2017.0, "pmid_journal_5": "Orphanet J Rare Dis"}, {"pmid_title_6": "Human FOXN1-deficiency is associated with \u03b1\u03b2 double-negative and FoxP3+ T-cell expansions that are distinctly modulated upon thymic transplantation.", "pmid_6": 22590644.0, "pmid_date_6": 2012.0, "pmid_journal_6": "PLoS One"}, {"pmid_title_7": "First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases.", "pmid_7": 20978268.0, "pmid_date_7": 2011.0, "pmid_journal_7": "Blood"}, {"pmid_title_8": "Congenital Alopecia and nail dystrophy associated with severe functional T-cell immunodeficiency in two sibs.", "pmid_8": 8911612.0, "pmid_date_8": 1996.0, "pmid_journal_8": "Am J Med Genet"}]}, {"_id": "12765-OMIM:618806", "condition": {"condition_name": "T-CELL LYMPHOPENIA, INFANTILE, WITH OR WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["T-CELL LYMPHOPENIA, INFANTILE, WITH OR WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT", "T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY"]}, "gene information": {"db_hgnc_gene_id": 12765.0}, "interventions": [{"int_description_1": "Mechanical ventilation"}, {"int_description_2": "Oxygen therapy"}, {"int_description_3": "Prednisone"}, {"int_description_4": "Human immunoglobulin G"}, {"int_description_5": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_6": "Daclizumab"}, {"int_description_7": "Cyclosporine"}, {"int_description_8": "Amphotericin B"}, {"int_description_9": "Cyclophosphamide"}, {"int_description_10": "Ethambutol"}, {"int_description_11": "Trimethoprim"}, {"int_description_12": "Sulfamethoxazole"}, {"int_description_13": "Vincristine"}, {"int_description_14": "Rifampicin"}, {"int_description_15": "Itraconazole"}, {"int_description_16": "Pentamidine"}, {"int_description_17": "Streptomycin"}, {"int_description_18": "Acyclovir"}, {"int_description_19": "Methylprednisolone"}, {"int_description_20": "Steroids"}, {"int_description_21": "Thyroid hormone"}, {"int_description_22": "Irradiated blood transfusions"}, {"int_description_23": "Red blood cell transfusions"}, {"int_description_24": "Hematopoietic stem cell transplantation"}, {"int_description_25": "Thymic transplantation"}], "references": [{"pmid_title_1": "Epstein-Barr virus associated with high-grade B-cell lymphoma in nude severe combined immunodeficiency.", "pmid_1": 31151968.0, "pmid_date_1": 2019.0, "pmid_journal_1": "BMJ Case Rep"}, {"pmid_title_2": "Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis.", "pmid_2": 31447097.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Am J Hum Genet"}, {"pmid_title_3": "FOXN1 compound heterozygous mutations cause selective thymic hypoplasia in humans.", "pmid_3": 31566583.0, "pmid_date_3": 2019.0, "pmid_journal_3": "J Clin Invest"}, {"pmid_title_4": "FOXN1 Deficiency: from the Discovery to Novel Therapeutic Approaches.", "pmid_4": 28932937.0, "pmid_date_4": 2017.0, "pmid_journal_4": "J Clin Immunol"}, {"pmid_title_5": "FOXN1 deficient nude severe combined immunodeficiency.", "pmid_5": 28077132.0, "pmid_date_5": 2017.0, "pmid_journal_5": "Orphanet J Rare Dis"}, {"pmid_title_6": "Human FOXN1-deficiency is associated with \u03b1\u03b2 double-negative and FoxP3+ T-cell expansions that are distinctly modulated upon thymic transplantation.", "pmid_6": 22590644.0, "pmid_date_6": 2012.0, "pmid_journal_6": "PLoS One"}, {"pmid_title_7": "First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases.", "pmid_7": 20978268.0, "pmid_date_7": 2011.0, "pmid_journal_7": "Blood"}, {"pmid_title_8": "Congenital Alopecia and nail dystrophy associated with severe functional T-cell immunodeficiency in two sibs.", "pmid_8": 8911612.0, "pmid_date_8": 1996.0, "pmid_journal_8": "Am J Med Genet"}]}, {"_id": "1304-OMIM:607398", "condition": {"condition_name": "GLUCOCORTICOID DEFICIENCY 2; GCCD2", "freq_per_birth": "The prevalence of familial glucocorticoid deficiency is unknown.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["GLUCOCORTICOID DEFICIENCY 2; GCCD2"]}, "gene information": {"db_hgnc_gene_id": 1304.0}, "interventions": [{"int_description_1": "Assisted ventilation"}, {"int_description_2": "Epinephrine"}, {"int_description_3": "Corticotropin"}, {"int_description_4": "Dobutamine"}, {"int_description_5": "Dopamine", "timeframe_int5": "Hours", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Hydrocortisone"}, {"int_description_7": "Antibiotics"}, {"int_description_8": "Glucocorticoid therapy"}, {"int_description_9": "Steroid treatment", "timeframe_int9": "Hours", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Case report(s)", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Sodium bicarbonate"}, {"int_description_11": "Exchange transfusion"}], "references": [{"pmid_title_1": "The genetics of familial glucocorticoid deficiency.", "pmid_1": 19500760.0, "pmid_date_1": 2009.0, "pmid_journal_1": "Best practice & research. Clinical endocrinology & metabolism"}, {"pmid_title_2": "Clinical and biological phenotype of a patient with familial glucocorticoid deficiency type 2 caused by a mutation of melanocortin 2 receptor accessory protein.", "pmid_2": 17893271.0, "pmid_date_2": 2007.0, "pmid_journal_2": "European journal of endocrinology"}, {"pmid_title_3": "Unusual presentation of familial glucocorticoid deficiency with a novel MRAP mutation.", "pmid_3": 16868047.0, "pmid_date_3": 2006.0, "pmid_journal_3": "The Journal of clinical endocrinology and metabolism"}]}, {"_id": "1318-OMIM:612925", "condition": {"condition_name": "HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5", "freq_per_birth": "The incidence of atypical hemolytic-uremic syndrome is estimated to be 1 in 500,000 people per year in the United States. The atypical form is probably about 10 times less common than the typical form.", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE", "HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5", "MACULAR DEGENERATION, AGE-RELATED, 9"]}, "gene information": {"db_hgnc_gene_id": 1318.0}, "interventions": [{"int_description_1": "Prednisone"}, {"int_description_2": "Dexamethasone"}, {"int_description_3": "Labetalol"}, {"int_description_4": "Doxazosin"}, {"int_description_5": "Amlodipine", "timeframe_int5": "Days or Weeks,Years", "age_use_int5": "Infant,Child", "contra_int5": "Yes", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Eculizumab"}, {"int_description_7": "Basiliximab"}, {"int_description_8": "Etanercept"}, {"int_description_9": "Cyclosporine"}, {"int_description_10": "Metronidazole"}, {"int_description_11": "Sirolimus"}, {"int_description_12": "Piperacillin", "timeframe_int12": "Hours,Days or Weeks,Years", "age_use_int12": "Neonate,Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Captopril"}, {"int_description_14": "Tazobactam"}, {"int_description_15": "Ciprofloxacin", "timeframe_int15": "Hours,Days or Weeks,Years", "age_use_int15": "Neonate,Infant,Child", "contra_int15": "No", "qualscale_reclass_drug15": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug15": "Effective / Ameliorative"}, {"int_description_16": "Ceftriaxone"}, {"int_description_17": "Nifedipine"}, {"int_description_18": "Vincristine"}, {"int_description_19": "Fluconazole"}, {"int_description_20": "Tacrolimus"}, {"int_description_21": "Azathioprine"}, {"int_description_22": "Mycophenolate mofetil"}, {"int_description_23": "Lansoprazole"}, {"int_description_24": "Methylprednisolone"}, {"int_description_25": "Corticosteroids"}, {"int_description_26": "Iron"}, {"int_description_27": "Calcium carbonate"}, {"int_description_28": "Alginic acid", "timeframe_int28": "Days or Weeks,Years", "age_use_int28": "Infant,Child", "contra_int28": "Yes", "qualscale_reclass_drug28": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug28": "Effective / Ameliorative"}, {"int_description_29": "Meningococcal vaccine"}, {"int_description_30": "Serine protease inhibitor"}, {"int_description_31": "Sodium bicarbonate", "timeframe_int31": "Hours,Days or Weeks,Years", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Hemodialysis", "timeframe_int32": "Hours,Days or Weeks,Years", "age_use_int32": "Neonate,Infant,Child", "contra_int32": "Yes", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Peritoneal dialysis", "timeframe_int33": "Hours,Days or Weeks", "age_use_int33": "Neonate,Infant,Child", "contra_int33": "No", "qualscale_reclass_drug33": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug33": "Effective / Ameliorative"}, {"int_description_34": "Plasma exchange"}, {"int_description_35": "Transfusion with packed red cells"}, {"int_description_36": "Bilateral nephrectomy"}, {"int_description_37": "Kidney transplantation"}, {"timeframe_int40": "Days or Weeks,Years", "age_use_int40": "Neonate,Infant,Child", "qualscale_reclass_drug40": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug40": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "A complement factor B mutation in a large kindred with atypical hemolytic uremic syndrome.", "pmid_1": 24906628.0, "pmid_date_1": 2014.0, "pmid_journal_1": "J Clin Immunol"}, {"pmid_title_2": "Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft.", "pmid_2": 22591029.0, "pmid_date_2": 2012.0, "pmid_journal_2": "Transpl Int"}, {"pmid_title_3": "Complement deficiency states and associated infections.", "pmid_3": 21624663.0, "pmid_date_3": 2011.0, "pmid_journal_3": "Mol Immunol"}, {"pmid_title_4": "Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy.", "pmid_4": 21643943.0, "pmid_date_4": 2011.0, "pmid_journal_4": "Pediatr Nephrol"}, {"pmid_title_5": "Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome.", "pmid_5": 22287852.0, "pmid_date_5": 2011.0, "pmid_journal_5": "Clin Pharmacol"}, {"pmid_title_6": "An adult with acute poststreptococcal glomerulonephritis complicated by hemolytic uremic syndrome and nephrotic syndrome.", "pmid_6": 16183409.0, "pmid_date_6": 2005.0, "pmid_journal_6": "Am J Kidney Dis"}, {"pmid_title_7": "Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency.", "pmid_7": 10344366.0, "pmid_date_7": 1999.0, "pmid_journal_7": "Nephrol Dial Transplant"}, {"pmid_title_8": "Human complement factor H deficiency associated with hemolytic uremic syndrome.", "pmid_8": 9848786.0, "pmid_date_8": 1998.0, "pmid_journal_8": "J Am Soc Nephrol"}]}, {"_id": "1318-OMIM:613779", "condition": {"condition_name": "COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5", "COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE", "MACULAR DEGENERATION, AGE-RELATED, 9"]}, "gene information": {"db_hgnc_gene_id": 1318.0}, "references": [{"pmid_title_1": "Recurrent meningococcal meningitis with complement 6 (C6) deficiency: A case report.", "pmid_1": 32481330.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Medicine (Baltimore)"}, {"pmid_title_2": "Hereditary Deficiency of the Second Component of Complement: Early Diagnosis and 21-Year Follow-Up of a Family.", "pmid_2": 32164349.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Medicina (Kaunas)"}, {"pmid_title_3": "Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017).", "pmid_3": 31200658.0, "pmid_date_3": 2019.0, "pmid_journal_3": "BMC Infect Dis"}, {"pmid_title_4": "Clinical and Genetic Spectrum of a Large Cohort With Total and Sub-total Complement Deficiencies.", "pmid_4": 31440263.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Front Immunol"}, {"pmid_title_5": "Inherited Classical and Alternative Pathway Complement Deficiencies in Children: A Single Center Experience.", "pmid_5": 30593745.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Iran J Immunol"}, {"pmid_title_6": "Late presentation of subtotal C6 deficiency in a patient with recurrent Neisseria meningitides infections.", "pmid_6": 29625666.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Ann Allergy Asthma Immunol"}, {"pmid_title_7": "Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus.", "pmid_7": 29671280.0, "pmid_date_7": 2018.0, "pmid_journal_7": "Arthritis Rheumatol"}, {"pmid_title_8": "Delayed Generalized Necrotic Purpuric Rash in a C6-deficient 12-year-old Girl Treated for Group W Meningococcal Disease.", "pmid_8": 29474263.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Pediatr Infect Dis J"}, {"pmid_title_9": "Cutaneous Vasculitis and Digital Ischaemia Caused by Heterozygous Gain-of-Function Mutation in <i>C3</i>.", "pmid_9": 30443255.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Front Immunol"}, {"pmid_title_10": "Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I.", "pmid_10": 29696024.0, "pmid_date_10": 2018.0, "pmid_journal_10": "Front Immunol"}, {"pmid_title_11": "A Case of Fulminant Meningococcemia: It Is All in the Complement.", "pmid_11": 28808592.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Case Rep Infect Dis"}, {"pmid_title_12": "Urticarial vasculitis in the childhood with C2 hypocomplementenemia: a rare case.", "pmid_12": 27852431.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Eur Ann Allergy Clin Immunol"}, {"pmid_title_13": "High frequency of immunodeficiency-like states in systemic lupus erythematosus: a cross-sectional study in 300 consecutive patients.", "pmid_13": 27274095.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Rheumatology (Oxford)"}, {"pmid_title_14": "Infections Revealing Complement Deficiency in Adults: A French Nationwide Study Enrolling 41 Patients.", "pmid_14": 27175654.0, "pmid_date_14": 2016.0, "pmid_journal_14": "Medicine (Baltimore)"}, {"pmid_title_15": "Supraglottitis due to group B streptococcus in an adult with IgG4 and C2 deficiency: a case report and review of the literature.", "pmid_15": 25124395.0, "pmid_date_15": 2015.0, "pmid_journal_15": "Laryngoscope"}, {"pmid_title_16": "Novel CFI mutation in a patient with leukocytoclastic vasculitis may redefine the clinical spectrum of Complement Factor I deficiency.", "pmid_16": 25988862.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Clin Immunol"}, {"pmid_title_17": "Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across Europe.", "pmid_17": 25663093.0, "pmid_date_17": 2015.0, "pmid_journal_17": "J Clin Immunol"}, {"pmid_title_18": "Chronic gonococcal arthritis with C5 deficiency presenting with brief flare-ups: case study and literature review.", "pmid_18": 24777471.0, "pmid_date_18": 2014.0, "pmid_journal_18": "Clin Rheumatol"}, {"pmid_title_19": "Severe infantile Bordetella pertussis pneumonia in monozygotic twins with a congenital C3 deficiency.", "pmid_19": 23963626.0, "pmid_date_19": 2014.0, "pmid_journal_19": "Eur J Pediatr"}, {"pmid_title_20": "Compound heterozygous mutations in the C6 gene of a child with recurrent infections.", "pmid_20": 24378253.0, "pmid_date_20": 2014.0, "pmid_journal_20": "Mol Immunol"}, {"pmid_title_21": "Association of low serum complement C3 with reduced patient and renal survival in antimyeloperoxidase-associated small-vessel vasculitis.", "pmid_21": 24577364.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Nephron Clin Pract"}, {"pmid_title_22": "C5 complement deficiency in a Saudi family, molecular characterization of mutation and literature review.", "pmid_22": 23371790.0, "pmid_date_22": 2013.0, "pmid_journal_22": "J Clin Immunol"}, {"pmid_title_23": "Deficiency in complement factor B.", "pmid_23": 24152280.0, "pmid_date_23": 2013.0, "pmid_journal_23": "N Engl J Med"}, {"pmid_title_24": "Post-vaccine glomerulonephritis in an infant with hereditary C2 complement deficiency: case study.", "pmid_24": 24382852.0, "pmid_date_24": 2013.0, "pmid_journal_24": "Croat Med J"}, {"pmid_title_25": "Complete deficiency of the sixth complement component (C6Q0), susceptibility to Neisseria meningitidis infections and analysis of the frequencies of C6Q0 gene defects in South Africans.", "pmid_25": 22288589.0, "pmid_date_25": 2012.0, "pmid_journal_25": "Clin Exp Immunol"}, {"pmid_title_26": "Rheumatoid factor-positive synovitis in a patient with C3 deficiency.", "pmid_26": 23043374.0, "pmid_date_26": 2012.0, "pmid_journal_26": "Scand J Rheumatol"}, {"pmid_title_27": "Complement deficiency states and associated infections.", "pmid_27": 21624663.0, "pmid_date_27": 2011.0, "pmid_journal_27": "Mol Immunol"}, {"pmid_title_28": "A novel mutation in the C3 gene and recurrent invasive pneumococcal infection: a clue for vaccine development.", "pmid_28": 21676463.0, "pmid_date_28": 2011.0, "pmid_journal_28": "Mol Immunol"}, {"pmid_title_29": "Recurrent meningococcal sepsis in a presumptive immunocompetent host shown to be complement C5 deficient-a case report.", "pmid_29": 21635555.0, "pmid_date_29": 2011.0, "pmid_journal_29": "APMIS"}, {"pmid_title_30": "Complement C2 deficiency disarranging innate and adaptive humoral immune responses in a pediatric patient: treatment with rituximab.", "pmid_30": 20890976.0, "pmid_date_30": 2011.0, "pmid_journal_30": "Arthritis Care Res (Hoboken)"}, {"pmid_title_31": "Infections of people with complement deficiencies and patients who have undergone splenectomy.", "pmid_31": 20930072.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Clin Microbiol Rev"}, {"pmid_title_32": "Recurrent meningitis secondary to isolated C3 deficiency.", "pmid_32": 19391010.0, "pmid_date_32": 2009.0, "pmid_journal_32": "Indian J Pediatr"}, {"pmid_title_33": "A novel mutation in a patient with a deficiency of the eighth component of complement associated with recurrent meningococcal meningitis.", "pmid_33": 19434484.0, "pmid_date_33": 2009.0, "pmid_journal_33": "J Clin Immunol"}, {"pmid_title_34": "Molecular characterization of three new mutations causing C5 deficiency in two non-related families.", "pmid_34": 19414197.0, "pmid_date_34": 2009.0, "pmid_journal_34": "Mol Immunol"}, {"pmid_title_35": "Complement C1q and C8beta deficiency in an individual with recurrent bacterial meningitis and adult-onset systemic lupus erythematosus-like illness.", "pmid_35": 18682415.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Rheumatology (Oxford)"}, {"pmid_title_36": "Hereditary complement deficiency and lupus: report of four Tunisian cases.", "pmid_36": 17893986.0, "pmid_date_36": 2007.0, "pmid_journal_36": "Ann N Y Acad Sci"}, {"pmid_title_37": "Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency.", "pmid_37": 17478473.0, "pmid_date_37": 2007.0, "pmid_journal_37": "Rheumatology (Oxford)"}, {"pmid_title_38": "C2 deficiency primary meningococcal arthritis of the elbow by Neisseria meningitidis serogroup Y in a 12-year old girl.", "pmid_38": 17653506.0, "pmid_date_38": 2007.0, "pmid_journal_38": "Infection"}, {"pmid_title_39": "Deficiency of the seventh component of complement in a Taiwanese boy.", "pmid_39": 16959627.0, "pmid_date_39": 2006.0, "pmid_journal_39": "J Formos Med Assoc"}, {"pmid_title_40": "Recurrent meningitis in a family with C3 deficiency.", "pmid_40": 16585828.0, "pmid_date_40": 2006.0, "pmid_journal_40": "Indian Pediatr"}, {"pmid_title_41": "Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections.", "pmid_41": 16527897.0, "pmid_date_41": 2006.0, "pmid_journal_41": "Blood"}, {"pmid_title_42": "Linking C5 deficiency to an exonic splicing enhancer mutation.", "pmid_42": 15778377.0, "pmid_date_42": 2005.0, "pmid_journal_42": "J Immunol"}, {"pmid_title_43": "Molecular analysis of a novel hereditary C3 deficiency with systemic lupus erythematosus.", "pmid_43": 15781264.0, "pmid_date_43": 2005.0, "pmid_journal_43": "Biochem Biophys Res Commun"}, {"pmid_title_44": "Complement C7 deficiency presenting as recurrent aseptic meningitis.", "pmid_44": 15328683.0, "pmid_date_44": 2004.0, "pmid_journal_44": "Ann Allergy Asthma Immunol"}, {"pmid_title_45": "Necrotic facial papules in an adolescent: C2 deficiency with eventual development of lupus erythematosus.", "pmid_45": 12869153.0, "pmid_date_45": 2003.0, "pmid_journal_45": "Pediatr Dermatol"}, {"pmid_title_46": "Recurrent pneumococcal meningitis in homozygous C3 deficiency.", "pmid_46": 12173704.0, "pmid_date_46": 2002.0, "pmid_journal_46": "Indian J Pediatr"}, {"pmid_title_47": "A family with complement factor D deficiency.", "pmid_47": 11457876.0, "pmid_date_47": 2001.0, "pmid_journal_47": "J Clin Invest"}, {"pmid_title_48": "Complement factor I deficiency associated with recurrent meningitis coinciding with menstruation.", "pmid_48": 11709004.0, "pmid_date_48": 2001.0, "pmid_journal_48": "Arch Neurol"}, {"pmid_title_49": "Hereditary human complement C3 deficiency owing to reduced levels of C3 mRNA.", "pmid_49": 11422912.0, "pmid_date_49": 2001.0, "pmid_journal_49": "Scand J Immunol"}, {"pmid_title_50": "Hereditary complement (C9) deficiency associated with dermatomyositis.", "pmid_50": 11359403.0, "pmid_date_50": 2001.0, "pmid_journal_50": "Br J Dermatol"}, {"pmid_title_51": "Pyoderma gangrenosum in a patient with autoimmune haemolytic anaemia and complement deficiency.", "pmid_51": 10886151.0, "pmid_date_51": 2000.0, "pmid_journal_51": "Br J Dermatol"}, {"pmid_title_52": "Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement-deficient patients.", "pmid_52": 10632668.0, "pmid_date_52": 2000.0, "pmid_journal_52": "Clin Exp Immunol"}, {"pmid_title_53": "A novel type II complement C2 deficiency allele in an African-American family.", "pmid_53": 9670930.0, "pmid_date_53": 1998.0, "pmid_journal_53": "J Immunol"}, {"pmid_title_54": "A 4-year-old girl with right elbow erythema, warmth, and induration.", "pmid_54": 9088752.0, "pmid_date_54": 1997.0, "pmid_journal_54": "Curr Opin Pediatr"}, {"pmid_title_55": "Systemic lupus erythematosus complicating complement type 2 deficiency: successful treatment with fresh frozen plasma.", "pmid_55": 9115923.0, "pmid_date_55": 1997.0, "pmid_journal_55": "Br J Dermatol"}, {"pmid_title_56": "Multifocal stenosing ulcerations of the small intestine revealing vasculitis associated with C2 deficiency.", "pmid_56": 8613071.0, "pmid_date_56": 1996.0, "pmid_journal_56": "Gastroenterology"}, {"pmid_title_57": "Heterozygous and homozygous factor H deficiency states in a Dutch family.", "pmid_57": 8809142.0, "pmid_date_57": 1996.0, "pmid_journal_57": "Clin Exp Immunol"}, {"pmid_title_58": "Invasive Haemophilus influenzae type b infection in a child with familial deficiency of the beta subunit of the eighth component of complement.", "pmid_58": 8551398.0, "pmid_date_58": 1996.0, "pmid_journal_58": "J Pediatr"}, {"pmid_title_59": "How partial C7 deficiency with chronic and recurrent bacterial infections can mimic total C7 deficiency: temporary restoration of host C7 levels following plasma transfusion.", "pmid_59": 8774358.0, "pmid_date_59": 1996.0, "pmid_journal_59": "Immunology"}, {"pmid_title_60": "C9 deficiency in a patient with poststreptococcal glomerulonephritis.", "pmid_60": 8747118.0, "pmid_date_60": 1995.0, "pmid_journal_60": "Pediatr Nephrol"}, {"pmid_title_61": "Childhood subacute cutaneous lupus erythematosus associated with homozygous complement 2 deficiency.", "pmid_61": 8747579.0, "pmid_date_61": 1995.0, "pmid_journal_61": "Pediatr Dermatol"}, {"pmid_title_62": "Phenotypically similar clones of serogroup B Neisseria meningitidis causing recurrent meningitis in a patient with total C5 deficiency.", "pmid_62": 7806892.0, "pmid_date_62": 1994.0, "pmid_journal_62": "J Infect"}, {"pmid_title_63": "Hereditary deficiency of the seventh component of complement and recurrent meningococcal infection: investigations of an Irish family using a novel haemolytic screening assay for complement activity and C7 M/N allotyping.", "pmid_63": 7523157.0, "pmid_date_63": 1994.0, "pmid_journal_63": "Epidemiol Infect"}, {"pmid_title_64": "Recurrent infections, pericarditis and renal disease in a patient with total C2 deficiency and decreased NK cell function consistent with acute rheumatic fever and systemic lupus erythematosus.", "pmid_64": 8203960.0, "pmid_date_64": 1994.0, "pmid_journal_64": "Ann Rheum Dis"}, {"pmid_title_65": "Recurrent meningococcal infections in a patient with congenital C5 deficiency.", "pmid_65": 8388602.0, "pmid_date_65": 1993.0, "pmid_journal_65": "Acta Clin Belg"}, {"pmid_title_66": "Complement component deficiencies and infection: C5, C8 and C3 deficiencies in three families.", "pmid_66": 1396929.0, "pmid_date_66": 1992.0, "pmid_journal_66": "Eur J Pediatr"}, {"pmid_title_67": "Hereditary dysfunction of the third component of complement associated with a systemic lupus erythematosus-like syndrome and meningococcal meningitis.", "pmid_67": 1575793.0, "pmid_date_67": 1992.0, "pmid_journal_67": "Arthritis Rheum"}, {"pmid_title_68": "Complement factor 2 deficiency: a clinical and serological family study.", "pmid_68": 1361318.0, "pmid_date_68": 1992.0, "pmid_journal_68": "Ann Rheum Dis"}, {"pmid_title_69": "Selective C7 complement deficiency causing recurrent meningococcal infection.", "pmid_69": 2071909.0, "pmid_date_69": 1991.0, "pmid_journal_69": "J Infect"}, {"pmid_title_70": "Combined complete C5 and partial C4 deficiency in humans: clinical consequences and complement-mediated functions in vitro.", "pmid_70": 2306879.0, "pmid_date_70": 1990.0, "pmid_journal_70": "Clin Immunol Immunopathol"}, {"pmid_title_71": "Prophylaxis against Neisseria meningitidis infections and antibody responses in patients with deficiency of the sixth component of complement.", "pmid_71": 2109021.0, "pmid_date_71": 1990.0, "pmid_journal_71": "J Infect Dis"}, {"pmid_title_72": "Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency.", "pmid_72": 2290166.0, "pmid_date_72": 1990.0, "pmid_journal_72": "J Rheumatol"}, {"pmid_title_73": "Complete and partial deficiencies of complement factor D in a Dutch family.", "pmid_73": 2687330.0, "pmid_date_73": 1989.0, "pmid_journal_73": "J Clin Invest"}, {"pmid_title_74": "A case of hereditary combined deficiency of complement components C6 and C7 in man.", "pmid_74": 2702782.0, "pmid_date_74": 1989.0, "pmid_journal_74": "Clin Exp Immunol"}, {"pmid_title_75": "Combined homozygous factor H and heterozygous C2 deficiency in an Italian family.", "pmid_75": 2966809.0, "pmid_date_75": 1988.0, "pmid_journal_75": "J Clin Immunol"}, {"pmid_title_76": "Inherited C3 deficiency with recurrent infections and glomerulonephritis.", "pmid_76": 2963536.0, "pmid_date_76": 1988.0, "pmid_journal_76": "Am J Dis Child"}, {"pmid_title_77": "Meningitis caused by a nonencapsulated strain of Neisseria meningitidis in twin infants with a C6 deficiency.", "pmid_77": 3102634.0, "pmid_date_77": 1987.0, "pmid_journal_77": "J Infect Dis"}, {"pmid_title_78": "Meningococcal disease in congenital absence of the fifth component of complement.", "pmid_78": 3441749.0, "pmid_date_78": 1987.0, "pmid_journal_78": "Scand J Infect Dis"}, {"pmid_title_79": "Hypocomplementemic vasculitis and renal involvement.", "pmid_79": 2951605.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Nephron"}, {"pmid_title_80": "Arthritis and antinuclear antibodies (ANA) with inherited deficiency of the sixth component of complement (C6).", "pmid_80": 3487293.0, "pmid_date_80": 1986.0, "pmid_journal_80": "Ann Rheum Dis"}, {"pmid_title_81": "Atypical hypocomplementemic vasculitis syndrome in a child.", "pmid_81": 2987470.0, "pmid_date_81": 1985.0, "pmid_journal_81": "J Pediatr"}, {"pmid_title_82": "Terminal complement component deficiencies and rheumatic disease: development of a rheumatic syndrome and anticomplementary activity in a patient with complete C6 deficiency.", "pmid_82": 3931570.0, "pmid_date_82": 1985.0, "pmid_journal_82": "Ann Rheum Dis"}, {"pmid_title_83": "Thrombotic thrombocytopenic purpura developing during pregnancy in a C2-deficient patient with a history of systemic lupus erythematosus.", "pmid_83": 4038880.0, "pmid_date_83": 1985.0, "pmid_journal_83": "Arthritis Rheum"}, {"pmid_title_84": "Complement deficiency syndromes and bacterial infections.", "pmid_84": 6665131.0, "pmid_date_84": 1983.0, "pmid_journal_84": "Prog Brain Res"}, {"pmid_title_85": "Recurrent meningococcal meningitis due to partial complement defects and poor anti-meningococcal antibody response.", "pmid_85": 6411822.0, "pmid_date_85": 1983.0, "pmid_journal_85": "J Infect"}, {"pmid_title_86": "Circulating immune complexes and glomerulonephritis in a patient with congenital absence of the third component of complement.", "pmid_86": 6835307.0, "pmid_date_86": 1983.0, "pmid_journal_86": "N Engl J Med"}, {"pmid_title_87": "Identification of the alpha-gamma subunit of the eighth component of complement (C8) in a patient with systemic lupus erythematosus and absent C8 activity: patients and family studies.", "pmid_87": 7105499.0, "pmid_date_87": 1982.0, "pmid_journal_87": "Clin Immunol Immunopathol"}, {"pmid_title_88": "Combined hereditary deficiency of the sixth component of complement and factor VIII coagulant activity in a Dutch family.", "pmid_88": 6811172.0, "pmid_date_88": 1982.0, "pmid_journal_88": "Clin Exp Immunol"}, {"pmid_title_89": "Fulminant meningococcemia in a child with hereditary deficiency of the seventh component of complement and proteinuria.", "pmid_89": 7446104.0, "pmid_date_89": 1980.0, "pmid_journal_89": "Acta Paediatr Scand"}, {"pmid_title_90": "Recurrent bacterial meningitis due to genetic deficiencies of terminal complement components (C5 and C6).", "pmid_90": 7193645.0, "pmid_date_90": 1980.0, "pmid_journal_90": "Immunobiology"}, {"pmid_title_91": "Recurrent bacterial meningitis in patients with genetic defects of terminal complement components.", "pmid_91": 7389212.0, "pmid_date_91": 1980.0, "pmid_journal_91": "Clin Exp Immunol"}, {"pmid_title_92": "Familial partial deficiency of the third component of complement (C3) and the hypocomplementemic cutaneous vasculitis syndrome.", "pmid_92": 7369233.0, "pmid_date_92": 1980.0, "pmid_journal_92": "Am J Med"}, {"pmid_title_93": "Deficiency of the fifth component of complement in human subjects. Clinical, genetic and immunologic studies in a large kindred.", "pmid_93": 495634.0, "pmid_date_93": 1979.0, "pmid_journal_93": "Am J Med"}, {"pmid_title_94": "Hereditary C2 deficiency associated with cutaneous lupus erythematosus: clinical, laboratory, and genetic studies.", "pmid_94": 760659.0, "pmid_date_94": 1979.0, "pmid_journal_94": "Arch Dermatol"}, {"pmid_title_95": "Hereditary deficiency of the third component of complement in a child with fever, skin rash, and arthralgias: response to transfusion of whole blood.", "pmid_95": 318684.0, "pmid_date_95": 1977.0, "pmid_journal_95": "J Pediatr"}, {"pmid_title_96": "Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.", "pmid_96": 932197.0, "pmid_date_96": 1976.0, "pmid_journal_96": "J Clin Invest"}, {"pmid_title_97": "C2 deficiency. Development of lupus erythematosus.", "pmid_97": 4578155.0, "pmid_date_97": 1973.0, "pmid_journal_97": "J Clin Invest"}]}, {"_id": "1331-OMIM:609536", "condition": {"condition_name": "COMPLEMENT COMPONENT 5 DEFICIENCY", "alternate_names": ["COMPLEMENT COMPONENT 5 DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 1331.0}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Prednisone"}, {"int_description_3": "Dexamethasone"}, {"int_description_4": "Epoprostenol"}, {"int_description_5": "Caffeine"}, {"int_description_6": "Human immunoglobulin G"}, {"int_description_7": "Cetirizine"}, {"int_description_8": "Hydroxychloroquine"}, {"int_description_9": "Rituximab"}, {"int_description_10": "Eculizumab"}, {"int_description_11": "Clarithromycin"}, {"int_description_12": "Cyclosporine"}, {"int_description_13": "Cyclophosphamide"}, {"int_description_14": "Dipyridamole"}, {"int_description_15": "Levamisole"}, {"int_description_16": "Erythromycin"}, {"int_description_17": "Azithromycin"}, {"int_description_18": "Chloramphenicol"}, {"int_description_19": "Trimethoprim"}, {"int_description_20": "Dapsone"}, {"int_description_21": "Sulfisoxazole"}, {"int_description_22": "Sulfadiazine"}, {"int_description_23": "Sulfamethoxazole"}, {"int_description_24": "Sulfamethazine"}, {"int_description_25": "Ciprofloxacin"}, {"int_description_26": "Ampicillin"}, {"int_description_27": "Phenoxymethylpenicillin"}, {"int_description_28": "Cefalotin"}, {"int_description_29": "Cefotaxime"}, {"int_description_30": "Cefaclor"}, {"int_description_31": "Benzylpenicillin", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Amoxicillin", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "No", "qualscale_reclass_drug32": "Case report(s)", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Cefuroxime"}, {"int_description_34": "Ceftriaxone"}, {"int_description_35": "Cefepime"}, {"int_description_36": "Sulbactam"}, {"int_description_37": "Clavulanic acid"}, {"int_description_38": "Nifedipine"}, {"int_description_39": "Diclofenac"}, {"int_description_40": "Naproxen"}, {"int_description_41": "Ibuprofen"}, {"int_description_42": "Rifampicin"}, {"int_description_43": "Pyrimethamine"}, {"int_description_44": "Methotrexate"}, {"int_description_45": "Leflunomide"}, {"int_description_46": "Vancomycin"}, {"int_description_47": "Gentamicin"}, {"int_description_48": "Chloroquine"}, {"int_description_49": "Tacrolimus"}, {"int_description_50": "Mizoribine"}, {"int_description_51": "Azathioprine"}, {"int_description_52": "Ascorbic acid"}, {"int_description_53": "Mycophenolate mofetil"}, {"int_description_54": "Mycophenolic acid"}, {"int_description_55": "Hydrocortisone"}, {"int_description_56": "Flucloxacillin"}, {"int_description_57": "Carbazochrome"}, {"int_description_58": "Acetylsalicylic acid"}, {"int_description_59": "Metamizole"}, {"int_description_60": "Methylprednisolone"}, {"int_description_61": "Leucovorin"}, {"int_description_62": "Warfarin"}, {"int_description_63": "Belimumab"}, {"int_description_64": "23-valent pneumococcal polysaccharide vaccine"}, {"int_description_65": "Anti-histaminic drugs", "timeframe_int65": "Days or Weeks,Years", "age_use_int65": "Infant,Child", "contra_int65": "No", "qualscale_reclass_drug65": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug65": "Effective / Ameliorative"}, {"int_description_66": "Antibiotics"}, {"int_description_67": "Antimalarial agents"}, {"int_description_68": "Conjugate pneumococcal vaccine"}, {"int_description_69": "Conjugate vaccine against N. meningitides serogroup B (Bexero\u00ae, Novartis Vaccines and Diagnostics S.r.l., Siena, Italy)"}, {"int_description_70": "Corticosteroids"}, {"int_description_71": "Spiramycin"}, {"int_description_72": "Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen"}, {"int_description_73": "Streptococcus pneumoniae type 4 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_74": "Streptococcus pneumoniae type 6b capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_75": "Streptococcus pneumoniae type 9v capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_76": "Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_77": "Streptococcus pneumoniae type 18c capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_78": "Streptococcus pneumoniae type 19f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_79": "Streptococcus pneumoniae type 23f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_80": "Streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_81": "Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_82": "Streptococcus pneumoniae type 5 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_83": "Streptococcus pneumoniae type 6a capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_84": "Streptococcus pneumoniae type 7f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_85": "Streptococcus pneumoniae type 19a capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_86": "Streptococcus pneumoniae type 1 capsular polysaccharide antigen"}, {"int_description_87": "Streptococcus pneumoniae type 2 capsular polysaccharide antigen"}, {"int_description_88": "Streptococcus pneumoniae type 3 capsular polysaccharide antigen"}, {"int_description_89": "Streptococcus pneumoniae type 4 capsular polysaccharide antigen"}, {"int_description_90": "Streptococcus pneumoniae type 5 capsular polysaccharide antigen"}, {"int_description_91": "Streptococcus pneumoniae type 6b capsular polysaccharide antigen"}, {"int_description_92": "Streptococcus pneumoniae type 7f capsular polysaccharide antigen"}, {"int_description_93": "Streptococcus pneumoniae type 8 capsular polysaccharide antigen"}, {"int_description_94": "Streptococcus pneumoniae type 9n capsular polysaccharide antigen"}, {"int_description_95": "Streptococcus pneumoniae type 9v capsular polysaccharide antigen"}, {"int_description_96": "Streptococcus pneumoniae type 10a capsular polysaccharide antigen"}, {"int_description_97": "Streptococcus pneumoniae type 11a capsular polysaccharide antigen"}, {"int_description_98": "Streptococcus pneumoniae type 12f capsular polysaccharide antigen"}, {"int_description_99": "Streptococcus pneumoniae type 14 capsular polysaccharide antigen"}, {"int_description_100": "Streptococcus pneumoniae type 15b capsular polysaccharide antigen"}, {"int_description_101": "Streptococcus pneumoniae type 17f capsular polysaccharide antigen"}, {"int_description_102": "Streptococcus pneumoniae type 18c capsular polysaccharide antigen"}, {"int_description_103": "Streptococcus pneumoniae type 19f capsular polysaccharide antigen"}, {"int_description_104": "Streptococcus pneumoniae type 19a capsular polysaccharide antigen"}, {"int_description_105": "Streptococcus pneumoniae type 20 capsular polysaccharide antigen"}, {"int_description_106": "Streptococcus pneumoniae type 22f capsular polysaccharide antigen"}, {"int_description_107": "Streptococcus pneumoniae type 23f capsular polysaccharide antigen"}, {"int_description_108": "Streptococcus pneumoniae type 33f capsular polysaccharide antigen"}, {"int_description_109": "Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_110": "Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_111": "Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_112": "Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_113": "Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_114": "Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_115": "Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_116": "Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_117": "Glucocorticoids"}, {"int_description_118": "H. influenzae vaccine"}, {"int_description_119": "Hib (H. influenzae type b) conjugate vaccines"}, {"int_description_120": "Meningococcal vaccine"}, {"int_description_121": "Mild steroid cream"}, {"int_description_122": "Monovalent Neisseria meningitidis serogroup C conjugate vaccines"}, {"int_description_123": "Pneumococcal vaccine polysaccharide"}, {"int_description_124": "Pneumococcal vaccine"}, {"int_description_125": "Steroids"}, {"int_description_126": "Sulphonamide"}, {"int_description_127": "Sunscreen"}, {"int_description_128": "Tetravalent A, C, Y and W135 meningococcal polysaccharide vaccine (MencevaxACYW)"}, {"int_description_129": "Topic steroid cycles"}, {"int_description_130": "Vaccine against Neisseria meningitidis serogroup B"}, {"int_description_131": "Cochlear implant surgery"}, {"int_description_132": "Endotracheal intubation with ventilatory support"}, {"int_description_133": "Extracorporeal membrane oxygenation"}, {"int_description_134": "Fresh frozen plasma transfusions"}, {"int_description_135": "Hemodialysis"}, {"int_description_136": "Highfrequency oscillation with nitrogen monoxide ventilation"}, {"int_description_137": "Nasal rinses"}, {"int_description_138": "Plasma infusion"}, {"int_description_139": "Whole blood transfusions"}, {"int_description_140": "Adenoidectomy"}, {"int_description_141": "Enlargement of the sphenoid sinus ostium"}, {"int_description_142": "Resection of jejunum and ileum"}, {"int_description_143": "Splenectomy"}, {"int_description_144": "Surgery with a three-vessel coronary bypass grafting"}, {"int_description_145": "Tonsillectomy"}], "references": [{"pmid_title_1": "Recurrent meningococcal meningitis with complement 6 (C6) deficiency: A case report.", "pmid_1": 32481330.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Medicine (Baltimore)"}, {"pmid_title_2": "Hereditary Deficiency of the Second Component of Complement: Early Diagnosis and 21-Year Follow-Up of a Family.", "pmid_2": 32164349.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Medicina (Kaunas)"}, {"pmid_title_3": "Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017).", "pmid_3": 31200658.0, "pmid_date_3": 2019.0, "pmid_journal_3": "BMC Infect Dis"}, {"pmid_title_4": "Clinical and Genetic Spectrum of a Large Cohort With Total and Sub-total Complement Deficiencies.", "pmid_4": 31440263.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Front Immunol"}, {"pmid_title_5": "Inherited Classical and Alternative Pathway Complement Deficiencies in Children: A Single Center Experience.", "pmid_5": 30593745.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Iran J Immunol"}, {"pmid_title_6": "Late presentation of subtotal C6 deficiency in a patient with recurrent Neisseria meningitides infections.", "pmid_6": 29625666.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Ann Allergy Asthma Immunol"}, {"pmid_title_7": "Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus.", "pmid_7": 29671280.0, "pmid_date_7": 2018.0, "pmid_journal_7": "Arthritis Rheumatol"}, {"pmid_title_8": "Delayed Generalized Necrotic Purpuric Rash in a C6-deficient 12-year-old Girl Treated for Group W Meningococcal Disease.", "pmid_8": 29474263.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Pediatr Infect Dis J"}, {"pmid_title_9": "Cutaneous Vasculitis and Digital Ischaemia Caused by Heterozygous Gain-of-Function Mutation in <i>C3</i>.", "pmid_9": 30443255.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Front Immunol"}, {"pmid_title_10": "Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I.", "pmid_10": 29696024.0, "pmid_date_10": 2018.0, "pmid_journal_10": "Front Immunol"}, {"pmid_title_11": "A Case of Fulminant Meningococcemia: It Is All in the Complement.", "pmid_11": 28808592.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Case Rep Infect Dis"}, {"pmid_title_12": "Urticarial vasculitis in the childhood with C2 hypocomplementenemia: a rare case.", "pmid_12": 27852431.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Eur Ann Allergy Clin Immunol"}, {"pmid_title_13": "High frequency of immunodeficiency-like states in systemic lupus erythematosus: a cross-sectional study in 300 consecutive patients.", "pmid_13": 27274095.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Rheumatology (Oxford)"}, {"pmid_title_14": "Infections Revealing Complement Deficiency in Adults: A French Nationwide Study Enrolling 41 Patients.", "pmid_14": 27175654.0, "pmid_date_14": 2016.0, "pmid_journal_14": "Medicine (Baltimore)"}, {"pmid_title_15": "Supraglottitis due to group B streptococcus in an adult with IgG4 and C2 deficiency: a case report and review of the literature.", "pmid_15": 25124395.0, "pmid_date_15": 2015.0, "pmid_journal_15": "Laryngoscope"}, {"pmid_title_16": "Novel CFI mutation in a patient with leukocytoclastic vasculitis may redefine the clinical spectrum of Complement Factor I deficiency.", "pmid_16": 25988862.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Clin Immunol"}, {"pmid_title_17": "Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across Europe.", "pmid_17": 25663093.0, "pmid_date_17": 2015.0, "pmid_journal_17": "J Clin Immunol"}, {"pmid_title_18": "Chronic gonococcal arthritis with C5 deficiency presenting with brief flare-ups: case study and literature review.", "pmid_18": 24777471.0, "pmid_date_18": 2014.0, "pmid_journal_18": "Clin Rheumatol"}, {"pmid_title_19": "Severe infantile Bordetella pertussis pneumonia in monozygotic twins with a congenital C3 deficiency.", "pmid_19": 23963626.0, "pmid_date_19": 2014.0, "pmid_journal_19": "Eur J Pediatr"}, {"pmid_title_20": "Compound heterozygous mutations in the C6 gene of a child with recurrent infections.", "pmid_20": 24378253.0, "pmid_date_20": 2014.0, "pmid_journal_20": "Mol Immunol"}, {"pmid_title_21": "Association of low serum complement C3 with reduced patient and renal survival in antimyeloperoxidase-associated small-vessel vasculitis.", "pmid_21": 24577364.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Nephron Clin Pract"}, {"pmid_title_22": "C5 complement deficiency in a Saudi family, molecular characterization of mutation and literature review.", "pmid_22": 23371790.0, "pmid_date_22": 2013.0, "pmid_journal_22": "J Clin Immunol"}, {"pmid_title_23": "Deficiency in complement factor B.", "pmid_23": 24152280.0, "pmid_date_23": 2013.0, "pmid_journal_23": "N Engl J Med"}, {"pmid_title_24": "Post-vaccine glomerulonephritis in an infant with hereditary C2 complement deficiency: case study.", "pmid_24": 24382852.0, "pmid_date_24": 2013.0, "pmid_journal_24": "Croat Med J"}, {"pmid_title_25": "Complete deficiency of the sixth complement component (C6Q0), susceptibility to Neisseria meningitidis infections and analysis of the frequencies of C6Q0 gene defects in South Africans.", "pmid_25": 22288589.0, "pmid_date_25": 2012.0, "pmid_journal_25": "Clin Exp Immunol"}, {"pmid_title_26": "Rheumatoid factor-positive synovitis in a patient with C3 deficiency.", "pmid_26": 23043374.0, "pmid_date_26": 2012.0, "pmid_journal_26": "Scand J Rheumatol"}, {"pmid_title_27": "Complement deficiency states and associated infections.", "pmid_27": 21624663.0, "pmid_date_27": 2011.0, "pmid_journal_27": "Mol Immunol"}, {"pmid_title_28": "A novel mutation in the C3 gene and recurrent invasive pneumococcal infection: a clue for vaccine development.", "pmid_28": 21676463.0, "pmid_date_28": 2011.0, "pmid_journal_28": "Mol Immunol"}, {"pmid_title_29": "Recurrent meningococcal sepsis in a presumptive immunocompetent host shown to be complement C5 deficient-a case report.", "pmid_29": 21635555.0, "pmid_date_29": 2011.0, "pmid_journal_29": "APMIS"}, {"pmid_title_30": "Complement C2 deficiency disarranging innate and adaptive humoral immune responses in a pediatric patient: treatment with rituximab.", "pmid_30": 20890976.0, "pmid_date_30": 2011.0, "pmid_journal_30": "Arthritis Care Res (Hoboken)"}, {"pmid_title_31": "Infections of people with complement deficiencies and patients who have undergone splenectomy.", "pmid_31": 20930072.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Clin Microbiol Rev"}, {"pmid_title_32": "Recurrent meningitis secondary to isolated C3 deficiency.", "pmid_32": 19391010.0, "pmid_date_32": 2009.0, "pmid_journal_32": "Indian J Pediatr"}, {"pmid_title_33": "A novel mutation in a patient with a deficiency of the eighth component of complement associated with recurrent meningococcal meningitis.", "pmid_33": 19434484.0, "pmid_date_33": 2009.0, "pmid_journal_33": "J Clin Immunol"}, {"pmid_title_34": "Molecular characterization of three new mutations causing C5 deficiency in two non-related families.", "pmid_34": 19414197.0, "pmid_date_34": 2009.0, "pmid_journal_34": "Mol Immunol"}, {"pmid_title_35": "Complement C1q and C8beta deficiency in an individual with recurrent bacterial meningitis and adult-onset systemic lupus erythematosus-like illness.", "pmid_35": 18682415.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Rheumatology (Oxford)"}, {"pmid_title_36": "Hereditary complement deficiency and lupus: report of four Tunisian cases.", "pmid_36": 17893986.0, "pmid_date_36": 2007.0, "pmid_journal_36": "Ann N Y Acad Sci"}, {"pmid_title_37": "Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency.", "pmid_37": 17478473.0, "pmid_date_37": 2007.0, "pmid_journal_37": "Rheumatology (Oxford)"}, {"pmid_title_38": "C2 deficiency primary meningococcal arthritis of the elbow by Neisseria meningitidis serogroup Y in a 12-year old girl.", "pmid_38": 17653506.0, "pmid_date_38": 2007.0, "pmid_journal_38": "Infection"}, {"pmid_title_39": "Deficiency of the seventh component of complement in a Taiwanese boy.", "pmid_39": 16959627.0, "pmid_date_39": 2006.0, "pmid_journal_39": "J Formos Med Assoc"}, {"pmid_title_40": "Recurrent meningitis in a family with C3 deficiency.", "pmid_40": 16585828.0, "pmid_date_40": 2006.0, "pmid_journal_40": "Indian Pediatr"}, {"pmid_title_41": "Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections.", "pmid_41": 16527897.0, "pmid_date_41": 2006.0, "pmid_journal_41": "Blood"}, {"pmid_title_42": "Linking C5 deficiency to an exonic splicing enhancer mutation.", "pmid_42": 15778377.0, "pmid_date_42": 2005.0, "pmid_journal_42": "J Immunol"}, {"pmid_title_43": "Molecular analysis of a novel hereditary C3 deficiency with systemic lupus erythematosus.", "pmid_43": 15781264.0, "pmid_date_43": 2005.0, "pmid_journal_43": "Biochem Biophys Res Commun"}, {"pmid_title_44": "Complement C7 deficiency presenting as recurrent aseptic meningitis.", "pmid_44": 15328683.0, "pmid_date_44": 2004.0, "pmid_journal_44": "Ann Allergy Asthma Immunol"}, {"pmid_title_45": "Necrotic facial papules in an adolescent: C2 deficiency with eventual development of lupus erythematosus.", "pmid_45": 12869153.0, "pmid_date_45": 2003.0, "pmid_journal_45": "Pediatr Dermatol"}, {"pmid_title_46": "Recurrent pneumococcal meningitis in homozygous C3 deficiency.", "pmid_46": 12173704.0, "pmid_date_46": 2002.0, "pmid_journal_46": "Indian J Pediatr"}, {"pmid_title_47": "A family with complement factor D deficiency.", "pmid_47": 11457876.0, "pmid_date_47": 2001.0, "pmid_journal_47": "J Clin Invest"}, {"pmid_title_48": "Complement factor I deficiency associated with recurrent meningitis coinciding with menstruation.", "pmid_48": 11709004.0, "pmid_date_48": 2001.0, "pmid_journal_48": "Arch Neurol"}, {"pmid_title_49": "Hereditary human complement C3 deficiency owing to reduced levels of C3 mRNA.", "pmid_49": 11422912.0, "pmid_date_49": 2001.0, "pmid_journal_49": "Scand J Immunol"}, {"pmid_title_50": "Hereditary complement (C9) deficiency associated with dermatomyositis.", "pmid_50": 11359403.0, "pmid_date_50": 2001.0, "pmid_journal_50": "Br J Dermatol"}, {"pmid_title_51": "Pyoderma gangrenosum in a patient with autoimmune haemolytic anaemia and complement deficiency.", "pmid_51": 10886151.0, "pmid_date_51": 2000.0, "pmid_journal_51": "Br J Dermatol"}, {"pmid_title_52": "Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement-deficient patients.", "pmid_52": 10632668.0, "pmid_date_52": 2000.0, "pmid_journal_52": "Clin Exp Immunol"}, {"pmid_title_53": "A novel type II complement C2 deficiency allele in an African-American family.", "pmid_53": 9670930.0, "pmid_date_53": 1998.0, "pmid_journal_53": "J Immunol"}, {"pmid_title_54": "A 4-year-old girl with right elbow erythema, warmth, and induration.", "pmid_54": 9088752.0, "pmid_date_54": 1997.0, "pmid_journal_54": "Curr Opin Pediatr"}, {"pmid_title_55": "Systemic lupus erythematosus complicating complement type 2 deficiency: successful treatment with fresh frozen plasma.", "pmid_55": 9115923.0, "pmid_date_55": 1997.0, "pmid_journal_55": "Br J Dermatol"}, {"pmid_title_56": "Multifocal stenosing ulcerations of the small intestine revealing vasculitis associated with C2 deficiency.", "pmid_56": 8613071.0, "pmid_date_56": 1996.0, "pmid_journal_56": "Gastroenterology"}, {"pmid_title_57": "Heterozygous and homozygous factor H deficiency states in a Dutch family.", "pmid_57": 8809142.0, "pmid_date_57": 1996.0, "pmid_journal_57": "Clin Exp Immunol"}, {"pmid_title_58": "Invasive Haemophilus influenzae type b infection in a child with familial deficiency of the beta subunit of the eighth component of complement.", "pmid_58": 8551398.0, "pmid_date_58": 1996.0, "pmid_journal_58": "J Pediatr"}, {"pmid_title_59": "How partial C7 deficiency with chronic and recurrent bacterial infections can mimic total C7 deficiency: temporary restoration of host C7 levels following plasma transfusion.", "pmid_59": 8774358.0, "pmid_date_59": 1996.0, "pmid_journal_59": "Immunology"}, {"pmid_title_60": "C9 deficiency in a patient with poststreptococcal glomerulonephritis.", "pmid_60": 8747118.0, "pmid_date_60": 1995.0, "pmid_journal_60": "Pediatr Nephrol"}, {"pmid_title_61": "Childhood subacute cutaneous lupus erythematosus associated with homozygous complement 2 deficiency.", "pmid_61": 8747579.0, "pmid_date_61": 1995.0, "pmid_journal_61": "Pediatr Dermatol"}, {"pmid_title_62": "Phenotypically similar clones of serogroup B Neisseria meningitidis causing recurrent meningitis in a patient with total C5 deficiency.", "pmid_62": 7806892.0, "pmid_date_62": 1994.0, "pmid_journal_62": "J Infect"}, {"pmid_title_63": "Hereditary deficiency of the seventh component of complement and recurrent meningococcal infection: investigations of an Irish family using a novel haemolytic screening assay for complement activity and C7 M/N allotyping.", "pmid_63": 7523157.0, "pmid_date_63": 1994.0, "pmid_journal_63": "Epidemiol Infect"}, {"pmid_title_64": "Recurrent infections, pericarditis and renal disease in a patient with total C2 deficiency and decreased NK cell function consistent with acute rheumatic fever and systemic lupus erythematosus.", "pmid_64": 8203960.0, "pmid_date_64": 1994.0, "pmid_journal_64": "Ann Rheum Dis"}, {"pmid_title_65": "Recurrent meningococcal infections in a patient with congenital C5 deficiency.", "pmid_65": 8388602.0, "pmid_date_65": 1993.0, "pmid_journal_65": "Acta Clin Belg"}, {"pmid_title_66": "Complement component deficiencies and infection: C5, C8 and C3 deficiencies in three families.", "pmid_66": 1396929.0, "pmid_date_66": 1992.0, "pmid_journal_66": "Eur J Pediatr"}, {"pmid_title_67": "Hereditary dysfunction of the third component of complement associated with a systemic lupus erythematosus-like syndrome and meningococcal meningitis.", "pmid_67": 1575793.0, "pmid_date_67": 1992.0, "pmid_journal_67": "Arthritis Rheum"}, {"pmid_title_68": "Complement factor 2 deficiency: a clinical and serological family study.", "pmid_68": 1361318.0, "pmid_date_68": 1992.0, "pmid_journal_68": "Ann Rheum Dis"}, {"pmid_title_69": "Selective C7 complement deficiency causing recurrent meningococcal infection.", "pmid_69": 2071909.0, "pmid_date_69": 1991.0, "pmid_journal_69": "J Infect"}, {"pmid_title_70": "Combined complete C5 and partial C4 deficiency in humans: clinical consequences and complement-mediated functions in vitro.", "pmid_70": 2306879.0, "pmid_date_70": 1990.0, "pmid_journal_70": "Clin Immunol Immunopathol"}, {"pmid_title_71": "Prophylaxis against Neisseria meningitidis infections and antibody responses in patients with deficiency of the sixth component of complement.", "pmid_71": 2109021.0, "pmid_date_71": 1990.0, "pmid_journal_71": "J Infect Dis"}, {"pmid_title_72": "Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency.", "pmid_72": 2290166.0, "pmid_date_72": 1990.0, "pmid_journal_72": "J Rheumatol"}, {"pmid_title_73": "Complete and partial deficiencies of complement factor D in a Dutch family.", "pmid_73": 2687330.0, "pmid_date_73": 1989.0, "pmid_journal_73": "J Clin Invest"}, {"pmid_title_74": "A case of hereditary combined deficiency of complement components C6 and C7 in man.", "pmid_74": 2702782.0, "pmid_date_74": 1989.0, "pmid_journal_74": "Clin Exp Immunol"}, {"pmid_title_75": "Combined homozygous factor H and heterozygous C2 deficiency in an Italian family.", "pmid_75": 2966809.0, "pmid_date_75": 1988.0, "pmid_journal_75": "J Clin Immunol"}, {"pmid_title_76": "Inherited C3 deficiency with recurrent infections and glomerulonephritis.", "pmid_76": 2963536.0, "pmid_date_76": 1988.0, "pmid_journal_76": "Am J Dis Child"}, {"pmid_title_77": "Meningitis caused by a nonencapsulated strain of Neisseria meningitidis in twin infants with a C6 deficiency.", "pmid_77": 3102634.0, "pmid_date_77": 1987.0, "pmid_journal_77": "J Infect Dis"}, {"pmid_title_78": "Meningococcal disease in congenital absence of the fifth component of complement.", "pmid_78": 3441749.0, "pmid_date_78": 1987.0, "pmid_journal_78": "Scand J Infect Dis"}, {"pmid_title_79": "Hypocomplementemic vasculitis and renal involvement.", "pmid_79": 2951605.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Nephron"}, {"pmid_title_80": "Arthritis and antinuclear antibodies (ANA) with inherited deficiency of the sixth component of complement (C6).", "pmid_80": 3487293.0, "pmid_date_80": 1986.0, "pmid_journal_80": "Ann Rheum Dis"}, {"pmid_title_81": "Atypical hypocomplementemic vasculitis syndrome in a child.", "pmid_81": 2987470.0, "pmid_date_81": 1985.0, "pmid_journal_81": "J Pediatr"}, {"pmid_title_82": "Terminal complement component deficiencies and rheumatic disease: development of a rheumatic syndrome and anticomplementary activity in a patient with complete C6 deficiency.", "pmid_82": 3931570.0, "pmid_date_82": 1985.0, "pmid_journal_82": "Ann Rheum Dis"}, {"pmid_title_83": "Thrombotic thrombocytopenic purpura developing during pregnancy in a C2-deficient patient with a history of systemic lupus erythematosus.", "pmid_83": 4038880.0, "pmid_date_83": 1985.0, "pmid_journal_83": "Arthritis Rheum"}, {"pmid_title_84": "Complement deficiency syndromes and bacterial infections.", "pmid_84": 6665131.0, "pmid_date_84": 1983.0, "pmid_journal_84": "Prog Brain Res"}, {"pmid_title_85": "Recurrent meningococcal meningitis due to partial complement defects and poor anti-meningococcal antibody response.", "pmid_85": 6411822.0, "pmid_date_85": 1983.0, "pmid_journal_85": "J Infect"}, {"pmid_title_86": "Circulating immune complexes and glomerulonephritis in a patient with congenital absence of the third component of complement.", "pmid_86": 6835307.0, "pmid_date_86": 1983.0, "pmid_journal_86": "N Engl J Med"}, {"pmid_title_87": "Identification of the alpha-gamma subunit of the eighth component of complement (C8) in a patient with systemic lupus erythematosus and absent C8 activity: patients and family studies.", "pmid_87": 7105499.0, "pmid_date_87": 1982.0, "pmid_journal_87": "Clin Immunol Immunopathol"}, {"pmid_title_88": "Combined hereditary deficiency of the sixth component of complement and factor VIII coagulant activity in a Dutch family.", "pmid_88": 6811172.0, "pmid_date_88": 1982.0, "pmid_journal_88": "Clin Exp Immunol"}, {"pmid_title_89": "Fulminant meningococcemia in a child with hereditary deficiency of the seventh component of complement and proteinuria.", "pmid_89": 7446104.0, "pmid_date_89": 1980.0, "pmid_journal_89": "Acta Paediatr Scand"}, {"pmid_title_90": "Recurrent bacterial meningitis due to genetic deficiencies of terminal complement components (C5 and C6).", "pmid_90": 7193645.0, "pmid_date_90": 1980.0, "pmid_journal_90": "Immunobiology"}, {"pmid_title_91": "Recurrent bacterial meningitis in patients with genetic defects of terminal complement components.", "pmid_91": 7389212.0, "pmid_date_91": 1980.0, "pmid_journal_91": "Clin Exp Immunol"}, {"pmid_title_92": "Familial partial deficiency of the third component of complement (C3) and the hypocomplementemic cutaneous vasculitis syndrome.", "pmid_92": 7369233.0, "pmid_date_92": 1980.0, "pmid_journal_92": "Am J Med"}, {"pmid_title_93": "Deficiency of the fifth component of complement in human subjects. Clinical, genetic and immunologic studies in a large kindred.", "pmid_93": 495634.0, "pmid_date_93": 1979.0, "pmid_journal_93": "Am J Med"}, {"pmid_title_94": "Hereditary C2 deficiency associated with cutaneous lupus erythematosus: clinical, laboratory, and genetic studies.", "pmid_94": 760659.0, "pmid_date_94": 1979.0, "pmid_journal_94": "Arch Dermatol"}, {"pmid_title_95": "Hereditary deficiency of the third component of complement in a child with fever, skin rash, and arthralgias: response to transfusion of whole blood.", "pmid_95": 318684.0, "pmid_date_95": 1977.0, "pmid_journal_95": "J Pediatr"}, {"pmid_title_96": "Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.", "pmid_96": 932197.0, "pmid_date_96": 1976.0, "pmid_journal_96": "J Clin Invest"}, {"pmid_title_97": "C2 deficiency. Development of lupus erythematosus.", "pmid_97": 4578155.0, "pmid_date_97": 1973.0, "pmid_journal_97": "J Clin Invest"}]}, {"_id": "1339-OMIM:612446", "condition": {"condition_name": "COMPLEMENT COMPONENT 6 DEFICIENCY", "alternate_names": ["COMPLEMENT COMPONENT 6 DEFICIENCY"]}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Prednisone"}, {"int_description_3": "Dexamethasone"}, {"int_description_4": "Epoprostenol"}, {"int_description_5": "Caffeine"}, {"int_description_6": "Human immunoglobulin G"}, {"int_description_7": "Cetirizine"}, {"int_description_8": "Hydroxychloroquine"}, {"int_description_9": "Rituximab"}, {"int_description_10": "Eculizumab"}, {"int_description_11": "Clarithromycin"}, {"int_description_12": "Cyclosporine"}, {"int_description_13": "Cyclophosphamide"}, {"int_description_14": "Dipyridamole"}, {"int_description_15": "Levamisole"}, {"int_description_16": "Erythromycin"}, {"int_description_17": "Azithromycin"}, {"int_description_18": "Chloramphenicol"}, {"int_description_19": "Trimethoprim"}, {"int_description_20": "Dapsone"}, {"int_description_21": "Sulfisoxazole"}, {"int_description_22": "Sulfadiazine"}, {"int_description_23": "Sulfamethoxazole"}, {"int_description_24": "Sulfamethazine"}, {"int_description_25": "Ciprofloxacin"}, {"int_description_26": "Ampicillin"}, {"int_description_27": "Phenoxymethylpenicillin"}, {"int_description_28": "Cefalotin"}, {"int_description_29": "Cefotaxime"}, {"int_description_30": "Cefaclor"}, {"int_description_31": "Benzylpenicillin", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Amoxicillin", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "No", "qualscale_reclass_drug32": "Case report(s)", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Cefuroxime"}, {"int_description_34": "Ceftriaxone"}, {"int_description_35": "Cefepime"}, {"int_description_36": "Sulbactam"}, {"int_description_37": "Clavulanic acid"}, {"int_description_38": "Nifedipine"}, {"int_description_39": "Diclofenac"}, {"int_description_40": "Naproxen"}, {"int_description_41": "Ibuprofen"}, {"int_description_42": "Rifampicin"}, {"int_description_43": "Pyrimethamine"}, {"int_description_44": "Methotrexate"}, {"int_description_45": "Leflunomide"}, {"int_description_46": "Vancomycin"}, {"int_description_47": "Gentamicin"}, {"int_description_48": "Chloroquine"}, {"int_description_49": "Tacrolimus"}, {"int_description_50": "Mizoribine"}, {"int_description_51": "Azathioprine"}, {"int_description_52": "Ascorbic acid"}, {"int_description_53": "Mycophenolate mofetil"}, {"int_description_54": "Mycophenolic acid"}, {"int_description_55": "Hydrocortisone"}, {"int_description_56": "Flucloxacillin"}, {"int_description_57": "Carbazochrome"}, {"int_description_58": "Acetylsalicylic acid"}, {"int_description_59": "Metamizole"}, {"int_description_60": "Methylprednisolone"}, {"int_description_61": "Leucovorin"}, {"int_description_62": "Warfarin"}, {"int_description_63": "Belimumab"}, {"int_description_64": "23-valent pneumococcal polysaccharide vaccine"}, {"int_description_65": "Anti-histaminic drugs", "timeframe_int65": "Days or Weeks,Years", "age_use_int65": "Infant,Child", "contra_int65": "No", "qualscale_reclass_drug65": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug65": "Effective / Ameliorative"}, {"int_description_66": "Antibiotics"}, {"int_description_67": "Antimalarial agents"}, {"int_description_68": "Conjugate pneumococcal vaccine"}, {"int_description_69": "Conjugate vaccine against N. meningitides serogroup B (Bexero\u00ae, Novartis Vaccines and Diagnostics S.r.l., Siena, Italy)"}, {"int_description_70": "Corticosteroids"}, {"int_description_71": "Spiramycin"}, {"int_description_72": "Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen"}, {"int_description_73": "Streptococcus pneumoniae type 4 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_74": "Streptococcus pneumoniae type 6b capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_75": "Streptococcus pneumoniae type 9v capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_76": "Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_77": "Streptococcus pneumoniae type 18c capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_78": "Streptococcus pneumoniae type 19f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_79": "Streptococcus pneumoniae type 23f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_80": "Streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_81": "Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_82": "Streptococcus pneumoniae type 5 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_83": "Streptococcus pneumoniae type 6a capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_84": "Streptococcus pneumoniae type 7f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_85": "Streptococcus pneumoniae type 19a capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_86": "Streptococcus pneumoniae type 1 capsular polysaccharide antigen"}, {"int_description_87": "Streptococcus pneumoniae type 2 capsular polysaccharide antigen"}, {"int_description_88": "Streptococcus pneumoniae type 3 capsular polysaccharide antigen"}, {"int_description_89": "Streptococcus pneumoniae type 4 capsular polysaccharide antigen"}, {"int_description_90": "Streptococcus pneumoniae type 5 capsular polysaccharide antigen"}, {"int_description_91": "Streptococcus pneumoniae type 6b capsular polysaccharide antigen"}, {"int_description_92": "Streptococcus pneumoniae type 7f capsular polysaccharide antigen"}, {"int_description_93": "Streptococcus pneumoniae type 8 capsular polysaccharide antigen"}, {"int_description_94": "Streptococcus pneumoniae type 9n capsular polysaccharide antigen"}, {"int_description_95": "Streptococcus pneumoniae type 9v capsular polysaccharide antigen"}, {"int_description_96": "Streptococcus pneumoniae type 10a capsular polysaccharide antigen"}, {"int_description_97": "Streptococcus pneumoniae type 11a capsular polysaccharide antigen"}, {"int_description_98": "Streptococcus pneumoniae type 12f capsular polysaccharide antigen"}, {"int_description_99": "Streptococcus pneumoniae type 14 capsular polysaccharide antigen"}, {"int_description_100": "Streptococcus pneumoniae type 15b capsular polysaccharide antigen"}, {"int_description_101": "Streptococcus pneumoniae type 17f capsular polysaccharide antigen"}, {"int_description_102": "Streptococcus pneumoniae type 18c capsular polysaccharide antigen"}, {"int_description_103": "Streptococcus pneumoniae type 19f capsular polysaccharide antigen"}, {"int_description_104": "Streptococcus pneumoniae type 19a capsular polysaccharide antigen"}, {"int_description_105": "Streptococcus pneumoniae type 20 capsular polysaccharide antigen"}, {"int_description_106": "Streptococcus pneumoniae type 22f capsular polysaccharide antigen"}, {"int_description_107": "Streptococcus pneumoniae type 23f capsular polysaccharide antigen"}, {"int_description_108": "Streptococcus pneumoniae type 33f capsular polysaccharide antigen"}, {"int_description_109": "Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_110": "Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_111": "Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_112": "Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_113": "Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_114": "Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_115": "Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_116": "Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_117": "Glucocorticoids"}, {"int_description_118": "H. influenzae vaccine"}, {"int_description_119": "Hib (H. influenzae type b) conjugate vaccines"}, {"int_description_120": "Meningococcal vaccine"}, {"int_description_121": "Mild steroid cream"}, {"int_description_122": "Monovalent Neisseria meningitidis serogroup C conjugate vaccines"}, {"int_description_123": "Pneumococcal vaccine polysaccharide"}, {"int_description_124": "Pneumococcal vaccine"}, {"int_description_125": "Steroids"}, {"int_description_126": "Sulphonamide"}, {"int_description_127": "Sunscreen"}, {"int_description_128": "Tetravalent A, C, Y and W135 meningococcal polysaccharide vaccine (MencevaxACYW)"}, {"int_description_129": "Topic steroid cycles"}, {"int_description_130": "Vaccine against Neisseria meningitidis serogroup B"}, {"int_description_131": "Cochlear implant surgery"}, {"int_description_132": "Endotracheal intubation with ventilatory support"}, {"int_description_133": "Extracorporeal membrane oxygenation"}, {"int_description_134": "Fresh frozen plasma transfusions"}, {"int_description_135": "Hemodialysis"}, {"int_description_136": "Highfrequency oscillation with nitrogen monoxide ventilation"}, {"int_description_137": "Nasal rinses"}, {"int_description_138": "Plasma infusion"}, {"int_description_139": "Whole blood transfusions"}, {"int_description_140": "Adenoidectomy"}, {"int_description_141": "Enlargement of the sphenoid sinus ostium"}, {"int_description_142": "Resection of jejunum and ileum"}, {"int_description_143": "Splenectomy"}, {"int_description_144": "Surgery with a three-vessel coronary bypass grafting"}, {"int_description_145": "Tonsillectomy"}]}, {"_id": "1346-OMIM:610102", "condition": {"condition_name": "COMPLEMENT COMPONENT 7 DEFICIENCY", "alternate_names": ["COMPLEMENT COMPONENT 7 DEFICIENCY"]}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Prednisone"}, {"int_description_3": "Dexamethasone"}, {"int_description_4": "Epoprostenol"}, {"int_description_5": "Caffeine"}, {"int_description_6": "Human immunoglobulin G"}, {"int_description_7": "Cetirizine"}, {"int_description_8": "Hydroxychloroquine"}, {"int_description_9": "Rituximab"}, {"int_description_10": "Eculizumab"}, {"int_description_11": "Clarithromycin"}, {"int_description_12": "Cyclosporine"}, {"int_description_13": "Cyclophosphamide"}, {"int_description_14": "Dipyridamole"}, {"int_description_15": "Levamisole"}, {"int_description_16": "Erythromycin"}, {"int_description_17": "Azithromycin"}, {"int_description_18": "Chloramphenicol"}, {"int_description_19": "Trimethoprim"}, {"int_description_20": "Dapsone"}, {"int_description_21": "Sulfisoxazole"}, {"int_description_22": "Sulfadiazine"}, {"int_description_23": "Sulfamethoxazole"}, {"int_description_24": "Sulfamethazine"}, {"int_description_25": "Ciprofloxacin"}, {"int_description_26": "Ampicillin"}, {"int_description_27": "Phenoxymethylpenicillin"}, {"int_description_28": "Cefalotin"}, {"int_description_29": "Cefotaxime"}, {"int_description_30": "Cefaclor"}, {"int_description_31": "Benzylpenicillin", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Amoxicillin", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "No", "qualscale_reclass_drug32": "Case report(s)", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Cefuroxime"}, {"int_description_34": "Ceftriaxone"}, {"int_description_35": "Cefepime"}, {"int_description_36": "Sulbactam"}, {"int_description_37": "Clavulanic acid"}, {"int_description_38": "Nifedipine"}, {"int_description_39": "Diclofenac"}, {"int_description_40": "Naproxen"}, {"int_description_41": "Ibuprofen"}, {"int_description_42": "Rifampicin"}, {"int_description_43": "Pyrimethamine"}, {"int_description_44": "Methotrexate"}, {"int_description_45": "Leflunomide"}, {"int_description_46": "Vancomycin"}, {"int_description_47": "Gentamicin"}, {"int_description_48": "Chloroquine"}, {"int_description_49": "Tacrolimus"}, {"int_description_50": "Mizoribine"}, {"int_description_51": "Azathioprine"}, {"int_description_52": "Ascorbic acid"}, {"int_description_53": "Mycophenolate mofetil"}, {"int_description_54": "Mycophenolic acid"}, {"int_description_55": "Hydrocortisone"}, {"int_description_56": "Flucloxacillin"}, {"int_description_57": "Carbazochrome"}, {"int_description_58": "Acetylsalicylic acid"}, {"int_description_59": "Metamizole"}, {"int_description_60": "Methylprednisolone"}, {"int_description_61": "Leucovorin"}, {"int_description_62": "Warfarin"}, {"int_description_63": "Belimumab"}, {"int_description_64": "23-valent pneumococcal polysaccharide vaccine"}, {"int_description_65": "Anti-histaminic drugs", "timeframe_int65": "Days or Weeks,Years", "age_use_int65": "Infant,Child", "contra_int65": "No", "qualscale_reclass_drug65": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug65": "Effective / Ameliorative"}, {"int_description_66": "Antibiotics"}, {"int_description_67": "Antimalarial agents"}, {"int_description_68": "Conjugate pneumococcal vaccine"}, {"int_description_69": "Conjugate vaccine against N. meningitides serogroup B (Bexero\u00ae, Novartis Vaccines and Diagnostics S.r.l., Siena, Italy)"}, {"int_description_70": "Corticosteroids"}, {"int_description_71": "Spiramycin"}, {"int_description_72": "Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen"}, {"int_description_73": "Streptococcus pneumoniae type 4 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_74": "Streptococcus pneumoniae type 6b capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_75": "Streptococcus pneumoniae type 9v capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_76": "Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_77": "Streptococcus pneumoniae type 18c capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_78": "Streptococcus pneumoniae type 19f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_79": "Streptococcus pneumoniae type 23f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_80": "Streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_81": "Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_82": "Streptococcus pneumoniae type 5 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_83": "Streptococcus pneumoniae type 6a capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_84": "Streptococcus pneumoniae type 7f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_85": "Streptococcus pneumoniae type 19a capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_86": "Streptococcus pneumoniae type 1 capsular polysaccharide antigen"}, {"int_description_87": "Streptococcus pneumoniae type 2 capsular polysaccharide antigen"}, {"int_description_88": "Streptococcus pneumoniae type 3 capsular polysaccharide antigen"}, {"int_description_89": "Streptococcus pneumoniae type 4 capsular polysaccharide antigen"}, {"int_description_90": "Streptococcus pneumoniae type 5 capsular polysaccharide antigen"}, {"int_description_91": "Streptococcus pneumoniae type 6b capsular polysaccharide antigen"}, {"int_description_92": "Streptococcus pneumoniae type 7f capsular polysaccharide antigen"}, {"int_description_93": "Streptococcus pneumoniae type 8 capsular polysaccharide antigen"}, {"int_description_94": "Streptococcus pneumoniae type 9n capsular polysaccharide antigen"}, {"int_description_95": "Streptococcus pneumoniae type 9v capsular polysaccharide antigen"}, {"int_description_96": "Streptococcus pneumoniae type 10a capsular polysaccharide antigen"}, {"int_description_97": "Streptococcus pneumoniae type 11a capsular polysaccharide antigen"}, {"int_description_98": "Streptococcus pneumoniae type 12f capsular polysaccharide antigen"}, {"int_description_99": "Streptococcus pneumoniae type 14 capsular polysaccharide antigen"}, {"int_description_100": "Streptococcus pneumoniae type 15b capsular polysaccharide antigen"}, {"int_description_101": "Streptococcus pneumoniae type 17f capsular polysaccharide antigen"}, {"int_description_102": "Streptococcus pneumoniae type 18c capsular polysaccharide antigen"}, {"int_description_103": "Streptococcus pneumoniae type 19f capsular polysaccharide antigen"}, {"int_description_104": "Streptococcus pneumoniae type 19a capsular polysaccharide antigen"}, {"int_description_105": "Streptococcus pneumoniae type 20 capsular polysaccharide antigen"}, {"int_description_106": "Streptococcus pneumoniae type 22f capsular polysaccharide antigen"}, {"int_description_107": "Streptococcus pneumoniae type 23f capsular polysaccharide antigen"}, {"int_description_108": "Streptococcus pneumoniae type 33f capsular polysaccharide antigen"}, {"int_description_109": "Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_110": "Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_111": "Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_112": "Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_113": "Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_114": "Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_115": "Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_116": "Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_117": "Glucocorticoids"}, {"int_description_118": "H. influenzae vaccine"}, {"int_description_119": "Hib (H. influenzae type b) conjugate vaccines"}, {"int_description_120": "Meningococcal vaccine"}, {"int_description_121": "Mild steroid cream"}, {"int_description_122": "Monovalent Neisseria meningitidis serogroup C conjugate vaccines"}, {"int_description_123": "Pneumococcal vaccine polysaccharide"}, {"int_description_124": "Pneumococcal vaccine"}, {"int_description_125": "Steroids"}, {"int_description_126": "Sulphonamide"}, {"int_description_127": "Sunscreen"}, {"int_description_128": "Tetravalent A, C, Y and W135 meningococcal polysaccharide vaccine (MencevaxACYW)"}, {"int_description_129": "Topic steroid cycles"}, {"int_description_130": "Vaccine against Neisseria meningitidis serogroup B"}, {"int_description_131": "Cochlear implant surgery"}, {"int_description_132": "Endotracheal intubation with ventilatory support"}, {"int_description_133": "Extracorporeal membrane oxygenation"}, {"int_description_134": "Fresh frozen plasma transfusions"}, {"int_description_135": "Hemodialysis"}, {"int_description_136": "Highfrequency oscillation with nitrogen monoxide ventilation"}, {"int_description_137": "Nasal rinses"}, {"int_description_138": "Plasma infusion"}, {"int_description_139": "Whole blood transfusions"}, {"int_description_140": "Adenoidectomy"}, {"int_description_141": "Enlargement of the sphenoid sinus ostium"}, {"int_description_142": "Resection of jejunum and ileum"}, {"int_description_143": "Splenectomy"}, {"int_description_144": "Surgery with a three-vessel coronary bypass grafting"}, {"int_description_145": "Tonsillectomy"}]}, {"_id": "1352-OMIM:613790", "condition": {"condition_name": "COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I"]}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Prednisone"}, {"int_description_3": "Dexamethasone"}, {"int_description_4": "Epoprostenol"}, {"int_description_5": "Caffeine"}, {"int_description_6": "Human immunoglobulin G"}, {"int_description_7": "Cetirizine"}, {"int_description_8": "Hydroxychloroquine"}, {"int_description_9": "Rituximab"}, {"int_description_10": "Eculizumab"}, {"int_description_11": "Clarithromycin"}, {"int_description_12": "Cyclosporine"}, {"int_description_13": "Cyclophosphamide"}, {"int_description_14": "Dipyridamole"}, {"int_description_15": "Levamisole"}, {"int_description_16": "Erythromycin"}, {"int_description_17": "Azithromycin"}, {"int_description_18": "Chloramphenicol"}, {"int_description_19": "Trimethoprim"}, {"int_description_20": "Dapsone"}, {"int_description_21": "Sulfisoxazole"}, {"int_description_22": "Sulfadiazine"}, {"int_description_23": "Sulfamethoxazole"}, {"int_description_24": "Sulfamethazine"}, {"int_description_25": "Ciprofloxacin"}, {"int_description_26": "Ampicillin"}, {"int_description_27": "Phenoxymethylpenicillin"}, {"int_description_28": "Cefalotin"}, {"int_description_29": "Cefotaxime"}, {"int_description_30": "Cefaclor"}, {"int_description_31": "Benzylpenicillin", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Amoxicillin", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "No", "qualscale_reclass_drug32": "Case report(s)", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Cefuroxime"}, {"int_description_34": "Ceftriaxone"}, {"int_description_35": "Cefepime"}, {"int_description_36": "Sulbactam"}, {"int_description_37": "Clavulanic acid"}, {"int_description_38": "Nifedipine"}, {"int_description_39": "Diclofenac"}, {"int_description_40": "Naproxen"}, {"int_description_41": "Ibuprofen"}, {"int_description_42": "Rifampicin"}, {"int_description_43": "Pyrimethamine"}, {"int_description_44": "Methotrexate"}, {"int_description_45": "Leflunomide"}, {"int_description_46": "Vancomycin"}, {"int_description_47": "Gentamicin"}, {"int_description_48": "Chloroquine"}, {"int_description_49": "Tacrolimus"}, {"int_description_50": "Mizoribine"}, {"int_description_51": "Azathioprine"}, {"int_description_52": "Ascorbic acid"}, {"int_description_53": "Mycophenolate mofetil"}, {"int_description_54": "Mycophenolic acid"}, {"int_description_55": "Hydrocortisone"}, {"int_description_56": "Flucloxacillin"}, {"int_description_57": "Carbazochrome"}, {"int_description_58": "Acetylsalicylic acid"}, {"int_description_59": "Metamizole"}, {"int_description_60": "Methylprednisolone"}, {"int_description_61": "Leucovorin"}, {"int_description_62": "Warfarin"}, {"int_description_63": "Belimumab"}, {"int_description_64": "23-valent pneumococcal polysaccharide vaccine"}, {"int_description_65": "Anti-histaminic drugs", "timeframe_int65": "Days or Weeks,Years", "age_use_int65": "Infant,Child", "contra_int65": "No", "qualscale_reclass_drug65": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug65": "Effective / Ameliorative"}, {"int_description_66": "Antibiotics"}, {"int_description_67": "Antimalarial agents"}, {"int_description_68": "Conjugate pneumococcal vaccine"}, {"int_description_69": "Conjugate vaccine against N. meningitides serogroup B (Bexero\u00ae, Novartis Vaccines and Diagnostics S.r.l., Siena, Italy)"}, {"int_description_70": "Corticosteroids"}, {"int_description_71": "Spiramycin"}, {"int_description_72": "Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen"}, {"int_description_73": "Streptococcus pneumoniae type 4 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_74": "Streptococcus pneumoniae type 6b capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_75": "Streptococcus pneumoniae type 9v capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_76": "Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_77": "Streptococcus pneumoniae type 18c capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_78": "Streptococcus pneumoniae type 19f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_79": "Streptococcus pneumoniae type 23f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_80": "Streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_81": "Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_82": "Streptococcus pneumoniae type 5 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_83": "Streptococcus pneumoniae type 6a capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_84": "Streptococcus pneumoniae type 7f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_85": "Streptococcus pneumoniae type 19a capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_86": "Streptococcus pneumoniae type 1 capsular polysaccharide antigen"}, {"int_description_87": "Streptococcus pneumoniae type 2 capsular polysaccharide antigen"}, {"int_description_88": "Streptococcus pneumoniae type 3 capsular polysaccharide antigen"}, {"int_description_89": "Streptococcus pneumoniae type 4 capsular polysaccharide antigen"}, {"int_description_90": "Streptococcus pneumoniae type 5 capsular polysaccharide antigen"}, {"int_description_91": "Streptococcus pneumoniae type 6b capsular polysaccharide antigen"}, {"int_description_92": "Streptococcus pneumoniae type 7f capsular polysaccharide antigen"}, {"int_description_93": "Streptococcus pneumoniae type 8 capsular polysaccharide antigen"}, {"int_description_94": "Streptococcus pneumoniae type 9n capsular polysaccharide antigen"}, {"int_description_95": "Streptococcus pneumoniae type 9v capsular polysaccharide antigen"}, {"int_description_96": "Streptococcus pneumoniae type 10a capsular polysaccharide antigen"}, {"int_description_97": "Streptococcus pneumoniae type 11a capsular polysaccharide antigen"}, {"int_description_98": "Streptococcus pneumoniae type 12f capsular polysaccharide antigen"}, {"int_description_99": "Streptococcus pneumoniae type 14 capsular polysaccharide antigen"}, {"int_description_100": "Streptococcus pneumoniae type 15b capsular polysaccharide antigen"}, {"int_description_101": "Streptococcus pneumoniae type 17f capsular polysaccharide antigen"}, {"int_description_102": "Streptococcus pneumoniae type 18c capsular polysaccharide antigen"}, {"int_description_103": "Streptococcus pneumoniae type 19f capsular polysaccharide antigen"}, {"int_description_104": "Streptococcus pneumoniae type 19a capsular polysaccharide antigen"}, {"int_description_105": "Streptococcus pneumoniae type 20 capsular polysaccharide antigen"}, {"int_description_106": "Streptococcus pneumoniae type 22f capsular polysaccharide antigen"}, {"int_description_107": "Streptococcus pneumoniae type 23f capsular polysaccharide antigen"}, {"int_description_108": "Streptococcus pneumoniae type 33f capsular polysaccharide antigen"}, {"int_description_109": "Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_110": "Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_111": "Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_112": "Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_113": "Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_114": "Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_115": "Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_116": "Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_117": "Glucocorticoids"}, {"int_description_118": "H. influenzae vaccine"}, {"int_description_119": "Hib (H. influenzae type b) conjugate vaccines"}, {"int_description_120": "Meningococcal vaccine"}, {"int_description_121": "Mild steroid cream"}, {"int_description_122": "Monovalent Neisseria meningitidis serogroup C conjugate vaccines"}, {"int_description_123": "Pneumococcal vaccine polysaccharide"}, {"int_description_124": "Pneumococcal vaccine"}, {"int_description_125": "Steroids"}, {"int_description_126": "Sulphonamide"}, {"int_description_127": "Sunscreen"}, {"int_description_128": "Tetravalent A, C, Y and W135 meningococcal polysaccharide vaccine (MencevaxACYW)"}, {"int_description_129": "Topic steroid cycles"}, {"int_description_130": "Vaccine against Neisseria meningitidis serogroup B"}, {"int_description_131": "Cochlear implant surgery"}, {"int_description_132": "Endotracheal intubation with ventilatory support"}, {"int_description_133": "Extracorporeal membrane oxygenation"}, {"int_description_134": "Fresh frozen plasma transfusions"}, {"int_description_135": "Hemodialysis"}, {"int_description_136": "Highfrequency oscillation with nitrogen monoxide ventilation"}, {"int_description_137": "Nasal rinses"}, {"int_description_138": "Plasma infusion"}, {"int_description_139": "Whole blood transfusions"}, {"int_description_140": "Adenoidectomy"}, {"int_description_141": "Enlargement of the sphenoid sinus ostium"}, {"int_description_142": "Resection of jejunum and ileum"}, {"int_description_143": "Splenectomy"}, {"int_description_144": "Surgery with a three-vessel coronary bypass grafting"}, {"int_description_145": "Tonsillectomy"}]}, {"_id": "1353-OMIM:613789", "condition": {"condition_name": "COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II"]}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Prednisone"}, {"int_description_3": "Dexamethasone"}, {"int_description_4": "Epoprostenol"}, {"int_description_5": "Caffeine"}, {"int_description_6": "Human immunoglobulin G"}, {"int_description_7": "Cetirizine"}, {"int_description_8": "Hydroxychloroquine"}, {"int_description_9": "Rituximab"}, {"int_description_10": "Eculizumab"}, {"int_description_11": "Clarithromycin"}, {"int_description_12": "Cyclosporine"}, {"int_description_13": "Cyclophosphamide"}, {"int_description_14": "Dipyridamole"}, {"int_description_15": "Levamisole"}, {"int_description_16": "Erythromycin"}, {"int_description_17": "Azithromycin"}, {"int_description_18": "Chloramphenicol"}, {"int_description_19": "Trimethoprim"}, {"int_description_20": "Dapsone"}, {"int_description_21": "Sulfisoxazole"}, {"int_description_22": "Sulfadiazine"}, {"int_description_23": "Sulfamethoxazole"}, {"int_description_24": "Sulfamethazine"}, {"int_description_25": "Ciprofloxacin"}, {"int_description_26": "Ampicillin"}, {"int_description_27": "Phenoxymethylpenicillin"}, {"int_description_28": "Cefalotin"}, {"int_description_29": "Cefotaxime"}, {"int_description_30": "Cefaclor"}, {"int_description_31": "Benzylpenicillin", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Curative"}, {"int_description_32": "Amoxicillin", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "No", "qualscale_reclass_drug32": "Case report(s)", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Cefuroxime"}, {"int_description_34": "Ceftriaxone"}, {"int_description_35": "Cefepime"}, {"int_description_36": "Sulbactam"}, {"int_description_37": "Clavulanic acid"}, {"int_description_38": "Nifedipine"}, {"int_description_39": "Diclofenac"}, {"int_description_40": "Naproxen"}, {"int_description_41": "Ibuprofen"}, {"int_description_42": "Rifampicin"}, {"int_description_43": "Pyrimethamine"}, {"int_description_44": "Methotrexate"}, {"int_description_45": "Leflunomide"}, {"int_description_46": "Vancomycin"}, {"int_description_47": "Gentamicin"}, {"int_description_48": "Chloroquine"}, {"int_description_49": "Tacrolimus"}, {"int_description_50": "Mizoribine"}, {"int_description_51": "Azathioprine"}, {"int_description_52": "Ascorbic acid"}, {"int_description_53": "Mycophenolate mofetil"}, {"int_description_54": "Mycophenolic acid"}, {"int_description_55": "Hydrocortisone"}, {"int_description_56": "Flucloxacillin"}, {"int_description_57": "Carbazochrome"}, {"int_description_58": "Acetylsalicylic acid"}, {"int_description_59": "Metamizole"}, {"int_description_60": "Methylprednisolone"}, {"int_description_61": "Leucovorin"}, {"int_description_62": "Warfarin"}, {"int_description_63": "Belimumab"}, {"int_description_64": "23-valent pneumococcal polysaccharide vaccine"}, {"int_description_65": "Anti-histaminic drugs", "timeframe_int65": "Days or Weeks,Years", "age_use_int65": "Infant,Child", "contra_int65": "No", "qualscale_reclass_drug65": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug65": "Effective / Ameliorative"}, {"int_description_66": "Antibiotics"}, {"int_description_67": "Antimalarial agents"}, {"int_description_68": "Conjugate pneumococcal vaccine"}, {"int_description_69": "Conjugate vaccine against N. meningitides serogroup B (Bexero\u00ae, Novartis Vaccines and Diagnostics S.r.l., Siena, Italy)"}, {"int_description_70": "Corticosteroids"}, {"int_description_71": "Spiramycin"}, {"int_description_72": "Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen"}, {"int_description_73": "Streptococcus pneumoniae type 4 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_74": "Streptococcus pneumoniae type 6b capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_75": "Streptococcus pneumoniae type 9v capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_76": "Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_77": "Streptococcus pneumoniae type 18c capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_78": "Streptococcus pneumoniae type 19f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_79": "Streptococcus pneumoniae type 23f capsular polysaccharide diphtheria crm197 protein conjugate antigen", "timeframe_int79": "Hours", "contra_int79": "No", "qualscale_reclass_drug79": "Case report(s)", "rev1_eff_reclass_drug79": "Effective / Ameliorative"}, {"int_description_80": "Streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_81": "Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_82": "Streptococcus pneumoniae type 5 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_83": "Streptococcus pneumoniae type 6a capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_84": "Streptococcus pneumoniae type 7f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_85": "Streptococcus pneumoniae type 19a capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_86": "Streptococcus pneumoniae type 1 capsular polysaccharide antigen"}, {"int_description_87": "Streptococcus pneumoniae type 2 capsular polysaccharide antigen"}, {"int_description_88": "Streptococcus pneumoniae type 3 capsular polysaccharide antigen"}, {"int_description_89": "Streptococcus pneumoniae type 4 capsular polysaccharide antigen"}, {"int_description_90": "Streptococcus pneumoniae type 5 capsular polysaccharide antigen"}, {"int_description_91": "Streptococcus pneumoniae type 6b capsular polysaccharide antigen"}, {"int_description_92": "Streptococcus pneumoniae type 7f capsular polysaccharide antigen"}, {"int_description_93": "Streptococcus pneumoniae type 8 capsular polysaccharide antigen"}, {"int_description_94": "Streptococcus pneumoniae type 9n capsular polysaccharide antigen"}, {"int_description_95": "Streptococcus pneumoniae type 9v capsular polysaccharide antigen"}, {"int_description_96": "Streptococcus pneumoniae type 10a capsular polysaccharide antigen"}, {"int_description_97": "Streptococcus pneumoniae type 11a capsular polysaccharide antigen"}, {"int_description_98": "Streptococcus pneumoniae type 12f capsular polysaccharide antigen"}, {"int_description_99": "Streptococcus pneumoniae type 14 capsular polysaccharide antigen"}, {"int_description_100": "Streptococcus pneumoniae type 15b capsular polysaccharide antigen"}, {"int_description_101": "Streptococcus pneumoniae type 17f capsular polysaccharide antigen"}, {"int_description_102": "Streptococcus pneumoniae type 18c capsular polysaccharide antigen"}, {"int_description_103": "Streptococcus pneumoniae type 19f capsular polysaccharide antigen"}, {"int_description_104": "Streptococcus pneumoniae type 19a capsular polysaccharide antigen"}, {"int_description_105": "Streptococcus pneumoniae type 20 capsular polysaccharide antigen"}, {"int_description_106": "Streptococcus pneumoniae type 22f capsular polysaccharide antigen"}, {"int_description_107": "Streptococcus pneumoniae type 23f capsular polysaccharide antigen"}, {"int_description_108": "Streptococcus pneumoniae type 33f capsular polysaccharide antigen"}, {"int_description_109": "Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_110": "Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_111": "Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_112": "Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_113": "Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_114": "Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_115": "Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_116": "Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_117": "Glucocorticoids"}, {"int_description_118": "H. influenzae vaccine"}, {"int_description_119": "Hib (H. influenzae type b) conjugate vaccines"}, {"int_description_120": "Meningococcal vaccine"}, {"int_description_121": "Mild steroid cream"}, {"int_description_122": "Monovalent Neisseria meningitidis serogroup C conjugate vaccines"}, {"int_description_123": "Pneumococcal vaccine polysaccharide"}, {"int_description_124": "Pneumococcal vaccine"}, {"int_description_125": "Steroids"}, {"int_description_126": "Sulphonamide"}, {"int_description_127": "Sunscreen"}, {"int_description_128": "Tetravalent A, C, Y and W135 meningococcal polysaccharide vaccine (MencevaxACYW)"}, {"int_description_129": "Topic steroid cycles"}, {"int_description_130": "Vaccine against Neisseria meningitidis serogroup B"}, {"int_description_131": "Cochlear implant surgery"}, {"int_description_132": "Endotracheal intubation with ventilatory support"}, {"int_description_133": "Extracorporeal membrane oxygenation"}, {"int_description_134": "Fresh frozen plasma transfusions"}, {"int_description_135": "Hemodialysis"}, {"int_description_136": "Highfrequency oscillation with nitrogen monoxide ventilation"}, {"int_description_137": "Nasal rinses"}, {"int_description_138": "Plasma infusion"}, {"int_description_139": "Whole blood transfusions"}, {"int_description_140": "Adenoidectomy"}, {"int_description_141": "Enlargement of the sphenoid sinus ostium"}, {"int_description_142": "Resection of jejunum and ileum"}, {"int_description_143": "Splenectomy"}, {"int_description_144": "Surgery with a three-vessel coronary bypass grafting"}, {"int_description_145": "Tonsillectomy"}]}, {"_id": "1358-OMIM:613825", "condition": {"condition_name": "COMPLEMENT COMPONENT 9 DEFICIENCY", "alternate_names": ["COMPLEMENT COMPONENT 9 DEFICIENCY", "MACULAR DEGENERATION, AGE-RELATED, 15"]}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Prednisone"}, {"int_description_3": "Dexamethasone"}, {"int_description_4": "Epoprostenol"}, {"int_description_5": "Caffeine"}, {"int_description_6": "Human immunoglobulin G"}, {"int_description_7": "Cetirizine"}, {"int_description_8": "Hydroxychloroquine"}, {"int_description_9": "Rituximab"}, {"int_description_10": "Eculizumab"}, {"int_description_11": "Clarithromycin"}, {"int_description_12": "Cyclosporine"}, {"int_description_13": "Cyclophosphamide"}, {"int_description_14": "Dipyridamole"}, {"int_description_15": "Levamisole"}, {"int_description_16": "Erythromycin"}, {"int_description_17": "Azithromycin"}, {"int_description_18": "Chloramphenicol"}, {"int_description_19": "Trimethoprim"}, {"int_description_20": "Dapsone"}, {"int_description_21": "Sulfisoxazole"}, {"int_description_22": "Sulfadiazine"}, {"int_description_23": "Sulfamethoxazole"}, {"int_description_24": "Sulfamethazine"}, {"int_description_25": "Ciprofloxacin"}, {"int_description_26": "Ampicillin"}, {"int_description_27": "Phenoxymethylpenicillin"}, {"int_description_28": "Cefalotin"}, {"int_description_29": "Cefotaxime"}, {"int_description_30": "Cefaclor"}, {"int_description_31": "Benzylpenicillin", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Amoxicillin", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "No", "qualscale_reclass_drug32": "Case report(s)", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Cefuroxime"}, {"int_description_34": "Ceftriaxone"}, {"int_description_35": "Cefepime"}, {"int_description_36": "Sulbactam"}, {"int_description_37": "Clavulanic acid"}, {"int_description_38": "Nifedipine"}, {"int_description_39": "Diclofenac"}, {"int_description_40": "Naproxen"}, {"int_description_41": "Ibuprofen"}, {"int_description_42": "Rifampicin"}, {"int_description_43": "Pyrimethamine"}, {"int_description_44": "Methotrexate"}, {"int_description_45": "Leflunomide"}, {"int_description_46": "Vancomycin"}, {"int_description_47": "Gentamicin"}, {"int_description_48": "Chloroquine"}, {"int_description_49": "Tacrolimus"}, {"int_description_50": "Mizoribine"}, {"int_description_51": "Azathioprine"}, {"int_description_52": "Ascorbic acid"}, {"int_description_53": "Mycophenolate mofetil"}, {"int_description_54": "Mycophenolic acid"}, {"int_description_55": "Hydrocortisone"}, {"int_description_56": "Flucloxacillin"}, {"int_description_57": "Carbazochrome"}, {"int_description_58": "Acetylsalicylic acid"}, {"int_description_59": "Metamizole"}, {"int_description_60": "Methylprednisolone"}, {"int_description_61": "Leucovorin"}, {"int_description_62": "Warfarin"}, {"int_description_63": "Belimumab"}, {"int_description_64": "23-valent pneumococcal polysaccharide vaccine"}, {"int_description_65": "Anti-histaminic drugs", "timeframe_int65": "Days or Weeks,Years", "age_use_int65": "Infant,Child", "contra_int65": "No", "qualscale_reclass_drug65": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug65": "Effective / Ameliorative"}, {"int_description_66": "Antibiotics"}, {"int_description_67": "Antimalarial agents"}, {"int_description_68": "Conjugate pneumococcal vaccine"}, {"int_description_69": "Conjugate vaccine against N. meningitides serogroup B (Bexero\u00ae, Novartis Vaccines and Diagnostics S.r.l., Siena, Italy)"}, {"int_description_70": "Corticosteroids"}, {"int_description_71": "Spiramycin"}, {"int_description_72": "Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen"}, {"int_description_73": "Streptococcus pneumoniae type 4 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_74": "Streptococcus pneumoniae type 6b capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_75": "Streptococcus pneumoniae type 9v capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_76": "Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_77": "Streptococcus pneumoniae type 18c capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_78": "Streptococcus pneumoniae type 19f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_79": "Streptococcus pneumoniae type 23f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_80": "Streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_81": "Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_82": "Streptococcus pneumoniae type 5 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_83": "Streptococcus pneumoniae type 6a capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_84": "Streptococcus pneumoniae type 7f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_85": "Streptococcus pneumoniae type 19a capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_86": "Streptococcus pneumoniae type 1 capsular polysaccharide antigen"}, {"int_description_87": "Streptococcus pneumoniae type 2 capsular polysaccharide antigen"}, {"int_description_88": "Streptococcus pneumoniae type 3 capsular polysaccharide antigen"}, {"int_description_89": "Streptococcus pneumoniae type 4 capsular polysaccharide antigen"}, {"int_description_90": "Streptococcus pneumoniae type 5 capsular polysaccharide antigen"}, {"int_description_91": "Streptococcus pneumoniae type 6b capsular polysaccharide antigen"}, {"int_description_92": "Streptococcus pneumoniae type 7f capsular polysaccharide antigen"}, {"int_description_93": "Streptococcus pneumoniae type 8 capsular polysaccharide antigen"}, {"int_description_94": "Streptococcus pneumoniae type 9n capsular polysaccharide antigen"}, {"int_description_95": "Streptococcus pneumoniae type 9v capsular polysaccharide antigen"}, {"int_description_96": "Streptococcus pneumoniae type 10a capsular polysaccharide antigen"}, {"int_description_97": "Streptococcus pneumoniae type 11a capsular polysaccharide antigen"}, {"int_description_98": "Streptococcus pneumoniae type 12f capsular polysaccharide antigen"}, {"int_description_99": "Streptococcus pneumoniae type 14 capsular polysaccharide antigen"}, {"int_description_100": "Streptococcus pneumoniae type 15b capsular polysaccharide antigen"}, {"int_description_101": "Streptococcus pneumoniae type 17f capsular polysaccharide antigen"}, {"int_description_102": "Streptococcus pneumoniae type 18c capsular polysaccharide antigen"}, {"int_description_103": "Streptococcus pneumoniae type 19f capsular polysaccharide antigen"}, {"int_description_104": "Streptococcus pneumoniae type 19a capsular polysaccharide antigen"}, {"int_description_105": "Streptococcus pneumoniae type 20 capsular polysaccharide antigen"}, {"int_description_106": "Streptococcus pneumoniae type 22f capsular polysaccharide antigen"}, {"int_description_107": "Streptococcus pneumoniae type 23f capsular polysaccharide antigen"}, {"int_description_108": "Streptococcus pneumoniae type 33f capsular polysaccharide antigen"}, {"int_description_109": "Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_110": "Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_111": "Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_112": "Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_113": "Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_114": "Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_115": "Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_116": "Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_117": "Glucocorticoids"}, {"int_description_118": "H. influenzae vaccine"}, {"int_description_119": "Hib (H. influenzae type b) conjugate vaccines"}, {"int_description_120": "Meningococcal vaccine"}, {"int_description_121": "Mild steroid cream"}, {"int_description_122": "Monovalent Neisseria meningitidis serogroup C conjugate vaccines"}, {"int_description_123": "Pneumococcal vaccine polysaccharide"}, {"int_description_124": "Pneumococcal vaccine"}, {"int_description_125": "Steroids"}, {"int_description_126": "Sulphonamide"}, {"int_description_127": "Sunscreen"}, {"int_description_128": "Tetravalent A, C, Y and W135 meningococcal polysaccharide vaccine (MencevaxACYW)"}, {"int_description_129": "Topic steroid cycles"}, {"int_description_130": "Vaccine against Neisseria meningitidis serogroup B"}, {"int_description_131": "Cochlear implant surgery"}, {"int_description_132": "Endotracheal intubation with ventilatory support"}, {"int_description_133": "Extracorporeal membrane oxygenation"}, {"int_description_134": "Fresh frozen plasma transfusions"}, {"int_description_135": "Hemodialysis"}, {"int_description_136": "Highfrequency oscillation with nitrogen monoxide ventilation"}, {"int_description_137": "Nasal rinses"}, {"int_description_138": "Plasma infusion"}, {"int_description_139": "Whole blood transfusions"}, {"int_description_140": "Adenoidectomy"}, {"int_description_141": "Enlargement of the sphenoid sinus ostium"}, {"int_description_142": "Resection of jejunum and ileum"}, {"int_description_143": "Splenectomy"}, {"int_description_144": "Surgery with a three-vessel coronary bypass grafting"}, {"int_description_145": "Tonsillectomy"}]}, {"_id": "1366-OMIM:274150", "condition": {"condition_name": "THROMBOTIC THROMBOCYTOPENIC PURPURA, HEREDITARY", "freq_per_birth": "The precise incidence of thrombotic thrombocytopenic purpura is unknown.  Researchers estimate that, depending on geographic location, the condition affects 1.7 to 14.5 per million people each year in the United States. For unknown reasons, the disorder occurs more frequently in women than in men. The acquired form of thrombotic thrombocytopenic purpura is much more common than the familial form.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["THROMBOTIC THROMBOCYTOPENIC PURPURA, HEREDITARY"]}, "gene information": {"db_hgnc_gene_id": 1366.0}, "interventions": [{"int_description_1": "Epoprostenol"}, {"int_description_2": "Desogestrel"}, {"int_description_3": "Human immunoglobulin G"}, {"int_description_4": "Eculizumab"}, {"int_description_5": "Acetylsalicylic acid"}, {"int_description_6": "Methylprednisolone"}, {"int_description_7": "antibiotics"}, {"int_description_8": "anticonvulsants", "timeframe_int8": "Days or Weeks", "age_use_int8": "Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Cohort study or studies", "rev1_eff_reclass_drug8": "Still in Trials / Unproven"}, {"int_description_9": "Egaptivon pegol"}, {"int_description_10": "Plasma protein fraction (human)"}, {"int_description_11": "Beroctocog alfa"}, {"int_description_12": "Apadamtase alfa"}, {"int_description_13": "steroids"}, {"int_description_14": "Fresh frosen plasma regular infusions", "timeframe_int14": "Hours", "age_use_int14": "Neonate,Infant,Child", "contra_int14": "No", "qualscale_reclass_drug14": "Cohort study or studies", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}, {"int_description_15": "hemodialysis", "timeframe_int15": "Hours", "age_use_int15": "Neonate,Infant,Child", "contra_int15": "No", "qualscale_reclass_drug15": "Cohort study or studies", "rev1_eff_reclass_drug15": "Effective / Ameliorative"}, {"int_description_16": "photo-therapy"}, {"int_description_17": "Plasma exchange", "timeframe_int17": "Hours", "age_use_int17": "Neonate", "contra_int17": "No", "qualscale_reclass_drug17": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug17": "Effective / Ameliorative"}, {"int_description_18": "platelet transfusions"}, {"int_description_19": "red cell transfusion"}, {"int_description_20": "transcatheter arterial embolization of an arteriovenous malformation in the superior mesenteric artery territory"}, {"int_description_21": "hysterectomy"}], "references": [{"pmid_title_1": "Characterization and treatment of congenital thrombotic thrombocytopenic purpura.", "pmid_1": 30770395.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Blood"}, {"pmid_title_2": "Congenital thrombotic thrombocytopenic purpura presenting in adulthood with recurrent cerebrovascular events.", "pmid_2": 31585956.0, "pmid_date_2": 2019.0, "pmid_journal_2": "BMJ Case Rep"}, {"pmid_title_3": "Pharmacokinetics of plasma infusion in congenital thrombotic thrombocytopenic purpura.", "pmid_3": 30475428.0, "pmid_date_3": 2019.0, "pmid_journal_3": "J Thromb Haemost"}, {"pmid_title_4": "Relapse of congenital thrombotic thrombocytopenic purpura, after spontaneous remission, in a second-trimester primigravida: case report and review of the literature.", "pmid_4": 28443948.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Sao Paulo Med J"}, {"pmid_title_5": "Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura.", "pmid_5": 28912376.0, "pmid_date_5": 2017.0, "pmid_journal_5": "Blood"}, {"pmid_title_6": "Inherited Thrombotic Thrombocytopenic Purpura (Upshaw Schulman Syndrome) as Differential Diagnosis to Neonatal Septicaemia with Disseminated Intravascular Coagulation - a Case Series.", "pmid_6": 27383044.0, "pmid_date_6": 2017.0, "pmid_journal_6": "Z Geburtshilfe Neonatol"}, {"pmid_title_7": "ADAMTS13 Secretion and Residual Activity among Patients with Congenital Thrombotic Thrombocytopenic Purpura with and without Renal Impairment.", "pmid_7": 26342041.0, "pmid_date_7": 2015.0, "pmid_journal_7": "Clin J Am Soc Nephrol"}, {"pmid_title_8": "Treatment of Congenital Thrombotic Thrombocytopenic Purpura With Eculizumab.", "pmid_8": 26409664.0, "pmid_date_8": 2015.0, "pmid_journal_8": "Am J Kidney Dis"}, {"pmid_title_9": "A case of congenital TTP presenting with microganiopathy in adulthood.", "pmid_9": 25243071.0, "pmid_date_9": 2014.0, "pmid_journal_9": "BMC Hematol"}, {"pmid_title_10": "Successful treatment of congenital TTP with a novel approach using plasma-derived factor VIII.", "pmid_10": 23128332.0, "pmid_date_10": 2013.0, "pmid_journal_10": "J Pediatr Hematol Oncol"}, {"pmid_title_11": "Congenital Thrombotic Thrombocytopenic Purpura: Atypical Presentation and New ADAMTS 13 Mutation in a Tunisian Child.", "pmid_11": 23795279.0, "pmid_date_11": 2013.0, "pmid_journal_11": "Mediterr J Hematol Infect Dis"}, {"pmid_title_12": "Long term follow up of congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) on hemodialysis for 19 years: a case report.", "pmid_12": 23870247.0, "pmid_date_12": 2013.0, "pmid_journal_12": "BMC Nephrol"}, {"pmid_title_13": "Two newborn-onset patients of Upshaw-Schulman syndrome with distinct subsequent clinical courses.", "pmid_13": 23188471.0, "pmid_date_13": 2012.0, "pmid_journal_13": "Int J Hematol"}, {"pmid_title_14": "Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan.", "pmid_14": 21781265.0, "pmid_date_14": 2011.0, "pmid_journal_14": "J Thromb Haemost"}, {"pmid_title_15": "A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombocytopenic purpura.", "pmid_15": 21833442.0, "pmid_date_15": 2011.0, "pmid_journal_15": "Thromb Haemost"}, {"pmid_title_16": "Difficulties in diagnosing congenital thrombotic thrombocytopenic purpura.", "pmid_16": 20118810.0, "pmid_date_16": 2010.0, "pmid_journal_16": "J Pediatr Hematol Oncol"}, {"pmid_title_17": "Thrombotic thrombocytopenic purpura: incidence of congenital form of disease in north Moravia (region Moravia-Silesia).", "pmid_17": 19655700.0, "pmid_date_17": 2009.0, "pmid_journal_17": "Prague Med Rep"}, {"pmid_title_18": "Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients.", "pmid_18": 19055667.0, "pmid_date_18": 2009.0, "pmid_journal_18": "Br J Haematol"}, {"pmid_title_19": "The use of intermediate purity factor VIII concentrate BPL 8Y as prophylaxis and treatment in congenital thrombotic thrombocytopenic purpura.", "pmid_19": 16925793.0, "pmid_date_19": 2006.0, "pmid_journal_19": "Br J Haematol"}, {"pmid_title_20": "Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement.", "pmid_20": 15800115.0, "pmid_date_20": 2005.0, "pmid_journal_20": "J Am Soc Nephrol"}, {"pmid_title_21": "Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).", "pmid_21": 15009458.0, "pmid_date_21": 2004.0, "pmid_journal_21": "J Thromb Haemost"}, {"pmid_title_22": "Successful treatment of congenital thrombotic thrombocytopenic purpura using the intermediate purity factor VIII concentrate BPL 8Y.", "pmid_22": 12358923.0, "pmid_date_22": 2002.0, "pmid_journal_22": "Br J Haematol"}, {"pmid_title_23": "Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura.", "pmid_23": 11530798.0, "pmid_date_23": 2001.0, "pmid_journal_23": "Int J Hematol"}, {"pmid_title_24": "Von Willebrand factor--cleaving protease activity in congenital thrombotic thrombocytopenic purpura.", "pmid_24": 11167764.0, "pmid_date_24": 2000.0, "pmid_journal_24": "Br J Haematol"}, {"pmid_title_25": "Partial clinical improvement in Upshaw-Schulman syndrome following prostacyclin infusion.", "pmid_25": 7754778.0, "pmid_date_25": 1995.0, "pmid_journal_25": "Acta Paediatr Jpn"}]}, {"_id": "1377-OMIM:615751", "condition": {"condition_name": "CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD", "freq_per_birth": "The prevalence of carbonic anhydrase VA deficiency is unknown. Only a small number of affected individuals have been described in the medical literature. However, the disorder may be underdiagnosed because the metabolic crisis often does not recur after the first episode; researchers suspect that some babies diagnosed with transient hyperammonemia may actually have carbonic anhydrase VA deficiency.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD"]}, "gene information": {"db_hgnc_gene_id": 1377.0}, "interventions": [{"int_description_1": "Low protein diet and arginine supplementation", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Soybean oil", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Arginine", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Benzoic acid", "timeframe_int4": "Hours", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Cohort study or studies", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Glycerol phenylbutyrate", "timeframe_int5": "Hours", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Phenylacetic acid", "timeframe_int6": "Hours", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Carglumic acid"}, {"int_description_8": "D-glucose", "timeframe_int8": "Hours", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Hemodialysis", "timeframe_int9": "Hours", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Case report(s)", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "\u0421ontinuous veno-venous haemofiltration", "timeframe_int10": "Hours", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Case report(s)", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Mitochondrial carbonic anhydrase VA deficiency in three Indian infants manifesting early metabolic crisis.", "pmid_1": 32381389.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Brain & development"}, {"pmid_title_2": "Fatal metabolic decompensation in carbonic anhydrase VA deficiency despite early treatment and control of hyperammonemia.", "pmid_2": 31641285.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Genetics in medicine : official journal of the American College of Medical Genetics"}, {"pmid_title_3": "Defective hepatic bicarbonate production due to carbonic anhydrase VA deficiency leads to early-onset life-threatening metabolic crisis.", "pmid_3": 26913920.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Genetics in medicine : official journal of the American College of Medical Genetics"}, {"pmid_title_4": "Carbonic Anhydrase VA Deficiency", "pmid_4": 25834911.0, "pmid_date_4": 2015.0, "pmid_journal_4": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_5": "Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhood.", "pmid_5": 24530203.0, "pmid_date_5": 2014.0, "pmid_journal_5": "American journal of human genetics"}]}, {"_id": "13806-OMIM:610370", "condition": {"condition_name": "DIARRHEA 4, MALABSORPTIVE, CONGENITAL", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["DIARRHEA 4, MALABSORPTIVE, CONGENITAL"]}, "gene information": {"db_hgnc_gene_id": 13806.0}, "interventions": [{"int_description_1": "Ursodeoxycholic acid", "timeframe_int1": "Days or Weeks", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Still in Trials / Unproven"}, {"int_description_2": "Loperamide"}, {"int_description_3": "Insulin human"}, {"int_description_4": "Estradiol"}, {"int_description_5": "Tacrolimus"}, {"int_description_6": "Corticosteroids"}, {"int_description_7": "Cholestyramine"}, {"int_description_8": "Multivitamins"}, {"int_description_9": "Pancreatic enzyme replacement  monotherapy"}, {"int_description_10": "Sodium bicarbonate"}, {"int_description_11": "D-glucose"}, {"int_description_12": "Mixed enteral and parenteral nutrition", "timeframe_int12": "Hours,Days or Weeks,Years", "age_use_int12": "Neonate,Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Case report(s)", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Night-time parenteral nutrition"}, {"int_description_14": "Total parenteral nutrition", "timeframe_int14": "Hours,Days or Weeks,Years", "age_use_int14": "Neonate,Infant,Child", "contra_int14": "No", "qualscale_reclass_drug14": "Case report(s)", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}, {"int_description_15": "Subtotal enterectomy, total hepatectomy, an orthotopic en bloc liver-intestine transplant"}], "references": [{"pmid_title_1": "Enteric anendocrinosis attributable to a novel Neurogenin-3 variant.", "pmid_1": 32574610.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Eur J Med Genet"}, {"pmid_title_2": "A novel NEUROG3 mutation in neonatal diabetes associated with a neuro-intestinal syndrome.", "pmid_2": 28940958.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Pediatr Diabetes"}, {"pmid_title_3": "A New Case of Congenital Malabsorptive Diarrhea and Diabetes Secondary to Mutant <i>Neurogenin-3</i>.", "pmid_3": 28724572.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Pediatrics"}, {"pmid_title_4": "Mutant neurogenin-3 in a Turkish boy with congenital malabsorptive diarrhea.", "pmid_4": 26541772.0, "pmid_date_4": 2016.0, "pmid_journal_4": "Pediatr Int"}, {"pmid_title_5": "Hypogonadotropic Hypogonadism and Short Stature in Patients with Diabetes Due to Neurogenin 3 Deficiency.", "pmid_5": 27533310.0, "pmid_date_5": 2016.0, "pmid_journal_5": "J Clin Endocrinol Metab"}, {"pmid_title_6": "Extremely rare cause of congenital diarrhea: enteric anendocrinosis.", "pmid_6": 24134759.0, "pmid_date_6": 2013.0, "pmid_journal_6": "Pediatr Int"}, {"pmid_title_7": "Permanent Neonatal Diabetes and Enteric Anendocrinosis Associated With Biallelic Mutations in NEUROG3.", "pmid_7": 21378176.0, "pmid_date_7": 2011.0, "pmid_journal_7": "Diabetes"}, {"pmid_title_8": "Neonatal diabetes and congenital malabsorptive diarrhea attributable to a novel mutation in the human neurogenin-3 gene coding sequence.", "pmid_8": 21490072.0, "pmid_date_8": 2011.0, "pmid_journal_8": "J Clin Endocrinol Metab"}, {"pmid_title_9": "Enteroendocrine cell dysgenesis and malabsorption, a histopathologic and immunohistochemical characterization.", "pmid_9": 17258790.0, "pmid_date_9": 2007.0, "pmid_journal_9": "Hum Pathol"}, {"pmid_title_10": "Mutant neurogenin-3 in congenital malabsorptive diarrhea.", "pmid_10": 16855267.0, "pmid_date_10": 2006.0, "pmid_journal_10": "N Engl J Med"}]}, {"_id": "1390-OMIM:601005", "condition": {"condition_name": "TIMOTHY SYNDROME; TS", "freq_per_birth": "Timothy syndrome is a rare condition; fewer than 100 people with this disorder have been reported worldwide.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["LONG QT SYNDROME 8; LQT8", "TIMOTHY SYNDROME; TS", "BRUGADA SYNDROME 3; BRGDA3"]}, "gene information": {"db_hgnc_gene_id": 1390.0}, "interventions": [{"int_description_1": "Implantable cardioverter defibrillator"}, {"int_description_2": "Nasogastric tube"}, {"int_description_3": "Permanent pacemaker", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "Yes", "qualscale_reclass_drug3": "Cohort study or studies", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Isoprenaline", "timeframe_int4": "Hours", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Cohort study or studies", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Fentanyl"}, {"int_description_6": "Propranolol", "timeframe_int6": "Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Cohort study or studies", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Atenolol", "timeframe_int7": "Hours", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Case report(s)", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Nadolol"}, {"int_description_9": "Midazolam"}, {"int_description_10": "Lidocaine"}, {"int_description_11": "Mexiletine", "timeframe_int11": "Hours", "age_use_int11": "Neonate,Infant,Child", "contra_int11": "No", "qualscale_reclass_drug11": "Case report(s)", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "Magnesium"}, {"int_description_13": "Verapamil"}, {"int_description_14": "Nifedipine", "timeframe_int14": "Days or Weeks,Years", "age_use_int14": "Neonate,Infant,Child", "contra_int14": "No", "qualscale_reclass_drug14": "Cohort study or studies", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}, {"int_description_15": "Seliciclib"}, {"int_description_16": "Ranolazine", "timeframe_int16": "Days or Weeks,Years", "age_use_int16": "Neonate,Infant,Child", "contra_int16": "No", "qualscale_reclass_drug16": "Cohort study or studies", "rev1_eff_reclass_drug16": "Effective / Ameliorative"}, {"int_description_17": "Propofol", "timeframe_int17": "Hours", "age_use_int17": "Neonate,Infant,Child", "contra_int17": "No", "qualscale_reclass_drug17": "Cohort study or studies", "rev1_eff_reclass_drug17": "Effective / Ameliorative"}, {"int_description_18": "Beta-blockers"}, {"int_description_19": "Muscle relaxants", "timeframe_int19": "Days or Weeks,Years", "age_use_int19": "Infant,Child", "contra_int19": "No", "qualscale_reclass_drug19": "Case report(s)", "rev1_eff_reclass_drug19": "Effective / Ameliorative"}, {"int_description_20": "Phenobarbital"}, {"int_description_21": "Left cervical sympathetic denervation"}], "references": [{"pmid_title_1": "Dysfunctional Cav1.2 channel in Timothy syndrome, from cell to bedside.", "pmid_1": 31324123.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Experimental biology and medicine (Maywood, N.J.)"}, {"pmid_title_2": "Impaired chromaffin cell excitability and exocytosis in autistic Timothy syndrome TS2-neo mouse rescued by L-type calcium channel blockers.", "pmid_2": 30629744.0, "pmid_date_2": 2019.0, "pmid_journal_2": "The Journal of physiology"}, {"pmid_title_3": "Clinical Outcomes and Modes of Death in Timothy Syndrome: A Multicenter International Study of a Rare Disorder.", "pmid_3": 30067485.0, "pmid_date_3": 2018.0, "pmid_journal_3": "JACC. Clinical electrophysiology"}, {"pmid_title_4": "A multicentre study of patients with Timothy syndrome.", "pmid_4": 28371864.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology"}, {"pmid_title_5": "Timothy syndrome 1 genotype without syndactyly and major extracardiac manifestations.", "pmid_5": 28211989.0, "pmid_date_5": 2017.0, "pmid_journal_5": "American journal of medical genetics. Part A"}, {"pmid_title_6": "A case report: Is mexiletine usage effective in the shortening of QTC interval and improving the T-wave alternans in Timothy syndrome?", "pmid_6": 29194862.0, "pmid_date_6": 2017.0, "pmid_journal_6": "Ann Noninvasive Electrocardiol"}, {"pmid_title_7": "A case of Timothy syndrome with adrenal medullary dystrophy.", "pmid_7": 27593853.0, "pmid_date_7": 2016.0, "pmid_journal_7": "Pathology international"}, {"pmid_title_8": "Timothy Syndrome", "pmid_8": 20301577.0, "pmid_date_8": 2015.0, "pmid_journal_8": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_9": "Long QT syndrome with craniofacial, digital, and neurologic features: Is it useful to distinguish between Timothy syndrome types 1 and 2?", "pmid_9": 26227324.0, "pmid_date_9": 2015.0, "pmid_journal_9": "American journal of medical genetics. Part A"}, {"pmid_title_10": "Sudden cardiac arrest during anesthesia in a 30-month-old boy with syndactyly: a case of genetically proven Timothy syndrome.", "pmid_10": 23678275.0, "pmid_date_10": 2013.0, "pmid_journal_10": "J Korean Med Sci"}, {"pmid_title_11": "Inhibition of late sodium current by mexiletine: a novel pharmotherapeutical approach in timothy syndrome.", "pmid_11": 23580742.0, "pmid_date_11": 2013.0, "pmid_journal_11": "Circulation. Arrhythmia and electrophysiology"}, {"pmid_title_12": "A rare association of long QT syndrome and syndactyly: Timothy syndrome (LQT 8).", "pmid_12": 21915623.0, "pmid_date_12": 2011.0, "pmid_journal_12": "Clin Res Cardiol"}, {"pmid_title_13": "Verapamil decreases ventricular tachyarrhythmias in a patient with Timothy syndrome (LQT8).", "pmid_13": 16876748.0, "pmid_date_13": 2006.0, "pmid_journal_13": "Heart rhythm"}]}, {"_id": "1390-OMIM:618447", "condition": {"condition_name": "LONG QT SYNDROME 8; LQT8", "alternate_names": ["BRUGADA SYNDROME 3; BRGDA3", "LONG QT SYNDROME 8; LQT8", "TIMOTHY SYNDROME; TS"]}, "gene information": {"db_hgnc_gene_id": 1390.0}, "interventions": [{"int_description_1": "Implantable cardioverter-defibrillator"}, {"int_description_2": "Epinephrine"}, {"int_description_3": "Carvedilol"}, {"int_description_4": "Ranolazine", "timeframe_int4": "Days or Weeks", "age_use_int4": "Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Beta-blockers", "timeframe_int5": "Hours", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "ICD implantation"}, {"int_description_7": "Implantable cardioverter defibrillator"}, {"int_description_8": "Sympathetic denervation"}], "references": [{"pmid_title_1": "A case of congenital long QT syndrome, type 8, undergoing laparoscopic hysterectomy with general anesthesia.", "pmid_1": 31307750.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Taiwanese journal of obstetrics & gynecology"}, {"pmid_title_2": "Long QT Syndrome", "pmid_2": 20301308.0, "pmid_date_2": 2018.0, "pmid_journal_2": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_3": "Exome sequencing and systems biology converge to identify novel mutations in the L-type calcium channel, CACNA1C, linked to autosomal dominant long QT syndrome.", "pmid_3": 23677916.0, "pmid_date_3": 2013.0, "pmid_journal_3": "Circulation. Cardiovascular genetics"}, {"pmid_title_4": "The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.", "pmid_4": 23275262.0, "pmid_date_4": 2013.0, "pmid_journal_4": "Circulation. Arrhythmia and electrophysiology"}, {"pmid_title_5": "Ranolazine safely decreases ventricular and atrial fibrillation in Timothy syndrome (LQT8).", "pmid_5": 20883512.0, "pmid_date_5": 2012.0, "pmid_journal_5": "Pacing and clinical electrophysiology : PACE"}]}, {"_id": "1391-OMIM:615474", "condition": {"condition_name": "PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES; PASNA", "pattern_of_inheritance": "Not applicable", "alternate_names": ["PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES; PASNA"]}, "gene information": {"db_hgnc_gene_id": 1391.0}, "interventions": [{"int_description_1": "Clonidine", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Spironolactone", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Amlodipine", "timeframe_int3": "Hours,Days or Weeks,Years", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Nifedipine", "timeframe_int4": "Hours,Days or Weeks,Years", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Diazoxide", "timeframe_int5": "Hours,Days or Weeks,Years", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Adrenalectomy"}], "references": [{"pmid_title_1": "A de novo CACNA1D missense mutation in a patient with congenital hyperinsulinism, primary hyperaldosteronism and hypotonia.", "pmid_1": 32336187.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Channels (Austin, Tex.)"}, {"pmid_title_2": "Diagnosis and treatment of primary aldosteronism: practical clinical perspectives.", "pmid_2": 30255616.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Journal of internal medicine"}, {"pmid_title_3": "Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism.", "pmid_3": 23913001.0, "pmid_date_3": 2013.0, "pmid_journal_3": "Nature genetics"}]}, {"_id": "14025-OMIM:158580", "condition": {"condition_name": "NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA; HMN7A", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA; HMN7A"]}, "gene information": {"db_hgnc_gene_id": 14025.0}, "interventions": [{"int_description_1": "Salbutamol"}, {"int_description_2": "Acetylcholinesterase inhibitors", "qualscale_reclass_drug2": "Cohort study or studies"}, {"int_description_3": "Cricopharyngeal myotomy"}], "references": [{"pmid_title_1": "Congenital myasthenic syndrome with episodic apnoea: clinical, neurophysiological and genetic features in the long-term follow-up of 19 patients.", "pmid_1": 29189923.0, "pmid_date_1": 2017.0, "pmid_journal_1": "J Neurol"}, {"pmid_title_2": "Impaired Presynaptic High-Affinity Choline Transporter Causes a Congenital Myasthenic Syndrome with Episodic Apnea.", "pmid_2": 27569547.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Am J Hum Genet"}, {"pmid_title_3": "Oculopharyngeal Muscular Dystrophy", "pmid_3": 20301305.0, "pmid_date_3": 2014.0, "pmid_journal_3": "GeneReviews\u00ae"}]}, {"_id": "14211-OMIM:613502", "condition": {"condition_name": "AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE", "alternate_names": ["AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE"]}, "gene information": {"db_hgnc_gene_id": 14211.0}, "interventions": [{"int_description_1": "Human immunoglobulin G", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Aggressive antibiotic therapy", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Vorhyaluronidase alfa"}], "references": [{"pmid_title_1": "Agammaglobulinemia", "pmid_1": 32310401.0, "pmid_date_1": 2020.0}, {"pmid_title_2": "Further delineation of primary B cell immunodeficiency caused by novel variants of the BLNK gene in two Chinese patients.", "pmid_2": 32194234.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Clinical immunology (Orlando, Fla.)"}, {"pmid_title_3": "Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.", "pmid_3": 28786026.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Journal of clinical immunology"}, {"pmid_title_4": "Enteroviral Infection in a Patient with BLNK Adaptor Protein Deficiency.", "pmid_4": 25893637.0, "pmid_date_4": 2015.0, "pmid_journal_4": "Journal of clinical immunology"}]}, {"_id": "1421-OMIM:212138", "condition": {"condition_name": "CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY; CACTD", "freq_per_birth": "CACT deficiency is very rare; at least 30 cases have been reported.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY; CACTD"]}, "gene information": {"db_hgnc_gene_id": 1421.0}, "interventions": [{"int_description_1": "High-carbohydrate diet", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Low long-chain fat diet and medium-chain triglycerides (MCT) supplementation (as low as possible in C10 and C12 fatty acids)", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Still in Trials / Unproven"}, {"int_description_3": "Levocarnitine", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Triheptanoin", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Starch, corn", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Medium-chain triglycerides", "timeframe_int6": "Days or Weeks,Years", "age_use_int6": "Infant,Child", "contra_int6": "Yes", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "D-glucose", "timeframe_int7": "Hours,Days or Weeks", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Strict avoidance of fasting (fed every 3-6 hours)", "timeframe_int8": "Hours", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "The safety of Lipistart, a medium-chain triglyceride based formula, in the dietary treatment of long-chain fatty acid disorders: a phase I study.", "pmid_1": 29425111.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_2": "Triheptanoin: A Rescue Therapy for Cardiogenic Shock in Carnitine-acylcarnitine Translocase Deficiency.", "pmid_2": 28689308.0, "pmid_date_2": 2018.0, "pmid_journal_2": "JIMD reports"}, {"pmid_title_3": "Historical Perspective on Clinical Trials of Carnitine in Children and Adults.", "pmid_3": 27931034.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Annals of nutrition & metabolism"}, {"pmid_title_4": "Carnitine-acylcarnitine translocase deficiency: experience with four cases in Spain and review of the literature.", "pmid_4": 25614308.0, "pmid_date_4": 2015.0, "pmid_journal_4": "JIMD reports"}, {"pmid_title_5": "Prospective treatment in carnitine-acylcarnitine translocase deficiency.", "pmid_5": 17508264.0, "pmid_date_5": 2007.0, "pmid_journal_5": "Journal of inherited metabolic disease"}, {"pmid_title_6": "Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency.", "pmid_6": 15365988.0, "pmid_date_6": 2004.0, "pmid_journal_6": "Human mutation"}, {"pmid_title_7": "Response to therapy in carnitine/acylcarnitine translocase (CACT) deficiency due to a novel missense mutation.", "pmid_7": 15057979.0, "pmid_date_7": 2004.0, "pmid_journal_7": "American journal of medical genetics. Part A"}, {"pmid_title_8": "Carnitine-acylcarnitine translocase deficiency: phenotype, residual enzyme activity and outcome.", "pmid_8": 11271379.0, "pmid_date_8": 2001.0, "pmid_journal_8": "European journal of pediatrics"}, {"pmid_title_9": "Medium-chain triglyceride loading test in carnitine-acylcarnitine translocase deficiency: insights on treatment.", "pmid_9": 10472533.0, "pmid_date_9": 1999.0, "pmid_journal_9": "Journal of inherited metabolic disease"}]}, {"_id": "14537-OMIM:607625", "condition": {"condition_name": "NIEMANN-PICK DISEASE, TYPE C2", "freq_per_birth": "Niemann-Pick disease types A and B is estimated to affect 1 in 250,000 individuals. Niemann-Pick disease type A occurs more frequently among individuals of Ashkenazi (eastern and central European) Jewish descent than in the general population. The incidence within the Ashkenazi population is approximately 1 in 40,000 individuals.Combined, Niemann-Pick disease types C1 and C2 are estimated to affect 1 in 150,000 individuals; however, type C1 is by far the more common type, accounting for 95 percent of cases. The disease occurs more frequently in people of French-Acadian descent in Nova Scotia. In Nova Scotia, a population of affected French-Acadians were previously designated as having Niemann-Pick disease type D, however, it was shown that these individuals have mutations in the gene associated with Niemann-Pick disease type C1.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["NIEMANN-PICK DISEASE, TYPE C2"]}, "gene information": {"db_hgnc_gene_id": 14537.0}, "interventions": [{"int_description_1": "Alemtuzumab"}, {"int_description_2": "Levetiracetam"}, {"int_description_3": "Cyclophosphamide"}, {"int_description_4": "Busulfan", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Miglustat"}, {"int_description_6": "Vorinostat"}, {"int_description_7": "Trichostatin A"}, {"int_description_8": "Panobinostat"}, {"int_description_9": "Benzodiazepines"}, {"int_description_10": "CI-994"}, {"int_description_11": "Thioperamide"}, {"int_description_12": "Bronchoalveolar lavage", "timeframe_int12": "Days or Weeks", "age_use_int12": "Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Case report(s)", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Continuous artificial ventilation"}, {"int_description_14": "Oxygen therapy"}, {"int_description_15": "Allogenic bone marrow transplant"}, {"int_description_16": "Thoracotomy"}], "references": [{"pmid_title_1": "Niemann-Pick Disease Type C", "pmid_1": 20301473.0, "pmid_date_1": 2020.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Drug-induced increase in lysobisphosphatidic acid reduces the cholesterol overload in Niemann-Pick type C cells and mice.", "pmid_2": 31267706.0, "pmid_date_2": 2019.0, "pmid_journal_2": "EMBO Rep"}, {"pmid_title_3": "Niemann-Pick Type C-2 Disease: Identification by Analysis of Plasma Cholestane-3\u03b2,5\u03b1,6\u03b2-Triol and Further Insight into the Clinical Phenotype.", "pmid_3": 25772320.0, "pmid_date_3": 2015.0, "pmid_journal_3": "JIMD Rep"}, {"pmid_title_4": "Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C.", "pmid_4": 25888393.0, "pmid_date_4": 2015.0, "pmid_journal_4": "Orphanet J Rare Dis"}, {"pmid_title_5": "Developmental outcome post allogenic bone marrow transplant for Niemann Pick Type C2.", "pmid_5": 23219289.0, "pmid_date_5": 2013.0, "pmid_journal_5": "Mol Genet Metab"}, {"pmid_title_6": "The videofluoroscopic swallowing study shows a sustained improvement of dysphagia in children with Niemann-Pick disease type C after therapy with miglustat.", "pmid_6": 21344635.0, "pmid_date_6": 2011.0, "pmid_journal_6": "Am J Med Genet A"}, {"pmid_title_7": "Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts.", "pmid_7": 21436030.0, "pmid_date_7": 2011.0, "pmid_journal_7": "Proc Natl Acad Sci U S A"}, {"pmid_title_8": "Successful allogeneic bone marrow transplant for Niemann-Pick disease type C2 is likely to be associated with a severe 'graft versus substrate' effect.", "pmid_8": 20393800.0, "pmid_date_8": 2010.0, "pmid_journal_8": "J Inherit Metab Dis"}]}, {"_id": "14579-OMIM:615285", "condition": {"condition_name": "NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE", "freq_per_birth": "The incidence of severe congenital neutropenia is estimated to be 1 in 200,000 individuals.", "pattern_of_inheritance": "X-linked recessive, Autosomal dominant, Autosomal recessive", "alternate_names": ["NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE"]}, "gene information": {"db_hgnc_gene_id": 14579.0}, "interventions": [{"int_description_1": "Human immunoglobulin G"}, {"int_description_2": "Abatacept"}, {"int_description_3": "Rituximab"}, {"int_description_4": "Bortezomib"}, {"int_description_5": "Methylprednisolone hemisuccinate"}, {"int_description_6": "Daratumumab"}, {"int_description_7": "Granulocyte colony-stimulating factor"}, {"int_description_8": "Bone marrow transplantation", "timeframe_int8": "Days or Weeks", "age_use_int8": "Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Cohort study or studies", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Hematopoietic stem cell transplantation", "timeframe_int9": "Days or Weeks", "age_use_int9": "Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Cohort study or studies", "rev1_eff_reclass_drug9": "Curative"}, {"int_description_10": "Peripheral blood stem cell transplantation", "timeframe_int10": "Days or Weeks", "age_use_int10": "Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Case report(s)", "rev1_eff_reclass_drug10": "Curative"}], "references": [{"pmid_title_1": "Successful treatment with daratumumab for post-HSCT refractory hemolytic anemia.", "pmid_1": 31544339.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Pediatric blood & cancer"}, {"pmid_title_2": "A novel homozygous VPS45 p.P468L mutation leading to severe congenital neutropenia with myelofibrosis.", "pmid_2": 28453180.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Pediatric blood & cancer"}, {"pmid_title_3": "The Thr224Asn mutation in the VPS45 gene is associated with the congenital neutropenia and primary myelofibrosis of infancy.", "pmid_3": 23599270.0, "pmid_date_3": 2013.0, "pmid_journal_3": "Blood"}, {"pmid_title_4": "A congenital neutrophil defect syndrome associated with mutations in VPS45.", "pmid_4": 23738510.0, "pmid_date_4": 2013.0, "pmid_journal_4": "The New England journal of medicine"}, {"pmid_title_5": "VPS 45-associated primary infantile myelofibrosis--successful treatment with hematopoietic stem cell transplantation.", "pmid_5": 24164830.0, "pmid_date_5": 2013.0, "pmid_journal_5": "Pediatric transplantation"}]}, {"_id": "14604-OMIM:618882", "condition": {"condition_name": "IMERSLUND-GRASBECK SYNDROME 2", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["IMERSLUND-GRASBECK SYNDROME 2"]}, "gene information": {"db_hgnc_gene_id": 14604.0}, "interventions": [{"int_description_1": "Cyanocobalamin"}, {"int_description_2": "Cobamamide"}], "references": [{"pmid_title_1": "[IMERSLUND-GRASBECK SYNDROME CONGENITAL FORM OF VITAMIN B12 DEFICIENCY ANEMIA].", "pmid_1": 31322513.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Georgian medical news"}, {"pmid_title_2": "Imerslund-Grasbeck syndrome in a 5-year-old Iranian boy.", "pmid_2": 27942180.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Indian J Nephrol"}, {"pmid_title_3": "VIT. B12 DEFICIENCY IN CHILDREN (IMERSLUND-GRASBECK SYNDROME IN TWO PAIRS OF SIBLINGS).", "pmid_3": 26958680.0, "pmid_date_3": 2015.0, "pmid_journal_3": "Developmental period medicine"}, {"pmid_title_4": "Imerslund-Grasbeck syndrome in a 25-month-old Italian girl caused by a homozygous mutation in AMN.", "pmid_4": 24044590.0, "pmid_date_4": 2013.0, "pmid_journal_4": "Italian journal of pediatrics"}, {"pmid_title_5": "Efficacy of oral administration of high-dose cobamamide in a patient with Imerslund-Grasbeck syndrome.", "pmid_5": 8837146.0, "pmid_date_5": 1996.0, "pmid_journal_5": "Pediatric hematology and oncology"}]}, {"_id": "1514-OMIM:239200", "condition": {"condition_name": "HYPERPARATHYROIDISM, NEONATAL SEVERE", "pattern_of_inheritance": "Autosomal recessive, Not applicable", "alternate_names": ["HYPERPARATHYROIDISM, NEONATAL SEVERE", "HYPOCALCEMIA, AUTOSOMAL DOMINANT 1"]}, "gene information": {"db_hgnc_gene_id": 1514.0}, "interventions": [{"int_description_1": "Calcium"}, {"int_description_2": "Alfacalcidol"}, {"int_description_3": "Cholecalciferol"}, {"int_description_4": "Vitamin D"}, {"int_description_5": "Calcitriol"}, {"int_description_6": "Human calcitonin", "timeframe_int6": "Hours", "age_use_int6": "Neonate,Infant", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Furosemide"}, {"int_description_8": "Pamidronic acid", "timeframe_int8": "Hours", "age_use_int8": "Neonate,Infant", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Bisphosphonates", "timeframe_int9": "Hours", "age_use_int9": "Neonate,Infant", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Calcium carbonate"}, {"int_description_11": "Cinacalcet"}, {"int_description_12": "Subtotal parathyroidectomy"}, {"int_description_13": "Total parathyroidectomy + Vitamin D Supplementation", "timeframe_int13": "Hours,Days or Weeks", "age_use_int13": "Neonate,Infant", "contra_int13": "No", "qualscale_reclass_drug13": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Total parathyroidectomy + Vitamin D Supplementation (cholecalciferol and calcium carbonate)"}], "references": [{"pmid_title_1": "Familial Hypocalciuric Hypercalcemia and Neonatal Severe Hyperparathyroidism.", "pmid_1": 30641521.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Frontiers of hormone research"}, {"pmid_title_2": "Novel homozygous inactivating mutation of the calcium-sensing receptor gene in neonatal severe hyperparathyroidism responding to cinacalcet therapy: A case report and literature review.", "pmid_2": 30407334.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Medicine"}, {"pmid_title_3": "Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation.", "pmid_3": 30376845.0, "pmid_date_3": 2018.0, "pmid_journal_3": "BMC pediatrics"}, {"pmid_title_4": "Neonatal severe hyperparathyroidism secondary to a novel homozygous <i>CASR</i> gene mutation.", "pmid_4": 29354167.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases"}, {"pmid_title_5": "Successful treatment of neonatal severe hyperparathyroidism with cinacalcet in two patients.", "pmid_5": 26161261.0, "pmid_date_5": 2015.0, "pmid_journal_5": "Endocrinology, diabetes & metabolism case reports"}]}, {"_id": "1514-OMIM:601198", "condition": {"condition_name": "HYPOCALCEMIA, AUTOSOMAL DOMINANT 1", "freq_per_birth": "The prevalence of autosomal dominant hypocalcemia is unknown. The condition is likely underdiagnosed because it often causes no signs or symptoms.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["HYPOCALCEMIA, AUTOSOMAL DOMINANT 1", "HYPERPARATHYROIDISM, NEONATAL SEVERE"]}, "gene information": {"db_hgnc_gene_id": 1514.0}, "interventions": [{"int_description_1": "Calcium", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Ergocalciferol", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Dihydrotachysterol"}, {"int_description_4": "Alfacalcidol"}, {"int_description_5": "Nadolol", "age_use_int5": "Neonate,Infant", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Teriparatide", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Cholecalciferol"}, {"int_description_8": "Vitamin D", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Calcitriol", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Magnesium", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Indomethacin", "age_use_int11": "Neonate,Infant,Child", "contra_int11": "No", "qualscale_reclass_drug11": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "Hydrochlorothiazide", "age_use_int12": "Neonate,Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Trichlormethiazide", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Calcium carbonate"}, {"int_description_15": "Calcium gluconate"}, {"int_description_16": "Potassium"}], "references": [{"pmid_title_1": "Diagnosis and treatment of hypoparathyroidism: a position statement from the Brazilian Society of Endocrinology and Metabolism.", "pmid_1": 29694629.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Archives of endocrinology and metabolism"}, {"pmid_title_2": "Clinical characterization of a novel calcium sensing receptor genetic alteration in a Greek patient with autosomal dominant hypocalcemia type 1.", "pmid_2": 28742508.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Hormones (Athens, Greece)"}, {"pmid_title_3": "Autosomal dominant hypocalcemia due to a truncation in the C-tail of the calcium-sensing receptor.", "pmid_3": 27561204.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Molecular and cellular endocrinology"}, {"pmid_title_4": "Autosomal Dominant Hypocalcemia (Hypoparathyroidism) Types 1 and 2.", "pmid_4": 27803672.0, "pmid_date_4": 2016.0, "pmid_journal_4": "Frontiers in physiology"}, {"pmid_title_5": "Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway.", "pmid_5": 27186861.0, "pmid_date_5": 2016.0, "pmid_journal_5": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_6": "Novel calcium-sensing receptor cytoplasmic tail deletion mutation causing autosomal dominant hypocalcemia: molecular and clinical study.", "pmid_6": 26764418.0, "pmid_date_6": 2016.0, "pmid_journal_6": "European journal of endocrinology"}, {"pmid_title_7": "Hypocalcemia: Diagnosis and Treatment", "pmid_7": 25905251.0, "pmid_date_7": 2015.0, "pmid_journal_7": "Endotext"}, {"pmid_title_8": "Autosomal dominant hypocalcemia with Bartter syndrome due to a novel activating mutation of calcium sensing receptor, Y829C.", "pmid_8": 25932037.0, "pmid_date_8": 2015.0, "pmid_journal_8": "Korean journal of pediatrics"}, {"pmid_title_9": "Activating calcium-sensing receptor gene variants in children: a case study of infant hypocalcaemia and literature review.", "pmid_9": 25039540.0, "pmid_date_9": 2014.0, "pmid_journal_9": "Acta paediatrica (Oslo, Norway : 1992)"}, {"pmid_title_10": "A hypocalcemic child with a novel activating mutation of the calcium-sensing receptor gene: successful treatment with recombinant human parathyroid hormone.", "pmid_10": 16608894.0, "pmid_date_10": 2006.0, "pmid_journal_10": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_11": "Effect of parathyroid hormone administration in a patient with severe hypoparathyroidism caused by gain-of-function mutation of calcium-sensing receptor.", "pmid_11": 16983178.0, "pmid_date_11": 2006.0, "pmid_journal_11": "Endocrine journal"}, {"pmid_title_12": "Autosomal dominant hypocalcemia in monozygotic twins caused by a de novo germline mutation near the amino-terminus of the human calcium receptor.", "pmid_12": 15005845.0, "pmid_date_12": 2004.0, "pmid_journal_12": "Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research"}, {"pmid_title_13": "Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene.", "pmid_13": 12107202.0, "pmid_date_13": 2002.0, "pmid_journal_13": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_14": "Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome.", "pmid_14": 12191970.0, "pmid_date_14": 2002.0, "pmid_journal_14": "Journal of the American Society of Nephrology : JASN"}, {"pmid_title_15": "Association between activating mutations of calcium-sensing receptor and Bartter's syndrome.", "pmid_15": 12241879.0, "pmid_date_15": 2002.0, "pmid_journal_15": "Lancet (London, England)"}]}, {"_id": "1550-OMIM:236200", "condition": {"condition_name": "HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 1550.0}, "interventions": [{"int_description_1": "Protein- and methionine-restricted diets"}, {"int_description_2": "Taurine"}, {"int_description_3": "Cyanocobalamin", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Pyridoxine", "timeframe_int4": "Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Leucovorin", "timeframe_int5": "Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Glycine betaine", "timeframe_int6": "Hours", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Folic acid", "timeframe_int7": "Days or Weeks", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "Yes", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Biomarkers of oxidative stress, inflammation, and vascular dysfunction in inherited cystathionine \u03b2-synthase deficient homocystinuria and the impact of taurine treatment in a phase 1/2 human clinical trial.", "pmid_1": 30873612.0, "pmid_date_1": 2019.0, "pmid_journal_1": "J Inherit Metab Dis"}, {"pmid_title_2": "A case of homocystinuria due to CBS gene mutations revealed by cerebral venous thrombosis.", "pmid_2": 24169224.0, "pmid_date_2": 2014.0, "pmid_journal_2": "J Neurol Sci"}, {"pmid_title_3": "Clinical and molecular findings of 13 families from Saudi Arabia and a family from Sudan with homocystinuria.", "pmid_3": 21517828.0, "pmid_date_3": 2012.0, "pmid_journal_3": "Clin Genet"}]}, {"_id": "16187-OMIM:211500", "condition": {"condition_name": "FAZIO-LONDE DISEASE", "alternate_names": ["FAZIO-LONDE DISEASE", "BROWN-VIALETTO-VAN LAERE SYNDROME 1"]}, "gene information": {"db_hgnc_gene_id": 16187.0}, "interventions": [{"int_description_1": "Riboflavin", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Fazio-Londe syndrome in siblings from India with different phenotypes.", "pmid_1": 29501408.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Brain Dev"}, {"pmid_title_2": "Fazio Londe syndrome: A treatable disorder.", "pmid_2": 25745320.0, "pmid_date_2": 2015.0, "pmid_journal_2": "Ann Indian Acad Neurol"}, {"pmid_title_3": "Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment.", "pmid_3": 21110228.0, "pmid_date_3": 2011.0, "pmid_journal_3": "J Inherit Metab Dis"}]}, {"_id": "16187-OMIM:211530", "condition": {"condition_name": "BROWN-VIALETTO-VAN LAERE SYNDROME 1", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["BROWN-VIALETTO-VAN LAERE SYNDROME 1", "FAZIO-LONDE DISEASE"]}, "gene information": {"db_hgnc_gene_id": 16187.0}, "interventions": [{"int_description_1": "Riboflavin", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Riboflavin Treatment in Genetically Proven Brown-Vialetto-Van Laere Syndrome.", "pmid_1": 30937093.0, "pmid_date_1": 2018.0, "pmid_journal_1": "J Pediatr Neurosci"}, {"pmid_title_2": "A Case of Brown-Vialetto-Van Laere Syndrome Due To a Novel Mutation in <i>SLC52A3</i> Gene: Clinical Course and Response to Riboflavin.", "pmid_2": 28856173.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Child Neurol Open"}, {"pmid_title_3": "Brown-Vialetto-van Laere and Fazio-Londe overlap syndromes: a clinical, biochemical and genetic study.", "pmid_3": 22824638.0, "pmid_date_3": 2012.0, "pmid_journal_3": "Neuromuscul Disord"}, {"pmid_title_4": "Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment.", "pmid_4": 21110228.0, "pmid_date_4": 2011.0, "pmid_journal_4": "J Inherit Metab Dis"}]}, {"_id": "16266-OMIM:607483", "condition": {"condition_name": "THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2", "freq_per_birth": "Biotin-thiamine-responsive basal ganglia disease is a rare disorder; its prevalence is unknown. Approximately 48 cases have been reported in the medical literature; most of these are individuals from Arab populations.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2"]}, "gene information": {"db_hgnc_gene_id": 16266.0}, "interventions": [{"int_description_1": "Levodopa"}, {"int_description_2": "Clonazepam"}, {"int_description_3": "Baclofen"}, {"int_description_4": "Trihexyphenidyl"}, {"int_description_5": "Valproic acid"}, {"int_description_6": "Phenytoin"}, {"int_description_7": "Antiepileptic drugs", "timeframe_int7": "Hours,Days or Weeks", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Biotin"}, {"int_description_9": "Thiamine", "timeframe_int9": "Hours,Days or Weeks", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Speech therapy"}], "references": [{"pmid_title_1": "Biotin-Thiamine-Responsive Basal Ganglia Disease", "pmid_1": 24260777.0, "pmid_date_1": 2020.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Genetic defects of thiamine transport and metabolism: A review of clinical phenotypes, genetics, and functional studies.", "pmid_2": 31095747.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Journal of inherited metabolic disease"}, {"pmid_title_3": "SLC19A3 Gene Defects Sorting the Phenotype and Acronyms: Review.", "pmid_3": 28962040.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Neuropediatrics"}, {"pmid_title_4": "Biotin Thiamin Responsive Basal Ganglia Disease in Siblings.", "pmid_4": 29101630.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Indian journal of pediatrics"}, {"pmid_title_5": "Are diagnostic magnetic resonance patterns life-saving in children with biotin-thiamine-responsive basal ganglia disease?", "pmid_5": 30054086.0, "pmid_date_5": 2018.0, "pmid_journal_5": "European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society"}, {"pmid_title_6": "Biotin-thiamine responsive basal ganglia disease: Identification of a pyruvate peak on brain spectroscopy, novel mutation in SLC19A3, and calculation of prevalence based on allele frequencies from aggregated next-generation sequencing data.", "pmid_6": 28402605.0, "pmid_date_6": 2017.0, "pmid_journal_6": "American journal of medical genetics. Part A"}, {"pmid_title_7": "Biotin-thiamine-responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment.", "pmid_7": 27905264.0, "pmid_date_7": 2017.0, "pmid_journal_7": "Neurological research"}, {"pmid_title_8": "Free-thiamine is a potential biomarker of thiamine transporter-2 deficiency: a treatable cause of Leigh syndrome.", "pmid_8": 26657515.0, "pmid_date_8": 2016.0, "pmid_journal_8": "Brain : a journal of neurology"}, {"pmid_title_9": "Novel SLC19A3 Promoter Deletion and Allelic Silencing in Biotin-Thiamine-Responsive Basal Ganglia Encephalopathy.", "pmid_9": 26863430.0, "pmid_date_9": 2016.0, "pmid_journal_9": "PloS one"}, {"pmid_title_10": "Teaching NeuroImages: MRI findings of biotin-responsive basal ganglia disease before and after treatment.", "pmid_10": 26880816.0, "pmid_date_10": 2016.0, "pmid_journal_10": "Neurology"}, {"pmid_title_11": "Teaching NeuroImages: Biotin-responsive basal ganglia disease.", "pmid_11": 27164647.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Neurology"}, {"pmid_title_12": "A case report of biotin-thiamine-responsive basal ganglia disease in a Saudi child: Is extended genetic family study recommended?", "pmid_12": 27749535.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Medicine"}, {"pmid_title_13": "Biotin-responsive basal ganglia disease: a case diagnosed by whole exome sequencing.", "pmid_13": 25876998.0, "pmid_date_13": 2015.0, "pmid_journal_13": "Journal of human genetics"}, {"pmid_title_14": "Treatment of biotin-responsive basal ganglia disease: Open comparative study between the combination of biotin plus thiamine versus thiamine alone.", "pmid_14": 26095097.0, "pmid_date_14": 2015.0, "pmid_journal_14": "European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society"}, {"pmid_title_15": "Defects of thiamine transport and metabolism.", "pmid_15": 24789339.0, "pmid_date_15": 2014.0, "pmid_journal_15": "Journal of inherited metabolic disease"}, {"pmid_title_16": "Biotin-responsive Basal Ganglia disease: a treatable differential diagnosis of leigh syndrome.", "pmid_16": 24166474.0, "pmid_date_16": 2014.0, "pmid_journal_16": "JIMD reports"}, {"pmid_title_17": "Stress-induced upregulation of SLC19A3 is impaired in biotin-thiamine-responsive basal ganglia disease.", "pmid_17": 24372704.0, "pmid_date_17": 2014.0, "pmid_journal_17": "Brain pathology (Zurich, Switzerland)"}, {"pmid_title_18": "Biotin-responsive basal ganglia disease: neuroimaging features before and after treatment.", "pmid_18": 24812013.0, "pmid_date_18": 2014.0, "pmid_journal_18": "AJNR. American journal of neuroradiology"}, {"pmid_title_19": "Reply: Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.", "pmid_19": 24878500.0, "pmid_date_19": 2014.0, "pmid_journal_19": "Brain : a journal of neurology"}, {"pmid_title_20": "Reply: Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.", "pmid_20": 24878501.0, "pmid_date_20": 2014.0, "pmid_journal_20": "Brain : a journal of neurology"}, {"pmid_title_21": "Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.", "pmid_21": 24878502.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Brain : a journal of neurology"}, {"pmid_title_22": "Thiamine transporter-2 deficiency: outcome and treatment monitoring.", "pmid_22": 24957181.0, "pmid_date_22": 2014.0, "pmid_journal_22": "Orphanet journal of rare diseases"}, {"pmid_title_23": "Whole exome sequencing reveals compound heterozygous mutations in <i>SLC19A3</i> causing biotin-thiamine responsive basal ganglia disease.", "pmid_23": 27896110.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Molecular genetics and metabolism reports"}, {"pmid_title_24": "Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases.", "pmid_24": 23742248.0, "pmid_date_24": 2013.0, "pmid_journal_24": "Orphanet journal of rare diseases"}, {"pmid_title_25": "Biotin-responsive basal ganglia disease revisited: clinical, radiologic, and genetic findings.", "pmid_25": 23269594.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Neurology"}, {"pmid_title_26": "Bilateral external ophthalmoplegia in biotin-responsive basal ganglia disease.", "pmid_26": 23360564.0, "pmid_date_26": 2013.0, "pmid_journal_26": "The Journal of pediatrics"}, {"pmid_title_27": "Exome sequencing reveals mutated SLC19A3 in patients with an early-infantile, lethal encephalopathy.", "pmid_27": 23482991.0, "pmid_date_27": 2013.0, "pmid_journal_27": "Brain : a journal of neurology"}, {"pmid_title_28": "Reversible lactic acidosis in a newborn with thiamine transporter-2 deficiency.", "pmid_28": 23589815.0, "pmid_date_28": 2013.0, "pmid_journal_28": "Pediatrics"}, {"pmid_title_29": "Exome sequencing reveals a novel Moroccan founder mutation in SLC19A3 as a new cause of early-childhood fatal Leigh syndrome.", "pmid_29": 23423671.0, "pmid_date_29": 2013.0, "pmid_journal_29": "Brain : a journal of neurology"}, {"pmid_title_30": "Reversible generalized dystonia and encephalopathy from thiamine transporter 2 deficiency.", "pmid_30": 22777947.0, "pmid_date_30": 2012.0, "pmid_journal_30": "Movement disorders : official journal of the Movement Disorder Society"}, {"pmid_title_31": "Biotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutations.", "pmid_31": 20065143.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Archives of neurology"}, {"pmid_title_32": "A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations.", "pmid_32": 21176162.0, "pmid_date_32": 2010.0, "pmid_journal_32": "BMC medical genetics"}, {"pmid_title_33": "Biotin-responsive basal ganglia disease: a treatable and reversible neurological disorder of childhood.", "pmid_33": 19491117.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Journal of child neurology"}, {"pmid_title_34": "Biotin-responsive basal ganglia disease: case report and review of the literature.", "pmid_34": 19294600.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Neuropediatrics"}, {"pmid_title_35": "Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3.", "pmid_35": 15871139.0, "pmid_date_35": 2005.0, "pmid_journal_35": "American journal of human genetics"}]}, {"_id": "1673-OMIM:615617", "condition": {"condition_name": "IMMUNODEFICIENCY 19", "alternate_names": ["IMMUNODEFICIENCY 19"]}, "gene information": {"db_hgnc_gene_id": 1673.0}, "interventions": [{"int_description_1": "Mechanical ventilation"}, {"int_description_2": "Nasal continuous positive airway pressure treatment"}, {"int_description_3": "Transfer factor"}, {"int_description_4": "Testosterone"}, {"int_description_5": "Salmeterol"}, {"int_description_6": "Ursodeoxycholic acid"}, {"int_description_7": "Sargramostim"}, {"int_description_8": "Dopamine"}, {"int_description_9": "Prednisolone"}, {"int_description_10": "Prednisone", "timeframe_int10": "Days or Weeks", "age_use_int10": "Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Fluticasone"}, {"int_description_12": "Ketoconazole"}, {"int_description_13": "Ganciclovir"}, {"int_description_14": "Human immunoglobulin G"}, {"int_description_15": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_16": "Midazolam"}, {"int_description_17": "Rituximab"}, {"int_description_18": "Alemtuzumab"}, {"int_description_19": "Clarithromycin"}, {"int_description_20": "Cyclosporine"}, {"int_description_21": "Clofazimine"}, {"int_description_22": "Isoniazid"}, {"int_description_23": "Amphotericin B"}, {"int_description_24": "Budesonide"}, {"int_description_25": "Somatotropin"}, {"int_description_26": "Piperacillin"}, {"int_description_27": "Vitamin D"}, {"int_description_28": "Levetiracetam"}, {"int_description_29": "Cyclophosphamide"}, {"int_description_30": "Busulfan"}, {"int_description_31": "Melphalan", "timeframe_int31": "Days or Weeks", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Thiotepa"}, {"int_description_33": "Caspofungin"}, {"int_description_34": "Amikacin"}, {"int_description_35": "Pyrazinamide"}, {"int_description_36": "Linezolid"}, {"int_description_37": "Pyridoxine"}, {"int_description_38": "Ethambutol"}, {"int_description_39": "Azithromycin"}, {"int_description_40": "Trimethoprim"}, {"int_description_41": "Sulfamethoxazole"}, {"int_description_42": "Ciprofloxacin"}, {"int_description_43": "Ofloxacin"}, {"int_description_44": "Fusidic acid"}, {"int_description_45": "Ampicillin"}, {"int_description_46": "Cefotaxime"}, {"int_description_47": "Meropenem"}, {"int_description_48": "Amoxicillin"}, {"int_description_49": "Cefuroxime"}, {"int_description_50": "Ceftriaxone"}, {"int_description_51": "Cefazolin"}, {"int_description_52": "Cefoperazone"}, {"int_description_53": "Latamoxef"}, {"int_description_54": "Sulbactam"}, {"int_description_55": "Clavulanic acid"}, {"int_description_56": "Treosulfan"}, {"int_description_57": "Atovaquone"}, {"int_description_58": "Rifampicin"}, {"int_description_59": "Fluconazole"}, {"int_description_60": "Itraconazole"}, {"int_description_61": "Pyrimethamine"}, {"int_description_62": "Methotrexate"}, {"int_description_63": "Sulfadoxine"}, {"int_description_64": "Levofloxacin"}, {"int_description_65": "Fludarabine"}, {"int_description_66": "Pentamidine"}, {"int_description_67": "Vancomycin"}, {"int_description_68": "Tacrolimus"}, {"int_description_69": "Valproic acid"}, {"int_description_70": "Foscarnet"}, {"int_description_71": "Acyclovir"}, {"int_description_72": "Cidofovir"}, {"int_description_73": "Mycophenolate mofetil"}, {"int_description_74": "Ledipasvir"}, {"int_description_75": "Oxacillin"}, {"int_description_76": "Omeprazole"}, {"int_description_77": "Methylprednisolone"}, {"int_description_78": "Methimazole"}, {"int_description_79": "Infliximab"}, {"int_description_80": "Interferon alfa-2a, Recombinant"}, {"int_description_81": "Anti Thymocyte Globulin"}, {"int_description_82": "Anti-CD45 antibodies"}, {"int_description_83": "CMV hyperImmunoglobulin"}, {"int_description_84": "Nystatin"}, {"int_description_85": "Teicoplanin"}, {"int_description_86": "Sofosbuvir"}, {"int_description_87": "Antilymphocyte immunoglobulin (horse)", "timeframe_int87": "Days or Weeks", "age_use_int87": "Infant,Child", "contra_int87": "No", "qualscale_reclass_drug87": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug87": "Curative"}, {"int_description_88": "Human interleukin-2"}, {"int_description_89": "Thymic hormone"}, {"int_description_90": "Thyroid hormone"}, {"int_description_91": "Thyroxin"}, {"int_description_92": "Phenobarbital"}, {"int_description_93": "Filgrastim"}, {"int_description_94": "2'-Deoxycytidine"}, {"int_description_95": "Irradiated blood transfusions"}, {"int_description_96": "Parenteral nutrition"}, {"int_description_97": "Platelet transfusions"}, {"int_description_98": "Total body irradiation"}, {"int_description_99": "Hematopoietic stem cell transplantation"}], "references": [{"pmid_title_1": "Severe Combined Immunodeficiency", "pmid_1": 30969584.0, "pmid_date_1": 2021.0, "pmid_journal_1": "statpearls"}, {"pmid_title_2": "Reticular dysgenesis caused by an intronic pathogenic variant in <i>AK2</i>.", "pmid_2": 32532877.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Cold Spring Harb Mol Case Stud"}, {"pmid_title_3": "Biallelic Form of a Known CD3E Mutation in a Patient with Severe Combined Immunodeficiency.", "pmid_3": 32016651.0, "pmid_date_3": 2020.0, "pmid_journal_3": "J Clin Immunol"}, {"pmid_title_4": "Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.", "pmid_4": 30194989.0, "pmid_date_4": 2019.0, "pmid_journal_4": "J Allergy Clin Immunol"}, {"pmid_title_5": "Disseminated Bacille Calmette-Gu\u00e9rin infection in a patient with severe combined immunodeficiency caused by JAK3 gene mutation.", "pmid_5": 31309596.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Pediatr Dermatol"}, {"pmid_title_6": "Prevention of transfusion-transmitted cytomegalovirus infection using leukoreduced blood components in patients receiving seronegative umbilical cord blood transplantation.", "pmid_6": 31322734.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Transfusion"}, {"pmid_title_7": "Human interleukin-2 receptor \u03b2 mutations associated with defects in immunity and peripheral tolerance.", "pmid_7": 31040185.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Exp Med"}, {"pmid_title_8": "Combined Immunodeficiency With Late-Onset Progressive Hypogammaglobulinemia and Normal B Cell Count in a Patient With RAG2 Deficiency.", "pmid_8": 31058115.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Front Pediatr"}, {"pmid_title_9": "Hematopoietic stem cell transplantation for cytidine triphosphate synthase 1 (CTPS1) deficiency.", "pmid_9": 29884857.0, "pmid_date_9": 2019.0, "pmid_journal_9": "Bone Marrow Transplant"}, {"pmid_title_10": "Severe combined immunodeficiency (SCID) presenting in childhood, with agammaglobulinemia, associated with novel compound heterozygous mutations in DCLRE1C.", "pmid_10": 30630113.0, "pmid_date_10": 2019.0, "pmid_journal_10": "Clin Immunol"}, {"pmid_title_11": "Recent advances in understanding the pathogenesis and management of reticular dysgenesis.", "pmid_11": 29270983.0, "pmid_date_11": 2018.0, "pmid_journal_11": "Br J Haematol"}, {"pmid_title_12": "Two siblings with PRKDC defect who presented with cutaneous granulomas and review of the literature.", "pmid_12": 30121298.0, "pmid_date_12": 2018.0, "pmid_journal_12": "Clin Immunol"}, {"pmid_title_13": "SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.", "pmid_13": 30154114.0, "pmid_date_13": 2018.0, "pmid_journal_13": "Blood"}, {"pmid_title_14": "A Novel Homozygous <i>JAK3</i> Mutation Leading to T-B+NK- SCID in Two Brazilian Patients.", "pmid_14": 30177960.0, "pmid_date_14": 2018.0, "pmid_journal_14": "Front Pediatr"}, {"pmid_title_15": "Co-appearance of OPV and BCG vaccine-derived complications in two infants with severe combined immunodeficiency.", "pmid_15": 29804197.0, "pmid_date_15": 2018.0, "pmid_journal_15": "Immunol Res"}, {"pmid_title_16": "Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis.", "pmid_16": 30014500.0, "pmid_date_16": 2018.0, "pmid_journal_16": "Hepatology"}, {"pmid_title_17": "JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long-known gene.", "pmid_17": 30032486.0, "pmid_date_17": 2018.0, "pmid_journal_17": "Mol Genet Genomic Med"}, {"pmid_title_18": "Chronic active Epstein-Barr virus infection as the initial symptom in a Janus kinase 3 deficiency child: Case report and literature review.", "pmid_18": 29049190.0, "pmid_date_18": 2017.0, "pmid_journal_18": "Medicine (Baltimore)"}, {"pmid_title_19": "Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome.", "pmid_19": 28331055.0, "pmid_date_19": 2017.0, "pmid_journal_19": "Blood"}, {"pmid_title_20": "A novel deletion mutation in IL2RG gene results in X-linked severe combined immunodeficiency with an atypical phenotype.", "pmid_20": 27566612.0, "pmid_date_20": 2017.0, "pmid_journal_20": "Immunogenetics"}, {"pmid_title_21": "Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency.", "pmid_21": 28346229.0, "pmid_date_21": 2017.0, "pmid_journal_21": "J Clin Invest"}, {"pmid_title_22": "Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report.", "pmid_22": 28209722.0, "pmid_date_22": 2017.0, "pmid_journal_22": "Blood"}, {"pmid_title_23": "A 24-Year Enzyme Replacement Therapy in an Adenosine-deaminase-Deficient Patient.", "pmid_23": 26684479.0, "pmid_date_23": 2016.0, "pmid_journal_23": "Pediatrics"}, {"pmid_title_24": "Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.", "pmid_24": 27129325.0, "pmid_date_24": 2016.0, "pmid_journal_24": "Blood"}, {"pmid_title_25": "Insufficient immune reconstitution after allogeneic cord blood transplantation without chemotherapy conditioning in patients with SCID caused by CD3\u03b4 deficiency.", "pmid_25": 26999462.0, "pmid_date_25": 2016.0, "pmid_journal_25": "Bone Marrow Transplant"}, {"pmid_title_26": "Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency.", "pmid_26": 27099176.0, "pmid_date_26": 2016.0, "pmid_journal_26": "Sci Transl Med"}, {"pmid_title_27": "Case Report: Whole exome sequencing identifies variation c.2308G>A p.E770K in <i>RAG1</i> associated with B- T- NK+ severe combined immunodeficiency.", "pmid_27": 29067161.0, "pmid_date_27": 2016.0, "pmid_journal_27": "F1000Res"}, {"pmid_title_28": "CTP Synthase 1 Deficiency in Successfully Transplanted Siblings with Combined Immune Deficiency and Chronic Active EBV Infection.", "pmid_28": 27638562.0, "pmid_date_28": 2016.0, "pmid_journal_28": "J Clin Immunol"}, {"pmid_title_29": "Mutation c.256_257delAA in RAG1 Gene in Polish Children with Severe Combined Immunodeficiency: Diversity of Clinical Manifestations.", "pmid_29": 28083621.0, "pmid_date_29": 2016.0, "pmid_journal_29": "Arch Immunol Ther Exp (Warsz)"}, {"pmid_title_30": "Persistent rotavirus diarrhea post-transplant in a novel JAK3-SCID patient after vaccination.", "pmid_30": 26248889.0, "pmid_date_30": 2016.0, "pmid_journal_30": "Pediatr Allergy Immunol"}, {"pmid_title_31": "Novel compound heterozygous mutations in a Japanese girl with Janus kinase 3 deficiency.", "pmid_31": 27593409.0, "pmid_date_31": 2016.0, "pmid_journal_31": "Pediatr Int"}, {"pmid_title_32": "Mutations in Recombination Activating Gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt.", "pmid_32": 25869295.0, "pmid_date_32": 2015.0, "pmid_journal_32": "Clin Immunol"}, {"pmid_title_33": "A 15-year-old boy with severe combined immunodeficiency, fungal infection, and weight gain.", "pmid_33": 26314823.0, "pmid_date_33": 2015.0, "pmid_journal_33": "Allergy Asthma Proc"}, {"pmid_title_34": "A novel common gamma chain mutation in a Chinese family with X-linked severe combined immunodeficiency (X-SCID; T(-)NK(-)B(+)).", "pmid_34": 26409833.0, "pmid_date_34": 2015.0, "pmid_journal_34": "Immunogenetics"}, {"pmid_title_35": "PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity.", "pmid_35": 25842288.0, "pmid_date_35": 2015.0, "pmid_journal_35": "J Allergy Clin Immunol"}, {"pmid_title_36": "Transplantation outcomes for severe combined immunodeficiency, 2000-2009.", "pmid_36": 25075835.0, "pmid_date_36": 2014.0, "pmid_journal_36": "N Engl J Med"}, {"pmid_title_37": "Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.", "pmid_37": 25109802.0, "pmid_date_37": 2014.0, "pmid_journal_37": "J Allergy Clin Immunol"}, {"pmid_title_38": "SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.", "pmid_38": 24144642.0, "pmid_date_38": 2014.0, "pmid_journal_38": "Blood"}, {"pmid_title_39": "Severe combined immunodeficiency caused by a new homozygous RAG1 mutation with progressive encephalopathy.", "pmid_39": 24333136.0, "pmid_date_39": 2014.0, "pmid_journal_39": "Hematol Oncol Stem Cell Ther"}, {"pmid_title_40": "The many faces of Artemis-deficient combined immunodeficiency - Two patients with DCLRE1C mutations and a systematic literature review of genotype-phenotype correlation.", "pmid_40": 24230999.0, "pmid_date_40": 2013.0, "pmid_journal_40": "Clin Immunol"}, {"pmid_title_41": "Successful bone marrow transplantation with reduced intensity conditioning in a patient with delayed-onset adenosine deaminase deficiency.", "pmid_41": 22805442.0, "pmid_date_41": 2013.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Hemophagocytic bone marrow aplasia with plasma cells in a RAG2-deficient SCID case after a nonconditioned transplantation from a fully matched sibling.", "pmid_42": 23389499.0, "pmid_date_42": 2013.0, "pmid_journal_42": "J Pediatr Hematol Oncol"}, {"pmid_title_43": "Skeletal abnormalities and successful hematopoietic stem cell transplantation in patients with reticular dysgenesis.", "pmid_43": 23763981.0, "pmid_date_43": 2013.0, "pmid_journal_43": "J Allergy Clin Immunol"}, {"pmid_title_44": "Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency.", "pmid_44": 22409989.0, "pmid_date_44": 2012.0, "pmid_journal_44": "J Allergy Clin Immunol"}, {"pmid_title_45": "Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.", "pmid_45": 22791287.0, "pmid_date_45": 2012.0, "pmid_journal_45": "Blood"}, {"pmid_title_46": "Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.", "pmid_46": 22968453.0, "pmid_date_46": 2012.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "IL-21 is the primary common \u03b3 chain-binding cytokine required for human B-cell differentiation in vivo.", "pmid_47": 22039266.0, "pmid_date_47": 2011.0, "pmid_journal_47": "Blood"}, {"pmid_title_48": "Hematopoietic stem cell transplantation for CD3\u03b4 deficiency.", "pmid_48": 21757226.0, "pmid_date_48": 2011.0, "pmid_journal_48": "J Allergy Clin Immunol"}, {"pmid_title_49": "Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency.", "pmid_49": 21725047.0, "pmid_date_49": 2011.0, "pmid_journal_49": "Blood"}, {"pmid_title_50": "A leaky mutation in CD3D differentially affects \u03b1\u03b2 and \u03b3\u03b4 T cells and leads to a T\u03b1\u03b2-T\u03b3\u03b4+B+NK+ human SCID.", "pmid_50": 21926461.0, "pmid_date_50": 2011.0, "pmid_journal_50": "J Clin Invest"}, {"pmid_title_51": "Occurrence of myelodysplastic syndrome in 2 patients with reticular dysgenesis.", "pmid_51": 21458044.0, "pmid_date_51": 2011.0, "pmid_journal_51": "J Allergy Clin Immunol"}, {"pmid_title_52": "Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency.", "pmid_52": 20113887.0, "pmid_date_52": 2010.0, "pmid_journal_52": "Immunol Allergy Clin North Am"}, {"pmid_title_53": "Hemophagocytosis after bone marrow transplantation for JAK3-deficient severe combined immunodeficiency.", "pmid_53": 19659508.0, "pmid_date_53": 2010.0, "pmid_journal_53": "Pediatr Transplant"}, {"pmid_title_54": "A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining.", "pmid_54": 19075392.0, "pmid_date_54": 2009.0, "pmid_journal_54": "J Clin Invest"}, {"pmid_title_55": "Novel RAG2 mutation in a patient with T- B- severe combined immunodeficiency and disseminated BCG disease.", "pmid_55": 20128425.0, "pmid_date_55": 2009.0, "pmid_journal_55": "J Investig Allergol Clin Immunol"}, {"pmid_title_56": "A novel missense RAG-1 mutation results in T-B-NK+ SCID in Athabascan-speaking Dine Indians from the Canadian Northwest Territories.", "pmid_56": 18701881.0, "pmid_date_56": 2009.0, "pmid_journal_56": "Eur J Hum Genet"}, {"pmid_title_57": "Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID.", "pmid_57": 19458910.0, "pmid_date_57": 2009.0, "pmid_journal_57": "Clin Exp Med"}, {"pmid_title_58": "Gene therapy for immunodeficiency due to adenosine deaminase deficiency.", "pmid_58": 19179314.0, "pmid_date_58": 2009.0, "pmid_journal_58": "N Engl J Med"}, {"pmid_title_59": "Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency.", "pmid_59": 17825895.0, "pmid_date_59": 2007.0, "pmid_journal_59": "J Allergy Clin Immunol"}, {"pmid_title_60": "Novel RAG1 mutation in a case of severe combined immunodeficiency.", "pmid_60": 16061569.0, "pmid_date_60": 2005.0, "pmid_journal_60": "Pediatrics"}, {"pmid_title_61": "Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.", "pmid_61": 14615376.0, "pmid_date_61": 2004.0, "pmid_journal_61": "Blood"}, {"pmid_title_62": "Novel Artemis gene mutations of radiosensitive severe combined immunodeficiency in Japanese families.", "pmid_62": 12592555.0, "pmid_date_62": 2003.0, "pmid_journal_62": "Hum Genet"}, {"pmid_title_63": "Bone marrow transplantation for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans.", "pmid_63": 11360109.0, "pmid_date_63": 2001.0, "pmid_journal_63": "Bone Marrow Transplant"}, {"pmid_title_64": "Successful bone-marrow transplantation for reticular dysgenesis.", "pmid_64": 6132037.0, "pmid_date_64": 1983.0, "pmid_journal_64": "Lancet"}, {"pmid_title_65": "Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.", "pmid_65": 6983936.0, "pmid_date_65": 1982.0, "pmid_journal_65": "Clin Exp Immunol"}]}, {"_id": "1674-OMIM:615615", "condition": {"condition_name": "IMMUNODEFICIENCY 18", "alternate_names": ["IMMUNODEFICIENCY 18"]}, "gene information": {"db_hgnc_gene_id": 1674.0}, "interventions": [{"int_description_1": "Mechanical ventilation"}, {"int_description_2": "Nasal continuous positive airway pressure treatment"}, {"int_description_3": "Transfer factor"}, {"int_description_4": "Testosterone"}, {"int_description_5": "Salmeterol"}, {"int_description_6": "Ursodeoxycholic acid"}, {"int_description_7": "Sargramostim"}, {"int_description_8": "Dopamine"}, {"int_description_9": "Prednisolone"}, {"int_description_10": "Prednisone"}, {"int_description_11": "Fluticasone"}, {"int_description_12": "Ketoconazole"}, {"int_description_13": "Ganciclovir"}, {"int_description_14": "Human immunoglobulin G"}, {"int_description_15": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_16": "Midazolam"}, {"int_description_17": "Rituximab"}, {"int_description_18": "Alemtuzumab"}, {"int_description_19": "Clarithromycin"}, {"int_description_20": "Cyclosporine"}, {"int_description_21": "Clofazimine"}, {"int_description_22": "Isoniazid"}, {"int_description_23": "Amphotericin B"}, {"int_description_24": "Budesonide"}, {"int_description_25": "Somatotropin"}, {"int_description_26": "Piperacillin"}, {"int_description_27": "Vitamin D"}, {"int_description_28": "Levetiracetam"}, {"int_description_29": "Cyclophosphamide"}, {"int_description_30": "Busulfan"}, {"int_description_31": "Melphalan", "timeframe_int31": "Hours,Days or Weeks", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Thiotepa"}, {"int_description_33": "Caspofungin"}, {"int_description_34": "Amikacin"}, {"int_description_35": "Pyrazinamide"}, {"int_description_36": "Linezolid"}, {"int_description_37": "Pyridoxine"}, {"int_description_38": "Ethambutol"}, {"int_description_39": "Azithromycin"}, {"int_description_40": "Trimethoprim"}, {"int_description_41": "Sulfamethoxazole"}, {"int_description_42": "Ciprofloxacin"}, {"int_description_43": "Ofloxacin"}, {"int_description_44": "Fusidic acid"}, {"int_description_45": "Ampicillin"}, {"int_description_46": "Cefotaxime"}, {"int_description_47": "Meropenem"}, {"int_description_48": "Amoxicillin"}, {"int_description_49": "Cefuroxime"}, {"int_description_50": "Ceftriaxone"}, {"int_description_51": "Cefazolin"}, {"int_description_52": "Cefoperazone"}, {"int_description_53": "Latamoxef"}, {"int_description_54": "Sulbactam"}, {"int_description_55": "Clavulanic acid"}, {"int_description_56": "Treosulfan"}, {"int_description_57": "Atovaquone"}, {"int_description_58": "Rifampicin"}, {"int_description_59": "Fluconazole"}, {"int_description_60": "Itraconazole"}, {"int_description_61": "Pyrimethamine"}, {"int_description_62": "Methotrexate"}, {"int_description_63": "Sulfadoxine"}, {"int_description_64": "Levofloxacin"}, {"int_description_65": "Fludarabine"}, {"int_description_66": "Pentamidine"}, {"int_description_67": "Vancomycin"}, {"int_description_68": "Tacrolimus"}, {"int_description_69": "Valproic acid"}, {"int_description_70": "Foscarnet"}, {"int_description_71": "Acyclovir"}, {"int_description_72": "Cidofovir"}, {"int_description_73": "Mycophenolate mofetil"}, {"int_description_74": "Ledipasvir"}, {"int_description_75": "Oxacillin"}, {"int_description_76": "Omeprazole"}, {"int_description_77": "Methylprednisolone"}, {"int_description_78": "Methimazole"}, {"int_description_79": "Infliximab"}, {"int_description_80": "Interferon alfa-2a, Recombinant"}, {"int_description_81": "Anti Thymocyte Globulin"}, {"int_description_82": "Anti-CD45 antibodies"}, {"int_description_83": "CMV hyperImmunoglobulin"}, {"int_description_84": "Nystatin"}, {"int_description_85": "Teicoplanin"}, {"int_description_86": "Sofosbuvir"}, {"int_description_87": "Antilymphocyte immunoglobulin (horse)", "timeframe_int87": "Days or Weeks", "age_use_int87": "Infant,Child", "contra_int87": "No", "qualscale_reclass_drug87": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug87": "Curative"}, {"int_description_88": "Human interleukin-2"}, {"int_description_89": "Thymic hormone"}, {"int_description_90": "Thyroid hormone"}, {"int_description_91": "Thyroxin"}, {"int_description_92": "Phenobarbital"}, {"int_description_93": "Filgrastim"}, {"int_description_94": "2'-Deoxycytidine"}, {"int_description_95": "Irradiated blood transfusions"}, {"int_description_96": "Parenteral nutrition"}, {"int_description_97": "Platelet transfusions"}, {"int_description_98": "Total body irradiation"}, {"int_description_99": "Hematopoietic stem cell transplantation"}], "references": [{"pmid_title_1": "Severe Combined Immunodeficiency", "pmid_1": 30969584.0, "pmid_date_1": 2021.0, "pmid_journal_1": "statpearls"}, {"pmid_title_2": "Reticular dysgenesis caused by an intronic pathogenic variant in <i>AK2</i>.", "pmid_2": 32532877.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Cold Spring Harb Mol Case Stud"}, {"pmid_title_3": "Biallelic Form of a Known CD3E Mutation in a Patient with Severe Combined Immunodeficiency.", "pmid_3": 32016651.0, "pmid_date_3": 2020.0, "pmid_journal_3": "J Clin Immunol"}, {"pmid_title_4": "Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.", "pmid_4": 30194989.0, "pmid_date_4": 2019.0, "pmid_journal_4": "J Allergy Clin Immunol"}, {"pmid_title_5": "Disseminated Bacille Calmette-Gu\u00e9rin infection in a patient with severe combined immunodeficiency caused by JAK3 gene mutation.", "pmid_5": 31309596.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Pediatr Dermatol"}, {"pmid_title_6": "Prevention of transfusion-transmitted cytomegalovirus infection using leukoreduced blood components in patients receiving seronegative umbilical cord blood transplantation.", "pmid_6": 31322734.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Transfusion"}, {"pmid_title_7": "Human interleukin-2 receptor \u03b2 mutations associated with defects in immunity and peripheral tolerance.", "pmid_7": 31040185.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Exp Med"}, {"pmid_title_8": "Combined Immunodeficiency With Late-Onset Progressive Hypogammaglobulinemia and Normal B Cell Count in a Patient With RAG2 Deficiency.", "pmid_8": 31058115.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Front Pediatr"}, {"pmid_title_9": "Hematopoietic stem cell transplantation for cytidine triphosphate synthase 1 (CTPS1) deficiency.", "pmid_9": 29884857.0, "pmid_date_9": 2019.0, "pmid_journal_9": "Bone Marrow Transplant"}, {"pmid_title_10": "Severe combined immunodeficiency (SCID) presenting in childhood, with agammaglobulinemia, associated with novel compound heterozygous mutations in DCLRE1C.", "pmid_10": 30630113.0, "pmid_date_10": 2019.0, "pmid_journal_10": "Clin Immunol"}, {"pmid_title_11": "Recent advances in understanding the pathogenesis and management of reticular dysgenesis.", "pmid_11": 29270983.0, "pmid_date_11": 2018.0, "pmid_journal_11": "Br J Haematol"}, {"pmid_title_12": "Two siblings with PRKDC defect who presented with cutaneous granulomas and review of the literature.", "pmid_12": 30121298.0, "pmid_date_12": 2018.0, "pmid_journal_12": "Clin Immunol"}, {"pmid_title_13": "SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.", "pmid_13": 30154114.0, "pmid_date_13": 2018.0, "pmid_journal_13": "Blood"}, {"pmid_title_14": "A Novel Homozygous <i>JAK3</i> Mutation Leading to T-B+NK- SCID in Two Brazilian Patients.", "pmid_14": 30177960.0, "pmid_date_14": 2018.0, "pmid_journal_14": "Front Pediatr"}, {"pmid_title_15": "Co-appearance of OPV and BCG vaccine-derived complications in two infants with severe combined immunodeficiency.", "pmid_15": 29804197.0, "pmid_date_15": 2018.0, "pmid_journal_15": "Immunol Res"}, {"pmid_title_16": "Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis.", "pmid_16": 30014500.0, "pmid_date_16": 2018.0, "pmid_journal_16": "Hepatology"}, {"pmid_title_17": "JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long-known gene.", "pmid_17": 30032486.0, "pmid_date_17": 2018.0, "pmid_journal_17": "Mol Genet Genomic Med"}, {"pmid_title_18": "Chronic active Epstein-Barr virus infection as the initial symptom in a Janus kinase 3 deficiency child: Case report and literature review.", "pmid_18": 29049190.0, "pmid_date_18": 2017.0, "pmid_journal_18": "Medicine (Baltimore)"}, {"pmid_title_19": "Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome.", "pmid_19": 28331055.0, "pmid_date_19": 2017.0, "pmid_journal_19": "Blood"}, {"pmid_title_20": "A novel deletion mutation in IL2RG gene results in X-linked severe combined immunodeficiency with an atypical phenotype.", "pmid_20": 27566612.0, "pmid_date_20": 2017.0, "pmid_journal_20": "Immunogenetics"}, {"pmid_title_21": "Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency.", "pmid_21": 28346229.0, "pmid_date_21": 2017.0, "pmid_journal_21": "J Clin Invest"}, {"pmid_title_22": "Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report.", "pmid_22": 28209722.0, "pmid_date_22": 2017.0, "pmid_journal_22": "Blood"}, {"pmid_title_23": "A 24-Year Enzyme Replacement Therapy in an Adenosine-deaminase-Deficient Patient.", "pmid_23": 26684479.0, "pmid_date_23": 2016.0, "pmid_journal_23": "Pediatrics"}, {"pmid_title_24": "Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.", "pmid_24": 27129325.0, "pmid_date_24": 2016.0, "pmid_journal_24": "Blood"}, {"pmid_title_25": "Insufficient immune reconstitution after allogeneic cord blood transplantation without chemotherapy conditioning in patients with SCID caused by CD3\u03b4 deficiency.", "pmid_25": 26999462.0, "pmid_date_25": 2016.0, "pmid_journal_25": "Bone Marrow Transplant"}, {"pmid_title_26": "Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency.", "pmid_26": 27099176.0, "pmid_date_26": 2016.0, "pmid_journal_26": "Sci Transl Med"}, {"pmid_title_27": "Case Report: Whole exome sequencing identifies variation c.2308G>A p.E770K in <i>RAG1</i> associated with B- T- NK+ severe combined immunodeficiency.", "pmid_27": 29067161.0, "pmid_date_27": 2016.0, "pmid_journal_27": "F1000Res"}, {"pmid_title_28": "CTP Synthase 1 Deficiency in Successfully Transplanted Siblings with Combined Immune Deficiency and Chronic Active EBV Infection.", "pmid_28": 27638562.0, "pmid_date_28": 2016.0, "pmid_journal_28": "J Clin Immunol"}, {"pmid_title_29": "Mutation c.256_257delAA in RAG1 Gene in Polish Children with Severe Combined Immunodeficiency: Diversity of Clinical Manifestations.", "pmid_29": 28083621.0, "pmid_date_29": 2016.0, "pmid_journal_29": "Arch Immunol Ther Exp (Warsz)"}, {"pmid_title_30": "Persistent rotavirus diarrhea post-transplant in a novel JAK3-SCID patient after vaccination.", "pmid_30": 26248889.0, "pmid_date_30": 2016.0, "pmid_journal_30": "Pediatr Allergy Immunol"}, {"pmid_title_31": "Novel compound heterozygous mutations in a Japanese girl with Janus kinase 3 deficiency.", "pmid_31": 27593409.0, "pmid_date_31": 2016.0, "pmid_journal_31": "Pediatr Int"}, {"pmid_title_32": "Mutations in Recombination Activating Gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt.", "pmid_32": 25869295.0, "pmid_date_32": 2015.0, "pmid_journal_32": "Clin Immunol"}, {"pmid_title_33": "A 15-year-old boy with severe combined immunodeficiency, fungal infection, and weight gain.", "pmid_33": 26314823.0, "pmid_date_33": 2015.0, "pmid_journal_33": "Allergy Asthma Proc"}, {"pmid_title_34": "A novel common gamma chain mutation in a Chinese family with X-linked severe combined immunodeficiency (X-SCID; T(-)NK(-)B(+)).", "pmid_34": 26409833.0, "pmid_date_34": 2015.0, "pmid_journal_34": "Immunogenetics"}, {"pmid_title_35": "PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity.", "pmid_35": 25842288.0, "pmid_date_35": 2015.0, "pmid_journal_35": "J Allergy Clin Immunol"}, {"pmid_title_36": "Transplantation outcomes for severe combined immunodeficiency, 2000-2009.", "pmid_36": 25075835.0, "pmid_date_36": 2014.0, "pmid_journal_36": "N Engl J Med"}, {"pmid_title_37": "Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.", "pmid_37": 25109802.0, "pmid_date_37": 2014.0, "pmid_journal_37": "J Allergy Clin Immunol"}, {"pmid_title_38": "SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.", "pmid_38": 24144642.0, "pmid_date_38": 2014.0, "pmid_journal_38": "Blood"}, {"pmid_title_39": "Severe combined immunodeficiency caused by a new homozygous RAG1 mutation with progressive encephalopathy.", "pmid_39": 24333136.0, "pmid_date_39": 2014.0, "pmid_journal_39": "Hematol Oncol Stem Cell Ther"}, {"pmid_title_40": "The many faces of Artemis-deficient combined immunodeficiency - Two patients with DCLRE1C mutations and a systematic literature review of genotype-phenotype correlation.", "pmid_40": 24230999.0, "pmid_date_40": 2013.0, "pmid_journal_40": "Clin Immunol"}, {"pmid_title_41": "Successful bone marrow transplantation with reduced intensity conditioning in a patient with delayed-onset adenosine deaminase deficiency.", "pmid_41": 22805442.0, "pmid_date_41": 2013.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Hemophagocytic bone marrow aplasia with plasma cells in a RAG2-deficient SCID case after a nonconditioned transplantation from a fully matched sibling.", "pmid_42": 23389499.0, "pmid_date_42": 2013.0, "pmid_journal_42": "J Pediatr Hematol Oncol"}, {"pmid_title_43": "Skeletal abnormalities and successful hematopoietic stem cell transplantation in patients with reticular dysgenesis.", "pmid_43": 23763981.0, "pmid_date_43": 2013.0, "pmid_journal_43": "J Allergy Clin Immunol"}, {"pmid_title_44": "Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency.", "pmid_44": 22409989.0, "pmid_date_44": 2012.0, "pmid_journal_44": "J Allergy Clin Immunol"}, {"pmid_title_45": "Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.", "pmid_45": 22791287.0, "pmid_date_45": 2012.0, "pmid_journal_45": "Blood"}, {"pmid_title_46": "Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.", "pmid_46": 22968453.0, "pmid_date_46": 2012.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "IL-21 is the primary common \u03b3 chain-binding cytokine required for human B-cell differentiation in vivo.", "pmid_47": 22039266.0, "pmid_date_47": 2011.0, "pmid_journal_47": "Blood"}, {"pmid_title_48": "Hematopoietic stem cell transplantation for CD3\u03b4 deficiency.", "pmid_48": 21757226.0, "pmid_date_48": 2011.0, "pmid_journal_48": "J Allergy Clin Immunol"}, {"pmid_title_49": "Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency.", "pmid_49": 21725047.0, "pmid_date_49": 2011.0, "pmid_journal_49": "Blood"}, {"pmid_title_50": "A leaky mutation in CD3D differentially affects \u03b1\u03b2 and \u03b3\u03b4 T cells and leads to a T\u03b1\u03b2-T\u03b3\u03b4+B+NK+ human SCID.", "pmid_50": 21926461.0, "pmid_date_50": 2011.0, "pmid_journal_50": "J Clin Invest"}, {"pmid_title_51": "Occurrence of myelodysplastic syndrome in 2 patients with reticular dysgenesis.", "pmid_51": 21458044.0, "pmid_date_51": 2011.0, "pmid_journal_51": "J Allergy Clin Immunol"}, {"pmid_title_52": "Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency.", "pmid_52": 20113887.0, "pmid_date_52": 2010.0, "pmid_journal_52": "Immunol Allergy Clin North Am"}, {"pmid_title_53": "Hemophagocytosis after bone marrow transplantation for JAK3-deficient severe combined immunodeficiency.", "pmid_53": 19659508.0, "pmid_date_53": 2010.0, "pmid_journal_53": "Pediatr Transplant"}, {"pmid_title_54": "A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining.", "pmid_54": 19075392.0, "pmid_date_54": 2009.0, "pmid_journal_54": "J Clin Invest"}, {"pmid_title_55": "Novel RAG2 mutation in a patient with T- B- severe combined immunodeficiency and disseminated BCG disease.", "pmid_55": 20128425.0, "pmid_date_55": 2009.0, "pmid_journal_55": "J Investig Allergol Clin Immunol"}, {"pmid_title_56": "A novel missense RAG-1 mutation results in T-B-NK+ SCID in Athabascan-speaking Dine Indians from the Canadian Northwest Territories.", "pmid_56": 18701881.0, "pmid_date_56": 2009.0, "pmid_journal_56": "Eur J Hum Genet"}, {"pmid_title_57": "Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID.", "pmid_57": 19458910.0, "pmid_date_57": 2009.0, "pmid_journal_57": "Clin Exp Med"}, {"pmid_title_58": "Gene therapy for immunodeficiency due to adenosine deaminase deficiency.", "pmid_58": 19179314.0, "pmid_date_58": 2009.0, "pmid_journal_58": "N Engl J Med"}, {"pmid_title_59": "Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency.", "pmid_59": 17825895.0, "pmid_date_59": 2007.0, "pmid_journal_59": "J Allergy Clin Immunol"}, {"pmid_title_60": "Novel RAG1 mutation in a case of severe combined immunodeficiency.", "pmid_60": 16061569.0, "pmid_date_60": 2005.0, "pmid_journal_60": "Pediatrics"}, {"pmid_title_61": "Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.", "pmid_61": 14615376.0, "pmid_date_61": 2004.0, "pmid_journal_61": "Blood"}, {"pmid_title_62": "Novel Artemis gene mutations of radiosensitive severe combined immunodeficiency in Japanese families.", "pmid_62": 12592555.0, "pmid_date_62": 2003.0, "pmid_journal_62": "Hum Genet"}, {"pmid_title_63": "Bone marrow transplantation for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans.", "pmid_63": 11360109.0, "pmid_date_63": 2001.0, "pmid_journal_63": "Bone Marrow Transplant"}, {"pmid_title_64": "Successful bone-marrow transplantation for reticular dysgenesis.", "pmid_64": 6132037.0, "pmid_date_64": 1983.0, "pmid_journal_64": "Lancet"}, {"pmid_title_65": "Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.", "pmid_65": 6983936.0, "pmid_date_65": 1982.0, "pmid_journal_65": "Clin Exp Immunol"}]}, {"_id": "16812-OMIM:612016", "condition": {"condition_name": "COENZYME Q10 DEFICIENCY, PRIMARY, 4", "freq_per_birth": "The prevalence of primary coenzyme Q10 deficiency is thought to be less than 1 in 100,000 people.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["COENZYME Q10 DEFICIENCY, PRIMARY, 4"]}, "gene information": {"db_hgnc_gene_id": 16812.0}, "interventions": [{"int_description_1": "Ubidecarenone"}, {"int_description_2": "Idebenone"}], "references": [{"pmid_title_1": "ADCK3-related Coenzyme Q10 Deficiency: A Potentially Treatable Genetic Disease.", "pmid_1": 30637285.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Movement disorders clinical practice"}, {"pmid_title_2": "Cerebellar ataxia and severe muscle CoQ10 deficiency in a patient with a novel mutation in ADCK3.", "pmid_2": 26818466.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Clinical genetics"}, {"pmid_title_3": "ADCK3 mutations with epilepsy, stroke-like episodes and ataxia: a POLG mimic?", "pmid_3": 27106809.0, "pmid_date_3": 2016.0, "pmid_journal_3": "European journal of neurology"}, {"pmid_title_4": "Heterozygous Mutations in the ADCK3 Gene in Siblings with Cerebellar Atrophy and Extreme Phenotypic Variability.", "pmid_4": 24048965.0, "pmid_date_4": 2014.0, "pmid_journal_4": "JIMD reports"}, {"pmid_title_5": "Autosomal-recessive cerebellar ataxia caused by a novel ADCK3 mutation that elongates the protein: clinical, genetic and biochemical characterisation.", "pmid_5": 24218524.0, "pmid_date_5": 2014.0, "pmid_journal_5": "Journal of neurology, neurosurgery, and psychiatry"}, {"pmid_title_6": "Phenotypic variability in ARCA2 and identification of a core ataxic phenotype with slow progression.", "pmid_6": 24164873.0, "pmid_date_6": 2013.0, "pmid_journal_6": "Orphanet journal of rare diseases"}, {"pmid_title_7": "Adult-onset cerebellar ataxia due to mutations in CABC1/ADCK3.", "pmid_7": 22036850.0, "pmid_date_7": 2012.0, "pmid_journal_7": "Journal of neurology, neurosurgery, and psychiatry"}, {"pmid_title_8": "Coenzyme Q(10)-responsive ataxia: 2-year-treatment follow-up.", "pmid_8": 20629161.0, "pmid_date_8": 2010.0, "pmid_journal_8": "Movement disorders : official journal of the Movement Disorder Society"}]}, {"_id": "16902-OMIM:614923", "condition": {"condition_name": "BRANCHED-CHAIN KETO ACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["BRANCHED-CHAIN KETO ACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD"]}, "gene information": {"db_hgnc_gene_id": 16902.0}, "interventions": [{"int_description_1": "Protein-rich diet", "timeframe_int1": "Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Still in Trials / Unproven"}, {"int_description_2": "Leucine", "timeframe_int2": "Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Still in Trials / Unproven"}, {"int_description_3": "Isoleucine", "timeframe_int3": "Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Still in Trials / Unproven"}, {"int_description_4": "Valine"}], "references": [{"pmid_title_1": "Two novel mutations in the BCKDK (branched-chain keto-acid dehydrogenase kinase) gene are responsible for a neurobehavioral deficit in two pediatric unrelated patients.", "pmid_1": 24449431.0, "pmid_date_1": 2014.0, "pmid_journal_1": "Human mutation"}, {"pmid_title_2": "Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy.", "pmid_2": 22956686.0, "pmid_date_2": 2012.0, "pmid_journal_2": "Science (New York, N.Y.)"}]}, {"_id": "16915-OMIM:610738", "condition": {"condition_name": "NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3", "freq_per_birth": "The incidence of severe congenital neutropenia is estimated to be 1 in 200,000 individuals.", "pattern_of_inheritance": "X-linked recessive==Autosomal dominant==Autosomal recessive", "alternate_names": ["NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3"]}, "gene information": {"db_hgnc_gene_id": 16915.0}, "interventions": [{"int_description_1": "Recombinant human granulocyte colony-stimulating factor", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "St Jude Total XI Study ALL chemotherapy protocol"}, {"int_description_3": "Hematopoietic stem cell transplantation", "timeframe_int3": "Days or Weeks,Years", "age_use_int3": "Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Cohort study or studies", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Homozygous c.130-131 ins A (pW44X) mutation in the HAX1 gene as the most common cause of congenital neutropenia in Turkey: Report from the Turkish Severe Congenital Neutropenia Registry.", "pmid_1": 31321910.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Pediatric blood & cancer"}, {"pmid_title_2": "HAX1 mutations causing severe congenital neuropenia and neurological disease lead to cerebral microstructural abnormalities documented by quantitative MRI.", "pmid_2": 21108402.0, "pmid_date_2": 2010.0, "pmid_journal_2": "American journal of medical genetics. Part A"}, {"pmid_title_3": "Acute lymphoblastic leukemia in a patient with congenital neutropenia without G-CSF-R and ELA2 mutations.", "pmid_3": 15973448.0, "pmid_date_3": 2005.0, "pmid_journal_3": "Leukemia"}]}, {"_id": "1698-OMIM:613501", "condition": {"condition_name": "AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE", "alternate_names": ["AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE"]}, "gene information": {"db_hgnc_gene_id": 1698.0}, "interventions": [{"int_description_1": "Human immunoglobulin G", "timeframe_int1": "Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "Yes", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Aggressive antibiotic therapy", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Vorhyaluronidase alfa"}], "references": [{"pmid_title_1": "Agammaglobulinemia", "pmid_1": 32310401.0, "pmid_date_1": 2020.0}, {"pmid_title_2": "Genetic Approaches for Definitive Diagnosis of Agammaglobulinemia in Consanguineous Families.", "pmid_2": 31696364.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Journal of clinical immunology"}, {"pmid_title_3": "IgM Augments Complement Bactericidal Activity with Serum from a Patient with a Novel CD79a Mutation.", "pmid_3": 29335801.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Journal of clinical immunology"}, {"pmid_title_4": "Autosomal recessive agammaglobulinemia: a novel non-sense mutation in CD79a.", "pmid_4": 24481606.0, "pmid_date_4": 2014.0, "pmid_journal_4": "Journal of clinical immunology"}, {"pmid_title_5": "Primary B cell immunodeficiencies: comparisons and contrasts.", "pmid_5": 19302039.0, "pmid_date_5": 2009.0, "pmid_journal_5": "Annual review of immunology"}, {"pmid_title_6": "Novel Igalpha (CD79a) gene mutation in a Turkish patient with B cell-deficient agammaglobulinemia.", "pmid_6": 11920841.0, "pmid_date_6": 2002.0, "pmid_journal_6": "American journal of medical genetics"}, {"pmid_title_7": "Mutations in Igalpha (CD79a) result in a complete block in B-cell development.", "pmid_7": 10525050.0, "pmid_date_7": 1999.0, "pmid_journal_7": "The Journal of clinical investigation"}]}, {"_id": "1699-OMIM:612692", "condition": {"condition_name": "AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE", "alternate_names": ["AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE"]}, "gene information": {"db_hgnc_gene_id": 1699.0}, "interventions": [{"int_description_1": "Human immunoglobulin G", "timeframe_int1": "Hours", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Aggressive antibiotic therapy", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Cohort study or studies", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Vorhyaluronidase alfa"}], "references": [{"pmid_title_1": "Agammaglobulinemia", "pmid_1": 32310401.0, "pmid_date_1": 2020.0}, {"pmid_title_2": "Autosomal recessive agammaglobulinemia: the third case of Ig\u03b2 deficiency due to a novel non-sense mutation.", "pmid_2": 24722855.0, "pmid_date_2": 2014.0, "pmid_journal_2": "Journal of clinical immunology"}, {"pmid_title_3": "Primary B cell immunodeficiencies: comparisons and contrasts.", "pmid_3": 19302039.0, "pmid_date_3": 2009.0, "pmid_journal_3": "Annual review of immunology"}, {"pmid_title_4": "Ig beta deficiency in humans.", "pmid_4": 18978465.0, "pmid_date_4": 2008.0, "pmid_journal_4": "Current opinion in allergy and clinical immunology"}, {"pmid_title_5": "Cutting edge: a hypomorphic mutation in Igbeta (CD79b) in a patient with immunodeficiency and a leaky defect in B cell development.", "pmid_5": 17675462.0, "pmid_date_5": 2007.0, "pmid_journal_5": "Journal of immunology (Baltimore, Md. : 1950)"}, {"pmid_title_6": "Mutations of the Igbeta gene cause agammaglobulinemia in man.", "pmid_6": 17709424.0, "pmid_date_6": 2007.0, "pmid_journal_6": "The Journal of experimental medicine"}]}, {"_id": "175-OMIM:600376", "condition": {"condition_name": "TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2", "freq_per_birth": "The incidence of hereditary hemorrhagic telangiectasia is difficult to determine because the severity of symptoms can vary widely and some symptoms, such as frequent nosebleeds, are common in the general population. In addition, arteriovenous malformations may be associated with other medical conditions. Hereditary hemorrhagic telangiectasia is widely distributed, occurring in many ethnic groups around the world. It is believed to affect between 1 in 5,000 and 1 in 10,000 people.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2"]}, "gene information": {"db_hgnc_gene_id": 175.0}, "interventions": [{"int_description_1": "Iloprost"}, {"int_description_2": "Bosentan"}, {"int_description_3": "Beraprost"}, {"int_description_4": "Tadalafil"}, {"int_description_5": "Sildenafil"}, {"int_description_6": "Iron"}, {"int_description_7": "Nasal lubricants"}, {"int_description_8": "Oxygen"}, {"int_description_9": "Red cell blood transfusion"}, {"int_description_10": "Chemical cauterization"}, {"int_description_11": "Electrical cauterization"}, {"int_description_12": "Embolization", "timeframe_int12": "Days or Weeks", "age_use_int12": "Child", "contra_int12": "No", "qualscale_reclass_drug12": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Laser ablation"}, {"int_description_14": "Left upper lobectomy"}, {"int_description_15": "Ligation of feeding artery", "timeframe_int15": "Days or Weeks", "age_use_int15": "Child", "contra_int15": "No", "qualscale_reclass_drug15": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug15": "Effective / Ameliorative"}, {"int_description_16": "Nasal closure"}, {"int_description_17": "Neurosurgery", "timeframe_int17": "Days or Weeks", "age_use_int17": "Neonate,Infant,Child", "contra_int17": "No", "qualscale_reclass_drug17": "Cohort study or studies", "rev1_eff_reclass_drug17": "Effective / Ameliorative"}, {"int_description_18": "Orthotopic liver transplantation (OLT)"}, {"int_description_19": "Sclerotherapy"}, {"int_description_20": "Stereotactic radiosurgery", "timeframe_int20": "Days or Weeks", "age_use_int20": "Infant,Child", "contra_int20": "No", "qualscale_reclass_drug20": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug20": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Epistaxis in children and adolescents with hereditary hemorrhagic telangiectasia.", "pmid_1": 29171658.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Laryngoscope"}, {"pmid_title_2": "Clinical presentation and treatment paradigms of brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia.", "pmid_2": 29483005.0, "pmid_date_2": 2018.0, "pmid_journal_2": "J Clin Neurosci"}, {"pmid_title_3": "Hereditary Hemorrhagic Telangiectasia", "pmid_3": 20301525.0, "pmid_date_3": 2017.0, "pmid_journal_3": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_4": "Non-invasive CT screening for pulmonary arteriovenous malformations in children with confirmed hereditary hemorrhagic telangiectasia: Results from two pediatric centers.", "pmid_4": 28165669.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Pediatr Pulmonol"}, {"pmid_title_5": "Screening children for pulmonary arteriovenous malformations: Evaluation of 18 years of experience.", "pmid_5": 28407366.0, "pmid_date_5": 2017.0, "pmid_journal_5": "Pediatr Pulmonol"}, {"pmid_title_6": "Pulmonary arterial hypertension as the first manifestation in a patient with hereditary hemorrhagic telangiectasia.", "pmid_6": 25318803.0, "pmid_date_6": 2014.0, "pmid_journal_6": "Intern Med"}, {"pmid_title_7": "Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis.", "pmid_7": 21546842.0, "pmid_date_7": 2011.0, "pmid_journal_7": "Genet Med"}, {"pmid_title_8": "Hereditary hemorrhagic telangiectasia.", "pmid_8": 19364792.0, "pmid_date_8": 2009.0, "pmid_journal_8": "CMAJ"}, {"pmid_title_9": "Screening for pulmonary and cerebral arteriovenous malformations in children with hereditary haemorrhagic telangiectasia.", "pmid_9": 19386691.0, "pmid_date_9": 2009.0, "pmid_journal_9": "Eur Respir J"}, {"pmid_title_10": "Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia.", "pmid_10": 19357124.0, "pmid_date_10": 2009.0, "pmid_journal_10": "Arch Dis Child"}, {"pmid_title_11": "Symptomatic children with hereditary hemorrhagic telangiectasia: a pediatric center experience.", "pmid_11": 16754821.0, "pmid_date_11": 2006.0, "pmid_journal_11": "Arch Pediatr Adolesc Med"}, {"pmid_title_12": "Hereditary hemorrhagic telangiectasia: an overview of diagnosis and management in the molecular era for clinicians.", "pmid_12": 15266205.0, "pmid_date_12": 2004.0, "pmid_journal_12": "Genet Med"}]}, {"_id": "17642-OMIM:603554", "condition": {"condition_name": "OMENN SYNDROME", "freq_per_birth": "Overall, the various forms of SCID are estimated to affect 1 in 75,000 to 100,000 newborns. The exact prevalence of Omenn syndrome is unknown.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["OMENN SYNDROME", "SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION"]}, "gene information": {"db_hgnc_gene_id": 17642.0}, "interventions": [{"int_description_1": "Cardiopulmonary resuscitation"}, {"int_description_2": "Prednisolone"}, {"int_description_3": "Prednisone"}, {"int_description_4": "Dexamethasone"}, {"int_description_5": "Panthenol", "timeframe_int5": "Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Cohort study or studies", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Ganciclovir"}, {"int_description_7": "Human immunoglobulin G"}, {"int_description_8": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_9": "Alemtuzumab"}, {"int_description_10": "Clarithromycin"}, {"int_description_11": "Cyclosporine"}, {"int_description_12": "Isoniazid"}, {"int_description_13": "Interferon gamma-1b"}, {"int_description_14": "Cyclophosphamide"}, {"int_description_15": "Busulfan"}, {"int_description_16": "Melphalan"}, {"int_description_17": "Thiotepa"}, {"int_description_18": "Caspofungin"}, {"int_description_19": "Ethambutol"}, {"int_description_20": "Azithromycin"}, {"int_description_21": "Trimethoprim"}, {"int_description_22": "Sulfamethoxazole"}, {"int_description_23": "Treosulfan"}, {"int_description_24": "Rifampicin"}, {"int_description_25": "Fluconazole"}, {"int_description_26": "Voriconazole"}, {"int_description_27": "Methotrexate"}, {"int_description_28": "Fludarabine"}, {"int_description_29": "Etoposide"}, {"int_description_30": "Tacrolimus"}, {"int_description_31": "Foscarnet", "timeframe_int31": "Hours,Days or Weeks", "age_use_int31": "Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Cohort study or studies", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Mycophenolate mofetil", "timeframe_int32": "Days or Weeks", "age_use_int32": "Neonate,Infant,Child", "qualscale_reclass_drug32": "Cohort study or studies", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Methylprednisolone"}, {"int_description_34": "Anti-thymocyte globulin"}, {"int_description_35": "Antibiotics"}, {"int_description_36": "Palivizumab"}, {"int_description_37": "Antilymphocyte immunoglobulin (horse)"}, {"int_description_38": "Hypochlorite"}, {"int_description_39": "Low-pH emollient cream (CeraVe, New York, New York)", "timeframe_int39": "Hours,Days or Weeks", "age_use_int39": "Neonate,Infant,Child", "contra_int39": "No", "qualscale_reclass_drug39": "Cohort study or studies", "rev1_eff_reclass_drug39": "Effective / Ameliorative"}, {"int_description_40": "CD4-DLI"}, {"int_description_41": "Parenteral nutrition"}, {"int_description_42": "Red blood cells transfusion"}, {"int_description_43": "Hematopoietic stem cell transplantation", "timeframe_int43": "Days or Weeks", "age_use_int43": "Infant,Child", "contra_int43": "No", "qualscale_reclass_drug43": "Cohort study or studies", "rev1_eff_reclass_drug43": "Effective / Ameliorative"}, {"int_description_44": "Ileum resection"}, {"int_description_45": "Subtotal appendectomy"}, {"int_description_46": "Surgical removement of lymphadenitis"}], "references": [{"pmid_title_1": "Prominent dermal Langerhans cells in an Omenn syndrome patient with a novel mutation in the IL2RG gene.", "pmid_1": 31456262.0, "pmid_date_1": 2019.0, "pmid_journal_1": "J Dermatol"}, {"pmid_title_2": "Atypical Omenn Syndrome Due to RAG2 Gene Mutation, a Case Report.", "pmid_2": 31885011.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Iran J Immunol"}, {"pmid_title_3": "SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.", "pmid_3": 30154114.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Blood"}, {"pmid_title_4": "Topical Hypochlorite and Skin Acidification Improves Erythroderma of Omenn Syndrome.", "pmid_4": 29610161.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Pediatrics"}, {"pmid_title_5": "DNA recombination defects in Kuwait: Clinical, immunologic and genetic profile.", "pmid_5": 29051008.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Clin Immunol"}, {"pmid_title_6": "Characterization of T and B cell repertoire diversity in patients with RAG deficiency.", "pmid_6": 28783691.0, "pmid_date_6": 2016.0, "pmid_journal_6": "Sci Immunol"}, {"pmid_title_7": "Molecular Characteristics, Clinical and Immunologic Manifestations of 11 Children with Omenn Syndrome in East Slavs (Russia, Belarus, Ukraine).", "pmid_7": 26596586.0, "pmid_date_7": 2016.0, "pmid_journal_7": "J Clin Immunol"}, {"pmid_title_8": "Variable phenotype of severe immunodeficiencies associated with RMRP gene mutations.", "pmid_8": 25663137.0, "pmid_date_8": 2015.0, "pmid_journal_8": "J Clin Immunol"}, {"pmid_title_9": "Cyclosporin treatment improves skin findings in omenn syndrome.", "pmid_9": 25727345.0, "pmid_date_9": 2015.0, "pmid_journal_9": "Pediatr Dermatol"}, {"pmid_title_10": "SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.", "pmid_10": 24144642.0, "pmid_date_10": 2014.0, "pmid_journal_10": "Blood"}, {"pmid_title_11": "Atypical Omenn Syndrome due to Adenosine Deaminase Deficiency.", "pmid_11": 25954555.0, "pmid_date_11": 2012.0, "pmid_journal_11": "Case Reports Immunol"}, {"pmid_title_12": "Novel mutations in RAG1/2 and ADA genes in Israeli patients presenting with T-B-SCID or Omenn syndrome.", "pmid_12": 21624848.0, "pmid_date_12": 2011.0, "pmid_journal_12": "Clin Immunol"}, {"pmid_title_13": "Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation.", "pmid_13": 20375313.0, "pmid_date_13": 2010.0, "pmid_journal_13": "Blood"}, {"pmid_title_14": "Saving the red baby: successful allogeneic cord blood transplantation in Omenn syndrome.", "pmid_14": 19064334.0, "pmid_date_14": 2009.0, "pmid_journal_14": "Clin Immunol"}, {"pmid_title_15": "Rapid full engraftment and successful immune reconstitution after allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in Omenn syndrome.", "pmid_15": 18992055.0, "pmid_date_15": 2009.0, "pmid_journal_15": "Pediatr Transplant"}, {"pmid_title_16": "Variability of clinical and laboratory features among patients with ribonuclease mitochondrial RNA processing endoribonuclease gene mutations.", "pmid_16": 18804272.0, "pmid_date_16": 2008.0, "pmid_journal_16": "J Allergy Clin Immunol"}, {"pmid_title_17": "Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency.", "pmid_17": 17825895.0, "pmid_date_17": 2007.0, "pmid_journal_17": "J Allergy Clin Immunol"}, {"pmid_title_18": "Omenn syndrome--review of several phenotypes of Omenn syndrome and RAG1/RAG2 mutations in Japan.", "pmid_18": 17075247.0, "pmid_date_18": 2006.0, "pmid_journal_18": "Allergol Int"}, {"pmid_title_19": "Mutations in the RNA component of RNase mitochondrial RNA processing might cause Omenn syndrome.", "pmid_19": 16630949.0, "pmid_date_19": 2006.0, "pmid_journal_19": "J Allergy Clin Immunol"}, {"pmid_title_20": "Novel adopted immunotherapy for mixed chimerism after unrelated cord blood transplantation in Omenn syndrome.", "pmid_20": 16191096.0, "pmid_date_20": 2005.0, "pmid_journal_20": "Eur J Haematol"}, {"pmid_title_21": "Omenn syndrome due to ARTEMIS mutations.", "pmid_21": 15731174.0, "pmid_date_21": 2005.0, "pmid_journal_21": "Blood"}, {"pmid_title_22": "Reviewing Omenn syndrome.", "pmid_22": 11795679.0, "pmid_date_22": 2001.0, "pmid_journal_22": "Eur J Pediatr"}]}, {"_id": "17759-OMIM:614651", "condition": {"condition_name": "COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2", "freq_per_birth": "The prevalence of primary coenzyme Q10 deficiency is thought to be less than 1 in 100,000 people.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2"]}, "gene information": {"db_hgnc_gene_id": 17759.0}, "interventions": [{"int_description_1": "Ubidecarenone"}, {"int_description_2": "Ubiquinol"}], "references": [{"pmid_title_1": "Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency.", "pmid_1": 25091424.0, "pmid_date_1": 2015.0, "pmid_journal_1": "Journal of inherited metabolic disease"}, {"pmid_title_2": "Genetics of coenzyme q10 deficiency.", "pmid_2": 25126048.0, "pmid_date_2": 2014.0, "pmid_journal_2": "Molecular syndromology"}]}, {"_id": "1786-OMIM:130650", "condition": {"condition_name": "BECKWITH-WIEDEMANN SYNDROME; BWS", "freq_per_birth": "Beckwith-Wiedemann syndrome affects 1 in 10,500 to 13,700 newborns worldwide.  The condition may actually be more common than this estimate because some people with mild symptoms are never diagnosed.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES; IMAGE", "BECKWITH-WIEDEMANN SYNDROME; BWS", "SILVER-RUSSELL SYNDROME 1; SRS1"]}, "gene information": {"db_hgnc_gene_id": 1786.0}, "interventions": [{"int_description_1": "Abdominal wall repair", "timeframe_int1": "Days or Weeks", "age_use_int1": "Neonate", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Tongue reduction surgery", "timeframe_int2": "Days or Weeks,Years", "age_use_int2": "Infant,Child", "contra_int2": "Yes", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Curative"}], "references": [{"pmid_title_1": "Beckwith-Wiedemann Syndrome", "pmid_1": 20301568.0, "pmid_date_1": 2016.0, "pmid_journal_1": "GeneReviews\u00ae"}]}, {"_id": "1786-OMIM:614732", "condition": {"condition_name": "INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES; IMAGE", "freq_per_birth": "IMAGe syndrome is very rare, with only about 20 cases reported in the medical literature. The condition has been diagnosed more often in males than in females, probably because females do not have associated genital abnormalities.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["SILVER-RUSSELL SYNDROME 1; SRS1", "INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES; IMAGE", "BECKWITH-WIEDEMANN SYNDROME; BWS"]}, "gene information": {"db_hgnc_gene_id": 1786.0}, "interventions": [{"int_description_1": "Somatotropin", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Sodium chloride", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Glucocorticoid therapy", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Mineralocorticoid therapy", "timeframe_int4": "Hours", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "IMAGe Syndrome", "pmid_1": 24624461.0, "pmid_date_1": 2016.0, "pmid_journal_1": "GeneReviews\u00ae"}]}, {"_id": "1786-ORPHA:813", "condition": {"condition_name": "Silver-Russell syndrome", "pattern_of_inheritance": "Autosomal dominant, Not applicable", "alternate_names": ["INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES", "Silver-Russell syndrome", "BECKWITH-WIEDEMANN SYNDROME"]}, "gene information": {"db_hgnc_gene_id": 1786.0}, "interventions": [{"int_description_1": "Cyproheptadine", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Somatotropin", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "Yes", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Silver-Russell Syndrome", "pmid_1": 20301499.0, "pmid_date_1": 2019.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "CDKN1C mutation affecting the PCNA-binding domain as a cause of familial Russell Silver syndrome.", "pmid_2": 24065356.0, "pmid_date_2": 2013.0, "pmid_journal_2": "J Med Genet"}]}, {"_id": "17967-OMIM:607676", "condition": {"condition_name": "IMMUNODEFICIENCY 67", "freq_per_birth": "IRAK-4 deficiency is a very rare condition, although the exact prevalence is unknown. At least 49 individuals with this condition have been described in the scientific literature.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["IMMUNODEFICIENCY 67"]}, "gene information": {"db_hgnc_gene_id": 17967.0}, "interventions": [{"int_description_1": "Human immunoglobulin G", "timeframe_int1": "Hours,Days or Weeks,Years", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Amphotericin B"}, {"int_description_3": "Sulfasalazine"}, {"int_description_4": "Clindamycin"}, {"int_description_5": "Amoxicillin"}, {"int_description_6": "Ceftriaxone"}, {"int_description_7": "Ibuprofen"}, {"int_description_8": "Voriconazole"}, {"int_description_9": "Methotrexate"}, {"int_description_10": "23-valent pneumococcal vaccine", "timeframe_int10": "Hours,Days or Weeks,Years", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Cohort study or studies", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Antibiotic prophylaxis until remission"}, {"int_description_12": "Antimicrobial prophylaxis"}, {"int_description_13": "Heptavalent pneumococcal conjugate vaccine", "timeframe_int13": "Hours", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Case report(s)", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Intravenous antibiotics"}, {"int_description_15": "Right pneumonectomy"}, {"int_description_16": "Thoracoscopic debridement"}, {"int_description_17": "Thoracotomy"}], "references": [{"pmid_title_1": "Antinuclear Antibody-Positive Juvenile Idiopathic Arthritis Despite IRAK-4 Deficiency.", "pmid_1": 29707745.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Journal of clinical immunology"}, {"pmid_title_2": "Invasive Bacterial Infection in Patients with Interleukin-1 Receptor-associated Kinase 4 Deficiency: Case Report.", "pmid_2": 26825884.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Medicine"}, {"pmid_title_3": "PID in Disguise: Molecular Diagnosis of IRAK-4 Deficiency in an Adult Previously Misdiagnosed With Autosomal Dominant Hyper IgE Syndrome.", "pmid_3": 26472314.0, "pmid_date_3": 2015.0, "pmid_journal_3": "Journal of clinical immunology"}, {"pmid_title_4": "Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity.", "pmid_4": 17893200.0, "pmid_date_4": 2007.0, "pmid_journal_4": "The Journal of experimental medicine"}, {"pmid_title_5": "IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease.", "pmid_5": 16950813.0, "pmid_date_5": 2006.0, "pmid_journal_5": "J Med Genet"}]}, {"_id": "17996-OMIM:237310", "condition": {"condition_name": "N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY; NAGSD", "freq_per_birth": "N-acetylglutamate synthase deficiency is a very rare disorder. It is estimated to affect fewer than 1 in 2 million people worldwide.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY; NAGSD"]}, "gene information": {"db_hgnc_gene_id": 17996.0}, "interventions": [{"int_description_1": "Low protein diet and arginine supplementation", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Low protein diet and Essential amino acids (EAAs) supplementation", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Arginine", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Benzoic acid", "timeframe_int4": "Hours", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Phenylbutyric acid"}, {"int_description_6": "Glycerol phenylbutyrate"}, {"int_description_7": "Phenylacetic acid"}, {"int_description_8": "KB195 glycan"}, {"int_description_9": "Carglumic acid"}, {"int_description_10": "D-glucose", "timeframe_int10": "Hours", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Heterologous human adult liver-derived progenitor cells", "timeframe_int11": "Hours", "age_use_int11": "Neonate,Infant", "contra_int11": "No", "qualscale_reclass_drug11": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "Hemodialysis"}], "references": [{"pmid_title_1": "Impact of Diagnosis and Therapy on Cognitive Function in Urea Cycle Disorders.", "pmid_1": 31018246.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Ann Neurol"}, {"pmid_title_2": "Carglumic Acid Treatment of a Patient with Recurrent Valproic Acid-induced Hyperammonemia: A Rare Case Report.", "pmid_2": 30443462.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Cureus"}, {"pmid_title_3": "Urea Cycle Disorders Overview", "pmid_3": 20301396.0, "pmid_date_3": 2017.0, "pmid_journal_3": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_4": "Normal Neurological Development During Infancy Despite Massive Hyperammonemia in Early Treated NAGS Deficiency.", "pmid_4": 28275973.0, "pmid_date_4": 2017.0, "pmid_journal_4": "JIMD reports"}, {"pmid_title_5": "Diagnosis and treatment of urea cycle disorder in Japan.", "pmid_5": 25039902.0, "pmid_date_5": 2014.0, "pmid_journal_5": "Pediatrics international : official journal of the Japan Pediatric Society"}, {"pmid_title_6": "Low dose of carglumic acid for treatment of hyperammonemia due to N-acetylglutamate synthase deficiency.", "pmid_6": 25228620.0, "pmid_date_6": 2014.0, "pmid_journal_6": "Indian pediatrics"}, {"pmid_title_7": "Glycerol phenylbutyrate (Ravicti) for urea cycle disorders.", "pmid_7": 25118801.0, "pmid_date_7": 2014.0, "pmid_journal_7": "The Medical letter on drugs and therapeutics"}, {"pmid_title_8": "Early treatment of a child with NAGS deficiency using  N-carbamyl glutamate results in a normal  neurological outcome.", "pmid_8": 24233332.0, "pmid_date_8": 2014.0, "pmid_journal_8": "European journal of pediatrics"}, {"pmid_title_9": "Dietary management of urea cycle disorders: European practice.", "pmid_9": 24113687.0, "pmid_date_9": 2013.0, "pmid_journal_9": "Molecular genetics and metabolism"}, {"pmid_title_10": "Carglumic acid for the treatment of N-acetylglutamate synthase deficiency and acute hyperammonemia.", "pmid_10": 30780843.0, "pmid_date_10": 2012.0, "pmid_journal_10": "Expert review of endocrinology & metabolism"}, {"pmid_title_11": "Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency.", "pmid_11": 21941437.0, "pmid_date_11": 2011.0, "pmid_journal_11": "Therapeutics and clinical risk management"}, {"pmid_title_12": "Favourable long-term outcome after immediate treatment of neonatal hyperammonemia due to N-acetylglutamate synthase deficiency.", "pmid_12": 19533169.0, "pmid_date_12": 2010.0, "pmid_journal_12": "European journal of pediatrics"}, {"pmid_title_13": "Carglumic acid: a second look. Confirmed progress in a rare urea cycle disorder.", "pmid_13": 18516804.0, "pmid_date_13": 2008.0, "pmid_journal_13": "Prescrire international"}, {"pmid_title_14": "A trial with N-carbamylglutamate may not detect all patients with NAGS deficiency and neonatal onset.", "pmid_14": 17510757.0, "pmid_date_14": 2007.0, "pmid_journal_14": "Journal of inherited metabolic disease"}, {"pmid_title_15": "Misleading diagnosis of partial N-acetylglutamate synthase deficiency based on enzyme measurement corrected by mutation analysis.", "pmid_15": 15858972.0, "pmid_date_15": 2005.0, "pmid_journal_15": "Acta paediatrica (Oslo, Norway : 1992)"}, {"pmid_title_16": "A 6-year-old boy with hyperammonaemia: partial N-acetylglutamate synthase deficiency or portosystemic encephalopathy?", "pmid_16": 11131349.0, "pmid_date_16": 2000.0, "pmid_journal_16": "European journal of pediatrics"}, {"pmid_title_17": "Partial N-acetylglutamate synthetase deficiency in a 13-year-old girl: diagnosis and response to treatment with N-carbamylglutamate.", "pmid_17": 9877039.0, "pmid_date_17": 1998.0, "pmid_journal_17": "European journal of pediatrics"}, {"pmid_title_18": "N-acetylglutamate synthetase deficiency: clinical and laboratory observations.", "pmid_18": 1779615.0, "pmid_date_18": 1991.0, "pmid_journal_18": "Journal of inherited metabolic disease"}]}, {"_id": "18550-OMIM:614231", "condition": {"condition_name": "MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME"]}, "gene information": {"db_hgnc_gene_id": 18550.0}, "interventions": [{"int_description_1": "Gastrostomy tube"}, {"int_description_2": "Insulin pump (CSII)"}, {"int_description_3": "Clonazepam"}, {"int_description_4": "Diazepam"}, {"int_description_5": "Insulin lispro"}, {"int_description_6": "Insulin glargine"}, {"int_description_7": "Topiramate"}, {"int_description_8": "Vigabatrin"}, {"int_description_9": "Valproic acid"}, {"int_description_10": "Insulin (not specified)"}, {"int_description_11": "Phenobarbital"}, {"int_description_12": "neutral protamine Hagedorn"}], "references": [{"pmid_title_1": "Microcephaly with simplified gyral pattern, epilepsy and permanent neonatal diabetes syndrome (MEDS). A new patient and review of the literature.", "pmid_1": 28711742.0, "pmid_date_1": 2017.0, "pmid_journal_1": "European journal of medical genetics"}, {"pmid_title_2": "Permanent Neonatal Diabetes Mellitus", "pmid_2": 20301620.0, "pmid_date_2": 2016.0, "pmid_journal_2": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_3": "Microcephaly, epilepsy, and neonatal diabetes due to compound heterozygous mutations in IER3IP1: insights into the natural history of a rare disorder.", "pmid_3": 24138066.0, "pmid_date_3": 2014.0, "pmid_journal_3": "Pediatric diabetes"}, {"pmid_title_4": "A homozygous IER3IP1 mutation causes microcephaly with simplified gyral pattern, epilepsy, and permanent neonatal diabetes syndrome (MEDS).", "pmid_4": 22991235.0, "pmid_date_4": 2012.0, "pmid_journal_4": "American journal of medical genetics. Part A"}, {"pmid_title_5": "Microcephaly with simplified gyration, epilepsy, and infantile diabetes linked to inappropriate apoptosis of neural progenitors.", "pmid_5": 21835305.0, "pmid_date_5": 2011.0, "pmid_journal_5": "American journal of human genetics"}]}, {"_id": "186-OMIM:102700", "condition": {"condition_name": "SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY", "Omenn syndrome"]}, "gene information": {"db_hgnc_gene_id": 186.0}, "interventions": [{"int_description_1": "Mechanical ventilation"}, {"int_description_2": "Nasal continuous positive airway pressure treatment"}, {"int_description_3": "Oxygen supplementation"}, {"int_description_4": "Transfer factor"}, {"int_description_5": "Testosterone"}, {"int_description_6": "Salmeterol"}, {"int_description_7": "Ursodeoxycholic acid"}, {"int_description_8": "Sargramostim"}, {"int_description_9": "Dopamine"}, {"int_description_10": "Prednisolone", "timeframe_int10": "Hours,Days or Weeks", "age_use_int10": "Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Prednisone"}, {"int_description_12": "Dexamethasone"}, {"int_description_13": "Fluticasone"}, {"int_description_14": "Ketoconazole"}, {"int_description_15": "Ganciclovir"}, {"int_description_16": "Human immunoglobulin G"}, {"int_description_17": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_18": "Midazolam"}, {"int_description_19": "Rituximab"}, {"int_description_20": "Alemtuzumab"}, {"int_description_21": "Clarithromycin"}, {"int_description_22": "Cyclosporine"}, {"int_description_23": "Clofazimine"}, {"int_description_24": "Isoniazid"}, {"int_description_25": "Amphotericin B"}, {"int_description_26": "Budesonide"}, {"int_description_27": "Somatotropin"}, {"int_description_28": "Piperacillin"}, {"int_description_29": "Vitamin D"}, {"int_description_30": "Levetiracetam"}, {"int_description_31": "Cyclophosphamide", "timeframe_int31": "Days or Weeks", "age_use_int31": "Infant,Child", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Curative"}, {"int_description_32": "Busulfan", "timeframe_int32": "Hours,Days or Weeks", "age_use_int32": "Infant,Child", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Melphalan", "timeframe_int33": "Days or Weeks", "age_use_int33": "Neonate,Infant,Child", "qualscale_reclass_drug33": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug33": "Effective / Ameliorative"}, {"int_description_34": "Thiotepa", "timeframe_int34": "Hours,Days or Weeks", "age_use_int34": "Neonate,Infant,Child", "contra_int34": "No", "qualscale_reclass_drug34": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug34": "Effective / Ameliorative"}, {"int_description_35": "Caspofungin", "timeframe_int35": "Hours,Days or Weeks", "age_use_int35": "Neonate,Infant,Child", "contra_int35": "No", "qualscale_reclass_drug35": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug35": "Effective / Ameliorative"}, {"int_description_36": "Amikacin"}, {"int_description_37": "Pyrazinamide"}, {"int_description_38": "Linezolid"}, {"int_description_39": "Doxorubicin"}, {"int_description_40": "Cladribine"}, {"int_description_41": "Pyridoxine"}, {"int_description_42": "Mercaptopurine"}, {"int_description_43": "Ethambutol"}, {"int_description_44": "Azithromycin"}, {"int_description_45": "Trimethoprim"}, {"int_description_46": "Sulfamethoxazole"}, {"int_description_47": "Ciprofloxacin"}, {"int_description_48": "Ofloxacin"}, {"int_description_49": "Fusidic acid"}, {"int_description_50": "Ampicillin"}, {"int_description_51": "Cefotaxime"}, {"int_description_52": "Meropenem"}, {"int_description_53": "Amoxicillin"}, {"int_description_54": "Cefuroxime"}, {"int_description_55": "Ceftriaxone"}, {"int_description_56": "Cefazolin"}, {"int_description_57": "Cefoperazone"}, {"int_description_58": "Latamoxef"}, {"int_description_59": "Sulbactam"}, {"int_description_60": "Clavulanic acid"}, {"int_description_61": "Vincristine"}, {"int_description_62": "Treosulfan"}, {"int_description_63": "Atovaquone"}, {"int_description_64": "Rifampicin"}, {"int_description_65": "Fluconazole"}, {"int_description_66": "Itraconazole"}, {"int_description_67": "Pyrimethamine"}, {"int_description_68": "Methotrexate"}, {"int_description_69": "Sulfadoxine"}, {"int_description_70": "Levofloxacin"}, {"int_description_71": "Fludarabine"}, {"int_description_72": "Cytarabine"}, {"int_description_73": "Daunorubicin"}, {"int_description_74": "Etoposide"}, {"int_description_75": "Pentamidine"}, {"int_description_76": "Idarubicin"}, {"int_description_77": "Mitoxantrone"}, {"int_description_78": "Vancomycin"}, {"int_description_79": "Tacrolimus"}, {"int_description_80": "Valproic acid"}, {"int_description_81": "Foscarnet"}, {"int_description_82": "Acyclovir"}, {"int_description_83": "Cidofovir"}, {"int_description_84": "Mycophenolate mofetil"}, {"int_description_85": "Ledipasvir"}, {"int_description_86": "Oxacillin"}, {"int_description_87": "Omeprazole"}, {"int_description_88": "Methylprednisolone"}, {"int_description_89": "Phenytoin"}, {"int_description_90": "Methimazole"}, {"int_description_91": "Infliximab"}, {"int_description_92": "Interferon alfa-2a, Recombinant"}, {"int_description_93": "Anti Thymocyte Globulin"}, {"int_description_94": "Anti-CD45 antibodies"}, {"int_description_95": "CMV hyperImmunoglobulin"}, {"int_description_96": "Pegademase"}, {"int_description_97": "Nystatin"}, {"int_description_98": "Teicoplanin"}, {"int_description_99": "Sofosbuvir"}, {"int_description_100": "Antilymphocyte immunoglobulin (horse)"}, {"int_description_101": "Elapegademase"}, {"int_description_102": "Human interleukin-2", "timeframe_int102": "Days or Weeks", "contra_int102": "No", "qualscale_reclass_drug102": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug102": "Curative"}, {"int_description_103": "Polyethylene glycol-modified adenosine deaminase"}, {"int_description_104": "Thymic hormone"}, {"int_description_105": "Thyroid hormone"}, {"int_description_106": "Thyroxin"}, {"int_description_107": "Phenobarbital"}, {"int_description_108": "Filgrastim"}, {"int_description_109": "2'-Deoxycytidine"}, {"int_description_110": "Gammaretroviral vectors (autologous hematopoietic stem cell gene therapy)"}, {"int_description_111": "Irradiated blood transfusions"}, {"int_description_112": "Irradiation"}, {"int_description_113": "Parenteral nutrition"}, {"int_description_114": "Platelet transfusions"}, {"int_description_115": "Self-inactivating lentivirus vectors (autologous hematopoietic stem cell gene therapy)"}, {"int_description_116": "Total body irradiation"}, {"int_description_117": "Hematopoietic stem cell transplantation"}, {"int_description_118": "Surgical drainage of abcess"}], "references": [{"pmid_title_1": "Severe Combined Immunodeficiency", "pmid_1": 30969584.0, "pmid_date_1": 2021.0, "pmid_journal_1": "statpearls"}, {"pmid_title_2": "Reticular dysgenesis caused by an intronic pathogenic variant in <i>AK2</i>.", "pmid_2": 32532877.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Cold Spring Harb Mol Case Stud"}, {"pmid_title_3": "Comparison of elapegademase and pegademase in ADA-deficient patients and mice.", "pmid_3": 31989577.0, "pmid_date_3": 2020.0, "pmid_journal_3": "Clin Exp Immunol"}, {"pmid_title_4": "Biallelic Form of a Known CD3E Mutation in a Patient with Severe Combined Immunodeficiency.", "pmid_4": 32016651.0, "pmid_date_4": 2020.0, "pmid_journal_4": "J Clin Immunol"}, {"pmid_title_5": "Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.", "pmid_5": 30194989.0, "pmid_date_5": 2019.0, "pmid_journal_5": "J Allergy Clin Immunol"}, {"pmid_title_6": "Disseminated Bacille Calmette-Gu\u00e9rin infection in a patient with severe combined immunodeficiency caused by JAK3 gene mutation.", "pmid_6": 31309596.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Pediatr Dermatol"}, {"pmid_title_7": "Prevention of transfusion-transmitted cytomegalovirus infection using leukoreduced blood components in patients receiving seronegative umbilical cord blood transplantation.", "pmid_7": 31322734.0, "pmid_date_7": 2019.0, "pmid_journal_7": "Transfusion"}, {"pmid_title_8": "Human interleukin-2 receptor \u03b2 mutations associated with defects in immunity and peripheral tolerance.", "pmid_8": 31040185.0, "pmid_date_8": 2019.0, "pmid_journal_8": "J Exp Med"}, {"pmid_title_9": "Combined Immunodeficiency With Late-Onset Progressive Hypogammaglobulinemia and Normal B Cell Count in a Patient With RAG2 Deficiency.", "pmid_9": 31058115.0, "pmid_date_9": 2019.0, "pmid_journal_9": "Front Pediatr"}, {"pmid_title_10": "Hematopoietic stem cell transplantation for cytidine triphosphate synthase 1 (CTPS1) deficiency.", "pmid_10": 29884857.0, "pmid_date_10": 2019.0, "pmid_journal_10": "Bone Marrow Transplant"}, {"pmid_title_11": "Severe combined immunodeficiency (SCID) presenting in childhood, with agammaglobulinemia, associated with novel compound heterozygous mutations in DCLRE1C.", "pmid_11": 30630113.0, "pmid_date_11": 2019.0, "pmid_journal_11": "Clin Immunol"}, {"pmid_title_12": "Recent advances in understanding the pathogenesis and management of reticular dysgenesis.", "pmid_12": 29270983.0, "pmid_date_12": 2018.0, "pmid_journal_12": "Br J Haematol"}, {"pmid_title_13": "Two siblings with PRKDC defect who presented with cutaneous granulomas and review of the literature.", "pmid_13": 30121298.0, "pmid_date_13": 2018.0, "pmid_journal_13": "Clin Immunol"}, {"pmid_title_14": "First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature.", "pmid_14": 29456531.0, "pmid_date_14": 2018.0, "pmid_journal_14": "Front Immunol"}, {"pmid_title_15": "Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis.", "pmid_15": 30014500.0, "pmid_date_15": 2018.0, "pmid_journal_15": "Hepatology"}, {"pmid_title_16": "SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.", "pmid_16": 30154114.0, "pmid_date_16": 2018.0, "pmid_journal_16": "Blood"}, {"pmid_title_17": "Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety.", "pmid_17": 29433935.0, "pmid_date_17": 2018.0, "pmid_journal_17": "Mol Ther"}, {"pmid_title_18": "A Novel Homozygous <i>JAK3</i> Mutation Leading to T-B+NK- SCID in Two Brazilian Patients.", "pmid_18": 30177960.0, "pmid_date_18": 2018.0, "pmid_journal_18": "Front Pediatr"}, {"pmid_title_19": "Co-appearance of OPV and BCG vaccine-derived complications in two infants with severe combined immunodeficiency.", "pmid_19": 29804197.0, "pmid_date_19": 2018.0, "pmid_journal_19": "Immunol Res"}, {"pmid_title_20": "JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long-known gene.", "pmid_20": 30032486.0, "pmid_date_20": 2018.0, "pmid_journal_20": "Mol Genet Genomic Med"}, {"pmid_title_21": "Chronic active Epstein-Barr virus infection as the initial symptom in a Janus kinase 3 deficiency child: Case report and literature review.", "pmid_21": 29049190.0, "pmid_date_21": 2017.0, "pmid_journal_21": "Medicine (Baltimore)"}, {"pmid_title_22": "Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients.", "pmid_22": 28351939.0, "pmid_date_22": 2017.0, "pmid_journal_22": "Blood"}, {"pmid_title_23": "Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome.", "pmid_23": 28331055.0, "pmid_date_23": 2017.0, "pmid_journal_23": "Blood"}, {"pmid_title_24": "A novel deletion mutation in IL2RG gene results in X-linked severe combined immunodeficiency with an atypical phenotype.", "pmid_24": 27566612.0, "pmid_date_24": 2017.0, "pmid_journal_24": "Immunogenetics"}, {"pmid_title_25": "Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency.", "pmid_25": 28346229.0, "pmid_date_25": 2017.0, "pmid_journal_25": "J Clin Invest"}, {"pmid_title_26": "Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report.", "pmid_26": 28209722.0, "pmid_date_26": 2017.0, "pmid_journal_26": "Blood"}, {"pmid_title_27": "Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.", "pmid_27": 27129325.0, "pmid_date_27": 2016.0, "pmid_journal_27": "Blood"}, {"pmid_title_28": "Investor Outlook: Rising from the Ashes; GSK's European Approval of Strimvelis for ADA-SCID.", "pmid_28": 27267267.0, "pmid_date_28": 2016.0, "pmid_journal_28": "Hum Gene Ther Clin Dev"}, {"pmid_title_29": "Gene therapy's out-of-body experience.", "pmid_29": 27281416.0, "pmid_date_29": 2016.0, "pmid_journal_29": "Nat Biotechnol"}, {"pmid_title_30": "Insufficient immune reconstitution after allogeneic cord blood transplantation without chemotherapy conditioning in patients with SCID caused by CD3\u03b4 deficiency.", "pmid_30": 26999462.0, "pmid_date_30": 2016.0, "pmid_journal_30": "Bone Marrow Transplant"}, {"pmid_title_31": "Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency.", "pmid_31": 27099176.0, "pmid_date_31": 2016.0, "pmid_journal_31": "Sci Transl Med"}, {"pmid_title_32": "Case Report: Whole exome sequencing identifies variation c.2308G>A p.E770K in <i>RAG1</i> associated with B- T- NK+ severe combined immunodeficiency.", "pmid_32": 29067161.0, "pmid_date_32": 2016.0, "pmid_journal_32": "F1000Res"}, {"pmid_title_33": "CTP Synthase 1 Deficiency in Successfully Transplanted Siblings with Combined Immune Deficiency and Chronic Active EBV Infection.", "pmid_33": 27638562.0, "pmid_date_33": 2016.0, "pmid_journal_33": "J Clin Immunol"}, {"pmid_title_34": "Mutation c.256_257delAA in RAG1 Gene in Polish Children with Severe Combined Immunodeficiency: Diversity of Clinical Manifestations.", "pmid_34": 28083621.0, "pmid_date_34": 2016.0, "pmid_journal_34": "Arch Immunol Ther Exp (Warsz)"}, {"pmid_title_35": "Persistent rotavirus diarrhea post-transplant in a novel JAK3-SCID patient after vaccination.", "pmid_35": 26248889.0, "pmid_date_35": 2016.0, "pmid_journal_35": "Pediatr Allergy Immunol"}, {"pmid_title_36": "A 24-Year Enzyme Replacement Therapy in an Adenosine-deaminase-Deficient Patient.", "pmid_36": 26684479.0, "pmid_date_36": 2016.0, "pmid_journal_36": "Pediatrics"}, {"pmid_title_37": "Novel compound heterozygous mutations in a Japanese girl with Janus kinase 3 deficiency.", "pmid_37": 27593409.0, "pmid_date_37": 2016.0, "pmid_journal_37": "Pediatr Int"}, {"pmid_title_38": "Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning.", "pmid_38": 25875699.0, "pmid_date_38": 2015.0, "pmid_journal_38": "J Clin Immunol"}, {"pmid_title_39": "Mutations in Recombination Activating Gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt.", "pmid_39": 25869295.0, "pmid_date_39": 2015.0, "pmid_journal_39": "Clin Immunol"}, {"pmid_title_40": "A 15-year-old boy with severe combined immunodeficiency, fungal infection, and weight gain.", "pmid_40": 26314823.0, "pmid_date_40": 2015.0, "pmid_journal_40": "Allergy Asthma Proc"}, {"pmid_title_41": "A novel common gamma chain mutation in a Chinese family with X-linked severe combined immunodeficiency (X-SCID; T(-)NK(-)B(+)).", "pmid_41": 26409833.0, "pmid_date_41": 2015.0, "pmid_journal_41": "Immunogenetics"}, {"pmid_title_42": "PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity.", "pmid_42": 25842288.0, "pmid_date_42": 2015.0, "pmid_journal_42": "J Allergy Clin Immunol"}, {"pmid_title_43": "Transplantation outcomes for severe combined immunodeficiency, 2000-2009.", "pmid_43": 25075835.0, "pmid_date_43": 2014.0, "pmid_journal_43": "N Engl J Med"}, {"pmid_title_44": "Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.", "pmid_44": 25109802.0, "pmid_date_44": 2014.0, "pmid_journal_44": "J Allergy Clin Immunol"}, {"pmid_title_45": "SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.", "pmid_45": 24144642.0, "pmid_date_45": 2014.0, "pmid_journal_45": "Blood"}, {"pmid_title_46": "Severe combined immunodeficiency caused by a new homozygous RAG1 mutation with progressive encephalopathy.", "pmid_46": 24333136.0, "pmid_date_46": 2014.0, "pmid_journal_46": "Hematol Oncol Stem Cell Ther"}, {"pmid_title_47": "The many faces of Artemis-deficient combined immunodeficiency - Two patients with DCLRE1C mutations and a systematic literature review of genotype-phenotype correlation.", "pmid_47": 24230999.0, "pmid_date_47": 2013.0, "pmid_journal_47": "Clin Immunol"}, {"pmid_title_48": "Successful bone marrow transplantation with reduced intensity conditioning in a patient with delayed-onset adenosine deaminase deficiency.", "pmid_48": 22805442.0, "pmid_date_48": 2013.0, "pmid_journal_48": "Pediatr Transplant"}, {"pmid_title_49": "Hemophagocytic bone marrow aplasia with plasma cells in a RAG2-deficient SCID case after a nonconditioned transplantation from a fully matched sibling.", "pmid_49": 23389499.0, "pmid_date_49": 2013.0, "pmid_journal_49": "J Pediatr Hematol Oncol"}, {"pmid_title_50": "Skeletal abnormalities and successful hematopoietic stem cell transplantation in patients with reticular dysgenesis.", "pmid_50": 23763981.0, "pmid_date_50": 2013.0, "pmid_journal_50": "J Allergy Clin Immunol"}, {"pmid_title_51": "Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency.", "pmid_51": 22409989.0, "pmid_date_51": 2012.0, "pmid_journal_51": "J Allergy Clin Immunol"}, {"pmid_title_52": "Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.", "pmid_52": 22791287.0, "pmid_date_52": 2012.0, "pmid_journal_52": "Blood"}, {"pmid_title_53": "Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.", "pmid_53": 22968453.0, "pmid_date_53": 2012.0, "pmid_journal_53": "Blood"}, {"pmid_title_54": "IL-21 is the primary common \u03b3 chain-binding cytokine required for human B-cell differentiation in vivo.", "pmid_54": 22039266.0, "pmid_date_54": 2011.0, "pmid_journal_54": "Blood"}, {"pmid_title_55": "Hematopoietic stem cell transplantation for CD3\u03b4 deficiency.", "pmid_55": 21757226.0, "pmid_date_55": 2011.0, "pmid_journal_55": "J Allergy Clin Immunol"}, {"pmid_title_56": "Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction.", "pmid_56": 21865538.0, "pmid_date_56": 2011.0, "pmid_journal_56": "Sci Transl Med"}, {"pmid_title_57": "A leaky mutation in CD3D differentially affects \u03b1\u03b2 and \u03b3\u03b4 T cells and leads to a T\u03b1\u03b2-T\u03b3\u03b4+B+NK+ human SCID.", "pmid_57": 21926461.0, "pmid_date_57": 2011.0, "pmid_journal_57": "J Clin Invest"}, {"pmid_title_58": "Occurrence of myelodysplastic syndrome in 2 patients with reticular dysgenesis.", "pmid_58": 21458044.0, "pmid_date_58": 2011.0, "pmid_journal_58": "J Allergy Clin Immunol"}, {"pmid_title_59": "Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency.", "pmid_59": 21725047.0, "pmid_date_59": 2011.0, "pmid_journal_59": "Blood"}, {"pmid_title_60": "Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency.", "pmid_60": 20113887.0, "pmid_date_60": 2010.0, "pmid_journal_60": "Immunol Allergy Clin North Am"}, {"pmid_title_61": "Hemophagocytosis after bone marrow transplantation for JAK3-deficient severe combined immunodeficiency.", "pmid_61": 19659508.0, "pmid_date_61": 2010.0, "pmid_journal_61": "Pediatr Transplant"}, {"pmid_title_62": "Gene therapy for immunodeficiency due to adenosine deaminase deficiency.", "pmid_62": 19179314.0, "pmid_date_62": 2009.0, "pmid_journal_62": "N Engl J Med"}, {"pmid_title_63": "Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy.", "pmid_63": 19652199.0, "pmid_date_63": 2009.0, "pmid_journal_63": "Blood"}, {"pmid_title_64": "A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining.", "pmid_64": 19075392.0, "pmid_date_64": 2009.0, "pmid_journal_64": "J Clin Invest"}, {"pmid_title_65": "Novel RAG2 mutation in a patient with T- B- severe combined immunodeficiency and disseminated BCG disease.", "pmid_65": 20128425.0, "pmid_date_65": 2009.0, "pmid_journal_65": "J Investig Allergol Clin Immunol"}, {"pmid_title_66": "A novel missense RAG-1 mutation results in T-B-NK+ SCID in Athabascan-speaking Dine Indians from the Canadian Northwest Territories.", "pmid_66": 18701881.0, "pmid_date_66": 2009.0, "pmid_journal_66": "Eur J Hum Genet"}, {"pmid_title_67": "Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID.", "pmid_67": 19458910.0, "pmid_date_67": 2009.0, "pmid_journal_67": "Clin Exp Med"}, {"pmid_title_68": "Polyethylene glycol-modified adenosine deaminase improved lung disease but not liver disease in partial adenosine deaminase deficiency.", "pmid_68": 19665771.0, "pmid_date_68": 2009.0, "pmid_journal_68": "J Allergy Clin Immunol"}, {"pmid_title_69": "Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients.", "pmid_69": 18218852.0, "pmid_date_69": 2008.0, "pmid_journal_69": "Blood"}, {"pmid_title_70": "Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency.", "pmid_70": 17825895.0, "pmid_date_70": 2007.0, "pmid_journal_70": "J Allergy Clin Immunol"}, {"pmid_title_71": "Novel RAG1 mutation in a case of severe combined immunodeficiency.", "pmid_71": 16061569.0, "pmid_date_71": 2005.0, "pmid_journal_71": "Pediatrics"}, {"pmid_title_72": "Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.", "pmid_72": 14615376.0, "pmid_date_72": 2004.0, "pmid_journal_72": "Blood"}, {"pmid_title_73": "Novel Artemis gene mutations of radiosensitive severe combined immunodeficiency in Japanese families.", "pmid_73": 12592555.0, "pmid_date_73": 2003.0, "pmid_journal_73": "Hum Genet"}, {"pmid_title_74": "Adenosine deaminase deficiency with mosaicism for a second-site suppressor of a splicing mutation: decline in revertant T lymphocytes during enzyme replacement therapy.", "pmid_74": 11807006.0, "pmid_date_74": 2002.0, "pmid_journal_74": "Blood"}, {"pmid_title_75": "Bone marrow transplantation for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans.", "pmid_75": 11360109.0, "pmid_date_75": 2001.0, "pmid_journal_75": "Bone Marrow Transplant"}, {"pmid_title_76": "PEG-ADA: an alternative to haploidentical bone marrow transplantation and an adjunct to gene therapy for adenosine deaminase deficiency.", "pmid_76": 7749407.0, "pmid_date_76": 1995.0, "pmid_journal_76": "Hum Mutat"}, {"pmid_title_77": "Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype.", "pmid_77": 8227344.0, "pmid_date_77": 1993.0, "pmid_journal_77": "J Clin Invest"}, {"pmid_title_78": "Chondroosseous dysplasia in severe combined immunodeficiency due to adenosine deaminase deficiency (chondroosseous dysplasia in ADA deficiency SCID).", "pmid_78": 1749685.0, "pmid_date_78": 1991.0, "pmid_journal_78": "Pediatr Radiol"}, {"pmid_title_79": "Successful bone-marrow transplantation for reticular dysgenesis.", "pmid_79": 6132037.0, "pmid_date_79": 1983.0, "pmid_journal_79": "Lancet"}, {"pmid_title_80": "Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.", "pmid_80": 6983936.0, "pmid_date_80": 1982.0, "pmid_journal_80": "Clin Exp Immunol"}]}, {"_id": "186-ORPHA:39041", "condition": {"condition_name": "Omenn syndrome", "freq_per_birth": "Overall, the various forms of SCID are estimated to affect 1 in 75,000 to 100,000 newborns. The exact prevalence of Omenn syndrome is unknown.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["Omenn syndrome", "SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 186.0}, "interventions": [{"int_description_1": "Cardiopulmonary resuscitation"}, {"int_description_2": "Prednisolone"}, {"int_description_3": "Prednisone"}, {"int_description_4": "Dexamethasone"}, {"int_description_5": "Panthenol", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Ganciclovir"}, {"int_description_7": "Human immunoglobulin G"}, {"int_description_8": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_9": "Alemtuzumab", "timeframe_int9": "Hours,Days or Weeks", "age_use_int9": "Neonate,Infant", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Clarithromycin"}, {"int_description_11": "Cyclosporine", "timeframe_int11": "Hours,Days or Weeks", "age_use_int11": "Neonate,Infant", "contra_int11": "No", "qualscale_reclass_drug11": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "Isoniazid"}, {"int_description_13": "Interferon gamma-1b"}, {"int_description_14": "Cyclophosphamide"}, {"int_description_15": "Busulfan"}, {"int_description_16": "Melphalan"}, {"int_description_17": "Thiotepa"}, {"int_description_18": "Caspofungin"}, {"int_description_19": "Ethambutol"}, {"int_description_20": "Azithromycin"}, {"int_description_21": "Trimethoprim"}, {"int_description_22": "Sulfamethoxazole"}, {"int_description_23": "Treosulfan"}, {"int_description_24": "Rifampicin"}, {"int_description_25": "Fluconazole"}, {"int_description_26": "Voriconazole"}, {"int_description_27": "Methotrexate"}, {"int_description_28": "Fludarabine"}, {"int_description_29": "Etoposide"}, {"int_description_30": "Tacrolimus"}, {"int_description_31": "Foscarnet", "timeframe_int31": "Hours,Days or Weeks", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Mycophenolate mofetil"}, {"int_description_33": "Methylprednisolone"}, {"int_description_34": "Anti-thymocyte globulin"}, {"int_description_35": "Antibiotics"}, {"int_description_36": "Palivizumab"}, {"int_description_37": "Antilymphocyte immunoglobulin (horse)", "timeframe_int37": "Hours,Days or Weeks", "age_use_int37": "Neonate,Infant", "qualscale_reclass_drug37": "Case report(s)", "rev1_eff_reclass_drug37": "Effective / Ameliorative"}, {"int_description_38": "Hypochlorite", "timeframe_int38": "Days or Weeks", "age_use_int38": "Neonate,Infant,Child", "contra_int38": "No", "qualscale_reclass_drug38": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug38": "Effective / Ameliorative"}, {"int_description_39": "Low-pH emollient cream (CeraVe, New York, New York)"}, {"int_description_40": "PEG-ADA"}, {"int_description_41": "CD4-DLI"}, {"int_description_42": "Parenteral nutrition"}, {"int_description_43": "Red blood cells transfusion"}, {"int_description_44": "Hematopoietic stem cell transplantation", "timeframe_int44": "Days or Weeks", "age_use_int44": "Neonate,Infant", "contra_int44": "No", "rev1_eff_reclass_drug44": "Curative"}, {"int_description_45": "Ileum resection"}, {"int_description_46": "Subtotal appendectomy"}, {"int_description_47": "Surgical removement of lymphadenitis"}], "references": [{"pmid_title_1": "Prominent dermal Langerhans cells in an Omenn syndrome patient with a novel mutation in the IL2RG gene.", "pmid_1": 31456262.0, "pmid_date_1": 2019.0, "pmid_journal_1": "J Dermatol"}, {"pmid_title_2": "Atypical Omenn Syndrome Due to RAG2 Gene Mutation, a Case Report.", "pmid_2": 31885011.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Iran J Immunol"}, {"pmid_title_3": "SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.", "pmid_3": 30154114.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Blood"}, {"pmid_title_4": "Topical Hypochlorite and Skin Acidification Improves Erythroderma of Omenn Syndrome.", "pmid_4": 29610161.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Pediatrics"}, {"pmid_title_5": "DNA recombination defects in Kuwait: Clinical, immunologic and genetic profile.", "pmid_5": 29051008.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Clin Immunol"}, {"pmid_title_6": "Characterization of T and B cell repertoire diversity in patients with RAG deficiency.", "pmid_6": 28783691.0, "pmid_date_6": 2016.0, "pmid_journal_6": "Sci Immunol"}, {"pmid_title_7": "Molecular Characteristics, Clinical and Immunologic Manifestations of 11 Children with Omenn Syndrome in East Slavs (Russia, Belarus, Ukraine).", "pmid_7": 26596586.0, "pmid_date_7": 2016.0, "pmid_journal_7": "J Clin Immunol"}, {"pmid_title_8": "Variable phenotype of severe immunodeficiencies associated with RMRP gene mutations.", "pmid_8": 25663137.0, "pmid_date_8": 2015.0, "pmid_journal_8": "J Clin Immunol"}, {"pmid_title_9": "Cyclosporin treatment improves skin findings in omenn syndrome.", "pmid_9": 25727345.0, "pmid_date_9": 2015.0, "pmid_journal_9": "Pediatr Dermatol"}, {"pmid_title_10": "SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.", "pmid_10": 24144642.0, "pmid_date_10": 2014.0, "pmid_journal_10": "Blood"}, {"pmid_title_11": "Atypical Omenn Syndrome due to Adenosine Deaminase Deficiency.", "pmid_11": 25954555.0, "pmid_date_11": 2012.0, "pmid_journal_11": "Case Reports Immunol"}, {"pmid_title_12": "Novel mutations in RAG1/2 and ADA genes in Israeli patients presenting with T-B-SCID or Omenn syndrome.", "pmid_12": 21624848.0, "pmid_date_12": 2011.0, "pmid_journal_12": "Clin Immunol"}, {"pmid_title_13": "Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation.", "pmid_13": 20375313.0, "pmid_date_13": 2010.0, "pmid_journal_13": "Blood"}, {"pmid_title_14": "Saving the red baby: successful allogeneic cord blood transplantation in Omenn syndrome.", "pmid_14": 19064334.0, "pmid_date_14": 2009.0, "pmid_journal_14": "Clin Immunol"}, {"pmid_title_15": "Rapid full engraftment and successful immune reconstitution after allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in Omenn syndrome.", "pmid_15": 18992055.0, "pmid_date_15": 2009.0, "pmid_journal_15": "Pediatr Transplant"}, {"pmid_title_16": "Variability of clinical and laboratory features among patients with ribonuclease mitochondrial RNA processing endoribonuclease gene mutations.", "pmid_16": 18804272.0, "pmid_date_16": 2008.0, "pmid_journal_16": "J Allergy Clin Immunol"}, {"pmid_title_17": "Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency.", "pmid_17": 17825895.0, "pmid_date_17": 2007.0, "pmid_journal_17": "J Allergy Clin Immunol"}, {"pmid_title_18": "Omenn syndrome--review of several phenotypes of Omenn syndrome and RAG1/RAG2 mutations in Japan.", "pmid_18": 17075247.0, "pmid_date_18": 2006.0, "pmid_journal_18": "Allergol Int"}, {"pmid_title_19": "Mutations in the RNA component of RNase mitochondrial RNA processing might cause Omenn syndrome.", "pmid_19": 16630949.0, "pmid_date_19": 2006.0, "pmid_journal_19": "J Allergy Clin Immunol"}, {"pmid_title_20": "Novel adopted immunotherapy for mixed chimerism after unrelated cord blood transplantation in Omenn syndrome.", "pmid_20": 16191096.0, "pmid_date_20": 2005.0, "pmid_journal_20": "Eur J Haematol"}, {"pmid_title_21": "Omenn syndrome due to ARTEMIS mutations.", "pmid_21": 15731174.0, "pmid_date_21": 2005.0, "pmid_journal_21": "Blood"}, {"pmid_title_22": "Reviewing Omenn syndrome.", "pmid_22": 11795679.0, "pmid_date_22": 2001.0, "pmid_journal_22": "Eur J Pediatr"}]}, {"_id": "1884-OMIM:219700", "condition": {"condition_name": "CYSTIC FIBROSIS", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["CYSTIC FIBROSIS"]}, "gene information": {"db_hgnc_gene_id": 1884.0}, "interventions": [{"int_description_1": "High-calorie, high-fat nutritional diet"}, {"int_description_2": "Heparin"}, {"int_description_3": "Ivacaftor"}, {"int_description_4": "Lumacaftor"}, {"int_description_5": "Nitric Oxide"}, {"int_description_6": "Ursodeoxycholic acid", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline"}, {"int_description_7": "Insulin human"}, {"int_description_8": "Amelubant"}, {"int_description_9": "Zinc"}, {"int_description_10": "Amikacin"}, {"int_description_11": "Tobramycin"}, {"int_description_12": "Azithromycin"}, {"int_description_13": "Ciprofloxacin"}, {"int_description_14": "Aztreonam"}, {"int_description_15": "Meropenem"}, {"int_description_16": "Nafamostat"}, {"int_description_17": "Ibuprofen"}, {"int_description_18": "Levofloxacin"}, {"int_description_19": "Colistimethate", "qualscale_reclass_drug19": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug19": "Effective / Ameliorative"}, {"int_description_20": "Acebilustat"}, {"int_description_21": "Alpha-1-proteinase inhibitor"}, {"int_description_22": "Doconexent"}, {"int_description_23": "Temocillin"}, {"int_description_24": "Cysteamine"}, {"int_description_25": "Acetylcysteine"}, {"int_description_26": "Fosfomycin"}, {"int_description_27": "Ataluren"}, {"int_description_28": "Omega-3 fatty acids", "timeframe_int28": "Days or Weeks,Years", "age_use_int28": "Infant,Child", "contra_int28": "No", "qualscale_reclass_drug28": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug28": "Effective / Ameliorative"}, {"int_description_29": "Tezacaftor"}, {"int_description_30": "Elexacaftor"}, {"int_description_31": "(6aR,10aR)-3-(1',1'-dimethylheptyl)-delta-8-tetrahydrocannabinol-9-carboxylic acid (Ajulemic acid ,AJA, CT-3, IP-751, JBT-101, anabasum)", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "4,6,4'-trimethylangelicin", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Alginate oligosaccharide (G-block) fragment", "timeframe_int33": "Days or Weeks,Years", "contra_int33": "No", "qualscale_reclass_drug33": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug33": "Effective / Ameliorative"}, {"int_description_34": "Bacterial lipase", "contra_int34": "No", "qualscale_reclass_drug34": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug34": "Effective / Ameliorative"}, {"int_description_35": "cyclo[L-alanyl-L-seryl-L-isoleucyl-L-prolyl-L-prolyl-L-glutaminyl-L-lysyl-L-tyrosyl-D-prolyl-L-prolyl-(2S)-2-aminodecanoyl-L-alpha-glutamyl-L-threonyl]acetate (POL6014)", "rev1_eff_reclass_drug35": "Effective / Ameliorative"}, {"int_description_36": "Cystic fibrosis transmembrane conductance regulator (CFTR) amplifier"}, {"int_description_37": "Dornase alfa"}, {"int_description_38": "Pancrelipase"}, {"int_description_39": "Palivizumab"}, {"int_description_40": "Mannitol"}, {"int_description_41": "Denufosol"}, {"int_description_42": "Lancovutide"}, {"int_description_43": "talactoferrin alpha"}, {"int_description_44": "Recombinant alpha 1-antitrypsin"}, {"int_description_45": "Teicoplanin"}, {"int_description_46": "Sodium chloride"}, {"int_description_47": "Cavosonstat", "timeframe_int47": "Years", "age_use_int47": "Child", "contra_int47": "No", "qualscale_reclass_drug47": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug47": "Effective / Ameliorative"}, {"int_description_48": "ELX-02"}, {"int_description_49": "Hypothiocyanite and lactoferrin (ALX-009)"}, {"int_description_50": "Inhaled corticosteroids"}, {"int_description_51": "L-Lysine-N-Acetyl-L-Cysteinate"}, {"int_description_52": "Lenabasum"}, {"int_description_53": "Liprotamase"}, {"int_description_54": "Long-acting beta agonist"}, {"int_description_55": "Nesolicaftor (N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamide, PTI-428)"}, {"int_description_56": "Pegylated recombinant anti-Pseudomonas aeruginosa PcrV Fab' antibody"}, {"int_description_57": "Poly(N-acetyl, N-arginyl)glucosamine (PAAG15A, SNSP113)"}, {"int_description_58": "Recombinant human acid ceramidase"}, {"int_description_59": "Glutathione"}, {"int_description_60": "Influenza vaccination"}, {"int_description_61": "Lactobacillus rhamnosus GG"}, {"int_description_62": "Octovalent Pseudomonas aeruginosa O-polysaccharie-toxin A conjugate vaccine"}, {"int_description_63": "Physical exercise (maintain bone health and improve airway clearance)"}, {"int_description_64": "Rehydration"}, {"int_description_65": "Heart and lung transplantation"}, {"int_description_66": "Lung transplantation"}, {"int_description_67": "Orthotopic liver transplantation (OLT)", "qualscale_reclass_drug67": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug67": "Effective / Ameliorative"}, {"rev1_eff_reclass_drug68": "Effective / Ameliorative"}, {"qualscale_reclass_drug69": "Cohort study or studies", "rev1_eff_reclass_drug69": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Cystic fibrosis 2019: Year in review.", "pmid_1": 32359945.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Paediatr Respir Rev"}, {"pmid_title_2": "Efficacy of Glutathione for Patients With Cystic Fibrosis: A Meta-analysis of Randomized-Controlled Studies.", "pmid_2": 31550169.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Am J Rhinol Allergy"}, {"pmid_title_3": "ELX-02 Generates Protein via Premature Stop Codon Read-Through without Inducing Native Stop Codon Read-Through Proteins.", "pmid_3": 32376628.0, "pmid_date_3": 2020.0, "pmid_journal_3": "J Pharmacol Exp Ther"}, {"pmid_title_4": "Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: The international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF).", "pmid_4": 31983658.0, "pmid_date_4": 2020.0, "pmid_journal_4": "J Cyst Fibros"}, {"pmid_title_5": "Ataluren/ivacaftor combination therapy: Two N-of-1 trials in cystic fibrosis patients with nonsense mutations.", "pmid_5": 32281737.0, "pmid_date_5": 2020.0, "pmid_journal_5": "Pediatr Pulmonol"}, {"pmid_title_6": "Elexacaftor/tezacaftor/ivacaftor (Trikafta) for cystic fibrosis.", "pmid_6": 31999662.0, "pmid_date_6": 2020.0, "pmid_journal_6": "Med Lett Drugs Ther"}, {"pmid_title_7": "Quantifying Long-Term Changes in Lung Function and Exacerbations after Initiation of Azithromycin in Cystic Fibrosis.", "pmid_7": 31604024.0, "pmid_date_7": 2020.0, "pmid_journal_7": "Ann Am Thorac Soc"}, {"pmid_title_8": "Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis.", "pmid_8": 31661302.0, "pmid_date_8": 2020.0, "pmid_journal_8": "Am J Respir Crit Care Med"}, {"pmid_title_9": "Effectiveness of a multistep Pseudomonas aeruginosa eradication treatment protocol in children with cystic fibrosis in Brazil.", "pmid_9": 32696837.0, "pmid_date_9": 2020.0, "pmid_journal_9": "J Bras Pneumol"}, {"pmid_title_10": "Lung transplantation for cystic fibrosis.", "pmid_10": 32147452.0, "pmid_date_10": 2020.0, "pmid_journal_10": "J Heart Lung Transplant"}, {"pmid_title_11": "Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosis.", "pmid_11": 32387042.0, "pmid_date_11": 2020.0, "pmid_journal_11": "J Cyst Fibros"}, {"pmid_title_12": "Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis.", "pmid_12": 32569477.0, "pmid_date_12": 2020.0, "pmid_journal_12": "Am J Respir Crit Care Med"}, {"pmid_title_13": "Single dose escalation studies with inhaled POL6014, a potent novel selective reversible inhibitor of human neutrophil elastase, in healthy volunteers and subjects with cystic fibrosis.", "pmid_13": 31501052.0, "pmid_date_13": 2020.0, "pmid_journal_13": "J Cyst Fibros"}, {"pmid_title_14": "Elexacaftor/Ivacaftor/Tezacaftor: First Approval.", "pmid_14": 31784874.0, "pmid_date_14": 2019.0, "pmid_journal_14": "Drugs"}, {"pmid_title_15": "Clinical Review Report: Lumacaftor/Ivacaftor (Orkambi): (Vertex Pharmaceuticals (Canada) Incorporated): Indication: For the treatment of cystic fibrosis in patients aged six years and older who are homozygous for the F508del mutation in the cystic fibrosis transmembrane conductance regulator gene", "pmid_15": 31013018.0, "pmid_date_15": 2019.0, "pmid_journal_15": "Clinical Review Report: Lumacaftor/Ivacaftor (Orkambi): (Vertex Pharmaceuticals (Canada) Incorporated): Indication: For the treatment of cystic fibrosis in patients aged six years and older who are homozygous for the F508del mutation in the cystic fibrosis transmembrane conductance regulator gene"}, {"pmid_title_16": "Aztreonam Lysine Inhalation Solution in Cystic Fibrosis.", "pmid_16": 31019373.0, "pmid_date_16": 2019.0, "pmid_journal_16": "Clin Med Insights Circ Respir Pulm Med"}, {"pmid_title_17": "Growth and Nutrition in Cystic Fibrosis.", "pmid_17": 31659726.0, "pmid_date_17": 2019.0, "pmid_journal_17": "Semin Respir Crit Care Med"}, {"pmid_title_18": "Inhaled Corticosteroids for Cystic Fibrosis: A Review of Clinical Effectiveness", "pmid_18": 31411842.0, "pmid_date_18": 2019.0, "pmid_journal_18": "Inhaled Corticosteroids for Cystic Fibrosis: A Review of Clinical Effectiveness"}, {"pmid_title_19": "N-Acetylcysteine Instillation During Bronchoscopy for Patients Requiring Non-Cystic Fibrosis-Related Mucus Secretion Clearance: A Review of Clinical Effectiveness and Guidelines", "pmid_19": 31682390.0, "pmid_date_19": 2019.0, "pmid_journal_19": "N-Acetylcysteine Instillation During Bronchoscopy for Patients Requiring Non-Cystic Fibrosis-Related Mucus Secretion Clearance: A Review of Clinical Effectiveness and Guidelines"}, {"pmid_title_20": "Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of ELX-02, a Potential Treatment for Genetic Disorders Caused by Nonsense Mutations, in Healthy Volunteers.", "pmid_20": 30650260.0, "pmid_date_20": 2019.0, "pmid_journal_20": "Clin Pharmacol Drug Dev"}, {"pmid_title_21": "Population pharmacokinetics of amikacin in patients\u00a0with pediatric cystic fibrosis.", "pmid_21": 31402602.0, "pmid_date_21": 2019.0, "pmid_journal_21": "Pediatr Pulmonol"}, {"pmid_title_22": "A Systematic Review of the Clinical Efficacy and Safety of CFTR Modulators in Cystic Fibrosis.", "pmid_22": 31076617.0, "pmid_date_22": 2019.0, "pmid_journal_22": "Sci Rep"}, {"pmid_title_23": "Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.", "pmid_23": 31679946.0, "pmid_date_23": 2019.0, "pmid_journal_23": "Lancet"}, {"pmid_title_24": "Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.", "pmid_24": 31697873.0, "pmid_date_24": 2019.0, "pmid_journal_24": "N Engl J Med"}, {"pmid_title_25": "Oral Azithromycin and Response to Pulmonary Exacerbations Treated with Intravenous Tobramycin in Children with Cystic Fibrosis.", "pmid_25": 30874447.0, "pmid_date_25": 2019.0, "pmid_journal_25": "Ann Am Thorac Soc"}, {"pmid_title_26": "Pharmacokinetics and safety of tobramycin nebulization with the I-neb and PARI-LC Plus in children with cystic fibrosis: A randomized, crossover study.", "pmid_26": 31112621.0, "pmid_date_26": 2019.0, "pmid_journal_26": "Br J Clin Pharmacol"}, {"pmid_title_27": "Lung Transplantation for Cystic Fibrosis and Non-cystic Fibrosis Bronchiectasis: A Single-Center Experience.", "pmid_27": 31303417.0, "pmid_date_27": 2019.0, "pmid_journal_27": "Transplant Proc"}, {"pmid_title_28": "Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis.", "pmid_28": 31499593.0, "pmid_date_28": 2019.0, "pmid_journal_28": "Cochrane Database Syst Rev"}, {"pmid_title_29": "Inhaled corticosteroids for cystic fibrosis.", "pmid_29": 31271656.0, "pmid_date_29": 2019.0, "pmid_journal_29": "Cochrane Database Syst Rev"}, {"pmid_title_30": "Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial.", "pmid_30": 31178421.0, "pmid_date_30": 2019.0, "pmid_journal_30": "Lancet Respir Med"}, {"pmid_title_31": "Inhaled hypertonic saline for 3-6-year-olds with cystic fibrosis.", "pmid_31": 31178424.0, "pmid_date_31": 2019.0, "pmid_journal_31": "Lancet Respir Med"}, {"pmid_title_32": "Systematic Review of Probiotics for Cystic Fibrosis Patients: Moving Forward.", "pmid_32": 30358738.0, "pmid_date_32": 2019.0, "pmid_journal_32": "J Pediatr Gastroenterol Nutr"}, {"pmid_title_33": "A comprehensive evaluation of omega-3 fatty acid supplementation in cystic fibrosis patients using lipidomics.", "pmid_33": 30414540.0, "pmid_date_33": 2019.0, "pmid_journal_33": "J Nutr Biochem"}, {"pmid_title_34": "Palivizumab and Long-term Outcomes in Cystic Fibrosis.", "pmid_34": 31239289.0, "pmid_date_34": 2019.0, "pmid_journal_34": "Pediatrics"}, {"pmid_title_35": "A glycopolymer improves vascoelasticity and mucociliary transport of abnormal cystic fibrosis mucus.", "pmid_35": 30996141.0, "pmid_date_35": 2019.0, "pmid_journal_35": "JCI Insight"}, {"pmid_title_36": "Zinc Nutritional Status in Patients with Cystic Fibrosis.", "pmid_36": 30642010.0, "pmid_date_36": 2019.0, "pmid_journal_36": "Nutrients"}, {"pmid_title_37": "Ajulemic acid: potential treatment for chronic inflammation.", "pmid_37": 29638269.0, "pmid_date_37": 2018.0, "pmid_journal_37": "Pharmacol Res Perspect"}, {"pmid_title_38": "Theratyping in cystic fibrosis.", "pmid_38": 30124524.0, "pmid_date_38": 2018.0, "pmid_journal_38": "Curr Opin Pulm Med"}, {"pmid_title_39": "Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.", "pmid_39": 30070364.0, "pmid_date_39": 2018.0, "pmid_journal_39": "Cochrane Database Syst Rev"}, {"pmid_title_40": "Dornase alfa for cystic fibrosis.", "pmid_40": 30187450.0, "pmid_date_40": 2018.0, "pmid_journal_40": "Cochrane Database Syst Rev"}, {"pmid_title_41": "Tezacaftor for the treatment of cystic fibrosis.", "pmid_41": 30073878.0, "pmid_date_41": 2018.0, "pmid_journal_41": "Expert Rev Respir Med"}, {"pmid_title_42": "Nebulised hypertonic saline for cystic fibrosis.", "pmid_42": 30260472.0, "pmid_date_42": 2018.0, "pmid_journal_42": "Cochrane Database Syst Rev"}, {"pmid_title_43": "Pharmacological management of cystic fibrosis related diabetes.", "pmid_43": 29268054.0, "pmid_date_43": 2018.0, "pmid_journal_43": "Expert Rev Clin Pharmacol"}, {"pmid_title_44": "Long-acting inhaled bronchodilators for cystic fibrosis.", "pmid_44": 29754778.0, "pmid_date_44": 2018.0, "pmid_journal_44": "Paediatr Respir Rev"}, {"pmid_title_45": "Inhaled mannitol for cystic fibrosis.", "pmid_45": 29424930.0, "pmid_date_45": 2018.0, "pmid_journal_45": "Cochrane Database Syst Rev"}, {"pmid_title_46": "Sphingolipids as targets for inhalation treatment of cystic fibrosis.", "pmid_46": 29698625.0, "pmid_date_46": 2018.0, "pmid_journal_46": "Adv Drug Deliv Rev"}, {"pmid_title_47": "Molecular Mechanism of Action of Trimethylangelicin Derivatives as CFTR Modulators.", "pmid_47": 30022950.0, "pmid_date_47": 2018.0, "pmid_journal_47": "Front Pharmacol"}, {"pmid_title_48": "Positive Effect of Liposomal Amikacin for Inhalation on <i>Mycobacterium abcessus</i> in Cystic Fibrosis Patients.", "pmid_48": 29564361.0, "pmid_date_48": 2018.0, "pmid_journal_48": "Open Forum Infect Dis"}, {"pmid_title_49": "Tezacaftor/Ivacaftor (Symdeko) for cystic fibrosis.", "pmid_49": 30335045.0, "pmid_date_49": 2018.0, "pmid_journal_49": "Med Lett Drugs Ther"}, {"pmid_title_50": "VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.", "pmid_50": 30334692.0, "pmid_date_50": 2018.0, "pmid_journal_50": "N Engl J Med"}, {"pmid_title_51": "Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial.", "pmid_51": 29890086.0, "pmid_date_51": 2018.0, "pmid_journal_51": "Am J Respir Crit Care Med"}, {"pmid_title_52": "Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.", "pmid_52": 30376155.0, "pmid_date_52": 2018.0, "pmid_journal_52": "Cochrane Database Syst Rev"}, {"pmid_title_53": "Evaluation of autophagy inducers in epithelial cells carrying the \u0394F508 mutation of the cystic fibrosis transmembrane conductance regulator CFTR.", "pmid_53": 29415993.0, "pmid_date_53": 2018.0, "pmid_journal_53": "Cell Death Dis"}, {"pmid_title_54": "Use of a High-Throughput Phenotypic Screening Strategy to Identify Amplifiers, a Novel Pharmacological Class of Small Molecules That Exhibit Functional Synergy with Potentiators and Correctors.", "pmid_54": 28898585.0, "pmid_date_54": 2018.0, "pmid_journal_54": "SLAS Discov"}, {"pmid_title_55": "Cystic fibrosis clinical characteristics associated with dornase alfa treatment regimen change.", "pmid_55": 29064184.0, "pmid_date_55": 2018.0, "pmid_journal_55": "Pediatr Pulmonol"}, {"pmid_title_56": "Timing of dornase alfa inhalation for cystic fibrosis.", "pmid_56": 30480755.0, "pmid_date_56": 2018.0, "pmid_journal_56": "Cochrane Database Syst Rev"}, {"pmid_title_57": "Treatment compliance in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection treated with tobramycin inhalation powder: The FREE study.", "pmid_57": 29724399.0, "pmid_date_57": 2018.0, "pmid_journal_57": "Respir Med"}, {"pmid_title_58": "Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.", "pmid_58": 29084746.0, "pmid_date_58": 2018.0, "pmid_journal_58": "Antimicrob Agents Chemother"}, {"pmid_title_59": "Antimicrobial Activity of Ibuprofen against Cystic Fibrosis-Associated Gram-Negative Pathogens.", "pmid_59": 29311081.0, "pmid_date_59": 2018.0, "pmid_journal_59": "Antimicrob Agents Chemother"}, {"pmid_title_60": "Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trial.", "pmid_60": 29128317.0, "pmid_date_60": 2018.0, "pmid_journal_60": "J Cyst Fibros"}, {"pmid_title_61": "Meropenem time above the MIC exposure is predictive of response in cystic fibrosis children with acute pulmonary exacerbations.", "pmid_61": 29661528.0, "pmid_date_61": 2018.0, "pmid_journal_61": "Diagn Microbiol Infect Dis"}, {"pmid_title_62": "Activity of hypothiocyanite and lactoferrin (ALX-009) against respiratory cystic fibrosis pathogens in sputum.", "pmid_62": 30219825.0, "pmid_date_62": 2018.0, "pmid_journal_62": "J Antimicrob Chemother"}, {"pmid_title_63": "Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.", "pmid_63": 28102546.0, "pmid_date_63": 2017.0, "pmid_journal_63": "Cochrane Database Syst Rev"}, {"pmid_title_64": "Ataluren in cystic fibrosis: development, clinical studies and where are we now?", "pmid_64": 28730885.0, "pmid_date_64": 2017.0, "pmid_journal_64": "Expert Opin Pharmacother"}, {"pmid_title_65": "Cystic Fibrosis and Congenital Absence of the Vas Deferens", "pmid_65": 20301428.0, "pmid_date_65": 2017.0, "pmid_journal_65": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_66": "Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.", "pmid_66": 28440853.0, "pmid_date_66": 2017.0, "pmid_journal_66": "Cochrane Database Syst Rev"}, {"pmid_title_67": "Dornase alfa for cystic fibrosis.", "pmid_67": 27769785.0, "pmid_date_67": 2017.0, "pmid_journal_67": "Paediatr Respir Rev"}, {"pmid_title_68": "Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis.", "pmid_68": 28854668.0, "pmid_date_68": 2017.0, "pmid_journal_68": "FEMS Microbiol Lett"}, {"pmid_title_69": "Inhaled Heparin: Therapeutic Efficacy and Recent Formulations.", "pmid_69": 28418758.0, "pmid_date_69": 2017.0, "pmid_journal_69": "J Aerosol Med Pulm Drug Deliv"}, {"pmid_title_70": "Oral calorie supplements for cystic fibrosis.", "pmid_70": 28470972.0, "pmid_date_70": 2017.0, "pmid_journal_70": "Cochrane Database Syst Rev"}, {"pmid_title_71": "Cystic fibrosis year in review 2016.", "pmid_71": 28608632.0, "pmid_date_71": 2017.0, "pmid_journal_71": "Pediatr Pulmonol"}, {"pmid_title_72": "Long-acting inhaled bronchodilators for cystic fibrosis.", "pmid_72": 29253920.0, "pmid_date_72": 2017.0, "pmid_journal_72": "Cochrane Database Syst Rev"}, {"pmid_title_73": "Cystic fibrosis: current therapeutic targets and future approaches.", "pmid_73": 28449677.0, "pmid_date_73": 2017.0, "pmid_journal_73": "J Transl Med"}, {"pmid_title_74": "Systematic Review of the Safety and Efficacy of Palivizumab among Infants and Young Children with Cystic Fibrosis.", "pmid_74": 28423192.0, "pmid_date_74": 2017.0, "pmid_journal_74": "Pharmacotherapy"}, {"pmid_title_75": "Physical exercise training for cystic fibrosis.", "pmid_75": 29090734.0, "pmid_date_75": 2017.0, "pmid_journal_75": "Cochrane Database Syst Rev"}, {"pmid_title_76": "Ursodeoxycholic acid for cystic fibrosis-related liver disease.", "pmid_76": 28891588.0, "pmid_date_76": 2017.0, "pmid_journal_76": "Cochrane Database Syst Rev"}, {"pmid_title_77": "Phase I Studies of Acebilustat: Pharmacokinetics, Pharmacodynamics, Food Effect, and CYP3A Induction.", "pmid_77": 27792868.0, "pmid_date_77": 2017.0, "pmid_journal_77": "Clin Transl Sci"}, {"pmid_title_78": "Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis.", "pmid_78": 27806191.0, "pmid_date_78": 2017.0, "pmid_journal_78": "Clin Transl Sci"}, {"pmid_title_79": "A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.", "pmid_79": 28630204.0, "pmid_date_79": 2017.0, "pmid_journal_79": "Antimicrob Agents Chemother"}, {"pmid_title_80": "Tezacaftor-Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis.", "pmid_80": 29099333.0, "pmid_date_80": 2017.0, "pmid_journal_80": "N Engl J Med"}, {"pmid_title_81": "Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del.", "pmid_81": 29099344.0, "pmid_date_81": 2017.0, "pmid_journal_81": "N Engl J Med"}, {"pmid_title_82": "Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.", "pmid_82": 28614995.0, "pmid_date_82": 2017.0, "pmid_journal_82": "Ther Adv Respir Dis"}, {"pmid_title_83": "Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation.", "pmid_83": 28079883.0, "pmid_date_83": 2017.0, "pmid_journal_83": "Cell Death Dis"}, {"pmid_title_84": "Unusual Indications for a Liver Transplant: A Single-Center Experience.", "pmid_84": 28260452.0, "pmid_date_84": 2017.0, "pmid_journal_84": "Exp Clin Transplant"}, {"pmid_title_85": "Cystic Fibrosis-related Liver Disease: Research Challenges and Future Perspectives.", "pmid_85": 28753176.0, "pmid_date_85": 2017.0, "pmid_journal_85": "J Pediatr Gastroenterol Nutr"}, {"pmid_title_86": "Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic.", "pmid_86": 28091521.0, "pmid_date_86": 2017.0, "pmid_journal_86": "Sci Rep"}, {"pmid_title_87": "Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.", "pmid_87": 27115956.0, "pmid_date_87": 2016.0, "pmid_journal_87": "Ann Am Thorac Soc"}, {"pmid_title_88": "Delivery of Alpha-1 Antitrypsin to Airways.", "pmid_88": 27564672.0, "pmid_date_88": 2016.0, "pmid_journal_88": "Ann Am Thorac Soc"}, {"pmid_title_89": "New and emerging targeted therapies for cystic fibrosis.", "pmid_89": 27030675.0, "pmid_date_89": 2016.0, "pmid_journal_89": "BMJ"}, {"pmid_title_90": "Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis.", "pmid_90": 27394157.0, "pmid_date_90": 2016.0, "pmid_journal_90": "Drugs"}, {"pmid_title_91": "Dornase alfa for cystic fibrosis.", "pmid_91": 27043279.0, "pmid_date_91": 2016.0, "pmid_journal_91": "Cochrane Database Syst Rev"}, {"pmid_title_92": "Tobramycin inhalation powder (TOBI Podhaler) for the treatment of lung infection in patients with cystic fibrosis.", "pmid_92": 26559549.0, "pmid_date_92": 2016.0, "pmid_journal_92": "Expert Rev Anti Infect Ther"}, {"pmid_title_93": "Inhaled corticosteroids for cystic fibrosis.", "pmid_93": 27552284.0, "pmid_date_93": 2016.0, "pmid_journal_93": "Cochrane Database Syst Rev"}, {"pmid_title_94": "Timing of hypertonic saline inhalation for cystic fibrosis.", "pmid_94": 28146603.0, "pmid_date_94": 2016.0, "pmid_journal_94": "Cochrane Database Syst Rev"}, {"pmid_title_95": "Insulin therapy in patients with cystic fibrosis in the pre-diabetes stage: a systematic review.", "pmid_95": 26994743.0, "pmid_date_95": 2016.0, "pmid_journal_95": "Rev Paul Pediatr"}, {"pmid_title_96": "Inhaled Mannitol (Bronchitol) for Cystic Fibrosis.", "pmid_96": 26867712.0, "pmid_date_96": 2016.0, "pmid_journal_96": "Paediatr Respir Rev"}, {"pmid_title_97": "Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.", "pmid_97": 27439110.0, "pmid_date_97": 2016.0, "pmid_journal_97": "Cochrane Database Syst Rev"}, {"pmid_title_98": "[Impact of physical exercise in cystic fibrosis patients: A systematic review].", "pmid_98": 27209116.0, "pmid_date_98": 2016.0, "pmid_journal_98": "Rev Mal Respir"}, {"pmid_title_99": "Progress in therapies for cystic fibrosis.", "pmid_99": 27053340.0, "pmid_date_99": 2016.0, "pmid_journal_99": "Lancet Respir Med"}, {"pmid_title_100": "Inhaled alpha1-proteinase inhibitor therapy in patients with cystic fibrosis.", "pmid_100": 26321218.0, "pmid_date_100": 2016.0, "pmid_journal_100": "J Cyst Fibros"}]}, {"_id": "18865-OMIM:614959", "condition": {"condition_name": "EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14", "freq_per_birth": "MMPSI is a rare condition. Although its prevalence is unknown, approximately 100 cases have been described in the medical literature.", "pattern_of_inheritance": "Not inherited", "alternate_names": ["EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14", "EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5"]}, "gene information": {"db_hgnc_gene_id": 18865.0}, "interventions": [{"int_description_1": "Vagus nerve stimulation", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Ketogenic diet"}, {"int_description_3": "Clobazam", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Cohort study or studies", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Corticotropin", "timeframe_int4": "Hours", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Cohort study or studies", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Clonazepam", "timeframe_int5": "Hours", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Cohort study or studies", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Nitrazepam"}, {"int_description_7": "Diazepam"}, {"int_description_8": "Cannabidiol", "timeframe_int8": "Hours", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Cohort study or studies", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Topiramate"}, {"int_description_10": "Midazolam"}, {"int_description_11": "Levetiracetam"}, {"int_description_12": "Bepridil"}, {"int_description_13": "Oxcarbazepine"}, {"int_description_14": "Lidocaine", "timeframe_int14": "Days or Weeks", "age_use_int14": "Neonate,Infant,Child", "contra_int14": "No", "qualscale_reclass_drug14": "Case report(s)", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}, {"int_description_15": "Carbamazepine"}, {"int_description_16": "Lacosamide"}, {"int_description_17": "Pyridoxine"}, {"int_description_18": "Quinidine"}, {"int_description_19": "Gabapentin"}, {"int_description_20": "Zonisamide"}, {"int_description_21": "Rufinamide"}, {"int_description_22": "Vigabatrin", "timeframe_int22": "Hours", "age_use_int22": "Neonate,Infant,Child", "contra_int22": "No", "qualscale_reclass_drug22": "Cohort study or studies", "rev1_eff_reclass_drug22": "Effective / Ameliorative"}, {"int_description_23": "Valproic acid"}, {"int_description_24": "Hydrocortisone"}, {"int_description_25": "Lamotrigine"}, {"int_description_26": "Phenytoin"}, {"int_description_27": "Stiripentol"}, {"int_description_28": "Bromide"}, {"int_description_29": "Biotin"}, {"int_description_30": "Intravenous immunoglobulin therapy"}, {"int_description_31": "Potassium bromide", "timeframe_int31": "Hours,Days or Weeks", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Sodium thiamylal", "timeframe_int32": "Hours", "age_use_int32": "Neonate,Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Cohort study or studies", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Steroid pulse therapy"}, {"int_description_34": "Clorazepic acid"}, {"int_description_35": "Phenobarbital"}, {"int_description_36": "Pyridoxine phosphate"}, {"int_description_37": "Corpus callosotomy"}, {"int_description_38": "Embolization"}], "references": [{"pmid_title_1": "Infantile refractory seizures due to de novo KCNT 1 mutation.", "pmid_1": 31653631.0, "pmid_date_1": 2019.0, "pmid_journal_1": "BMJ Case Rep"}, {"pmid_title_2": "Two Patients With KCNT1-Related Epilepsy Responding to Phenobarbital and Potassium Bromide.", "pmid_2": 31208268.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Journal of child neurology"}, {"pmid_title_3": "KCNT1 epilepsy with migrating focal seizures shows a temporal sequence with poor outcome, high mortality and SUDEP.", "pmid_3": 31532509.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Brain : a journal of neurology"}, {"pmid_title_4": "Quinidine therapy and therapeutic drug monitoring in four patients with KCNT1 mutations.", "pmid_4": 30782581.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Epileptic disorders : international epilepsy journal with videotape"}, {"pmid_title_5": "Epilepsy with migrating focal seizures: KCNT1 mutation hotspots and phenotype variability.", "pmid_5": 31872048.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Neurol Genet"}, {"pmid_title_6": "<i>KCNT1</i>-Related Epilepsy", "pmid_6": 30234941.0, "pmid_date_6": 2018.0, "pmid_journal_6": "GeneReviews\u00ae"}, {"pmid_title_7": "Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy.", "pmid_7": 30112700.0, "pmid_date_7": 2018.0, "pmid_journal_7": "Neurotherapeutics"}, {"pmid_title_8": "Lack of response to quinidine in KCNT1-related neonatal epilepsy.", "pmid_8": 30182418.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Epilepsia"}, {"pmid_title_9": "Does age affect response to quinidine in patients with KCNT1 mutations? Report of three new cases and review of the literature.", "pmid_9": 29291456.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Seizure"}, {"pmid_title_10": "Usefulness of ketogenic diet in a girl with migrating partial seizures in infancy.", "pmid_10": 26785903.0, "pmid_date_10": 2016.0, "pmid_journal_10": "Brain & development"}, {"pmid_title_11": "Characterization of two de novoKCNT1 mutations in children with malignant migrating partial seizures in infancy.", "pmid_11": 26784557.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Molecular and cellular neurosciences"}, {"pmid_title_12": "De novo KCNT1 mutations in early-onset epileptic encephalopathy.", "pmid_12": 26140313.0, "pmid_date_12": 2015.0, "pmid_journal_12": "Epilepsia"}, {"pmid_title_13": "KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine.", "pmid_13": 24591078.0, "pmid_date_13": 2014.0, "pmid_journal_13": "Ann Neurol"}, {"pmid_title_14": "Targeted treatment of migrating partial seizures of infancy with quinidine.", "pmid_14": 25042079.0, "pmid_date_14": 2014.0, "pmid_journal_14": "Annals of neurology"}, {"pmid_title_15": "A recurrent KCNT1 mutation in two sporadic cases with malignant migrating partial seizures in infancy.", "pmid_15": 24029078.0, "pmid_date_15": 2013.0, "pmid_journal_15": "Gene"}]}, {"_id": "18865-OMIM:615005", "condition": {"condition_name": "EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5", "EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14"]}, "gene information": {"db_hgnc_gene_id": 18865.0}, "interventions": [{"int_description_1": "Vagus nerve stimulation", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Levetiracetam"}, {"int_description_3": "Carbamazepine", "timeframe_int3": "Days or Weeks", "age_use_int3": "Infant,Child", "contra_int3": "Yes", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Quinidine"}, {"int_description_5": "Phenobarbital"}, {"int_description_6": "L centro-parietal resection"}, {"int_description_7": "L parieto-occipital (+ temporo-occipital junction) resection"}], "references": [{"pmid_title_1": "Mild malformations of cortical development in sleep-related hypermotor epilepsy due to <i>KCNT1</i> mutations.", "pmid_1": 30847371.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Annals of clinical and translational neurology"}, {"pmid_title_2": "<i>KCNT1</i>-Related Epilepsy", "pmid_2": 30234941.0, "pmid_date_2": 2018.0, "pmid_journal_2": "GeneReviews\u00ae"}]}, {"_id": "18871-OMIM:251100", "condition": {"condition_name": "METHYLMALONIC ACIDURIA, cblA TYPE", "freq_per_birth": "This condition occurs in an estimated 1 in 50,000 to 100,000 people.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["METHYLMALONIC ACIDURIA, cblA TYPE"]}, "gene information": {"db_hgnc_gene_id": 18871.0}, "interventions": [{"int_description_1": "Protein-restricted diet", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Hydroxocobalamin"}, {"int_description_3": "Metronidazole", "timeframe_int3": "Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Cohort study or studies", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Cobalamin", "timeframe_int4": "Hours", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Levocarnitine", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Carglumic acid", "timeframe_int6": "Hours", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Kidney transplantation", "timeframe_int7": "Years", "age_use_int7": "Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Orthotopic liver transplantation (OLT)", "timeframe_int8": "Years", "age_use_int8": "Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Mild clinical features of isolated methylmalonic acidemia associated with a novel variant in the MMAA gene in two Chinese siblings.", "pmid_1": 29996803.0, "pmid_date_1": 2018.0, "pmid_journal_1": "BMC medical genetics"}, {"pmid_title_2": "Targeted exome sequencing for the identification of complementation groups in methylmalonic aciduria: A south Indian experience.", "pmid_2": 27591164.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Clinical biochemistry"}, {"pmid_title_3": "A critical reappraisal of dietary practices in methylmalonic acidemia raises concerns about the safety of medical foods. Part 1: isolated methylmalonic acidemias.", "pmid_3": 26270765.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Genetics in medicine : official journal of the American College of Medical Genetics"}, {"pmid_title_4": "[Acute encephalopathy induced by vaccination in an infant with methylmalonic aciduria cblA].", "pmid_4": 25748407.0, "pmid_date_4": 2015.0, "pmid_journal_4": "Zhonghua er ke za zhi = Chinese journal of pediatrics"}, {"pmid_title_5": "Variable dietary management of methylmalonic acidemia: metabolic and energetic correlations.", "pmid_5": 21048060.0, "pmid_date_5": 2011.0, "pmid_journal_5": "The American journal of clinical nutrition"}, {"pmid_title_6": "Methylmalonic acidaemia: examination of genotype and biochemical data in 32 patients belonging to mut, cblA or cblB complementation group.", "pmid_6": 17957493.0, "pmid_date_6": 2008.0, "pmid_journal_6": "Journal of inherited metabolic disease"}]}, {"_id": "19041-OMIM:615573", "condition": {"condition_name": "NEPHROTIC SYNDROME, TYPE 9", "freq_per_birth": "The prevalence of primary coenzyme Q10 deficiency is thought to be less than 1 in 100,000 people.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["NEPHROTIC SYNDROME, TYPE 9"]}, "gene information": {"db_hgnc_gene_id": 19041.0}, "interventions": [{"int_description_1": "Ubidecarenone"}, {"int_description_2": "Prednisolone"}, {"int_description_3": "Captopril", "timeframe_int3": "Days or Weeks", "age_use_int3": "Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Kidney transplantation"}], "references": [{"pmid_title_1": "COQ8B nephropathy: Early detection and optimal treatment.", "pmid_1": 32543055.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Molecular genetics & genomic medicine"}, {"pmid_title_2": "Steroid-resistant nephrotic syndrome caused by co-inheritance of mutations at <i>NPHS1</i> and <i>ADCK4</i> genes in two Chinese siblings.", "pmid_2": 29259860.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Intractable & rare diseases research"}, {"pmid_title_3": "Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment.", "pmid_3": 28337616.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Pediatric nephrology (Berlin, Germany)"}, {"pmid_title_4": "Focal segmental glomerulosclerosis and medullary nephrocalcinosis in children with ADCK4 mutations.", "pmid_4": 28405841.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Pediatric nephrology (Berlin, Germany)"}, {"pmid_title_5": "ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS.", "pmid_5": 25967120.0, "pmid_date_5": 2016.0, "pmid_journal_5": "Journal of the American Society of Nephrology : JASN"}, {"pmid_title_6": "ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.", "pmid_6": 24270420.0, "pmid_date_6": 2013.0, "pmid_journal_6": "The Journal of clinical investigation"}]}, {"_id": "19129-OMIM:610992", "condition": {"condition_name": "PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD"]}, "gene information": {"db_hgnc_gene_id": 19129.0}, "interventions": [{"int_description_1": "Clonazepam"}, {"int_description_2": "Glycine", "age_use_int2": "Neonate,Infant", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Pyridoxine"}, {"int_description_4": "Phenytoin"}, {"int_description_5": "Paraldehyde", "age_use_int5": "Neonate,Infant", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Serine"}, {"int_description_7": "Assisted respiration"}, {"int_description_8": "Feeding per gastrostomy tube"}, {"int_description_9": "Feeding per nasogastric tube"}], "references": [{"pmid_title_1": "Disturbed phospholipid metabolism in serine biosynthesis defects revealed by metabolomic profiling.", "pmid_1": 29269105.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Molecular genetics and metabolism"}, {"pmid_title_2": "Phosphoserine aminotransferase deficiency: imaging findings in a child with congenital microcephaly.", "pmid_2": 30122079.0, "pmid_date_2": 2018.0, "pmid_journal_2": "The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians"}, {"pmid_title_3": "Two new cases of serine deficiency disorders treated with l-serine.", "pmid_3": 26610677.0, "pmid_date_3": 2016.0, "pmid_journal_3": "European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society"}, {"pmid_title_4": "Neu-Laxova syndrome is a heterogeneous metabolic disorder caused by defects in enzymes of the L-serine biosynthesis pathway.", "pmid_4": 25152457.0, "pmid_date_4": 2014.0, "pmid_journal_4": "American journal of human genetics"}, {"pmid_title_5": "An update on serine deficiency disorders.", "pmid_5": 23463425.0, "pmid_date_5": 2013.0, "pmid_journal_5": "Journal of inherited metabolic disease"}, {"pmid_title_6": "L-serine synthesis in the central nervous system: a review on serine deficiency disorders.", "pmid_6": 19963421.0, "pmid_date_6": 2010.0, "pmid_journal_6": "Molecular genetics and metabolism"}, {"pmid_title_7": "Phosphoserine aminotransferase deficiency: a novel disorder of the serine biosynthesis pathway.", "pmid_7": 17436247.0, "pmid_date_7": 2007.0, "pmid_journal_7": "American journal of human genetics"}, {"pmid_title_8": "Treatment with amino acids in serine deficiency disorders.", "pmid_8": 16763900.0, "pmid_date_8": 2006.0, "pmid_journal_8": "Journal of inherited metabolic disease"}]}, {"_id": "1912-OMIM:254210", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC", "freq_per_birth": "The prevalence of congenital myasthenic syndrome is unknown. At least 600 families with affected individuals have been described in the scientific literature.", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC"]}, "gene information": {"db_hgnc_gene_id": 1912.0}, "interventions": [{"int_description_1": "Mechanical ventilation", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Salbutamol", "timeframe_int2": "Days or Weeks,Years", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Amifampridine"}, {"int_description_4": "Procaine", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Procainamide"}, {"int_description_6": "Pyridostigmine"}, {"int_description_7": "Ciprofloxacin"}, {"int_description_8": "Quinidine"}, {"int_description_9": "Chloroquine"}, {"int_description_10": "Phenytoin"}, {"int_description_11": "Beta-blockers"}, {"int_description_12": "Lithium"}, {"int_description_13": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "Congenital myasthenic syndrome with episodic apnoea: clinical, neurophysiological and genetic features in the long-term follow-up of 19 patients.", "pmid_1": 29189923.0, "pmid_date_1": 2017.0, "pmid_journal_1": "J Neurol"}, {"pmid_title_2": "Congenital Myasthenic Syndromes", "pmid_2": 20301347.0, "pmid_date_2": 2016.0, "pmid_journal_2": "GeneReviews\u00ae"}, {"pmid_title_3": "Choline Acetyltransferase Mutations Causing Congenital Myasthenic Syndrome: Molecular Findings and Genotype-Phenotype Correlations.", "pmid_3": 26080897.0, "pmid_date_3": 2015.0, "pmid_journal_3": "Human mutation"}, {"pmid_title_4": "Choline acetyltransferase mutations in myasthenic syndrome due to deficient acetylcholine resynthesis.", "pmid_4": 12548525.0, "pmid_date_4": 2003.0, "pmid_journal_4": "Muscle & nerve"}]}, {"_id": "19191-OMIM:243700", "condition": {"condition_name": "HYPER-IgE RECURRENT INFECTION SYNDROME 2, AUTOSOMAL RECESSIVE", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["HYPER-IgE RECURRENT INFECTION SYNDROME 2, AUTOSOMAL RECESSIVE"]}, "gene information": {"db_hgnc_gene_id": 19191.0}, "interventions": [{"int_description_1": "Valaciclovir"}, {"int_description_2": "Cidofovir"}, {"int_description_3": "Bone marrow transplantation"}, {"int_description_4": "Haematopoietic stem cell transplantation", "timeframe_int4": "Days or Weeks,Years", "age_use_int4": "Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Curative"}], "references": [{"pmid_title_1": "Successful hematopoietic stem cell transplantation after myeloablative conditioning in three patients with dedicator of cytokinesis 8 deficiency (DOCK8) related Hyper IgE syndrome.", "pmid_1": 29269803.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Bone Marrow Transplant"}, {"pmid_title_2": "Novel mutation in DOCK8-HIES with severe phenotype and successful transplantation.", "pmid_2": 27890707.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Clin Immunol"}, {"pmid_title_3": "Successful bone marrow transplantation for DOCK8 deficient hyper IgE syndrome.", "pmid_3": 22248482.0, "pmid_date_3": 2012.0, "pmid_journal_3": "Pediatr Transplant"}, {"pmid_title_4": "Cutaneous manifestations of DOCK8 deficiency syndrome.", "pmid_4": 21931011.0, "pmid_date_4": 2012.0, "pmid_journal_4": "Arch Dermatol"}, {"pmid_title_5": "Successful engraftment of donor marrow after allogeneic hematopoietic cell transplantation in autosomal-recessive hyper-IgE syndrome caused by dedicator of cytokinesis 8 deficiency.", "pmid_5": 20810158.0, "pmid_date_5": 2010.0, "pmid_journal_5": "J Allergy Clin Immunol"}]}, {"_id": "19331-OMIM:251110", "condition": {"condition_name": "METHYLMALONIC ACIDURIA, cblB TYPE", "freq_per_birth": "This condition occurs in an estimated 1 in 50,000 to 100,000 people.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["METHYLMALONIC ACIDURIA, cblB TYPE"]}, "gene information": {"db_hgnc_gene_id": 19331.0}, "interventions": [{"int_description_1": "Protein-restricted diet", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Hydroxocobalamin", "timeframe_int2": "Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Metronidazole", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Benzoic acid", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Levocarnitine", "timeframe_int5": "Hours,Days or Weeks,Years", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Carglumic acid", "timeframe_int6": "Hours,Days or Weeks,Years", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Kidney transplantation", "timeframe_int7": "Days or Weeks,Years", "age_use_int7": "Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "New perspectives for pharmacological chaperoning treatment in methylmalonic aciduria cblB type.", "pmid_1": 29197662.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Biochimica et biophysica acta. Molecular basis of disease"}, {"pmid_title_2": "[A Chinese boy with methylmalonic aciduria cblB type and a novel mutation in the MMAB gene].", "pmid_2": 25760844.0, "pmid_date_2": 2015.0, "pmid_journal_2": "Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics"}, {"pmid_title_3": "Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia.", "pmid_3": 25205257.0, "pmid_date_3": 2014.0, "pmid_journal_3": "Orphanet journal of rare diseases"}, {"pmid_title_4": "Methylmalonic acidemia and kidney transplantation.", "pmid_4": 23793882.0, "pmid_date_4": 2013.0, "pmid_journal_4": "Pediatric nephrology (Berlin, Germany)"}, {"pmid_title_5": "Renal transplant in methylmalonic acidemia: could it be the best option? Report on a case at 10 years and review of the literature.", "pmid_5": 17401587.0, "pmid_date_5": 2007.0, "pmid_journal_5": "Pediatric nephrology (Berlin, Germany)"}]}, {"_id": "19440-OMIM:260400", "condition": {"condition_name": "SHWACHMAN-DIAMOND SYNDROME 1", "pattern_of_inheritance": "Autosomal recessive, Autosomal dominant", "alternate_names": ["SHWACHMAN-DIAMOND SYNDROME 1"]}, "gene information": {"db_hgnc_gene_id": 19440.0}, "interventions": [{"int_description_1": "Phylloquinone"}, {"int_description_2": "Somatotropin"}, {"int_description_3": "Vitamin D"}, {"int_description_4": "Hydrocortisone"}, {"int_description_5": "Vitamin E"}, {"int_description_6": "Pancreatic enzymes replacement"}, {"int_description_7": "Filgrastim"}, {"int_description_8": "Vitamin A"}, {"int_description_9": "Bone marrow transplantation"}], "references": [{"pmid_title_1": "The Greek Registry of Shwachman Diamond-Syndrome: Molecular and clinical data.", "pmid_1": 28509441.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Pediatr Blood Cancer"}, {"pmid_title_2": "Structural variation in SBDS gene, with loss of exon 3, in two Shwachman-Diamond patients.", "pmid_2": 27519942.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Blood Cells Mol Dis"}, {"pmid_title_3": "A unique case of Shwachman-Diamond syndrome presenting with congenital hypopituitarism.", "pmid_3": 27754968.0, "pmid_date_3": 2016.0, "pmid_journal_3": "J Pediatr Endocrinol Metab"}]}, {"_id": "1955-OMIM:601462", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL; CMS1A", "freq_per_birth": "The prevalence of congenital myasthenic syndrome is unknown. At least 600 families with affected individuals have been described in the scientific literature.", "pattern_of_inheritance": "Autosomal dominant==Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL; CMS1A", "MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B"]}, "gene information": {"db_hgnc_gene_id": 1955.0}, "interventions": [{"int_description_1": "Mechanical ventilation"}, {"int_description_2": "Ephedrine"}, {"int_description_3": "Salbutamol"}, {"int_description_4": "Amifampridine"}, {"int_description_5": "Procaine"}, {"int_description_6": "Procainamide"}, {"int_description_7": "Pyridostigmine", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "Yes", "qualscale_reclass_drug7": "Case report(s)", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Ciprofloxacin"}, {"int_description_9": "Quinidine", "timeframe_int9": "Hours,Days or Weeks", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Cohort study or studies", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Chloroquine"}, {"int_description_11": "Fluoxetine"}, {"int_description_12": "Phenytoin"}, {"int_description_13": "Beta-blockers"}, {"int_description_14": "Lithium"}, {"int_description_15": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "Congenital Myasthenic Syndromes", "pmid_1": 20301347.0, "pmid_date_1": 2016.0, "pmid_journal_1": "GeneReviews\u00ae"}]}, {"_id": "1955-OMIM:608930", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B", "freq_per_birth": "The prevalence of congenital myasthenic syndrome is unknown. At least 600 families with affected individuals have been described in the scientific literature.", "pattern_of_inheritance": "Autosomal dominant==Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B", "MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL; CMS1A"]}, "gene information": {"db_hgnc_gene_id": 1955.0}, "interventions": [{"int_description_1": "Mechanical ventilation", "timeframe_int1": "Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Amifampridine"}, {"int_description_3": "Procaine", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Procainamide"}, {"int_description_5": "Pyridostigmine"}, {"int_description_6": "Ciprofloxacin"}, {"int_description_7": "Quinidine"}, {"int_description_8": "Chloroquine"}, {"int_description_9": "Phenytoin"}, {"int_description_10": "Beta-blockers"}, {"int_description_11": "Lithium"}, {"int_description_12": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "Congenital Myasthenic Syndromes", "pmid_1": 20301347.0, "pmid_date_1": 2016.0, "pmid_journal_1": "GeneReviews\u00ae"}, {"pmid_title_2": "Myasthenic syndrome AChR\u03b1 C-loop mutant disrupts initiation of channel gating.", "pmid_2": 22728938.0, "pmid_date_2": 2012.0, "pmid_journal_2": "The Journal of clinical investigation"}]}, {"_id": "1961-OMIM:616313", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A", "MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C"]}, "gene information": {"db_hgnc_gene_id": 1961.0}, "interventions": [{"int_description_1": "Mechanical ventilation"}, {"int_description_2": "Ephedrine"}, {"int_description_3": "Salbutamol"}, {"int_description_4": "Amifampridine"}, {"int_description_5": "Procaine"}, {"int_description_6": "Procainamide"}, {"int_description_7": "Pyridostigmine", "timeframe_int7": "Hours,Days or Weeks", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Ciprofloxacin"}, {"int_description_9": "Quinidine", "timeframe_int9": "Hours,Days or Weeks", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Chloroquine"}, {"int_description_11": "Fluoxetine"}, {"int_description_12": "Phenytoin"}, {"int_description_13": "Beta-blockers"}, {"int_description_14": "Lithium"}, {"int_description_15": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "Congenital Myasthenic Syndromes", "pmid_1": 20301347.0, "pmid_date_1": 2016.0, "pmid_journal_1": "GeneReviews\u00ae"}, {"pmid_title_2": "Molecular characterisation of congenital myasthenic syndromes in Southern Brazil.", "pmid_2": 20562457.0, "pmid_date_2": 2010.0, "pmid_journal_2": "Journal of neurology, neurosurgery, and psychiatry"}]}, {"_id": "1961-OMIM:616314", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C", "MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A"]}, "gene information": {"db_hgnc_gene_id": 1961.0}, "interventions": [{"int_description_1": "Mechanical ventilation", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Amifampridine"}, {"int_description_3": "Procaine", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Procainamide"}, {"int_description_5": "Pyridostigmine"}, {"int_description_6": "Ciprofloxacin"}, {"int_description_7": "Quinidine"}, {"int_description_8": "Chloroquine"}, {"int_description_9": "Phenytoin"}, {"int_description_10": "Beta-blockers"}, {"int_description_11": "Lithium"}, {"int_description_12": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "Congenital Myasthenic Syndromes", "pmid_1": 20301347.0, "pmid_date_1": 2016.0, "pmid_journal_1": "GeneReviews\u00ae"}]}, {"_id": "1965-OMIM:616321", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C", "MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A", "MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B"]}, "gene information": {"db_hgnc_gene_id": 1965.0}, "interventions": [{"int_description_1": "Mechanical ventilation"}, {"int_description_2": "Ephedrine"}, {"int_description_3": "Salbutamol"}, {"int_description_4": "Amifampridine"}, {"int_description_5": "Procaine"}, {"int_description_6": "Procainamide"}, {"int_description_7": "Pyridostigmine", "timeframe_int7": "Hours,Days or Weeks", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Ciprofloxacin"}, {"int_description_9": "Quinidine", "timeframe_int9": "Hours,Days or Weeks", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Chloroquine"}, {"int_description_11": "Fluoxetine"}, {"int_description_12": "Phenytoin"}, {"int_description_13": "Beta-blockers"}, {"int_description_14": "Lithium"}, {"int_description_15": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "Congenital Myasthenic Syndromes", "pmid_1": 20301347.0, "pmid_date_1": 2016.0, "pmid_journal_1": "GeneReviews\u00ae"}, {"pmid_title_2": "Congenital myasthenia-related AChR delta subunit mutation interferes with intersubunit communication essential for channel gating.", "pmid_2": 18398509.0, "pmid_date_2": 2008.0, "pmid_journal_2": "The Journal of clinical investigation"}]}, {"_id": "1965-OMIM:616322", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C", "MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B", "MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A"]}, "gene information": {"db_hgnc_gene_id": 1965.0}, "interventions": [{"int_description_1": "Mechanical ventilation", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Amifampridine"}, {"int_description_3": "Procaine", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Procainamide"}, {"int_description_5": "Pyridostigmine"}, {"int_description_6": "Ciprofloxacin"}, {"int_description_7": "Quinidine"}, {"int_description_8": "Chloroquine"}, {"int_description_9": "Phenytoin"}, {"int_description_10": "Beta-blockers"}, {"int_description_11": "Lithium"}, {"int_description_12": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "Congenital Myasthenic Syndromes", "pmid_1": 20301347.0, "pmid_date_1": 2016.0, "pmid_journal_1": "GeneReviews\u00ae"}, {"pmid_title_2": "Congenital myasthenia-related AChR delta subunit mutation interferes with intersubunit communication essential for channel gating.", "pmid_2": 18398509.0, "pmid_date_2": 2008.0, "pmid_journal_2": "The Journal of clinical investigation"}]}, {"_id": "1965-OMIM:616323", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B", "MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C", "MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A"]}, "gene information": {"db_hgnc_gene_id": 1965.0}, "interventions": [{"int_description_1": "Mechanical ventilation", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Amifampridine"}, {"int_description_3": "Procaine", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Procainamide"}, {"int_description_5": "Pyridostigmine"}, {"int_description_6": "Ciprofloxacin"}, {"int_description_7": "Quinidine"}, {"int_description_8": "Chloroquine"}, {"int_description_9": "Phenytoin"}, {"int_description_10": "Beta-blockers"}, {"int_description_11": "Lithium"}, {"int_description_12": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "Congenital Myasthenic Syndromes", "pmid_1": 20301347.0, "pmid_date_1": 2016.0, "pmid_journal_1": "GeneReviews\u00ae"}]}, {"_id": "1966-OMIM:605809", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A", "pattern_of_inheritance": "Autosomal dominant; Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B", "MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A", "MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS4C"]}, "gene information": {"db_hgnc_gene_id": 1966.0}, "interventions": [{"int_description_1": "Mechanical ventilation"}, {"int_description_2": "Ephedrine"}, {"int_description_3": "Salbutamol"}, {"int_description_4": "Amifampridine"}, {"int_description_5": "Procaine"}, {"int_description_6": "Procainamide"}, {"int_description_7": "Pyridostigmine", "timeframe_int7": "Hours,Days or Weeks", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Case report(s)", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Ciprofloxacin"}, {"int_description_9": "Quinidine", "timeframe_int9": "Hours,Days or Weeks", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Case report(s)", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Chloroquine"}, {"int_description_11": "Fluoxetine"}, {"int_description_12": "Phenytoin"}, {"int_description_13": "Acetylcholinesterase inhibitors"}, {"int_description_14": "Beta-blockers"}, {"int_description_15": "Lithium"}, {"int_description_16": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "Clinical and genetic characterization of an Italian family with slow-channel syndrome.", "pmid_1": 30542963.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"}, {"pmid_title_2": "Congenital Myasthenic Syndromes", "pmid_2": 20301347.0, "pmid_date_2": 2016.0, "pmid_journal_2": "GeneReviews\u00ae"}, {"pmid_title_3": "Molecular characterisation of congenital myasthenic syndromes in Southern Brazil.", "pmid_3": 20562457.0, "pmid_date_3": 2010.0, "pmid_journal_3": "Journal of neurology, neurosurgery, and psychiatry"}]}, {"_id": "1966-OMIM:608931", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS4C", "freq_per_birth": "The prevalence of congenital myasthenic syndrome is unknown. At least 600 families with affected individuals have been described in the scientific literature.", "pattern_of_inheritance": "Autosomal dominant==Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B", "MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS4C", "MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A"]}, "gene information": {"db_hgnc_gene_id": 1966.0}, "interventions": [{"int_description_1": "Mechanical ventilation", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Amifampridine"}, {"int_description_3": "Procaine", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Procainamide"}, {"int_description_5": "Pyridostigmine"}, {"int_description_6": "Ciprofloxacin"}, {"int_description_7": "Quinidine"}, {"int_description_8": "Chloroquine"}, {"int_description_9": "Phenytoin"}, {"int_description_10": "Acetylcholinesterase inhibitors"}, {"int_description_11": "Beta-blockers"}, {"int_description_12": "Lithium"}, {"int_description_13": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "Cardiac autonomic function evaluation in pediatric and adult patients with congenital myasthenic syndromes.", "pmid_1": 30898524.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Neuromuscular disorders : NMD"}, {"pmid_title_2": "Congenital Myasthenic Syndromes", "pmid_2": 20301347.0, "pmid_date_2": 2016.0, "pmid_journal_2": "GeneReviews\u00ae"}]}, {"_id": "1966-OMIM:616324", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS4C", "MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B", "MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A"]}, "gene information": {"db_hgnc_gene_id": 1966.0}, "interventions": [{"int_description_1": "Mechanical ventilation", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Salbutamol", "timeframe_int2": "Days or Weeks,Years", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Amifampridine"}, {"int_description_4": "Procaine", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Procainamide"}, {"int_description_6": "Pyridostigmine"}, {"int_description_7": "Ciprofloxacin"}, {"int_description_8": "Quinidine"}, {"int_description_9": "Chloroquine"}, {"int_description_10": "Phenytoin"}, {"int_description_11": "Beta-blockers"}, {"int_description_12": "Lithium"}, {"int_description_13": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "Molecular characterization of congenital myasthenic syndromes in Spain.", "pmid_1": 29054425.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Neuromuscular disorders : NMD"}, {"pmid_title_2": "Congenital Myasthenic Syndromes", "pmid_2": 20301347.0, "pmid_date_2": 2016.0, "pmid_journal_2": "GeneReviews\u00ae"}]}, {"_id": "1968-OMIM:214500", "condition": {"condition_name": "CHEDIAK-HIGASHI SYNDROME; CHS", "freq_per_birth": "Chediak-Higashi syndrome is a rare disorder. About 200 cases of the condition have been reported worldwide.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["CHEDIAK-HIGASHI SYNDROME; CHS"]}, "gene information": {"db_hgnc_gene_id": 1968.0}, "interventions": [{"int_description_1": "Levodopa", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Antibiotics"}, {"int_description_3": "Hematopoietic stem cell transplantation", "timeframe_int3": "Days or Weeks", "age_use_int3": "Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Curative"}], "references": [{"pmid_title_1": "Ch\u00e9diak-Higashi syndrome with novel gene mutation.", "pmid_1": 28183707.0, "pmid_date_1": 2017.0, "pmid_journal_1": "BMJ case reports"}, {"pmid_title_2": "Chediak-Higashi syndrome presenting as young-onset levodopa-responsive parkinsonism.", "pmid_2": 23436631.0, "pmid_date_2": 2013.0, "pmid_journal_2": "Movement disorders : official journal of the Movement Disorder Society"}, {"pmid_title_3": "Approach to hemophagocytic syndromes.", "pmid_3": 22160031.0, "pmid_date_3": 2011.0, "pmid_journal_3": "Hematology. American Society of Hematology. Education Program"}]}, {"_id": "19693-OMIM:616276", "condition": {"condition_name": "COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7", "freq_per_birth": "The prevalence of primary coenzyme Q10 deficiency is thought to be less than 1 in 100,000 people.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7"]}, "gene information": {"db_hgnc_gene_id": 19693.0}, "interventions": [{"int_description_1": "Ubidecarenone", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Still in Trials / Unproven"}, {"int_description_2": "Levocarnitine", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Still in Trials / Unproven"}, {"int_description_3": "Thiamine"}], "references": [{"pmid_title_1": "Clinical phenotype, in silico and biomedical analyses, and intervention for an East Asian population-specific c.370G>A (p.G124S) COQ4 mutation in a Chinese family with CoQ10 deficiency-associated Leigh syndrome.", "pmid_1": 30659264.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Journal of human genetics"}, {"pmid_title_2": "Mutations in COQ4, an essential component of coenzyme Q biosynthesis, cause lethal neonatal mitochondrial encephalomyopathy.", "pmid_2": 26185144.0, "pmid_date_2": 2015.0, "pmid_journal_2": "Journal of medical genetics"}]}, {"_id": "19750-OMIM:243150", "condition": {"condition_name": "GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME"]}, "gene information": {"db_hgnc_gene_id": 19750.0}, "interventions": [{"int_description_1": "Prednisone"}, {"int_description_2": "Ganciclovir"}, {"int_description_3": "Human immunoglobulin G", "timeframe_int3": "Hours,Days or Weeks,Years", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Alemtuzumab"}, {"int_description_5": "Basiliximab"}, {"int_description_6": "Daclizumab"}, {"int_description_7": "Cyclosporine"}, {"int_description_8": "Sirolimus"}, {"int_description_9": "Cyclophosphamide"}, {"int_description_10": "Thiotepa"}, {"int_description_11": "Trimethoprim"}, {"int_description_12": "Sulfamethoxazole"}, {"int_description_13": "Treosulfan"}, {"int_description_14": "Fluconazole"}, {"int_description_15": "Methotrexate"}, {"int_description_16": "Fludarabine"}, {"int_description_17": "Pentamidine"}, {"int_description_18": "Tacrolimus"}, {"int_description_19": "Azathioprine", "timeframe_int19": "Days or Weeks", "age_use_int19": "Neonate,Infant,Child", "contra_int19": "No", "qualscale_reclass_drug19": "Case report(s)", "rev1_eff_reclass_drug19": "Effective / Ameliorative"}, {"int_description_20": "Infliximab"}, {"int_description_21": "Antibiotics"}, {"int_description_22": "Antilymphocyte immunoglobulin (horse)"}, {"int_description_23": "Steroids"}, {"int_description_24": "Anti-thymocyte globulin"}, {"int_description_25": "Irradiated and CMV negative blood products transfusion", "timeframe_int25": "Hours,Days or Weeks", "age_use_int25": "Neonate,Infant,Child", "contra_int25": "No", "qualscale_reclass_drug25": "Case report(s)", "rev1_eff_reclass_drug25": "Effective / Ameliorative"}, {"int_description_26": "Total body irradiation", "timeframe_int26": "Days or Weeks,Years", "age_use_int26": "Infant,Child", "contra_int26": "No", "qualscale_reclass_drug26": "Case report(s)", "rev1_eff_reclass_drug26": "Effective / Ameliorative"}, {"int_description_27": "Total parenteral nutrition", "timeframe_int27": "Hours,Days or Weeks,Years", "age_use_int27": "Neonate,Infant,Child", "contra_int27": "No", "qualscale_reclass_drug27": "Case report(s)", "rev1_eff_reclass_drug27": "Effective / Ameliorative"}, {"int_description_28": "Hematopoietic stem cell transplantation"}, {"int_description_29": "Surgery of small bowel and colon"}, {"timeframe_int31": "Years", "age_use_int31": "Child", "qualscale_reclass_drug31": "Case report(s)", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Combined Immunodeficiency With Inflammatory Bowel Disease in a Patient With TTC7A Deficiency.", "pmid_1": 31616743.0, "pmid_date_1": 2019.0, "pmid_journal_1": "ACG Case Rep J"}, {"pmid_title_2": "Congenital intestinal atresias with multiple episodes of sepsis: A case report and review of literature.", "pmid_2": 29879038.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Medicine (Baltimore)"}, {"pmid_title_3": "Novel Mutations of the <i>Tetratricopeptide Repeat Domain 7A</i> Gene and Phenotype/Genotype Comparison.", "pmid_3": 28936210.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Front Immunol"}, {"pmid_title_4": "Stem cell transplantation for tetratricopeptide repeat domain 7A deficiency: long-term follow-up.", "pmid_4": 27418642.0, "pmid_date_4": 2016.0, "pmid_journal_4": "Blood"}, {"pmid_title_5": "Compound heterozygous mutations in TTC7A cause familial multiple intestinal atresias and severe combined immunodeficiency.", "pmid_5": 25534311.0, "pmid_date_5": 2015.0, "pmid_journal_5": "Clin Genet"}, {"pmid_title_6": "Multiple intestinal atresia with combined immune deficiency related to TTC7A defect is a multiorgan pathology: study of a French-Canadian-based cohort.", "pmid_6": 25546680.0, "pmid_date_6": 2014.0, "pmid_journal_6": "Medicine (Baltimore)"}, {"pmid_title_7": "Tetratricopeptide repeat domain 7A (TTC7A) mutation in a newborn with multiple intestinal atresia and combined immunodeficiency.", "pmid_7": 24931897.0, "pmid_date_7": 2014.0, "pmid_journal_7": "J Clin Immunol"}, {"pmid_title_8": "Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease.", "pmid_8": 24417819.0, "pmid_date_8": 2014.0, "pmid_journal_8": "Gastroenterology"}, {"pmid_title_9": "Exome sequencing identifies mutations in the gene TTC7A in French-Canadian cases with hereditary multiple intestinal atresia.", "pmid_9": 23423984.0, "pmid_date_9": 2013.0, "pmid_journal_9": "J Med Genet"}, {"pmid_title_10": "Whole-exome sequencing identifies tetratricopeptide repeat domain 7A (TTC7A) mutations for combined immunodeficiency with intestinal atresias.", "pmid_10": 23830146.0, "pmid_date_10": 2013.0, "pmid_journal_10": "J Allergy Clin Immunol"}]}, {"_id": "20233-OMIM:614650", "condition": {"condition_name": "COENZYME Q10 DEFICIENCY, PRIMARY, 6", "freq_per_birth": "The prevalence of primary coenzyme Q10 deficiency is thought to be less than 1 in 100,000 people.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["COENZYME Q10 DEFICIENCY, PRIMARY, 6"]}, "gene information": {"db_hgnc_gene_id": 20233.0}, "interventions": [{"int_description_1": "Ubidecarenone"}, {"int_description_2": "Kidney transplantation", "timeframe_int2": "Days or Weeks,Years", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Primary coenzyme Q10 Deficiency-6 (COQ10D6): Two siblings with variable expressivity of the renal phenotype.", "pmid_1": 30682496.0, "pmid_date_1": 2020.0, "pmid_journal_1": "European journal of medical genetics"}, {"pmid_title_2": "CoQ10-related sustained remission of proteinuria in a child with COQ6 glomerulopathy-a case report.", "pmid_2": 30232548.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Pediatric nephrology (Berlin, Germany)"}, {"pmid_title_3": "Further phenotypic heterogeneity of CoQ10 deficiency associated with steroid resistant nephrotic syndrome and novel COQ2 and COQ6 variants.", "pmid_3": 28044327.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Clinical genetics"}, {"pmid_title_4": "COQ6 Mutations in Children With Steroid-Resistant Focal Segmental Glomerulosclerosis and Sensorineural Hearing Loss.", "pmid_4": 28117207.0, "pmid_date_4": 2017.0, "pmid_journal_4": "American journal of kidney diseases : the official journal of the National Kidney Foundation"}, {"pmid_title_5": "COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness.", "pmid_5": 21540551.0, "pmid_date_5": 2011.0, "pmid_journal_5": "The Journal of clinical investigation"}]}, {"_id": "2025-OMIM:166600", "condition": {"condition_name": "OSTEOPETROSIS, AUTOSOMAL DOMINANT 2; OPTA2", "freq_per_birth": "Autosomal dominant osteopetrosis is the most common form of the disorder, affecting about 1 in 20,000 people. Autosomal recessive osteopetrosis is rarer, occurring in an estimated 1 in 250,000 people.Other forms of osteopetrosis are very rare. Only a few cases of intermediate autosomal osteopetrosis and OL-EDA-ID have been reported in the medical literature.", "pattern_of_inheritance": "Autosomal dominant==Autosomal recessive==X-linked recessive", "alternate_names": ["HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD", "OSTEOPETROSIS, AUTOSOMAL DOMINANT 2; OPTA2", "OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4"]}, "gene information": {"db_hgnc_gene_id": 2025.0}, "interventions": [{"int_description_1": "Calcium", "timeframe_int1": "Days or Weeks", "age_use_int1": "Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Cholecalciferol", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Parathyroid hormone"}, {"int_description_4": "Blood transfusions", "timeframe_int4": "Days or Weeks,Years", "age_use_int4": "Child", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Palliative care", "timeframe_int5": "Days or Weeks,Years", "age_use_int5": "Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Small interfering RNA therapy"}, {"int_description_7": "Orthopedic procedures", "timeframe_int7": "Days or Weeks,Years", "age_use_int7": "Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "One Disease, Many Genes: Implications for the Treatment of Osteopetroses.", "pmid_1": 30837952.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Frontiers in endocrinology"}, {"pmid_title_2": "Osteopetroses, emphasizing potential approaches to treatment.", "pmid_2": 28167345.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Bone"}, {"pmid_title_3": "Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2.", "pmid_3": 26325626.0, "pmid_date_3": 2015.0, "pmid_journal_3": "Molecular therapy. Nucleic acids"}]}, {"_id": "2025-OMIM:611490", "condition": {"condition_name": "OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4", "freq_per_birth": "Autosomal dominant osteopetrosis is the most common form of the disorder, affecting about 1 in 20,000 people. Autosomal recessive osteopetrosis is rarer, occurring in an estimated 1 in 250,000 people.Other forms of osteopetrosis are very rare. Only a few cases of intermediate autosomal osteopetrosis and OL-EDA-ID have been reported in the medical literature.", "pattern_of_inheritance": "Autosomal dominant==Autosomal recessive==X-linked recessive", "alternate_names": ["HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD", "OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4", "OSTEOPETROSIS, AUTOSOMAL DOMINANT 2; OPTA2"]}, "gene information": {"db_hgnc_gene_id": 2025.0}, "interventions": [{"int_description_1": "Denosumab"}, {"int_description_2": "Interferon-\u03b3", "timeframe_int2": "Hours", "age_use_int2": "Neonate", "contra_int2": "Yes", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Still in Trials / Unproven"}, {"int_description_3": "Hematopoietic stem cell transplantation", "timeframe_int3": "Days or Weeks", "age_use_int3": "Neonate", "contra_int3": "Yes", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Curative"}], "references": [{"pmid_title_1": "One Disease, Many Genes: Implications for the Treatment of Osteopetroses.", "pmid_1": 30837952.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Frontiers in endocrinology"}, {"pmid_title_2": "Osteopetroses, emphasizing potential approaches to treatment.", "pmid_2": 28167345.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Bone"}]}, {"_id": "2025-OMIM:618541", "condition": {"condition_name": "HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4", "HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD", "OSTEOPETROSIS, AUTOSOMAL DOMINANT 2; OPTA2"]}, "gene information": {"db_hgnc_gene_id": 2025.0}, "interventions": [{"int_description_1": "Palliative care", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "qualscale_reclass_drug1": "Case report(s)"}], "references": [{"pmid_title_1": "Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification.", "pmid_1": 31155284.0, "pmid_date_1": 2019.0, "pmid_journal_1": "American journal of human genetics"}]}, {"_id": "20473-OMIM:609054", "condition": {"condition_name": "FANCONI ANEMIA, COMPLEMENTATION GROUP J", "pattern_of_inheritance": "X-linked recessive, Autosomal recessive", "alternate_names": ["FANCONI ANEMIA, COMPLEMENTATION GROUP J", "BREAST CANCER"]}, "gene information": {"db_hgnc_gene_id": 20473.0}, "interventions": [{"int_description_1": "Healthy diet"}, {"int_description_2": "Oxandrolone"}, {"int_description_3": "Danazol"}, {"int_description_4": "Testosterone propionate"}, {"int_description_5": "Oxymetholone"}, {"int_description_6": "Metenolone"}, {"int_description_7": "Calcium"}, {"int_description_8": "Prednisone"}, {"int_description_9": "Dexamethasone"}, {"int_description_10": "Insulin aspart"}, {"int_description_11": "Medroxyprogesterone acetate"}, {"int_description_12": "Tretinoin"}, {"int_description_13": "Eltrombopag"}, {"int_description_14": "Levothyroxine"}, {"int_description_15": "Estradiol"}, {"int_description_16": "Cetuximab"}, {"int_description_17": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_18": "Alemtuzumab"}, {"int_description_19": "Coenzyme M"}, {"int_description_20": "Cyclosporine"}, {"int_description_21": "Dactinomycin"}, {"int_description_22": "Sirolimus"}, {"int_description_23": "Somatotropin"}, {"int_description_24": "Vitamin D"}, {"int_description_25": "Cyclophosphamide"}, {"int_description_26": "Carboplatin"}, {"int_description_27": "Busulfan"}, {"int_description_28": "Ifosfamide"}, {"int_description_29": "Thiotepa"}, {"int_description_30": "Doxorubicin"}, {"int_description_31": "Fluorouracil", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Mercaptopurine", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Neonate,Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Trimethoprim"}, {"int_description_34": "Sulfamethoxazole"}, {"int_description_35": "Gemcitabine"}, {"int_description_36": "Vincristine"}, {"int_description_37": "Methotrexate"}, {"int_description_38": "Fludarabine"}, {"int_description_39": "Cytarabine"}, {"int_description_40": "Irinotecan"}, {"int_description_41": "Daunorubicin"}, {"int_description_42": "Etoposide"}, {"int_description_43": "Idarubicin"}, {"int_description_44": "Tacrolimus"}, {"int_description_45": "Acyclovir"}, {"int_description_46": "Quercetin"}, {"int_description_47": "Tioguanine"}, {"int_description_48": "Mycophenolate mofetil"}, {"int_description_49": "Tranexamic acid"}, {"int_description_50": "Hydroxyurea"}, {"int_description_51": "Methylprednisolone"}, {"int_description_52": "Methyltestosterone"}, {"int_description_53": "Leucovorin"}, {"int_description_54": "Vinorelbine"}, {"int_description_55": "Deferasirox"}, {"int_description_56": "Deferiprone"}, {"int_description_57": "Co-trimoxazole"}, {"int_description_58": "Asparaginase Escherichia coli"}, {"int_description_59": "Cisplatin"}, {"int_description_60": "Antilymphocyte immunoglobulin (horse)"}, {"int_description_61": "Norethandrolone"}, {"int_description_62": "Phosphorus"}, {"int_description_63": "GM-CSF (granulocyte-macrophage colony-stimulating factor)"}, {"int_description_64": "rh-SOD"}, {"int_description_65": "Bevacizumab"}, {"int_description_66": "Filgrastim"}, {"int_description_67": "Amifostine"}, {"int_description_68": "Radiation therapy", "timeframe_int68": "Days or Weeks,Years", "age_use_int68": "Child", "contra_int68": "No", "qualscale_reclass_drug68": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug68": "Effective / Ameliorative"}, {"int_description_69": "Total abdominal radiation"}, {"int_description_70": "Total body irradiation"}, {"int_description_71": "Total lymphoid irradiation"}, {"int_description_72": "Transfusion of blood products"}, {"int_description_73": "Bone marrow transplantation"}, {"int_description_74": "Hematopoietic stem cell transplantation"}, {"int_description_75": "Surgery for polydactyly, carpectomy"}, {"int_description_76": "Surgical intervention"}, {"int_description_77": "\u042burgical tumor removement"}], "references": [{"pmid_title_1": "Gingival Bleeding in a Child with Fanconi Anemia: A Case Report and Literature Review.", "pmid_1": 32231808.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Case Rep Dent"}, {"pmid_title_2": "Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.", "pmid_2": 29668547.0, "pmid_date_2": 2019.0, "pmid_journal_2": "J Pediatr Hematol Oncol"}, {"pmid_title_3": "Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.", "pmid_3": 31192125.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Front Oncol"}, {"pmid_title_4": "Fanconi anemia: a single center experience of a large cohort.", "pmid_4": 31990462.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Turk J Pediatr"}, {"pmid_title_5": "Therapeutic research in the crystal chromosome disease Fanconi anemia.", "pmid_5": 30389152.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Mutat Res Genet Toxicol Environ Mutagen"}, {"pmid_title_6": "Oral cancer in Fanconi anemia: Review of 121 cases.", "pmid_6": 29650274.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Crit Rev Oncol Hematol"}, {"pmid_title_7": "Essential Role of BRCA2 in Ovarian Development and Function.", "pmid_7": 30207912.0, "pmid_date_7": 2018.0, "pmid_journal_7": "N Engl J Med"}, {"pmid_title_8": "Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.", "pmid_8": 29203412.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Biol Blood Marrow Transplant"}, {"pmid_title_9": "How I manage patients with Fanconi anaemia.", "pmid_9": 28474441.0, "pmid_date_9": 2017.0, "pmid_journal_9": "Br J Haematol"}, {"pmid_title_10": "Eltrombopag for the treatment of aplastic anemia: current perspectives.", "pmid_10": 27695288.0, "pmid_date_10": 2016.0, "pmid_journal_10": "Drug Des Devel Ther"}, {"pmid_title_11": "Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.", "pmid_11": 27246371.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Biol Blood Marrow Transplant"}, {"pmid_title_12": "Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.", "pmid_12": 26900943.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Pediatr Hematol Oncol"}, {"pmid_title_13": "Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.", "pmid_13": 26657402.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Eur J Med Genet"}, {"pmid_title_14": "Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.", "pmid_14": 25575015.0, "pmid_date_14": 2015.0, "pmid_journal_14": "J Clin Endocrinol Metab"}, {"pmid_title_15": "Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.", "pmid_15": 25862235.0, "pmid_date_15": 2015.0, "pmid_journal_15": "Ann Hematol"}, {"pmid_title_16": "Alternative donor hematopoietic cell transplantation for Fanconi anemia.", "pmid_16": 25824692.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Blood"}, {"pmid_title_17": "Fanconi anemia and solid malignancies in childhood: a national retrospective study.", "pmid_17": 25381700.0, "pmid_date_17": 2015.0, "pmid_journal_17": "Pediatr Blood Cancer"}, {"pmid_title_18": "Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.", "pmid_18": 25531282.0, "pmid_date_18": 2015.0, "pmid_journal_18": "Bone Marrow Transplant"}, {"pmid_title_19": "Clear cell sarcoma of the kidney in a child with Fanconi anemia.", "pmid_19": 24735155.0, "pmid_date_19": 2014.0, "pmid_journal_19": "Pediatr Dev Pathol"}, {"pmid_title_20": "Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.", "pmid_20": 25085358.0, "pmid_date_20": 2014.0, "pmid_journal_20": "Haematologica"}, {"pmid_title_21": "Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.", "pmid_21": 24019220.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Management of dental extraction in a female patient with fanconi anemia.", "pmid_22": 25628690.0, "pmid_date_22": 2014.0, "pmid_journal_22": "J Dent (Tehran)"}, {"pmid_title_23": "Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature.", "pmid_23": 22965917.0, "pmid_date_23": 2013.0, "pmid_journal_23": "Head Neck"}, {"pmid_title_24": "Deferasirox therapy in children with Fanconi aplastic anemia.", "pmid_24": 22510772.0, "pmid_date_24": 2012.0, "pmid_journal_24": "J Pediatr Hematol Oncol"}, {"pmid_title_25": "Fatal course of tonsillar squamous cell carcinoma associated with Fanconi anaemia: a mini review.", "pmid_25": 21925890.0, "pmid_date_25": 2012.0, "pmid_journal_25": "J Craniomaxillofac Surg"}, {"pmid_title_26": "Treatment of the bone marrow failure in Fanconi anemia patients with danazol.", "pmid_26": 22178060.0, "pmid_date_26": 2012.0, "pmid_journal_26": "Blood Cells Mol Dis"}, {"pmid_title_27": "Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing.", "pmid_27": 21519011.0, "pmid_date_27": 2011.0, "pmid_journal_27": "J Clin Oncol"}, {"pmid_title_28": "Successful treatment of esophageal squamous cell carcinoma in a patient with Fanconi anemia.", "pmid_28": 20410055.0, "pmid_date_28": 2010.0, "pmid_journal_28": "Jpn J Clin Oncol"}, {"pmid_title_29": "Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.", "pmid_29": 19564748.0, "pmid_date_29": 2009.0, "pmid_journal_29": "J Pediatr Hematol Oncol"}, {"pmid_title_30": "Treatment with deferiprone for iron overload alleviates bone marrow failure in a Fanconi anemia patient.", "pmid_30": 19814681.0, "pmid_date_30": 2009.0, "pmid_journal_30": "Hemoglobin"}, {"pmid_title_31": "Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.", "pmid_31": 18302713.0, "pmid_date_31": 2008.0, "pmid_journal_31": "Br J Haematol"}, {"pmid_title_32": "Thrombocytopenia in the neonate.", "pmid_32": 18433954.0, "pmid_date_32": 2008.0, "pmid_journal_32": "Blood Rev"}, {"pmid_title_33": "Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.", "pmid_33": 18379369.0, "pmid_date_33": 2008.0, "pmid_journal_33": "J Thorac Oncol"}, {"pmid_title_34": "Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function.", "pmid_34": 18623197.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Pediatr Blood Cancer"}, {"pmid_title_35": "Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.", "pmid_35": 18831513.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Cancer"}, {"pmid_title_36": "Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.", "pmid_36": 17950918.0, "pmid_date_36": 2007.0, "pmid_journal_36": "Biol Blood Marrow Transplant"}, {"pmid_title_37": "Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.", "pmid_37": 17038525.0, "pmid_date_37": 2007.0, "pmid_journal_37": "Blood"}, {"pmid_title_38": "Chemotherapy for myeloid malignancy in children with Fanconi anemia.", "pmid_38": 16609946.0, "pmid_date_38": 2007.0, "pmid_journal_38": "Pediatr Blood Cancer"}, {"pmid_title_39": "A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.", "pmid_39": 17096012.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Leukemia"}, {"pmid_title_40": "HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.", "pmid_40": 18022575.0, "pmid_date_40": 2007.0, "pmid_journal_40": "Biol Blood Marrow Transplant"}, {"pmid_title_41": "Anesthesia and Fanconi anemia: a case report and review of literature.", "pmid_41": 16918663.0, "pmid_date_41": 2006.0, "pmid_journal_41": "Paediatr Anaesth"}, {"pmid_title_42": "Squamous cell carcinoma of the hypopharynx in a young woman with Fanconi's anemia.", "pmid_42": 17308840.0, "pmid_date_42": 2006.0, "pmid_journal_42": "Braz J Otorhinolaryngol"}, {"pmid_title_43": "Squamous cell vulvar carcinoma associated with Fanconi's anemia: a case report.", "pmid_43": 11975685.0, "pmid_date_43": 2002.0, "pmid_journal_43": "Int J Gynecol Cancer"}, {"pmid_title_44": "Growth hormone deficiency caused by pituitary stalk interruption in Fanconi's anemia.", "pmid_44": 11148528.0, "pmid_date_44": 2001.0, "pmid_journal_44": "J Pediatr"}, {"pmid_title_45": "Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.", "pmid_45": 9658728.0, "pmid_date_45": 1998.0, "pmid_journal_45": "Haematologica"}, {"pmid_title_46": "Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.", "pmid_46": 8781414.0, "pmid_date_46": 1996.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.", "pmid_47": 7644282.0, "pmid_date_47": 1995.0, "pmid_journal_47": "Pediatr Nurs"}, {"pmid_title_48": "Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.", "pmid_48": 8283365.0, "pmid_date_48": 1994.0, "pmid_journal_48": "J Pediatr"}, {"pmid_title_49": "A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia.", "pmid_49": 8280614.0, "pmid_date_49": 1993.0, "pmid_journal_49": "Br J Haematol"}, {"pmid_title_50": "Fanconi's anemia. A family study with 20-year follow-up including associated breast pathology.", "pmid_50": 6478420.0, "pmid_date_50": 1984.0, "pmid_journal_50": "Cancer"}, {"pmid_title_51": "Multiple hepatic tumors and peliosis hepatis in Fanconi's anemia treated with androgens.", "pmid_51": 199056.0, "pmid_date_51": 1977.0, "pmid_journal_51": "Am J Dis Child"}, {"pmid_title_52": "Hepatic lesions in patients treated with synthetic anabolic steriods.", "pmid_52": 185239.0, "pmid_date_52": 1976.0, "pmid_journal_52": "J Clin Pathol"}, {"pmid_title_53": "The defective absorption of phosphorus and calcium and the effect of vitamin D in the Fanconi syndrome.", "pmid_53": 13610080.0, "pmid_date_53": 1958.0, "pmid_journal_53": "Guys Hosp Rep"}]}, {"_id": "20748-OMIM:614083", "condition": {"condition_name": "FANCONI ANEMIA, COMPLEMENTATION GROUP L", "pattern_of_inheritance": "X-linked recessive, Autosomal recessive", "alternate_names": ["FANCONI ANEMIA, COMPLEMENTATION GROUP L"]}, "gene information": {"db_hgnc_gene_id": 20748.0}, "interventions": [{"int_description_1": "Healthy diet"}, {"int_description_2": "Oxandrolone"}, {"int_description_3": "Danazol"}, {"int_description_4": "Testosterone propionate"}, {"int_description_5": "Oxymetholone"}, {"int_description_6": "Metenolone"}, {"int_description_7": "Calcium"}, {"int_description_8": "Prednisone"}, {"int_description_9": "Dexamethasone"}, {"int_description_10": "Insulin aspart"}, {"int_description_11": "Medroxyprogesterone acetate"}, {"int_description_12": "Tretinoin"}, {"int_description_13": "Eltrombopag"}, {"int_description_14": "Levothyroxine"}, {"int_description_15": "Estradiol"}, {"int_description_16": "Cetuximab"}, {"int_description_17": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_18": "Alemtuzumab"}, {"int_description_19": "Coenzyme M"}, {"int_description_20": "Cyclosporine"}, {"int_description_21": "Dactinomycin"}, {"int_description_22": "Sirolimus"}, {"int_description_23": "Somatotropin"}, {"int_description_24": "Vitamin D"}, {"int_description_25": "Cyclophosphamide"}, {"int_description_26": "Carboplatin"}, {"int_description_27": "Busulfan"}, {"int_description_28": "Ifosfamide"}, {"int_description_29": "Thiotepa"}, {"int_description_30": "Doxorubicin"}, {"int_description_31": "Fluorouracil", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Mercaptopurine", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Neonate,Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Trimethoprim"}, {"int_description_34": "Sulfamethoxazole"}, {"int_description_35": "Gemcitabine"}, {"int_description_36": "Vincristine"}, {"int_description_37": "Methotrexate"}, {"int_description_38": "Fludarabine"}, {"int_description_39": "Cytarabine"}, {"int_description_40": "Irinotecan"}, {"int_description_41": "Daunorubicin"}, {"int_description_42": "Etoposide"}, {"int_description_43": "Idarubicin"}, {"int_description_44": "Tacrolimus"}, {"int_description_45": "Acyclovir"}, {"int_description_46": "Quercetin"}, {"int_description_47": "Tioguanine"}, {"int_description_48": "Mycophenolate mofetil"}, {"int_description_49": "Tranexamic acid"}, {"int_description_50": "Hydroxyurea"}, {"int_description_51": "Methylprednisolone"}, {"int_description_52": "Methyltestosterone"}, {"int_description_53": "Leucovorin"}, {"int_description_54": "Vinorelbine"}, {"int_description_55": "Deferasirox"}, {"int_description_56": "Deferiprone"}, {"int_description_57": "Co-trimoxazole"}, {"int_description_58": "Asparaginase Escherichia coli"}, {"int_description_59": "Cisplatin"}, {"int_description_60": "Antilymphocyte immunoglobulin (horse)"}, {"int_description_61": "Norethandrolone"}, {"int_description_62": "Phosphorus"}, {"int_description_63": "GM-CSF (granulocyte-macrophage colony-stimulating factor)"}, {"int_description_64": "rh-SOD"}, {"int_description_65": "Bevacizumab"}, {"int_description_66": "Filgrastim"}, {"int_description_67": "Amifostine"}, {"int_description_68": "Radiation therapy", "timeframe_int68": "Days or Weeks,Years", "age_use_int68": "Child", "contra_int68": "No", "qualscale_reclass_drug68": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug68": "Effective / Ameliorative"}, {"int_description_69": "Total abdominal radiation"}, {"int_description_70": "Total body irradiation"}, {"int_description_71": "Total lymphoid irradiation"}, {"int_description_72": "Transfusion of blood products"}, {"int_description_73": "Bone marrow transplantation"}, {"int_description_74": "Hematopoietic stem cell transplantation"}, {"int_description_75": "Surgery for polydactyly, carpectomy"}, {"int_description_76": "Surgical intervention"}, {"int_description_77": "\u042burgical tumor removement"}], "references": [{"pmid_title_1": "Gingival Bleeding in a Child with Fanconi Anemia: A Case Report and Literature Review.", "pmid_1": 32231808.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Case Rep Dent"}, {"pmid_title_2": "Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.", "pmid_2": 29668547.0, "pmid_date_2": 2019.0, "pmid_journal_2": "J Pediatr Hematol Oncol"}, {"pmid_title_3": "Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.", "pmid_3": 31192125.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Front Oncol"}, {"pmid_title_4": "Fanconi anemia: a single center experience of a large cohort.", "pmid_4": 31990462.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Turk J Pediatr"}, {"pmid_title_5": "Therapeutic research in the crystal chromosome disease Fanconi anemia.", "pmid_5": 30389152.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Mutat Res Genet Toxicol Environ Mutagen"}, {"pmid_title_6": "Oral cancer in Fanconi anemia: Review of 121 cases.", "pmid_6": 29650274.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Crit Rev Oncol Hematol"}, {"pmid_title_7": "Essential Role of BRCA2 in Ovarian Development and Function.", "pmid_7": 30207912.0, "pmid_date_7": 2018.0, "pmid_journal_7": "N Engl J Med"}, {"pmid_title_8": "Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.", "pmid_8": 29203412.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Biol Blood Marrow Transplant"}, {"pmid_title_9": "How I manage patients with Fanconi anaemia.", "pmid_9": 28474441.0, "pmid_date_9": 2017.0, "pmid_journal_9": "Br J Haematol"}, {"pmid_title_10": "Eltrombopag for the treatment of aplastic anemia: current perspectives.", "pmid_10": 27695288.0, "pmid_date_10": 2016.0, "pmid_journal_10": "Drug Des Devel Ther"}, {"pmid_title_11": "Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.", "pmid_11": 27246371.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Biol Blood Marrow Transplant"}, {"pmid_title_12": "Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.", "pmid_12": 26900943.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Pediatr Hematol Oncol"}, {"pmid_title_13": "Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.", "pmid_13": 26657402.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Eur J Med Genet"}, {"pmid_title_14": "Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.", "pmid_14": 25575015.0, "pmid_date_14": 2015.0, "pmid_journal_14": "J Clin Endocrinol Metab"}, {"pmid_title_15": "Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.", "pmid_15": 25862235.0, "pmid_date_15": 2015.0, "pmid_journal_15": "Ann Hematol"}, {"pmid_title_16": "Alternative donor hematopoietic cell transplantation for Fanconi anemia.", "pmid_16": 25824692.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Blood"}, {"pmid_title_17": "Fanconi anemia and solid malignancies in childhood: a national retrospective study.", "pmid_17": 25381700.0, "pmid_date_17": 2015.0, "pmid_journal_17": "Pediatr Blood Cancer"}, {"pmid_title_18": "Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.", "pmid_18": 25531282.0, "pmid_date_18": 2015.0, "pmid_journal_18": "Bone Marrow Transplant"}, {"pmid_title_19": "Clear cell sarcoma of the kidney in a child with Fanconi anemia.", "pmid_19": 24735155.0, "pmid_date_19": 2014.0, "pmid_journal_19": "Pediatr Dev Pathol"}, {"pmid_title_20": "Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.", "pmid_20": 25085358.0, "pmid_date_20": 2014.0, "pmid_journal_20": "Haematologica"}, {"pmid_title_21": "Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.", "pmid_21": 24019220.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Management of dental extraction in a female patient with fanconi anemia.", "pmid_22": 25628690.0, "pmid_date_22": 2014.0, "pmid_journal_22": "J Dent (Tehran)"}, {"pmid_title_23": "Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature.", "pmid_23": 22965917.0, "pmid_date_23": 2013.0, "pmid_journal_23": "Head Neck"}, {"pmid_title_24": "Deferasirox therapy in children with Fanconi aplastic anemia.", "pmid_24": 22510772.0, "pmid_date_24": 2012.0, "pmid_journal_24": "J Pediatr Hematol Oncol"}, {"pmid_title_25": "Fatal course of tonsillar squamous cell carcinoma associated with Fanconi anaemia: a mini review.", "pmid_25": 21925890.0, "pmid_date_25": 2012.0, "pmid_journal_25": "J Craniomaxillofac Surg"}, {"pmid_title_26": "Treatment of the bone marrow failure in Fanconi anemia patients with danazol.", "pmid_26": 22178060.0, "pmid_date_26": 2012.0, "pmid_journal_26": "Blood Cells Mol Dis"}, {"pmid_title_27": "Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing.", "pmid_27": 21519011.0, "pmid_date_27": 2011.0, "pmid_journal_27": "J Clin Oncol"}, {"pmid_title_28": "Successful treatment of esophageal squamous cell carcinoma in a patient with Fanconi anemia.", "pmid_28": 20410055.0, "pmid_date_28": 2010.0, "pmid_journal_28": "Jpn J Clin Oncol"}, {"pmid_title_29": "Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.", "pmid_29": 19564748.0, "pmid_date_29": 2009.0, "pmid_journal_29": "J Pediatr Hematol Oncol"}, {"pmid_title_30": "Treatment with deferiprone for iron overload alleviates bone marrow failure in a Fanconi anemia patient.", "pmid_30": 19814681.0, "pmid_date_30": 2009.0, "pmid_journal_30": "Hemoglobin"}, {"pmid_title_31": "Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.", "pmid_31": 18302713.0, "pmid_date_31": 2008.0, "pmid_journal_31": "Br J Haematol"}, {"pmid_title_32": "Thrombocytopenia in the neonate.", "pmid_32": 18433954.0, "pmid_date_32": 2008.0, "pmid_journal_32": "Blood Rev"}, {"pmid_title_33": "Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.", "pmid_33": 18379369.0, "pmid_date_33": 2008.0, "pmid_journal_33": "J Thorac Oncol"}, {"pmid_title_34": "Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function.", "pmid_34": 18623197.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Pediatr Blood Cancer"}, {"pmid_title_35": "Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.", "pmid_35": 18831513.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Cancer"}, {"pmid_title_36": "Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.", "pmid_36": 17950918.0, "pmid_date_36": 2007.0, "pmid_journal_36": "Biol Blood Marrow Transplant"}, {"pmid_title_37": "Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.", "pmid_37": 17038525.0, "pmid_date_37": 2007.0, "pmid_journal_37": "Blood"}, {"pmid_title_38": "Chemotherapy for myeloid malignancy in children with Fanconi anemia.", "pmid_38": 16609946.0, "pmid_date_38": 2007.0, "pmid_journal_38": "Pediatr Blood Cancer"}, {"pmid_title_39": "A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.", "pmid_39": 17096012.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Leukemia"}, {"pmid_title_40": "HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.", "pmid_40": 18022575.0, "pmid_date_40": 2007.0, "pmid_journal_40": "Biol Blood Marrow Transplant"}, {"pmid_title_41": "Anesthesia and Fanconi anemia: a case report and review of literature.", "pmid_41": 16918663.0, "pmid_date_41": 2006.0, "pmid_journal_41": "Paediatr Anaesth"}, {"pmid_title_42": "Squamous cell carcinoma of the hypopharynx in a young woman with Fanconi's anemia.", "pmid_42": 17308840.0, "pmid_date_42": 2006.0, "pmid_journal_42": "Braz J Otorhinolaryngol"}, {"pmid_title_43": "Squamous cell vulvar carcinoma associated with Fanconi's anemia: a case report.", "pmid_43": 11975685.0, "pmid_date_43": 2002.0, "pmid_journal_43": "Int J Gynecol Cancer"}, {"pmid_title_44": "Growth hormone deficiency caused by pituitary stalk interruption in Fanconi's anemia.", "pmid_44": 11148528.0, "pmid_date_44": 2001.0, "pmid_journal_44": "J Pediatr"}, {"pmid_title_45": "Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.", "pmid_45": 9658728.0, "pmid_date_45": 1998.0, "pmid_journal_45": "Haematologica"}, {"pmid_title_46": "Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.", "pmid_46": 8781414.0, "pmid_date_46": 1996.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.", "pmid_47": 7644282.0, "pmid_date_47": 1995.0, "pmid_journal_47": "Pediatr Nurs"}, {"pmid_title_48": "Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.", "pmid_48": 8283365.0, "pmid_date_48": 1994.0, "pmid_journal_48": "J Pediatr"}, {"pmid_title_49": "A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia.", "pmid_49": 8280614.0, "pmid_date_49": 1993.0, "pmid_journal_49": "Br J Haematol"}, {"pmid_title_50": "Fanconi's anemia. A family study with 20-year follow-up including associated breast pathology.", "pmid_50": 6478420.0, "pmid_date_50": 1984.0, "pmid_journal_50": "Cancer"}, {"pmid_title_51": "Multiple hepatic tumors and peliosis hepatis in Fanconi's anemia treated with androgens.", "pmid_51": 199056.0, "pmid_date_51": 1977.0, "pmid_journal_51": "Am J Dis Child"}, {"pmid_title_52": "Hepatic lesions in patients treated with synthetic anabolic steriods.", "pmid_52": 185239.0, "pmid_date_52": 1976.0, "pmid_journal_52": "J Clin Pathol"}, {"pmid_title_53": "The defective absorption of phosphorus and calcium and the effect of vitamin D in the Fanconi syndrome.", "pmid_53": 13610080.0, "pmid_date_53": 1958.0, "pmid_journal_53": "Guys Hosp Rep"}]}, {"_id": "20862-OMIM:616721", "condition": {"condition_name": "CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn"]}, "gene information": {"db_hgnc_gene_id": 20862.0}, "interventions": [{"int_description_1": "Bi-level non-invasive ventilator", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Manganese"}, {"int_description_3": "Clobazam"}, {"int_description_4": "Ubidecarenone"}, {"int_description_5": "Levodopa"}, {"int_description_6": "Cisapride"}, {"int_description_7": "Cimetidine"}, {"int_description_8": "Levetiracetam"}, {"int_description_9": "Pyridoxine"}, {"int_description_10": "Uridine"}, {"int_description_11": "Carbidopa"}, {"int_description_12": "Vigabatrin"}, {"int_description_13": "Omeprazole"}, {"int_description_14": "Dichloroacetic acid", "timeframe_int14": "Days or Weeks,Years", "age_use_int14": "Infant,Child", "contra_int14": "No", "qualscale_reclass_drug14": "Case report(s)", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}, {"int_description_15": "Lamotrigine"}, {"int_description_16": "Galactose"}, {"int_description_17": "Glucocorticoid therapy", "timeframe_int17": "Hours,Days or Weeks,Years", "age_use_int17": "Infant,Child", "contra_int17": "No", "qualscale_reclass_drug17": "Case report(s)", "rev1_eff_reclass_drug17": "Effective / Ameliorative"}, {"int_description_18": "Multivitamin supplementation"}, {"int_description_19": "Thiamine"}, {"int_description_20": "Adenoidectomy"}, {"int_description_21": "Fundoplication"}, {"int_description_22": "Gastrostomy"}, {"int_description_23": "Jejunostomy tube feeding"}, {"int_description_24": "Palatoplasty"}, {"int_description_25": "Supraglottoplasty"}, {"int_description_26": "Tongue base reduction"}, {"int_description_27": "Tonsillectomy"}], "references": [{"pmid_title_1": "SLC39A8 deficiency: biochemical correction and major clinical improvement by manganese therapy.", "pmid_1": 28749473.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Genet Med"}, {"pmid_title_2": "A SLC39A8 variant causes manganese deficiency, and glycosylation and mitochondrial disorders.", "pmid_2": 27995398.0, "pmid_date_2": 2017.0, "pmid_journal_2": "J Inherit Metab Dis"}, {"pmid_title_3": "SLC39A8 Deficiency: A Disorder of Manganese Transport and Glycosylation.", "pmid_3": 26637979.0, "pmid_date_3": 2015.0, "pmid_journal_3": "Am J Hum Genet"}]}, {"_id": "21478-OMIM:615710", "condition": {"condition_name": "MITCHELL-RILEY SYNDROME", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MITCHELL-RILEY SYNDROME"]}, "gene information": {"db_hgnc_gene_id": 21478.0}, "interventions": [{"int_description_1": "Insulin pump", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Free amino acids formula"}, {"int_description_3": "Insulin human"}, {"int_description_4": "Insulin lispro"}, {"int_description_5": "Insulin glargine"}, {"int_description_6": "Fish oil"}, {"int_description_7": "Parenteral nutrition"}], "references": [{"pmid_title_1": "Mitchell-Riley Syndrome Due to a Novel Mutation in RFX6.", "pmid_1": 31275908.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Front Pediatr"}, {"pmid_title_2": "A Newly-Discovered Mutation in the RFX6 Gene of the Rare Mitchell-Riley Syndrome.", "pmid_2": 26761945.0, "pmid_date_2": 2016.0, "pmid_journal_2": "J Clin Res Pediatr Endocrinol"}, {"pmid_title_3": "Two novel RFX6 variants in siblings with Mitchell-Riley syndrome with later diabetes onset and heterotopic gastric mucosa.", "pmid_3": 27523286.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Eur J Med Genet"}, {"pmid_title_4": "Mitchell-Riley Syndrome: A Novel Mutation in RFX6 Gene.", "pmid_4": 26770845.0, "pmid_date_4": 2015.0, "pmid_journal_4": "Case Rep Genet"}, {"pmid_title_5": "Biallelic RFX6 mutations can cause childhood as well as neonatal onset diabetes mellitus.", "pmid_5": 26264437.0, "pmid_date_5": 2015.0, "pmid_journal_5": "Eur J Hum Genet"}, {"pmid_title_6": "Neonatal diabetes, gallbladder agenesis, duodenal atresia, and intestinal malrotation caused by a novel homozygous mutation in RFX6.", "pmid_6": 23914949.0, "pmid_date_6": 2014.0, "pmid_journal_6": "Pediatr Diabetes"}, {"pmid_title_7": "Clinical characterization of a newly described neonatal diabetes syndrome caused by RFX6 mutations.", "pmid_7": 21965172.0, "pmid_date_7": 2011.0, "pmid_journal_7": "Am J Med Genet A"}]}, {"_id": "21497-OMIM:611126", "condition": {"condition_name": "MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20; MC1DN20", "freq_per_birth": "The prevalence of ACAD9 deficiency is unknown. At least 25 people with this condition have been described in the scientific literature.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20; MC1DN20"]}, "gene information": {"db_hgnc_gene_id": 21497.0}, "interventions": [{"int_description_1": "Ubidecarenone", "timeframe_int1": "Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Carvedilol"}, {"int_description_3": "Levetiracetam"}, {"int_description_4": "Pyruvic acid"}, {"int_description_5": "Riboflavin", "timeframe_int5": "Hours", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Cohort study or studies", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Triheptanoin"}, {"int_description_7": "ACE inhibitors"}, {"int_description_8": "Beta-blocking agents"}, {"int_description_9": "Calcium-channel blockers"}, {"int_description_10": "Diuretics"}, {"int_description_11": "D-glucose"}, {"int_description_12": "Heart transplantation", "timeframe_int12": "Years", "age_use_int12": "Infant,Child", "qualscale_reclass_drug12": "Cohort study or studies", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Successful treatment of infantile-onset ACAD9-related cardiomyopathy with a combination of sodium pyruvate, beta-blocker, and coenzyme Q10.", "pmid_1": 31473688.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_2": "Clinical, biochemical and genetic spectrum of 70 patients with ACAD9 deficiency: is riboflavin supplementation effective?", "pmid_2": 30025539.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Orphanet journal of rare diseases"}, {"pmid_title_3": "Severe defect in mitochondrial complex I assembly with mitochondrial DNA deletions in ACAD9-deficient mild myopathy.", "pmid_3": 27438479.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Muscle & nerve"}, {"pmid_title_4": "An atypical presentation of ACAD9 deficiency: Diagnosis by whole exome sequencing broadens the phenotypic spectrum and alters treatment approach.", "pmid_4": 28070495.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Molecular genetics and metabolism reports"}, {"pmid_title_5": "Evidence of a wide spectrum of cardiac involvement due to ACAD9 mutations: Report on nine patients.", "pmid_5": 27233227.0, "pmid_date_5": 2016.0, "pmid_journal_5": "Molecular genetics and metabolism"}, {"pmid_title_6": "High incidence and variable clinical outcome of cardiac hypertrophy due to ACAD9 mutations in childhood.", "pmid_6": 26669660.0, "pmid_date_6": 2016.0, "pmid_journal_6": "European journal of human genetics : EJHG"}, {"pmid_title_7": "Lethal Neonatal Progression of Fetal Cardiomegaly Associated to ACAD9 Deficiency.", "pmid_7": 26475292.0, "pmid_date_7": 2015.0, "pmid_journal_7": "JIMD reports"}, {"pmid_title_8": "Complex I assembly function and fatty acid oxidation enzyme activity of ACAD9 both contribute to disease severity in ACAD9 deficiency.", "pmid_8": 25721401.0, "pmid_date_8": 2015.0, "pmid_journal_8": "Human molecular genetics"}, {"pmid_title_9": "Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10).", "pmid_9": 22231380.0, "pmid_date_9": 2012.0, "pmid_journal_9": "Journal of inherited metabolic disease"}, {"pmid_title_10": "Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene.", "pmid_10": 20929961.0, "pmid_date_10": 2011.0, "pmid_journal_10": "Brain : a journal of neurology"}, {"pmid_title_11": "Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency.", "pmid_11": 21057504.0, "pmid_date_11": 2010.0, "pmid_journal_11": "Nature genetics"}]}, {"_id": "21734-OMIM:262700", "condition": {"condition_name": "PITUITARY HORMONE DEFICIENCY, COMBINED, 4; CPHD4", "freq_per_birth": "The prevalence of combined pituitary hormone deficiency is estimated to be 1 in 8,000 individuals worldwide.", "pattern_of_inheritance": "Autosomal recessive==Autosomal dominant", "alternate_names": ["PITUITARY HORMONE DEFICIENCY, COMBINED, 4; CPHD4"]}, "gene information": {"db_hgnc_gene_id": 21734.0}, "interventions": [{"int_description_1": "Testosterone"}, {"int_description_2": "Somatotropin"}, {"int_description_3": "Hydrocortisone", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "A novel dysfunctional LHX4 mutation with high phenotypical variability in patients with hypopituitarism.", "pmid_1": 18445675.0, "pmid_date_1": 2008.0, "pmid_journal_1": "The Journal of clinical endocrinology and metabolism"}]}, {"_id": "2190-OMIM:616720", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 19", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 19"]}, "gene information": {"db_hgnc_gene_id": 2190.0}, "interventions": [{"int_description_1": "Mechanical ventilation", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Salbutamol", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Amifampridine"}, {"int_description_4": "Procaine"}, {"int_description_5": "Procainamide"}, {"int_description_6": "Pyridostigmine"}, {"int_description_7": "Ciprofloxacin"}, {"int_description_8": "Quinidine"}, {"int_description_9": "Chloroquine"}, {"int_description_10": "Phenytoin"}, {"int_description_11": "Acetylcholinesterase inhibitors"}, {"int_description_12": "Beta-blockers"}, {"int_description_13": "Lithium"}, {"int_description_14": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations.", "pmid_1": 31081514.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Brain : a journal of neurology"}, {"pmid_title_2": "Congenital myasthenic syndrome caused by novel COL13A1 mutations.", "pmid_2": 30767057.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Journal of neurology"}, {"pmid_title_3": "Congenital Myasthenic Syndromes: a Clinical and Treatment Approach.", "pmid_3": 30032336.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Current treatment options in neurology"}, {"pmid_title_4": "Myasthenic syndromes due to defects in COL13A1 and in the N-linked glycosylation pathway.", "pmid_4": 29363764.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Annals of the New York Academy of Sciences"}, {"pmid_title_5": "The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes.", "pmid_5": 29874875.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Int J Mol Sci"}, {"pmid_title_6": "Congenital Myasthenic Syndromes", "pmid_6": 20301347.0, "pmid_date_6": 2016.0, "pmid_journal_6": "GeneReviews\u00ae"}, {"pmid_title_7": "Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII \u03b11 Chain.", "pmid_7": 26626625.0, "pmid_date_7": 2015.0, "pmid_journal_7": "American journal of human genetics"}]}, {"_id": "2226-OMIM:603034", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 5", "freq_per_birth": "The prevalence of congenital myasthenic syndrome is unknown. At least 600 families with affected individuals have been described in the scientific literature.", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 5"]}, "gene information": {"db_hgnc_gene_id": 2226.0}, "interventions": [{"int_description_1": "Mechanical ventilation", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Ephedrine", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Salbutamol"}, {"int_description_4": "Edrophonium"}, {"int_description_5": "Amifampridine"}, {"int_description_6": "Procaine"}, {"int_description_7": "Procainamide"}, {"int_description_8": "Pyridostigmine"}, {"int_description_9": "Ciprofloxacin"}, {"int_description_10": "Quinidine"}, {"int_description_11": "Chloroquine"}, {"int_description_12": "Phenytoin"}, {"int_description_13": "Acetylcholinesterase inhibitors"}, {"int_description_14": "Beta-blockers"}, {"int_description_15": "Lithium"}, {"int_description_16": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "Mechanism hypotheses for the electrophysiological manifestations of two cases of endplate acetylcholinesterase deficiency related congenital myasthenic syndrome.", "pmid_1": 29150079.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia"}, {"pmid_title_2": "Molecular characterization of congenital myasthenic syndromes in Spain.", "pmid_2": 29054425.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Neuromuscular disorders : NMD"}, {"pmid_title_3": "Congenital Myasthenic Syndromes", "pmid_3": 20301347.0, "pmid_date_3": 2016.0, "pmid_journal_3": "GeneReviews\u00ae"}, {"pmid_title_4": "Developmental consequences of the ColQ/MuSK interactions.", "pmid_4": 23089045.0, "pmid_date_4": 2013.0, "pmid_journal_4": "Chemico-biological interactions"}, {"pmid_title_5": "Long-term follow-up of patients with congenital myasthenic syndrome caused by COLQ mutations.", "pmid_5": 22088788.0, "pmid_date_5": 2012.0, "pmid_journal_5": "Neuromuscular disorders : NMD"}, {"pmid_title_6": "Recurrent COLQ mutation in congenital myasthenic syndrome.", "pmid_6": 22490774.0, "pmid_date_6": 2012.0, "pmid_journal_6": "Pediatric neurology"}, {"pmid_title_7": "The spectrum of mutations causing end-plate acetylcholinesterase deficiency.", "pmid_7": 10665486.0, "pmid_date_7": 2000.0, "pmid_journal_7": "Annals of neurology"}]}, {"_id": "2244-OMIM:616733", "condition": {"condition_name": "COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8", "freq_per_birth": "The prevalence of primary coenzyme Q10 deficiency is thought to be less than 1 in 100,000 people.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8"]}, "gene information": {"db_hgnc_gene_id": 2244.0}, "interventions": [{"int_description_1": "Ubidecarenone", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Rescue of primary ubiquinone deficiency due to a novel COQ7 defect using 2,4-dihydroxybensoic acid.", "pmid_1": 26084283.0, "pmid_date_1": 2015.0, "pmid_journal_1": "Journal of medical genetics"}]}, {"_id": "23038-OMIM:277380", "condition": {"condition_name": "METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE; MAHCF", "freq_per_birth": "The most common form of the condition, called methylmalonic acidemia with homocystinuria, cblC type, is estimated to affect 1 in 200,000 newborns worldwide. Studies indicate that this form of the condition may be even more common in particular populations. These studies estimate the condition occurs in 1 in 100,000 people in New York and 1 in 60,000 people in California. Other types of methylmalonic acidemia with homocystinuria are much less common. Fewer than 20 cases of each of the other types have been reported in the medical literature.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE; MAHCF"]}, "gene information": {"db_hgnc_gene_id": 23038.0}, "interventions": [{"int_description_1": "Hydroxocobalamin"}, {"int_description_2": "Cyanocobalamin", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Glycine betaine"}, {"int_description_4": "Carglumic acid", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "A New, Atypical Case of Cobalamin F Disorder Diagnosed by Whole Exome Sequencing.", "pmid_1": 26997947.0, "pmid_date_1": 2016.0, "pmid_journal_1": "Molecular syndromology"}, {"pmid_title_2": "A patient with an inborn error of vitamin B12 metabolism (cblF) detected by newborn screening.", "pmid_2": 23776111.0, "pmid_date_2": 2013.0, "pmid_journal_2": "Pediatrics"}, {"pmid_title_3": "Eighteen-year follow-up of a patient with cobalamin F disease (cblF): report and review.", "pmid_3": 21910240.0, "pmid_date_3": 2011.0, "pmid_journal_3": "American journal of medical genetics. Part A"}, {"pmid_title_4": "Cobalamin F disease detected by newborn screening and follow-up on a 14-year-old patient.", "pmid_4": 22065268.0, "pmid_date_4": 2011.0, "pmid_journal_4": "Pediatrics"}, {"pmid_title_5": "A novel mutation in LMBRD1 causes the cblF defect of vitamin B(12) metabolism in a Turkish patient.", "pmid_5": 20127417.0, "pmid_date_5": 2010.0, "pmid_journal_5": "Journal of inherited metabolic disease"}]}, {"_id": "23041-OMIM:614652", "condition": {"condition_name": "COENZYME Q10 DEFICIENCY, PRIMARY, 3", "freq_per_birth": "The prevalence of primary coenzyme Q10 deficiency is thought to be less than 1 in 100,000 people.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["COENZYME Q10 DEFICIENCY, PRIMARY, 3"]}, "gene information": {"db_hgnc_gene_id": 23041.0}, "interventions": [{"int_description_1": "Ubidecarenone"}, {"int_description_2": "Levocarnitine"}, {"int_description_3": "Riboflavin"}, {"int_description_4": "Biotin"}, {"int_description_5": "Idebenone"}, {"int_description_6": "Vatiquinone"}, {"int_description_7": "Thiamine"}], "references": [{"pmid_title_1": "Diffuse mesangial sclerosis in a PDSS2 mutation-induced coenzyme Q10 deficiency.", "pmid_1": 29032433.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Pediatric nephrology (Berlin, Germany)"}, {"pmid_title_2": "Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency.", "pmid_2": 25091424.0, "pmid_date_2": 2015.0, "pmid_journal_2": "Journal of inherited metabolic disease"}, {"pmid_title_3": "Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations.", "pmid_3": 17186472.0, "pmid_date_3": 2006.0, "pmid_journal_3": "American journal of human genetics"}, {"pmid_title_4": "Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency.", "pmid_4": 10972372.0, "pmid_date_4": 2000.0, "pmid_journal_4": "Lancet (London, England)"}]}, {"_id": "23089-OMIM:615905", "condition": {"condition_name": "DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 25, WITH AMELOGENESIS IMPERFECTA", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 25, WITH AMELOGENESIS IMPERFECTA"]}, "gene information": {"db_hgnc_gene_id": 23089.0}, "interventions": [{"int_description_1": "Vagus nerve stimulation"}, {"int_description_2": "Ketogenic diet"}, {"int_description_3": "Clobazam"}, {"int_description_4": "Clonazepam"}, {"int_description_5": "Diazepam"}, {"int_description_6": "Glycerin"}, {"int_description_7": "Felbamate"}, {"int_description_8": "Topiramate"}, {"int_description_9": "Midazolam"}, {"int_description_10": "Levetiracetam"}, {"int_description_11": "Oxcarbazepine"}, {"int_description_12": "Lidocaine"}, {"int_description_13": "Carbamazepine"}, {"int_description_14": "Pyridoxine"}, {"int_description_15": "Ethosuximide"}, {"int_description_16": "Acetazolamide"}, {"int_description_17": "Sulthiame"}, {"int_description_18": "Methotrexate"}, {"int_description_19": "Vigabatrin"}, {"int_description_20": "Valproic acid"}, {"int_description_21": "Phenylbutyric acid"}, {"int_description_22": "Lamotrigine"}, {"int_description_23": "Phenytoin"}, {"int_description_24": "4-aminopyrimidine"}, {"int_description_25": "Heptanoic acid"}, {"int_description_26": "Sebacic acid"}, {"int_description_27": "NBCe1"}, {"int_description_28": "SGLT1"}, {"int_description_29": "Lorazepam"}, {"int_description_30": "Thiopental"}, {"int_description_31": "Phenobarbital"}, {"int_description_32": "Resection of the right frontoparietal lesion"}], "references": [{"pmid_title_1": "Disease Heterogeneity in Na<sup>+</sup>/Citrate Cotransporter Deficiency.", "pmid_1": 26960556.0, "pmid_date_1": 2017.0, "pmid_journal_1": "JIMD Rep"}, {"pmid_title_2": "Punctate white matter lesions in full-term infants with neonatal seizures associated with SLC13A5 mutations.", "pmid_2": 27913086.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Eur J Paediatr Neurol"}, {"pmid_title_3": "Mutations in the Na(+)/citrate cotransporter NaCT (SLC13A5) in pediatric patients with epilepsy and developmental delay.", "pmid_3": 27261973.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Mol Med"}, {"pmid_title_4": "Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia.", "pmid_4": 26384929.0, "pmid_date_4": 2015.0, "pmid_journal_4": "Brain"}]}, {"_id": "23147-OMIM:608898", "condition": {"condition_name": "HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3", "freq_per_birth": "Familial hemophagocytic lymphohistiocytosis occurs in approximately 1 in 50,000 individuals worldwide.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3"]}, "gene information": {"db_hgnc_gene_id": 23147.0}, "interventions": [{"int_description_1": "Dexamethasone"}, {"int_description_2": "Cyclosporine"}, {"int_description_3": "Methotrexate"}, {"int_description_4": "Etoposide"}, {"int_description_5": "HLH-94 treatment protocol", "timeframe_int5": "Days or Weeks", "age_use_int5": "Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Lentiviral gene therapy"}, {"int_description_7": "Hematopoietic stem cell transplantation", "timeframe_int7": "Days or Weeks", "age_use_int7": "Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Curative"}, {"int_description_8": "Umbilical cord blood stem cell transplantation", "timeframe_int8": "Days or Weeks", "age_use_int8": "Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Case report(s)", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "UNC13D mutation presenting as fulminant familial hemophagocytic lymphohistiocytosis.", "pmid_1": 32327331.0, "pmid_date_1": 2020.0, "pmid_journal_1": "J Microbiol Immunol Infect"}, {"pmid_title_2": "Risk factors affecting outcome of unrelated cord blood transplantation for children with familial haemophagocytic lymphohistiocytosis.", "pmid_2": 30460979.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "A Case of Recurrent Pregnancy-Induced Adult Onset Familial Hemophagocytic Lymphohistiocytosis.", "pmid_3": 30220951.0, "pmid_date_3": 2018.0, "pmid_journal_3": "World J Oncol"}, {"pmid_title_4": "HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society.", "pmid_4": 9121398.0, "pmid_date_4": 1997.0, "pmid_journal_4": "Med Pediatr Oncol"}]}, {"_id": "23151-OMIM:612840", "condition": {"condition_name": "LEUKOCYTE ADHESION DEFICIENCY, TYPE III", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["LEUKOCYTE ADHESION DEFICIENCY, TYPE III"]}, "gene information": {"db_hgnc_gene_id": 23151.0}, "interventions": [{"int_description_1": "Human immunoglobulin G", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Coagulation factor VIIa Recombinant Human"}, {"int_description_3": "Prophylactic antibiotics", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Gene therapy", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Platelet transfusion", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Red blood cell transfusions", "timeframe_int6": "Hours,Days or Weeks", "age_use_int6": "Neonate,Infant", "contra_int6": "No", "qualscale_reclass_drug6": "Case report(s)", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Allogeneic stem cell transplantation", "timeframe_int7": "Days or Weeks", "age_use_int7": "Neonate,Infant", "contra_int7": "No", "qualscale_reclass_drug7": "Case report(s)", "rev1_eff_reclass_drug7": "Curative"}, {"int_description_8": "Stem cell transplantation"}], "references": [{"pmid_title_1": "Successful hematopoietic stem cell transplant in leukocyte adhesion deficiency type III presenting primarily as malignant infantile osteopetrosis.", "pmid_1": 32092470.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Clin Immunol"}, {"pmid_title_2": "Long-term management of leukocyte adhesion deficiency type III without hematopoietic stem cell transplantation.", "pmid_2": 29472353.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Haematologica"}, {"pmid_title_3": "Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models.", "pmid_3": 21917754.0, "pmid_date_3": 2011.0, "pmid_journal_3": "Blood"}, {"pmid_title_4": "Novel integrin-dependent platelet malfunction in siblings with leukocyte adhesion deficiency-III (LAD-III) caused by a point mutation in FERMT3.", "pmid_4": 20216991.0, "pmid_date_4": 2010.0, "pmid_journal_4": "Thromb Haemost"}]}, {"_id": "2321-OMIM:121300", "condition": {"condition_name": "COPROPORPHYRIA, HEREDITARY", "freq_per_birth": "The exact prevalence of porphyria is unknown, but it probably ranges from 1 in 500 to 1 in 50,000 people worldwide. Overall, porphyria cutanea tarda is the most common type of porphyria. For some forms of porphyria, the prevalence is unknown because many people with a genetic mutation associated with the disease never experience signs or symptoms.Acute intermittent porphyria is the most common form of acute porphyria in most countries. It may occur more frequently in northern European countries, such as Sweden, and in the United Kingdom. Another form of the disorder, hereditary coproporphyria, has been reported mostly in Europe and North America. Variegate porphyria is most common in the Afrikaner population of South Africa; about 3 in 1,000 people in this population have the genetic change that causes this form of the disorder.", "pattern_of_inheritance": "Autosomal dominant, X-linked dominant, Autosomal recessive", "alternate_names": ["COPROPORPHYRIA, HEREDITARY"]}, "gene information": {"db_hgnc_gene_id": 2321.0}, "interventions": [{"int_description_1": "Intubation"}, {"int_description_2": "Topiramate"}, {"int_description_3": "Midazolam"}, {"int_description_4": "Levetiracetam"}, {"int_description_5": "Lacosamide"}, {"int_description_6": "Magnesium"}, {"int_description_7": "Gabapentin"}, {"int_description_8": "Vigabatrin", "timeframe_int8": "Hours,Days or Weeks", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Acyclovir"}, {"int_description_10": "Hemin"}, {"int_description_11": "Hematin"}, {"int_description_12": "Phenytoin"}, {"int_description_13": "Deferoxamine"}, {"int_description_14": "Propofol"}, {"int_description_15": "Benzodiazepine", "timeframe_int15": "Hours", "age_use_int15": "Neonate,Infant,Child", "contra_int15": "No", "qualscale_reclass_drug15": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug15": "Effective / Ameliorative"}, {"int_description_16": "Glucose-containing IV solution"}, {"int_description_17": "Gonadotropin-releasing hormone agonist"}, {"int_description_18": "Intravenous immunoglobulin therapy"}, {"int_description_19": "Opiates"}, {"int_description_20": "Rehydration w/10% dextrose in 0.5N sodium chloride"}, {"int_description_21": "Isoflurane"}, {"int_description_22": "Phenobarbital"}, {"int_description_23": "Phototherapy"}, {"int_description_24": "Blood transfusions"}, {"int_description_25": "Erythrocyte transfusions"}, {"int_description_26": "Plasma exchange"}, {"int_description_27": "Cholecystectomy"}, {"int_description_28": "Laparotomy (removal of spleen and pancreatic cyst)"}, {"int_description_29": "Liver transplant"}, {"int_description_30": "Surgical removal of ovaries"}, {"timeframe_int31": "Hours", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Case report(s)", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Clinical Guide and Update on Porphyrias.", "pmid_1": 31085196.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Gastroenterology"}, {"pmid_title_2": "Harderoporphyria: Case of lifelong photosensitivity associated with compound heterozygous coproporphyrinogen oxidase (CPOX) mutations.", "pmid_2": 30828546.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Molecular genetics and metabolism reports"}, {"pmid_title_3": "Hereditary Coproporphyria", "pmid_3": 23236641.0, "pmid_date_3": 2018.0, "pmid_journal_3": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_4": "Hepatic porphyria: A narrative review.", "pmid_4": 27796941.0, "pmid_date_4": 2016.0, "pmid_journal_4": "Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology"}, {"pmid_title_5": "Acute porphyria presenting as epilepsia partialis continua.", "pmid_5": 23898283.0, "pmid_date_5": 2013.0, "pmid_journal_5": "Case reports in neurology"}, {"pmid_title_6": "Harderoporphyria due to homozygosity for coproporphyrinogen oxidase missense mutation H327R.", "pmid_6": 21103937.0, "pmid_date_6": 2011.0, "pmid_journal_6": "Journal of inherited metabolic disease"}, {"pmid_title_7": "Mutations in human CPO gene predict clinical expression of either hepatic hereditary coproporphyria or erythropoietic harderoporphyria.", "pmid_7": 16159891.0, "pmid_date_7": 2005.0, "pmid_journal_7": "Human molecular genetics"}, {"pmid_title_8": "Neonatal hemolytic anemia due to inherited harderoporphyria: clinical characteristics and molecular basis.", "pmid_8": 9454777.0, "pmid_date_8": 1998.0, "pmid_journal_8": "Blood"}]}, {"_id": "2323-OMIM:237300", "condition": {"condition_name": "CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO", "freq_per_birth": "Carbamoyl phosphate synthetase I deficiency is a rare disorder; its overall incidence is unknown. Researchers in Japan have estimated that it occurs in 1 in 800,000 newborns in that country.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO"]}, "gene information": {"db_hgnc_gene_id": 2323.0}, "interventions": [{"int_description_1": "Low protein diet and citrulline supplementation", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Low protein diet and Essential amino acids (EAAs) supplementation", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Soybean oil", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Arginine", "timeframe_int4": "Days or Weeks", "age_use_int4": "Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Cohort study or studies", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Benzoic acid", "timeframe_int5": "Hours", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Phenylbutyric acid", "timeframe_int6": "Hours", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Glycerol phenylbutyrate", "timeframe_int7": "Hours,Days or Weeks", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Citrulline", "timeframe_int8": "Days or Weeks", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Cohort study or studies", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Phenylacetic acid"}, {"int_description_10": "Carglumic acid"}, {"int_description_11": "D-glucose"}, {"int_description_12": "Heterologous human adult liver-derived progenitor cells", "timeframe_int12": "Days or Weeks", "age_use_int12": "Neonate,Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Heterologous human adult liver-derived stem cells", "timeframe_int13": "Hours", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Human heterologous liver cells (for infusion)", "timeframe_int14": "Hours", "age_use_int14": "Neonate,Infant", "contra_int14": "No", "qualscale_reclass_drug14": "Case report(s)", "rev1_eff_reclass_drug14": "Still in Trials / Unproven"}, {"int_description_15": "Therapeutic hypothermia", "timeframe_int15": "Hours", "age_use_int15": "Neonate,Infant,Child", "contra_int15": "No", "qualscale_reclass_drug15": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug15": "Effective / Ameliorative"}, {"int_description_16": "Hemodialysis", "timeframe_int16": "Hours", "age_use_int16": "Neonate,Infant,Child", "contra_int16": "No", "qualscale_reclass_drug16": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug16": "Effective / Ameliorative"}, {"int_description_17": "\u0421ontinuous veno-venous haemofiltration"}, {"int_description_18": "Orthotopic liver transplantation (OLT)"}], "references": [{"pmid_title_1": "Aminoacidopathies: Prevalence, Etiology, Screening, and Treatment Options.", "pmid_1": 29094226.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Biochemical genetics"}, {"pmid_title_2": "Glycerol Phenylbutyrate (Ravicti)", "pmid_2": 29381293.0, "pmid_date_2": 2018.0, "pmid_journal_2": "CADTH Common Drug Reviews"}, {"pmid_title_3": "Early liver transplantation in neonatal-onset and moderate urea cycle disorders may lead to normal neurodevelopment.", "pmid_3": 29948653.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Metabolic brain disease"}, {"pmid_title_4": "Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorder.", "pmid_4": 28281899.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Expert opinion on therapeutic targets"}, {"pmid_title_5": "Citrulline for urea cycle disorders in Japan.", "pmid_5": 27613354.0, "pmid_date_5": 2017.0, "pmid_journal_5": "Pediatrics international : official journal of the Japan Pediatric Society"}, {"pmid_title_6": "Liver transplantation may prevent neurodevelopmental deterioration in high-risk patients with urea cycle disorders.", "pmid_6": 28608518.0, "pmid_date_6": 2017.0, "pmid_journal_6": "Pediatric transplantation"}, {"pmid_title_7": "Efficacy and safety of i.v. sodium benzoate in urea cycle disorders: a multicentre retrospective study.", "pmid_7": 27663197.0, "pmid_date_7": 2016.0, "pmid_journal_7": "Orphanet journal of rare diseases"}, {"pmid_title_8": "Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013.", "pmid_8": 27538463.0, "pmid_date_8": 2016.0, "pmid_journal_8": "Orphanet journal of rare diseases"}, {"pmid_title_9": "Urea cycle disorders: a case report of a successful treatment with liver transplant and a literature review.", "pmid_9": 25852294.0, "pmid_date_9": 2015.0, "pmid_journal_9": "World journal of gastroenterology"}, {"pmid_title_10": "Short-term survival of hyperammonemic neonates treated with dialysis.", "pmid_10": 25185886.0, "pmid_date_10": 2015.0, "pmid_journal_10": "Pediatric nephrology (Berlin, Germany)"}, {"pmid_title_11": "Augmenting ureagenesis in patients with partial carbamyl phosphate synthetase 1 deficiency with N-carbamyl-L-glutamate.", "pmid_11": 24880889.0, "pmid_date_11": 2014.0, "pmid_journal_11": "The Journal of pediatrics"}, {"pmid_title_12": "Dietary management of urea cycle disorders: European practice.", "pmid_12": 24113687.0, "pmid_date_12": 2013.0, "pmid_journal_12": "Molecular genetics and metabolism"}, {"pmid_title_13": "Living-donor liver transplantation for carbamoyl phosphate synthetase 1 deficiency.", "pmid_13": 21108709.0, "pmid_date_13": 2010.0, "pmid_journal_13": "Pediatric transplantation"}, {"pmid_title_14": "Early neonatal onset carbamoyl-phosphate synthase 1 deficiency treated with continuous hemodiafiltration and early living-related liver transplantation.", "pmid_14": 19500281.0, "pmid_date_14": 2009.0, "pmid_journal_14": "Pediatrics international : official journal of the Japan Pediatric Society"}, {"pmid_title_15": "Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.", "pmid_15": 17538087.0, "pmid_date_15": 2007.0, "pmid_journal_15": "The New England journal of medicine"}, {"pmid_title_16": "High-volume continuous venovenous hemofiltration as an effective therapy for acute management of inborn errors of metabolism in young children.", "pmid_16": 17643056.0, "pmid_date_16": 2007.0, "pmid_journal_16": "Blood purification"}, {"pmid_title_17": "Ammonia detoxification by continuous venovenous haemofiltration in an infant with urea cycle defect.", "pmid_17": 12055368.0, "pmid_date_17": 2002.0, "pmid_journal_17": "Hong Kong medical journal = Xianggang yi xue za zhi"}, {"pmid_title_18": "A case of neonatal-onset carbamoyl-phosphate synthase I deficiency treated by continuous haemodiafiltration.", "pmid_18": 10968246.0, "pmid_date_18": 2000.0, "pmid_journal_18": "European journal of pediatrics"}, {"pmid_title_19": "Liver transplantation in urea cycle disorders.", "pmid_19": 10603100.0, "pmid_date_19": 1999.0, "pmid_journal_19": "European journal of pediatrics"}, {"pmid_title_20": "Hemodialysis catheter placement and recirculation in treatment of hyperammonemia.", "pmid_20": 9761362.0, "pmid_date_20": 1998.0, "pmid_journal_20": "Pediatric nephrology (Berlin, Germany)"}, {"pmid_title_21": "Therapeutic use of carbamylglutamate in the case of carbamoyl-phosphate synthetase deficiency.", "pmid_21": 8739970.0, "pmid_date_21": 1996.0, "pmid_journal_21": "Journal of inherited metabolic disease"}, {"pmid_title_22": "Orthotopic liver transplantation for urea cycle enzyme deficiency.", "pmid_22": 1544622.0, "pmid_date_22": 1992.0, "pmid_journal_22": "Hepatology (Baltimore, Md.)"}]}, {"_id": "23287-OMIM:602473", "condition": {"condition_name": "ENCEPHALOPATHY, ETHYLMALONIC; EE", "freq_per_birth": "About 70 individuals with this condition have been identified worldwide, mostly in Mediterranean and Arab populations. Although ethylmalonic encephalopathy appears to be very rare, researchers suggest that some cases have been misdiagnosed as other neurological disorders.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ENCEPHALOPATHY, ETHYLMALONIC; EE"]}, "gene information": {"db_hgnc_gene_id": 23287.0}, "interventions": [{"int_description_1": "Isoleucine-restricted diet"}, {"int_description_2": "Low protein diet"}, {"int_description_3": "Sulfur amino acid restriction diet"}, {"int_description_4": "Clobazam"}, {"int_description_5": "Ubidecarenone", "timeframe_int5": "Hours", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Baclofen"}, {"int_description_7": "Topiramate"}, {"int_description_8": "Metronidazole"}, {"int_description_9": "Cyanocobalamin"}, {"int_description_10": "Levetiracetam"}, {"int_description_11": "Pyridoxine"}, {"int_description_12": "Neomycin"}, {"int_description_13": "Ascorbic acid", "timeframe_int13": "Hours,Days or Weeks,Years", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Case report(s)", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Vitamin E", "timeframe_int14": "Hours", "age_use_int14": "Neonate,Infant,Child", "contra_int14": "No", "qualscale_reclass_drug14": "Case report(s)", "rev1_eff_reclass_drug14": "Still in Trials / Unproven"}, {"int_description_15": "Levocarnitine"}, {"int_description_16": "Botulinum toxin type A"}, {"int_description_17": "Acetylcysteine"}, {"int_description_18": "Riboflavin"}, {"int_description_19": "Antispastic medications"}, {"int_description_20": "Biotin"}, {"int_description_21": "Phenobarbital", "timeframe_int21": "Days or Weeks", "age_use_int21": "Neonate,Infant,Child", "contra_int21": "No", "qualscale_reclass_drug21": "Case report(s)", "rev1_eff_reclass_drug21": "Still in Trials / Unproven"}, {"int_description_22": "Sodium bicarbonate"}, {"int_description_23": "D-glucose"}, {"int_description_24": "Thiamine"}, {"int_description_25": "Assisted respiration"}, {"int_description_26": "Feeding per gastrostomy tube", "timeframe_int26": "Days or Weeks", "age_use_int26": "Neonate,Infant,Child", "contra_int26": "No", "qualscale_reclass_drug26": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug26": "Effective / Ameliorative"}, {"int_description_27": "Feeding per nasogastric tube"}, {"int_description_28": "Physical therapy", "timeframe_int28": "Hours", "age_use_int28": "Neonate,Infant,Child", "contra_int28": "Yes", "qualscale_reclass_drug28": "Case report(s)", "rev1_eff_reclass_drug28": "Still in Trials / Unproven"}, {"int_description_29": "\u0421ontinuous veno-venous haemofiltration", "timeframe_int29": "Days or Weeks", "age_use_int29": "Neonate,Infant,Child", "contra_int29": "No", "qualscale_reclass_drug29": "Case report(s)", "rev1_eff_reclass_drug29": "Still in Trials / Unproven"}, {"int_description_30": "Orthotopic liver transplantation (OLT)"}, {"int_description_31": "Surgery for a severe scoliosis"}, {"int_description_32": "Surgery for hip subluxation"}], "references": [{"pmid_title_1": "Child Neurology: Ethylmalonic encephalopathy.", "pmid_1": 32111695.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Neurology"}, {"pmid_title_2": "Novel Compound Heterozygous Variants of <i>ETHE1</i> Causing Ethylmalonic Encephalopathy in a Chinese Patient: A Case Report.", "pmid_2": 32362910.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Frontiers in genetics"}, {"pmid_title_3": "Acute and Chronic Management in an Atypical Case of Ethylmalonic Encephalopathy.", "pmid_3": 30349987.0, "pmid_date_3": 2019.0, "pmid_journal_3": "JIMD reports"}, {"pmid_title_4": "Improved clinical outcome following liver transplant in patients with ethylmalonic encephalopathy.", "pmid_4": 30864297.0, "pmid_date_4": 2019.0, "pmid_journal_4": "American journal of medical genetics. Part A"}, {"pmid_title_5": "Response to medical and a novel dietary treatment in newborn screen identified patients with ethylmalonic encephalopathy.", "pmid_5": 29526615.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Molecular genetics and metabolism"}, {"pmid_title_6": "Ethylmalonic Encephalopathy", "pmid_6": 28933811.0, "pmid_date_6": 2017.0, "pmid_journal_6": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_7": "Recent advances in liver transplantation for metabolic disease.", "pmid_7": 28168361.0, "pmid_date_7": 2017.0, "pmid_journal_7": "Journal of inherited metabolic disease"}, {"pmid_title_8": "Successful treatment of a patient with ethylmalonic encephalopathy by intravenous N-acetylcysteine.", "pmid_8": 27830356.0, "pmid_date_8": 2017.0, "pmid_journal_8": "Metabolic brain disease"}, {"pmid_title_9": "Mitochondrial diseases.", "pmid_9": 27775730.0, "pmid_date_9": 2016.0, "pmid_journal_9": "Nature reviews. Disease primers"}, {"pmid_title_10": "Liver transplant in ethylmalonic encephalopathy: a new treatment for an otherwise fatal disease.", "pmid_10": 26917598.0, "pmid_date_10": 2016.0, "pmid_journal_10": "Brain : a journal of neurology"}, {"pmid_title_11": "Ethylmalonic encephalopathy: application of improved biochemical and molecular diagnostic approaches.", "pmid_11": 20528888.0, "pmid_date_11": 2011.0, "pmid_journal_11": "Clinical genetics"}, {"pmid_title_12": "Multiple sources of metabolic disturbance in ETHE1-related ethylmalonic encephalopathy.", "pmid_12": 20978941.0, "pmid_date_12": 2010.0, "pmid_journal_12": "Journal of inherited metabolic disease"}, {"pmid_title_13": "Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy.", "pmid_13": 20657580.0, "pmid_date_13": 2010.0, "pmid_journal_13": "Nature medicine"}, {"pmid_title_14": "Clinical heterogeneity in ethylmalonic encephalopathy.", "pmid_14": 19289697.0, "pmid_date_14": 2009.0, "pmid_journal_14": "Journal of child neurology"}, {"pmid_title_15": "Ethylmalonic encephalopathy: clinical and biochemical observations.", "pmid_15": 17712735.0, "pmid_date_15": 2007.0, "pmid_journal_15": "Neuropediatrics"}, {"pmid_title_16": "Ethylmalonic encephalopathy-report of two cases.", "pmid_16": 16376514.0, "pmid_date_16": 2006.0, "pmid_journal_16": "Brain & development"}, {"pmid_title_17": "Therapeutic trial in the first three Asian cases of ethylmalonic encephalopathy: response to riboflavin.", "pmid_17": 11916321.0, "pmid_date_17": 2001.0, "pmid_journal_17": "Journal of inherited metabolic disease"}]}, {"_id": "2328-OMIM:255120", "condition": {"condition_name": "CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 2328.0}, "interventions": [{"int_description_1": "Diet rich in high carbohydrate, low fat and inclusion of medium chain triglyceride oil", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Low fat diet"}, {"int_description_3": "Medium-chain triglycerides"}], "references": [{"pmid_title_1": "A patient with atypical presentation of chronic hepatosteatosis harboring a novel variant in the CPT1A gene.", "pmid_1": 32781271.0, "pmid_date_1": 2021.0, "pmid_journal_1": "European journal of medical genetics"}, {"pmid_title_2": "Utility of Genetic Testing for Confirmation of Abnormal Newborn Screening in Disorders of Long-Chain Fatty Acids: A Missed Case of Carnitine Palmitoyltransferase 1A (CPT1A) Deficiency.", "pmid_2": 28748224.0, "pmid_date_2": 2017.0, "pmid_journal_2": "International journal of neonatal screening"}, {"pmid_title_3": "Novel Mutations in the CPT1A Gene Identified in the Patient Presenting Jaundice as the First Manifestation of Carnitine Palmitoyltransferase 1A Deficiency.", "pmid_3": 27066452.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Pediatric gastroenterology, hepatology & nutrition"}, {"pmid_title_4": "Carrier frequency of a common mutation of carnitine palmitoyltransferase 1A deficiency and long-term follow-up in Finland.", "pmid_4": 21962599.0, "pmid_date_4": 2012.0, "pmid_journal_4": "The Journal of pediatrics"}, {"pmid_title_5": "A Novel Mutation in CPT1A Resulting in Hepatic CPT Deficiency.", "pmid_5": 23430932.0, "pmid_date_5": 2012.0, "pmid_journal_5": "JIMD reports"}, {"pmid_title_6": "Molecular analysis of a presymptomatic case of carnitine palmitoyl transferase I (CPT I) deficiency detected by tandem mass spectrometry newborn screening in Japan.", "pmid_6": 19345525.0, "pmid_date_6": 2010.0, "pmid_journal_6": "Brain & development"}]}, {"_id": "23734-OMIM:615935", "condition": {"condition_name": "PANCREATIC AGENESIS 2; PAGEN2", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["PANCREATIC AGENESIS 2; PAGEN2"]}, "gene information": {"db_hgnc_gene_id": 23734.0}, "interventions": [{"int_description_1": "Insulin lispro", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Insulin glargine", "timeframe_int2": "Days or Weeks", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Pancreatic enzyme replacement  monotherapy"}], "references": [{"pmid_title_1": "Neonatal Diabetes: Two Cases with Isolated Pancreas Agenesis due to Homozygous PTF1A Enhancer Mutations and One with Developmental Delay, Epilepsy, and Neonatal Diabetes Syndrome due to KCNJ11 Mutation", "pmid_1": 28943513.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Journal of clinical research in pediatric endocrinology"}, {"pmid_title_2": "Pancreatic Agenesis due to Compound Heterozygosity for a Novel Enhancer and Truncating Mutation in the PTF1A Gene.", "pmid_2": 28663161.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Journal of clinical research in pediatric endocrinology"}, {"pmid_title_3": "Isolated Pancreatic Aplasia Due to a Hypomorphic PTF1A Mutation.", "pmid_3": 27284104.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Diabetes"}]}, {"_id": "23845-OMIM:613951", "condition": {"condition_name": "FANCONI ANEMIA, COMPLEMENTATION GROUP P", "pattern_of_inheritance": "X-linked recessive, Autosomal recessive", "alternate_names": ["FANCONI ANEMIA, COMPLEMENTATION GROUP P"]}, "gene information": {"db_hgnc_gene_id": 23845.0}, "interventions": [{"int_description_1": "Healthy diet"}, {"int_description_2": "Oxandrolone"}, {"int_description_3": "Danazol"}, {"int_description_4": "Testosterone propionate"}, {"int_description_5": "Oxymetholone"}, {"int_description_6": "Stanozolol"}, {"int_description_7": "Metenolone"}, {"int_description_8": "Calcium"}, {"int_description_9": "Prednisone"}, {"int_description_10": "Dexamethasone"}, {"int_description_11": "Insulin aspart"}, {"int_description_12": "Medroxyprogesterone acetate"}, {"int_description_13": "Tretinoin"}, {"int_description_14": "Eltrombopag"}, {"int_description_15": "Levothyroxine"}, {"int_description_16": "Estradiol"}, {"int_description_17": "Cetuximab"}, {"int_description_18": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_19": "Alemtuzumab"}, {"int_description_20": "Coenzyme M"}, {"int_description_21": "Cyclosporine"}, {"int_description_22": "Dactinomycin"}, {"int_description_23": "Sirolimus"}, {"int_description_24": "Somatotropin"}, {"int_description_25": "Vitamin D"}, {"int_description_26": "Cyclophosphamide"}, {"int_description_27": "Carboplatin"}, {"int_description_28": "Busulfan"}, {"int_description_29": "Ifosfamide"}, {"int_description_30": "Thiotepa"}, {"int_description_31": "Doxorubicin", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Fluorouracil", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Neonate,Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Mercaptopurine"}, {"int_description_34": "Trimethoprim"}, {"int_description_35": "Sulfamethoxazole"}, {"int_description_36": "Gemcitabine"}, {"int_description_37": "Vincristine"}, {"int_description_38": "Methotrexate"}, {"int_description_39": "Fludarabine"}, {"int_description_40": "Cytarabine"}, {"int_description_41": "Irinotecan"}, {"int_description_42": "Daunorubicin"}, {"int_description_43": "Etoposide"}, {"int_description_44": "Idarubicin"}, {"int_description_45": "Tacrolimus"}, {"int_description_46": "Acyclovir"}, {"int_description_47": "Quercetin"}, {"int_description_48": "Tioguanine"}, {"int_description_49": "Mycophenolate mofetil"}, {"int_description_50": "Tranexamic acid"}, {"int_description_51": "Hydroxyurea"}, {"int_description_52": "Methylprednisolone"}, {"int_description_53": "Methyltestosterone"}, {"int_description_54": "Leucovorin"}, {"int_description_55": "Vinorelbine"}, {"int_description_56": "Deferasirox"}, {"int_description_57": "Deferiprone"}, {"int_description_58": "Chemotherapy"}, {"int_description_59": "Co-trimoxazole"}, {"int_description_60": "Asparaginase Escherichia coli"}, {"int_description_61": "Cisplatin"}, {"int_description_62": "Antilymphocyte immunoglobulin (horse)"}, {"int_description_63": "Norethandrolone"}, {"int_description_64": "Phosphorus"}, {"int_description_65": "GM-CSF (granulocyte-macrophage colony-stimulating factor)"}, {"int_description_66": "Granulocyte colony-stimulating factor"}, {"int_description_67": "rh-SOD"}, {"int_description_68": "Bevacizumab"}, {"int_description_69": "Filgrastim"}, {"int_description_70": "Amifostine", "timeframe_int70": "Days or Weeks,Years", "age_use_int70": "Child", "contra_int70": "No", "qualscale_reclass_drug70": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug70": "Effective / Ameliorative"}, {"int_description_71": "Radiation therapy"}, {"int_description_72": "Total abdominal radiation"}, {"int_description_73": "Total body irradiation"}, {"int_description_74": "Total lymphoid irradiation"}, {"int_description_75": "Transfusion of blood products"}, {"int_description_76": "Bone marrow transplantation"}, {"int_description_77": "Hematopoietic stem cell transplantation"}, {"int_description_78": "Surgery for polydactyly, carpectomy"}, {"int_description_79": "Surgical intervention"}, {"int_description_80": "Tumor removal"}, {"int_description_81": "\u042burgical tumor removement"}], "references": [{"pmid_title_1": "Gingival Bleeding in a Child with Fanconi Anemia: A Case Report and Literature Review.", "pmid_1": 32231808.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Case Rep Dent"}, {"pmid_title_2": "Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.", "pmid_2": 29668547.0, "pmid_date_2": 2019.0, "pmid_journal_2": "J Pediatr Hematol Oncol"}, {"pmid_title_3": "Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.", "pmid_3": 31192125.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Front Oncol"}, {"pmid_title_4": "Fanconi anemia: a single center experience of a large cohort.", "pmid_4": 31990462.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Turk J Pediatr"}, {"pmid_title_5": "Therapeutic research in the crystal chromosome disease Fanconi anemia.", "pmid_5": 30389152.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Mutat Res Genet Toxicol Environ Mutagen"}, {"pmid_title_6": "Fanconi Anemia", "pmid_6": 20301575.0, "pmid_date_6": 2018.0, "pmid_journal_6": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_7": "Oral cancer in Fanconi anemia: Review of 121 cases.", "pmid_7": 29650274.0, "pmid_date_7": 2018.0, "pmid_journal_7": "Crit Rev Oncol Hematol"}, {"pmid_title_8": "Essential Role of BRCA2 in Ovarian Development and Function.", "pmid_8": 30207912.0, "pmid_date_8": 2018.0, "pmid_journal_8": "N Engl J Med"}, {"pmid_title_9": "Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.", "pmid_9": 29203412.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Biol Blood Marrow Transplant"}, {"pmid_title_10": "How I manage patients with Fanconi anaemia.", "pmid_10": 28474441.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Br J Haematol"}, {"pmid_title_11": "Eltrombopag for the treatment of aplastic anemia: current perspectives.", "pmid_11": 27695288.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Drug Des Devel Ther"}, {"pmid_title_12": "Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.", "pmid_12": 27246371.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Biol Blood Marrow Transplant"}, {"pmid_title_13": "Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.", "pmid_13": 26900943.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Pediatr Hematol Oncol"}, {"pmid_title_14": "Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.", "pmid_14": 26657402.0, "pmid_date_14": 2016.0, "pmid_journal_14": "Eur J Med Genet"}, {"pmid_title_15": "Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.", "pmid_15": 25575015.0, "pmid_date_15": 2015.0, "pmid_journal_15": "J Clin Endocrinol Metab"}, {"pmid_title_16": "Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.", "pmid_16": 25862235.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Ann Hematol"}, {"pmid_title_17": "Alternative donor hematopoietic cell transplantation for Fanconi anemia.", "pmid_17": 25824692.0, "pmid_date_17": 2015.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Fanconi anemia and solid malignancies in childhood: a national retrospective study.", "pmid_18": 25381700.0, "pmid_date_18": 2015.0, "pmid_journal_18": "Pediatr Blood Cancer"}, {"pmid_title_19": "Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.", "pmid_19": 25531282.0, "pmid_date_19": 2015.0, "pmid_journal_19": "Bone Marrow Transplant"}, {"pmid_title_20": "Clear cell sarcoma of the kidney in a child with Fanconi anemia.", "pmid_20": 24735155.0, "pmid_date_20": 2014.0, "pmid_journal_20": "Pediatr Dev Pathol"}, {"pmid_title_21": "Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.", "pmid_21": 25085358.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Haematologica"}, {"pmid_title_22": "Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.", "pmid_22": 24019220.0, "pmid_date_22": 2014.0, "pmid_journal_22": "Pediatr Blood Cancer"}, {"pmid_title_23": "Management of dental extraction in a female patient with fanconi anemia.", "pmid_23": 25628690.0, "pmid_date_23": 2014.0, "pmid_journal_23": "J Dent (Tehran)"}, {"pmid_title_24": "Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature.", "pmid_24": 22965917.0, "pmid_date_24": 2013.0, "pmid_journal_24": "Head Neck"}, {"pmid_title_25": "Deferasirox therapy in children with Fanconi aplastic anemia.", "pmid_25": 22510772.0, "pmid_date_25": 2012.0, "pmid_journal_25": "J Pediatr Hematol Oncol"}, {"pmid_title_26": "Fatal course of tonsillar squamous cell carcinoma associated with Fanconi anaemia: a mini review.", "pmid_26": 21925890.0, "pmid_date_26": 2012.0, "pmid_journal_26": "J Craniomaxillofac Surg"}, {"pmid_title_27": "Treatment of the bone marrow failure in Fanconi anemia patients with danazol.", "pmid_27": 22178060.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Blood Cells Mol Dis"}, {"pmid_title_28": "Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing.", "pmid_28": 21519011.0, "pmid_date_28": 2011.0, "pmid_journal_28": "J Clin Oncol"}, {"pmid_title_29": "Successful treatment of esophageal squamous cell carcinoma in a patient with Fanconi anemia.", "pmid_29": 20410055.0, "pmid_date_29": 2010.0, "pmid_journal_29": "Jpn J Clin Oncol"}, {"pmid_title_30": "Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.", "pmid_30": 19564748.0, "pmid_date_30": 2009.0, "pmid_journal_30": "J Pediatr Hematol Oncol"}, {"pmid_title_31": "Treatment with deferiprone for iron overload alleviates bone marrow failure in a Fanconi anemia patient.", "pmid_31": 19814681.0, "pmid_date_31": 2009.0, "pmid_journal_31": "Hemoglobin"}, {"pmid_title_32": "Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.", "pmid_32": 18302713.0, "pmid_date_32": 2008.0, "pmid_journal_32": "Br J Haematol"}, {"pmid_title_33": "Thrombocytopenia in the neonate.", "pmid_33": 18433954.0, "pmid_date_33": 2008.0, "pmid_journal_33": "Blood Rev"}, {"pmid_title_34": "Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.", "pmid_34": 18379369.0, "pmid_date_34": 2008.0, "pmid_journal_34": "J Thorac Oncol"}, {"pmid_title_35": "Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function.", "pmid_35": 18623197.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Pediatr Blood Cancer"}, {"pmid_title_36": "Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.", "pmid_36": 18831513.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Cancer"}, {"pmid_title_37": "Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.", "pmid_37": 17950918.0, "pmid_date_37": 2007.0, "pmid_journal_37": "Biol Blood Marrow Transplant"}, {"pmid_title_38": "Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.", "pmid_38": 17038525.0, "pmid_date_38": 2007.0, "pmid_journal_38": "Blood"}, {"pmid_title_39": "Chemotherapy for myeloid malignancy in children with Fanconi anemia.", "pmid_39": 16609946.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Pediatr Blood Cancer"}, {"pmid_title_40": "A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.", "pmid_40": 17096012.0, "pmid_date_40": 2007.0, "pmid_journal_40": "Leukemia"}, {"pmid_title_41": "HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.", "pmid_41": 18022575.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Biol Blood Marrow Transplant"}, {"pmid_title_42": "Anesthesia and Fanconi anemia: a case report and review of literature.", "pmid_42": 16918663.0, "pmid_date_42": 2006.0, "pmid_journal_42": "Paediatr Anaesth"}, {"pmid_title_43": "Squamous cell carcinoma of the hypopharynx in a young woman with Fanconi's anemia.", "pmid_43": 17308840.0, "pmid_date_43": 2006.0, "pmid_journal_43": "Braz J Otorhinolaryngol"}, {"pmid_title_44": "Squamous cell vulvar carcinoma associated with Fanconi's anemia: a case report.", "pmid_44": 11975685.0, "pmid_date_44": 2002.0, "pmid_journal_44": "Int J Gynecol Cancer"}, {"pmid_title_45": "Growth hormone deficiency caused by pituitary stalk interruption in Fanconi's anemia.", "pmid_45": 11148528.0, "pmid_date_45": 2001.0, "pmid_journal_45": "J Pediatr"}, {"pmid_title_46": "Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.", "pmid_46": 9658728.0, "pmid_date_46": 1998.0, "pmid_journal_46": "Haematologica"}, {"pmid_title_47": "Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.", "pmid_47": 8781414.0, "pmid_date_47": 1996.0, "pmid_journal_47": "Blood"}, {"pmid_title_48": "GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.", "pmid_48": 7644282.0, "pmid_date_48": 1995.0, "pmid_journal_48": "Pediatr Nurs"}, {"pmid_title_49": "Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.", "pmid_49": 8283365.0, "pmid_date_49": 1994.0, "pmid_journal_49": "J Pediatr"}, {"pmid_title_50": "A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia.", "pmid_50": 8280614.0, "pmid_date_50": 1993.0, "pmid_journal_50": "Br J Haematol"}, {"pmid_title_51": "Fanconi's anemia. A family study with 20-year follow-up including associated breast pathology.", "pmid_51": 6478420.0, "pmid_date_51": 1984.0, "pmid_journal_51": "Cancer"}, {"pmid_title_52": "Multiple hepatic tumors and peliosis hepatis in Fanconi's anemia treated with androgens.", "pmid_52": 199056.0, "pmid_date_52": 1977.0, "pmid_journal_52": "Am J Dis Child"}, {"pmid_title_53": "Hepatic lesions in patients treated with synthetic anabolic steriods.", "pmid_53": 185239.0, "pmid_date_53": 1976.0, "pmid_journal_53": "J Clin Pathol"}, {"pmid_title_54": "The defective absorption of phosphorus and calcium and the effect of vitamin D in the Fanconi syndrome.", "pmid_54": 13610080.0, "pmid_date_54": 1958.0, "pmid_journal_54": "Guys Hosp Rep"}]}, {"_id": "2439-OMIM:617014", "condition": {"condition_name": "NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE", "freq_per_birth": "The incidence of severe congenital neutropenia is estimated to be 1 in 200,000 individuals.", "pattern_of_inheritance": "X-linked recessive, Autosomal dominant, Autosomal recessive", "alternate_names": ["NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE", "Hereditary neutrophilia"]}, "gene information": {"db_hgnc_gene_id": 2439.0}, "interventions": [{"int_description_1": "Sargramostim", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Trimethoprim"}, {"int_description_3": "Sulfamethoxazole"}, {"int_description_4": "Granulocyte colony-stimulating factor ( 5 mcg/kg/d every 3 days)"}, {"int_description_5": "Granulocyte colony-stimulating factor"}, {"int_description_6": "Parenteral antibiotics", "timeframe_int6": "Hours,Days or Weeks,Years", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Case report(s)", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Prophylactic oral antibiotics", "timeframe_int7": "Hours,Days or Weeks", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Case report(s)", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Recombinant human granulocyte colony-stimulating factor"}], "references": [{"pmid_title_1": "Management of a Patient With Congenital Biallelic CSF3R Mutation With GM-CSF.", "pmid_1": 30499904.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Journal of pediatric hematology/oncology"}, {"pmid_title_2": "Congenital Neutropenia Patient With Hypomorphic Biallelic CSF3R Mutation Responding to GCSF.", "pmid_2": 30028820.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Journal of pediatric hematology/oncology"}, {"pmid_title_3": "GM-CSF stimulates granulopoiesis in a congenital neutropenia patient with loss-of-function biallelic heterozygous CSF3R mutations.", "pmid_3": 26324699.0, "pmid_date_3": 2015.0, "pmid_journal_3": "Blood"}, {"pmid_title_4": "Inherited biallelic CSF3R mutations in severe congenital neutropenia.", "pmid_4": 24753537.0, "pmid_date_4": 2014.0, "pmid_journal_4": "Blood"}]}, {"_id": "2439-ORPHA:279943", "condition": {"condition_name": "Hereditary neutrophilia", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["Hereditary neutrophilia", "NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE"]}, "gene information": {"db_hgnc_gene_id": 2439.0}, "interventions": [{"int_description_1": "Ruxolitinib"}], "references": [{"pmid_title_1": "Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.", "pmid_1": 31880950.0, "pmid_date_1": 2020.0, "pmid_journal_1": "J Clin Oncol"}]}, {"_id": "24525-OMIM:277400", "condition": {"condition_name": "METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC", "freq_per_birth": "The most common form of the condition, called methylmalonic acidemia with homocystinuria, cblC type, is estimated to affect 1 in 200,000 newborns worldwide. Studies indicate that this form of the condition may be even more common in particular populations. These studies estimate the condition occurs in 1 in 100,000 people in New York and 1 in 60,000 people in California. Other types of methylmalonic acidemia with homocystinuria are much less common. Fewer than 20 cases of each of the other types have been reported in the medical literature.", "pattern_of_inheritance": "X-linked recessive==Autosomal recessive", "alternate_names": ["METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC"]}, "gene information": {"db_hgnc_gene_id": 24525.0}, "interventions": [{"int_description_1": "Protein-restricted diet"}, {"int_description_2": "Hydroxocobalamin", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Metronidazole", "timeframe_int3": "Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Levocarnitine", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Still in Trials / Unproven"}, {"int_description_5": "Leucovorin"}, {"int_description_6": "Glycine betaine"}, {"int_description_7": "Vatiquinone", "timeframe_int7": "Hours,Days or Weeks", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Carglumic acid"}, {"int_description_9": "Kidney-liver transplantation"}], "references": [{"pmid_title_1": "Clinical presentation, gene analysis and outcomes in young patients with early-treated combined methylmalonic acidemia and homocysteinemia (cblC type) in Shandong province, China.", "pmid_1": 26563984.0, "pmid_date_1": 2016.0, "pmid_journal_1": "Brain & development"}, {"pmid_title_2": "Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type.", "pmid_2": 23954310.0, "pmid_date_2": 2013.0, "pmid_journal_2": "Molecular genetics and metabolism"}, {"pmid_title_3": "Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management.", "pmid_3": 21748409.0, "pmid_date_3": 2012.0, "pmid_journal_3": "Journal of inherited metabolic disease"}]}, {"_id": "24671-OMIM:255100", "condition": {"condition_name": "LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY; LSMFLAD", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY; LSMFLAD"]}, "gene information": {"db_hgnc_gene_id": 24671.0}, "interventions": [{"int_description_1": "high carbohydrate diet"}, {"int_description_2": "low fat diet"}, {"int_description_3": "MCT diet"}, {"int_description_4": "Ubidecarenone"}, {"int_description_5": "Bezafibrate", "timeframe_int5": "Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Still in Trials / Unproven"}, {"int_description_6": "Cyanocobalamin", "timeframe_int6": "Hours,Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Case report(s)", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Pyridoxine"}, {"int_description_8": "Levocarnitine"}, {"int_description_9": "Riboflavin"}, {"int_description_10": "D,L-3-hydroxybutyrate"}, {"int_description_11": "Sodium bicarbonate"}, {"int_description_12": "D-glucose"}, {"int_description_13": "Thiamine", "timeframe_int13": "Days or Weeks", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Case report(s)", "rev1_eff_reclass_drug13": "Still in Trials / Unproven"}, {"int_description_14": "avoid fasting"}], "references": [{"pmid_title_1": "Efficacy and safety of D,L-3-hydroxybutyrate (D,L-3-HB) treatment in multiple acyl-CoA dehydrogenase deficiency.", "pmid_1": 31904027.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Genetics in medicine : official journal of the American College of Medical Genetics"}, {"pmid_title_2": "Needle EMG, a Jigsaw to Disclose Lipid Storage Myopathy Due to Multiple Acyl-CoA Dehydrogenase Deficiency.", "pmid_2": 31136308.0, "pmid_date_2": 2020.0, "pmid_journal_2": "American journal of physical medicine & rehabilitation"}, {"pmid_title_3": "Skin damage in a patient with lipid storage myopathy with a novel ETFDH mutation responsive to riboflavin.", "pmid_3": 32064983.0, "pmid_date_3": 2020.0, "pmid_journal_3": "The International journal of neuroscience"}, {"pmid_title_4": "Multiple acyl-COA dehydrogenase deficiency in elderly carriers.", "pmid_4": 31997039.0, "pmid_date_4": 2020.0, "pmid_journal_4": "Journal of neurology"}, {"pmid_title_5": "A Synonymous Variant c.579A>G in the ETFDH Gene Caused Exon Skipping in a Patient With Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency: A Case Report.", "pmid_5": 32292771.0, "pmid_date_5": 2020.0, "pmid_journal_5": "Frontiers in pediatrics"}, {"pmid_title_6": "Late-onset multiple acyl-CoA dehydrogenase deficiency with cardiac syncope: A case report.", "pmid_6": 32190638.0, "pmid_date_6": 2020.0, "pmid_journal_6": "World journal of clinical cases"}, {"pmid_title_7": "Correlation between ETFDH mutations and dysregulation of serum myomiRs in MADD patients.", "pmid_7": 32499892.0, "pmid_date_7": 2020.0, "pmid_journal_7": "European journal of translational myology"}, {"pmid_title_8": "A case report of a mild form of multiple acyl-CoA dehydrogenase deficiency due to compound heterozygous mutations in the ETFA gene.", "pmid_8": 31996215.0, "pmid_date_8": 2020.0, "pmid_journal_8": "BMC medical genomics"}, {"pmid_title_9": "A novel electron transfer flavoprotein dehydrogenase (ETFDH) gene mutation identified in a newborn with glutaric acidemia type II: a case report of a Chinese family.", "pmid_9": 32393189.0, "pmid_date_9": 2020.0, "pmid_journal_9": "BMC medical genetics"}, {"pmid_title_10": "Metabolic lipid muscle disorders: biomarkers and treatment.", "pmid_10": 31040882.0, "pmid_date_10": 2019.0, "pmid_journal_10": "Therapeutic advances in neurological disorders"}, {"pmid_title_11": "Expanded newborn screening for inherited metabolic disorders and genetic characteristics in a southern Chinese population.", "pmid_11": 30904546.0, "pmid_date_11": 2019.0, "pmid_journal_11": "Clinica chimica acta; international journal of clinical chemistry"}, {"pmid_title_12": "Long-term ketone body therapy of severe multiple acyl-CoA dehydrogenase deficiency: A case report.", "pmid_12": 30557775.0, "pmid_date_12": 2019.0, "pmid_journal_12": "Nutrition (Burbank, Los Angeles County, Calif.)"}, {"pmid_title_13": "Ketone body therapy with D/L-\u03b2-hydroxybutyric acid solution in severe MADD.", "pmid_13": 31312603.0, "pmid_date_13": 2019.0, "pmid_journal_13": "Molecular genetics and metabolism reports"}, {"pmid_title_14": "A Novel Truncating FLAD1 Variant, Causing Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) in an 8-Year-Old Boy.", "pmid_14": 30311138.0, "pmid_date_14": 2019.0, "pmid_journal_14": "JIMD reports"}, {"pmid_title_15": "ETF-QO Mutants Uncoupled Fatty Acid \u03b2-Oxidation and Mitochondrial Bioenergetics Leading to Lipid Pathology.", "pmid_15": 30709034.0, "pmid_date_15": 2019.0, "pmid_journal_15": "Cells"}, {"pmid_title_16": "Follow-up of fatty acid \u03b2-oxidation disorders in expanded newborn screening era.", "pmid_16": 30617651.0, "pmid_date_16": 2019.0, "pmid_journal_16": "European journal of pediatrics"}, {"pmid_title_17": "Determinants of Riboflavin Responsiveness in Multiple Acyl-CoA Dehydrogenase Deficiency.", "pmid_17": 31331668.0, "pmid_date_17": 2019.0, "pmid_journal_17": "Pediatric neurology"}, {"pmid_title_18": "FLAD1-associated multiple acyl-CoA dehydrogenase deficiency identified by newborn screening.", "pmid_18": 31392824.0, "pmid_date_18": 2019.0, "pmid_journal_18": "Molecular genetics & genomic medicine"}, {"pmid_title_19": "Molecular and Clinical Investigations on Portuguese Patients with Multiple acyl-CoA Dehydrogenase Deficiency.", "pmid_19": 31418342.0, "pmid_date_19": 2019.0, "pmid_journal_19": "Current molecular medicine"}, {"pmid_title_20": "Rhabdomyolysis and respiratory insufficiency due to the common ETFDH mutation of c.250G>A in two patients with late-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_20": 31058673.0, "pmid_date_20": 2019.0, "pmid_journal_20": "Chinese medical journal"}, {"pmid_title_21": "Impaired fat oxidation during exercise in multiple acyl-CoA dehydrogenase deficiency.", "pmid_21": 31240159.0, "pmid_date_21": 2019.0, "pmid_journal_21": "JIMD reports"}, {"pmid_title_22": "Myogenic Disease and Metabolic Acidosis: Consider Multiple Acyl-Coenzyme A Dehydrogenase Deficiency.", "pmid_22": 31934457.0, "pmid_date_22": 2019.0, "pmid_journal_22": "Case reports in critical care"}, {"pmid_title_23": "Long-term outcomes of a patient with late-onset multiple acyl-CoA dehydrogenase deficiency caused by novel mutations in ETFDH: A case report.", "pmid_23": 30508893.0, "pmid_date_23": 2018.0, "pmid_journal_23": "Medicine"}, {"pmid_title_24": "Glutaric acidemia type II patient with thalassemia minor and novel electron transfer flavoprotein-A gene mutations: A case report and review of literature.", "pmid_24": 30510944.0, "pmid_date_24": 2018.0, "pmid_journal_24": "World journal of clinical cases"}, {"pmid_title_25": "Encephalopathy associated with a reversible splenial lesion in riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_25": 30072122.0, "pmid_date_25": 2018.0, "pmid_journal_25": "Revue neurologique"}, {"pmid_title_26": "Acute-onset multiple acyl-CoA dehydrogenase deficiency mimicking Guillain-Barr\u00e9 syndrome: two cases report.", "pmid_26": 30587156.0, "pmid_date_26": 2018.0, "pmid_journal_26": "BMC neurology"}, {"pmid_title_27": "Post-mortem detection of FLAD1 mutations in 2 Turkish siblings with hypotonia in early infancy.", "pmid_27": 30061063.0, "pmid_date_27": 2018.0, "pmid_journal_27": "Neuromuscular disorders : NMD"}, {"pmid_title_28": "Lipid Storage Myopathy with Ketonuria: A Case of Fatty Acid Oxidation-Related Myopathy and Encephalopathy due to Multiple Acyl-CoA Dehydrogenase Deficiency.", "pmid_28": 30271477.0, "pmid_date_28": 2018.0, "pmid_journal_28": "Journal of pediatric neurosciences"}, {"pmid_title_29": "Clinical Features of Multiple Acyl-CoA Dehydrogenase Deficiency With ETFDH Variants in the First Korean Cases.", "pmid_29": 30027710.0, "pmid_date_29": 2018.0, "pmid_journal_29": "Annals of laboratory medicine"}, {"pmid_title_30": "Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_30": 30424791.0, "pmid_date_30": 2018.0, "pmid_journal_30": "Lipids in health and disease"}, {"pmid_title_31": "A novel mutation in ETFDH manifesting as severe neonatal-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_31": 29249369.0, "pmid_date_31": 2018.0, "pmid_journal_31": "Journal of the neurological sciences"}, {"pmid_title_32": "Successful Pregnancy in a Young Woman with Multiple Acyl-CoA Dehydrogenase Deficiency.", "pmid_32": 28685490.0, "pmid_date_32": 2018.0, "pmid_journal_32": "JIMD reports"}, {"pmid_title_33": "A novel ETFDH mutation in an adult patient with late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_33": 28914566.0, "pmid_date_33": 2018.0, "pmid_journal_33": "The International journal of neuroscience"}, {"pmid_title_34": "Patient with multiple acyl-CoA dehydrogenase deficiency disease and ETFDH mutations benefits from riboflavin therapy: a case report.", "pmid_34": 29615056.0, "pmid_date_34": 2018.0, "pmid_journal_34": "BMC medical genomics"}, {"pmid_title_35": "Novel <i>ETFDH</i> mutations in four cases of riboflavin responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_35": 29988809.0, "pmid_date_35": 2018.0, "pmid_journal_35": "Molecular genetics and metabolism reports"}, {"pmid_title_36": "Efficacy of bezafibrate on fibroblasts of glutaric acidemia type II patients evaluated using an in vitro probe acylcarnitine assay.", "pmid_36": 27591119.0, "pmid_date_36": 2017.0, "pmid_journal_36": "Brain & development"}, {"pmid_title_37": "Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency: delayed hypersensitivity reaction and efficacy of low-dose intermittent supplementation.", "pmid_37": 28643959.0, "pmid_date_37": 2017.0, "pmid_journal_37": "European journal of neurology"}, {"pmid_title_38": "Riboflavin-Responsive Multiple Acyl-CoA Dehydrogenase Deficiency Associated with Hepatoencephalomyopathy and White Matter Signal Abnormalities on Brain MRI.", "pmid_38": 28388738.0, "pmid_date_38": 2017.0, "pmid_journal_38": "Neuropediatrics"}, {"pmid_title_39": "Significant clinical heterogeneity with similar ETFDH genotype in three Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_39": 27000805.0, "pmid_date_39": 2016.0, "pmid_journal_39": "Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"}, {"pmid_title_40": "Severe sensory neuropathy in patients with adult-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_40": 26821934.0, "pmid_date_40": 2016.0, "pmid_journal_40": "Neuromuscular disorders : NMD"}, {"pmid_title_41": "Bent spine syndrome as an initial manifestation of late-onset multiple acyl-CoA dehydrogenase deficiency: a case report and literature review.", "pmid_41": 26205240.0, "pmid_date_41": 2015.0, "pmid_journal_41": "BMC neurology"}, {"pmid_title_42": "Highly efficient ketone body treatment in multiple acyl-CoA dehydrogenase deficiency-related leukodystrophy.", "pmid_42": 25289702.0, "pmid_date_42": 2015.0, "pmid_journal_42": "Pediatric research"}, {"pmid_title_43": "A case of late-onset riboflavin responsive multiple acyl-CoA dehydrogenase deficiency (MADD) with a novel mutation in ETFDH gene.", "pmid_43": 25913573.0, "pmid_date_43": 2015.0, "pmid_journal_43": "Journal of the neurological sciences"}, {"pmid_title_44": "Clinical features and ETFDH mutation spectrum in a cohort of 90 Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_44": 24357026.0, "pmid_date_44": 2014.0, "pmid_journal_44": "Journal of inherited metabolic disease"}, {"pmid_title_45": "Novel ETFDH mutation and imaging findings in an adult with glutaric aciduria type II.", "pmid_45": 23893693.0, "pmid_date_45": 2014.0, "pmid_journal_45": "Muscle & nerve"}, {"pmid_title_46": "Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency with unknown genetic defect.", "pmid_46": 22190129.0, "pmid_date_46": 2012.0, "pmid_journal_46": "Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"}, {"pmid_title_47": "A case of late-onset riboflavin responsive multiple acyl-CoA dehydrogenase deficiency with novel mutations in ETFDH gene.", "pmid_47": 23106979.0, "pmid_date_47": 2012.0, "pmid_journal_47": "CNS neuroscience & therapeutics"}, {"pmid_title_48": "Multiple acyl-CoA-dehydrogenase deficiency (MADD)--a novel mutation of electron-transferring-flavoprotein dehydrogenase ETFDH.", "pmid_48": 21616504.0, "pmid_date_48": 2011.0, "pmid_journal_48": "Journal of the neurological sciences"}, {"pmid_title_49": "A case of late onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency manifesting as recurrent rhabdomyolysis and acute renal failure.", "pmid_49": 22041377.0, "pmid_date_49": 2011.0, "pmid_journal_49": "Internal medicine (Tokyo, Japan)"}, {"pmid_title_50": "Central nervous system and muscle involvement in an adolescent patient with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_50": 19783111.0, "pmid_date_50": 2010.0, "pmid_journal_50": "Brain & development"}, {"pmid_title_51": "High resolution melting analysis facilitates mutation screening of ETFDH gene: applications in riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_51": 20138856.0, "pmid_date_51": 2010.0, "pmid_journal_51": "Clinica chimica acta; international journal of clinical chemistry"}, {"pmid_title_52": "ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_52": 19249206.0, "pmid_date_52": 2009.0, "pmid_journal_52": "Neuromuscular disorders : NMD"}, {"pmid_title_53": "Novel mutations in ETFDH gene in Chinese patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_53": 19265687.0, "pmid_date_53": 2009.0, "pmid_journal_53": "Clinica chimica acta; international journal of clinical chemistry"}, {"pmid_title_54": "Late-onset multiple acyl-CoA dehydrogenase deficiency: a frequently missed diagnosis?", "pmid_54": 17060596.0, "pmid_date_54": 2006.0, "pmid_journal_54": "Neurology"}, {"pmid_title_55": "D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD).", "pmid_55": 12727399.0, "pmid_date_55": 2003.0, "pmid_journal_55": "Lancet (London, England)"}, {"pmid_title_56": "Adult-Onset Presentation of Glutaric Acidemia Type II With Myopathy.", "pmid_56": 19078703.0, "pmid_date_56": 2003.0, "pmid_journal_56": "Journal of clinical neuromuscular disease"}]}, {"_id": "24861-OMIM:612541", "condition": {"condition_name": "NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE", "freq_per_birth": "The incidence of severe congenital neutropenia is estimated to be 1 in 200,000 individuals.", "pattern_of_inheritance": "X-linked recessive, Autosomal dominant, Autosomal recessive", "alternate_names": ["NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE"]}, "gene information": {"db_hgnc_gene_id": 24861.0}, "interventions": [{"int_description_1": "Occluder device"}, {"int_description_2": "Ursodeoxycholic acid"}, {"int_description_3": "Prednisolone"}, {"int_description_4": "Iloprost"}, {"int_description_5": "Adalimumab"}, {"int_description_6": "Digoxin"}, {"int_description_7": "Captopril"}, {"int_description_8": "Trimethoprim"}, {"int_description_9": "Sulfamethoxazole"}, {"int_description_10": "Levofloxacin"}, {"int_description_11": "Sildenafil"}, {"int_description_12": "Colchicine"}, {"int_description_13": "Anti-TNF therapy"}, {"int_description_14": "Antibiotic"}, {"int_description_15": "Antibiotics", "timeframe_int15": "Days or Weeks", "age_use_int15": "Neonate,Infant,Child", "contra_int15": "No", "qualscale_reclass_drug15": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug15": "Effective / Ameliorative"}, {"int_description_16": "Chemotherapy"}, {"int_description_17": "G-CSF, granulocyte colony-stimulating factor"}, {"int_description_18": "G-CSF", "timeframe_int18": "Hours,Days or Weeks", "age_use_int18": "Neonate,Infant,Child", "contra_int18": "No", "qualscale_reclass_drug18": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug18": "Effective / Ameliorative"}, {"int_description_19": "Granulocyte colony stimulating factor"}, {"int_description_20": "Oral corticosteroid therapy"}, {"int_description_21": "Oral steroids"}, {"int_description_22": "Prophylactic antibiotics", "timeframe_int22": "Days or Weeks", "age_use_int22": "Child", "contra_int22": "No", "qualscale_reclass_drug22": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug22": "Effective / Ameliorative"}, {"int_description_23": "Steroid"}, {"int_description_24": "Intravenous immunoglobulins (IVIG)", "timeframe_int24": "Days or Weeks", "age_use_int24": "Infant,Child", "contra_int24": "No", "qualscale_reclass_drug24": "Case report(s)", "rev1_eff_reclass_drug24": "Effective / Ameliorative"}, {"int_description_25": "Cardiac surgery"}, {"int_description_26": "Hematopoietic stem cell transplantation"}, {"int_description_27": "Surgery for pulmonary artery banding"}, {"int_description_28": "Tonsillectomy"}], "references": [{"pmid_title_1": "Glucose-6-Phosphatase Catalytic Subunit 3 (<i>G6PC3</i>) Deficiency Associated With Autoinflammatory Complications.", "pmid_1": 29163546.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Frontiers in immunology"}, {"pmid_title_2": "G6PC3 Deficiency", "pmid_2": 25879134.0, "pmid_date_2": 2015.0, "pmid_journal_2": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_3": "Genetic analysis and clinical picture of severe congenital neutropenia in Israel.", "pmid_3": 25284454.0, "pmid_date_3": 2015.0, "pmid_journal_3": "Pediatric blood & cancer"}, {"pmid_title_4": "G6PC3 Deficiency: Primary Immune Deficiency Beyond Just Neutropenia.", "pmid_4": 26479985.0, "pmid_date_4": 2015.0, "pmid_journal_4": "Journal of pediatric hematology/oncology"}, {"pmid_title_5": "Clinical spectrum and long-term follow-up of 14 cases with G6PC3 mutations from the French Severe Congenital Neutropenia Registry.", "pmid_5": 25491320.0, "pmid_date_5": 2014.0, "pmid_journal_5": "Orphanet journal of rare diseases"}, {"pmid_title_6": "A clinical and molecular review of ubiquitous glucose-6-phosphatase deficiency caused by G6PC3 mutations.", "pmid_6": 23758768.0, "pmid_date_6": 2013.0, "pmid_journal_6": "Orphanet journal of rare diseases"}, {"pmid_title_7": "A novel phenotype variant of severe congenital neutropenia caused by G6PC3 deficiency.", "pmid_7": 23441086.0, "pmid_date_7": 2013.0, "pmid_journal_7": "Pediatric blood & cancer"}, {"pmid_title_8": "G6PC3 mutations cause non-syndromic severe congenital neutropenia.", "pmid_8": 23298686.0, "pmid_date_8": 2013.0, "pmid_journal_8": "Molecular genetics and metabolism"}, {"pmid_title_9": "Phenotypic heterogeneity and evidence of a founder effect associated with G6PC3 mutations in patients with severe congenital neutropenia.", "pmid_9": 22469094.0, "pmid_date_9": 2012.0, "pmid_journal_9": "British journal of haematology"}, {"pmid_title_10": "Extended spectrum of human glucose-6-phosphatase catalytic subunit 3 deficiency: novel genotypes and phenotypic variability in severe congenital neutropenia.", "pmid_10": 22050868.0, "pmid_date_10": 2012.0, "pmid_journal_10": "The Journal of pediatrics"}, {"pmid_title_11": "Two cases of syndromic neutropenia with a report of novel mutation in G6PC3.", "pmid_11": 21891829.0, "pmid_date_11": 2011.0, "pmid_journal_11": "Iranian journal of allergy, asthma, and immunology"}, {"pmid_title_12": "Further delineation of the phenotype of severe congenital neutropenia type 4 due to mutations in G6PC3.", "pmid_12": 20717171.0, "pmid_date_12": 2011.0, "pmid_journal_12": "European journal of human genetics : EJHG"}, {"pmid_title_13": "Mutations in the G6PC3 gene cause Dursun syndrome.", "pmid_13": 20799326.0, "pmid_date_13": 2010.0, "pmid_journal_13": "American journal of medical genetics. Part A"}, {"pmid_title_14": "Cardiac and renal malformations in a patient with sepsis and severe congenital neutropenia.", "pmid_14": 23056709.0, "pmid_date_14": 2010.0, "pmid_journal_14": "Iranian journal of pediatrics"}, {"pmid_title_15": "Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis.", "pmid_15": 20616219.0, "pmid_date_15": 2010.0, "pmid_journal_15": "Blood"}, {"pmid_title_16": "A syndrome with congenital neutropenia and mutations in G6PC3.", "pmid_16": 19118303.0, "pmid_date_16": 2009.0, "pmid_journal_16": "The New England journal of medicine"}, {"pmid_title_17": "Familial pulmonary arterial hypertension, leucopenia, and atrial septal defect: a probable new familial syndrome with multisystem involvement.", "pmid_17": 19011569.0, "pmid_date_17": 2009.0, "pmid_journal_17": "Clinical dysmorphology"}]}, {"_id": "25009-OMIM:616435", "condition": {"condition_name": "FANCONI ANEMIA, COMPLEMENTATION GROUP T", "alternate_names": ["FANCONI ANEMIA, COMPLEMENTATION GROUP T"]}, "gene information": {"db_hgnc_gene_id": 25009.0}, "interventions": [{"int_description_1": "Healthy diet"}, {"int_description_2": "Oxandrolone"}, {"int_description_3": "Danazol"}, {"int_description_4": "Testosterone propionate"}, {"int_description_5": "Oxymetholone"}, {"int_description_6": "Stanozolol"}, {"int_description_7": "Metenolone"}, {"int_description_8": "Calcium"}, {"int_description_9": "Prednisone"}, {"int_description_10": "Dexamethasone"}, {"int_description_11": "Insulin aspart"}, {"int_description_12": "Medroxyprogesterone acetate"}, {"int_description_13": "Tretinoin"}, {"int_description_14": "Eltrombopag"}, {"int_description_15": "Levothyroxine"}, {"int_description_16": "Estradiol"}, {"int_description_17": "Cetuximab"}, {"int_description_18": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_19": "Alemtuzumab"}, {"int_description_20": "Coenzyme M"}, {"int_description_21": "Cyclosporine"}, {"int_description_22": "Dactinomycin"}, {"int_description_23": "Sirolimus"}, {"int_description_24": "Somatotropin"}, {"int_description_25": "Vitamin D"}, {"int_description_26": "Cyclophosphamide"}, {"int_description_27": "Carboplatin"}, {"int_description_28": "Busulfan"}, {"int_description_29": "Ifosfamide"}, {"int_description_30": "Thiotepa"}, {"int_description_31": "Doxorubicin", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Fluorouracil", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Neonate,Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Mercaptopurine"}, {"int_description_34": "Trimethoprim"}, {"int_description_35": "Sulfamethoxazole"}, {"int_description_36": "Gemcitabine"}, {"int_description_37": "Vincristine"}, {"int_description_38": "Methotrexate"}, {"int_description_39": "Fludarabine"}, {"int_description_40": "Cytarabine"}, {"int_description_41": "Irinotecan"}, {"int_description_42": "Daunorubicin"}, {"int_description_43": "Etoposide"}, {"int_description_44": "Idarubicin"}, {"int_description_45": "Tacrolimus"}, {"int_description_46": "Acyclovir"}, {"int_description_47": "Quercetin"}, {"int_description_48": "Tioguanine"}, {"int_description_49": "Mycophenolate mofetil"}, {"int_description_50": "Tranexamic acid"}, {"int_description_51": "Hydroxyurea"}, {"int_description_52": "Methylprednisolone"}, {"int_description_53": "Methyltestosterone"}, {"int_description_54": "Leucovorin"}, {"int_description_55": "Vinorelbine"}, {"int_description_56": "Deferasirox"}, {"int_description_57": "Deferiprone"}, {"int_description_58": "Chemotherapy"}, {"int_description_59": "Co-trimoxazole"}, {"int_description_60": "Asparaginase Escherichia coli"}, {"int_description_61": "Cisplatin"}, {"int_description_62": "Antilymphocyte immunoglobulin (horse)"}, {"int_description_63": "Norethandrolone"}, {"int_description_64": "Phosphorus"}, {"int_description_65": "GM-CSF (granulocyte-macrophage colony-stimulating factor)"}, {"int_description_66": "Granulocyte colony-stimulating factor"}, {"int_description_67": "rh-SOD"}, {"int_description_68": "Bevacizumab"}, {"int_description_69": "Filgrastim"}, {"int_description_70": "Amifostine", "timeframe_int70": "Days or Weeks,Years", "age_use_int70": "Child", "contra_int70": "No", "qualscale_reclass_drug70": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug70": "Effective / Ameliorative"}, {"int_description_71": "Radiation therapy"}, {"int_description_72": "Total abdominal radiation"}, {"int_description_73": "Total body irradiation"}, {"int_description_74": "Total lymphoid irradiation"}, {"int_description_75": "Transfusion of blood products"}, {"int_description_76": "Bone marrow transplantation"}, {"int_description_77": "Hematopoietic stem cell transplantation"}, {"int_description_78": "Surgery for polydactyly, carpectomy"}, {"int_description_79": "Surgical intervention"}, {"int_description_80": "Tumor removal"}, {"int_description_81": "\u042burgical tumor removement"}], "references": [{"pmid_title_1": "Gingival Bleeding in a Child with Fanconi Anemia: A Case Report and Literature Review.", "pmid_1": 32231808.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Case Rep Dent"}, {"pmid_title_2": "Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.", "pmid_2": 29668547.0, "pmid_date_2": 2019.0, "pmid_journal_2": "J Pediatr Hematol Oncol"}, {"pmid_title_3": "Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.", "pmid_3": 31192125.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Front Oncol"}, {"pmid_title_4": "Fanconi anemia: a single center experience of a large cohort.", "pmid_4": 31990462.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Turk J Pediatr"}, {"pmid_title_5": "Therapeutic research in the crystal chromosome disease Fanconi anemia.", "pmid_5": 30389152.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Mutat Res Genet Toxicol Environ Mutagen"}, {"pmid_title_6": "Fanconi Anemia", "pmid_6": 20301575.0, "pmid_date_6": 2018.0, "pmid_journal_6": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_7": "Oral cancer in Fanconi anemia: Review of 121 cases.", "pmid_7": 29650274.0, "pmid_date_7": 2018.0, "pmid_journal_7": "Crit Rev Oncol Hematol"}, {"pmid_title_8": "Essential Role of BRCA2 in Ovarian Development and Function.", "pmid_8": 30207912.0, "pmid_date_8": 2018.0, "pmid_journal_8": "N Engl J Med"}, {"pmid_title_9": "Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.", "pmid_9": 29203412.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Biol Blood Marrow Transplant"}, {"pmid_title_10": "How I manage patients with Fanconi anaemia.", "pmid_10": 28474441.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Br J Haematol"}, {"pmid_title_11": "Eltrombopag for the treatment of aplastic anemia: current perspectives.", "pmid_11": 27695288.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Drug Des Devel Ther"}, {"pmid_title_12": "Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.", "pmid_12": 27246371.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Biol Blood Marrow Transplant"}, {"pmid_title_13": "Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.", "pmid_13": 26900943.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Pediatr Hematol Oncol"}, {"pmid_title_14": "Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.", "pmid_14": 26657402.0, "pmid_date_14": 2016.0, "pmid_journal_14": "Eur J Med Genet"}, {"pmid_title_15": "Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.", "pmid_15": 25575015.0, "pmid_date_15": 2015.0, "pmid_journal_15": "J Clin Endocrinol Metab"}, {"pmid_title_16": "Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.", "pmid_16": 25862235.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Ann Hematol"}, {"pmid_title_17": "Alternative donor hematopoietic cell transplantation for Fanconi anemia.", "pmid_17": 25824692.0, "pmid_date_17": 2015.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Mutations in the gene encoding the E2 conjugating enzyme UBE2T cause Fanconi anemia.", "pmid_18": 26046368.0, "pmid_date_18": 2015.0, "pmid_journal_18": "Am J Hum Genet"}, {"pmid_title_19": "Fanconi anemia and solid malignancies in childhood: a national retrospective study.", "pmid_19": 25381700.0, "pmid_date_19": 2015.0, "pmid_journal_19": "Pediatr Blood Cancer"}, {"pmid_title_20": "Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.", "pmid_20": 25531282.0, "pmid_date_20": 2015.0, "pmid_journal_20": "Bone Marrow Transplant"}, {"pmid_title_21": "Clear cell sarcoma of the kidney in a child with Fanconi anemia.", "pmid_21": 24735155.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Pediatr Dev Pathol"}, {"pmid_title_22": "Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.", "pmid_22": 25085358.0, "pmid_date_22": 2014.0, "pmid_journal_22": "Haematologica"}, {"pmid_title_23": "Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.", "pmid_23": 24019220.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Pediatr Blood Cancer"}, {"pmid_title_24": "Management of dental extraction in a female patient with fanconi anemia.", "pmid_24": 25628690.0, "pmid_date_24": 2014.0, "pmid_journal_24": "J Dent (Tehran)"}, {"pmid_title_25": "Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature.", "pmid_25": 22965917.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Head Neck"}, {"pmid_title_26": "Deferasirox therapy in children with Fanconi aplastic anemia.", "pmid_26": 22510772.0, "pmid_date_26": 2012.0, "pmid_journal_26": "J Pediatr Hematol Oncol"}, {"pmid_title_27": "Fatal course of tonsillar squamous cell carcinoma associated with Fanconi anaemia: a mini review.", "pmid_27": 21925890.0, "pmid_date_27": 2012.0, "pmid_journal_27": "J Craniomaxillofac Surg"}, {"pmid_title_28": "Treatment of the bone marrow failure in Fanconi anemia patients with danazol.", "pmid_28": 22178060.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Blood Cells Mol Dis"}, {"pmid_title_29": "Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing.", "pmid_29": 21519011.0, "pmid_date_29": 2011.0, "pmid_journal_29": "J Clin Oncol"}, {"pmid_title_30": "Successful treatment of esophageal squamous cell carcinoma in a patient with Fanconi anemia.", "pmid_30": 20410055.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Jpn J Clin Oncol"}, {"pmid_title_31": "Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.", "pmid_31": 19564748.0, "pmid_date_31": 2009.0, "pmid_journal_31": "J Pediatr Hematol Oncol"}, {"pmid_title_32": "Treatment with deferiprone for iron overload alleviates bone marrow failure in a Fanconi anemia patient.", "pmid_32": 19814681.0, "pmid_date_32": 2009.0, "pmid_journal_32": "Hemoglobin"}, {"pmid_title_33": "Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.", "pmid_33": 18302713.0, "pmid_date_33": 2008.0, "pmid_journal_33": "Br J Haematol"}, {"pmid_title_34": "Thrombocytopenia in the neonate.", "pmid_34": 18433954.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.", "pmid_35": 18379369.0, "pmid_date_35": 2008.0, "pmid_journal_35": "J Thorac Oncol"}, {"pmid_title_36": "Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function.", "pmid_36": 18623197.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Pediatr Blood Cancer"}, {"pmid_title_37": "Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.", "pmid_37": 18831513.0, "pmid_date_37": 2008.0, "pmid_journal_37": "Cancer"}, {"pmid_title_38": "Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.", "pmid_38": 17950918.0, "pmid_date_38": 2007.0, "pmid_journal_38": "Biol Blood Marrow Transplant"}, {"pmid_title_39": "Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.", "pmid_39": 17038525.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Blood"}, {"pmid_title_40": "Chemotherapy for myeloid malignancy in children with Fanconi anemia.", "pmid_40": 16609946.0, "pmid_date_40": 2007.0, "pmid_journal_40": "Pediatr Blood Cancer"}, {"pmid_title_41": "A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.", "pmid_41": 17096012.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Leukemia"}, {"pmid_title_42": "HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.", "pmid_42": 18022575.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Biol Blood Marrow Transplant"}, {"pmid_title_43": "Anesthesia and Fanconi anemia: a case report and review of literature.", "pmid_43": 16918663.0, "pmid_date_43": 2006.0, "pmid_journal_43": "Paediatr Anaesth"}, {"pmid_title_44": "Squamous cell carcinoma of the hypopharynx in a young woman with Fanconi's anemia.", "pmid_44": 17308840.0, "pmid_date_44": 2006.0, "pmid_journal_44": "Braz J Otorhinolaryngol"}, {"pmid_title_45": "Squamous cell vulvar carcinoma associated with Fanconi's anemia: a case report.", "pmid_45": 11975685.0, "pmid_date_45": 2002.0, "pmid_journal_45": "Int J Gynecol Cancer"}, {"pmid_title_46": "Growth hormone deficiency caused by pituitary stalk interruption in Fanconi's anemia.", "pmid_46": 11148528.0, "pmid_date_46": 2001.0, "pmid_journal_46": "J Pediatr"}, {"pmid_title_47": "Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.", "pmid_47": 9658728.0, "pmid_date_47": 1998.0, "pmid_journal_47": "Haematologica"}, {"pmid_title_48": "Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.", "pmid_48": 8781414.0, "pmid_date_48": 1996.0, "pmid_journal_48": "Blood"}, {"pmid_title_49": "GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.", "pmid_49": 7644282.0, "pmid_date_49": 1995.0, "pmid_journal_49": "Pediatr Nurs"}, {"pmid_title_50": "Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.", "pmid_50": 8283365.0, "pmid_date_50": 1994.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia.", "pmid_51": 8280614.0, "pmid_date_51": 1993.0, "pmid_journal_51": "Br J Haematol"}, {"pmid_title_52": "Fanconi's anemia. A family study with 20-year follow-up including associated breast pathology.", "pmid_52": 6478420.0, "pmid_date_52": 1984.0, "pmid_journal_52": "Cancer"}, {"pmid_title_53": "Multiple hepatic tumors and peliosis hepatis in Fanconi's anemia treated with androgens.", "pmid_53": 199056.0, "pmid_date_53": 1977.0, "pmid_journal_53": "Am J Dis Child"}, {"pmid_title_54": "Hepatic lesions in patients treated with synthetic anabolic steriods.", "pmid_54": 185239.0, "pmid_date_54": 1976.0, "pmid_journal_54": "J Clin Pathol"}, {"pmid_title_55": "The defective absorption of phosphorus and calcium and the effect of vitamin D in the Fanconi syndrome.", "pmid_55": 13610080.0, "pmid_date_55": 1958.0, "pmid_journal_55": "Guys Hosp Rep"}]}, {"_id": "2519-OMIM:615897", "condition": {"condition_name": "IMMUNODEFICIENCY 24", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["IMMUNODEFICIENCY 24"]}, "gene information": {"db_hgnc_gene_id": 2519.0}, "interventions": [{"int_description_1": "Mechanical ventilation"}, {"int_description_2": "Nasal continuous positive airway pressure treatment"}, {"int_description_3": "Transfer factor"}, {"int_description_4": "Testosterone"}, {"int_description_5": "Salmeterol"}, {"int_description_6": "Ursodeoxycholic acid"}, {"int_description_7": "Sargramostim"}, {"int_description_8": "Dopamine"}, {"int_description_9": "Prednisolone"}, {"int_description_10": "Prednisone", "timeframe_int10": "Days or Weeks", "age_use_int10": "Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Fluticasone"}, {"int_description_12": "Ketoconazole"}, {"int_description_13": "Ganciclovir"}, {"int_description_14": "Human immunoglobulin G"}, {"int_description_15": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_16": "Midazolam"}, {"int_description_17": "Rituximab"}, {"int_description_18": "Alemtuzumab"}, {"int_description_19": "Clarithromycin"}, {"int_description_20": "Cyclosporine"}, {"int_description_21": "Clofazimine"}, {"int_description_22": "Isoniazid"}, {"int_description_23": "Amphotericin B"}, {"int_description_24": "Budesonide"}, {"int_description_25": "Somatotropin"}, {"int_description_26": "Piperacillin"}, {"int_description_27": "Vitamin D"}, {"int_description_28": "Levetiracetam"}, {"int_description_29": "Cyclophosphamide"}, {"int_description_30": "Busulfan"}, {"int_description_31": "Melphalan", "timeframe_int31": "Days or Weeks", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Thiotepa"}, {"int_description_33": "Caspofungin"}, {"int_description_34": "Amikacin"}, {"int_description_35": "Pyrazinamide"}, {"int_description_36": "Linezolid"}, {"int_description_37": "Pyridoxine"}, {"int_description_38": "Ethambutol"}, {"int_description_39": "Azithromycin"}, {"int_description_40": "Trimethoprim"}, {"int_description_41": "Sulfamethoxazole"}, {"int_description_42": "Ciprofloxacin"}, {"int_description_43": "Ofloxacin"}, {"int_description_44": "Fusidic acid"}, {"int_description_45": "Ampicillin"}, {"int_description_46": "Cefotaxime"}, {"int_description_47": "Meropenem"}, {"int_description_48": "Amoxicillin"}, {"int_description_49": "Cefuroxime"}, {"int_description_50": "Ceftriaxone"}, {"int_description_51": "Cefazolin"}, {"int_description_52": "Cefoperazone"}, {"int_description_53": "Latamoxef"}, {"int_description_54": "Sulbactam"}, {"int_description_55": "Clavulanic acid"}, {"int_description_56": "Treosulfan"}, {"int_description_57": "Atovaquone"}, {"int_description_58": "Rifampicin"}, {"int_description_59": "Fluconazole"}, {"int_description_60": "Itraconazole"}, {"int_description_61": "Pyrimethamine"}, {"int_description_62": "Methotrexate"}, {"int_description_63": "Sulfadoxine"}, {"int_description_64": "Levofloxacin"}, {"int_description_65": "Fludarabine"}, {"int_description_66": "Pentamidine"}, {"int_description_67": "Vancomycin"}, {"int_description_68": "Tacrolimus"}, {"int_description_69": "Valproic acid"}, {"int_description_70": "Foscarnet"}, {"int_description_71": "Acyclovir"}, {"int_description_72": "Cidofovir"}, {"int_description_73": "Mycophenolate mofetil"}, {"int_description_74": "Ledipasvir"}, {"int_description_75": "Oxacillin"}, {"int_description_76": "Omeprazole"}, {"int_description_77": "Methylprednisolone"}, {"int_description_78": "Methimazole"}, {"int_description_79": "Infliximab"}, {"int_description_80": "Interferon alfa-2a, Recombinant"}, {"int_description_81": "Anti Thymocyte Globulin"}, {"int_description_82": "Anti-CD45 antibodies"}, {"int_description_83": "CMV hyperImmunoglobulin"}, {"int_description_84": "Nystatin"}, {"int_description_85": "Teicoplanin"}, {"int_description_86": "Sofosbuvir"}, {"int_description_87": "Antilymphocyte immunoglobulin (horse)", "timeframe_int87": "Days or Weeks", "age_use_int87": "Infant,Child", "contra_int87": "No", "qualscale_reclass_drug87": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug87": "Curative"}, {"int_description_88": "Human interleukin-2"}, {"int_description_89": "Thymic hormone"}, {"int_description_90": "Thyroid hormone"}, {"int_description_91": "Thyroxin"}, {"int_description_92": "Phenobarbital"}, {"int_description_93": "Filgrastim"}, {"int_description_94": "2'-Deoxycytidine"}, {"int_description_95": "Irradiated blood transfusions"}, {"int_description_96": "Parenteral nutrition"}, {"int_description_97": "Platelet transfusions"}, {"int_description_98": "Total body irradiation"}, {"int_description_99": "Hematopoietic stem cell transplantation"}], "references": [{"pmid_title_1": "Severe Combined Immunodeficiency", "pmid_1": 30969584.0, "pmid_date_1": 2021.0, "pmid_journal_1": "statpearls"}, {"pmid_title_2": "Reticular dysgenesis caused by an intronic pathogenic variant in <i>AK2</i>.", "pmid_2": 32532877.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Cold Spring Harb Mol Case Stud"}, {"pmid_title_3": "Biallelic Form of a Known CD3E Mutation in a Patient with Severe Combined Immunodeficiency.", "pmid_3": 32016651.0, "pmid_date_3": 2020.0, "pmid_journal_3": "J Clin Immunol"}, {"pmid_title_4": "Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.", "pmid_4": 30194989.0, "pmid_date_4": 2019.0, "pmid_journal_4": "J Allergy Clin Immunol"}, {"pmid_title_5": "Disseminated Bacille Calmette-Gu\u00e9rin infection in a patient with severe combined immunodeficiency caused by JAK3 gene mutation.", "pmid_5": 31309596.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Pediatr Dermatol"}, {"pmid_title_6": "Prevention of transfusion-transmitted cytomegalovirus infection using leukoreduced blood components in patients receiving seronegative umbilical cord blood transplantation.", "pmid_6": 31322734.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Transfusion"}, {"pmid_title_7": "Human interleukin-2 receptor \u03b2 mutations associated with defects in immunity and peripheral tolerance.", "pmid_7": 31040185.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Exp Med"}, {"pmid_title_8": "Combined Immunodeficiency With Late-Onset Progressive Hypogammaglobulinemia and Normal B Cell Count in a Patient With RAG2 Deficiency.", "pmid_8": 31058115.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Front Pediatr"}, {"pmid_title_9": "Hematopoietic stem cell transplantation for cytidine triphosphate synthase 1 (CTPS1) deficiency.", "pmid_9": 29884857.0, "pmid_date_9": 2019.0, "pmid_journal_9": "Bone Marrow Transplant"}, {"pmid_title_10": "Severe combined immunodeficiency (SCID) presenting in childhood, with agammaglobulinemia, associated with novel compound heterozygous mutations in DCLRE1C.", "pmid_10": 30630113.0, "pmid_date_10": 2019.0, "pmid_journal_10": "Clin Immunol"}, {"pmid_title_11": "Recent advances in understanding the pathogenesis and management of reticular dysgenesis.", "pmid_11": 29270983.0, "pmid_date_11": 2018.0, "pmid_journal_11": "Br J Haematol"}, {"pmid_title_12": "Two siblings with PRKDC defect who presented with cutaneous granulomas and review of the literature.", "pmid_12": 30121298.0, "pmid_date_12": 2018.0, "pmid_journal_12": "Clin Immunol"}, {"pmid_title_13": "SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.", "pmid_13": 30154114.0, "pmid_date_13": 2018.0, "pmid_journal_13": "Blood"}, {"pmid_title_14": "A Novel Homozygous <i>JAK3</i> Mutation Leading to T-B+NK- SCID in Two Brazilian Patients.", "pmid_14": 30177960.0, "pmid_date_14": 2018.0, "pmid_journal_14": "Front Pediatr"}, {"pmid_title_15": "Co-appearance of OPV and BCG vaccine-derived complications in two infants with severe combined immunodeficiency.", "pmid_15": 29804197.0, "pmid_date_15": 2018.0, "pmid_journal_15": "Immunol Res"}, {"pmid_title_16": "Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis.", "pmid_16": 30014500.0, "pmid_date_16": 2018.0, "pmid_journal_16": "Hepatology"}, {"pmid_title_17": "JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long-known gene.", "pmid_17": 30032486.0, "pmid_date_17": 2018.0, "pmid_journal_17": "Mol Genet Genomic Med"}, {"pmid_title_18": "Chronic active Epstein-Barr virus infection as the initial symptom in a Janus kinase 3 deficiency child: Case report and literature review.", "pmid_18": 29049190.0, "pmid_date_18": 2017.0, "pmid_journal_18": "Medicine (Baltimore)"}, {"pmid_title_19": "Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome.", "pmid_19": 28331055.0, "pmid_date_19": 2017.0, "pmid_journal_19": "Blood"}, {"pmid_title_20": "A novel deletion mutation in IL2RG gene results in X-linked severe combined immunodeficiency with an atypical phenotype.", "pmid_20": 27566612.0, "pmid_date_20": 2017.0, "pmid_journal_20": "Immunogenetics"}, {"pmid_title_21": "Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency.", "pmid_21": 28346229.0, "pmid_date_21": 2017.0, "pmid_journal_21": "J Clin Invest"}, {"pmid_title_22": "Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report.", "pmid_22": 28209722.0, "pmid_date_22": 2017.0, "pmid_journal_22": "Blood"}, {"pmid_title_23": "A 24-Year Enzyme Replacement Therapy in an Adenosine-deaminase-Deficient Patient.", "pmid_23": 26684479.0, "pmid_date_23": 2016.0, "pmid_journal_23": "Pediatrics"}, {"pmid_title_24": "Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.", "pmid_24": 27129325.0, "pmid_date_24": 2016.0, "pmid_journal_24": "Blood"}, {"pmid_title_25": "Insufficient immune reconstitution after allogeneic cord blood transplantation without chemotherapy conditioning in patients with SCID caused by CD3\u03b4 deficiency.", "pmid_25": 26999462.0, "pmid_date_25": 2016.0, "pmid_journal_25": "Bone Marrow Transplant"}, {"pmid_title_26": "Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency.", "pmid_26": 27099176.0, "pmid_date_26": 2016.0, "pmid_journal_26": "Sci Transl Med"}, {"pmid_title_27": "Case Report: Whole exome sequencing identifies variation c.2308G>A p.E770K in <i>RAG1</i> associated with B- T- NK+ severe combined immunodeficiency.", "pmid_27": 29067161.0, "pmid_date_27": 2016.0, "pmid_journal_27": "F1000Res"}, {"pmid_title_28": "CTP Synthase 1 Deficiency in Successfully Transplanted Siblings with Combined Immune Deficiency and Chronic Active EBV Infection.", "pmid_28": 27638562.0, "pmid_date_28": 2016.0, "pmid_journal_28": "J Clin Immunol"}, {"pmid_title_29": "Mutation c.256_257delAA in RAG1 Gene in Polish Children with Severe Combined Immunodeficiency: Diversity of Clinical Manifestations.", "pmid_29": 28083621.0, "pmid_date_29": 2016.0, "pmid_journal_29": "Arch Immunol Ther Exp (Warsz)"}, {"pmid_title_30": "Persistent rotavirus diarrhea post-transplant in a novel JAK3-SCID patient after vaccination.", "pmid_30": 26248889.0, "pmid_date_30": 2016.0, "pmid_journal_30": "Pediatr Allergy Immunol"}, {"pmid_title_31": "Novel compound heterozygous mutations in a Japanese girl with Janus kinase 3 deficiency.", "pmid_31": 27593409.0, "pmid_date_31": 2016.0, "pmid_journal_31": "Pediatr Int"}, {"pmid_title_32": "Mutations in Recombination Activating Gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt.", "pmid_32": 25869295.0, "pmid_date_32": 2015.0, "pmid_journal_32": "Clin Immunol"}, {"pmid_title_33": "A 15-year-old boy with severe combined immunodeficiency, fungal infection, and weight gain.", "pmid_33": 26314823.0, "pmid_date_33": 2015.0, "pmid_journal_33": "Allergy Asthma Proc"}, {"pmid_title_34": "A novel common gamma chain mutation in a Chinese family with X-linked severe combined immunodeficiency (X-SCID; T(-)NK(-)B(+)).", "pmid_34": 26409833.0, "pmid_date_34": 2015.0, "pmid_journal_34": "Immunogenetics"}, {"pmid_title_35": "PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity.", "pmid_35": 25842288.0, "pmid_date_35": 2015.0, "pmid_journal_35": "J Allergy Clin Immunol"}, {"pmid_title_36": "Transplantation outcomes for severe combined immunodeficiency, 2000-2009.", "pmid_36": 25075835.0, "pmid_date_36": 2014.0, "pmid_journal_36": "N Engl J Med"}, {"pmid_title_37": "Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.", "pmid_37": 25109802.0, "pmid_date_37": 2014.0, "pmid_journal_37": "J Allergy Clin Immunol"}, {"pmid_title_38": "SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.", "pmid_38": 24144642.0, "pmid_date_38": 2014.0, "pmid_journal_38": "Blood"}, {"pmid_title_39": "Severe combined immunodeficiency caused by a new homozygous RAG1 mutation with progressive encephalopathy.", "pmid_39": 24333136.0, "pmid_date_39": 2014.0, "pmid_journal_39": "Hematol Oncol Stem Cell Ther"}, {"pmid_title_40": "The many faces of Artemis-deficient combined immunodeficiency - Two patients with DCLRE1C mutations and a systematic literature review of genotype-phenotype correlation.", "pmid_40": 24230999.0, "pmid_date_40": 2013.0, "pmid_journal_40": "Clin Immunol"}, {"pmid_title_41": "Successful bone marrow transplantation with reduced intensity conditioning in a patient with delayed-onset adenosine deaminase deficiency.", "pmid_41": 22805442.0, "pmid_date_41": 2013.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Hemophagocytic bone marrow aplasia with plasma cells in a RAG2-deficient SCID case after a nonconditioned transplantation from a fully matched sibling.", "pmid_42": 23389499.0, "pmid_date_42": 2013.0, "pmid_journal_42": "J Pediatr Hematol Oncol"}, {"pmid_title_43": "Skeletal abnormalities and successful hematopoietic stem cell transplantation in patients with reticular dysgenesis.", "pmid_43": 23763981.0, "pmid_date_43": 2013.0, "pmid_journal_43": "J Allergy Clin Immunol"}, {"pmid_title_44": "Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency.", "pmid_44": 22409989.0, "pmid_date_44": 2012.0, "pmid_journal_44": "J Allergy Clin Immunol"}, {"pmid_title_45": "Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.", "pmid_45": 22791287.0, "pmid_date_45": 2012.0, "pmid_journal_45": "Blood"}, {"pmid_title_46": "Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.", "pmid_46": 22968453.0, "pmid_date_46": 2012.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "IL-21 is the primary common \u03b3 chain-binding cytokine required for human B-cell differentiation in vivo.", "pmid_47": 22039266.0, "pmid_date_47": 2011.0, "pmid_journal_47": "Blood"}, {"pmid_title_48": "Hematopoietic stem cell transplantation for CD3\u03b4 deficiency.", "pmid_48": 21757226.0, "pmid_date_48": 2011.0, "pmid_journal_48": "J Allergy Clin Immunol"}, {"pmid_title_49": "Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency.", "pmid_49": 21725047.0, "pmid_date_49": 2011.0, "pmid_journal_49": "Blood"}, {"pmid_title_50": "A leaky mutation in CD3D differentially affects \u03b1\u03b2 and \u03b3\u03b4 T cells and leads to a T\u03b1\u03b2-T\u03b3\u03b4+B+NK+ human SCID.", "pmid_50": 21926461.0, "pmid_date_50": 2011.0, "pmid_journal_50": "J Clin Invest"}, {"pmid_title_51": "Occurrence of myelodysplastic syndrome in 2 patients with reticular dysgenesis.", "pmid_51": 21458044.0, "pmid_date_51": 2011.0, "pmid_journal_51": "J Allergy Clin Immunol"}, {"pmid_title_52": "Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency.", "pmid_52": 20113887.0, "pmid_date_52": 2010.0, "pmid_journal_52": "Immunol Allergy Clin North Am"}, {"pmid_title_53": "Hemophagocytosis after bone marrow transplantation for JAK3-deficient severe combined immunodeficiency.", "pmid_53": 19659508.0, "pmid_date_53": 2010.0, "pmid_journal_53": "Pediatr Transplant"}, {"pmid_title_54": "A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining.", "pmid_54": 19075392.0, "pmid_date_54": 2009.0, "pmid_journal_54": "J Clin Invest"}, {"pmid_title_55": "Novel RAG2 mutation in a patient with T- B- severe combined immunodeficiency and disseminated BCG disease.", "pmid_55": 20128425.0, "pmid_date_55": 2009.0, "pmid_journal_55": "J Investig Allergol Clin Immunol"}, {"pmid_title_56": "A novel missense RAG-1 mutation results in T-B-NK+ SCID in Athabascan-speaking Dine Indians from the Canadian Northwest Territories.", "pmid_56": 18701881.0, "pmid_date_56": 2009.0, "pmid_journal_56": "Eur J Hum Genet"}, {"pmid_title_57": "Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID.", "pmid_57": 19458910.0, "pmid_date_57": 2009.0, "pmid_journal_57": "Clin Exp Med"}, {"pmid_title_58": "Gene therapy for immunodeficiency due to adenosine deaminase deficiency.", "pmid_58": 19179314.0, "pmid_date_58": 2009.0, "pmid_journal_58": "N Engl J Med"}, {"pmid_title_59": "Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency.", "pmid_59": 17825895.0, "pmid_date_59": 2007.0, "pmid_journal_59": "J Allergy Clin Immunol"}, {"pmid_title_60": "Novel RAG1 mutation in a case of severe combined immunodeficiency.", "pmid_60": 16061569.0, "pmid_date_60": 2005.0, "pmid_journal_60": "Pediatrics"}, {"pmid_title_61": "Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.", "pmid_61": 14615376.0, "pmid_date_61": 2004.0, "pmid_journal_61": "Blood"}, {"pmid_title_62": "Novel Artemis gene mutations of radiosensitive severe combined immunodeficiency in Japanese families.", "pmid_62": 12592555.0, "pmid_date_62": 2003.0, "pmid_journal_62": "Hum Genet"}, {"pmid_title_63": "Bone marrow transplantation for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans.", "pmid_63": 11360109.0, "pmid_date_63": 2001.0, "pmid_journal_63": "Bone Marrow Transplant"}, {"pmid_title_64": "Successful bone-marrow transplantation for reticular dysgenesis.", "pmid_64": 6132037.0, "pmid_date_64": 1983.0, "pmid_journal_64": "Lancet"}, {"pmid_title_65": "Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.", "pmid_65": 6983936.0, "pmid_date_65": 1982.0, "pmid_journal_65": "Clin Exp Immunol"}]}, {"_id": "25221-OMIM:277410", "condition": {"condition_name": "METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE; MAHCD", "freq_per_birth": "The most common form of homocystinuria affects at least 1 in 200,000 to 335,000 people worldwide. The disorder appears to be more common in some countries, such as Ireland (1 in 65,000), Germany (1 in 17,800), Norway (1 in 6,400), and Qatar (1 in 1,800). The rarer forms of homocystinuria each have a small number of cases reported in the scientific literature.", "pattern_of_inheritance": "Autosomal recessive==X-linked recessive==Autosomal recessive", "alternate_names": ["METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE; MAHCD"]}, "gene information": {"db_hgnc_gene_id": 25221.0}, "interventions": [{"int_description_1": "Protein-restricted diet"}, {"int_description_2": "Hydroxocobalamin"}, {"int_description_3": "Metronidazole", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Cyanocobalamin", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Still in Trials / Unproven"}, {"int_description_5": "Levocarnitine", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Still in Trials / Unproven"}, {"int_description_6": "Leucovorin"}, {"int_description_7": "Glycine betaine"}, {"int_description_8": "Carglumic acid"}, {"int_description_9": "Folic acid", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Kidney-liver transplantation"}], "references": [{"pmid_title_1": "Neutropenia and Increased Mean Corpuscular Volume (MCV) With Abnormal Neurologic Findings: A Case of Cobalamin D Deficiency.", "pmid_1": 29620684.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Journal of pediatric hematology/oncology"}, {"pmid_title_2": "A Novel Two-Nucleotide Deletion of <i>MMADHC</i> Gene Causing cblD Disease in a Chinese Family.", "pmid_2": 30334532.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Chinese medical journal"}, {"pmid_title_3": "The cblD defect causes either isolated or combined deficiency of methylcobalamin and adenosylcobalamin synthesis.", "pmid_3": 15292234.0, "pmid_date_3": 2004.0, "pmid_journal_3": "The Journal of biological chemistry"}]}, {"_id": "25223-OMIM:607426", "condition": {"condition_name": "COENZYME Q10 DEFICIENCY, PRIMARY, 1", "freq_per_birth": "The prevalence of primary coenzyme Q10 deficiency is thought to be less than 1 in 100,000 people.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["COENZYME Q10 DEFICIENCY, PRIMARY, 1"]}, "gene information": {"db_hgnc_gene_id": 25223.0}, "interventions": [{"int_description_1": "Ubidecarenone"}], "references": [{"pmid_title_1": "Response to Early Coenzyme Q10 Supplementation Is not Sustained in CoQ10 Deficiency Caused by CoQ2 Mutation.", "pmid_1": 30337132.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Pediatric neurology"}, {"pmid_title_2": "Primary coenzyme Q10 deficiency presenting as fatal neonatal multiorgan failure.", "pmid_2": 25564041.0, "pmid_date_2": 2015.0, "pmid_journal_2": "European journal of human genetics : EJHG"}, {"pmid_title_3": "Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency.", "pmid_3": 18579827.0, "pmid_date_3": 2008.0, "pmid_journal_3": "The New England journal of medicine"}, {"pmid_title_4": "A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency.", "pmid_4": 16400613.0, "pmid_date_4": 2006.0, "pmid_journal_4": "American journal of human genetics"}]}, {"_id": "25302-OMIM:614654", "condition": {"condition_name": "COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5", "freq_per_birth": "The prevalence of primary coenzyme Q10 deficiency is thought to be less than 1 in 100,000 people.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5"]}, "gene information": {"db_hgnc_gene_id": 25302.0}, "interventions": [{"int_description_1": "Ubidecarenone"}, {"int_description_2": "Ubiquinol"}, {"int_description_3": "Vatiquinone"}], "references": [{"pmid_title_1": "A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease.", "pmid_1": 19375058.0, "pmid_date_1": 2009.0, "pmid_journal_1": "American journal of human genetics"}]}, {"_id": "25455-OMIM:300946", "condition": {"condition_name": "DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS"]}, "gene information": {"db_hgnc_gene_id": 25455.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Methotrexate", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "Yes", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Fludarabine"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole", "timeframe_int54": "Hours,Days or Weeks,Years", "age_use_int54": "Neonate,Infant,Child", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Effective / Ameliorative"}, {"int_description_55": "Cisplatin"}, {"int_description_56": "Muplestim"}, {"int_description_57": "Filgrastim", "timeframe_int57": "Days or Weeks,Years", "age_use_int57": "Infant,Child", "contra_int57": "No", "qualscale_reclass_drug57": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug57": "Curative"}, {"int_description_58": "Total body irradiation"}, {"int_description_59": "Radiotherapy"}, {"int_description_60": "red blood cells transfusion"}, {"int_description_61": "Thoracoabdominal irradiation"}, {"int_description_62": "Total lymphoid irradiation"}, {"int_description_63": "Above-knee amputation"}, {"int_description_64": "Bone marrow transplantation"}, {"int_description_65": "Hematopoietic stem cell transplantation (HSCT)"}, {"int_description_66": "laparotomy, tumor dissection"}, {"int_description_67": "limb-salvage surgery"}, {"int_description_68": "Maxillectomy"}, {"int_description_69": "umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "How I manage children with Diamond-Blackfan anaemia.", "pmid_2": 30515771.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_3": 31916719.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Turk J Pediatr"}, {"pmid_title_4": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_4": 31355022.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Case Rep Hematol"}, {"pmid_title_5": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_5": 30811439.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PLoS One"}, {"pmid_title_6": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_6": 30881276.0, "pmid_date_6": 2019.0, "pmid_journal_6": "EJIFCC"}, {"pmid_title_7": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_7": 31208452.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Med Case Rep"}, {"pmid_title_8": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_8": 31574871.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_9": 30411682.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Curr Gene Ther"}, {"pmid_title_10": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_10": 29222242.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_11": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_11": 28623394.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Ann Hematol"}, {"pmid_title_12": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_12": 27882484.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Int J Hematol"}, {"pmid_title_13": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_13": 27537786.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Eur J Haematol"}, {"pmid_title_14": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_14": 28602958.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_15": 27082377.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Blood Cancer"}, {"pmid_title_16": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_16": 26872907.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Int J Hematol"}, {"pmid_title_17": "Pure red cell aplasia.", "pmid_17": 27881371.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Pure red cell aplasia.", "pmid_18": 27913462.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_19": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_19": 27329125.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Int J Hematol"}, {"pmid_title_20": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_20": 26496000.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_21": 25492299.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_22": 25963299.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Am J Hematol"}, {"pmid_title_23": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_23": 24611452.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_24": 24296492.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Biol Blood Marrow Transplant"}, {"pmid_title_25": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_25": 23795277.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Mediterr J Hematol Infect Dis"}, {"pmid_title_26": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_26": 22619618.0, "pmid_date_26": 2012.0, "pmid_journal_26": "ScientificWorldJournal"}, {"pmid_title_27": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_27": 23016900.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Br J Haematol"}, {"pmid_title_28": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_28": 24744655.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Turk J Haematol"}, {"pmid_title_29": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_29": 21062271.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Clin Exp Immunol"}, {"pmid_title_30": "How I treat Diamond-Blackfan anemia.", "pmid_30": 20651069.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Blood"}, {"pmid_title_31": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_31": 20655265.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Transfus Clin Biol"}, {"pmid_title_32": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_32": 20190482.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Intern Med"}, {"pmid_title_33": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_33": 19415275.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Ann Hematol"}, {"pmid_title_34": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_34": 18164793.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_35": 18671700.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Br J Haematol"}, {"pmid_title_36": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_36": 18028431.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Eur J Haematol"}, {"pmid_title_37": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_37": 18776763.0, "pmid_date_37": 2008.0, "pmid_journal_37": "J Pediatr Hematol Oncol"}, {"pmid_title_38": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_38": 18331650.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_39": "Deferasirox.", "pmid_39": 17353569.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Am J Health Syst Pharm"}, {"pmid_title_40": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_40": 17414568.0, "pmid_date_40": 2007.0, "pmid_journal_40": "J Pediatr Hematol Oncol"}, {"pmid_title_41": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_41": 17663681.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_42": 17562599.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Haematologica"}, {"pmid_title_43": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_43": 17312003.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Blood"}, {"pmid_title_44": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_44": 17921858.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_45": 16679921.0, "pmid_date_45": 2006.0, "pmid_journal_45": "J Pediatr Hematol Oncol"}, {"pmid_title_46": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_46": 17325961.0, "pmid_date_46": 2006.0, "pmid_journal_46": "Hematology"}, {"pmid_title_47": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_47": 16317735.0, "pmid_date_47": 2006.0, "pmid_journal_47": "Pediatr Blood Cancer"}, {"pmid_title_48": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_48": 16785135.0, "pmid_date_48": 2006.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_49": 16304857.0, "pmid_date_49": 2005.0, "pmid_journal_49": "J Pak Med Assoc"}, {"pmid_title_50": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_50": 16291361.0, "pmid_date_50": 2005.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_51": 15692602.0, "pmid_date_51": 2005.0, "pmid_journal_51": "Hematol J"}, {"pmid_title_52": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_52": 16041310.0, "pmid_date_52": 2005.0, "pmid_journal_52": "Biol Blood Marrow Transplant"}, {"pmid_title_53": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_53": 15813920.0, "pmid_date_53": 2005.0, "pmid_journal_53": "Eur J Haematol"}, {"pmid_title_54": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_54": 15795909.0, "pmid_date_54": 2005.0, "pmid_journal_54": "Am J Hematol"}, {"pmid_title_55": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_55": 14984172.0, "pmid_date_55": 2004.0, "pmid_journal_55": "J Trop Pediatr"}, {"pmid_title_56": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_56": 15220956.0, "pmid_date_56": 2004.0, "pmid_journal_56": "Bone Marrow Transplant"}, {"pmid_title_57": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_57": 14979474.0, "pmid_date_57": 2004.0, "pmid_journal_57": "Int J Hematol"}, {"pmid_title_58": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_58": 15382270.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatr Blood Cancer"}, {"pmid_title_59": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_59": 18521394.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Sarcoma"}, {"pmid_title_60": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_60": 14608205.0, "pmid_date_60": 2003.0, "pmid_journal_60": "J Pediatr Hematol Oncol"}, {"pmid_title_61": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_61": 12359817.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_62": 12351372.0, "pmid_date_62": 2002.0, "pmid_journal_62": "Blood"}, {"pmid_title_63": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_63": 12022425.0, "pmid_date_63": 2002.0, "pmid_journal_63": "J Trop Pediatr"}, {"pmid_title_64": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_64": 12142794.0, "pmid_date_64": 2002.0, "pmid_journal_64": "J Pediatr Hematol Oncol"}, {"pmid_title_65": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_65": 11313667.0, "pmid_date_65": 2001.0, "pmid_journal_65": "Bone Marrow Transplant"}, {"pmid_title_66": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_66": 11196268.0, "pmid_date_66": 2001.0, "pmid_journal_66": "J Pediatr Hematol Oncol"}, {"pmid_title_67": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_67": 11563769.0, "pmid_date_67": 2001.0, "pmid_journal_67": "J Pediatr Hematol Oncol"}, {"pmid_title_68": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_68": 10779036.0, "pmid_date_68": 2000.0, "pmid_journal_68": "J Pediatr Hematol Oncol"}, {"pmid_title_69": "Diamond-Blackfan anemia.", "pmid_69": 10698294.0, "pmid_date_69": 2000.0, "pmid_journal_69": "Curr Opin Hematol"}, {"pmid_title_70": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_70": 10673683.0, "pmid_date_70": 2000.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_71": 27263505.0, "pmid_date_71": 2000.0, "pmid_journal_71": "Turk J Haematol"}, {"pmid_title_72": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_72": 10714760.0, "pmid_date_72": 2000.0, "pmid_journal_72": "J Pediatr Endocrinol Metab"}, {"pmid_title_73": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_73": 10397110.0, "pmid_date_73": 1999.0, "pmid_journal_73": "AJR Am J Roentgenol"}, {"pmid_title_74": "Bone marrow transplantation in non-malignant disorders.", "pmid_74": 9916644.0, "pmid_date_74": 1998.0, "pmid_journal_74": "Bone Marrow Transplant"}, {"pmid_title_75": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_75": 8846147.0, "pmid_date_75": 1996.0, "pmid_journal_75": "J Pediatr Hematol Oncol"}, {"pmid_title_76": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_76": 8606629.0, "pmid_date_76": 1996.0, "pmid_journal_76": "Medicine (Baltimore)"}, {"pmid_title_77": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_77": 8625135.0, "pmid_date_77": 1995.0, "pmid_journal_77": "Cancer"}, {"pmid_title_78": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_78": 7691318.0, "pmid_date_78": 1993.0, "pmid_journal_78": "Stem Cells"}, {"pmid_title_79": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_79": 3109937.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Eur J Haematol"}, {"pmid_title_80": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_80": 13105384.0, "pmid_date_80": 1953.0, "pmid_journal_80": "Arch Dis Child"}]}, {"_id": "2548-OMIM:261100", "condition": {"condition_name": "IMERSLUND-GRASBECK SYNDROME 1", "freq_per_birth": "Imerslund-Gr\u00e4sbeck syndrome is a rare condition that was first described in Finland and Norway; in these regions, the condition is estimated to affect 1 in 200,000 people. The condition has also been reported in other countries worldwide; its prevalence in these countries is unknown.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["IMERSLUND-GRASBECK SYNDROME 1"]}, "gene information": {"db_hgnc_gene_id": 2548.0}, "interventions": [{"int_description_1": "Hydroxocobalamin"}, {"int_description_2": "Cobalamin"}, {"int_description_3": "Cyanocobalamin", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Red cell blood transfusion"}], "references": [{"pmid_title_1": "Profound vitamin D deficiency in four siblings with Imerslund-Grasbeck syndrome with homozygous CUBN mutation.", "pmid_1": 31497480.0, "pmid_date_1": 2019.0, "pmid_journal_1": "JIMD Rep"}, {"pmid_title_2": "[IMERSLUND-GRASBECK SYNDROME CONGENITAL FORM OF VITAMIN B12 DEFICIENCY ANEMIA].", "pmid_2": 31322513.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Georgian Med News"}, {"pmid_title_3": "Imerslund-Grasbeck syndrome in a 5-year-old Iranian boy.", "pmid_3": 27942180.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Indian J Nephrol"}, {"pmid_title_4": "VIT. B12 DEFICIENCY IN CHILDREN (IMERSLUND-GRASBECK SYNDROME IN TWO PAIRS OF SIBLINGS).", "pmid_4": 26958680.0, "pmid_date_4": 2015.0, "pmid_journal_4": "Dev Period Med"}, {"pmid_title_5": "Imerslund-Grasbeck syndrome in a 15-year-old German girl caused by compound heterozygous mutations in CUBN.", "pmid_5": 17668238.0, "pmid_date_5": 2008.0, "pmid_journal_5": "Eur J Pediatr"}, {"pmid_title_6": "Late onset of Imerslund-Grasbeck syndrome without proteinuria in four children of one family from the Lebanon.", "pmid_6": 14593474.0, "pmid_date_6": 2003.0, "pmid_journal_6": "Eur J Pediatr"}, {"pmid_title_7": "Imerslund-Grasbeck syndrome in an African patient.", "pmid_7": 10341506.0, "pmid_date_7": 1999.0, "pmid_journal_7": "J Trop Pediatr"}, {"pmid_title_8": "Imerslund-Grasbeck syndrome in a Libyan boy.", "pmid_8": 2475066.0, "pmid_date_8": 1989.0, "pmid_journal_8": "Ann Trop Paediatr"}]}, {"_id": "25539-OMIM:617784", "condition": {"condition_name": "FANCONI ANEMIA, COMPLEMENTATION GROUP W", "alternate_names": ["FANCONI ANEMIA, COMPLEMENTATION GROUP W"]}, "gene information": {"db_hgnc_gene_id": 25539.0}, "interventions": [{"int_description_1": "Healthy diet"}, {"int_description_2": "Oxandrolone"}, {"int_description_3": "Danazol"}, {"int_description_4": "Testosterone propionate"}, {"int_description_5": "Oxymetholone"}, {"int_description_6": "Stanozolol"}, {"int_description_7": "Metenolone"}, {"int_description_8": "Calcium"}, {"int_description_9": "Prednisone"}, {"int_description_10": "Dexamethasone"}, {"int_description_11": "Insulin aspart"}, {"int_description_12": "Medroxyprogesterone acetate"}, {"int_description_13": "Tretinoin"}, {"int_description_14": "Eltrombopag"}, {"int_description_15": "Levothyroxine"}, {"int_description_16": "Estradiol"}, {"int_description_17": "Cetuximab"}, {"int_description_18": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_19": "Alemtuzumab"}, {"int_description_20": "Coenzyme M"}, {"int_description_21": "Cyclosporine"}, {"int_description_22": "Dactinomycin"}, {"int_description_23": "Sirolimus"}, {"int_description_24": "Somatotropin"}, {"int_description_25": "Vitamin D"}, {"int_description_26": "Cyclophosphamide"}, {"int_description_27": "Carboplatin"}, {"int_description_28": "Busulfan"}, {"int_description_29": "Ifosfamide"}, {"int_description_30": "Thiotepa"}, {"int_description_31": "Doxorubicin", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Infant,Child", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Fluorouracil", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Neonate,Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Mercaptopurine"}, {"int_description_34": "Trimethoprim"}, {"int_description_35": "Sulfamethoxazole"}, {"int_description_36": "Gemcitabine"}, {"int_description_37": "Vincristine"}, {"int_description_38": "Methotrexate"}, {"int_description_39": "Fludarabine"}, {"int_description_40": "Cytarabine"}, {"int_description_41": "Irinotecan"}, {"int_description_42": "Camptothecin"}, {"int_description_43": "Daunorubicin"}, {"int_description_44": "Etoposide"}, {"int_description_45": "Idarubicin"}, {"int_description_46": "Tacrolimus"}, {"int_description_47": "Acyclovir"}, {"int_description_48": "Quercetin"}, {"int_description_49": "Tioguanine"}, {"int_description_50": "Mycophenolate mofetil"}, {"int_description_51": "Tranexamic acid"}, {"int_description_52": "Olaparib"}, {"int_description_53": "Hydroxyurea"}, {"int_description_54": "Methylprednisolone"}, {"int_description_55": "Methyltestosterone"}, {"int_description_56": "Leucovorin"}, {"int_description_57": "Vinorelbine"}, {"int_description_58": "Deferasirox"}, {"int_description_59": "Deferiprone"}, {"int_description_60": "ATM inhibitors"}, {"int_description_61": "ATR inhibitors"}, {"int_description_62": "Chemotherapy"}, {"int_description_63": "Co-trimoxazole"}, {"int_description_64": "Asparaginase Escherichia coli"}, {"int_description_65": "Cisplatin"}, {"int_description_66": "Antilymphocyte immunoglobulin (horse)"}, {"int_description_67": "Norethandrolone"}, {"int_description_68": "Phosphorus"}, {"int_description_69": "GM-CSF (granulocyte-macrophage colony-stimulating factor)"}, {"int_description_70": "Granulocyte colony-stimulating factor"}, {"int_description_71": "rh-SOD"}, {"int_description_72": "Bevacizumab"}, {"int_description_73": "Filgrastim", "timeframe_int73": "Days or Weeks,Years", "age_use_int73": "Child", "contra_int73": "No", "qualscale_reclass_drug73": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug73": "Effective / Ameliorative"}, {"int_description_74": "Amifostine"}, {"int_description_75": "Radiation therapy"}, {"int_description_76": "Total abdominal radiation"}, {"int_description_77": "Total body irradiation"}, {"int_description_78": "Total lymphoid irradiation"}, {"int_description_79": "Transfusion of blood products"}, {"int_description_80": "Bone marrow transplantation"}, {"int_description_81": "Hematopoietic stem cell transplantation"}, {"int_description_82": "Surgery for polydactyly, carpectomy"}, {"int_description_83": "Surgical intervention"}, {"int_description_84": "Tumor removal"}, {"int_description_85": "\u042burgical tumor removement"}], "references": [{"pmid_title_1": "Gingival Bleeding in a Child with Fanconi Anemia: A Case Report and Literature Review.", "pmid_1": 32231808.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Case Rep Dent"}, {"pmid_title_2": "Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.", "pmid_2": 29668547.0, "pmid_date_2": 2019.0, "pmid_journal_2": "J Pediatr Hematol Oncol"}, {"pmid_title_3": "Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.", "pmid_3": 31192125.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Front Oncol"}, {"pmid_title_4": "Fanconi anemia: a single center experience of a large cohort.", "pmid_4": 31990462.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Turk J Pediatr"}, {"pmid_title_5": "Therapeutic research in the crystal chromosome disease Fanconi anemia.", "pmid_5": 30389152.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Mutat Res Genet Toxicol Environ Mutagen"}, {"pmid_title_6": "Fanconi Anemia", "pmid_6": 20301575.0, "pmid_date_6": 2018.0, "pmid_journal_6": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_7": "Oral cancer in Fanconi anemia: Review of 121 cases.", "pmid_7": 29650274.0, "pmid_date_7": 2018.0, "pmid_journal_7": "Crit Rev Oncol Hematol"}, {"pmid_title_8": "Essential Role of BRCA2 in Ovarian Development and Function.", "pmid_8": 30207912.0, "pmid_date_8": 2018.0, "pmid_journal_8": "N Engl J Med"}, {"pmid_title_9": "Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.", "pmid_9": 29203412.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Biol Blood Marrow Transplant"}, {"pmid_title_10": "How I manage patients with Fanconi anaemia.", "pmid_10": 28474441.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Br J Haematol"}, {"pmid_title_11": "RFWD3-Mediated Ubiquitination Promotes Timely Removal of Both RPA and RAD51 from DNA Damage Sites to Facilitate Homologous Recombination.", "pmid_11": 28575658.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Mol Cell"}, {"pmid_title_12": "Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia.", "pmid_12": 28691929.0, "pmid_date_12": 2017.0, "pmid_journal_12": "J Clin Invest"}, {"pmid_title_13": "Eltrombopag for the treatment of aplastic anemia: current perspectives.", "pmid_13": 27695288.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Drug Des Devel Ther"}, {"pmid_title_14": "Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.", "pmid_14": 27246371.0, "pmid_date_14": 2016.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.", "pmid_15": 26900943.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Hematol Oncol"}, {"pmid_title_16": "Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.", "pmid_16": 26657402.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Eur J Med Genet"}, {"pmid_title_17": "Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.", "pmid_17": 25575015.0, "pmid_date_17": 2015.0, "pmid_journal_17": "J Clin Endocrinol Metab"}, {"pmid_title_18": "Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.", "pmid_18": 25862235.0, "pmid_date_18": 2015.0, "pmid_journal_18": "Ann Hematol"}, {"pmid_title_19": "Alternative donor hematopoietic cell transplantation for Fanconi anemia.", "pmid_19": 25824692.0, "pmid_date_19": 2015.0, "pmid_journal_19": "Blood"}, {"pmid_title_20": "Fanconi anemia and solid malignancies in childhood: a national retrospective study.", "pmid_20": 25381700.0, "pmid_date_20": 2015.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.", "pmid_21": 25531282.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Bone Marrow Transplant"}, {"pmid_title_22": "Clear cell sarcoma of the kidney in a child with Fanconi anemia.", "pmid_22": 24735155.0, "pmid_date_22": 2014.0, "pmid_journal_22": "Pediatr Dev Pathol"}, {"pmid_title_23": "Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.", "pmid_23": 25085358.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Haematologica"}, {"pmid_title_24": "Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.", "pmid_24": 24019220.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Pediatr Blood Cancer"}, {"pmid_title_25": "Management of dental extraction in a female patient with fanconi anemia.", "pmid_25": 25628690.0, "pmid_date_25": 2014.0, "pmid_journal_25": "J Dent (Tehran)"}, {"pmid_title_26": "Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature.", "pmid_26": 22965917.0, "pmid_date_26": 2013.0, "pmid_journal_26": "Head Neck"}, {"pmid_title_27": "Deferasirox therapy in children with Fanconi aplastic anemia.", "pmid_27": 22510772.0, "pmid_date_27": 2012.0, "pmid_journal_27": "J Pediatr Hematol Oncol"}, {"pmid_title_28": "Fatal course of tonsillar squamous cell carcinoma associated with Fanconi anaemia: a mini review.", "pmid_28": 21925890.0, "pmid_date_28": 2012.0, "pmid_journal_28": "J Craniomaxillofac Surg"}, {"pmid_title_29": "Treatment of the bone marrow failure in Fanconi anemia patients with danazol.", "pmid_29": 22178060.0, "pmid_date_29": 2012.0, "pmid_journal_29": "Blood Cells Mol Dis"}, {"pmid_title_30": "Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing.", "pmid_30": 21519011.0, "pmid_date_30": 2011.0, "pmid_journal_30": "J Clin Oncol"}, {"pmid_title_31": "Successful treatment of esophageal squamous cell carcinoma in a patient with Fanconi anemia.", "pmid_31": 20410055.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Jpn J Clin Oncol"}, {"pmid_title_32": "Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.", "pmid_32": 19564748.0, "pmid_date_32": 2009.0, "pmid_journal_32": "J Pediatr Hematol Oncol"}, {"pmid_title_33": "Treatment with deferiprone for iron overload alleviates bone marrow failure in a Fanconi anemia patient.", "pmid_33": 19814681.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Hemoglobin"}, {"pmid_title_34": "Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.", "pmid_34": 18302713.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Br J Haematol"}, {"pmid_title_35": "Thrombocytopenia in the neonate.", "pmid_35": 18433954.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Blood Rev"}, {"pmid_title_36": "Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.", "pmid_36": 18379369.0, "pmid_date_36": 2008.0, "pmid_journal_36": "J Thorac Oncol"}, {"pmid_title_37": "Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function.", "pmid_37": 18623197.0, "pmid_date_37": 2008.0, "pmid_journal_37": "Pediatr Blood Cancer"}, {"pmid_title_38": "Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.", "pmid_38": 18831513.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Cancer"}, {"pmid_title_39": "Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.", "pmid_39": 17950918.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Biol Blood Marrow Transplant"}, {"pmid_title_40": "Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.", "pmid_40": 17038525.0, "pmid_date_40": 2007.0, "pmid_journal_40": "Blood"}, {"pmid_title_41": "Chemotherapy for myeloid malignancy in children with Fanconi anemia.", "pmid_41": 16609946.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Blood Cancer"}, {"pmid_title_42": "A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.", "pmid_42": 17096012.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Leukemia"}, {"pmid_title_43": "HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.", "pmid_43": 18022575.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Biol Blood Marrow Transplant"}, {"pmid_title_44": "Anesthesia and Fanconi anemia: a case report and review of literature.", "pmid_44": 16918663.0, "pmid_date_44": 2006.0, "pmid_journal_44": "Paediatr Anaesth"}, {"pmid_title_45": "Squamous cell carcinoma of the hypopharynx in a young woman with Fanconi's anemia.", "pmid_45": 17308840.0, "pmid_date_45": 2006.0, "pmid_journal_45": "Braz J Otorhinolaryngol"}, {"pmid_title_46": "Squamous cell vulvar carcinoma associated with Fanconi's anemia: a case report.", "pmid_46": 11975685.0, "pmid_date_46": 2002.0, "pmid_journal_46": "Int J Gynecol Cancer"}, {"pmid_title_47": "Growth hormone deficiency caused by pituitary stalk interruption in Fanconi's anemia.", "pmid_47": 11148528.0, "pmid_date_47": 2001.0, "pmid_journal_47": "J Pediatr"}, {"pmid_title_48": "Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.", "pmid_48": 9658728.0, "pmid_date_48": 1998.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.", "pmid_49": 8781414.0, "pmid_date_49": 1996.0, "pmid_journal_49": "Blood"}, {"pmid_title_50": "GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.", "pmid_50": 7644282.0, "pmid_date_50": 1995.0, "pmid_journal_50": "Pediatr Nurs"}, {"pmid_title_51": "Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.", "pmid_51": 8283365.0, "pmid_date_51": 1994.0, "pmid_journal_51": "J Pediatr"}, {"pmid_title_52": "A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia.", "pmid_52": 8280614.0, "pmid_date_52": 1993.0, "pmid_journal_52": "Br J Haematol"}, {"pmid_title_53": "Fanconi's anemia. A family study with 20-year follow-up including associated breast pathology.", "pmid_53": 6478420.0, "pmid_date_53": 1984.0, "pmid_journal_53": "Cancer"}, {"pmid_title_54": "Multiple hepatic tumors and peliosis hepatis in Fanconi's anemia treated with androgens.", "pmid_54": 199056.0, "pmid_date_54": 1977.0, "pmid_journal_54": "Am J Dis Child"}, {"pmid_title_55": "Hepatic lesions in patients treated with synthetic anabolic steriods.", "pmid_55": 185239.0, "pmid_date_55": 1976.0, "pmid_journal_55": "J Clin Pathol"}, {"pmid_title_56": "The defective absorption of phosphorus and calcium and the effect of vitamin D in the Fanconi syndrome.", "pmid_56": 13610080.0, "pmid_date_56": 1958.0, "pmid_journal_56": "Guys Hosp Rep"}]}, {"_id": "25568-OMIM:609053", "condition": {"condition_name": "FANCONI ANEMIA, COMPLEMENTATION GROUP I", "pattern_of_inheritance": "X-linked recessive, Autosomal recessive", "alternate_names": ["FANCONI ANEMIA, COMPLEMENTATION GROUP I"]}, "gene information": {"db_hgnc_gene_id": 25568.0}, "interventions": [{"int_description_1": "Healthy diet"}, {"int_description_2": "Oxandrolone"}, {"int_description_3": "Danazol"}, {"int_description_4": "Testosterone propionate"}, {"int_description_5": "Oxymetholone"}, {"int_description_6": "Metenolone"}, {"int_description_7": "Calcium"}, {"int_description_8": "Prednisone"}, {"int_description_9": "Dexamethasone"}, {"int_description_10": "Insulin aspart"}, {"int_description_11": "Medroxyprogesterone acetate"}, {"int_description_12": "Tretinoin"}, {"int_description_13": "Eltrombopag"}, {"int_description_14": "Levothyroxine"}, {"int_description_15": "Estradiol"}, {"int_description_16": "Cetuximab"}, {"int_description_17": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_18": "Alemtuzumab"}, {"int_description_19": "Coenzyme M"}, {"int_description_20": "Cyclosporine"}, {"int_description_21": "Dactinomycin"}, {"int_description_22": "Sirolimus"}, {"int_description_23": "Somatotropin"}, {"int_description_24": "Vitamin D"}, {"int_description_25": "Cyclophosphamide"}, {"int_description_26": "Carboplatin"}, {"int_description_27": "Busulfan"}, {"int_description_28": "Ifosfamide"}, {"int_description_29": "Thiotepa"}, {"int_description_30": "Doxorubicin"}, {"int_description_31": "Fluorouracil", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Mercaptopurine", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Neonate,Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Trimethoprim"}, {"int_description_34": "Sulfamethoxazole"}, {"int_description_35": "Gemcitabine"}, {"int_description_36": "Vincristine"}, {"int_description_37": "Methotrexate"}, {"int_description_38": "Fludarabine"}, {"int_description_39": "Cytarabine"}, {"int_description_40": "Irinotecan"}, {"int_description_41": "Daunorubicin"}, {"int_description_42": "Etoposide"}, {"int_description_43": "Idarubicin"}, {"int_description_44": "Tacrolimus"}, {"int_description_45": "Acyclovir"}, {"int_description_46": "Quercetin"}, {"int_description_47": "Tioguanine"}, {"int_description_48": "Mycophenolate mofetil"}, {"int_description_49": "Tranexamic acid"}, {"int_description_50": "Hydroxyurea"}, {"int_description_51": "Methylprednisolone"}, {"int_description_52": "Methyltestosterone"}, {"int_description_53": "Leucovorin"}, {"int_description_54": "Vinorelbine"}, {"int_description_55": "Deferasirox"}, {"int_description_56": "Deferiprone"}, {"int_description_57": "Co-trimoxazole"}, {"int_description_58": "Asparaginase Escherichia coli"}, {"int_description_59": "Cisplatin"}, {"int_description_60": "Antilymphocyte immunoglobulin (horse)"}, {"int_description_61": "Norethandrolone"}, {"int_description_62": "Phosphorus"}, {"int_description_63": "GM-CSF (granulocyte-macrophage colony-stimulating factor)"}, {"int_description_64": "rh-SOD"}, {"int_description_65": "Bevacizumab"}, {"int_description_66": "Filgrastim"}, {"int_description_67": "Amifostine"}, {"int_description_68": "Radiation therapy", "timeframe_int68": "Days or Weeks,Years", "age_use_int68": "Child", "contra_int68": "No", "qualscale_reclass_drug68": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug68": "Effective / Ameliorative"}, {"int_description_69": "Total abdominal radiation"}, {"int_description_70": "Total body irradiation"}, {"int_description_71": "Total lymphoid irradiation"}, {"int_description_72": "Transfusion of blood products"}, {"int_description_73": "Bone marrow transplantation"}, {"int_description_74": "Hematopoietic stem cell transplantation"}, {"int_description_75": "Surgery for polydactyly, carpectomy"}, {"int_description_76": "Surgical intervention"}, {"int_description_77": "\u042burgical tumor removement"}], "references": [{"pmid_title_1": "Gingival Bleeding in a Child with Fanconi Anemia: A Case Report and Literature Review.", "pmid_1": 32231808.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Case Rep Dent"}, {"pmid_title_2": "Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.", "pmid_2": 29668547.0, "pmid_date_2": 2019.0, "pmid_journal_2": "J Pediatr Hematol Oncol"}, {"pmid_title_3": "Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.", "pmid_3": 31192125.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Front Oncol"}, {"pmid_title_4": "Fanconi anemia: a single center experience of a large cohort.", "pmid_4": 31990462.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Turk J Pediatr"}, {"pmid_title_5": "Therapeutic research in the crystal chromosome disease Fanconi anemia.", "pmid_5": 30389152.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Mutat Res Genet Toxicol Environ Mutagen"}, {"pmid_title_6": "Oral cancer in Fanconi anemia: Review of 121 cases.", "pmid_6": 29650274.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Crit Rev Oncol Hematol"}, {"pmid_title_7": "Essential Role of BRCA2 in Ovarian Development and Function.", "pmid_7": 30207912.0, "pmid_date_7": 2018.0, "pmid_journal_7": "N Engl J Med"}, {"pmid_title_8": "Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.", "pmid_8": 29203412.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Biol Blood Marrow Transplant"}, {"pmid_title_9": "How I manage patients with Fanconi anaemia.", "pmid_9": 28474441.0, "pmid_date_9": 2017.0, "pmid_journal_9": "Br J Haematol"}, {"pmid_title_10": "Eltrombopag for the treatment of aplastic anemia: current perspectives.", "pmid_10": 27695288.0, "pmid_date_10": 2016.0, "pmid_journal_10": "Drug Des Devel Ther"}, {"pmid_title_11": "Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.", "pmid_11": 27246371.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Biol Blood Marrow Transplant"}, {"pmid_title_12": "Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.", "pmid_12": 26900943.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Pediatr Hematol Oncol"}, {"pmid_title_13": "Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.", "pmid_13": 26657402.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Eur J Med Genet"}, {"pmid_title_14": "Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.", "pmid_14": 25575015.0, "pmid_date_14": 2015.0, "pmid_journal_14": "J Clin Endocrinol Metab"}, {"pmid_title_15": "Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.", "pmid_15": 25862235.0, "pmid_date_15": 2015.0, "pmid_journal_15": "Ann Hematol"}, {"pmid_title_16": "Alternative donor hematopoietic cell transplantation for Fanconi anemia.", "pmid_16": 25824692.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Blood"}, {"pmid_title_17": "Fanconi anemia and solid malignancies in childhood: a national retrospective study.", "pmid_17": 25381700.0, "pmid_date_17": 2015.0, "pmid_journal_17": "Pediatr Blood Cancer"}, {"pmid_title_18": "Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.", "pmid_18": 25531282.0, "pmid_date_18": 2015.0, "pmid_journal_18": "Bone Marrow Transplant"}, {"pmid_title_19": "Clear cell sarcoma of the kidney in a child with Fanconi anemia.", "pmid_19": 24735155.0, "pmid_date_19": 2014.0, "pmid_journal_19": "Pediatr Dev Pathol"}, {"pmid_title_20": "Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.", "pmid_20": 25085358.0, "pmid_date_20": 2014.0, "pmid_journal_20": "Haematologica"}, {"pmid_title_21": "Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.", "pmid_21": 24019220.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Management of dental extraction in a female patient with fanconi anemia.", "pmid_22": 25628690.0, "pmid_date_22": 2014.0, "pmid_journal_22": "J Dent (Tehran)"}, {"pmid_title_23": "Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature.", "pmid_23": 22965917.0, "pmid_date_23": 2013.0, "pmid_journal_23": "Head Neck"}, {"pmid_title_24": "Deferasirox therapy in children with Fanconi aplastic anemia.", "pmid_24": 22510772.0, "pmid_date_24": 2012.0, "pmid_journal_24": "J Pediatr Hematol Oncol"}, {"pmid_title_25": "Fatal course of tonsillar squamous cell carcinoma associated with Fanconi anaemia: a mini review.", "pmid_25": 21925890.0, "pmid_date_25": 2012.0, "pmid_journal_25": "J Craniomaxillofac Surg"}, {"pmid_title_26": "Treatment of the bone marrow failure in Fanconi anemia patients with danazol.", "pmid_26": 22178060.0, "pmid_date_26": 2012.0, "pmid_journal_26": "Blood Cells Mol Dis"}, {"pmid_title_27": "Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing.", "pmid_27": 21519011.0, "pmid_date_27": 2011.0, "pmid_journal_27": "J Clin Oncol"}, {"pmid_title_28": "Successful treatment of esophageal squamous cell carcinoma in a patient with Fanconi anemia.", "pmid_28": 20410055.0, "pmid_date_28": 2010.0, "pmid_journal_28": "Jpn J Clin Oncol"}, {"pmid_title_29": "Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.", "pmid_29": 19564748.0, "pmid_date_29": 2009.0, "pmid_journal_29": "J Pediatr Hematol Oncol"}, {"pmid_title_30": "Treatment with deferiprone for iron overload alleviates bone marrow failure in a Fanconi anemia patient.", "pmid_30": 19814681.0, "pmid_date_30": 2009.0, "pmid_journal_30": "Hemoglobin"}, {"pmid_title_31": "Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.", "pmid_31": 18302713.0, "pmid_date_31": 2008.0, "pmid_journal_31": "Br J Haematol"}, {"pmid_title_32": "Thrombocytopenia in the neonate.", "pmid_32": 18433954.0, "pmid_date_32": 2008.0, "pmid_journal_32": "Blood Rev"}, {"pmid_title_33": "Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.", "pmid_33": 18379369.0, "pmid_date_33": 2008.0, "pmid_journal_33": "J Thorac Oncol"}, {"pmid_title_34": "Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function.", "pmid_34": 18623197.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Pediatr Blood Cancer"}, {"pmid_title_35": "Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.", "pmid_35": 18831513.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Cancer"}, {"pmid_title_36": "Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.", "pmid_36": 17950918.0, "pmid_date_36": 2007.0, "pmid_journal_36": "Biol Blood Marrow Transplant"}, {"pmid_title_37": "Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.", "pmid_37": 17038525.0, "pmid_date_37": 2007.0, "pmid_journal_37": "Blood"}, {"pmid_title_38": "Chemotherapy for myeloid malignancy in children with Fanconi anemia.", "pmid_38": 16609946.0, "pmid_date_38": 2007.0, "pmid_journal_38": "Pediatr Blood Cancer"}, {"pmid_title_39": "A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.", "pmid_39": 17096012.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Leukemia"}, {"pmid_title_40": "HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.", "pmid_40": 18022575.0, "pmid_date_40": 2007.0, "pmid_journal_40": "Biol Blood Marrow Transplant"}, {"pmid_title_41": "Anesthesia and Fanconi anemia: a case report and review of literature.", "pmid_41": 16918663.0, "pmid_date_41": 2006.0, "pmid_journal_41": "Paediatr Anaesth"}, {"pmid_title_42": "Squamous cell carcinoma of the hypopharynx in a young woman with Fanconi's anemia.", "pmid_42": 17308840.0, "pmid_date_42": 2006.0, "pmid_journal_42": "Braz J Otorhinolaryngol"}, {"pmid_title_43": "Squamous cell vulvar carcinoma associated with Fanconi's anemia: a case report.", "pmid_43": 11975685.0, "pmid_date_43": 2002.0, "pmid_journal_43": "Int J Gynecol Cancer"}, {"pmid_title_44": "Growth hormone deficiency caused by pituitary stalk interruption in Fanconi's anemia.", "pmid_44": 11148528.0, "pmid_date_44": 2001.0, "pmid_journal_44": "J Pediatr"}, {"pmid_title_45": "Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.", "pmid_45": 9658728.0, "pmid_date_45": 1998.0, "pmid_journal_45": "Haematologica"}, {"pmid_title_46": "Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.", "pmid_46": 8781414.0, "pmid_date_46": 1996.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.", "pmid_47": 7644282.0, "pmid_date_47": 1995.0, "pmid_journal_47": "Pediatr Nurs"}, {"pmid_title_48": "Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.", "pmid_48": 8283365.0, "pmid_date_48": 1994.0, "pmid_journal_48": "J Pediatr"}, {"pmid_title_49": "A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia.", "pmid_49": 8280614.0, "pmid_date_49": 1993.0, "pmid_journal_49": "Br J Haematol"}, {"pmid_title_50": "Fanconi's anemia. A family study with 20-year follow-up including associated breast pathology.", "pmid_50": 6478420.0, "pmid_date_50": 1984.0, "pmid_journal_50": "Cancer"}, {"pmid_title_51": "Multiple hepatic tumors and peliosis hepatis in Fanconi's anemia treated with androgens.", "pmid_51": 199056.0, "pmid_date_51": 1977.0, "pmid_journal_51": "Am J Dis Child"}, {"pmid_title_52": "Hepatic lesions in patients treated with synthetic anabolic steriods.", "pmid_52": 185239.0, "pmid_date_52": 1976.0, "pmid_journal_52": "J Clin Pathol"}, {"pmid_title_53": "The defective absorption of phosphorus and calcium and the effect of vitamin D in the Fanconi syndrome.", "pmid_53": 13610080.0, "pmid_date_53": 1958.0, "pmid_journal_53": "Guys Hosp Rep"}]}, {"_id": "2561-OMIM:193670", "condition": {"condition_name": "WHIM SYNDROME", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive, Not applicable", "alternate_names": ["WHIM SYNDROME"]}, "gene information": {"db_hgnc_gene_id": 2561.0}, "interventions": [{"int_description_1": "Lenograstim"}, {"int_description_2": "Plerixafor", "timeframe_int2": "Days or Weeks", "age_use_int2": "Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Still in Trials / Unproven"}, {"int_description_3": "Human immunoglobulin G", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_5": "Rituximab"}, {"int_description_6": "Cyclosporine"}, {"int_description_7": "Cyclophosphamide"}, {"int_description_8": "Busulfan"}, {"int_description_9": "Melphalan"}, {"int_description_10": "Fluorouracil"}, {"int_description_11": "Trimethoprim"}, {"int_description_12": "Sulfamethoxazole"}, {"int_description_13": "Meropenem"}, {"int_description_14": "Salicylic acid"}, {"int_description_15": "Methotrexate"}, {"int_description_16": "Fludarabine"}, {"int_description_17": "Tacrolimus"}, {"int_description_18": "Foscarnet"}, {"int_description_19": "Valaciclovir"}, {"int_description_20": "Methylprednisolone"}, {"int_description_21": "Imiquimod"}, {"int_description_22": "Bronchodilatator drugs", "timeframe_int22": "Days or Weeks,Years", "age_use_int22": "Child", "contra_int22": "No", "qualscale_reclass_drug22": "Case report(s)", "rev1_eff_reclass_drug22": "Still in Trials / Unproven"}, {"int_description_23": "CXCR4-Specific Nanobodies, 10A10"}, {"int_description_24": "Quadrivalent HPV vaccine (Gardasil\u00ae, Merck & Co., Inc.)", "timeframe_int24": "Days or Weeks,Years", "age_use_int24": "Infant,Child", "contra_int24": "No", "qualscale_reclass_drug24": "Cohort study or studies", "rev1_eff_reclass_drug24": "Curative"}, {"int_description_25": "Filgrastim"}, {"int_description_26": "Total body irradiation"}, {"int_description_27": "Hematopoietic stem cell transplant (HSCT)"}, {"int_description_28": "Splenectomy"}, {"int_description_29": "Surgery (cancer management)"}, {"int_description_30": "Surgical correction of heart defect"}, {"int_description_31": "Umbilical cord blood (UCB) transplantation", "timeframe_int31": "Days or Weeks", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Cohort study or studies", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Family studies of warts, hypogammaglobulinemia, immunodeficiency, myelokathexis syndrome.", "pmid_1": 31652152.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Curr Opin Hematol"}, {"pmid_title_2": "WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure.", "pmid_2": 31313072.0, "pmid_date_2": 2019.0, "pmid_journal_2": "J Clin Immunol"}, {"pmid_title_3": "Plerixafor for the Treatment of WHIM Syndrome.", "pmid_3": 30625055.0, "pmid_date_3": 2019.0, "pmid_journal_3": "N Engl J Med"}, {"pmid_title_4": "Case Report: Ocular toxoplasmosis in a WHIM syndrome immunodeficiency patient.", "pmid_4": 31249677.0, "pmid_date_4": 2019.0, "pmid_journal_4": "F1000Res"}, {"pmid_title_5": "Transient Marked Increase of \u03b3\u03b4 T Cells in WHIM Syndrome After Successful HSCT.", "pmid_5": 29974365.0, "pmid_date_5": 2018.0, "pmid_journal_5": "J Clin Immunol"}, {"pmid_title_6": "CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome.", "pmid_6": 28768817.0, "pmid_date_6": 2017.0, "pmid_journal_6": "J Pharmacol Exp Ther"}, {"pmid_title_7": "Preference of Genetic Diagnosis of CXCR4 Mutation Compared with Clinical Diagnosis of WHIM Syndrome.", "pmid_7": 28353164.0, "pmid_date_7": 2017.0, "pmid_journal_7": "J Clin Immunol"}, {"pmid_title_8": "Successful hematopoietic stem cell transplantation for myelofibrosis in an adult with warts-hypogammaglobulinemia-immunodeficiency-myelokathexis syndrome.", "pmid_8": 27484033.0, "pmid_date_8": 2016.0, "pmid_journal_8": "J Allergy Clin Immunol"}, {"pmid_title_9": "Primary cutaneous follicle center lymphoma in a patient with WHIM syndrome.", "pmid_9": 25571909.0, "pmid_date_9": 2016.0, "pmid_journal_9": "J Eur Acad Dermatol Venereol"}, {"pmid_title_10": "Chromothriptic cure of WHIM syndrome.", "pmid_10": 25662009.0, "pmid_date_10": 2015.0, "pmid_journal_10": "Cell"}, {"pmid_title_11": "A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor.", "pmid_11": 24523241.0, "pmid_date_11": 2014.0, "pmid_journal_11": "Blood"}, {"pmid_title_12": "WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4.", "pmid_12": 22596258.0, "pmid_date_12": 2012.0, "pmid_journal_12": "Blood"}, {"pmid_title_13": "Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry.", "pmid_13": 23009155.0, "pmid_date_13": 2012.0, "pmid_journal_13": "Orphanet J Rare Dis"}, {"pmid_title_14": "Tetralogy of fallot is an uncommon manifestation of warts, hypogammaglobulinemia, infections, and myelokathexis syndrome.", "pmid_14": 22748845.0, "pmid_date_14": 2012.0, "pmid_journal_14": "J Pediatr"}, {"pmid_title_15": "AMD3100 is a potent antagonist at CXCR4(R334X) , a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome.", "pmid_15": 21070597.0, "pmid_date_15": 2011.0, "pmid_journal_15": "J Cell Mol Med"}, {"pmid_title_16": "The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome.", "pmid_16": 21890643.0, "pmid_date_16": 2011.0, "pmid_journal_16": "Blood"}, {"pmid_title_17": "Successful umbilical cord blood stem cell transplantation in a child with WHIM syndrome.", "pmid_17": 19878273.0, "pmid_date_17": 2010.0, "pmid_journal_17": "Eur J Haematol"}, {"pmid_title_18": "A quadrivalent HPV vaccine induces humoral and cellular immune responses in WHIM immunodeficiency syndrome.", "pmid_18": 20472031.0, "pmid_date_18": 2010.0, "pmid_journal_18": "Vaccine"}, {"pmid_title_19": "Clinical and genetic diagnosis of warts, hypogammaglobulinemia, infections, and myelokathexis syndrome in 10 patients.", "pmid_19": 19321197.0, "pmid_date_19": 2009.0, "pmid_journal_19": "J Allergy Clin Immunol"}, {"pmid_title_20": "Familial occurrence of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome.", "pmid_20": 19043667.0, "pmid_date_20": 2008.0, "pmid_journal_20": "Arch Immunol Ther Exp (Warsz)"}, {"pmid_title_21": "Recurrent CXCR4 sequence variation in a girl with WHIM syndrome.", "pmid_21": 17087743.0, "pmid_date_21": 2007.0, "pmid_journal_21": "Eur J Haematol"}, {"pmid_title_22": "Sporadic case of warts, hypogammaglobulinemia, immunodeficiency, and myelokathexis syndrome.", "pmid_22": 16275383.0, "pmid_date_22": 2005.0, "pmid_journal_22": "J Allergy Clin Immunol"}]}, {"_id": "25737-OMIM:611291", "condition": {"condition_name": "SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO IONIZING RADIATION", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO IONIZING RADIATION"]}, "gene information": {"db_hgnc_gene_id": 25737.0}, "interventions": [{"int_description_1": "Prednisone"}, {"int_description_2": "Levothyroxine"}, {"int_description_3": "Ganciclovir"}, {"int_description_4": "Human immunoglobulin G"}, {"int_description_5": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_6": "Rituximab"}, {"int_description_7": "Clarithromycin"}, {"int_description_8": "Cyclosporine"}, {"int_description_9": "Cyclophosphamide"}, {"int_description_10": "Melphalan"}, {"int_description_11": "Amikacin"}, {"int_description_12": "Doxorubicin"}, {"int_description_13": "Trimethoprim"}, {"int_description_14": "Sulfamethoxazole"}, {"int_description_15": "Ampicillin"}, {"int_description_16": "Sulbactam"}, {"int_description_17": "Vincristine"}, {"int_description_18": "Fluconazole"}, {"int_description_19": "Methotrexate"}, {"int_description_20": "Fludarabine"}, {"int_description_21": "Tacrolimus"}, {"int_description_22": "Tenofovir"}, {"int_description_23": "Mycophenolate mofetil"}, {"int_description_24": "Methylprednisolone"}, {"int_description_25": "Anti-thymocyte globulin"}, {"int_description_26": "Corticosteroids"}, {"int_description_27": "Immunosuppressive therapy"}, {"int_description_28": "Filgrastim"}, {"int_description_29": "Antibiotics"}, {"int_description_30": "EBV\u2010specific CTL infusion"}, {"int_description_31": "Irradiated erythrocyte transfusions", "timeframe_int31": "Days or Weeks", "age_use_int31": "Neonate,Infant", "contra_int31": "No", "qualscale_reclass_drug31": "Case report(s)", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Hematopoietic stem cell transplantation"}, {"int_description_33": "Splenectomy"}], "references": [{"pmid_title_1": "Extreme Phenotypes With Identical Mutations: Two Patients With Same Non-sense <i>NHEJ1</i> Homozygous Mutation.", "pmid_1": 30666249.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Front Immunol"}, {"pmid_title_2": "Cernunnos deficiency associated with BCG adenitis and autoimmunity: First case from the national Iranian registry and review of the literature.", "pmid_2": 28729231.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Clin Immunol"}, {"pmid_title_3": "Loss of NHEJ1 Protein Due to a Novel Splice Site Mutation in a Family Presenting with Combined Immunodeficiency, Microcephaly, and Growth Retardation and Literature Review.", "pmid_3": 28741180.0, "pmid_date_3": 2017.0, "pmid_journal_3": "J Clin Immunol"}, {"pmid_title_4": "Mutations in XLF/NHEJ1/Cernunnos gene results in downregulation of telomerase genes expression and telomere shortening.", "pmid_4": 28369633.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Hum Mol Genet"}, {"pmid_title_5": "Two SCID cases with Cernunnos-XLF deficiency successfully treated by hematopoietic stem cell transplantation.", "pmid_5": 21535335.0, "pmid_date_5": 2012.0, "pmid_journal_5": "Pediatr Transplant"}, {"pmid_title_6": "Cernunnos deficiency: a case report.", "pmid_6": 21721379.0, "pmid_date_6": 2011.0, "pmid_journal_6": "J Investig Allergol Clin Immunol"}, {"pmid_title_7": "Unrelated hematopoietic stem cell transplantation for Cernunnos-XLF deficiency.", "pmid_7": 19067926.0, "pmid_date_7": 2009.0, "pmid_journal_7": "Pediatr Transplant"}, {"pmid_title_8": "Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly.", "pmid_8": 16439204.0, "pmid_date_8": 2006.0, "pmid_journal_8": "Cell"}, {"pmid_title_9": "Nonhomologous end joining and V(D)J recombination require an additional factor.", "pmid_9": 12604777.0, "pmid_date_9": 2003.0, "pmid_journal_9": "Proc Natl Acad Sci U S A"}, {"pmid_title_10": "Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.", "pmid_10": 2869085.0, "pmid_date_10": 1986.0, "pmid_journal_10": "J Immunol"}]}, {"_id": "2577-OMIM:233690", "condition": {"condition_name": "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 4; CGD4", "freq_per_birth": "Chronic granulomatous disease is estimated to occur in 1 in 200,000 to 250,000 people worldwide.", "pattern_of_inheritance": "X-linked recessive==Autosomal recessive", "alternate_names": ["GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 4; CGD4"]}, "gene information": {"db_hgnc_gene_id": 2577.0}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Prednisone"}, {"int_description_3": "Lenograstim"}, {"int_description_4": "Pioglitazone"}, {"int_description_5": "Anakinra"}, {"int_description_6": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_7": "Hydroxychloroquine"}, {"int_description_8": "Alemtuzumab"}, {"int_description_9": "Cyclosporine", "timeframe_int9": "Days or Weeks", "age_use_int9": "Child", "contra_int9": "No", "qualscale_reclass_drug9": "Case report(s)", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Metronidazole"}, {"int_description_11": "Amphotericin B"}, {"int_description_12": "Sirolimus"}, {"int_description_13": "Interferon gamma-1b", "timeframe_int13": "Days or Weeks", "age_use_int13": "Child", "contra_int13": "No", "qualscale_reclass_drug13": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Piperacillin"}, {"int_description_15": "Cyclophosphamide"}, {"int_description_16": "Busulfan"}, {"int_description_17": "Melphalan"}, {"int_description_18": "Caspofungin"}, {"int_description_19": "Linezolid"}, {"int_description_20": "Mercaptopurine"}, {"int_description_21": "Mesalazine"}, {"int_description_22": "Sulfasalazine"}, {"int_description_23": "Clindamycin"}, {"int_description_24": "Tazobactam"}, {"int_description_25": "Trimethoprim"}, {"int_description_26": "Sulfamethoxazole"}, {"int_description_27": "Ciprofloxacin"}, {"int_description_28": "Meropenem"}, {"int_description_29": "Cefuroxime"}, {"int_description_30": "Thalidomide"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks", "age_use_int31": "Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Itraconazole", "timeframe_int32": "Days or Weeks", "age_use_int32": "Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Posaconazole", "timeframe_int33": "Hours,Days or Weeks", "age_use_int33": "Child", "contra_int33": "No", "qualscale_reclass_drug33": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug33": "Effective / Ameliorative"}, {"int_description_34": "Methotrexate", "timeframe_int34": "Hours", "age_use_int34": "Neonate,Infant,Child", "contra_int34": "No", "qualscale_reclass_drug34": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug34": "Effective / Ameliorative"}, {"int_description_35": "Fludarabine"}, {"int_description_36": "Cytarabine"}, {"int_description_37": "Tacrolimus", "timeframe_int37": "Days or Weeks", "age_use_int37": "Child", "contra_int37": "No", "qualscale_reclass_drug37": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug37": "Effective / Ameliorative"}, {"int_description_38": "Azathioprine"}, {"int_description_39": "Mycophenolic acid"}, {"int_description_40": "Ustekinumab"}, {"int_description_41": "Isavuconazole"}, {"int_description_42": "Ceftazidime"}, {"int_description_43": "Methylprednisolone"}, {"int_description_44": "Infliximab"}, {"int_description_45": "antimicrobial therapy"}, {"int_description_46": "corticosteroids", "timeframe_int46": "Hours,Days or Weeks", "age_use_int46": "Infant,Child", "contra_int46": "No", "qualscale_reclass_drug46": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug46": "Effective / Ameliorative"}, {"int_description_47": "Teicoplanin"}, {"int_description_48": "granulocyte transfusions", "timeframe_int48": "Days or Weeks", "age_use_int48": "Infant,Child", "contra_int48": "No", "qualscale_reclass_drug48": "Case report(s)", "rev1_eff_reclass_drug48": "Effective / Ameliorative"}, {"int_description_49": "sun protection"}, {"int_description_50": "Total body irradiation"}, {"int_description_51": "Bone marrow transplantation", "timeframe_int51": "Days or Weeks,Years", "contra_int51": "No", "qualscale_reclass_drug51": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug51": "Curative"}, {"int_description_52": "Hematopoietic stem cell transplantation"}, {"int_description_53": "surgery"}], "references": [{"pmid_title_1": "Chronic Granulomatous Disease: a Comprehensive Review.", "pmid_1": 32524254.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Clinical reviews in allergy & immunology"}, {"pmid_title_2": "Recent advances in chronic granulomatous disease.", "pmid_2": 32181279.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Genes & diseases"}, {"pmid_title_3": "Hemophagocytic lymphohistiocytosis resulting from a cytokine storm triggered by septicemia in a child with chronic granuloma disease: a case report and literature review.", "pmid_3": 32126983.0, "pmid_date_3": 2020.0, "pmid_journal_3": "BMC pediatrics"}, {"pmid_title_4": "Chronic Granulomatous Disease.", "pmid_4": 31172494.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Methods in molecular biology (Clifton, N.J.)"}, {"pmid_title_5": "[A clinical study of haploid hematopoietic stem cells combined with third-party umbilical cord blood transplantation in the treatment of chronic granulomatous disease].", "pmid_5": 31208508.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics"}, {"pmid_title_6": "Macrophage activation syndrome/haemophagocytic lymphohistiocytosis secondary to <i>Burkholderia cepacia</i> complex septicaemia in an elderly female carrier of X-linked chronic granulomatous disease with extreme lyonisation: 'cepacia syndrome' revisited.", "pmid_6": 31473638.0, "pmid_date_6": 2019.0, "pmid_journal_6": "BMJ case reports"}, {"pmid_title_7": "A novel mutation in <i>NCF2</i> resulting in very-early-onset colitis and juvenile idiopathic arthritis in a patient with chronic granulomatous disease.", "pmid_7": 31832070.0, "pmid_date_7": 2019.0, "pmid_journal_7": "Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology"}, {"pmid_title_8": "Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.", "pmid_8": 29746680.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Journal of the Pediatric Infectious Diseases Society"}, {"pmid_title_9": "Seven chronic granulomatous disease cases in a single-center experience and a review of the literature.", "pmid_9": 28577521.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Asian Pacific journal of allergy and immunology"}, {"pmid_title_10": "Successful transcatheter arterial antimicrobial and steroid therapy for refractory liver abscess in chronic granulomatous disease: A case report and review of literature.", "pmid_10": 29132925.0, "pmid_date_10": 2018.0, "pmid_journal_10": "Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy"}, {"pmid_title_11": "Prevention of Infectious Complications in Patients With Chronic Granulomatous Disease.", "pmid_11": 29746681.0, "pmid_date_11": 2018.0, "pmid_journal_11": "Journal of the Pediatric Infectious Diseases Society"}, {"pmid_title_12": "Infectious Complications in Patients With Chronic Granulomatous Disease.", "pmid_12": 29746678.0, "pmid_date_12": 2018.0, "pmid_journal_12": "Journal of the Pediatric Infectious Diseases Society"}, {"pmid_title_13": "Chronic Granulomatous Disease in children: a single center experience.", "pmid_13": 29223406.0, "pmid_date_13": 2018.0, "pmid_journal_13": "Clinical immunology (Orlando, Fla.)"}, {"pmid_title_14": "New onset colitis in an adult patient with chronic granulomatous disease treated with hematopoietic stem cell transplantation: a diagnostic dilemma.", "pmid_14": 29755533.0, "pmid_date_14": 2018.0, "pmid_journal_14": "Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology"}, {"pmid_title_15": "An Update on the Use of Immunomodulators in Primary Immunodeficiencies.", "pmid_15": 27873163.0, "pmid_date_15": 2017.0, "pmid_journal_15": "Clinical reviews in allergy & immunology"}, {"pmid_title_16": "Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial.", "pmid_16": 28752258.0, "pmid_date_16": 2017.0, "pmid_journal_16": "Journal of clinical immunology"}, {"pmid_title_17": "Inflammatory bowel disease in chronic granulomatous disease: An emerging problem over a twenty years' experience.", "pmid_17": 28981976.0, "pmid_date_17": 2017.0, "pmid_journal_17": "Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology"}, {"pmid_title_18": "<i>Chromobacterium violaceum</i> infection in chronic granulomatous disease: a case report and review of the literature.", "pmid_18": 28348801.0, "pmid_date_18": 2017.0, "pmid_journal_18": "JMM case reports"}, {"pmid_title_19": "A rare complication of chronic granulomatous disease in a child: constrictive aspergillus pericarditis.", "pmid_19": 28990950.0, "pmid_date_19": 2017.0, "pmid_journal_19": "Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir"}, {"pmid_title_20": "Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD).", "pmid_20": 26951230.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Current gastroenterology reports"}, {"pmid_title_21": "Aspergillosis in Chronic Granulomatous Disease.", "pmid_21": 29376932.0, "pmid_date_21": 2016.0, "pmid_journal_21": "Journal of fungi (Basel, Switzerland)"}, {"pmid_title_22": "Association Between Discoid Lupus Erythematosus and Chronic Granulomatous Disease--Report of Two Cases and Review of the Literature.", "pmid_22": 27001332.0, "pmid_date_22": 2016.0, "pmid_journal_22": "Pediatric dermatology"}, {"pmid_title_23": "Chronic Granulomatous Disease.", "pmid_23": 26865172.0, "pmid_date_23": 2016.0, "pmid_journal_23": "Indian journal of pediatrics"}, {"pmid_title_24": "Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.", "pmid_24": 26680691.0, "pmid_date_24": 2016.0, "pmid_journal_24": "Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology"}, {"pmid_title_25": "Treatment of CGD-associated Colitis with the IL-23 Blocker Ustekinumab.", "pmid_25": 27465505.0, "pmid_date_25": 2016.0, "pmid_journal_25": "Journal of clinical immunology"}, {"pmid_title_26": "Pioglitazone as a novel therapeutic approach in chronic granulomatous disease.", "pmid_26": 27056268.0, "pmid_date_26": 2016.0, "pmid_journal_26": "The Journal of allergy and clinical immunology"}, {"pmid_title_27": "Low-dose total-body irradiation and alemtuzumab-based reduced-intensity conditioning regimen results in durable engraftment and correction of clinical disease among children with chronic granulomatous disease.", "pmid_27": 25845644.0, "pmid_date_27": 2015.0, "pmid_journal_27": "Pediatric transplantation"}, {"pmid_title_28": "Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis.", "pmid_28": 26052777.0, "pmid_date_28": 2015.0, "pmid_journal_28": "The American journal of gastroenterology"}, {"pmid_title_29": "Mobilization characteristics and strategies to improve hematopoietic progenitor cell mobilization and collection in patients with chronic granulomatous disease and severe combined immunodeficiency.", "pmid_29": 25143186.0, "pmid_date_29": 2015.0, "pmid_journal_29": "Transfusion"}, {"pmid_title_30": "Severe and Rapid Progression in Very Early-Onset Chronic Granulomatous Disease-Associated Colitis.", "pmid_30": 26233238.0, "pmid_date_30": 2015.0, "pmid_journal_30": "Journal of clinical immunology"}, {"pmid_title_31": "Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment.", "pmid_31": 26386811.0, "pmid_date_31": 2015.0, "pmid_journal_31": "The Journal of allergy and clinical immunology"}, {"pmid_title_32": "Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.", "pmid_32": 24161820.0, "pmid_date_32": 2014.0, "pmid_journal_32": "Lancet (London, England)"}, {"pmid_title_33": "IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans.", "pmid_33": 24550444.0, "pmid_date_33": 2014.0, "pmid_journal_33": "Proceedings of the National Academy of Sciences of the United States of America"}, {"pmid_title_34": "Assessment of atherosclerosis in chronic granulomatous disease.", "pmid_34": 25239440.0, "pmid_date_34": 2014.0, "pmid_journal_34": "Circulation"}, {"pmid_title_35": "Resistant invasive aspergillosis in an autosomal recessive chronic granulomatous disease.", "pmid_35": 23002911.0, "pmid_date_35": 2013.0, "pmid_journal_35": "Fetal and pediatric pathology"}, {"pmid_title_36": "Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison of those managed conservatively with those that have undergone haematopoietic stem cell transplant.", "pmid_36": 23011479.0, "pmid_date_36": 2013.0, "pmid_journal_36": "Journal of clinical immunology"}, {"pmid_title_37": "Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease.", "pmid_37": 22078471.0, "pmid_date_37": 2012.0, "pmid_journal_37": "The Journal of allergy and clinical immunology"}, {"pmid_title_38": "Corticosteroid therapy for liver abscess in chronic granulomatous disease.", "pmid_38": 22157170.0, "pmid_date_38": 2012.0, "pmid_journal_38": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_39": "Gene therapy of chronic granulomatous disease: the engraftment dilemma.", "pmid_39": 21045810.0, "pmid_date_39": 2011.0, "pmid_journal_39": "Molecular therapy : the journal of the American Society of Gene Therapy"}, {"pmid_title_40": "Anakinra for the inflammatory complications of chronic granulomatous disease.", "pmid_40": 21411850.0, "pmid_date_40": 2011.0, "pmid_journal_40": "The Netherlands journal of medicine"}, {"pmid_title_41": "A twice daily posaconazole dosing algorithm for children with chronic granulomatous disease.", "pmid_41": 21772229.0, "pmid_date_41": 2011.0, "pmid_journal_41": "The Pediatric infectious disease journal"}, {"pmid_title_42": "Allogeneic haematopoietic stem cell transplantation as therapy for chronic granulomatous disease--single centre experience.", "pmid_42": 21384251.0, "pmid_date_42": 2011.0, "pmid_journal_42": "Journal of clinical immunology"}, {"pmid_title_43": "The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort.", "pmid_43": 21175646.0, "pmid_date_43": 2011.0, "pmid_journal_43": "Transfusion"}, {"pmid_title_44": "Chronic granulomatous disease: recent advances in pathophysiology and treatment.", "pmid_44": 21116026.0, "pmid_date_44": 2010.0, "pmid_journal_44": "The Netherlands journal of medicine"}, {"pmid_title_45": "Chronic granulomatous disease.", "pmid_45": 19504359.0, "pmid_date_45": 2010.0, "pmid_journal_45": "Clinical reviews in allergy & immunology"}, {"pmid_title_46": "Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease.", "pmid_46": 20495074.0, "pmid_date_46": 2010.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils.", "pmid_47": 19965657.0, "pmid_date_47": 2010.0, "pmid_journal_47": "Blood"}, {"pmid_title_48": "Residual NADPH oxidase and survival in chronic granulomatous disease.", "pmid_48": 21190454.0, "pmid_date_48": 2010.0, "pmid_journal_48": "The New England journal of medicine"}, {"pmid_title_49": "Complications of tumor necrosis factor-\u03b1 blockade in chronic granulomatous disease-related colitis.", "pmid_49": 21058909.0, "pmid_date_49": 2010.0, "pmid_journal_49": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_50": "Linezolid an oral treatment option for staphylococcal liver abscess in chronic granulomatous disease.", "pmid_50": 19859022.0, "pmid_date_50": 2009.0, "pmid_journal_50": "The Pediatric infectious disease journal"}, {"pmid_title_51": "Modern management of chronic granulomatous disease.", "pmid_51": 18217895.0, "pmid_date_51": 2008.0, "pmid_journal_51": "British journal of haematology"}, {"pmid_title_52": "Gastrointestinal manifestations of chronic granulomatous disease.", "pmid_52": 16970572.0, "pmid_date_52": 2006.0, "pmid_journal_52": "Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland"}, {"pmid_title_53": "Corticosteroid therapy for refractory infections in chronic granulomatous disease: case reports and review of the literature.", "pmid_53": 16937761.0, "pmid_date_53": 2006.0, "pmid_journal_53": "Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology"}, {"pmid_title_54": "Nonmyeloablative stem cell transplantation for nonmalignant diseases in children with severe organ dysfunction.", "pmid_54": 17013427.0, "pmid_date_54": 2006.0, "pmid_journal_54": "Bone marrow transplantation"}, {"pmid_title_55": "Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients.", "pmid_55": 15940051.0, "pmid_date_55": 2005.0, "pmid_journal_55": "Transplantation"}, {"pmid_title_56": "Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection.", "pmid_56": 15889369.0, "pmid_date_56": 2005.0, "pmid_journal_56": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_57": "Granulocyte transfusions in children with chronic granulomatous disease and invasive aspergillosis.", "pmid_57": 15828925.0, "pmid_date_57": 2005.0, "pmid_journal_57": "Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy"}, {"pmid_title_58": "Gastrointestinal involvement in chronic granulomatous disease.", "pmid_58": 15286231.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatrics"}, {"pmid_title_59": "Long-term interferon-gamma therapy for patients with chronic granulomatous disease.", "pmid_59": 15356785.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_60": "Itraconazole to prevent fungal infections in chronic granulomatous disease.", "pmid_60": 12802027.0, "pmid_date_60": 2003.0, "pmid_journal_60": "The New England journal of medicine"}, {"pmid_title_61": "Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.", "pmid_61": 12393596.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Blood"}, {"pmid_title_62": "Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.", "pmid_62": 11259721.0, "pmid_date_62": 2001.0, "pmid_journal_62": "The New England journal of medicine"}, {"pmid_title_63": "Colitis in chronic granulomatous disease.", "pmid_63": 11159292.0, "pmid_date_63": 2001.0, "pmid_journal_63": "Archives of disease in childhood"}, {"pmid_title_64": "Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.", "pmid_64": 11100285.0, "pmid_date_64": 2000.0, "pmid_journal_64": "Bone marrow transplantation"}, {"pmid_title_65": "Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B.", "pmid_65": 9763555.0, "pmid_date_65": 1998.0, "pmid_journal_65": "Blood"}, {"pmid_title_66": "Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor.", "pmid_66": 9505898.0, "pmid_date_66": 1998.0, "pmid_journal_66": "Gut"}, {"pmid_title_67": "Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine.", "pmid_67": 7815206.0, "pmid_date_67": 1995.0, "pmid_journal_67": "The Journal of pediatrics"}, {"pmid_title_68": "Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease.", "pmid_68": 8673477.0, "pmid_date_68": 1995.0, "pmid_journal_68": "Blood cells, molecules & diseases"}, {"pmid_title_69": "Chronic granulomatous disease presenting in childhood with Pseudomonas cepacia septicaemia.", "pmid_69": 7508484.0, "pmid_date_69": 1993.0, "pmid_journal_69": "The Journal of infection"}, {"pmid_title_70": "A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group.", "pmid_70": 1846940.0, "pmid_date_70": 1991.0, "pmid_journal_70": "The New England journal of medicine"}, {"pmid_title_71": "The effect of teicoplanin on leukocytic activity and intraleukocytic micro-organisms.", "pmid_71": 2871098.0, "pmid_date_71": 1986.0, "pmid_journal_71": "The Journal of hospital infection"}, {"pmid_title_72": "Bone marrow transplantation in chronic granulomatous disease.", "pmid_72": 6376746.0, "pmid_date_72": 1984.0, "pmid_journal_72": "The Journal of pediatrics"}, {"pmid_title_73": "Colitis in chronic granulomatous disease.", "pmid_73": 6119271.0, "pmid_date_73": 1982.0, "pmid_journal_73": "Gastroenterology"}]}, {"_id": "25789-OMIM:617941", "condition": {"condition_name": "SHWACHMAN-DIAMOND SYNDROME 2", "alternate_names": ["SHWACHMAN-DIAMOND SYNDROME 2"]}, "gene information": {"db_hgnc_gene_id": 25789.0}, "interventions": [{"int_description_1": "Phylloquinone"}, {"int_description_2": "Vitamin D"}, {"int_description_3": "Hydrochlorothiazide"}, {"int_description_4": "Vitamin E"}, {"int_description_5": "Fluoride ion"}, {"int_description_6": "Oral pancreatic enzymes"}, {"int_description_7": "Prophylactic antibiotics"}, {"int_description_8": "Filgrastim"}, {"int_description_9": "Vitamin A"}, {"int_description_10": "Blood exchange transfusion"}, {"int_description_11": "Platelet transfusion"}, {"int_description_12": "Red cell blood transfusion"}, {"int_description_13": "Bone marrow transplantation"}, {"int_description_14": "Haematopoietic stem cell transplantation"}, {"int_description_15": "Orthopedic surgery"}], "references": [{"pmid_title_1": "Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives.", "pmid_1": 30413969.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Mol Diagn Ther"}, {"pmid_title_2": "EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome.", "pmid_2": 31151987.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Blood"}, {"pmid_title_3": "Diagnosis, Treatment, and Molecular Pathology of Shwachman-Diamond Syndrome.", "pmid_3": 30047420.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Hematol Oncol Clin North Am"}, {"pmid_title_4": "Shwachman-Diamond Syndrome", "pmid_4": 20301722.0, "pmid_date_4": 2018.0, "pmid_journal_4": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_5": "Further evidence for the involvement of <i>EFL1</i> in a Shwachman-Diamond-like syndrome and expansion of the phenotypic features.", "pmid_5": 29970384.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Cold Spring Harb Mol Case Stud"}, {"pmid_title_6": "Nutritional status in children with Shwachman-diamond syndrome.", "pmid_6": 25742431.0, "pmid_date_6": 2015.0, "pmid_journal_6": "Pancreas"}]}, {"_id": "2578-OMIM:300645", "condition": {"condition_name": "IMMUNODEFICIENCY 34; IMD34", "pattern_of_inheritance": "X-linked recessive", "alternate_names": ["IMMUNODEFICIENCY 34; IMD34", "GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CGDX"]}, "gene information": {"db_hgnc_gene_id": 2578.0}, "interventions": [{"int_description_1": "Isoniazid"}, {"int_description_2": "Interferon gamma-1b", "timeframe_int2": "Days or Weeks", "age_use_int2": "Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Pyrazinamide"}, {"int_description_4": "Ethambutol"}, {"int_description_5": "Ofloxacin"}, {"int_description_6": "Rifampicin"}, {"int_description_7": "Streptomycin"}, {"int_description_8": "Surgical treatment"}], "references": [{"pmid_title_1": "The Child with Recurrent Mycobacterial Disease.", "pmid_1": 29936646.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Current allergy and asthma reports"}, {"pmid_title_2": "Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs).", "pmid_2": 22248828.0, "pmid_date_2": 2011.0, "pmid_journal_2": "Journal of the Formosan Medical Association = Taiwan yi zhi"}, {"pmid_title_3": "Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease.", "pmid_3": 21278736.0, "pmid_date_3": 2011.0, "pmid_journal_3": "Nature immunology"}]}, {"_id": "2578-OMIM:306400", "condition": {"condition_name": "GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CGDX", "freq_per_birth": "Chronic granulomatous disease is estimated to occur in 1 in 200,000 to 250,000 people worldwide.", "pattern_of_inheritance": "X-linked recessive==Autosomal recessive", "alternate_names": ["GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CGDX", "IMMUNODEFICIENCY 34; IMD34"]}, "gene information": {"db_hgnc_gene_id": 2578.0}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Prednisone"}, {"int_description_3": "Lenograstim"}, {"int_description_4": "Pioglitazone"}, {"int_description_5": "Anakinra"}, {"int_description_6": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_7": "Hydroxychloroquine"}, {"int_description_8": "Alemtuzumab"}, {"int_description_9": "Cyclosporine"}, {"int_description_10": "Metronidazole"}, {"int_description_11": "Amphotericin B"}, {"int_description_12": "Sirolimus"}, {"int_description_13": "Interferon gamma-1b", "timeframe_int13": "Days or Weeks", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Case report(s)", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Piperacillin"}, {"int_description_15": "Cyclophosphamide"}, {"int_description_16": "Busulfan"}, {"int_description_17": "Melphalan"}, {"int_description_18": "Caspofungin"}, {"int_description_19": "Linezolid"}, {"int_description_20": "Mercaptopurine"}, {"int_description_21": "Mesalazine"}, {"int_description_22": "Sulfasalazine"}, {"int_description_23": "Clindamycin"}, {"int_description_24": "Tazobactam"}, {"int_description_25": "Trimethoprim"}, {"int_description_26": "Sulfamethoxazole"}, {"int_description_27": "Ciprofloxacin"}, {"int_description_28": "Meropenem"}, {"int_description_29": "Cefuroxime"}, {"int_description_30": "Thalidomide"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Hours,Days or Weeks", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Itraconazole"}, {"int_description_33": "Posaconazole"}, {"int_description_34": "Methotrexate"}, {"int_description_35": "Fludarabine"}, {"int_description_36": "Cytarabine"}, {"int_description_37": "Tacrolimus"}, {"int_description_38": "Azathioprine"}, {"int_description_39": "Mycophenolic acid"}, {"int_description_40": "Ustekinumab"}, {"int_description_41": "Isavuconazole"}, {"int_description_42": "Ceftazidime"}, {"int_description_43": "Methylprednisolone"}, {"int_description_44": "Infliximab", "qualscale_reclass_drug44": "Authoritative published clinical practice guideline"}, {"int_description_45": "antimicrobial therapy", "timeframe_int45": "Hours,Days or Weeks,Years", "age_use_int45": "Neonate,Infant,Child", "contra_int45": "No", "qualscale_reclass_drug45": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug45": "Effective / Ameliorative"}, {"int_description_46": "corticosteroids", "timeframe_int46": "Days or Weeks,Years", "age_use_int46": "Neonate,Infant,Child", "contra_int46": "No", "qualscale_reclass_drug46": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug46": "Effective / Ameliorative"}, {"int_description_47": "Teicoplanin"}, {"int_description_48": "Gene editing: autologous CD34+ cells transduced with MT-gp91"}, {"int_description_49": "granulocyte transfusions", "timeframe_int49": "Days or Weeks,Years", "age_use_int49": "Neonate,Infant,Child", "qualscale_reclass_drug49": "Case report(s)", "rev1_eff_reclass_drug49": "Still in Trials / Unproven"}, {"int_description_50": "sun protection", "age_use_int50": "Infant"}, {"int_description_51": "Total body irradiation"}, {"int_description_52": "Bone marrow transplantation", "timeframe_int52": "Days or Weeks,Years", "contra_int52": "No", "qualscale_reclass_drug52": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug52": "Curative"}, {"int_description_53": "Hematopoietic stem cell transplantation"}, {"int_description_54": "surgery"}], "references": [{"pmid_title_1": "Chronic Granulomatous Disease: a Comprehensive Review.", "pmid_1": 32524254.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Clinical reviews in allergy & immunology"}, {"pmid_title_2": "Recent advances in chronic granulomatous disease.", "pmid_2": 32181279.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Genes & diseases"}, {"pmid_title_3": "Lentiviral gene therapy for X-linked chronic granulomatous disease.", "pmid_3": 31988463.0, "pmid_date_3": 2020.0, "pmid_journal_3": "Nature medicine"}, {"pmid_title_4": "Hemophagocytic lymphohistiocytosis resulting from a cytokine storm triggered by septicemia in a child with chronic granuloma disease: a case report and literature review.", "pmid_4": 32126983.0, "pmid_date_4": 2020.0, "pmid_journal_4": "BMC pediatrics"}, {"pmid_title_5": "Chronic Granulomatous Disease.", "pmid_5": 31172494.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Methods in molecular biology (Clifton, N.J.)"}, {"pmid_title_6": "[A clinical study of haploid hematopoietic stem cells combined with third-party umbilical cord blood transplantation in the treatment of chronic granulomatous disease].", "pmid_6": 31208508.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics"}, {"pmid_title_7": "Macrophage activation syndrome/haemophagocytic lymphohistiocytosis secondary to <i>Burkholderia cepacia</i> complex septicaemia in an elderly female carrier of X-linked chronic granulomatous disease with extreme lyonisation: 'cepacia syndrome' revisited.", "pmid_7": 31473638.0, "pmid_date_7": 2019.0, "pmid_journal_7": "BMJ case reports"}, {"pmid_title_8": "A novel mutation in <i>NCF2</i> resulting in very-early-onset colitis and juvenile idiopathic arthritis in a patient with chronic granulomatous disease.", "pmid_8": 31832070.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology"}, {"pmid_title_9": "Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.", "pmid_9": 29746680.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Journal of the Pediatric Infectious Diseases Society"}, {"pmid_title_10": "Seven chronic granulomatous disease cases in a single-center experience and a review of the literature.", "pmid_10": 28577521.0, "pmid_date_10": 2018.0, "pmid_journal_10": "Asian Pacific journal of allergy and immunology"}, {"pmid_title_11": "Successful transcatheter arterial antimicrobial and steroid therapy for refractory liver abscess in chronic granulomatous disease: A case report and review of literature.", "pmid_11": 29132925.0, "pmid_date_11": 2018.0, "pmid_journal_11": "Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy"}, {"pmid_title_12": "Prevention of Infectious Complications in Patients With Chronic Granulomatous Disease.", "pmid_12": 29746681.0, "pmid_date_12": 2018.0, "pmid_journal_12": "Journal of the Pediatric Infectious Diseases Society"}, {"pmid_title_13": "Infectious Complications in Patients With Chronic Granulomatous Disease.", "pmid_13": 29746678.0, "pmid_date_13": 2018.0, "pmid_journal_13": "Journal of the Pediatric Infectious Diseases Society"}, {"pmid_title_14": "Chronic Granulomatous Disease in children: a single center experience.", "pmid_14": 29223406.0, "pmid_date_14": 2018.0, "pmid_journal_14": "Clinical immunology (Orlando, Fla.)"}, {"pmid_title_15": "New onset colitis in an adult patient with chronic granulomatous disease treated with hematopoietic stem cell transplantation: a diagnostic dilemma.", "pmid_15": 29755533.0, "pmid_date_15": 2018.0, "pmid_journal_15": "Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology"}, {"pmid_title_16": "An Update on the Use of Immunomodulators in Primary Immunodeficiencies.", "pmid_16": 27873163.0, "pmid_date_16": 2017.0, "pmid_journal_16": "Clinical reviews in allergy & immunology"}, {"pmid_title_17": "Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial.", "pmid_17": 28752258.0, "pmid_date_17": 2017.0, "pmid_journal_17": "Journal of clinical immunology"}, {"pmid_title_18": "Inflammatory bowel disease in chronic granulomatous disease: An emerging problem over a twenty years' experience.", "pmid_18": 28981976.0, "pmid_date_18": 2017.0, "pmid_journal_18": "Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology"}, {"pmid_title_19": "<i>Chromobacterium violaceum</i> infection in chronic granulomatous disease: a case report and review of the literature.", "pmid_19": 28348801.0, "pmid_date_19": 2017.0, "pmid_journal_19": "JMM case reports"}, {"pmid_title_20": "A rare complication of chronic granulomatous disease in a child: constrictive aspergillus pericarditis.", "pmid_20": 28990950.0, "pmid_date_20": 2017.0, "pmid_journal_20": "Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir"}, {"pmid_title_21": "Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD).", "pmid_21": 26951230.0, "pmid_date_21": 2016.0, "pmid_journal_21": "Current gastroenterology reports"}, {"pmid_title_22": "Aspergillosis in Chronic Granulomatous Disease.", "pmid_22": 29376932.0, "pmid_date_22": 2016.0, "pmid_journal_22": "Journal of fungi (Basel, Switzerland)"}, {"pmid_title_23": "Association Between Discoid Lupus Erythematosus and Chronic Granulomatous Disease--Report of Two Cases and Review of the Literature.", "pmid_23": 27001332.0, "pmid_date_23": 2016.0, "pmid_journal_23": "Pediatric dermatology"}, {"pmid_title_24": "Chronic Granulomatous Disease.", "pmid_24": 26865172.0, "pmid_date_24": 2016.0, "pmid_journal_24": "Indian journal of pediatrics"}, {"pmid_title_25": "Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.", "pmid_25": 26680691.0, "pmid_date_25": 2016.0, "pmid_journal_25": "Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology"}, {"pmid_title_26": "Treatment of CGD-associated Colitis with the IL-23 Blocker Ustekinumab.", "pmid_26": 27465505.0, "pmid_date_26": 2016.0, "pmid_journal_26": "Journal of clinical immunology"}, {"pmid_title_27": "Pioglitazone as a novel therapeutic approach in chronic granulomatous disease.", "pmid_27": 27056268.0, "pmid_date_27": 2016.0, "pmid_journal_27": "The Journal of allergy and clinical immunology"}, {"pmid_title_28": "Low-dose total-body irradiation and alemtuzumab-based reduced-intensity conditioning regimen results in durable engraftment and correction of clinical disease among children with chronic granulomatous disease.", "pmid_28": 25845644.0, "pmid_date_28": 2015.0, "pmid_journal_28": "Pediatric transplantation"}, {"pmid_title_29": "Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis.", "pmid_29": 26052777.0, "pmid_date_29": 2015.0, "pmid_journal_29": "The American journal of gastroenterology"}, {"pmid_title_30": "Mobilization characteristics and strategies to improve hematopoietic progenitor cell mobilization and collection in patients with chronic granulomatous disease and severe combined immunodeficiency.", "pmid_30": 25143186.0, "pmid_date_30": 2015.0, "pmid_journal_30": "Transfusion"}, {"pmid_title_31": "Severe and Rapid Progression in Very Early-Onset Chronic Granulomatous Disease-Associated Colitis.", "pmid_31": 26233238.0, "pmid_date_31": 2015.0, "pmid_journal_31": "Journal of clinical immunology"}, {"pmid_title_32": "Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment.", "pmid_32": 26386811.0, "pmid_date_32": 2015.0, "pmid_journal_32": "The Journal of allergy and clinical immunology"}, {"pmid_title_33": "Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.", "pmid_33": 24161820.0, "pmid_date_33": 2014.0, "pmid_journal_33": "Lancet (London, England)"}, {"pmid_title_34": "IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans.", "pmid_34": 24550444.0, "pmid_date_34": 2014.0, "pmid_journal_34": "Proceedings of the National Academy of Sciences of the United States of America"}, {"pmid_title_35": "Assessment of atherosclerosis in chronic granulomatous disease.", "pmid_35": 25239440.0, "pmid_date_35": 2014.0, "pmid_journal_35": "Circulation"}, {"pmid_title_36": "Resistant invasive aspergillosis in an autosomal recessive chronic granulomatous disease.", "pmid_36": 23002911.0, "pmid_date_36": 2013.0, "pmid_journal_36": "Fetal and pediatric pathology"}, {"pmid_title_37": "Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison of those managed conservatively with those that have undergone haematopoietic stem cell transplant.", "pmid_37": 23011479.0, "pmid_date_37": 2013.0, "pmid_journal_37": "Journal of clinical immunology"}, {"pmid_title_38": "Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease.", "pmid_38": 22078471.0, "pmid_date_38": 2012.0, "pmid_journal_38": "The Journal of allergy and clinical immunology"}, {"pmid_title_39": "Corticosteroid therapy for liver abscess in chronic granulomatous disease.", "pmid_39": 22157170.0, "pmid_date_39": 2012.0, "pmid_journal_39": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_40": "Gene therapy of chronic granulomatous disease: the engraftment dilemma.", "pmid_40": 21045810.0, "pmid_date_40": 2011.0, "pmid_journal_40": "Molecular therapy : the journal of the American Society of Gene Therapy"}, {"pmid_title_41": "Anakinra for the inflammatory complications of chronic granulomatous disease.", "pmid_41": 21411850.0, "pmid_date_41": 2011.0, "pmid_journal_41": "The Netherlands journal of medicine"}, {"pmid_title_42": "Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I/II trial.", "pmid_42": 21878903.0, "pmid_date_42": 2011.0, "pmid_journal_42": "Molecular therapy : the journal of the American Society of Gene Therapy"}, {"pmid_title_43": "A twice daily posaconazole dosing algorithm for children with chronic granulomatous disease.", "pmid_43": 21772229.0, "pmid_date_43": 2011.0, "pmid_journal_43": "The Pediatric infectious disease journal"}, {"pmid_title_44": "Allogeneic haematopoietic stem cell transplantation as therapy for chronic granulomatous disease--single centre experience.", "pmid_44": 21384251.0, "pmid_date_44": 2011.0, "pmid_journal_44": "Journal of clinical immunology"}, {"pmid_title_45": "The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort.", "pmid_45": 21175646.0, "pmid_date_45": 2011.0, "pmid_journal_45": "Transfusion"}, {"pmid_title_46": "Chronic granulomatous disease: recent advances in pathophysiology and treatment.", "pmid_46": 21116026.0, "pmid_date_46": 2010.0, "pmid_journal_46": "The Netherlands journal of medicine"}, {"pmid_title_47": "Chronic granulomatous disease.", "pmid_47": 19504359.0, "pmid_date_47": 2010.0, "pmid_journal_47": "Clinical reviews in allergy & immunology"}, {"pmid_title_48": "Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease.", "pmid_48": 20495074.0, "pmid_date_48": 2010.0, "pmid_journal_48": "Blood"}, {"pmid_title_49": "Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils.", "pmid_49": 19965657.0, "pmid_date_49": 2010.0, "pmid_journal_49": "Blood"}, {"pmid_title_50": "Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease.", "pmid_50": 20098431.0, "pmid_date_50": 2010.0, "pmid_journal_50": "Nature medicine"}, {"pmid_title_51": "Residual NADPH oxidase and survival in chronic granulomatous disease.", "pmid_51": 21190454.0, "pmid_date_51": 2010.0, "pmid_journal_51": "The New England journal of medicine"}, {"pmid_title_52": "Complications of tumor necrosis factor-\u03b1 blockade in chronic granulomatous disease-related colitis.", "pmid_52": 21058909.0, "pmid_date_52": 2010.0, "pmid_journal_52": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_53": "Linezolid an oral treatment option for staphylococcal liver abscess in chronic granulomatous disease.", "pmid_53": 19859022.0, "pmid_date_53": 2009.0, "pmid_journal_53": "The Pediatric infectious disease journal"}, {"pmid_title_54": "Modern management of chronic granulomatous disease.", "pmid_54": 18217895.0, "pmid_date_54": 2008.0, "pmid_journal_54": "British journal of haematology"}, {"pmid_title_55": "Gastrointestinal manifestations of chronic granulomatous disease.", "pmid_55": 16970572.0, "pmid_date_55": 2006.0, "pmid_journal_55": "Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland"}, {"pmid_title_56": "Corticosteroid therapy for refractory infections in chronic granulomatous disease: case reports and review of the literature.", "pmid_56": 16937761.0, "pmid_date_56": 2006.0, "pmid_journal_56": "Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology"}, {"pmid_title_57": "Nonmyeloablative stem cell transplantation for nonmalignant diseases in children with severe organ dysfunction.", "pmid_57": 17013427.0, "pmid_date_57": 2006.0, "pmid_journal_57": "Bone marrow transplantation"}, {"pmid_title_58": "Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients.", "pmid_58": 15940051.0, "pmid_date_58": 2005.0, "pmid_journal_58": "Transplantation"}, {"pmid_title_59": "Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection.", "pmid_59": 15889369.0, "pmid_date_59": 2005.0, "pmid_journal_59": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_60": "Granulocyte transfusions in children with chronic granulomatous disease and invasive aspergillosis.", "pmid_60": 15828925.0, "pmid_date_60": 2005.0, "pmid_journal_60": "Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy"}, {"pmid_title_61": "Gastrointestinal involvement in chronic granulomatous disease.", "pmid_61": 15286231.0, "pmid_date_61": 2004.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Long-term interferon-gamma therapy for patients with chronic granulomatous disease.", "pmid_62": 15356785.0, "pmid_date_62": 2004.0, "pmid_journal_62": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_63": "Gene therapy for chronic granulomatous disease.", "pmid_63": 14583668.0, "pmid_date_63": 2003.0, "pmid_journal_63": "Acta haematologica"}, {"pmid_title_64": "Itraconazole to prevent fungal infections in chronic granulomatous disease.", "pmid_64": 12802027.0, "pmid_date_64": 2003.0, "pmid_journal_64": "The New England journal of medicine"}, {"pmid_title_65": "Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.", "pmid_65": 12393596.0, "pmid_date_65": 2002.0, "pmid_journal_65": "Blood"}, {"pmid_title_66": "Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.", "pmid_66": 11259721.0, "pmid_date_66": 2001.0, "pmid_journal_66": "The New England journal of medicine"}, {"pmid_title_67": "Colitis in chronic granulomatous disease.", "pmid_67": 11159292.0, "pmid_date_67": 2001.0, "pmid_journal_67": "Archives of disease in childhood"}, {"pmid_title_68": "Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.", "pmid_68": 11100285.0, "pmid_date_68": 2000.0, "pmid_journal_68": "Bone marrow transplantation"}, {"pmid_title_69": "Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B.", "pmid_69": 9763555.0, "pmid_date_69": 1998.0, "pmid_journal_69": "Blood"}, {"pmid_title_70": "Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor.", "pmid_70": 9505898.0, "pmid_date_70": 1998.0, "pmid_journal_70": "Gut"}, {"pmid_title_71": "Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine.", "pmid_71": 7815206.0, "pmid_date_71": 1995.0, "pmid_journal_71": "The Journal of pediatrics"}, {"pmid_title_72": "Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease.", "pmid_72": 8673477.0, "pmid_date_72": 1995.0, "pmid_journal_72": "Blood cells, molecules & diseases"}, {"pmid_title_73": "Chronic granulomatous disease presenting in childhood with Pseudomonas cepacia septicaemia.", "pmid_73": 7508484.0, "pmid_date_73": 1993.0, "pmid_journal_73": "The Journal of infection"}, {"pmid_title_74": "A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group.", "pmid_74": 1846940.0, "pmid_date_74": 1991.0, "pmid_journal_74": "The New England journal of medicine"}, {"pmid_title_75": "The effect of teicoplanin on leukocytic activity and intraleukocytic micro-organisms.", "pmid_75": 2871098.0, "pmid_date_75": 1986.0, "pmid_journal_75": "The Journal of hospital infection"}, {"pmid_title_76": "Bone marrow transplantation in chronic granulomatous disease.", "pmid_76": 6376746.0, "pmid_date_76": 1984.0, "pmid_journal_76": "The Journal of pediatrics"}, {"pmid_title_77": "Colitis in chronic granulomatous disease.", "pmid_77": 6119271.0, "pmid_date_77": 1982.0, "pmid_journal_77": "Gastroenterology"}]}, {"_id": "2590-OMIM:613743", "condition": {"condition_name": "ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE"]}, "gene information": {"db_hgnc_gene_id": 2590.0}, "interventions": [{"int_description_1": "Testosterone cypionate", "age_use_int1": "Child", "contra_int1": "Yes", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Fludrocortisone", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Vitamin D"}, {"int_description_4": "Hydrocortisone", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Dextroamphetamine"}, {"int_description_6": "Chorionic Gonadotropin (Human)"}, {"int_description_7": "Salt", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Genitoplasty"}], "references": [{"pmid_title_1": "A novel splice site variant in CYP11A1 in trans with the p.E314K variant in a male patient with congenital adrenal insufficiency.", "pmid_1": 29178636.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Mol Genet Genomic Med"}, {"pmid_title_2": "A novel entity of clinically isolated adrenal insufficiency caused by a partially inactivating mutation of the gene encoding for P450 side chain cleavage enzyme (CYP11A1).", "pmid_2": 21880796.0, "pmid_date_2": 2011.0, "pmid_journal_2": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_3": "Partial defect in the cholesterol side-chain cleavage enzyme P450scc (CYP11A1) resembling nonclassic congenital lipoid adrenal hyperplasia.", "pmid_3": 21159840.0, "pmid_date_3": 2010.0, "pmid_journal_3": "J Clin Endocrinol Metab"}, {"pmid_title_4": "Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterol side chain cleavage enzyme, P450scc.", "pmid_4": 18182448.0, "pmid_date_4": 2008.0, "pmid_journal_4": "J Clin Endocrinol Metab"}, {"pmid_title_5": "Compound heterozygous mutations in the cholesterol side-chain cleavage enzyme gene (CYP11A) cause congenital adrenal insufficiency in humans.", "pmid_5": 12161514.0, "pmid_date_5": 2002.0, "pmid_journal_5": "The Journal of clinical endocrinology and metabolism"}]}, {"_id": "2591-OMIM:202010", "condition": {"condition_name": "ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY", "freq_per_birth": "CAH due to 11-beta-hydroxylase deficiency accounts for 5 to 8 percent of all cases of congenital adrenal hyperplasia. It is estimated that CAH due to 11-beta-hydroxylase deficiency occurs in 1 in 100,000 to 200,000 newborns. This condition is more common in Moroccan Jews living in Israel, occurring in approximately 1 in 5,000 to 7,000 newborns. The classic form of CAH due to 11-beta-hydroxylase deficiency appears to be much more common than the non-classic form.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 2591.0}, "interventions": [{"int_description_1": "Fludrocortisone", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Dexamethasone"}, {"int_description_3": "Flutamide"}, {"int_description_4": "Somatotropin"}, {"int_description_5": "Testolactone"}, {"int_description_6": "Nifedipine"}, {"int_description_7": "Letrozole", "timeframe_int7": "Hours", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Cohort study or studies", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Hydrocortisone"}, {"int_description_9": "Beta-blockers"}, {"int_description_10": "Corticotherapy"}, {"int_description_11": "Glucocorticoid therapy"}, {"int_description_12": "Mineralocorticoid therapy", "timeframe_int12": "Years", "age_use_int12": "Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Case report(s)", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Bilateral adrenalectomy"}], "references": [{"pmid_title_1": "Clinical perspectives in congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency.", "pmid_1": 27928728.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Endocrine"}, {"pmid_title_2": "Radiation Treatment Time and Overall Survival in Locally Advanced Non-small Cell Lung Cancer.", "pmid_2": 28721898.0, "pmid_date_2": 2017.0, "pmid_journal_2": "International journal of radiation oncology, biology, physics"}, {"pmid_title_3": "A high rate of novel CYP11B1 mutations in Saudi Arabia.", "pmid_3": 28962970.0, "pmid_date_3": 2017.0, "pmid_journal_3": "The Journal of steroid biochemistry and molecular biology"}, {"pmid_title_4": "Two novel mutations in CYP11B1 and modeling the consequent alterations of the translated protein in classic congenital adrenal hyperplasia patients.", "pmid_4": 23345044.0, "pmid_date_4": 2013.0, "pmid_journal_4": "Endocrine"}, {"pmid_title_5": "Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia.", "pmid_5": 10487675.0, "pmid_date_5": 1999.0, "pmid_journal_5": "The Journal of clinical endocrinology and metabolism"}]}, {"_id": "2592-OMIM:203400", "condition": {"condition_name": "CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY", "freq_per_birth": "Corticosterone methyloxidase deficiency is a rare disorder; its prevalence is unknown. Researchers have described two types of the condition: Type I is more common in the Amish population of Lancaster, Pennsylvania, while type II is more common in people of Iranian Jewish ancestry. The two types have similar signs and symptoms but can be distinguished by laboratory testing.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY", "CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 2592.0}, "interventions": [{"int_description_1": "Fludrocortisone", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Desoxycorticosterone acetate"}, {"int_description_3": "Spironolactone"}, {"int_description_4": "Eplerenone"}, {"int_description_5": "Amiloride"}, {"int_description_6": "Hydrochlorothiazide"}, {"int_description_7": "Sodium chloride"}, {"int_description_8": "Sodium bicarbonate", "timeframe_int8": "Days or Weeks", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Cohort study or studies", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Analysis of novel heterozygous mutations in the CYP11B2 gene causing congenital aldosterone synthase deficiency and literature review.", "pmid_1": 31302112.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Steroids"}, {"pmid_title_2": "Controlling resistant hypertension.", "pmid_2": 30022799.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Stroke and vascular neurology"}, {"pmid_title_3": "Corticosterone Methyl Oxidase Deficiency Type 1 with Normokalemia in an Infant.", "pmid_3": 27125267.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Journal of clinical research in pediatric endocrinology"}, {"pmid_title_4": "Primary aldosteronism and low-renin hypertension: a continuum?", "pmid_4": 23535225.0, "pmid_date_4": 2013.0, "pmid_journal_4": "Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"}, {"pmid_title_5": "A case of primary selective hypoaldosteronism carrying three mutations in the aldosterone synthase (Cyp11b2) gene.", "pmid_5": 22465514.0, "pmid_date_5": 2012.0, "pmid_journal_5": "Gene"}, {"pmid_title_6": "Novel CYP11B2 mutation causing aldosterone synthase (P450c11AS) deficiency.", "pmid_6": 22801770.0, "pmid_date_6": 2012.0, "pmid_journal_6": "European journal of pediatrics"}, {"pmid_title_7": "Homozygosity for a mutation in the CYP11B2 gene in an infant with congenital corticosterone methyl oxidase deficiency type II.", "pmid_7": 22931312.0, "pmid_date_7": 2012.0, "pmid_journal_7": "Acta paediatrica (Oslo, Norway : 1992)"}, {"pmid_title_8": "Aldosterone and arterial hypertension.", "pmid_8": 20027193.0, "pmid_date_8": 2010.0, "pmid_journal_8": "Nature reviews. Endocrinology"}, {"pmid_title_9": "Low-renin status in therapy-resistant hypertension: a clue to efficient treatment.", "pmid_9": 15480108.0, "pmid_date_9": 2004.0, "pmid_journal_9": "Journal of hypertension"}, {"pmid_title_10": "A particular phenotype in a girl with aldosterone synthase deficiency.", "pmid_10": 15240589.0, "pmid_date_10": 2004.0, "pmid_journal_10": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_11": "A compound heterozygote case of type II aldosterone synthase deficiency.", "pmid_11": 12788848.0, "pmid_date_11": 2003.0, "pmid_journal_11": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_12": "Molecular genetic study in two patients with congenital hypoaldosteronism (types I and II) in relation to previously published hormonal studies.", "pmid_12": 9703385.0, "pmid_date_12": 1998.0, "pmid_journal_12": "European journal of endocrinology"}, {"pmid_title_13": "Isolated aldosterone synthase deficiency caused by simultaneous E198D and V386A mutations in the CYP11B2 gene.", "pmid_13": 9814506.0, "pmid_date_13": 1998.0, "pmid_journal_13": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_14": "Mutation T318M in the CYP11B2 gene encoding P450c11AS (aldosterone synthase) causes corticosterone methyl oxidase II deficiency.", "pmid_14": 7485152.0, "pmid_date_14": 1995.0, "pmid_journal_14": "American journal of human genetics"}, {"pmid_title_15": "A NEW HEREDITARY DEFECT IN THE BIOSYNTHESIS OF ALDOSTERONE: URINARY C21-CORTICOSTEROID PATTERN IN THREE RELATED PATIENTS WITH A SALT-LOSING SYNDROME, SUGGESTING AN 18-OXIDATION DEFECT.", "pmid_15": 14250395.0, "pmid_date_15": 1964.0, "pmid_journal_15": "Acta endocrinologica"}]}, {"_id": "2592-OMIM:610600", "condition": {"condition_name": "CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY", "freq_per_birth": "Corticosterone methyloxidase deficiency is a rare disorder; its prevalence is unknown. Researchers have described two types of the condition: Type I is more common in the Amish population of Lancaster, Pennsylvania, while type II is more common in people of Iranian Jewish ancestry. The two types have similar signs and symptoms but can be distinguished by laboratory testing.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY", "CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 2592.0}, "interventions": [{"int_description_1": "Fludrocortisone", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Desoxycorticosterone acetate"}, {"int_description_3": "Spironolactone"}, {"int_description_4": "Eplerenone"}, {"int_description_5": "Amiloride"}, {"int_description_6": "Hydrochlorothiazide"}, {"int_description_7": "Sodium chloride"}, {"int_description_8": "Sodium bicarbonate", "timeframe_int8": "Hours,Days or Weeks", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Case report(s)", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Analysis of novel heterozygous mutations in the CYP11B2 gene causing congenital aldosterone synthase deficiency and literature review.", "pmid_1": 31302112.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Steroids"}, {"pmid_title_2": "Controlling resistant hypertension.", "pmid_2": 30022799.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Stroke and vascular neurology"}, {"pmid_title_3": "Corticosterone Methyl Oxidase Deficiency Type 1 with Normokalemia in an Infant.", "pmid_3": 27125267.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Journal of clinical research in pediatric endocrinology"}, {"pmid_title_4": "Primary aldosteronism and low-renin hypertension: a continuum?", "pmid_4": 23535225.0, "pmid_date_4": 2013.0, "pmid_journal_4": "Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"}, {"pmid_title_5": "A case of primary selective hypoaldosteronism carrying three mutations in the aldosterone synthase (Cyp11b2) gene.", "pmid_5": 22465514.0, "pmid_date_5": 2012.0, "pmid_journal_5": "Gene"}, {"pmid_title_6": "Novel CYP11B2 mutation causing aldosterone synthase (P450c11AS) deficiency.", "pmid_6": 22801770.0, "pmid_date_6": 2012.0, "pmid_journal_6": "European journal of pediatrics"}, {"pmid_title_7": "Homozygosity for a mutation in the CYP11B2 gene in an infant with congenital corticosterone methyl oxidase deficiency type II.", "pmid_7": 22931312.0, "pmid_date_7": 2012.0, "pmid_journal_7": "Acta paediatrica (Oslo, Norway : 1992)"}, {"pmid_title_8": "Aldosterone and arterial hypertension.", "pmid_8": 20027193.0, "pmid_date_8": 2010.0, "pmid_journal_8": "Nature reviews. Endocrinology"}, {"pmid_title_9": "Low-renin status in therapy-resistant hypertension: a clue to efficient treatment.", "pmid_9": 15480108.0, "pmid_date_9": 2004.0, "pmid_journal_9": "Journal of hypertension"}, {"pmid_title_10": "A particular phenotype in a girl with aldosterone synthase deficiency.", "pmid_10": 15240589.0, "pmid_date_10": 2004.0, "pmid_journal_10": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_11": "A compound heterozygote case of type II aldosterone synthase deficiency.", "pmid_11": 12788848.0, "pmid_date_11": 2003.0, "pmid_journal_11": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_12": "Molecular genetic study in two patients with congenital hypoaldosteronism (types I and II) in relation to previously published hormonal studies.", "pmid_12": 9703385.0, "pmid_date_12": 1998.0, "pmid_journal_12": "European journal of endocrinology"}, {"pmid_title_13": "Isolated aldosterone synthase deficiency caused by simultaneous E198D and V386A mutations in the CYP11B2 gene.", "pmid_13": 9814506.0, "pmid_date_13": 1998.0, "pmid_journal_13": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_14": "Mutation T318M in the CYP11B2 gene encoding P450c11AS (aldosterone synthase) causes corticosterone methyl oxidase II deficiency.", "pmid_14": 7485152.0, "pmid_date_14": 1995.0, "pmid_journal_14": "American journal of human genetics"}, {"pmid_title_15": "A NEW HEREDITARY DEFECT IN THE BIOSYNTHESIS OF ALDOSTERONE: URINARY C21-CORTICOSTEROID PATTERN IN THREE RELATED PATIENTS WITH A SALT-LOSING SYNDROME, SUGGESTING AN 18-OXIDATION DEFECT.", "pmid_15": 14250395.0, "pmid_date_15": 1964.0, "pmid_journal_15": "Acta endocrinologica"}]}, {"_id": "2593-OMIM:202110", "condition": {"condition_name": "ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY", "freq_per_birth": "17\u03b1-hydroxylase/17,20-lyase deficiency accounts for about 1 percent of congenital adrenal hyperplasia cases. It is estimated to occur in 1 in 1 million people worldwide.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 2593.0}, "interventions": [{"int_description_1": "Testosterone cypionate"}, {"int_description_2": "Spironolactone"}, {"int_description_3": "Estradiol"}, {"int_description_4": "Eplerenone"}, {"int_description_5": "Amiloride"}, {"int_description_6": "Hydrocortisone", "timeframe_int6": "Hours", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Still in Trials / Unproven"}, {"int_description_7": "Glucocorticoid therapy", "timeframe_int7": "Days or Weeks", "age_use_int7": "Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Cohort study or studies", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Mineralocorticoid receptor antagonist therapy"}], "references": [{"pmid_title_1": "Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic.", "pmid_1": 26862015.0, "pmid_date_1": 2016.0, "pmid_journal_1": "J Steroid Biochem Mol Biol"}]}, {"_id": "2600-OMIM:201910", "condition": {"condition_name": "ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY", "freq_per_birth": "The classic forms of 21-hydroxylase deficiency occur in 1 in 15,000 newborns. The prevalence of the non-classic form of 21-hydroxylase deficiency is estimated to be 1 in 1,000 individuals. The prevalence of both classic and non-classic forms varies among different ethnic populations.21-hydroxylase deficiency is one of a group of disorders known as congenital adrenal hyperplasias that impair hormone production and disrupt sexual development.  21-hydroxylase deficiency is responsible for about 95 percent of all cases of congenital adrenal hyperplasia.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 2600.0}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Fludrocortisone"}, {"int_description_3": "Dexamethasone", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Hydrocortisone", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Glucocorticoid therapy"}, {"int_description_6": "Testicular sperm extraction-intracytoplasmic sperm injection"}], "references": [{"pmid_title_1": "Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.", "pmid_1": 32190901.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Cochrane Database Syst Rev"}, {"pmid_title_2": "The impact of CYP21A2 (P30L/I172N) genotype on female fertility in one family.", "pmid_2": 31217034.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Eur J Med Res"}, {"pmid_title_3": "Ultralow-dose Dexamethasone to Preserve Endogenous Cortisol Stress Response in Nonclassical Congenital Adrenal Hyperplasia: A New Promising Treatment.", "pmid_3": 25237318.0, "pmid_date_3": 2014.0, "pmid_journal_3": "Int J Endocrinol Metab"}, {"pmid_title_4": "Divergent phenotype of two siblings human leukocyte antigen identical, affected by nonclassical and classical congenital adrenal hyperplasia caused by 21-hydroxylase deficiency.", "pmid_4": 16912133.0, "pmid_date_4": 2006.0, "pmid_journal_4": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_5": "Gene duplications in 21-hydroxylase deficiency: the importance of accurate molecular diagnosis in carrier detection and prenatal diagnosis.", "pmid_5": 17042033.0, "pmid_date_5": 2006.0, "pmid_journal_5": "Prenatal diagnosis"}, {"pmid_title_6": "Genotyping of congenital adrenal hyperplasia due to 21-hydroxylase deficiency presenting as male infertility: case report and literature review.", "pmid_6": 17033937.0, "pmid_date_6": 2006.0, "pmid_journal_6": "J Assist Reprod Genet"}]}, {"_id": "26594-OMIM:254300", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 10", "freq_per_birth": "The prevalence of congenital myasthenic syndrome is unknown. At least 600 families with affected individuals have been described in the scientific literature.", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 10"]}, "gene information": {"db_hgnc_gene_id": 26594.0}, "interventions": [{"int_description_1": "Mechanical ventilation", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Ephedrine", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Salbutamol"}, {"int_description_4": "Amifampridine"}, {"int_description_5": "Procaine"}, {"int_description_6": "Procainamide"}, {"int_description_7": "Pyridostigmine"}, {"int_description_8": "Ciprofloxacin"}, {"int_description_9": "Quinidine"}, {"int_description_10": "Chloroquine"}, {"int_description_11": "Phenytoin"}, {"int_description_12": "Beta-blockers"}, {"int_description_13": "Lithium"}, {"int_description_14": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "Congenital Myasthenic Syndromes: a Clinical and Treatment Approach.", "pmid_1": 30032336.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Current treatment options in neurology"}, {"pmid_title_2": "Congenital Myasthenic Syndrome due to <i>DOK7</i> mutations in a family from Chile.", "pmid_2": 29118959.0, "pmid_date_2": 2017.0, "pmid_journal_2": "European journal of translational myology"}, {"pmid_title_3": "Congenital Myasthenic Syndromes", "pmid_3": 20301347.0, "pmid_date_3": 2016.0, "pmid_journal_3": "GeneReviews\u00ae"}, {"pmid_title_4": "KLHL40-related nemaline myopathy with a sustained, positive response to treatment with acetylcholinesterase inhibitors.", "pmid_4": 26754003.0, "pmid_date_4": 2016.0, "pmid_journal_4": "Journal of neurology"}, {"pmid_title_5": "Limb girdle weakness responding to salbutamol: an Indian family with DOK7 mutation.", "pmid_5": 25849006.0, "pmid_date_5": 2015.0, "pmid_journal_5": "Indian pediatrics"}, {"pmid_title_6": "Salbutamol therapy in congenital myasthenic syndrome due to DOK7 mutation.", "pmid_6": 23790237.0, "pmid_date_6": 2013.0, "pmid_journal_6": "Journal of the neurological sciences"}, {"pmid_title_7": "Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7.", "pmid_7": 20012313.0, "pmid_date_7": 2010.0, "pmid_journal_7": "Journal of neurology"}, {"pmid_title_8": "Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.", "pmid_8": 20458068.0, "pmid_date_8": 2010.0, "pmid_journal_8": "Neurology"}, {"pmid_title_9": "Clinical features of the DOK7 neuromuscular junction synaptopathy.", "pmid_9": 17452375.0, "pmid_date_9": 2007.0, "pmid_journal_9": "Brain : a journal of neurology"}]}, {"_id": "2698-OMIM:248600", "condition": {"condition_name": "MAPLE SYRUP URINE DISEASE; MSUD", "freq_per_birth": "Maple syrup urine disease affects an estimated 1 in 185,000 infants worldwide.  The disorder occurs much more frequently in the Old Order Mennonite population, with an estimated incidence of about 1 in 380 newborns.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MAPLE SYRUP URINE DISEASE; MSUD"]}, "gene information": {"db_hgnc_gene_id": 2698.0}, "interventions": [{"int_description_1": "Diet based on a metabolic formula, devoid of branched-chain amino acids, in combination with Isoleucine and valine supplements", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Non-branched chain amino acids diet", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Non-branched chain amino acids diet with thiamine supplementation"}, {"int_description_4": "Protein-restricted diet"}, {"int_description_5": "Isoleucine", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Insulin human", "timeframe_int6": "Hours", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Furosemide", "timeframe_int7": "Hours,Days or Weeks", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Phenylbutyric acid", "timeframe_int8": "Hours,Days or Weeks", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Valine", "timeframe_int9": "Hours,Days or Weeks", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Mannitol"}, {"int_description_11": "D-glucose"}, {"int_description_12": "Thiamine"}, {"int_description_13": "Hemodialysis", "timeframe_int13": "Hours", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "Yes", "qualscale_reclass_drug13": "Cohort study or studies", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Orthotopic liver transplantation (OLT)"}], "references": [{"pmid_title_1": "Maple Syrup Urine Disease", "pmid_1": 20301495.0, "pmid_date_1": 2020.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Clues and challenges in the diagnosis of intermittent maple syrup urine disease.", "pmid_2": 32151765.0, "pmid_date_2": 2020.0, "pmid_journal_2": "European journal of medical genetics"}, {"pmid_title_3": "Case report: maple syrup urine disease with a novel DBT gene mutation.", "pmid_3": 31830945.0, "pmid_date_3": 2019.0, "pmid_journal_3": "BMC pediatrics"}, {"pmid_title_4": "A Patient with MSUD: Acute Management with Sodium Phenylacetate/Sodium Benzoate and Sodium Phenylbutyrate.", "pmid_4": 28589054.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Case reports in pediatrics"}, {"pmid_title_5": "Intermittent maple syrup urine disease: two case reports.", "pmid_5": 24394677.0, "pmid_date_5": 2014.0, "pmid_journal_5": "Pediatrics"}, {"pmid_title_6": "Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach.", "pmid_6": 24881969.0, "pmid_date_6": 2014.0, "pmid_journal_6": "Molecular genetics and metabolism"}, {"pmid_title_7": "Phenylbutyrate therapy for maple syrup urine disease.", "pmid_7": 21098507.0, "pmid_date_7": 2011.0, "pmid_journal_7": "Human molecular genetics"}, {"pmid_title_8": "Elective liver transplantation for the treatment of classical maple syrup urine disease.", "pmid_8": 16468966.0, "pmid_date_8": 2006.0, "pmid_journal_8": "American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"}, {"pmid_title_9": "Structural and biochemical basis for novel mutations in homozygous Israeli maple syrup urine disease patients: a proposed mechanism for the thiamin-responsive phenotype.", "pmid_9": 14742428.0, "pmid_date_9": 2004.0, "pmid_journal_9": "The Journal of biological chemistry"}, {"pmid_title_10": "[Intermittent maple syrup urine disease in a 12-year-old boy: clinical aspects, diagnosis and treatment].", "pmid_10": 6632715.0, "pmid_date_10": 1983.0, "pmid_journal_10": "Klinische Padiatrie"}]}, {"_id": "2719-OMIM:608643", "condition": {"condition_name": "AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY", "freq_per_birth": "AADC deficiency is a rare disorder. Only about 100 people with this condition have been described in the medical literature worldwide; about 20 percent of these individuals are from Taiwan.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 2719.0}, "interventions": [{"int_description_1": "Nasogastric tube", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Non-invasive positive pressure ventilation", "timeframe_int2": "Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Cohort study or studies", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Levodopa"}, {"int_description_4": "Pyridoxine"}, {"int_description_5": "MAO-B inhibitor", "timeframe_int5": "Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Bilateral globus pallidus interna deep brain stimulation"}, {"int_description_7": "Gastrostomy"}, {"int_description_8": "Laryngotracheal separation"}], "references": [{"pmid_title_1": "Gene therapy improves motor and mental function of aromatic l-amino acid decarboxylase deficiency.", "pmid_1": 30689738.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Brain : a journal of neurology"}, {"pmid_title_2": "<i>KMT2B</i>-Related Dystonia", "pmid_2": 29697234.0, "pmid_date_2": 2018.0, "pmid_journal_2": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_3": "A female case of aromatic l-amino acid decarboxylase deficiency responsive to MAO-B inhibition.", "pmid_3": 27371992.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Brain & development"}]}, {"_id": "2771-OMIM:613912", "condition": {"condition_name": "COMPLEMENT FACTOR D DEFICIENCY", "alternate_names": ["COMPLEMENT FACTOR D DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 2771.0}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Prednisone"}, {"int_description_3": "Dexamethasone"}, {"int_description_4": "Epoprostenol"}, {"int_description_5": "Caffeine"}, {"int_description_6": "Human immunoglobulin G"}, {"int_description_7": "Cetirizine"}, {"int_description_8": "Hydroxychloroquine"}, {"int_description_9": "Rituximab"}, {"int_description_10": "Eculizumab"}, {"int_description_11": "Clarithromycin"}, {"int_description_12": "Cyclosporine"}, {"int_description_13": "Cyclophosphamide"}, {"int_description_14": "Dipyridamole"}, {"int_description_15": "Levamisole"}, {"int_description_16": "Erythromycin"}, {"int_description_17": "Azithromycin"}, {"int_description_18": "Chloramphenicol"}, {"int_description_19": "Trimethoprim"}, {"int_description_20": "Dapsone"}, {"int_description_21": "Sulfisoxazole"}, {"int_description_22": "Sulfadiazine"}, {"int_description_23": "Sulfamethoxazole"}, {"int_description_24": "Sulfamethazine"}, {"int_description_25": "Ciprofloxacin"}, {"int_description_26": "Ampicillin"}, {"int_description_27": "Phenoxymethylpenicillin"}, {"int_description_28": "Cefalotin"}, {"int_description_29": "Cefotaxime"}, {"int_description_30": "Cefaclor"}, {"int_description_31": "Benzylpenicillin", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Expert Opinion", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Amoxicillin", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "contra_int32": "No", "qualscale_reclass_drug32": "Case report(s)", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Cefuroxime"}, {"int_description_34": "Ceftriaxone"}, {"int_description_35": "Cefepime"}, {"int_description_36": "Sulbactam"}, {"int_description_37": "Clavulanic acid"}, {"int_description_38": "Nifedipine"}, {"int_description_39": "Diclofenac"}, {"int_description_40": "Naproxen"}, {"int_description_41": "Ibuprofen"}, {"int_description_42": "Rifampicin"}, {"int_description_43": "Pyrimethamine"}, {"int_description_44": "Methotrexate"}, {"int_description_45": "Leflunomide"}, {"int_description_46": "Vancomycin"}, {"int_description_47": "Gentamicin"}, {"int_description_48": "Chloroquine"}, {"int_description_49": "Tacrolimus"}, {"int_description_50": "Mizoribine"}, {"int_description_51": "Azathioprine"}, {"int_description_52": "Ascorbic acid"}, {"int_description_53": "Mycophenolate mofetil"}, {"int_description_54": "Mycophenolic acid"}, {"int_description_55": "Hydrocortisone"}, {"int_description_56": "Flucloxacillin"}, {"int_description_57": "Carbazochrome"}, {"int_description_58": "Acetylsalicylic acid"}, {"int_description_59": "Metamizole"}, {"int_description_60": "Methylprednisolone"}, {"int_description_61": "Leucovorin"}, {"int_description_62": "Warfarin"}, {"int_description_63": "Belimumab"}, {"int_description_64": "23-valent pneumococcal polysaccharide vaccine"}, {"int_description_65": "Anti-histaminic drugs", "timeframe_int65": "Days or Weeks,Years", "age_use_int65": "Infant,Child", "contra_int65": "No", "qualscale_reclass_drug65": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug65": "Effective / Ameliorative"}, {"int_description_66": "Antibiotics"}, {"int_description_67": "Antimalarial agents"}, {"int_description_68": "Conjugate pneumococcal vaccine"}, {"int_description_69": "Conjugate vaccine against N. meningitides serogroup B (Bexero\u00ae, Novartis Vaccines and Diagnostics S.r.l., Siena, Italy)"}, {"int_description_70": "Corticosteroids"}, {"int_description_71": "Spiramycin"}, {"int_description_72": "Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen"}, {"int_description_73": "Streptococcus pneumoniae type 4 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_74": "Streptococcus pneumoniae type 6b capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_75": "Streptococcus pneumoniae type 9v capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_76": "Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_77": "Streptococcus pneumoniae type 18c capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_78": "Streptococcus pneumoniae type 19f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_79": "Streptococcus pneumoniae type 23f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_80": "Streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_81": "Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_82": "Streptococcus pneumoniae type 5 capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_83": "Streptococcus pneumoniae type 6a capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_84": "Streptococcus pneumoniae type 7f capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_85": "Streptococcus pneumoniae type 19a capsular polysaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_86": "Streptococcus pneumoniae type 1 capsular polysaccharide antigen"}, {"int_description_87": "Streptococcus pneumoniae type 2 capsular polysaccharide antigen"}, {"int_description_88": "Streptococcus pneumoniae type 3 capsular polysaccharide antigen"}, {"int_description_89": "Streptococcus pneumoniae type 4 capsular polysaccharide antigen"}, {"int_description_90": "Streptococcus pneumoniae type 5 capsular polysaccharide antigen"}, {"int_description_91": "Streptococcus pneumoniae type 6b capsular polysaccharide antigen"}, {"int_description_92": "Streptococcus pneumoniae type 7f capsular polysaccharide antigen"}, {"int_description_93": "Streptococcus pneumoniae type 8 capsular polysaccharide antigen"}, {"int_description_94": "Streptococcus pneumoniae type 9n capsular polysaccharide antigen"}, {"int_description_95": "Streptococcus pneumoniae type 9v capsular polysaccharide antigen"}, {"int_description_96": "Streptococcus pneumoniae type 10a capsular polysaccharide antigen"}, {"int_description_97": "Streptococcus pneumoniae type 11a capsular polysaccharide antigen"}, {"int_description_98": "Streptococcus pneumoniae type 12f capsular polysaccharide antigen"}, {"int_description_99": "Streptococcus pneumoniae type 14 capsular polysaccharide antigen"}, {"int_description_100": "Streptococcus pneumoniae type 15b capsular polysaccharide antigen"}, {"int_description_101": "Streptococcus pneumoniae type 17f capsular polysaccharide antigen"}, {"int_description_102": "Streptococcus pneumoniae type 18c capsular polysaccharide antigen"}, {"int_description_103": "Streptococcus pneumoniae type 19f capsular polysaccharide antigen"}, {"int_description_104": "Streptococcus pneumoniae type 19a capsular polysaccharide antigen"}, {"int_description_105": "Streptococcus pneumoniae type 20 capsular polysaccharide antigen"}, {"int_description_106": "Streptococcus pneumoniae type 22f capsular polysaccharide antigen"}, {"int_description_107": "Streptococcus pneumoniae type 23f capsular polysaccharide antigen"}, {"int_description_108": "Streptococcus pneumoniae type 33f capsular polysaccharide antigen"}, {"int_description_109": "Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_110": "Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_111": "Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_112": "Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen"}, {"int_description_113": "Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_114": "Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_115": "Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_116": "Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen"}, {"int_description_117": "Glucocorticoids"}, {"int_description_118": "H. influenzae vaccine"}, {"int_description_119": "Hib (H. influenzae type b) conjugate vaccines"}, {"int_description_120": "Meningococcal vaccine"}, {"int_description_121": "Mild steroid cream"}, {"int_description_122": "Monovalent Neisseria meningitidis serogroup C conjugate vaccines"}, {"int_description_123": "Pneumococcal vaccine polysaccharide"}, {"int_description_124": "Pneumococcal vaccine"}, {"int_description_125": "Steroids"}, {"int_description_126": "Sulphonamide"}, {"int_description_127": "Sunscreen"}, {"int_description_128": "Tetravalent A, C, Y and W135 meningococcal polysaccharide vaccine (MencevaxACYW)"}, {"int_description_129": "Topic steroid cycles"}, {"int_description_130": "Vaccine against Neisseria meningitidis serogroup B"}, {"int_description_131": "Cochlear implant surgery"}, {"int_description_132": "Endotracheal intubation with ventilatory support"}, {"int_description_133": "Extracorporeal membrane oxygenation"}, {"int_description_134": "Fresh frozen plasma transfusions"}, {"int_description_135": "Hemodialysis"}, {"int_description_136": "Highfrequency oscillation with nitrogen monoxide ventilation"}, {"int_description_137": "Nasal rinses"}, {"int_description_138": "Plasma infusion"}, {"int_description_139": "Whole blood transfusions"}, {"int_description_140": "Adenoidectomy"}, {"int_description_141": "Enlargement of the sphenoid sinus ostium"}, {"int_description_142": "Resection of jejunum and ileum"}, {"int_description_143": "Splenectomy"}, {"int_description_144": "Surgery with a three-vessel coronary bypass grafting"}, {"int_description_145": "Tonsillectomy"}], "references": [{"pmid_title_1": "Recurrent meningococcal meningitis with complement 6 (C6) deficiency: A case report.", "pmid_1": 32481330.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Medicine (Baltimore)"}, {"pmid_title_2": "Hereditary Deficiency of the Second Component of Complement: Early Diagnosis and 21-Year Follow-Up of a Family.", "pmid_2": 32164349.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Medicina (Kaunas)"}, {"pmid_title_3": "Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017).", "pmid_3": 31200658.0, "pmid_date_3": 2019.0, "pmid_journal_3": "BMC Infect Dis"}, {"pmid_title_4": "Clinical and Genetic Spectrum of a Large Cohort With Total and Sub-total Complement Deficiencies.", "pmid_4": 31440263.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Front Immunol"}, {"pmid_title_5": "Inherited Classical and Alternative Pathway Complement Deficiencies in Children: A Single Center Experience.", "pmid_5": 30593745.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Iran J Immunol"}, {"pmid_title_6": "Late presentation of subtotal C6 deficiency in a patient with recurrent Neisseria meningitides infections.", "pmid_6": 29625666.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Ann Allergy Asthma Immunol"}, {"pmid_title_7": "Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus.", "pmid_7": 29671280.0, "pmid_date_7": 2018.0, "pmid_journal_7": "Arthritis Rheumatol"}, {"pmid_title_8": "Delayed Generalized Necrotic Purpuric Rash in a C6-deficient 12-year-old Girl Treated for Group W Meningococcal Disease.", "pmid_8": 29474263.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Pediatr Infect Dis J"}, {"pmid_title_9": "Cutaneous Vasculitis and Digital Ischaemia Caused by Heterozygous Gain-of-Function Mutation in <i>C3</i>.", "pmid_9": 30443255.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Front Immunol"}, {"pmid_title_10": "Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I.", "pmid_10": 29696024.0, "pmid_date_10": 2018.0, "pmid_journal_10": "Front Immunol"}, {"pmid_title_11": "A Case of Fulminant Meningococcemia: It Is All in the Complement.", "pmid_11": 28808592.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Case Rep Infect Dis"}, {"pmid_title_12": "Urticarial vasculitis in the childhood with C2 hypocomplementenemia: a rare case.", "pmid_12": 27852431.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Eur Ann Allergy Clin Immunol"}, {"pmid_title_13": "High frequency of immunodeficiency-like states in systemic lupus erythematosus: a cross-sectional study in 300 consecutive patients.", "pmid_13": 27274095.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Rheumatology (Oxford)"}, {"pmid_title_14": "Infections Revealing Complement Deficiency in Adults: A French Nationwide Study Enrolling 41 Patients.", "pmid_14": 27175654.0, "pmid_date_14": 2016.0, "pmid_journal_14": "Medicine (Baltimore)"}, {"pmid_title_15": "Supraglottitis due to group B streptococcus in an adult with IgG4 and C2 deficiency: a case report and review of the literature.", "pmid_15": 25124395.0, "pmid_date_15": 2015.0, "pmid_journal_15": "Laryngoscope"}, {"pmid_title_16": "Novel CFI mutation in a patient with leukocytoclastic vasculitis may redefine the clinical spectrum of Complement Factor I deficiency.", "pmid_16": 25988862.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Clin Immunol"}, {"pmid_title_17": "Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across Europe.", "pmid_17": 25663093.0, "pmid_date_17": 2015.0, "pmid_journal_17": "J Clin Immunol"}, {"pmid_title_18": "Chronic gonococcal arthritis with C5 deficiency presenting with brief flare-ups: case study and literature review.", "pmid_18": 24777471.0, "pmid_date_18": 2014.0, "pmid_journal_18": "Clin Rheumatol"}, {"pmid_title_19": "Severe infantile Bordetella pertussis pneumonia in monozygotic twins with a congenital C3 deficiency.", "pmid_19": 23963626.0, "pmid_date_19": 2014.0, "pmid_journal_19": "Eur J Pediatr"}, {"pmid_title_20": "Compound heterozygous mutations in the C6 gene of a child with recurrent infections.", "pmid_20": 24378253.0, "pmid_date_20": 2014.0, "pmid_journal_20": "Mol Immunol"}, {"pmid_title_21": "Association of low serum complement C3 with reduced patient and renal survival in antimyeloperoxidase-associated small-vessel vasculitis.", "pmid_21": 24577364.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Nephron Clin Pract"}, {"pmid_title_22": "C5 complement deficiency in a Saudi family, molecular characterization of mutation and literature review.", "pmid_22": 23371790.0, "pmid_date_22": 2013.0, "pmid_journal_22": "J Clin Immunol"}, {"pmid_title_23": "Deficiency in complement factor B.", "pmid_23": 24152280.0, "pmid_date_23": 2013.0, "pmid_journal_23": "N Engl J Med"}, {"pmid_title_24": "Post-vaccine glomerulonephritis in an infant with hereditary C2 complement deficiency: case study.", "pmid_24": 24382852.0, "pmid_date_24": 2013.0, "pmid_journal_24": "Croat Med J"}, {"pmid_title_25": "Complete deficiency of the sixth complement component (C6Q0), susceptibility to Neisseria meningitidis infections and analysis of the frequencies of C6Q0 gene defects in South Africans.", "pmid_25": 22288589.0, "pmid_date_25": 2012.0, "pmid_journal_25": "Clin Exp Immunol"}, {"pmid_title_26": "Rheumatoid factor-positive synovitis in a patient with C3 deficiency.", "pmid_26": 23043374.0, "pmid_date_26": 2012.0, "pmid_journal_26": "Scand J Rheumatol"}, {"pmid_title_27": "Complement deficiency states and associated infections.", "pmid_27": 21624663.0, "pmid_date_27": 2011.0, "pmid_journal_27": "Mol Immunol"}, {"pmid_title_28": "A novel mutation in the C3 gene and recurrent invasive pneumococcal infection: a clue for vaccine development.", "pmid_28": 21676463.0, "pmid_date_28": 2011.0, "pmid_journal_28": "Mol Immunol"}, {"pmid_title_29": "Recurrent meningococcal sepsis in a presumptive immunocompetent host shown to be complement C5 deficient-a case report.", "pmid_29": 21635555.0, "pmid_date_29": 2011.0, "pmid_journal_29": "APMIS"}, {"pmid_title_30": "Complement C2 deficiency disarranging innate and adaptive humoral immune responses in a pediatric patient: treatment with rituximab.", "pmid_30": 20890976.0, "pmid_date_30": 2011.0, "pmid_journal_30": "Arthritis Care Res (Hoboken)"}, {"pmid_title_31": "Infections of people with complement deficiencies and patients who have undergone splenectomy.", "pmid_31": 20930072.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Clin Microbiol Rev"}, {"pmid_title_32": "Recurrent meningitis secondary to isolated C3 deficiency.", "pmid_32": 19391010.0, "pmid_date_32": 2009.0, "pmid_journal_32": "Indian J Pediatr"}, {"pmid_title_33": "A novel mutation in a patient with a deficiency of the eighth component of complement associated with recurrent meningococcal meningitis.", "pmid_33": 19434484.0, "pmid_date_33": 2009.0, "pmid_journal_33": "J Clin Immunol"}, {"pmid_title_34": "Molecular characterization of three new mutations causing C5 deficiency in two non-related families.", "pmid_34": 19414197.0, "pmid_date_34": 2009.0, "pmid_journal_34": "Mol Immunol"}, {"pmid_title_35": "Complement C1q and C8beta deficiency in an individual with recurrent bacterial meningitis and adult-onset systemic lupus erythematosus-like illness.", "pmid_35": 18682415.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Rheumatology (Oxford)"}, {"pmid_title_36": "Hereditary complement deficiency and lupus: report of four Tunisian cases.", "pmid_36": 17893986.0, "pmid_date_36": 2007.0, "pmid_journal_36": "Ann N Y Acad Sci"}, {"pmid_title_37": "Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency.", "pmid_37": 17478473.0, "pmid_date_37": 2007.0, "pmid_journal_37": "Rheumatology (Oxford)"}, {"pmid_title_38": "C2 deficiency primary meningococcal arthritis of the elbow by Neisseria meningitidis serogroup Y in a 12-year old girl.", "pmid_38": 17653506.0, "pmid_date_38": 2007.0, "pmid_journal_38": "Infection"}, {"pmid_title_39": "Deficiency of the seventh component of complement in a Taiwanese boy.", "pmid_39": 16959627.0, "pmid_date_39": 2006.0, "pmid_journal_39": "J Formos Med Assoc"}, {"pmid_title_40": "Recurrent meningitis in a family with C3 deficiency.", "pmid_40": 16585828.0, "pmid_date_40": 2006.0, "pmid_journal_40": "Indian Pediatr"}, {"pmid_title_41": "Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections.", "pmid_41": 16527897.0, "pmid_date_41": 2006.0, "pmid_journal_41": "Blood"}, {"pmid_title_42": "Linking C5 deficiency to an exonic splicing enhancer mutation.", "pmid_42": 15778377.0, "pmid_date_42": 2005.0, "pmid_journal_42": "J Immunol"}, {"pmid_title_43": "Molecular analysis of a novel hereditary C3 deficiency with systemic lupus erythematosus.", "pmid_43": 15781264.0, "pmid_date_43": 2005.0, "pmid_journal_43": "Biochem Biophys Res Commun"}, {"pmid_title_44": "Complement C7 deficiency presenting as recurrent aseptic meningitis.", "pmid_44": 15328683.0, "pmid_date_44": 2004.0, "pmid_journal_44": "Ann Allergy Asthma Immunol"}, {"pmid_title_45": "Necrotic facial papules in an adolescent: C2 deficiency with eventual development of lupus erythematosus.", "pmid_45": 12869153.0, "pmid_date_45": 2003.0, "pmid_journal_45": "Pediatr Dermatol"}, {"pmid_title_46": "Recurrent pneumococcal meningitis in homozygous C3 deficiency.", "pmid_46": 12173704.0, "pmid_date_46": 2002.0, "pmid_journal_46": "Indian J Pediatr"}, {"pmid_title_47": "A family with complement factor D deficiency.", "pmid_47": 11457876.0, "pmid_date_47": 2001.0, "pmid_journal_47": "J Clin Invest"}, {"pmid_title_48": "Complement factor I deficiency associated with recurrent meningitis coinciding with menstruation.", "pmid_48": 11709004.0, "pmid_date_48": 2001.0, "pmid_journal_48": "Arch Neurol"}, {"pmid_title_49": "Hereditary human complement C3 deficiency owing to reduced levels of C3 mRNA.", "pmid_49": 11422912.0, "pmid_date_49": 2001.0, "pmid_journal_49": "Scand J Immunol"}, {"pmid_title_50": "Hereditary complement (C9) deficiency associated with dermatomyositis.", "pmid_50": 11359403.0, "pmid_date_50": 2001.0, "pmid_journal_50": "Br J Dermatol"}, {"pmid_title_51": "Pyoderma gangrenosum in a patient with autoimmune haemolytic anaemia and complement deficiency.", "pmid_51": 10886151.0, "pmid_date_51": 2000.0, "pmid_journal_51": "Br J Dermatol"}, {"pmid_title_52": "Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement-deficient patients.", "pmid_52": 10632668.0, "pmid_date_52": 2000.0, "pmid_journal_52": "Clin Exp Immunol"}, {"pmid_title_53": "A novel type II complement C2 deficiency allele in an African-American family.", "pmid_53": 9670930.0, "pmid_date_53": 1998.0, "pmid_journal_53": "J Immunol"}, {"pmid_title_54": "A 4-year-old girl with right elbow erythema, warmth, and induration.", "pmid_54": 9088752.0, "pmid_date_54": 1997.0, "pmid_journal_54": "Curr Opin Pediatr"}, {"pmid_title_55": "Systemic lupus erythematosus complicating complement type 2 deficiency: successful treatment with fresh frozen plasma.", "pmid_55": 9115923.0, "pmid_date_55": 1997.0, "pmid_journal_55": "Br J Dermatol"}, {"pmid_title_56": "Multifocal stenosing ulcerations of the small intestine revealing vasculitis associated with C2 deficiency.", "pmid_56": 8613071.0, "pmid_date_56": 1996.0, "pmid_journal_56": "Gastroenterology"}, {"pmid_title_57": "Heterozygous and homozygous factor H deficiency states in a Dutch family.", "pmid_57": 8809142.0, "pmid_date_57": 1996.0, "pmid_journal_57": "Clin Exp Immunol"}, {"pmid_title_58": "Invasive Haemophilus influenzae type b infection in a child with familial deficiency of the beta subunit of the eighth component of complement.", "pmid_58": 8551398.0, "pmid_date_58": 1996.0, "pmid_journal_58": "J Pediatr"}, {"pmid_title_59": "How partial C7 deficiency with chronic and recurrent bacterial infections can mimic total C7 deficiency: temporary restoration of host C7 levels following plasma transfusion.", "pmid_59": 8774358.0, "pmid_date_59": 1996.0, "pmid_journal_59": "Immunology"}, {"pmid_title_60": "C9 deficiency in a patient with poststreptococcal glomerulonephritis.", "pmid_60": 8747118.0, "pmid_date_60": 1995.0, "pmid_journal_60": "Pediatr Nephrol"}, {"pmid_title_61": "Childhood subacute cutaneous lupus erythematosus associated with homozygous complement 2 deficiency.", "pmid_61": 8747579.0, "pmid_date_61": 1995.0, "pmid_journal_61": "Pediatr Dermatol"}, {"pmid_title_62": "Phenotypically similar clones of serogroup B Neisseria meningitidis causing recurrent meningitis in a patient with total C5 deficiency.", "pmid_62": 7806892.0, "pmid_date_62": 1994.0, "pmid_journal_62": "J Infect"}, {"pmid_title_63": "Hereditary deficiency of the seventh component of complement and recurrent meningococcal infection: investigations of an Irish family using a novel haemolytic screening assay for complement activity and C7 M/N allotyping.", "pmid_63": 7523157.0, "pmid_date_63": 1994.0, "pmid_journal_63": "Epidemiol Infect"}, {"pmid_title_64": "Recurrent infections, pericarditis and renal disease in a patient with total C2 deficiency and decreased NK cell function consistent with acute rheumatic fever and systemic lupus erythematosus.", "pmid_64": 8203960.0, "pmid_date_64": 1994.0, "pmid_journal_64": "Ann Rheum Dis"}, {"pmid_title_65": "Recurrent meningococcal infections in a patient with congenital C5 deficiency.", "pmid_65": 8388602.0, "pmid_date_65": 1993.0, "pmid_journal_65": "Acta Clin Belg"}, {"pmid_title_66": "Complement component deficiencies and infection: C5, C8 and C3 deficiencies in three families.", "pmid_66": 1396929.0, "pmid_date_66": 1992.0, "pmid_journal_66": "Eur J Pediatr"}, {"pmid_title_67": "Hereditary dysfunction of the third component of complement associated with a systemic lupus erythematosus-like syndrome and meningococcal meningitis.", "pmid_67": 1575793.0, "pmid_date_67": 1992.0, "pmid_journal_67": "Arthritis Rheum"}, {"pmid_title_68": "Complement factor 2 deficiency: a clinical and serological family study.", "pmid_68": 1361318.0, "pmid_date_68": 1992.0, "pmid_journal_68": "Ann Rheum Dis"}, {"pmid_title_69": "Selective C7 complement deficiency causing recurrent meningococcal infection.", "pmid_69": 2071909.0, "pmid_date_69": 1991.0, "pmid_journal_69": "J Infect"}, {"pmid_title_70": "Combined complete C5 and partial C4 deficiency in humans: clinical consequences and complement-mediated functions in vitro.", "pmid_70": 2306879.0, "pmid_date_70": 1990.0, "pmid_journal_70": "Clin Immunol Immunopathol"}, {"pmid_title_71": "Prophylaxis against Neisseria meningitidis infections and antibody responses in patients with deficiency of the sixth component of complement.", "pmid_71": 2109021.0, "pmid_date_71": 1990.0, "pmid_journal_71": "J Infect Dis"}, {"pmid_title_72": "Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency.", "pmid_72": 2290166.0, "pmid_date_72": 1990.0, "pmid_journal_72": "J Rheumatol"}, {"pmid_title_73": "Complete and partial deficiencies of complement factor D in a Dutch family.", "pmid_73": 2687330.0, "pmid_date_73": 1989.0, "pmid_journal_73": "J Clin Invest"}, {"pmid_title_74": "A case of hereditary combined deficiency of complement components C6 and C7 in man.", "pmid_74": 2702782.0, "pmid_date_74": 1989.0, "pmid_journal_74": "Clin Exp Immunol"}, {"pmid_title_75": "Combined homozygous factor H and heterozygous C2 deficiency in an Italian family.", "pmid_75": 2966809.0, "pmid_date_75": 1988.0, "pmid_journal_75": "J Clin Immunol"}, {"pmid_title_76": "Inherited C3 deficiency with recurrent infections and glomerulonephritis.", "pmid_76": 2963536.0, "pmid_date_76": 1988.0, "pmid_journal_76": "Am J Dis Child"}, {"pmid_title_77": "Meningitis caused by a nonencapsulated strain of Neisseria meningitidis in twin infants with a C6 deficiency.", "pmid_77": 3102634.0, "pmid_date_77": 1987.0, "pmid_journal_77": "J Infect Dis"}, {"pmid_title_78": "Meningococcal disease in congenital absence of the fifth component of complement.", "pmid_78": 3441749.0, "pmid_date_78": 1987.0, "pmid_journal_78": "Scand J Infect Dis"}, {"pmid_title_79": "Hypocomplementemic vasculitis and renal involvement.", "pmid_79": 2951605.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Nephron"}, {"pmid_title_80": "Arthritis and antinuclear antibodies (ANA) with inherited deficiency of the sixth component of complement (C6).", "pmid_80": 3487293.0, "pmid_date_80": 1986.0, "pmid_journal_80": "Ann Rheum Dis"}, {"pmid_title_81": "Atypical hypocomplementemic vasculitis syndrome in a child.", "pmid_81": 2987470.0, "pmid_date_81": 1985.0, "pmid_journal_81": "J Pediatr"}, {"pmid_title_82": "Terminal complement component deficiencies and rheumatic disease: development of a rheumatic syndrome and anticomplementary activity in a patient with complete C6 deficiency.", "pmid_82": 3931570.0, "pmid_date_82": 1985.0, "pmid_journal_82": "Ann Rheum Dis"}, {"pmid_title_83": "Thrombotic thrombocytopenic purpura developing during pregnancy in a C2-deficient patient with a history of systemic lupus erythematosus.", "pmid_83": 4038880.0, "pmid_date_83": 1985.0, "pmid_journal_83": "Arthritis Rheum"}, {"pmid_title_84": "Complement deficiency syndromes and bacterial infections.", "pmid_84": 6665131.0, "pmid_date_84": 1983.0, "pmid_journal_84": "Prog Brain Res"}, {"pmid_title_85": "Recurrent meningococcal meningitis due to partial complement defects and poor anti-meningococcal antibody response.", "pmid_85": 6411822.0, "pmid_date_85": 1983.0, "pmid_journal_85": "J Infect"}, {"pmid_title_86": "Circulating immune complexes and glomerulonephritis in a patient with congenital absence of the third component of complement.", "pmid_86": 6835307.0, "pmid_date_86": 1983.0, "pmid_journal_86": "N Engl J Med"}, {"pmid_title_87": "Identification of the alpha-gamma subunit of the eighth component of complement (C8) in a patient with systemic lupus erythematosus and absent C8 activity: patients and family studies.", "pmid_87": 7105499.0, "pmid_date_87": 1982.0, "pmid_journal_87": "Clin Immunol Immunopathol"}, {"pmid_title_88": "Combined hereditary deficiency of the sixth component of complement and factor VIII coagulant activity in a Dutch family.", "pmid_88": 6811172.0, "pmid_date_88": 1982.0, "pmid_journal_88": "Clin Exp Immunol"}, {"pmid_title_89": "Fulminant meningococcemia in a child with hereditary deficiency of the seventh component of complement and proteinuria.", "pmid_89": 7446104.0, "pmid_date_89": 1980.0, "pmid_journal_89": "Acta Paediatr Scand"}, {"pmid_title_90": "Recurrent bacterial meningitis due to genetic deficiencies of terminal complement components (C5 and C6).", "pmid_90": 7193645.0, "pmid_date_90": 1980.0, "pmid_journal_90": "Immunobiology"}, {"pmid_title_91": "Recurrent bacterial meningitis in patients with genetic defects of terminal complement components.", "pmid_91": 7389212.0, "pmid_date_91": 1980.0, "pmid_journal_91": "Clin Exp Immunol"}, {"pmid_title_92": "Familial partial deficiency of the third component of complement (C3) and the hypocomplementemic cutaneous vasculitis syndrome.", "pmid_92": 7369233.0, "pmid_date_92": 1980.0, "pmid_journal_92": "Am J Med"}, {"pmid_title_93": "Deficiency of the fifth component of complement in human subjects. Clinical, genetic and immunologic studies in a large kindred.", "pmid_93": 495634.0, "pmid_date_93": 1979.0, "pmid_journal_93": "Am J Med"}, {"pmid_title_94": "Hereditary C2 deficiency associated with cutaneous lupus erythematosus: clinical, laboratory, and genetic studies.", "pmid_94": 760659.0, "pmid_date_94": 1979.0, "pmid_journal_94": "Arch Dermatol"}, {"pmid_title_95": "Hereditary deficiency of the third component of complement in a child with fever, skin rash, and arthralgias: response to transfusion of whole blood.", "pmid_95": 318684.0, "pmid_date_95": 1977.0, "pmid_journal_95": "J Pediatr"}, {"pmid_title_96": "Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.", "pmid_96": 932197.0, "pmid_date_96": 1976.0, "pmid_journal_96": "J Clin Invest"}, {"pmid_title_97": "C2 deficiency. Development of lupus erythematosus.", "pmid_97": 4578155.0, "pmid_date_97": 1973.0, "pmid_journal_97": "J Clin Invest"}]}, {"_id": "28287-OMIM:616227", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15"]}, "gene information": {"db_hgnc_gene_id": 28287.0}, "interventions": [{"int_description_1": "Mechanical ventilation"}, {"int_description_2": "Ephedrine", "timeframe_int2": "Days or Weeks", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Amifampridine"}, {"int_description_4": "Procaine", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Procainamide"}, {"int_description_6": "Pyridostigmine"}, {"int_description_7": "Ciprofloxacin"}, {"int_description_8": "Quinidine"}, {"int_description_9": "Chloroquine"}, {"int_description_10": "Phenytoin"}, {"int_description_11": "Beta-blockers"}, {"int_description_12": "Lithium"}, {"int_description_13": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "Early and lethal neurodegeneration with myasthenic and myopathic features: A new <i>ALG14</i>-CDG.", "pmid_1": 28733338.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Neurology"}, {"pmid_title_2": "Congenital Myasthenic Syndromes", "pmid_2": 20301347.0, "pmid_date_2": 2016.0, "pmid_journal_2": "GeneReviews\u00ae"}, {"pmid_title_3": "Congenital myasthenic syndromes due to mutations in ALG2 and ALG14.", "pmid_3": 23404334.0, "pmid_date_3": 2013.0, "pmid_journal_3": "Brain : a journal of neurology"}]}, {"_id": "2843-OMIM:615863", "condition": {"condition_name": "DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE"]}, "gene information": {"db_hgnc_gene_id": 2843.0}, "interventions": [{"int_description_1": "Low-fat diet", "timeframe_int1": "Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Human immunoglobulin G", "timeframe_int2": "Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Cohort study or studies", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Vitamin D", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Albumin human", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Cholestyramine", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Pancreatic enzyme replacement"}, {"int_description_7": "Medium-chain triglycerides"}, {"int_description_8": "Oral rehydration solution"}, {"int_description_9": "Feeding per gastrostomy tube"}, {"int_description_10": "Parenteral nutrition", "timeframe_int10": "Hours,Days or Weeks", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Cohort study or studies", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Small bowel transplantation", "timeframe_int11": "Days or Weeks,Years", "age_use_int11": "Infant,Child", "contra_int11": "No", "qualscale_reclass_drug11": "Case report(s)", "rev1_eff_reclass_drug11": "Still in Trials / Unproven"}], "references": [{"pmid_title_1": "Genetic variants in DGAT1 cause diverse clinical presentations of malnutrition through a specific molecular mechanism.", "pmid_1": 31778854.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Eur J Med Genet"}, {"pmid_title_2": "Phenotype and Genotype of a Cohort of Chinese Children with Early-Onset Protein-Losing Enteropathy.", "pmid_2": 30853196.0, "pmid_date_2": 2019.0, "pmid_journal_2": "J Pediatr"}, {"pmid_title_3": "Intestinal Failure and Aberrant Lipid Metabolism in Patients With\u00a0DGAT1 Deficiency.", "pmid_3": 29604290.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Gastroenterology"}, {"pmid_title_4": "Congenital Diarrhea From DGAT1 Mutation Leading to Electrolyte Derangements, Protein-losing Enteropathy, and Rickets.", "pmid_4": 28937539.0, "pmid_date_4": 2018.0, "pmid_journal_4": "J Pediatr Gastroenterol Nutr"}, {"pmid_title_5": "Reversible deficits in apical transporter trafficking associated with deficiency in diacylglycerol acyltransferase.", "pmid_5": 30095213.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Traffic"}, {"pmid_title_6": "Identification and characterization of a novel <i>DGAT1</i> missense mutation associated with congenital diarrhea.", "pmid_6": 28373485.0, "pmid_date_6": 2017.0, "pmid_journal_6": "J Lipid Res"}, {"pmid_title_7": "Congenital protein losing enteropathy: an inborn error of lipid metabolism due to DGAT1 mutations.", "pmid_7": 26883093.0, "pmid_date_7": 2016.0, "pmid_journal_7": "Eur J Hum Genet"}, {"pmid_title_8": "DGAT1 mutation is linked to a congenital diarrheal disorder.", "pmid_8": 23114594.0, "pmid_date_8": 2012.0, "pmid_journal_8": "J Clin Invest"}]}, {"_id": "28510-OMIM:610199", "condition": {"condition_name": "DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH"]}, "gene information": {"db_hgnc_gene_id": 28510.0}, "interventions": [{"int_description_1": "Phylloquinone"}, {"int_description_2": "Ursodeoxycholic acid"}, {"int_description_3": "Calcium"}, {"int_description_4": "Insulin human", "timeframe_int4": "Hours", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Cohort study or studies", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Levothyroxine", "timeframe_int5": "Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Cohort study or studies", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Ergocalciferol"}, {"int_description_7": "Vitamin D"}, {"int_description_8": "Vitamin E"}, {"int_description_9": "Vitamin A"}], "references": [{"pmid_title_1": "Expanding the Clinical Spectrum Associated With GLIS3 Mutations.", "pmid_1": 26259131.0, "pmid_date_1": 2015.0, "pmid_journal_1": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_2": "Novel GLIS3 mutations demonstrate an extended multisystem phenotype.", "pmid_2": 21139041.0, "pmid_date_2": 2011.0, "pmid_journal_2": "European journal of endocrinology"}, {"pmid_title_3": "Neonatal diabetes mellitus, congenital hypothyroidism, hepatic fibrosis, polycystic kidneys, and congenital glaucoma: a new autosomal recessive syndrome?", "pmid_3": 12966531.0, "pmid_date_3": 2003.0, "pmid_journal_3": "American journal of medical genetics. Part A"}]}, {"_id": "2890-OMIM:305000", "condition": {"condition_name": "DYSKERATOSIS CONGENITA, X-LINKED", "pattern_of_inheritance": "Autosomal dominant, X-linked recessive, Autosomal recessive", "alternate_names": ["DYSKERATOSIS CONGENITA, X-LINKED", "Hoyeraal-Hreidarsson syndrome"]}, "gene information": {"db_hgnc_gene_id": 2890.0}, "interventions": [{"int_description_1": "Acitretin"}, {"int_description_2": "Hematopoietic stem cell transplantation (HSCT)", "timeframe_int2": "Days or Weeks,Years", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Curative"}], "references": [{"pmid_title_1": "Dyskeratosis congenita--two siblings with a new missense mutation in the DKC1 gene.", "pmid_1": 21736606.0, "pmid_date_1": 2011.0, "pmid_journal_1": "Pediatr Dermatol"}, {"pmid_title_2": "Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita.", "pmid_2": 12634734.0, "pmid_date_2": 2003.0, "pmid_journal_2": "Bone Marrow Transplant"}]}, {"_id": "28956-OMIM:611777", "condition": {"condition_name": "BRUGADA SYNDROME 2", "alternate_names": ["BRUGADA SYNDROME 2"]}, "gene information": {"db_hgnc_gene_id": 28956.0}, "interventions": [{"int_description_1": "Implantable cardioverter-defibrillator", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Isoprenaline"}, {"int_description_3": "Quinine", "timeframe_int3": "Days or Weeks,Years", "age_use_int3": "Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Quinidine"}, {"int_description_5": "Disopyramide"}, {"int_description_6": "Cilostazol", "timeframe_int6": "Days or Weeks,Years", "age_use_int6": "Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Catheter ablation", "timeframe_int7": "Days or Weeks,Years", "age_use_int7": "Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Cohort study or studies", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Ablation for the treatment of Brugada syndrome: current status and future prospects.", "pmid_1": 31986921.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Expert Rev Med Devices"}, {"pmid_title_2": "Brugada syndrome.", "pmid_2": 32684122.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Acta Cardiol"}, {"pmid_title_3": "Pharmacological Therapy in Brugada Syndrome.", "pmid_3": 29967687.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Arrhythm Electrophysiol Rev"}, {"pmid_title_4": "Isoprenaline and quinidine to calm Brugada VF storm.", "pmid_4": 22891011.0, "pmid_date_4": 2012.0, "pmid_journal_4": "BMJ Case Rep"}]}, {"_id": "2898-OMIM:246900", "condition": {"condition_name": "DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 2898.0}, "interventions": [{"int_description_1": "Branched-chain amino acid-free powder formula"}, {"int_description_2": "Ketogenic/high-fat diet"}, {"int_description_3": "Protein-restricted diet", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Still in Trials / Unproven"}, {"int_description_4": "Isoleucine", "timeframe_int4": "Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Still in Trials / Unproven"}, {"int_description_5": "Levocarnitine"}, {"int_description_6": "Dichloroacetic acid", "timeframe_int6": "Hours,Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Case report(s)", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Acetylcysteine"}, {"int_description_8": "Valine"}, {"int_description_9": "Riboflavin"}, {"int_description_10": "Biotin"}, {"int_description_11": "Lipoic acid", "timeframe_int11": "Hours,Days or Weeks", "age_use_int11": "Neonate,Infant,Child", "qualscale_reclass_drug11": "Case report(s)", "rev1_eff_reclass_drug11": "Still in Trials / Unproven"}, {"int_description_12": "Maltodextrin"}, {"int_description_13": "Sodium bicarbonate"}, {"int_description_14": "D-glucose"}, {"int_description_15": "Thiamine", "timeframe_int15": "Days or Weeks", "age_use_int15": "Neonate,Infant,Child", "contra_int15": "No", "qualscale_reclass_drug15": "Case report(s)", "rev1_eff_reclass_drug15": "Still in Trials / Unproven"}, {"int_description_16": "Feeding per gastrostomy tube"}, {"int_description_17": "Fresh frozen plasma transfusion"}, {"int_description_18": "\u0421ontinuous veno-venous haemofiltration"}], "references": [{"pmid_title_1": "Dihydrolipoamide Dehydrogenase Deficiency", "pmid_1": 25032271.0, "pmid_date_1": 2020.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Riboflavin responsive mitochondrial myopathy is a new phenotype of dihydrolipoamide dehydrogenase deficiency. The chaperon-like effect of vitamin B2.", "pmid_2": 25251739.0, "pmid_date_2": 2014.0, "pmid_journal_2": "Mitochondrion"}, {"pmid_title_3": "Leigh syndrome in a girl with a novel DLD mutation causing E3 deficiency.", "pmid_3": 23290025.0, "pmid_date_3": 2013.0, "pmid_journal_3": "Pediatr Neurol"}, {"pmid_title_4": "Dihydrolipoamide dehydrogenase deficiency: a still overlooked cause of recurrent acute liver failure and Reye-like syndrome.", "pmid_4": 23478190.0, "pmid_date_4": 2013.0, "pmid_journal_4": "Mol Genet Metab"}, {"pmid_title_5": "Identification of a common mutation (Gly194Cys) in both Arab Moslem and Ashkenazi Jewish patients with dihydrolipoamide dehydrogenase (E3) deficiency: possible beneficial effect of vitamin therapy.", "pmid_5": 14765544.0, "pmid_date_5": 2003.0, "pmid_journal_5": "J Inherit Metab Dis"}, {"pmid_title_6": "Congenital lacticacidemia caused by lipoamide dehydrogenase deficiency with favorable outcome.", "pmid_6": 7815230.0, "pmid_date_6": 1995.0, "pmid_journal_6": "J Pediatr"}, {"pmid_title_7": "Lipoamide dehydrogenase deficiency with primary lactic acidosis: favorable response to treatment with oral lipoic acid.", "pmid_7": 6418873.0, "pmid_date_7": 1984.0, "pmid_journal_7": "J Pediatr"}]}, {"_id": "2928-OMIM:300376", "condition": {"condition_name": "MUSCULAR DYSTROPHY, BECKER TYPE", "pattern_of_inheritance": "X-linked recessive", "alternate_names": ["MUSCULAR DYSTROPHY, DUCHENNE TYPE", "MUSCULAR DYSTROPHY, BECKER TYPE", "CARDIOMYOPATHY, DILATED, 3B"]}, "gene information": {"db_hgnc_gene_id": 2928.0}, "interventions": [{"int_description_1": "Invasive ventilation"}, {"int_description_2": "Nocturnal BiPAP (bilevel positive airway pressure)"}, {"int_description_3": "Non-invasive ventilation"}, {"int_description_4": "Subcutaneous defibrillators"}, {"int_description_5": "Diet rich in vitamin D and calcium"}, {"int_description_6": "Protein supplements"}, {"int_description_7": "Ubidecarenone"}, {"int_description_8": "Dobutamine"}, {"int_description_9": "Salbutamol"}, {"int_description_10": "Calcium"}, {"int_description_11": "Arginine"}, {"int_description_12": "Prednisolone"}, {"int_description_13": "Prednisone"}, {"int_description_14": "Carvedilol"}, {"int_description_15": "Spironolactone"}, {"int_description_16": "Oxybutynin"}, {"int_description_17": "Cyclosporine"}, {"int_description_18": "Somatotropin"}, {"int_description_19": "Vitamin D"}, {"int_description_20": "Bisoprolol"}, {"int_description_21": "Amiodarone"}, {"int_description_22": "Ivabradine"}, {"int_description_23": "Digoxin"}, {"int_description_24": "Furosemide"}, {"int_description_25": "Magnesium"}, {"int_description_26": "Ramipril"}, {"int_description_27": "Fosinopril"}, {"int_description_28": "Enalapril"}, {"int_description_29": "Captopril"}, {"int_description_30": "Imidapril"}, {"int_description_31": "Gentamicin"}, {"int_description_32": "Alendronic acid"}, {"int_description_33": "Tadalafil"}, {"int_description_34": "Valproic acid"}, {"int_description_35": "Azathioprine"}, {"int_description_36": "Deflazacort"}, {"int_description_37": "Ascorbic acid"}, {"int_description_38": "Metformin"}, {"int_description_39": "Vitamin E"}, {"int_description_40": "Milrinone"}, {"int_description_41": "Sildenafil"}, {"int_description_42": "Pidolic acid"}, {"int_description_43": "Fish oil"}, {"int_description_44": "Methylprednisolone"}, {"int_description_45": "Warfarin"}, {"int_description_46": "Ataluren"}, {"int_description_47": "Creatine"}, {"int_description_48": "ACE (angiotensin-converting enzyme) inhibitors"}, {"int_description_49": "Angiotensin II-receptor blockers (ARBs)"}, {"int_description_50": "Benzodiazepines"}, {"int_description_51": "Beta-blockers"}, {"int_description_52": "Bisphosphonates"}, {"int_description_53": "Carperitide"}, {"int_description_54": "Congestor"}, {"int_description_55": "Corticosteroids"}, {"int_description_56": "Citrulline", "qualscale_reclass_drug56": "Authoritative published clinical practice guideline"}, {"int_description_57": "Eteplirsen"}, {"int_description_58": "beta-Hydroxyisovaleric acid"}, {"int_description_59": "Diphosphonate"}, {"int_description_60": "Diuretics"}, {"int_description_61": "Multivitamins"}, {"int_description_62": "Pneumococcal and influenza immunizations"}, {"int_description_63": "Sodium nitrate"}, {"int_description_64": "Ubiquinone"}, {"int_description_65": "Glutathione"}, {"int_description_66": "Sapropterin"}, {"int_description_67": "Biventricular pacing"}, {"int_description_68": "Chest physiotherapy"}, {"int_description_69": "Chiropractic treatments"}, {"int_description_70": "Endurance training"}, {"int_description_71": "Massage"}, {"int_description_72": "Naturopathy"}, {"int_description_73": "Occupational therapy"}, {"int_description_74": "Osteopathy", "qualscale_reclass_drug74": "Authoritative published clinical practice guideline"}, {"int_description_75": "Physical therapy"}, {"int_description_76": "Physiotherapy", "qualscale_reclass_drug76": "Authoritative published clinical practice guideline"}, {"int_description_77": "Heart transplantation"}, {"int_description_78": "Spinal surgery"}, {"int_description_79": "Tracheotomy"}], "references": [{"pmid_title_1": "Current and emerging therapies in Becker muscular dystrophy (BMD).", "pmid_1": 31788661.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Acta Myol"}, {"pmid_title_2": "Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy.", "pmid_2": 31261494.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Medicine (Baltimore)"}, {"pmid_title_3": "Characteristics of Japanese Patients with Becker Muscular Dystrophy and Intermediate Muscular Dystrophy in a Japanese National Registry of Muscular Dystrophy (Remudy): Heterogeneity and Clinical Variation.", "pmid_3": 29614690.0, "pmid_date_3": 2018.0, "pmid_journal_3": "J Neuromuscul Dis"}, {"pmid_title_4": "Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.", "pmid_4": 30326162.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Cochrane Database Syst Rev"}, {"pmid_title_5": "Effects of single and combined metformin and L-citrulline supplementation on L-arginine-related pathways in Becker muscular dystrophy patients: possible biochemical and clinical implications.", "pmid_5": 30003335.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Amino Acids"}, {"pmid_title_6": "Effects of Sildenafil on Cerebrovascular Reactivity in Patients with Becker Muscular Dystrophy.", "pmid_6": 27485237.0, "pmid_date_6": 2017.0, "pmid_journal_6": "Neurotherapeutics"}, {"pmid_title_7": "Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy: A Randomized Clinical Trial.", "pmid_7": 27926769.0, "pmid_date_7": 2017.0, "pmid_journal_7": "JAMA Cardiol"}, {"pmid_title_8": "Physical activity and the use of standard and complementary therapies in Duchenne and Becker muscular dystrophies.", "pmid_8": 26966801.0, "pmid_date_8": 2016.0, "pmid_journal_8": "J Pediatr Rehabil Med"}, {"pmid_title_9": "Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study.", "pmid_9": 26799743.0, "pmid_date_9": 2016.0, "pmid_journal_9": "PLoS One"}, {"pmid_title_10": "Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial.", "pmid_10": 27488051.0, "pmid_date_10": 2016.0, "pmid_journal_10": "Trials"}, {"pmid_title_11": "A Case of Refractory Heart Failure in Becker Muscular Dystrophy Improved With Corticosteroid Therapy.", "pmid_11": 27535714.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Int Heart J"}, {"pmid_title_12": "Cardiac implantable electronic devices in tracheotomized muscular dystrophy patients: Safety and risks.", "pmid_12": 27526372.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Int J Cardiol"}, {"pmid_title_13": "Risk Factors for First Fractures Among Males With Duchenne or Becker Muscular Dystrophy.", "pmid_13": 25379822.0, "pmid_date_13": 2015.0, "pmid_journal_13": "J Pediatr Orthop"}, {"pmid_title_14": "Sodium nitrate alleviates functional muscle ischaemia in patients with Becker muscular dystrophy.", "pmid_14": 26437761.0, "pmid_date_14": 2015.0, "pmid_journal_14": "J Physiol"}, {"pmid_title_15": "Effect of sildenafil on skeletal and cardiac muscle in Becker muscular dystrophy.", "pmid_15": 25042931.0, "pmid_date_15": 2014.0, "pmid_journal_15": "Ann Neurol"}, {"pmid_title_16": "Sildenafil does not improve cardiomyopathy in Duchenne/Becker muscular dystrophy.", "pmid_16": 25042693.0, "pmid_date_16": 2014.0, "pmid_journal_16": "Ann Neurol"}, {"pmid_title_17": "Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy).", "pmid_17": 23601510.0, "pmid_date_17": 2013.0, "pmid_journal_17": "Orphanet J Rare Dis"}, {"pmid_title_18": "Beneficial effect of ivabradine in dilated cardiomyopathy from Becker muscular dystrophy.", "pmid_18": 22718185.0, "pmid_date_18": 2012.0, "pmid_journal_18": "Herz"}, {"pmid_title_19": "Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.", "pmid_19": 23197572.0, "pmid_date_19": 2012.0, "pmid_journal_19": "Sci Transl Med"}, {"pmid_title_20": "Cardiac assessment in duchenne and becker muscular dystrophies.", "pmid_20": 20857240.0, "pmid_date_20": 2010.0, "pmid_journal_20": "Curr Heart Fail Rep"}, {"pmid_title_21": "Read-through strategies for suppression of nonsense mutations in Duchenne/ Becker muscular dystrophy: aminoglycosides and ataluren (PTC124).", "pmid_21": 20519671.0, "pmid_date_21": 2010.0, "pmid_journal_21": "J Child Neurol"}, {"pmid_title_22": "Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy.", "pmid_22": 19432907.0, "pmid_date_22": 2009.0, "pmid_journal_22": "J Am Acad Nurse Pract"}, {"pmid_title_23": "Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy.", "pmid_23": 18678574.0, "pmid_date_23": 2008.0, "pmid_journal_23": "Clin Rehabil"}, {"pmid_title_24": "Endurance training improves fitness and strength in patients with Becker muscular dystrophy.", "pmid_24": 18776212.0, "pmid_date_24": 2008.0, "pmid_journal_24": "Brain"}, {"pmid_title_25": "Pilot trial of albuterol in Duchenne and Becker muscular dystrophy.", "pmid_25": 15037714.0, "pmid_date_25": 2004.0, "pmid_journal_25": "Neurology"}, {"pmid_title_26": "New treatment alternatives for Duchenne and Becker muscular dystrophy.", "pmid_26": 15037729.0, "pmid_date_26": 2004.0, "pmid_journal_26": "Neurology"}, {"pmid_title_27": "Becker muscular dystrophy-related cardiomyopathy: a favorable response to medical therapy.", "pmid_27": 11927228.0, "pmid_date_27": 2002.0, "pmid_journal_27": "J Heart Lung Transplant"}, {"pmid_title_28": "Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations.", "pmid_28": 11409421.0, "pmid_date_28": 2001.0, "pmid_journal_28": "Ann Neurol"}, {"pmid_title_29": "Low-dose prednisolone treatment in Duchenne and Becker muscular dystrophy.", "pmid_29": 7633189.0, "pmid_date_29": 1995.0, "pmid_journal_29": "Neuromuscul Disord"}]}, {"_id": "2928-OMIM:310200", "condition": {"condition_name": "MUSCULAR DYSTROPHY, DUCHENNE TYPE", "pattern_of_inheritance": "X-linked recessive", "alternate_names": ["CARDIOMYOPATHY, DILATED, 3B", "MUSCULAR DYSTROPHY, DUCHENNE TYPE", "MUSCULAR DYSTROPHY, BECKER TYPE"]}, "gene information": {"db_hgnc_gene_id": 2928.0}, "interventions": [{"int_description_1": "Invasive ventilation"}, {"int_description_2": "Nocturnal BiPAP (bilevel positive airway pressure)"}, {"int_description_3": "Non-invasive ventilation"}, {"int_description_4": "Subcutaneous defibrillators"}, {"int_description_5": "Ventilation support"}, {"int_description_6": "Protein supplements"}, {"int_description_7": "Ubidecarenone"}, {"int_description_8": "Salbutamol"}, {"int_description_9": "Calcium"}, {"int_description_10": "Prednisolone"}, {"int_description_11": "Prednisone"}, {"int_description_12": "Melatonin"}, {"int_description_13": "Carvedilol"}, {"int_description_14": "Spironolactone"}, {"int_description_15": "Losartan"}, {"int_description_16": "Metoprolol"}, {"int_description_17": "Eplerenone"}, {"int_description_18": "Somatotropin"}, {"int_description_19": "Vitamin D"}, {"int_description_20": "Bisoprolol"}, {"int_description_21": "Amiodarone"}, {"int_description_22": "Ivabradine"}, {"int_description_23": "Valsartan"}, {"int_description_24": "Digoxin"}, {"int_description_25": "Fosinopril"}, {"int_description_26": "Enalapril"}, {"int_description_27": "Lisinopril"}, {"int_description_28": "Perindopril"}, {"int_description_29": "Cilazapril"}, {"int_description_30": "Verapamil"}, {"int_description_31": "Gentamicin", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Tadalafil"}, {"int_description_33": "Givinostat"}, {"int_description_34": "Deflazacort"}, {"int_description_35": "Sacubitril"}, {"int_description_36": "Vitamin E"}, {"int_description_37": "Milrinone"}, {"int_description_38": "Sildenafil"}, {"int_description_39": "Ajmaline"}, {"int_description_40": "Fish oil"}, {"int_description_41": "Ataluren"}, {"int_description_42": "Creatine"}, {"int_description_43": "ACE inhibitors"}, {"int_description_44": "Angiotensin II-receptor blockers (ARBs)"}, {"int_description_45": "Beta blockers"}, {"int_description_46": "Bisphosphonates"}, {"int_description_47": "Corticosteroids"}, {"int_description_48": "Eteplirsen"}, {"int_description_49": "Idebenone"}, {"int_description_50": "Drisapersen", "contra_int50": "No", "qualscale_reclass_drug50": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug50": "Effective / Ameliorative"}, {"int_description_51": "Viltolarsen"}, {"int_description_52": "beta-Hydroxyisovaleric acid"}, {"int_description_53": "Diuretics"}, {"int_description_54": "Multivitamins"}, {"int_description_55": "Ubiquinone"}, {"int_description_56": "Glutathione"}, {"int_description_57": "Beetroot Juice"}, {"int_description_58": "Biventricular pacing"}, {"int_description_59": "Chiropractic treatments"}, {"int_description_60": "Gene-addition therapy"}, {"int_description_61": "Massage"}, {"int_description_62": "Naturopathy"}, {"int_description_63": "Occupational therapy"}, {"int_description_64": "Osteopathy"}, {"int_description_65": "Physical therapy"}, {"int_description_66": "Physiotherapy", "qualscale_reclass_drug66": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug66": "Effective / Ameliorative"}, {"int_description_67": "Allogenic cardiosphere derived cells (CDCs) transplantation"}, {"int_description_68": "Autologous bone marrow mononuclear cells transplantation"}, {"int_description_69": "Posterior spinal fusion to sacrum"}, {"int_description_70": "Scoliosis surgery"}, {"int_description_71": "Tracheotomy"}], "references": [{"pmid_title_1": "Intramuscular blood flow in Duchenne and Becker Muscular Dystrophy: Quantitative power Doppler sonography relates to disease severity.", "pmid_1": 31751835.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Clin Neurophysiol"}, {"pmid_title_2": "Duchenne muscular dystrophy: preliminary experience with sacubitril-valsartan in patients with asymptomatic left ventricular dysfunction.", "pmid_2": 32965001.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Eur Rev Med Pharmacol Sci"}, {"pmid_title_3": "Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial.", "pmid_3": 32453377.0, "pmid_date_3": 2020.0, "pmid_journal_3": "JAMA Neurol"}, {"pmid_title_4": "Current and emerging therapies in Becker muscular dystrophy (BMD).", "pmid_4": 31788661.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Acta Myol"}, {"pmid_title_5": "Therapeutic developments for Duchenne muscular dystrophy.", "pmid_5": 31147635.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Nat Rev Neurol"}, {"pmid_title_6": "Update in Duchenne and Becker muscular dystrophy.", "pmid_6": 31343429.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Curr Opin Neurol"}, {"pmid_title_7": "Cardiac and skeletal muscle effects in the randomized HOPE-Duchenne trial.", "pmid_7": 30674601.0, "pmid_date_7": 2019.0, "pmid_journal_7": "Neurology"}, {"pmid_title_8": "Progressive left ventricular dysfunction and myocardial fibrosis in Duchenne and Becker muscular dystrophy: a longitudinal cardiovascular magnetic resonance study.", "pmid_8": 30564867.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Pediatr Cardiol"}, {"pmid_title_9": "Effect and safety of treatment with ACE-inhibitor Enalapril and \u03b2-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial.", "pmid_9": 31077250.0, "pmid_date_9": 2019.0, "pmid_journal_9": "Orphanet J Rare Dis"}, {"pmid_title_10": "Variability and trends in corticosteroid use by male United States participants with Duchenne muscular dystrophy in the Duchenne Registry.", "pmid_10": 31046703.0, "pmid_date_10": 2019.0, "pmid_journal_10": "BMC Neurol"}, {"pmid_title_11": "Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.", "pmid_11": 30326162.0, "pmid_date_11": 2018.0, "pmid_journal_11": "Cochrane Database Syst Rev"}, {"pmid_title_12": "Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy: A Randomized Clinical Trial.", "pmid_12": 27926769.0, "pmid_date_12": 2017.0, "pmid_journal_12": "JAMA Cardiol"}, {"pmid_title_13": "Cardiac profile of asymptomatic children with Becker and Duchenne muscular dystrophy under treatment with steroids and with/without perindopril.", "pmid_13": 28738778.0, "pmid_date_13": 2017.0, "pmid_journal_13": "BMC Cardiovasc Disord"}, {"pmid_title_14": "Nutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the Conjecture.", "pmid_14": 27834844.0, "pmid_date_14": 2016.0, "pmid_journal_14": "Nutrients"}, {"pmid_title_15": "Physical activity and the use of standard and complementary therapies in Duchenne and Becker muscular dystrophies.", "pmid_15": 26966801.0, "pmid_date_15": 2016.0, "pmid_journal_15": "J Pediatr Rehabil Med"}, {"pmid_title_16": "Histological effects of givinostat in boys with Duchenne muscular dystrophy.", "pmid_16": 27566866.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Neuromuscul Disord"}, {"pmid_title_17": "Cardiac implantable electronic devices in tracheotomized muscular dystrophy patients: Safety and risks.", "pmid_17": 27526372.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Int J Cardiol"}, {"pmid_title_18": "Risk Factors for First Fractures Among Males With Duchenne or Becker Muscular Dystrophy.", "pmid_18": 25379822.0, "pmid_date_18": 2015.0, "pmid_journal_18": "J Pediatr Orthop"}, {"pmid_title_19": "Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial.", "pmid_19": 25907158.0, "pmid_date_19": 2015.0, "pmid_journal_19": "Lancet"}, {"pmid_title_20": "Sildenafil does not improve cardiomyopathy in Duchenne/Becker muscular dystrophy.", "pmid_20": 25042693.0, "pmid_date_20": 2014.0, "pmid_journal_20": "Ann Neurol"}, {"pmid_title_21": "Posterior spinal fusion to sacrum in non-ambulatory hypotonic neuromuscular patients: sacral rod/bone graft onlay method.", "pmid_21": 24728975.0, "pmid_date_21": 2014.0, "pmid_journal_21": "J Child Orthop"}, {"pmid_title_22": "PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy.", "pmid_22": 24808022.0, "pmid_date_22": 2014.0, "pmid_journal_22": "Neurology"}, {"pmid_title_23": "Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy).", "pmid_23": 23601510.0, "pmid_date_23": 2013.0, "pmid_journal_23": "Orphanet J Rare Dis"}, {"pmid_title_24": "Catheter ablation of multiple accessory pathways in duchenne muscular dystrophy.", "pmid_24": 23508228.0, "pmid_date_24": 2013.0, "pmid_journal_24": "Korean Circ J"}, {"pmid_title_25": "A clinical study shows safety and efficacy of autologous bone marrow mononuclear cell therapy to improve quality of life in muscular dystrophy patients.", "pmid_25": 24070109.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Cell Transplant"}, {"pmid_title_26": "Gene therapy for muscular dystrophy: lessons learned and path forward.", "pmid_26": 22609847.0, "pmid_date_26": 2012.0, "pmid_journal_26": "Neurosci Lett"}, {"pmid_title_27": "The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy.", "pmid_27": 22297733.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Osteoporos Int"}, {"pmid_title_28": "Systemic administration of PRO051 in Duchenne's muscular dystrophy.", "pmid_28": 21428760.0, "pmid_date_28": 2011.0, "pmid_journal_28": "N Engl J Med"}, {"pmid_title_29": "Cardiac assessment in duchenne and becker muscular dystrophies.", "pmid_29": 20857240.0, "pmid_date_29": 2010.0, "pmid_journal_29": "Curr Heart Fail Rep"}, {"pmid_title_30": "Read-through strategies for suppression of nonsense mutations in Duchenne/ Becker muscular dystrophy: aminoglycosides and ataluren (PTC124).", "pmid_30": 20519671.0, "pmid_date_30": 2010.0, "pmid_journal_30": "J Child Neurol"}, {"pmid_title_31": "Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy.", "pmid_31": 19432907.0, "pmid_date_31": 2009.0, "pmid_journal_31": "J Am Acad Nurse Pract"}, {"pmid_title_32": "Calcium antagonists for Duchenne muscular dystrophy.", "pmid_32": 18843663.0, "pmid_date_32": 2008.0, "pmid_journal_32": "Cochrane Database Syst Rev"}, {"pmid_title_33": "Local dystrophin restoration with antisense oligonucleotide PRO051.", "pmid_33": 18160687.0, "pmid_date_33": 2007.0, "pmid_journal_33": "N Engl J Med"}, {"pmid_title_34": "Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade.", "pmid_34": 16545568.0, "pmid_date_34": 2006.0, "pmid_journal_34": "Neuromuscul Disord"}, {"pmid_title_35": "Left ventricular hypertrabeculation/noncompaction as a cardiac manifestation of Duchenne muscular dystrophy under non-invasive positive-pressure ventilation.", "pmid_35": 16128380.0, "pmid_date_35": 2005.0, "pmid_journal_35": "Acta Cardiol"}, {"pmid_title_36": "Pilot trial of albuterol in Duchenne and Becker muscular dystrophy.", "pmid_36": 15037714.0, "pmid_date_36": 2004.0, "pmid_journal_36": "Neurology"}, {"pmid_title_37": "New treatment alternatives for Duchenne and Becker muscular dystrophy.", "pmid_37": 15037729.0, "pmid_date_37": 2004.0, "pmid_journal_37": "Neurology"}, {"pmid_title_38": "Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations.", "pmid_38": 11409421.0, "pmid_date_38": 2001.0, "pmid_journal_38": "Ann Neurol"}, {"pmid_title_39": "[Effective milrinone therapy to a Duchenne muscular dystrophy patient with advanced congestive heart failure].", "pmid_39": 10502990.0, "pmid_date_39": 1999.0, "pmid_journal_39": "Rinsho Shinkeigaku"}, {"pmid_title_40": "Low-dose prednisolone treatment in Duchenne and Becker muscular dystrophy.", "pmid_40": 7633189.0, "pmid_date_40": 1995.0, "pmid_journal_40": "Neuromuscul Disord"}]}, {"_id": "29401-OMIM:618116", "condition": {"condition_name": "BONE MARROW FAILURE SYNDROME 4", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["BONE MARROW FAILURE SYNDROME 4"]}, "gene information": {"db_hgnc_gene_id": 29401.0}, "interventions": [{"int_description_1": "Human immunoglobulin G"}, {"int_description_2": "Alemtuzumab"}, {"int_description_3": "Cyclosporine"}, {"int_description_4": "Captopril"}, {"int_description_5": "Trimethoprim"}, {"int_description_6": "Sulfamethoxazole"}, {"int_description_7": "Treosulfan"}, {"int_description_8": "Fludarabine"}, {"int_description_9": "Mycophenolate mofetil"}, {"int_description_10": "Antibiotics"}, {"int_description_11": "Red blood cells transfusion"}, {"int_description_12": "Hematopoietic stem cell transplantation", "timeframe_int12": "Days or Weeks,Years", "age_use_int12": "Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Case report(s)", "rev1_eff_reclass_drug12": "Curative"}], "references": [{"pmid_title_1": "Further delineation of bone marrow failure syndrome caused by novel compound heterozygous variants of MYSM1.", "pmid_1": 32640305.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Gene"}, {"pmid_title_2": "Myb-like, SWIRM, and MPN domains 1 (MYSM1) deficiency: Genotoxic stress-associated bone marrow failure and developmental aberrations.", "pmid_2": 28115216.0, "pmid_date_2": 2017.0, "pmid_journal_2": "J Allergy Clin Immunol"}, {"pmid_title_3": "An in vivo genetic reversion highlights the crucial role of Myb-Like, SWIRM, and MPN domains 1 (MYSM1) in human hematopoiesis and lymphocyte differentiation.", "pmid_3": 26220525.0, "pmid_date_3": 2015.0, "pmid_journal_3": "J Allergy Clin Immunol"}, {"pmid_title_4": "MYSM1 is mutated in a family with transient transfusion-dependent anemia, mild thrombocytopenia, and low NK- and B-cell counts.", "pmid_4": 24288411.0, "pmid_date_4": 2013.0, "pmid_journal_4": "Blood"}]}, {"_id": "29796-OMIM:610798", "condition": {"condition_name": "IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN"]}, "gene information": {"db_hgnc_gene_id": 29796.0}, "interventions": [{"int_description_1": "Low-dose granulocyte colony-stimulating factor (G-CSF) therapy", "timeframe_int1": "Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14.", "pmid_1": 17195838.0, "pmid_date_1": 2007.0, "pmid_journal_1": "Nature medicine"}]}, {"_id": "2995-OMIM:608093", "condition": {"condition_name": "CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J", "MYASTHENIC SYNDROME, CONGENITAL, 13; CMS13"]}, "gene information": {"db_hgnc_gene_id": 2995.0}, "interventions": [{"int_description_1": "Phenobarbital"}], "references": [{"pmid_title_1": "Further Delineation of the Phenotype of Congenital Disorder of Glycosylation DPAGT1-CDG (CDG-Ij) Identified by Homozygosity Mapping.", "pmid_1": 23430862.0, "pmid_date_1": 2011.0, "pmid_journal_1": "JIMD Rep"}]}, {"_id": "2995-OMIM:614750", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 13; CMS13", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 13; CMS13", "CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J"]}, "gene information": {"db_hgnc_gene_id": 2995.0}, "interventions": [{"int_description_1": "Mechanical ventilation"}, {"int_description_2": "Salbutamol"}, {"int_description_3": "Amifampridine"}, {"int_description_4": "Procaine", "timeframe_int4": "Hours,Days or Weeks,Years", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Cohort study or studies", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Procainamide"}, {"int_description_6": "Pyridostigmine"}, {"int_description_7": "Ciprofloxacin"}, {"int_description_8": "Quinidine"}, {"int_description_9": "Chloroquine"}, {"int_description_10": "Phenytoin"}, {"int_description_11": "Beta-blockers"}, {"int_description_12": "Lithium"}, {"int_description_13": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "Congenital Myasthenic Syndromes", "pmid_1": 20301347.0, "pmid_date_1": 2016.0, "pmid_journal_1": "GeneReviews\u00ae"}, {"pmid_title_2": "Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates.", "pmid_2": 22742743.0, "pmid_date_2": 2012.0, "pmid_journal_2": "Am J Hum Genet"}]}, {"_id": "30224-OMIM:614707", "condition": {"condition_name": "BROWN-VIALETTO-VAN LAERE SYNDROME 2", "alternate_names": ["BROWN-VIALETTO-VAN LAERE SYNDROME 2"]}, "gene information": {"db_hgnc_gene_id": 30224.0}, "interventions": [{"int_description_1": "Riboflavin", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Brown-Vialetto-Van Laere syndrome: A rare case report of MND mimic.", "pmid_1": 33109881.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Neurol India"}, {"pmid_title_2": "A Chinese pedigree with Brown-Vialetto-Van Laere syndrome due to two novel mutations of SLC52A2 gene: clinical course and response to riboflavin.", "pmid_2": 31064337.0, "pmid_date_2": 2019.0, "pmid_journal_2": "BMC Med Genet"}, {"pmid_title_3": "Successful treatment of a genetic childhood ataxia due to riboflavin transporter deficiency.", "pmid_3": 30377535.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Cerebellum Ataxias"}, {"pmid_title_4": "Brown-Vialetto-Van Laere Syndrome as a Mimic of Neuroimmune Disorders: 3 Cases From the Clinic and Review of the Literature.", "pmid_4": 28116953.0, "pmid_date_4": 2017.0, "pmid_journal_4": "J Child Neurol"}, {"pmid_title_5": "Exome sequencing results in successful riboflavin treatment of a rapidly progressive neurological condition.", "pmid_5": 27148561.0, "pmid_date_5": 2015.0, "pmid_journal_5": "Cold Spring Harb Mol Case Stud"}, {"pmid_title_6": "Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2.", "pmid_6": 24253200.0, "pmid_date_6": 2014.0, "pmid_journal_6": "Brain"}, {"pmid_title_7": "Mutations in riboflavin transporter present with severe sensory loss and deafness in childhood.", "pmid_7": 24616084.0, "pmid_date_7": 2014.0, "pmid_journal_7": "Muscle Nerve"}, {"pmid_title_8": "Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease.", "pmid_8": 22740598.0, "pmid_date_8": 2012.0, "pmid_journal_8": "Brain"}]}, {"_id": "30228-OMIM:616224", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 22", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 22"]}, "gene information": {"db_hgnc_gene_id": 30228.0}, "interventions": [{"int_description_1": "Mechanical ventilation"}, {"int_description_2": "Nasogastric tube"}, {"int_description_3": "Edrophonium"}, {"int_description_4": "Amifampridine", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Procaine"}, {"int_description_6": "Procainamide"}, {"int_description_7": "Pyridostigmine"}, {"int_description_8": "Ciprofloxacin"}, {"int_description_9": "Quinidine"}, {"int_description_10": "Chloroquine"}, {"int_description_11": "Phenytoin"}, {"int_description_12": "Beta-blockers"}, {"int_description_13": "Lithium"}, {"int_description_14": "Jejunostomy tube feeding"}, {"int_description_15": "Percutaneous endoscopic gastrostomy"}, {"int_description_16": "Strabismus surgery"}], "references": [{"pmid_title_1": "Congenital Myasthenic Syndromes in 2018.", "pmid_1": 29892917.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Current neurology and neuroscience reports"}, {"pmid_title_2": "PREPL deficiency: delineation of the phenotype and development of a functional blood assay.", "pmid_2": 28726805.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Genetics in medicine : official journal of the American College of Medical Genetics"}, {"pmid_title_3": "Congenital Myasthenic Syndromes", "pmid_3": 20301347.0, "pmid_date_3": 2016.0, "pmid_journal_3": "GeneReviews\u00ae"}, {"pmid_title_4": "PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome.", "pmid_4": 24610330.0, "pmid_date_4": 2014.0, "pmid_journal_4": "Neurology"}]}, {"_id": "30260-OMIM:610090", "condition": {"condition_name": "PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY; PNPOD", "freq_per_birth": "Pyridoxal 5'-phosphate-dependent epilepsy is a rare condition; approximately 14 cases have been described in the scientific literature.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY; PNPOD"]}, "gene information": {"db_hgnc_gene_id": 30260.0}, "interventions": [{"int_description_1": "Ketogenic diet"}, {"int_description_2": "Clobazam"}, {"int_description_3": "Clonazepam"}, {"int_description_4": "Topiramate", "timeframe_int4": "Hours", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Cohort study or studies", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Pyridoxal phosphate"}, {"int_description_6": "Midazolam"}, {"int_description_7": "Lidocaine", "timeframe_int7": "Hours", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Cohort study or studies", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Pyridoxine"}, {"int_description_9": "Phenytoin", "timeframe_int9": "Days or Weeks", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Case report(s)", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Riboflavin"}, {"int_description_11": "Chloral hydrate"}, {"int_description_12": "Paraldehyde"}, {"int_description_13": "Benzodiazepine"}, {"int_description_14": "Lorazepam"}, {"int_description_15": "Thiopental"}, {"int_description_16": "Phenobarbital"}, {"int_description_17": "Piracetam"}], "references": [{"pmid_title_1": "Nonketotic Hyperglycinemia", "pmid_1": 20301531.0, "pmid_date_1": 2019.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Pyridoxine-Dependent Epilepsy", "pmid_2": 20301659.0, "pmid_date_2": 2017.0, "pmid_journal_2": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_3": "Systemic Manifestations in Pyridox(am)ine 5'-Phosphate Oxidase Deficiency.", "pmid_3": 28985901.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Pediatric neurology"}, {"pmid_title_4": "Pyridoxine-5'-phosphate oxidase (Pnpo) deficiency: Clinical and biochemical alterations associated with the C.347g>A (P.\u00b7Arg116gln) mutation.", "pmid_4": 28818555.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Molecular genetics and metabolism"}, {"pmid_title_5": "PNPO Deficiency and Cirrhosis: Expanding the Clinical Phenotype?", "pmid_5": 26108646.0, "pmid_date_5": 2016.0, "pmid_journal_5": "JIMD reports"}, {"pmid_title_6": "Pyridox(am)ine-5-Phosphate Oxidase Deficiency Treatable Cause of Neonatal Epileptic Encephalopathy With Burst Suppression: Case Report and Review of the Literature.", "pmid_6": 25296925.0, "pmid_date_6": 2015.0, "pmid_journal_6": "Journal of child neurology"}, {"pmid_title_7": "Normal Cerebrospinal Fluid Pyridoxal 5'-Phosphate Level in a PNPO-Deficient Patient with Neonatal-Onset Epileptic Encephalopathy.", "pmid_7": 25762494.0, "pmid_date_7": 2015.0, "pmid_journal_7": "JIMD reports"}, {"pmid_title_8": "Typical and atypical phenotypes of PNPO deficiency with elevated CSF and plasma pyridoxamine on treatment.", "pmid_8": 24266778.0, "pmid_date_8": 2014.0, "pmid_journal_8": "Developmental medicine and child neurology"}, {"pmid_title_9": "Pyridoxine responsiveness in novel mutations of the PNPO gene.", "pmid_9": 24658933.0, "pmid_date_9": 2014.0, "pmid_journal_9": "Neurology"}, {"pmid_title_10": "Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome.", "pmid_10": 24645144.0, "pmid_date_10": 2014.0, "pmid_journal_10": "Brain : a journal of neurology"}, {"pmid_title_11": "Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5'-phosphate oxidase.", "pmid_11": 15772097.0, "pmid_date_11": 2005.0, "pmid_journal_11": "Human molecular genetics"}]}, {"_id": "30500-OMIM:128200", "condition": {"condition_name": "EPISODIC KINESIGENIC DYSKINESIA 1", "freq_per_birth": "Familial paroxysmal kinesigenic dyskinesia is estimated to occur in 1 in 150,000 individuals. For unknown reasons, this condition affects more males than females.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["SEIZURES, BENIGN FAMILIAL INFANTILE, 2", "EPISODIC KINESIGENIC DYSKINESIA 1", "Familial or sporadic hemiplegic migraine", "CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS"]}, "gene information": {"db_hgnc_gene_id": 30500.0}, "interventions": [{"int_description_1": "Levodopa"}, {"int_description_2": "Clonazepam"}, {"int_description_3": "Baclofen"}, {"int_description_4": "Topiramate"}, {"int_description_5": "Levetiracetam"}, {"int_description_6": "Oxcarbazepine", "timeframe_int6": "Days or Weeks", "age_use_int6": "Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Carbamazepine", "timeframe_int7": "Days or Weeks", "age_use_int7": "Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Gabapentin"}, {"int_description_9": "Acetazolamide"}, {"int_description_10": "Valproic acid"}, {"int_description_11": "Lamotrigine"}, {"int_description_12": "Phenytoin"}], "references": [{"pmid_title_1": "Clinical features of patients with paroxysmal kinesigenic dyskinesia, mutation screening of PRRT2 and the effects of morning draughts of oxcarbazepine.", "pmid_1": 31722684.0, "pmid_date_1": 2019.0, "pmid_journal_1": "BMC Pediatr"}, {"pmid_title_2": "Compound heterozygosity with <i>PRRT2</i>: Pushing the phenotypic envelope in genetic epilepsies.", "pmid_2": 31193310.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Epilepsy Behav Case Rep"}, {"pmid_title_3": "Paroxysmal Dyskinesias.", "pmid_3": 29735119.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Semin Pediatr Neurol"}, {"pmid_title_4": "<i>PRRT2</i>-Associated Paroxysmal Movement Disorders", "pmid_4": 29334453.0, "pmid_date_4": 2018.0, "pmid_journal_4": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_5": "Clinical and genetic features of paroxysmal kinesigenic dyskinesia in Italian patients.", "pmid_5": 26384010.0, "pmid_date_5": 2016.0, "pmid_journal_5": "Eur J Paediatr Neurol"}, {"pmid_title_6": "Novel Locus for Paroxysmal Kinesigenic Dyskinesia Mapped to Chromosome 3q28-29.", "pmid_6": 27173777.0, "pmid_date_6": 2016.0, "pmid_journal_6": "Sci Rep"}, {"pmid_title_7": "Lamotrigine monotherapy for paroxysmal kinesigenic dyskinesia in children.", "pmid_7": 26987034.0, "pmid_date_7": 2016.0, "pmid_journal_7": "Seizure"}, {"pmid_title_8": "Paroxysmal kinesigenic dyskinesia in a patient with a <i>PRRT2</i> mutation and centrotemporal spike discharges on electroencephalogram: case report of a 10-year-old girl.", "pmid_8": 28018471.0, "pmid_date_8": 2016.0, "pmid_journal_8": "Korean J Pediatr"}, {"pmid_title_9": "Five cases of paroxysmal kinesigenic dyskinesia by genetic diagnosis.", "pmid_9": 25667652.0, "pmid_date_9": 2015.0, "pmid_journal_9": "Exp Ther Med"}, {"pmid_title_10": "PRRT2: a major cause of infantile epilepsy and other paroxysmal disorders of childhood.", "pmid_10": 25194488.0, "pmid_date_10": 2014.0, "pmid_journal_10": "Prog Brain Res"}, {"pmid_title_11": "Successful control with carbamazepine of family with paroxysmal kinesigenic dyskinesia of PRRT2 mutation.", "pmid_11": 25520928.0, "pmid_date_11": 2014.0, "pmid_journal_11": "Biomedicine (Taipei)"}, {"pmid_title_12": "Clinical features of childhood-onset paroxysmal kinesigenic dyskinesia with PRRT2 gene mutations.", "pmid_12": 23363396.0, "pmid_date_12": 2013.0, "pmid_journal_12": "Dev Med Child Neurol"}, {"pmid_title_13": "Mutations of proline-rich transmembrane protein-2 and paroxysmal kinesigenic dyskinesia in Taiwan.", "pmid_13": 23436308.0, "pmid_date_13": 2013.0, "pmid_journal_13": "Mov Disord"}, {"pmid_title_14": "Phenotypic overlap among paroxysmal dyskinesia subtypes: Lesson from a family with PRRT2 gene mutation.", "pmid_14": 22902309.0, "pmid_date_14": 2013.0, "pmid_journal_14": "Brain Dev"}]}, {"_id": "30500-OMIM:602066", "condition": {"condition_name": "CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS; ICCA", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2", "CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS; ICCA", "SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2", "EPISODIC KINESIGENIC DYSKINESIA 1; EKD1"]}, "gene information": {"db_hgnc_gene_id": 30500.0}, "interventions": [{"int_description_1": "Levetiracetam"}, {"int_description_2": "Oxcarbazepine", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Carbamazepine", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Valproic acid", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Phenytoin", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Phenobarbital"}], "references": [{"pmid_title_1": "Clinical features of patients with paroxysmal kinesigenic dyskinesia, mutation screening of PRRT2 and the effects of morning draughts of oxcarbazepine.", "pmid_1": 31722684.0, "pmid_date_1": 2019.0, "pmid_journal_1": "BMC Pediatr"}, {"pmid_title_2": "Genetic analysis of benign familial epilepsies in the first year of life in a Chinese cohort.", "pmid_2": 29215089.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Journal of human genetics"}, {"pmid_title_3": "Reduced Penetrance of PRRT2 Mutation in a Chinese Family With Infantile Convulsion and Choreoathetosis Syndrome.", "pmid_3": 25403460.0, "pmid_date_3": 2015.0, "pmid_journal_3": "Journal of child neurology"}, {"pmid_title_4": "PRRT2-related disorders: further PKD and ICCA cases and review of the literature.", "pmid_4": 23299620.0, "pmid_date_4": 2013.0, "pmid_journal_4": "Journal of neurology"}]}, {"_id": "30500-OMIM:605751", "condition": {"condition_name": "SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS; ICCA", "SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2", "MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2", "EPISODIC KINESIGENIC DYSKINESIA 1; EKD1"]}, "gene information": {"db_hgnc_gene_id": 30500.0}, "interventions": [{"int_description_1": "Diazepam", "timeframe_int1": "Days or Weeks", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Midazolam", "timeframe_int2": "Days or Weeks", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Levetiracetam"}, {"int_description_4": "Oxcarbazepine", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Carbamazepine", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Lorazepam"}, {"int_description_7": "Phenobarbital"}], "references": [{"pmid_title_1": "Different experiences of two PRRT2-associated self-limited familial infantile epilepsy.", "pmid_1": 32246320.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Acta neurologica Belgica"}, {"pmid_title_2": "Familial hemiplegic migraine with a PRRT2 mutation: Phenotypic variations and carbamazepine efficacy.", "pmid_2": 31902651.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Brain & development"}, {"pmid_title_3": "<i>PRRT2</i>-Associated Paroxysmal Movement Disorders", "pmid_3": 29334453.0, "pmid_date_3": 2018.0, "pmid_journal_3": "GeneReviews\u00ae"}, {"pmid_title_4": "Compound heterozygosity with <i>PRRT2</i>: Pushing the phenotypic envelope in genetic epilepsies.", "pmid_4": 31193310.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Epilepsy Behav Case Rep"}, {"pmid_title_5": "Clinical and genetic features of paroxysmal kinesigenic dyskinesia in Italian patients.", "pmid_5": 26384010.0, "pmid_date_5": 2016.0, "pmid_journal_5": "European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society"}]}, {"_id": "30500-ORPHA:569", "condition": {"condition_name": "Familial or sporadic hemiplegic migraine", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS", "Familial or sporadic hemiplegic migraine", "SEIZURES, BENIGN FAMILIAL INFANTILE, 2", "EPISODIC KINESIGENIC DYSKINESIA 1"]}, "gene information": {"db_hgnc_gene_id": 30500.0}, "interventions": [{"int_description_1": "Eletriptan"}, {"int_description_2": "Rizatriptan"}, {"int_description_3": "Zolmitriptan"}, {"int_description_4": "Carbamazepine", "timeframe_int4": "Days or Weeks", "age_use_int4": "Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Familial hemiplegic migraine with a PRRT2 mutation: Phenotypic variations and carbamazepine efficacy.", "pmid_1": 31902651.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Brain Dev"}, {"pmid_title_2": "Benefit of carbamazepine in a patient with hemiplegic migraine associated with PRRT2 mutation.", "pmid_2": 24506539.0, "pmid_date_2": 2014.0, "pmid_journal_2": "Dev Med Child Neurol"}]}, {"_id": "30521-OMIM:229050", "condition": {"condition_name": "FOLATE MALABSORPTION, HEREDITARY", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["FOLATE MALABSORPTION, HEREDITARY"]}, "gene information": {"db_hgnc_gene_id": 30521.0}, "interventions": [{"int_description_1": "Leucovorin"}, {"int_description_2": "Levoleucovorin"}, {"int_description_3": "Folic acid"}], "references": [{"pmid_title_1": "Successful Treatment of Hereditary Folate Malabsorption With Intramuscular Folinic Acid.", "pmid_1": 31371121.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Pediatr Neurol"}, {"pmid_title_2": "A deep intronic mutation of c.1166-285\u202fT\u202f>\u202fG in SLC46A1 is shared by four unrelated Japanese patients with hereditary folate malabsorption (HFM).", "pmid_2": 31494288.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Clin Immunol"}, {"pmid_title_3": "Hereditary folate malabsorption due to a mutation in the external gate of the proton-coupled folate transporter SLC46A1.", "pmid_3": 29344585.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Blood Adv"}, {"pmid_title_4": "Role of Intramuscular Levofolinate Administration in the Treatment of Hereditary Folate Malabsorption: Report of Three Cases.", "pmid_4": 28685492.0, "pmid_date_4": 2018.0, "pmid_journal_4": "JIMD Rep"}, {"pmid_title_5": "Hereditary folate malabsorption with a novel mutation on SLC46A1: A case report.", "pmid_5": 29390264.0, "pmid_date_5": 2017.0, "pmid_journal_5": "Medicine (Baltimore)"}, {"pmid_title_6": "The first Chinese case report of hereditary folate malabsorption with a novel mutation on SLC46A1.", "pmid_6": 24534056.0, "pmid_date_6": 2015.0, "pmid_journal_6": "Brain Dev"}, {"pmid_title_7": "A novel deletion mutation in the proton-coupled folate transporter (PCFT; SLC46A1) in a Nicaraguan child with hereditary folate malabsorption.", "pmid_7": 23816405.0, "pmid_date_7": 2013.0, "pmid_journal_7": "Gene"}, {"pmid_title_8": "Identification of novel mutations in the proton-coupled folate transporter (PCFT-SLC46A1) associated with hereditary folate malabsorption.", "pmid_8": 21333572.0, "pmid_date_8": 2011.0, "pmid_journal_8": "Mol Genet Metab"}, {"pmid_title_9": "A novel PCFT gene mutation (p.Cys66LeufsX99) causing hereditary folate malabsorption.", "pmid_9": 20005757.0, "pmid_date_9": 2010.0, "pmid_journal_9": "Mol Genet Metab"}, {"pmid_title_10": "Mutation of the proton-coupled folate transporter gene (PCFT-SLC46A1) in Turkish siblings with hereditary folate malabsorption.", "pmid_10": 20795774.0, "pmid_date_10": 2010.0, "pmid_journal_10": "Pediatr Hematol Oncol"}, {"pmid_title_11": "Functional roles of aspartate residues of the proton-coupled folate transporter (PCFT-SLC46A1); a D156Y mutation causing hereditary folate malabsorption.", "pmid_11": 20805364.0, "pmid_date_11": 2010.0, "pmid_journal_11": "Blood"}]}, {"_id": "3052-OMIM:605676", "condition": {"condition_name": "CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK", "freq_per_birth": "Keratoderma with woolly hair is rare; its prevalence worldwide is unknown.Type I (Naxos disease) was first described in families from the Greek island of Naxos. Since then, affected families have been found in other Greek islands, Turkey, and the Middle East. This form of the condition may affect up to 1 in 1,000 people from the Greek islands.Type II (Carvajal syndrome), type III, and type IV have each been identified in only a small number of families worldwide.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS", "CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK", "KERATOSIS PALMOPLANTARIS STRIATA II; PPKS2", "EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA", "ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8; ARVD8", "CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA"]}, "gene information": {"db_hgnc_gene_id": 3052.0}, "interventions": [{"int_description_1": "Implantable cardioverter-defibrillator", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Still in Trials / Unproven"}, {"int_description_2": "Carvedilol", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Still in Trials / Unproven"}, {"int_description_3": "Metoprolol"}, {"int_description_4": "Nesiritide", "timeframe_int4": "Hours", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "Yes", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Still in Trials / Unproven"}, {"int_description_5": "Amiodarone"}, {"int_description_6": "Ivabradine"}, {"int_description_7": "Digoxin", "timeframe_int7": "Hours", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "Yes", "qualscale_reclass_drug7": "Case report(s)", "rev1_eff_reclass_drug7": "Still in Trials / Unproven"}, {"int_description_8": "Furosemide"}, {"int_description_9": "Enalapril"}, {"int_description_10": "Captopril", "timeframe_int10": "Days or Weeks", "age_use_int10": "Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Case report(s)", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Simvastatin"}, {"int_description_12": "Ubiquinol"}, {"int_description_13": "Qiliqiangxin"}, {"int_description_14": "Intracoronary administration of autologous bone marrow derived mononuclear cells"}, {"int_description_15": "Intracoronary autologous stem cell infusion", "timeframe_int15": "Days or Weeks,Years", "age_use_int15": "Neonate,Infant,Child", "contra_int15": "No", "qualscale_reclass_drug15": "Case report(s)", "rev1_eff_reclass_drug15": "Effective / Ameliorative"}, {"int_description_16": "Transcoronary infusion of cardiac progenitor cells"}, {"int_description_17": "Heart transplantation"}], "references": [{"pmid_title_1": "Novel desmoplakin mutations in familial Carvajal syndrome.", "pmid_1": 30944905.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology"}, {"pmid_title_2": "Arrhythmogenic right ventricular dysplasia, cutaneous manifestations and desmoplakin mutation: Carvajal syndrome.", "pmid_2": 30345701.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Pediatrics international : official journal of the Japan Pediatric Society"}, {"pmid_title_3": "A novel mutation in the desmoplakin gene in two female siblings with a rare form of dilated cardiomyopathy: Carvajal syndrome.", "pmid_3": 29256881.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Anatolian journal of cardiology"}, {"pmid_title_4": "Two Novel Homozygous Desmoplakin Mutations in Carvajal Syndrome.", "pmid_4": 25824144.0, "pmid_date_4": 2015.0, "pmid_journal_4": "Pediatric dermatology"}, {"pmid_title_5": "Arrhythmogenic dilated cardiomyopathy due to a novel mutation in the desmoplakin gene.", "pmid_5": 21193976.0, "pmid_date_5": 2011.0, "pmid_journal_5": "Indian journal of pediatrics"}]}, {"_id": "3052-OMIM:607450", "condition": {"condition_name": "ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8; ARVD8", "freq_per_birth": "ARVC occurs in an estimated 1 in 1,000 to 1 in 1,250 people. This disorder may be underdiagnosed because it can be difficult to detect in people with mild or no symptoms.", "pattern_of_inheritance": "Autosomal dominant==Autosomal recessive", "alternate_names": ["SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS", "ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8; ARVD8", "KERATOSIS PALMOPLANTARIS STRIATA II; PPKS2", "EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA", "CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK", "CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA"]}, "gene information": {"db_hgnc_gene_id": 3052.0}, "interventions": [{"int_description_1": "Implantable cardioverter-defibrillator", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "Yes", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Amiodarone", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "Yes", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Sotalol", "timeframe_int3": "Days or Weeks,Years", "age_use_int3": "Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Angiotensin II type1 receptor blockers monotherapy"}, {"int_description_5": "Angiotensin-converting enzyme (ACE) inhibitor monotherapy"}, {"int_description_6": "Beta-blockers", "timeframe_int6": "Hours,Days or Weeks,Years", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Catheter ablation", "timeframe_int7": "Days or Weeks", "age_use_int7": "Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Heart transplantation"}, {"int_description_9": "Radiofrequency ablation", "timeframe_int9": "Days or Weeks", "age_use_int9": "Child", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An Updated Review of Diagnosis and Management.", "pmid_1": 31616612.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Cureus"}, {"pmid_title_2": "Arrhythmogenic Right Ventricular Cardiomyopathy", "pmid_2": 20301310.0, "pmid_date_2": 2017.0, "pmid_journal_2": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_3": "Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement.", "pmid_3": 26216213.0, "pmid_date_3": 2015.0, "pmid_journal_3": "Circulation"}]}, {"_id": "3052-OMIM:607655", "condition": {"condition_name": "SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8; ARVD8", "SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS", "KERATOSIS PALMOPLANTARIS STRIATA II; PPKS2", "EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA", "CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK", "CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA"]}, "gene information": {"db_hgnc_gene_id": 3052.0}, "interventions": [{"int_description_1": "Urea"}], "references": [{"pmid_title_1": "Novel homozygous mutation in DSP causing skin fragility-woolly hair syndrome: report of a large family and review of the desmoplakin-related phenotypes.", "pmid_1": 20738328.0, "pmid_date_1": 2011.0, "pmid_journal_1": "Clinical genetics"}]}, {"_id": "3052-OMIM:609638", "condition": {"condition_name": "EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8; ARVD8", "EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA", "KERATOSIS PALMOPLANTARIS STRIATA II; PPKS2", "SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS", "CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK", "CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA"]}, "gene information": {"db_hgnc_gene_id": 3052.0}, "interventions": [{"int_description_1": "Morphine"}, {"int_description_2": "Fentanyl"}, {"int_description_3": "Midazolam"}, {"int_description_4": "Albumin human"}, {"int_description_5": "Assisted respiration"}, {"int_description_6": "Feeding per nasogastric tube"}], "references": [{"pmid_title_1": "Loss of desmoplakin tail causes lethal acantholytic epidermolysis bullosa.", "pmid_1": 16175511.0, "pmid_date_1": 2005.0, "pmid_journal_1": "American journal of human genetics"}]}, {"_id": "3052-OMIM:612908", "condition": {"condition_name": "KERATOSIS PALMOPLANTARIS STRIATA II; PPKS2", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8; ARVD8", "KERATOSIS PALMOPLANTARIS STRIATA II; PPKS2", "EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA", "SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS", "CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK", "CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA"]}, "gene information": {"db_hgnc_gene_id": 3052.0}, "interventions": [{"int_description_1": "Retinoids"}, {"int_description_2": "Mechanical debridement"}], "references": [{"pmid_title_1": "Hereditary Palmoplantar Keratoderma: A Practical Approach to the Diagnosis.", "pmid_1": 31334055.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Indian dermatology online journal"}]}, {"_id": "3052-OMIM:615821", "condition": {"condition_name": "CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA", "freq_per_birth": "Keratoderma with woolly hair is rare; its prevalence worldwide is unknown.Type I (Naxos disease) was first described in families from the Greek island of Naxos. Since then, affected families have been found in other Greek islands, Turkey, and the Middle East. This form of the condition may affect up to 1 in 1,000 people from the Greek islands.Type II (Carvajal syndrome), type III, and type IV have each been identified in only a small number of families worldwide.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8; ARVD8", "CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA", "EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA", "SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS", "CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK", "KERATOSIS PALMOPLANTARIS STRIATA II; PPKS2"]}, "gene information": {"db_hgnc_gene_id": 3052.0}, "interventions": [{"int_description_1": "Nesiritide"}, {"int_description_2": "Ivabradine"}, {"int_description_3": "Simvastatin"}, {"int_description_4": "Ubiquinol"}, {"int_description_5": "Qiliqiangxin"}, {"int_description_6": "Intracoronary administration of autologous bone marrow derived mononuclear cells"}, {"int_description_7": "Intracoronary autologous stem cell infusion"}, {"int_description_8": "Transcoronary infusion of cardiac progenitor cells"}, {"int_description_9": "Heart transplantation"}], "references": [{"pmid_title_1": "A new hypo/oligodontia syndrome: Carvajal/Naxos syndrome secondary to desmoplakin-dominant mutations.", "pmid_1": 20940358.0, "pmid_date_1": 2011.0, "pmid_journal_1": "Journal of dental research"}]}, {"_id": "321-OMIM:232400", "condition": {"condition_name": "GLYCOGEN STORAGE DISEASE III; GSD3", "freq_per_birth": "The incidence of GSDIII in the United States is 1 in 100,000 individuals.  This condition is seen more frequently in people of North African Jewish ancestry; in this population, 1 in 5,400 individuals are estimated to be affected.GSDIIIa is the most common form of GSDIII, accounting for about 85 percent of all cases. GSDIIIb accounts for about 15 percent of cases. GSD types IIIc and IIId are very rare, and their signs and symptoms are poorly defined. Only a small number of affected individuals have been suspected to have GSD types IIIc and IIId.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["GLYCOGEN STORAGE DISEASE III; GSD3"]}, "gene information": {"db_hgnc_gene_id": 321.0}, "interventions": [{"int_description_1": "High-protein diet with cornstarch supplementation", "timeframe_int1": "Days or Weeks", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Still in Trials / Unproven"}, {"int_description_2": "Ketogenic diet with cornstarch supplementation"}, {"int_description_3": "Triheptanoin"}, {"int_description_4": "Starch, corn", "timeframe_int4": "Days or Weeks,Years", "age_use_int4": "Infant,Child", "contra_int4": "Yes", "qualscale_reclass_drug4": "Cohort study or studies", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Orthotopic liver transplantation (OLT)"}], "references": [{"pmid_title_1": "Liver transplantation in patients with type IIIa glycogen storage disease, cirrhosis and hepatocellular carcinoma.", "pmid_1": 30318896.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva"}, {"pmid_title_2": "Uniparental isodisomy of chromosome 1 results in glycogen storage disease type III with profound growth retardation.", "pmid_2": 30916492.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Mol Genet Genomic Med"}, {"pmid_title_3": "Modified Atkins ketogenic diet improves heart and skeletal muscle function in glycogen storage disease type III.", "pmid_3": 31309177.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology"}, {"pmid_title_4": "Late presentation of glycogen storage disease types Ia and III in children with short stature and hepatomegaly.", "pmid_4": 29374762.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_5": "Glycogen Storage Disease Type III", "pmid_5": 20301788.0, "pmid_date_5": 2016.0, "pmid_journal_5": "GeneReviews\u00ae"}, {"pmid_title_6": "Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome.", "pmid_6": 27106217.0, "pmid_date_6": 2016.0, "pmid_journal_6": "J Inherit Metab Dis"}, {"pmid_title_7": "The effect of tailoring of cornstarch intake on stature in children with glycogen storage disease type III.", "pmid_7": 25153581.0, "pmid_date_7": 2015.0, "pmid_journal_7": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_8": "Improvement of Cardiomyopathy After High-Fat Diet in Two Siblings with Glycogen Storage Disease Type III.", "pmid_8": 25308556.0, "pmid_date_8": 2014.0, "pmid_journal_8": "JIMD Rep"}, {"pmid_title_9": "Glycogen storage disease type III: modified Atkins diet improves myopathy.", "pmid_9": 25431232.0, "pmid_date_9": 2014.0, "pmid_journal_9": "Orphanet J Rare Dis"}, {"pmid_title_10": "Successful treatment of severe cardiomyopathy in glycogen storage disease type III With D,L-3-hydroxybutyrate, ketogenic and high-protein diet.", "pmid_10": 21857385.0, "pmid_date_10": 2011.0, "pmid_journal_10": "Pediatric research"}, {"pmid_title_11": "Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet.", "pmid_11": 19322675.0, "pmid_date_11": 2009.0, "pmid_journal_11": "J Inherit Metab Dis"}, {"pmid_title_12": "Liver transplantation in children with glycogen storage disease: controversies and evaluation of the risk/benefit of this procedure.", "pmid_12": 18307661.0, "pmid_date_12": 2008.0, "pmid_journal_12": "Pediatric transplantation"}, {"pmid_title_13": "Long-term results of living donor liver transplantation for glycogen storage disorders in children.", "pmid_13": 17539004.0, "pmid_date_13": 2007.0, "pmid_journal_13": "Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society"}, {"pmid_title_14": "Liver transplantation for glycogen storage disease types I, III, and IV.", "pmid_14": 10603098.0, "pmid_date_14": 1999.0, "pmid_journal_14": "Eur J Pediatr"}, {"pmid_title_15": "Nutrition therapy for hepatic glycogen storage diseases.", "pmid_15": 8245377.0, "pmid_date_15": 1993.0, "pmid_journal_15": "Journal of the American Dietetic Association"}, {"pmid_title_16": "Efficacy of cornstarch therapy in type III glycogen-storage disease.", "pmid_16": 2403059.0, "pmid_date_16": 1990.0, "pmid_journal_16": "The American journal of clinical nutrition"}, {"pmid_title_17": "Cornstarch therapy in a patient with type III glycogen storage disease.", "pmid_17": 3480949.0, "pmid_date_17": 1987.0, "pmid_journal_17": "Journal of pediatric gastroenterology and nutrition"}, {"pmid_title_18": "Reversal of debrancher deficiency myopathy by the use of high-protein nutrition.", "pmid_18": 7049057.0, "pmid_date_18": 1982.0, "pmid_journal_18": "Annals of neurology"}]}, {"_id": "3255-OMIM:226980", "condition": {"condition_name": "EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS"]}, "gene information": {"db_hgnc_gene_id": 3255.0}, "interventions": [{"int_description_1": "Ornithine"}, {"int_description_2": "Insulin human", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Cohort study or studies", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Insulin glargine"}, {"int_description_4": "Insulin aspart"}, {"int_description_5": "Vitamin D"}, {"int_description_6": "Iron"}, {"int_description_7": "Glutathione"}, {"int_description_8": "Hemodialysis"}, {"int_description_9": "En bloc combined liver and pancreas transplant (Liver transplantation)"}, {"int_description_10": "En bloc combined liver and pancreas transplant (Pancreas transplantation)"}, {"int_description_11": "En bloc combined liver, pancreas and double kidney transplant (Double kidney transplantation)"}, {"int_description_12": "En bloc combined liver, pancreas and double kidney transplant (Liver transplantation)"}, {"int_description_13": "En bloc combined liver, pancreas and double kidney transplant (Pancreas transplantation)"}, {"int_description_14": "Orthotopic liver transplantation (OLT)"}], "references": [{"pmid_title_1": "Diabetes management in Wolcott-Rallison syndrome: analysis from the German/Austrian DPV database.", "pmid_1": 32321554.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Orphanet J Rare Dis"}, {"pmid_title_2": "Practical management in Wolcott-Rallison syndrome with associated hypothyroidism, neutropenia, and recurrent liver failure: A case report.", "pmid_2": 31183082.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Clin Case Rep"}, {"pmid_title_3": "Wolcott-Rallison syndrome due to the same mutation in EIF2AK3 (c.205G>T) in two unrelated families: A case report.", "pmid_3": 30906465.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Exp Ther Med"}, {"pmid_title_4": "World's smallest combined en bloc liver-pancreas transplantation.", "pmid_4": 29139617.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Pediatr Transplant"}, {"pmid_title_5": "Wolcott-Rallison Syndrome With Different Clinical Presentations and Genetic Patterns in 2 Infants.", "pmid_5": 30234637.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Health Care Manag (Frederick)"}, {"pmid_title_6": "Recent advances in liver transplantation for metabolic disease.", "pmid_6": 28168361.0, "pmid_date_6": 2017.0, "pmid_journal_6": "J Inherit Metab Dis"}, {"pmid_title_7": "Ketoacidosis in Neonatal Diabetes Mellitus, Part of Wolcott-Rallison Syndrome.", "pmid_7": 28652565.0, "pmid_date_7": 2017.0, "pmid_journal_7": "Am J Case Rep"}, {"pmid_title_8": "En bloc multiorgan transplant (liver, pancreas, and kidney) for acute liver and renal failure in a patient with Wolcott-Rallison syndrome.", "pmid_8": 26784269.0, "pmid_date_8": 2016.0, "pmid_journal_8": "Liver Transpl"}, {"pmid_title_9": "Liver, pancreas and kidney transplantation for the treatment of Wolcott-Rallison syndrome.", "pmid_9": 25384546.0, "pmid_date_9": 2015.0, "pmid_journal_9": "Am J Transplant"}, {"pmid_title_10": "Liver disease and other comorbidities in Wolcott-Rallison syndrome: different phenotype and variable associations in a large cohort.", "pmid_10": 25659842.0, "pmid_date_10": 2015.0, "pmid_journal_10": "Horm Res Paediatr"}, {"pmid_title_11": "EIF2AK3 mutations in South Indian children with permanent neonatal diabetes mellitus associated with Wolcott-Rallison syndrome.", "pmid_11": 24168455.0, "pmid_date_11": 2014.0, "pmid_journal_11": "Pediatr Diabetes"}, {"pmid_title_12": "Wolcott-Rallison syndrome due to a novel mutation (R491X) in EIF2AK3 gene.", "pmid_12": 22672868.0, "pmid_date_12": 2012.0, "pmid_journal_12": "J Clin Res Pediatr Endocrinol"}]}, {"_id": "329-OMIM:615120", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 8", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 8", "MYASTHENIC SYNDROME, CONGENITAL, 19"]}, "gene information": {"db_hgnc_gene_id": 329.0}, "interventions": [{"int_description_1": "Mechanical ventilation", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Ephedrine", "timeframe_int2": "Days or Weeks,Years", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Salbutamol"}, {"int_description_4": "Amifampridine"}, {"int_description_5": "Procaine"}, {"int_description_6": "Procainamide"}, {"int_description_7": "Pyridostigmine"}, {"int_description_8": "Ciprofloxacin"}, {"int_description_9": "Quinidine"}, {"int_description_10": "Chloroquine"}, {"int_description_11": "Phenytoin"}, {"int_description_12": "Acetylcholinesterase inhibitors"}, {"int_description_13": "Beta-blockers"}, {"int_description_14": "Lithium"}, {"int_description_15": "\u03b22-receptor agonist"}, {"int_description_16": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "The congenital myasthenic syndromes: expanding genetic and phenotypic spectrums and refining treatment strategies.", "pmid_1": 31361628.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Current opinion in neurology"}, {"pmid_title_2": "Novel SEA and LG2 Agrin mutations causing congenital Myasthenic syndrome.", "pmid_2": 29258548.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Orphanet journal of rare diseases"}, {"pmid_title_3": "A Novel Missense Variant in the AGRN Gene; Congenital Myasthenic Syndrome Presenting With Head Drop.", "pmid_3": 28221305.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Journal of clinical neuromuscular disease"}, {"pmid_title_4": "Congenital Myasthenic Syndromes", "pmid_4": 20301347.0, "pmid_date_4": 2016.0, "pmid_journal_4": "GeneReviews\u00ae"}, {"pmid_title_5": "Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy.", "pmid_5": 24951643.0, "pmid_date_5": 2014.0, "pmid_journal_5": "Brain : a journal of neurology"}]}, {"_id": "3309-OMIM:162800", "condition": {"condition_name": "CYCLIC NEUTROPENIA", "freq_per_birth": "Cyclic neutropenia is a rare condition and is estimated to occur in 1 in 1 million individuals worldwide.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["CYCLIC NEUTROPENIA", "NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT; SCN1"]}, "gene information": {"db_hgnc_gene_id": 3309.0}, "interventions": [{"int_description_1": "Recombinant human granulocyte colony-stimulating factor", "timeframe_int1": "Hours,Days or Weeks,Years", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Treatment of cyclic neutropenia with granulocyte colony-stimulating factor.", "pmid_1": 2469956.0, "pmid_date_1": 1989.0, "pmid_journal_1": "The New England journal of medicine"}]}, {"_id": "3309-OMIM:202700", "condition": {"condition_name": "NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT; SCN1", "freq_per_birth": "The incidence of severe congenital neutropenia is estimated to be 1 in 200,000 individuals.", "pattern_of_inheritance": "X-linked recessive==Autosomal dominant==Autosomal recessive", "alternate_names": ["NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT; SCN1", "CYCLIC NEUTROPENIA"]}, "gene information": {"db_hgnc_gene_id": 3309.0}, "interventions": [{"int_description_1": "Hematopoietic stem cell transplantation", "timeframe_int1": "Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Hematopoietic stem cell transplantation for severe congenital neutropenia.", "pmid_1": 22080845.0, "pmid_date_1": 2012.0, "pmid_journal_1": "Current opinion in hematology"}]}, {"_id": "3356-OMIM:208000", "condition": {"condition_name": "ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1", "freq_per_birth": "The prevalence of GACI has been estimated to be about 1 in 391,000. At least 200 affected individuals have been described in the medical literature.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1", "HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2"]}, "gene information": {"db_hgnc_gene_id": 3356.0}, "interventions": [{"int_description_1": "Dopamine"}, {"int_description_2": "Alprostadil"}, {"int_description_3": "Ergocalciferol"}, {"int_description_4": "Alfacalcidol"}, {"int_description_5": "Propranolol"}, {"int_description_6": "Amlodipine"}, {"int_description_7": "Etidronic acid", "timeframe_int7": "Days or Weeks,Years", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Vitamin D"}, {"int_description_9": "Calcitriol", "timeframe_int9": "Hours", "age_use_int9": "Neonate,Infant", "contra_int9": "No", "qualscale_reclass_drug9": "Cohort study or studies", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Valsartan"}, {"int_description_11": "Digoxin"}, {"int_description_12": "Furosemide"}, {"int_description_13": "Clodronic acid", "timeframe_int13": "Hours,Days or Weeks,Years", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Hydralazine"}, {"int_description_15": "Enalapril", "timeframe_int15": "Days or Weeks", "age_use_int15": "Neonate,Infant,Child", "contra_int15": "Yes", "qualscale_reclass_drug15": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug15": "Effective / Ameliorative"}, {"int_description_16": "Lisinopril"}, {"int_description_17": "Captopril"}, {"int_description_18": "Pamidronic acid", "timeframe_int18": "Hours,Days or Weeks,Years", "age_use_int18": "Infant,Child", "contra_int18": "No", "qualscale_reclass_drug18": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug18": "Effective / Ameliorative"}, {"int_description_19": "Risedronic acid"}, {"int_description_20": "Acetylsalicylic acid"}, {"int_description_21": "Phosphorus"}, {"int_description_22": "Phenobarbital"}, {"int_description_23": "Oxygen"}, {"int_description_24": "Assisted respiration"}], "references": [{"pmid_title_1": "Generalized Arterial Calcification of Infancy", "pmid_1": 25392903.0, "pmid_date_1": 2020.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Novel homozygous ENPP1 mutation causes generalized arterial calcifications of infancy, thrombocytopenia, and cardiovascular and central nervous system syndrome.", "pmid_2": 31444901.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Am J Med Genet A"}, {"pmid_title_3": "Generalized arterial calcification of infancy with a novel ENPP1 mutation: a case report.", "pmid_3": 29976176.0, "pmid_date_3": 2018.0, "pmid_journal_3": "BMC Pediatr"}, {"pmid_title_4": "Inherited Arterial Calcification Syndromes: Etiologies and Treatment Concepts.", "pmid_4": 28585220.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Curr Osteoporos Rep"}, {"pmid_title_5": "Effects of Different Variants in the ENPP1 Gene on the Functional Properties of Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 1.", "pmid_5": 27467858.0, "pmid_date_5": 2016.0, "pmid_journal_5": "Hum Mutat"}, {"pmid_title_6": "Two newborn babies with generalized arterial calcification of infancy, two new mutations.", "pmid_6": 28276217.0, "pmid_date_6": 2016.0, "pmid_journal_6": "Turk J Pediatr"}, {"pmid_title_7": "Treatment of hypophosphatemic rickets in generalized arterial calcification of infancy (GACI) without worsening of vascular calcification.", "pmid_7": 26857895.0, "pmid_date_7": 2016.0, "pmid_journal_7": "Am J Med Genet A"}, {"pmid_title_8": "Hypophosphatemic rickets developed after treatment with etidronate disodium in a patient with generalized arterial calcification in infancy.", "pmid_8": 28377967.0, "pmid_date_8": 2015.0, "pmid_journal_8": "Bone Rep"}, {"pmid_title_9": "Molecular diagnosis of generalized arterial calcification of infancy (GACI).", "pmid_9": 22629037.0, "pmid_date_9": 2012.0, "pmid_journal_9": "J Cardiovasc Dis Res"}, {"pmid_title_10": "Efficacy and safety of 2-year etidronate treatment in a child with generalized arterial calcification of infancy.", "pmid_10": 21932012.0, "pmid_date_10": 2011.0, "pmid_journal_10": "Eur J Pediatr"}, {"pmid_title_11": "Generalized Arterial Calcification of Infancy: Fatal Clinical Course Associated with a Novel Mutation in ENPP1.", "pmid_11": 23430823.0, "pmid_date_11": 2011.0, "pmid_journal_11": "JIMD Rep"}, {"pmid_title_12": "Generalized arterial calcification of infancy: treatment with bisphosphonates.", "pmid_12": 19229237.0, "pmid_date_12": 2009.0, "pmid_journal_12": "Nat Clin Pract Endocrinol Metab"}, {"pmid_title_13": "Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy.", "pmid_13": 20016754.0, "pmid_date_13": 2008.0, "pmid_journal_13": "Circ Cardiovasc Genet"}, {"pmid_title_14": "Generalized arterial calcification of infancy: two siblings with prolonged survival.", "pmid_14": 16315058.0, "pmid_date_14": 2006.0, "pmid_journal_14": "Eur J Pediatr"}, {"pmid_title_15": "Generalized arterial calcification of infancy: different clinical courses in two affected siblings.", "pmid_15": 15940697.0, "pmid_date_15": 2005.0, "pmid_journal_15": "Am J Med Genet A"}, {"pmid_title_16": "Idiopathic arterial calcification of infancy: effectiveness of prostaglandin infusion for treatment of secondary hypertension refractory to conventional therapy: case report.", "pmid_16": 8960499.0, "pmid_date_16": 1997.0, "pmid_journal_16": "Pediatr Cardiol"}]}, {"_id": "3436-OMIM:278760", "condition": {"condition_name": "XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F", "freq_per_birth": "Xeroderma pigmentosum is a rare disorder; it is estimated to affect about 1 in 1 million people in the United States and Europe. The condition is more common in Japan, North Africa, and the Middle East.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F", "FANCONI ANEMIA, COMPLEMENTATION GROUP Q"]}, "gene information": {"db_hgnc_gene_id": 3436.0}, "interventions": [{"int_description_1": "Feeding tubes"}, {"int_description_2": "Hearing aids"}, {"int_description_3": "Tizanidine"}, {"int_description_4": "Levodopa"}, {"int_description_5": "Baclofen", "timeframe_int5": "Days or Weeks,Years", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Isotretinoin"}, {"int_description_7": "Vitamin D"}, {"int_description_8": "Fluorouracil"}, {"int_description_9": "Carbidopa"}, {"int_description_10": "Imiquimod"}, {"int_description_11": "Botulinum toxin type A"}, {"int_description_12": "A liposome lotion containing prokaryotic DNA repair enzyme (bacteriophage T4 endonuclease V)"}, {"int_description_13": "Botulinum toxin"}, {"int_description_14": "Interferon alfa"}, {"int_description_15": "Nitrogen"}, {"int_description_16": "Aggressive dental care"}, {"int_description_17": "Avoid sun and other UV exposure", "timeframe_int17": "Hours", "age_use_int17": "Neonate,Infant,Child", "contra_int17": "No", "qualscale_reclass_drug17": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug17": "Effective / Ameliorative"}, {"int_description_18": "Cochlear implants"}, {"int_description_19": "Curettage"}, {"int_description_20": "Dermabrasion"}, {"int_description_21": "Developmental preschool"}, {"int_description_22": "Dorsiflexion exercise"}, {"int_description_23": "Educational activities"}, {"int_description_24": "Electrochemotherapy"}, {"int_description_25": "Electrodesiccation"}, {"int_description_26": "Hearing aids"}, {"int_description_27": "Heel cord lengthening procedures"}, {"int_description_28": "Massage"}, {"int_description_29": "Occupational, physical, speech, and feeding therapy"}, {"int_description_30": "Orthopedic procedures"}, {"int_description_31": "Parent-child swimming from infancy and childhood"}, {"int_description_32": "Physiotherapy"}, {"int_description_33": "Practice stretching"}, {"int_description_34": "Therapeutic dermatome shaving"}, {"int_description_35": "Whole\u2010body exercise"}, {"int_description_36": "Corneal transplantation"}, {"int_description_37": "Mohs micrographic surgery"}, {"int_description_38": "Surgery to remove the opaque lens"}, {"int_description_39": "Surgical excision"}], "references": [{"pmid_title_1": "Cockayne Syndrome", "pmid_1": 30252254.0, "pmid_date_1": 2021.0, "pmid_journal_1": "statpearls"}, {"pmid_title_2": "Cockayne Syndrome", "pmid_2": 20301516.0, "pmid_date_2": 2019.0, "pmid_journal_2": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_3": "Xeroderma pigmentosum-Cockayne syndrome complex.", "pmid_3": 28376890.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Orphanet J Rare Dis"}, {"pmid_title_4": "Xeroderma pigmentosum clinical practice guidelines.", "pmid_4": 28771907.0, "pmid_date_4": 2017.0, "pmid_journal_4": "J Dermatol"}, {"pmid_title_5": "Xeroderma Pigmentosum", "pmid_5": 20301571.0, "pmid_date_5": 2016.0, "pmid_journal_5": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_6": "Development of effective skin cancer treatment and prevention in xeroderma pigmentosum.", "pmid_6": 25382223.0, "pmid_date_6": 2015.0, "pmid_journal_6": "Photochem Photobiol"}, {"pmid_title_7": "Excellent response of basal cell carcinomas and pigmentary changes in xeroderma pigmentosum to imiquimod 5% cream.", "pmid_7": 14616381.0, "pmid_date_7": 2003.0, "pmid_journal_7": "Br J Dermatol"}, {"pmid_title_8": "Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group.", "pmid_8": 11289350.0, "pmid_date_8": 2001.0, "pmid_journal_8": "Lancet"}, {"pmid_title_9": "Clearing of melanoma in situ with intralesional interferon alfa in a patient with xeroderma pigmentosum.", "pmid_9": 7986121.0, "pmid_date_9": 1994.0, "pmid_journal_9": "Arch Dermatol"}, {"pmid_title_10": "Prevention of skin cancer in xeroderma pigmentosum with oral isotretinoin.", "pmid_10": 2721244.0, "pmid_date_10": 1989.0, "pmid_journal_10": "Cutis"}]}, {"_id": "3436-OMIM:615272", "condition": {"condition_name": "FANCONI ANEMIA, COMPLEMENTATION GROUP Q", "alternate_names": ["FANCONI ANEMIA, COMPLEMENTATION GROUP Q", "XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F"]}, "gene information": {"db_hgnc_gene_id": 3436.0}, "interventions": [{"int_description_1": "Healthy diet"}, {"int_description_2": "Oxandrolone"}, {"int_description_3": "Danazol"}, {"int_description_4": "Testosterone propionate"}, {"int_description_5": "Oxymetholone"}, {"int_description_6": "Metenolone"}, {"int_description_7": "Calcium"}, {"int_description_8": "Prednisone"}, {"int_description_9": "Dexamethasone"}, {"int_description_10": "Insulin aspart"}, {"int_description_11": "Medroxyprogesterone acetate"}, {"int_description_12": "Tretinoin"}, {"int_description_13": "Eltrombopag"}, {"int_description_14": "Levothyroxine"}, {"int_description_15": "Estradiol"}, {"int_description_16": "Cetuximab"}, {"int_description_17": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_18": "Alemtuzumab"}, {"int_description_19": "Coenzyme M"}, {"int_description_20": "Cyclosporine"}, {"int_description_21": "Dactinomycin"}, {"int_description_22": "Sirolimus"}, {"int_description_23": "Somatotropin"}, {"int_description_24": "Vitamin D"}, {"int_description_25": "Cyclophosphamide"}, {"int_description_26": "Carboplatin"}, {"int_description_27": "Busulfan"}, {"int_description_28": "Ifosfamide"}, {"int_description_29": "Thiotepa"}, {"int_description_30": "Doxorubicin"}, {"int_description_31": "Fluorouracil", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Mercaptopurine", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Neonate,Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Trimethoprim"}, {"int_description_34": "Sulfamethoxazole"}, {"int_description_35": "Gemcitabine"}, {"int_description_36": "Vincristine"}, {"int_description_37": "Methotrexate"}, {"int_description_38": "Fludarabine"}, {"int_description_39": "Cytarabine"}, {"int_description_40": "Irinotecan"}, {"int_description_41": "Daunorubicin"}, {"int_description_42": "Etoposide"}, {"int_description_43": "Idarubicin"}, {"int_description_44": "Tacrolimus"}, {"int_description_45": "Acyclovir"}, {"int_description_46": "Quercetin"}, {"int_description_47": "Tioguanine"}, {"int_description_48": "Mycophenolate mofetil"}, {"int_description_49": "Tranexamic acid"}, {"int_description_50": "Hydroxyurea"}, {"int_description_51": "Methylprednisolone"}, {"int_description_52": "Methyltestosterone"}, {"int_description_53": "Leucovorin"}, {"int_description_54": "Vinorelbine"}, {"int_description_55": "Deferasirox"}, {"int_description_56": "Deferiprone"}, {"int_description_57": "Co-trimoxazole"}, {"int_description_58": "Asparaginase Escherichia coli"}, {"int_description_59": "Cisplatin"}, {"int_description_60": "Antilymphocyte immunoglobulin (horse)"}, {"int_description_61": "Norethandrolone"}, {"int_description_62": "Phosphorus"}, {"int_description_63": "GM-CSF (granulocyte-macrophage colony-stimulating factor)"}, {"int_description_64": "rh-SOD"}, {"int_description_65": "Bevacizumab"}, {"int_description_66": "Filgrastim"}, {"int_description_67": "Amifostine"}, {"int_description_68": "Radiation therapy", "timeframe_int68": "Days or Weeks,Years", "age_use_int68": "Child", "contra_int68": "No", "qualscale_reclass_drug68": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug68": "Effective / Ameliorative"}, {"int_description_69": "Total abdominal radiation"}, {"int_description_70": "Total body irradiation"}, {"int_description_71": "Total lymphoid irradiation"}, {"int_description_72": "Transfusion of blood products"}, {"int_description_73": "Bone marrow transplantation"}, {"int_description_74": "Hematopoietic stem cell transplantation"}, {"int_description_75": "Surgery for polydactyly, carpectomy"}, {"int_description_76": "Surgical intervention"}, {"int_description_77": "\u042burgical tumor removement"}], "references": [{"pmid_title_1": "Gingival Bleeding in a Child with Fanconi Anemia: A Case Report and Literature Review.", "pmid_1": 32231808.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Case Rep Dent"}, {"pmid_title_2": "Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.", "pmid_2": 29668547.0, "pmid_date_2": 2019.0, "pmid_journal_2": "J Pediatr Hematol Oncol"}, {"pmid_title_3": "Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.", "pmid_3": 31192125.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Front Oncol"}, {"pmid_title_4": "Fanconi anemia: a single center experience of a large cohort.", "pmid_4": 31990462.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Turk J Pediatr"}, {"pmid_title_5": "Therapeutic research in the crystal chromosome disease Fanconi anemia.", "pmid_5": 30389152.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Mutat Res Genet Toxicol Environ Mutagen"}, {"pmid_title_6": "Oral cancer in Fanconi anemia: Review of 121 cases.", "pmid_6": 29650274.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Crit Rev Oncol Hematol"}, {"pmid_title_7": "Essential Role of BRCA2 in Ovarian Development and Function.", "pmid_7": 30207912.0, "pmid_date_7": 2018.0, "pmid_journal_7": "N Engl J Med"}, {"pmid_title_8": "Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.", "pmid_8": 29203412.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Biol Blood Marrow Transplant"}, {"pmid_title_9": "How I manage patients with Fanconi anaemia.", "pmid_9": 28474441.0, "pmid_date_9": 2017.0, "pmid_journal_9": "Br J Haematol"}, {"pmid_title_10": "Eltrombopag for the treatment of aplastic anemia: current perspectives.", "pmid_10": 27695288.0, "pmid_date_10": 2016.0, "pmid_journal_10": "Drug Des Devel Ther"}, {"pmid_title_11": "Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.", "pmid_11": 27246371.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Biol Blood Marrow Transplant"}, {"pmid_title_12": "Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.", "pmid_12": 26900943.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Pediatr Hematol Oncol"}, {"pmid_title_13": "Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.", "pmid_13": 26657402.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Eur J Med Genet"}, {"pmid_title_14": "Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.", "pmid_14": 25575015.0, "pmid_date_14": 2015.0, "pmid_journal_14": "J Clin Endocrinol Metab"}, {"pmid_title_15": "Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.", "pmid_15": 25862235.0, "pmid_date_15": 2015.0, "pmid_journal_15": "Ann Hematol"}, {"pmid_title_16": "Alternative donor hematopoietic cell transplantation for Fanconi anemia.", "pmid_16": 25824692.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Blood"}, {"pmid_title_17": "Fanconi anemia and solid malignancies in childhood: a national retrospective study.", "pmid_17": 25381700.0, "pmid_date_17": 2015.0, "pmid_journal_17": "Pediatr Blood Cancer"}, {"pmid_title_18": "Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.", "pmid_18": 25531282.0, "pmid_date_18": 2015.0, "pmid_journal_18": "Bone Marrow Transplant"}, {"pmid_title_19": "Clear cell sarcoma of the kidney in a child with Fanconi anemia.", "pmid_19": 24735155.0, "pmid_date_19": 2014.0, "pmid_journal_19": "Pediatr Dev Pathol"}, {"pmid_title_20": "Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.", "pmid_20": 25085358.0, "pmid_date_20": 2014.0, "pmid_journal_20": "Haematologica"}, {"pmid_title_21": "Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.", "pmid_21": 24019220.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Management of dental extraction in a female patient with fanconi anemia.", "pmid_22": 25628690.0, "pmid_date_22": 2014.0, "pmid_journal_22": "J Dent (Tehran)"}, {"pmid_title_23": "Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature.", "pmid_23": 22965917.0, "pmid_date_23": 2013.0, "pmid_journal_23": "Head Neck"}, {"pmid_title_24": "Deferasirox therapy in children with Fanconi aplastic anemia.", "pmid_24": 22510772.0, "pmid_date_24": 2012.0, "pmid_journal_24": "J Pediatr Hematol Oncol"}, {"pmid_title_25": "Fatal course of tonsillar squamous cell carcinoma associated with Fanconi anaemia: a mini review.", "pmid_25": 21925890.0, "pmid_date_25": 2012.0, "pmid_journal_25": "J Craniomaxillofac Surg"}, {"pmid_title_26": "Treatment of the bone marrow failure in Fanconi anemia patients with danazol.", "pmid_26": 22178060.0, "pmid_date_26": 2012.0, "pmid_journal_26": "Blood Cells Mol Dis"}, {"pmid_title_27": "Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing.", "pmid_27": 21519011.0, "pmid_date_27": 2011.0, "pmid_journal_27": "J Clin Oncol"}, {"pmid_title_28": "Successful treatment of esophageal squamous cell carcinoma in a patient with Fanconi anemia.", "pmid_28": 20410055.0, "pmid_date_28": 2010.0, "pmid_journal_28": "Jpn J Clin Oncol"}, {"pmid_title_29": "Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.", "pmid_29": 19564748.0, "pmid_date_29": 2009.0, "pmid_journal_29": "J Pediatr Hematol Oncol"}, {"pmid_title_30": "Treatment with deferiprone for iron overload alleviates bone marrow failure in a Fanconi anemia patient.", "pmid_30": 19814681.0, "pmid_date_30": 2009.0, "pmid_journal_30": "Hemoglobin"}, {"pmid_title_31": "Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.", "pmid_31": 18302713.0, "pmid_date_31": 2008.0, "pmid_journal_31": "Br J Haematol"}, {"pmid_title_32": "Thrombocytopenia in the neonate.", "pmid_32": 18433954.0, "pmid_date_32": 2008.0, "pmid_journal_32": "Blood Rev"}, {"pmid_title_33": "Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.", "pmid_33": 18379369.0, "pmid_date_33": 2008.0, "pmid_journal_33": "J Thorac Oncol"}, {"pmid_title_34": "Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function.", "pmid_34": 18623197.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Pediatr Blood Cancer"}, {"pmid_title_35": "Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.", "pmid_35": 18831513.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Cancer"}, {"pmid_title_36": "Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.", "pmid_36": 17950918.0, "pmid_date_36": 2007.0, "pmid_journal_36": "Biol Blood Marrow Transplant"}, {"pmid_title_37": "Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.", "pmid_37": 17038525.0, "pmid_date_37": 2007.0, "pmid_journal_37": "Blood"}, {"pmid_title_38": "Chemotherapy for myeloid malignancy in children with Fanconi anemia.", "pmid_38": 16609946.0, "pmid_date_38": 2007.0, "pmid_journal_38": "Pediatr Blood Cancer"}, {"pmid_title_39": "A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.", "pmid_39": 17096012.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Leukemia"}, {"pmid_title_40": "HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.", "pmid_40": 18022575.0, "pmid_date_40": 2007.0, "pmid_journal_40": "Biol Blood Marrow Transplant"}, {"pmid_title_41": "Anesthesia and Fanconi anemia: a case report and review of literature.", "pmid_41": 16918663.0, "pmid_date_41": 2006.0, "pmid_journal_41": "Paediatr Anaesth"}, {"pmid_title_42": "Squamous cell carcinoma of the hypopharynx in a young woman with Fanconi's anemia.", "pmid_42": 17308840.0, "pmid_date_42": 2006.0, "pmid_journal_42": "Braz J Otorhinolaryngol"}, {"pmid_title_43": "Squamous cell vulvar carcinoma associated with Fanconi's anemia: a case report.", "pmid_43": 11975685.0, "pmid_date_43": 2002.0, "pmid_journal_43": "Int J Gynecol Cancer"}, {"pmid_title_44": "Growth hormone deficiency caused by pituitary stalk interruption in Fanconi's anemia.", "pmid_44": 11148528.0, "pmid_date_44": 2001.0, "pmid_journal_44": "J Pediatr"}, {"pmid_title_45": "Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.", "pmid_45": 9658728.0, "pmid_date_45": 1998.0, "pmid_journal_45": "Haematologica"}, {"pmid_title_46": "Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.", "pmid_46": 8781414.0, "pmid_date_46": 1996.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.", "pmid_47": 7644282.0, "pmid_date_47": 1995.0, "pmid_journal_47": "Pediatr Nurs"}, {"pmid_title_48": "Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.", "pmid_48": 8283365.0, "pmid_date_48": 1994.0, "pmid_journal_48": "J Pediatr"}, {"pmid_title_49": "A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia.", "pmid_49": 8280614.0, "pmid_date_49": 1993.0, "pmid_journal_49": "Br J Haematol"}, {"pmid_title_50": "Fanconi's anemia. A family study with 20-year follow-up including associated breast pathology.", "pmid_50": 6478420.0, "pmid_date_50": 1984.0, "pmid_journal_50": "Cancer"}, {"pmid_title_51": "Multiple hepatic tumors and peliosis hepatis in Fanconi's anemia treated with androgens.", "pmid_51": 199056.0, "pmid_date_51": 1977.0, "pmid_journal_51": "Am J Dis Child"}, {"pmid_title_52": "Hepatic lesions in patients treated with synthetic anabolic steriods.", "pmid_52": 185239.0, "pmid_date_52": 1976.0, "pmid_journal_52": "J Clin Pathol"}, {"pmid_title_53": "The defective absorption of phosphorus and calcium and the effect of vitamin D in the Fanconi syndrome.", "pmid_53": 13610080.0, "pmid_date_53": 1958.0, "pmid_journal_53": "Guys Hosp Rep"}]}, {"_id": "343-OMIM:613752", "condition": {"condition_name": "HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 343.0}, "interventions": [{"int_description_1": "Low methionine diet"}, {"int_description_2": "Phylloquinone"}, {"int_description_4": "Creatine"}], "references": [{"pmid_title_1": "Abnormal Hypermethylation at Imprinting Control Regions in Patients with S-Adenosylhomocysteine Hydrolase (AHCY) Deficiency.", "pmid_1": 26974671.0, "pmid_date_1": 2016.0, "pmid_journal_1": "PLoS One"}, {"pmid_title_2": "Liver transplantation for treatment of severe S-adenosylhomocysteine hydrolase deficiency.", "pmid_2": 26095522.0, "pmid_date_2": 2015.0, "pmid_journal_2": "Mol Genet Metab"}, {"pmid_title_3": "Adult-onset liver disease and hepatocellular carcinoma in S-adenosylhomocysteine hydrolase deficiency.", "pmid_3": 26527160.0, "pmid_date_3": 2015.0, "pmid_journal_3": "Mol Genet Metab"}, {"pmid_title_4": "Clinical picture of S-adenosylhomocysteine hydrolase deficiency resembles phosphomannomutase 2 deficiency.", "pmid_4": 22959829.0, "pmid_date_4": 2012.0, "pmid_journal_4": "Mol Genet Metab"}, {"pmid_title_5": "S-adenosylhomocysteine hydrolase deficiency: two siblings with fetal hydrops and fatal outcomes.", "pmid_5": 20852937.0, "pmid_date_5": 2010.0, "pmid_journal_5": "J Inherit Metab Dis"}]}, {"_id": "3481-OMIM:231680", "condition": {"condition_name": "MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD", "freq_per_birth": "Glutaric acidemia type II is a very rare disorder; its precise incidence is unknown. It has been reported in several different ethnic groups.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD"]}, "gene information": {"db_hgnc_gene_id": 3481.0}, "interventions": [{"int_description_1": "high carbohydrate diet"}, {"int_description_2": "low fat diet", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "MCT diet"}, {"int_description_4": "Ubidecarenone"}, {"int_description_5": "Bezafibrate", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Cohort study or studies", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Cyanocobalamin", "timeframe_int6": "Hours,Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Cohort study or studies", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Pyridoxine"}, {"int_description_8": "Levocarnitine", "timeframe_int8": "Hours", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Riboflavin"}, {"int_description_10": "D,L-3-hydroxybutyrate"}, {"int_description_11": "Sodium bicarbonate", "timeframe_int11": "Hours,Days or Weeks,Years", "age_use_int11": "Neonate,Infant,Child", "contra_int11": "No", "qualscale_reclass_drug11": "Cohort study or studies", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "D-glucose", "timeframe_int12": "Hours,Days or Weeks,Years", "age_use_int12": "Neonate,Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Cohort study or studies", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Thiamine", "timeframe_int13": "Days or Weeks,Years", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Cohort study or studies", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "avoid fasting", "timeframe_int14": "Hours", "age_use_int14": "Neonate,Infant,Child", "contra_int14": "No", "qualscale_reclass_drug14": "Cohort study or studies", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Efficacy and safety of D,L-3-hydroxybutyrate (D,L-3-HB) treatment in multiple acyl-CoA dehydrogenase deficiency.", "pmid_1": 31904027.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Genetics in medicine : official journal of the American College of Medical Genetics"}, {"pmid_title_2": "Needle EMG, a Jigsaw to Disclose Lipid Storage Myopathy Due to Multiple Acyl-CoA Dehydrogenase Deficiency.", "pmid_2": 31136308.0, "pmid_date_2": 2020.0, "pmid_journal_2": "American journal of physical medicine & rehabilitation"}, {"pmid_title_3": "Skin damage in a patient with lipid storage myopathy with a novel ETFDH mutation responsive to riboflavin.", "pmid_3": 32064983.0, "pmid_date_3": 2020.0, "pmid_journal_3": "The International journal of neuroscience"}, {"pmid_title_4": "Multiple acyl-COA dehydrogenase deficiency in elderly carriers.", "pmid_4": 31997039.0, "pmid_date_4": 2020.0, "pmid_journal_4": "Journal of neurology"}, {"pmid_title_5": "A Synonymous Variant c.579A>G in the ETFDH Gene Caused Exon Skipping in a Patient With Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency: A Case Report.", "pmid_5": 32292771.0, "pmid_date_5": 2020.0, "pmid_journal_5": "Frontiers in pediatrics"}, {"pmid_title_6": "Late-onset multiple acyl-CoA dehydrogenase deficiency with cardiac syncope: A case report.", "pmid_6": 32190638.0, "pmid_date_6": 2020.0, "pmid_journal_6": "World journal of clinical cases"}, {"pmid_title_7": "Correlation between ETFDH mutations and dysregulation of serum myomiRs in MADD patients.", "pmid_7": 32499892.0, "pmid_date_7": 2020.0, "pmid_journal_7": "European journal of translational myology"}, {"pmid_title_8": "A case report of a mild form of multiple acyl-CoA dehydrogenase deficiency due to compound heterozygous mutations in the ETFA gene.", "pmid_8": 31996215.0, "pmid_date_8": 2020.0, "pmid_journal_8": "BMC medical genomics"}, {"pmid_title_9": "A novel electron transfer flavoprotein dehydrogenase (ETFDH) gene mutation identified in a newborn with glutaric acidemia type II: a case report of a Chinese family.", "pmid_9": 32393189.0, "pmid_date_9": 2020.0, "pmid_journal_9": "BMC medical genetics"}, {"pmid_title_10": "Metabolic lipid muscle disorders: biomarkers and treatment.", "pmid_10": 31040882.0, "pmid_date_10": 2019.0, "pmid_journal_10": "Therapeutic advances in neurological disorders"}, {"pmid_title_11": "Expanded newborn screening for inherited metabolic disorders and genetic characteristics in a southern Chinese population.", "pmid_11": 30904546.0, "pmid_date_11": 2019.0, "pmid_journal_11": "Clinica chimica acta; international journal of clinical chemistry"}, {"pmid_title_12": "Long-term ketone body therapy of severe multiple acyl-CoA dehydrogenase deficiency: A case report.", "pmid_12": 30557775.0, "pmid_date_12": 2019.0, "pmid_journal_12": "Nutrition (Burbank, Los Angeles County, Calif.)"}, {"pmid_title_13": "Ketone body therapy with D/L-\u03b2-hydroxybutyric acid solution in severe MADD.", "pmid_13": 31312603.0, "pmid_date_13": 2019.0, "pmid_journal_13": "Molecular genetics and metabolism reports"}, {"pmid_title_14": "A Novel Truncating FLAD1 Variant, Causing Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) in an 8-Year-Old Boy.", "pmid_14": 30311138.0, "pmid_date_14": 2019.0, "pmid_journal_14": "JIMD reports"}, {"pmid_title_15": "ETF-QO Mutants Uncoupled Fatty Acid \u03b2-Oxidation and Mitochondrial Bioenergetics Leading to Lipid Pathology.", "pmid_15": 30709034.0, "pmid_date_15": 2019.0, "pmid_journal_15": "Cells"}, {"pmid_title_16": "Follow-up of fatty acid \u03b2-oxidation disorders in expanded newborn screening era.", "pmid_16": 30617651.0, "pmid_date_16": 2019.0, "pmid_journal_16": "European journal of pediatrics"}, {"pmid_title_17": "Determinants of Riboflavin Responsiveness in Multiple Acyl-CoA Dehydrogenase Deficiency.", "pmid_17": 31331668.0, "pmid_date_17": 2019.0, "pmid_journal_17": "Pediatric neurology"}, {"pmid_title_18": "FLAD1-associated multiple acyl-CoA dehydrogenase deficiency identified by newborn screening.", "pmid_18": 31392824.0, "pmid_date_18": 2019.0, "pmid_journal_18": "Molecular genetics & genomic medicine"}, {"pmid_title_19": "Molecular and Clinical Investigations on Portuguese Patients with Multiple acyl-CoA Dehydrogenase Deficiency.", "pmid_19": 31418342.0, "pmid_date_19": 2019.0, "pmid_journal_19": "Current molecular medicine"}, {"pmid_title_20": "Rhabdomyolysis and respiratory insufficiency due to the common ETFDH mutation of c.250G>A in two patients with late-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_20": 31058673.0, "pmid_date_20": 2019.0, "pmid_journal_20": "Chinese medical journal"}, {"pmid_title_21": "Impaired fat oxidation during exercise in multiple acyl-CoA dehydrogenase deficiency.", "pmid_21": 31240159.0, "pmid_date_21": 2019.0, "pmid_journal_21": "JIMD reports"}, {"pmid_title_22": "Myogenic Disease and Metabolic Acidosis: Consider Multiple Acyl-Coenzyme A Dehydrogenase Deficiency.", "pmid_22": 31934457.0, "pmid_date_22": 2019.0, "pmid_journal_22": "Case reports in critical care"}, {"pmid_title_23": "Long-term outcomes of a patient with late-onset multiple acyl-CoA dehydrogenase deficiency caused by novel mutations in ETFDH: A case report.", "pmid_23": 30508893.0, "pmid_date_23": 2018.0, "pmid_journal_23": "Medicine"}, {"pmid_title_24": "Glutaric acidemia type II patient with thalassemia minor and novel electron transfer flavoprotein-A gene mutations: A case report and review of literature.", "pmid_24": 30510944.0, "pmid_date_24": 2018.0, "pmid_journal_24": "World journal of clinical cases"}, {"pmid_title_25": "Encephalopathy associated with a reversible splenial lesion in riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_25": 30072122.0, "pmid_date_25": 2018.0, "pmid_journal_25": "Revue neurologique"}, {"pmid_title_26": "Acute-onset multiple acyl-CoA dehydrogenase deficiency mimicking Guillain-Barr\u00e9 syndrome: two cases report.", "pmid_26": 30587156.0, "pmid_date_26": 2018.0, "pmid_journal_26": "BMC neurology"}, {"pmid_title_27": "Post-mortem detection of FLAD1 mutations in 2 Turkish siblings with hypotonia in early infancy.", "pmid_27": 30061063.0, "pmid_date_27": 2018.0, "pmid_journal_27": "Neuromuscular disorders : NMD"}, {"pmid_title_28": "Lipid Storage Myopathy with Ketonuria: A Case of Fatty Acid Oxidation-Related Myopathy and Encephalopathy due to Multiple Acyl-CoA Dehydrogenase Deficiency.", "pmid_28": 30271477.0, "pmid_date_28": 2018.0, "pmid_journal_28": "Journal of pediatric neurosciences"}, {"pmid_title_29": "Clinical Features of Multiple Acyl-CoA Dehydrogenase Deficiency With ETFDH Variants in the First Korean Cases.", "pmid_29": 30027710.0, "pmid_date_29": 2018.0, "pmid_journal_29": "Annals of laboratory medicine"}, {"pmid_title_30": "Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_30": 30424791.0, "pmid_date_30": 2018.0, "pmid_journal_30": "Lipids in health and disease"}, {"pmid_title_31": "A novel mutation in ETFDH manifesting as severe neonatal-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_31": 29249369.0, "pmid_date_31": 2018.0, "pmid_journal_31": "Journal of the neurological sciences"}, {"pmid_title_32": "Successful Pregnancy in a Young Woman with Multiple Acyl-CoA Dehydrogenase Deficiency.", "pmid_32": 28685490.0, "pmid_date_32": 2018.0, "pmid_journal_32": "JIMD reports"}, {"pmid_title_33": "A novel ETFDH mutation in an adult patient with late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_33": 28914566.0, "pmid_date_33": 2018.0, "pmid_journal_33": "The International journal of neuroscience"}, {"pmid_title_34": "Patient with multiple acyl-CoA dehydrogenase deficiency disease and ETFDH mutations benefits from riboflavin therapy: a case report.", "pmid_34": 29615056.0, "pmid_date_34": 2018.0, "pmid_journal_34": "BMC medical genomics"}, {"pmid_title_35": "Novel <i>ETFDH</i> mutations in four cases of riboflavin responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_35": 29988809.0, "pmid_date_35": 2018.0, "pmid_journal_35": "Molecular genetics and metabolism reports"}, {"pmid_title_36": "Efficacy of bezafibrate on fibroblasts of glutaric acidemia type II patients evaluated using an in vitro probe acylcarnitine assay.", "pmid_36": 27591119.0, "pmid_date_36": 2017.0, "pmid_journal_36": "Brain & development"}, {"pmid_title_37": "Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency: delayed hypersensitivity reaction and efficacy of low-dose intermittent supplementation.", "pmid_37": 28643959.0, "pmid_date_37": 2017.0, "pmid_journal_37": "European journal of neurology"}, {"pmid_title_38": "Riboflavin-Responsive Multiple Acyl-CoA Dehydrogenase Deficiency Associated with Hepatoencephalomyopathy and White Matter Signal Abnormalities on Brain MRI.", "pmid_38": 28388738.0, "pmid_date_38": 2017.0, "pmid_journal_38": "Neuropediatrics"}, {"pmid_title_39": "Significant clinical heterogeneity with similar ETFDH genotype in three Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_39": 27000805.0, "pmid_date_39": 2016.0, "pmid_journal_39": "Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"}, {"pmid_title_40": "Severe sensory neuropathy in patients with adult-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_40": 26821934.0, "pmid_date_40": 2016.0, "pmid_journal_40": "Neuromuscular disorders : NMD"}, {"pmid_title_41": "Bent spine syndrome as an initial manifestation of late-onset multiple acyl-CoA dehydrogenase deficiency: a case report and literature review.", "pmid_41": 26205240.0, "pmid_date_41": 2015.0, "pmid_journal_41": "BMC neurology"}, {"pmid_title_42": "Highly efficient ketone body treatment in multiple acyl-CoA dehydrogenase deficiency-related leukodystrophy.", "pmid_42": 25289702.0, "pmid_date_42": 2015.0, "pmid_journal_42": "Pediatric research"}, {"pmid_title_43": "A case of late-onset riboflavin responsive multiple acyl-CoA dehydrogenase deficiency (MADD) with a novel mutation in ETFDH gene.", "pmid_43": 25913573.0, "pmid_date_43": 2015.0, "pmid_journal_43": "Journal of the neurological sciences"}, {"pmid_title_44": "Clinical features and ETFDH mutation spectrum in a cohort of 90 Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_44": 24357026.0, "pmid_date_44": 2014.0, "pmid_journal_44": "Journal of inherited metabolic disease"}, {"pmid_title_45": "Novel ETFDH mutation and imaging findings in an adult with glutaric aciduria type II.", "pmid_45": 23893693.0, "pmid_date_45": 2014.0, "pmid_journal_45": "Muscle & nerve"}, {"pmid_title_46": "Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency with unknown genetic defect.", "pmid_46": 22190129.0, "pmid_date_46": 2012.0, "pmid_journal_46": "Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"}, {"pmid_title_47": "A case of late-onset riboflavin responsive multiple acyl-CoA dehydrogenase deficiency with novel mutations in ETFDH gene.", "pmid_47": 23106979.0, "pmid_date_47": 2012.0, "pmid_journal_47": "CNS neuroscience & therapeutics"}, {"pmid_title_48": "Multiple acyl-CoA-dehydrogenase deficiency (MADD)--a novel mutation of electron-transferring-flavoprotein dehydrogenase ETFDH.", "pmid_48": 21616504.0, "pmid_date_48": 2011.0, "pmid_journal_48": "Journal of the neurological sciences"}, {"pmid_title_49": "A case of late onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency manifesting as recurrent rhabdomyolysis and acute renal failure.", "pmid_49": 22041377.0, "pmid_date_49": 2011.0, "pmid_journal_49": "Internal medicine (Tokyo, Japan)"}, {"pmid_title_50": "Central nervous system and muscle involvement in an adolescent patient with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_50": 19783111.0, "pmid_date_50": 2010.0, "pmid_journal_50": "Brain & development"}, {"pmid_title_51": "High resolution melting analysis facilitates mutation screening of ETFDH gene: applications in riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_51": 20138856.0, "pmid_date_51": 2010.0, "pmid_journal_51": "Clinica chimica acta; international journal of clinical chemistry"}, {"pmid_title_52": "ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_52": 19249206.0, "pmid_date_52": 2009.0, "pmid_journal_52": "Neuromuscular disorders : NMD"}, {"pmid_title_53": "Novel mutations in ETFDH gene in Chinese patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_53": 19265687.0, "pmid_date_53": 2009.0, "pmid_journal_53": "Clinica chimica acta; international journal of clinical chemistry"}, {"pmid_title_54": "Late-onset multiple acyl-CoA dehydrogenase deficiency: a frequently missed diagnosis?", "pmid_54": 17060596.0, "pmid_date_54": 2006.0, "pmid_journal_54": "Neurology"}, {"pmid_title_55": "D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD).", "pmid_55": 12727399.0, "pmid_date_55": 2003.0, "pmid_journal_55": "Lancet (London, England)"}, {"pmid_title_56": "Adult-Onset Presentation of Glutaric Acidemia Type II With Myopathy.", "pmid_56": 19078703.0, "pmid_date_56": 2003.0, "pmid_journal_56": "Journal of clinical neuromuscular disease"}]}, {"_id": "3482-OMIM:231680", "condition": {"condition_name": "MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY", "freq_per_birth": "Glutaric acidemia type II is a very rare disorder; its precise incidence is unknown. It has been reported in several different ethnic groups.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 3482.0}, "interventions": [{"int_description_1": "high carbohydrate diet"}, {"int_description_2": "low fat diet", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "MCT diet"}, {"int_description_4": "Ubidecarenone"}, {"int_description_5": "Bezafibrate", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Cyanocobalamin", "timeframe_int6": "Hours,Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Pyridoxine"}, {"int_description_8": "Levocarnitine", "timeframe_int8": "Hours", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Riboflavin"}, {"int_description_10": "D,L-3-hydroxybutyrate"}, {"int_description_11": "Sodium bicarbonate", "timeframe_int11": "Hours,Days or Weeks,Years", "age_use_int11": "Neonate,Infant,Child", "contra_int11": "No", "qualscale_reclass_drug11": "Cohort study or studies", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "D-glucose", "timeframe_int12": "Hours,Days or Weeks,Years", "age_use_int12": "Neonate,Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Cohort study or studies", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Thiamine", "timeframe_int13": "Days or Weeks,Years", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Cohort study or studies", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "avoid fasting", "timeframe_int14": "Hours", "age_use_int14": "Neonate,Infant,Child", "contra_int14": "No", "qualscale_reclass_drug14": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Efficacy and safety of D,L-3-hydroxybutyrate (D,L-3-HB) treatment in multiple acyl-CoA dehydrogenase deficiency.", "pmid_1": 31904027.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Genet Med"}, {"pmid_title_2": "Needle EMG, a Jigsaw to Disclose Lipid Storage Myopathy Due to Multiple Acyl-CoA Dehydrogenase Deficiency.", "pmid_2": 31136308.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Am J Phys Med Rehabil"}, {"pmid_title_3": "Skin damage in a patient with lipid storage myopathy with a novel ETFDH mutation responsive to riboflavin.", "pmid_3": 32064983.0, "pmid_date_3": 2020.0, "pmid_journal_3": "Int J Neurosci"}, {"pmid_title_4": "Multiple acyl-COA dehydrogenase deficiency in elderly carriers.", "pmid_4": 31997039.0, "pmid_date_4": 2020.0, "pmid_journal_4": "J Neurol"}, {"pmid_title_5": "A Synonymous Variant c.579A>G in the ETFDH Gene Caused Exon Skipping in a Patient With Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency: A Case Report.", "pmid_5": 32292771.0, "pmid_date_5": 2020.0, "pmid_journal_5": "Front Pediatr"}, {"pmid_title_6": "Late-onset multiple acyl-CoA dehydrogenase deficiency with cardiac syncope: A case report.", "pmid_6": 32190638.0, "pmid_date_6": 2020.0, "pmid_journal_6": "World J Clin Cases"}, {"pmid_title_7": "A case report of a mild form of multiple acyl-CoA dehydrogenase deficiency due to compound heterozygous mutations in the ETFA gene.", "pmid_7": 31996215.0, "pmid_date_7": 2020.0, "pmid_journal_7": "BMC Med Genomics"}, {"pmid_title_8": "Correlation between ETFDH mutations and dysregulation of serum myomiRs in MADD patients.", "pmid_8": 32499892.0, "pmid_date_8": 2020.0, "pmid_journal_8": "Eur J Transl Myol"}, {"pmid_title_9": "A novel electron transfer flavoprotein dehydrogenase (ETFDH) gene mutation identified in a newborn with glutaric acidemia type II: a case report of a Chinese family.", "pmid_9": 32393189.0, "pmid_date_9": 2020.0, "pmid_journal_9": "BMC Med Genet"}, {"pmid_title_10": "Metabolic lipid muscle disorders: biomarkers and treatment.", "pmid_10": 31040882.0, "pmid_date_10": 2019.0, "pmid_journal_10": "Ther Adv Neurol Disord"}, {"pmid_title_11": "Expanded newborn screening for inherited metabolic disorders and genetic characteristics in a southern Chinese population.", "pmid_11": 30904546.0, "pmid_date_11": 2019.0, "pmid_journal_11": "Clin Chim Acta"}, {"pmid_title_12": "Long-term ketone body therapy of severe multiple acyl-CoA dehydrogenase deficiency: A case report.", "pmid_12": 30557775.0, "pmid_date_12": 2019.0, "pmid_journal_12": "Nutrition"}, {"pmid_title_13": "Ketone body therapy with D/L-\u03b2-hydroxybutyric acid solution in severe MADD.", "pmid_13": 31312603.0, "pmid_date_13": 2019.0, "pmid_journal_13": "Mol Genet Metab Rep"}, {"pmid_title_14": "A Novel Truncating FLAD1 Variant, Causing Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) in an 8-Year-Old Boy.", "pmid_14": 30311138.0, "pmid_date_14": 2019.0, "pmid_journal_14": "JIMD Rep"}, {"pmid_title_15": "ETF-QO Mutants Uncoupled Fatty Acid \u03b2-Oxidation and Mitochondrial Bioenergetics Leading to Lipid Pathology.", "pmid_15": 30709034.0, "pmid_date_15": 2019.0, "pmid_journal_15": "Cells"}, {"pmid_title_16": "Follow-up of fatty acid \u03b2-oxidation disorders in expanded newborn screening era.", "pmid_16": 30617651.0, "pmid_date_16": 2019.0, "pmid_journal_16": "Eur J Pediatr"}, {"pmid_title_17": "Determinants of Riboflavin Responsiveness in Multiple Acyl-CoA Dehydrogenase Deficiency.", "pmid_17": 31331668.0, "pmid_date_17": 2019.0, "pmid_journal_17": "Pediatr Neurol"}, {"pmid_title_18": "FLAD1-associated multiple acyl-CoA dehydrogenase deficiency identified by newborn screening.", "pmid_18": 31392824.0, "pmid_date_18": 2019.0, "pmid_journal_18": "Mol Genet Genomic Med"}, {"pmid_title_19": "Molecular and Clinical Investigations on Portuguese Patients with Multiple acyl-CoA Dehydrogenase Deficiency.", "pmid_19": 31418342.0, "pmid_date_19": 2019.0, "pmid_journal_19": "Curr Mol Med"}, {"pmid_title_20": "Rhabdomyolysis and respiratory insufficiency due to the common ETFDH mutation of c.250G>A in two patients with late-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_20": 31058673.0, "pmid_date_20": 2019.0, "pmid_journal_20": "Chin Med J (Engl)"}, {"pmid_title_21": "Impaired fat oxidation during exercise in multiple acyl-CoA dehydrogenase deficiency.", "pmid_21": 31240159.0, "pmid_date_21": 2019.0, "pmid_journal_21": "JIMD Rep"}, {"pmid_title_22": "Myogenic Disease and Metabolic Acidosis: Consider Multiple Acyl-Coenzyme A Dehydrogenase Deficiency.", "pmid_22": 31934457.0, "pmid_date_22": 2019.0, "pmid_journal_22": "Case Rep Crit Care"}, {"pmid_title_23": "Long-term outcomes of a patient with late-onset multiple acyl-CoA dehydrogenase deficiency caused by novel mutations in ETFDH: A case report.", "pmid_23": 30508893.0, "pmid_date_23": 2018.0, "pmid_journal_23": "Medicine (Baltimore)"}, {"pmid_title_24": "Glutaric acidemia type II patient with thalassemia minor and novel electron transfer flavoprotein-A gene mutations: A case report and review of literature.", "pmid_24": 30510944.0, "pmid_date_24": 2018.0, "pmid_journal_24": "World J Clin Cases"}, {"pmid_title_25": "Encephalopathy associated with a reversible splenial lesion in riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_25": 30072122.0, "pmid_date_25": 2018.0, "pmid_journal_25": "Rev Neurol (Paris)"}, {"pmid_title_26": "Acute-onset multiple acyl-CoA dehydrogenase deficiency mimicking Guillain-Barr\u00e9 syndrome: two cases report.", "pmid_26": 30587156.0, "pmid_date_26": 2018.0, "pmid_journal_26": "BMC Neurol"}, {"pmid_title_27": "Post-mortem detection of FLAD1 mutations in 2 Turkish siblings with hypotonia in early infancy.", "pmid_27": 30061063.0, "pmid_date_27": 2018.0, "pmid_journal_27": "Neuromuscul Disord"}, {"pmid_title_28": "Lipid Storage Myopathy with Ketonuria: A Case of Fatty Acid Oxidation-Related Myopathy and Encephalopathy due to Multiple Acyl-CoA Dehydrogenase Deficiency.", "pmid_28": 30271477.0, "pmid_date_28": 2018.0, "pmid_journal_28": "J Pediatr Neurosci"}, {"pmid_title_29": "Clinical Features of Multiple Acyl-CoA Dehydrogenase Deficiency With ETFDH Variants in the First Korean Cases.", "pmid_29": 30027710.0, "pmid_date_29": 2018.0, "pmid_journal_29": "Ann Lab Med"}, {"pmid_title_30": "Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_30": 30424791.0, "pmid_date_30": 2018.0, "pmid_journal_30": "Lipids Health Dis"}, {"pmid_title_31": "A novel mutation in ETFDH manifesting as severe neonatal-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_31": 29249369.0, "pmid_date_31": 2018.0, "pmid_journal_31": "J Neurol Sci"}, {"pmid_title_32": "Successful Pregnancy in a Young Woman with Multiple Acyl-CoA Dehydrogenase Deficiency.", "pmid_32": 28685490.0, "pmid_date_32": 2018.0, "pmid_journal_32": "JIMD Rep"}, {"pmid_title_33": "A novel ETFDH mutation in an adult patient with late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_33": 28914566.0, "pmid_date_33": 2018.0, "pmid_journal_33": "Int J Neurosci"}, {"pmid_title_34": "Patient with multiple acyl-CoA dehydrogenase deficiency disease and ETFDH mutations benefits from riboflavin therapy: a case report.", "pmid_34": 29615056.0, "pmid_date_34": 2018.0, "pmid_journal_34": "BMC Med Genomics"}, {"pmid_title_35": "Novel <i>ETFDH</i> mutations in four cases of riboflavin responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_35": 29988809.0, "pmid_date_35": 2018.0, "pmid_journal_35": "Mol Genet Metab Rep"}, {"pmid_title_36": "Efficacy of bezafibrate on fibroblasts of glutaric acidemia type II patients evaluated using an in vitro probe acylcarnitine assay.", "pmid_36": 27591119.0, "pmid_date_36": 2017.0, "pmid_journal_36": "Brain Dev"}, {"pmid_title_37": "Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency: delayed hypersensitivity reaction and efficacy of low-dose intermittent supplementation.", "pmid_37": 28643959.0, "pmid_date_37": 2017.0, "pmid_journal_37": "Eur J Neurol"}, {"pmid_title_38": "Riboflavin-Responsive Multiple Acyl-CoA Dehydrogenase Deficiency Associated with Hepatoencephalomyopathy and White Matter Signal Abnormalities on Brain MRI.", "pmid_38": 28388738.0, "pmid_date_38": 2017.0, "pmid_journal_38": "Neuropediatrics"}, {"pmid_title_39": "Significant clinical heterogeneity with similar ETFDH genotype in three Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_39": 27000805.0, "pmid_date_39": 2016.0, "pmid_journal_39": "Neurol Sci"}, {"pmid_title_40": "Severe sensory neuropathy in patients with adult-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_40": 26821934.0, "pmid_date_40": 2016.0, "pmid_journal_40": "Neuromuscul Disord"}, {"pmid_title_41": "Bent spine syndrome as an initial manifestation of late-onset multiple acyl-CoA dehydrogenase deficiency: a case report and literature review.", "pmid_41": 26205240.0, "pmid_date_41": 2015.0, "pmid_journal_41": "BMC Neurol"}, {"pmid_title_42": "Highly efficient ketone body treatment in multiple acyl-CoA dehydrogenase deficiency-related leukodystrophy.", "pmid_42": 25289702.0, "pmid_date_42": 2015.0, "pmid_journal_42": "Pediatr Res"}, {"pmid_title_43": "A case of late-onset riboflavin responsive multiple acyl-CoA dehydrogenase deficiency (MADD) with a novel mutation in ETFDH gene.", "pmid_43": 25913573.0, "pmid_date_43": 2015.0, "pmid_journal_43": "J Neurol Sci"}, {"pmid_title_44": "Clinical features and ETFDH mutation spectrum in a cohort of 90 Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_44": 24357026.0, "pmid_date_44": 2014.0, "pmid_journal_44": "J Inherit Metab Dis"}, {"pmid_title_45": "Novel ETFDH mutation and imaging findings in an adult with glutaric aciduria type II.", "pmid_45": 23893693.0, "pmid_date_45": 2014.0, "pmid_journal_45": "Muscle Nerve"}, {"pmid_title_46": "Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency with unknown genetic defect.", "pmid_46": 22190129.0, "pmid_date_46": 2012.0, "pmid_journal_46": "Neurol Sci"}, {"pmid_title_47": "A case of late-onset riboflavin responsive multiple acyl-CoA dehydrogenase deficiency with novel mutations in ETFDH gene.", "pmid_47": 23106979.0, "pmid_date_47": 2012.0, "pmid_journal_47": "CNS Neurosci Ther"}, {"pmid_title_48": "Multiple acyl-CoA-dehydrogenase deficiency (MADD)--a novel mutation of electron-transferring-flavoprotein dehydrogenase ETFDH.", "pmid_48": 21616504.0, "pmid_date_48": 2011.0, "pmid_journal_48": "J Neurol Sci"}, {"pmid_title_49": "A case of late onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency manifesting as recurrent rhabdomyolysis and acute renal failure.", "pmid_49": 22041377.0, "pmid_date_49": 2011.0, "pmid_journal_49": "Intern Med"}, {"pmid_title_50": "Central nervous system and muscle involvement in an adolescent patient with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_50": 19783111.0, "pmid_date_50": 2010.0, "pmid_journal_50": "Brain Dev"}, {"pmid_title_51": "High resolution melting analysis facilitates mutation screening of ETFDH gene: applications in riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_51": 20138856.0, "pmid_date_51": 2010.0, "pmid_journal_51": "Clin Chim Acta"}, {"pmid_title_52": "ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_52": 19249206.0, "pmid_date_52": 2009.0, "pmid_journal_52": "Neuromuscul Disord"}, {"pmid_title_53": "Novel mutations in ETFDH gene in Chinese patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_53": 19265687.0, "pmid_date_53": 2009.0, "pmid_journal_53": "Clin Chim Acta"}, {"pmid_title_54": "Late-onset multiple acyl-CoA dehydrogenase deficiency: a frequently missed diagnosis?", "pmid_54": 17060596.0, "pmid_date_54": 2006.0, "pmid_journal_54": "Neurology"}, {"pmid_title_55": "D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD).", "pmid_55": 12727399.0, "pmid_date_55": 2003.0, "pmid_journal_55": "Lancet"}, {"pmid_title_56": "Adult-Onset Presentation of Glutaric Acidemia Type II With Myopathy.", "pmid_56": 19078703.0, "pmid_date_56": 2003.0, "pmid_journal_56": "J Clin Neuromuscul Dis"}]}, {"_id": "3483-OMIM:231680", "condition": {"condition_name": "MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY", "freq_per_birth": "Glutaric acidemia type II is a very rare disorder; its precise incidence is unknown. It has been reported in several different ethnic groups.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 3483.0}, "interventions": [{"int_description_1": "high carbohydrate diet"}, {"int_description_2": "low fat diet", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "MCT diet"}, {"int_description_4": "Ubidecarenone"}, {"int_description_5": "Bezafibrate", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Cohort study or studies", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Cyanocobalamin", "timeframe_int6": "Hours,Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Cohort study or studies", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Pyridoxine"}, {"int_description_8": "Levocarnitine", "timeframe_int8": "Hours", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Case report(s)", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Riboflavin"}, {"int_description_10": "D,L-3-hydroxybutyrate"}, {"int_description_11": "Sodium bicarbonate", "timeframe_int11": "Hours,Days or Weeks,Years", "age_use_int11": "Neonate,Infant,Child", "contra_int11": "No", "qualscale_reclass_drug11": "Cohort study or studies", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "D-glucose", "timeframe_int12": "Hours,Days or Weeks,Years", "age_use_int12": "Neonate,Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Cohort study or studies", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Thiamine", "timeframe_int13": "Days or Weeks,Years", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Cohort study or studies", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "avoid fasting", "timeframe_int14": "Hours", "age_use_int14": "Neonate,Infant,Child", "contra_int14": "No", "qualscale_reclass_drug14": "Cohort study or studies", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Efficacy and safety of D,L-3-hydroxybutyrate (D,L-3-HB) treatment in multiple acyl-CoA dehydrogenase deficiency.", "pmid_1": 31904027.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Genet Med"}, {"pmid_title_2": "Needle EMG, a Jigsaw to Disclose Lipid Storage Myopathy Due to Multiple Acyl-CoA Dehydrogenase Deficiency.", "pmid_2": 31136308.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Am J Phys Med Rehabil"}, {"pmid_title_3": "Skin damage in a patient with lipid storage myopathy with a novel ETFDH mutation responsive to riboflavin.", "pmid_3": 32064983.0, "pmid_date_3": 2020.0, "pmid_journal_3": "Int J Neurosci"}, {"pmid_title_4": "Multiple acyl-COA dehydrogenase deficiency in elderly carriers.", "pmid_4": 31997039.0, "pmid_date_4": 2020.0, "pmid_journal_4": "J Neurol"}, {"pmid_title_5": "A Synonymous Variant c.579A>G in the ETFDH Gene Caused Exon Skipping in a Patient With Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency: A Case Report.", "pmid_5": 32292771.0, "pmid_date_5": 2020.0, "pmid_journal_5": "Front Pediatr"}, {"pmid_title_6": "Late-onset multiple acyl-CoA dehydrogenase deficiency with cardiac syncope: A case report.", "pmid_6": 32190638.0, "pmid_date_6": 2020.0, "pmid_journal_6": "World J Clin Cases"}, {"pmid_title_7": "A case report of a mild form of multiple acyl-CoA dehydrogenase deficiency due to compound heterozygous mutations in the ETFA gene.", "pmid_7": 31996215.0, "pmid_date_7": 2020.0, "pmid_journal_7": "BMC Med Genomics"}, {"pmid_title_8": "Correlation between ETFDH mutations and dysregulation of serum myomiRs in MADD patients.", "pmid_8": 32499892.0, "pmid_date_8": 2020.0, "pmid_journal_8": "Eur J Transl Myol"}, {"pmid_title_9": "A novel electron transfer flavoprotein dehydrogenase (ETFDH) gene mutation identified in a newborn with glutaric acidemia type II: a case report of a Chinese family.", "pmid_9": 32393189.0, "pmid_date_9": 2020.0, "pmid_journal_9": "BMC Med Genet"}, {"pmid_title_10": "Metabolic lipid muscle disorders: biomarkers and treatment.", "pmid_10": 31040882.0, "pmid_date_10": 2019.0, "pmid_journal_10": "Ther Adv Neurol Disord"}, {"pmid_title_11": "Expanded newborn screening for inherited metabolic disorders and genetic characteristics in a southern Chinese population.", "pmid_11": 30904546.0, "pmid_date_11": 2019.0, "pmid_journal_11": "Clin Chim Acta"}, {"pmid_title_12": "Long-term ketone body therapy of severe multiple acyl-CoA dehydrogenase deficiency: A case report.", "pmid_12": 30557775.0, "pmid_date_12": 2019.0, "pmid_journal_12": "Nutrition"}, {"pmid_title_13": "Ketone body therapy with D/L-\u03b2-hydroxybutyric acid solution in severe MADD.", "pmid_13": 31312603.0, "pmid_date_13": 2019.0, "pmid_journal_13": "Mol Genet Metab Rep"}, {"pmid_title_14": "A Novel Truncating FLAD1 Variant, Causing Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) in an 8-Year-Old Boy.", "pmid_14": 30311138.0, "pmid_date_14": 2019.0, "pmid_journal_14": "JIMD Rep"}, {"pmid_title_15": "ETF-QO Mutants Uncoupled Fatty Acid \u03b2-Oxidation and Mitochondrial Bioenergetics Leading to Lipid Pathology.", "pmid_15": 30709034.0, "pmid_date_15": 2019.0, "pmid_journal_15": "Cells"}, {"pmid_title_16": "Follow-up of fatty acid \u03b2-oxidation disorders in expanded newborn screening era.", "pmid_16": 30617651.0, "pmid_date_16": 2019.0, "pmid_journal_16": "Eur J Pediatr"}, {"pmid_title_17": "Determinants of Riboflavin Responsiveness in Multiple Acyl-CoA Dehydrogenase Deficiency.", "pmid_17": 31331668.0, "pmid_date_17": 2019.0, "pmid_journal_17": "Pediatr Neurol"}, {"pmid_title_18": "FLAD1-associated multiple acyl-CoA dehydrogenase deficiency identified by newborn screening.", "pmid_18": 31392824.0, "pmid_date_18": 2019.0, "pmid_journal_18": "Mol Genet Genomic Med"}, {"pmid_title_19": "Molecular and Clinical Investigations on Portuguese Patients with Multiple acyl-CoA Dehydrogenase Deficiency.", "pmid_19": 31418342.0, "pmid_date_19": 2019.0, "pmid_journal_19": "Curr Mol Med"}, {"pmid_title_20": "Rhabdomyolysis and respiratory insufficiency due to the common ETFDH mutation of c.250G>A in two patients with late-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_20": 31058673.0, "pmid_date_20": 2019.0, "pmid_journal_20": "Chin Med J (Engl)"}, {"pmid_title_21": "Impaired fat oxidation during exercise in multiple acyl-CoA dehydrogenase deficiency.", "pmid_21": 31240159.0, "pmid_date_21": 2019.0, "pmid_journal_21": "JIMD Rep"}, {"pmid_title_22": "Myogenic Disease and Metabolic Acidosis: Consider Multiple Acyl-Coenzyme A Dehydrogenase Deficiency.", "pmid_22": 31934457.0, "pmid_date_22": 2019.0, "pmid_journal_22": "Case Rep Crit Care"}, {"pmid_title_23": "Long-term outcomes of a patient with late-onset multiple acyl-CoA dehydrogenase deficiency caused by novel mutations in ETFDH: A case report.", "pmid_23": 30508893.0, "pmid_date_23": 2018.0, "pmid_journal_23": "Medicine (Baltimore)"}, {"pmid_title_24": "Glutaric acidemia type II patient with thalassemia minor and novel electron transfer flavoprotein-A gene mutations: A case report and review of literature.", "pmid_24": 30510944.0, "pmid_date_24": 2018.0, "pmid_journal_24": "World J Clin Cases"}, {"pmid_title_25": "Encephalopathy associated with a reversible splenial lesion in riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_25": 30072122.0, "pmid_date_25": 2018.0, "pmid_journal_25": "Rev Neurol (Paris)"}, {"pmid_title_26": "Acute-onset multiple acyl-CoA dehydrogenase deficiency mimicking Guillain-Barr\u00e9 syndrome: two cases report.", "pmid_26": 30587156.0, "pmid_date_26": 2018.0, "pmid_journal_26": "BMC Neurol"}, {"pmid_title_27": "Post-mortem detection of FLAD1 mutations in 2 Turkish siblings with hypotonia in early infancy.", "pmid_27": 30061063.0, "pmid_date_27": 2018.0, "pmid_journal_27": "Neuromuscul Disord"}, {"pmid_title_28": "Lipid Storage Myopathy with Ketonuria: A Case of Fatty Acid Oxidation-Related Myopathy and Encephalopathy due to Multiple Acyl-CoA Dehydrogenase Deficiency.", "pmid_28": 30271477.0, "pmid_date_28": 2018.0, "pmid_journal_28": "J Pediatr Neurosci"}, {"pmid_title_29": "Clinical Features of Multiple Acyl-CoA Dehydrogenase Deficiency With ETFDH Variants in the First Korean Cases.", "pmid_29": 30027710.0, "pmid_date_29": 2018.0, "pmid_journal_29": "Ann Lab Med"}, {"pmid_title_30": "Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_30": 30424791.0, "pmid_date_30": 2018.0, "pmid_journal_30": "Lipids Health Dis"}, {"pmid_title_31": "A novel mutation in ETFDH manifesting as severe neonatal-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_31": 29249369.0, "pmid_date_31": 2018.0, "pmid_journal_31": "J Neurol Sci"}, {"pmid_title_32": "Successful Pregnancy in a Young Woman with Multiple Acyl-CoA Dehydrogenase Deficiency.", "pmid_32": 28685490.0, "pmid_date_32": 2018.0, "pmid_journal_32": "JIMD Rep"}, {"pmid_title_33": "A novel ETFDH mutation in an adult patient with late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_33": 28914566.0, "pmid_date_33": 2018.0, "pmid_journal_33": "Int J Neurosci"}, {"pmid_title_34": "Patient with multiple acyl-CoA dehydrogenase deficiency disease and ETFDH mutations benefits from riboflavin therapy: a case report.", "pmid_34": 29615056.0, "pmid_date_34": 2018.0, "pmid_journal_34": "BMC Med Genomics"}, {"pmid_title_35": "Novel <i>ETFDH</i> mutations in four cases of riboflavin responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_35": 29988809.0, "pmid_date_35": 2018.0, "pmid_journal_35": "Mol Genet Metab Rep"}, {"pmid_title_36": "Efficacy of bezafibrate on fibroblasts of glutaric acidemia type II patients evaluated using an in vitro probe acylcarnitine assay.", "pmid_36": 27591119.0, "pmid_date_36": 2017.0, "pmid_journal_36": "Brain Dev"}, {"pmid_title_37": "Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency: delayed hypersensitivity reaction and efficacy of low-dose intermittent supplementation.", "pmid_37": 28643959.0, "pmid_date_37": 2017.0, "pmid_journal_37": "Eur J Neurol"}, {"pmid_title_38": "Riboflavin-Responsive Multiple Acyl-CoA Dehydrogenase Deficiency Associated with Hepatoencephalomyopathy and White Matter Signal Abnormalities on Brain MRI.", "pmid_38": 28388738.0, "pmid_date_38": 2017.0, "pmid_journal_38": "Neuropediatrics"}, {"pmid_title_39": "Significant clinical heterogeneity with similar ETFDH genotype in three Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_39": 27000805.0, "pmid_date_39": 2016.0, "pmid_journal_39": "Neurol Sci"}, {"pmid_title_40": "Severe sensory neuropathy in patients with adult-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_40": 26821934.0, "pmid_date_40": 2016.0, "pmid_journal_40": "Neuromuscul Disord"}, {"pmid_title_41": "Bent spine syndrome as an initial manifestation of late-onset multiple acyl-CoA dehydrogenase deficiency: a case report and literature review.", "pmid_41": 26205240.0, "pmid_date_41": 2015.0, "pmid_journal_41": "BMC Neurol"}, {"pmid_title_42": "Highly efficient ketone body treatment in multiple acyl-CoA dehydrogenase deficiency-related leukodystrophy.", "pmid_42": 25289702.0, "pmid_date_42": 2015.0, "pmid_journal_42": "Pediatr Res"}, {"pmid_title_43": "A case of late-onset riboflavin responsive multiple acyl-CoA dehydrogenase deficiency (MADD) with a novel mutation in ETFDH gene.", "pmid_43": 25913573.0, "pmid_date_43": 2015.0, "pmid_journal_43": "J Neurol Sci"}, {"pmid_title_44": "Clinical features and ETFDH mutation spectrum in a cohort of 90 Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency.", "pmid_44": 24357026.0, "pmid_date_44": 2014.0, "pmid_journal_44": "J Inherit Metab Dis"}, {"pmid_title_45": "Novel ETFDH mutation and imaging findings in an adult with glutaric aciduria type II.", "pmid_45": 23893693.0, "pmid_date_45": 2014.0, "pmid_journal_45": "Muscle Nerve"}, {"pmid_title_46": "Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency with unknown genetic defect.", "pmid_46": 22190129.0, "pmid_date_46": 2012.0, "pmid_journal_46": "Neurol Sci"}, {"pmid_title_47": "A case of late-onset riboflavin responsive multiple acyl-CoA dehydrogenase deficiency with novel mutations in ETFDH gene.", "pmid_47": 23106979.0, "pmid_date_47": 2012.0, "pmid_journal_47": "CNS Neurosci Ther"}, {"pmid_title_48": "Multiple acyl-CoA-dehydrogenase deficiency (MADD)--a novel mutation of electron-transferring-flavoprotein dehydrogenase ETFDH.", "pmid_48": 21616504.0, "pmid_date_48": 2011.0, "pmid_journal_48": "J Neurol Sci"}, {"pmid_title_49": "A case of late onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency manifesting as recurrent rhabdomyolysis and acute renal failure.", "pmid_49": 22041377.0, "pmid_date_49": 2011.0, "pmid_journal_49": "Intern Med"}, {"pmid_title_50": "Central nervous system and muscle involvement in an adolescent patient with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_50": 19783111.0, "pmid_date_50": 2010.0, "pmid_journal_50": "Brain Dev"}, {"pmid_title_51": "High resolution melting analysis facilitates mutation screening of ETFDH gene: applications in riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_51": 20138856.0, "pmid_date_51": 2010.0, "pmid_journal_51": "Clin Chim Acta"}, {"pmid_title_52": "ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_52": 19249206.0, "pmid_date_52": 2009.0, "pmid_journal_52": "Neuromuscul Disord"}, {"pmid_title_53": "Novel mutations in ETFDH gene in Chinese patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.", "pmid_53": 19265687.0, "pmid_date_53": 2009.0, "pmid_journal_53": "Clin Chim Acta"}, {"pmid_title_54": "Late-onset multiple acyl-CoA dehydrogenase deficiency: a frequently missed diagnosis?", "pmid_54": 17060596.0, "pmid_date_54": 2006.0, "pmid_journal_54": "Neurology"}, {"pmid_title_55": "D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD).", "pmid_55": 12727399.0, "pmid_date_55": 2003.0, "pmid_journal_55": "Lancet"}, {"pmid_title_56": "Adult-Onset Presentation of Glutaric Acidemia Type II With Myopathy.", "pmid_56": 19078703.0, "pmid_date_56": 2003.0, "pmid_journal_56": "J Clin Neuromuscul Dis"}]}, {"_id": "3531-OMIM:613225", "condition": {"condition_name": "FACTOR XIII, A SUBUNIT, DEFICIENCY OF", "freq_per_birth": "Inherited factor XIII deficiency affects 1 to 3 per million people worldwide. Researchers suspect that mild factor XIII deficiency, including the acquired form of the disorder, is underdiagnosed because many affected people never have a major episode of abnormal bleeding that would lead to a diagnosis.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["FACTOR XIII, A SUBUNIT, DEFICIENCY OF"]}, "gene information": {"db_hgnc_gene_id": 3531.0}, "interventions": [{"int_description_1": "Catridecacog", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Factor XIII (human)", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Cohort study or studies", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Cryoprecipitate", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Cohort study or studies", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Cryoprecipitate on demand"}, {"int_description_5": "Fresh frozen plasma", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Cohort study or studies", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Identification of a novel nonsense mutation leading to congenital factor XIII deficiency.", "pmid_1": 29604433.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Thromb Res"}, {"pmid_title_2": "Comparison of F13A1 gene mutations in 73 patients treated with recombinant FXIII-A<sub>2</sub>.", "pmid_2": 28520207.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Haemophilia"}, {"pmid_title_3": "Genetic basis of severe factor XIII deficiency in a large cohort of Indian patients: Identification of fourteen novel mutations.", "pmid_3": 26852661.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Blood Cells Mol Dis"}, {"pmid_title_4": "Novel and recurrent mutations in the F13A1 gene in unrelated Korean patients with congenital factor XIII deficiency.", "pmid_4": 25004025.0, "pmid_date_4": 2015.0, "pmid_journal_4": "Blood Coagul Fibrinolysis"}, {"pmid_title_5": "Factor XIII deficiency management: a review of the literature.", "pmid_5": 24401950.0, "pmid_date_5": 2014.0, "pmid_journal_5": "Blood Coagul Fibrinolysis"}, {"pmid_title_6": "Phenotype-genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations.", "pmid_6": 17880458.0, "pmid_date_6": 2007.0, "pmid_journal_6": "Haemophilia"}]}, {"_id": "3534-OMIM:613235", "condition": {"condition_name": "FACTOR XIII, B SUBUNIT, DEFICIENCY OF", "freq_per_birth": "Inherited factor XIII deficiency affects 1 to 3 per million people worldwide. Researchers suspect that mild factor XIII deficiency, including the acquired form of the disorder, is underdiagnosed because many affected people never have a major episode of abnormal bleeding that would lead to a diagnosis.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["FACTOR XIII, B SUBUNIT, DEFICIENCY OF"]}, "gene information": {"db_hgnc_gene_id": 3534.0}, "interventions": [{"int_description_1": "Factor XIII (human)"}, {"int_description_2": "Transfusions of erythrocyte concentrates"}, {"int_description_3": "Cryoprecipitate", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Fresh frozen plasma", "timeframe_int4": "Hours", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Mutations affecting disulphide bonds contribute to a fairly common prevalence of F13B gene defects: results of a genetic study in 14 families with factor XIII B deficiency.", "pmid_1": 20331752.0, "pmid_date_1": 2010.0, "pmid_journal_1": "Haemophilia : the official journal of the World Federation of Hemophilia"}, {"pmid_title_2": "Factor XIII Deficiency.", "pmid_2": 19598071.0, "pmid_date_2": 2009.0, "pmid_journal_2": "Seminars in thrombosis and hemostasis"}]}, {"_id": "3535-OMIM:188050", "condition": {"condition_name": "THROMBOPHILIA DUE TO THROMBIN DEFECT; THPH1", "freq_per_birth": "Prothrombin thrombophilia is the second most common inherited form of thrombophilia after factor V Leiden thrombophilia. Approximately 1 in 50 people in the white population in the United States and Europe has prothrombin thrombophilia. This condition is less common in other ethnic groups, occurring in less than one percent of African American, Native American, or Asian populations.", "pattern_of_inheritance": "Pattern unknown", "alternate_names": ["THROMBOPHILIA DUE TO THROMBIN DEFECT; THPH1", "PROTHROMBIN DEFICIENCY, CONGENITAL"]}, "gene information": {"db_hgnc_gene_id": 3535.0}, "interventions": [{"int_description_1": "Warfarin", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Thrombosis from a prothrombin mutation conveying antithrombin resistance.", "pmid_1": 22716977.0, "pmid_date_1": 2012.0, "pmid_journal_1": "The New England journal of medicine"}]}, {"_id": "3535-OMIM:613679", "condition": {"condition_name": "PROTHROMBIN DEFICIENCY, CONGENITAL", "freq_per_birth": "Prothrombin deficiency is very rare; it is estimated to affect 1 in 2 million people in the general population.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["PROTHROMBIN DEFICIENCY, CONGENITAL", "THROMBOPHILIA DUE TO THROMBIN DEFECT; THPH1"]}, "gene information": {"db_hgnc_gene_id": 3535.0}, "interventions": [{"int_description_1": "Factor IX Complex (Human)"}, {"int_description_2": "Low molecular weight heparin (LMWH)"}, {"int_description_3": "Fresh frozen plasma transfusion", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Paradoxical bleeding and thrombotic episodes of dysprothrombinaemia due to a homozygous Arg382His mutation.", "pmid_1": 27975099.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Thrombosis and haemostasis"}, {"pmid_title_2": "Congenital factor II deficiency: moroccan cases.", "pmid_2": 23190616.0, "pmid_date_2": 2013.0, "pmid_journal_2": "International journal of laboratory hematology"}, {"pmid_title_3": "Prophylactic administration of prothrombin complex concentrates for congenital prothrombin deficiency with a novel frameshift mutation, prothrombin saitama.", "pmid_3": 23152198.0, "pmid_date_3": 2013.0, "pmid_journal_3": "Pediatric blood & cancer"}, {"pmid_title_4": "A severe neonatal presentation of factor II deficiency.", "pmid_4": 21692854.0, "pmid_date_4": 2011.0, "pmid_journal_4": "European journal of haematology"}]}, {"_id": "3546-OMIM:306700", "condition": {"condition_name": "HEMOPHILIA A", "freq_per_birth": "The two major forms of hemophilia occur much more commonly in males than in females. Hemophilia A is the most common type of the condition; 1 in 4,000 to 1 in 5,000 males worldwide are born with this disorder. Hemophilia B occurs in approximately 1 in 20,000 newborn males worldwide.", "pattern_of_inheritance": "X-linked recessive", "alternate_names": ["HEMOPHILIA A"]}, "gene information": {"db_hgnc_gene_id": 3546.0}, "interventions": [{"int_description_1": "Desmopressin", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Aminocaproic acid"}, {"int_description_3": "Tranexamic acid"}, {"int_description_4": "Antifibrinolytic"}, {"int_description_5": "Coagulation factor VIIa Recombinant Human"}, {"int_description_6": "Blood transfusion"}, {"int_description_7": "FVII concentrates"}, {"int_description_8": "FVIII replacement therapy, FVII concentrates"}, {"int_description_9": "FVIII replacement, FVII concentrates"}, {"int_description_10": "Immune tolerance induction"}, {"int_description_11": "Immune tolerance therapy"}, {"int_description_12": "Plasma derived factor VIII"}, {"int_description_13": "Recombinant factor VIII"}, {"int_description_14": "Recombinant FVIII"}], "references": [{"pmid_title_1": "Hemophilia A", "pmid_1": 29261993.0, "pmid_date_1": 2021.0, "pmid_journal_1": "statpearls"}, {"pmid_title_2": "Recurrent and novel disease-causing F8 variants in boys with severe haemophilia A in Poland.", "pmid_2": 31134694.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Haemophilia"}, {"pmid_title_3": "Desmopressin in moderate hemophilia A patients: a treatment worth considering.", "pmid_3": 29305412.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Haematologica"}, {"pmid_title_4": "Inhibitor Risk Stratification and Individualized Treatment in Patients With Nonsevere Hemophilia A: A Single-Institution Practice Audit.", "pmid_4": 29108420.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Clin Appl Thromb Hemost"}, {"pmid_title_5": "Combined deficiency of factors V and VIII by chance coinheritance of parahaemophilia and haemophilia A, but not by mutations of either LMAN1 or MCFD2, in a Japanese family.", "pmid_5": 29082580.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Haemophilia"}, {"pmid_title_6": "Hemophilia A", "pmid_6": 20301578.0, "pmid_date_6": 2017.0, "pmid_journal_6": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_7": "Outcomes in Patients With Hemophilia and von Willebrand Disease Undergoing Invasive or Surgical Procedures.", "pmid_7": 27418638.0, "pmid_date_7": 2017.0, "pmid_journal_7": "Clin Appl Thromb Hemost"}, {"pmid_title_8": "Specific and global coagulation tests in patients with mild haemophilia A with a double mutation (Glu113Asp, Arg593Cys).", "pmid_8": 26057490.0, "pmid_date_8": 2015.0, "pmid_journal_8": "Blood Transfus"}, {"pmid_title_9": "Factor VIII mutation and desmopressin-responsiveness in 62 patients with mild haemophilia A.", "pmid_9": 23711294.0, "pmid_date_9": 2013.0, "pmid_journal_9": "Haemophilia"}, {"pmid_title_10": "Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A.", "pmid_10": 19719828.0, "pmid_date_10": 2009.0, "pmid_journal_10": "J Thromb Haemost"}, {"pmid_title_11": "Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors.", "pmid_11": 19740093.0, "pmid_date_11": 2009.0, "pmid_journal_11": "J Thromb Haemost"}]}, {"_id": "3551-OMIM:306900", "condition": {"condition_name": "HEMOPHILIA B", "freq_per_birth": "The two major forms of hemophilia occur much more commonly in males than in females. Hemophilia A is the most common type of the condition; 1 in 4,000 to 1 in 5,000 males worldwide are born with this disorder. Hemophilia B occurs in approximately 1 in 20,000 newborn males worldwide.", "pattern_of_inheritance": "X-linked recessive", "alternate_names": ["HEMOPHILIA B"]}, "gene information": {"db_hgnc_gene_id": 3551.0}, "interventions": [{"int_description_1": "Heparin"}, {"int_description_2": "Coagulation Factor IX (Recombinant)", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Albutrepenonacog alfa", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Nonacog beta pegol"}, {"int_description_5": "Aminocaproic acid"}, {"int_description_6": "Rituximab"}, {"int_description_7": "Geneticin"}, {"int_description_8": "Gentamicin"}, {"int_description_9": "Mycophenolate mofetil"}, {"int_description_10": "Tranexamic acid"}, {"int_description_11": "Warfarin"}, {"int_description_12": "Ataluren"}, {"int_description_13": "Coagulation factor VIIa Recombinant Human"}, {"int_description_14": "Factor IX Complex (Human)", "timeframe_int14": "Hours,Days or Weeks", "age_use_int14": "Child", "qualscale_reclass_drug14": "Case report(s)", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}, {"int_description_15": "Monoclonal antibodies"}, {"int_description_16": "Recombinant Factor IX-Transferrin Fusion Protein ( rFIX-Tf/G2)"}, {"int_description_17": "AAV-FIX"}, {"int_description_18": "AMT-060 (gene therapy)"}, {"int_description_19": "eRF1-ASO"}, {"int_description_20": "eRF3a-ASO"}, {"int_description_21": "FIX concentrates"}, {"int_description_22": "Fresh frozen plasma"}, {"int_description_23": "Hepatic gene transfer-based ITI"}, {"int_description_24": "Human full-length F9 cDNA was inserted into the AAVS1 locus of iPSCs of a hemophilia B patient using the CRISPR-Cas9 system"}, {"int_description_25": "Immune tolerance induction"}, {"int_description_26": "Plasmapheresis"}, {"int_description_27": "Replacement of factor IX"}, {"int_description_28": "rIX-FP", "timeframe_int28": "Hours,Days or Weeks", "age_use_int28": "Child", "contra_int28": "No", "qualscale_reclass_drug28": "Case report(s)", "rev1_eff_reclass_drug28": "Effective / Ameliorative"}, {"int_description_29": "The point mutation in those iPSCs was genetically corrected using CRISPR/Cas9 technology"}, {"int_description_30": "Liver transplant + continuous rFIX infusion"}], "references": [{"pmid_title_1": "Hemophilia B", "pmid_1": 32809627.0, "pmid_date_1": 2021.0, "pmid_journal_1": "StatPearls"}, {"pmid_title_2": "Factor IX alteration p.Arg338Gln (FIX Shanghai) potentiates FIX clotting activity and causes thrombosis.", "pmid_2": 32079698.0, "pmid_date_2": 2021.0, "pmid_journal_2": "Haematologica"}, {"pmid_title_3": "The Liver That Cured Christmas: Case Report of Orthotopic Liver Transplant in a Patient with Hemophilia B.", "pmid_3": 32257502.0, "pmid_date_3": 2020.0, "pmid_journal_3": "Case Rep Transplant"}, {"pmid_title_4": "Long-Term Safety and Efficacy of Nonacog Beta Pegol (N9-GP) Administered for at Least 5 Years in Previously Treated Children with Hemophilia B.", "pmid_4": 32369845.0, "pmid_date_4": 2020.0, "pmid_journal_4": "Thromb Haemost"}, {"pmid_title_5": "Long-term safety and efficacy of rIX-FP prophylaxis with extended dosing intervals up to 21\u00a0days in adults/adolescents with hemophilia B.", "pmid_5": 32078256.0, "pmid_date_5": 2020.0, "pmid_journal_5": "J Thromb Haemost"}, {"pmid_title_6": "Real-World Utilisation and Bleed Rates in Patients with Haemophilia B Who Switched to Recombinant Factor IX Fusion Protein (rIX-FP): A Retrospective International Analysis.", "pmid_6": 32333327.0, "pmid_date_6": 2020.0, "pmid_journal_6": "Adv Ther"}, {"pmid_title_7": "Targeting Translation Termination Machinery with Antisense Oligonucleotides for Diseases Caused by Nonsense Mutations.", "pmid_7": 31070517.0, "pmid_date_7": 2019.0, "pmid_journal_7": "Nucleic Acid Ther"}, {"pmid_title_8": "Identification of candidate nonsense mutations of FVIII for ribosomal readthrough therapy.", "pmid_8": 31004034.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Haematologica"}, {"pmid_title_9": "Discovery of An Orally Effective Factor IX-Transferrin Fusion Protein for Hemophilia B.", "pmid_9": 31861459.0, "pmid_date_9": 2019.0, "pmid_journal_9": "Int J Mol Sci"}, {"pmid_title_10": "Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B.", "pmid_10": 29246900.0, "pmid_date_10": 2018.0, "pmid_journal_10": "Blood"}, {"pmid_title_11": "Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.", "pmid_11": 29625575.0, "pmid_date_11": 2018.0, "pmid_journal_11": "Stem Cell Res Ther"}, {"pmid_title_12": "Hemophilia B", "pmid_12": 20301668.0, "pmid_date_12": 2017.0, "pmid_journal_12": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_13": "Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations.", "pmid_13": 28196793.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Blood"}, {"pmid_title_14": "Genetic Correction and Hepatic Differentiation of Hemophilia B-specific Human Induced Pluripotent Stem Cells.", "pmid_14": 28956740.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Chin Med Sci J"}, {"pmid_title_15": "Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Results of a phase 3 trial.", "pmid_15": 27583313.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Thromb Haemost"}, {"pmid_title_16": "Genetic determinants of immunogenicity to factor IX during the treatment of haemophilia B.", "pmid_16": 25470321.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Haemophilia"}, {"pmid_title_17": "Risk factors associated with inhibitor development in Chinese patients with haemophilia B.", "pmid_17": 25929987.0, "pmid_date_17": 2015.0, "pmid_journal_17": "Haemophilia"}, {"pmid_title_18": "Effective gene therapy for haemophilic mice with pathogenic factor IX antibodies.", "pmid_18": 24106230.0, "pmid_date_18": 2013.0, "pmid_journal_18": "EMBO Mol Med"}, {"pmid_title_19": "Adenovirus-associated virus vector-mediated gene transfer in hemophilia B.", "pmid_19": 22149959.0, "pmid_date_19": 2011.0, "pmid_journal_19": "N Engl J Med"}, {"pmid_title_20": "X-linked thrombophilia with a mutant factor IX (factor IX Padua).", "pmid_20": 19846852.0, "pmid_date_20": 2009.0, "pmid_journal_20": "N Engl J Med"}, {"pmid_title_21": "Skewed X chromosome inactivation in fraternal female twins results in moderately severe and mild haemophilia B.", "pmid_21": 18540891.0, "pmid_date_21": 2008.0, "pmid_journal_21": "Haemophilia"}, {"pmid_title_22": "A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticin.", "pmid_22": 17881586.0, "pmid_date_22": 2007.0, "pmid_journal_22": "Proc Natl Acad Sci U S A"}, {"pmid_title_23": "Clinical gene transfer studies for hemophilia B.", "pmid_23": 15118937.0, "pmid_date_23": 2004.0, "pmid_journal_23": "Semin Thromb Hemost"}]}, {"_id": "3579-OMIM:276700", "condition": {"condition_name": "TYROSINEMIA, TYPE I; TYRSN1", "freq_per_birth": "Worldwide, tyrosinemia type I affects about 1 in 100,000 individuals. This type is more common in Norway where 1 in 60,000 to 74,000 individuals are affected. Tyrosinemia type I is even more common in Quebec, Canada where it occurs in about 1 in 16,000 individuals. In the Saguenay-Lac St. Jean region of Quebec, tyrosinemia type I affects 1 in 1,846 people.Tyrosinemia type II occurs in fewer than 1 in 250,000 individuals worldwide. Tyrosinemia type III is very rare; only a few cases have been reported.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["TYROSINEMIA, TYPE I; TYRSN1"]}, "gene information": {"db_hgnc_gene_id": 3579.0}, "interventions": [{"int_description_1": "Phenylalanine/tyrosine -restricted diet and Phenylalanine supplementation"}, {"int_description_2": "Phenylalanine/tyrosine-restricted diet", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Cohort study or studies", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Vitamin D", "timeframe_int3": "Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Nitisinone"}, {"int_description_5": "Phenylalanine", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Orthotopic liver transplantation (OLT)"}], "references": [{"pmid_title_1": "Living-donor liver transplantation for children with tyrosinemia type I.", "pmid_1": 31953907.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Journal of digestive diseases"}, {"pmid_title_2": "Clinical Review Report: Nitisinone (Nitisinone Tablets): (Cycle Pharmaceuticals Ltd.): Indication: For the treatment of patients with hereditary tyrosinemia type 1 in combination with dietary restriction of tyrosine and phenylalanine", "pmid_2": 30973686.0, "pmid_date_2": 2019.0, "pmid_journal_2": "CADTH Common Drug Reviews"}, {"pmid_title_3": "Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain.", "pmid_3": 31574857.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Medicine"}, {"pmid_title_4": "Mutational spectrum of Mexican patients with tyrosinemia type 1: In silico modeling and predicted pathogenic effect of a novel missense FAH variant.", "pmid_4": 31568711.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Molecular genetics & genomic medicine"}, {"pmid_title_5": "Live donor liver transplantation for type 1 tyrosinemia: An analysis of 15 patients.", "pmid_5": 31155831.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Pediatric transplantation"}, {"pmid_title_6": "The Liver in Tyrosinemia Type I: Clinical Management and Course in Quebec.", "pmid_6": 28755185.0, "pmid_date_6": 2017.0, "pmid_journal_6": "Advances in experimental medicine and biology"}, {"pmid_title_7": "Liver Cancer in Tyrosinemia Type 1.", "pmid_7": 28755188.0, "pmid_date_7": 2017.0, "pmid_journal_7": "Advances in experimental medicine and biology"}, {"pmid_title_8": "Tyrosinemia Type I", "pmid_8": 20301688.0, "pmid_date_8": 2017.0, "pmid_journal_8": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_9": "Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations.", "pmid_9": 28771246.0, "pmid_date_9": 2017.0, "pmid_journal_9": "Genetics in medicine : official journal of the American College of Medical Genetics"}, {"pmid_title_10": "Tyrosinemia and Liver Transplantation: Experience at CHU Sainte-Justine.", "pmid_10": 28755184.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Advances in experimental medicine and biology"}, {"pmid_title_11": "Dietary Considerations in Tyrosinemia Type I.", "pmid_11": 28755197.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Advances in experimental medicine and biology"}, {"pmid_title_12": "Tyrosinemia Type I in Japan: A Report of Five Cases.", "pmid_12": 28755191.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Advances in experimental medicine and biology"}, {"pmid_title_13": "A novel homozygous mutation causing hereditary tyrosinemia type I in yakut patient in russia: case report.", "pmid_13": 27487552.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Wiadomosci lekarskie (Warsaw, Poland : 1960)"}, {"pmid_title_14": "The outcome of seven patients with hereditary tyrosinemia type 1.", "pmid_14": 27682708.0, "pmid_date_14": 2016.0, "pmid_journal_14": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_15": "Tyrosinemia type I: Case series with response to treatment to NTBC.", "pmid_15": 27109516.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology"}, {"pmid_title_16": "Infants with Tyrosinemia Type 1: Should phenylalanine be supplemented?", "pmid_16": 25256450.0, "pmid_date_16": 2015.0, "pmid_journal_16": "JIMD reports"}, {"pmid_title_17": "Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice.", "pmid_17": 25081276.0, "pmid_date_17": 2014.0, "pmid_journal_17": "Orphanet journal of rare diseases"}, {"pmid_title_18": "Recommendations for the management of tyrosinaemia type 1.", "pmid_18": 23311542.0, "pmid_date_18": 2013.0, "pmid_journal_18": "Orphanet journal of rare diseases"}, {"pmid_title_19": "Biochemical and molecular diagnosis of tyrosinemia type I with two novel FAH mutations in a Hong Kong chinese patient: recommendation for expanded newborn screening in Hong Kong.", "pmid_19": 23000314.0, "pmid_date_19": 2013.0, "pmid_journal_19": "Clinical biochemistry"}, {"pmid_title_20": "Single dose NTBC-treatment of hereditary tyrosinemia type I.", "pmid_20": 22307209.0, "pmid_date_20": 2012.0, "pmid_journal_20": "Journal of inherited metabolic disease"}, {"pmid_title_21": "Tyrosinemia type I: long-term outcome in a patient treated with doses of NTBC lower than recommended.", "pmid_21": 21340489.0, "pmid_date_21": 2011.0, "pmid_journal_21": "European journal of pediatrics"}, {"pmid_title_22": "Liver transplantation for hereditary tyrosinemia type I: analysis of the UNOS database.", "pmid_22": 21504522.0, "pmid_date_22": 2011.0, "pmid_journal_22": "Pediatric transplantation"}]}, {"_id": "3582-OMIM:227650", "condition": {"condition_name": "FANCONI ANEMIA, COMPLEMENTATION GROUP A", "pattern_of_inheritance": "X-linked recessive, Autosomal recessive", "alternate_names": ["FANCONI ANEMIA, COMPLEMENTATION GROUP A"]}, "gene information": {"db_hgnc_gene_id": 3582.0}, "interventions": [{"int_description_1": "Healthy diet"}, {"int_description_2": "Oxandrolone"}, {"int_description_3": "Danazol"}, {"int_description_4": "Testosterone propionate"}, {"int_description_5": "Oxymetholone"}, {"int_description_6": "Metenolone"}, {"int_description_7": "Calcium"}, {"int_description_8": "Prednisone"}, {"int_description_9": "Dexamethasone"}, {"int_description_10": "Insulin aspart"}, {"int_description_11": "Medroxyprogesterone acetate"}, {"int_description_12": "Tretinoin"}, {"int_description_13": "Eltrombopag"}, {"int_description_14": "Levothyroxine"}, {"int_description_15": "Estradiol"}, {"int_description_16": "Cetuximab"}, {"int_description_17": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_18": "Alemtuzumab"}, {"int_description_19": "Coenzyme M"}, {"int_description_20": "Cyclosporine"}, {"int_description_21": "Dactinomycin"}, {"int_description_22": "Sirolimus"}, {"int_description_23": "Somatotropin"}, {"int_description_24": "Vitamin D"}, {"int_description_25": "Cyclophosphamide"}, {"int_description_26": "Carboplatin"}, {"int_description_27": "Busulfan"}, {"int_description_28": "Ifosfamide"}, {"int_description_29": "Thiotepa"}, {"int_description_30": "Doxorubicin"}, {"int_description_31": "Fluorouracil", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Mercaptopurine", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Neonate,Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Trimethoprim"}, {"int_description_34": "Sulfamethoxazole"}, {"int_description_35": "Gemcitabine"}, {"int_description_36": "Vincristine"}, {"int_description_37": "Methotrexate"}, {"int_description_38": "Fludarabine"}, {"int_description_39": "Cytarabine"}, {"int_description_40": "Irinotecan"}, {"int_description_41": "Daunorubicin"}, {"int_description_42": "Etoposide"}, {"int_description_43": "Idarubicin"}, {"int_description_44": "Tacrolimus"}, {"int_description_45": "Acyclovir"}, {"int_description_46": "Quercetin"}, {"int_description_47": "Tioguanine"}, {"int_description_48": "Mycophenolate mofetil"}, {"int_description_49": "Tranexamic acid"}, {"int_description_50": "Hydroxyurea"}, {"int_description_51": "Methylprednisolone"}, {"int_description_52": "Methyltestosterone"}, {"int_description_53": "Leucovorin"}, {"int_description_54": "Vinorelbine"}, {"int_description_55": "Deferasirox"}, {"int_description_56": "Deferiprone"}, {"int_description_57": "Co-trimoxazole"}, {"int_description_58": "Asparaginase Escherichia coli"}, {"int_description_59": "Cisplatin"}, {"int_description_60": "Antilymphocyte immunoglobulin (horse)"}, {"int_description_61": "Norethandrolone"}, {"int_description_62": "Phosphorus"}, {"int_description_63": "GM-CSF (granulocyte-macrophage colony-stimulating factor)"}, {"int_description_64": "rh-SOD"}, {"int_description_65": "Bevacizumab"}, {"int_description_66": "Filgrastim"}, {"int_description_67": "Amifostine"}, {"int_description_68": "Radiation therapy"}, {"int_description_69": "Stem cell gene therapy", "timeframe_int69": "Days or Weeks,Years", "age_use_int69": "Child", "contra_int69": "No", "qualscale_reclass_drug69": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug69": "Effective / Ameliorative"}, {"int_description_70": "Total abdominal radiation"}, {"int_description_71": "Total body irradiation"}, {"int_description_72": "Total lymphoid irradiation"}, {"int_description_73": "Transfusion of blood products"}, {"int_description_74": "Bone marrow transplantation"}, {"int_description_75": "Hematopoietic stem cell transplantation"}, {"int_description_76": "Surgery for polydactyly, carpectomy"}, {"int_description_77": "Surgical intervention"}, {"int_description_78": "\u042burgical tumor removement"}], "references": [{"pmid_title_1": "Gingival Bleeding in a Child with Fanconi Anemia: A Case Report and Literature Review.", "pmid_1": 32231808.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Case Rep Dent"}, {"pmid_title_2": "Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.", "pmid_2": 29668547.0, "pmid_date_2": 2019.0, "pmid_journal_2": "J Pediatr Hematol Oncol"}, {"pmid_title_3": "Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.", "pmid_3": 31192125.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Front Oncol"}, {"pmid_title_4": "Fanconi anemia: a single center experience of a large cohort.", "pmid_4": 31990462.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Turk J Pediatr"}, {"pmid_title_5": "Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia.", "pmid_5": 31501599.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Nat Med"}, {"pmid_title_6": "Therapeutic research in the crystal chromosome disease Fanconi anemia.", "pmid_6": 30389152.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Mutat Res Genet Toxicol Environ Mutagen"}, {"pmid_title_7": "Oral cancer in Fanconi anemia: Review of 121 cases.", "pmid_7": 29650274.0, "pmid_date_7": 2018.0, "pmid_journal_7": "Crit Rev Oncol Hematol"}, {"pmid_title_8": "Essential Role of BRCA2 in Ovarian Development and Function.", "pmid_8": 30207912.0, "pmid_date_8": 2018.0, "pmid_journal_8": "N Engl J Med"}, {"pmid_title_9": "Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.", "pmid_9": 29203412.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Biol Blood Marrow Transplant"}, {"pmid_title_10": "How I manage patients with Fanconi anaemia.", "pmid_10": 28474441.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Br J Haematol"}, {"pmid_title_11": "Eltrombopag for the treatment of aplastic anemia: current perspectives.", "pmid_11": 27695288.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Drug Des Devel Ther"}, {"pmid_title_12": "Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.", "pmid_12": 27246371.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Biol Blood Marrow Transplant"}, {"pmid_title_13": "Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.", "pmid_13": 26900943.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Pediatr Hematol Oncol"}, {"pmid_title_14": "Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.", "pmid_14": 26657402.0, "pmid_date_14": 2016.0, "pmid_journal_14": "Eur J Med Genet"}, {"pmid_title_15": "Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.", "pmid_15": 25575015.0, "pmid_date_15": 2015.0, "pmid_journal_15": "J Clin Endocrinol Metab"}, {"pmid_title_16": "Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.", "pmid_16": 25862235.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Ann Hematol"}, {"pmid_title_17": "Alternative donor hematopoietic cell transplantation for Fanconi anemia.", "pmid_17": 25824692.0, "pmid_date_17": 2015.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Fanconi anemia and solid malignancies in childhood: a national retrospective study.", "pmid_18": 25381700.0, "pmid_date_18": 2015.0, "pmid_journal_18": "Pediatr Blood Cancer"}, {"pmid_title_19": "Phase I/II Gene Therapy Trial of Fanconi Anemia Patients with a New Orphan Drug Consisting of a Lentiviral Vector Carrying the FANCA Gene: A Coordinated International Action (EuroFancolen).", "pmid_19": 26086753.0, "pmid_date_19": 2015.0, "pmid_journal_19": "Hum Gene Ther Clin Dev"}, {"pmid_title_20": "Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.", "pmid_20": 25531282.0, "pmid_date_20": 2015.0, "pmid_journal_20": "Bone Marrow Transplant"}, {"pmid_title_21": "Clear cell sarcoma of the kidney in a child with Fanconi anemia.", "pmid_21": 24735155.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Pediatr Dev Pathol"}, {"pmid_title_22": "Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.", "pmid_22": 25085358.0, "pmid_date_22": 2014.0, "pmid_journal_22": "Haematologica"}, {"pmid_title_23": "Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.", "pmid_23": 24019220.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Pediatr Blood Cancer"}, {"pmid_title_24": "Management of dental extraction in a female patient with fanconi anemia.", "pmid_24": 25628690.0, "pmid_date_24": 2014.0, "pmid_journal_24": "J Dent (Tehran)"}, {"pmid_title_25": "Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature.", "pmid_25": 22965917.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Head Neck"}, {"pmid_title_26": "Deferasirox therapy in children with Fanconi aplastic anemia.", "pmid_26": 22510772.0, "pmid_date_26": 2012.0, "pmid_journal_26": "J Pediatr Hematol Oncol"}, {"pmid_title_27": "Fatal course of tonsillar squamous cell carcinoma associated with Fanconi anaemia: a mini review.", "pmid_27": 21925890.0, "pmid_date_27": 2012.0, "pmid_journal_27": "J Craniomaxillofac Surg"}, {"pmid_title_28": "Treatment of the bone marrow failure in Fanconi anemia patients with danazol.", "pmid_28": 22178060.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Blood Cells Mol Dis"}, {"pmid_title_29": "Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing.", "pmid_29": 21519011.0, "pmid_date_29": 2011.0, "pmid_journal_29": "J Clin Oncol"}, {"pmid_title_30": "Successful treatment of esophageal squamous cell carcinoma in a patient with Fanconi anemia.", "pmid_30": 20410055.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Jpn J Clin Oncol"}, {"pmid_title_31": "Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.", "pmid_31": 19564748.0, "pmid_date_31": 2009.0, "pmid_journal_31": "J Pediatr Hematol Oncol"}, {"pmid_title_32": "Treatment with deferiprone for iron overload alleviates bone marrow failure in a Fanconi anemia patient.", "pmid_32": 19814681.0, "pmid_date_32": 2009.0, "pmid_journal_32": "Hemoglobin"}, {"pmid_title_33": "Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.", "pmid_33": 18302713.0, "pmid_date_33": 2008.0, "pmid_journal_33": "Br J Haematol"}, {"pmid_title_34": "Thrombocytopenia in the neonate.", "pmid_34": 18433954.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.", "pmid_35": 18379369.0, "pmid_date_35": 2008.0, "pmid_journal_35": "J Thorac Oncol"}, {"pmid_title_36": "Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function.", "pmid_36": 18623197.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Pediatr Blood Cancer"}, {"pmid_title_37": "Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.", "pmid_37": 18831513.0, "pmid_date_37": 2008.0, "pmid_journal_37": "Cancer"}, {"pmid_title_38": "Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.", "pmid_38": 17950918.0, "pmid_date_38": 2007.0, "pmid_journal_38": "Biol Blood Marrow Transplant"}, {"pmid_title_39": "Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.", "pmid_39": 17038525.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Blood"}, {"pmid_title_40": "Chemotherapy for myeloid malignancy in children with Fanconi anemia.", "pmid_40": 16609946.0, "pmid_date_40": 2007.0, "pmid_journal_40": "Pediatr Blood Cancer"}, {"pmid_title_41": "A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.", "pmid_41": 17096012.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Leukemia"}, {"pmid_title_42": "HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.", "pmid_42": 18022575.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Biol Blood Marrow Transplant"}, {"pmid_title_43": "Stem cell collection and gene transfer in Fanconi anemia.", "pmid_43": 17164793.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Mol Ther"}, {"pmid_title_44": "Anesthesia and Fanconi anemia: a case report and review of literature.", "pmid_44": 16918663.0, "pmid_date_44": 2006.0, "pmid_journal_44": "Paediatr Anaesth"}, {"pmid_title_45": "Squamous cell carcinoma of the hypopharynx in a young woman with Fanconi's anemia.", "pmid_45": 17308840.0, "pmid_date_45": 2006.0, "pmid_journal_45": "Braz J Otorhinolaryngol"}, {"pmid_title_46": "Squamous cell vulvar carcinoma associated with Fanconi's anemia: a case report.", "pmid_46": 11975685.0, "pmid_date_46": 2002.0, "pmid_journal_46": "Int J Gynecol Cancer"}, {"pmid_title_47": "Growth hormone deficiency caused by pituitary stalk interruption in Fanconi's anemia.", "pmid_47": 11148528.0, "pmid_date_47": 2001.0, "pmid_journal_47": "J Pediatr"}, {"pmid_title_48": "Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.", "pmid_48": 9658728.0, "pmid_date_48": 1998.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.", "pmid_49": 8781414.0, "pmid_date_49": 1996.0, "pmid_journal_49": "Blood"}, {"pmid_title_50": "GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.", "pmid_50": 7644282.0, "pmid_date_50": 1995.0, "pmid_journal_50": "Pediatr Nurs"}, {"pmid_title_51": "Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.", "pmid_51": 8283365.0, "pmid_date_51": 1994.0, "pmid_journal_51": "J Pediatr"}, {"pmid_title_52": "A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia.", "pmid_52": 8280614.0, "pmid_date_52": 1993.0, "pmid_journal_52": "Br J Haematol"}, {"pmid_title_53": "Fanconi's anemia. A family study with 20-year follow-up including associated breast pathology.", "pmid_53": 6478420.0, "pmid_date_53": 1984.0, "pmid_journal_53": "Cancer"}, {"pmid_title_54": "Multiple hepatic tumors and peliosis hepatis in Fanconi's anemia treated with androgens.", "pmid_54": 199056.0, "pmid_date_54": 1977.0, "pmid_journal_54": "Am J Dis Child"}, {"pmid_title_55": "Hepatic lesions in patients treated with synthetic anabolic steriods.", "pmid_55": 185239.0, "pmid_date_55": 1976.0, "pmid_journal_55": "J Clin Pathol"}, {"pmid_title_56": "The defective absorption of phosphorus and calcium and the effect of vitamin D in the Fanconi syndrome.", "pmid_56": 13610080.0, "pmid_date_56": 1958.0, "pmid_journal_56": "Guys Hosp Rep"}]}, {"_id": "3583-OMIM:300514", "condition": {"condition_name": "FANCONI ANEMIA, COMPLEMENTATION GROUP B", "pattern_of_inheritance": "X-linked recessive, Autosomal recessive", "alternate_names": ["FANCONI ANEMIA, COMPLEMENTATION GROUP B", "VACTERL with hydrocephalus"]}, "gene information": {"db_hgnc_gene_id": 3583.0}, "interventions": [{"int_description_1": "Healthy diet"}, {"int_description_2": "Oxandrolone"}, {"int_description_3": "Danazol"}, {"int_description_4": "Testosterone propionate"}, {"int_description_5": "Oxymetholone"}, {"int_description_6": "Metenolone"}, {"int_description_7": "Calcium"}, {"int_description_8": "Prednisone"}, {"int_description_9": "Dexamethasone"}, {"int_description_10": "Insulin aspart"}, {"int_description_11": "Medroxyprogesterone acetate"}, {"int_description_12": "Tretinoin"}, {"int_description_13": "Eltrombopag"}, {"int_description_14": "Levothyroxine"}, {"int_description_15": "Estradiol"}, {"int_description_16": "Cetuximab"}, {"int_description_17": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_18": "Alemtuzumab"}, {"int_description_19": "Coenzyme M"}, {"int_description_20": "Cyclosporine"}, {"int_description_21": "Dactinomycin"}, {"int_description_22": "Sirolimus"}, {"int_description_23": "Somatotropin"}, {"int_description_24": "Vitamin D"}, {"int_description_25": "Cyclophosphamide"}, {"int_description_26": "Carboplatin"}, {"int_description_27": "Busulfan"}, {"int_description_28": "Ifosfamide"}, {"int_description_29": "Thiotepa"}, {"int_description_30": "Doxorubicin"}, {"int_description_31": "Fluorouracil", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Mercaptopurine", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Neonate,Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Trimethoprim"}, {"int_description_34": "Sulfamethoxazole"}, {"int_description_35": "Gemcitabine"}, {"int_description_36": "Vincristine"}, {"int_description_37": "Methotrexate"}, {"int_description_38": "Fludarabine"}, {"int_description_39": "Cytarabine"}, {"int_description_40": "Irinotecan"}, {"int_description_41": "Daunorubicin"}, {"int_description_42": "Etoposide"}, {"int_description_43": "Idarubicin"}, {"int_description_44": "Tacrolimus"}, {"int_description_45": "Acyclovir"}, {"int_description_46": "Quercetin"}, {"int_description_47": "Tioguanine"}, {"int_description_48": "Mycophenolate mofetil"}, {"int_description_49": "Tranexamic acid"}, {"int_description_50": "Hydroxyurea"}, {"int_description_51": "Methylprednisolone"}, {"int_description_52": "Methyltestosterone"}, {"int_description_53": "Leucovorin"}, {"int_description_54": "Vinorelbine"}, {"int_description_55": "Deferasirox"}, {"int_description_56": "Deferiprone"}, {"int_description_57": "Co-trimoxazole"}, {"int_description_58": "Asparaginase Escherichia coli"}, {"int_description_59": "Cisplatin"}, {"int_description_60": "Antilymphocyte immunoglobulin (horse)"}, {"int_description_61": "Norethandrolone"}, {"int_description_62": "Phosphorus"}, {"int_description_63": "GM-CSF (granulocyte-macrophage colony-stimulating factor)"}, {"int_description_64": "rh-SOD"}, {"int_description_65": "Bevacizumab"}, {"int_description_66": "Filgrastim"}, {"int_description_67": "Amifostine"}, {"int_description_68": "Radiation therapy", "timeframe_int68": "Days or Weeks,Years", "age_use_int68": "Child", "contra_int68": "No", "qualscale_reclass_drug68": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug68": "Effective / Ameliorative"}, {"int_description_69": "Total abdominal radiation"}, {"int_description_70": "Total body irradiation"}, {"int_description_71": "Total lymphoid irradiation"}, {"int_description_72": "Transfusion of blood products"}, {"int_description_73": "Bone marrow transplantation"}, {"int_description_74": "Hematopoietic stem cell transplantation"}, {"int_description_75": "Surgery for polydactyly, carpectomy"}, {"int_description_76": "Surgical intervention"}, {"int_description_77": "\u042burgical tumor removement"}], "references": [{"pmid_title_1": "Gingival Bleeding in a Child with Fanconi Anemia: A Case Report and Literature Review.", "pmid_1": 32231808.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Case Rep Dent"}, {"pmid_title_2": "Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.", "pmid_2": 29668547.0, "pmid_date_2": 2019.0, "pmid_journal_2": "J Pediatr Hematol Oncol"}, {"pmid_title_3": "Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.", "pmid_3": 31192125.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Front Oncol"}, {"pmid_title_4": "Fanconi anemia: a single center experience of a large cohort.", "pmid_4": 31990462.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Turk J Pediatr"}, {"pmid_title_5": "Therapeutic research in the crystal chromosome disease Fanconi anemia.", "pmid_5": 30389152.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Mutat Res Genet Toxicol Environ Mutagen"}, {"pmid_title_6": "Oral cancer in Fanconi anemia: Review of 121 cases.", "pmid_6": 29650274.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Crit Rev Oncol Hematol"}, {"pmid_title_7": "Essential Role of BRCA2 in Ovarian Development and Function.", "pmid_7": 30207912.0, "pmid_date_7": 2018.0, "pmid_journal_7": "N Engl J Med"}, {"pmid_title_8": "Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.", "pmid_8": 29203412.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Biol Blood Marrow Transplant"}, {"pmid_title_9": "How I manage patients with Fanconi anaemia.", "pmid_9": 28474441.0, "pmid_date_9": 2017.0, "pmid_journal_9": "Br J Haematol"}, {"pmid_title_10": "Eltrombopag for the treatment of aplastic anemia: current perspectives.", "pmid_10": 27695288.0, "pmid_date_10": 2016.0, "pmid_journal_10": "Drug Des Devel Ther"}, {"pmid_title_11": "Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.", "pmid_11": 27246371.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Biol Blood Marrow Transplant"}, {"pmid_title_12": "Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.", "pmid_12": 26900943.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Pediatr Hematol Oncol"}, {"pmid_title_13": "Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.", "pmid_13": 26657402.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Eur J Med Genet"}, {"pmid_title_14": "Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.", "pmid_14": 25575015.0, "pmid_date_14": 2015.0, "pmid_journal_14": "J Clin Endocrinol Metab"}, {"pmid_title_15": "Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.", "pmid_15": 25862235.0, "pmid_date_15": 2015.0, "pmid_journal_15": "Ann Hematol"}, {"pmid_title_16": "Alternative donor hematopoietic cell transplantation for Fanconi anemia.", "pmid_16": 25824692.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Blood"}, {"pmid_title_17": "Fanconi anemia and solid malignancies in childhood: a national retrospective study.", "pmid_17": 25381700.0, "pmid_date_17": 2015.0, "pmid_journal_17": "Pediatr Blood Cancer"}, {"pmid_title_18": "Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.", "pmid_18": 25531282.0, "pmid_date_18": 2015.0, "pmid_journal_18": "Bone Marrow Transplant"}, {"pmid_title_19": "Clear cell sarcoma of the kidney in a child with Fanconi anemia.", "pmid_19": 24735155.0, "pmid_date_19": 2014.0, "pmid_journal_19": "Pediatr Dev Pathol"}, {"pmid_title_20": "Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.", "pmid_20": 25085358.0, "pmid_date_20": 2014.0, "pmid_journal_20": "Haematologica"}, {"pmid_title_21": "Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.", "pmid_21": 24019220.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Management of dental extraction in a female patient with fanconi anemia.", "pmid_22": 25628690.0, "pmid_date_22": 2014.0, "pmid_journal_22": "J Dent (Tehran)"}, {"pmid_title_23": "Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature.", "pmid_23": 22965917.0, "pmid_date_23": 2013.0, "pmid_journal_23": "Head Neck"}, {"pmid_title_24": "Deferasirox therapy in children with Fanconi aplastic anemia.", "pmid_24": 22510772.0, "pmid_date_24": 2012.0, "pmid_journal_24": "J Pediatr Hematol Oncol"}, {"pmid_title_25": "Fatal course of tonsillar squamous cell carcinoma associated with Fanconi anaemia: a mini review.", "pmid_25": 21925890.0, "pmid_date_25": 2012.0, "pmid_journal_25": "J Craniomaxillofac Surg"}, {"pmid_title_26": "Treatment of the bone marrow failure in Fanconi anemia patients with danazol.", "pmid_26": 22178060.0, "pmid_date_26": 2012.0, "pmid_journal_26": "Blood Cells Mol Dis"}, {"pmid_title_27": "Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing.", "pmid_27": 21519011.0, "pmid_date_27": 2011.0, "pmid_journal_27": "J Clin Oncol"}, {"pmid_title_28": "Successful treatment of esophageal squamous cell carcinoma in a patient with Fanconi anemia.", "pmid_28": 20410055.0, "pmid_date_28": 2010.0, "pmid_journal_28": "Jpn J Clin Oncol"}, {"pmid_title_29": "Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.", "pmid_29": 19564748.0, "pmid_date_29": 2009.0, "pmid_journal_29": "J Pediatr Hematol Oncol"}, {"pmid_title_30": "Treatment with deferiprone for iron overload alleviates bone marrow failure in a Fanconi anemia patient.", "pmid_30": 19814681.0, "pmid_date_30": 2009.0, "pmid_journal_30": "Hemoglobin"}, {"pmid_title_31": "Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.", "pmid_31": 18302713.0, "pmid_date_31": 2008.0, "pmid_journal_31": "Br J Haematol"}, {"pmid_title_32": "Thrombocytopenia in the neonate.", "pmid_32": 18433954.0, "pmid_date_32": 2008.0, "pmid_journal_32": "Blood Rev"}, {"pmid_title_33": "Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.", "pmid_33": 18379369.0, "pmid_date_33": 2008.0, "pmid_journal_33": "J Thorac Oncol"}, {"pmid_title_34": "Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function.", "pmid_34": 18623197.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Pediatr Blood Cancer"}, {"pmid_title_35": "Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.", "pmid_35": 18831513.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Cancer"}, {"pmid_title_36": "Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.", "pmid_36": 17950918.0, "pmid_date_36": 2007.0, "pmid_journal_36": "Biol Blood Marrow Transplant"}, {"pmid_title_37": "Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.", "pmid_37": 17038525.0, "pmid_date_37": 2007.0, "pmid_journal_37": "Blood"}, {"pmid_title_38": "Chemotherapy for myeloid malignancy in children with Fanconi anemia.", "pmid_38": 16609946.0, "pmid_date_38": 2007.0, "pmid_journal_38": "Pediatr Blood Cancer"}, {"pmid_title_39": "A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.", "pmid_39": 17096012.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Leukemia"}, {"pmid_title_40": "HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.", "pmid_40": 18022575.0, "pmid_date_40": 2007.0, "pmid_journal_40": "Biol Blood Marrow Transplant"}, {"pmid_title_41": "Anesthesia and Fanconi anemia: a case report and review of literature.", "pmid_41": 16918663.0, "pmid_date_41": 2006.0, "pmid_journal_41": "Paediatr Anaesth"}, {"pmid_title_42": "Squamous cell carcinoma of the hypopharynx in a young woman with Fanconi's anemia.", "pmid_42": 17308840.0, "pmid_date_42": 2006.0, "pmid_journal_42": "Braz J Otorhinolaryngol"}, {"pmid_title_43": "Squamous cell vulvar carcinoma associated with Fanconi's anemia: a case report.", "pmid_43": 11975685.0, "pmid_date_43": 2002.0, "pmid_journal_43": "Int J Gynecol Cancer"}, {"pmid_title_44": "Growth hormone deficiency caused by pituitary stalk interruption in Fanconi's anemia.", "pmid_44": 11148528.0, "pmid_date_44": 2001.0, "pmid_journal_44": "J Pediatr"}, {"pmid_title_45": "Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.", "pmid_45": 9658728.0, "pmid_date_45": 1998.0, "pmid_journal_45": "Haematologica"}, {"pmid_title_46": "Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.", "pmid_46": 8781414.0, "pmid_date_46": 1996.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.", "pmid_47": 7644282.0, "pmid_date_47": 1995.0, "pmid_journal_47": "Pediatr Nurs"}, {"pmid_title_48": "Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.", "pmid_48": 8283365.0, "pmid_date_48": 1994.0, "pmid_journal_48": "J Pediatr"}, {"pmid_title_49": "A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia.", "pmid_49": 8280614.0, "pmid_date_49": 1993.0, "pmid_journal_49": "Br J Haematol"}, {"pmid_title_50": "Fanconi's anemia. A family study with 20-year follow-up including associated breast pathology.", "pmid_50": 6478420.0, "pmid_date_50": 1984.0, "pmid_journal_50": "Cancer"}, {"pmid_title_51": "Multiple hepatic tumors and peliosis hepatis in Fanconi's anemia treated with androgens.", "pmid_51": 199056.0, "pmid_date_51": 1977.0, "pmid_journal_51": "Am J Dis Child"}, {"pmid_title_52": "Hepatic lesions in patients treated with synthetic anabolic steriods.", "pmid_52": 185239.0, "pmid_date_52": 1976.0, "pmid_journal_52": "J Clin Pathol"}, {"pmid_title_53": "The defective absorption of phosphorus and calcium and the effect of vitamin D in the Fanconi syndrome.", "pmid_53": 13610080.0, "pmid_date_53": 1958.0, "pmid_journal_53": "Guys Hosp Rep"}]}, {"_id": "3583-ORPHA:3412", "condition": {"condition_name": "VACTERL with hydrocephalus", "pattern_of_inheritance": "Autosomal recessive, X-linked recessive", "alternate_names": ["VACTERL with hydrocephalus", "FANCONI ANEMIA, COMPLEMENTATION GROUP B"]}, "gene information": {"db_hgnc_gene_id": 3583.0}, "interventions": [{"int_description_1": "Surgical correction", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Surgical correction of tracheo-oesophageal fistula and oesophageal atresia in infants with VACTERL association: a retrospective case-control study.", "pmid_1": 22991204.0, "pmid_date_1": 2012.0, "pmid_journal_1": "Pediatr Surg Int"}]}, {"_id": "3584-OMIM:227645", "condition": {"condition_name": "FANCONI ANEMIA, COMPLEMENTATION GROUP C", "pattern_of_inheritance": "X-linked recessive, Autosomal recessive", "alternate_names": ["FANCONI ANEMIA, COMPLEMENTATION GROUP C"]}, "gene information": {"db_hgnc_gene_id": 3584.0}, "interventions": [{"int_description_1": "Healthy diet"}, {"int_description_2": "Oxandrolone"}, {"int_description_3": "Danazol"}, {"int_description_4": "Testosterone propionate"}, {"int_description_5": "Oxymetholone"}, {"int_description_6": "Metenolone"}, {"int_description_7": "Calcium"}, {"int_description_8": "Prednisone"}, {"int_description_9": "Dexamethasone"}, {"int_description_10": "Insulin aspart"}, {"int_description_11": "Medroxyprogesterone acetate"}, {"int_description_12": "Tretinoin"}, {"int_description_13": "Eltrombopag"}, {"int_description_14": "Levothyroxine"}, {"int_description_15": "Estradiol"}, {"int_description_16": "Cetuximab"}, {"int_description_17": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_18": "Alemtuzumab"}, {"int_description_19": "Coenzyme M"}, {"int_description_20": "Cyclosporine"}, {"int_description_21": "Dactinomycin"}, {"int_description_22": "Sirolimus"}, {"int_description_23": "Somatotropin"}, {"int_description_24": "Vitamin D"}, {"int_description_25": "Cyclophosphamide"}, {"int_description_26": "Carboplatin"}, {"int_description_27": "Busulfan"}, {"int_description_28": "Ifosfamide"}, {"int_description_29": "Thiotepa"}, {"int_description_30": "Doxorubicin"}, {"int_description_31": "Fluorouracil", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Mercaptopurine", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Trimethoprim"}, {"int_description_34": "Sulfamethoxazole"}, {"int_description_35": "Gemcitabine"}, {"int_description_36": "Vincristine"}, {"int_description_37": "Methotrexate"}, {"int_description_38": "Fludarabine"}, {"int_description_39": "Cytarabine"}, {"int_description_40": "Irinotecan"}, {"int_description_41": "Daunorubicin"}, {"int_description_42": "Etoposide"}, {"int_description_43": "Idarubicin"}, {"int_description_44": "Tacrolimus"}, {"int_description_45": "Acyclovir"}, {"int_description_46": "Quercetin"}, {"int_description_47": "Tioguanine"}, {"int_description_48": "Mycophenolate mofetil"}, {"int_description_49": "Tranexamic acid"}, {"int_description_50": "Hydroxyurea"}, {"int_description_51": "Methylprednisolone"}, {"int_description_52": "Methyltestosterone"}, {"int_description_53": "Leucovorin"}, {"int_description_54": "Vinorelbine"}, {"int_description_55": "Deferasirox"}, {"int_description_56": "Deferiprone"}, {"int_description_57": "Co-trimoxazole"}, {"int_description_58": "Asparaginase Escherichia coli"}, {"int_description_59": "Cisplatin"}, {"int_description_60": "Antilymphocyte immunoglobulin (horse)"}, {"int_description_61": "Norethandrolone"}, {"int_description_62": "Phosphorus"}, {"int_description_63": "GM-CSF (granulocyte-macrophage colony-stimulating factor)"}, {"int_description_64": "rh-SOD"}, {"int_description_65": "Bevacizumab"}, {"int_description_66": "Filgrastim"}, {"int_description_67": "Amifostine"}, {"int_description_68": "Radiation therapy", "timeframe_int68": "Days or Weeks,Years", "age_use_int68": "Child", "contra_int68": "No", "qualscale_reclass_drug68": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug68": "Effective / Ameliorative"}, {"int_description_69": "Total abdominal radiation"}, {"int_description_70": "Total body irradiation"}, {"int_description_71": "Total lymphoid irradiation"}, {"int_description_72": "Transfusion of blood products"}, {"int_description_73": "Bone marrow transplantation"}, {"int_description_74": "Hematopoietic stem cell transplantation"}, {"int_description_75": "Surgery for polydactyly, carpectomy"}, {"int_description_76": "Surgical intervention"}, {"int_description_77": "\u042burgical tumor removement"}], "references": [{"pmid_title_1": "Gingival Bleeding in a Child with Fanconi Anemia: A Case Report and Literature Review.", "pmid_1": 32231808.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Case Rep Dent"}, {"pmid_title_2": "Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.", "pmid_2": 29668547.0, "pmid_date_2": 2019.0, "pmid_journal_2": "J Pediatr Hematol Oncol"}, {"pmid_title_3": "Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.", "pmid_3": 31192125.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Front Oncol"}, {"pmid_title_4": "Fanconi anemia: a single center experience of a large cohort.", "pmid_4": 31990462.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Turk J Pediatr"}, {"pmid_title_5": "Therapeutic research in the crystal chromosome disease Fanconi anemia.", "pmid_5": 30389152.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Mutat Res Genet Toxicol Environ Mutagen"}, {"pmid_title_6": "Oral cancer in Fanconi anemia: Review of 121 cases.", "pmid_6": 29650274.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Crit Rev Oncol Hematol"}, {"pmid_title_7": "Essential Role of BRCA2 in Ovarian Development and Function.", "pmid_7": 30207912.0, "pmid_date_7": 2018.0, "pmid_journal_7": "N Engl J Med"}, {"pmid_title_8": "Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.", "pmid_8": 29203412.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Biol Blood Marrow Transplant"}, {"pmid_title_9": "How I manage patients with Fanconi anaemia.", "pmid_9": 28474441.0, "pmid_date_9": 2017.0, "pmid_journal_9": "Br J Haematol"}, {"pmid_title_10": "Eltrombopag for the treatment of aplastic anemia: current perspectives.", "pmid_10": 27695288.0, "pmid_date_10": 2016.0, "pmid_journal_10": "Drug Des Devel Ther"}, {"pmid_title_11": "Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.", "pmid_11": 27246371.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Biol Blood Marrow Transplant"}, {"pmid_title_12": "Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.", "pmid_12": 26900943.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Pediatr Hematol Oncol"}, {"pmid_title_13": "Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.", "pmid_13": 26657402.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Eur J Med Genet"}, {"pmid_title_14": "Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.", "pmid_14": 25575015.0, "pmid_date_14": 2015.0, "pmid_journal_14": "J Clin Endocrinol Metab"}, {"pmid_title_15": "Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.", "pmid_15": 25862235.0, "pmid_date_15": 2015.0, "pmid_journal_15": "Ann Hematol"}, {"pmid_title_16": "Alternative donor hematopoietic cell transplantation for Fanconi anemia.", "pmid_16": 25824692.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Blood"}, {"pmid_title_17": "Fanconi anemia and solid malignancies in childhood: a national retrospective study.", "pmid_17": 25381700.0, "pmid_date_17": 2015.0, "pmid_journal_17": "Pediatr Blood Cancer"}, {"pmid_title_18": "Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.", "pmid_18": 25531282.0, "pmid_date_18": 2015.0, "pmid_journal_18": "Bone Marrow Transplant"}, {"pmid_title_19": "Clear cell sarcoma of the kidney in a child with Fanconi anemia.", "pmid_19": 24735155.0, "pmid_date_19": 2014.0, "pmid_journal_19": "Pediatr Dev Pathol"}, {"pmid_title_20": "Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.", "pmid_20": 25085358.0, "pmid_date_20": 2014.0, "pmid_journal_20": "Haematologica"}, {"pmid_title_21": "Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.", "pmid_21": 24019220.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Management of dental extraction in a female patient with fanconi anemia.", "pmid_22": 25628690.0, "pmid_date_22": 2014.0, "pmid_journal_22": "J Dent (Tehran)"}, {"pmid_title_23": "Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature.", "pmid_23": 22965917.0, "pmid_date_23": 2013.0, "pmid_journal_23": "Head Neck"}, {"pmid_title_24": "Deferasirox therapy in children with Fanconi aplastic anemia.", "pmid_24": 22510772.0, "pmid_date_24": 2012.0, "pmid_journal_24": "J Pediatr Hematol Oncol"}, {"pmid_title_25": "Fatal course of tonsillar squamous cell carcinoma associated with Fanconi anaemia: a mini review.", "pmid_25": 21925890.0, "pmid_date_25": 2012.0, "pmid_journal_25": "J Craniomaxillofac Surg"}, {"pmid_title_26": "Treatment of the bone marrow failure in Fanconi anemia patients with danazol.", "pmid_26": 22178060.0, "pmid_date_26": 2012.0, "pmid_journal_26": "Blood Cells Mol Dis"}, {"pmid_title_27": "Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing.", "pmid_27": 21519011.0, "pmid_date_27": 2011.0, "pmid_journal_27": "J Clin Oncol"}, {"pmid_title_28": "Successful treatment of esophageal squamous cell carcinoma in a patient with Fanconi anemia.", "pmid_28": 20410055.0, "pmid_date_28": 2010.0, "pmid_journal_28": "Jpn J Clin Oncol"}, {"pmid_title_29": "Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.", "pmid_29": 19564748.0, "pmid_date_29": 2009.0, "pmid_journal_29": "J Pediatr Hematol Oncol"}, {"pmid_title_30": "Treatment with deferiprone for iron overload alleviates bone marrow failure in a Fanconi anemia patient.", "pmid_30": 19814681.0, "pmid_date_30": 2009.0, "pmid_journal_30": "Hemoglobin"}, {"pmid_title_31": "Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.", "pmid_31": 18302713.0, "pmid_date_31": 2008.0, "pmid_journal_31": "Br J Haematol"}, {"pmid_title_32": "Thrombocytopenia in the neonate.", "pmid_32": 18433954.0, "pmid_date_32": 2008.0, "pmid_journal_32": "Blood Rev"}, {"pmid_title_33": "Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.", "pmid_33": 18379369.0, "pmid_date_33": 2008.0, "pmid_journal_33": "J Thorac Oncol"}, {"pmid_title_34": "Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function.", "pmid_34": 18623197.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Pediatr Blood Cancer"}, {"pmid_title_35": "Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.", "pmid_35": 18831513.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Cancer"}, {"pmid_title_36": "Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.", "pmid_36": 17950918.0, "pmid_date_36": 2007.0, "pmid_journal_36": "Biol Blood Marrow Transplant"}, {"pmid_title_37": "Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.", "pmid_37": 17038525.0, "pmid_date_37": 2007.0, "pmid_journal_37": "Blood"}, {"pmid_title_38": "Chemotherapy for myeloid malignancy in children with Fanconi anemia.", "pmid_38": 16609946.0, "pmid_date_38": 2007.0, "pmid_journal_38": "Pediatr Blood Cancer"}, {"pmid_title_39": "A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.", "pmid_39": 17096012.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Leukemia"}, {"pmid_title_40": "HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.", "pmid_40": 18022575.0, "pmid_date_40": 2007.0, "pmid_journal_40": "Biol Blood Marrow Transplant"}, {"pmid_title_41": "Anesthesia and Fanconi anemia: a case report and review of literature.", "pmid_41": 16918663.0, "pmid_date_41": 2006.0, "pmid_journal_41": "Paediatr Anaesth"}, {"pmid_title_42": "Squamous cell carcinoma of the hypopharynx in a young woman with Fanconi's anemia.", "pmid_42": 17308840.0, "pmid_date_42": 2006.0, "pmid_journal_42": "Braz J Otorhinolaryngol"}, {"pmid_title_43": "Squamous cell vulvar carcinoma associated with Fanconi's anemia: a case report.", "pmid_43": 11975685.0, "pmid_date_43": 2002.0, "pmid_journal_43": "Int J Gynecol Cancer"}, {"pmid_title_44": "Growth hormone deficiency caused by pituitary stalk interruption in Fanconi's anemia.", "pmid_44": 11148528.0, "pmid_date_44": 2001.0, "pmid_journal_44": "J Pediatr"}, {"pmid_title_45": "Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.", "pmid_45": 9658728.0, "pmid_date_45": 1998.0, "pmid_journal_45": "Haematologica"}, {"pmid_title_46": "Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.", "pmid_46": 8781414.0, "pmid_date_46": 1996.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.", "pmid_47": 7644282.0, "pmid_date_47": 1995.0, "pmid_journal_47": "Pediatr Nurs"}, {"pmid_title_48": "Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.", "pmid_48": 8283365.0, "pmid_date_48": 1994.0, "pmid_journal_48": "J Pediatr"}, {"pmid_title_49": "A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia.", "pmid_49": 8280614.0, "pmid_date_49": 1993.0, "pmid_journal_49": "Br J Haematol"}, {"pmid_title_50": "Fanconi's anemia. A family study with 20-year follow-up including associated breast pathology.", "pmid_50": 6478420.0, "pmid_date_50": 1984.0, "pmid_journal_50": "Cancer"}, {"pmid_title_51": "Multiple hepatic tumors and peliosis hepatis in Fanconi's anemia treated with androgens.", "pmid_51": 199056.0, "pmid_date_51": 1977.0, "pmid_journal_51": "Am J Dis Child"}, {"pmid_title_52": "Hepatic lesions in patients treated with synthetic anabolic steriods.", "pmid_52": 185239.0, "pmid_date_52": 1976.0, "pmid_journal_52": "J Clin Pathol"}, {"pmid_title_53": "The defective absorption of phosphorus and calcium and the effect of vitamin D in the Fanconi syndrome.", "pmid_53": 13610080.0, "pmid_date_53": 1958.0, "pmid_journal_53": "Guys Hosp Rep"}]}, {"_id": "3585-OMIM:227646", "condition": {"condition_name": "FANCONI ANEMIA, COMPLEMENTATION GROUP D2", "pattern_of_inheritance": "X-linked recessive, Autosomal recessive", "alternate_names": ["FANCONI ANEMIA, COMPLEMENTATION GROUP D2"]}, "gene information": {"db_hgnc_gene_id": 3585.0}, "interventions": [{"int_description_1": "Healthy diet"}, {"int_description_2": "Oxandrolone"}, {"int_description_3": "Danazol"}, {"int_description_4": "Testosterone propionate"}, {"int_description_5": "Oxymetholone"}, {"int_description_6": "Metenolone"}, {"int_description_7": "Calcium"}, {"int_description_8": "Prednisone"}, {"int_description_9": "Dexamethasone"}, {"int_description_10": "Insulin aspart"}, {"int_description_11": "Medroxyprogesterone acetate"}, {"int_description_12": "Tretinoin"}, {"int_description_13": "Eltrombopag"}, {"int_description_14": "Levothyroxine"}, {"int_description_15": "Estradiol"}, {"int_description_16": "Cetuximab"}, {"int_description_17": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_18": "Alemtuzumab"}, {"int_description_19": "Coenzyme M"}, {"int_description_20": "Cyclosporine"}, {"int_description_21": "Dactinomycin"}, {"int_description_22": "Sirolimus"}, {"int_description_23": "Somatotropin"}, {"int_description_24": "Vitamin D"}, {"int_description_25": "Cyclophosphamide"}, {"int_description_26": "Carboplatin"}, {"int_description_27": "Busulfan"}, {"int_description_28": "Ifosfamide"}, {"int_description_29": "Thiotepa"}, {"int_description_30": "Doxorubicin"}, {"int_description_31": "Fluorouracil", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Mercaptopurine", "timeframe_int32": "Days or Weeks", "age_use_int32": "Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Trimethoprim"}, {"int_description_34": "Sulfamethoxazole"}, {"int_description_35": "Gemcitabine"}, {"int_description_36": "Vincristine"}, {"int_description_37": "Methotrexate"}, {"int_description_38": "Fludarabine"}, {"int_description_39": "Cytarabine"}, {"int_description_40": "Irinotecan"}, {"int_description_41": "Daunorubicin"}, {"int_description_42": "Etoposide"}, {"int_description_43": "Idarubicin"}, {"int_description_44": "Tacrolimus"}, {"int_description_45": "Acyclovir"}, {"int_description_46": "Quercetin"}, {"int_description_47": "Tioguanine"}, {"int_description_48": "Mycophenolate mofetil"}, {"int_description_49": "Tranexamic acid"}, {"int_description_50": "Hydroxyurea"}, {"int_description_51": "Methylprednisolone"}, {"int_description_52": "Methyltestosterone"}, {"int_description_53": "Leucovorin"}, {"int_description_54": "Vinorelbine"}, {"int_description_55": "Deferasirox"}, {"int_description_56": "Deferiprone"}, {"int_description_57": "Co-trimoxazole"}, {"int_description_58": "Asparaginase Escherichia coli"}, {"int_description_59": "Cisplatin"}, {"int_description_60": "Antilymphocyte immunoglobulin (horse)"}, {"int_description_61": "Norethandrolone"}, {"int_description_62": "Phosphorus"}, {"int_description_63": "GM-CSF (granulocyte-macrophage colony-stimulating factor)"}, {"int_description_64": "rh-SOD"}, {"int_description_65": "Bevacizumab"}, {"int_description_66": "Filgrastim"}, {"int_description_67": "Amifostine"}, {"int_description_68": "Radiation therapy", "timeframe_int68": "Days or Weeks,Years", "age_use_int68": "Child", "contra_int68": "No", "qualscale_reclass_drug68": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug68": "Effective / Ameliorative"}, {"int_description_69": "Total abdominal radiation"}, {"int_description_70": "Total body irradiation"}, {"int_description_71": "Total lymphoid irradiation"}, {"int_description_72": "Transfusion of blood products"}, {"int_description_73": "Bone marrow transplantation"}, {"int_description_74": "Hematopoietic stem cell transplantation"}, {"int_description_75": "Surgery for polydactyly, carpectomy"}, {"int_description_76": "Surgical intervention"}, {"int_description_77": "\u042burgical tumor removement"}], "references": [{"pmid_title_1": "Gingival Bleeding in a Child with Fanconi Anemia: A Case Report and Literature Review.", "pmid_1": 32231808.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Case Rep Dent"}, {"pmid_title_2": "Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.", "pmid_2": 29668547.0, "pmid_date_2": 2019.0, "pmid_journal_2": "J Pediatr Hematol Oncol"}, {"pmid_title_3": "Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.", "pmid_3": 31192125.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Front Oncol"}, {"pmid_title_4": "Fanconi anemia: a single center experience of a large cohort.", "pmid_4": 31990462.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Turk J Pediatr"}, {"pmid_title_5": "Therapeutic research in the crystal chromosome disease Fanconi anemia.", "pmid_5": 30389152.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Mutat Res Genet Toxicol Environ Mutagen"}, {"pmid_title_6": "Oral cancer in Fanconi anemia: Review of 121 cases.", "pmid_6": 29650274.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Crit Rev Oncol Hematol"}, {"pmid_title_7": "Essential Role of BRCA2 in Ovarian Development and Function.", "pmid_7": 30207912.0, "pmid_date_7": 2018.0, "pmid_journal_7": "N Engl J Med"}, {"pmid_title_8": "Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.", "pmid_8": 29203412.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Biol Blood Marrow Transplant"}, {"pmid_title_9": "How I manage patients with Fanconi anaemia.", "pmid_9": 28474441.0, "pmid_date_9": 2017.0, "pmid_journal_9": "Br J Haematol"}, {"pmid_title_10": "Eltrombopag for the treatment of aplastic anemia: current perspectives.", "pmid_10": 27695288.0, "pmid_date_10": 2016.0, "pmid_journal_10": "Drug Des Devel Ther"}, {"pmid_title_11": "Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.", "pmid_11": 27246371.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Biol Blood Marrow Transplant"}, {"pmid_title_12": "Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.", "pmid_12": 26900943.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Pediatr Hematol Oncol"}, {"pmid_title_13": "Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.", "pmid_13": 26657402.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Eur J Med Genet"}, {"pmid_title_14": "Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.", "pmid_14": 25575015.0, "pmid_date_14": 2015.0, "pmid_journal_14": "J Clin Endocrinol Metab"}, {"pmid_title_15": "Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.", "pmid_15": 25862235.0, "pmid_date_15": 2015.0, "pmid_journal_15": "Ann Hematol"}, {"pmid_title_16": "Alternative donor hematopoietic cell transplantation for Fanconi anemia.", "pmid_16": 25824692.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Blood"}, {"pmid_title_17": "Fanconi anemia and solid malignancies in childhood: a national retrospective study.", "pmid_17": 25381700.0, "pmid_date_17": 2015.0, "pmid_journal_17": "Pediatr Blood Cancer"}, {"pmid_title_18": "Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.", "pmid_18": 25531282.0, "pmid_date_18": 2015.0, "pmid_journal_18": "Bone Marrow Transplant"}, {"pmid_title_19": "Clear cell sarcoma of the kidney in a child with Fanconi anemia.", "pmid_19": 24735155.0, "pmid_date_19": 2014.0, "pmid_journal_19": "Pediatr Dev Pathol"}, {"pmid_title_20": "Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.", "pmid_20": 25085358.0, "pmid_date_20": 2014.0, "pmid_journal_20": "Haematologica"}, {"pmid_title_21": "Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.", "pmid_21": 24019220.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Management of dental extraction in a female patient with fanconi anemia.", "pmid_22": 25628690.0, "pmid_date_22": 2014.0, "pmid_journal_22": "J Dent (Tehran)"}, {"pmid_title_23": "Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature.", "pmid_23": 22965917.0, "pmid_date_23": 2013.0, "pmid_journal_23": "Head Neck"}, {"pmid_title_24": "Deferasirox therapy in children with Fanconi aplastic anemia.", "pmid_24": 22510772.0, "pmid_date_24": 2012.0, "pmid_journal_24": "J Pediatr Hematol Oncol"}, {"pmid_title_25": "Fatal course of tonsillar squamous cell carcinoma associated with Fanconi anaemia: a mini review.", "pmid_25": 21925890.0, "pmid_date_25": 2012.0, "pmid_journal_25": "J Craniomaxillofac Surg"}, {"pmid_title_26": "Treatment of the bone marrow failure in Fanconi anemia patients with danazol.", "pmid_26": 22178060.0, "pmid_date_26": 2012.0, "pmid_journal_26": "Blood Cells Mol Dis"}, {"pmid_title_27": "Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing.", "pmid_27": 21519011.0, "pmid_date_27": 2011.0, "pmid_journal_27": "J Clin Oncol"}, {"pmid_title_28": "Successful treatment of esophageal squamous cell carcinoma in a patient with Fanconi anemia.", "pmid_28": 20410055.0, "pmid_date_28": 2010.0, "pmid_journal_28": "Jpn J Clin Oncol"}, {"pmid_title_29": "Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.", "pmid_29": 19564748.0, "pmid_date_29": 2009.0, "pmid_journal_29": "J Pediatr Hematol Oncol"}, {"pmid_title_30": "Treatment with deferiprone for iron overload alleviates bone marrow failure in a Fanconi anemia patient.", "pmid_30": 19814681.0, "pmid_date_30": 2009.0, "pmid_journal_30": "Hemoglobin"}, {"pmid_title_31": "Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.", "pmid_31": 18302713.0, "pmid_date_31": 2008.0, "pmid_journal_31": "Br J Haematol"}, {"pmid_title_32": "Thrombocytopenia in the neonate.", "pmid_32": 18433954.0, "pmid_date_32": 2008.0, "pmid_journal_32": "Blood Rev"}, {"pmid_title_33": "Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.", "pmid_33": 18379369.0, "pmid_date_33": 2008.0, "pmid_journal_33": "J Thorac Oncol"}, {"pmid_title_34": "Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function.", "pmid_34": 18623197.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Pediatr Blood Cancer"}, {"pmid_title_35": "Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.", "pmid_35": 18831513.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Cancer"}, {"pmid_title_36": "Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.", "pmid_36": 17950918.0, "pmid_date_36": 2007.0, "pmid_journal_36": "Biol Blood Marrow Transplant"}, {"pmid_title_37": "Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.", "pmid_37": 17038525.0, "pmid_date_37": 2007.0, "pmid_journal_37": "Blood"}, {"pmid_title_38": "Chemotherapy for myeloid malignancy in children with Fanconi anemia.", "pmid_38": 16609946.0, "pmid_date_38": 2007.0, "pmid_journal_38": "Pediatr Blood Cancer"}, {"pmid_title_39": "A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.", "pmid_39": 17096012.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Leukemia"}, {"pmid_title_40": "HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.", "pmid_40": 18022575.0, "pmid_date_40": 2007.0, "pmid_journal_40": "Biol Blood Marrow Transplant"}, {"pmid_title_41": "Anesthesia and Fanconi anemia: a case report and review of literature.", "pmid_41": 16918663.0, "pmid_date_41": 2006.0, "pmid_journal_41": "Paediatr Anaesth"}, {"pmid_title_42": "Squamous cell carcinoma of the hypopharynx in a young woman with Fanconi's anemia.", "pmid_42": 17308840.0, "pmid_date_42": 2006.0, "pmid_journal_42": "Braz J Otorhinolaryngol"}, {"pmid_title_43": "Squamous cell vulvar carcinoma associated with Fanconi's anemia: a case report.", "pmid_43": 11975685.0, "pmid_date_43": 2002.0, "pmid_journal_43": "Int J Gynecol Cancer"}, {"pmid_title_44": "Growth hormone deficiency caused by pituitary stalk interruption in Fanconi's anemia.", "pmid_44": 11148528.0, "pmid_date_44": 2001.0, "pmid_journal_44": "J Pediatr"}, {"pmid_title_45": "Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.", "pmid_45": 9658728.0, "pmid_date_45": 1998.0, "pmid_journal_45": "Haematologica"}, {"pmid_title_46": "Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.", "pmid_46": 8781414.0, "pmid_date_46": 1996.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.", "pmid_47": 7644282.0, "pmid_date_47": 1995.0, "pmid_journal_47": "Pediatr Nurs"}, {"pmid_title_48": "Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.", "pmid_48": 8283365.0, "pmid_date_48": 1994.0, "pmid_journal_48": "J Pediatr"}, {"pmid_title_49": "A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia.", "pmid_49": 8280614.0, "pmid_date_49": 1993.0, "pmid_journal_49": "Br J Haematol"}, {"pmid_title_50": "Fanconi's anemia. A family study with 20-year follow-up including associated breast pathology.", "pmid_50": 6478420.0, "pmid_date_50": 1984.0, "pmid_journal_50": "Cancer"}, {"pmid_title_51": "Multiple hepatic tumors and peliosis hepatis in Fanconi's anemia treated with androgens.", "pmid_51": 199056.0, "pmid_date_51": 1977.0, "pmid_journal_51": "Am J Dis Child"}, {"pmid_title_52": "Hepatic lesions in patients treated with synthetic anabolic steriods.", "pmid_52": 185239.0, "pmid_date_52": 1976.0, "pmid_journal_52": "J Clin Pathol"}, {"pmid_title_53": "The defective absorption of phosphorus and calcium and the effect of vitamin D in the Fanconi syndrome.", "pmid_53": 13610080.0, "pmid_date_53": 1958.0, "pmid_journal_53": "Guys Hosp Rep"}]}, {"_id": "3586-OMIM:600901", "condition": {"condition_name": "FANCONI ANEMIA, COMPLEMENTATION GROUP E", "pattern_of_inheritance": "X-linked recessive, Autosomal recessive", "alternate_names": ["FANCONI ANEMIA, COMPLEMENTATION GROUP E"]}, "gene information": {"db_hgnc_gene_id": 3586.0}, "interventions": [{"int_description_1": "Healthy diet"}, {"int_description_2": "Oxandrolone"}, {"int_description_3": "Danazol"}, {"int_description_4": "Testosterone propionate"}, {"int_description_5": "Oxymetholone"}, {"int_description_6": "Metenolone"}, {"int_description_7": "Calcium"}, {"int_description_8": "Prednisone"}, {"int_description_9": "Dexamethasone"}, {"int_description_10": "Insulin aspart"}, {"int_description_11": "Medroxyprogesterone acetate"}, {"int_description_12": "Tretinoin"}, {"int_description_13": "Eltrombopag"}, {"int_description_14": "Levothyroxine"}, {"int_description_15": "Estradiol"}, {"int_description_16": "Cetuximab"}, {"int_description_17": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_18": "Alemtuzumab"}, {"int_description_19": "Coenzyme M"}, {"int_description_20": "Cyclosporine"}, {"int_description_21": "Dactinomycin"}, {"int_description_22": "Sirolimus"}, {"int_description_23": "Somatotropin"}, {"int_description_24": "Vitamin D"}, {"int_description_25": "Cyclophosphamide"}, {"int_description_26": "Carboplatin"}, {"int_description_27": "Busulfan"}, {"int_description_28": "Ifosfamide"}, {"int_description_29": "Thiotepa"}, {"int_description_30": "Doxorubicin"}, {"int_description_31": "Fluorouracil", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Mercaptopurine", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Trimethoprim"}, {"int_description_34": "Sulfamethoxazole"}, {"int_description_35": "Gemcitabine"}, {"int_description_36": "Vincristine"}, {"int_description_37": "Methotrexate"}, {"int_description_38": "Fludarabine"}, {"int_description_39": "Cytarabine"}, {"int_description_40": "Irinotecan"}, {"int_description_41": "Daunorubicin"}, {"int_description_42": "Etoposide"}, {"int_description_43": "Idarubicin"}, {"int_description_44": "Tacrolimus"}, {"int_description_45": "Acyclovir"}, {"int_description_46": "Quercetin"}, {"int_description_47": "Tioguanine"}, {"int_description_48": "Mycophenolate mofetil"}, {"int_description_49": "Tranexamic acid"}, {"int_description_50": "Hydroxyurea"}, {"int_description_51": "Methylprednisolone"}, {"int_description_52": "Methyltestosterone"}, {"int_description_53": "Leucovorin"}, {"int_description_54": "Vinorelbine"}, {"int_description_55": "Deferasirox"}, {"int_description_56": "Deferiprone"}, {"int_description_57": "Co-trimoxazole"}, {"int_description_58": "Asparaginase Escherichia coli"}, {"int_description_59": "Cisplatin"}, {"int_description_60": "Antilymphocyte immunoglobulin (horse)"}, {"int_description_61": "Norethandrolone"}, {"int_description_62": "Phosphorus"}, {"int_description_63": "GM-CSF (granulocyte-macrophage colony-stimulating factor)"}, {"int_description_64": "rh-SOD"}, {"int_description_65": "Bevacizumab"}, {"int_description_66": "Filgrastim"}, {"int_description_67": "Amifostine"}, {"int_description_68": "Radiation therapy", "timeframe_int68": "Days or Weeks,Years", "age_use_int68": "Child", "contra_int68": "No", "qualscale_reclass_drug68": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug68": "Effective / Ameliorative"}, {"int_description_69": "Total abdominal radiation"}, {"int_description_70": "Total body irradiation"}, {"int_description_71": "Total lymphoid irradiation"}, {"int_description_72": "Transfusion of blood products"}, {"int_description_73": "Bone marrow transplantation"}, {"int_description_74": "Hematopoietic stem cell transplantation"}, {"int_description_75": "Surgery for polydactyly, carpectomy"}, {"int_description_76": "Surgical intervention"}, {"int_description_77": "\u042burgical tumor removement"}], "references": [{"pmid_title_1": "Gingival Bleeding in a Child with Fanconi Anemia: A Case Report and Literature Review.", "pmid_1": 32231808.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Case Rep Dent"}, {"pmid_title_2": "Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.", "pmid_2": 29668547.0, "pmid_date_2": 2019.0, "pmid_journal_2": "J Pediatr Hematol Oncol"}, {"pmid_title_3": "Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.", "pmid_3": 31192125.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Front Oncol"}, {"pmid_title_4": "Fanconi anemia: a single center experience of a large cohort.", "pmid_4": 31990462.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Turk J Pediatr"}, {"pmid_title_5": "Therapeutic research in the crystal chromosome disease Fanconi anemia.", "pmid_5": 30389152.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Mutat Res Genet Toxicol Environ Mutagen"}, {"pmid_title_6": "Oral cancer in Fanconi anemia: Review of 121 cases.", "pmid_6": 29650274.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Crit Rev Oncol Hematol"}, {"pmid_title_7": "Essential Role of BRCA2 in Ovarian Development and Function.", "pmid_7": 30207912.0, "pmid_date_7": 2018.0, "pmid_journal_7": "N Engl J Med"}, {"pmid_title_8": "Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.", "pmid_8": 29203412.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Biol Blood Marrow Transplant"}, {"pmid_title_9": "How I manage patients with Fanconi anaemia.", "pmid_9": 28474441.0, "pmid_date_9": 2017.0, "pmid_journal_9": "Br J Haematol"}, {"pmid_title_10": "Eltrombopag for the treatment of aplastic anemia: current perspectives.", "pmid_10": 27695288.0, "pmid_date_10": 2016.0, "pmid_journal_10": "Drug Des Devel Ther"}, {"pmid_title_11": "Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.", "pmid_11": 27246371.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Biol Blood Marrow Transplant"}, {"pmid_title_12": "Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.", "pmid_12": 26900943.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Pediatr Hematol Oncol"}, {"pmid_title_13": "Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.", "pmid_13": 26657402.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Eur J Med Genet"}, {"pmid_title_14": "Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.", "pmid_14": 25575015.0, "pmid_date_14": 2015.0, "pmid_journal_14": "J Clin Endocrinol Metab"}, {"pmid_title_15": "Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.", "pmid_15": 25862235.0, "pmid_date_15": 2015.0, "pmid_journal_15": "Ann Hematol"}, {"pmid_title_16": "Alternative donor hematopoietic cell transplantation for Fanconi anemia.", "pmid_16": 25824692.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Blood"}, {"pmid_title_17": "Fanconi anemia and solid malignancies in childhood: a national retrospective study.", "pmid_17": 25381700.0, "pmid_date_17": 2015.0, "pmid_journal_17": "Pediatr Blood Cancer"}, {"pmid_title_18": "Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.", "pmid_18": 25531282.0, "pmid_date_18": 2015.0, "pmid_journal_18": "Bone Marrow Transplant"}, {"pmid_title_19": "Clear cell sarcoma of the kidney in a child with Fanconi anemia.", "pmid_19": 24735155.0, "pmid_date_19": 2014.0, "pmid_journal_19": "Pediatr Dev Pathol"}, {"pmid_title_20": "Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.", "pmid_20": 25085358.0, "pmid_date_20": 2014.0, "pmid_journal_20": "Haematologica"}, {"pmid_title_21": "Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.", "pmid_21": 24019220.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Management of dental extraction in a female patient with fanconi anemia.", "pmid_22": 25628690.0, "pmid_date_22": 2014.0, "pmid_journal_22": "J Dent (Tehran)"}, {"pmid_title_23": "Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature.", "pmid_23": 22965917.0, "pmid_date_23": 2013.0, "pmid_journal_23": "Head Neck"}, {"pmid_title_24": "Deferasirox therapy in children with Fanconi aplastic anemia.", "pmid_24": 22510772.0, "pmid_date_24": 2012.0, "pmid_journal_24": "J Pediatr Hematol Oncol"}, {"pmid_title_25": "Fatal course of tonsillar squamous cell carcinoma associated with Fanconi anaemia: a mini review.", "pmid_25": 21925890.0, "pmid_date_25": 2012.0, "pmid_journal_25": "J Craniomaxillofac Surg"}, {"pmid_title_26": "Treatment of the bone marrow failure in Fanconi anemia patients with danazol.", "pmid_26": 22178060.0, "pmid_date_26": 2012.0, "pmid_journal_26": "Blood Cells Mol Dis"}, {"pmid_title_27": "Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing.", "pmid_27": 21519011.0, "pmid_date_27": 2011.0, "pmid_journal_27": "J Clin Oncol"}, {"pmid_title_28": "Successful treatment of esophageal squamous cell carcinoma in a patient with Fanconi anemia.", "pmid_28": 20410055.0, "pmid_date_28": 2010.0, "pmid_journal_28": "Jpn J Clin Oncol"}, {"pmid_title_29": "Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.", "pmid_29": 19564748.0, "pmid_date_29": 2009.0, "pmid_journal_29": "J Pediatr Hematol Oncol"}, {"pmid_title_30": "Treatment with deferiprone for iron overload alleviates bone marrow failure in a Fanconi anemia patient.", "pmid_30": 19814681.0, "pmid_date_30": 2009.0, "pmid_journal_30": "Hemoglobin"}, {"pmid_title_31": "Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.", "pmid_31": 18302713.0, "pmid_date_31": 2008.0, "pmid_journal_31": "Br J Haematol"}, {"pmid_title_32": "Thrombocytopenia in the neonate.", "pmid_32": 18433954.0, "pmid_date_32": 2008.0, "pmid_journal_32": "Blood Rev"}, {"pmid_title_33": "Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.", "pmid_33": 18379369.0, "pmid_date_33": 2008.0, "pmid_journal_33": "J Thorac Oncol"}, {"pmid_title_34": "Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function.", "pmid_34": 18623197.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Pediatr Blood Cancer"}, {"pmid_title_35": "Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.", "pmid_35": 18831513.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Cancer"}, {"pmid_title_36": "Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.", "pmid_36": 17950918.0, "pmid_date_36": 2007.0, "pmid_journal_36": "Biol Blood Marrow Transplant"}, {"pmid_title_37": "Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.", "pmid_37": 17038525.0, "pmid_date_37": 2007.0, "pmid_journal_37": "Blood"}, {"pmid_title_38": "Chemotherapy for myeloid malignancy in children with Fanconi anemia.", "pmid_38": 16609946.0, "pmid_date_38": 2007.0, "pmid_journal_38": "Pediatr Blood Cancer"}, {"pmid_title_39": "A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.", "pmid_39": 17096012.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Leukemia"}, {"pmid_title_40": "HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.", "pmid_40": 18022575.0, "pmid_date_40": 2007.0, "pmid_journal_40": "Biol Blood Marrow Transplant"}, {"pmid_title_41": "Anesthesia and Fanconi anemia: a case report and review of literature.", "pmid_41": 16918663.0, "pmid_date_41": 2006.0, "pmid_journal_41": "Paediatr Anaesth"}, {"pmid_title_42": "Squamous cell carcinoma of the hypopharynx in a young woman with Fanconi's anemia.", "pmid_42": 17308840.0, "pmid_date_42": 2006.0, "pmid_journal_42": "Braz J Otorhinolaryngol"}, {"pmid_title_43": "Squamous cell vulvar carcinoma associated with Fanconi's anemia: a case report.", "pmid_43": 11975685.0, "pmid_date_43": 2002.0, "pmid_journal_43": "Int J Gynecol Cancer"}, {"pmid_title_44": "Growth hormone deficiency caused by pituitary stalk interruption in Fanconi's anemia.", "pmid_44": 11148528.0, "pmid_date_44": 2001.0, "pmid_journal_44": "J Pediatr"}, {"pmid_title_45": "Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.", "pmid_45": 9658728.0, "pmid_date_45": 1998.0, "pmid_journal_45": "Haematologica"}, {"pmid_title_46": "Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.", "pmid_46": 8781414.0, "pmid_date_46": 1996.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.", "pmid_47": 7644282.0, "pmid_date_47": 1995.0, "pmid_journal_47": "Pediatr Nurs"}, {"pmid_title_48": "Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.", "pmid_48": 8283365.0, "pmid_date_48": 1994.0, "pmid_journal_48": "J Pediatr"}, {"pmid_title_49": "A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia.", "pmid_49": 8280614.0, "pmid_date_49": 1993.0, "pmid_journal_49": "Br J Haematol"}, {"pmid_title_50": "Fanconi's anemia. A family study with 20-year follow-up including associated breast pathology.", "pmid_50": 6478420.0, "pmid_date_50": 1984.0, "pmid_journal_50": "Cancer"}, {"pmid_title_51": "Multiple hepatic tumors and peliosis hepatis in Fanconi's anemia treated with androgens.", "pmid_51": 199056.0, "pmid_date_51": 1977.0, "pmid_journal_51": "Am J Dis Child"}, {"pmid_title_52": "Hepatic lesions in patients treated with synthetic anabolic steriods.", "pmid_52": 185239.0, "pmid_date_52": 1976.0, "pmid_journal_52": "J Clin Pathol"}, {"pmid_title_53": "The defective absorption of phosphorus and calcium and the effect of vitamin D in the Fanconi syndrome.", "pmid_53": 13610080.0, "pmid_date_53": 1958.0, "pmid_journal_53": "Guys Hosp Rep"}]}, {"_id": "3587-OMIM:603467", "condition": {"condition_name": "FANCONI ANEMIA, COMPLEMENTATION GROUP F", "pattern_of_inheritance": "X-linked recessive, Autosomal recessive", "alternate_names": ["FANCONI ANEMIA, COMPLEMENTATION GROUP F"]}, "gene information": {"db_hgnc_gene_id": 3587.0}, "interventions": [{"int_description_1": "Healthy diet"}, {"int_description_2": "Oxandrolone"}, {"int_description_3": "Danazol"}, {"int_description_4": "Testosterone propionate"}, {"int_description_5": "Oxymetholone"}, {"int_description_6": "Metenolone"}, {"int_description_7": "Calcium"}, {"int_description_8": "Prednisone"}, {"int_description_9": "Dexamethasone"}, {"int_description_10": "Insulin aspart"}, {"int_description_11": "Medroxyprogesterone acetate"}, {"int_description_12": "Tretinoin"}, {"int_description_13": "Eltrombopag"}, {"int_description_14": "Levothyroxine"}, {"int_description_15": "Estradiol"}, {"int_description_16": "Cetuximab"}, {"int_description_17": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_18": "Alemtuzumab"}, {"int_description_19": "Coenzyme M"}, {"int_description_20": "Cyclosporine"}, {"int_description_21": "Dactinomycin"}, {"int_description_22": "Sirolimus"}, {"int_description_23": "Somatotropin"}, {"int_description_24": "Vitamin D"}, {"int_description_25": "Cyclophosphamide"}, {"int_description_26": "Carboplatin"}, {"int_description_27": "Busulfan"}, {"int_description_28": "Ifosfamide"}, {"int_description_29": "Thiotepa"}, {"int_description_30": "Doxorubicin"}, {"int_description_31": "Fluorouracil", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Mercaptopurine", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Trimethoprim"}, {"int_description_34": "Sulfamethoxazole"}, {"int_description_35": "Gemcitabine"}, {"int_description_36": "Vincristine"}, {"int_description_37": "Methotrexate"}, {"int_description_38": "Fludarabine"}, {"int_description_39": "Cytarabine"}, {"int_description_40": "Irinotecan"}, {"int_description_41": "Daunorubicin"}, {"int_description_42": "Etoposide"}, {"int_description_43": "Idarubicin"}, {"int_description_44": "Tacrolimus"}, {"int_description_45": "Acyclovir"}, {"int_description_46": "Quercetin"}, {"int_description_47": "Tioguanine"}, {"int_description_48": "Mycophenolate mofetil"}, {"int_description_49": "Tranexamic acid"}, {"int_description_50": "Hydroxyurea"}, {"int_description_51": "Methylprednisolone"}, {"int_description_52": "Methyltestosterone"}, {"int_description_53": "Leucovorin"}, {"int_description_54": "Vinorelbine"}, {"int_description_55": "Deferasirox"}, {"int_description_56": "Deferiprone"}, {"int_description_57": "Co-trimoxazole"}, {"int_description_58": "Asparaginase Escherichia coli"}, {"int_description_59": "Cisplatin"}, {"int_description_60": "Antilymphocyte immunoglobulin (horse)"}, {"int_description_61": "Norethandrolone"}, {"int_description_62": "Phosphorus"}, {"int_description_63": "GM-CSF (granulocyte-macrophage colony-stimulating factor)"}, {"int_description_64": "rh-SOD"}, {"int_description_65": "Bevacizumab"}, {"int_description_66": "Filgrastim"}, {"int_description_67": "Amifostine"}, {"int_description_68": "Radiation therapy", "timeframe_int68": "Days or Weeks,Years", "age_use_int68": "Child", "contra_int68": "No", "qualscale_reclass_drug68": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug68": "Effective / Ameliorative"}, {"int_description_69": "Total abdominal radiation"}, {"int_description_70": "Total body irradiation"}, {"int_description_71": "Total lymphoid irradiation"}, {"int_description_72": "Transfusion of blood products"}, {"int_description_73": "Bone marrow transplantation"}, {"int_description_74": "Hematopoietic stem cell transplantation"}, {"int_description_75": "Surgery for polydactyly, carpectomy"}, {"int_description_76": "Surgical intervention"}, {"int_description_77": "\u042burgical tumor removement"}], "references": [{"pmid_title_1": "Gingival Bleeding in a Child with Fanconi Anemia: A Case Report and Literature Review.", "pmid_1": 32231808.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Case Rep Dent"}, {"pmid_title_2": "Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.", "pmid_2": 29668547.0, "pmid_date_2": 2019.0, "pmid_journal_2": "J Pediatr Hematol Oncol"}, {"pmid_title_3": "Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.", "pmid_3": 31192125.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Front Oncol"}, {"pmid_title_4": "Fanconi anemia: a single center experience of a large cohort.", "pmid_4": 31990462.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Turk J Pediatr"}, {"pmid_title_5": "Therapeutic research in the crystal chromosome disease Fanconi anemia.", "pmid_5": 30389152.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Mutat Res Genet Toxicol Environ Mutagen"}, {"pmid_title_6": "Oral cancer in Fanconi anemia: Review of 121 cases.", "pmid_6": 29650274.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Crit Rev Oncol Hematol"}, {"pmid_title_7": "Essential Role of BRCA2 in Ovarian Development and Function.", "pmid_7": 30207912.0, "pmid_date_7": 2018.0, "pmid_journal_7": "N Engl J Med"}, {"pmid_title_8": "Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.", "pmid_8": 29203412.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Biol Blood Marrow Transplant"}, {"pmid_title_9": "How I manage patients with Fanconi anaemia.", "pmid_9": 28474441.0, "pmid_date_9": 2017.0, "pmid_journal_9": "Br J Haematol"}, {"pmid_title_10": "Eltrombopag for the treatment of aplastic anemia: current perspectives.", "pmid_10": 27695288.0, "pmid_date_10": 2016.0, "pmid_journal_10": "Drug Des Devel Ther"}, {"pmid_title_11": "Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.", "pmid_11": 27246371.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Biol Blood Marrow Transplant"}, {"pmid_title_12": "Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.", "pmid_12": 26900943.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Pediatr Hematol Oncol"}, {"pmid_title_13": "Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.", "pmid_13": 26657402.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Eur J Med Genet"}, {"pmid_title_14": "Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.", "pmid_14": 25575015.0, "pmid_date_14": 2015.0, "pmid_journal_14": "J Clin Endocrinol Metab"}, {"pmid_title_15": "Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.", "pmid_15": 25862235.0, "pmid_date_15": 2015.0, "pmid_journal_15": "Ann Hematol"}, {"pmid_title_16": "Alternative donor hematopoietic cell transplantation for Fanconi anemia.", "pmid_16": 25824692.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Blood"}, {"pmid_title_17": "Fanconi anemia and solid malignancies in childhood: a national retrospective study.", "pmid_17": 25381700.0, "pmid_date_17": 2015.0, "pmid_journal_17": "Pediatr Blood Cancer"}, {"pmid_title_18": "Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.", "pmid_18": 25531282.0, "pmid_date_18": 2015.0, "pmid_journal_18": "Bone Marrow Transplant"}, {"pmid_title_19": "Clear cell sarcoma of the kidney in a child with Fanconi anemia.", "pmid_19": 24735155.0, "pmid_date_19": 2014.0, "pmid_journal_19": "Pediatr Dev Pathol"}, {"pmid_title_20": "Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.", "pmid_20": 25085358.0, "pmid_date_20": 2014.0, "pmid_journal_20": "Haematologica"}, {"pmid_title_21": "Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.", "pmid_21": 24019220.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Management of dental extraction in a female patient with fanconi anemia.", "pmid_22": 25628690.0, "pmid_date_22": 2014.0, "pmid_journal_22": "J Dent (Tehran)"}, {"pmid_title_23": "Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature.", "pmid_23": 22965917.0, "pmid_date_23": 2013.0, "pmid_journal_23": "Head Neck"}, {"pmid_title_24": "Deferasirox therapy in children with Fanconi aplastic anemia.", "pmid_24": 22510772.0, "pmid_date_24": 2012.0, "pmid_journal_24": "J Pediatr Hematol Oncol"}, {"pmid_title_25": "Fatal course of tonsillar squamous cell carcinoma associated with Fanconi anaemia: a mini review.", "pmid_25": 21925890.0, "pmid_date_25": 2012.0, "pmid_journal_25": "J Craniomaxillofac Surg"}, {"pmid_title_26": "Treatment of the bone marrow failure in Fanconi anemia patients with danazol.", "pmid_26": 22178060.0, "pmid_date_26": 2012.0, "pmid_journal_26": "Blood Cells Mol Dis"}, {"pmid_title_27": "Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing.", "pmid_27": 21519011.0, "pmid_date_27": 2011.0, "pmid_journal_27": "J Clin Oncol"}, {"pmid_title_28": "Successful treatment of esophageal squamous cell carcinoma in a patient with Fanconi anemia.", "pmid_28": 20410055.0, "pmid_date_28": 2010.0, "pmid_journal_28": "Jpn J Clin Oncol"}, {"pmid_title_29": "Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.", "pmid_29": 19564748.0, "pmid_date_29": 2009.0, "pmid_journal_29": "J Pediatr Hematol Oncol"}, {"pmid_title_30": "Treatment with deferiprone for iron overload alleviates bone marrow failure in a Fanconi anemia patient.", "pmid_30": 19814681.0, "pmid_date_30": 2009.0, "pmid_journal_30": "Hemoglobin"}, {"pmid_title_31": "Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.", "pmid_31": 18302713.0, "pmid_date_31": 2008.0, "pmid_journal_31": "Br J Haematol"}, {"pmid_title_32": "Thrombocytopenia in the neonate.", "pmid_32": 18433954.0, "pmid_date_32": 2008.0, "pmid_journal_32": "Blood Rev"}, {"pmid_title_33": "Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.", "pmid_33": 18379369.0, "pmid_date_33": 2008.0, "pmid_journal_33": "J Thorac Oncol"}, {"pmid_title_34": "Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function.", "pmid_34": 18623197.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Pediatr Blood Cancer"}, {"pmid_title_35": "Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.", "pmid_35": 18831513.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Cancer"}, {"pmid_title_36": "Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.", "pmid_36": 17950918.0, "pmid_date_36": 2007.0, "pmid_journal_36": "Biol Blood Marrow Transplant"}, {"pmid_title_37": "Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.", "pmid_37": 17038525.0, "pmid_date_37": 2007.0, "pmid_journal_37": "Blood"}, {"pmid_title_38": "Chemotherapy for myeloid malignancy in children with Fanconi anemia.", "pmid_38": 16609946.0, "pmid_date_38": 2007.0, "pmid_journal_38": "Pediatr Blood Cancer"}, {"pmid_title_39": "A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.", "pmid_39": 17096012.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Leukemia"}, {"pmid_title_40": "HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.", "pmid_40": 18022575.0, "pmid_date_40": 2007.0, "pmid_journal_40": "Biol Blood Marrow Transplant"}, {"pmid_title_41": "Anesthesia and Fanconi anemia: a case report and review of literature.", "pmid_41": 16918663.0, "pmid_date_41": 2006.0, "pmid_journal_41": "Paediatr Anaesth"}, {"pmid_title_42": "Squamous cell carcinoma of the hypopharynx in a young woman with Fanconi's anemia.", "pmid_42": 17308840.0, "pmid_date_42": 2006.0, "pmid_journal_42": "Braz J Otorhinolaryngol"}, {"pmid_title_43": "Squamous cell vulvar carcinoma associated with Fanconi's anemia: a case report.", "pmid_43": 11975685.0, "pmid_date_43": 2002.0, "pmid_journal_43": "Int J Gynecol Cancer"}, {"pmid_title_44": "Growth hormone deficiency caused by pituitary stalk interruption in Fanconi's anemia.", "pmid_44": 11148528.0, "pmid_date_44": 2001.0, "pmid_journal_44": "J Pediatr"}, {"pmid_title_45": "Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.", "pmid_45": 9658728.0, "pmid_date_45": 1998.0, "pmid_journal_45": "Haematologica"}, {"pmid_title_46": "Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.", "pmid_46": 8781414.0, "pmid_date_46": 1996.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.", "pmid_47": 7644282.0, "pmid_date_47": 1995.0, "pmid_journal_47": "Pediatr Nurs"}, {"pmid_title_48": "Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.", "pmid_48": 8283365.0, "pmid_date_48": 1994.0, "pmid_journal_48": "J Pediatr"}, {"pmid_title_49": "A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia.", "pmid_49": 8280614.0, "pmid_date_49": 1993.0, "pmid_journal_49": "Br J Haematol"}, {"pmid_title_50": "Fanconi's anemia. A family study with 20-year follow-up including associated breast pathology.", "pmid_50": 6478420.0, "pmid_date_50": 1984.0, "pmid_journal_50": "Cancer"}, {"pmid_title_51": "Multiple hepatic tumors and peliosis hepatis in Fanconi's anemia treated with androgens.", "pmid_51": 199056.0, "pmid_date_51": 1977.0, "pmid_journal_51": "Am J Dis Child"}, {"pmid_title_52": "Hepatic lesions in patients treated with synthetic anabolic steriods.", "pmid_52": 185239.0, "pmid_date_52": 1976.0, "pmid_journal_52": "J Clin Pathol"}, {"pmid_title_53": "The defective absorption of phosphorus and calcium and the effect of vitamin D in the Fanconi syndrome.", "pmid_53": 13610080.0, "pmid_date_53": 1958.0, "pmid_journal_53": "Guys Hosp Rep"}]}, {"_id": "3588-OMIM:614082", "condition": {"condition_name": "FANCONI ANEMIA, COMPLEMENTATION GROUP G", "pattern_of_inheritance": "X-linked recessive, Autosomal recessive", "alternate_names": ["FANCONI ANEMIA, COMPLEMENTATION GROUP G"]}, "gene information": {"db_hgnc_gene_id": 3588.0}, "interventions": [{"int_description_1": "Healthy diet"}, {"int_description_2": "Oxandrolone"}, {"int_description_3": "Danazol"}, {"int_description_4": "Testosterone propionate"}, {"int_description_5": "Oxymetholone"}, {"int_description_6": "Metenolone"}, {"int_description_7": "Calcium"}, {"int_description_8": "Prednisone"}, {"int_description_9": "Dexamethasone"}, {"int_description_10": "Insulin aspart"}, {"int_description_11": "Medroxyprogesterone acetate"}, {"int_description_12": "Tretinoin"}, {"int_description_13": "Eltrombopag"}, {"int_description_14": "Levothyroxine"}, {"int_description_15": "Estradiol"}, {"int_description_16": "Cetuximab"}, {"int_description_17": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_18": "Alemtuzumab"}, {"int_description_19": "Coenzyme M"}, {"int_description_20": "Cyclosporine"}, {"int_description_21": "Dactinomycin"}, {"int_description_22": "Sirolimus"}, {"int_description_23": "Somatotropin"}, {"int_description_24": "Vitamin D"}, {"int_description_25": "Cyclophosphamide"}, {"int_description_26": "Carboplatin"}, {"int_description_27": "Busulfan"}, {"int_description_28": "Ifosfamide"}, {"int_description_29": "Thiotepa"}, {"int_description_30": "Doxorubicin"}, {"int_description_31": "Fluorouracil", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Mercaptopurine", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Trimethoprim"}, {"int_description_34": "Sulfamethoxazole"}, {"int_description_35": "Gemcitabine"}, {"int_description_36": "Vincristine"}, {"int_description_37": "Methotrexate"}, {"int_description_38": "Fludarabine"}, {"int_description_39": "Cytarabine"}, {"int_description_40": "Irinotecan"}, {"int_description_41": "Daunorubicin"}, {"int_description_42": "Etoposide"}, {"int_description_43": "Idarubicin"}, {"int_description_44": "Tacrolimus"}, {"int_description_45": "Acyclovir"}, {"int_description_46": "Quercetin"}, {"int_description_47": "Tioguanine"}, {"int_description_48": "Mycophenolate mofetil"}, {"int_description_49": "Tranexamic acid"}, {"int_description_50": "Hydroxyurea"}, {"int_description_51": "Methylprednisolone"}, {"int_description_52": "Methyltestosterone"}, {"int_description_53": "Leucovorin"}, {"int_description_54": "Vinorelbine"}, {"int_description_55": "Deferasirox"}, {"int_description_56": "Deferiprone"}, {"int_description_57": "Co-trimoxazole"}, {"int_description_58": "Asparaginase Escherichia coli"}, {"int_description_59": "Cisplatin"}, {"int_description_60": "Antilymphocyte immunoglobulin (horse)"}, {"int_description_61": "Norethandrolone"}, {"int_description_62": "Phosphorus"}, {"int_description_63": "GM-CSF (granulocyte-macrophage colony-stimulating factor)"}, {"int_description_64": "rh-SOD"}, {"int_description_65": "Bevacizumab"}, {"int_description_66": "Filgrastim"}, {"int_description_67": "Amifostine"}, {"int_description_68": "Radiation therapy", "timeframe_int68": "Days or Weeks,Years", "age_use_int68": "Child", "contra_int68": "No", "qualscale_reclass_drug68": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug68": "Effective / Ameliorative"}, {"int_description_69": "Total abdominal radiation"}, {"int_description_70": "Total body irradiation"}, {"int_description_71": "Total lymphoid irradiation"}, {"int_description_72": "Transfusion of blood products"}, {"int_description_73": "Bone marrow transplantation"}, {"int_description_74": "Hematopoietic stem cell transplantation"}, {"int_description_75": "Surgery for polydactyly, carpectomy"}, {"int_description_76": "Surgical intervention"}, {"int_description_77": "\u042burgical tumor removement"}], "references": [{"pmid_title_1": "Gingival Bleeding in a Child with Fanconi Anemia: A Case Report and Literature Review.", "pmid_1": 32231808.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Case Rep Dent"}, {"pmid_title_2": "Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.", "pmid_2": 29668547.0, "pmid_date_2": 2019.0, "pmid_journal_2": "J Pediatr Hematol Oncol"}, {"pmid_title_3": "Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.", "pmid_3": 31192125.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Front Oncol"}, {"pmid_title_4": "Fanconi anemia: a single center experience of a large cohort.", "pmid_4": 31990462.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Turk J Pediatr"}, {"pmid_title_5": "Therapeutic research in the crystal chromosome disease Fanconi anemia.", "pmid_5": 30389152.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Mutat Res Genet Toxicol Environ Mutagen"}, {"pmid_title_6": "Oral cancer in Fanconi anemia: Review of 121 cases.", "pmid_6": 29650274.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Crit Rev Oncol Hematol"}, {"pmid_title_7": "Essential Role of BRCA2 in Ovarian Development and Function.", "pmid_7": 30207912.0, "pmid_date_7": 2018.0, "pmid_journal_7": "N Engl J Med"}, {"pmid_title_8": "Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.", "pmid_8": 29203412.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Biol Blood Marrow Transplant"}, {"pmid_title_9": "How I manage patients with Fanconi anaemia.", "pmid_9": 28474441.0, "pmid_date_9": 2017.0, "pmid_journal_9": "Br J Haematol"}, {"pmid_title_10": "Eltrombopag for the treatment of aplastic anemia: current perspectives.", "pmid_10": 27695288.0, "pmid_date_10": 2016.0, "pmid_journal_10": "Drug Des Devel Ther"}, {"pmid_title_11": "Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.", "pmid_11": 27246371.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Biol Blood Marrow Transplant"}, {"pmid_title_12": "Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.", "pmid_12": 26900943.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Pediatr Hematol Oncol"}, {"pmid_title_13": "Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.", "pmid_13": 26657402.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Eur J Med Genet"}, {"pmid_title_14": "Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.", "pmid_14": 25575015.0, "pmid_date_14": 2015.0, "pmid_journal_14": "J Clin Endocrinol Metab"}, {"pmid_title_15": "Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.", "pmid_15": 25862235.0, "pmid_date_15": 2015.0, "pmid_journal_15": "Ann Hematol"}, {"pmid_title_16": "Alternative donor hematopoietic cell transplantation for Fanconi anemia.", "pmid_16": 25824692.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Blood"}, {"pmid_title_17": "Fanconi anemia and solid malignancies in childhood: a national retrospective study.", "pmid_17": 25381700.0, "pmid_date_17": 2015.0, "pmid_journal_17": "Pediatr Blood Cancer"}, {"pmid_title_18": "Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.", "pmid_18": 25531282.0, "pmid_date_18": 2015.0, "pmid_journal_18": "Bone Marrow Transplant"}, {"pmid_title_19": "Clear cell sarcoma of the kidney in a child with Fanconi anemia.", "pmid_19": 24735155.0, "pmid_date_19": 2014.0, "pmid_journal_19": "Pediatr Dev Pathol"}, {"pmid_title_20": "Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.", "pmid_20": 25085358.0, "pmid_date_20": 2014.0, "pmid_journal_20": "Haematologica"}, {"pmid_title_21": "Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.", "pmid_21": 24019220.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Management of dental extraction in a female patient with fanconi anemia.", "pmid_22": 25628690.0, "pmid_date_22": 2014.0, "pmid_journal_22": "J Dent (Tehran)"}, {"pmid_title_23": "Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature.", "pmid_23": 22965917.0, "pmid_date_23": 2013.0, "pmid_journal_23": "Head Neck"}, {"pmid_title_24": "Deferasirox therapy in children with Fanconi aplastic anemia.", "pmid_24": 22510772.0, "pmid_date_24": 2012.0, "pmid_journal_24": "J Pediatr Hematol Oncol"}, {"pmid_title_25": "Fatal course of tonsillar squamous cell carcinoma associated with Fanconi anaemia: a mini review.", "pmid_25": 21925890.0, "pmid_date_25": 2012.0, "pmid_journal_25": "J Craniomaxillofac Surg"}, {"pmid_title_26": "Treatment of the bone marrow failure in Fanconi anemia patients with danazol.", "pmid_26": 22178060.0, "pmid_date_26": 2012.0, "pmid_journal_26": "Blood Cells Mol Dis"}, {"pmid_title_27": "Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing.", "pmid_27": 21519011.0, "pmid_date_27": 2011.0, "pmid_journal_27": "J Clin Oncol"}, {"pmid_title_28": "Successful treatment of esophageal squamous cell carcinoma in a patient with Fanconi anemia.", "pmid_28": 20410055.0, "pmid_date_28": 2010.0, "pmid_journal_28": "Jpn J Clin Oncol"}, {"pmid_title_29": "Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.", "pmid_29": 19564748.0, "pmid_date_29": 2009.0, "pmid_journal_29": "J Pediatr Hematol Oncol"}, {"pmid_title_30": "Treatment with deferiprone for iron overload alleviates bone marrow failure in a Fanconi anemia patient.", "pmid_30": 19814681.0, "pmid_date_30": 2009.0, "pmid_journal_30": "Hemoglobin"}, {"pmid_title_31": "Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.", "pmid_31": 18302713.0, "pmid_date_31": 2008.0, "pmid_journal_31": "Br J Haematol"}, {"pmid_title_32": "Thrombocytopenia in the neonate.", "pmid_32": 18433954.0, "pmid_date_32": 2008.0, "pmid_journal_32": "Blood Rev"}, {"pmid_title_33": "Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.", "pmid_33": 18379369.0, "pmid_date_33": 2008.0, "pmid_journal_33": "J Thorac Oncol"}, {"pmid_title_34": "Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function.", "pmid_34": 18623197.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Pediatr Blood Cancer"}, {"pmid_title_35": "Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.", "pmid_35": 18831513.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Cancer"}, {"pmid_title_36": "Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.", "pmid_36": 17950918.0, "pmid_date_36": 2007.0, "pmid_journal_36": "Biol Blood Marrow Transplant"}, {"pmid_title_37": "Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.", "pmid_37": 17038525.0, "pmid_date_37": 2007.0, "pmid_journal_37": "Blood"}, {"pmid_title_38": "Chemotherapy for myeloid malignancy in children with Fanconi anemia.", "pmid_38": 16609946.0, "pmid_date_38": 2007.0, "pmid_journal_38": "Pediatr Blood Cancer"}, {"pmid_title_39": "A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.", "pmid_39": 17096012.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Leukemia"}, {"pmid_title_40": "HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.", "pmid_40": 18022575.0, "pmid_date_40": 2007.0, "pmid_journal_40": "Biol Blood Marrow Transplant"}, {"pmid_title_41": "Anesthesia and Fanconi anemia: a case report and review of literature.", "pmid_41": 16918663.0, "pmid_date_41": 2006.0, "pmid_journal_41": "Paediatr Anaesth"}, {"pmid_title_42": "Squamous cell carcinoma of the hypopharynx in a young woman with Fanconi's anemia.", "pmid_42": 17308840.0, "pmid_date_42": 2006.0, "pmid_journal_42": "Braz J Otorhinolaryngol"}, {"pmid_title_43": "Squamous cell vulvar carcinoma associated with Fanconi's anemia: a case report.", "pmid_43": 11975685.0, "pmid_date_43": 2002.0, "pmid_journal_43": "Int J Gynecol Cancer"}, {"pmid_title_44": "Growth hormone deficiency caused by pituitary stalk interruption in Fanconi's anemia.", "pmid_44": 11148528.0, "pmid_date_44": 2001.0, "pmid_journal_44": "J Pediatr"}, {"pmid_title_45": "Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.", "pmid_45": 9658728.0, "pmid_date_45": 1998.0, "pmid_journal_45": "Haematologica"}, {"pmid_title_46": "Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.", "pmid_46": 8781414.0, "pmid_date_46": 1996.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.", "pmid_47": 7644282.0, "pmid_date_47": 1995.0, "pmid_journal_47": "Pediatr Nurs"}, {"pmid_title_48": "Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.", "pmid_48": 8283365.0, "pmid_date_48": 1994.0, "pmid_journal_48": "J Pediatr"}, {"pmid_title_49": "A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia.", "pmid_49": 8280614.0, "pmid_date_49": 1993.0, "pmid_journal_49": "Br J Haematol"}, {"pmid_title_50": "Fanconi's anemia. A family study with 20-year follow-up including associated breast pathology.", "pmid_50": 6478420.0, "pmid_date_50": 1984.0, "pmid_journal_50": "Cancer"}, {"pmid_title_51": "Multiple hepatic tumors and peliosis hepatis in Fanconi's anemia treated with androgens.", "pmid_51": 199056.0, "pmid_date_51": 1977.0, "pmid_journal_51": "Am J Dis Child"}, {"pmid_title_52": "Hepatic lesions in patients treated with synthetic anabolic steriods.", "pmid_52": 185239.0, "pmid_date_52": 1976.0, "pmid_journal_52": "J Clin Pathol"}, {"pmid_title_53": "The defective absorption of phosphorus and calcium and the effect of vitamin D in the Fanconi syndrome.", "pmid_53": 13610080.0, "pmid_date_53": 1958.0, "pmid_journal_53": "Guys Hosp Rep"}]}, {"_id": "3606-OMIM:229700", "condition": {"condition_name": "FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY; FBP1D", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY; FBP1D"]}, "gene information": {"db_hgnc_gene_id": 3606.0}, "interventions": [{"int_description_1": "Fructose, sucrose, glycerol, sorbitol-restricted diet"}, {"int_description_2": "Allopurinol"}, {"int_description_3": "Starch, corn", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Sodium bicarbonate", "timeframe_int4": "Hours,Days or Weeks,Years", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "D-glucose", "timeframe_int5": "Days or Weeks,Years", "age_use_int5": "Infant,Child", "contra_int5": "Yes", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Strict avoidance of fasting (fed every 3-6 hours)", "timeframe_int6": "Hours,Days or Weeks,Years", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Fructose-1,6-Bisphosphatase Deficiency", "pmid_1": 31804789.0, "pmid_date_1": 2019.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Exon 2 deletion represents a common mutation in Turkish patients with fructose-1,6-bisphosphatase deficiency.", "pmid_2": 31278438.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Metabolic brain disease"}, {"pmid_title_3": "Novel fructose bisphosphatase 1 gene mutation presenting as recurrent episodes of vomiting in an Indian child.", "pmid_3": 29992913.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Journal of postgraduate medicine"}, {"pmid_title_4": "International practices in the dietary management of fructose 1-6 biphosphatase deficiency.", "pmid_4": 29370874.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Orphanet journal of rare diseases"}, {"pmid_title_5": "Fructose-1,6-bisphosphatase deficiency as a\u00a0cause of recurrent hypoglycemia and metabolic acidosis: Clinical and molecular findings in Malaysian patients.", "pmid_5": 29203193.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Pediatrics and neonatology"}, {"pmid_title_6": "Fructose-1,6-bisphosphatase deficiency caused by a novel homozygous Alu element insertion in the FBP1 gene and delayed diagnosis.", "pmid_6": 28599390.0, "pmid_date_6": 2017.0, "pmid_journal_6": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_7": "Clinical and Molecular Characterization of Patients with Fructose 1,6-Bisphosphatase Deficiency.", "pmid_7": 28420223.0, "pmid_date_7": 2017.0, "pmid_journal_7": "International journal of molecular sciences"}, {"pmid_title_8": "Fructose-1,6-diphosphatase deficiency: a treatable neurometabolic disorder.", "pmid_8": 25246452.0, "pmid_date_8": 2014.0, "pmid_journal_8": "BMJ case reports"}, {"pmid_title_9": "Fructose 1,6-bisphosphatase deficiency: enzyme and mutation analysis performed on calcitriol-stimulated monocytes with a note on long-term prognosis.", "pmid_9": 20151204.0, "pmid_date_9": 2010.0, "pmid_journal_9": "Journal of inherited metabolic disease"}]}, {"_id": "362-OMIM:267500", "condition": {"condition_name": "RETICULAR DYSGENESIS", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["RETICULAR DYSGENESIS"]}, "gene information": {"db_hgnc_gene_id": 362.0}, "interventions": [{"int_description_1": "Mechanical ventilation"}, {"int_description_2": "Nasal continuous positive airway pressure treatment"}, {"int_description_3": "Transfer factor"}, {"int_description_4": "Testosterone"}, {"int_description_5": "Salmeterol"}, {"int_description_6": "Ursodeoxycholic acid"}, {"int_description_7": "Sargramostim"}, {"int_description_8": "Dopamine"}, {"int_description_9": "Prednisolone"}, {"int_description_10": "Prednisone"}, {"int_description_11": "Fluticasone"}, {"int_description_12": "Ketoconazole"}, {"int_description_13": "Ganciclovir"}, {"int_description_14": "Human immunoglobulin G"}, {"int_description_15": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_16": "Midazolam"}, {"int_description_17": "Rituximab"}, {"int_description_18": "Alemtuzumab"}, {"int_description_19": "Clarithromycin"}, {"int_description_20": "Cyclosporine"}, {"int_description_21": "Clofazimine"}, {"int_description_22": "Isoniazid"}, {"int_description_23": "Amphotericin B"}, {"int_description_24": "Budesonide"}, {"int_description_25": "Somatotropin"}, {"int_description_26": "Piperacillin"}, {"int_description_27": "Vitamin D"}, {"int_description_28": "Levetiracetam"}, {"int_description_29": "Cyclophosphamide"}, {"int_description_30": "Busulfan"}, {"int_description_31": "Melphalan", "timeframe_int31": "Hours,Days or Weeks", "age_use_int31": "Neonate,Infant", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Thiotepa"}, {"int_description_33": "Caspofungin"}, {"int_description_34": "Amikacin"}, {"int_description_35": "Pyrazinamide"}, {"int_description_36": "Linezolid"}, {"int_description_37": "Pyridoxine"}, {"int_description_38": "Ethambutol"}, {"int_description_39": "Azithromycin"}, {"int_description_40": "Trimethoprim"}, {"int_description_41": "Sulfamethoxazole"}, {"int_description_42": "Ciprofloxacin"}, {"int_description_43": "Ofloxacin"}, {"int_description_44": "Fusidic acid"}, {"int_description_45": "Ampicillin"}, {"int_description_46": "Cefotaxime"}, {"int_description_47": "Meropenem"}, {"int_description_48": "Amoxicillin"}, {"int_description_49": "Cefuroxime"}, {"int_description_50": "Ceftriaxone"}, {"int_description_51": "Cefazolin"}, {"int_description_52": "Cefoperazone"}, {"int_description_53": "Latamoxef"}, {"int_description_54": "Sulbactam"}, {"int_description_55": "Clavulanic acid"}, {"int_description_56": "Treosulfan"}, {"int_description_57": "Atovaquone"}, {"int_description_58": "Rifampicin"}, {"int_description_59": "Fluconazole"}, {"int_description_60": "Itraconazole"}, {"int_description_61": "Pyrimethamine"}, {"int_description_62": "Methotrexate"}, {"int_description_63": "Sulfadoxine"}, {"int_description_64": "Levofloxacin"}, {"int_description_65": "Fludarabine"}, {"int_description_66": "Pentamidine"}, {"int_description_67": "Vancomycin"}, {"int_description_68": "Tacrolimus"}, {"int_description_69": "Valproic acid"}, {"int_description_70": "Foscarnet"}, {"int_description_71": "Acyclovir"}, {"int_description_72": "Cidofovir"}, {"int_description_73": "Mycophenolate mofetil"}, {"int_description_74": "Ledipasvir"}, {"int_description_75": "Oxacillin"}, {"int_description_76": "Omeprazole"}, {"int_description_77": "Methylprednisolone"}, {"int_description_78": "Methimazole"}, {"int_description_79": "Infliximab"}, {"int_description_80": "Interferon alfa-2a, Recombinant"}, {"int_description_81": "Anti Thymocyte Globulin"}, {"int_description_82": "Anti-CD45 antibodies"}, {"int_description_83": "CMV hyperImmunoglobulin"}, {"int_description_84": "Nystatin"}, {"int_description_85": "Teicoplanin"}, {"int_description_86": "Sofosbuvir"}, {"int_description_87": "Antilymphocyte immunoglobulin (horse)", "timeframe_int87": "Days or Weeks", "contra_int87": "No", "qualscale_reclass_drug87": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug87": "Curative"}, {"int_description_88": "Human interleukin-2"}, {"int_description_89": "Thymic hormone"}, {"int_description_90": "Thyroid hormone"}, {"int_description_91": "Thyroxin"}, {"int_description_92": "Phenobarbital"}, {"int_description_93": "Filgrastim"}, {"int_description_94": "2'-Deoxycytidine"}, {"int_description_95": "Irradiated blood transfusions"}, {"int_description_96": "Parenteral nutrition"}, {"int_description_97": "Platelet transfusions"}, {"int_description_98": "Total body irradiation"}, {"int_description_99": "Hematopoietic stem cell transplantation"}], "references": [{"pmid_title_1": "Severe Combined Immunodeficiency", "pmid_1": 30969584.0, "pmid_date_1": 2021.0, "pmid_journal_1": "statpearls"}, {"pmid_title_2": "Reticular dysgenesis caused by an intronic pathogenic variant in <i>AK2</i>.", "pmid_2": 32532877.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Cold Spring Harb Mol Case Stud"}, {"pmid_title_3": "Biallelic Form of a Known CD3E Mutation in a Patient with Severe Combined Immunodeficiency.", "pmid_3": 32016651.0, "pmid_date_3": 2020.0, "pmid_journal_3": "J Clin Immunol"}, {"pmid_title_4": "Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.", "pmid_4": 30194989.0, "pmid_date_4": 2019.0, "pmid_journal_4": "J Allergy Clin Immunol"}, {"pmid_title_5": "Disseminated Bacille Calmette-Gu\u00e9rin infection in a patient with severe combined immunodeficiency caused by JAK3 gene mutation.", "pmid_5": 31309596.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Pediatr Dermatol"}, {"pmid_title_6": "Prevention of transfusion-transmitted cytomegalovirus infection using leukoreduced blood components in patients receiving seronegative umbilical cord blood transplantation.", "pmid_6": 31322734.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Transfusion"}, {"pmid_title_7": "Human interleukin-2 receptor \u03b2 mutations associated with defects in immunity and peripheral tolerance.", "pmid_7": 31040185.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Exp Med"}, {"pmid_title_8": "Combined Immunodeficiency With Late-Onset Progressive Hypogammaglobulinemia and Normal B Cell Count in a Patient With RAG2 Deficiency.", "pmid_8": 31058115.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Front Pediatr"}, {"pmid_title_9": "Hematopoietic stem cell transplantation for cytidine triphosphate synthase 1 (CTPS1) deficiency.", "pmid_9": 29884857.0, "pmid_date_9": 2019.0, "pmid_journal_9": "Bone Marrow Transplant"}, {"pmid_title_10": "Severe combined immunodeficiency (SCID) presenting in childhood, with agammaglobulinemia, associated with novel compound heterozygous mutations in DCLRE1C.", "pmid_10": 30630113.0, "pmid_date_10": 2019.0, "pmid_journal_10": "Clin Immunol"}, {"pmid_title_11": "Recent advances in understanding the pathogenesis and management of reticular dysgenesis.", "pmid_11": 29270983.0, "pmid_date_11": 2018.0, "pmid_journal_11": "Br J Haematol"}, {"pmid_title_12": "Two siblings with PRKDC defect who presented with cutaneous granulomas and review of the literature.", "pmid_12": 30121298.0, "pmid_date_12": 2018.0, "pmid_journal_12": "Clin Immunol"}, {"pmid_title_13": "SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.", "pmid_13": 30154114.0, "pmid_date_13": 2018.0, "pmid_journal_13": "Blood"}, {"pmid_title_14": "A Novel Homozygous <i>JAK3</i> Mutation Leading to T-B+NK- SCID in Two Brazilian Patients.", "pmid_14": 30177960.0, "pmid_date_14": 2018.0, "pmid_journal_14": "Front Pediatr"}, {"pmid_title_15": "Co-appearance of OPV and BCG vaccine-derived complications in two infants with severe combined immunodeficiency.", "pmid_15": 29804197.0, "pmid_date_15": 2018.0, "pmid_journal_15": "Immunol Res"}, {"pmid_title_16": "Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis.", "pmid_16": 30014500.0, "pmid_date_16": 2018.0, "pmid_journal_16": "Hepatology"}, {"pmid_title_17": "JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long-known gene.", "pmid_17": 30032486.0, "pmid_date_17": 2018.0, "pmid_journal_17": "Mol Genet Genomic Med"}, {"pmid_title_18": "Chronic active Epstein-Barr virus infection as the initial symptom in a Janus kinase 3 deficiency child: Case report and literature review.", "pmid_18": 29049190.0, "pmid_date_18": 2017.0, "pmid_journal_18": "Medicine (Baltimore)"}, {"pmid_title_19": "Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome.", "pmid_19": 28331055.0, "pmid_date_19": 2017.0, "pmid_journal_19": "Blood"}, {"pmid_title_20": "A novel deletion mutation in IL2RG gene results in X-linked severe combined immunodeficiency with an atypical phenotype.", "pmid_20": 27566612.0, "pmid_date_20": 2017.0, "pmid_journal_20": "Immunogenetics"}, {"pmid_title_21": "Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency.", "pmid_21": 28346229.0, "pmid_date_21": 2017.0, "pmid_journal_21": "J Clin Invest"}, {"pmid_title_22": "Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report.", "pmid_22": 28209722.0, "pmid_date_22": 2017.0, "pmid_journal_22": "Blood"}, {"pmid_title_23": "A 24-Year Enzyme Replacement Therapy in an Adenosine-deaminase-Deficient Patient.", "pmid_23": 26684479.0, "pmid_date_23": 2016.0, "pmid_journal_23": "Pediatrics"}, {"pmid_title_24": "Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.", "pmid_24": 27129325.0, "pmid_date_24": 2016.0, "pmid_journal_24": "Blood"}, {"pmid_title_25": "Insufficient immune reconstitution after allogeneic cord blood transplantation without chemotherapy conditioning in patients with SCID caused by CD3\u03b4 deficiency.", "pmid_25": 26999462.0, "pmid_date_25": 2016.0, "pmid_journal_25": "Bone Marrow Transplant"}, {"pmid_title_26": "Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency.", "pmid_26": 27099176.0, "pmid_date_26": 2016.0, "pmid_journal_26": "Sci Transl Med"}, {"pmid_title_27": "Case Report: Whole exome sequencing identifies variation c.2308G>A p.E770K in <i>RAG1</i> associated with B- T- NK+ severe combined immunodeficiency.", "pmid_27": 29067161.0, "pmid_date_27": 2016.0, "pmid_journal_27": "F1000Res"}, {"pmid_title_28": "CTP Synthase 1 Deficiency in Successfully Transplanted Siblings with Combined Immune Deficiency and Chronic Active EBV Infection.", "pmid_28": 27638562.0, "pmid_date_28": 2016.0, "pmid_journal_28": "J Clin Immunol"}, {"pmid_title_29": "Mutation c.256_257delAA in RAG1 Gene in Polish Children with Severe Combined Immunodeficiency: Diversity of Clinical Manifestations.", "pmid_29": 28083621.0, "pmid_date_29": 2016.0, "pmid_journal_29": "Arch Immunol Ther Exp (Warsz)"}, {"pmid_title_30": "Persistent rotavirus diarrhea post-transplant in a novel JAK3-SCID patient after vaccination.", "pmid_30": 26248889.0, "pmid_date_30": 2016.0, "pmid_journal_30": "Pediatr Allergy Immunol"}, {"pmid_title_31": "Novel compound heterozygous mutations in a Japanese girl with Janus kinase 3 deficiency.", "pmid_31": 27593409.0, "pmid_date_31": 2016.0, "pmid_journal_31": "Pediatr Int"}, {"pmid_title_32": "Mutations in Recombination Activating Gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt.", "pmid_32": 25869295.0, "pmid_date_32": 2015.0, "pmid_journal_32": "Clin Immunol"}, {"pmid_title_33": "A 15-year-old boy with severe combined immunodeficiency, fungal infection, and weight gain.", "pmid_33": 26314823.0, "pmid_date_33": 2015.0, "pmid_journal_33": "Allergy Asthma Proc"}, {"pmid_title_34": "A novel common gamma chain mutation in a Chinese family with X-linked severe combined immunodeficiency (X-SCID; T(-)NK(-)B(+)).", "pmid_34": 26409833.0, "pmid_date_34": 2015.0, "pmid_journal_34": "Immunogenetics"}, {"pmid_title_35": "PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity.", "pmid_35": 25842288.0, "pmid_date_35": 2015.0, "pmid_journal_35": "J Allergy Clin Immunol"}, {"pmid_title_36": "Transplantation outcomes for severe combined immunodeficiency, 2000-2009.", "pmid_36": 25075835.0, "pmid_date_36": 2014.0, "pmid_journal_36": "N Engl J Med"}, {"pmid_title_37": "Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.", "pmid_37": 25109802.0, "pmid_date_37": 2014.0, "pmid_journal_37": "J Allergy Clin Immunol"}, {"pmid_title_38": "SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.", "pmid_38": 24144642.0, "pmid_date_38": 2014.0, "pmid_journal_38": "Blood"}, {"pmid_title_39": "Severe combined immunodeficiency caused by a new homozygous RAG1 mutation with progressive encephalopathy.", "pmid_39": 24333136.0, "pmid_date_39": 2014.0, "pmid_journal_39": "Hematol Oncol Stem Cell Ther"}, {"pmid_title_40": "The many faces of Artemis-deficient combined immunodeficiency - Two patients with DCLRE1C mutations and a systematic literature review of genotype-phenotype correlation.", "pmid_40": 24230999.0, "pmid_date_40": 2013.0, "pmid_journal_40": "Clin Immunol"}, {"pmid_title_41": "Successful bone marrow transplantation with reduced intensity conditioning in a patient with delayed-onset adenosine deaminase deficiency.", "pmid_41": 22805442.0, "pmid_date_41": 2013.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Hemophagocytic bone marrow aplasia with plasma cells in a RAG2-deficient SCID case after a nonconditioned transplantation from a fully matched sibling.", "pmid_42": 23389499.0, "pmid_date_42": 2013.0, "pmid_journal_42": "J Pediatr Hematol Oncol"}, {"pmid_title_43": "Skeletal abnormalities and successful hematopoietic stem cell transplantation in patients with reticular dysgenesis.", "pmid_43": 23763981.0, "pmid_date_43": 2013.0, "pmid_journal_43": "J Allergy Clin Immunol"}, {"pmid_title_44": "Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency.", "pmid_44": 22409989.0, "pmid_date_44": 2012.0, "pmid_journal_44": "J Allergy Clin Immunol"}, {"pmid_title_45": "Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.", "pmid_45": 22791287.0, "pmid_date_45": 2012.0, "pmid_journal_45": "Blood"}, {"pmid_title_46": "Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.", "pmid_46": 22968453.0, "pmid_date_46": 2012.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "IL-21 is the primary common \u03b3 chain-binding cytokine required for human B-cell differentiation in vivo.", "pmid_47": 22039266.0, "pmid_date_47": 2011.0, "pmid_journal_47": "Blood"}, {"pmid_title_48": "Hematopoietic stem cell transplantation for CD3\u03b4 deficiency.", "pmid_48": 21757226.0, "pmid_date_48": 2011.0, "pmid_journal_48": "J Allergy Clin Immunol"}, {"pmid_title_49": "Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency.", "pmid_49": 21725047.0, "pmid_date_49": 2011.0, "pmid_journal_49": "Blood"}, {"pmid_title_50": "A leaky mutation in CD3D differentially affects \u03b1\u03b2 and \u03b3\u03b4 T cells and leads to a T\u03b1\u03b2-T\u03b3\u03b4+B+NK+ human SCID.", "pmid_50": 21926461.0, "pmid_date_50": 2011.0, "pmid_journal_50": "J Clin Invest"}, {"pmid_title_51": "Occurrence of myelodysplastic syndrome in 2 patients with reticular dysgenesis.", "pmid_51": 21458044.0, "pmid_date_51": 2011.0, "pmid_journal_51": "J Allergy Clin Immunol"}, {"pmid_title_52": "Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency.", "pmid_52": 20113887.0, "pmid_date_52": 2010.0, "pmid_journal_52": "Immunol Allergy Clin North Am"}, {"pmid_title_53": "Hemophagocytosis after bone marrow transplantation for JAK3-deficient severe combined immunodeficiency.", "pmid_53": 19659508.0, "pmid_date_53": 2010.0, "pmid_journal_53": "Pediatr Transplant"}, {"pmid_title_54": "A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining.", "pmid_54": 19075392.0, "pmid_date_54": 2009.0, "pmid_journal_54": "J Clin Invest"}, {"pmid_title_55": "Novel RAG2 mutation in a patient with T- B- severe combined immunodeficiency and disseminated BCG disease.", "pmid_55": 20128425.0, "pmid_date_55": 2009.0, "pmid_journal_55": "J Investig Allergol Clin Immunol"}, {"pmid_title_56": "A novel missense RAG-1 mutation results in T-B-NK+ SCID in Athabascan-speaking Dine Indians from the Canadian Northwest Territories.", "pmid_56": 18701881.0, "pmid_date_56": 2009.0, "pmid_journal_56": "Eur J Hum Genet"}, {"pmid_title_57": "Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID.", "pmid_57": 19458910.0, "pmid_date_57": 2009.0, "pmid_journal_57": "Clin Exp Med"}, {"pmid_title_58": "Gene therapy for immunodeficiency due to adenosine deaminase deficiency.", "pmid_58": 19179314.0, "pmid_date_58": 2009.0, "pmid_journal_58": "N Engl J Med"}, {"pmid_title_59": "Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency.", "pmid_59": 17825895.0, "pmid_date_59": 2007.0, "pmid_journal_59": "J Allergy Clin Immunol"}, {"pmid_title_60": "Novel RAG1 mutation in a case of severe combined immunodeficiency.", "pmid_60": 16061569.0, "pmid_date_60": 2005.0, "pmid_journal_60": "Pediatrics"}, {"pmid_title_61": "Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.", "pmid_61": 14615376.0, "pmid_date_61": 2004.0, "pmid_journal_61": "Blood"}, {"pmid_title_62": "Novel Artemis gene mutations of radiosensitive severe combined immunodeficiency in Japanese families.", "pmid_62": 12592555.0, "pmid_date_62": 2003.0, "pmid_journal_62": "Hum Genet"}, {"pmid_title_63": "Bone marrow transplantation for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans.", "pmid_63": 11360109.0, "pmid_date_63": 2001.0, "pmid_journal_63": "Bone Marrow Transplant"}, {"pmid_title_64": "Successful bone-marrow transplantation for reticular dysgenesis.", "pmid_64": 6132037.0, "pmid_date_64": 1983.0, "pmid_journal_64": "Lancet"}, {"pmid_title_65": "Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.", "pmid_65": 6983936.0, "pmid_date_65": 1982.0, "pmid_journal_65": "Clin Exp Immunol"}]}, {"_id": "4021-OMIM:617526", "condition": {"condition_name": "ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4; EKVP4", "freq_per_birth": "EKVP is a rare disorder; its prevalence is unknown. More than 200 cases have been reported in the medical literature.", "pattern_of_inheritance": "Autosomal recessive==Autosomal dominant", "alternate_names": ["ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4; EKVP4"]}, "gene information": {"db_hgnc_gene_id": 4021.0}, "interventions": [{"int_description_1": "Isotretinoin", "timeframe_int1": "Days or Weeks", "age_use_int1": "Neonate,Infant", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Mutations in KDSR Cause Recessive Progressive Symmetric Erythrokeratoderma.", "pmid_1": 28575652.0, "pmid_date_1": 2017.0, "pmid_journal_1": "American journal of human genetics"}]}, {"_id": "4056-OMIM:232200", "condition": {"condition_name": "GLYCOGEN STORAGE DISEASE Ia; GSD1A", "freq_per_birth": "The overall incidence of GSDI is 1 in 100,000 individuals.  GSDIa is more common than GSDIb, accounting for 80 percent of all GSDI cases.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["GLYCOGEN STORAGE DISEASE Ia; GSD1A"]}, "gene information": {"db_hgnc_gene_id": 4056.0}, "interventions": [{"int_description_1": "High-carbohydrate diet"}, {"int_description_2": "Low-purine diet and allopurinol combination therapy"}, {"int_description_3": "Testosterone"}, {"int_description_4": "Fenofibrate"}, {"int_description_5": "Captopril"}, {"int_description_6": "Niacin"}, {"int_description_7": "Atorvastatin"}, {"int_description_8": "Fish oil", "timeframe_int8": "Days or Weeks,Years", "age_use_int8": "Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Clofibrate", "timeframe_int9": "Days or Weeks,Years", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Cohort study or studies", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Allopurinol"}, {"int_description_11": "Potassium citrate", "timeframe_int11": "Hours,Days or Weeks", "age_use_int11": "Neonate,Infant,Child", "contra_int11": "No", "qualscale_reclass_drug11": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "Diazoxide"}, {"int_description_13": "Iron", "timeframe_int13": "Hours,Days or Weeks", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Starch, corn"}, {"int_description_15": "Folic acid", "timeframe_int15": "Hours,Days or Weeks,Years", "age_use_int15": "Infant,Child", "contra_int15": "Yes", "qualscale_reclass_drug15": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug15": "Effective / Ameliorative"}, {"int_description_16": "D-glucose"}, {"int_description_17": "Heterologous human adult liver-derived progenitor cells"}, {"int_description_18": "Hemodialysis"}, {"int_description_19": "Nighttime intragastric feedings", "timeframe_int19": "Days or Weeks", "age_use_int19": "Neonate,Infant,Child", "contra_int19": "No", "qualscale_reclass_drug19": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug19": "Effective / Ameliorative"}, {"int_description_20": "Kidney transplantation"}, {"int_description_21": "Orthotopic liver transplantation (OLT)"}], "references": [{"pmid_title_1": "Hepatic Glycogenoses Among Children-Clinical and Biochemical Characterization: Single-Center Study.", "pmid_1": 32405178.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Journal of clinical and experimental hepatology"}, {"pmid_title_2": "Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia.", "pmid_2": 32046761.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Orphanet journal of rare diseases"}, {"pmid_title_3": "A patient with glycogen storage disease type Ia combined with chronic hepatitis B infection: a case report.", "pmid_3": 31109299.0, "pmid_date_3": 2019.0, "pmid_journal_3": "BMC medical genetics"}, {"pmid_title_4": "Late presentation of glycogen storage disease types Ia and III in children with short stature and hepatomegaly.", "pmid_4": 29374762.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_5": "Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control.", "pmid_5": 28568353.0, "pmid_date_5": 2017.0, "pmid_journal_5": "Pediatric diabetes"}, {"pmid_title_6": "Glycogen Storage Disease Type I", "pmid_6": 20301489.0, "pmid_date_6": 2016.0, "pmid_journal_6": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_7": "Regression of hepatocellular adenomas with strict dietary therapy in patients with glycogen storage disease type I.", "pmid_7": 25308557.0, "pmid_date_7": 2015.0, "pmid_journal_7": "JIMD reports"}, {"pmid_title_8": "Biodistribution of adult derived human liver stem cells following intraportal infusion in a 17-year-old patient with glycogenosis type 1A.", "pmid_8": 24607438.0, "pmid_date_8": 2014.0, "pmid_journal_8": "Nuclear medicine and biology"}, {"pmid_title_9": "Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics.", "pmid_9": 25356975.0, "pmid_date_9": 2014.0, "pmid_journal_9": "Genetics in medicine : official journal of the American College of Medical Genetics"}, {"pmid_title_10": "Glycogen Storage Disease type 1a - a secondary cause for hyperlipidemia: report of five cases.", "pmid_10": 23738826.0, "pmid_date_10": 2013.0, "pmid_journal_10": "Journal of diabetes and metabolic disorders"}, {"pmid_title_11": "Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism.", "pmid_11": 23312056.0, "pmid_date_11": 2012.0, "pmid_journal_11": "Journal of clinical lipidology"}, {"pmid_title_12": "Severe hypertriglyceridemia and recurrent pancreatitis in a girl with type Ia glycogen storage disease and type III hyperlipoproteinemia.", "pmid_12": 19842193.0, "pmid_date_12": 2009.0, "pmid_journal_12": "American journal of medical genetics. Part A"}, {"pmid_title_13": "Liver transplantation for glycogen storage disease type Ia.", "pmid_13": 19596478.0, "pmid_date_13": 2009.0, "pmid_journal_13": "Journal of hepatology"}, {"pmid_title_14": "Preemptive living donor liver transplantation in glycogen storage disease Ia: case report.", "pmid_14": 18929868.0, "pmid_date_14": 2008.0, "pmid_journal_14": "Transplantation proceedings"}, {"pmid_title_15": "A 20-year follow-up of a male patient with type Ia glycogen storage disease.", "pmid_15": 12846528.0, "pmid_date_15": 2003.0, "pmid_journal_15": "Chang Gung medical journal"}, {"pmid_title_16": "Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I).", "pmid_16": 12373567.0, "pmid_date_16": 2002.0, "pmid_journal_16": "European journal of pediatrics"}, {"pmid_title_17": "Type 1 glycogen storage disease and recurrent calcium nephrolithiasis.", "pmid_17": 11390734.0, "pmid_date_17": 2001.0, "pmid_journal_17": "Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"}, {"pmid_title_18": "Short-term effect of captopril on microalbuminuria in children with glycogen storage disease type Ia.", "pmid_18": 10947200.0, "pmid_date_18": 2000.0, "pmid_journal_18": "Journal of inherited metabolic disease"}, {"pmid_title_19": "Treatment with low-dose diazoxide in two growth-retarded prepubertal girls with glycogen storage disease type Ia resulted in catch-up growth.", "pmid_19": 9427147.0, "pmid_date_19": 1997.0, "pmid_journal_19": "Journal of inherited metabolic disease"}, {"pmid_title_20": "Metabolic control and renal dysfunction in type I glycogen storage disease.", "pmid_20": 9266393.0, "pmid_date_20": 1997.0, "pmid_journal_20": "Journal of inherited metabolic disease"}, {"pmid_title_21": "Beneficial effects of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type I.", "pmid_21": 8503363.0, "pmid_date_21": 1993.0, "pmid_journal_21": "The American journal of clinical nutrition"}, {"pmid_title_22": "The long-term outcome of patients with glycogen storage disease type Ia.", "pmid_22": 8319726.0, "pmid_date_22": 1993.0, "pmid_journal_22": "European journal of pediatrics"}, {"pmid_title_23": "Hyperlipidemia and fatty acid composition in patients treated for type IA glycogen storage disease.", "pmid_23": 1880653.0, "pmid_date_23": 1991.0, "pmid_journal_23": "The Journal of pediatrics"}, {"pmid_title_24": "Amelioration of proximal renal tubular dysfunction in type I glycogen storage disease with dietary therapy.", "pmid_24": 2199830.0, "pmid_date_24": 1990.0, "pmid_journal_24": "The New England journal of medicine"}, {"pmid_title_25": "Physical growth and development of children with type 1 glycogen-storage disease: comparison of the effects of long-term use of dextrose and uncooked cornstarch.", "pmid_25": 2239780.0, "pmid_date_25": 1990.0, "pmid_journal_25": "The American journal of clinical nutrition"}, {"pmid_title_26": "Glycogen storage disease: long-term follow-up of nocturnal intragastric feeding.", "pmid_26": 6805987.0, "pmid_date_26": 1982.0, "pmid_journal_26": "Clinical genetics"}]}, {"_id": "4057-OMIM:300908", "condition": {"condition_name": "ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY", "pattern_of_inheritance": "X-linked dominant", "alternate_names": ["ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 4057.0}, "interventions": [{"int_description_1": "Blood transfusion", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "A novel G6PD gene variant in a Chinese girl with favism.", "pmid_1": 32557798.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Journal of clinical laboratory analysis"}, {"pmid_title_2": "Glucose-6-Phosphate Dehydrogenase Deficiency.", "pmid_2": 27040960.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Hematology/oncology clinics of North America"}]}, {"_id": "4061-OMIM:232220", "condition": {"condition_name": "GLYCOGEN STORAGE DISEASE Ib; GSD1B", "freq_per_birth": "The overall incidence of GSDI is 1 in 100,000 individuals.  GSDIa is more common than GSDIb, accounting for 80 percent of all GSDI cases.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["GLYCOGEN STORAGE DISEASE Ib; GSD1B"]}, "gene information": {"db_hgnc_gene_id": 4061.0}, "interventions": [{"int_description_1": "Empagliflozin", "timeframe_int1": "Days or Weeks", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Still in Trials / Unproven"}, {"int_description_2": "Alemtuzumab"}, {"int_description_3": "Somatotropin"}, {"int_description_4": "Melphalan"}, {"int_description_5": "Voglibose"}, {"int_description_6": "Mesalazine"}, {"int_description_7": "Sulfasalazine", "timeframe_int7": "Days or Weeks,Years", "age_use_int7": "Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Fludarabine"}, {"int_description_9": "Allopurinol", "timeframe_int9": "Days or Weeks", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Cohort study or studies", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Starch, corn", "timeframe_int10": "Hours,Days or Weeks,Years", "age_use_int10": "Infant,Child", "contra_int10": "Yes", "qualscale_reclass_drug10": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Medium-chain triglycerides"}, {"int_description_12": "Filgrastim", "timeframe_int12": "Hours,Days or Weeks", "age_use_int12": "Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Nighttime intragastric feedings"}, {"int_description_14": "HLA-matched unrelated bone marrow transplant with reduced conditioning regimen (fludarabine, melphalan, alemtuzumab)"}, {"int_description_15": "Orthotopic liver transplantation (OLT)"}, {"int_description_16": "Terminolateral portacaval shunt (PCS)"}], "references": [{"pmid_title_1": "Treating neutropenia and neutrophil dysfunction in glycogen storage disease IB with an SGLT2-inhibitor.", "pmid_1": 32294159.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood"}, {"pmid_title_2": "Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor.", "pmid_2": 30451720.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Current opinion in hematology"}, {"pmid_title_3": "Mutation analysis of <i>SLC37A4</i> in a patient with glycogen storage disease-type Ib.", "pmid_3": 31617422.0, "pmid_date_3": 2019.0, "pmid_journal_3": "The Journal of international medical research"}, {"pmid_title_4": "Matched unrelated donor transplantation in glycogen storage disease type 1b patient corrects severe neutropenia and recurrent infections.", "pmid_4": 29515247.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Bone marrow transplantation"}, {"pmid_title_5": "Involvement of endocrine system in a patient affected by glycogen storage disease 1b: speculation on the role of autoimmunity.", "pmid_5": 24646511.0, "pmid_date_5": 2014.0, "pmid_journal_5": "Italian journal of pediatrics"}, {"pmid_title_6": "Glycogen storage disease type 1b: an early onset severe phenotype associated with a novel mutation (IVS4) in the glucose 6-phosphate translocase (SLC37A4) gene in a Turkish patient.", "pmid_6": 25804016.0, "pmid_date_6": 2014.0, "pmid_journal_6": "Genetic counseling (Geneva, Switzerland)"}, {"pmid_title_7": "Impaired bone metabolism in glycogen storage disease type 1 is associated with poor metabolic control in type 1a and with granulocyte colony-stimulating factor therapy in type 1b.", "pmid_7": 24401800.0, "pmid_date_7": 2014.0, "pmid_journal_7": "Hormone research in paediatrics"}, {"pmid_title_8": "Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics.", "pmid_8": 25356975.0, "pmid_date_8": 2014.0, "pmid_journal_8": "Genetics in medicine : official journal of the American College of Medical Genetics"}, {"pmid_title_9": "Glycemic management in living donor liver transplantation for patients with glycogen storage disease type 1b.", "pmid_9": 22574785.0, "pmid_date_9": 2012.0, "pmid_journal_9": "Pediatric transplantation"}, {"pmid_title_10": "Long term G-CSF-induced remission of ulcerative colitis-like inflammatory bowel disease in a patient with glycogen storage disease Ib and evaluation of associated neutrophil function.", "pmid_10": 20830779.0, "pmid_date_10": 2010.0, "pmid_journal_10": "Pediatric blood & cancer"}, {"pmid_title_11": "Glycogen storage disease type 1: impact of medium-chain triglycerides on metabolic control and growth.", "pmid_11": 20357432.0, "pmid_date_11": 2010.0, "pmid_journal_11": "Annals of nutrition & metabolism"}, {"pmid_title_12": "Glycogen storage disease type Ib: the first case in Taiwan.", "pmid_12": 19579760.0, "pmid_date_12": 2009.0, "pmid_journal_12": "Pediatrics and neonatology"}, {"pmid_title_13": "Living donor liver transplantation for glycogen storage disease type Ib.", "pmid_13": 19938129.0, "pmid_date_13": 2009.0, "pmid_journal_13": "Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society"}, {"pmid_title_14": "Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib.", "pmid_14": 18996862.0, "pmid_date_14": 2008.0, "pmid_journal_14": "The American journal of clinical nutrition"}, {"pmid_title_15": "An open-label pilot study of granulocyte colony-stimulating factor for the treatment of severe endoscopic postoperative recurrence in Crohn's disease.", "pmid_15": 14581762.0, "pmid_date_15": 2003.0, "pmid_journal_15": "Digestion"}, {"pmid_title_16": "Crohn's-like ileo-colitis in patients affected by glycogen storage disease Ib: two years' follow-up of patients with a wide spectrum of gastrointestinal signs.", "pmid_16": 14971792.0, "pmid_date_16": 2003.0, "pmid_journal_16": "Acta paediatrica (Oslo, Norway : 1992)"}, {"pmid_title_17": "Improved growth with growth hormone therapy in a child with glycogen storage disease Ib.", "pmid_17": 12948077.0, "pmid_date_17": 2003.0, "pmid_journal_17": "Acta paediatrica (Oslo, Norway : 1992)"}, {"pmid_title_18": "Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I).", "pmid_18": 12373584.0, "pmid_date_18": 2002.0, "pmid_journal_18": "European journal of pediatrics"}, {"pmid_title_19": "Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1.", "pmid_19": 12373578.0, "pmid_date_19": 2002.0, "pmid_journal_19": "European journal of pediatrics"}, {"pmid_title_20": "Inflammatory bowel disease-like colitis in glycogen storage disease type 1b.", "pmid_20": 11383585.0, "pmid_date_20": 2001.0, "pmid_journal_20": "Inflammatory bowel diseases"}, {"pmid_title_21": "Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b.", "pmid_21": 11154211.0, "pmid_date_21": 2001.0, "pmid_journal_21": "Blood"}, {"pmid_title_22": "Renal carcinoma in a patient with glycogen storage disease Ib receiving long-term granulocyte colony-stimulating factor therapy.", "pmid_22": 10779042.0, "pmid_date_22": 2000.0, "pmid_journal_22": "Journal of pediatric hematology/oncology"}, {"pmid_title_23": "Long-term follow-up of portacaval shunt in glycogen storage disease type 1B.", "pmid_23": 10789932.0, "pmid_date_23": 2000.0, "pmid_journal_23": "European journal of pediatrics"}, {"pmid_title_24": "Gastric drip feeding in patients with glycogen storage disease type I: its effects on growth and plasma lipids and apolipoproteins.", "pmid_24": 2542871.0, "pmid_date_24": 1989.0, "pmid_journal_24": "Pediatric research"}, {"pmid_title_25": "The dietary treatment of children with type I glycogen storage disease with slow release carbohydrate.", "pmid_25": 6384910.0, "pmid_date_25": 1984.0, "pmid_journal_25": "Pediatric research"}]}, {"_id": "4065-OMIM:232300", "condition": {"condition_name": "GLYCOGEN STORAGE DISEASE II; GSD2", "freq_per_birth": "Pompe disease affects about 1 in 40,000 people in the United States. The incidence of this disorder varies among different ethnic groups.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["GLYCOGEN STORAGE DISEASE II; GSD2"]}, "gene information": {"db_hgnc_gene_id": 4065.0}, "interventions": [{"int_description_1": "Continuous positive airway pressure"}, {"int_description_2": "NeuDx Diaphragm pacer"}, {"int_description_3": "High-protein diet"}, {"int_description_4": "Salbutamol"}, {"int_description_5": "Clenbuterol", "timeframe_int5": "Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Cohort study or studies", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Human immunoglobulin G"}, {"int_description_7": "Rituximab"}, {"int_description_8": "Alglucosidase alfa"}, {"int_description_9": "Cyclophosphamide"}, {"int_description_10": "Bortezomib"}, {"int_description_11": "Miglustat"}, {"int_description_12": "Methotrexate", "timeframe_int12": "Days or Weeks", "age_use_int12": "Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Cohort study or studies", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "ATB200 combination"}, {"int_description_14": "Avalglucosidase alfa (GZ402666)"}, {"int_description_15": "AT2220"}, {"int_description_16": "Reveglucosidase alfa"}, {"int_description_17": "VAL-1221"}, {"int_description_18": "AAV2/8LSPhGAA"}, {"int_description_19": "AT845 (AAV8-hGAA)"}, {"int_description_20": "rAAV1-CMV-GAA"}, {"int_description_21": "rAAV9-DES-hGAA"}, {"int_description_22": "SPK-3006"}, {"int_description_23": "Lingual Muscle Training"}, {"int_description_24": "Resistance Exercise Training"}, {"int_description_25": "Respiratory Muscle Training"}], "references": [{"pmid_title_1": "Comparisons of Infant and Adult Mice Reveal Age Effects for Liver Depot Gene Therapy in Pompe Disease.", "pmid_1": 31909086.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Molecular therapy. Methods & clinical development"}, {"pmid_title_2": "Higher dosing of alglucosidase alfa improves outcomes in children with Pompe disease: a clinical study and review of the literature.", "pmid_2": 31904026.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Genetics in medicine : official journal of the American College of Medical Genetics"}, {"pmid_title_3": "Adapted physical activity and therapeutic exercise in late-onset Pompe disease (LOPD): a two-step rehabilitative approach.", "pmid_3": 31811531.0, "pmid_date_3": 2020.0, "pmid_journal_3": "Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"}, {"pmid_title_4": "Training, detraining, and retraining: Two 12-week respiratory muscle training regimens in a child with infantile-onset Pompe disease.", "pmid_4": 32176666.0, "pmid_date_4": 2020.0, "pmid_journal_4": "Journal of pediatric rehabilitation medicine"}, {"pmid_title_5": "Improved muscle function in a phase I/II clinical trial of albuterol in Pompe disease.", "pmid_5": 31839530.0, "pmid_date_5": 2020.0, "pmid_journal_5": "Molecular genetics and metabolism"}, {"pmid_title_6": "Nutrition and exercise in Pompe disease.", "pmid_6": 31392194.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Annals of translational medicine"}, {"pmid_title_7": "Clinical characteristics and genotypes in the ADVANCE baseline data set, a comprehensive cohort of US children and adolescents with Pompe disease.", "pmid_7": 31086307.0, "pmid_date_7": 2019.0, "pmid_journal_7": "Genetics in medicine : official journal of the American College of Medical Genetics"}, {"pmid_title_8": "Challenges in treating Pompe disease: an industry perspective.", "pmid_8": 31392203.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Ann Transl Med"}, {"pmid_title_9": "Long-Term Observation of the Safety and Effectiveness of Enzyme Replacement Therapy in Japanese Patients with Pompe Disease: Results From the Post-marketing Surveillance.", "pmid_9": 31559584.0, "pmid_date_9": 2019.0, "pmid_journal_9": "Neurol Ther"}, {"pmid_title_10": "Safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of the novel enzyme replacement therapy avalglucosidase alfa (neoGAA) in treatment-na\u00efve and alglucosidase alfa-treated patients with late-onset Pompe disease: A phase 1, open-label, multicenter, multinational, ascending dose study.", "pmid_10": 30770310.0, "pmid_date_10": 2019.0, "pmid_journal_10": "Neuromuscular disorders : NMD"}, {"pmid_title_11": "Effects of immunomodulation in classic infantile Pompe patients with high antibody titers.", "pmid_11": 30902109.0, "pmid_date_11": 2019.0, "pmid_journal_11": "Orphanet J Rare Dis"}, {"pmid_title_12": "Improved efficacy of a next-generation ERT in murine Pompe disease.", "pmid_12": 30843882.0, "pmid_date_12": 2019.0, "pmid_journal_12": "JCI Insight"}, {"pmid_title_13": "Safety and efficacy of short- and long-term inspiratory muscle training in late-onset Pompe disease (LOPD): a pilot study.", "pmid_13": 30430231.0, "pmid_date_13": 2019.0, "pmid_journal_13": "Journal of neurology"}, {"pmid_title_14": "Rehabilitation management of Pompe disease, from childhood trough adulthood: A systematic review of the literature.", "pmid_14": 31281600.0, "pmid_date_14": 2019.0, "pmid_journal_14": "Neurology international"}, {"pmid_title_15": "Respiratory muscle training (RMT) in late-onset Pompe disease (LOPD): A protocol for a sham-controlled clinical trial.", "pmid_15": 31303277.0, "pmid_date_15": 2019.0, "pmid_journal_15": "Molecular genetics and metabolism"}, {"pmid_title_16": "The role of rehabilitation in the management of late-onset Pompe disease: a narrative review of the level of evidence.", "pmid_16": 30944902.0, "pmid_date_16": 2018.0, "pmid_journal_16": "Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology"}, {"pmid_title_17": "Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD).", "pmid_17": 28574618.0, "pmid_date_17": 2018.0, "pmid_journal_17": "Neuropathology and applied neurobiology"}, {"pmid_title_18": "Long-term follow-up of 17 patients with childhood Pompe disease treated with enzyme replacement therapy.", "pmid_18": 29556838.0, "pmid_date_18": 2018.0, "pmid_journal_18": "J Inherit Metab Dis"}, {"pmid_title_19": "Efficacy, safety profile, and immunogenicity of alglucosidase alfa produced at the 4,000-liter scale in US children and adolescents with Pompe disease: ADVANCE, a phase IV, open-label, prospective study.", "pmid_19": 29565424.0, "pmid_date_19": 2018.0, "pmid_journal_19": "Genetics in medicine : official journal of the American College of Medical Genetics"}, {"pmid_title_20": "Cardiac outcome in classic infantile Pompe disease after 13\u202fyears of treatment with recombinant human acid alpha-glucosidase.", "pmid_20": 30049495.0, "pmid_date_20": 2018.0, "pmid_journal_20": "International journal of cardiology"}, {"pmid_title_21": "Enzyme replacement therapy with alglucosidase alfa in a late-onset Pompe disease patient during pregnancy.", "pmid_21": 30314719.0, "pmid_date_21": 2018.0, "pmid_journal_21": "Neuromuscular disorders : NMD"}, {"pmid_title_22": "Early higher dosage of alglucosidase alpha in classic Pompe disease.", "pmid_22": 30433875.0, "pmid_date_22": 2018.0, "pmid_journal_22": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_23": "Correction of Biochemical Abnormalities and Improved Muscle Function in a Phase I/II Clinical Trial of Clenbuterol in Pompe Disease.", "pmid_23": 30025991.0, "pmid_date_23": 2018.0, "pmid_journal_23": "Molecular therapy : the journal of the American Society of Gene Therapy"}, {"pmid_title_24": "Rapidly Progressive White Matter Involvement in Early Childhood: The Expanding Phenotype of Infantile Onset Pompe?", "pmid_24": 28726123.0, "pmid_date_24": 2018.0, "pmid_journal_24": "JIMD reports"}, {"pmid_title_25": "High Sustained Antibody Titers in Patients with Classic Infantile Pompe Disease Following Immunomodulation at Start of Enzyme Replacement Therapy.", "pmid_25": 29428273.0, "pmid_date_25": 2018.0, "pmid_journal_25": "The Journal of pediatrics"}, {"pmid_title_26": "An immune tolerance approach using transient low-dose methotrexate in the ERT-na\u00efve setting of patients treated with a therapeutic protein: experience in infantile-onset Pompe disease.", "pmid_26": 30214072.0, "pmid_date_26": 2018.0, "pmid_journal_26": "Genet Med"}, {"pmid_title_27": "Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction.", "pmid_27": 28344998.0, "pmid_date_27": 2017.0, "pmid_journal_27": "Molecular therapy. Methods & clinical development"}, {"pmid_title_28": "Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis.", "pmid_28": 27372449.0, "pmid_date_28": 2017.0, "pmid_journal_28": "Journal of neurology"}, {"pmid_title_29": "Alglucosidase alfa therapy for Pompe disease in pregnancy - Case report.", "pmid_29": 28320122.0, "pmid_date_29": 2017.0, "pmid_journal_29": "Journal of the neurological sciences"}, {"pmid_title_30": "European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience.", "pmid_30": 28477382.0, "pmid_date_30": 2017.0, "pmid_journal_30": "European journal of neurology"}, {"pmid_title_31": "Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme\u00ae) in 12 patients with advanced late-onset Pompe disease.", "pmid_31": 28648663.0, "pmid_date_31": 2017.0, "pmid_journal_31": "Molecular genetics and metabolism"}, {"pmid_title_32": "Enzyme replacement therapy for infantile-onset Pompe disease.", "pmid_32": 29155436.0, "pmid_date_32": 2017.0, "pmid_journal_32": "Cochrane Database Syst Rev"}, {"pmid_title_33": "Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in adult patients with Pompe disease.", "pmid_33": 29237491.0, "pmid_date_33": 2017.0, "pmid_journal_33": "Orphanet J Rare Dis"}, {"pmid_title_34": "Enzyme replacement therapy with alglucosidase alfa in Pompe disease: Clinical experience with rate escalation.", "pmid_34": 29289479.0, "pmid_date_34": 2017.0, "pmid_journal_34": "Mol Genet Metab"}, {"pmid_title_35": "Duvoglustat HCl Increases Systemic and Tissue Exposure of Active Acid \u03b1-Glucosidase in Pompe Patients Co-administered with Alglucosidase \u03b1.", "pmid_35": 28341561.0, "pmid_date_35": 2017.0, "pmid_journal_35": "Mol Ther"}, {"pmid_title_36": "High dose IVIG successfully reduces high rhGAA IgG antibody titers in a CRIM-negative infantile Pompe disease patient.", "pmid_36": 28648664.0, "pmid_date_36": 2017.0, "pmid_journal_36": "Mol Genet Metab"}, {"pmid_title_37": "Sustained immune tolerance induction in enzyme replacement therapy-treated CRIM-negative patients with infantile Pompe disease.", "pmid_37": 28814660.0, "pmid_date_37": 2017.0, "pmid_journal_37": "JCI Insight"}, {"pmid_title_38": "N-Butyl-l-deoxynojirimycin (l-NBDNJ): Synthesis of an Allosteric Enhancer of \u03b1-Glucosidase Activity for the Treatment of Pompe Disease.", "pmid_38": 29112434.0, "pmid_date_38": 2017.0, "pmid_journal_38": "Journal of medicinal chemistry"}, {"pmid_title_39": "Inspiratory muscle conditioning exercise and diaphragm gene therapy in Pompe disease: Clinical evidence of respiratory plasticity.", "pmid_39": 27453480.0, "pmid_date_39": 2017.0, "pmid_journal_39": "Experimental neurology"}, {"pmid_title_40": "A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease.", "pmid_40": 28838325.0, "pmid_date_40": 2017.0, "pmid_journal_40": "Orphanet journal of rare diseases"}, {"pmid_title_41": "Albuterol as an adjunctive treatment to enzyme replacement therapy in infantile-onset Pompe disease.", "pmid_41": 28480166.0, "pmid_date_41": 2017.0, "pmid_journal_41": "Molecular genetics and metabolism reports"}, {"pmid_title_42": "Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV-hGAA) Gene Therapy in Children Affected by Pompe Disease.", "pmid_42": 29160099.0, "pmid_date_42": 2017.0, "pmid_journal_42": "Human gene therapy. Clinical development"}, {"pmid_title_43": "Guidelines for the diagnosis, treatment and clinical monitoring of patients with juvenile and adult Pompe disease.", "pmid_43": 26690841.0, "pmid_date_43": 2016.0, "pmid_journal_43": "Arquivos de neuro-psiquiatria"}, {"pmid_title_44": "Effects of a higher dose of alglucosidase alfa on ventilator-free survival and motor outcome in classic infantile Pompe disease: an open-label single-center study.", "pmid_44": 26768149.0, "pmid_date_44": 2016.0, "pmid_journal_44": "J Inherit Metab Dis"}, {"pmid_title_45": "Durable and sustained immune tolerance to ERT in Pompe disease with entrenched immune responses.", "pmid_45": 27493997.0, "pmid_date_45": 2016.0, "pmid_journal_45": "JCI Insight"}, {"pmid_title_46": "Diaphragm Pacing as a Rehabilitative Tool for Patients With Pompe Disease Who Are Ventilator-Dependent: Case Series.", "pmid_46": 26893511.0, "pmid_date_46": 2016.0, "pmid_journal_46": "Phys Ther"}, {"pmid_title_47": "Respiratory muscle training (RMT) in late-onset Pompe disease (LOPD): Effects of training and detraining.", "pmid_47": 26381077.0, "pmid_date_47": 2016.0, "pmid_journal_47": "Molecular genetics and metabolism"}, {"pmid_title_48": "Inspiratory Muscle Training in Late-Onset Pompe Disease: The Effects on Pulmonary Function Tests, Quality of Life, and Sleep Quality.", "pmid_48": 27106274.0, "pmid_date_48": 2016.0, "pmid_journal_48": "Lung"}, {"pmid_title_49": "Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease.", "pmid_49": 25617983.0, "pmid_date_49": 2015.0, "pmid_journal_49": "Neuromuscular disorders : NMD"}, {"pmid_title_50": "Long-term enzyme-replacement therapy (ERT) with alglucosidase alfa: Evolution of two siblings with juvenile late-onset Pompe disease.", "pmid_50": 26279333.0, "pmid_date_50": 2015.0, "pmid_journal_50": "Journal of the neurological sciences"}, {"pmid_title_51": "A 4-Year Observational Clinical Study of 24 Adult Pompe Disease Patients under Alglucosidase Alfa Enzyme Replacement Therapy.", "pmid_51": 27858656.0, "pmid_date_51": 2015.0, "pmid_journal_51": "Journal of neuromuscular diseases"}, {"pmid_title_52": "A Phase 4 Prospective Study in Patients with Adult Pompe Disease Treated with Alglucosidase Alfa.", "pmid_52": 27858658.0, "pmid_date_52": 2015.0, "pmid_journal_52": "Journal of neuromuscular diseases"}, {"pmid_title_53": "Enzyme enhancers for the treatment of Fabry and Pompe disease.", "pmid_53": 25409744.0, "pmid_date_53": 2015.0, "pmid_journal_53": "Mol Ther"}, {"pmid_title_54": "Late-onset Pompe disease with left-sided bronchomalacia.", "pmid_54": 25316892.0, "pmid_date_54": 2015.0, "pmid_journal_54": "Respiratory care"}, {"pmid_title_55": "Immune Tolerance Strategies in Siblings with Infantile Pompe Disease-Advantages for a Preemptive Approach to High-Sustained Antibody Titers.", "pmid_55": 26167453.0, "pmid_date_55": 2015.0, "pmid_journal_55": "Mol Genet Metab Rep"}, {"pmid_title_56": "Exercise training in adults with Pompe disease: the effects on pain, fatigue, and functioning.", "pmid_56": 25499687.0, "pmid_date_56": 2015.0, "pmid_journal_56": "Archives of physical medicine and rehabilitation"}, {"pmid_title_57": "Safety and efficacy of exercise training in adults with Pompe disease: evalution of endurance, muscle strength and core stability before and after a 12 week training program.", "pmid_57": 26187632.0, "pmid_date_57": 2015.0, "pmid_journal_57": "Orphanet journal of rare diseases"}, {"pmid_title_58": "Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease.", "pmid_58": 28649546.0, "pmid_date_58": 2015.0, "pmid_journal_58": "Molecular genetics and metabolism reports"}, {"pmid_title_59": "Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning.", "pmid_59": 26390092.0, "pmid_date_59": 2015.0, "pmid_journal_59": "Human gene therapy. Clinical development"}, {"pmid_title_60": "Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease.", "pmid_60": 24884717.0, "pmid_date_60": 2014.0, "pmid_journal_60": "Orphanet J Rare Dis"}, {"pmid_title_61": "Cessation and resuming of alglucosidase alfa in Pompe disease: a retrospective analysis.", "pmid_61": 24923245.0, "pmid_date_61": 2014.0, "pmid_journal_61": "Journal of neurology"}, {"pmid_title_62": "New therapeutic approaches for Pompe disease: enzyme replacement therapy and beyond.", "pmid_62": 25345093.0, "pmid_date_62": 2014.0, "pmid_journal_62": "Pediatric endocrinology reviews : PER"}, {"pmid_title_63": "Sleep breathing disorders and nocturnal respiratory pattern in patients with glycogenosis type II.", "pmid_63": 25709380.0, "pmid_date_63": 2014.0, "pmid_journal_63": "Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology"}, {"pmid_title_64": "Immune tolerance induced using plasma exchange and rituximab in an infantile Pompe disease patient.", "pmid_64": 23620524.0, "pmid_date_64": 2014.0, "pmid_journal_64": "Journal of child neurology"}, {"pmid_title_65": "B-Cell Depletion is Protective Against Anti-AAV Capsid Immune Response: A Human Subject Case Study.", "pmid_65": 25541616.0, "pmid_date_65": 2014.0, "pmid_journal_65": "Molecular therapy. Methods & clinical development"}, {"pmid_title_66": "Effects of immune modulation therapy in the first Croatian infant diagnosed with Pompe disease: a 3-year follow-up study.", "pmid_66": 24337590.0, "pmid_date_66": 2014.0, "pmid_journal_66": "Wiener klinische Wochenschrift"}, {"pmid_title_67": "A chaperone enhances blood \u03b1-glucosidase activity in Pompe disease patients treated with enzyme replacement therapy.", "pmid_67": 25052852.0, "pmid_date_67": 2014.0, "pmid_journal_67": "Mol Ther"}, {"pmid_title_68": "Effects of respiratory muscle training (RMT) in children with infantile-onset Pompe disease and respiratory muscle weakness.", "pmid_68": 25260508.0, "pmid_date_68": 2014.0, "pmid_journal_68": "Journal of pediatric rehabilitation medicine"}, {"pmid_title_69": "Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease.", "pmid_69": 24443373.0, "pmid_date_69": 2014.0, "pmid_journal_69": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology"}, {"pmid_title_70": "Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review.", "pmid_70": 22926164.0, "pmid_date_70": 2013.0, "pmid_journal_70": "Journal of neurology"}, {"pmid_title_71": "Enzyme replacement therapy improves respiratory outcomes in patients with late-onset type II glycogenosis and high ventilator dependency.", "pmid_71": 23839583.0, "pmid_date_71": 2013.0, "pmid_journal_71": "Lung"}, {"pmid_title_72": "B-Cell depletion and immunomodulation before initiation of enzyme replacement therapy blocks the immune response to acid alpha-glucosidase in infantile-onset Pompe disease.", "pmid_72": 23601496.0, "pmid_date_72": 2013.0, "pmid_journal_72": "J Pediatr"}, {"pmid_title_73": "Algorithm for the early diagnosis and treatment of patients with cross reactive immunologic material-negative classic infantile pompe disease: a step towards improving the efficacy of ERT.", "pmid_73": 23825616.0, "pmid_date_73": 2013.0, "pmid_journal_73": "PLoS One"}, {"pmid_title_74": "Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes.", "pmid_74": 23570273.0, "pmid_date_74": 2013.0, "pmid_journal_74": "Human gene therapy"}, {"pmid_title_75": "Consensus treatment recommendations for late-onset Pompe disease.", "pmid_75": 22173792.0, "pmid_date_75": 2012.0, "pmid_journal_75": "Muscle & nerve"}, {"pmid_title_76": "36 months observational clinical study of 38 adult Pompe  disease patients under alglucosidase alfa enzyme  replacement therapy.", "pmid_76": 22290025.0, "pmid_date_76": 2012.0, "pmid_journal_76": "Journal of inherited metabolic disease"}, {"pmid_title_77": "Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfa.", "pmid_77": 23031366.0, "pmid_date_77": 2012.0, "pmid_journal_77": "Molecular genetics and metabolism"}, {"pmid_title_78": "Recent developments, utilization, and spending trends for pompe disease therapies.", "pmid_78": 24991319.0, "pmid_date_78": 2012.0, "pmid_journal_78": "American health & drug benefits"}, {"pmid_title_79": "Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease.", "pmid_79": 22237443.0, "pmid_date_79": 2012.0, "pmid_journal_79": "Genet Med"}, {"pmid_title_80": "Persistence of high sustained antibodies to enzyme replacement therapy despite extensive immunomodulatory therapy in an infant with Pompe disease: need for agents to target antibody-secreting plasma cells.", "pmid_80": 22365055.0, "pmid_date_80": 2012.0, "pmid_journal_80": "Mol Genet Metab"}, {"pmid_title_81": "Bortezomib in the rapid reduction of high sustained antibody titers in disorders treated with therapeutic protein: lessons learned from Pompe disease.", "pmid_81": 23060045.0, "pmid_date_81": 2012.0, "pmid_journal_81": "Genet Med"}, {"pmid_title_82": "Physiotherapy management in late-onset Pompe disease: clinical practice in 88 patients.", "pmid_82": 22901700.0, "pmid_date_82": 2012.0, "pmid_journal_82": "Molecular genetics and metabolism"}, {"pmid_title_83": "24-months results in two adults with Pompe disease on enzyme replacement therapy.", "pmid_83": 21477922.0, "pmid_date_83": 2011.0, "pmid_journal_83": "Clinical neurology and neurosurgery"}, {"pmid_title_84": "Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to Pompe disease.", "pmid_84": 21550241.0, "pmid_date_84": 2011.0, "pmid_journal_84": "Neuromuscular disorders : NMD"}, {"pmid_title_85": "An individually, modified approach to desensitize infants and young children with Pompe disease, and significant reactions to alglucosidase alfa infusions.", "pmid_85": 21802969.0, "pmid_date_85": 2011.0, "pmid_journal_85": "Mol Genet Metab"}, {"pmid_title_86": "First experience with enzyme replacement therapy during pregnancy and lactation in Pompe disease.", "pmid_86": 21967859.0, "pmid_date_86": 2011.0, "pmid_journal_86": "Molecular genetics and metabolism"}, {"pmid_title_87": "Biochemical and structural study on a S529V mutant acid \u03b1-glucosidase responsive to pharmacological chaperones.", "pmid_87": 21471980.0, "pmid_date_87": 2011.0, "pmid_journal_87": "Journal of human genetics"}, {"pmid_title_88": "Proteasome inhibitors improve the function of mutant lysosomal \u03b1-glucosidase in fibroblasts from Pompe disease patient carrying c.546G>T mutation.", "pmid_88": 22027144.0, "pmid_date_88": 2011.0, "pmid_journal_88": "Biochemical and biophysical research communications"}, {"pmid_title_89": "Immune Modulation Therapy in a CRIM-Positive and IgG Antibody-Positive Infant with Pompe Disease Treated with Alglucosidase Alfa: A Case Report.", "pmid_89": 23430847.0, "pmid_date_89": 2011.0, "pmid_journal_89": "JIMD Rep"}, {"pmid_title_90": "Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy.", "pmid_90": 21640624.0, "pmid_date_90": 2011.0, "pmid_journal_90": "Molecular genetics and metabolism"}, {"pmid_title_91": "Increased inspiratory and expiratory muscle strength following respiratory muscle strength training (RMST) in two patients with late-onset Pompe disease.", "pmid_91": 21641843.0, "pmid_date_91": 2011.0, "pmid_journal_91": "Molecular genetics and metabolism"}, {"pmid_title_92": "Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial.", "pmid_92": 19649685.0, "pmid_date_92": 2010.0, "pmid_journal_92": "Journal of neurology"}, {"pmid_title_93": "A randomized study of alglucosidase alfa in late-onset Pompe's disease.", "pmid_93": 20393176.0, "pmid_date_93": 2010.0, "pmid_journal_93": "The New England journal of medicine"}, {"pmid_title_94": "High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa.", "pmid_94": 20826098.0, "pmid_date_94": 2010.0, "pmid_journal_94": "Molecular genetics and metabolism"}, {"pmid_title_95": "Long-term follow-up results in enzyme replacement therapy for Pompe disease: a case report.", "pmid_95": 20830524.0, "pmid_date_95": 2010.0, "pmid_journal_95": "Journal of inherited metabolic disease"}, {"pmid_title_96": "Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease.", "pmid_96": 19287243.0, "pmid_date_96": 2009.0, "pmid_journal_96": "Genetics in medicine : official journal of the American College of Medical Genetics"}, {"pmid_title_97": "Desensitization of an adult patient with Pompe disease and a history of anaphylaxis to alglucosidase alfa.", "pmid_97": 19640753.0, "pmid_date_97": 2009.0, "pmid_journal_97": "Molecular genetics and metabolism"}, {"pmid_title_98": "Alglucosidase alfa: Long term use in the treatment of patients with Pompe disease.", "pmid_98": 19816575.0, "pmid_date_98": 2009.0, "pmid_journal_98": "Ther Clin Risk Manag"}, {"pmid_title_99": "The pharmacological chaperone 1-deoxynojirimycin increases the activity and lysosomal trafficking of multiple mutant forms of acid alpha-glucosidase.", "pmid_99": 19862843.0, "pmid_date_99": 2009.0, "pmid_journal_99": "Human mutation"}, {"pmid_title_100": "The pharmacological chaperone N-butyldeoxynojirimycin enhances enzyme replacement therapy in Pompe disease fibroblasts.", "pmid_100": 19293774.0, "pmid_date_100": 2009.0, "pmid_journal_100": "Mol Ther"}]}, {"_id": "4116-OMIM:230350", "condition": {"condition_name": "GALACTOSEMIA III; GALAC3", "freq_per_birth": "Classic galactosemia occurs in 1 in 30,000 to 60,000 newborns.  Galactosemia type II and type III are less common; type II probably affects fewer than 1 in 100,000 newborns and type III appears to be very rare.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["GALACTOSEMIA III; GALAC3"]}, "gene information": {"db_hgnc_gene_id": 4116.0}, "interventions": [{"int_description_1": "Lactose-containing diet"}, {"int_description_2": "Nutramigen"}, {"int_description_3": "Intravenous dextrose"}], "references": [{"pmid_title_1": "Molecular characterization of a unique patient with epimerase-deficiency galactosaemia.", "pmid_1": 9700591.0, "pmid_date_1": 1998.0, "pmid_journal_1": "Journal of inherited metabolic disease"}, {"pmid_title_2": "Galactosaemia: a new severe variant due to uridine diphosphate galactose-4-epimerase deficiency.", "pmid_2": 7305435.0, "pmid_date_2": 1981.0, "pmid_journal_2": "Archives of disease in childhood"}]}, {"_id": "4118-OMIM:230200", "condition": {"condition_name": "GALACTOSEMIA II; GALAC2", "freq_per_birth": "Classic galactosemia occurs in 1 in 30,000 to 60,000 newborns.  Galactosemia type II and type III are less common; type II probably affects fewer than 1 in 100,000 newborns and type III appears to be very rare.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["GALACTOSEMIA II; GALAC2"]}, "gene information": {"db_hgnc_gene_id": 4118.0}, "interventions": [{"int_description_1": "Lactose- and galactose-free or reduced diet"}], "references": [{"pmid_title_1": "Structural analysis of missense mutations in galactokinase 1 (GALK1) leading to galactosemia type-2.", "pmid_1": 29893426.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Journal of cellular biochemistry"}, {"pmid_title_2": "Pilot study of classic galactosemia: Neurodevelopmental impact and other complications urge neonatal screening in Egypt.", "pmid_2": 30038819.0, "pmid_date_2": 2018.0, "pmid_journal_2": "J Adv Res"}, {"pmid_title_3": "Sweet and sour: an update on classic galactosemia.", "pmid_3": 28281081.0, "pmid_date_3": 2017.0, "pmid_journal_3": "J Inherit Metab Dis"}, {"pmid_title_4": "Biochemical characterization of two GALK1 mutations in patients with galactokinase deficiency.", "pmid_4": 15024738.0, "pmid_date_4": 2004.0, "pmid_journal_4": "Human mutation"}, {"pmid_title_5": "The P28T mutation in the GALK1 gene accounts for galactokinase deficiency in Roma (Gypsy) patients across Europe.", "pmid_5": 11978884.0, "pmid_date_5": 2002.0, "pmid_journal_5": "Pediatric research"}, {"pmid_title_6": "Molecular characterization of galactokinase deficiency in Japanese patients.", "pmid_6": 10570908.0, "pmid_date_6": 1999.0, "pmid_journal_6": "Journal of human genetics"}]}, {"_id": "4135-OMIM:230400", "condition": {"condition_name": "GALACTOSEMIA I", "freq_per_birth": "Classic galactosemia occurs in 1 in 30,000 to 60,000 newborns.  Galactosemia type II and type III are less common; type II probably affects fewer than 1 in 100,000 newborns and type III appears to be very rare.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["GALACTOSEMIA I"]}, "gene information": {"db_hgnc_gene_id": 4135.0}, "interventions": [{"int_description_1": "Enfamil lipil"}, {"int_description_2": "Enteral nutrition with soy milk"}, {"int_description_3": "Folic acid, iron supplementation"}, {"int_description_4": "Galactose-restricted diet"}, {"int_description_5": "Isomil soy powdered formula"}, {"int_description_6": "Neocate"}, {"int_description_7": "Nutramigen"}, {"int_description_8": "Pregestimil"}, {"int_description_9": "Soy-Based Formula"}, {"int_description_10": "Phylloquinone", "timeframe_int10": "Hours", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Dexamethasone"}, {"int_description_12": "Spironolactone"}, {"int_description_13": "Vitamin D"}, {"int_description_14": "Furosemide"}, {"int_description_15": "Phenytoin"}, {"int_description_16": "Antibiotics"}, {"int_description_17": "Arginine aspartate administration"}, {"int_description_18": "Albumin human"}, {"int_description_19": "Mannitol"}, {"int_description_20": "Galactose"}, {"int_description_21": "Glucose/arginine infusion"}, {"int_description_22": "Hormone replacement therapy"}, {"int_description_23": "Intravenous immunoglobulins (IVIG)"}, {"int_description_24": "Exchange transfusion"}, {"int_description_25": "Fresh frozen plasma"}, {"int_description_26": "Galactose-restricted diet"}, {"int_description_27": "Ovarian tissue cryopreservation"}, {"int_description_28": "Phototherapy"}, {"int_description_29": "Liver transplant"}], "references": [{"pmid_title_1": "Deep phenotyping classical galactosemia: clinical outcomes and biochemical markers.", "pmid_1": 32954279.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Brain Commun"}, {"pmid_title_2": "Novel Mutation in GALT Gene in Galactosemia Patient with Group B Streptococcus Meningitis and Acute Liver Failure.", "pmid_2": 30987402.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Medicina (Kaunas)"}, {"pmid_title_3": "The ability of an LC-MS/MS-based erythrocyte GALT enzyme assay to predict the phenotype in subjects with GALT deficiency.", "pmid_3": 30718057.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Mol Genet Metab"}, {"pmid_title_4": "Extreme neonatal hyperbilirubinemia, acute bilirubin encephalopathy, and kernicterus spectrum disorder in children with galactosemia.", "pmid_4": 29892033.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Pediatr Res"}, {"pmid_title_5": "Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia.", "pmid_5": 30477550.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Orphanet J Rare Dis"}, {"pmid_title_6": "Molecular basis and clinical presentation of classic galactosemia in a Croatian population.", "pmid_6": 29252199.0, "pmid_date_6": 2018.0, "pmid_journal_6": "J Pediatr Endocrinol Metab"}, {"pmid_title_7": "International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up.", "pmid_7": 27858262.0, "pmid_date_7": 2017.0, "pmid_journal_7": "J Inherit Metab Dis"}, {"pmid_title_8": "Sweet and sour: an update on classic galactosemia.", "pmid_8": 28281081.0, "pmid_date_8": 2017.0, "pmid_journal_8": "J Inherit Metab Dis"}, {"pmid_title_9": "A Term Newborn with Suspected Sepsis Following Prolonged Premature Rupture of Membranes.", "pmid_9": 29184040.0, "pmid_date_9": 2017.0, "pmid_journal_9": "Clin Chem"}, {"pmid_title_10": "Clinical, molecular, and genetic evaluation of galactosemia in Turkish children.", "pmid_10": 28123333.0, "pmid_date_10": 2016.0, "pmid_journal_10": "Turk Pediatri Ars"}, {"pmid_title_11": "Clinical profile and molecular characterization of Galactosemia in Brazil: identification of seven novel mutations.", "pmid_11": 27176039.0, "pmid_date_11": 2016.0, "pmid_journal_11": "BMC Med Genet"}, {"pmid_title_12": "Effects of temporary low-dose galactose supplements in children aged 5-12 y with classical galactosemia: a pilot study.", "pmid_12": 26053138.0, "pmid_date_12": 2015.0, "pmid_journal_12": "Pediatr Res"}, {"pmid_title_13": "A Novel Large Deletion Encompassing the Whole of the Galactose-1-Phosphate Uridyltransferase (GALT) Gene and Extending into the Adjacent Interleukin 11 Receptor Alpha (IL11RA) Gene Causes Classic Galactosemia Associated with Additional Phenotypic Abnormalities.", "pmid_13": 24002815.0, "pmid_date_13": 2014.0, "pmid_journal_13": "JIMD Rep"}, {"pmid_title_14": "Galactosemia: when is it a newborn screening emergency?", "pmid_14": 22483615.0, "pmid_date_14": 2012.0, "pmid_journal_14": "Mol Genet Metab"}, {"pmid_title_15": "Problems with the new born screen for galactosaemia.", "pmid_15": 22693313.0, "pmid_date_15": 2011.0, "pmid_journal_15": "BMJ Case Rep"}, {"pmid_title_16": "Long-term complications in Estonian galactosemia patients with a less strict lactose-free diet and metabolic control.", "pmid_16": 21501963.0, "pmid_date_16": 2011.0, "pmid_journal_16": "Mol Genet Metab"}, {"pmid_title_17": "Ovarian tissue cryopreservation and subsequent spontaneous pregnancies in a patient with classic galactosemia.", "pmid_17": 20663501.0, "pmid_date_17": 2011.0, "pmid_journal_17": "Fertil Steril"}, {"pmid_title_18": "Molecular and clinical analysis of patients with classic and Duarte galactosemia in western Hungary.", "pmid_18": 20213376.0, "pmid_date_18": 2010.0, "pmid_journal_18": "Wien Klin Wochenschr"}, {"pmid_title_19": "Negative screening tests in classical galactosaemia caused by S135L homozygosity.", "pmid_19": 19418241.0, "pmid_date_19": 2009.0, "pmid_journal_19": "J Inherit Metab Dis"}, {"pmid_title_20": "Galactosaemia: early treatment with an elemental formula.", "pmid_20": 15877205.0, "pmid_date_20": 2005.0, "pmid_journal_20": "J Inherit Metab Dis"}, {"pmid_title_21": "Living with classical galactosemia: health-related quality of life consequences.", "pmid_21": 15121984.0, "pmid_date_21": 2004.0, "pmid_journal_21": "Pediatrics"}, {"pmid_title_22": "Pregnancy and delivery after stimulation with rFSH of a galatosemia patient suffering hypergonadotropic hypogonadism: case report.", "pmid_22": 15202737.0, "pmid_date_22": 2004.0, "pmid_journal_22": "J Assist Reprod Genet"}, {"pmid_title_23": "High tolerance for oral galactose in classical galactosaemia: dietary implications.", "pmid_23": 15499058.0, "pmid_date_23": 2004.0, "pmid_journal_23": "Arch Dis Child"}, {"pmid_title_24": "Two adult galactosaemia females with normal ovarian function and identical GALT mutations (Q188R/R333G).", "pmid_24": 12872845.0, "pmid_date_24": 2003.0, "pmid_journal_24": "J Inherit Metab Dis"}, {"pmid_title_25": "Bone mineral density in patients with classic galactosaemia.", "pmid_25": 12089126.0, "pmid_date_25": 2002.0, "pmid_journal_25": "Arch Dis Child"}, {"pmid_title_26": "Evidence for alternate galactose oxidation in a patient with deletion of the galactose-1-phosphate uridyltransferase gene.", "pmid_26": 11286505.0, "pmid_date_26": 2001.0, "pmid_journal_26": "Mol Genet Metab"}, {"pmid_title_27": "A prevalent mutation for galactosemia among black Americans.", "pmid_27": 8551426.0, "pmid_date_27": 1996.0, "pmid_journal_27": "J Pediatr"}, {"pmid_title_28": "Identification and functional analysis of three distinct mutations in the human galactose-1-phosphate uridyltransferase gene associated with galactosemia in a single family.", "pmid_28": 7887417.0, "pmid_date_28": 1995.0, "pmid_journal_28": "Am J Hum Genet"}]}, {"_id": "4136-OMIM:612736", "condition": {"condition_name": "CEREBRAL CREATINE DEFICIENCY SYNDROME 2", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["CEREBRAL CREATINE DEFICIENCY SYNDROME 2"]}, "gene information": {"db_hgnc_gene_id": 4136.0}, "interventions": [{"int_description_1": "Dietary restriction of arginine", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Protein-restricted diet"}, {"int_description_3": "Ornithine"}, {"int_description_4": "Ademetionine", "timeframe_int4": "Hours", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Benzoic acid", "timeframe_int5": "Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Creatine", "timeframe_int6": "Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Guanidinoacetate methyltransferase (GAMT) deficiency: a rare but treatable epilepsy.", "pmid_1": 28119378.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Pract Neurol"}, {"pmid_title_2": "Review: Human guanidinoacetate n-methyl transferase (GAMT) deficiency: A treatable inborn error of metabolism.", "pmid_2": 26639513.0, "pmid_date_2": 2015.0, "pmid_journal_2": "Pak J Pharm Sci"}, {"pmid_title_3": "Guanidinoacetate methyltransferase (GAMT) deficiency: outcomes in 48 individuals and recommendations for diagnosis, treatment and monitoring.", "pmid_3": 24268530.0, "pmid_date_3": 2014.0, "pmid_journal_3": "Mol Genet Metab"}, {"pmid_title_4": "Elevation of guanidinoacetate in newborn dried blood spots and impact of early treatment in GAMT deficiency.", "pmid_4": 23583224.0, "pmid_date_4": 2013.0, "pmid_journal_4": "Mol Genet Metab"}, {"pmid_title_5": "Evidence-based treatment of guanidinoacetate methyltransferase (GAMT) deficiency.", "pmid_5": 24071436.0, "pmid_date_5": 2013.0, "pmid_journal_5": "Mol Genet Metab"}, {"pmid_title_6": "Guanidinoacetate methyltransferase deficiency (GAMT).", "pmid_6": 19289269.0, "pmid_date_6": 2010.0, "pmid_journal_6": "Brain Dev"}, {"pmid_title_7": "Expanded clinical and molecular spectrum of guanidinoacetate methyltransferase (GAMT) deficiency.", "pmid_7": 19027335.0, "pmid_date_7": 2009.0, "pmid_journal_7": "Mol Genet Metab"}, {"pmid_title_8": "Guanidinoacetate methyltransferase deficiency masquerading as a mitochondrial encephalopathy.", "pmid_8": 17171576.0, "pmid_date_8": 2007.0, "pmid_journal_8": "J Inherit Metab Dis"}, {"pmid_title_9": "Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency.", "pmid_9": 16924036.0, "pmid_date_9": 2006.0, "pmid_journal_9": "Neurology"}]}, {"_id": "4170-OMIM:300367", "condition": {"condition_name": "THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA", "freq_per_birth": "Dyserythropoietic anemia and thrombocytopenia is a rare condition; its prevalence is unknown.  Occasionally, individuals with this disorder are mistakenly diagnosed as having more common blood disorders, making it even more difficult to determine how many people have dyserythropoietic anemia and thrombocytopenia.", "pattern_of_inheritance": "X-linked recessive", "alternate_names": ["Blackfan-Diamond anemia", "THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA", "Acute megakaryoblastic leukemia in Down syndrome", "Congenital erythropoietic porphyria", "Transient myeloproliferative syndrome", "ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES", "Acute basophilic leukemia"]}, "gene information": {"db_hgnc_gene_id": 4170.0}, "interventions": [{"int_description_1": "Intrauterine transfusions of packed red blood cells"}, {"int_description_2": "Platelet transfusions", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Red blood cell transfusion", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Bone marrow transplantation", "timeframe_int4": "Days or Weeks,Years", "age_use_int4": "Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Curative"}], "references": [{"pmid_title_1": "Congenital transfusion-dependent anemia and thrombocytopenia with myelodysplasia due to a recurrent GATA1(G208R) germline mutation.", "pmid_1": 17713552.0, "pmid_date_1": 2008.0, "pmid_journal_1": "Leukemia"}, {"pmid_title_2": "Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1.", "pmid_2": 16103636.0, "pmid_date_2": 2005.0, "pmid_journal_2": "Acta haematologica"}, {"pmid_title_3": "X-linked thrombocytopenia caused by a novel mutation of GATA-1.", "pmid_3": 11675338.0, "pmid_date_3": 2001.0, "pmid_journal_3": "Blood"}, {"pmid_title_4": "Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1.", "pmid_4": 10700180.0, "pmid_date_4": 2000.0, "pmid_journal_4": "Nature genetics"}]}, {"_id": "4170-OMIM:300835", "condition": {"condition_name": "ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES; XLANP", "pattern_of_inheritance": "X-linked recessive", "alternate_names": ["Blackfan-Diamond anemia", "ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES; XLANP", "Acute megakaryoblastic leukemia in Down syndrome", "Congenital erythropoietic porphyria", "Transient myeloproliferative syndrome", "THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA; XLTDA", "Acute basophilic leukemia"]}, "gene information": {"db_hgnc_gene_id": 4170.0}, "interventions": [{"int_description_1": "Steroids", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Still in Trials / Unproven"}, {"int_description_2": "Erythrocyte transfusion", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Bone marrow transplantation", "timeframe_int3": "Days or Weeks,Years", "age_use_int3": "Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Curative"}, {"int_description_4": "Surgery for evacuation of a muscular hematoma"}], "references": [{"pmid_title_1": "An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis.", "pmid_1": 16783379.0, "pmid_date_1": 2006.0, "pmid_journal_1": "Nature genetics"}, {"pmid_title_2": "Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation.", "pmid_2": 11418466.0, "pmid_date_2": 2001.0, "pmid_journal_2": "Blood"}]}, {"_id": "4170-ORPHA:124", "condition": {"condition_name": "Blackfan-Diamond anemia", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES", "Blackfan-Diamond anemia", "Acute megakaryoblastic leukemia in Down syndrome", "Congenital erythropoietic porphyria", "Transient myeloproliferative syndrome", "THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA", "Acute basophilic leukemia"]}, "gene information": {"db_hgnc_gene_id": 4170.0}, "interventions": [{"int_description_1": "Procarbazine"}, {"int_description_2": "Leucine"}, {"int_description_3": "Danazol"}, {"int_description_4": "Sargramostim"}, {"int_description_5": "Prednisolone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone"}, {"int_description_8": "Eltrombopag"}, {"int_description_9": "Metoclopramide"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Daclizumab"}, {"int_description_15": "Cyclosporine"}, {"int_description_16": "Somatotropin"}, {"int_description_17": "Diphenhydramine"}, {"int_description_18": "Cyclophosphamide"}, {"int_description_19": "Busulfan"}, {"int_description_20": "Melphalan"}, {"int_description_21": "Ifosfamide"}, {"int_description_22": "Thiotepa"}, {"int_description_23": "Doxorubicin"}, {"int_description_24": "Trimethoprim"}, {"int_description_25": "Sulfamethoxazole"}, {"int_description_26": "Vincristine"}, {"int_description_27": "Treosulfan"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Ibuprofen"}, {"int_description_30": "Fluconazole"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Curative"}, {"int_description_32": "Methotrexate", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Child", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Fludarabine", "timeframe_int33": "Hours,Days or Weeks,Years", "age_use_int33": "Child", "contra_int33": "Yes", "qualscale_reclass_drug33": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug33": "Effective / Ameliorative"}, {"int_description_34": "Cytarabine"}, {"int_description_35": "Dexrazoxane"}, {"int_description_36": "Etoposide"}, {"int_description_37": "Carmustine"}, {"int_description_38": "Bleomycin"}, {"int_description_39": "Pentamidine"}, {"int_description_40": "Dacarbazine"}, {"int_description_41": "Tacrolimus"}, {"int_description_42": "Valproic acid"}, {"int_description_43": "Acyclovir"}, {"int_description_44": "Cidofovir"}, {"int_description_45": "Mycophenolate mofetil"}, {"int_description_46": "Sertraline"}, {"int_description_47": "Hydroxyurea"}, {"int_description_48": "Methylprednisolone"}, {"int_description_49": "Phenytoin"}, {"int_description_50": "Vinblastine"}, {"int_description_51": "Deferoxamine"}, {"int_description_52": "Deferasirox"}, {"int_description_53": "Deferiprone"}, {"int_description_54": "Co-trimoxazole", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Effective / Ameliorative"}, {"int_description_55": "Cisplatin"}, {"int_description_56": "Muplestim"}, {"int_description_57": "Filgrastim"}, {"int_description_58": "Total body irradiation"}, {"int_description_59": "Radiotherapy"}, {"int_description_60": "red blood cells transfusion"}, {"int_description_61": "Thoracoabdominal irradiation"}, {"int_description_62": "Total lymphoid irradiation"}, {"int_description_63": "Above-knee amputation"}, {"int_description_64": "Bone marrow transplantation"}, {"int_description_65": "Hematopoietic stem cell transplantation (HSCT)"}], "references": [{"pmid_title_1": "Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.", "pmid_1": 32330244.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Blood Adv"}, {"pmid_title_2": "How I manage children with Diamond-Blackfan anaemia.", "pmid_2": 30515771.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Br J Haematol"}, {"pmid_title_3": "Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.", "pmid_3": 31916719.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Turk J Pediatr"}, {"pmid_title_4": "Danazol: An Effective and Underutilised Treatment Option in Diamond-Blackfan Anaemia.", "pmid_4": 31355022.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Case Rep Hematol"}, {"pmid_title_5": "Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox.", "pmid_5": 30811439.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PLoS One"}, {"pmid_title_6": "Diamond Blackfan Anemia: Genetics, Pathogenesis, Diagnosis and Treatment.", "pmid_6": 30881276.0, "pmid_date_6": 2019.0, "pmid_journal_6": "EJIFCC"}, {"pmid_title_7": "Diamond-Blackfan anemia RPL35A: a case report.", "pmid_7": 31208452.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Med Case Rep"}, {"pmid_title_8": "Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report.", "pmid_8": 31574871.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Emerging Therapeutic Approaches for Diamond Blackfan Anemia.", "pmid_9": 30411682.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Curr Gene Ther"}, {"pmid_title_10": "Treatment of inherited bone marrow failure syndromes beyond transplantation.", "pmid_10": 29222242.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_11": "Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.", "pmid_11": 28623394.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Ann Hematol"}, {"pmid_title_12": "Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.", "pmid_12": 27882484.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Int J Hematol"}, {"pmid_title_13": "Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).", "pmid_13": 27537786.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Eur J Haematol"}, {"pmid_title_14": "Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.", "pmid_14": 28602958.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Biol Blood Marrow Transplant"}, {"pmid_title_15": "Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis.", "pmid_15": 27082377.0, "pmid_date_15": 2016.0, "pmid_journal_15": "Pediatr Blood Cancer"}, {"pmid_title_16": "Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.", "pmid_16": 26872907.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Int J Hematol"}, {"pmid_title_17": "Pure red cell aplasia.", "pmid_17": 27881371.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Pure red cell aplasia.", "pmid_18": 27913462.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Hematology Am Soc Hematol Educ Program"}, {"pmid_title_19": "Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.", "pmid_19": 27329125.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Int J Hematol"}, {"pmid_title_20": "Endocrine Dysfunction in Diamond-Blackfan Anemia (DBA): A Report from the DBA Registry (DBAR).", "pmid_20": 26496000.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Pediatr Blood Cancer"}, {"pmid_title_21": "Growth hormone improves short stature in children with Diamond-Blackfan anemia.", "pmid_21": 25492299.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Pediatr Blood Cancer"}, {"pmid_title_22": "Immune status of patients with inherited bone marrow failure syndromes.", "pmid_22": 25963299.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Am J Hematol"}, {"pmid_title_23": "Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry.", "pmid_23": 24611452.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Br J Haematol"}, {"pmid_title_24": "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.", "pmid_24": 24296492.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Biol Blood Marrow Transplant"}, {"pmid_title_25": "Diamond blackfan anemia: a tertiary care center experience.", "pmid_25": 23795277.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Mediterr J Hematol Infect Dis"}, {"pmid_title_26": "Progress towards mechanism-based treatment for Diamond-Blackfan anemia.", "pmid_26": 22619618.0, "pmid_date_26": 2012.0, "pmid_journal_26": "ScientificWorldJournal"}, {"pmid_title_27": "Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia.", "pmid_27": 23016900.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Br J Haematol"}, {"pmid_title_28": "Successful treatment of refractory diamond-blackfan anemia using metoclopramide and prednisolone.", "pmid_28": 24744655.0, "pmid_date_28": 2012.0, "pmid_journal_28": "Turk J Haematol"}, {"pmid_title_29": "Do ribosomopathies explain some cases of common variable immunodeficiency?", "pmid_29": 21062271.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Clin Exp Immunol"}, {"pmid_title_30": "How I treat Diamond-Blackfan anemia.", "pmid_30": 20651069.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Blood"}, {"pmid_title_31": "Diamond-Blackfan anemia, ribosome and erythropoiesis.", "pmid_31": 20655265.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Transfus Clin Biol"}, {"pmid_title_32": "Successful allogeneic bone marrow transplantation for diamond-blackfan anemia complicated by severe cardiac dysfunction due to transfusion-induced hemochromatosis.", "pmid_32": 20190482.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Intern Med"}, {"pmid_title_33": "Transfusion independence in Diamond-Blackfan anemia after deferasirox therapy.", "pmid_33": 19415275.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Ann Hematol"}, {"pmid_title_34": "Inherited aplastic anaemias/bone marrow failure syndromes.", "pmid_34": 18164793.0, "pmid_date_34": 2008.0, "pmid_journal_34": "Blood Rev"}, {"pmid_title_35": "Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.", "pmid_35": 18671700.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Br J Haematol"}, {"pmid_title_36": "Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.", "pmid_36": 18028431.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Eur J Haematol"}, {"pmid_title_37": "Congenital erythroid and myeloid hypoplasia terminating myelodysplastic syndrome.", "pmid_37": 18776763.0, "pmid_date_37": 2008.0, "pmid_journal_37": "J Pediatr Hematol Oncol"}, {"pmid_title_38": "Obsessive compulsive disorder comorbidity in DBA.", "pmid_38": 18331650.0, "pmid_date_38": 2008.0, "pmid_journal_38": "Clin Pract Epidemiol Ment Health"}, {"pmid_title_39": "Deferasirox.", "pmid_39": 17353569.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Am J Health Syst Pharm"}, {"pmid_title_40": "Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.", "pmid_40": 17414568.0, "pmid_date_40": 2007.0, "pmid_journal_40": "J Pediatr Hematol Oncol"}, {"pmid_title_41": "Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology.", "pmid_41": 17663681.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine.", "pmid_42": 17562599.0, "pmid_date_42": 2007.0, "pmid_journal_42": "Haematologica"}, {"pmid_title_43": "Metoclopramide treatment in DBA patients: no complete response in a French prospective study.", "pmid_43": 17312003.0, "pmid_date_43": 2007.0, "pmid_journal_43": "Blood"}, {"pmid_title_44": "Successful treatment of Diamond Blackfan anemia with metoclopramide.", "pmid_44": 17921858.0, "pmid_date_44": 2007.0, "pmid_journal_44": "J Pediatr Hematol Oncol"}, {"pmid_title_45": "Hodgkin lymphoma in a child with Diamond Blackfan anemia.", "pmid_45": 16679921.0, "pmid_date_45": 2006.0, "pmid_journal_45": "J Pediatr Hematol Oncol"}, {"pmid_title_46": "Diamond-Blackfan anemia: clinical features and treatment results in 4 cases.", "pmid_46": 17325961.0, "pmid_date_46": 2006.0, "pmid_journal_46": "Hematology"}, {"pmid_title_47": "Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.", "pmid_47": 16317735.0, "pmid_date_47": 2006.0, "pmid_journal_47": "Pediatr Blood Cancer"}, {"pmid_title_48": "Diamond-Blackfan anemia in remission for 2 years on valproic acid.", "pmid_48": 16785135.0, "pmid_date_48": 2006.0, "pmid_journal_48": "Haematologica"}, {"pmid_title_49": "Allogeneic peripheral blood stem cell transplant (PBSCT) using anti-IL2 receptor antibody Daclizumab for the prevention of acute graft versus host disease in steroid refractory Diamond Blackfan anaemia: a case report.", "pmid_49": 16304857.0, "pmid_date_49": 2005.0, "pmid_journal_49": "J Pak Med Assoc"}, {"pmid_title_50": "Diamond-blackfan anemia and growth status: the French registry.", "pmid_50": 16291361.0, "pmid_date_50": 2005.0, "pmid_journal_50": "J Pediatr"}, {"pmid_title_51": "Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy.", "pmid_51": 15692602.0, "pmid_date_51": 2005.0, "pmid_journal_51": "Hematol J"}, {"pmid_title_52": "Bone marrow transplantation for diamond-blackfan anemia.", "pmid_52": 16041310.0, "pmid_date_52": 2005.0, "pmid_journal_52": "Biol Blood Marrow Transplant"}, {"pmid_title_53": "Use of rituximab to treat refractory Diamond-Blackfan anemia.", "pmid_53": 15813920.0, "pmid_date_53": 2005.0, "pmid_journal_53": "Eur J Haematol"}, {"pmid_title_54": "Successful treatment of Diamond-Blackfan anemia with metoclopramide.", "pmid_54": 15795909.0, "pmid_date_54": 2005.0, "pmid_journal_54": "Am J Hematol"}, {"pmid_title_55": "Familial Diamond-Blackfan anemia. Case reports and a review of the related literature.", "pmid_55": 14984172.0, "pmid_date_55": 2004.0, "pmid_journal_55": "J Trop Pediatr"}, {"pmid_title_56": "Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond-Blackfan anemia.", "pmid_56": 15220956.0, "pmid_date_56": 2004.0, "pmid_journal_56": "Bone Marrow Transplant"}, {"pmid_title_57": "Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic stem cell transplantation.", "pmid_57": 14979474.0, "pmid_date_57": 2004.0, "pmid_journal_57": "Int J Hematol"}, {"pmid_title_58": "Growth hormone therapy for short stature in Diamond Blackfan anemia.", "pmid_58": 15382270.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatr Blood Cancer"}, {"pmid_title_59": "Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.", "pmid_59": 18521394.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Sarcoma"}, {"pmid_title_60": "Sustained cyclosporine-induced erythropoietic response in identical male twins with diamond-blackfan anemia.", "pmid_60": 14608205.0, "pmid_date_60": 2003.0, "pmid_journal_60": "J Pediatr Hematol Oncol"}, {"pmid_title_61": "Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.", "pmid_61": 12359817.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Pediatrics"}, {"pmid_title_62": "Response of Diamond-Blackfan anemia to metoclopramide: evidence for a role for prolactin in erythropoiesis.", "pmid_62": 12351372.0, "pmid_date_62": 2002.0, "pmid_journal_62": "Blood"}, {"pmid_title_63": "Clinico-haematological profile of pure red cell aplasia in children.", "pmid_63": 12022425.0, "pmid_date_63": 2002.0, "pmid_journal_63": "J Trop Pediatr"}, {"pmid_title_64": "Pneumocystis carinii pneumonia in patients with Diamond-Blackfan anemia receiving high-dose corticosteroids.", "pmid_64": 12142794.0, "pmid_date_64": 2002.0, "pmid_journal_64": "J Pediatr Hematol Oncol"}, {"pmid_title_65": "Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.", "pmid_65": 11313667.0, "pmid_date_65": 2001.0, "pmid_journal_65": "Bone Marrow Transplant"}, {"pmid_title_66": "Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry.", "pmid_66": 11196268.0, "pmid_date_66": 2001.0, "pmid_journal_66": "J Pediatr Hematol Oncol"}, {"pmid_title_67": "Oral megadose methylprednisolone therapy for refractory Diamond-Blackfan anemia. International Diamond-Blackfan Anemia Study Group.", "pmid_67": 11563769.0, "pmid_date_67": 2001.0, "pmid_journal_67": "J Pediatr Hematol Oncol"}, {"pmid_title_68": "Diamond-blackfan anemia and cyclosporine therapy revisited.", "pmid_68": 10779036.0, "pmid_date_68": 2000.0, "pmid_journal_68": "J Pediatr Hematol Oncol"}, {"pmid_title_69": "Diamond-Blackfan anemia.", "pmid_69": 10698294.0, "pmid_date_69": 2000.0, "pmid_journal_69": "Curr Opin Hematol"}, {"pmid_title_70": "Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.", "pmid_70": 10673683.0, "pmid_date_70": 2000.0, "pmid_journal_70": "Bone Marrow Transplant"}, {"pmid_title_71": "Could Parvovirus B19 Induce a Rejection After Bone Marrow Transplantation in a Patient with Diamond-Blackfan Anemia?", "pmid_71": 27263505.0, "pmid_date_71": 2000.0, "pmid_journal_71": "Turk J Haematol"}, {"pmid_title_72": "Multiple endocrine abnormalities in a child with Blackfan-Diamond anemia and hemochromatosis. Significant improvement of growth velocity and predicted adult height following growth hormone treatment despite liver damage.", "pmid_72": 10714760.0, "pmid_date_72": 2000.0, "pmid_journal_72": "J Pediatr Endocrinol Metab"}, {"pmid_title_73": "Non-Hodgkin's lymphoma in a patient with Diamond-Blackfan anemia.", "pmid_73": 10397110.0, "pmid_date_73": 1999.0, "pmid_journal_73": "AJR Am J Roentgenol"}, {"pmid_title_74": "Bone marrow transplantation in non-malignant disorders.", "pmid_74": 9916644.0, "pmid_date_74": 1998.0, "pmid_journal_74": "Bone Marrow Transplant"}, {"pmid_title_75": "Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia.", "pmid_75": 8846147.0, "pmid_date_75": 1996.0, "pmid_journal_75": "J Pediatr Hematol Oncol"}, {"pmid_title_76": "Diamond-Blackfan anemia. Natural history and sequelae of treatment.", "pmid_76": 8606629.0, "pmid_date_76": 1996.0, "pmid_journal_76": "Medicine (Baltimore)"}, {"pmid_title_77": "Diamond-Blackfan anemia and malignancy. A case report and a review of the literature.", "pmid_77": 8625135.0, "pmid_date_77": 1995.0, "pmid_journal_77": "Cancer"}, {"pmid_title_78": "Successful treatment of Diamond-Blackfan anemia with interleukin 3.", "pmid_78": 7691318.0, "pmid_date_78": 1993.0, "pmid_journal_78": "Stem Cells"}, {"pmid_title_79": "Success of bone marrow transplantation in congenital Diamond-Blackfan anaemia: a case report.", "pmid_79": 3109937.0, "pmid_date_79": 1987.0, "pmid_journal_79": "Eur J Haematol"}, {"pmid_title_80": "Erythrogenesis imperfecta or congenital hypoplastic anaemia (Diamond-Blackfan type).", "pmid_80": 13105384.0, "pmid_date_80": 1953.0, "pmid_journal_80": "Arch Dis Child"}]}, {"_id": "4170-ORPHA:79277", "condition": {"condition_name": "Congenital erythropoietic porphyria", "freq_per_birth": "The exact prevalence of porphyria is unknown, but it probably ranges from 1 in 500 to 1 in 50,000 people worldwide. Overall, porphyria cutanea tarda is the most common type of porphyria. For some forms of porphyria, the prevalence is unknown because many people with a genetic mutation associated with the disease never experience signs or symptoms.Acute intermittent porphyria is the most common form of acute porphyria in most countries. It may occur more frequently in northern European countries, such as Sweden, and in the United Kingdom. Another form of the disorder, hereditary coproporphyria, has been reported mostly in Europe and North America. Variegate porphyria is most common in the Afrikaner population of South Africa; about 3 in 1,000 people in this population have the genetic change that causes this form of the disorder.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES", "Congenital erythropoietic porphyria", "Acute megakaryoblastic leukemia in Down syndrome", "Transient myeloproliferative syndrome", "Blackfan-Diamond anemia", "THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA", "Acute basophilic leukemia"]}, "gene information": {"db_hgnc_gene_id": 4170.0}, "interventions": [{"int_description_1": "Photodynamic therapy"}, {"int_description_2": "Plasmapheresis"}, {"int_description_3": "Prednisone", "timeframe_int3": "Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Hydroxychloroquine"}, {"int_description_5": "Vitamin D"}, {"int_description_6": "Hematin"}, {"int_description_7": "Hydroxyurea"}, {"int_description_8": "Deferasirox"}, {"int_description_9": "Bisphosphonates"}, {"int_description_10": "Bleach baths"}, {"int_description_11": "Activated charcoal"}, {"int_description_12": "Hypochlorous acid"}, {"int_description_13": "Intravenous antibiotics and long-term oral antibiotic"}, {"int_description_14": "Skin antiseptics"}, {"int_description_15": "Sunscreen lotions containing zinc oxide or titanium oxide", "timeframe_int15": "Days or Weeks,Years", "age_use_int15": "Infant,Child", "contra_int15": "No", "qualscale_reclass_drug15": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug15": "Effective / Ameliorative"}, {"int_description_16": "Topical antibiotics"}, {"int_description_17": "Blood transfusions", "timeframe_int17": "Hours", "age_use_int17": "Neonate,Infant,Child", "contra_int17": "No", "qualscale_reclass_drug17": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug17": "Effective / Ameliorative"}, {"int_description_18": "Skin trauma should avoiding"}, {"int_description_19": "Sun avoidance and skin protection"}, {"int_description_20": "Wraparound sun glasses"}, {"int_description_21": "Bone marrow transplantation"}, {"int_description_22": "Corrective surgery of the eyelid"}, {"int_description_23": "Hematopoietic stem cell transplantation", "timeframe_int23": "Days or Weeks,Years", "age_use_int23": "Infant,Child", "contra_int23": "Yes", "qualscale_reclass_drug23": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug23": "Curative"}, {"int_description_24": "Splenectomy", "timeframe_int24": "Days or Weeks,Years", "age_use_int24": "Child", "contra_int24": "No", "qualscale_reclass_drug24": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug24": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Congenital erythropoietic porphyria: Recent advances.", "pmid_1": 30685241.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Mol Genet Metab"}, {"pmid_title_2": "Congenital erythropoietic porphyria linked to GATA1-R216W mutation: challenges for diagnosis.", "pmid_2": 25251786.0, "pmid_date_2": 2015.0, "pmid_journal_2": "Eur J Haematol"}, {"pmid_title_3": "Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria.", "pmid_3": 17148589.0, "pmid_date_3": 2007.0, "pmid_journal_3": "Blood"}]}, {"_id": "4173-OMIM:187500", "condition": {"condition_name": "TETRALOGY OF FALLOT; TOF", "freq_per_birth": "Heart defects are the most common type of birth defect, accounting for more than 30 percent of all infant deaths due to birth defects. CCHD represents some of the most serious types of heart defects. About 7,200 newborns, or 18 per 10,000, in the United States are diagnosed with CCHD each year.", "pattern_of_inheritance": "Pattern unknown", "alternate_names": ["VENTRICULAR SEPTAL DEFECT 1; VSD1", "TETRALOGY OF FALLOT; TOF", "ATRIAL SEPTAL DEFECT 2; ASD2"]}, "gene information": {"db_hgnc_gene_id": 4173.0}, "interventions": [{"int_description_1": "Implantable cardioverter-defibrillator"}, {"int_description_2": "Phenylephrine"}, {"int_description_3": "Fentanyl"}, {"int_description_4": "Cardiac Resynchronization Therapy"}, {"int_description_5": "Corrective surgery"}], "references": [{"pmid_title_1": "Fentanyl-associated anaphylaxis in an infant with tetralogy of Fallot: a case report.", "pmid_1": 32026060.0, "pmid_date_1": 2019.0, "pmid_journal_1": "JA clinical reports"}, {"pmid_title_2": "Cardiac resynchronization therapy in congenital heart disease: Results from the German National Register for Congenital Heart Defects.", "pmid_2": 30297188.0, "pmid_date_2": 2018.0, "pmid_journal_2": "International journal of cardiology"}, {"pmid_title_3": "Cardiac resynchronization therapy via transvenous approach in a 2-year-old boy with a complete atrioventricular block after a tetralogy of Fallot repair.", "pmid_3": 29255519.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Journal of arrhythmia"}, {"pmid_title_4": "Hot topics in tetralogy of Fallot.", "pmid_4": 24076489.0, "pmid_date_4": 2013.0, "pmid_journal_4": "Journal of the American College of Cardiology"}, {"pmid_title_5": "Tetralogy of Fallot.", "pmid_5": 19683809.0, "pmid_date_5": 2009.0, "pmid_journal_5": "Lancet (London, England)"}, {"pmid_title_6": "Phenylephrine increases pulmonary blood flow in children with tetralogy of Fallot.", "pmid_6": 14617591.0, "pmid_date_6": 2003.0, "pmid_journal_6": "Canadian journal of anaesthesia = Journal canadien d'anesthesie"}]}, {"_id": "4173-OMIM:607941", "condition": {"condition_name": "ATRIAL SEPTAL DEFECT 2; ASD2", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["VENTRICULAR SEPTAL DEFECT 1; VSD1", "ATRIAL SEPTAL DEFECT 2; ASD2", "TETRALOGY OF FALLOT; TOF"]}, "gene information": {"db_hgnc_gene_id": 4173.0}, "interventions": [{"int_description_1": "Endoscopic ASD repair"}], "references": [{"pmid_title_1": "Robotically assisted totally endoscopic atrial septal defect repair: insights from operative times, learning curves, and clinical outcome.", "pmid_1": 16863785.0, "pmid_date_1": 2006.0, "pmid_journal_1": "The Annals of thoracic surgery"}]}, {"_id": "4173-OMIM:614429", "condition": {"condition_name": "VENTRICULAR SEPTAL DEFECT 1; VSD1", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["ATRIAL SEPTAL DEFECT 2; ASD2", "VENTRICULAR SEPTAL DEFECT 1; VSD1", "TETRALOGY OF FALLOT; TOF"]}, "gene information": {"db_hgnc_gene_id": 4173.0}, "interventions": [{"int_description_1": "Amplatzer Muscular VSD occluder"}, {"int_description_2": "Dexmedetomidine"}, {"int_description_3": "Ketamine"}, {"int_description_4": "Hybrid techniques"}, {"int_description_5": "Surgical closure"}, {"int_description_6": "Thoracoscopic surgery"}, {"int_description_7": "Transcatheter closure"}], "references": [{"pmid_title_1": "Preincision Initiation of Dexmedetomidine Maximally Reduces the Risk of Junctional Ectopic Tachycardia in Children Undergoing Ventricular Septal Defect Repairs.", "pmid_1": 28774644.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Journal of cardiothoracic and vascular anesthesia"}, {"pmid_title_2": "Comparison of hemodynamic effects of sevoflurane and ketamine as basal anesthesia by a new and direct monitoring during induction in children with ventricular septal defect: A prospective, randomized research.", "pmid_2": 29390298.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Medicine"}, {"pmid_title_3": "Transcatheter device closure of muscular ventricular septal defect.", "pmid_3": 21385649.0, "pmid_date_3": 2011.0, "pmid_journal_3": "Pediatrics and neonatology"}, {"pmid_title_4": "Ventricular septal defect.", "pmid_4": 21349577.0, "pmid_date_4": 2011.0, "pmid_journal_4": "Lancet (London, England)"}, {"pmid_title_5": "Totally thoracoscopic repair of ventricular septal defect: a short-term clinical observation on safety and feasibility.", "pmid_5": 21458006.0, "pmid_date_5": 2011.0, "pmid_journal_5": "The Journal of thoracic and cardiovascular surgery"}]}, {"_id": "4174-OMIM:187500", "condition": {"condition_name": "TETRALOGY OF FALLOT; TOF", "freq_per_birth": "Heart defects are the most common type of birth defect, accounting for more than 30 percent of all infant deaths due to birth defects. CCHD represents some of the most serious types of heart defects. About 7,200 newborns, or 18 per 10,000, in the United States are diagnosed with CCHD each year.", "pattern_of_inheritance": "Pattern unknown", "alternate_names": ["HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA", "TETRALOGY OF FALLOT; TOF", "ATRIAL SEPTAL DEFECT 9; ASD9", "CONOTRUNCAL HEART MALFORMATIONS; CTHM"]}, "gene information": {"db_hgnc_gene_id": 4174.0}, "interventions": [{"int_description_1": "Implantable cardioverter-defibrillator"}, {"int_description_2": "Phenylephrine"}, {"int_description_3": "Fentanyl"}, {"int_description_4": "Cardiac Resynchronization Therapy"}, {"int_description_5": "Corrective surgery"}], "references": [{"pmid_title_1": "Fentanyl-associated anaphylaxis in an infant with tetralogy of Fallot: a case report.", "pmid_1": 32026060.0, "pmid_date_1": 2019.0, "pmid_journal_1": "JA clinical reports"}, {"pmid_title_2": "Cardiac resynchronization therapy in congenital heart disease: Results from the German National Register for Congenital Heart Defects.", "pmid_2": 30297188.0, "pmid_date_2": 2018.0, "pmid_journal_2": "International journal of cardiology"}, {"pmid_title_3": "Cardiac resynchronization therapy via transvenous approach in a 2-year-old boy with a complete atrioventricular block after a tetralogy of Fallot repair.", "pmid_3": 29255519.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Journal of arrhythmia"}, {"pmid_title_4": "Hot topics in tetralogy of Fallot.", "pmid_4": 24076489.0, "pmid_date_4": 2013.0, "pmid_journal_4": "Journal of the American College of Cardiology"}, {"pmid_title_5": "Tetralogy of Fallot.", "pmid_5": 19683809.0, "pmid_date_5": 2009.0, "pmid_journal_5": "Lancet (London, England)"}, {"pmid_title_6": "Phenylephrine increases pulmonary blood flow in children with tetralogy of Fallot.", "pmid_6": 14617591.0, "pmid_date_6": 2003.0, "pmid_journal_6": "Canadian journal of anaesthesia = Journal canadien d'anesthesie"}]}, {"_id": "4174-OMIM:217095", "condition": {"condition_name": "CONOTRUNCAL HEART MALFORMATIONS; CTHM", "freq_per_birth": "Heart defects are the most common type of birth defect, accounting for more than 30 percent of all infant deaths due to birth defects. CCHD represents some of the most serious types of heart defects. About 7,200 newborns, or 18 per 10,000, in the United States are diagnosed with CCHD each year.", "pattern_of_inheritance": "Pattern unknown", "alternate_names": ["HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA", "CONOTRUNCAL HEART MALFORMATIONS; CTHM", "ATRIAL SEPTAL DEFECT 9; ASD9", "TETRALOGY OF FALLOT; TOF"]}, "gene information": {"db_hgnc_gene_id": 4174.0}, "interventions": [{"int_description_1": "Surgery via median sternotomy"}], "references": [{"pmid_title_1": "Outcomes of Right Ventricular Outflow Tract Reconstruction for Children with Persistent Truncus Arteriosus: A 10-Year Single-Center Experience.", "pmid_1": 29255914.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Pediatric cardiology"}]}, {"_id": "4174-OMIM:600001", "condition": {"condition_name": "HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["CONOTRUNCAL HEART MALFORMATIONS; CTHM", "HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA", "ATRIAL SEPTAL DEFECT 9; ASD9", "TETRALOGY OF FALLOT; TOF"]}, "gene information": {"db_hgnc_gene_id": 4174.0}, "interventions": [{"int_description_1": "Insulin human"}, {"int_description_2": "Pancreatic enzyme replacement  monotherapy"}], "references": [{"pmid_title_1": "GATA6 mutations: Characterization of two novel patients and a comprehensive overview of the GATA6 genotypic and phenotypic spectrum.", "pmid_1": 31301121.0, "pmid_date_1": 2019.0, "pmid_journal_1": "American journal of medical genetics. Part A"}, {"pmid_title_2": "GATA6 mutations cause a broad phenotypic spectrum of diabetes from pancreatic agenesis to adult-onset diabetes without exocrine insufficiency.", "pmid_2": 23223019.0, "pmid_date_2": 2013.0, "pmid_journal_2": "Diabetes"}]}, {"_id": "4174-OMIM:614475", "condition": {"condition_name": "ATRIAL SEPTAL DEFECT 9; ASD9", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["CONOTRUNCAL HEART MALFORMATIONS; CTHM", "ATRIAL SEPTAL DEFECT 9; ASD9", "HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA", "TETRALOGY OF FALLOT; TOF"]}, "gene information": {"db_hgnc_gene_id": 4174.0}, "interventions": [{"int_description_1": "Dexmedetomidine"}, {"int_description_2": "Transcatheter Closure"}], "references": [{"pmid_title_1": "Recent review of transcatheter closure of atrial septal defect.", "pmid_1": 30063008.0, "pmid_date_1": 2018.0, "pmid_journal_1": "The Kaohsiung journal of medical sciences"}, {"pmid_title_2": "Dexmedetomidine for Transesophageal Echocardiography-Guided Percutaneous Closure of an Atrial Septal Defect in an Infant without Endotracheal Intubation.", "pmid_2": 30127233.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Chinese medical journal"}, {"pmid_title_3": "Long-Term Outcomes After Percutaneous Closure of Ostium Secundum Atrial Septal Defect in\u00a0the\u00a0Young: A Nationwide Cohort Study.", "pmid_3": 29673513.0, "pmid_date_3": 2018.0, "pmid_journal_3": "JACC. Cardiovascular interventions"}]}, {"_id": "417-OMIM:229600", "condition": {"condition_name": "FRUCTOSE INTOLERANCE, HEREDITARY; HFI", "freq_per_birth": "The incidence of hereditary fructose intolerance is estimated to be 1 in 20,000 to 30,000 individuals each year worldwide.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["FRUCTOSE INTOLERANCE, HEREDITARY; HFI"]}, "gene information": {"db_hgnc_gene_id": 417.0}, "interventions": [{"int_description_1": "Fructose and sucrose free formula", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Fructose-free formula"}], "references": [{"pmid_title_1": "Acute liver failure in neonates with undiagnosed hereditary fructose intolerance due to exposure from widely available infant formulas.", "pmid_1": 29510902.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Molecular genetics and metabolism"}]}, {"_id": "4189-OMIM:231670", "condition": {"condition_name": "GLUTARIC ACIDEMIA I; GA1", "freq_per_birth": "Glutaric acidemia type I occurs in approximately 1 in 100,000 individuals. It is much more common in the Amish community and in the Ojibwa population of Canada, where up to 1 in 300 newborns may be affected.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["GLUTARIC ACIDEMIA I; GA1"]}, "gene information": {"db_hgnc_gene_id": 4189.0}, "interventions": [{"int_description_1": "Lysine restricted diet with L-Carnitine supplementation"}, {"int_description_2": "Clonazepam"}, {"int_description_3": "Diazepam"}, {"int_description_4": "Baclofen"}, {"int_description_5": "Insulin human"}, {"int_description_6": "Trihexyphenidyl"}, {"int_description_7": "Oxcarbazepine"}, {"int_description_8": "Acetaminophen", "timeframe_int8": "Hours,Days or Weeks", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Ibuprofen"}, {"int_description_10": "Levocarnitine"}, {"int_description_11": "Botulinum toxin type A"}, {"int_description_12": "Riboflavin", "timeframe_int12": "Hours,Days or Weeks", "age_use_int12": "Neonate,Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Maltodextrin"}, {"int_description_14": "Sodium bicarbonate"}, {"int_description_15": "D-glucose"}], "references": [{"pmid_title_1": "Glutaric Acidemia Type 1", "pmid_1": 31536184.0, "pmid_date_1": 2019.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Oxidative damage in glutaric aciduria type I patients and the protective effects of l-carnitine treatment.", "pmid_2": 30129250.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Journal of cellular biochemistry"}, {"pmid_title_3": "Newborn screening: A disease-changing intervention for glutaric aciduria type 1.", "pmid_3": 29665094.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Annals of neurology"}, {"pmid_title_4": "Glutaric Acidemia Type 1: A Case of Infantile Stroke.", "pmid_4": 28411331.0, "pmid_date_4": 2018.0, "pmid_journal_4": "JIMD reports"}, {"pmid_title_5": "Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision.", "pmid_5": 27853989.0, "pmid_date_5": 2017.0, "pmid_journal_5": "Journal of inherited metabolic disease"}, {"pmid_title_6": "Intraventricular Baclofen for Treatment of Severe Dystonia Associated with Glutaryl-CoA Dehydrogenase Deficiency (GA1): Report of Two Cases.", "pmid_6": 30713921.0, "pmid_date_6": 2016.0, "pmid_journal_6": "Movement disorders clinical practice"}, {"pmid_title_7": "The long-term treatment of a patient with type 1 diabetes mellitus and glutaric aciduria type 1: the effect of insulin.", "pmid_7": 26847429.0, "pmid_date_7": 2016.0, "pmid_journal_7": "European journal of pediatrics"}, {"pmid_title_8": "Glutaric aciduria type 1 as a cause of dystonic cerebral palsy.", "pmid_8": 26593172.0, "pmid_date_8": 2015.0, "pmid_journal_8": "Saudi medical journal"}, {"pmid_title_9": "Glutaric aciduria type I: outcome of patients with early- versus late-diagnosis.", "pmid_9": 23395213.0, "pmid_date_9": 2013.0, "pmid_journal_9": "European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society"}, {"pmid_title_10": "Diagnosis and management of glutaric aciduria type I--revised recommendations.", "pmid_10": 21431622.0, "pmid_date_10": 2011.0, "pmid_journal_10": "Journal of inherited metabolic disease"}, {"pmid_title_11": "Use of guidelines improves the neurological outcome in glutaric aciduria type I.", "pmid_11": 21031586.0, "pmid_date_11": 2010.0, "pmid_journal_11": "Annals of neurology"}, {"pmid_title_12": "Glutaric aciduria type I: outcome following detection by newborn screening.", "pmid_12": 18683078.0, "pmid_date_12": 2008.0, "pmid_journal_12": "Journal of inherited metabolic disease"}, {"pmid_title_13": "Glutaric acidemia type I: a neurosurgical perspective. Report of two cases.", "pmid_13": 18459892.0, "pmid_date_13": 2007.0, "pmid_journal_13": "Journal of neurosurgery"}, {"pmid_title_14": "Riboflavin-responsive glutaryl CoA dehydrogenase deficiency.", "pmid_14": 16377226.0, "pmid_date_14": 2006.0, "pmid_journal_14": "Molecular genetics and metabolism"}, {"pmid_title_15": "Bilateral pallidotomy for severe dystonia in an 18-month-old child with glutaric aciduria.", "pmid_15": 15305079.0, "pmid_date_15": 2004.0, "pmid_journal_15": "Stereotactic and functional neurosurgery"}]}, {"_id": "4193-OMIM:128230", "condition": {"condition_name": "DYSTONIA, DOPA-RESPONSIVE; DRD", "freq_per_birth": "Dopa-responsive dystonia is estimated to affect 1 per million people worldwide. However, the disorder is likely underdiagnosed because the condition may not be identified in people with mild symptoms, or it may be misdiagnosed in people who have symptoms similar to other movement disorders.", "pattern_of_inheritance": "Autosomal recessive==Autosomal dominant", "alternate_names": ["DYSTONIA, DOPA-RESPONSIVE; DRD", "HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B"]}, "gene information": {"db_hgnc_gene_id": 4193.0}, "interventions": [{"int_description_1": "Levodopa", "timeframe_int1": "Days or Weeks", "age_use_int1": "Infant,Child", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Carbidopa", "timeframe_int2": "Days or Weeks", "age_use_int2": "Child", "contra_int2": "No", "qualscale_reclass_drug2": "Cohort study or studies", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Dystonia.", "pmid_1": 30237473.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Nature reviews. Disease primers"}, {"pmid_title_2": "GCH1 heterozygous mutation identified by whole-exome sequencing as a treatable condition in a patient presenting with progressive spastic paraplegia.", "pmid_2": 24509643.0, "pmid_date_2": 2014.0, "pmid_journal_2": "Journal of neurology"}, {"pmid_title_3": "Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia.", "pmid_3": 19491146.0, "pmid_date_3": 2009.0, "pmid_journal_3": "Brain : a journal of neurology"}, {"pmid_title_4": "Phenylalanine loading as a diagnostic test for DRD: interpreting the utility of the test.", "pmid_4": 15542391.0, "pmid_date_4": 2004.0, "pmid_journal_4": "Molecular genetics and metabolism"}]}, {"_id": "4193-OMIM:233910", "condition": {"condition_name": "HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B", "freq_per_birth": "This condition is rare, affecting an estimated 1 in 500,000 to 1 in 1 million newborns. In most parts of the world, tetrahydrobiopterin deficiency accounts for 1 to 3 percent of all cases of elevated phenylalanine levels. The remaining cases are caused by a similar condition called phenylketonuria (PKU). In certain countries, including Saudi Arabia, Taiwan, China, and Turkey, it is more common for elevated levels of phenylalanine to be caused by tetrahydrobiopterin deficiency than by PKU.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B", "DYSTONIA, DOPA-RESPONSIVE; DRD"]}, "gene information": {"db_hgnc_gene_id": 4193.0}, "interventions": [{"int_description_1": "Levodopa", "timeframe_int1": "Days or Weeks", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Benserazide", "timeframe_int2": "Days or Weeks", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia", "pmid_1": 20301681.0, "pmid_date_1": 2019.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "A novel GTPCH deficiency mouse model exhibiting tetrahydrobiopterin-related metabolic disturbance and infancy-onset motor impairments.", "pmid_2": 30742839.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Metabolism: clinical and experimental"}]}, {"_id": "4195-OMIM:602485", "condition": {"condition_name": "HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3", "freq_per_birth": "Congenital hyperinsulinism affects approximately 1 in 50,000 newborns. This condition is more common in certain populations, affecting up to 1 in 2,500 newborns.", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["DIABETES MELLITUS, PERMANENT NEONATAL, 1", "HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3", "MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2"]}, "gene information": {"db_hgnc_gene_id": 4195.0}, "interventions": [{"int_description_1": "Glucagon", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Lanreotide", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Octreotide", "timeframe_int3": "Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Chlorothiazide"}, {"int_description_5": "Diazoxide", "timeframe_int5": "Hours", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Starch, corn", "timeframe_int6": "Hours", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Avexitide", "timeframe_int7": "Days or Weeks", "age_use_int7": "Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Dasiglucagon", "timeframe_int8": "Hours", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Case report(s)", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Recombinant human monoclonal antibody to insulin receptor (RZ358, XOMA358) monotherapy"}, {"int_description_10": "D-glucose"}, {"int_description_11": "Subtotal pancreatectomy", "timeframe_int11": "Days or Weeks", "age_use_int11": "Infant,Child", "contra_int11": "No", "qualscale_reclass_drug11": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Familial Hyperinsulinism", "pmid_1": 20301549.0, "pmid_date_1": 2019.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders.", "pmid_2": 26908106.0, "pmid_date_2": 2016.0, "pmid_journal_2": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_3": "Large islets, beta-cell proliferation, and a glucokinase mutation.", "pmid_3": 20375417.0, "pmid_date_3": 2010.0, "pmid_journal_3": "The New England journal of medicine"}, {"pmid_title_4": "Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.", "pmid_4": 19790256.0, "pmid_date_4": 2009.0, "pmid_journal_4": "Human mutation"}, {"pmid_title_5": "Heterogeneity in disease severity in a family with a novel G68V GCK activating mutation causing persistent hyperinsulinaemic hypoglycaemia of infancy.", "pmid_5": 17976205.0, "pmid_date_5": 2007.0, "pmid_journal_5": "Diabetic medicine : a journal of the British Diabetic Association"}, {"pmid_title_6": "The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy.", "pmid_6": 11916951.0, "pmid_date_6": 2002.0, "pmid_journal_6": "Diabetes"}]}, {"_id": "4195-OMIM:606176", "condition": {"condition_name": "DIABETES MELLITUS, PERMANENT NEONATAL, 1", "freq_per_birth": "In the United States, up to 14 percent of all pregnancies are affected by gestational diabetes. The prevalence of gestational diabetes has been increasing rapidly over the past few decades (a trend similar to the increase in obesity and type 2 diabetes).The risk of developing gestational diabetes varies by ethnic background. Women of Native American, Asian, Hispanic, or African American heritage are more likely to be diagnosed with the disease than are non-Hispanic white women.", "pattern_of_inheritance": "Pattern unknown, Autosomal recessive, Autosomal dominant", "alternate_names": ["HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3", "DIABETES MELLITUS, PERMANENT NEONATAL, 1", "MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2"]}, "gene information": {"db_hgnc_gene_id": 4195.0}, "interventions": [{"int_description_1": "Insulin human", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Glyburide", "timeframe_int2": "Days or Weeks", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Cohort study or studies", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Clinical characteristics and molecular genetic analysis of 22 patients with neonatal diabetes from the South-Eastern region of Turkey: predominance of non-KATP channel mutations.", "pmid_1": 25755231.0, "pmid_date_1": 2015.0, "pmid_journal_1": "European journal of endocrinology"}, {"pmid_title_2": "Phenotypic heterogeneity in monogenic diabetes: the clinical and diagnostic utility of a gene panel-based next-generation sequencing approach.", "pmid_2": 25306193.0, "pmid_date_2": 2014.0, "pmid_journal_2": "Molecular genetics and metabolism"}, {"pmid_title_3": "Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.", "pmid_3": 19790256.0, "pmid_date_3": 2009.0, "pmid_journal_3": "Human mutation"}, {"pmid_title_4": "Neonatal diabetes mellitus due to complete glucokinase deficiency.", "pmid_4": 11372010.0, "pmid_date_4": 2001.0, "pmid_journal_4": "The New England journal of medicine"}]}, {"_id": "4241-OMIM:610542", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 12", "freq_per_birth": "The prevalence of congenital myasthenic syndrome is unknown. At least 600 families with affected individuals have been described in the scientific literature.", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 12"]}, "gene information": {"db_hgnc_gene_id": 4241.0}, "interventions": [{"int_description_1": "Mechanical ventilation", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Salbutamol", "timeframe_int2": "Days or Weeks,Years", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Amifampridine"}, {"int_description_4": "Procaine", "timeframe_int4": "Days or Weeks,Years", "age_use_int4": "Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Procainamide"}, {"int_description_6": "Pyridostigmine"}, {"int_description_7": "Ciprofloxacin"}, {"int_description_8": "Quinidine"}, {"int_description_9": "Chloroquine"}, {"int_description_10": "Phenytoin", "timeframe_int10": "Days or Weeks,Years", "age_use_int10": "Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Case report(s)", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Acetylcholinesterase inhibitors"}, {"int_description_12": "Beta-blockers"}, {"int_description_13": "Lithium"}, {"int_description_14": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "Congenital Myasthenic Syndromes in 2018.", "pmid_1": 29892917.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Current neurology and neuroscience reports"}, {"pmid_title_2": "Mutations in GFPT1-related congenital myasthenic syndromes are associated with synaptic morphological defects and underlie a tubular aggregate myopathy with synaptopathy.", "pmid_2": 28712002.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Journal of neurology"}, {"pmid_title_3": "Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up.", "pmid_3": 29395675.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Neuromuscul Disord"}, {"pmid_title_4": "Congenital Myasthenic Syndromes", "pmid_4": 20301347.0, "pmid_date_4": 2016.0, "pmid_journal_4": "GeneReviews\u00ae"}, {"pmid_title_5": "Mutations in GFPT1 that underlie limb-girdle congenital myasthenic syndrome result in reduced cell-surface expression of muscle AChR.", "pmid_5": 23569079.0, "pmid_date_5": 2013.0, "pmid_journal_5": "Human molecular genetics"}, {"pmid_title_6": "Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations.", "pmid_6": 21975507.0, "pmid_date_6": 2012.0, "pmid_journal_6": "Journal of neurology"}]}, {"_id": "4268-OMIM:261000", "condition": {"condition_name": "INTRINSIC FACTOR DEFICIENCY; IFD", "pattern_of_inheritance": "Autosomal recessive, Not applicable", "alternate_names": ["INTRINSIC FACTOR DEFICIENCY; IFD"]}, "gene information": {"db_hgnc_gene_id": 4268.0}, "interventions": [{"int_description_1": "Cyanocobalamin"}, {"int_description_2": "Iron"}], "references": [{"pmid_title_1": "Biochemical and Hematologic Manifestations of Gastric Intrinsic Factor (GIF) Deficiency: A Treatable Cause of B12 Deficiency in the Old Order Mennonite Population of Southwestern Ontario.", "pmid_1": 25308559.0, "pmid_date_1": 2015.0, "pmid_journal_1": "JIMD reports"}, {"pmid_title_2": "How can cobalamin injections be spaced in long-term therapy for inborn errors of vitamin B(12) absorption?", "pmid_2": 22854512.0, "pmid_date_2": 2012.0, "pmid_journal_2": "Molecular genetics and metabolism"}, {"pmid_title_3": "Vitamin B12 deficiency in a 15-year old boy due to mutations in the intrinsic factor gene, GIF.", "pmid_3": 20408840.0, "pmid_date_3": 2010.0, "pmid_journal_3": "British journal of haematology"}]}, {"_id": "4326-OMIM:149400", "condition": {"condition_name": "HYPEREKPLEXIA 1", "freq_per_birth": "The exact prevalence of hereditary hyperekplexia is unknown. This condition has been identified in more than 150 individuals worldwide.", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["HYPEREKPLEXIA 1"]}, "gene information": {"db_hgnc_gene_id": 4326.0}, "interventions": [{"int_description_1": "Clobazam"}, {"int_description_2": "Clonazepam", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Diazepam"}, {"int_description_4": "Oxitriptan"}, {"int_description_5": "Carbamazepine"}, {"int_description_6": "Valproic acid"}, {"int_description_7": "Phenobarbital"}, {"int_description_8": "Piracetam"}, {"int_description_9": "Cognitive behavior therapy\u00a0(CBT)"}, {"int_description_10": "Physical Exercise Training"}], "references": [{"pmid_title_1": "Hereditary Hyperekplexia Overview", "pmid_1": 20301437.0, "pmid_date_1": 2019.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Human Hyperekplexic Mutations in Glycine Receptors Disinhibit the Brainstem by Hijacking GABA<sub>A</sub> Receptors.", "pmid_2": 31450193.0, "pmid_date_2": 2019.0, "pmid_journal_2": "iScience"}, {"pmid_title_3": "A novel nonsense autosomal dominant mutation in the GLRA1 gene causing hyperekplexia.", "pmid_3": 30182260.0, "pmid_date_3": 2018.0, "pmid_journal_3": "J Neural Transm (Vienna)"}, {"pmid_title_4": "An Unusual Startling.", "pmid_4": 26702184.0, "pmid_date_4": 2015.0, "pmid_journal_4": "Indian J Psychol Med"}, {"pmid_title_5": "Clobazam-clonazepam combination effective for stimulus-induced falling in hyperekplexia.", "pmid_5": 24453146.0, "pmid_date_5": 2015.0, "pmid_journal_5": "J Child Neurol"}, {"pmid_title_6": "Clinical and genetic investigation of 17 Japanese patients with hyperekplexia.", "pmid_6": 25356525.0, "pmid_date_6": 2015.0, "pmid_journal_6": "Dev Med Child Neurol"}, {"pmid_title_7": "Genotype-phenotype correlations in hyperekplexia: apnoeas, learning difficulties and speech delay.", "pmid_7": 24030948.0, "pmid_date_7": 2013.0, "pmid_journal_7": "Brain"}, {"pmid_title_8": "Anaesthetic implications of hyperekplexia--'startle disease'.", "pmid_8": 18361020.0, "pmid_date_8": 2008.0, "pmid_journal_8": "Anaesth Intensive Care"}, {"pmid_title_9": "Hyperekplexia (startle disease) mimicking neonatal seizures: report of one case.", "pmid_9": 19653412.0, "pmid_date_9": 2007.0, "pmid_journal_9": "Acta Paediatr Taiwan"}, {"pmid_title_10": "A case of major form familial hyperekplexia: prenatal diagnosis and effective treatment with clonazepam.", "pmid_10": 17641268.0, "pmid_date_10": 2007.0, "pmid_journal_10": "J Child Neurol"}, {"pmid_title_11": "Sporadic major hyperekplexia in neonates and infants: clinical manifestations and outcome.", "pmid_11": 15246489.0, "pmid_date_11": 2004.0, "pmid_journal_11": "Pediatr Neurol"}, {"pmid_title_12": "Two novel mutations of the glycine receptor gene in a Taiwanese hyperekplexia family.", "pmid_12": 15365143.0, "pmid_date_12": 2004.0, "pmid_journal_12": "Neurology"}, {"pmid_title_13": "Successful treatment of severe infantile hyperekplexia with low-dose clobazam.", "pmid_13": 11952081.0, "pmid_date_13": 2002.0, "pmid_journal_13": "J Child Neurol"}, {"pmid_title_14": "Neonatal sporadic hyperekplexia: a rare and often unrecognized entity.", "pmid_14": 9134197.0, "pmid_date_14": 1997.0, "pmid_journal_14": "Brain Dev"}, {"pmid_title_15": "The effects of clonazepam and vigabatrin in hyperekplexia.", "pmid_15": 9168167.0, "pmid_date_15": 1997.0, "pmid_journal_15": "J Neurol Sci"}, {"pmid_title_16": "Hyperekplexia, a cause of neonatal apnea: a case report.", "pmid_16": 7625544.0, "pmid_date_16": 1995.0, "pmid_journal_16": "Brain Dev"}, {"pmid_title_17": "Startle disease or hyperekplexia: adolescent onset and response to valproate.", "pmid_17": 2496695.0, "pmid_date_17": 1989.0, "pmid_journal_17": "Pediatr Neurol"}, {"pmid_title_18": "Hyperekplexia: a syndrome of pathological startle responses.", "pmid_18": 6424556.0, "pmid_date_18": 1984.0, "pmid_journal_18": "Ann Neurol"}]}, {"_id": "4329-OMIM:614619", "condition": {"condition_name": "HYPEREKPLEXIA 2", "freq_per_birth": "The exact prevalence of hereditary hyperekplexia is unknown. This condition has been identified in more than 150 individuals worldwide.", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["HYPEREKPLEXIA 2"]}, "gene information": {"db_hgnc_gene_id": 4329.0}, "interventions": [{"int_description_1": "Clobazam"}, {"int_description_2": "Clonazepam", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Nitrazepam"}, {"int_description_4": "Cognitive behavior therapy\u00a0(CBT)"}, {"int_description_5": "Physical Exercise Training"}], "references": [{"pmid_title_1": "Hereditary Hyperekplexia Overview", "pmid_1": 20301437.0, "pmid_date_1": 2019.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "[Clinical and genetic analysis of hyperekplexia in a Chinese child and literature review].", "pmid_2": 28173650.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Zhonghua Er Ke Za Zhi"}, {"pmid_title_3": "Hyperekplexia: Report on phenotype and genotype of 16 Jordanian patients.", "pmid_3": 27843043.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Brain Dev"}, {"pmid_title_4": "Clinical and genetic investigation of 17 Japanese patients with hyperekplexia.", "pmid_4": 25356525.0, "pmid_date_4": 2015.0, "pmid_journal_4": "Dev Med Child Neurol"}, {"pmid_title_5": "Clinical features and genetic analysis of children with hyperekplexia in Korea.", "pmid_5": 22532536.0, "pmid_date_5": 2013.0, "pmid_journal_5": "J Child Neurol"}, {"pmid_title_6": "A 14-year-old girl with hyperekplexia having GLRB mutations.", "pmid_6": 23182654.0, "pmid_date_6": 2013.0, "pmid_journal_6": "Brain Dev"}, {"pmid_title_7": "GLRB is the third major gene of effect in hyperekplexia.", "pmid_7": 23184146.0, "pmid_date_7": 2013.0, "pmid_journal_7": "Hum Mol Genet"}, {"pmid_title_8": "Novel missense mutations in the glycine receptor \u03b2 subunit gene (GLRB) in startle disease.", "pmid_8": 23238346.0, "pmid_date_8": 2013.0, "pmid_journal_8": "Neurobiol Dis"}, {"pmid_title_9": "Genotype-phenotype correlations in hyperekplexia: apnoeas, learning difficulties and speech delay.", "pmid_9": 24030948.0, "pmid_date_9": 2013.0, "pmid_journal_9": "Brain"}, {"pmid_title_10": "Novel mutation in GLRB in a large family with hereditary hyperekplexia.", "pmid_10": 21391991.0, "pmid_date_10": 2012.0, "pmid_journal_10": "Clin Genet"}, {"pmid_title_11": "Hyperekplexia associated with compound heterozygote mutations in the beta-subunit of the human inhibitory glycine receptor (GLRB).", "pmid_11": 11929858.0, "pmid_date_11": 2002.0, "pmid_journal_11": "Hum Mol Genet"}]}, {"_id": "4335-OMIM:606762", "condition": {"condition_name": "HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6", "freq_per_birth": "Congenital hyperinsulinism affects approximately 1 in 50,000 newborns. This condition is more common in certain populations, affecting up to 1 in 2,500 newborns.", "pattern_of_inheritance": "Autosomal dominant==Autosomal recessive", "alternate_names": ["HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6"]}, "gene information": {"db_hgnc_gene_id": 4335.0}, "interventions": [{"int_description_1": "Bihormonal bionic pancreas", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Frequent high-carbohydrate feedings with slowly released carbohydrates", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "High-carbohydrate and low-protein diet", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Cohort study or studies", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Leucine-restricted diet"}, {"int_description_5": "Glucagon"}, {"int_description_6": "Lanreotide", "timeframe_int6": "Hours", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Octreotide", "timeframe_int7": "Hours", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Nifedipine"}, {"int_description_9": "Vitamin E", "timeframe_int9": "Days or Weeks", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Diazoxide"}, {"int_description_11": "Starch, corn", "timeframe_int11": "Days or Weeks", "age_use_int11": "Neonate,Infant,Child", "contra_int11": "No", "qualscale_reclass_drug11": "Cohort study or studies", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "Avexitide", "timeframe_int12": "Days or Weeks", "age_use_int12": "Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Dasiglucagon", "timeframe_int13": "Days or Weeks", "age_use_int13": "Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Cohort study or studies", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Glucagon analogue linked to a human immunoglobulin Fc fragment (HM15136) monotherapy"}, {"int_description_15": "Recombinant human monoclonal antibody to insulin receptor (RZ358, XOMA358) monotherapy"}, {"int_description_16": "D-glucose"}, {"int_description_17": "Feeding per gastrostomy tube"}, {"int_description_18": "Restrictive pancreatic resection (laparoscopy)"}], "references": [{"pmid_title_1": "Hyperinsulinism-hyperammonemia Syndrome in an Infant with Seizures.", "pmid_1": 30425915.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Balkan journal of medical genetics : BJMG"}, {"pmid_title_2": "A severe case of hyperinsulinism due to hemizygous activating mutation of glutamate dehydrogenase.", "pmid_2": 28165182.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Pediatric diabetes"}, {"pmid_title_3": "Hyperinsulinism-hyperammonemia syndrome: a de novo mutation of the GLUD1 gene in twins and a review of the literature.", "pmid_3": 27383869.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_4": "A novel mutation in GLUD1 causing hyperinsulinism-hyperammonemia in a patient with high density of homozygosity on microarray: a case report.", "pmid_4": 26839063.0, "pmid_date_4": 2016.0, "pmid_journal_4": "Journal of medical case reports"}, {"pmid_title_5": "A novel mutation in the glutamate dehydrogenase (GLUD1) of a patient with congenital hyperinsulinism-hyperammonemia (HI/HA).", "pmid_5": 26656609.0, "pmid_date_5": 2016.0, "pmid_journal_5": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_6": "Seizures and diagnostic difficulties in hyperinsulinism-hyperammonemia syndrome.", "pmid_6": 28621098.0, "pmid_date_6": 2016.0, "pmid_journal_6": "The Turkish journal of pediatrics"}, {"pmid_title_7": "Early Presentation of Hyperinsulinism/Hyperammonemia Syndrome in Three Serbian Patients.", "pmid_7": 26759084.0, "pmid_date_7": 2016.0, "pmid_journal_7": "Journal of clinical research in pediatric endocrinology"}, {"pmid_title_8": "Hyperinsulinemic hypoglycemia: think of hyperinsulinism/hyperammonemia (HI/HA) syndrome caused by mutations in the GLUD1 gene.", "pmid_8": 25781533.0, "pmid_date_8": 2015.0, "pmid_journal_8": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_9": "Congenital hyperinsulinism: current status and future perspectives.", "pmid_9": 25077087.0, "pmid_date_9": 2014.0, "pmid_journal_9": "Annals of pediatric endocrinology & metabolism"}, {"pmid_title_10": "Monogenic hyperinsulinemic hypoglycemia: current insights into the pathogenesis and management.", "pmid_10": 23384201.0, "pmid_date_10": 2013.0, "pmid_journal_10": "International journal of pediatric endocrinology"}, {"pmid_title_11": "Intractable absence seizures in hyperinsulinism-hyperammonemia syndrome.", "pmid_11": 22759688.0, "pmid_date_11": 2012.0, "pmid_journal_11": "Pediatric neurology"}, {"pmid_title_12": "Hyperinsulinism/hyperammonemia (HI/HA) syndrome due to a mutation in the glutamate dehydrogenase gene.", "pmid_12": 23295286.0, "pmid_date_12": 2012.0, "pmid_journal_12": "Arquivos brasileiros de endocrinologia e metabologia"}, {"pmid_title_13": "Successful treatment of congenital hyperinsulinism with long-acting release octreotide.", "pmid_13": 22048969.0, "pmid_date_13": 2012.0, "pmid_journal_13": "European journal of endocrinology"}, {"pmid_title_14": "Glucose metabolism in 105 children and adolescents after pancreatectomy for congenital hyperinsulinism.", "pmid_14": 22190679.0, "pmid_date_14": 2012.0, "pmid_journal_14": "Diabetes care"}, {"pmid_title_15": "Surgical management of congenital hyperinsulinism of infancy.", "pmid_15": 21186005.0, "pmid_date_15": 2011.0, "pmid_journal_15": "Seminars in pediatric surgery"}, {"pmid_title_16": "Hyperinsulinism and hyperammonaemia syndrome and severe myoclonic epilepsy of infancy.", "pmid_16": 21163222.0, "pmid_date_16": 2011.0, "pmid_journal_16": "Neurologia (Barcelona, Spain)"}, {"pmid_title_17": "Spectrum of glutamate dehydrogenase mutations in Japanese patients with congenital hyperinsulinism and hyperammonemia syndrome.", "pmid_17": 22106762.0, "pmid_date_17": 2011.0, "pmid_journal_17": "Osaka city medical journal"}, {"pmid_title_18": "Biochemical evaluation of an infant with hypoglycemia resulting from a novel de novo mutation of the GLUD1 gene and hyperinsulinism-hyperammonemia syndrome.", "pmid_18": 21932603.0, "pmid_date_18": 2011.0, "pmid_journal_18": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_19": "Treatment of congenital hyperinsulinism with lanreotide acetate (Somatuline Autogel).", "pmid_19": 21697252.0, "pmid_date_19": 2011.0, "pmid_journal_19": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_20": "The hyperinsulinism/hyperammonemia syndrome.", "pmid_20": 20936362.0, "pmid_date_20": 2010.0, "pmid_journal_20": "Reviews in endocrine & metabolic disorders"}, {"pmid_title_21": "Familial hyperinsulinism-hyperammonemia syndrome in a family with seizures: case report.", "pmid_21": 21073125.0, "pmid_date_21": 2010.0, "pmid_journal_21": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_22": "Neurological aspects of hyperinsulinism-hyperammonaemia syndrome.", "pmid_22": 19046187.0, "pmid_date_22": 2008.0, "pmid_journal_22": "Developmental medicine and child neurology"}, {"pmid_title_23": "Mechanisms of Disease: advances in diagnosis and treatment of hyperinsulinism in neonates.", "pmid_23": 17179930.0, "pmid_date_23": 2007.0, "pmid_journal_23": "Nature clinical practice. Endocrinology & metabolism"}, {"pmid_title_24": "Central nervous system hyperexcitability associated with glutamate dehydrogenase gain of function mutations.", "pmid_24": 15756227.0, "pmid_date_24": 2005.0, "pmid_journal_24": "The Journal of pediatrics"}, {"pmid_title_25": "Medications used in the treatment of hypoglycemia due to congenital hyperinsulinism of infancy (HI).", "pmid_25": 16456495.0, "pmid_date_25": 2004.0, "pmid_journal_25": "Pediatric endocrinology reviews : PER"}, {"pmid_title_26": "[Hyperinsulinism-hyperammonemia syndrome due to a de novo mutation in exon 7 (G979A) of the glutamate dehydrogenase gene with excellent response to diazoxide].", "pmid_26": 15530324.0, "pmid_date_26": 2004.0, "pmid_journal_26": "Anales de pediatria (Barcelona, Spain : 2003)"}, {"pmid_title_27": "Persistent hyperinsulinaemic hypoglycaemia.", "pmid_27": 12069542.0, "pmid_date_27": 2002.0, "pmid_journal_27": "Seminars in neonatology : SN"}, {"pmid_title_28": "Hyperinsulinism and hyperammonemia syndrome: report of twelve unrelated patients.", "pmid_28": 11518822.0, "pmid_date_28": 2001.0, "pmid_journal_28": "Pediatric research"}, {"pmid_title_29": "Novel missense mutations outside the allosteric domain of glutamate dehydrogenase are prevalent in European patients with the congenital hyperinsulinism-hyperammonemia syndrome.", "pmid_29": 11214910.0, "pmid_date_29": 2001.0, "pmid_journal_29": "Human genetics"}, {"pmid_title_30": "Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome.", "pmid_30": 11241047.0, "pmid_date_30": 2001.0, "pmid_journal_30": "The Journal of pediatrics"}, {"pmid_title_31": "Hyperinsulinism/hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphate-binding domain of glutamate dehydrogenase.", "pmid_31": 11297618.0, "pmid_date_31": 2001.0, "pmid_journal_31": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_32": "Acute insulin responses to leucine in children with the hyperinsulinism/hyperammonemia syndrome.", "pmid_32": 11502802.0, "pmid_date_32": 2001.0, "pmid_journal_32": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_33": "Calcium-stimulated insulin secretion in diffuse and focal forms of congenital hyperinsulinism.", "pmid_33": 10931418.0, "pmid_date_33": 2000.0, "pmid_journal_33": "The Journal of pediatrics"}, {"pmid_title_34": "Functional hyperactivity of hepatic glutamate dehydrogenase as a cause of the hyperinsulinism/hyperammonemia syndrome: effect of treatment.", "pmid_34": 10969108.0, "pmid_date_34": 2000.0, "pmid_journal_34": "Pediatrics"}, {"pmid_title_35": "Novel missense mutations in the glutamate dehydrogenase gene in the congenital hyperinsulinism-hyperammonemia syndrome.", "pmid_35": 10636977.0, "pmid_date_35": 2000.0, "pmid_journal_35": "The Journal of pediatrics"}, {"pmid_title_36": "Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. HI/HA Contributing Investigators.", "pmid_36": 10871207.0, "pmid_date_36": 2000.0, "pmid_journal_36": "Diabetes"}, {"pmid_title_37": "Hyperinsulinism-hyperammonemia syndrome caused by mutant glutamate dehydrogenase accompanied by novel enzyme kinetics.", "pmid_37": 10453735.0, "pmid_date_37": 1999.0, "pmid_journal_37": "Human genetics"}, {"pmid_title_38": "Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene.", "pmid_38": 9571255.0, "pmid_date_38": 1998.0, "pmid_journal_38": "The New England journal of medicine"}, {"pmid_title_39": "Familial hyperinsulinism with apparent autosomal dominant inheritance: clinical and genetic differences from the autosomal recessive variant.", "pmid_39": 9469993.0, "pmid_date_39": 1998.0, "pmid_journal_39": "The Journal of pediatrics"}]}, {"_id": "438-OMIM:241500", "condition": {"condition_name": "HYPOPHOSPHATASIA, INFANTILE", "freq_per_birth": "Severe forms of hypophosphatasia affect an estimated 1 in 100,000 newborns.  Milder cases, such as those that appear in childhood or adulthood, probably occur more frequently.Hypophosphatasia has been reported worldwide in people of various ethnic backgrounds.  This condition appears to be most common in white populations.  It is particularly frequent in a Mennonite population in Manitoba, Canada, where about 1 in 2,500 infants is born with severe features of the condition.", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["HYPOPHOSPHATASIA, CHILDHOOD", "HYPOPHOSPHATASIA, INFANTILE", "HYPOPHOSPHATASIA, ADULT"]}, "gene information": {"db_hgnc_gene_id": 438.0}, "interventions": [{"int_description_1": "Dentures", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Mechanical ventilation"}, {"int_description_3": "Asfotase alfa"}, {"int_description_4": "Levetiracetam"}, {"int_description_5": "Pyridoxine"}, {"int_description_6": "Salmon calcitonin"}, {"int_description_7": "Phenobarbital"}, {"int_description_8": "Assisted respiration"}, {"int_description_9": "Palliative care"}, {"int_description_10": "Bone marrow and allogenic mesenchymal stem cells transplantation"}, {"int_description_11": "Craniotomy"}, {"int_description_12": "Marrow and bone cell transplantation"}], "references": [{"pmid_title_1": "Hypophosphatasia: Current Literature for Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment.", "pmid_1": 32676235.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Cureus"}, {"pmid_title_2": "Prenatal diagnosis facilitated prompt enzyme replacement therapy for prenatal benign hypophosphatasia.", "pmid_2": 31335231.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology"}, {"pmid_title_3": "Clinical Practice Guidelines for Hypophosphatasia.", "pmid_3": 32029969.0, "pmid_date_3": 2020.0, "pmid_journal_3": "Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology"}, {"pmid_title_4": "Alkaline Phosphatase Replacement Therapy.", "pmid_4": 31482501.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Advances in experimental medicine and biology"}, {"pmid_title_5": "Hypophosphatasia.", "pmid_5": 28939177.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Metabolism: clinical and experimental"}, {"pmid_title_6": "Safety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: Results from a Japanese clinical trial.", "pmid_6": 28374482.0, "pmid_date_6": 2017.0, "pmid_journal_6": "Clinical endocrinology"}, {"pmid_title_7": "Perinatal and infantile hypophosphatasia: clinical features and treatment.", "pmid_7": 29405934.0, "pmid_date_7": 2017.0, "pmid_journal_7": "Archives de pediatrie : organe officiel de la Societe francaise de pediatrie"}, {"pmid_title_8": "Asfotase Alfa in Perinatal/Infantile-Onset and Juvenile-Onset Hypophosphatasia: A Guide to Its Use in the USA.", "pmid_8": 26832358.0, "pmid_date_8": 2016.0, "pmid_journal_8": "BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy"}, {"pmid_title_9": "Pathophysiology of hypophosphatasia and the potential role of asfotase alfa.", "pmid_9": 27274262.0, "pmid_date_9": 2016.0, "pmid_journal_9": "Therapeutics and clinical risk management"}, {"pmid_title_10": "Hypophosphatasia", "pmid_10": 20301329.0, "pmid_date_10": 2016.0, "pmid_journal_10": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_11": "Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.", "pmid_11": 26893260.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Nature reviews. Endocrinology"}, {"pmid_title_12": "Compound heterozygosity of two functional null mutations in the ALPL gene associated with deleterious neurological outcome in an infant with hypophosphatasia.", "pmid_12": 23454488.0, "pmid_date_12": 2013.0, "pmid_journal_12": "Bone"}, {"pmid_title_13": "Enzyme-replacement therapy in life-threatening hypophosphatasia.", "pmid_13": 22397652.0, "pmid_date_13": 2012.0, "pmid_journal_13": "The New England journal of medicine"}, {"pmid_title_14": "Infantile hypophosphatasia: transplantation therapy trial using bone fragments and cultured osteoblasts.", "pmid_14": 17519318.0, "pmid_date_14": 2007.0, "pmid_journal_14": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_15": "Marrow cell transplantation for infantile hypophosphatasia.", "pmid_15": 12674323.0, "pmid_date_15": 2003.0, "pmid_journal_15": "Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research"}]}, {"_id": "438-OMIM:241510", "condition": {"condition_name": "HYPOPHOSPHATASIA, CHILDHOOD", "freq_per_birth": "Severe forms of hypophosphatasia affect an estimated 1 in 100,000 newborns.  Milder cases, such as those that appear in childhood or adulthood, probably occur more frequently.Hypophosphatasia has been reported worldwide in people of various ethnic backgrounds.  This condition appears to be most common in white populations.  It is particularly frequent in a Mennonite population in Manitoba, Canada, where about 1 in 2,500 infants is born with severe features of the condition.", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["HYPOPHOSPHATASIA, INFANTILE", "HYPOPHOSPHATASIA, CHILDHOOD", "HYPOPHOSPHATASIA, ADULT"]}, "gene information": {"db_hgnc_gene_id": 438.0}, "interventions": [{"int_description_1": "Dentures", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Mechanical ventilation"}, {"int_description_3": "Asfotase alfa"}, {"int_description_4": "Vitamin D"}, {"int_description_5": "Human calcitonin"}, {"int_description_6": "Pyridoxine"}, {"int_description_7": "Assisted respiration"}, {"int_description_8": "Palliative care"}, {"int_description_9": "Allogeneic  bone marrow transplant"}, {"int_description_10": "Craniotomy"}, {"int_description_11": "Internal fixation of fracture"}], "references": [{"pmid_title_1": "Hypophosphatasia: Current Literature for Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment.", "pmid_1": 32676235.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Cureus"}, {"pmid_title_2": "Clinical Practice Guidelines for Hypophosphatasia.", "pmid_2": 32029969.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology"}, {"pmid_title_3": "Alkaline Phosphatase Replacement Therapy.", "pmid_3": 31482501.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Advances in experimental medicine and biology"}, {"pmid_title_4": "Hypophosphatasia.", "pmid_4": 28939177.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Metabolism: clinical and experimental"}, {"pmid_title_5": "Safety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: Results from a Japanese clinical trial.", "pmid_5": 28374482.0, "pmid_date_5": 2017.0, "pmid_journal_5": "Clinical endocrinology"}, {"pmid_title_6": "Perinatal and infantile hypophosphatasia: clinical features and treatment.", "pmid_6": 29405934.0, "pmid_date_6": 2017.0, "pmid_journal_6": "Archives de pediatrie : organe officiel de la Societe francaise de pediatrie"}, {"pmid_title_7": "Hypophosphatasia in children and adolescents: clinical features and treatment.", "pmid_7": 29405935.0, "pmid_date_7": 2017.0, "pmid_journal_7": "Archives de pediatrie : organe officiel de la Societe francaise de pediatrie"}, {"pmid_title_8": "Asfotase Alfa in Perinatal/Infantile-Onset and Juvenile-Onset Hypophosphatasia: A Guide to Its Use in the USA.", "pmid_8": 26832358.0, "pmid_date_8": 2016.0, "pmid_journal_8": "BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy"}, {"pmid_title_9": "Pathophysiology of hypophosphatasia and the potential role of asfotase alfa.", "pmid_9": 27274262.0, "pmid_date_9": 2016.0, "pmid_journal_9": "Therapeutics and clinical risk management"}, {"pmid_title_10": "Hypophosphatasia", "pmid_10": 20301329.0, "pmid_date_10": 2016.0, "pmid_journal_10": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_11": "Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.", "pmid_11": 26893260.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Nature reviews. Endocrinology"}, {"pmid_title_12": "Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia.", "pmid_12": 26529632.0, "pmid_date_12": 2016.0, "pmid_journal_12": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_13": "Asfotase alfa therapy for children with hypophosphatasia.", "pmid_13": 27699270.0, "pmid_date_13": 2016.0, "pmid_journal_13": "JCI insight"}, {"pmid_title_14": "Enzyme-replacement therapy in life-threatening hypophosphatasia.", "pmid_14": 22397652.0, "pmid_date_14": 2012.0, "pmid_journal_14": "The New England journal of medicine"}, {"pmid_title_15": "Childhood hypophosphatasia due to a de novo missense mutation in the tissue-nonspecific alkaline phosphatase gene.", "pmid_15": 15671102.0, "pmid_date_15": 2005.0, "pmid_journal_15": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_16": "Marrow cell transplantation for infantile hypophosphatasia.", "pmid_16": 12674323.0, "pmid_date_16": 2003.0, "pmid_journal_16": "Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research"}, {"pmid_title_17": "Infantile hypophosphatasia: disappointing results of treatment.", "pmid_17": 10914973.0, "pmid_date_17": 2000.0, "pmid_journal_17": "Acta paediatrica (Oslo, Norway : 1992)"}]}, {"_id": "4433-OMIM:618721", "condition": {"condition_name": "EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 82; EIEE82", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 82; EIEE82"]}, "gene information": {"db_hgnc_gene_id": 4433.0}, "interventions": [{"int_description_1": "Ketogenic diet", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Pyridoxine", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Serine"}], "references": [{"pmid_title_1": "Bi-allelic GOT2 Mutations Cause a Treatable Malate-Aspartate Shuttle-Related Encephalopathy.", "pmid_1": 31422819.0, "pmid_date_1": 2019.0, "pmid_journal_1": "American journal of human genetics"}]}, {"_id": "4585-OMIM:245570", "condition": {"condition_name": "EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT MENTAL RETARDATION; FESD", "freq_per_birth": "The prevalence of the epilepsy-aphasia spectrum is unknown. Most of the conditions in the spectrum are rare; however, CECTS is one of the most common forms of epilepsy in children, accounting for 8 to 25 percent of cases. It is estimated to occur in 1 in 5,000 children younger than 16.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT MENTAL RETARDATION; FESD"]}, "gene information": {"db_hgnc_gene_id": 4585.0}, "interventions": [{"int_description_1": "Vagus nerve stimulation", "timeframe_int1": "Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Ketogenic diet"}, {"int_description_3": "Clonazepam", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Cohort study or studies", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Dextromethorphan", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Amantadine", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Memantine"}, {"int_description_7": "Ketamine"}, {"int_description_8": "Dextrorphan", "timeframe_int8": "Hours,Days or Weeks", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Topiramate", "timeframe_int9": "Hours,Days or Weeks", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Levetiracetam"}, {"int_description_11": "Oxcarbazepine"}, {"int_description_12": "Carbamazepine"}, {"int_description_13": "Lacosamide", "timeframe_int13": "Days or Weeks,Years", "age_use_int13": "Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Ethosuximide", "timeframe_int14": "Days or Weeks,Years", "age_use_int14": "Infant,Child", "contra_int14": "No", "qualscale_reclass_drug14": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}, {"int_description_15": "Sulthiame"}, {"int_description_16": "Rufinamide", "timeframe_int16": "Hours,Days or Weeks", "age_use_int16": "Neonate,Infant,Child", "contra_int16": "No", "qualscale_reclass_drug16": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug16": "Effective / Ameliorative"}, {"int_description_17": "Valproic acid", "timeframe_int17": "Hours,Days or Weeks,Years", "age_use_int17": "Infant,Child", "contra_int17": "No", "qualscale_reclass_drug17": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug17": "Effective / Ameliorative"}, {"int_description_18": "Phenytoin"}, {"int_description_19": "Barbiturates"}, {"int_description_20": "Corticotherapy"}, {"int_description_21": "Benzodiazepine"}], "references": [{"pmid_title_1": "The human NMDA receptor GluN2A<sup>N615K</sup> variant influences channel blocker potency.", "pmid_1": 31249692.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Pharmacology research & perspectives"}, {"pmid_title_2": "Mutations of N-Methyl-D-Aspartate Receptor Subunits in Epilepsy.", "pmid_2": 29124671.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Neuroscience bulletin"}, {"pmid_title_3": "A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia.", "pmid_3": 28182669.0, "pmid_date_3": 2017.0, "pmid_journal_3": "PLoS One"}, {"pmid_title_4": "<i>GRIN2A</i>-Related Speech Disorders and Epilepsy", "pmid_4": 27683935.0, "pmid_date_4": 2016.0, "pmid_journal_4": "GeneReviews\u00ae"}, {"pmid_title_5": "<i>GRIN2A</i> mutation and early-onset epileptic encephalopathy: personalized therapy with memantine.", "pmid_5": 24839611.0, "pmid_date_5": 2014.0, "pmid_journal_5": "Annals of clinical and translational neurology"}]}, {"_id": "4696-OMIM:253220", "condition": {"condition_name": "MUCOPOLYSACCHARIDOSIS, TYPE VII", "freq_per_birth": "The exact incidence of MPS VII is unknown, although it is estimated to occur in 1 in 250,000 newborns. It is one of the rarest types of mucopolysaccharidosis.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MUCOPOLYSACCHARIDOSIS, TYPE VII"]}, "gene information": {"db_hgnc_gene_id": 4696.0}, "interventions": [{"int_description_1": "Enteral nutrition"}, {"int_description_2": "Levothyroxine"}, {"int_description_3": "Vestronidase alfa", "timeframe_int3": "Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Bilateral inguinal hernioraphy"}, {"int_description_5": "Bone marrow transplantation"}, {"int_description_6": "Hematopoietic stem cell allograft transplantation"}, {"int_description_7": "Hematopoietic stem cell transplantation", "timeframe_int7": "Days or Weeks,Years", "age_use_int7": "Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Case report(s)", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Ponseti method"}, {"int_description_9": "Surgical repairs to correct the umbilical hernia and inguinal hernia"}, {"int_description_10": "Tracheotomy"}], "references": [{"pmid_title_1": "Long-Term Follow-up Posthematopoietic Stem Cell Transplantation in a Japanese Patient with Type-VII Mucopolysaccharidosis.", "pmid_1": 32079065.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Diagnostics (Basel, Switzerland)"}, {"pmid_title_2": "First Report of a Patient with MPS Type VII, Due to Novel Mutations in <i>GUSB</i>, Who Underwent Enzyme Replacement and Then Hematopoietic Stem Cell Transplantation.", "pmid_2": 31661765.0, "pmid_date_2": 2019.0, "pmid_journal_2": "International journal of molecular sciences"}, {"pmid_title_3": "Oral manifestations in patients and dogs with mucopolysaccharidosis Type VII.", "pmid_3": 30653816.0, "pmid_date_3": 2019.0, "pmid_journal_3": "American journal of medical genetics. Part A"}, {"pmid_title_4": "Mucopolysaccharidosis VII: clinical, biochemical and molecular investigation of a Brazilian family.", "pmid_4": 12859417.0, "pmid_date_4": 2003.0, "pmid_journal_4": "Clinical genetics"}, {"pmid_title_5": "Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation.", "pmid_5": 9543069.0, "pmid_date_5": 1998.0, "pmid_journal_5": "Bone marrow transplantation"}]}, {"_id": "4799-OMIM:609975", "condition": {"condition_name": "HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4", "freq_per_birth": "Congenital hyperinsulinism affects approximately 1 in 50,000 newborns. This condition is more common in certain populations, affecting up to 1 in 2,500 newborns.", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4"]}, "gene information": {"db_hgnc_gene_id": 4799.0}, "interventions": [{"int_description_1": "Leucine-restricted diet", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Protein-restricted diet", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Glucagon", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Lanreotide"}, {"int_description_5": "Octreotide", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Nifedipine", "timeframe_int6": "Hours,Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Chlorothiazide", "timeframe_int7": "Hours", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Diazoxide"}, {"int_description_9": "Starch, corn"}, {"int_description_10": "Avexitide"}, {"int_description_11": "Dasiglucagon"}, {"int_description_12": "Glucagon analogue linked to a human immunoglobulin Fc fragment"}, {"int_description_13": "Recombinant human monoclonal antibody to insulin receptor (RZ358, XOMA358) monotherapy"}, {"int_description_14": "D-glucose"}, {"int_description_15": "Feeding per gastrostomy tube"}, {"int_description_16": "Feeding per nasogastric tube"}, {"int_description_17": "Frequent feeding", "timeframe_int17": "Hours,Days or Weeks", "age_use_int17": "Neonate,Infant,Child", "contra_int17": "No", "qualscale_reclass_drug17": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug17": "Effective / Ameliorative"}, {"int_description_18": "Subtotal pancreatectomy"}], "references": [{"pmid_title_1": "Familial Hyperinsulinism", "pmid_1": 20301549.0, "pmid_date_1": 2019.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Diagnosis and management of hyperinsulinaemic hypoglycaemia.", "pmid_2": 30086874.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Best Pract Res Clin Endocrinol Metab"}, {"pmid_title_3": "Analysis on the pathogenic genes of 60 Chinese children with congenital hyperinsulinemia.", "pmid_3": 30352420.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Endocr Connect"}, {"pmid_title_4": "Diagnosis and treatment of hyperinsulinaemic hypoglycaemia and its implications for paediatric endocrinology.", "pmid_4": 28855921.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Int J Pediatr Endocrinol"}, {"pmid_title_5": "Congenital Hyperinsulinism: Diagnosis and Treatment Update.", "pmid_5": 29280746.0, "pmid_date_5": 2017.0, "pmid_journal_5": "J Clin Res Pediatr Endocrinol"}, {"pmid_title_6": "Current Status of Childhood Hyperinsulinemic Hypoglycemia in Turkey.", "pmid_6": 27181376.0, "pmid_date_6": 2016.0, "pmid_journal_6": "J Clin Res Pediatr Endocrinol"}, {"pmid_title_7": "Clinical and Genetic Characteristics, Management and Long-Term Follow-Up of Turkish Patients with Congenital Hyperinsulinism.", "pmid_7": 26758964.0, "pmid_date_7": 2016.0, "pmid_journal_7": "J Clin Res Pediatr Endocrinol"}, {"pmid_title_8": "Hyperinsulinemic Hypoglycemia of Infancy due to Novel HADH Mutation in Two Siblings.", "pmid_8": 27771675.0, "pmid_date_8": 2016.0, "pmid_journal_8": "Indian Pediatr"}, {"pmid_title_9": "A Case Series: Congenital Hyperinsulinism.", "pmid_9": 28123437.0, "pmid_date_9": 2016.0, "pmid_journal_9": "Int J Endocrinol Metab"}, {"pmid_title_10": "The Diagnosis and Management of Hyperinsulinaemic Hypoglycaemia.", "pmid_10": 26316429.0, "pmid_date_10": 2015.0, "pmid_journal_10": "J Clin Res Pediatr Endocrinol"}, {"pmid_title_11": "Genotype and phenotype correlations in Iranian patients with hyperinsulinaemic hypoglycaemia.", "pmid_11": 26268944.0, "pmid_date_11": 2015.0, "pmid_journal_11": "BMC Res Notes"}, {"pmid_title_12": "Uncovering the molecular pathogenesis of congenital hyperinsulinism by panel gene sequencing in 32 Chinese patients.", "pmid_12": 26740944.0, "pmid_date_12": 2015.0, "pmid_journal_12": "Mol Genet Genomic Med"}, {"pmid_title_13": "A Deep Intronic HADH Splicing Mutation (c.636+471G>T) in a Congenital Hyperinsulinemic Hypoglycemia Case: Long Term Clinical Course.", "pmid_13": 26316438.0, "pmid_date_13": 2015.0, "pmid_journal_13": "J Clin Res Pediatr Endocrinol"}, {"pmid_title_14": "Protein-induced hyperinsulinaemic hypoglycaemia due to a homozygous HADH mutation in three siblings of a Saudi family.", "pmid_14": 25915078.0, "pmid_date_14": 2015.0, "pmid_journal_14": "J Pediatr Endocrinol Metab"}, {"pmid_title_15": "Molecular mechanisms of protein induced hyperinsulinaemic hypoglycaemia.", "pmid_15": 25317244.0, "pmid_date_15": 2014.0, "pmid_journal_15": "World J Diabetes"}, {"pmid_title_16": "Congenital hyperinsulinism: current status and future perspectives.", "pmid_16": 25077087.0, "pmid_date_16": 2014.0, "pmid_journal_16": "Ann Pediatr Endocrinol Metab"}, {"pmid_title_17": "Novel insights into fatty acid oxidation, amino acid metabolism, and insulin secretion from studying patients with loss of function mutations in 3-hydroxyacyl-CoA dehydrogenase.", "pmid_17": 23253615.0, "pmid_date_17": 2013.0, "pmid_journal_17": "J Clin Endocrinol Metab"}, {"pmid_title_18": "Genetic analysis of Italian patients with congenital hyperinsulinism of infancy.", "pmid_18": 23652837.0, "pmid_date_18": 2013.0, "pmid_journal_18": "Horm Res Paediatr"}, {"pmid_title_19": "Next-generation sequencing reveals deep intronic cryptic ABCC8 and HADH splicing founder mutations causing hyperinsulinism by pseudoexon activation.", "pmid_19": 23273570.0, "pmid_date_19": 2013.0, "pmid_journal_19": "Am J Hum Genet"}, {"pmid_title_20": "The molecular mechanisms, diagnosis and management of congenital hyperinsulinism.", "pmid_20": 23776849.0, "pmid_date_20": 2013.0, "pmid_journal_20": "Indian J Endocrinol Metab"}, {"pmid_title_21": "Hyperinsulinaemic hypoglycaemia: genetic mechanisms, diagnosis and management.", "pmid_21": 22231386.0, "pmid_date_21": 2012.0, "pmid_journal_21": "J Inherit Metab Dis"}, {"pmid_title_22": "Hyperinsulinaemic hypoglycaemia:genetic mechanisms, diagnosis and management.", "pmid_22": 23032149.0, "pmid_date_22": 2012.0, "pmid_journal_22": "J Clin Res Pediatr Endocrinol"}, {"pmid_title_23": "Diagnosis of a patient with a kinetic variant of medium and short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency by newborn screening.", "pmid_23": 22579592.0, "pmid_date_23": 2012.0, "pmid_journal_23": "Mol Genet Metab"}, {"pmid_title_24": "3-hydroxyacyl-coenzyme a dehydrogenase deficiency: identification of a new mutation causing hyperinsulinemic hypoketotic hypoglycemia, altered organic acids and acylcarnitines concentrations.", "pmid_24": 23430856.0, "pmid_date_24": 2012.0, "pmid_journal_24": "JIMD Rep"}, {"pmid_title_25": "Leucine-sensitive hyperinsulinaemic hypoglycaemia in patients with loss of function mutations in 3-Hydroxyacyl-CoA Dehydrogenase.", "pmid_25": 22583614.0, "pmid_date_25": 2012.0, "pmid_journal_25": "Orphanet J Rare Dis"}, {"pmid_title_26": "Congenital hyperinsulinism: current trends in diagnosis and therapy.", "pmid_26": 21967988.0, "pmid_date_26": 2011.0, "pmid_journal_26": "Orphanet J Rare Dis"}, {"pmid_title_27": "Rare forms of congenital hyperinsulinism.", "pmid_27": 21186003.0, "pmid_date_27": 2011.0, "pmid_journal_27": "Semin Pediatr Surg"}, {"pmid_title_28": "Genome-wide homozygosity analysis reveals HADH mutations as a common cause of diazoxide-responsive hyperinsulinemic-hypoglycemia in consanguineous pedigrees.", "pmid_28": 21252247.0, "pmid_date_28": 2011.0, "pmid_journal_28": "J Clin Endocrinol Metab"}, {"pmid_title_29": "Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: the clinical relevance of an early diagnosis and report of four new cases.", "pmid_29": 21347589.0, "pmid_date_29": 2011.0, "pmid_journal_29": "J Inherit Metab Dis"}, {"pmid_title_30": "Congenital hyperinsulinism due to mutations in HNF4A and HADH.", "pmid_30": 20931292.0, "pmid_date_30": 2010.0, "pmid_journal_30": "Rev Endocr Metab Disord"}, {"pmid_title_31": "Congenital hyperinsulinism.", "pmid_31": 20550977.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Early Hum Dev"}, {"pmid_title_32": "Severe dietary protein sensitivity and hyperinsulinemic hypoglycemia in a patient with heterozygous mutation in HADH gene.", "pmid_32": 21175096.0, "pmid_date_32": 2010.0, "pmid_journal_32": "J Pediatr Endocrinol Metab"}, {"pmid_title_33": "Identification of a diffuse form of hyperinsulinemic hypoglycemia by 18-fluoro-L-3,4 dihydroxyphenylalanine positron emission tomography/CT in a patient carrying a novel mutation of the HADH gene.", "pmid_33": 19318379.0, "pmid_date_33": 2009.0, "pmid_journal_33": "Eur J Endocrinol"}, {"pmid_title_34": "3-Hydroxyacyl-coenzyme A dehydrogenase deficiency and hyperinsulinemic hypoglycemia: characterization of a novel mutation and severe dietary protein sensitivity.", "pmid_34": 19417036.0, "pmid_date_34": 2009.0, "pmid_journal_34": "J Clin Endocrinol Metab"}, {"pmid_title_35": "Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation.", "pmid_35": 14693719.0, "pmid_date_35": 2004.0, "pmid_journal_35": "Diabetes"}, {"pmid_title_36": "Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion.", "pmid_36": 11489939.0, "pmid_date_36": 2001.0, "pmid_journal_36": "J Clin Invest"}]}, {"_id": "4801-OMIM:609015", "condition": {"condition_name": "MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD", "freq_per_birth": "Mitochondrial trifunctional protein deficiency is a rare disorder; its incidence is unknown.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD", "LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 4801.0}, "interventions": [{"int_description_1": "Low fat diet, high  carbohydrates diet with restriction of long chain fatty acid intake and substitution with medium chain fatty acids", "timeframe_int1": "Days or Weeks", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Levocarnitine", "timeframe_int2": "Days or Weeks", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Cohort study or studies", "rev1_eff_reclass_drug2": "Still in Trials / Unproven"}, {"int_description_3": "Triheptanoin", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Starch, corn"}, {"int_description_5": "Medium-chain triglycerides", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Avoidance of fasting", "timeframe_int6": "Hours,Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Frequent feeding"}, {"int_description_8": "Limitation of exercise"}], "references": [{"pmid_title_1": "Evaluation of earlier versus later dietary management in long-chain 3-hydroxyacyl-CoA dehydrogenase or mitochondrial trifunctional protein deficiency: a systematic review.", "pmid_1": 31730477.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Orphanet journal of rare diseases"}, {"pmid_title_2": "Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD).", "pmid_2": 30740733.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Journal of inherited metabolic disease"}, {"pmid_title_3": "UX007 for the treatment of long chain-fatty acid oxidation disorders: Safety and efficacy in children and adults following 24weeks of treatment.", "pmid_3": 28189603.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Molecular genetics and metabolism"}, {"pmid_title_4": "Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency.", "pmid_4": 16876451.0, "pmid_date_4": 2006.0, "pmid_journal_4": "Molecular genetics and metabolism"}, {"pmid_title_5": "Neonatal screening for defects of the mitochondrial trifunctional protein.", "pmid_5": 15896654.0, "pmid_date_5": 2005.0, "pmid_journal_5": "Molecular genetics and metabolism"}, {"pmid_title_6": "Management of fatty acid oxidation disorders: a survey of current treatment strategies.", "pmid_6": 12487544.0, "pmid_date_6": 2002.0, "pmid_journal_6": "Journal of the American Dietetic Association"}, {"pmid_title_7": "Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.", "pmid_7": 10229030.0, "pmid_date_7": 1999.0, "pmid_journal_7": "Acta paediatrica (Oslo, Norway : 1992)"}]}, {"_id": "4801-OMIM:609016", "condition": {"condition_name": "LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY", "freq_per_birth": "The incidence of LCHAD deficiency is unknown.  One estimate, based on a Finnish population, indicates that 1 in 62,000 pregnancies is affected by this disorder.  In the United States, the incidence is probably much lower.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY", "MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD"]}, "gene information": {"db_hgnc_gene_id": 4801.0}, "interventions": [{"int_description_1": "Canola oil, coldpressed"}, {"int_description_2": "Flaxseed oil", "timeframe_int2": "Days or Weeks,Years", "age_use_int2": "Neonate,Infant", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "High protein diet", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Low fat diet, high  carbohydrates diet with restriction of long chain fatty acid intake and substitution with medium chain fatty acids", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Walnuts oil"}, {"int_description_6": "Wheat germ oil"}, {"int_description_7": "Soybean oil"}, {"int_description_8": "Doconexent"}, {"int_description_9": "Levocarnitine", "timeframe_int9": "Days or Weeks", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Triheptanoin"}, {"int_description_11": "Linseed oil"}, {"int_description_12": "Starch, corn"}, {"int_description_13": "Tricaprylin"}, {"int_description_14": "Medium-chain triglycerides", "timeframe_int14": "Days or Weeks", "age_use_int14": "Neonate,Infant,Child", "contra_int14": "No", "qualscale_reclass_drug14": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}, {"int_description_15": "D-glucose"}, {"int_description_16": "Assisted respiration"}, {"int_description_17": "Avoidance of fasting", "timeframe_int17": "Hours,Days or Weeks", "age_use_int17": "Neonate,Infant,Child", "contra_int17": "No", "qualscale_reclass_drug17": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug17": "Effective / Ameliorative"}, {"int_description_18": "Feeding per gastrostomy tube"}, {"int_description_19": "Feeding per nasogastric tube"}, {"int_description_20": "Frequent feeding"}, {"int_description_21": "Limitation of exercise"}], "references": [{"pmid_title_1": "Serial fatty acid profiles in a preterm infant with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.", "pmid_1": 31025818.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Pediatrics international : official journal of the Japan Pediatric Society"}, {"pmid_title_2": "Impaired Fat Oxidation During Exercise in Long-Chain Acyl-CoA Dehydrogenase Deficiency Patients and Effect of IV-Glucose.", "pmid_2": 30990523.0, "pmid_date_2": 2019.0, "pmid_journal_2": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_3": "Collapsing glomerulopathy in a child with LCHAD deficiency: a rare association.", "pmid_3": 30747351.0, "pmid_date_3": 2019.0, "pmid_journal_3": "CEN case reports"}, {"pmid_title_4": "Evaluation of earlier versus later dietary management in long-chain 3-hydroxyacyl-CoA dehydrogenase or mitochondrial trifunctional protein deficiency: a systematic review.", "pmid_4": 31730477.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Orphanet journal of rare diseases"}, {"pmid_title_5": "HADHA and HADHB gene associated phenotypes - Identification of rare variants in a patient cohort by Next Generation Sequencing.", "pmid_5": 30682426.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Molecular and cellular probes"}, {"pmid_title_6": "Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD).", "pmid_6": 30740733.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Journal of inherited metabolic disease"}, {"pmid_title_7": "The safety of Lipistart, a medium-chain triglyceride based formula, in the dietary treatment of long-chain fatty acid disorders: a phase I study.", "pmid_7": 29425111.0, "pmid_date_7": 2018.0, "pmid_journal_7": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_8": "Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening.", "pmid_8": 29519241.0, "pmid_date_8": 2018.0, "pmid_journal_8": "BMC pediatrics"}, {"pmid_title_9": "Fatal pitfalls in newborn screening for mitochondrial trifunctional protein (MTP)/long-chain 3-Hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency.", "pmid_9": 30029694.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Orphanet journal of rare diseases"}, {"pmid_title_10": "Energy exchangers with LCT as a precision method for diet control in LCHADD.", "pmid_10": 28791828.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Advances in clinical and experimental medicine : official organ Wroclaw Medical University"}, {"pmid_title_11": "MULTIMODAL IMAGING AND ELECTRORETINOGRAPHY IN LONG-CHAIN 3-HYDROXYACYL COENZYME A DEHYDROGENASE DEFICIENCY.", "pmid_11": 27652820.0, "pmid_date_11": 2017.0, "pmid_journal_11": "Retinal cases & brief reports"}, {"pmid_title_12": "Diagnosis, Treatment, and Clinical Outcome of Patients with Mitochondrial Trifunctional Protein/Long-Chain 3-Hydroxy Acyl-CoA Dehydrogenase Deficiency.", "pmid_12": 27117294.0, "pmid_date_12": 2017.0, "pmid_journal_12": "JIMD reports"}, {"pmid_title_13": "UX007 for the treatment of long chain-fatty acid oxidation disorders: Safety and efficacy in children and adults following 24weeks of treatment.", "pmid_13": 28189603.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Molecular genetics and metabolism"}, {"pmid_title_14": "Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial.", "pmid_14": 28871440.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Journal of inherited metabolic disease"}, {"pmid_title_15": "Neuropsychological Development in Patients with Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase (LCHAD) Deficiency.", "pmid_15": 26545880.0, "pmid_date_15": 2016.0, "pmid_journal_15": "JIMD reports"}, {"pmid_title_16": "Earlier diagnosis and strict diets improve the survival rate and clinical course of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.", "pmid_16": 26676313.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Acta paediatrica (Oslo, Norway : 1992)"}, {"pmid_title_17": "Most patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency develop pathological or subnormal retinal function.", "pmid_17": 27461099.0, "pmid_date_17": 2016.0, "pmid_journal_17": "Acta paediatrica (Oslo, Norway : 1992)"}, {"pmid_title_18": "Characterization of Chorioretinopathy Associated with Mitochondrial Trifunctional Protein Disorders: Long-Term Follow-up of 21 Cases.", "pmid_18": 27491397.0, "pmid_date_18": 2016.0, "pmid_journal_18": "Ophthalmology"}, {"pmid_title_19": "Clinical outcome, biochemical and therapeutic follow-up in 14 Austrian patients with Long-Chain 3-Hydroxy Acyl CoA Dehydrogenase Deficiency (LCHADD).", "pmid_19": 25888220.0, "pmid_date_19": 2015.0, "pmid_journal_19": "Orphanet journal of rare diseases"}, {"pmid_title_20": "Growth in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency.", "pmid_20": 23430524.0, "pmid_date_20": 2013.0, "pmid_journal_20": "JIMD reports"}, {"pmid_title_21": "Variability in the clinical management of fatty acid oxidation disorders: results of a survey of Canadian metabolic physicians.", "pmid_21": 21630065.0, "pmid_date_21": 2012.0, "pmid_journal_21": "Journal of inherited metabolic disease"}, {"pmid_title_22": "Urgent metabolic service improves survival in long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency detected by symptomatic identification and pilot newborn screening.", "pmid_22": 21103935.0, "pmid_date_22": 2011.0, "pmid_journal_22": "Journal of inherited metabolic disease"}, {"pmid_title_23": "Perioperative management of a child with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency.", "pmid_23": 20470346.0, "pmid_date_23": 2010.0, "pmid_journal_23": "Paediatric anaesthesia"}, {"pmid_title_24": "Outcome in six patients with mitochondrial trifunctional protein disorders identified by newborn screening.", "pmid_24": 20659813.0, "pmid_date_24": 2010.0, "pmid_journal_24": "Molecular genetics and metabolism"}, {"pmid_title_25": "Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop.", "pmid_25": 19399638.0, "pmid_date_25": 2009.0, "pmid_journal_25": "Journal of inherited metabolic disease"}, {"pmid_title_26": "EFFECT OF FEEDING, EXERCISE AND GENOTYPE ON PLASMA 3-HYDROXYACYLCARNITINES IN CHILDREN WITH LCHAD DEFICIENCY.", "pmid_26": 20589231.0, "pmid_date_26": 2009.0, "pmid_journal_26": "Topics in clinical nutrition"}, {"pmid_title_27": "Ocular characteristics in 10 children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a cross-sectional study with long-term follow-up.", "pmid_27": 18162058.0, "pmid_date_27": 2008.0, "pmid_journal_27": "Acta ophthalmologica"}, {"pmid_title_28": "Effects of higher dietary protein intake on energy balance and metabolic control in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency.", "pmid_28": 16996288.0, "pmid_date_28": 2007.0, "pmid_journal_28": "Molecular genetics and metabolism"}, {"pmid_title_29": "Identification of novel mutations of the HADHA and HADHB genes in patients with mitochondrial trifunctional protein deficiency.", "pmid_29": 17143551.0, "pmid_date_29": 2007.0, "pmid_journal_29": "International journal of molecular medicine"}, {"pmid_title_30": "Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency.", "pmid_30": 16876451.0, "pmid_date_30": 2006.0, "pmid_journal_30": "Molecular genetics and metabolism"}, {"pmid_title_31": "Neonatal screening for defects of the mitochondrial trifunctional protein.", "pmid_31": 15896654.0, "pmid_date_31": 2005.0, "pmid_journal_31": "Molecular genetics and metabolism"}, {"pmid_title_32": "Acute respiratory distress syndrome in long-chain 3-hydroxyacyl-CoA dehydrogenase and mitochondrial trifunctional protein deficiencies.", "pmid_32": 14605499.0, "pmid_date_32": 2003.0, "pmid_journal_32": "Journal of inherited metabolic disease"}, {"pmid_title_33": "Striking improvement of muscle strength under creatine therapy in a patient with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.", "pmid_33": 12872842.0, "pmid_date_33": 2003.0, "pmid_journal_33": "Journal of inherited metabolic disease"}, {"pmid_title_34": "What is the role of medium-chain triglycerides in the management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency?", "pmid_34": 12971423.0, "pmid_date_34": 2003.0, "pmid_journal_34": "Journal of inherited metabolic disease"}, {"pmid_title_35": "Management of fatty acid oxidation disorders: a survey of current treatment strategies.", "pmid_35": 12487544.0, "pmid_date_35": 2002.0, "pmid_journal_35": "Journal of the American Dietetic Association"}, {"pmid_title_36": "Feeding difficulties in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.", "pmid_36": 11719334.0, "pmid_date_36": 2001.0, "pmid_journal_36": "Archives of disease in childhood"}, {"pmid_title_37": "Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.", "pmid_37": 10229030.0, "pmid_date_37": 1999.0, "pmid_journal_37": "Acta paediatrica (Oslo, Norway : 1992)"}]}, {"_id": "4803-OMIM:609015", "condition": {"condition_name": "MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY", "freq_per_birth": "Mitochondrial trifunctional protein deficiency is a rare disorder; its incidence is unknown.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 4803.0}, "interventions": [{"int_description_1": "Canola oil, coldpressed"}, {"int_description_2": "High protein diet"}, {"int_description_3": "Low fat diet, high  carbohydrates diet with restriction of long chain fatty acid intake and substitution with medium chain fatty acids", "timeframe_int3": "Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Still in Trials / Unproven"}, {"int_description_4": "Walnuts oil", "timeframe_int4": "Hours", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Doconexent"}, {"int_description_6": "Levocarnitine"}, {"int_description_7": "Triheptanoin"}, {"int_description_8": "Starch, corn"}, {"int_description_9": "Medium-chain triglycerides"}, {"int_description_10": "D-glucose"}, {"int_description_11": "Assisted respiration"}, {"int_description_12": "Avoidance of fasting", "timeframe_int12": "Hours", "age_use_int12": "Neonate,Infant,Child", "qualscale_reclass_drug12": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Feeding per gastrostomy tube"}, {"int_description_14": "Feeding per nasogastric tube"}, {"int_description_15": "Frequent feeding"}, {"int_description_16": "Limitation of exercise"}], "references": [{"pmid_title_1": "Evaluation of earlier versus later dietary management in long-chain 3-hydroxyacyl-CoA dehydrogenase or mitochondrial trifunctional protein deficiency: a systematic review.", "pmid_1": 31730477.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Orphanet J Rare Dis"}, {"pmid_title_2": "HADHA and HADHB gene associated phenotypes - Identification of rare variants in a patient cohort by Next Generation Sequencing.", "pmid_2": 30682426.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Mol Cell Probes"}, {"pmid_title_3": "Peripheral Neuropathy, Episodic Rhabdomyolysis, and Hypoparathyroidism in a Patient with Mitochondrial Trifunctional Protein Deficiency.", "pmid_3": 28685493.0, "pmid_date_3": 2018.0, "pmid_journal_3": "JIMD Rep"}, {"pmid_title_4": "Fatal pitfalls in newborn screening for mitochondrial trifunctional protein (MTP)/long-chain 3-Hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency.", "pmid_4": 30029694.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Orphanet J Rare Dis"}, {"pmid_title_5": "Mitochondrial trifunctional protein deficiency due to <i>HADHB</i> gene mutation in a Chinese family.", "pmid_5": 28649548.0, "pmid_date_5": 2015.0, "pmid_journal_5": "Mol Genet Metab Rep"}, {"pmid_title_6": "Use of propofol for short duration procedures in children with long chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiencies.", "pmid_6": 24780638.0, "pmid_date_6": 2014.0, "pmid_journal_6": "Mol Genet Metab"}, {"pmid_title_7": "Child neurology: Recurrent rhabdomyolysis due to a fatty acid oxidation disorder.", "pmid_7": 24379101.0, "pmid_date_7": 2014.0, "pmid_journal_7": "Neurology"}, {"pmid_title_8": "Necrotizing enterocolitis and respiratory distress syndrome as first clinical presentation of mitochondrial trifunctional protein deficiency.", "pmid_8": 23430487.0, "pmid_date_8": 2013.0, "pmid_journal_8": "JIMD Rep"}, {"pmid_title_9": "Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening.", "pmid_9": 20449660.0, "pmid_date_9": 2010.0, "pmid_journal_9": "J Inherit Metab Dis"}, {"pmid_title_10": "Two novel HADHB gene mutations in a Korean patient with mitochondrial trifunctional protein deficiency.", "pmid_10": 19880769.0, "pmid_date_10": 2009.0, "pmid_journal_10": "Ann Clin Lab Sci"}, {"pmid_title_11": "Effects of higher dietary protein intake on energy balance and metabolic control in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency.", "pmid_11": 16996288.0, "pmid_date_11": 2007.0, "pmid_journal_11": "Mol Genet Metab"}, {"pmid_title_12": "Identification of novel mutations of the HADHA and HADHB genes in patients with mitochondrial trifunctional protein deficiency.", "pmid_12": 17143551.0, "pmid_date_12": 2007.0, "pmid_journal_12": "Int J Mol Med"}, {"pmid_title_13": "Choice of oils for essential fat supplements can enhance production of abnormal metabolites in fat oxidation disorders.", "pmid_13": 17825594.0, "pmid_date_13": 2007.0, "pmid_journal_13": "Mol Genet Metab"}, {"pmid_title_14": "Partial hypoparathyroidism associated with mitochondrial trifunctional protein deficiency.", "pmid_14": 16523289.0, "pmid_date_14": 2006.0, "pmid_journal_14": "Eur J Pediatr"}, {"pmid_title_15": "Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency.", "pmid_15": 16876451.0, "pmid_date_15": 2006.0, "pmid_journal_15": "Mol Genet Metab"}, {"pmid_title_16": "Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency.", "pmid_16": 16040264.0, "pmid_date_16": 2005.0, "pmid_journal_16": "Mol Genet Metab"}, {"pmid_title_17": "General mitochondrial trifunctional protein (TFP) deficiency as a result of either alpha- or beta-subunit mutations exhibits similar phenotypes because mutations in either subunit alter TFP complex expression and subunit turnover.", "pmid_17": 14630990.0, "pmid_date_17": 2004.0, "pmid_journal_17": "Pediatr Res"}, {"pmid_title_18": "Peripheral neuropathy, episodic myoglobinuria, and respiratory failure in deficiency of the mitochondrial trifunctional protein.", "pmid_18": 14694500.0, "pmid_date_18": 2004.0, "pmid_journal_18": "Muscle Nerve"}, {"pmid_title_19": "Molecular and phenotypic heterogeneity in mitochondrial trifunctional protein deficiency due to beta-subunit mutations.", "pmid_19": 12754706.0, "pmid_date_19": 2003.0, "pmid_journal_19": "Hum Mutat"}, {"pmid_title_20": "Management of fatty acid oxidation disorders: a survey of current treatment strategies.", "pmid_20": 12487544.0, "pmid_date_20": 2002.0, "pmid_journal_20": "J Am Diet Assoc"}]}, {"_id": "4823-OMIM:604131", "condition": {"condition_name": "ALPHA-THALASSEMIA", "freq_per_birth": "Alpha thalassemia is a fairly common blood disorder worldwide. Thousands of infants with Hb Bart syndrome and HbH disease are born each year, particularly in Southeast Asia. Alpha thalassemia also occurs frequently in people from Mediterranean countries, Africa, the Middle East, India, and Central Asia.", "pattern_of_inheritance": "Pattern unknown", "alternate_names": ["ALPHA-THALASSEMIA", "HEMOGLOBIN H DISEASE; HBH"]}, "gene information": {"db_hgnc_gene_id": 4823.0}, "interventions": [{"int_description_1": "Folic acid supplement"}, {"int_description_2": "Nutritional supplementation"}, {"int_description_3": "Iron chelation therapy"}, {"int_description_4": "Blood transfusions", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Cholecystectomy"}, {"int_description_6": "Splenectomy"}], "references": [{"pmid_title_1": "Molecular basis of \u03b1-thalassemia.", "pmid_1": 29032940.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Blood cells, molecules & diseases"}, {"pmid_title_2": "Hemoglobin H disease: not necessarily a benign disorder.", "pmid_2": 12393486.0, "pmid_date_2": 2003.0, "pmid_journal_2": "Blood"}]}, {"_id": "4823-OMIM:613978", "condition": {"condition_name": "HEMOGLOBIN H DISEASE; HBH", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["HEMOGLOBIN H DISEASE; HBH", "ALPHA-THALASSEMIA"]}, "gene information": {"db_hgnc_gene_id": 4823.0}, "interventions": [{"int_description_1": "Folic acid supplement"}, {"int_description_2": "Nutritional supplementation"}, {"int_description_3": "Iron chelation therapy", "timeframe_int3": "Days or Weeks,Years", "age_use_int3": "Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Blood transfusions", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Cholecystectomy"}, {"int_description_6": "Splenectomy"}], "references": [{"pmid_title_1": "Molecular basis of \u03b1-thalassemia.", "pmid_1": 29032940.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Blood cells, molecules & diseases"}, {"pmid_title_2": "Hemoglobin H disease: not necessarily a benign disorder.", "pmid_2": 12393486.0, "pmid_date_2": 2003.0, "pmid_journal_2": "Blood"}]}, {"_id": "4824-OMIM:604131", "condition": {"condition_name": "ALPHA-THALASSEMIA", "freq_per_birth": "Alpha thalassemia is a fairly common blood disorder worldwide. Thousands of infants with Hb Bart syndrome and HbH disease are born each year, particularly in Southeast Asia. Alpha thalassemia also occurs frequently in people from Mediterranean countries, Africa, the Middle East, India, and Central Asia.", "pattern_of_inheritance": "Pattern unknown", "alternate_names": ["ALPHA-THALASSEMIA"]}, "gene information": {"db_hgnc_gene_id": 4824.0}, "interventions": [{"int_description_1": "Dietary supplement with folate and multivitamins without iron"}, {"int_description_2": "Chronic anticoagulation therapy"}, {"int_description_3": "Empirical antibiotics"}, {"int_description_4": "Iron chelation therapy"}, {"int_description_5": "NSAIDs"}, {"int_description_6": "Phototherapy"}, {"int_description_7": "Abortion"}, {"int_description_8": "Blood cell transfusion"}, {"int_description_9": "Intermittent transfusions", "timeframe_int9": "Hours,Days or Weeks,Years", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Intravenous fluid therapy"}, {"int_description_11": "Bone marrow transplantation"}, {"int_description_12": "Splenectomy"}, {"int_description_13": "Stem cell transplantation"}], "references": [{"pmid_title_1": "Perinatal Management of Bart's Hemoglobinopathy: Paradoxical Effects of Intrauterine, Transplacental, and Partial Exchange Transfusions.", "pmid_1": 31993246.0, "pmid_date_1": 2020.0, "pmid_journal_1": "AJP Rep"}, {"pmid_title_2": "Molecular basis of \u03b1-thalassemia.", "pmid_2": 29032940.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Blood Cells Mol Dis"}, {"pmid_title_3": "Clinical Classification, Screening and Diagnosis for Thalassemia.", "pmid_3": 29458726.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Hematol Oncol Clin North Am"}, {"pmid_title_4": "Hb Adana (HBA2 or HBA1: c.179G\u00a0>\u00a0A) and alpha thalassemia: Genotype-phenotype correlation.", "pmid_4": 29749692.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Pediatr Blood Cancer"}, {"pmid_title_5": "Fetal Anemia and Hydrops Fetalis Associated with Homozygous Hb Constant Spring (HBA2: c.427T\u2009>\u2009C).", "pmid_5": 26757782.0, "pmid_date_5": 2016.0, "pmid_journal_5": "Hemoglobin"}, {"pmid_title_6": "Clinical manifestations of \u03b1-thalassemia.", "pmid_6": 23543077.0, "pmid_date_6": 2013.0, "pmid_journal_6": "Cold Spring Harb Perspect Med"}, {"pmid_title_7": "Complexity of alpha thalassemia: growing health problem with new approaches to screening, diagnosis, and therapy.", "pmid_7": 20712791.0, "pmid_date_7": 2010.0, "pmid_journal_7": "Ann N Y Acad Sci"}, {"pmid_title_8": "Hb H disease: clinical course and disease modifiers.", "pmid_8": 20008179.0, "pmid_date_8": 2009.0, "pmid_journal_8": "Hematology Am Soc Hematol Educ Program"}]}, {"_id": "4832-OMIM:613977", "condition": {"condition_name": "CYANOSIS, TRANSIENT NEONATAL; TNCY", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["CYANOSIS, TRANSIENT NEONATAL; TNCY", "FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HBFQTL1"]}, "gene information": {"db_hgnc_gene_id": 4832.0}, "interventions": [{"int_description_1": "Red cell blood transfusion"}], "references": [{"pmid_title_1": "Hb F-Wentzville [<sup>G</sup>\u03b324(B6)Gly\u2192Glu; <i>HBG2</i>: c.74G>A, p.Gly25Glu]: An Unstable <sup>G</sup>\u03b3-Globin Variant Associated with Neonatal Hemolytic Anemia.", "pmid_1": 31985299.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Hemoglobin"}, {"pmid_title_2": "A hemoglobin variant associated with neonatal cyanosis and anemia.", "pmid_2": 21561349.0, "pmid_date_2": 2011.0, "pmid_journal_2": "The New England journal of medicine"}]}, {"_id": "4839-OMIM:309541", "condition": {"condition_name": "METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE", "pattern_of_inheritance": "X-linked recessive", "alternate_names": ["METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE"]}, "gene information": {"db_hgnc_gene_id": 4839.0}, "interventions": [{"int_description_1": "Glycine betaine"}, {"int_description_2": "Carglumic acid"}], "references": [{"pmid_title_1": "Disorders of Intracellular Cobalamin Metabolism", "pmid_1": 20301503.0, "pmid_date_1": 2018.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}]}, {"_id": "4877-OMIM:182230", "condition": {"condition_name": "SEPTOOPTIC DYSPLASIA", "freq_per_birth": "Septo-optic dysplasia has a reported incidence of 1 in 10,000 newborns.", "pattern_of_inheritance": "Autosomal dominant==Autosomal recessive", "alternate_names": ["SEPTOOPTIC DYSPLASIA"]}, "gene information": {"db_hgnc_gene_id": 4877.0}, "interventions": [{"int_description_1": "Cortisone acetate", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "Yes", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Buserelin"}, {"int_description_3": "Levothyroxine", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "Yes", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Somatotropin", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "Yes", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Hydrocortisone", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "Yes", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Sex steroid replacement therapy", "timeframe_int6": "Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "Yes", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Bilateral orchidopexies", "timeframe_int7": "Days or Weeks,Years", "age_use_int7": "Infant,Child", "contra_int7": "Yes", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "HESX1 mutations in patients with congenital hypopituitarism: variable phenotypes with the same genotype.", "pmid_1": 27000987.0, "pmid_date_1": 2016.0, "pmid_journal_1": "Clin Endocrinol (Oxf)"}, {"pmid_title_2": "<i>PROP1</i>-Related Combined Pituitary Hormone Deficiency", "pmid_2": 20301521.0, "pmid_date_2": 2014.0, "pmid_journal_2": "GeneReviews\u00ae"}, {"pmid_title_3": "Heterozygous mutation of HESX1 causing hypopituitarism and multiple anatomical malformations without features of septo-optic dysplasia.", "pmid_3": 18852528.0, "pmid_date_3": 2008.0, "pmid_journal_3": "Journal of endocrinological investigation"}, {"pmid_title_4": "A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction.", "pmid_4": 14561704.0, "pmid_date_4": 2003.0, "pmid_journal_4": "The Journal of clinical investigation"}, {"pmid_title_5": "Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia.", "pmid_5": 11136712.0, "pmid_date_5": 2001.0, "pmid_journal_5": "Human molecular genetics"}]}, {"_id": "4883-OMIM:235400", "condition": {"condition_name": "HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1", "freq_per_birth": "The incidence of atypical hemolytic-uremic syndrome is estimated to be 1 in 500,000 people per year in the United States. The atypical form is probably about 10 times less common than the typical form.", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["COMPLEMENT FACTOR H DEFICIENCY", "HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1", "HELLP syndrome", "MACULAR DEGENERATION, AGE-RELATED, 4", "BASAL LAMINAR DRUSEN"]}, "gene information": {"db_hgnc_gene_id": 4883.0}, "interventions": [{"int_description_1": "Prednisone"}, {"int_description_2": "Dexamethasone"}, {"int_description_3": "Labetalol"}, {"int_description_4": "Doxazosin"}, {"int_description_5": "Amlodipine", "timeframe_int5": "Hours", "age_use_int5": "Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Eculizumab"}, {"int_description_7": "Basiliximab"}, {"int_description_8": "Etanercept"}, {"int_description_9": "Cyclosporine"}, {"int_description_10": "Metronidazole"}, {"int_description_11": "Sirolimus"}, {"int_description_12": "Piperacillin", "timeframe_int12": "Hours,Days or Weeks", "age_use_int12": "Infant,Child", "qualscale_reclass_drug12": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Captopril"}, {"int_description_14": "Tazobactam"}, {"int_description_15": "Ciprofloxacin"}, {"int_description_16": "Ceftriaxone"}, {"int_description_17": "Nifedipine"}, {"int_description_18": "Vincristine"}, {"int_description_19": "Fluconazole"}, {"int_description_20": "Tacrolimus"}, {"int_description_21": "Azathioprine"}, {"int_description_22": "Mycophenolate mofetil"}, {"int_description_23": "Lansoprazole"}, {"int_description_24": "Methylprednisolone"}, {"int_description_25": "Corticosteroids"}, {"int_description_26": "Iron"}, {"int_description_27": "Calcium carbonate"}, {"int_description_28": "Alginic acid"}, {"int_description_29": "Meningococcal vaccine"}, {"int_description_30": "Serine protease inhibitor"}, {"int_description_31": "Sodium bicarbonate"}, {"int_description_32": "Hemodialysis"}, {"int_description_33": "Peritoneal dialysis"}, {"int_description_34": "Plasma exchange"}, {"int_description_35": "Transfusion with packed red cells"}, {"int_description_36": "Bilateral nephrectomy"}, {"int_description_37": "Kidney transplantation", "timeframe_int37": "Hours,Days or Weeks", "age_use_int37": "Infant,Child", "contra_int37": "No", "qualscale_reclass_drug37": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug37": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "A complement factor B mutation in a large kindred with atypical hemolytic uremic syndrome.", "pmid_1": 24906628.0, "pmid_date_1": 2014.0, "pmid_journal_1": "J Clin Immunol"}, {"pmid_title_2": "Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft.", "pmid_2": 22591029.0, "pmid_date_2": 2012.0, "pmid_journal_2": "Transpl Int"}, {"pmid_title_3": "Complement deficiency states and associated infections.", "pmid_3": 21624663.0, "pmid_date_3": 2011.0, "pmid_journal_3": "Mol Immunol"}, {"pmid_title_4": "Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy.", "pmid_4": 21643943.0, "pmid_date_4": 2011.0, "pmid_journal_4": "Pediatr Nephrol"}, {"pmid_title_5": "Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome.", "pmid_5": 22287852.0, "pmid_date_5": 2011.0, "pmid_journal_5": "Clin Pharmacol"}, {"pmid_title_6": "An adult with acute poststreptococcal glomerulonephritis complicated by hemolytic uremic syndrome and nephrotic syndrome.", "pmid_6": 16183409.0, "pmid_date_6": 2005.0, "pmid_journal_6": "Am J Kidney Dis"}, {"pmid_title_7": "Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency.", "pmid_7": 10344366.0, "pmid_date_7": 1999.0, "pmid_journal_7": "Nephrol Dial Transplant"}, {"pmid_title_8": "Human complement factor H deficiency associated with hemolytic uremic syndrome.", "pmid_8": 9848786.0, "pmid_date_8": 1998.0, "pmid_journal_8": "J Am Soc Nephrol"}]}, {"_id": "4888-OMIM:235400", "condition": {"condition_name": "HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1", "freq_per_birth": "The incidence of atypical hemolytic-uremic syndrome is estimated to be 1 in 500,000 people per year in the United States. The atypical form is probably about 10 times less common than the typical form.", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1", "C3 glomerulopathy"]}, "gene information": {"db_hgnc_gene_id": 4888.0}, "interventions": [{"int_description_1": "Prednisone", "timeframe_int1": "Days or Weeks", "age_use_int1": "Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Dexamethasone"}, {"int_description_3": "Labetalol"}, {"int_description_4": "Doxazosin"}, {"int_description_5": "Amlodipine", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Eculizumab"}, {"int_description_7": "Basiliximab"}, {"int_description_8": "Etanercept"}, {"int_description_9": "Cyclosporine"}, {"int_description_10": "Metronidazole"}, {"int_description_11": "Sirolimus"}, {"int_description_12": "Piperacillin", "timeframe_int12": "Hours,Days or Weeks", "age_use_int12": "Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Captopril"}, {"int_description_14": "Tazobactam"}, {"int_description_15": "Ciprofloxacin"}, {"int_description_16": "Ceftriaxone"}, {"int_description_17": "Nifedipine"}, {"int_description_18": "Vincristine"}, {"int_description_19": "Fluconazole"}, {"int_description_20": "Tacrolimus"}, {"int_description_21": "Azathioprine"}, {"int_description_22": "Mycophenolate mofetil"}, {"int_description_23": "Lansoprazole"}, {"int_description_24": "Methylprednisolone"}, {"int_description_25": "Corticosteroids"}, {"int_description_26": "Iron"}, {"int_description_27": "Calcium carbonate"}, {"int_description_28": "Alginic acid"}, {"int_description_29": "Meningococcal vaccine"}, {"int_description_30": "Serine protease inhibitor"}, {"int_description_31": "Sodium bicarbonate"}, {"int_description_32": "Hemodialysis"}, {"int_description_33": "Peritoneal dialysis"}, {"int_description_34": "Plasma exchange"}, {"int_description_35": "Transfusion with packed red cells"}, {"int_description_36": "Bilateral nephrectomy"}, {"int_description_37": "Kidney transplantation", "timeframe_int37": "Hours,Days or Weeks", "age_use_int37": "Infant,Child", "contra_int37": "No", "qualscale_reclass_drug37": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug37": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "A complement factor B mutation in a large kindred with atypical hemolytic uremic syndrome.", "pmid_1": 24906628.0, "pmid_date_1": 2014.0, "pmid_journal_1": "J Clin Immunol"}, {"pmid_title_2": "Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft.", "pmid_2": 22591029.0, "pmid_date_2": 2012.0, "pmid_journal_2": "Transpl Int"}, {"pmid_title_3": "Complement deficiency states and associated infections.", "pmid_3": 21624663.0, "pmid_date_3": 2011.0, "pmid_journal_3": "Mol Immunol"}, {"pmid_title_4": "Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy.", "pmid_4": 21643943.0, "pmid_date_4": 2011.0, "pmid_journal_4": "Pediatr Nephrol"}, {"pmid_title_5": "Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome.", "pmid_5": 22287852.0, "pmid_date_5": 2011.0, "pmid_journal_5": "Clin Pharmacol"}, {"pmid_title_6": "An adult with acute poststreptococcal glomerulonephritis complicated by hemolytic uremic syndrome and nephrotic syndrome.", "pmid_6": 16183409.0, "pmid_date_6": 2005.0, "pmid_journal_6": "Am J Kidney Dis"}, {"pmid_title_7": "Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency.", "pmid_7": 10344366.0, "pmid_date_7": 1999.0, "pmid_journal_7": "Nephrol Dial Transplant"}, {"pmid_title_8": "Human complement factor H deficiency associated with hemolytic uremic syndrome.", "pmid_8": 9848786.0, "pmid_date_8": 1998.0, "pmid_journal_8": "J Am Soc Nephrol"}]}, {"_id": "4922-OMIM:235700", "condition": {"condition_name": "HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 4922.0}, "interventions": [{"int_description_1": "Blood exchange transfusion", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Red cell blood transfusion", "timeframe_int2": "Hours,Days or Weeks,Years", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Allogeneic  bone marrow transplant", "timeframe_int3": "Years", "age_use_int3": "Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Laparoscopic splenectomy"}], "references": [{"pmid_title_1": "Allogeneic bone marrow transplantation for treatment of severe hemolytic anemia attributable to hexokinase deficiency.", "pmid_1": 27297791.0, "pmid_date_1": 2016.0, "pmid_journal_1": "Blood"}, {"pmid_title_2": "Molecular characterization of six new cases of red blood cell hexokinase deficiency yields four novel mutations in HK1.", "pmid_2": 27282571.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Blood cells, molecules & diseases"}]}, {"_id": "4976-OMIM:253270", "condition": {"condition_name": "HOLOCARBOXYLASE SYNTHETASE DEFICIENCY", "freq_per_birth": "The exact incidence of this condition is unknown, but it is estimated to affect 1 in 87,000 people.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["HOLOCARBOXYLASE SYNTHETASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 4976.0}, "interventions": [{"int_description_1": "Levocarnitine", "timeframe_int1": "Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Biotin"}, {"int_description_3": "Sodium bicarbonate", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Case report of holocarboxylase synthetase deficiency (late-onset) in 2 Chinese patients.", "pmid_1": 32358368.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Medicine"}, {"pmid_title_2": "Paracentric Inversion of Chromosome 21 Leading to Disruption of the HLCS Gene in a Family with Holocarboxylase Synthetase Deficiency.", "pmid_2": 27518780.0, "pmid_date_2": 2017.0, "pmid_journal_2": "JIMD reports"}, {"pmid_title_3": "Holocarboxylase synthetase deficiency pre and post newborn screening.", "pmid_3": 27114915.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Molecular genetics and metabolism reports"}, {"pmid_title_4": "Severe neonatal holocarboxylase synthetase deficiency in west african siblings.", "pmid_4": 25690727.0, "pmid_date_4": 2015.0, "pmid_journal_4": "JIMD reports"}, {"pmid_title_5": "Clinical Presentation and Positive Outcome of Two Siblings with Holocarboxylase Synthetase Deficiency Caused by a Homozygous L216R Mutation.", "pmid_5": 24085707.0, "pmid_date_5": 2014.0, "pmid_journal_5": "JIMD reports"}, {"pmid_title_6": "The first reported HLCS gene mutation causing holocarboxylase synthetase deficiency in a Vietnamese patient.", "pmid_6": 21874615.0, "pmid_date_6": 2012.0, "pmid_journal_6": "World journal of pediatrics : WJP"}, {"pmid_title_7": "Holocarboxylase synthetase deficiency: novel clinical and molecular findings.", "pmid_7": 20095979.0, "pmid_date_7": 2010.0, "pmid_journal_7": "Clinical genetics"}]}, {"_id": "4979-OMIM:176450", "condition": {"condition_name": "CURRARINO SYNDROME", "pattern_of_inheritance": "Autosomal dominant, Not applicable", "alternate_names": ["CURRARINO SYNDROME"]}, "gene information": {"db_hgnc_gene_id": 4979.0}, "interventions": [{"int_description_1": "Anal dilatation (Hegar dilator)"}, {"int_description_2": "Enema"}, {"int_description_3": "Fibrin glue muscle graft"}, {"int_description_4": "Gore-Tex Tissue Patch"}, {"int_description_5": "Peristeen anal irrigation"}, {"int_description_6": "Ureteral stent"}, {"int_description_7": "High fibre diet"}, {"int_description_8": "Glycerin"}, {"int_description_9": "Somatostatin"}, {"int_description_10": "Oxybutynin"}, {"int_description_11": "Metronidazole"}, {"int_description_12": "Piperacillin"}, {"int_description_13": "Magnesium hydroxide"}, {"int_description_14": "Tazobactam"}, {"int_description_15": "Cefotaxime"}, {"int_description_16": "Meropenem"}, {"int_description_17": "Benzylpenicillin"}, {"int_description_18": "Amoxicillin"}, {"int_description_19": "Ceftriaxone"}, {"int_description_20": "Etoposide"}, {"int_description_21": "Bleomycin"}, {"int_description_22": "Vancomycin"}, {"int_description_23": "Ceftazidime"}, {"int_description_24": "Meticillin"}, {"int_description_25": "Antibiotics"}, {"int_description_26": "Cisplatin"}, {"int_description_27": "Teicoplanin"}, {"int_description_28": "Interferon"}, {"int_description_29": "Laxatives"}, {"int_description_30": "Clean intermittent catheterization"}, {"int_description_31": "Drainage", "timeframe_int31": "Days or Weeks", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Case report(s)", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Intermittent lumbar CSF-tap"}, {"int_description_33": "Radiotherapy"}, {"int_description_34": "Anal fistulectomy"}, {"int_description_35": "Anorectoplasty by a transanal approach"}, {"int_description_36": "Anterior sagittal anorectoplasty"}, {"int_description_37": "Appendicostomy"}, {"int_description_38": "Coloanal anastomosis"}, {"int_description_39": "Colostomy"}, {"int_description_40": "Duhamel operation"}, {"int_description_41": "Duraplasty"}, {"int_description_42": "Fistula excision"}, {"int_description_43": "Glenn-Anderson procedure"}, {"int_description_44": "Ileostomy"}, {"int_description_45": "Laminectomy"}, {"int_description_46": "Laparoscopic-assisted anorectal pull-through"}, {"int_description_47": "Meningocele cavity ligation"}, {"int_description_48": "Nephrectomy"}, {"int_description_49": "Neurosurgery"}, {"int_description_50": "Perineal hypospadias repair"}, {"int_description_51": "Posterior sacrospinous ligaments resection"}, {"int_description_52": "Posterior sagittal anorectoplasty"}, {"int_description_53": "Posterior sagittal transsacral and perineal [PSSP] approach"}, {"int_description_54": "Presacral mass excision"}, {"int_description_55": "Rectosigmoid junction resection", "timeframe_int55": "Days or Weeks", "age_use_int55": "Neonate,Infant,Child", "contra_int55": "No", "qualscale_reclass_drug55": "Case report(s)", "rev1_eff_reclass_drug55": "Effective / Ameliorative"}, {"int_description_56": "Rectovaginal fistula repair"}, {"int_description_57": "Repair of the bicornuate uterus"}, {"int_description_58": "Sigmoidectomy"}, {"int_description_59": "Sigmoidostomy"}, {"int_description_60": "Stenosed bowel segment excision"}, {"int_description_61": "Tethered cord detethering"}, {"int_description_62": "Tumor resection", "timeframe_int62": "Days or Weeks", "age_use_int62": "Infant,Child", "contra_int62": "No", "qualscale_reclass_drug62": "Case report(s)", "rev1_eff_reclass_drug62": "Effective / Ameliorative"}, {"int_description_63": "Ureteral reimplantation"}, {"int_description_64": "Ureterostomy"}, {"int_description_65": "Vaginostomy"}, {"int_description_66": "Vesicostomy"}], "references": [{"pmid_title_1": "Laparoscopic-Assisted Anorectal Pull-Through for Currarino Syndrome.", "pmid_1": 32302513.0, "pmid_date_1": 2020.0, "pmid_journal_1": "J Laparoendosc Adv Surg Tech A"}, {"pmid_title_2": "Severe bacterial meningitis due to an enterothecal fistula in a 6-year-old child with Currarino syndrome: evaluation of surgical strategy with review of the literature.", "pmid_2": 30968178.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Childs Nerv Syst"}, {"pmid_title_3": "Currarino Triad: Importance of Preoperative Magnetic Resonance Imaging.", "pmid_3": 31763131.0, "pmid_date_3": 2019.0, "pmid_journal_3": "European J Pediatr Surg Rep"}, {"pmid_title_4": "Malignant neuroendocrine tumour in an adult female diagnosed with Currarino syndrome.", "pmid_4": 31773935.0, "pmid_date_4": 2019.0, "pmid_journal_4": "S Afr J Surg"}, {"pmid_title_5": "Neurosurgical management of Currarino syndrome: A case series and review of literature.", "pmid_5": 31528408.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Surg Neurol Int"}, {"pmid_title_6": "Carcinoid transformation of presacral dermoid cyst in patient with currarino syndrome: a case report.", "pmid_6": 28612626.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Br J Neurosurg"}, {"pmid_title_7": "Adenocarcinoma and neuroendocrine tumor arising within presacral teratoma associated with Currarino syndrome: A case report.", "pmid_7": 31741605.0, "pmid_date_7": 2019.0, "pmid_journal_7": "Indian J Radiol Imaging"}, {"pmid_title_8": "Multiple neurosurgical treatments for different members of the same family with Currarino syndrome.", "pmid_8": 29731315.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Neurochirurgie"}, {"pmid_title_9": "Surgical management for a huge presacral teratoma and a meningocele in an adult with Currarino triad: a case report.", "pmid_9": 29352751.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Surg Case Rep"}, {"pmid_title_10": "Currarino syndrome: repair of the dysraphic anomalies and resection of the presacral mass in a combined neurosurgical and general surgical approach.", "pmid_10": 30095346.0, "pmid_date_10": 2018.0, "pmid_journal_10": "J Neurosurg Pediatr"}, {"pmid_title_11": "The Currarino Triad.", "pmid_11": 30449925.0, "pmid_date_11": 2018.0, "pmid_journal_11": "Med J Armed Forces India"}, {"pmid_title_12": "The Currarino triad: What pediatric surgeons need to know.", "pmid_12": 28065719.0, "pmid_date_12": 2017.0, "pmid_journal_12": "J Pediatr Surg"}, {"pmid_title_13": "Multidisciplinary surgical treatment of presacral meningocele and teratoma in an adult with Currarino triad.", "pmid_13": 28584680.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Surg Neurol Int"}, {"pmid_title_14": "Combined abdomino-sacral laparoscopically assisted approach for retrorectal mass resection in a patient with Currarino's Syndrome - video vignette.", "pmid_14": 29211327.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Colorectal Dis"}, {"pmid_title_15": "Currarino syndrome: Rare clinical variants.", "pmid_15": 27695213.0, "pmid_date_15": 2016.0, "pmid_journal_15": "J Indian Assoc Pediatr Surg"}, {"pmid_title_16": "Currarino triad with Mullerian duct anomaly in mother and daughter without MNX1 gene mutation.", "pmid_16": 26793693.0, "pmid_date_16": 2016.0, "pmid_journal_16": "Ann Surg Treat Res"}, {"pmid_title_17": "A Very Rare Cause of Anal Atresia: Currarino Syndrome.", "pmid_17": 27081429.0, "pmid_date_17": 2016.0, "pmid_journal_17": "J Clin Med Res"}, {"pmid_title_18": "Currarino Syndrome and the Effect of a Large Anterior Sacral Meningocele on Distal Colostogram in an Anorectal Malformation.", "pmid_18": 27761181.0, "pmid_date_18": 2016.0, "pmid_journal_18": "J Radiol Case Rep"}, {"pmid_title_19": "Ectopic Vas Deferens Inserting Into Distal Retroiliac Ureter in the Currarino Syndrome.", "pmid_19": 27233932.0, "pmid_date_19": 2016.0, "pmid_journal_19": "Urology"}, {"pmid_title_20": "A late-recognized Currarino syndrome in an adult revealed by an anal fistula.", "pmid_20": 24704728.0, "pmid_date_20": 2014.0, "pmid_journal_20": "Int J Surg Case Rep"}, {"pmid_title_21": "Retained medullary cord confirmed by intraoperative neurophysiological mapping.", "pmid_21": 24562472.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Childs Nerv Syst"}, {"pmid_title_22": "Currarino syndrome: report of five consecutive patients.", "pmid_22": 24013264.0, "pmid_date_22": 2014.0, "pmid_journal_22": "Childs Nerv Syst"}, {"pmid_title_23": "Urological outcome in patients with Currarino syndrome.", "pmid_23": 25475810.0, "pmid_date_23": 2014.0, "pmid_journal_23": "J Pediatr Surg"}, {"pmid_title_24": "Currarino syndrome in an adult presenting with a presacral abscess: a case report.", "pmid_24": 24571710.0, "pmid_date_24": 2014.0, "pmid_journal_24": "J Med Case Rep"}, {"pmid_title_25": "Unusual presentation of sacrococcygeal teratomas and associated malformations in children: clinical experience and review of the literature.", "pmid_25": 23160138.0, "pmid_date_25": 2013.0, "pmid_journal_25": "Ann Ital Chir"}, {"pmid_title_26": "Anterior sacral meningocele in a patient with currarino syndrome as a cause of ileus.", "pmid_26": 23590527.0, "pmid_date_26": 2013.0, "pmid_journal_26": "Br J Neurosurg"}, {"pmid_title_27": "This bicycle gives me a headache, a congenital anomaly.", "pmid_27": 24124700.0, "pmid_date_27": 2013.0, "pmid_journal_27": "BMC Res Notes"}, {"pmid_title_28": "Familial Currarino syndrome associated with Hirschsprung disease: two cases of a mother and daughter.", "pmid_28": 23331821.0, "pmid_date_28": 2013.0, "pmid_journal_28": "J Pediatr Surg"}, {"pmid_title_29": "Epidermoid cyst inside anterior sacral meningocele in an adult patient of Currarino syndrome manifesting with meningitis.", "pmid_29": 23015348.0, "pmid_date_29": 2012.0, "pmid_journal_29": "Turk Neurosurg"}, {"pmid_title_30": "A case of Currarino's syndrome presenting as neonatal bowel obstruction.", "pmid_30": 22901924.0, "pmid_date_30": 2012.0, "pmid_journal_30": "J Pediatr Surg"}, {"pmid_title_31": "Long-term functional outcomes in children with Currarino syndrome.", "pmid_31": 20473613.0, "pmid_date_31": 2010.0, "pmid_journal_31": "Pediatr Surg Int"}, {"pmid_title_32": "A 40-year-old woman with cauda equina syndrome caused by rectothecal fistula arising from an anterior sacral meningocele.", "pmid_32": 20871432.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Neurosurgery"}, {"pmid_title_33": "Currarino triad: surgical management and follow-up results of four [correction of three] cases.", "pmid_33": 20664237.0, "pmid_date_33": 2010.0, "pmid_journal_33": "Pediatr Neurosurg"}, {"pmid_title_34": "Treatment-resistant meningitis leading to the diagnosis of Currarino syndrome: a case report.", "pmid_34": 19483525.0, "pmid_date_34": 2009.0, "pmid_journal_34": "Pediatr Infect Dis J"}, {"pmid_title_35": "Currarino's syndrome misinterpreted as Hirschsprung's disease for 17 years: a case report.", "pmid_35": 19192271.0, "pmid_date_35": 2009.0, "pmid_journal_35": "Cases J"}, {"pmid_title_36": "The shrinking of an anterior sacral meningocele in time following transdural ligation of its neck in a case of the Currarino triad.", "pmid_36": 18814114.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Turk Neurosurg"}, {"pmid_title_37": "Currarino triad associated with malrotation of the colon.", "pmid_37": 17268712.0, "pmid_date_37": 2007.0, "pmid_journal_37": "Saudi Med J"}, {"pmid_title_38": "Currarino syndrome as an etiology of a neonatal Escherichia coli meningitis.", "pmid_38": 17724455.0, "pmid_date_38": 2007.0, "pmid_journal_38": "J Perinatol"}, {"pmid_title_39": "The Currarino triad: neurosurgical considerations.", "pmid_39": 16639328.0, "pmid_date_39": 2006.0, "pmid_journal_39": "Neurosurgery"}, {"pmid_title_40": "Leiomyomatosis peritonealis disseminata in association with Currarino syndrome?", "pmid_40": 16686944.0, "pmid_date_40": 2006.0, "pmid_journal_40": "BMC Cancer"}, {"pmid_title_41": "New clinical and therapeutic perspectives in Currarino syndrome (study of 29 cases).", "pmid_41": 16410121.0, "pmid_date_41": 2006.0, "pmid_journal_41": "J Pediatr Surg"}, {"pmid_title_42": "Currarino syndrome associated with penoscrotal inversion and perineal fissure.", "pmid_42": 16025272.0, "pmid_date_42": 2005.0, "pmid_journal_42": "Pediatr Surg Int"}, {"pmid_title_43": "Presacral meningocele associated with hereditary sacral agenesis and treated surgically: evaluation in three members of the same family.", "pmid_43": 16145509.0, "pmid_date_43": 2005.0, "pmid_journal_43": "Neurosurgery"}, {"pmid_title_44": "Rectal duplication cyst presenting as perianal sepsis: report of two cases and review of the literature.", "pmid_44": 15657675.0, "pmid_date_44": 2004.0, "pmid_journal_44": "Dis Colon Rectum"}, {"pmid_title_45": "Currarino syndrome: proposal of a diagnostic and therapeutic protocol.", "pmid_45": 15359381.0, "pmid_date_45": 2004.0, "pmid_journal_45": "J Pediatr Surg"}, {"pmid_title_46": "Currarino triad with dual pathology in the presacral mass: report of a case.", "pmid_46": 12847376.0, "pmid_date_46": 2003.0, "pmid_journal_46": "Dis Colon Rectum"}, {"pmid_title_47": "Complete Currarino syndrome in an adult, presenting as a fecalith obstruction: report of a case.", "pmid_47": 12930112.0, "pmid_date_47": 2003.0, "pmid_journal_47": "Can J Surg"}, {"pmid_title_48": "Presacral tumor associated with the Currarino triad in an adolescent.", "pmid_48": 11195108.0, "pmid_date_48": 2001.0, "pmid_journal_48": "Arch Orthop Trauma Surg"}, {"pmid_title_49": "Diagnostic steps and staged operative approach in Currarino's triad: a case report and review of the literature.", "pmid_49": 11007505.0, "pmid_date_49": 2000.0, "pmid_journal_49": "Childs Nerv Syst"}, {"pmid_title_50": "Posterior sagittal approach for Currarino syndrome with anterior sacral meningocele: a case report.", "pmid_50": 10917308.0, "pmid_date_50": 2000.0, "pmid_journal_50": "J Pediatr Surg"}, {"pmid_title_51": "Currarino triad--diagnostic dilemma and a combined surgical approach.", "pmid_51": 11101738.0, "pmid_date_51": 2000.0, "pmid_journal_51": "J Pediatr Surg"}, {"pmid_title_52": "Polymicrobial meningitis revealing an anterior sacral meningocele in a 23-year-old woman.", "pmid_52": 10841102.0, "pmid_date_52": 2000.0, "pmid_journal_52": "J Infect"}, {"pmid_title_53": "A case of incomplete Currarino triad with malignant transformation.", "pmid_53": 10415302.0, "pmid_date_53": 1999.0, "pmid_journal_53": "Pediatr Surg Int"}, {"pmid_title_54": "Currarino triad: anorectal malformation, sacral bony abnormality, and presacral mass--a review of 11 cases.", "pmid_54": 9021570.0, "pmid_date_54": 1997.0, "pmid_journal_54": "J Pediatr Surg"}, {"pmid_title_55": "The Currarino syndrome--hereditary transmitted syndrome of anorectal, sacral and presacral anomalies. Case report and review of the literature.", "pmid_55": 8740138.0, "pmid_date_55": 1996.0, "pmid_journal_55": "Eur J Pediatr Surg"}, {"pmid_title_56": "Tethered cord with anorectal malformation, sacral anomalies and presacral masses: an under-recognized association.", "pmid_56": 7756242.0, "pmid_date_56": 1995.0, "pmid_journal_56": "Eur J Pediatr Surg"}]}, {"_id": "5005-OMIM:246450", "condition": {"condition_name": "3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY", "freq_per_birth": "HMG-CoA lyase deficiency is a rare condition; it has been reported in fewer than 100 individuals worldwide.  Most people diagnosed with this disorder have been from Saudi Arabia, Portugal, or Spain.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 5005.0}, "interventions": [{"int_description_1": "High-carbohydrate diet", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Leucine-restricted diet"}, {"int_description_3": "Low-fat diet"}, {"int_description_4": "Protein-restricted diet"}, {"int_description_5": "Levocarnitine"}], "references": [{"pmid_title_1": "Management and long-term evolution of a patient with 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency.", "pmid_1": 28257639.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Italian journal of pediatrics"}, {"pmid_title_2": "Favourable Outcome in Two Pregnancies in a Patient with 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency.", "pmid_2": 28220407.0, "pmid_date_2": 2017.0, "pmid_journal_2": "JIMD reports"}, {"pmid_title_3": "3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: Clinical presentation and outcome in a series of 37 patients.", "pmid_3": 28583327.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Molecular genetics and metabolism"}, {"pmid_title_4": "The management of pregnancy and delivery in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency.", "pmid_4": 26997609.0, "pmid_date_4": 2016.0, "pmid_journal_4": "American journal of medical genetics. Part A"}, {"pmid_title_5": "3-HMG Coenzyme A Lyase Deficiency: Macrocephaly and Left Ventricular Noncompaction with a Novel Mutation.", "pmid_5": 25708061.0, "pmid_date_5": 2015.0, "pmid_journal_5": "Indian journal of pediatrics"}, {"pmid_title_6": "A neonatal case of 3-hydroxy-3-methylglutaric-coenzyme A lyase deficiency.", "pmid_6": 23705938.0, "pmid_date_6": 2013.0, "pmid_journal_6": "Italian journal of pediatrics"}, {"pmid_title_7": "[Late onset 3-HMG-CoA lyase deficiency: a rare but treatable disorder].", "pmid_7": 19932602.0, "pmid_date_7": 2010.0, "pmid_journal_7": "Archives de pediatrie : organe officiel de la Societe francaise de pediatrie"}]}, {"_id": "5022-ORPHA:657", "condition": {"condition_name": "Congenital isolated hyperinsulinism", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["Congenital isolated hyperinsulinism", "Combined pituitary hormone deficiencies, genetic forms"]}, "gene information": {"db_hgnc_gene_id": 5022.0}, "interventions": [{"int_description_1": "Chlorothiazide", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Diazoxide", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "D-glucose", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Feeding per gastro-jejonostomy  tube"}], "references": [{"pmid_title_1": "Congenital Hyperinsulinism and Hypopituitarism Attributable to a Mutation in FOXA2.", "pmid_1": 29329447.0, "pmid_date_1": 2018.0, "pmid_journal_1": "J Clin Endocrinol Metab"}, {"pmid_title_2": "Novel FOXA2 mutation causes Hyperinsulinism, Hypopituitarism with Craniofacial and Endoderm-derived organ abnormalities.", "pmid_2": 28973288.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Hum Mol Genet"}]}, {"_id": "5022-ORPHA:95494", "condition": {"condition_name": "Combined pituitary hormone deficiencies, genetic forms", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive, X-linked recessive", "alternate_names": ["Combined pituitary hormone deficiencies, genetic forms", "Congenital isolated hyperinsulinism"]}, "gene information": {"db_hgnc_gene_id": 5022.0}, "interventions": [{"int_description_1": "Levothyroxine", "timeframe_int1": "Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Desmopressin", "timeframe_int2": "Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Somatotropin", "timeframe_int3": "Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Hydrocortisone", "timeframe_int4": "Hours", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "FOXA2 gene mutation in a patient with congenital complex pituitary hormone deficiency.", "pmid_1": 30414530.0, "pmid_date_1": 2019.0, "pmid_journal_1": "European journal of medical genetics"}, {"pmid_title_2": "Congenital Hyperinsulinism and Hypopituitarism Attributable to a Mutation in FOXA2.", "pmid_2": 29329447.0, "pmid_date_2": 2018.0, "pmid_journal_2": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_3": "Novel FOXA2 mutation causes Hyperinsulinism, Hypopituitarism with Craniofacial and Endoderm-derived organ abnormalities.", "pmid_3": 28973288.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Human molecular genetics"}]}, {"_id": "5024-OMIM:125850", "condition": {"condition_name": "MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1", "freq_per_birth": "MODY is estimated to account for 1 to 3 percent of all cases of diabetes.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["Hyperinsulinism due to HNF4A deficiency", "MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1", "FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG"]}, "gene information": {"db_hgnc_gene_id": 5024.0}, "interventions": [{"int_description_1": "Insulin human", "timeframe_int1": "Days or Weeks", "age_use_int1": "Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Glyburide", "timeframe_int2": "Hours", "age_use_int2": "Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Glimepiride", "timeframe_int3": "Hours", "age_use_int3": "Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Metformin"}], "references": [{"pmid_title_1": "Screening of HNF1A and HNF4A mutation and clinical phenotype analysis in a large cohort of Chinese patients with maturity-onset diabetes of the young.", "pmid_1": 30293189.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Acta diabetologica"}, {"pmid_title_2": "Maturity Onset Diabetes of the Young due to Glucokinase, HNF1-A, HNF1-B, and HNF4-A Mutations in a Cohort of Turkish Children Diagnosed as Type 1 Diabetes Mellitus.", "pmid_2": 30481753.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Hormone research in paediatrics"}, {"pmid_title_3": "Detection and characterization of two novel mutations in the HNF4A gene in maturity-onset diabetes of the young type 1 in two Japanese families.", "pmid_3": 23652628.0, "pmid_date_3": 2013.0, "pmid_journal_3": "Hormone research in paediatrics"}, {"pmid_title_4": "Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.", "pmid_4": 21683639.0, "pmid_date_4": 2011.0, "pmid_journal_4": "Diabetes & metabolism"}]}, {"_id": "5024-OMIM:616026", "condition": {"condition_name": "FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["Hyperinsulinism due to HNF4A deficiency", "FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4", "MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1; MODY1"]}, "gene information": {"db_hgnc_gene_id": 5024.0}, "interventions": [{"int_description_1": "Calcium", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Cholecalciferol", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Diazoxide", "age_use_int3": "Neonate,Infant", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Fainting Fanconi syndrome clarified by proxy: a case report.", "pmid_1": 28693455.0, "pmid_date_1": 2017.0, "pmid_journal_1": "BMC nephrology"}, {"pmid_title_2": "The HNF4A R76W mutation causes atypical dominant Fanconi syndrome in addition to a \u03b2 cell phenotype.", "pmid_2": 24285859.0, "pmid_date_2": 2014.0, "pmid_journal_2": "Journal of medical genetics"}]}, {"_id": "5024-ORPHA:263455", "condition": {"condition_name": "Hyperinsulinism due to HNF4A deficiency", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG", "Hyperinsulinism due to HNF4A deficiency", "MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1"]}, "gene information": {"db_hgnc_gene_id": 5024.0}, "interventions": [{"int_description_1": "Chlorothiazide", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Diazoxide", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Exceptional diazoxide sensitivity in hyperinsulinaemic hypoglycaemia due to a novel HNF4A mutation.", "pmid_1": 31096182.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Endocrinol Diabetes Metab Case Rep"}, {"pmid_title_2": "Clinical heterogeneity of hyperinsulinism due to HNF1A and HNF4A mutations.", "pmid_2": 29493090.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Pediatr Diabetes"}, {"pmid_title_3": "The evolving course of HNF4A hyperinsulinaemic hypoglycaemia--a case series.", "pmid_3": 23796040.0, "pmid_date_3": 2014.0, "pmid_journal_3": "Diabet Med"}, {"pmid_title_4": "Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations.", "pmid_4": 20164212.0, "pmid_date_4": 2010.0, "pmid_journal_4": "Eur J Endocrinol"}]}, {"_id": "5147-OMIM:140350", "condition": {"condition_name": "HAWKINSINURIA", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["HAWKINSINURIA", "TYROSINEMIA, TYPE III"]}, "gene information": {"db_hgnc_gene_id": 5147.0}, "interventions": [{"int_description_1": "Low protein diet", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Still in Trials / Unproven"}, {"int_description_2": "Phenylalanine/tyrosine-restricted diet", "timeframe_int2": "Days or Weeks", "age_use_int2": "Infant", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Still in Trials / Unproven"}, {"int_description_3": "Tyrosine-restricted diet"}, {"int_description_4": "Ascorbic acid"}, {"int_description_5": "Acetylcysteine"}, {"int_description_6": "Phosphorus"}, {"int_description_7": "Sodium bicarbonate"}, {"int_description_8": "D-glucose"}, {"int_description_9": "Feeding per nasogastric tube"}], "references": [{"pmid_title_1": "Hawkinsinuria clinical practice guidelines: a Mexican case report and literature review.", "pmid_1": 31342835.0, "pmid_date_1": 2020.0, "pmid_journal_1": "J Int Med Res"}, {"pmid_title_2": "Hawkinsinuria With Direct Hyperbilirubinemia in Egyptian-Lebanese Boy.", "pmid_2": 30984715.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Front Pediatr"}, {"pmid_title_3": "Hawkinsinuria in two unrelated Greek newborns: identification of a novel variant, biochemical findings and treatment.", "pmid_3": 26226126.0, "pmid_date_3": 2016.0, "pmid_journal_3": "J Pediatr Endocrinol Metab"}, {"pmid_title_4": "Expanding the phenotype of hawkinsinuria: new insights from response to N-acetyl-L-cysteine.", "pmid_4": 27488560.0, "pmid_date_4": 2016.0, "pmid_journal_4": "J Inherit Metab Dis"}, {"pmid_title_5": "Manifestation of hawkinsinuria in a patient compound heterozygous for hawkinsinuria and tyrosinemia III.", "pmid_5": 17560158.0, "pmid_date_5": 2007.0, "pmid_journal_5": "Mol Genet Metab"}, {"pmid_title_6": "The genetic tyrosinemias.", "pmid_6": 16602095.0, "pmid_date_6": 2006.0, "pmid_journal_6": "Am J Med Genet C Semin Med Genet"}, {"pmid_title_7": "Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria.", "pmid_7": 11073718.0, "pmid_date_7": 2000.0, "pmid_journal_7": "Mol Genet Metab"}, {"pmid_title_8": "Long-term follow up of a new case of hawkinsinuria.", "pmid_8": 10412819.0, "pmid_date_8": 1999.0, "pmid_journal_8": "Eur J Pediatr"}, {"pmid_title_9": "Hawkinsinuria in two families.", "pmid_9": 1519651.0, "pmid_date_9": 1992.0, "pmid_journal_9": "Am J Med Genet"}, {"pmid_title_10": "Hawkinsinuria: a dominantly inherited defect of tyrosine metabolism with severe effects in infancy.", "pmid_10": 7278885.0, "pmid_date_10": 1981.0, "pmid_journal_10": "N Engl J Med"}]}, {"_id": "5147-OMIM:276710", "condition": {"condition_name": "TYROSINEMIA, TYPE III", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["TYROSINEMIA, TYPE III", "HAWKINSINURIA"]}, "gene information": {"db_hgnc_gene_id": 5147.0}, "interventions": [{"int_description_1": "Low protein diet", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Still in Trials / Unproven"}, {"int_description_2": "Phenylalanine/tyrosine-restricted diet"}, {"int_description_3": "Ascorbic acid"}], "references": [{"pmid_title_1": "TYROSINEMIA TYPE III: A CASE REPORT OF SIBLINGS AND LITERATURE REVIEW.", "pmid_1": 32520295.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Rev Paul Pediatr"}, {"pmid_title_2": "A Case of Tyrosinemia Type III with Status Epilepticus and Mental Retardation.", "pmid_2": 29456978.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Adv Biomed Res"}, {"pmid_title_3": "Tyrosinemia Type III detected via neonatal screening: management and outcome.", "pmid_3": 23036342.0, "pmid_date_3": 2012.0, "pmid_journal_3": "Mol Genet Metab"}, {"pmid_title_4": "The genetic tyrosinemias.", "pmid_4": 16602095.0, "pmid_date_4": 2006.0, "pmid_journal_4": "Am J Med Genet C Semin Med Genet"}, {"pmid_title_5": "Outcome of tyrosinaemia type III.", "pmid_5": 11916315.0, "pmid_date_5": 2001.0, "pmid_journal_5": "J Inherit Metab Dis"}, {"pmid_title_6": "Mutations in the 4-hydroxyphenylpyruvate dioxygenase gene (HPD) in patients with tyrosinemia type III.", "pmid_6": 10942115.0, "pmid_date_6": 2000.0, "pmid_journal_6": "Hum Genet"}, {"pmid_title_7": "Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria.", "pmid_7": 11073718.0, "pmid_date_7": 2000.0, "pmid_journal_7": "Mol Genet Metab"}, {"pmid_title_8": "Tyrosinemia type III: diagnosis and ten-year follow-up.", "pmid_8": 9343288.0, "pmid_date_8": 1997.0, "pmid_journal_8": "Acta Paediatr"}]}, {"_id": "5218-OMIM:201810", "condition": {"condition_name": "ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY", "freq_per_birth": "The exact prevalence of 3\u03b2-HSD deficiency is unknown. At least 60 affected individuals have been reported.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 5218.0}, "interventions": [{"int_description_1": "Rehydration", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Fludrocortisone", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Hydrocortisone", "timeframe_int3": "Hours", "age_use_int3": "Neonate", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Long-term glucocorticoid and mineralocorticoid replacement"}, {"int_description_5": "Sex steroid replacement therapy"}, {"int_description_6": "Adrenal crisis management"}, {"int_description_7": "Correction of hypoglycemia"}, {"int_description_8": "Genitoplasty"}], "references": [{"pmid_title_1": "Clinical perspectives in congenital adrenal hyperplasia due to 3\u03b2-hydroxysteroid dehydrogenase type 2 deficiency.", "pmid_1": 30719691.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Endocrine"}, {"pmid_title_2": "Human 3beta-hydroxysteroid dehydrogenase deficiency associated with normal spermatic numeration despite a severe enzyme deficit.", "pmid_2": 29420188.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Endocr Connect"}]}, {"_id": "5391-OMIM:607014", "condition": {"condition_name": "HURLER SYNDROME", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["SCHEIE SYNDROME", "HURLER SYNDROME", "HURLER-SCHEIE SYNDROME"]}, "gene information": {"db_hgnc_gene_id": 5391.0}, "interventions": [{"int_description_1": "Continuous positive airway pressure"}, {"int_description_2": "Pressure Equalizer (PE)\u00a0Tube\u00a0Insertion"}, {"int_description_3": "Pentosan polysulfate"}, {"int_description_4": "Adalimumab"}, {"int_description_5": "Somatotropin"}, {"int_description_6": "Ataluren"}, {"int_description_7": "Blood-brain-barrier (BBB)-penetrating recombinant alpha-L-iduronidase (JR-171)"}, {"int_description_8": "Laronidase"}, {"int_description_9": "ELX-02"}, {"int_description_10": "Valanafusp alfa"}, {"int_description_11": "Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus"}, {"int_description_12": "Autologous CD34+ haematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the alpha-L-iduronidase cDNA"}, {"int_description_13": "Autologous Plasmablasts\u00a0engineered to express alpha-L-iduronidase (IDUA)"}, {"int_description_14": "Haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate (ECT-001)", "timeframe_int14": "Days or Weeks", "age_use_int14": "Infant,Child", "contra_int14": "No", "qualscale_reclass_drug14": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}, {"int_description_15": "Adeno-associated viral vector serotype 2/6 encoding zinc-finger nucleases and the human alpha L-iduronidase gene (SB-318)"}, {"int_description_16": "Recombinant adeno-associated viral vector serotype 9 containing human iduronidase gene (RGX-111)"}, {"int_description_17": "Physical therapy"}, {"int_description_18": "Adenoidectomy"}, {"int_description_19": "Bone marrow transplantation"}, {"int_description_20": "Cardiac valve replacement"}, {"int_description_21": "Corneal transplantation"}, {"int_description_22": "Haematopoietic stem cell transplantation", "timeframe_int22": "Days or Weeks", "age_use_int22": "Infant,Child", "contra_int22": "No", "qualscale_reclass_drug22": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug22": "Effective / Ameliorative"}, {"int_description_23": "Orthopaedic surgery (atlanto-occipital stabilization)"}, {"int_description_24": "Orthopaedic surgery (early median nerve decompression)"}, {"int_description_25": "Orthopaedic surgery (joint replacement)"}, {"int_description_26": "Tonsillectomy"}, {"int_description_27": "Tracheostomy"}, {"int_description_28": "Ventriculoperitoneal shunting"}], "references": [{"pmid_title_1": "ELX-02 Generates Protein via Premature Stop Codon Read-Through without Inducing Native Stop Codon Read-Through Proteins.", "pmid_1": 32376628.0, "pmid_date_1": 2020.0, "pmid_journal_1": "The Journal of pharmacology and experimental therapeutics"}, {"pmid_title_2": "ELX-02: an investigational read-through agent for the treatment of nonsense mutation-related genetic disease.", "pmid_2": 32972261.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Expert opinion on investigational drugs"}, {"pmid_title_3": "Intrathecal enzyme replacement for cognitive decline in mucopolysaccharidosis type I, a randomized, open-label, controlled pilot study.", "pmid_3": 31839529.0, "pmid_date_3": 2020.0, "pmid_journal_3": "Molecular genetics and metabolism"}, {"pmid_title_4": "Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of ELX-02, a Potential Treatment for Genetic Disorders Caused by Nonsense Mutations, in Healthy Volunteers.", "pmid_4": 30650260.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Clinical pharmacology in drug development"}, {"pmid_title_5": "The novel aminoglycoside, ELX-02, permits CTNSW138X translational read-through and restores lysosomal cystine efflux in cystinosis.", "pmid_5": 31800572.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PloS one"}, {"pmid_title_6": "CRISPR target prediction remains blunt tool for clinical applications.", "pmid_6": 30833770.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Nature biotechnology"}, {"pmid_title_7": "Publisher Correction: CRISPR target prediction remains blunt tool for clinical applications.", "pmid_7": 30894681.0, "pmid_date_7": 2019.0, "pmid_journal_7": "Nature biotechnology"}, {"pmid_title_8": "Hematopoietic cell transplantation for severe MPS I in the first six months of life: The heart of the matter.", "pmid_8": 30503158.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Molecular genetics and metabolism"}, {"pmid_title_9": "Early enzyme replacement therapy enables a successful hematopoietic stem cell transplantation in mucopolysaccharidosis type IH: Divergent clinical outcomes in two Japanese siblings.", "pmid_9": 30755342.0, "pmid_date_9": 2019.0, "pmid_journal_9": "Brain & development"}, {"pmid_title_10": "Deep Anterior Lamellar Keratoplasty in a Case of Hurler-Scheie Syndrome Undergoing Enzyme Replacement Therapy.", "pmid_10": 30575621.0, "pmid_date_10": 2019.0, "pmid_journal_10": "Cornea"}, {"pmid_title_11": "Limited data to evaluate real-world effectiveness of enzyme replacement therapy for mucopolysaccharidosis type I.", "pmid_11": 31020996.0, "pmid_date_11": 2019.0, "pmid_journal_11": "Journal of inherited metabolic disease"}, {"pmid_title_12": "Healthcare Resource Utilization and the Cost of Care for Mucopolysaccharidosis I Patients in Iran.", "pmid_12": 31082797.0, "pmid_date_12": 2019.0, "pmid_journal_12": "Value in health regional issues"}, {"pmid_title_13": "CASE SERIES OF PATIENTS UNDER BIWEEKLY TREATMENT WITH LARONIDASE: A REPORT OF A SINGLE CENTER EXPERIENCE.", "pmid_13": 31090850.0, "pmid_date_13": 2019.0, "pmid_journal_13": "Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo"}, {"pmid_title_14": "Enzyme replacement therapy with laronidase (Aldurazyme<sup>\u00ae</sup>) for treating mucopolysaccharidosis type I.", "pmid_14": 31211405.0, "pmid_date_14": 2019.0, "pmid_journal_14": "The Cochrane database of systematic reviews"}, {"pmid_title_15": "Post-transplant laronidase augmentation for children with Hurler syndrome: biochemical outcomes.", "pmid_15": 31575939.0, "pmid_date_15": 2019.0, "pmid_journal_15": "Scientific reports"}, {"pmid_title_16": "Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases.", "pmid_16": 31639024.0, "pmid_date_16": 2019.0, "pmid_journal_16": "Orphanet journal of rare diseases"}, {"pmid_title_17": "Agreement between the results of meta-analyses from case reports and from clinical studies regarding the efficacy of laronidase therapy in patients with mucopolysaccharidosis type I who initiated enzyme replacement therapy in adult age: An example of case reports meta-analyses as an useful tool for evidence-based medicine in rare diseases.", "pmid_17": 29336994.0, "pmid_date_17": 2018.0, "pmid_journal_17": "Molecular genetics and metabolism"}, {"pmid_title_18": "International working group identifies need for newborn screening for mucopolysaccharidosis type I but states that existing hurdles must be overcome.", "pmid_18": 30242902.0, "pmid_date_18": 2018.0, "pmid_journal_18": "Acta paediatrica (Oslo, Norway : 1992)"}, {"pmid_title_19": "The effect of haemopoietic stem cell transplantation on the ocular phenotype in mucopolysaccharidosis type I (Hurler).", "pmid_19": 29240299.0, "pmid_date_19": 2018.0, "pmid_journal_19": "Acta ophthalmologica"}, {"pmid_title_20": "Carbon nanotubes as nanovectors for intracellular delivery of laronidase in Mucopolysaccharidosis type I.", "pmid_20": 29239447.0, "pmid_date_20": 2018.0, "pmid_journal_20": "Nanoscale"}, {"pmid_title_21": "Plasma Pharmacokinetics of Valanafusp Alpha, a Human Insulin Receptor Antibody-Iduronidase Fusion Protein, in Patients with Mucopolysaccharidosis Type I.", "pmid_21": 29442294.0, "pmid_date_21": 2018.0, "pmid_journal_21": "BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy"}, {"pmid_title_22": "Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial.", "pmid_22": 29976218.0, "pmid_date_22": 2018.0, "pmid_journal_22": "Orphanet journal of rare diseases"}, {"pmid_title_23": "Short stature as a presenting symptom of attenuated Mucopolysaccharidosis type I: case report and clinical insights.", "pmid_23": 30419879.0, "pmid_date_23": 2018.0, "pmid_journal_23": "BMC endocrine disorders"}, {"pmid_title_24": "Open issues in Mucopolysaccharidosis type I-Hurler.", "pmid_24": 28619065.0, "pmid_date_24": 2017.0, "pmid_journal_24": "Orphanet journal of rare diseases"}, {"pmid_title_25": "Efficacy of laronidase therapy in patients with mucopolysaccharidosis type I who initiated enzyme replacement therapy in adult age. A systematic review and meta-analysis.", "pmid_25": 28410878.0, "pmid_date_25": 2017.0, "pmid_journal_25": "Molecular genetics and metabolism"}, {"pmid_title_26": "Efficacy and safety of intravenous laronidase for mucopolysaccharidosis type I: A systematic review and meta-analysis.", "pmid_26": 28859139.0, "pmid_date_26": 2017.0, "pmid_journal_26": "PloS one"}, {"pmid_title_27": "Pilot study of the safety and effect of adalimumab on pain, physical function, and musculoskeletal disease in mucopolysaccharidosis types I and II.", "pmid_27": 28119823.0, "pmid_date_27": 2017.0, "pmid_journal_27": "Molecular genetics and metabolism reports"}, {"pmid_title_28": "Outcome of Combined Mitral and Aortic Valve Replacement in Adults With Mucopolysaccharidosis (the Hurler Syndrome).", "pmid_28": 28964381.0, "pmid_date_28": 2017.0, "pmid_journal_28": "The American journal of cardiology"}, {"pmid_title_29": "Mortality after hematopoietic stem cell transplantation for severe mucopolysaccharidosis type I: the 30-year University of Minnesota experience.", "pmid_29": 28054207.0, "pmid_date_29": 2017.0, "pmid_journal_29": "Journal of inherited metabolic disease"}, {"pmid_title_30": "Changes in the incidence, patterns and outcomes of graft failure following hematopoietic stem cell transplantation for Hurler syndrome.", "pmid_30": 28218755.0, "pmid_date_30": 2017.0, "pmid_journal_30": "Bone marrow transplantation"}, {"pmid_title_31": "Long term survival and cardiopulmonary outcome in children with Hurler syndrome after haematopoietic stem cell transplantation.", "pmid_31": 28283844.0, "pmid_date_31": 2017.0, "pmid_journal_31": "Journal of inherited metabolic disease"}, {"pmid_title_32": "Incomplete biomarker response in mucopolysaccharidosis type I after successful hematopoietic cell transplantation.", "pmid_32": 28684085.0, "pmid_date_32": 2017.0, "pmid_journal_32": "Molecular genetics and metabolism"}, {"pmid_title_33": "Role of rehabilitation in Hurler's syndrome.", "pmid_33": 27911282.0, "pmid_date_33": 2017.0, "pmid_journal_33": "Journal of back and musculoskeletal rehabilitation"}, {"pmid_title_34": "Early disease progression of Hurler syndrome.", "pmid_34": 28193245.0, "pmid_date_34": 2017.0, "pmid_journal_34": "Orphanet journal of rare diseases"}, {"pmid_title_35": "Mucopolysaccharidosis Type I", "pmid_35": 20301341.0, "pmid_date_35": 2016.0, "pmid_journal_35": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_36": "Enzyme replacement therapy with laronidase (Aldurazyme(\u00ae)) for treating mucopolysaccharidosis type I.", "pmid_36": 27033167.0, "pmid_date_36": 2016.0, "pmid_journal_36": "The Cochrane database of systematic reviews"}, {"pmid_title_37": "Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres.", "pmid_37": 26832957.0, "pmid_date_37": 2016.0, "pmid_journal_37": "Molecular genetics and metabolism"}, {"pmid_title_38": "The impact of laronidase treatment in otolaryngological manifestations of patients with mucopolysaccharidosis.", "pmid_38": 26750310.0, "pmid_date_38": 2016.0, "pmid_journal_38": "Brazilian journal of otorhinolaryngology"}, {"pmid_title_39": "Effect of anti-laronidase antibodies on efficacy and safety of laronidase enzyme replacement therapy for MPS I: A comprehensive meta-analysis of pooled data from multiple studies.", "pmid_39": 26920513.0, "pmid_date_39": 2016.0, "pmid_journal_39": "Molecular genetics and metabolism"}, {"pmid_title_40": "12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatment.", "pmid_40": 26965916.0, "pmid_date_40": 2016.0, "pmid_journal_40": "BMC medical genetics"}, {"pmid_title_41": "Alternative laronidase dose regimen for patients with mucopolysaccharidosis I: a multinational, retrospective, chart review case series.", "pmid_41": 27129473.0, "pmid_date_41": 2016.0, "pmid_journal_41": "Orphanet journal of rare diseases"}, {"pmid_title_42": "Outcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type I.", "pmid_42": 27788836.0, "pmid_date_42": 2016.0, "pmid_journal_42": "The Journal of pediatrics"}, {"pmid_title_43": "Laronidase desensitization during stem cell transplant in a child with Hurler syndrome.", "pmid_43": 26916445.0, "pmid_date_43": 2016.0, "pmid_journal_43": "Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology"}, {"pmid_title_44": "Treatment with pentosan polysulphate in patients with MPS I: results from an open label, randomized, monocentric phase II study.", "pmid_44": 27590017.0, "pmid_date_44": 2016.0, "pmid_journal_44": "Journal of inherited metabolic disease"}, {"pmid_title_45": "Enzymes approved for human therapy: indications, mechanisms and adverse effects.", "pmid_45": 25648140.0, "pmid_date_45": 2015.0, "pmid_journal_45": "BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy"}, {"pmid_title_46": "Urgent resection of a giant left atrial appendage aneurysm and mitral valve replacement in a complex case of Hurler-Scheie syndrome.", "pmid_46": 26546621.0, "pmid_date_46": 2015.0, "pmid_journal_46": "BMJ case reports"}, {"pmid_title_47": "Residual glycosaminoglycan accumulation in mitral and aortic valves of a patient with attenuated MPS I (Scheie syndrome) after 6\u00a0years of enzyme replacement therapy: Implications for early diagnosis and therapy.", "pmid_47": 28649551.0, "pmid_date_47": 2015.0, "pmid_journal_47": "Molecular genetics and metabolism reports"}, {"pmid_title_48": "Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study.", "pmid_48": 25624320.0, "pmid_date_48": 2015.0, "pmid_journal_48": "Blood"}, {"pmid_title_49": "Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines.", "pmid_49": 25708213.0, "pmid_date_49": 2015.0, "pmid_journal_49": "Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation"}, {"pmid_title_50": "Obstructive sleep apnea syndrome after hematopoietic stem cell transplantation in children with mucopolysaccharidosis type I.", "pmid_50": 26602600.0, "pmid_date_50": 2015.0, "pmid_journal_50": "Molecular genetics and metabolism"}, {"pmid_title_51": "Biomarker responses correlate with antibody status in mucopolysaccharidosis type I patients on long-term enzyme replacement therapy.", "pmid_51": 25467058.0, "pmid_date_51": 2015.0, "pmid_journal_51": "Molecular genetics and metabolism"}, {"pmid_title_52": "Successful pregnancy and breastfeeding in a woman with mucopolysaccharidosis type I while receiving laronidase enzyme replacement. therapy.", "pmid_52": 25864295.0, "pmid_date_52": 2015.0, "pmid_journal_52": "Clinical and experimental obstetrics & gynecology"}, {"pmid_title_53": "Diffusion tensor imaging and myelin composition analysis reveal abnormal myelination in corpus callosum of canine mucopolysaccharidosis I.", "pmid_53": 26222335.0, "pmid_date_53": 2015.0, "pmid_journal_53": "Experimental neurology"}, {"pmid_title_54": "Safety of laronidase delivered into the spinal canal for treatment of cervical stenosis in mucopolysaccharidosis I.", "pmid_54": 26260077.0, "pmid_date_54": 2015.0, "pmid_journal_54": "Molecular genetics and metabolism"}, {"pmid_title_55": "Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships.", "pmid_55": 26446585.0, "pmid_date_55": 2015.0, "pmid_journal_55": "Orphanet journal of rare diseases"}, {"pmid_title_56": "Mucopolysaccharidosis type I.", "pmid_56": 25345091.0, "pmid_date_56": 2014.0, "pmid_journal_56": "Pediatric endocrinology reviews : PER"}, {"pmid_title_57": "Effect of recombinant human growth hormone on changes in height, bone mineral density, and body composition over 1-2 years in children with Hurler or Hunter syndrome.", "pmid_57": 24368158.0, "pmid_date_57": 2014.0, "pmid_journal_57": "Molecular genetics and metabolism"}, {"pmid_title_58": "Growth hormone treatment in a patient with Hurler-Scheie syndrome.", "pmid_58": 24825081.0, "pmid_date_58": 2014.0, "pmid_journal_58": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_59": "Mucopolysaccharide disorders in orthopaedic surgery.", "pmid_59": 23281467.0, "pmid_date_59": 2013.0, "pmid_journal_59": "The Journal of the American Academy of Orthopaedic Surgeons"}, {"pmid_title_60": "Cardiac Ultrasound Findings in Infants with Severe (Hurler Phenotype) Untreated Mucopolysaccharidosis (MPS) Type I.", "pmid_60": 23430808.0, "pmid_date_60": 2013.0, "pmid_journal_60": "JIMD reports"}, {"pmid_title_61": "Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experience.", "pmid_61": 22718273.0, "pmid_date_61": 2013.0, "pmid_journal_61": "Journal of inherited metabolic disease"}, {"pmid_title_62": "Enzyme replacement is associated with better cognitive outcomes after transplant in Hurler syndrome.", "pmid_62": 22974573.0, "pmid_date_62": 2013.0, "pmid_journal_62": "The Journal of pediatrics"}, {"pmid_title_63": "Residual \u03b1-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.", "pmid_63": 23786846.0, "pmid_date_63": 2013.0, "pmid_journal_63": "Molecular genetics and metabolism"}, {"pmid_title_64": "Pentosan polysulfate: a novel therapy for the mucopolysaccharidoses.", "pmid_64": 23365668.0, "pmid_date_64": 2013.0, "pmid_journal_64": "PloS one"}, {"pmid_title_65": "Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler's syndrome after pharmacological enzyme replacement therapy.", "pmid_65": 22371174.0, "pmid_date_65": 2012.0, "pmid_journal_65": "Haematologica"}, {"pmid_title_66": "[Carpal tunnel syndrome in children with mucopolysaccharidosis type 1H: diagnosis and therapy in an interdisciplinary centre].", "pmid_66": 22382905.0, "pmid_date_66": 2012.0, "pmid_journal_66": "Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V..."}, {"pmid_title_67": "High rate of postoperative mortality in patients with mucopolysaccharidosis I: findings from the MPS I Registry.", "pmid_67": 22424341.0, "pmid_date_67": 2012.0, "pmid_journal_67": "Journal of pediatric surgery"}, {"pmid_title_68": "Anesthetic management in children with Hurler's syndrome undergoing emergency ventriculoperitoneal shunt surgery.", "pmid_68": 22754449.0, "pmid_date_68": 2012.0, "pmid_journal_68": "Saudi journal of anaesthesia"}, {"pmid_title_69": "Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure.", "pmid_69": 21831279.0, "pmid_date_69": 2011.0, "pmid_journal_69": "Orphanet journal of rare diseases"}, {"pmid_title_70": "Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions.", "pmid_70": 19919654.0, "pmid_date_70": 2010.0, "pmid_journal_70": "British journal of haematology"}, {"pmid_title_71": "Pre-transplant risk factors affecting outcome in Hurler syndrome.", "pmid_71": 19898501.0, "pmid_date_71": 2010.0, "pmid_journal_71": "Bone marrow transplantation"}, {"pmid_title_72": "Oral features and dental health in Hurler Syndrome following hematopoietic stem cell transplantation.", "pmid_72": 20545789.0, "pmid_date_72": 2010.0, "pmid_journal_72": "International journal of paediatric dentistry"}, {"pmid_title_73": "Clinical outcome of cerebrospinal fluid shunting for communicating hydrocephalus in mucopolysaccharidoses I, II, and III: a retrospective analysis of 13 patients.", "pmid_73": 21107178.0, "pmid_date_73": 2010.0, "pmid_journal_73": "Neurosurgery"}, {"pmid_title_74": "Characterization of surgical procedures in patients with mucopolysaccharidosis type I: findings from the MPS I Registry.", "pmid_74": 19217123.0, "pmid_date_74": 2009.0, "pmid_journal_74": "The Journal of pediatrics"}, {"pmid_title_75": "Cervical fixation in the pediatric patient: our experience.", "pmid_75": 19404690.0, "pmid_date_75": 2009.0, "pmid_journal_75": "European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society"}, {"pmid_title_76": "Short-term growth hormone treatment in children with Hurler syndrome after hematopoietic cell transplantation.", "pmid_76": 19252529.0, "pmid_date_76": 2009.0, "pmid_journal_76": "Bone marrow transplantation"}, {"pmid_title_77": "Mobility in Hurler syndrome.", "pmid_77": 18388709.0, "pmid_date_77": 2008.0, "pmid_journal_77": "Journal of pediatric orthopedics"}, {"pmid_title_78": "Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I.", "pmid_78": 16860035.0, "pmid_date_78": 2006.0, "pmid_journal_78": "The American journal of cardiology"}, {"pmid_title_79": "Musculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantation.", "pmid_79": 14676543.0, "pmid_date_79": 2004.0, "pmid_journal_79": "Journal of pediatric orthopedics"}, {"pmid_title_80": "Airway management in mucopolysaccharide storage disorders.", "pmid_80": 14967758.0, "pmid_date_80": 2004.0, "pmid_journal_80": "Archives of otolaryngology--head & neck surgery"}, {"pmid_title_81": "Usefulness of bone marrow transplantation in the Hurler syndrome.", "pmid_81": 14516901.0, "pmid_date_81": 2003.0, "pmid_journal_81": "The American journal of cardiology"}]}, {"_id": "5391-OMIM:607015", "condition": {"condition_name": "HURLER-SCHEIE SYNDROME", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["SCHEIE SYNDROME", "HURLER-SCHEIE SYNDROME", "HURLER SYNDROME"]}, "gene information": {"db_hgnc_gene_id": 5391.0}, "interventions": [{"int_description_1": "Continuous positive airway pressure"}, {"int_description_2": "Pressure Equalizer (PE)\u00a0Tube\u00a0Insertion"}, {"int_description_3": "Pentosan polysulfate"}, {"int_description_4": "Adalimumab"}, {"int_description_5": "Somatotropin"}, {"int_description_6": "Ataluren"}, {"int_description_7": "Blood-brain-barrier (BBB)-penetrating recombinant alpha-L-iduronidase (JR-171)"}, {"int_description_8": "Laronidase"}, {"int_description_9": "ELX-02"}, {"int_description_10": "Valanafusp alfa"}, {"int_description_11": "Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus"}, {"int_description_12": "Autologous CD34+ haematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the alpha-L-iduronidase cDNA"}, {"int_description_13": "Autologous Plasmablasts\u00a0engineered to express alpha-L-iduronidase (IDUA)"}, {"int_description_14": "Haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate (ECT-001)", "timeframe_int14": "Days or Weeks", "age_use_int14": "Infant,Child", "contra_int14": "No", "qualscale_reclass_drug14": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}, {"int_description_15": "Adeno-associated viral vector serotype 2/6 encoding zinc-finger nucleases and the human alpha L-iduronidase gene (SB-318)"}, {"int_description_16": "Recombinant adeno-associated viral vector serotype 9 containing human iduronidase gene (RGX-111)"}, {"int_description_17": "Physical therapy"}, {"int_description_18": "Adenoidectomy"}, {"int_description_19": "Bone marrow transplantation"}, {"int_description_20": "Cardiac valve replacement"}, {"int_description_21": "Corneal transplantation"}, {"int_description_22": "Haematopoietic stem cell transplantation", "timeframe_int22": "Days or Weeks", "age_use_int22": "Infant,Child", "contra_int22": "No", "qualscale_reclass_drug22": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug22": "Effective / Ameliorative"}, {"int_description_23": "Orthopaedic surgery (atlanto-occipital stabilization)"}, {"int_description_24": "Orthopaedic surgery (early median nerve decompression)"}, {"int_description_25": "Orthopaedic surgery (joint replacement)"}, {"int_description_26": "Tonsillectomy"}, {"int_description_27": "Tracheostomy"}, {"int_description_28": "Ventriculoperitoneal shunting"}], "references": [{"pmid_title_1": "ELX-02 Generates Protein via Premature Stop Codon Read-Through without Inducing Native Stop Codon Read-Through Proteins.", "pmid_1": 32376628.0, "pmid_date_1": 2020.0, "pmid_journal_1": "The Journal of pharmacology and experimental therapeutics"}, {"pmid_title_2": "ELX-02: an investigational read-through agent for the treatment of nonsense mutation-related genetic disease.", "pmid_2": 32972261.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Expert opinion on investigational drugs"}, {"pmid_title_3": "Intrathecal enzyme replacement for cognitive decline in mucopolysaccharidosis type I, a randomized, open-label, controlled pilot study.", "pmid_3": 31839529.0, "pmid_date_3": 2020.0, "pmid_journal_3": "Molecular genetics and metabolism"}, {"pmid_title_4": "Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of ELX-02, a Potential Treatment for Genetic Disorders Caused by Nonsense Mutations, in Healthy Volunteers.", "pmid_4": 30650260.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Clinical pharmacology in drug development"}, {"pmid_title_5": "The novel aminoglycoside, ELX-02, permits CTNSW138X translational read-through and restores lysosomal cystine efflux in cystinosis.", "pmid_5": 31800572.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PloS one"}, {"pmid_title_6": "CRISPR target prediction remains blunt tool for clinical applications.", "pmid_6": 30833770.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Nature biotechnology"}, {"pmid_title_7": "Publisher Correction: CRISPR target prediction remains blunt tool for clinical applications.", "pmid_7": 30894681.0, "pmid_date_7": 2019.0, "pmid_journal_7": "Nature biotechnology"}, {"pmid_title_8": "Hematopoietic cell transplantation for severe MPS I in the first six months of life: The heart of the matter.", "pmid_8": 30503158.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Molecular genetics and metabolism"}, {"pmid_title_9": "Early enzyme replacement therapy enables a successful hematopoietic stem cell transplantation in mucopolysaccharidosis type IH: Divergent clinical outcomes in two Japanese siblings.", "pmid_9": 30755342.0, "pmid_date_9": 2019.0, "pmid_journal_9": "Brain & development"}, {"pmid_title_10": "Deep Anterior Lamellar Keratoplasty in a Case of Hurler-Scheie Syndrome Undergoing Enzyme Replacement Therapy.", "pmid_10": 30575621.0, "pmid_date_10": 2019.0, "pmid_journal_10": "Cornea"}, {"pmid_title_11": "Limited data to evaluate real-world effectiveness of enzyme replacement therapy for mucopolysaccharidosis type I.", "pmid_11": 31020996.0, "pmid_date_11": 2019.0, "pmid_journal_11": "Journal of inherited metabolic disease"}, {"pmid_title_12": "Healthcare Resource Utilization and the Cost of Care for Mucopolysaccharidosis I Patients in Iran.", "pmid_12": 31082797.0, "pmid_date_12": 2019.0, "pmid_journal_12": "Value in health regional issues"}, {"pmid_title_13": "CASE SERIES OF PATIENTS UNDER BIWEEKLY TREATMENT WITH LARONIDASE: A REPORT OF A SINGLE CENTER EXPERIENCE.", "pmid_13": 31090850.0, "pmid_date_13": 2019.0, "pmid_journal_13": "Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo"}, {"pmid_title_14": "Enzyme replacement therapy with laronidase (Aldurazyme<sup>\u00ae</sup>) for treating mucopolysaccharidosis type I.", "pmid_14": 31211405.0, "pmid_date_14": 2019.0, "pmid_journal_14": "The Cochrane database of systematic reviews"}, {"pmid_title_15": "Post-transplant laronidase augmentation for children with Hurler syndrome: biochemical outcomes.", "pmid_15": 31575939.0, "pmid_date_15": 2019.0, "pmid_journal_15": "Scientific reports"}, {"pmid_title_16": "Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases.", "pmid_16": 31639024.0, "pmid_date_16": 2019.0, "pmid_journal_16": "Orphanet journal of rare diseases"}, {"pmid_title_17": "Agreement between the results of meta-analyses from case reports and from clinical studies regarding the efficacy of laronidase therapy in patients with mucopolysaccharidosis type I who initiated enzyme replacement therapy in adult age: An example of case reports meta-analyses as an useful tool for evidence-based medicine in rare diseases.", "pmid_17": 29336994.0, "pmid_date_17": 2018.0, "pmid_journal_17": "Molecular genetics and metabolism"}, {"pmid_title_18": "International working group identifies need for newborn screening for mucopolysaccharidosis type I but states that existing hurdles must be overcome.", "pmid_18": 30242902.0, "pmid_date_18": 2018.0, "pmid_journal_18": "Acta paediatrica (Oslo, Norway : 1992)"}, {"pmid_title_19": "The effect of haemopoietic stem cell transplantation on the ocular phenotype in mucopolysaccharidosis type I (Hurler).", "pmid_19": 29240299.0, "pmid_date_19": 2018.0, "pmid_journal_19": "Acta ophthalmologica"}, {"pmid_title_20": "Carbon nanotubes as nanovectors for intracellular delivery of laronidase in Mucopolysaccharidosis type I.", "pmid_20": 29239447.0, "pmid_date_20": 2018.0, "pmid_journal_20": "Nanoscale"}, {"pmid_title_21": "Plasma Pharmacokinetics of Valanafusp Alpha, a Human Insulin Receptor Antibody-Iduronidase Fusion Protein, in Patients with Mucopolysaccharidosis Type I.", "pmid_21": 29442294.0, "pmid_date_21": 2018.0, "pmid_journal_21": "BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy"}, {"pmid_title_22": "Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial.", "pmid_22": 29976218.0, "pmid_date_22": 2018.0, "pmid_journal_22": "Orphanet journal of rare diseases"}, {"pmid_title_23": "Short stature as a presenting symptom of attenuated Mucopolysaccharidosis type I: case report and clinical insights.", "pmid_23": 30419879.0, "pmid_date_23": 2018.0, "pmid_journal_23": "BMC endocrine disorders"}, {"pmid_title_24": "Open issues in Mucopolysaccharidosis type I-Hurler.", "pmid_24": 28619065.0, "pmid_date_24": 2017.0, "pmid_journal_24": "Orphanet journal of rare diseases"}, {"pmid_title_25": "Efficacy of laronidase therapy in patients with mucopolysaccharidosis type I who initiated enzyme replacement therapy in adult age. A systematic review and meta-analysis.", "pmid_25": 28410878.0, "pmid_date_25": 2017.0, "pmid_journal_25": "Molecular genetics and metabolism"}, {"pmid_title_26": "Efficacy and safety of intravenous laronidase for mucopolysaccharidosis type I: A systematic review and meta-analysis.", "pmid_26": 28859139.0, "pmid_date_26": 2017.0, "pmid_journal_26": "PloS one"}, {"pmid_title_27": "Pilot study of the safety and effect of adalimumab on pain, physical function, and musculoskeletal disease in mucopolysaccharidosis types I and II.", "pmid_27": 28119823.0, "pmid_date_27": 2017.0, "pmid_journal_27": "Molecular genetics and metabolism reports"}, {"pmid_title_28": "Outcome of Combined Mitral and Aortic Valve Replacement in Adults With Mucopolysaccharidosis (the Hurler Syndrome).", "pmid_28": 28964381.0, "pmid_date_28": 2017.0, "pmid_journal_28": "The American journal of cardiology"}, {"pmid_title_29": "Mortality after hematopoietic stem cell transplantation for severe mucopolysaccharidosis type I: the 30-year University of Minnesota experience.", "pmid_29": 28054207.0, "pmid_date_29": 2017.0, "pmid_journal_29": "Journal of inherited metabolic disease"}, {"pmid_title_30": "Changes in the incidence, patterns and outcomes of graft failure following hematopoietic stem cell transplantation for Hurler syndrome.", "pmid_30": 28218755.0, "pmid_date_30": 2017.0, "pmid_journal_30": "Bone marrow transplantation"}, {"pmid_title_31": "Long term survival and cardiopulmonary outcome in children with Hurler syndrome after haematopoietic stem cell transplantation.", "pmid_31": 28283844.0, "pmid_date_31": 2017.0, "pmid_journal_31": "Journal of inherited metabolic disease"}, {"pmid_title_32": "Incomplete biomarker response in mucopolysaccharidosis type I after successful hematopoietic cell transplantation.", "pmid_32": 28684085.0, "pmid_date_32": 2017.0, "pmid_journal_32": "Molecular genetics and metabolism"}, {"pmid_title_33": "Role of rehabilitation in Hurler's syndrome.", "pmid_33": 27911282.0, "pmid_date_33": 2017.0, "pmid_journal_33": "Journal of back and musculoskeletal rehabilitation"}, {"pmid_title_34": "Early disease progression of Hurler syndrome.", "pmid_34": 28193245.0, "pmid_date_34": 2017.0, "pmid_journal_34": "Orphanet journal of rare diseases"}, {"pmid_title_35": "Mucopolysaccharidosis Type I", "pmid_35": 20301341.0, "pmid_date_35": 2016.0, "pmid_journal_35": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_36": "Enzyme replacement therapy with laronidase (Aldurazyme(\u00ae)) for treating mucopolysaccharidosis type I.", "pmid_36": 27033167.0, "pmid_date_36": 2016.0, "pmid_journal_36": "The Cochrane database of systematic reviews"}, {"pmid_title_37": "Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres.", "pmid_37": 26832957.0, "pmid_date_37": 2016.0, "pmid_journal_37": "Molecular genetics and metabolism"}, {"pmid_title_38": "The impact of laronidase treatment in otolaryngological manifestations of patients with mucopolysaccharidosis.", "pmid_38": 26750310.0, "pmid_date_38": 2016.0, "pmid_journal_38": "Brazilian journal of otorhinolaryngology"}, {"pmid_title_39": "Effect of anti-laronidase antibodies on efficacy and safety of laronidase enzyme replacement therapy for MPS I: A comprehensive meta-analysis of pooled data from multiple studies.", "pmid_39": 26920513.0, "pmid_date_39": 2016.0, "pmid_journal_39": "Molecular genetics and metabolism"}, {"pmid_title_40": "12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatment.", "pmid_40": 26965916.0, "pmid_date_40": 2016.0, "pmid_journal_40": "BMC medical genetics"}, {"pmid_title_41": "Alternative laronidase dose regimen for patients with mucopolysaccharidosis I: a multinational, retrospective, chart review case series.", "pmid_41": 27129473.0, "pmid_date_41": 2016.0, "pmid_journal_41": "Orphanet journal of rare diseases"}, {"pmid_title_42": "Outcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type I.", "pmid_42": 27788836.0, "pmid_date_42": 2016.0, "pmid_journal_42": "The Journal of pediatrics"}, {"pmid_title_43": "Laronidase desensitization during stem cell transplant in a child with Hurler syndrome.", "pmid_43": 26916445.0, "pmid_date_43": 2016.0, "pmid_journal_43": "Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology"}, {"pmid_title_44": "Treatment with pentosan polysulphate in patients with MPS I: results from an open label, randomized, monocentric phase II study.", "pmid_44": 27590017.0, "pmid_date_44": 2016.0, "pmid_journal_44": "Journal of inherited metabolic disease"}, {"pmid_title_45": "Enzymes approved for human therapy: indications, mechanisms and adverse effects.", "pmid_45": 25648140.0, "pmid_date_45": 2015.0, "pmid_journal_45": "BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy"}, {"pmid_title_46": "Urgent resection of a giant left atrial appendage aneurysm and mitral valve replacement in a complex case of Hurler-Scheie syndrome.", "pmid_46": 26546621.0, "pmid_date_46": 2015.0, "pmid_journal_46": "BMJ case reports"}, {"pmid_title_47": "Residual glycosaminoglycan accumulation in mitral and aortic valves of a patient with attenuated MPS I (Scheie syndrome) after 6\u00a0years of enzyme replacement therapy: Implications for early diagnosis and therapy.", "pmid_47": 28649551.0, "pmid_date_47": 2015.0, "pmid_journal_47": "Molecular genetics and metabolism reports"}, {"pmid_title_48": "Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study.", "pmid_48": 25624320.0, "pmid_date_48": 2015.0, "pmid_journal_48": "Blood"}, {"pmid_title_49": "Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines.", "pmid_49": 25708213.0, "pmid_date_49": 2015.0, "pmid_journal_49": "Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation"}, {"pmid_title_50": "Obstructive sleep apnea syndrome after hematopoietic stem cell transplantation in children with mucopolysaccharidosis type I.", "pmid_50": 26602600.0, "pmid_date_50": 2015.0, "pmid_journal_50": "Molecular genetics and metabolism"}, {"pmid_title_51": "Biomarker responses correlate with antibody status in mucopolysaccharidosis type I patients on long-term enzyme replacement therapy.", "pmid_51": 25467058.0, "pmid_date_51": 2015.0, "pmid_journal_51": "Molecular genetics and metabolism"}, {"pmid_title_52": "Successful pregnancy and breastfeeding in a woman with mucopolysaccharidosis type I while receiving laronidase enzyme replacement. therapy.", "pmid_52": 25864295.0, "pmid_date_52": 2015.0, "pmid_journal_52": "Clinical and experimental obstetrics & gynecology"}, {"pmid_title_53": "Diffusion tensor imaging and myelin composition analysis reveal abnormal myelination in corpus callosum of canine mucopolysaccharidosis I.", "pmid_53": 26222335.0, "pmid_date_53": 2015.0, "pmid_journal_53": "Experimental neurology"}, {"pmid_title_54": "Safety of laronidase delivered into the spinal canal for treatment of cervical stenosis in mucopolysaccharidosis I.", "pmid_54": 26260077.0, "pmid_date_54": 2015.0, "pmid_journal_54": "Molecular genetics and metabolism"}, {"pmid_title_55": "Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships.", "pmid_55": 26446585.0, "pmid_date_55": 2015.0, "pmid_journal_55": "Orphanet journal of rare diseases"}, {"pmid_title_56": "Mucopolysaccharidosis type I.", "pmid_56": 25345091.0, "pmid_date_56": 2014.0, "pmid_journal_56": "Pediatric endocrinology reviews : PER"}, {"pmid_title_57": "Effect of recombinant human growth hormone on changes in height, bone mineral density, and body composition over 1-2 years in children with Hurler or Hunter syndrome.", "pmid_57": 24368158.0, "pmid_date_57": 2014.0, "pmid_journal_57": "Molecular genetics and metabolism"}, {"pmid_title_58": "Growth hormone treatment in a patient with Hurler-Scheie syndrome.", "pmid_58": 24825081.0, "pmid_date_58": 2014.0, "pmid_journal_58": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_59": "Mucopolysaccharide disorders in orthopaedic surgery.", "pmid_59": 23281467.0, "pmid_date_59": 2013.0, "pmid_journal_59": "The Journal of the American Academy of Orthopaedic Surgeons"}, {"pmid_title_60": "Cardiac Ultrasound Findings in Infants with Severe (Hurler Phenotype) Untreated Mucopolysaccharidosis (MPS) Type I.", "pmid_60": 23430808.0, "pmid_date_60": 2013.0, "pmid_journal_60": "JIMD reports"}, {"pmid_title_61": "Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experience.", "pmid_61": 22718273.0, "pmid_date_61": 2013.0, "pmid_journal_61": "Journal of inherited metabolic disease"}, {"pmid_title_62": "Enzyme replacement is associated with better cognitive outcomes after transplant in Hurler syndrome.", "pmid_62": 22974573.0, "pmid_date_62": 2013.0, "pmid_journal_62": "The Journal of pediatrics"}, {"pmid_title_63": "Residual \u03b1-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.", "pmid_63": 23786846.0, "pmid_date_63": 2013.0, "pmid_journal_63": "Molecular genetics and metabolism"}, {"pmid_title_64": "Pentosan polysulfate: a novel therapy for the mucopolysaccharidoses.", "pmid_64": 23365668.0, "pmid_date_64": 2013.0, "pmid_journal_64": "PloS one"}, {"pmid_title_65": "Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler's syndrome after pharmacological enzyme replacement therapy.", "pmid_65": 22371174.0, "pmid_date_65": 2012.0, "pmid_journal_65": "Haematologica"}, {"pmid_title_66": "[Carpal tunnel syndrome in children with mucopolysaccharidosis type 1H: diagnosis and therapy in an interdisciplinary centre].", "pmid_66": 22382905.0, "pmid_date_66": 2012.0, "pmid_journal_66": "Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V..."}, {"pmid_title_67": "High rate of postoperative mortality in patients with mucopolysaccharidosis I: findings from the MPS I Registry.", "pmid_67": 22424341.0, "pmid_date_67": 2012.0, "pmid_journal_67": "Journal of pediatric surgery"}, {"pmid_title_68": "Anesthetic management in children with Hurler's syndrome undergoing emergency ventriculoperitoneal shunt surgery.", "pmid_68": 22754449.0, "pmid_date_68": 2012.0, "pmid_journal_68": "Saudi journal of anaesthesia"}, {"pmid_title_69": "Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure.", "pmid_69": 21831279.0, "pmid_date_69": 2011.0, "pmid_journal_69": "Orphanet journal of rare diseases"}, {"pmid_title_70": "Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions.", "pmid_70": 19919654.0, "pmid_date_70": 2010.0, "pmid_journal_70": "British journal of haematology"}, {"pmid_title_71": "Pre-transplant risk factors affecting outcome in Hurler syndrome.", "pmid_71": 19898501.0, "pmid_date_71": 2010.0, "pmid_journal_71": "Bone marrow transplantation"}, {"pmid_title_72": "Oral features and dental health in Hurler Syndrome following hematopoietic stem cell transplantation.", "pmid_72": 20545789.0, "pmid_date_72": 2010.0, "pmid_journal_72": "International journal of paediatric dentistry"}, {"pmid_title_73": "Clinical outcome of cerebrospinal fluid shunting for communicating hydrocephalus in mucopolysaccharidoses I, II, and III: a retrospective analysis of 13 patients.", "pmid_73": 21107178.0, "pmid_date_73": 2010.0, "pmid_journal_73": "Neurosurgery"}, {"pmid_title_74": "Characterization of surgical procedures in patients with mucopolysaccharidosis type I: findings from the MPS I Registry.", "pmid_74": 19217123.0, "pmid_date_74": 2009.0, "pmid_journal_74": "The Journal of pediatrics"}, {"pmid_title_75": "Cervical fixation in the pediatric patient: our experience.", "pmid_75": 19404690.0, "pmid_date_75": 2009.0, "pmid_journal_75": "European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society"}, {"pmid_title_76": "Short-term growth hormone treatment in children with Hurler syndrome after hematopoietic cell transplantation.", "pmid_76": 19252529.0, "pmid_date_76": 2009.0, "pmid_journal_76": "Bone marrow transplantation"}, {"pmid_title_77": "Mobility in Hurler syndrome.", "pmid_77": 18388709.0, "pmid_date_77": 2008.0, "pmid_journal_77": "Journal of pediatric orthopedics"}, {"pmid_title_78": "Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I.", "pmid_78": 16860035.0, "pmid_date_78": 2006.0, "pmid_journal_78": "The American journal of cardiology"}, {"pmid_title_79": "Musculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantation.", "pmid_79": 14676543.0, "pmid_date_79": 2004.0, "pmid_journal_79": "Journal of pediatric orthopedics"}, {"pmid_title_80": "Airway management in mucopolysaccharide storage disorders.", "pmid_80": 14967758.0, "pmid_date_80": 2004.0, "pmid_journal_80": "Archives of otolaryngology--head & neck surgery"}, {"pmid_title_81": "Usefulness of bone marrow transplantation in the Hurler syndrome.", "pmid_81": 14516901.0, "pmid_date_81": 2003.0, "pmid_journal_81": "The American journal of cardiology"}]}, {"_id": "5391-OMIM:607016", "condition": {"condition_name": "SCHEIE SYNDROME", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["HURLER-SCHEIE SYNDROME", "SCHEIE SYNDROME", "HURLER SYNDROME"]}, "gene information": {"db_hgnc_gene_id": 5391.0}, "interventions": [{"int_description_1": "Continuous positive airway pressure"}, {"int_description_2": "Pressure Equalizer (PE)\u00a0Tube\u00a0Insertion"}, {"int_description_3": "Pentosan polysulfate"}, {"int_description_4": "Adalimumab"}, {"int_description_5": "Somatotropin"}, {"int_description_6": "Ataluren"}, {"int_description_7": "Blood-brain-barrier (BBB)-penetrating recombinant alpha-L-iduronidase (JR-171)"}, {"int_description_8": "Laronidase"}, {"int_description_9": "ELX-02"}, {"int_description_10": "Valanafusp alfa"}, {"int_description_11": "Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus"}, {"int_description_12": "Autologous CD34+ haematopoietic stem and progenitor cells genetically modified with the lentiviral vector IDUA LV, encoding for the alpha-L-iduronidase cDNA"}, {"int_description_13": "Autologous Plasmablasts\u00a0engineered to express alpha-L-iduronidase (IDUA)"}, {"int_description_14": "Haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate (ECT-001)", "timeframe_int14": "Days or Weeks", "age_use_int14": "Infant,Child", "contra_int14": "No", "qualscale_reclass_drug14": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}, {"int_description_15": "Adeno-associated viral vector serotype 2/6 encoding zinc-finger nucleases and the human alpha L-iduronidase gene (SB-318)"}, {"int_description_16": "Recombinant adeno-associated viral vector serotype 9 containing human iduronidase gene (RGX-111)"}, {"int_description_17": "Physical therapy"}, {"int_description_18": "Adenoidectomy"}, {"int_description_19": "Bone marrow transplantation"}, {"int_description_20": "Cardiac valve replacement"}, {"int_description_21": "Corneal transplantation"}, {"int_description_22": "Haematopoietic stem cell transplantation"}, {"int_description_23": "Orthopaedic surgery (atlanto-occipital stabilization)"}, {"int_description_24": "Orthopaedic surgery (early median nerve decompression)"}, {"int_description_25": "Orthopaedic surgery (joint replacement)"}, {"int_description_26": "Tonsillectomy"}, {"int_description_27": "Tracheostomy"}, {"int_description_28": "Ventriculoperitoneal shunting"}], "references": [{"pmid_title_1": "ELX-02 Generates Protein via Premature Stop Codon Read-Through without Inducing Native Stop Codon Read-Through Proteins.", "pmid_1": 32376628.0, "pmid_date_1": 2020.0, "pmid_journal_1": "The Journal of pharmacology and experimental therapeutics"}, {"pmid_title_2": "ELX-02: an investigational read-through agent for the treatment of nonsense mutation-related genetic disease.", "pmid_2": 32972261.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Expert opinion on investigational drugs"}, {"pmid_title_3": "Intrathecal enzyme replacement for cognitive decline in mucopolysaccharidosis type I, a randomized, open-label, controlled pilot study.", "pmid_3": 31839529.0, "pmid_date_3": 2020.0, "pmid_journal_3": "Molecular genetics and metabolism"}, {"pmid_title_4": "Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of ELX-02, a Potential Treatment for Genetic Disorders Caused by Nonsense Mutations, in Healthy Volunteers.", "pmid_4": 30650260.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Clinical pharmacology in drug development"}, {"pmid_title_5": "The novel aminoglycoside, ELX-02, permits CTNSW138X translational read-through and restores lysosomal cystine efflux in cystinosis.", "pmid_5": 31800572.0, "pmid_date_5": 2019.0, "pmid_journal_5": "PloS one"}, {"pmid_title_6": "CRISPR target prediction remains blunt tool for clinical applications.", "pmid_6": 30833770.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Nature biotechnology"}, {"pmid_title_7": "Publisher Correction: CRISPR target prediction remains blunt tool for clinical applications.", "pmid_7": 30894681.0, "pmid_date_7": 2019.0, "pmid_journal_7": "Nature biotechnology"}, {"pmid_title_8": "Hematopoietic cell transplantation for severe MPS I in the first six months of life: The heart of the matter.", "pmid_8": 30503158.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Molecular genetics and metabolism"}, {"pmid_title_9": "Early enzyme replacement therapy enables a successful hematopoietic stem cell transplantation in mucopolysaccharidosis type IH: Divergent clinical outcomes in two Japanese siblings.", "pmid_9": 30755342.0, "pmid_date_9": 2019.0, "pmid_journal_9": "Brain & development"}, {"pmid_title_10": "Deep Anterior Lamellar Keratoplasty in a Case of Hurler-Scheie Syndrome Undergoing Enzyme Replacement Therapy.", "pmid_10": 30575621.0, "pmid_date_10": 2019.0, "pmid_journal_10": "Cornea"}, {"pmid_title_11": "Limited data to evaluate real-world effectiveness of enzyme replacement therapy for mucopolysaccharidosis type I.", "pmid_11": 31020996.0, "pmid_date_11": 2019.0, "pmid_journal_11": "Journal of inherited metabolic disease"}, {"pmid_title_12": "Healthcare Resource Utilization and the Cost of Care for Mucopolysaccharidosis I Patients in Iran.", "pmid_12": 31082797.0, "pmid_date_12": 2019.0, "pmid_journal_12": "Value in health regional issues"}, {"pmid_title_13": "CASE SERIES OF PATIENTS UNDER BIWEEKLY TREATMENT WITH LARONIDASE: A REPORT OF A SINGLE CENTER EXPERIENCE.", "pmid_13": 31090850.0, "pmid_date_13": 2019.0, "pmid_journal_13": "Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo"}, {"pmid_title_14": "Enzyme replacement therapy with laronidase (Aldurazyme<sup>\u00ae</sup>) for treating mucopolysaccharidosis type I.", "pmid_14": 31211405.0, "pmid_date_14": 2019.0, "pmid_journal_14": "The Cochrane database of systematic reviews"}, {"pmid_title_15": "Post-transplant laronidase augmentation for children with Hurler syndrome: biochemical outcomes.", "pmid_15": 31575939.0, "pmid_date_15": 2019.0, "pmid_journal_15": "Scientific reports"}, {"pmid_title_16": "Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases.", "pmid_16": 31639024.0, "pmid_date_16": 2019.0, "pmid_journal_16": "Orphanet journal of rare diseases"}, {"pmid_title_17": "Agreement between the results of meta-analyses from case reports and from clinical studies regarding the efficacy of laronidase therapy in patients with mucopolysaccharidosis type I who initiated enzyme replacement therapy in adult age: An example of case reports meta-analyses as an useful tool for evidence-based medicine in rare diseases.", "pmid_17": 29336994.0, "pmid_date_17": 2018.0, "pmid_journal_17": "Molecular genetics and metabolism"}, {"pmid_title_18": "International working group identifies need for newborn screening for mucopolysaccharidosis type I but states that existing hurdles must be overcome.", "pmid_18": 30242902.0, "pmid_date_18": 2018.0, "pmid_journal_18": "Acta paediatrica (Oslo, Norway : 1992)"}, {"pmid_title_19": "The effect of haemopoietic stem cell transplantation on the ocular phenotype in mucopolysaccharidosis type I (Hurler).", "pmid_19": 29240299.0, "pmid_date_19": 2018.0, "pmid_journal_19": "Acta ophthalmologica"}, {"pmid_title_20": "Carbon nanotubes as nanovectors for intracellular delivery of laronidase in Mucopolysaccharidosis type I.", "pmid_20": 29239447.0, "pmid_date_20": 2018.0, "pmid_journal_20": "Nanoscale"}, {"pmid_title_21": "Plasma Pharmacokinetics of Valanafusp Alpha, a Human Insulin Receptor Antibody-Iduronidase Fusion Protein, in Patients with Mucopolysaccharidosis Type I.", "pmid_21": 29442294.0, "pmid_date_21": 2018.0, "pmid_journal_21": "BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy"}, {"pmid_title_22": "Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial.", "pmid_22": 29976218.0, "pmid_date_22": 2018.0, "pmid_journal_22": "Orphanet journal of rare diseases"}, {"pmid_title_23": "Short stature as a presenting symptom of attenuated Mucopolysaccharidosis type I: case report and clinical insights.", "pmid_23": 30419879.0, "pmid_date_23": 2018.0, "pmid_journal_23": "BMC endocrine disorders"}, {"pmid_title_24": "Open issues in Mucopolysaccharidosis type I-Hurler.", "pmid_24": 28619065.0, "pmid_date_24": 2017.0, "pmid_journal_24": "Orphanet journal of rare diseases"}, {"pmid_title_25": "Efficacy of laronidase therapy in patients with mucopolysaccharidosis type I who initiated enzyme replacement therapy in adult age. A systematic review and meta-analysis.", "pmid_25": 28410878.0, "pmid_date_25": 2017.0, "pmid_journal_25": "Molecular genetics and metabolism"}, {"pmid_title_26": "Efficacy and safety of intravenous laronidase for mucopolysaccharidosis type I: A systematic review and meta-analysis.", "pmid_26": 28859139.0, "pmid_date_26": 2017.0, "pmid_journal_26": "PloS one"}, {"pmid_title_27": "Pilot study of the safety and effect of adalimumab on pain, physical function, and musculoskeletal disease in mucopolysaccharidosis types I and II.", "pmid_27": 28119823.0, "pmid_date_27": 2017.0, "pmid_journal_27": "Molecular genetics and metabolism reports"}, {"pmid_title_28": "Outcome of Combined Mitral and Aortic Valve Replacement in Adults With Mucopolysaccharidosis (the Hurler Syndrome).", "pmid_28": 28964381.0, "pmid_date_28": 2017.0, "pmid_journal_28": "The American journal of cardiology"}, {"pmid_title_29": "Mortality after hematopoietic stem cell transplantation for severe mucopolysaccharidosis type I: the 30-year University of Minnesota experience.", "pmid_29": 28054207.0, "pmid_date_29": 2017.0, "pmid_journal_29": "Journal of inherited metabolic disease"}, {"pmid_title_30": "Changes in the incidence, patterns and outcomes of graft failure following hematopoietic stem cell transplantation for Hurler syndrome.", "pmid_30": 28218755.0, "pmid_date_30": 2017.0, "pmid_journal_30": "Bone marrow transplantation"}, {"pmid_title_31": "Long term survival and cardiopulmonary outcome in children with Hurler syndrome after haematopoietic stem cell transplantation.", "pmid_31": 28283844.0, "pmid_date_31": 2017.0, "pmid_journal_31": "Journal of inherited metabolic disease"}, {"pmid_title_32": "Incomplete biomarker response in mucopolysaccharidosis type I after successful hematopoietic cell transplantation.", "pmid_32": 28684085.0, "pmid_date_32": 2017.0, "pmid_journal_32": "Molecular genetics and metabolism"}, {"pmid_title_33": "Role of rehabilitation in Hurler's syndrome.", "pmid_33": 27911282.0, "pmid_date_33": 2017.0, "pmid_journal_33": "Journal of back and musculoskeletal rehabilitation"}, {"pmid_title_34": "Early disease progression of Hurler syndrome.", "pmid_34": 28193245.0, "pmid_date_34": 2017.0, "pmid_journal_34": "Orphanet journal of rare diseases"}, {"pmid_title_35": "Mucopolysaccharidosis Type I", "pmid_35": 20301341.0, "pmid_date_35": 2016.0, "pmid_journal_35": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_36": "Enzyme replacement therapy with laronidase (Aldurazyme(\u00ae)) for treating mucopolysaccharidosis type I.", "pmid_36": 27033167.0, "pmid_date_36": 2016.0, "pmid_journal_36": "The Cochrane database of systematic reviews"}, {"pmid_title_37": "Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres.", "pmid_37": 26832957.0, "pmid_date_37": 2016.0, "pmid_journal_37": "Molecular genetics and metabolism"}, {"pmid_title_38": "The impact of laronidase treatment in otolaryngological manifestations of patients with mucopolysaccharidosis.", "pmid_38": 26750310.0, "pmid_date_38": 2016.0, "pmid_journal_38": "Brazilian journal of otorhinolaryngology"}, {"pmid_title_39": "Effect of anti-laronidase antibodies on efficacy and safety of laronidase enzyme replacement therapy for MPS I: A comprehensive meta-analysis of pooled data from multiple studies.", "pmid_39": 26920513.0, "pmid_date_39": 2016.0, "pmid_journal_39": "Molecular genetics and metabolism"}, {"pmid_title_40": "12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatment.", "pmid_40": 26965916.0, "pmid_date_40": 2016.0, "pmid_journal_40": "BMC medical genetics"}, {"pmid_title_41": "Alternative laronidase dose regimen for patients with mucopolysaccharidosis I: a multinational, retrospective, chart review case series.", "pmid_41": 27129473.0, "pmid_date_41": 2016.0, "pmid_journal_41": "Orphanet journal of rare diseases"}, {"pmid_title_42": "Outcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type I.", "pmid_42": 27788836.0, "pmid_date_42": 2016.0, "pmid_journal_42": "The Journal of pediatrics"}, {"pmid_title_43": "Laronidase desensitization during stem cell transplant in a child with Hurler syndrome.", "pmid_43": 26916445.0, "pmid_date_43": 2016.0, "pmid_journal_43": "Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology"}, {"pmid_title_44": "Treatment with pentosan polysulphate in patients with MPS I: results from an open label, randomized, monocentric phase II study.", "pmid_44": 27590017.0, "pmid_date_44": 2016.0, "pmid_journal_44": "Journal of inherited metabolic disease"}, {"pmid_title_45": "Enzymes approved for human therapy: indications, mechanisms and adverse effects.", "pmid_45": 25648140.0, "pmid_date_45": 2015.0, "pmid_journal_45": "BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy"}, {"pmid_title_46": "Urgent resection of a giant left atrial appendage aneurysm and mitral valve replacement in a complex case of Hurler-Scheie syndrome.", "pmid_46": 26546621.0, "pmid_date_46": 2015.0, "pmid_journal_46": "BMJ case reports"}, {"pmid_title_47": "Residual glycosaminoglycan accumulation in mitral and aortic valves of a patient with attenuated MPS I (Scheie syndrome) after 6\u00a0years of enzyme replacement therapy: Implications for early diagnosis and therapy.", "pmid_47": 28649551.0, "pmid_date_47": 2015.0, "pmid_journal_47": "Molecular genetics and metabolism reports"}, {"pmid_title_48": "Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study.", "pmid_48": 25624320.0, "pmid_date_48": 2015.0, "pmid_journal_48": "Blood"}, {"pmid_title_49": "Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines.", "pmid_49": 25708213.0, "pmid_date_49": 2015.0, "pmid_journal_49": "Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation"}, {"pmid_title_50": "Obstructive sleep apnea syndrome after hematopoietic stem cell transplantation in children with mucopolysaccharidosis type I.", "pmid_50": 26602600.0, "pmid_date_50": 2015.0, "pmid_journal_50": "Molecular genetics and metabolism"}, {"pmid_title_51": "Biomarker responses correlate with antibody status in mucopolysaccharidosis type I patients on long-term enzyme replacement therapy.", "pmid_51": 25467058.0, "pmid_date_51": 2015.0, "pmid_journal_51": "Molecular genetics and metabolism"}, {"pmid_title_52": "Successful pregnancy and breastfeeding in a woman with mucopolysaccharidosis type I while receiving laronidase enzyme replacement. therapy.", "pmid_52": 25864295.0, "pmid_date_52": 2015.0, "pmid_journal_52": "Clinical and experimental obstetrics & gynecology"}, {"pmid_title_53": "Diffusion tensor imaging and myelin composition analysis reveal abnormal myelination in corpus callosum of canine mucopolysaccharidosis I.", "pmid_53": 26222335.0, "pmid_date_53": 2015.0, "pmid_journal_53": "Experimental neurology"}, {"pmid_title_54": "Safety of laronidase delivered into the spinal canal for treatment of cervical stenosis in mucopolysaccharidosis I.", "pmid_54": 26260077.0, "pmid_date_54": 2015.0, "pmid_journal_54": "Molecular genetics and metabolism"}, {"pmid_title_55": "Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships.", "pmid_55": 26446585.0, "pmid_date_55": 2015.0, "pmid_journal_55": "Orphanet journal of rare diseases"}, {"pmid_title_56": "Mucopolysaccharidosis type I.", "pmid_56": 25345091.0, "pmid_date_56": 2014.0, "pmid_journal_56": "Pediatric endocrinology reviews : PER"}, {"pmid_title_57": "Effect of recombinant human growth hormone on changes in height, bone mineral density, and body composition over 1-2 years in children with Hurler or Hunter syndrome.", "pmid_57": 24368158.0, "pmid_date_57": 2014.0, "pmid_journal_57": "Molecular genetics and metabolism"}, {"pmid_title_58": "Growth hormone treatment in a patient with Hurler-Scheie syndrome.", "pmid_58": 24825081.0, "pmid_date_58": 2014.0, "pmid_journal_58": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_59": "Mucopolysaccharide disorders in orthopaedic surgery.", "pmid_59": 23281467.0, "pmid_date_59": 2013.0, "pmid_journal_59": "The Journal of the American Academy of Orthopaedic Surgeons"}, {"pmid_title_60": "Cardiac Ultrasound Findings in Infants with Severe (Hurler Phenotype) Untreated Mucopolysaccharidosis (MPS) Type I.", "pmid_60": 23430808.0, "pmid_date_60": 2013.0, "pmid_journal_60": "JIMD reports"}, {"pmid_title_61": "Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experience.", "pmid_61": 22718273.0, "pmid_date_61": 2013.0, "pmid_journal_61": "Journal of inherited metabolic disease"}, {"pmid_title_62": "Enzyme replacement is associated with better cognitive outcomes after transplant in Hurler syndrome.", "pmid_62": 22974573.0, "pmid_date_62": 2013.0, "pmid_journal_62": "The Journal of pediatrics"}, {"pmid_title_63": "Residual \u03b1-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.", "pmid_63": 23786846.0, "pmid_date_63": 2013.0, "pmid_journal_63": "Molecular genetics and metabolism"}, {"pmid_title_64": "Pentosan polysulfate: a novel therapy for the mucopolysaccharidoses.", "pmid_64": 23365668.0, "pmid_date_64": 2013.0, "pmid_journal_64": "PloS one"}, {"pmid_title_65": "Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler's syndrome after pharmacological enzyme replacement therapy.", "pmid_65": 22371174.0, "pmid_date_65": 2012.0, "pmid_journal_65": "Haematologica"}, {"pmid_title_66": "[Carpal tunnel syndrome in children with mucopolysaccharidosis type 1H: diagnosis and therapy in an interdisciplinary centre].", "pmid_66": 22382905.0, "pmid_date_66": 2012.0, "pmid_journal_66": "Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V..."}, {"pmid_title_67": "High rate of postoperative mortality in patients with mucopolysaccharidosis I: findings from the MPS I Registry.", "pmid_67": 22424341.0, "pmid_date_67": 2012.0, "pmid_journal_67": "Journal of pediatric surgery"}, {"pmid_title_68": "Anesthetic management in children with Hurler's syndrome undergoing emergency ventriculoperitoneal shunt surgery.", "pmid_68": 22754449.0, "pmid_date_68": 2012.0, "pmid_journal_68": "Saudi journal of anaesthesia"}, {"pmid_title_69": "Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure.", "pmid_69": 21831279.0, "pmid_date_69": 2011.0, "pmid_journal_69": "Orphanet journal of rare diseases"}, {"pmid_title_70": "Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions.", "pmid_70": 19919654.0, "pmid_date_70": 2010.0, "pmid_journal_70": "British journal of haematology"}, {"pmid_title_71": "Pre-transplant risk factors affecting outcome in Hurler syndrome.", "pmid_71": 19898501.0, "pmid_date_71": 2010.0, "pmid_journal_71": "Bone marrow transplantation"}, {"pmid_title_72": "Oral features and dental health in Hurler Syndrome following hematopoietic stem cell transplantation.", "pmid_72": 20545789.0, "pmid_date_72": 2010.0, "pmid_journal_72": "International journal of paediatric dentistry"}, {"pmid_title_73": "Clinical outcome of cerebrospinal fluid shunting for communicating hydrocephalus in mucopolysaccharidoses I, II, and III: a retrospective analysis of 13 patients.", "pmid_73": 21107178.0, "pmid_date_73": 2010.0, "pmid_journal_73": "Neurosurgery"}, {"pmid_title_74": "Characterization of surgical procedures in patients with mucopolysaccharidosis type I: findings from the MPS I Registry.", "pmid_74": 19217123.0, "pmid_date_74": 2009.0, "pmid_journal_74": "The Journal of pediatrics"}, {"pmid_title_75": "Cervical fixation in the pediatric patient: our experience.", "pmid_75": 19404690.0, "pmid_date_75": 2009.0, "pmid_journal_75": "European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society"}, {"pmid_title_76": "Short-term growth hormone treatment in children with Hurler syndrome after hematopoietic cell transplantation.", "pmid_76": 19252529.0, "pmid_date_76": 2009.0, "pmid_journal_76": "Bone marrow transplantation"}, {"pmid_title_77": "Mobility in Hurler syndrome.", "pmid_77": 18388709.0, "pmid_date_77": 2008.0, "pmid_journal_77": "Journal of pediatric orthopedics"}, {"pmid_title_78": "Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I.", "pmid_78": 16860035.0, "pmid_date_78": 2006.0, "pmid_journal_78": "The American journal of cardiology"}, {"pmid_title_79": "Musculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantation.", "pmid_79": 14676543.0, "pmid_date_79": 2004.0, "pmid_journal_79": "Journal of pediatric orthopedics"}, {"pmid_title_80": "Airway management in mucopolysaccharide storage disorders.", "pmid_80": 14967758.0, "pmid_date_80": 2004.0, "pmid_journal_80": "Archives of otolaryngology--head & neck surgery"}, {"pmid_title_81": "Usefulness of bone marrow transplantation in the Hurler syndrome.", "pmid_81": 14516901.0, "pmid_date_81": 2003.0, "pmid_journal_81": "The American journal of cardiology"}]}, {"_id": "5394-OMIM:612923", "condition": {"condition_name": "HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3", "freq_per_birth": "The incidence of atypical hemolytic-uremic syndrome is estimated to be 1 in 500,000 people per year in the United States. The atypical form is probably about 10 times less common than the typical form.", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["MACULAR DEGENERATION, AGE-RELATED, 13", "HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3", "HELLP syndrome", "COMPLEMENT FACTOR I DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 5394.0}, "interventions": [{"int_description_1": "Prednisone"}, {"int_description_2": "Dexamethasone"}, {"int_description_3": "Labetalol"}, {"int_description_4": "Doxazosin"}, {"int_description_5": "Amlodipine", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Eculizumab"}, {"int_description_7": "Basiliximab"}, {"int_description_8": "Etanercept"}, {"int_description_9": "Cyclosporine"}, {"int_description_10": "Metronidazole"}, {"int_description_11": "Sirolimus"}, {"int_description_12": "Piperacillin", "timeframe_int12": "Days or Weeks,Years", "age_use_int12": "Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Captopril"}, {"int_description_14": "Tazobactam"}, {"int_description_15": "Ciprofloxacin"}, {"int_description_16": "Ceftriaxone"}, {"int_description_17": "Nifedipine"}, {"int_description_18": "Vincristine"}, {"int_description_19": "Fluconazole"}, {"int_description_20": "Tacrolimus"}, {"int_description_21": "Azathioprine"}, {"int_description_22": "Mycophenolate mofetil"}, {"int_description_23": "Lansoprazole"}, {"int_description_24": "Methylprednisolone"}, {"int_description_25": "Corticosteroids"}, {"int_description_26": "Iron"}, {"int_description_27": "Calcium carbonate"}, {"int_description_28": "Alginic acid"}, {"int_description_29": "Meningococcal vaccine"}, {"int_description_30": "Serine protease inhibitor"}, {"int_description_31": "Sodium bicarbonate"}, {"int_description_32": "Hemodialysis"}, {"int_description_33": "Peritoneal dialysis"}, {"int_description_34": "Plasma exchange"}, {"int_description_35": "Transfusion with packed red cells"}, {"int_description_36": "Bilateral nephrectomy"}, {"int_description_37": "Kidney transplantation", "timeframe_int37": "Hours,Days or Weeks", "age_use_int37": "Neonate,Infant,Child", "contra_int37": "No", "qualscale_reclass_drug37": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug37": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "A complement factor B mutation in a large kindred with atypical hemolytic uremic syndrome.", "pmid_1": 24906628.0, "pmid_date_1": 2014.0, "pmid_journal_1": "J Clin Immunol"}, {"pmid_title_2": "Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft.", "pmid_2": 22591029.0, "pmid_date_2": 2012.0, "pmid_journal_2": "Transpl Int"}, {"pmid_title_3": "Complement deficiency states and associated infections.", "pmid_3": 21624663.0, "pmid_date_3": 2011.0, "pmid_journal_3": "Mol Immunol"}, {"pmid_title_4": "Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy.", "pmid_4": 21643943.0, "pmid_date_4": 2011.0, "pmid_journal_4": "Pediatr Nephrol"}, {"pmid_title_5": "Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome.", "pmid_5": 22287852.0, "pmid_date_5": 2011.0, "pmid_journal_5": "Clin Pharmacol"}, {"pmid_title_6": "An adult with acute poststreptococcal glomerulonephritis complicated by hemolytic uremic syndrome and nephrotic syndrome.", "pmid_6": 16183409.0, "pmid_date_6": 2005.0, "pmid_journal_6": "Am J Kidney Dis"}, {"pmid_title_7": "Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency.", "pmid_7": 10344366.0, "pmid_date_7": 1999.0, "pmid_journal_7": "Nephrol Dial Transplant"}, {"pmid_title_8": "Human complement factor H deficiency associated with hemolytic uremic syndrome.", "pmid_8": 9848786.0, "pmid_date_8": 1998.0, "pmid_journal_8": "J Am Soc Nephrol"}]}, {"_id": "5541-OMIM:601495", "condition": {"condition_name": "AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE", "alternate_names": ["AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE"]}, "gene information": {"db_hgnc_gene_id": 5541.0}, "interventions": [{"int_description_1": "Human immunoglobulin G", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Aggressive antibiotic therapy", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Vorhyaluronidase alfa"}], "references": [{"pmid_title_1": "Agammaglobulinemia", "pmid_1": 32310401.0, "pmid_date_1": 2020.0}, {"pmid_title_2": "Genetic Approaches for Definitive Diagnosis of Agammaglobulinemia in Consanguineous Families.", "pmid_2": 31696364.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Journal of clinical immunology"}, {"pmid_title_3": "Autosomal recessive agammaglobulinemic patient with a novel large deletion in IGHM presenting with mild clinical phenotype.", "pmid_3": 31683053.0, "pmid_date_3": 2020.0, "pmid_journal_3": "Clinical immunology (Orlando, Fla.)"}, {"pmid_title_4": "Autosomal recessive agammaglobulinemia due to defect in \u03bc heavy chain caused by a novel mutation in the IGHM gene.", "pmid_4": 28769069.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Genes and immunity"}, {"pmid_title_5": "Clinical characteristics and molecular analysis of 21 Chinese children with congenital agammaglobulinemia.", "pmid_5": 21039741.0, "pmid_date_5": 2010.0, "pmid_journal_5": "Scandinavian journal of immunology"}, {"pmid_title_6": "Molecular analysis of the pre-BCR complex in a large cohort of patients affected by autosomal-recessive agammaglobulinemia.", "pmid_6": 17410177.0, "pmid_date_6": 2007.0, "pmid_journal_6": "Genes and immunity"}, {"pmid_title_7": "A new case of autosomal recessive agammaglobulinaemia with impaired pre-B cell differentiation due to a large deletion of the IGH locus.", "pmid_7": 12200606.0, "pmid_date_7": 2002.0, "pmid_journal_7": "European journal of pediatrics"}, {"pmid_title_8": "Clinical and molecular analysis of patients with defects in micro heavy chain gene.", "pmid_8": 12370281.0, "pmid_date_8": 2002.0, "pmid_journal_8": "The Journal of clinical investigation"}, {"pmid_title_9": "Mutations in the mu heavy-chain gene in patients with agammaglobulinemia.", "pmid_9": 8890099.0, "pmid_date_9": 1996.0, "pmid_journal_9": "The New England journal of medicine"}]}, {"_id": "57-OMIM:264800", "condition": {"condition_name": "PSEUDOXANTHOMA ELASTICUM; PXE", "freq_per_birth": "PXE affects approximately 1 in 50,000 people worldwide. For reasons that are unclear, this disorder is diagnosed twice as frequently in females as in males.", "pattern_of_inheritance": "Autosomal dominant==Autosomal recessive", "alternate_names": ["PSEUDOXANTHOMA ELASTICUM; PXE", "ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2"]}, "gene information": {"db_hgnc_gene_id": 57.0}, "interventions": [{"int_description_1": "Limiting dietary calcium intake", "timeframe_int1": "Days or Weeks", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Pseudoxanthoma elasticum.", "pmid_1": 26564082.0, "pmid_date_1": 2015.0, "pmid_journal_1": "Handbook of clinical neurology"}, {"pmid_title_2": "Pseudoxanthoma elasticum: high calcium intake in early life correlates with severity.", "pmid_2": 6507474.0, "pmid_date_2": 1984.0, "pmid_journal_2": "American journal of medical genetics"}]}, {"_id": "57-OMIM:614473", "condition": {"condition_name": "ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2", "freq_per_birth": "The prevalence of GACI has been estimated to be about 1 in 391,000. At least 200 affected individuals have been described in the medical literature.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2", "PSEUDOXANTHOMA ELASTICUM; PXE"]}, "gene information": {"db_hgnc_gene_id": 57.0}, "interventions": [{"int_description_1": "Etidronic acid"}, {"int_description_2": "Thiosulfuric acid"}, {"int_description_3": "Pamidronic acid"}, {"int_description_4": "Angiotensin II type1 receptor blockers monotherapy"}, {"int_description_5": "Angiotensin-converting enzyme (ACE) inhibitor monotherapy"}], "references": [{"pmid_title_1": "Generalized Arterial Calcification of Infancy: New Insights, Controversies, and Approach to Management.", "pmid_1": 32172442.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Current osteoporosis reports"}, {"pmid_title_2": "Bisphosphonate therapy in an infant with generalized arterial calcification with an ABCC6 mutation.", "pmid_2": 30206659.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"}, {"pmid_title_3": "Generalized Arterial Calcification of Infancy", "pmid_3": 25392903.0, "pmid_date_3": 2014.0, "pmid_journal_3": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_4": "Efficacy and safety of 2-year etidronate treatment in a child with generalized arterial calcification of infancy.", "pmid_4": 21932012.0, "pmid_date_4": 2011.0, "pmid_journal_4": "European journal of pediatrics"}]}, {"_id": "5870-OMIM:613500", "condition": {"condition_name": "AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE", "alternate_names": ["AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE"]}, "gene information": {"db_hgnc_gene_id": 5870.0}, "interventions": [{"int_description_1": "Human immunoglobulin G", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Aggressive antibiotic therapy", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Vorhyaluronidase alfa"}], "references": [{"pmid_title_1": "Agammaglobulinemia", "pmid_1": 32310401.0, "pmid_date_1": 2020.0}, {"pmid_title_2": "Autosomal recessive agammaglobulinemia associated with an IGLL1 gene missense mutation.", "pmid_2": 27576013.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology"}, {"pmid_title_3": "Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia.", "pmid_3": 9419212.0, "pmid_date_3": 1998.0, "pmid_journal_3": "The Journal of experimental medicine"}]}, {"_id": "592-OMIM:300635", "condition": {"condition_name": "LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2", "freq_per_birth": "XLP1 is estimated to occur in about 1 per million males worldwide. XLP2 is less common, occurring in about 1 per 5 million males.", "pattern_of_inheritance": "X-linked recessive", "alternate_names": ["LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2"]}, "gene information": {"db_hgnc_gene_id": 592.0}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Prednisone"}, {"int_description_3": "Dexamethasone"}, {"int_description_4": "Ganciclovir"}, {"int_description_5": "Human immunoglobulin G"}, {"int_description_6": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_7": "Rituximab"}, {"int_description_8": "Alemtuzumab"}, {"int_description_9": "Vedolizumab"}, {"int_description_10": "Adalimumab"}, {"int_description_11": "Cyclosporine"}, {"int_description_12": "Muromonab"}, {"int_description_13": "Cyclophosphamide"}, {"int_description_14": "Busulfan"}, {"int_description_15": "Melphalan"}, {"int_description_16": "Thiotepa"}, {"int_description_17": "Doxorubicin"}, {"int_description_18": "Mercaptopurine"}, {"int_description_19": "Mesalazine"}, {"int_description_20": "Sulfasalazine"}, {"int_description_21": "Vincristine"}, {"int_description_22": "Treosulfan"}, {"int_description_23": "Methotrexate"}, {"int_description_24": "Fludarabine"}, {"int_description_25": "Etoposide"}, {"int_description_26": "Tacrolimus"}, {"int_description_27": "Foscarnet"}, {"int_description_28": "Acyclovir"}, {"int_description_29": "Azathioprine"}, {"int_description_30": "Mycophenolate mofetil"}, {"int_description_31": "Hydrocortisone", "timeframe_int31": "Days or Weeks", "age_use_int31": "Child", "contra_int31": "No", "qualscale_reclass_drug31": "Case report(s)", "rev1_eff_reclass_drug31": "Still in Trials / Unproven"}, {"int_description_32": "Tocilizumab"}, {"int_description_33": "Methylprednisolone"}, {"int_description_34": "Infliximab"}, {"int_description_35": "Emapalumab"}, {"int_description_36": "Cefotaxime"}, {"int_description_37": "Total body irradiation"}, {"int_description_38": "Total parental nutrition"}, {"int_description_39": "Allogeneic stem cell transplantation"}, {"int_description_40": "Colectomy"}, {"int_description_41": "Diverting ileostomy"}, {"int_description_42": "Surgical management"}], "references": [{"pmid_title_1": "Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis.", "pmid_1": 32374962.0, "pmid_date_1": 2020.0, "pmid_journal_1": "N Engl J Med"}, {"pmid_title_2": "Hematopoietic Stem Cell Transplantation for XIAP Deficiency in Japan.", "pmid_2": 27815752.0, "pmid_date_2": 2017.0, "pmid_journal_2": "J Clin Immunol"}, {"pmid_title_3": "Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study.", "pmid_3": 28935695.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Blood"}, {"pmid_title_4": "Progressive reduction of circulating B lymphocytes in patients with X-linked lymphoproliferative disease (XLP).", "pmid_4": 27220551.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Br J Haematol"}, {"pmid_title_5": "Novel Mutations in SH2D1A Gene in X-linked Lymphoproliferative Syndrome, Diagnosed After B-Cell Non-Hodgkin Lymphoma.", "pmid_5": 28267077.0, "pmid_date_5": 2017.0, "pmid_journal_5": "J Pediatr Hematol Oncol"}, {"pmid_title_6": "Symptomatic males and female carriers in a large Caucasian kindred with XIAP deficiency.", "pmid_6": 25943627.0, "pmid_date_6": 2015.0, "pmid_journal_6": "J Clin Immunol"}, {"pmid_title_7": "Cerebral Vasculitis in X-linked Lymphoproliferative Disease Cured by Matched Unrelated Cord Blood Transplant.", "pmid_7": 26433589.0, "pmid_date_7": 2015.0, "pmid_journal_7": "J Clin Immunol"}, {"pmid_title_8": "A de novo whole gene deletion of XIAP detected by exome sequencing analysis in very early onset inflammatory bowel disease: a case report.", "pmid_8": 26581487.0, "pmid_date_8": 2015.0, "pmid_journal_8": "BMC Gastroenterol"}, {"pmid_title_9": "BIRC4 Mutation: An Important Rare Cause of Uveitis.", "pmid_9": 26513308.0, "pmid_date_9": 2015.0, "pmid_journal_9": "J Clin Rheumatol"}, {"pmid_title_10": "A female patient with incomplete hemophagocytic lymphohistiocytosis caused by a heterozygous XIAP mutation associated with non-random X-chromosome inactivation skewed towards the wild-type XIAP allele.", "pmid_10": 25744037.0, "pmid_date_10": 2015.0, "pmid_journal_10": "J Clin Immunol"}, {"pmid_title_11": "Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes.", "pmid_11": 23131490.0, "pmid_date_11": 2013.0, "pmid_journal_11": "Blood"}, {"pmid_title_12": "Interleukin-21 overexpression dominates T cell response to Epstein-Barr virus in a fatal case of X-linked lymphoproliferative syndrome type 1.", "pmid_12": 23467775.0, "pmid_date_12": 2013.0, "pmid_journal_12": "Clin Vaccine Immunol"}, {"pmid_title_13": "X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.", "pmid_13": 20926771.0, "pmid_date_13": 2011.0, "pmid_journal_13": "Blood"}, {"pmid_title_14": "Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature.", "pmid_14": 15908972.0, "pmid_date_14": 2005.0, "pmid_journal_14": "Bone Marrow Transplant"}, {"pmid_title_15": "Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation.", "pmid_15": 12239144.0, "pmid_date_15": 2002.0, "pmid_journal_15": "Blood"}]}, {"_id": "5964-OMIM:613148", "condition": {"condition_name": "INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE", "pattern_of_inheritance": "Pattern unknown", "alternate_names": ["INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE"]}, "gene information": {"db_hgnc_gene_id": 5964.0}, "interventions": [{"int_description_1": "Elemental diet"}, {"int_description_2": "Extensively-hydrolyzed formula"}, {"int_description_3": "Probiotics"}, {"int_description_4": "Heparin"}, {"int_description_5": "Loperamide"}, {"int_description_6": "Codeine"}, {"int_description_7": "Opium"}, {"int_description_8": "Prednisolone"}, {"int_description_9": "Beclomethasone dipropionate"}, {"int_description_10": "Betamethasone"}, {"int_description_11": "Prednisone"}, {"int_description_12": "Dexamethasone"}, {"int_description_13": "Diphenoxylate"}, {"int_description_14": "Ganciclovir"}, {"int_description_15": "Ketamine"}, {"int_description_16": "Human immunoglobulin G"}, {"int_description_17": "Cimetidine"}, {"int_description_18": "Ranitidine"}, {"int_description_19": "Atropine"}, {"int_description_20": "Clopidogrel"}, {"int_description_21": "Alemtuzumab"}, {"int_description_22": "Natalizumab"}, {"int_description_23": "Vedolizumab"}, {"int_description_24": "Etanercept"}, {"int_description_25": "Adalimumab"}, {"int_description_26": "Golimumab"}, {"int_description_27": "Colistin"}, {"int_description_28": "Cyclosporine"}, {"int_description_29": "Tinidazole"}, {"int_description_30": "Metronidazole"}, {"int_description_31": "Amphotericin B"}, {"int_description_32": "Budesonide"}, {"int_description_33": "Thiotepa"}, {"int_description_34": "Doxycycline"}, {"int_description_35": "Tobramycin"}, {"int_description_36": "Mercaptopurine"}, {"int_description_37": "Mesalazine"}, {"int_description_38": "Sulfasalazine"}, {"int_description_39": "Tetracycline"}, {"int_description_40": "Ciprofloxacin"}, {"int_description_41": "Amoxicillin"}, {"int_description_42": "Ceftriaxone"}, {"int_description_43": "Colesevelam"}, {"int_description_44": "Treosulfan"}, {"int_description_45": "Fondaparinux"}, {"int_description_46": "Rivaroxaban"}, {"int_description_47": "Thalidomide"}, {"int_description_48": "Olsalazine"}, {"int_description_49": "Rifaximin"}, {"int_description_50": "Fluconazole"}, {"int_description_51": "Itraconazole"}, {"int_description_52": "Methotrexate"}, {"int_description_53": "Vidofludimus"}, {"int_description_54": "Fludarabine", "timeframe_int54": "Days or Weeks", "age_use_int54": "Infant,Child", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Still in Trials / Unproven"}, {"int_description_55": "Vancomycin"}, {"int_description_56": "Gentamicin"}, {"int_description_57": "Tacrolimus"}, {"int_description_58": "Foscarnet"}, {"int_description_59": "Acyclovir"}, {"int_description_60": "Cidofovir"}, {"int_description_61": "Azathioprine"}, {"int_description_62": "Mycophenolate mofetil"}, {"int_description_63": "Hydrocortisone"}, {"int_description_64": "Ustekinumab"}, {"int_description_65": "Colestipol"}, {"int_description_66": "Esomeprazole"}, {"int_description_67": "Pantoprazole"}, {"int_description_68": "Omeprazole"}, {"int_description_69": "Lansoprazole"}, {"int_description_70": "Rabeprazole"}, {"int_description_71": "Acetylsalicylic acid", "timeframe_int71": "Days or Weeks", "age_use_int71": "Infant,Child", "contra_int71": "No", "qualscale_reclass_drug71": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug71": "Effective / Ameliorative"}, {"int_description_72": "Methylprednisolone"}, {"int_description_73": "Infliximab"}, {"int_description_74": "Tofacitinib"}, {"int_description_75": "Warfarin"}, {"int_description_76": "Allopurinol"}, {"int_description_77": "Balsalazide"}, {"int_description_78": "Certolizumab pegol"}, {"int_description_79": "Andrographis paniculata"}, {"int_description_80": "Anti-TNF agents"}, {"int_description_81": "Antibiotics"}, {"int_description_82": "Calcineurin inhibitors"}, {"int_description_83": "Corticosteroids"}, {"int_description_84": "Albumin human"}, {"int_description_85": "Famciclovir"}, {"int_description_86": "Cholestyramine"}, {"int_description_87": "Dextran"}, {"int_description_88": "Polyethylene glycol"}, {"int_description_89": "Clostridium tetani toxoid antigen (formaldehyde inactivated)"}, {"int_description_90": "Hepatitis A Vaccine"}, {"int_description_91": "Hepatitis B Vaccine (Recombinant)"}, {"int_description_92": "Pertussis vaccine"}, {"int_description_93": "E. coli strain Nissle"}, {"int_description_94": "Human papilloma virus (HPV) vaccine"}, {"int_description_95": "Immunosuppressive agents"}, {"int_description_96": "Low molecular weight heparin"}, {"int_description_97": "Meningococcal vaccines"}, {"int_description_98": "Nonlive trivalent inactivated influenza vaccine"}, {"int_description_99": "Pneumococcal vaccine (PCV13 and PPSV23)"}, {"int_description_100": "Steroids"}, {"int_description_101": "Thiopurines", "timeframe_int101": "Days or Weeks", "contra_int101": "No", "qualscale_reclass_drug101": "Case report(s)", "rev1_eff_reclass_drug101": "Curative"}, {"int_description_102": "Thrombolytics"}, {"int_description_103": "Vitamin K antagonists"}, {"int_description_104": "Concentrated red cells transfusion"}, {"int_description_105": "Erythrocyte infusion"}, {"int_description_106": "Granulomonocyteapheresis (GMA) with an Adacolumn"}, {"int_description_107": "Inferior vena cava filter"}, {"int_description_108": "Total parenteral nutrition"}, {"int_description_109": "Bowel resection"}, {"int_description_110": "Colectomy"}, {"int_description_111": "Colostomy"}, {"int_description_112": "Cryoprecipitate and plasma frozen transfusion"}, {"int_description_113": "Enterostomy"}, {"int_description_114": "Fecal microbiota transplantation"}, {"int_description_115": "Hematopoietic stem cell transplantation"}, {"int_description_116": "Ileal resection"}, {"int_description_117": "Ileocolostomy"}, {"int_description_118": "Ileostomy"}, {"int_description_119": "Operation for fistulae"}, {"int_description_120": "Operation for perianal abscess"}, {"int_description_121": "Rectal stricture dilatations"}, {"int_description_122": "Repair of colonic perforation"}, {"int_description_123": "Stricture-plasty"}, {"int_description_124": "Thrombectomy"}], "references": [{"pmid_title_1": "Dose Escalation Assessment Among Targeted Immunomodulators in the Management of Inflammatory Bowel Disease.", "pmid_1": 32191593.0, "pmid_date_1": 2020.0, "pmid_journal_1": "J Manag Care Spec Pharm"}, {"pmid_title_2": "Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.", "pmid_2": 32856298.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Cochrane Database Syst Rev"}, {"pmid_title_3": "British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.", "pmid_3": 31562236.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Gut"}, {"pmid_title_4": "Pyoderma gangrenosum successfully treated with golimumab: Case report and review of the literature.", "pmid_4": 30980454.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Dermatol Ther"}, {"pmid_title_5": "Adalimumab for treatment of very early onset inflammatory bowel disease.", "pmid_5": 31856064.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Chin Med J (Engl)"}, {"pmid_title_6": "Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis.", "pmid_6": 30458248.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Clin Gastroenterol Hepatol"}, {"pmid_title_7": "Phenotypic characteristics and clinical manifestations of inflammatory bowel disease in infants and children under 2 years of age in Liaoning Province, China: five of six infants with IL-10R mutations.", "pmid_7": 30900524.0, "pmid_date_7": 2019.0, "pmid_journal_7": "Paediatr Int Child Health"}, {"pmid_title_8": "Therapeutic strategies of thromboembolic events in patients with inflammatory bowel diseases: Two case reports.", "pmid_8": 30817579.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Phenotypic Characterization of Very Early-Onset Inflammatory Bowel Disease with Interleukin-10 Signaling Deficiency: Based on a Large Cohort Study.", "pmid_9": 30212871.0, "pmid_date_9": 2019.0, "pmid_journal_9": "Inflamm Bowel Dis"}, {"pmid_title_10": "Vedolizumab in the treatment of chronic, antibiotic-dependent or refractory pouchitis.", "pmid_10": 29266360.0, "pmid_date_10": 2018.0, "pmid_journal_10": "Aliment Pharmacol Ther"}, {"pmid_title_11": "Anticoagulant therapy for venous thromboembolism in patients with inflammatory bowel disease.", "pmid_11": 29462026.0, "pmid_date_11": 2018.0, "pmid_journal_11": "Eur J Gastroenterol Hepatol"}, {"pmid_title_12": "Copy number variations and founder effect underlying complete IL-10R\u03b2 deficiency in Portuguese kindreds.", "pmid_12": 30365510.0, "pmid_date_12": 2018.0, "pmid_journal_12": "PLoS One"}, {"pmid_title_13": "Treatment options for children and adolescents with inflammatory bowel disease: is granulomonocytapheresis an effective alternative to drug therapy?", "pmid_13": 28612637.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Expert Rev Gastroenterol Hepatol"}, {"pmid_title_14": "Preventive care in inflammatory bowel disease.", "pmid_14": 28699605.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Turk J Gastroenterol"}, {"pmid_title_15": "Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early Onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey.", "pmid_15": 28267044.0, "pmid_date_15": 2017.0, "pmid_journal_15": "Inflamm Bowel Dis"}, {"pmid_title_16": "Late-Onset of Acute Severe Ulcerative Colitis: Clinical Case.", "pmid_16": 28147350.0, "pmid_date_16": 2017.0, "pmid_journal_16": "Dig Dis"}, {"pmid_title_17": "Phenotype and Management of Infantile-onset Inflammatory Bowel Disease: Experience from a Tertiary Care Center in China.", "pmid_17": 29140941.0, "pmid_date_17": 2017.0, "pmid_journal_17": "Inflamm Bowel Dis"}, {"pmid_title_18": "Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.", "pmid_18": 28513805.0, "pmid_date_18": 2017.0, "pmid_journal_18": "J Crohns Colitis"}, {"pmid_title_19": "Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease: A Randomized Clinical Trial.", "pmid_19": 29084080.0, "pmid_date_19": 2017.0, "pmid_journal_19": "Inflamm Bowel Dis"}, {"pmid_title_20": "Inflammatory bowel diseases: a burden in pediatrics: Case series and a review of the literature.", "pmid_20": 28296755.0, "pmid_date_20": 2017.0, "pmid_journal_20": "Medicine (Baltimore)"}, {"pmid_title_21": "Oral Vancomycin and Gentamicin for Treatment of Very Early Onset Inflammatory Bowel Disease.", "pmid_21": 28564649.0, "pmid_date_21": 2017.0, "pmid_journal_21": "Digestion"}, {"pmid_title_22": "Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN.", "pmid_22": 28605483.0, "pmid_date_22": 2017.0, "pmid_journal_22": "J Crohns Colitis"}, {"pmid_title_23": "Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational Study.", "pmid_23": 27271488.0, "pmid_date_23": 2016.0, "pmid_journal_23": "Inflamm Bowel Dis"}, {"pmid_title_24": "Thromboembolism as an important complication of inflammatory bowel disease.", "pmid_24": 26513610.0, "pmid_date_24": 2016.0, "pmid_journal_24": "Eur J Gastroenterol Hepatol"}, {"pmid_title_25": "Novel exonic mutation inducing aberrant splicing in the IL10RA gene and resulting in infantile-onset inflammatory bowel disease: a case report.", "pmid_25": 26822028.0, "pmid_date_25": 2016.0, "pmid_journal_25": "BMC Gastroenterol"}, {"pmid_title_26": "Clinical features of interleukin 10 receptor gene mutations in children with very early-onset inflammatory bowel disease.", "pmid_26": 25373860.0, "pmid_date_26": 2015.0, "pmid_journal_26": "J Pediatr Gastroenterol Nutr"}, {"pmid_title_27": "Chronic use of PPI and H2 antagonists decreases the risk of pouchitis after IPAA for ulcerative colitis.", "pmid_27": 23532599.0, "pmid_date_27": 2013.0, "pmid_journal_27": "J Gastrointest Surg"}, {"pmid_title_28": "Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study.", "pmid_28": 23078909.0, "pmid_date_28": 2013.0, "pmid_journal_28": "J Crohns Colitis"}, {"pmid_title_29": "Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy.", "pmid_29": 22549091.0, "pmid_date_29": 2012.0, "pmid_journal_29": "Gastroenterology"}, {"pmid_title_30": "Selective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease.", "pmid_30": 22969694.0, "pmid_date_30": 2012.0, "pmid_journal_30": "Transfus Med Hemother"}, {"pmid_title_31": "Exome sequencing identifies novel compound heterozygous mutations of IL-10 receptor 1 in neonatal-onset Crohn's disease.", "pmid_31": 22476154.0, "pmid_date_31": 2012.0, "pmid_journal_31": "Genes Immun"}, {"pmid_title_32": "Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease.", "pmid_32": 22670722.0, "pmid_date_32": 2012.0, "pmid_journal_32": "Aliment Pharmacol Ther"}, {"pmid_title_33": "Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management.", "pmid_33": 23040451.0, "pmid_date_33": 2012.0, "pmid_journal_33": "J Crohns Colitis"}, {"pmid_title_34": "Hepatobiliary complications of inflammatory bowel disease.", "pmid_34": 21773706.0, "pmid_date_34": 2011.0, "pmid_journal_34": "Curr Gastroenterol Rep"}, {"pmid_title_35": "Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN.", "pmid_35": 21224839.0, "pmid_date_35": 2011.0, "pmid_journal_35": "Am J Gastroenterol"}, {"pmid_title_36": "Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up.", "pmid_36": 20837778.0, "pmid_date_36": 2010.0, "pmid_journal_36": "Blood"}, {"pmid_title_37": "Treatment of diarrhea in patients with inflammatory bowel disease: concepts and cautions.", "pmid_37": 18192964.0, "pmid_date_37": 2007.0, "pmid_journal_37": "Rev Gastroenterol Disord"}, {"pmid_title_38": "Efficacy and tolerability of olsalazine (dipentum) in the treatment of patients with ulcerative colitis--results of a field study.", "pmid_38": 16795963.0, "pmid_date_38": 2006.0, "pmid_journal_38": "Hepatogastroenterology"}, {"pmid_title_39": "Safety of balsalazide therapy in the treatment of inflammatory bowel disease.", "pmid_39": 16127348.0, "pmid_date_39": 2005.0, "pmid_journal_39": "Rev Gastroenterol Disord"}, {"pmid_title_40": "A Gly15Arg mutation in the interleukin-10 gene reduces secretion of interleukin-10 in Crohn disease.", "pmid_40": 12825869.0, "pmid_date_40": 2003.0, "pmid_journal_40": "Scand J Gastroenterol"}, {"pmid_title_41": "Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens.", "pmid_41": 7732340.0, "pmid_date_41": 1995.0, "pmid_journal_41": "Scand J Gastroenterol"}, {"pmid_title_42": "The efficacy of tobramycin in the treatment of ulcerative colitis.", "pmid_42": 2104079.0, "pmid_date_42": 1990.0, "pmid_journal_42": "Aliment Pharmacol Ther"}]}, {"_id": "5965-OMIM:612567", "condition": {"condition_name": "INFLAMMATORY BOWEL DISEASE 25, AUTOSOMAL RECESSIVE", "pattern_of_inheritance": "Pattern unknown", "alternate_names": ["INFLAMMATORY BOWEL DISEASE 25, AUTOSOMAL RECESSIVE", "HEPATITIS B VIRUS, SUSCEPTIBILITY TO"]}, "gene information": {"db_hgnc_gene_id": 5965.0}, "interventions": [{"int_description_1": "Elemental diet"}, {"int_description_2": "Extensively-hydrolyzed formula"}, {"int_description_3": "Probiotics"}, {"int_description_4": "Heparin"}, {"int_description_5": "Loperamide"}, {"int_description_6": "Codeine"}, {"int_description_7": "Opium"}, {"int_description_8": "Prednisolone"}, {"int_description_9": "Beclomethasone dipropionate"}, {"int_description_10": "Betamethasone"}, {"int_description_11": "Prednisone"}, {"int_description_12": "Dexamethasone"}, {"int_description_13": "Diphenoxylate"}, {"int_description_14": "Ganciclovir"}, {"int_description_15": "Ketamine"}, {"int_description_16": "Human immunoglobulin G"}, {"int_description_17": "Cimetidine"}, {"int_description_18": "Ranitidine"}, {"int_description_19": "Atropine"}, {"int_description_20": "Clopidogrel"}, {"int_description_21": "Alemtuzumab"}, {"int_description_22": "Natalizumab"}, {"int_description_23": "Vedolizumab"}, {"int_description_24": "Etanercept"}, {"int_description_25": "Adalimumab"}, {"int_description_26": "Golimumab"}, {"int_description_27": "Colistin"}, {"int_description_28": "Cyclosporine"}, {"int_description_29": "Tinidazole"}, {"int_description_30": "Metronidazole"}, {"int_description_31": "Amphotericin B"}, {"int_description_32": "Budesonide"}, {"int_description_33": "Thiotepa"}, {"int_description_34": "Doxycycline"}, {"int_description_35": "Tobramycin"}, {"int_description_36": "Mercaptopurine"}, {"int_description_37": "Mesalazine"}, {"int_description_38": "Sulfasalazine"}, {"int_description_39": "Tetracycline"}, {"int_description_40": "Ciprofloxacin"}, {"int_description_41": "Amoxicillin"}, {"int_description_42": "Ceftriaxone"}, {"int_description_43": "Colesevelam"}, {"int_description_44": "Treosulfan"}, {"int_description_45": "Fondaparinux"}, {"int_description_46": "Rivaroxaban"}, {"int_description_47": "Thalidomide"}, {"int_description_48": "Olsalazine"}, {"int_description_49": "Rifaximin"}, {"int_description_50": "Fluconazole"}, {"int_description_51": "Itraconazole"}, {"int_description_52": "Methotrexate"}, {"int_description_53": "Vidofludimus"}, {"int_description_54": "Fludarabine", "timeframe_int54": "Days or Weeks", "age_use_int54": "Infant,Child", "contra_int54": "No", "qualscale_reclass_drug54": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug54": "Effective / Ameliorative"}, {"int_description_55": "Vancomycin"}, {"int_description_56": "Gentamicin"}, {"int_description_57": "Tacrolimus"}, {"int_description_58": "Foscarnet"}, {"int_description_59": "Acyclovir"}, {"int_description_60": "Cidofovir"}, {"int_description_61": "Azathioprine"}, {"int_description_62": "Mycophenolate mofetil"}, {"int_description_63": "Hydrocortisone"}, {"int_description_64": "Ustekinumab"}, {"int_description_65": "Colestipol"}, {"int_description_66": "Esomeprazole"}, {"int_description_67": "Pantoprazole"}, {"int_description_68": "Omeprazole"}, {"int_description_69": "Lansoprazole"}, {"int_description_70": "Rabeprazole"}, {"int_description_71": "Acetylsalicylic acid", "timeframe_int71": "Days or Weeks", "age_use_int71": "Infant,Child", "contra_int71": "No", "qualscale_reclass_drug71": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug71": "Effective / Ameliorative"}, {"int_description_72": "Methylprednisolone"}, {"int_description_73": "Infliximab"}, {"int_description_74": "Tofacitinib"}, {"int_description_75": "Warfarin"}, {"int_description_76": "Allopurinol"}, {"int_description_77": "Balsalazide"}, {"int_description_78": "Certolizumab pegol"}, {"int_description_79": "Andrographis paniculata"}, {"int_description_80": "Anti-TNF agents"}, {"int_description_81": "Antibiotics"}, {"int_description_82": "Calcineurin inhibitors"}, {"int_description_83": "Corticosteroids"}, {"int_description_84": "Albumin human"}, {"int_description_85": "Famciclovir"}, {"int_description_86": "Cholestyramine"}, {"int_description_87": "Dextran"}, {"int_description_88": "Polyethylene glycol"}, {"int_description_89": "Clostridium tetani toxoid antigen (formaldehyde inactivated)"}, {"int_description_90": "Hepatitis A Vaccine"}, {"int_description_91": "Hepatitis B Vaccine (Recombinant)"}, {"int_description_92": "Pertussis vaccine"}, {"int_description_93": "E. coli strain Nissle"}, {"int_description_94": "Human papilloma virus (HPV) vaccine"}, {"int_description_95": "Immunosuppressive agents"}, {"int_description_96": "Low molecular weight heparin"}, {"int_description_97": "Meningococcal vaccines"}, {"int_description_98": "Nonlive trivalent inactivated influenza vaccine"}, {"int_description_99": "Pneumococcal vaccine (PCV13 and PPSV23)"}, {"int_description_100": "Steroids"}, {"int_description_101": "Thiopurines", "timeframe_int101": "Days or Weeks", "contra_int101": "No", "qualscale_reclass_drug101": "Case report(s)", "rev1_eff_reclass_drug101": "Curative"}, {"int_description_102": "Thrombolytics"}, {"int_description_103": "Vitamin K antagonists"}, {"int_description_104": "Concentrated red cells transfusion"}, {"int_description_105": "Erythrocyte infusion"}, {"int_description_106": "Granulomonocyteapheresis (GMA) with an Adacolumn"}, {"int_description_107": "Inferior vena cava filter"}, {"int_description_108": "Total parenteral nutrition"}, {"int_description_109": "Bowel resection"}, {"int_description_110": "Colectomy"}, {"int_description_111": "Colostomy"}, {"int_description_112": "Cryoprecipitate and plasma frozen transfusion"}, {"int_description_113": "Enterostomy"}, {"int_description_114": "Fecal microbiota transplantation"}, {"int_description_115": "Hematopoietic stem cell transplantation"}, {"int_description_116": "Ileal resection"}, {"int_description_117": "Ileocolostomy"}, {"int_description_118": "Ileostomy"}, {"int_description_119": "Operation for fistulae"}, {"int_description_120": "Operation for perianal abscess"}, {"int_description_121": "Rectal stricture dilatations"}, {"int_description_122": "Repair of colonic perforation"}, {"int_description_123": "Stricture-plasty"}, {"int_description_124": "Thrombectomy"}], "references": [{"pmid_title_1": "Dose Escalation Assessment Among Targeted Immunomodulators in the Management of Inflammatory Bowel Disease.", "pmid_1": 32191593.0, "pmid_date_1": 2020.0, "pmid_journal_1": "J Manag Care Spec Pharm"}, {"pmid_title_2": "Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.", "pmid_2": 32856298.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Cochrane Database Syst Rev"}, {"pmid_title_3": "British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.", "pmid_3": 31562236.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Gut"}, {"pmid_title_4": "Pyoderma gangrenosum successfully treated with golimumab: Case report and review of the literature.", "pmid_4": 30980454.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Dermatol Ther"}, {"pmid_title_5": "Adalimumab for treatment of very early onset inflammatory bowel disease.", "pmid_5": 31856064.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Chin Med J (Engl)"}, {"pmid_title_6": "Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis.", "pmid_6": 30458248.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Clin Gastroenterol Hepatol"}, {"pmid_title_7": "Phenotypic characteristics and clinical manifestations of inflammatory bowel disease in infants and children under 2 years of age in Liaoning Province, China: five of six infants with IL-10R mutations.", "pmid_7": 30900524.0, "pmid_date_7": 2019.0, "pmid_journal_7": "Paediatr Int Child Health"}, {"pmid_title_8": "Therapeutic strategies of thromboembolic events in patients with inflammatory bowel diseases: Two case reports.", "pmid_8": 30817579.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Medicine (Baltimore)"}, {"pmid_title_9": "Phenotypic Characterization of Very Early-Onset Inflammatory Bowel Disease with Interleukin-10 Signaling Deficiency: Based on a Large Cohort Study.", "pmid_9": 30212871.0, "pmid_date_9": 2019.0, "pmid_journal_9": "Inflamm Bowel Dis"}, {"pmid_title_10": "Vedolizumab in the treatment of chronic, antibiotic-dependent or refractory pouchitis.", "pmid_10": 29266360.0, "pmid_date_10": 2018.0, "pmid_journal_10": "Aliment Pharmacol Ther"}, {"pmid_title_11": "Anticoagulant therapy for venous thromboembolism in patients with inflammatory bowel disease.", "pmid_11": 29462026.0, "pmid_date_11": 2018.0, "pmid_journal_11": "Eur J Gastroenterol Hepatol"}, {"pmid_title_12": "Copy number variations and founder effect underlying complete IL-10R\u03b2 deficiency in Portuguese kindreds.", "pmid_12": 30365510.0, "pmid_date_12": 2018.0, "pmid_journal_12": "PLoS One"}, {"pmid_title_13": "Treatment options for children and adolescents with inflammatory bowel disease: is granulomonocytapheresis an effective alternative to drug therapy?", "pmid_13": 28612637.0, "pmid_date_13": 2017.0, "pmid_journal_13": "Expert Rev Gastroenterol Hepatol"}, {"pmid_title_14": "Preventive care in inflammatory bowel disease.", "pmid_14": 28699605.0, "pmid_date_14": 2017.0, "pmid_journal_14": "Turk J Gastroenterol"}, {"pmid_title_15": "Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early Onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey.", "pmid_15": 28267044.0, "pmid_date_15": 2017.0, "pmid_journal_15": "Inflamm Bowel Dis"}, {"pmid_title_16": "Late-Onset of Acute Severe Ulcerative Colitis: Clinical Case.", "pmid_16": 28147350.0, "pmid_date_16": 2017.0, "pmid_journal_16": "Dig Dis"}, {"pmid_title_17": "Phenotype and Management of Infantile-onset Inflammatory Bowel Disease: Experience from a Tertiary Care Center in China.", "pmid_17": 29140941.0, "pmid_date_17": 2017.0, "pmid_journal_17": "Inflamm Bowel Dis"}, {"pmid_title_18": "Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.", "pmid_18": 28513805.0, "pmid_date_18": 2017.0, "pmid_journal_18": "J Crohns Colitis"}, {"pmid_title_19": "Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease: A Randomized Clinical Trial.", "pmid_19": 29084080.0, "pmid_date_19": 2017.0, "pmid_journal_19": "Inflamm Bowel Dis"}, {"pmid_title_20": "Inflammatory bowel diseases: a burden in pediatrics: Case series and a review of the literature.", "pmid_20": 28296755.0, "pmid_date_20": 2017.0, "pmid_journal_20": "Medicine (Baltimore)"}, {"pmid_title_21": "Oral Vancomycin and Gentamicin for Treatment of Very Early Onset Inflammatory Bowel Disease.", "pmid_21": 28564649.0, "pmid_date_21": 2017.0, "pmid_journal_21": "Digestion"}, {"pmid_title_22": "Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN.", "pmid_22": 28605483.0, "pmid_date_22": 2017.0, "pmid_journal_22": "J Crohns Colitis"}, {"pmid_title_23": "Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational Study.", "pmid_23": 27271488.0, "pmid_date_23": 2016.0, "pmid_journal_23": "Inflamm Bowel Dis"}, {"pmid_title_24": "Thromboembolism as an important complication of inflammatory bowel disease.", "pmid_24": 26513610.0, "pmid_date_24": 2016.0, "pmid_journal_24": "Eur J Gastroenterol Hepatol"}, {"pmid_title_25": "Novel exonic mutation inducing aberrant splicing in the IL10RA gene and resulting in infantile-onset inflammatory bowel disease: a case report.", "pmid_25": 26822028.0, "pmid_date_25": 2016.0, "pmid_journal_25": "BMC Gastroenterol"}, {"pmid_title_26": "Clinical features of interleukin 10 receptor gene mutations in children with very early-onset inflammatory bowel disease.", "pmid_26": 25373860.0, "pmid_date_26": 2015.0, "pmid_journal_26": "J Pediatr Gastroenterol Nutr"}, {"pmid_title_27": "Chronic use of PPI and H2 antagonists decreases the risk of pouchitis after IPAA for ulcerative colitis.", "pmid_27": 23532599.0, "pmid_date_27": 2013.0, "pmid_journal_27": "J Gastrointest Surg"}, {"pmid_title_28": "Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study.", "pmid_28": 23078909.0, "pmid_date_28": 2013.0, "pmid_journal_28": "J Crohns Colitis"}, {"pmid_title_29": "Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy.", "pmid_29": 22549091.0, "pmid_date_29": 2012.0, "pmid_journal_29": "Gastroenterology"}, {"pmid_title_30": "Selective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease.", "pmid_30": 22969694.0, "pmid_date_30": 2012.0, "pmid_journal_30": "Transfus Med Hemother"}, {"pmid_title_31": "Exome sequencing identifies novel compound heterozygous mutations of IL-10 receptor 1 in neonatal-onset Crohn's disease.", "pmid_31": 22476154.0, "pmid_date_31": 2012.0, "pmid_journal_31": "Genes Immun"}, {"pmid_title_32": "Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease.", "pmid_32": 22670722.0, "pmid_date_32": 2012.0, "pmid_journal_32": "Aliment Pharmacol Ther"}, {"pmid_title_33": "Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management.", "pmid_33": 23040451.0, "pmid_date_33": 2012.0, "pmid_journal_33": "J Crohns Colitis"}, {"pmid_title_34": "Hepatobiliary complications of inflammatory bowel disease.", "pmid_34": 21773706.0, "pmid_date_34": 2011.0, "pmid_journal_34": "Curr Gastroenterol Rep"}, {"pmid_title_35": "Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN.", "pmid_35": 21224839.0, "pmid_date_35": 2011.0, "pmid_journal_35": "Am J Gastroenterol"}, {"pmid_title_36": "Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up.", "pmid_36": 20837778.0, "pmid_date_36": 2010.0, "pmid_journal_36": "Blood"}, {"pmid_title_37": "Treatment of diarrhea in patients with inflammatory bowel disease: concepts and cautions.", "pmid_37": 18192964.0, "pmid_date_37": 2007.0, "pmid_journal_37": "Rev Gastroenterol Disord"}, {"pmid_title_38": "Efficacy and tolerability of olsalazine (dipentum) in the treatment of patients with ulcerative colitis--results of a field study.", "pmid_38": 16795963.0, "pmid_date_38": 2006.0, "pmid_journal_38": "Hepatogastroenterology"}, {"pmid_title_39": "Safety of balsalazide therapy in the treatment of inflammatory bowel disease.", "pmid_39": 16127348.0, "pmid_date_39": 2005.0, "pmid_journal_39": "Rev Gastroenterol Disord"}, {"pmid_title_40": "A Gly15Arg mutation in the interleukin-10 gene reduces secretion of interleukin-10 in Crohn disease.", "pmid_40": 12825869.0, "pmid_date_40": 2003.0, "pmid_journal_40": "Scand J Gastroenterol"}, {"pmid_title_41": "Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens.", "pmid_41": 7732340.0, "pmid_date_41": 1995.0, "pmid_journal_41": "Scand J Gastroenterol"}, {"pmid_title_42": "The efficacy of tobramycin in the treatment of ulcerative colitis.", "pmid_42": 2104079.0, "pmid_date_42": 1990.0, "pmid_journal_42": "Aliment Pharmacol Ther"}]}, {"_id": "59-OMIM:256450", "condition": {"condition_name": "HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1", "freq_per_birth": "Congenital hyperinsulinism affects approximately 1 in 50,000 newborns. This condition is more common in certain populations, affecting up to 1 in 2,500 newborns.", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1", "DIABETES MELLITUS, PERMANENT NEONATAL, 3"]}, "gene information": {"db_hgnc_gene_id": 59.0}, "interventions": [{"int_description_1": "Glucagon", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Diazoxide", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Avexitide", "timeframe_int3": "Days or Weeks", "age_use_int3": "Child", "contra_int3": "Yes", "qualscale_reclass_drug3": "Cohort study or studies", "rev1_eff_reclass_drug3": "Still in Trials / Unproven"}, {"int_description_4": "Dasiglucagon"}, {"int_description_5": "Glucagon analogue linked to a human immunoglobulin Fc fragment (HM15136) monotherapy"}, {"int_description_6": "Recombinant human monoclonal antibody to insulin receptor (RZ358, XOMA358) monotherapy", "timeframe_int6": "Days or Weeks", "age_use_int6": "Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Cohort study or studies", "rev1_eff_reclass_drug6": "Still in Trials / Unproven"}, {"int_description_7": "Subtotal pancreatectomy", "timeframe_int7": "Days or Weeks", "age_use_int7": "Infant,Child", "contra_int7": "No", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Acute insulin response tests for the differential diagnosis of congenital hyperinsulinism.", "pmid_1": 12364426.0, "pmid_date_1": 2002.0, "pmid_journal_1": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_2": "Practical management of hyperinsulinism in infancy.", "pmid_2": 10685981.0, "pmid_date_2": 2000.0, "pmid_journal_2": "Archives of disease in childhood. Fetal and neonatal edition"}, {"pmid_title_3": "Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1.", "pmid_3": 11018078.0, "pmid_date_3": 2000.0, "pmid_journal_3": "The Journal of clinical investigation"}, {"pmid_title_4": "A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland.", "pmid_4": 10334322.0, "pmid_date_4": 1999.0, "pmid_journal_4": "Diabetes"}]}, {"_id": "59-OMIM:618857", "condition": {"condition_name": "DIABETES MELLITUS, PERMANENT NEONATAL, 3", "pattern_of_inheritance": "Autosomal dominant; Autosomal recessive", "alternate_names": ["DIABETES MELLITUS, PERMANENT NEONATAL, 3", "HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1"]}, "gene information": {"db_hgnc_gene_id": 59.0}, "interventions": [{"int_description_1": "Insulin human", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Glyburide", "timeframe_int2": "Days or Weeks", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Cohort study or studies", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Tolbutamide", "timeframe_int3": "Days or Weeks", "age_use_int3": "Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Cohort study or studies", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Glibenclamide oral suspension: Suitable and effective in patients with neonatal diabetes.", "pmid_1": 30684309.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Pediatric diabetes"}, {"pmid_title_2": "Neonatal Diabetes Mellitus: An Update on Diagnosis and Management.", "pmid_2": 29406006.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Clinics in perinatology"}, {"pmid_title_3": "Insulin therapy in neonatal diabetes mellitus: a review of the literature.", "pmid_3": 28527303.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Diabetes research and clinical practice"}, {"pmid_title_4": "Successful transition to sulfonylurea therapy in two Iraqi siblings with neonatal diabetes mellitus and iDEND syndrome due to ABCC8 mutation.", "pmid_4": 27849623.0, "pmid_date_4": 2016.0, "pmid_journal_4": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_5": "Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (DEND) syndrome and a novel ABCC8 gene mutation.", "pmid_5": 21109997.0, "pmid_date_5": 2011.0, "pmid_journal_5": "Diabetologia"}, {"pmid_title_6": "Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations.", "pmid_6": 18025408.0, "pmid_date_6": 2008.0, "pmid_journal_6": "Diabetes care"}, {"pmid_title_7": "Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.", "pmid_7": 16885549.0, "pmid_date_7": 2006.0, "pmid_journal_7": "The New England journal of medicine"}]}, {"_id": "6009-OMIM:618495", "condition": {"condition_name": "IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["Oligoarticular juvenile idiopathic arthritis", "IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63", "Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis"]}, "gene information": {"db_hgnc_gene_id": 6009.0}, "interventions": [{"int_description_1": "Heparin"}, {"int_description_2": "Ganciclovir"}, {"int_description_3": "Valganciclovir"}, {"int_description_4": "Rituximab"}, {"int_description_5": "Alemtuzumab"}, {"int_description_6": "Sirolimus"}, {"int_description_7": "Amoxicillin"}, {"int_description_8": "Hydrocortisone"}, {"int_description_9": "Methylprednisolone"}, {"int_description_10": "Infliximab"}, {"int_description_11": "Antibiotics"}, {"int_description_12": "Antiviral therapy"}, {"int_description_13": "Immunosuppression therapy"}, {"int_description_14": "Steroids"}, {"int_description_15": "Filgrastim"}, {"int_description_16": "Parenteral nutrition"}, {"int_description_17": "Plasmapheresis"}, {"int_description_18": "Supplemental oxygen"}, {"int_description_19": "Adenotonsillectomy", "timeframe_int19": "Days or Weeks", "age_use_int19": "Infant,Child", "contra_int19": "No", "qualscale_reclass_drug19": "Case report(s)", "rev1_eff_reclass_drug19": "Curative"}, {"int_description_20": "Hematopoietic stem cell transplantation"}], "references": [{"pmid_title_1": "Human interleukin-2 receptor \u03b2 mutations associated with defects in immunity and peripheral tolerance.", "pmid_1": 31040185.0, "pmid_date_1": 2019.0, "pmid_journal_1": "The Journal of experimental medicine"}, {"pmid_title_2": "A novel human <i>IL2RB</i> mutation results in T and NK cell-driven immune dysregulation.", "pmid_2": 31040184.0, "pmid_date_2": 2019.0, "pmid_journal_2": "The Journal of experimental medicine"}]}, {"_id": "6010-OMIM:312863", "condition": {"condition_name": "COMBINED IMMUNODEFICIENCY, X-LINKED", "pattern_of_inheritance": "X-linked recessive", "alternate_names": ["Omenn syndrome", "COMBINED IMMUNODEFICIENCY, X-LINKED", "SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED"]}, "gene information": {"db_hgnc_gene_id": 6010.0}, "interventions": [{"int_description_1": "Ursodeoxycholic acid", "timeframe_int1": "Days or Weeks", "age_use_int1": "Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Human immunoglobulin G", "timeframe_int2": "Days or Weeks", "age_use_int2": "Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Melphalan"}, {"int_description_4": "Azithromycin", "timeframe_int4": "Days or Weeks", "age_use_int4": "Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Trimethoprim", "timeframe_int5": "Days or Weeks", "age_use_int5": "Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Sulfamethoxazole", "timeframe_int6": "Days or Weeks", "age_use_int6": "Child", "contra_int6": "No", "qualscale_reclass_drug6": "Case report(s)", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Fludarabine"}, {"int_description_8": "Vitamin supplements"}, {"int_description_9": "Hypercaloric enteral nutrition"}, {"int_description_10": "Total body irradiation"}, {"int_description_11": "Hematopoietic stem cell transplantation", "timeframe_int11": "Days or Weeks", "age_use_int11": "Child", "qualscale_reclass_drug11": "Case report(s)", "rev1_eff_reclass_drug11": "Curative"}], "references": [{"pmid_title_1": "Alternative Splicing Rescues Loss of Common Gamma Chain Function and Results in IL-21R-like Deficiency.", "pmid_1": 30903457.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Journal of clinical immunology"}, {"pmid_title_2": "Late-Onset Combined Immunodeficiency with a Novel IL2RG Mutation and Probable Revertant Somatic Mosaicism.", "pmid_2": 26407811.0, "pmid_date_2": 2015.0, "pmid_journal_2": "Journal of clinical immunology"}, {"pmid_title_3": "Laboratory evaluation for T-cell dysfunction.", "pmid_3": 23374275.0, "pmid_date_3": 2013.0, "pmid_journal_3": "The Journal of allergy and clinical immunology"}, {"pmid_title_4": "An interleukin-2 receptor gamma chain mutation with normal thymus morphology.", "pmid_4": 9399950.0, "pmid_date_4": 1997.0, "pmid_journal_4": "The Journal of clinical investigation"}, {"pmid_title_5": "Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells.", "pmid_5": 8900089.0, "pmid_date_5": 1996.0, "pmid_journal_5": "The New England journal of medicine"}]}, {"_id": "6024-OMIM:608971", "condition": {"condition_name": "SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE"]}, "gene information": {"db_hgnc_gene_id": 6024.0}, "interventions": [{"int_description_1": "Human immunoglobulin G"}, {"int_description_2": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_3": "Alemtuzumab"}, {"int_description_4": "Melphalan"}, {"int_description_5": "Fludarabine"}, {"int_description_6": "Corticosteroids monotherapy"}, {"int_description_7": "Filgrastim"}, {"int_description_8": "Allogeneic  bone marrow transplant"}, {"int_description_9": "Stem cell transplantation combination therapy"}], "references": [{"pmid_title_1": "A Case of IL-7R Deficiency Caused by a Novel Synonymous Mutation and Implications for Mutation Screening in SCID Diagnosis.", "pmid_1": 27833609.0, "pmid_date_1": 2016.0, "pmid_journal_1": "Frontiers in immunology"}, {"pmid_title_2": "Autoimmune manifestations in SCID due to IL7R mutations: Omenn syndrome and cytopenias.", "pmid_2": 24759676.0, "pmid_date_2": 2014.0, "pmid_journal_2": "Human immunology"}]}, {"_id": "6081-OMIM:613370", "condition": {"condition_name": "MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10; MODY10", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10; MODY10", "DIABETES MELLITUS, PERMANENT NEONATAL 4; PNDM4"]}, "gene information": {"db_hgnc_gene_id": 6081.0}, "interventions": [{"int_description_1": "Insulin glargine"}], "references": [{"pmid_title_1": "A homozygous mutation in the insulin gene (INS) causing autosomal recessive neonatal diabetes in Saudi families.", "pmid_1": 32252216.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Annals of pediatric endocrinology & metabolism"}]}, {"_id": "6081-OMIM:618858", "condition": {"condition_name": "DIABETES MELLITUS, PERMANENT NEONATAL 4; PNDM4", "pattern_of_inheritance": "Autosomal dominant; Autosomal recessive", "alternate_names": ["DIABETES MELLITUS, PERMANENT NEONATAL 4; PNDM4", "MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10; MODY10"]}, "gene information": {"db_hgnc_gene_id": 6081.0}, "interventions": [{"int_description_1": "Insulin human", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Glyburide"}, {"int_description_3": "Rehydration"}], "references": [{"pmid_title_1": "A homozygous mutation in the insulin gene (INS) causing autosomal recessive neonatal diabetes in Saudi families.", "pmid_1": 32252216.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Annals of pediatric endocrinology & metabolism"}, {"pmid_title_2": "\u03b2 Cell Replacement after Gene Editing of a Neonatal Diabetes-Causing Mutation at the Insulin Locus.", "pmid_2": 30503261.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Stem cell reports"}, {"pmid_title_3": "Permanent Neonatal Diabetes Mellitus", "pmid_3": 20301620.0, "pmid_date_3": 2016.0, "pmid_journal_3": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_4": "Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes.", "pmid_4": 18192540.0, "pmid_date_4": 2008.0, "pmid_journal_4": "Diabetes"}]}, {"_id": "60-ORPHA:130", "condition": {"condition_name": "Brugada syndrome", "freq_per_birth": "The exact prevalence of Brugada syndrome is unknown, although it is estimated to affect 5 in 10,000 people worldwide.  This condition occurs much more frequently in people of Asian ancestry, particularly in Japanese and Southeast Asian populations.Although Brugada syndrome affects both men and women, the condition appears to be 8 to 10 times more common in men.  Researchers suspect that testosterone, a sex hormone present at much higher levels in men, may account for this difference.", "pattern_of_inheritance": "Autosomal dominant, Not applicable", "alternate_names": ["CARDIOMYOPATHY, DILATED, 1O", "Brugada syndrome", "Hypertrichosis-acromegaloid facial appearance syndrome", "ATRIAL FIBRILLATION, FAMILIAL, 12", "CANTU SYNDROME"]}, "gene information": {"db_hgnc_gene_id": 60.0}, "interventions": [{"int_description_1": "Implantable cardioverter defibrillator (ICD)", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Placement of a temporary pacemaker"}, {"int_description_3": "Isoprenaline", "timeframe_int3": "Days or Weeks", "age_use_int3": "Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Verapamil"}, {"int_description_5": "Quinidine", "timeframe_int5": "Days or Weeks", "age_use_int5": "Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Cohort study or studies", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Epicardial Substrate Ablation"}], "references": [{"pmid_title_1": "Non-invasive assessment of the arrhythmogenic substrate in Brugada syndrome using signal-averaged electrocardiogram: clinical implications from a prospective clinical trial.", "pmid_1": 31647530.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Europace"}, {"pmid_title_2": "Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.", "pmid_2": 28500178.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Circ Arrhythm Electrophysiol"}, {"pmid_title_3": "Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation.", "pmid_3": 26291334.0, "pmid_date_3": 2015.0, "pmid_journal_3": "Circ Arrhythm Electrophysiol"}, {"pmid_title_4": "ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene.", "pmid_4": 24439875.0, "pmid_date_4": 2014.0, "pmid_journal_4": "Int J Cardiol"}, {"pmid_title_5": "Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium.", "pmid_5": 21403098.0, "pmid_date_5": 2011.0, "pmid_journal_5": "Circulation"}, {"pmid_title_6": "Monomorphic ventricular tachycardia due to Brugada syndrome successfully treated by hydroquinidine therapy in a 3-year-old child.", "pmid_6": 16426410.0, "pmid_date_6": 2006.0, "pmid_journal_6": "J Cardiovasc Electrophysiol"}, {"pmid_title_7": "Efficacy of quinidine in high-risk patients with Brugada syndrome.", "pmid_7": 15381640.0, "pmid_date_7": 2004.0, "pmid_journal_7": "Circulation"}, {"pmid_title_8": "Electrical storm in Brugada syndrome successfully treated using isoprenaline.", "pmid_8": 15018871.0, "pmid_date_8": 2004.0, "pmid_journal_8": "Europace"}, {"pmid_title_9": "Hydroquinidine therapy in Brugada syndrome.", "pmid_9": 15145111.0, "pmid_date_9": 2004.0, "pmid_journal_9": "J Am Coll Cardiol"}]}, {"_id": "60-ORPHA:966", "condition": {"condition_name": "Hypertrichosis-acromegaloid facial appearance syndrome", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["CARDIOMYOPATHY, DILATED, 1O", "Hypertrichosis-acromegaloid facial appearance syndrome", "Brugada syndrome", "ATRIAL FIBRILLATION, FAMILIAL, 12", "CANTU SYNDROME"]}, "gene information": {"db_hgnc_gene_id": 60.0}, "interventions": [{"int_description_1": "Laser hair removal"}, {"int_description_2": "Shaving"}], "references": [{"pmid_title_1": "De Novo Mutation in ABCC9 Causes Hypertrichosis Acromegaloid Facial Features Disorder.", "pmid_1": 26871653.0, "pmid_date_1": 2016.0, "pmid_journal_1": "Pediatr Dermatol"}, {"pmid_title_2": "Wide clinical variability in conditions with coarse facial features and hypertrichosis caused by mutations in ABCC9.", "pmid_2": 23307537.0, "pmid_date_2": 2013.0, "pmid_journal_2": "Am J Med Genet A"}]}, {"_id": "6106-OMIM:304790", "condition": {"condition_name": "IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED", "pattern_of_inheritance": "X-linked recessive", "alternate_names": ["IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED"]}, "gene information": {"db_hgnc_gene_id": 6106.0}, "interventions": [{"int_description_1": "Nasogastric tube"}, {"int_description_2": "Gluten free diet"}, {"int_description_3": "NEOCATE; Nutricia, Gaithersburg, MD"}, {"int_description_4": "Prednisolone", "timeframe_int4": "Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "Yes", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Betamethasone"}, {"int_description_6": "Prednisone"}, {"int_description_7": "Dexamethasone", "timeframe_int7": "Days or Weeks", "age_use_int7": "Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Insulin glargine"}, {"int_description_9": "Levothyroxine"}, {"int_description_10": "Human immunoglobulin G"}, {"int_description_11": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_12": "Rituximab"}, {"int_description_13": "Alemtuzumab"}, {"int_description_14": "Cyclosporine"}, {"int_description_15": "Sirolimus"}, {"int_description_16": "Cyclophosphamide"}, {"int_description_17": "Busulfan"}, {"int_description_18": "Melphalan"}, {"int_description_19": "Mercaptopurine"}, {"int_description_20": "Mesalazine"}, {"int_description_21": "Trimethoprim"}, {"int_description_22": "Dapsone"}, {"int_description_23": "Sulfamethoxazole"}, {"int_description_24": "Verapamil"}, {"int_description_25": "Vincristine"}, {"int_description_26": "Rofecoxib"}, {"int_description_27": "Methotrexate"}, {"int_description_28": "Fludarabine"}, {"int_description_29": "Tacrolimus"}, {"int_description_30": "Acyclovir"}, {"int_description_31": "Azathioprine", "timeframe_int31": "Days or Weeks", "age_use_int31": "Neonate,Infant", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Mycophenolate mofetil", "timeframe_int32": "Hours,Days or Weeks", "age_use_int32": "Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Methylprednisolone", "timeframe_int33": "Days or Weeks", "age_use_int33": "Neonate,Infant", "contra_int33": "No", "qualscale_reclass_drug33": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug33": "Effective / Ameliorative"}, {"int_description_34": "Infliximab"}, {"int_description_35": "Anti-thymocyte globulin"}, {"int_description_36": "Anti-TNF-\u03b1"}, {"int_description_37": "Antibiotics"}, {"int_description_38": "Corticosteroids"}, {"int_description_39": "Fresh frozen plasma", "timeframe_int39": "Hours,Days or Weeks", "age_use_int39": "Neonate,Infant,Child", "contra_int39": "No", "qualscale_reclass_drug39": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug39": "Effective / Ameliorative"}, {"int_description_40": "Human colostrum"}, {"int_description_41": "Insulin"}, {"int_description_42": "Pancreatic enzymes", "timeframe_int42": "Hours,Days or Weeks", "age_use_int42": "Neonate,Infant,Child", "contra_int42": "Yes", "qualscale_reclass_drug42": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug42": "Effective / Ameliorative"}, {"int_description_43": "Steroids"}, {"int_description_44": "Thyroid hormone"}, {"int_description_45": "Filgrastim"}, {"int_description_46": "Blood transfusions"}, {"int_description_47": "Human bone marrow-derived mesenchymal stem cells (TEMCELL HS Inj., JCR Pharmaceuticals Co., Ltd., Japan)"}, {"int_description_48": "Intravenous nutrition"}, {"int_description_49": "Parenteral nutrition"}, {"int_description_50": "Total body irradiation"}, {"int_description_51": "Washed red blood cells"}, {"int_description_52": "Adenoidectomy"}, {"int_description_53": "Hematopoietic stem cell transplantation", "timeframe_int53": "Days or Weeks", "age_use_int53": "Infant,Child", "contra_int53": "No", "qualscale_reclass_drug53": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug53": "Curative"}, {"int_description_54": "Illeostomy"}, {"int_description_55": "Tonsillectomy"}], "references": [{"pmid_title_1": "Treatment with rapamycin can restore regulatory T-cell function in IPEX patients.", "pmid_1": 31874182.0, "pmid_date_1": 2020.0, "pmid_journal_1": "J Allergy Clin Immunol"}, {"pmid_title_2": "Hematopoietic stem cell transplantation recovers insulin deficiency in type 1 diabetes mellitus associated with IPEX syndrome.", "pmid_2": 31322807.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Pediatr Diabetes"}, {"pmid_title_3": "Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome.", "pmid_3": 30443250.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Front Immunol"}, {"pmid_title_4": "Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity.", "pmid_4": 23060872.0, "pmid_date_4": 2012.0, "pmid_journal_4": "Front Immunol"}, {"pmid_title_5": "Use of sirolimus in IPEX and IPEX-like children.", "pmid_5": 18481161.0, "pmid_date_5": 2008.0, "pmid_journal_5": "J Clin Immunol"}, {"pmid_title_6": "IPEX as a result of mutations in FOXP3.", "pmid_6": 18317533.0, "pmid_date_6": 2007.0, "pmid_journal_6": "Clin Dev Immunol"}, {"pmid_title_7": "Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning.", "pmid_7": 16990602.0, "pmid_date_7": 2007.0, "pmid_journal_7": "Blood"}, {"pmid_title_8": "Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene.", "pmid_8": 17484868.0, "pmid_date_8": 2007.0, "pmid_journal_8": "Gastroenterology"}, {"pmid_title_9": "Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome).", "pmid_9": 16126062.0, "pmid_date_9": 2005.0, "pmid_journal_9": "J Pediatr"}, {"pmid_title_10": "Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.", "pmid_10": 12161590.0, "pmid_date_10": 2002.0, "pmid_journal_10": "J Med Genet"}, {"pmid_title_11": "Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome.", "pmid_11": 10706361.0, "pmid_date_11": 2000.0, "pmid_journal_11": "Am J Med Genet"}, {"pmid_title_12": "Combination therapy with tacrolimus and betamethasone for a patient with X-linked auto-immune enteropathy.", "pmid_12": 7556338.0, "pmid_date_12": 1995.0, "pmid_journal_12": "Eur J Pediatr"}, {"pmid_title_13": "A Japanese family of X-linked auto-immune enteropathy with haemolytic anaemia and polyendocrinopathy.", "pmid_13": 8482279.0, "pmid_date_13": 1993.0, "pmid_journal_13": "Eur J Pediatr"}]}, {"_id": "6155-OMIM:116920", "condition": {"condition_name": "LEUKOCYTE ADHESION DEFICIENCY, TYPE I; LAD", "freq_per_birth": "Leukocyte adhesion deficiency type 1 is estimated to occur in 1 per million people worldwide. At least 300 cases of this condition have been reported in the scientific literature.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["LEUKOCYTE ADHESION DEFICIENCY, TYPE I; LAD"]}, "gene information": {"db_hgnc_gene_id": 6155.0}, "interventions": [{"int_description_1": "Ganciclovir"}, {"int_description_2": "Human immunoglobulin G"}, {"int_description_3": "Cyclosporine"}, {"int_description_4": "Cyclophosphamide"}, {"int_description_5": "Busulfan"}, {"int_description_6": "Micafungin"}, {"int_description_7": "Sulfamethoxazole"}, {"int_description_8": "Voriconazole"}, {"int_description_9": "Fludarabine"}, {"int_description_10": "Acyclovir"}, {"int_description_11": "Broad-spectrum antibiotics"}, {"int_description_12": "Cycophenolate mofetil"}, {"int_description_13": "Umbilical cord blood stem cell transplantation"}, {"int_description_14": "Umbilical cord blood transplantation"}], "references": [{"pmid_title_1": "Successful umbilical cord blood transplantation in children with leukocyte adhesion deficiency type I.", "pmid_1": 32154133.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Transl Pediatr"}, {"pmid_title_2": "Report of a Chinese Cohort with Leukocyte Adhesion Deficiency-I and Four Novel Mutations.", "pmid_2": 30919141.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Journal of clinical immunology"}]}, {"_id": "6186-OMIM:243500", "condition": {"condition_name": "ISOVALERIC ACIDEMIA; IVA", "freq_per_birth": "Isovaleric acidemia is estimated to affect at least 1 in 250,000 people in the United States.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ISOVALERIC ACIDEMIA; IVA"]}, "gene information": {"db_hgnc_gene_id": 6186.0}, "interventions": [{"int_description_1": "Leucine-free formula"}, {"int_description_2": "Leucine-restricted diet", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Protein-restricted diet"}, {"int_description_4": "Leucine", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Glycine", "timeframe_int5": "Hours", "age_use_int5": "Neonate", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Hydroxocobalamin", "timeframe_int6": "Hours,Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Levocarnitine", "timeframe_int7": "Hours,Days or Weeks", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Carglumic acid", "timeframe_int8": "Hours,Days or Weeks", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Blood exchange transfusion"}], "references": [{"pmid_title_1": "Eight novel mutations detected from eight Chinese patients with isovaleric acidemia.", "pmid_1": 31442447.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Clinica chimica acta; international journal of clinical chemistry"}, {"pmid_title_2": "Unusual Metabolites in a Patient with Isovaleric Acidemia.", "pmid_2": 30923063.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Clinical chemistry"}, {"pmid_title_3": "Genotype and phenotype characterization in a Spanish cohort with isovaleric acidemia.", "pmid_3": 27904153.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Journal of human genetics"}, {"pmid_title_4": "Infantile Spasms during Acute Metabolic Decompensation in an Infant with Isovaleric Acidemia.", "pmid_4": 27165427.0, "pmid_date_4": 2016.0, "pmid_journal_4": "Journal of clinical neurology (Seoul, Korea)"}, {"pmid_title_5": "Phenotypic Variability and Newly Identified Mutations of the IVD Gene in Japanese Patients with Isovaleric Acidemia.", "pmid_5": 26018748.0, "pmid_date_5": 2015.0, "pmid_journal_5": "The Tohoku journal of experimental medicine"}, {"pmid_title_6": "Clinical and molecular analysis of isovaleric acidemia patients in the United Arab Emirates reveals remarkable phenotypes and four novel mutations in the IVD gene.", "pmid_6": 22960500.0, "pmid_date_6": 2012.0, "pmid_journal_6": "European journal of medical genetics"}, {"pmid_title_7": "Phenotypic and mutation spectrums of Thai patients with isovaleric acidemia.", "pmid_7": 22004070.0, "pmid_date_7": 2011.0, "pmid_journal_7": "Pediatrics international : official journal of the Japan Pediatric Society"}, {"pmid_title_8": "A novel duplication at the putative DNA polymerase alpha arrest site and a founder mutation in Chinese in the IVD gene underlie isovaleric acidaemia.", "pmid_8": 20519759.0, "pmid_date_8": 2010.0, "pmid_journal_8": "Hong Kong medical journal = Xianggang yi xue za zhi"}]}, {"_id": "6193-OMIM:600802", "condition": {"condition_name": "SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE"]}, "gene information": {"db_hgnc_gene_id": 6193.0}, "interventions": [{"int_description_1": "Mechanical ventilation"}, {"int_description_2": "Nasal continuous positive airway pressure treatment"}, {"int_description_3": "Transfer factor"}, {"int_description_4": "Testosterone"}, {"int_description_5": "Salmeterol"}, {"int_description_6": "Ursodeoxycholic acid"}, {"int_description_7": "Sargramostim"}, {"int_description_8": "Dopamine"}, {"int_description_9": "Prednisolone"}, {"int_description_10": "Prednisone", "timeframe_int10": "Days or Weeks", "age_use_int10": "Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Fluticasone"}, {"int_description_12": "Ketoconazole"}, {"int_description_13": "Ganciclovir"}, {"int_description_14": "Human immunoglobulin G"}, {"int_description_15": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_16": "Midazolam"}, {"int_description_17": "Rituximab"}, {"int_description_18": "Alemtuzumab"}, {"int_description_19": "Clarithromycin"}, {"int_description_20": "Cyclosporine"}, {"int_description_21": "Clofazimine"}, {"int_description_22": "Isoniazid"}, {"int_description_23": "Amphotericin B"}, {"int_description_24": "Budesonide"}, {"int_description_25": "Somatotropin"}, {"int_description_26": "Piperacillin"}, {"int_description_27": "Vitamin D"}, {"int_description_28": "Levetiracetam"}, {"int_description_29": "Cyclophosphamide"}, {"int_description_30": "Busulfan"}, {"int_description_31": "Melphalan", "timeframe_int31": "Days or Weeks", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Thiotepa"}, {"int_description_33": "Caspofungin"}, {"int_description_34": "Amikacin"}, {"int_description_35": "Pyrazinamide"}, {"int_description_36": "Linezolid"}, {"int_description_37": "Pyridoxine"}, {"int_description_38": "Ethambutol"}, {"int_description_39": "Azithromycin"}, {"int_description_40": "Trimethoprim"}, {"int_description_41": "Sulfamethoxazole"}, {"int_description_42": "Ciprofloxacin"}, {"int_description_43": "Ofloxacin"}, {"int_description_44": "Fusidic acid"}, {"int_description_45": "Ampicillin"}, {"int_description_46": "Cefotaxime"}, {"int_description_47": "Meropenem"}, {"int_description_48": "Amoxicillin"}, {"int_description_49": "Cefuroxime"}, {"int_description_50": "Ceftriaxone"}, {"int_description_51": "Cefazolin"}, {"int_description_52": "Cefoperazone"}, {"int_description_53": "Latamoxef"}, {"int_description_54": "Sulbactam"}, {"int_description_55": "Clavulanic acid"}, {"int_description_56": "Treosulfan"}, {"int_description_57": "Atovaquone"}, {"int_description_58": "Rifampicin"}, {"int_description_59": "Fluconazole"}, {"int_description_60": "Itraconazole"}, {"int_description_61": "Pyrimethamine"}, {"int_description_62": "Methotrexate"}, {"int_description_63": "Sulfadoxine"}, {"int_description_64": "Levofloxacin"}, {"int_description_65": "Fludarabine"}, {"int_description_66": "Pentamidine"}, {"int_description_67": "Vancomycin"}, {"int_description_68": "Tacrolimus"}, {"int_description_69": "Valproic acid"}, {"int_description_70": "Foscarnet"}, {"int_description_71": "Acyclovir"}, {"int_description_72": "Cidofovir"}, {"int_description_73": "Mycophenolate mofetil"}, {"int_description_74": "Ledipasvir"}, {"int_description_75": "Oxacillin"}, {"int_description_76": "Omeprazole"}, {"int_description_77": "Methylprednisolone"}, {"int_description_78": "Methimazole"}, {"int_description_79": "Infliximab"}, {"int_description_80": "Interferon alfa-2a, Recombinant"}, {"int_description_81": "Anti Thymocyte Globulin"}, {"int_description_82": "Anti-CD45 antibodies"}, {"int_description_83": "CMV hyperImmunoglobulin"}, {"int_description_84": "Nystatin"}, {"int_description_85": "Teicoplanin"}, {"int_description_86": "Sofosbuvir"}, {"int_description_87": "Antilymphocyte immunoglobulin (horse)", "timeframe_int87": "Days or Weeks", "age_use_int87": "Infant,Child", "contra_int87": "No", "qualscale_reclass_drug87": "Case report(s)", "rev1_eff_reclass_drug87": "Curative"}, {"int_description_88": "Human interleukin-2"}, {"int_description_89": "Thymic hormone"}, {"int_description_90": "Thyroid hormone"}, {"int_description_91": "Thyroxin"}, {"int_description_92": "Phenobarbital"}, {"int_description_93": "Filgrastim"}, {"int_description_94": "2'-Deoxycytidine"}, {"int_description_95": "Irradiated blood transfusions"}, {"int_description_96": "Parenteral nutrition"}, {"int_description_97": "Platelet transfusions"}, {"int_description_98": "Total body irradiation"}, {"int_description_99": "Hematopoietic stem cell transplantation"}], "references": [{"pmid_title_1": "Severe Combined Immunodeficiency", "pmid_1": 30969584.0, "pmid_date_1": 2021.0, "pmid_journal_1": "statpearls"}, {"pmid_title_2": "Reticular dysgenesis caused by an intronic pathogenic variant in <i>AK2</i>.", "pmid_2": 32532877.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Cold Spring Harb Mol Case Stud"}, {"pmid_title_3": "Biallelic Form of a Known CD3E Mutation in a Patient with Severe Combined Immunodeficiency.", "pmid_3": 32016651.0, "pmid_date_3": 2020.0, "pmid_journal_3": "J Clin Immunol"}, {"pmid_title_4": "Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.", "pmid_4": 30194989.0, "pmid_date_4": 2019.0, "pmid_journal_4": "J Allergy Clin Immunol"}, {"pmid_title_5": "Disseminated Bacille Calmette-Gu\u00e9rin infection in a patient with severe combined immunodeficiency caused by JAK3 gene mutation.", "pmid_5": 31309596.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Pediatr Dermatol"}, {"pmid_title_6": "Prevention of transfusion-transmitted cytomegalovirus infection using leukoreduced blood components in patients receiving seronegative umbilical cord blood transplantation.", "pmid_6": 31322734.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Transfusion"}, {"pmid_title_7": "Human interleukin-2 receptor \u03b2 mutations associated with defects in immunity and peripheral tolerance.", "pmid_7": 31040185.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Exp Med"}, {"pmid_title_8": "Combined Immunodeficiency With Late-Onset Progressive Hypogammaglobulinemia and Normal B Cell Count in a Patient With RAG2 Deficiency.", "pmid_8": 31058115.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Front Pediatr"}, {"pmid_title_9": "Hematopoietic stem cell transplantation for cytidine triphosphate synthase 1 (CTPS1) deficiency.", "pmid_9": 29884857.0, "pmid_date_9": 2019.0, "pmid_journal_9": "Bone Marrow Transplant"}, {"pmid_title_10": "Severe combined immunodeficiency (SCID) presenting in childhood, with agammaglobulinemia, associated with novel compound heterozygous mutations in DCLRE1C.", "pmid_10": 30630113.0, "pmid_date_10": 2019.0, "pmid_journal_10": "Clin Immunol"}, {"pmid_title_11": "Recent advances in understanding the pathogenesis and management of reticular dysgenesis.", "pmid_11": 29270983.0, "pmid_date_11": 2018.0, "pmid_journal_11": "Br J Haematol"}, {"pmid_title_12": "Two siblings with PRKDC defect who presented with cutaneous granulomas and review of the literature.", "pmid_12": 30121298.0, "pmid_date_12": 2018.0, "pmid_journal_12": "Clin Immunol"}, {"pmid_title_13": "SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.", "pmid_13": 30154114.0, "pmid_date_13": 2018.0, "pmid_journal_13": "Blood"}, {"pmid_title_14": "A Novel Homozygous <i>JAK3</i> Mutation Leading to T-B+NK- SCID in Two Brazilian Patients.", "pmid_14": 30177960.0, "pmid_date_14": 2018.0, "pmid_journal_14": "Front Pediatr"}, {"pmid_title_15": "Co-appearance of OPV and BCG vaccine-derived complications in two infants with severe combined immunodeficiency.", "pmid_15": 29804197.0, "pmid_date_15": 2018.0, "pmid_journal_15": "Immunol Res"}, {"pmid_title_16": "Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis.", "pmid_16": 30014500.0, "pmid_date_16": 2018.0, "pmid_journal_16": "Hepatology"}, {"pmid_title_17": "JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long-known gene.", "pmid_17": 30032486.0, "pmid_date_17": 2018.0, "pmid_journal_17": "Mol Genet Genomic Med"}, {"pmid_title_18": "Chronic active Epstein-Barr virus infection as the initial symptom in a Janus kinase 3 deficiency child: Case report and literature review.", "pmid_18": 29049190.0, "pmid_date_18": 2017.0, "pmid_journal_18": "Medicine (Baltimore)"}, {"pmid_title_19": "Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome.", "pmid_19": 28331055.0, "pmid_date_19": 2017.0, "pmid_journal_19": "Blood"}, {"pmid_title_20": "A novel deletion mutation in IL2RG gene results in X-linked severe combined immunodeficiency with an atypical phenotype.", "pmid_20": 27566612.0, "pmid_date_20": 2017.0, "pmid_journal_20": "Immunogenetics"}, {"pmid_title_21": "Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency.", "pmid_21": 28346229.0, "pmid_date_21": 2017.0, "pmid_journal_21": "J Clin Invest"}, {"pmid_title_22": "Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report.", "pmid_22": 28209722.0, "pmid_date_22": 2017.0, "pmid_journal_22": "Blood"}, {"pmid_title_23": "A 24-Year Enzyme Replacement Therapy in an Adenosine-deaminase-Deficient Patient.", "pmid_23": 26684479.0, "pmid_date_23": 2016.0, "pmid_journal_23": "Pediatrics"}, {"pmid_title_24": "Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.", "pmid_24": 27129325.0, "pmid_date_24": 2016.0, "pmid_journal_24": "Blood"}, {"pmid_title_25": "Insufficient immune reconstitution after allogeneic cord blood transplantation without chemotherapy conditioning in patients with SCID caused by CD3\u03b4 deficiency.", "pmid_25": 26999462.0, "pmid_date_25": 2016.0, "pmid_journal_25": "Bone Marrow Transplant"}, {"pmid_title_26": "Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency.", "pmid_26": 27099176.0, "pmid_date_26": 2016.0, "pmid_journal_26": "Sci Transl Med"}, {"pmid_title_27": "Case Report: Whole exome sequencing identifies variation c.2308G>A p.E770K in <i>RAG1</i> associated with B- T- NK+ severe combined immunodeficiency.", "pmid_27": 29067161.0, "pmid_date_27": 2016.0, "pmid_journal_27": "F1000Res"}, {"pmid_title_28": "CTP Synthase 1 Deficiency in Successfully Transplanted Siblings with Combined Immune Deficiency and Chronic Active EBV Infection.", "pmid_28": 27638562.0, "pmid_date_28": 2016.0, "pmid_journal_28": "J Clin Immunol"}, {"pmid_title_29": "Mutation c.256_257delAA in RAG1 Gene in Polish Children with Severe Combined Immunodeficiency: Diversity of Clinical Manifestations.", "pmid_29": 28083621.0, "pmid_date_29": 2016.0, "pmid_journal_29": "Arch Immunol Ther Exp (Warsz)"}, {"pmid_title_30": "Persistent rotavirus diarrhea post-transplant in a novel JAK3-SCID patient after vaccination.", "pmid_30": 26248889.0, "pmid_date_30": 2016.0, "pmid_journal_30": "Pediatr Allergy Immunol"}, {"pmid_title_31": "Novel compound heterozygous mutations in a Japanese girl with Janus kinase 3 deficiency.", "pmid_31": 27593409.0, "pmid_date_31": 2016.0, "pmid_journal_31": "Pediatr Int"}, {"pmid_title_32": "Mutations in Recombination Activating Gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt.", "pmid_32": 25869295.0, "pmid_date_32": 2015.0, "pmid_journal_32": "Clin Immunol"}, {"pmid_title_33": "A 15-year-old boy with severe combined immunodeficiency, fungal infection, and weight gain.", "pmid_33": 26314823.0, "pmid_date_33": 2015.0, "pmid_journal_33": "Allergy Asthma Proc"}, {"pmid_title_34": "A novel common gamma chain mutation in a Chinese family with X-linked severe combined immunodeficiency (X-SCID; T(-)NK(-)B(+)).", "pmid_34": 26409833.0, "pmid_date_34": 2015.0, "pmid_journal_34": "Immunogenetics"}, {"pmid_title_35": "PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity.", "pmid_35": 25842288.0, "pmid_date_35": 2015.0, "pmid_journal_35": "J Allergy Clin Immunol"}, {"pmid_title_36": "Transplantation outcomes for severe combined immunodeficiency, 2000-2009.", "pmid_36": 25075835.0, "pmid_date_36": 2014.0, "pmid_journal_36": "N Engl J Med"}, {"pmid_title_37": "Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.", "pmid_37": 25109802.0, "pmid_date_37": 2014.0, "pmid_journal_37": "J Allergy Clin Immunol"}, {"pmid_title_38": "SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.", "pmid_38": 24144642.0, "pmid_date_38": 2014.0, "pmid_journal_38": "Blood"}, {"pmid_title_39": "Severe combined immunodeficiency caused by a new homozygous RAG1 mutation with progressive encephalopathy.", "pmid_39": 24333136.0, "pmid_date_39": 2014.0, "pmid_journal_39": "Hematol Oncol Stem Cell Ther"}, {"pmid_title_40": "The many faces of Artemis-deficient combined immunodeficiency - Two patients with DCLRE1C mutations and a systematic literature review of genotype-phenotype correlation.", "pmid_40": 24230999.0, "pmid_date_40": 2013.0, "pmid_journal_40": "Clin Immunol"}, {"pmid_title_41": "Successful bone marrow transplantation with reduced intensity conditioning in a patient with delayed-onset adenosine deaminase deficiency.", "pmid_41": 22805442.0, "pmid_date_41": 2013.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Hemophagocytic bone marrow aplasia with plasma cells in a RAG2-deficient SCID case after a nonconditioned transplantation from a fully matched sibling.", "pmid_42": 23389499.0, "pmid_date_42": 2013.0, "pmid_journal_42": "J Pediatr Hematol Oncol"}, {"pmid_title_43": "Skeletal abnormalities and successful hematopoietic stem cell transplantation in patients with reticular dysgenesis.", "pmid_43": 23763981.0, "pmid_date_43": 2013.0, "pmid_journal_43": "J Allergy Clin Immunol"}, {"pmid_title_44": "Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency.", "pmid_44": 22409989.0, "pmid_date_44": 2012.0, "pmid_journal_44": "J Allergy Clin Immunol"}, {"pmid_title_45": "Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.", "pmid_45": 22791287.0, "pmid_date_45": 2012.0, "pmid_journal_45": "Blood"}, {"pmid_title_46": "Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.", "pmid_46": 22968453.0, "pmid_date_46": 2012.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "IL-21 is the primary common \u03b3 chain-binding cytokine required for human B-cell differentiation in vivo.", "pmid_47": 22039266.0, "pmid_date_47": 2011.0, "pmid_journal_47": "Blood"}, {"pmid_title_48": "Hematopoietic stem cell transplantation for CD3\u03b4 deficiency.", "pmid_48": 21757226.0, "pmid_date_48": 2011.0, "pmid_journal_48": "J Allergy Clin Immunol"}, {"pmid_title_49": "Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency.", "pmid_49": 21725047.0, "pmid_date_49": 2011.0, "pmid_journal_49": "Blood"}, {"pmid_title_50": "A leaky mutation in CD3D differentially affects \u03b1\u03b2 and \u03b3\u03b4 T cells and leads to a T\u03b1\u03b2-T\u03b3\u03b4+B+NK+ human SCID.", "pmid_50": 21926461.0, "pmid_date_50": 2011.0, "pmid_journal_50": "J Clin Invest"}, {"pmid_title_51": "Occurrence of myelodysplastic syndrome in 2 patients with reticular dysgenesis.", "pmid_51": 21458044.0, "pmid_date_51": 2011.0, "pmid_journal_51": "J Allergy Clin Immunol"}, {"pmid_title_52": "Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency.", "pmid_52": 20113887.0, "pmid_date_52": 2010.0, "pmid_journal_52": "Immunol Allergy Clin North Am"}, {"pmid_title_53": "Hemophagocytosis after bone marrow transplantation for JAK3-deficient severe combined immunodeficiency.", "pmid_53": 19659508.0, "pmid_date_53": 2010.0, "pmid_journal_53": "Pediatr Transplant"}, {"pmid_title_54": "A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining.", "pmid_54": 19075392.0, "pmid_date_54": 2009.0, "pmid_journal_54": "J Clin Invest"}, {"pmid_title_55": "Novel RAG2 mutation in a patient with T- B- severe combined immunodeficiency and disseminated BCG disease.", "pmid_55": 20128425.0, "pmid_date_55": 2009.0, "pmid_journal_55": "J Investig Allergol Clin Immunol"}, {"pmid_title_56": "A novel missense RAG-1 mutation results in T-B-NK+ SCID in Athabascan-speaking Dine Indians from the Canadian Northwest Territories.", "pmid_56": 18701881.0, "pmid_date_56": 2009.0, "pmid_journal_56": "Eur J Hum Genet"}, {"pmid_title_57": "Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID.", "pmid_57": 19458910.0, "pmid_date_57": 2009.0, "pmid_journal_57": "Clin Exp Med"}, {"pmid_title_58": "Gene therapy for immunodeficiency due to adenosine deaminase deficiency.", "pmid_58": 19179314.0, "pmid_date_58": 2009.0, "pmid_journal_58": "N Engl J Med"}, {"pmid_title_59": "Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency.", "pmid_59": 17825895.0, "pmid_date_59": 2007.0, "pmid_journal_59": "J Allergy Clin Immunol"}, {"pmid_title_60": "Novel RAG1 mutation in a case of severe combined immunodeficiency.", "pmid_60": 16061569.0, "pmid_date_60": 2005.0, "pmid_journal_60": "Pediatrics"}, {"pmid_title_61": "Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.", "pmid_61": 14615376.0, "pmid_date_61": 2004.0, "pmid_journal_61": "Blood"}, {"pmid_title_62": "Novel Artemis gene mutations of radiosensitive severe combined immunodeficiency in Japanese families.", "pmid_62": 12592555.0, "pmid_date_62": 2003.0, "pmid_journal_62": "Hum Genet"}, {"pmid_title_63": "Bone marrow transplantation for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans.", "pmid_63": 11360109.0, "pmid_date_63": 2001.0, "pmid_journal_63": "Bone Marrow Transplant"}, {"pmid_title_64": "Successful bone-marrow transplantation for reticular dysgenesis.", "pmid_64": 6132037.0, "pmid_date_64": 1983.0, "pmid_journal_64": "Lancet"}, {"pmid_title_65": "Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.", "pmid_65": 6983936.0, "pmid_date_65": 1982.0, "pmid_journal_65": "Clin Exp Immunol"}]}, {"_id": "6257-OMIM:601820", "condition": {"condition_name": "HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2", "freq_per_birth": "Congenital hyperinsulinism affects approximately 1 in 50,000 newborns. This condition is more common in certain populations, affecting up to 1 in 2,500 newborns.", "pattern_of_inheritance": "Autosomal dominant==Autosomal recessive", "alternate_names": ["DIABETES MELLITUS, PERMANENT NEONATAL 2; PNDM2", "HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2", "DIABETES MELLITUS, TRANSIENT NEONATAL, 3"]}, "gene information": {"db_hgnc_gene_id": 6257.0}, "interventions": [{"int_description_1": "Octreotide", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Sirolimus", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Diazoxide", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Sirolimus therapy for congenital hyperinsulinism in an infant with a novel homozygous KCNJ11 mutation.", "pmid_1": 29176012.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_2": "A Novel Homozygous Mutation in the KCNJ11 Gene of a Neonate with Congenital Hyperinsulinism and Successful Management with Sirolimus.", "pmid_2": 27181099.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Journal of clinical research in pediatric endocrinology"}, {"pmid_title_3": "Persistent hyperinsulinemic hypoglycemia of infancy due to homozygous KCNJ11 (T294M) mutation.", "pmid_3": 20589481.0, "pmid_date_3": 2010.0, "pmid_journal_3": "Indian journal of pediatrics"}]}, {"_id": "6257-OMIM:610582", "condition": {"condition_name": "DIABETES MELLITUS, TRANSIENT NEONATAL, 3", "freq_per_birth": "In the United States, up to 14 percent of all pregnancies are affected by gestational diabetes. The prevalence of gestational diabetes has been increasing rapidly over the past few decades (a trend similar to the increase in obesity and type 2 diabetes).The risk of developing gestational diabetes varies by ethnic background. Women of Native American, Asian, Hispanic, or African American heritage are more likely to be diagnosed with the disease than are non-Hispanic white women.", "pattern_of_inheritance": "Pattern unknown", "alternate_names": ["DIABETES MELLITUS, PERMANENT NEONATAL 2; PNDM2", "DIABETES MELLITUS, TRANSIENT NEONATAL, 3", "HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2"]}, "gene information": {"db_hgnc_gene_id": 6257.0}, "interventions": [{"int_description_1": "Insulin human", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Insulin glargine"}], "references": [{"pmid_title_1": "A Novel KCNJ11 Mutation Associated with Transient Neonatal Diabetes", "pmid_1": 28943514.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Journal of clinical research in pediatric endocrinology"}, {"pmid_title_2": "Transient Neonatal Diabetes due to a Mutation in KCNJ11 in a Child with Klinefelter Syndrome.", "pmid_2": 28766502.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Journal of clinical research in pediatric endocrinology"}, {"pmid_title_3": "Transient neonatal diabetes mellitus and activating mutation in the KCNJ11 gene in two siblings.", "pmid_3": 28347637.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Archives de pediatrie : organe officiel de la Societe francaise de pediatrie"}, {"pmid_title_4": "Personalized precision medicine in extreme preterm infants with transient neonatal diabetes mellitus.", "pmid_4": 28350539.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Journal of pediatric endocrinology & metabolism : JPEM"}]}, {"_id": "6257-OMIM:618856", "condition": {"condition_name": "DIABETES MELLITUS, PERMANENT NEONATAL 2; PNDM2", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["DIABETES MELLITUS, TRANSIENT NEONATAL, 3", "DIABETES MELLITUS, PERMANENT NEONATAL 2; PNDM2", "HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2"]}, "gene information": {"db_hgnc_gene_id": 6257.0}, "interventions": [{"int_description_1": "Insulin human", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Insulin lispro", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Insulin glargine"}, {"int_description_4": "Insulin aspart"}, {"int_description_5": "Glyburide"}], "references": [{"pmid_title_1": "Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.", "pmid_1": 29880308.0, "pmid_date_1": 2018.0, "pmid_journal_1": "The lancet. Diabetes & endocrinology"}, {"pmid_title_2": "Neonatal Diabetes: Two Cases with Isolated Pancreas Agenesis due to Homozygous PTF1A Enhancer Mutations and One with Developmental Delay, Epilepsy, and Neonatal Diabetes Syndrome due to KCNJ11 Mutation", "pmid_2": 28943513.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Journal of clinical research in pediatric endocrinology"}, {"pmid_title_3": "Utilizing the KCNJ11 Gene Mutations in Spotting Egyptian Patients With Permanent Neonatal Diabetes Who Can Benefit From Treatment Shift.", "pmid_3": 28460053.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Laboratory medicine"}, {"pmid_title_4": "Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes.", "pmid_4": 27033559.0, "pmid_date_4": 2016.0, "pmid_journal_4": "Diabetologia"}, {"pmid_title_5": "Successful sulfonylurea treatment in a patient with permanent neonatal diabetes mellitus with a novel KCNJ11 mutation.", "pmid_5": 26388896.0, "pmid_date_5": 2015.0, "pmid_journal_5": "Korean journal of pediatrics"}, {"pmid_title_6": "Permanent neonatal diabetes mellitus - a case report of a rare cause of diabetes mellitus in East Africa.", "pmid_6": 26958039.0, "pmid_date_6": 2015.0, "pmid_journal_6": "African health sciences"}, {"pmid_title_7": "Permanent neonatal diabetes by a new mutation in KCNJ11: unsuccessful switch to sulfonylurea.", "pmid_7": 26331221.0, "pmid_date_7": 2015.0, "pmid_journal_7": "Archives of endocrinology and metabolism"}, {"pmid_title_8": "Permanent neonatal diabetes misdiagnosed as type 1 diabetes in a 28-year-old female: a life-changing diagnosis.", "pmid_8": 25308342.0, "pmid_date_8": 2014.0, "pmid_journal_8": "Diabetes research and clinical practice"}, {"pmid_title_9": "Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study.", "pmid_9": 23050777.0, "pmid_date_9": 2013.0, "pmid_journal_9": "Pediatric diabetes"}, {"pmid_title_10": "KCNJ11 activating mutations cause both transient and permanent neonatal diabetes mellitus in Cypriot patients.", "pmid_10": 21352428.0, "pmid_date_10": 2011.0, "pmid_journal_10": "Pediatric diabetes"}, {"pmid_title_11": "Interaction between mutations in the slide helix of Kir6.2 associated with neonatal diabetes and neurological symptoms.", "pmid_11": 20022885.0, "pmid_date_11": 2010.0, "pmid_journal_11": "Human molecular genetics"}, {"pmid_title_12": "KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes.", "pmid_12": 15580558.0, "pmid_date_12": 2005.0, "pmid_journal_12": "Human mutation"}]}, {"_id": "6269-ORPHA:130", "condition": {"condition_name": "Brugada syndrome", "freq_per_birth": "The exact prevalence of Brugada syndrome is unknown, although it is estimated to affect 5 in 10,000 people worldwide.  This condition occurs much more frequently in people of Asian ancestry, particularly in Japanese and Southeast Asian populations.Although Brugada syndrome affects both men and women, the condition appears to be 8 to 10 times more common in men.  Researchers suspect that testosterone, a sex hormone present at much higher levels in men, may account for this difference.", "pattern_of_inheritance": "Autosomal dominant, Not applicable", "alternate_names": ["Brugada syndrome", "Hypertrichotic osteochondrodysplasia, Cantu type"]}, "gene information": {"db_hgnc_gene_id": 6269.0}, "interventions": [{"int_description_1": "Implantable cardioverter defibrillator (ICD)", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Neonate,Infant,Child", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Placement of a temporary pacemaker"}, {"int_description_3": "Isoprenaline", "timeframe_int3": "Days or Weeks,Years", "age_use_int3": "Infant,Child", "contra_int3": "No", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Verapamil"}, {"int_description_5": "Quinidine", "timeframe_int5": "Days or Weeks,Years", "age_use_int5": "Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Epicardial Substrate Ablation"}], "references": [{"pmid_title_1": "Non-invasive assessment of the arrhythmogenic substrate in Brugada syndrome using signal-averaged electrocardiogram: clinical implications from a prospective clinical trial.", "pmid_1": 31647530.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Europace"}, {"pmid_title_2": "Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.", "pmid_2": 28500178.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Circ Arrhythm Electrophysiol"}, {"pmid_title_3": "Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation.", "pmid_3": 26291334.0, "pmid_date_3": 2015.0, "pmid_journal_3": "Circ Arrhythm Electrophysiol"}, {"pmid_title_4": "ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene.", "pmid_4": 24439875.0, "pmid_date_4": 2014.0, "pmid_journal_4": "Int J Cardiol"}, {"pmid_title_5": "Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium.", "pmid_5": 21403098.0, "pmid_date_5": 2011.0, "pmid_journal_5": "Circulation"}, {"pmid_title_6": "Monomorphic ventricular tachycardia due to Brugada syndrome successfully treated by hydroquinidine therapy in a 3-year-old child.", "pmid_6": 16426410.0, "pmid_date_6": 2006.0, "pmid_journal_6": "J Cardiovasc Electrophysiol"}, {"pmid_title_7": "Efficacy of quinidine in high-risk patients with Brugada syndrome.", "pmid_7": 15381640.0, "pmid_date_7": 2004.0, "pmid_journal_7": "Circulation"}, {"pmid_title_8": "Electrical storm in Brugada syndrome successfully treated using isoprenaline.", "pmid_8": 15018871.0, "pmid_date_8": 2004.0, "pmid_journal_8": "Europace"}, {"pmid_title_9": "Hydroquinidine therapy in Brugada syndrome.", "pmid_9": 15145111.0, "pmid_date_9": 2004.0, "pmid_journal_9": "J Am Coll Cardiol"}]}, {"_id": "6269-ORPHA:1517", "condition": {"condition_name": "Hypertrichotic osteochondrodysplasia, Cantu type", "freq_per_birth": "Cant\u00fa syndrome is a rare condition. About three dozen affected individuals have been reported in the medical literature.", "pattern_of_inheritance": "Autosomal dominant, Not applicable", "alternate_names": ["Hypertrichotic osteochondrodysplasia, Cantu type", "Brugada syndrome"]}, "gene information": {"db_hgnc_gene_id": 6269.0}, "interventions": [{"int_description_1": "Braces"}, {"int_description_2": "Invasive ventilation"}, {"int_description_3": "Laser hair removal"}, {"int_description_4": "Myofunctional appliance"}, {"int_description_5": "Testosterone"}, {"int_description_6": "Diazepam"}, {"int_description_7": "Amitriptyline"}, {"int_description_8": "Caffeine"}, {"int_description_9": "Propranolol"}, {"int_description_10": "Spironolactone"}, {"int_description_11": "Losartan"}, {"int_description_12": "Metoprolol"}, {"int_description_13": "Atenolol"}, {"int_description_14": "Topiramate"}, {"int_description_15": "Human immunoglobulin G"}, {"int_description_16": "Clopidogrel"}, {"int_description_17": "Ondansetron"}, {"int_description_18": "Somatotropin"}, {"int_description_19": "Bisoprolol"}, {"int_description_20": "Amiodarone"}, {"int_description_21": "Levetiracetam"}, {"int_description_22": "Furosemide"}, {"int_description_23": "Glyburide"}, {"int_description_24": "Indomethacin"}, {"int_description_25": "Enalapril"}, {"int_description_26": "Quinapril"}, {"int_description_27": "Diltiazem"}, {"int_description_28": "Acetaminophen"}, {"int_description_29": "Dexmethylphenidate"}, {"int_description_30": "Hydrocortisone"}, {"int_description_31": "Tolbutamide"}, {"int_description_32": "Sildenafil"}, {"int_description_33": "Lamotrigine"}, {"int_description_34": "Colchicine"}, {"int_description_35": "ACE inhibitor"}, {"int_description_36": "Beta blocker"}, {"int_description_37": "CBD oil"}, {"int_description_38": "Diuretics"}, {"int_description_39": "Potassium supplementation"}, {"int_description_40": "Steroid therapy"}, {"int_description_41": "Butalbital"}, {"int_description_42": "Phenobarbital"}, {"int_description_43": "Compression stocking"}, {"int_description_44": "Gastrostomy feeding"}, {"int_description_45": "Home noninvasive ventilation"}, {"int_description_46": "Nasogastric tube feeding"}, {"int_description_47": "Shaving"}, {"int_description_48": "Speech, occupational, and physical therapies"}, {"int_description_49": "Ventriculo-peritoneal shunt"}, {"int_description_50": "Bilateral myringotomy tube placements"}, {"int_description_51": "Elective adenoidectomy"}, {"int_description_52": "Ligation"}, {"int_description_53": "Orthognathic surgery"}, {"int_description_54": "Pericardectomy/ pericardial stripping"}, {"int_description_55": "Pericardial fenestration/cardiac percutaneous window"}, {"int_description_56": "Pericardiocentesis"}, {"int_description_57": "Surgical closure of PDA"}, {"int_description_58": "Surgical intervention for thoracic aneurysm"}, {"int_description_59": "Surgical treatment for umbilical hernia"}, {"int_description_60": "Tracheostomy"}], "references": [{"pmid_title_1": "Cant\u00fa Syndrome", "pmid_1": 25275207.0, "pmid_date_1": 2020.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Cantu syndrome: A longitudinal review of vascular findings in three individuals.", "pmid_2": 32065455.0, "pmid_date_2": 2020.0, "pmid_journal_2": "American journal of medical genetics. Part A"}, {"pmid_title_3": "You Cantu: Multidisciplinary Collaboration Resulting in Successful Orthognathic Surgery.", "pmid_3": 31401848.0, "pmid_date_3": 2020.0, "pmid_journal_3": "The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association"}, {"pmid_title_4": "Glibenclamide treatment in a Cant\u00fa syndrome patient with a pathogenic ABCC9 gain-of-function variant: Initial experience.", "pmid_4": 31175705.0, "pmid_date_4": 2019.0, "pmid_journal_4": "American journal of medical genetics. Part A"}, {"pmid_title_5": "Cantu syndrome and hypopituitarism: implications for endocrine monitoring.", "pmid_5": 31743099.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Endocrinology, diabetes & metabolism case reports"}, {"pmid_title_6": "Aortic and pulmonary artery dilatation in Cantu syndrome: expanding the phenotype.", "pmid_6": 30921097.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Clinical dysmorphology"}, {"pmid_title_7": "Cant\u00fa syndrome: Findings from 74 patients in the International Cant\u00fa Syndrome Registry.", "pmid_7": 31828977.0, "pmid_date_7": 2019.0, "pmid_journal_7": "American journal of medical genetics. Part C, Seminars in medical genetics"}, {"pmid_title_8": "Cant\u00fa syndrome with coexisting familial pituitary adenoma.", "pmid_8": 29327300.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Endocrine"}, {"pmid_title_9": "Cant\u00fa Syndrome Associated with Ovarian Agenesis.", "pmid_9": 28690487.0, "pmid_date_9": 2017.0, "pmid_journal_9": "Molecular syndromology"}, {"pmid_title_10": "K(ATP) channel gain-of-function leads to increased myocardial L-type Ca(2+) current and contractility in Cantu syndrome.", "pmid_10": 27247394.0, "pmid_date_10": 2016.0, "pmid_journal_10": "Proceedings of the National Academy of Sciences of the United States of America"}, {"pmid_title_11": "Aortic aneurysm and craniosynostosis in a family with Cantu syndrome.", "pmid_11": 24352916.0, "pmid_date_11": 2014.0, "pmid_journal_11": "American journal of medical genetics. Part A"}, {"pmid_title_12": "Mutation of KCNJ8 in a patient with Cant\u00fa syndrome with unique vascular abnormalities - support for the role of K(ATP) channels in this condition.", "pmid_12": 24176758.0, "pmid_date_12": 2013.0, "pmid_journal_12": "European journal of medical genetics"}, {"pmid_title_13": "Cant\u00fa syndrome: report of nine new cases and expansion of the clinical phenotype.", "pmid_13": 21344641.0, "pmid_date_13": 2011.0, "pmid_journal_13": "American journal of medical genetics. Part A"}, {"pmid_title_14": "Cantu syndrome and lymphoedema.", "pmid_14": 20890180.0, "pmid_date_14": 2011.0, "pmid_journal_14": "Clinical dysmorphology"}, {"pmid_title_15": "Cantu syndrome in a woman and her two daughters: Further confirmation of autosomal dominant inheritance and review of the cardiac manifestations.", "pmid_15": 16835932.0, "pmid_date_15": 2006.0, "pmid_journal_15": "American journal of medical genetics. Part A"}, {"pmid_title_16": "Further case of Cant\u00fa syndrome: exclusion of cryptic subtelomeric chromosome aberrations.", "pmid_16": 12210352.0, "pmid_date_16": 2002.0, "pmid_journal_16": "American journal of medical genetics"}, {"pmid_title_17": "Autosomal dominant inheritance in Cant\u00fa syndrome (congenital hypertrichosis, osteochondrodysplasia, and cardiomegaly).", "pmid_17": 11050630.0, "pmid_date_17": 2000.0, "pmid_journal_17": "American journal of medical genetics"}, {"pmid_title_18": "Congenital hypertrichosis, cardiomegaly and mild osteochondrodysplasia.", "pmid_18": 8957508.0, "pmid_date_18": 1996.0, "pmid_journal_18": "American journal of medical genetics"}]}, {"_id": "6294-OMIM:192500", "condition": {"condition_name": "LONG QT SYNDROME 1; LQT1", "freq_per_birth": "Romano-Ward syndrome is the most common form of inherited long QT syndrome, which affects an estimated 1 in 2,000 people worldwide. Long QT syndrome may actually be more common than this estimate, however, because some people never experience any symptoms associated with arrhythmia and therefore may not be diagnosed.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1", "LONG QT SYNDROME 1; LQT1", "SHORT QT SYNDROME 2; SQT2", "ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3", "ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS"]}, "gene information": {"db_hgnc_gene_id": 6294.0}, "interventions": [{"int_description_1": "Implantable cardioverter-defibrillator"}, {"int_description_2": "Pacemaker"}, {"int_description_3": "Temporary ventricular pacing wires"}, {"int_description_4": "Nicorandil"}, {"int_description_5": "Salbutamol"}, {"int_description_6": "Propranolol"}, {"int_description_7": "Esmolol"}, {"int_description_8": "Metoprolol"}, {"int_description_9": "Atenolol"}, {"int_description_10": "Carteolol"}, {"int_description_11": "Bisoprolol"}, {"int_description_12": "Lidocaine"}, {"int_description_13": "Mexiletine"}, {"int_description_14": "Magnesium sulfate", "timeframe_int14": "Hours,Days or Weeks", "age_use_int14": "Child", "contra_int14": "No", "qualscale_reclass_drug14": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}, {"int_description_15": "Magnesium"}, {"int_description_16": "Lisinopril"}, {"int_description_17": "Hydrochlorothiazide", "timeframe_int17": "Hours,Days or Weeks", "age_use_int17": "Neonate,Infant,Child", "contra_int17": "No", "qualscale_reclass_drug17": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug17": "Effective / Ameliorative"}, {"int_description_18": "Verapamil"}, {"int_description_19": "Propafenone"}, {"int_description_20": "Beta-blocker"}, {"int_description_21": "Bicarbonate"}, {"int_description_22": "Potassium"}, {"int_description_23": "Fructose sodium diphosphate oral solution"}, {"int_description_24": "LUF7346", "timeframe_int24": "Days or Weeks,Years", "age_use_int24": "Child", "contra_int24": "No", "qualscale_reclass_drug24": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug24": "Effective / Ameliorative"}, {"int_description_25": "Sodium channel blockers"}, {"int_description_26": "Sodium creatine phosphate"}, {"int_description_27": "Phenobarbital"}, {"int_description_28": "Left cardiac sympathetic denervation"}], "references": [{"pmid_title_1": "Head-up tilt test induces T-wave alternans in long QT syndrome with KCNQ1 gene mutation: Case report CARE-compliant article.", "pmid_1": 32443288.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Medicine"}, {"pmid_title_2": "Long QT Syndrome", "pmid_2": 20301308.0, "pmid_date_2": 2018.0, "pmid_journal_2": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_3": "Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients : Koponen et al. Follow-up of adult LQTS patients.", "pmid_3": 29622001.0, "pmid_date_3": 2018.0, "pmid_journal_3": "BMC medical genetics"}, {"pmid_title_4": "Wearable cardioverter defibrillators for patients with long QT syndrome.", "pmid_4": 30041777.0, "pmid_date_4": 2018.0, "pmid_journal_4": "International journal of cardiology"}, {"pmid_title_5": "Late-onset severe long QT syndrome.", "pmid_5": 29194874.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc"}, {"pmid_title_6": "The Effects of Pharmacological Compounds on Beat Rate Variations in Human Long QT-Syndrome Cardiomyocytes.", "pmid_6": 27646833.0, "pmid_date_6": 2016.0, "pmid_journal_6": "Stem cell reviews and reports"}, {"pmid_title_7": "A new hERG allosteric modulator rescues genetic and drug-induced long-QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells.", "pmid_7": 27470144.0, "pmid_date_7": 2016.0, "pmid_journal_7": "EMBO molecular medicine"}, {"pmid_title_8": "Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.", "pmid_8": 26063740.0, "pmid_date_8": 2015.0, "pmid_journal_8": "Circulation. Arrhythmia and electrophysiology"}, {"pmid_title_9": "Efficacy of ventricular pacing in the treatment of an arrhythmic storm associated with a congenital long QT mutation.", "pmid_9": 23075154.0, "pmid_date_9": 2013.0, "pmid_journal_9": "Congenital heart disease"}, {"pmid_title_10": "Genotype-phenotype analysis of three Chinese families with Jervell and Lange-Nielsen syndrome.", "pmid_10": 22629021.0, "pmid_date_10": 2012.0, "pmid_journal_10": "Journal of cardiovascular disease research"}, {"pmid_title_11": "Fetal atrioventricular block and postpartum augmentative QT prolongation in a patient with long-QT syndrome with KCNQ1 mutation.", "pmid_11": 20487114.0, "pmid_date_11": 2010.0, "pmid_journal_11": "Journal of cardiovascular electrophysiology"}, {"pmid_title_12": "Patient-specific induced pluripotent stem-cell models for long-QT syndrome.", "pmid_12": 20660394.0, "pmid_date_12": 2010.0, "pmid_journal_12": "The New England journal of medicine"}, {"pmid_title_13": "Atrial Arrhythmias in long-QT syndrome under daily life conditions: a nested case control study.", "pmid_13": 19017345.0, "pmid_date_13": 2009.0, "pmid_journal_13": "Journal of cardiovascular electrophysiology"}, {"pmid_title_14": "High prevalence of four long QT syndrome founder mutations in the Finnish population.", "pmid_14": 19160088.0, "pmid_date_14": 2009.0, "pmid_journal_14": "Annals of medicine"}, {"pmid_title_15": "Importance of Knowing the Genotype and the Specific Mutation When Managing Patients with Long QT Syndrome.", "pmid_15": 19701491.0, "pmid_date_15": 2008.0, "pmid_journal_15": "Circulation. Arrhythmia and electrophysiology"}, {"pmid_title_16": "The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification.", "pmid_16": 17984373.0, "pmid_date_16": 2007.0, "pmid_journal_16": "Circulation"}, {"pmid_title_17": "Phenotype reveals genotype in a Greek long QT syndrome family.", "pmid_17": 16627448.0, "pmid_date_17": 2006.0, "pmid_journal_17": "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology"}, {"pmid_title_18": "The long QT syndrome: therapeutic implications of a genetic diagnosis.", "pmid_18": 15979599.0, "pmid_date_18": 2005.0, "pmid_journal_18": "Cardiovascular research"}, {"pmid_title_19": "Images in cardiovascular medicine. Himalayan T waves in the congenital long-QT syndrome.", "pmid_19": 15781747.0, "pmid_date_19": 2005.0, "pmid_journal_19": "Circulation"}, {"pmid_title_20": "Additional gene variants reduce effectiveness of beta-blockers in the LQT1 form of long QT syndrome.", "pmid_20": 15028050.0, "pmid_date_20": 2004.0, "pmid_journal_20": "Journal of cardiovascular electrophysiology"}, {"pmid_title_21": "KCNQ1 mutations in patients with a family history of lethal cardiac arrhythmias and sudden death.", "pmid_21": 12702160.0, "pmid_date_21": 2003.0, "pmid_journal_21": "Clinical genetics"}, {"pmid_title_22": "Characterization and subcellular localization of KCNQ1 with a heterozygous mutation in the C terminus.", "pmid_22": 11162126.0, "pmid_date_22": 2001.0, "pmid_journal_22": "Journal of molecular and cellular cardiology"}]}, {"_id": "6294-OMIM:220400", "condition": {"condition_name": "JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1", "freq_per_birth": "Jervell and Lange-Nielsen syndrome is uncommon; it affects an estimated 1.6 to 6 per 1 million people worldwide.  This condition has a higher prevalence in Denmark, Sweden, and Norway, where it affects at least 1 in 200,000 people.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["LONG QT SYNDROME 1; LQT1", "JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1", "SHORT QT SYNDROME 2; SQT2", "ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3", "ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS"]}, "gene information": {"db_hgnc_gene_id": 6294.0}, "interventions": [{"int_description_1": "Cardioverter-defibrillator"}, {"int_description_2": "Cochlear implant"}, {"int_description_3": "Implantable cardioverter-defibrillator"}, {"int_description_4": "Pacemaker"}, {"int_description_5": "Propranolol", "timeframe_int5": "Days or Weeks", "age_use_int5": "Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Metoprolol"}, {"int_description_7": "Nadolol"}, {"int_description_8": "Beta-antiadrenergic medication"}, {"int_description_9": "Beta-blocker", "timeframe_int9": "Days or Weeks", "age_use_int9": "Child", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Left cardiac sympathetic denervation"}], "references": [{"pmid_title_1": "Jervell and Lange-Nielsen Syndrome", "pmid_1": 20301579.0, "pmid_date_1": 2017.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "The Jervell and Lange-Nielsen syndrome; atrial pacing combined with ss-blocker therapy, a favorable approach in young high-risk patients with long QT syndrome?", "pmid_2": 27451284.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Heart rhythm"}, {"pmid_title_3": "Images in cardiovascular medicine. Himalayan T waves in the congenital long-QT syndrome.", "pmid_3": 15781747.0, "pmid_date_3": 2005.0, "pmid_journal_3": "Circulation"}, {"pmid_title_4": "A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics.", "pmid_4": 11216980.0, "pmid_date_4": 2001.0, "pmid_journal_4": "Journal of the American College of Cardiology"}]}, {"_id": "6294-OMIM:609621", "condition": {"condition_name": "SHORT QT SYNDROME 2; SQT2", "freq_per_birth": "Short QT syndrome appears to be rare. At least 70 cases have been identified worldwide since the condition was discovered in 2000. However, the condition may be underdiagnosed because some affected individuals never experience symptoms.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["LONG QT SYNDROME 1; LQT1", "SHORT QT SYNDROME 2; SQT2", "ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3", "JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1", "ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS"]}, "gene information": {"db_hgnc_gene_id": 6294.0}, "interventions": [{"int_description_1": "Implantable cardioverter-defibrillator"}, {"int_description_2": "Carvedilol"}, {"int_description_3": "Metoprolol"}, {"int_description_4": "Amiodarone"}, {"int_description_5": "Sotalol"}, {"int_description_6": "Quinidine"}, {"int_description_7": "Mefloquine"}, {"int_description_8": "Ibutilide"}, {"int_description_9": "Flecainide"}, {"int_description_10": "Disopyramide", "timeframe_int10": "Hours,Days or Weeks", "age_use_int10": "Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Case report(s)", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Propafenone"}, {"int_description_12": "Nifekalant"}], "references": [{"pmid_title_1": "Emerging therapeutic targets in the short QT syndrome.", "pmid_1": 29697308.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Expert opinion on therapeutic targets"}, {"pmid_title_2": "Recent Advances in Short QT Syndrome.", "pmid_2": 30420954.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Frontiers in cardiovascular medicine"}, {"pmid_title_3": "Differential effects of the \u03b2-adrenoceptor blockers carvedilol and metoprolol on SQT1- and SQT2-mutant channels.", "pmid_3": 23718892.0, "pmid_date_3": 2013.0, "pmid_journal_3": "Journal of cardiovascular electrophysiology"}, {"pmid_title_4": "Action potential clamp and mefloquine sensitivity of recombinant 'I KS' channels incorporating the V307L KCNQ1 mutation.", "pmid_4": 20436212.0, "pmid_date_4": 2010.0, "pmid_journal_4": "Journal of physiology and pharmacology : an official journal of the Polish Physiological Society"}]}, {"_id": "6296-OMIM:121200", "condition": {"condition_name": "SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1", "freq_per_birth": "Benign familial neonatal seizures occurs in approximately 1 in 100,000 newborns.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1", "EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7; EIEE7"]}, "gene information": {"db_hgnc_gene_id": 6296.0}, "interventions": [{"int_description_1": "Hexobarbital"}, {"int_description_2": "Ezogabine"}, {"int_description_3": "Corticotropin"}, {"int_description_4": "Clonazepam"}, {"int_description_5": "Diazepam"}, {"int_description_6": "Topiramate", "timeframe_int6": "Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Cohort study or studies", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Human immunoglobulin G"}, {"int_description_8": "Midazolam"}, {"int_description_9": "Levetiracetam", "timeframe_int9": "Days or Weeks", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Cohort study or studies", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Tubocurarine"}, {"int_description_11": "Oxcarbazepine", "timeframe_int11": "Hours", "age_use_int11": "Neonate,Infant,Child", "contra_int11": "No", "qualscale_reclass_drug11": "Cohort study or studies", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "Lidocaine", "timeframe_int12": "Hours", "age_use_int12": "Neonate,Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Cohort study or studies", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Carbamazepine"}, {"int_description_14": "Pyridoxine"}, {"int_description_15": "Pyrithione"}, {"int_description_16": "Pentetrazol"}, {"int_description_17": "Vigabatrin"}, {"int_description_18": "Valproic acid"}, {"int_description_19": "Lamotrigine"}, {"int_description_20": "Phenytoin", "timeframe_int20": "Hours", "age_use_int20": "Neonate,Infant,Child", "contra_int20": "No", "qualscale_reclass_drug20": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug20": "Effective / Ameliorative"}, {"int_description_21": "Leucovorin"}, {"int_description_22": "Primidone"}, {"int_description_23": "Benzodiazepine", "timeframe_int23": "Hours", "age_use_int23": "Neonate,Infant,Child", "contra_int23": "No", "qualscale_reclass_drug23": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug23": "Effective / Ameliorative"}, {"int_description_24": "Phenobarbital"}, {"int_description_25": "Piracetam"}], "references": [{"pmid_title_1": "Genetics of neonatal-onset epilepsies.", "pmid_1": 31324323.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Handbook of clinical neurology"}, {"pmid_title_2": "KCNQ2 mutations in childhood nonlesional epilepsy: Variable phenotypes and a novel mutation in a case series.", "pmid_2": 31199083.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Mol Genet Genomic Med"}, {"pmid_title_3": "<i>KCNQ2</i>-Related Disorders", "pmid_3": 20437616.0, "pmid_date_3": 2018.0, "pmid_journal_3": "GeneReviews\u00ae"}, {"pmid_title_4": "Neonatal epilepsies: Clinical management.", "pmid_4": 29426806.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Seminars in fetal & neonatal medicine"}, {"pmid_title_5": "A Case of KCNQ2-Associated Movement Disorder Triggered by Fever.", "pmid_5": 29129156.0, "pmid_date_5": 2017.0, "pmid_journal_5": "Journal of child neurology"}, {"pmid_title_6": "A KCNQ2 E515D mutation associated with benign familial neonatal seizures and continuous spike and waves during slow-wave sleep syndrome in Taiwan.", "pmid_6": 28038823.0, "pmid_date_6": 2017.0, "pmid_journal_6": "Journal of the Formosan Medical Association = Taiwan yi zhi"}, {"pmid_title_7": "Retigabine, a Kv7.2/Kv7.3-Channel Opener, Attenuates Drug-Induced Seizures in Knock-In Mice Harboring Kcnq2 Mutations.", "pmid_7": 26910900.0, "pmid_date_7": 2016.0, "pmid_journal_7": "PLoS One"}, {"pmid_title_8": "Rapid and safe response to low-dose carbamazepine in neonatal epilepsy.", "pmid_8": 27888506.0, "pmid_date_8": 2016.0, "pmid_journal_8": "Epilepsia"}, {"pmid_title_9": "Whole-exome sequencing broadens the phenotypic spectrum of rare pediatric epilepsy: a retrospective study.", "pmid_9": 25046240.0, "pmid_date_9": 2015.0, "pmid_journal_9": "Clinical genetics"}, {"pmid_title_10": "The kick-in system: a novel rapid knock-in strategy.", "pmid_10": 24586341.0, "pmid_date_10": 2014.0, "pmid_journal_10": "PLoS One"}, {"pmid_title_11": "Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance.", "pmid_11": 23360469.0, "pmid_date_11": 2013.0, "pmid_journal_11": "Epilepsia"}, {"pmid_title_12": "Neonatal seizures associated with a severe neonatal myoclonus like dyskinesia due to a familial KCNQ2 gene mutation.", "pmid_12": 22169383.0, "pmid_date_12": 2012.0, "pmid_journal_12": "European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society"}, {"pmid_title_13": "Isoform-specific prolongation of Kv7 (KCNQ) potassium channel opening mediated by new molecular determinants for drug-channel interactions.", "pmid_13": 20584905.0, "pmid_date_13": 2010.0, "pmid_journal_13": "J Biol Chem"}, {"pmid_title_14": "Novel mutation in KCNQ2 causing benign familial neonatal seizures.", "pmid_14": 19818940.0, "pmid_date_14": 2009.0, "pmid_journal_14": "Pediatric neurology"}, {"pmid_title_15": "Neutralization of a unique, negatively-charged residue in the voltage sensor of K V 7.2 subunits in a sporadic case of benign familial neonatal seizures.", "pmid_15": 19344764.0, "pmid_date_15": 2009.0, "pmid_journal_15": "Neurobiology of disease"}, {"pmid_title_16": "A de novo KCNQ2 mutation detected in non-familial benign neonatal convulsions.", "pmid_16": 18640800.0, "pmid_date_16": 2009.0, "pmid_journal_16": "Brain & development"}, {"pmid_title_17": "Benign familial neonatal convulsions: novel mutation in a newborn.", "pmid_17": 19380078.0, "pmid_date_17": 2009.0, "pmid_journal_17": "Pediatric neurology"}, {"pmid_title_18": "Germ-line mutation of KCNQ2, p.R213W, in a Japanese family with benign familial neonatal convulsion.", "pmid_18": 18353052.0, "pmid_date_18": 2008.0, "pmid_journal_18": "Pediatrics international : official journal of the Japan Pediatric Society"}, {"pmid_title_19": "Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations.", "pmid_19": 17872363.0, "pmid_date_19": 2007.0, "pmid_journal_19": "Neurology"}, {"pmid_title_20": "Neutralization of a negative charge in the S1-S2 region of the KV7.2 (KCNQ2) channel affects voltage-dependent activation in neonatal epilepsy.", "pmid_20": 18006581.0, "pmid_date_20": 2007.0, "pmid_journal_20": "J Physiol"}, {"pmid_title_21": "A novel missense mutation (N258S) in the KCNQ2 gene in a Turkish family afflicted with benign familial neonatal convulsions (BFNC).", "pmid_21": 18246739.0, "pmid_date_21": 2007.0, "pmid_journal_21": "The Turkish journal of pediatrics"}, {"pmid_title_22": "Zinc pyrithione-mediated activation of voltage-gated KCNQ potassium channels rescues epileptogenic mutants.", "pmid_22": 17435769.0, "pmid_date_22": 2007.0, "pmid_journal_22": "Nature chemical biology"}, {"pmid_title_23": "Subthreshold changes of voltage-dependent activation of the K(V)7.2 channel in neonatal epilepsy.", "pmid_23": 16916607.0, "pmid_date_23": 2006.0, "pmid_journal_23": "Neurobiology of disease"}, {"pmid_title_24": "A novel splicing mutation in KCNQ2 in a multigenerational family with BFNC followed for 25 years.", "pmid_24": 16686649.0, "pmid_date_24": 2006.0, "pmid_journal_24": "Epilepsia"}, {"pmid_title_25": "Functional analysis of novel KCNQ2 and KCNQ3 gene variants found in a large pedigree with benign familial neonatal convulsions (BFNC).", "pmid_25": 16235065.0, "pmid_date_25": 2005.0, "pmid_journal_25": "Neurogenetics"}, {"pmid_title_26": "Neonatal seizures with tonic clonic sequences and poor developmental outcome.", "pmid_26": 16039833.0, "pmid_date_26": 2005.0, "pmid_journal_26": "Epilepsy research"}, {"pmid_title_27": "A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation.", "pmid_27": 15249611.0, "pmid_date_27": 2004.0, "pmid_journal_27": "Neurology"}, {"pmid_title_28": "Complete loss of the cytoplasmic carboxyl terminus of the KCNQ2 potassium channel: a novel mutation in a large Czech pedigree with benign neonatal convulsions or other epileptic phenotypes.", "pmid_28": 15030501.0, "pmid_date_28": 2004.0, "pmid_journal_28": "Epilepsia"}, {"pmid_title_29": "A novel mutation in KCNQ2 gene causes benign familial neonatal convulsions in a Chinese family.", "pmid_29": 15178210.0, "pmid_date_29": 2004.0, "pmid_journal_29": "Journal of the neurological sciences"}, {"pmid_title_30": "A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes.", "pmid_30": 12847176.0, "pmid_date_30": 2003.0, "pmid_journal_30": "Neurology"}, {"pmid_title_31": "Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel.", "pmid_31": 11572947.0, "pmid_date_31": 2001.0, "pmid_journal_31": "Proc Natl Acad Sci U S A"}, {"pmid_title_32": "Benign familial neonatal convulsions (BFNC) resulting from mutation of the KCNQ2 voltage sensor.", "pmid_32": 11175290.0, "pmid_date_32": 2000.0, "pmid_journal_32": "European journal of human genetics : EJHG"}]}, {"_id": "6296-OMIM:613720", "condition": {"condition_name": "EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7; EIEE7", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7; EIEE7", "SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1"]}, "gene information": {"db_hgnc_gene_id": 6296.0}, "interventions": [{"int_description_1": "Non-invasive focal neuromodulation (tDCS): Device: High-definition (HD) transcranial direct current stimulator, HD-tDCS with 4x1 HD adaptor"}, {"int_description_2": "Ketogenic diet", "timeframe_int2": "Days or Weeks", "age_use_int2": "Child", "contra_int2": "Yes", "qualscale_reclass_drug2": "Cohort study or studies", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Clobazam", "timeframe_int3": "Days or Weeks", "age_use_int3": "Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Ezogabine"}, {"int_description_5": "Corticotropin"}, {"int_description_6": "Clonazepam", "timeframe_int6": "Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Case report(s)", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Cannabidiol"}, {"int_description_8": "Topiramate", "timeframe_int8": "Days or Weeks", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Case report(s)", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Pyridoxal phosphate", "timeframe_int9": "Hours", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Levetiracetam", "timeframe_int10": "Hours", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Oxcarbazepine"}, {"int_description_12": "Lidocaine"}, {"int_description_13": "Carbamazepine"}, {"int_description_14": "Lacosamide"}, {"int_description_15": "Pyridoxine"}, {"int_description_16": "Gabapentin"}, {"int_description_17": "Zonisamide", "timeframe_int17": "Days or Weeks", "age_use_int17": "Neonate,Infant", "contra_int17": "No", "qualscale_reclass_drug17": "Case report(s)", "rev1_eff_reclass_drug17": "Effective / Ameliorative"}, {"int_description_18": "Sulthiame"}, {"int_description_19": "Rufinamide"}, {"int_description_20": "Vigabatrin", "timeframe_int20": "Hours", "age_use_int20": "Neonate,Infant,Child", "contra_int20": "No", "qualscale_reclass_drug20": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug20": "Effective / Ameliorative"}, {"int_description_21": "Valproic acid"}, {"int_description_22": "Lamotrigine", "timeframe_int22": "Hours", "age_use_int22": "Neonate,Infant,Child", "contra_int22": "No", "qualscale_reclass_drug22": "Case report(s)", "rev1_eff_reclass_drug22": "Effective / Ameliorative"}, {"int_description_23": "Phenytoin"}, {"int_description_24": "Fosphenytoin"}, {"int_description_25": "Leucovorin"}, {"int_description_26": "Chloral hydrate"}, {"int_description_27": "Potassium"}, {"int_description_28": "Phenobarbital"}], "references": [{"pmid_title_1": "Why we urgently need improved seizure and epilepsy therapies for children and neonates.", "pmid_1": 31751548.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Neuropharmacology"}, {"pmid_title_2": "Antiepileptic Effects of a Novel Non-invasive Neuromodulation Treatment in a Subject With Early-Onset Epileptic Encephalopathy: Case Report With 20 Sessions of HD-tDCS Intervention.", "pmid_2": 31191235.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Front Neurosci"}, {"pmid_title_3": "Genetics of neonatal-onset epilepsies.", "pmid_3": 31324323.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Handbook of clinical neurology"}, {"pmid_title_4": "KCNQ2 mutations in childhood nonlesional epilepsy: Variable phenotypes and a novel mutation in a case series.", "pmid_4": 31199083.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Mol Genet Genomic Med"}, {"pmid_title_5": "Epileptic Encephalopathy In A Patient With A Novel Variant In The Kv7.2 S2 Transmembrane Segment: Clinical, Genetic, and Functional Features.", "pmid_5": 31295832.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Int J Mol Sci"}, {"pmid_title_6": "KCNQ2 related early-onset epileptic encephalopathies in Chinese children.", "pmid_6": 31152295.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Journal of neurology"}, {"pmid_title_7": "<i>KCNQ2</i>-Related Disorders", "pmid_7": 20437616.0, "pmid_date_7": 2018.0, "pmid_journal_7": "GeneReviews\u00ae"}, {"pmid_title_8": "KCNQ2 encephalopathy: A case due to a de novo deletion.", "pmid_8": 28728838.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Brain & development"}, {"pmid_title_9": "A patient with early myoclonic encephalopathy (EME) with a de novo KCNQ2 mutation.", "pmid_9": 28687180.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Brain & development"}, {"pmid_title_10": "Neonatal epilepsies: Clinical management.", "pmid_10": 29426806.0, "pmid_date_10": 2018.0, "pmid_journal_10": "Seminars in fetal & neonatal medicine"}, {"pmid_title_11": "Targeted gene panel and genotype-phenotype correlation in children with developmental and epileptic encephalopathy.", "pmid_11": 29455050.0, "pmid_date_11": 2018.0, "pmid_journal_11": "Epilepsy research"}, {"pmid_title_12": "Diagnostic work-up and rehabilitation of cerebral visual impairment in infancy: A case of epileptic perinatal encephalopathy due to KCNQ2-related channelopathy", "pmid_12": 28655139.0, "pmid_date_12": 2018.0, "pmid_journal_12": "Journal of pediatric rehabilitation medicine"}, {"pmid_title_13": "Rapid Diagnosis of KCNQ2-Associated Early Infantile Epileptic Encephalopathy Improved Outcome.", "pmid_13": 30107960.0, "pmid_date_13": 2018.0, "pmid_journal_13": "Pediatr Neurol"}, {"pmid_title_14": "Variable expressivity of a likely pathogenic variant in KCNQ2 in a three-generation pedigree presenting with intellectual disability with childhood onset seizures.", "pmid_14": 28602030.0, "pmid_date_14": 2017.0, "pmid_journal_14": "American journal of medical genetics. Part A"}, {"pmid_title_15": "Ketogenic diet in the treatment of epilepsy in children under the age of 2 years: study protocol for a randomised controlled trial.", "pmid_15": 28446244.0, "pmid_date_15": 2017.0, "pmid_journal_15": "Trials"}, {"pmid_title_16": "Pointed rhythmic theta waves: a unique EEG pattern in KCNQ2-related neonatal epileptic encephalopathy.", "pmid_16": 28832002.0, "pmid_date_16": 2017.0, "pmid_journal_16": "Epileptic disorders : international epilepsy journal with videotape"}, {"pmid_title_17": "A Distinctive Ictal Amplitude-Integrated Electroencephalography Pattern in Newborns with Neonatal Epilepsy Associated with KCNQ2 Mutations.", "pmid_17": 28926830.0, "pmid_date_17": 2017.0, "pmid_journal_17": "Neonatology"}, {"pmid_title_18": "Neonatal nonepileptic myoclonus is a prominent clinical feature of KCNQ2 gain-of-function variants R201C and R201H.", "pmid_18": 28139826.0, "pmid_date_18": 2017.0, "pmid_journal_18": "Epilepsia"}, {"pmid_title_19": "Vitamin B6-Responsive Epilepsy due to a Novel KCNQ2 Mutation.", "pmid_19": 28420012.0, "pmid_date_19": 2017.0, "pmid_journal_19": "Neuropediatrics"}, {"pmid_title_20": "Sodium channel blockers in KCNQ2-encephalopathy: Lacosamide as a new treatment option.", "pmid_20": 28881259.0, "pmid_date_20": 2017.0, "pmid_journal_20": "Seizure"}, {"pmid_title_21": "Gene mutation analysis of 175 Chinese patients with early-onset epileptic encephalopathy.", "pmid_21": 27779742.0, "pmid_date_21": 2017.0, "pmid_journal_21": "Clinical genetics"}, {"pmid_title_22": "Clinical and genetic features of 13 Spanish patients with KCNQ2 mutations.", "pmid_22": 27535030.0, "pmid_date_22": 2017.0, "pmid_journal_22": "Journal of human genetics"}, {"pmid_title_23": "KCNQ2 Mutation Explains the Etiology of Chloral Hydrate-Responsive Ohtahara Syndrome.", "pmid_23": 28065823.0, "pmid_date_23": 2017.0, "pmid_journal_23": "Pediatric neurology"}, {"pmid_title_24": "Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant.", "pmid_24": 27861786.0, "pmid_date_24": 2016.0, "pmid_journal_24": "Epilepsia"}, {"pmid_title_25": "KCNQ2 encephalopathy: Features, mutational hot spots, and ezogabine treatment of 11 patients.", "pmid_25": 27602407.0, "pmid_date_25": 2016.0, "pmid_journal_25": "Neurol Genet"}, {"pmid_title_26": "Early and effective treatment of KCNQ2 encephalopathy.", "pmid_26": 25880994.0, "pmid_date_26": 2015.0, "pmid_journal_26": "Epilepsia"}, {"pmid_title_27": "KCNQ2 encephalopathy: delineation of the electroclinical phenotype and treatment response.", "pmid_27": 24371303.0, "pmid_date_27": 2014.0, "pmid_journal_27": "Neurology"}, {"pmid_title_28": "Video/EEG findings in a KCNQ2 epileptic encephalopathy: a case report and revision of literature data.", "pmid_28": 23774309.0, "pmid_date_28": 2013.0, "pmid_journal_28": "Epileptic disorders : international epilepsy journal with videotape"}, {"pmid_title_29": "Extending the KCNQ2 encephalopathy spectrum: clinical and neuroimaging findings in 17 patients.", "pmid_29": 24107868.0, "pmid_date_29": 2013.0, "pmid_journal_29": "Neurology"}, {"pmid_title_30": "Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation.", "pmid_30": 23621294.0, "pmid_date_30": 2013.0, "pmid_journal_30": "Epilepsia"}, {"pmid_title_31": "Similar early characteristics but variable neurological outcome of patients with a de novo mutation of KCNQ2.", "pmid_31": 23692823.0, "pmid_date_31": 2013.0, "pmid_journal_31": "Orphanet J Rare Dis"}, {"pmid_title_32": "Ring chromosome 20: a pediatric potassium channelopathy responsive to treatment with ezogabine.", "pmid_32": 23916860.0, "pmid_date_32": 2013.0, "pmid_journal_32": "Pediatric neurology"}, {"pmid_title_33": "KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy.", "pmid_33": 22275249.0, "pmid_date_33": 2012.0, "pmid_journal_33": "Annals of neurology"}, {"pmid_title_34": "The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy.", "pmid_34": 22220513.0, "pmid_date_34": 2012.0, "pmid_journal_34": "Epilepsia"}, {"pmid_title_35": "Whole exome sequencing identifies KCNQ2 mutations in Ohtahara syndrome.", "pmid_35": 22926866.0, "pmid_date_35": 2012.0, "pmid_journal_35": "Annals of neurology"}, {"pmid_title_36": "The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial.", "pmid_36": 18456557.0, "pmid_date_36": 2008.0, "pmid_journal_36": "The Lancet. Neurology"}, {"pmid_title_37": "Retigabine: in partial seizures.", "pmid_37": 16800718.0, "pmid_date_37": 2006.0, "pmid_journal_37": "CNS drugs"}, {"pmid_title_38": "Neonatal convulsions and epileptic encephalopathy in an Italian family with a missense mutation in the fifth transmembrane region of KCNQ2.", "pmid_38": 12742592.0, "pmid_date_38": 2003.0, "pmid_journal_38": "Epilepsy research"}]}, {"_id": "634-OMIM:125800", "condition": {"condition_name": "DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL", "freq_per_birth": "The prevalence of nephrogenic diabetes insipidus is unknown, although the condition is thought to be rare. The acquired form occurs more frequently than the hereditary form.", "pattern_of_inheritance": "Autosomal dominant, X-linked recessive, Autosomal recessive", "alternate_names": ["DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL"]}, "gene information": {"db_hgnc_gene_id": 634.0}, "interventions": [{"int_description_1": "Continuous or intermittent bladder catheterization"}, {"int_description_2": "Dietary restriction of sodium to 1 mmol/kg/day"}, {"int_description_3": "Desmopressin", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "Yes", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Vasopressin", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Indomethacin"}, {"int_description_6": "Amiloride", "timeframe_int6": "Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Case report(s)", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Hydrochlorothiazide"}, {"int_description_8": "Ibuprofen"}, {"int_description_9": "Tanespimycin", "timeframe_int9": "Hours,Days or Weeks", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Sodium chloride", "timeframe_int10": "Hours", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Potassium"}, {"int_description_12": "Dextrose in water, 5%"}, {"int_description_13": "Isotonic fluid", "timeframe_int13": "Hours,Days or Weeks", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Normal saline solution"}, {"int_description_15": "Thiazide diuretic"}, {"int_description_16": "Thiazide", "timeframe_int16": "Hours,Days or Weeks", "age_use_int16": "Neonate,Infant,Child", "contra_int16": "No", "qualscale_reclass_drug16": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug16": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Hereditary Nephrogenic Diabetes Insipidus", "pmid_1": 20301356.0, "pmid_date_1": 2020.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Long-term outcome in inherited nephrogenic diabetes insipidus.", "pmid_2": 30976394.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Clin Kidney J"}, {"pmid_title_3": "Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.", "pmid_3": 29125546.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Int J Mol Sci"}, {"pmid_title_4": "Novel AQP2 mutation causing congenital nephrogenic diabetes insipidus: challenges in management during infancy.", "pmid_4": 23950570.0, "pmid_date_4": 2014.0, "pmid_journal_4": "J Pediatr Endocrinol Metab"}, {"pmid_title_5": "Hsp90 inhibitor partially corrects nephrogenic diabetes insipidus in a conditional knock-in mouse model of aquaporin-2 mutation.", "pmid_5": 18854434.0, "pmid_date_5": 2009.0, "pmid_journal_5": "FASEB J"}, {"pmid_title_6": "Lack of arginine vasopressin-induced phosphorylation of aquaporin-2 mutant AQP2-R254L explains dominant nephrogenic diabetes insipidus.", "pmid_6": 16120822.0, "pmid_date_6": 2005.0, "pmid_journal_6": "J Am Soc Nephrol"}, {"pmid_title_7": "A novel mechanism in recessive nephrogenic diabetes insipidus: wild-type aquaporin-2 rescues the apical membrane expression of intracellularly retained AQP2-P262L.", "pmid_7": 15509592.0, "pmid_date_7": 2004.0, "pmid_journal_7": "Hum Mol Genet"}, {"pmid_title_8": "Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus.", "pmid_8": 10477148.0, "pmid_date_8": 1999.0, "pmid_journal_8": "J Am Soc Nephrol"}, {"pmid_title_9": "An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex.", "pmid_9": 9649557.0, "pmid_date_9": 1998.0, "pmid_journal_9": "J Clin Invest"}]}, {"_id": "6595-OMIM:221750", "condition": {"condition_name": "PITUITARY HORMONE DEFICIENCY, COMBINED, 3; CPHD3", "freq_per_birth": "The prevalence of combined pituitary hormone deficiency is estimated to be 1 in 8,000 individuals worldwide.", "pattern_of_inheritance": "Autosomal recessive==Autosomal dominant", "alternate_names": ["PITUITARY HORMONE DEFICIENCY, COMBINED, 3; CPHD3"]}, "gene information": {"db_hgnc_gene_id": 6595.0}, "interventions": [{"int_description_1": "Levothyroxine"}, {"int_description_2": "Somatotropin"}, {"int_description_3": "Hydrocortisone"}], "references": [{"pmid_title_1": "Congenital Hypopituitarism: Various Genes, Various Phenotypes.", "pmid_1": 30759489.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme"}, {"pmid_title_2": "A novel mutation of LHX3 is associated with combined pituitary hormone deficiency including ACTH deficiency, sensorineural hearing loss, and short neck-a case report and review of the literature.", "pmid_2": 21249393.0, "pmid_date_2": 2011.0, "pmid_journal_2": "European journal of pediatrics"}, {"pmid_title_3": "Novel mutations in LHX3 are associated with hypopituitarism and sensorineural hearing loss.", "pmid_3": 18407919.0, "pmid_date_3": 2008.0, "pmid_journal_3": "Human molecular genetics"}]}, {"_id": "6617-OMIM:278000", "condition": {"condition_name": "LYSOSOMAL ACID LIPASE DEFICIENCY", "freq_per_birth": "Lysosomal acid lipase deficiency is estimated to occur in 1 in 40,000 to 300,000 individuals, varying by population. The later-onset form is more common than the early-onset form.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["LYSOSOMAL ACID LIPASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 6617.0}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Sebelipase alfa"}, {"int_description_3": "Enzyme replacement therapy (human LAL)", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Blood transfusions"}, {"int_description_5": "Hematopoietic stem cell transplantation"}, {"int_description_6": "Liver transplant"}], "references": [{"pmid_title_1": "Lysosomal Acid Lipase Deficiency: Therapeutic Options.", "pmid_1": 32103901.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Drug design, development and therapy"}, {"pmid_title_2": "Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study.", "pmid_2": 28179030.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Orphanet journal of rare diseases"}, {"pmid_title_3": "Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infants.", "pmid_3": 26312827.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Genetics in medicine : official journal of the American College of Medical Genetics"}, {"pmid_title_4": "Wolman's disease: the first case in Japan.", "pmid_4": 5972796.0, "pmid_date_4": 1966.0, "pmid_journal_4": "The Tohoku journal of experimental medicine"}]}, {"_id": "663-OMIM:207800", "condition": {"condition_name": "ARGININEMIA", "freq_per_birth": "Arginase deficiency is a very rare disorder; it has been estimated to occur once in every 300,000 to 1,000,000 individuals.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ARGININEMIA"]}, "gene information": {"db_hgnc_gene_id": 663.0}, "interventions": [{"int_description_1": "Low protein diet and Arginine-free essential amino acid mixture supplementation", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Low protein diet and Arginine-free essential amino acids mixture supplementation", "timeframe_int2": "Days or Weeks", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Cohort study or studies", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Low protein diet and citrulline supplementation", "timeframe_int3": "Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Benzoic acid"}, {"int_description_5": "Phenylbutyric acid"}, {"int_description_6": "Glycerol phenylbutyrate"}, {"int_description_7": "Citrulline"}, {"int_description_8": "Phenylacetic acid"}, {"int_description_9": "Pegzilarginase"}, {"int_description_10": "Heterologous human adult liver-derived progenitor cells", "timeframe_int10": "Hours", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Human heterologous liver cells (for infusion)"}, {"int_description_12": "Blood exchange transfusion", "timeframe_int12": "Days or Weeks", "age_use_int12": "Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Cohort study or studies", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Hemodialysis"}, {"int_description_14": "Red cell blood transfusion", "timeframe_int14": "Days or Weeks", "age_use_int14": "Infant,Child", "contra_int14": "No", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}, {"int_description_15": "\u0421ontinuous veno-venous haemofiltration"}, {"int_description_16": "Orthotopic liver transplantation (OLT)"}], "references": [{"pmid_title_1": "Sodium phenylbutyrate improved the clinical state in an adult patient with arginase 1 deficiency.", "pmid_1": 31604595.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Brain & development"}, {"pmid_title_2": "Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision.", "pmid_2": 30982989.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Journal of inherited metabolic disease"}, {"pmid_title_3": "Glycerol Phenylbutyrate (Ravicti)", "pmid_3": 29381293.0, "pmid_date_3": 2018.0, "pmid_journal_3": "CADTH Common Drug Reviews"}, {"pmid_title_4": "A case report of neurological complications owing to lately diagnosed hyperargininemia emphasizing the role of national neonatal screening policies in the kingdom of Bahrain.", "pmid_4": 29768370.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Medicine"}, {"pmid_title_5": "Coagulation Disturbances in Patients with Argininemia.", "pmid_5": 30355940.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Acta haematologica"}, {"pmid_title_6": "Argininemia as a cause of severe chronic stunting and partial growth hormone deficiency (PGHD): A case report.", "pmid_6": 29443755.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Medicine"}, {"pmid_title_7": "Recurrent hepatic failure and status epilepticus: an uncommon presentation of hyperargininemia.", "pmid_7": 29961243.0, "pmid_date_7": 2018.0, "pmid_journal_7": "Metabolic brain disease"}, {"pmid_title_8": "Argininemia as a cause of severe chronic stunting in a low-resource developing country setting: a case report.", "pmid_8": 27549856.0, "pmid_date_8": 2016.0, "pmid_journal_8": "BMC pediatrics"}, {"pmid_title_9": "Clinical phenotype, biochemical profile, and treatment in 19 patients with arginase 1 deficiency.", "pmid_9": 27038030.0, "pmid_date_9": 2016.0, "pmid_journal_9": "Journal of inherited metabolic disease"}, {"pmid_title_10": "Hyperargininemia due to arginase I deficiency: the original patients and their natural history, and a review of the literature.", "pmid_10": 26123990.0, "pmid_date_10": 2015.0, "pmid_journal_10": "Amino acids"}, {"pmid_title_11": "Epilepsia partialis continua and generalized nonconvulsive status epilepticus during the course of argininemia: a report on two cases.", "pmid_11": 24258525.0, "pmid_date_11": 2014.0, "pmid_journal_11": "Neuropediatrics"}, {"pmid_title_12": "Hyperargininemia: 7-month follow-up under sodium benzoate therapy in an Italian child presenting progressive spastic paraparesis, cognitive decline, and novel mutation in ARG1 gene.", "pmid_12": 24997092.0, "pmid_date_12": 2014.0, "pmid_journal_12": "Pediatric neurology"}, {"pmid_title_13": "Treatment of arginase deficiency revisited: guanidinoacetate as a therapeutic target and biomarker for therapeutic monitoring.", "pmid_13": 24814679.0, "pmid_date_13": 2014.0, "pmid_journal_13": "Developmental medicine and child neurology"}, {"pmid_title_14": "Ammonia control in children ages 2 months through 5 years with urea cycle disorders: comparison of sodium phenylbutyrate and glycerol phenylbutyrate.", "pmid_14": 23324524.0, "pmid_date_14": 2013.0, "pmid_journal_14": "J Pediatr"}, {"pmid_title_15": "Recurrent unexplained hyperammonemia in an adolescent with arginase deficiency.", "pmid_15": 22971419.0, "pmid_date_15": 2012.0, "pmid_journal_15": "Clinical biochemistry"}, {"pmid_title_16": "A long-term survival case of arginase deficiency with severe multicystic white matter and compound mutations.", "pmid_16": 20456883.0, "pmid_date_16": 2011.0, "pmid_journal_16": "Brain & development"}, {"pmid_title_17": "Neonatal cholestasis: an uncommon presentation of hyperargininemia.", "pmid_17": 21229317.0, "pmid_date_17": 2010.0, "pmid_journal_17": "Journal of inherited metabolic disease"}, {"pmid_title_18": "Long-term neurodevelopmental effects of early detection and treatment in a 6-year-old patient with argininaemia diagnosed by newborn screening.", "pmid_18": 19562505.0, "pmid_date_18": 2009.0, "pmid_journal_18": "Journal of inherited metabolic disease"}, {"pmid_title_19": "Early-onset hyperargininaemia: a severe disorder?", "pmid_19": 19381865.0, "pmid_date_19": 2009.0, "pmid_journal_19": "Journal of inherited metabolic disease"}, {"pmid_title_20": "Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency.", "pmid_20": 16602094.0, "pmid_date_20": 2006.0, "pmid_journal_20": "American journal of medical genetics. Part C, Seminars in medical genetics"}, {"pmid_title_21": "Hyperargininemia due to liver arginase deficiency.", "pmid_21": 15694174.0, "pmid_date_21": 2005.0, "pmid_journal_21": "Molecular genetics and metabolism"}, {"pmid_title_22": "Liver transplantation in a case of argininaemia.", "pmid_22": 11916327.0, "pmid_date_22": 2001.0, "pmid_journal_22": "Journal of inherited metabolic disease"}, {"pmid_title_23": "Arginase deficiency presenting with cerebral oedema and failure to thrive.", "pmid_23": 10947208.0, "pmid_date_23": 2000.0, "pmid_journal_23": "Journal of inherited metabolic disease"}, {"pmid_title_24": "Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan.", "pmid_24": 9686352.0, "pmid_date_24": 1998.0, "pmid_journal_24": "Journal of inherited metabolic disease"}, {"pmid_title_25": "Argininemia: a treatable genetic cause of progressive spastic diplegia simulating cerebral palsy: case reports and literature review.", "pmid_25": 9378897.0, "pmid_date_25": 1997.0, "pmid_journal_25": "Journal of child neurology"}, {"pmid_title_26": "[Proposal for a diet treatment in arginase deficiency].", "pmid_26": 9295913.0, "pmid_date_26": 1997.0, "pmid_journal_26": "Archives de pediatrie : organe officiel de la Societe francaise de pediatrie"}, {"pmid_title_27": "Haemodialysis and continuous veno-venous haemofiltration in a patient with hyperargininaemia and acute renal failure.", "pmid_27": 8295416.0, "pmid_date_27": 1993.0, "pmid_journal_27": "Journal of inherited metabolic disease"}, {"pmid_title_28": "Hyperargininemia: intellectual and motor improvement related to changes in biochemical data.", "pmid_28": 1999785.0, "pmid_date_28": 1991.0, "pmid_journal_28": "The Journal of pediatrics"}, {"pmid_title_29": "A new case of hyperargininaemia: neurological and biochemical findings prior to and during dietary treatment.", "pmid_29": 2311630.0, "pmid_date_29": 1990.0, "pmid_journal_29": "European journal of pediatrics"}, {"pmid_title_30": "Enzyme replacement therapy in a patient with hyperargininemia.", "pmid_30": 3590176.0, "pmid_date_30": 1987.0, "pmid_journal_30": "The Tohoku journal of experimental medicine"}, {"pmid_title_31": "Treatment of hyperargininemia with sodium benzoate and arginine-restricted diet.", "pmid_31": 6707802.0, "pmid_date_31": 1984.0, "pmid_journal_31": "The Journal of pediatrics"}, {"pmid_title_32": "Hyperargininemia: effect of ornithine and lysine supplementation.", "pmid_32": 6415261.0, "pmid_date_32": 1983.0, "pmid_journal_32": "The Journal of pediatrics"}, {"pmid_title_33": "Hyperargininemia: clinical course and treatment with sodium benzoate and phenylacetic acid.", "pmid_33": 6670711.0, "pmid_date_33": 1983.0, "pmid_journal_33": "Brain & development"}, {"pmid_title_34": "Treatment of hyperargininaemia due to arginase deficiency with a chemically defined diet.", "pmid_34": 6820432.0, "pmid_date_34": 1982.0, "pmid_journal_34": "Journal of inherited metabolic disease"}, {"pmid_title_35": "Argininemia treated from birth.", "pmid_35": 480013.0, "pmid_date_35": 1979.0, "pmid_journal_35": "The Journal of pediatrics"}]}, {"_id": "6696-OMIM:614305", "condition": {"condition_name": "SCLEROSTEOSIS 2; SOST2", "pattern_of_inheritance": "Autosomal dominant; Autosomal recessive", "alternate_names": ["SCLEROSTEOSIS 2; SOST2", "MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17"]}, "gene information": {"db_hgnc_gene_id": 6696.0}, "interventions": [{"int_description_1": "Hearing aids"}, {"int_description_2": "Abaloparatide"}, {"int_description_3": "Denosumab"}, {"int_description_4": "Teriparatide"}, {"int_description_5": "Romosozumab"}, {"int_description_6": "Bisphosphonates"}, {"int_description_7": "Selective estrogen receptor modulators"}, {"int_description_8": "Bone reduction surgery"}, {"int_description_9": "Cochlear implant"}, {"int_description_10": "Middle-ear surgery"}], "references": [{"pmid_title_1": "<i>SOST</i>-Related Sclerosing Bone Dysplasias", "pmid_1": 20301406.0, "pmid_date_1": 2019.0, "pmid_journal_1": "GeneReviews\u00ae"}]}, {"_id": "6696-OMIM:616304", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17", "SCLEROSTEOSIS 2; SOST2"]}, "gene information": {"db_hgnc_gene_id": 6696.0}, "interventions": [{"int_description_1": "Mechanical ventilation", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Ephedrine"}, {"int_description_3": "Amifampridine"}, {"int_description_4": "Pyridostigmine"}, {"int_description_5": "Quinidine"}, {"int_description_6": "Fluoxetine"}], "references": [{"pmid_title_1": "Congenital Myasthenic Syndromes in 2018.", "pmid_1": 29892917.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Current neurology and neuroscience reports"}, {"pmid_title_2": "Congenital Myasthenic Syndromes", "pmid_2": 20301347.0, "pmid_date_2": 2016.0, "pmid_journal_2": "GeneReviews\u00ae"}]}, {"_id": "6764-OMIM:617243", "condition": {"condition_name": "FANCONI ANEMIA, COMPLEMENTATION GROUP V", "alternate_names": ["FANCONI ANEMIA, COMPLEMENTATION GROUP V"]}, "gene information": {"db_hgnc_gene_id": 6764.0}, "interventions": [{"int_description_1": "Healthy diet"}, {"int_description_2": "Oxandrolone"}, {"int_description_3": "Danazol"}, {"int_description_4": "Testosterone propionate"}, {"int_description_5": "Oxymetholone"}, {"int_description_6": "Stanozolol"}, {"int_description_7": "Metenolone"}, {"int_description_8": "Calcium"}, {"int_description_9": "Prednisone"}, {"int_description_10": "Dexamethasone"}, {"int_description_11": "Insulin aspart"}, {"int_description_12": "Medroxyprogesterone acetate"}, {"int_description_13": "Tretinoin"}, {"int_description_14": "Eltrombopag"}, {"int_description_15": "Levothyroxine"}, {"int_description_16": "Estradiol"}, {"int_description_17": "Cetuximab"}, {"int_description_18": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_19": "Alemtuzumab"}, {"int_description_20": "Coenzyme M"}, {"int_description_21": "Cyclosporine"}, {"int_description_22": "Dactinomycin"}, {"int_description_23": "Sirolimus"}, {"int_description_24": "Somatotropin"}, {"int_description_25": "Vitamin D"}, {"int_description_26": "Cyclophosphamide"}, {"int_description_27": "Carboplatin"}, {"int_description_28": "Busulfan"}, {"int_description_29": "Ifosfamide"}, {"int_description_30": "Thiotepa"}, {"int_description_31": "Doxorubicin", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Fluorouracil", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Neonate,Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Mercaptopurine"}, {"int_description_34": "Trimethoprim"}, {"int_description_35": "Sulfamethoxazole"}, {"int_description_36": "Gemcitabine"}, {"int_description_37": "Vincristine"}, {"int_description_38": "Methotrexate"}, {"int_description_39": "Fludarabine"}, {"int_description_40": "Cytarabine"}, {"int_description_41": "Irinotecan"}, {"int_description_42": "Daunorubicin"}, {"int_description_43": "Etoposide"}, {"int_description_44": "Idarubicin"}, {"int_description_45": "Tacrolimus"}, {"int_description_46": "Acyclovir"}, {"int_description_47": "Quercetin"}, {"int_description_48": "Tioguanine"}, {"int_description_49": "Mycophenolate mofetil"}, {"int_description_50": "Tranexamic acid"}, {"int_description_51": "Hydroxyurea"}, {"int_description_52": "Methylprednisolone"}, {"int_description_53": "Methyltestosterone"}, {"int_description_54": "Leucovorin"}, {"int_description_55": "Vinorelbine"}, {"int_description_56": "Deferasirox"}, {"int_description_57": "Deferiprone"}, {"int_description_58": "Chemotherapy"}, {"int_description_59": "Co-trimoxazole"}, {"int_description_60": "Asparaginase Escherichia coli"}, {"int_description_61": "Cisplatin"}, {"int_description_62": "Antilymphocyte immunoglobulin (horse)"}, {"int_description_63": "Norethandrolone"}, {"int_description_64": "Phosphorus"}, {"int_description_65": "GM-CSF (granulocyte-macrophage colony-stimulating factor)"}, {"int_description_66": "Granulocyte colony-stimulating factor"}, {"int_description_67": "rh-SOD"}, {"int_description_68": "Bevacizumab"}, {"int_description_69": "Filgrastim"}, {"int_description_70": "Amifostine", "timeframe_int70": "Days or Weeks,Years", "age_use_int70": "Child", "contra_int70": "No", "qualscale_reclass_drug70": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug70": "Effective / Ameliorative"}, {"int_description_71": "Radiation therapy"}, {"int_description_72": "Total abdominal radiation"}, {"int_description_73": "Total body irradiation"}, {"int_description_74": "Total lymphoid irradiation"}, {"int_description_75": "Transfusion of blood products"}, {"int_description_76": "Bone marrow transplantation"}, {"int_description_77": "Hematopoietic stem cell transplantation"}, {"int_description_78": "Surgery for polydactyly, carpectomy"}, {"int_description_79": "Surgical intervention"}, {"int_description_80": "Tumor removal"}, {"int_description_81": "\u042burgical tumor removement"}], "references": [{"pmid_title_1": "Gingival Bleeding in a Child with Fanconi Anemia: A Case Report and Literature Review.", "pmid_1": 32231808.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Case Rep Dent"}, {"pmid_title_2": "Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.", "pmid_2": 29668547.0, "pmid_date_2": 2019.0, "pmid_journal_2": "J Pediatr Hematol Oncol"}, {"pmid_title_3": "Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.", "pmid_3": 31192125.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Front Oncol"}, {"pmid_title_4": "Fanconi anemia: a single center experience of a large cohort.", "pmid_4": 31990462.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Turk J Pediatr"}, {"pmid_title_5": "Therapeutic research in the crystal chromosome disease Fanconi anemia.", "pmid_5": 30389152.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Mutat Res Genet Toxicol Environ Mutagen"}, {"pmid_title_6": "Fanconi Anemia", "pmid_6": 20301575.0, "pmid_date_6": 2018.0, "pmid_journal_6": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_7": "Oral cancer in Fanconi anemia: Review of 121 cases.", "pmid_7": 29650274.0, "pmid_date_7": 2018.0, "pmid_journal_7": "Crit Rev Oncol Hematol"}, {"pmid_title_8": "Essential Role of BRCA2 in Ovarian Development and Function.", "pmid_8": 30207912.0, "pmid_date_8": 2018.0, "pmid_journal_8": "N Engl J Med"}, {"pmid_title_9": "Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.", "pmid_9": 29203412.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Biol Blood Marrow Transplant"}, {"pmid_title_10": "How I manage patients with Fanconi anaemia.", "pmid_10": 28474441.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Br J Haematol"}, {"pmid_title_11": "Eltrombopag for the treatment of aplastic anemia: current perspectives.", "pmid_11": 27695288.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Drug Des Devel Ther"}, {"pmid_title_12": "Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.", "pmid_12": 27246371.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Biol Blood Marrow Transplant"}, {"pmid_title_13": "Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.", "pmid_13": 26900943.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Pediatr Hematol Oncol"}, {"pmid_title_14": "Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.", "pmid_14": 26657402.0, "pmid_date_14": 2016.0, "pmid_journal_14": "Eur J Med Genet"}, {"pmid_title_15": "Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.", "pmid_15": 25575015.0, "pmid_date_15": 2015.0, "pmid_journal_15": "J Clin Endocrinol Metab"}, {"pmid_title_16": "Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.", "pmid_16": 25862235.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Ann Hematol"}, {"pmid_title_17": "Alternative donor hematopoietic cell transplantation for Fanconi anemia.", "pmid_17": 25824692.0, "pmid_date_17": 2015.0, "pmid_journal_17": "Blood"}, {"pmid_title_18": "Fanconi anemia and solid malignancies in childhood: a national retrospective study.", "pmid_18": 25381700.0, "pmid_date_18": 2015.0, "pmid_journal_18": "Pediatr Blood Cancer"}, {"pmid_title_19": "Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.", "pmid_19": 25531282.0, "pmid_date_19": 2015.0, "pmid_journal_19": "Bone Marrow Transplant"}, {"pmid_title_20": "Clear cell sarcoma of the kidney in a child with Fanconi anemia.", "pmid_20": 24735155.0, "pmid_date_20": 2014.0, "pmid_journal_20": "Pediatr Dev Pathol"}, {"pmid_title_21": "Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.", "pmid_21": 25085358.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Haematologica"}, {"pmid_title_22": "Oxandrolone for the treatment of bone marrow failure in Fanconi anemia.", "pmid_22": 24019220.0, "pmid_date_22": 2014.0, "pmid_journal_22": "Pediatr Blood Cancer"}, {"pmid_title_23": "Management of dental extraction in a female patient with fanconi anemia.", "pmid_23": 25628690.0, "pmid_date_23": 2014.0, "pmid_journal_23": "J Dent (Tehran)"}, {"pmid_title_24": "Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature.", "pmid_24": 22965917.0, "pmid_date_24": 2013.0, "pmid_journal_24": "Head Neck"}, {"pmid_title_25": "Deferasirox therapy in children with Fanconi aplastic anemia.", "pmid_25": 22510772.0, "pmid_date_25": 2012.0, "pmid_journal_25": "J Pediatr Hematol Oncol"}, {"pmid_title_26": "Fatal course of tonsillar squamous cell carcinoma associated with Fanconi anaemia: a mini review.", "pmid_26": 21925890.0, "pmid_date_26": 2012.0, "pmid_journal_26": "J Craniomaxillofac Surg"}, {"pmid_title_27": "Treatment of the bone marrow failure in Fanconi anemia patients with danazol.", "pmid_27": 22178060.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Blood Cells Mol Dis"}, {"pmid_title_28": "Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing.", "pmid_28": 21519011.0, "pmid_date_28": 2011.0, "pmid_journal_28": "J Clin Oncol"}, {"pmid_title_29": "Successful treatment of esophageal squamous cell carcinoma in a patient with Fanconi anemia.", "pmid_29": 20410055.0, "pmid_date_29": 2010.0, "pmid_journal_29": "Jpn J Clin Oncol"}, {"pmid_title_30": "Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.", "pmid_30": 19564748.0, "pmid_date_30": 2009.0, "pmid_journal_30": "J Pediatr Hematol Oncol"}, {"pmid_title_31": "Treatment with deferiprone for iron overload alleviates bone marrow failure in a Fanconi anemia patient.", "pmid_31": 19814681.0, "pmid_date_31": 2009.0, "pmid_journal_31": "Hemoglobin"}, {"pmid_title_32": "Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.", "pmid_32": 18302713.0, "pmid_date_32": 2008.0, "pmid_journal_32": "Br J Haematol"}, {"pmid_title_33": "Thrombocytopenia in the neonate.", "pmid_33": 18433954.0, "pmid_date_33": 2008.0, "pmid_journal_33": "Blood Rev"}, {"pmid_title_34": "Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.", "pmid_34": 18379369.0, "pmid_date_34": 2008.0, "pmid_journal_34": "J Thorac Oncol"}, {"pmid_title_35": "Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function.", "pmid_35": 18623197.0, "pmid_date_35": 2008.0, "pmid_journal_35": "Pediatr Blood Cancer"}, {"pmid_title_36": "Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.", "pmid_36": 18831513.0, "pmid_date_36": 2008.0, "pmid_journal_36": "Cancer"}, {"pmid_title_37": "Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.", "pmid_37": 17950918.0, "pmid_date_37": 2007.0, "pmid_journal_37": "Biol Blood Marrow Transplant"}, {"pmid_title_38": "Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia.", "pmid_38": 17038525.0, "pmid_date_38": 2007.0, "pmid_journal_38": "Blood"}, {"pmid_title_39": "Chemotherapy for myeloid malignancy in children with Fanconi anemia.", "pmid_39": 16609946.0, "pmid_date_39": 2007.0, "pmid_journal_39": "Pediatr Blood Cancer"}, {"pmid_title_40": "A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.", "pmid_40": 17096012.0, "pmid_date_40": 2007.0, "pmid_journal_40": "Leukemia"}, {"pmid_title_41": "HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.", "pmid_41": 18022575.0, "pmid_date_41": 2007.0, "pmid_journal_41": "Biol Blood Marrow Transplant"}, {"pmid_title_42": "Anesthesia and Fanconi anemia: a case report and review of literature.", "pmid_42": 16918663.0, "pmid_date_42": 2006.0, "pmid_journal_42": "Paediatr Anaesth"}, {"pmid_title_43": "Squamous cell carcinoma of the hypopharynx in a young woman with Fanconi's anemia.", "pmid_43": 17308840.0, "pmid_date_43": 2006.0, "pmid_journal_43": "Braz J Otorhinolaryngol"}, {"pmid_title_44": "Squamous cell vulvar carcinoma associated with Fanconi's anemia: a case report.", "pmid_44": 11975685.0, "pmid_date_44": 2002.0, "pmid_journal_44": "Int J Gynecol Cancer"}, {"pmid_title_45": "Growth hormone deficiency caused by pituitary stalk interruption in Fanconi's anemia.", "pmid_45": 11148528.0, "pmid_date_45": 2001.0, "pmid_journal_45": "J Pediatr"}, {"pmid_title_46": "Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.", "pmid_46": 9658728.0, "pmid_date_46": 1998.0, "pmid_journal_46": "Haematologica"}, {"pmid_title_47": "Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.", "pmid_47": 8781414.0, "pmid_date_47": 1996.0, "pmid_journal_47": "Blood"}, {"pmid_title_48": "GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.", "pmid_48": 7644282.0, "pmid_date_48": 1995.0, "pmid_journal_48": "Pediatr Nurs"}, {"pmid_title_49": "Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.", "pmid_49": 8283365.0, "pmid_date_49": 1994.0, "pmid_journal_49": "J Pediatr"}, {"pmid_title_50": "A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia.", "pmid_50": 8280614.0, "pmid_date_50": 1993.0, "pmid_journal_50": "Br J Haematol"}, {"pmid_title_51": "Fanconi's anemia. A family study with 20-year follow-up including associated breast pathology.", "pmid_51": 6478420.0, "pmid_date_51": 1984.0, "pmid_journal_51": "Cancer"}, {"pmid_title_52": "Multiple hepatic tumors and peliosis hepatis in Fanconi's anemia treated with androgens.", "pmid_52": 199056.0, "pmid_date_52": 1977.0, "pmid_journal_52": "Am J Dis Child"}, {"pmid_title_53": "Hepatic lesions in patients treated with synthetic anabolic steriods.", "pmid_53": 185239.0, "pmid_date_53": 1976.0, "pmid_journal_53": "J Clin Pathol"}, {"pmid_title_54": "The defective absorption of phosphorus and calcium and the effect of vitamin D in the Fanconi syndrome.", "pmid_54": 13610080.0, "pmid_date_54": 1958.0, "pmid_journal_54": "Guys Hosp Rep"}]}, {"_id": "68-OMIM:614857", "condition": {"condition_name": "METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE; MAHCJ", "freq_per_birth": "The most common form of the condition, called methylmalonic acidemia with homocystinuria, cblC type, is estimated to affect 1 in 200,000 newborns worldwide. Studies indicate that this form of the condition may be even more common in particular populations. These studies estimate the condition occurs in 1 in 100,000 people in New York and 1 in 60,000 people in California. Other types of methylmalonic acidemia with homocystinuria are much less common. Fewer than 20 cases of each of the other types have been reported in the medical literature.", "pattern_of_inheritance": "X-linked recessive==Autosomal recessive", "alternate_names": ["METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE; MAHCJ"]}, "gene information": {"db_hgnc_gene_id": 68.0}, "interventions": [{"int_description_1": "Cyanocobalamin"}, {"int_description_2": "Mecobalamin"}, {"int_description_3": "Glycine betaine"}, {"int_description_4": "Carglumic acid", "timeframe_int4": "Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Clinical or ATPase domain mutations in ABCD4 disrupt the interaction between the vitamin B<sub>12</sub>-trafficking proteins ABCD4 and LMBD1.", "pmid_1": 28572511.0, "pmid_date_1": 2017.0, "pmid_journal_1": "The Journal of biological chemistry"}, {"pmid_title_2": "Late onset of symptoms in an atypical patient with the cblJ inborn error of vitamin B12 metabolism: diagnosis and novel mutation revealed by exome sequencing.", "pmid_2": 23141461.0, "pmid_date_2": 2012.0, "pmid_journal_2": "Molecular genetics and metabolism"}]}, {"_id": "6930-OMIM:202200", "condition": {"condition_name": "GLUCOCORTICOID DEFICIENCY 1", "freq_per_birth": "The prevalence of familial glucocorticoid deficiency is unknown.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["GLUCOCORTICOID DEFICIENCY 1"]}, "gene information": {"db_hgnc_gene_id": 6930.0}, "interventions": [{"int_description_1": "Fludrocortisone"}, {"int_description_2": "Dexamethasone"}, {"int_description_3": "Hydrocortisone", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Cohort study or studies", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Glucocorticoid therapy"}], "references": [{"pmid_title_1": "Pathophysiology of melanocortin receptors and their accessory proteins.", "pmid_1": 29678289.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Best Pract Res Clin Endocrinol Metab"}, {"pmid_title_2": "Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2.", "pmid_2": 19558534.0, "pmid_date_2": 2010.0, "pmid_journal_2": "Clin Endocrinol (Oxf)"}, {"pmid_title_3": "The majority of adrenocorticotropin receptor (melanocortin 2 receptor) mutations found in familial glucocorticoid deficiency type 1 lead to defective trafficking of the receptor to the cell surface.", "pmid_3": 18840636.0, "pmid_date_3": 2008.0, "pmid_journal_3": "J Clin Endocrinol Metab"}, {"pmid_title_4": "Severe loss-of-function mutations in the adrenocorticotropin receptor (ACTHR, MC2R) can be found in patients diagnosed with salt-losing adrenal hypoplasia.", "pmid_4": 17223989.0, "pmid_date_4": 2007.0, "pmid_journal_4": "Clin Endocrinol (Oxf)"}, {"pmid_title_5": "Functional relationships between three novel homozygous mutations in the ACTH receptor gene and familial glucocorticoid deficiency.", "pmid_5": 12110946.0, "pmid_date_5": 2002.0, "pmid_journal_5": "J Mol Med (Berl)"}, {"pmid_title_6": "Demonstration by transfection studies that mutations in the adrenocorticotropin receptor gene are one cause of the hereditary syndrome of glucocorticoid deficiency.", "pmid_6": 8636348.0, "pmid_date_6": 1996.0, "pmid_journal_6": "J Clin Endocrinol Metab"}, {"pmid_title_7": "Adrenocorticotropin receptor gene mutations in familial glucocorticoid deficiency: relationships with clinical features in four families.", "pmid_7": 7829641.0, "pmid_date_7": 1995.0, "pmid_journal_7": "J Clin Endocrinol Metab"}]}, {"_id": "6936-OMIM:210200", "condition": {"condition_name": "3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D", "freq_per_birth": "This condition is detected in an estimated 1 in 36,000 newborns worldwide.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D"]}, "gene information": {"db_hgnc_gene_id": 6936.0}, "interventions": [{"int_description_1": "Leucine-restricted diet", "timeframe_int1": "Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Still in Trials / Unproven"}, {"int_description_2": "Protein-restricted diet"}, {"int_description_3": "Levocarnitine", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Biotin"}, {"int_description_5": "Sodium bicarbonate"}, {"int_description_6": "D-glucose"}, {"int_description_7": "Avoidance of fasting", "timeframe_int7": "Hours", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Outcomes of cases with 3-methylcrotonyl-CoA carboxylase (3-MCC) deficiency - Report from the Inborn Errors of Metabolism Information System.", "pmid_1": 27033733.0, "pmid_date_1": 2016.0, "pmid_journal_1": "Molecular genetics and metabolism"}, {"pmid_title_2": "Is L-Carnitine Supplementation Beneficial in 3-Methylcrotonyl-CoA Carboxylase Deficiency?", "pmid_2": 25732994.0, "pmid_date_2": 2015.0, "pmid_journal_2": "JIMD reports"}, {"pmid_title_3": "Analysis of cases of 3-methylcrotonyl CoA carboxylase deficiency (3-MCCD) in the California newborn screening program reported in the state database.", "pmid_3": 24103308.0, "pmid_date_3": 2013.0, "pmid_journal_3": "Molecular genetics and metabolism"}, {"pmid_title_4": "A Delphi-based consensus clinical practice protocol for the diagnosis and management of 3-methylcrotonyl CoA carboxylase deficiency.", "pmid_4": 18155630.0, "pmid_date_4": 2008.0, "pmid_journal_4": "Molecular genetics and metabolism"}, {"pmid_title_5": "Molecular mechanism of dominant expression in 3-methylcrotonyl-CoA carboxylase deficiency.", "pmid_5": 15868465.0, "pmid_date_5": 2005.0, "pmid_journal_5": "Journal of inherited metabolic disease"}, {"pmid_title_6": "Isolated 3-methylcrotonyl-CoA carboxylase deficiency: evidence for an allele-specific dominant negative effect and responsiveness to biotin therapy.", "pmid_6": 15359379.0, "pmid_date_6": 2004.0, "pmid_journal_6": "American journal of human genetics"}, {"pmid_title_7": "Isolated 3-methylcrotonyl-CoA carboxylase deficiency in a 15-year-old girl.", "pmid_7": 9187484.0, "pmid_date_7": 1997.0, "pmid_journal_7": "Brain & development"}]}, {"_id": "6937-OMIM:210210", "condition": {"condition_name": "3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D", "freq_per_birth": "This condition is detected in an estimated 1 in 36,000 newborns worldwide.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D"]}, "gene information": {"db_hgnc_gene_id": 6937.0}, "interventions": [{"int_description_1": "Leucine-restricted diet"}, {"int_description_2": "Protein-restricted diet"}, {"int_description_3": "Glycine", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Midazolam"}, {"int_description_5": "Levocarnitine", "timeframe_int5": "Hours", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Biotin"}, {"int_description_7": "Sodium bicarbonate"}, {"int_description_8": "D-glucose"}, {"int_description_9": "Assisted respiration"}], "references": [{"pmid_title_1": "3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals.", "pmid_1": 22642865.0, "pmid_date_1": 2012.0, "pmid_journal_1": "Orphanet journal of rare diseases"}, {"pmid_title_2": "Outcome of infants diagnosed with 3-methyl-crotonyl-CoA-carboxylase deficiency by newborn screening.", "pmid_2": 22658692.0, "pmid_date_2": 2012.0, "pmid_journal_2": "Molecular genetics and metabolism"}, {"pmid_title_3": "Recurrent attacks of status epilepticus as predominant symptom in 3-methylcrotonyl-CoA carboxylase deficiency.", "pmid_3": 17869468.0, "pmid_date_3": 2008.0, "pmid_journal_3": "Brain & development"}, {"pmid_title_4": "A Delphi-based consensus clinical practice protocol for the diagnosis and management of 3-methylcrotonyl CoA carboxylase deficiency.", "pmid_4": 18155630.0, "pmid_date_4": 2008.0, "pmid_journal_4": "Molecular genetics and metabolism"}, {"pmid_title_5": "Novel mutations in five Japanese patients with 3-methylcrotonyl-CoA carboxylase deficiency.", "pmid_5": 17968484.0, "pmid_date_5": 2007.0, "pmid_journal_5": "Journal of human genetics"}, {"pmid_title_6": "Isolated 3-methylcrotonyl-coenzyme A carboxylase deficiency in a child with metabolic stroke.", "pmid_6": 16601894.0, "pmid_date_6": 2006.0, "pmid_journal_6": "Journal of inherited metabolic disease"}, {"pmid_title_7": "Consanguineous 3-methylcrotonyl-CoA carboxylase deficiency: early-onset necrotizing encephalopathy with lethal outcome.", "pmid_7": 15877210.0, "pmid_date_7": 2005.0, "pmid_journal_7": "Journal of inherited metabolic disease"}, {"pmid_title_8": "Paget's disease of the scrotum: a case report and review of current literature.", "pmid_8": 1660189.0, "pmid_date_8": 1991.0, "pmid_journal_8": "Texas medicine"}]}, {"_id": "6953-OMIM:612922", "condition": {"condition_name": "HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2", "freq_per_birth": "The incidence of atypical hemolytic-uremic syndrome is estimated to be 1 in 500,000 people per year in the United States. The atypical form is probably about 10 times less common than the typical form.", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2", "HELLP syndrome"]}, "gene information": {"db_hgnc_gene_id": 6953.0}, "interventions": [{"int_description_1": "Prednisone"}, {"int_description_2": "Dexamethasone"}, {"int_description_3": "Labetalol"}, {"int_description_4": "Doxazosin"}, {"int_description_5": "Amlodipine", "timeframe_int5": "Days or Weeks", "age_use_int5": "Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Eculizumab"}, {"int_description_7": "Basiliximab"}, {"int_description_8": "Etanercept"}, {"int_description_9": "Cyclosporine"}, {"int_description_10": "Metronidazole"}, {"int_description_11": "Sirolimus"}, {"int_description_12": "Piperacillin"}, {"int_description_13": "Captopril"}, {"int_description_14": "Tazobactam"}, {"int_description_15": "Ciprofloxacin"}, {"int_description_16": "Ceftriaxone"}, {"int_description_17": "Nifedipine"}, {"int_description_18": "Vincristine"}, {"int_description_19": "Fluconazole"}, {"int_description_20": "Tacrolimus"}, {"int_description_21": "Azathioprine"}, {"int_description_22": "Mycophenolate mofetil"}, {"int_description_23": "Lansoprazole"}, {"int_description_24": "Methylprednisolone"}, {"int_description_25": "Corticosteroids", "timeframe_int25": "Days or Weeks", "age_use_int25": "Infant,Child", "contra_int25": "No", "qualscale_reclass_drug25": "Case report(s)", "rev1_eff_reclass_drug25": "Still in Trials / Unproven"}, {"int_description_26": "Iron"}, {"int_description_27": "Calcium carbonate"}, {"int_description_28": "Alginic acid", "timeframe_int28": "Days or Weeks", "age_use_int28": "Infant,Child", "contra_int28": "No", "qualscale_reclass_drug28": "Authoritative published clinical practice guideline"}, {"int_description_29": "Meningococcal vaccine"}, {"int_description_30": "Serine protease inhibitor"}, {"int_description_31": "Sodium bicarbonate", "timeframe_int31": "Days or Weeks", "age_use_int31": "Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Hemodialysis", "timeframe_int32": "Days or Weeks", "age_use_int32": "Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Peritoneal dialysis"}, {"int_description_34": "Plasma exchange"}, {"int_description_35": "Transfusion with packed red cells"}, {"int_description_36": "Bilateral nephrectomy"}, {"int_description_37": "Kidney transplantation"}], "references": [{"pmid_title_1": "A complement factor B mutation in a large kindred with atypical hemolytic uremic syndrome.", "pmid_1": 24906628.0, "pmid_date_1": 2014.0, "pmid_journal_1": "J Clin Immunol"}, {"pmid_title_2": "Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft.", "pmid_2": 22591029.0, "pmid_date_2": 2012.0, "pmid_journal_2": "Transpl Int"}, {"pmid_title_3": "Complement deficiency states and associated infections.", "pmid_3": 21624663.0, "pmid_date_3": 2011.0, "pmid_journal_3": "Mol Immunol"}, {"pmid_title_4": "Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy.", "pmid_4": 21643943.0, "pmid_date_4": 2011.0, "pmid_journal_4": "Pediatr Nephrol"}, {"pmid_title_5": "Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome.", "pmid_5": 22287852.0, "pmid_date_5": 2011.0, "pmid_journal_5": "Clin Pharmacol"}, {"pmid_title_6": "An adult with acute poststreptococcal glomerulonephritis complicated by hemolytic uremic syndrome and nephrotic syndrome.", "pmid_6": 16183409.0, "pmid_date_6": 2005.0, "pmid_journal_6": "Am J Kidney Dis"}, {"pmid_title_7": "Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency.", "pmid_7": 10344366.0, "pmid_date_7": 1999.0, "pmid_journal_7": "Nephrol Dial Transplant"}, {"pmid_title_8": "Human complement factor H deficiency associated with hemolytic uremic syndrome.", "pmid_8": 9848786.0, "pmid_date_8": 1998.0, "pmid_journal_8": "J Am Soc Nephrol"}]}, {"_id": "704-OMIM:617718", "condition": {"condition_name": "IMMUNODEFICIENCY 71 WITH INFLAMMATORY DISEASE AND CONGENITAL THROMBOCYTOPENIA", "alternate_names": ["IMMUNODEFICIENCY 71 WITH INFLAMMATORY DISEASE AND CONGENITAL THROMBOCYTOPENIA"]}, "gene information": {"db_hgnc_gene_id": 704.0}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Valganciclovir"}, {"int_description_3": "Human immunoglobulin G", "timeframe_int3": "Days or Weeks", "age_use_int3": "Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Cohort study or studies", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Hydroxychloroquine"}, {"int_description_5": "Sirolimus"}, {"int_description_6": "Azithromycin"}, {"int_description_7": "Fluconazole"}, {"int_description_8": "Mycophenolate mofetil"}, {"int_description_9": "Haematopoietic stem cell transplantation", "timeframe_int9": "Days or Weeks", "age_use_int9": "Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Cohort study or studies", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "A male infant with COVID-19 in the context of ARPC1B deficiency.", "pmid_1": 32683750.0, "pmid_date_1": 2021.0, "pmid_journal_1": "Pediatr Allergy Immunol"}, {"pmid_title_2": "A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency.", "pmid_2": 30771411.0, "pmid_date_2": 2019.0, "pmid_journal_2": "J Allergy Clin Immunol"}, {"pmid_title_3": "T-cell defects in patients with <i>ARPC1B</i> germline mutations account for combined immunodeficiency.", "pmid_3": 30254128.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Blood"}]}, {"_id": "7190-OMIM:252150", "condition": {"condition_name": "MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA", "freq_per_birth": "Molybdenum cofactor deficiency is a rare condition that is estimated to occur in 1 in 100,000 to 200,000 newborns worldwide. More than 100 cases have been reported in the medical literature, although it is thought that the condition is underdiagnosed, so the number of affected individuals may be higher.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA"]}, "gene information": {"db_hgnc_gene_id": 7190.0}, "interventions": [{"int_description_1": "Intravenous cyclic pyranopterin monophosphate (cPMP)", "timeframe_int1": "Hours", "age_use_int1": "Neonate", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Molybdenum cofactor deficiency type A: Prenatal monitoring using MRI.", "pmid_1": 29274890.0, "pmid_date_1": 2018.0, "pmid_journal_1": "European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society"}, {"pmid_title_2": "Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type A: a prospective cohort study.", "pmid_2": 26343839.0, "pmid_date_2": 2015.0, "pmid_journal_2": "Lancet (London, England)"}, {"pmid_title_3": "Favorable outcome in a newborn with molybdenum cofactor type A deficiency treated with cPMP.", "pmid_3": 22987873.0, "pmid_date_3": 2012.0, "pmid_journal_3": "Pediatrics"}, {"pmid_title_4": "Successful treatment of molybdenum cofactor deficiency type A with cPMP.", "pmid_4": 20385644.0, "pmid_date_4": 2010.0, "pmid_journal_4": "Pediatrics"}]}, {"_id": "7468-OMIM:250940", "condition": {"condition_name": "HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblG COMPLEMENTATION TYPE; HMAG", "freq_per_birth": "The most common form of homocystinuria affects at least 1 in 200,000 to 335,000 people worldwide. The disorder appears to be more common in some countries, such as Ireland (1 in 65,000), Germany (1 in 17,800), Norway (1 in 6,400), and Qatar (1 in 1,800). The rarer forms of homocystinuria each have a small number of cases reported in the scientific literature.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblG COMPLEMENTATION TYPE; HMAG"]}, "gene information": {"db_hgnc_gene_id": 7468.0}, "interventions": [{"int_description_1": "Hydroxocobalamin"}, {"int_description_2": "Cyanocobalamin", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Cobamamide"}, {"int_description_4": "Levocarnitine"}, {"int_description_5": "Leucovorin", "timeframe_int5": "Hours", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Glycine betaine", "timeframe_int6": "Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Cohort study or studies", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Folic acid", "timeframe_int7": "Hours", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Methionine", "timeframe_int8": "Hours", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Patients with cobalamin G or J defect missed by the current newborn screening program: diagnosis and novel mutations.", "pmid_1": 30651581.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Journal of human genetics"}, {"pmid_title_2": "Intractable Epilepsy due to MTR Deficiency: Importance of Homocysteine Analysis.", "pmid_2": 28666289.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Neuropediatrics"}, {"pmid_title_3": "Clinical onset and course, response to treatment and outcome in 24 patients with the cblE or cblG remethylation defect complemented by genetic and in vitro enzyme study data.", "pmid_3": 25526710.0, "pmid_date_3": 2015.0, "pmid_journal_3": "Journal of inherited metabolic disease"}]}, {"_id": "746-OMIM:207900", "condition": {"condition_name": "ARGININOSUCCINIC ACIDURIA", "freq_per_birth": "Argininosuccinic aciduria occurs in approximately 1 in 70,000 to 218,000 newborns. Most cases of this condition are detected shortly after birth by newborn screening.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ARGININOSUCCINIC ACIDURIA"]}, "gene information": {"db_hgnc_gene_id": 746.0}, "interventions": [{"int_description_1": "Essential amino acids supplementation"}, {"int_description_2": "Low protein diet", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Nitric Oxide", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Cohort study or studies", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Arginine", "timeframe_int4": "Days or Weeks,Years", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Benzoic acid"}, {"int_description_6": "Phenylbutyric acid", "timeframe_int6": "Hours,Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Glycerol phenylbutyrate"}, {"int_description_8": "Phenylacetic acid"}, {"int_description_9": "Modified messenger ribonucleic acid encoding human argininosuccinate lyase enzyme encapsulated into lipid nanoparticles"}, {"int_description_10": "Heterologous human adult liver-derived progenitor cells", "timeframe_int10": "Hours", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Human heterologous liver cells (for infusion)"}, {"int_description_12": "Therapeutic hypothermia", "timeframe_int12": "Hours", "age_use_int12": "Neonate,Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Hemodialysis"}, {"int_description_14": "Orthotopic liver transplantation (OLT)"}], "references": [{"pmid_title_1": "Intrahepatic Administration of Human Liver Stem Cells in Infants with Inherited Neonatal-Onset Hyperammonemia: A Phase I Study.", "pmid_1": 31792768.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Stem cell reviews and reports"}, {"pmid_title_2": "Infusion-related thrombogenesis by liver-derived mesenchymal stem cells controlled by anticoagulant drugs in 11 patients with liver-based metabolic disorders.", "pmid_2": 32028991.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Stem cell research & therapy"}, {"pmid_title_3": "Argininosuccinic aciduria: Recent pathophysiological insights and therapeutic prospects.", "pmid_3": 30723942.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Journal of inherited metabolic disease"}, {"pmid_title_4": "Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patients.", "pmid_4": 31326288.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Molecular genetics and metabolism"}, {"pmid_title_5": "Phase I/II Trial of Liver-derived Mesenchymal Stem Cells in Pediatric Liver-based Metabolic Disorders: A Prospective, Open Label, Multicenter, Partially Randomized, Safety Study of One Cycle of Heterologous Human Adult Liver-derived Progenitor Cells (HepaStem) in Urea Cycle Disorders and Crigler-Najjar Syndrome Patients.", "pmid_5": 30801523.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Transplantation"}, {"pmid_title_6": "Differential Intraoperative Effect of Liver Transplant in Different Inborn Errors of Metabolism.", "pmid_6": 30964822.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Journal of pediatric gastroenterology and nutrition"}, {"pmid_title_7": "Impact of Diagnosis and Therapy on Cognitive Function in Urea Cycle Disorders.", "pmid_7": 31018246.0, "pmid_date_7": 2019.0, "pmid_journal_7": "Ann Neurol"}, {"pmid_title_8": "Influence of implementing a protocol for an intravenously administered ammonia scavenger on the management of acute hyperammonemia in a pediatric intensive care unit.", "pmid_8": 30740742.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Journal of inherited metabolic disease"}, {"pmid_title_9": "Glycerol Phenylbutyrate (Ravicti)", "pmid_9": 29381293.0, "pmid_date_9": 2018.0, "pmid_journal_9": "CADTH Common Drug Reviews"}, {"pmid_title_10": "Adeno-associated viral gene therapy corrects a mouse model of argininosuccinic aciduria.", "pmid_10": 30253962.0, "pmid_date_10": 2018.0, "pmid_journal_10": "Molecular genetics and metabolism"}, {"pmid_title_11": "Pharmacokinetics of glycerol phenylbutyrate in pediatric patients 2\u202fmonths to 2\u202fyears of age with urea cycle disorders.", "pmid_11": 30217721.0, "pmid_date_11": 2018.0, "pmid_journal_11": "Molecular genetics and metabolism"}, {"pmid_title_12": "Human heterologous liver cells transiently improve hyperammonemia and ureagenesis in individuals with severe urea cycle disorders.", "pmid_12": 29027067.0, "pmid_date_12": 2018.0, "pmid_journal_12": "Journal of inherited metabolic disease"}, {"pmid_title_13": "Clinical and genetic diversity of congenital hyperammonemia.", "pmid_13": 30534838.0, "pmid_date_13": 2018.0, "pmid_journal_13": "Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie"}, {"pmid_title_14": "A retrospective biochemical, molecular, and neurocognitive review of Saudi patients with argininosuccinic aciduria.", "pmid_14": 29326055.0, "pmid_date_14": 2018.0, "pmid_journal_14": "European journal of medical genetics"}, {"pmid_title_15": "Safety and efficacy of glycerol phenylbutyrate for management of urea cycle disorders in patients aged 2months to 2years.", "pmid_15": 28916119.0, "pmid_date_15": 2017.0, "pmid_journal_15": "Molecular genetics and metabolism"}, {"pmid_title_16": "Argininosuccinic Aciduria-A Rare Indication for Liver Transplant: Report of Two Cases.", "pmid_16": 26768012.0, "pmid_date_16": 2017.0, "pmid_journal_16": "Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation"}, {"pmid_title_17": "Expanding the phenotype in argininosuccinic aciduria: need for new therapies.", "pmid_17": 28251416.0, "pmid_date_17": 2017.0, "pmid_journal_17": "J Inherit Metab Dis"}, {"pmid_title_18": "Argininosuccinic Acid Lyase Deficiency Missed by Newborn Screen.", "pmid_18": 27515243.0, "pmid_date_18": 2016.0, "pmid_journal_18": "JIMD Rep"}, {"pmid_title_19": "Recent advances in the treatment of hyperammonemia.", "pmid_19": 25895618.0, "pmid_date_19": 2015.0, "pmid_journal_19": "Advanced drug delivery reviews"}, {"pmid_title_20": "Atrioventricular block in siblings with argininosuccinic aciduria.", "pmid_20": 25889439.0, "pmid_date_20": 2015.0, "pmid_journal_20": "International journal of cardiology"}, {"pmid_title_21": "Report of 3 Patients With Urea Cycle Defects Treated With Related Living-Donor Liver Transplant.", "pmid_21": 26640932.0, "pmid_date_21": 2015.0, "pmid_journal_21": "Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation"}, {"pmid_title_22": "Self-reported treatment-associated symptoms among patients with urea cycle disorders participating in glycerol phenylbutyrate clinical trials.", "pmid_22": 26296711.0, "pmid_date_22": 2015.0, "pmid_journal_22": "Mol Genet Metab"}, {"pmid_title_23": "Liver transplantation for pediatric metabolic disease.", "pmid_23": 24495602.0, "pmid_date_23": 2014.0, "pmid_journal_23": "Molecular genetics and metabolism"}, {"pmid_title_24": "Diagnosis and treatment of urea cycle disorder in Japan.", "pmid_24": 25039902.0, "pmid_date_24": 2014.0, "pmid_journal_24": "Pediatrics international : official journal of the Japan Pediatric Society"}, {"pmid_title_25": "Glycerol phenylbutyrate (Ravicti) for urea cycle disorders.", "pmid_25": 25118801.0, "pmid_date_25": 2014.0, "pmid_journal_25": "The Medical letter on drugs and therapeutics"}, {"pmid_title_26": "A longitudinal study of urea cycle disorders.", "pmid_26": 25135652.0, "pmid_date_26": 2014.0, "pmid_journal_26": "Mol Genet Metab"}, {"pmid_title_27": "Direct acting inhibitors of ammoniagenesis: a role in post-TIPS encephalopathy?", "pmid_27": 24552859.0, "pmid_date_27": 2014.0, "pmid_journal_27": "Annals of hepatology"}, {"pmid_title_28": "Urea cycle disorders in Spain: an observational, cross-sectional and multicentric study of 104 cases.", "pmid_28": 25433810.0, "pmid_date_28": 2014.0, "pmid_journal_28": "Orphanet J Rare Dis"}, {"pmid_title_29": "Glycerol phenylbutyrate treatment in children with urea cycle disorders: pooled analysis of short and long-term ammonia control and outcomes.", "pmid_29": 24630270.0, "pmid_date_29": 2014.0, "pmid_journal_29": "Mol Genet Metab"}, {"pmid_title_30": "Dietary management of urea cycle disorders: European practice.", "pmid_30": 24113687.0, "pmid_date_30": 2013.0, "pmid_journal_30": "Molecular genetics and metabolism"}, {"pmid_title_31": "Use of continuous hemodiafiltration for the treatment of a neonate with hyperammonemia secondary to argininosuccinate lyase (ASAL) deficiency.", "pmid_31": 23539248.0, "pmid_date_31": 2013.0, "pmid_journal_31": "Indian journal of pediatrics"}, {"pmid_title_32": "Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate.", "pmid_32": 22961727.0, "pmid_date_32": 2013.0, "pmid_journal_32": "Hepatology"}, {"pmid_title_33": "Urea cycle disorder drug approved.", "pmid_33": 23563410.0, "pmid_date_33": 2013.0, "pmid_journal_33": "Nature biotechnology"}, {"pmid_title_34": "Ammonia control in children ages 2 months through 5 years with urea cycle disorders: comparison of sodium phenylbutyrate and glycerol phenylbutyrate.", "pmid_34": 23324524.0, "pmid_date_34": 2013.0, "pmid_journal_34": "J Pediatr"}, {"pmid_title_35": "Population pharmacokinetic modeling and dosing simulations of nitrogen-scavenging compounds: disposition of glycerol phenylbutyrate and sodium phenylbutyrate in adult and pediatric patients with urea cycle disorders.", "pmid_35": 23775211.0, "pmid_date_35": 2013.0, "pmid_journal_35": "J Clin Pharmacol"}, {"pmid_title_36": "Optimizing therapy for argininosuccinic aciduria.", "pmid_36": 22841516.0, "pmid_date_36": 2012.0, "pmid_journal_36": "Mol Genet Metab"}, {"pmid_title_37": "Argininosuccinate lyase deficiency.", "pmid_37": 22241104.0, "pmid_date_37": 2012.0, "pmid_journal_37": "Genet Med"}, {"pmid_title_38": "Nitric-oxide supplementation for treatment of long-term complications in argininosuccinic aciduria.", "pmid_38": 22541557.0, "pmid_date_38": 2012.0, "pmid_journal_38": "Am J Hum Genet"}, {"pmid_title_39": "A randomized controlled trial to evaluate the effects of high-dose versus low-dose of arginine therapy on hepatic function tests in argininosuccinic aciduria.", "pmid_39": 23040521.0, "pmid_date_39": 2012.0, "pmid_journal_39": "Mol Genet Metab"}, {"pmid_title_40": "Dietary management of urea cycle disorders: UK practice.", "pmid_40": 22594780.0, "pmid_date_40": 2012.0, "pmid_journal_40": "Journal of human nutrition and dietetics : the official journal of the British Dietetic Association"}, {"pmid_title_41": "Urea cycle disorder--argininosuccinic lyase deficiency.", "pmid_41": 22784324.0, "pmid_date_41": 2012.0, "pmid_journal_41": "Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry"}, {"pmid_title_42": "Rhode Island metabolic newborn screening: the effect of early identification. A case report of argininosuccinic aciduria (ASA).", "pmid_42": 21710918.0, "pmid_date_42": 2011.0, "pmid_journal_42": "Medicine and health, Rhode Island"}, {"pmid_title_43": "The ketogenic diet is well tolerated and can be effective in patients with argininosuccinate lyase deficiency and refractory epilepsy.", "pmid_43": 23430928.0, "pmid_date_43": 2011.0, "pmid_journal_43": "JIMD Rep"}, {"pmid_title_44": "Ammonia control in children with urea cycle disorders (UCDs); phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate.", "pmid_44": 21612962.0, "pmid_date_44": 2011.0, "pmid_journal_44": "Mol Genet Metab"}, {"pmid_title_45": "Long-term outcome of patients with argininosuccinate lyase deficiency diagnosed by newborn screening in Austria.", "pmid_45": 20236848.0, "pmid_date_45": 2010.0, "pmid_journal_45": "Molecular genetics and metabolism"}, {"pmid_title_46": "Argininosuccinic aciduria: clinical and biochemical phenotype findings in Malaysian children.", "pmid_46": 21329179.0, "pmid_date_46": 2010.0, "pmid_journal_46": "The Malaysian journal of pathology"}, {"pmid_title_47": "Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: safety, pharmacokinetics and ammonia control.", "pmid_47": 20382058.0, "pmid_date_47": 2010.0, "pmid_journal_47": "Mol Genet Metab"}, {"pmid_title_48": "New insights in nutritional management and amino acid supplementation in urea cycle disorders.", "pmid_48": 20299258.0, "pmid_date_48": 2010.0, "pmid_journal_48": "Mol Genet Metab"}, {"pmid_title_49": "Experience with the treatment of argininosuccinic aciduria during pregnancy.", "pmid_49": 19585269.0, "pmid_date_49": 2009.0, "pmid_journal_49": "Journal of inherited metabolic disease"}, {"pmid_title_50": "Argininosuccinate lyase deficiency: longterm outcome of 13 patients detected by newborn screening.", "pmid_50": 19635676.0, "pmid_date_50": 2009.0, "pmid_journal_50": "Mol Genet Metab"}, {"pmid_title_51": "Liver transplantation for argininosuccinic aciduria: clinical, biochemical, and metabolic outcome.", "pmid_51": 18161830.0, "pmid_date_51": 2008.0, "pmid_journal_51": "Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society"}, {"pmid_title_52": "Living related liver transplant in a patient with argininosuccinic aciduria and cirrhosis: metabolic follow-up.", "pmid_52": 18367960.0, "pmid_date_52": 2008.0, "pmid_journal_52": "Journal of pediatric gastroenterology and nutrition"}, {"pmid_title_53": "Cross-sectional multicenter study of patients with urea cycle disorders in the United States.", "pmid_53": 18562231.0, "pmid_date_53": 2008.0, "pmid_journal_53": "Mol Genet Metab"}, {"pmid_title_54": "Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes.", "pmid_54": 18647279.0, "pmid_date_54": 2008.0, "pmid_journal_54": "Acta Paediatr"}, {"pmid_title_55": "Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.", "pmid_55": 17538087.0, "pmid_date_55": 2007.0, "pmid_journal_55": "The New England journal of medicine"}, {"pmid_title_56": "Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency.", "pmid_56": 16618422.0, "pmid_date_56": 2006.0, "pmid_journal_56": "Gastroenterology"}, {"pmid_title_57": "Successful liver transplantation for argininosuccinate lyase deficiency (ASLD).", "pmid_57": 16601888.0, "pmid_date_57": 2006.0, "pmid_journal_57": "Journal of inherited metabolic disease"}, {"pmid_title_58": "Liver transplantation for inborn errors of metabolism.", "pmid_58": 16286891.0, "pmid_date_58": 2005.0, "pmid_journal_58": "Transplantation"}, {"pmid_title_59": "Progressive liver fibrosis in late-onset argininosuccinate lyase deficiency.", "pmid_59": 12370774.0, "pmid_date_59": 2002.0, "pmid_journal_59": "Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society"}, {"pmid_title_60": "Urea cycle disorders in Thai infants: a report of 5 cases.", "pmid_60": 12403252.0, "pmid_date_60": 2002.0, "pmid_journal_60": "Journal of the Medical Association of Thailand = Chotmaihet thangphaet"}, {"pmid_title_61": "Long-term correction of urea cycle disorders.", "pmid_61": 11148551.0, "pmid_date_61": 2001.0, "pmid_journal_61": "The Journal of pediatrics"}, {"pmid_title_62": "[Congenital hyperammonemia in neonates treated with hemodiafiltration].", "pmid_62": 11434179.0, "pmid_date_62": 2001.0, "pmid_journal_62": "Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego"}, {"pmid_title_63": "Liver transplantation in urea cycle disorders.", "pmid_63": 10603100.0, "pmid_date_63": 1999.0, "pmid_journal_63": "European journal of pediatrics"}, {"pmid_title_64": "Sodium citrate supplementation in inborn argininosuccinate lyase deficiency: a study in a 5-year-old patient under total parenteral nutrition.", "pmid_64": 8582405.0, "pmid_date_64": 1995.0, "pmid_journal_64": "European journal of pediatrics"}, {"pmid_title_65": "Long-term follow-up of 12 patients with the late-onset variant of argininosuccinic acid lyase deficiency: no impairment of intellectual and psychomotor development during therapy.", "pmid_65": 1594374.0, "pmid_date_65": 1992.0, "pmid_journal_65": "Pediatrics"}, {"pmid_title_66": "Dietary management reverses grooving and abnormal polarization of hair shafts in argininosuccinase deficiency.", "pmid_66": 1897577.0, "pmid_date_66": 1991.0, "pmid_journal_66": "American journal of medical genetics"}, {"pmid_title_67": "Argininosuccinic aciduria: long-term treatment with arginine.", "pmid_67": 3116334.0, "pmid_date_67": 1987.0, "pmid_journal_67": "Journal of inherited metabolic disease"}, {"pmid_title_68": "Prospective prevention of neonatal hyperammonaemia in argininosuccinic acidura by arginine therapy.", "pmid_68": 3921755.0, "pmid_date_68": 1985.0, "pmid_journal_68": "Journal of inherited metabolic disease"}, {"pmid_title_69": "Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis.", "pmid_69": 6427608.0, "pmid_date_69": 1984.0, "pmid_journal_69": "The New England journal of medicine"}, {"pmid_title_70": "Arginine therapy of argininosuccinase deficiency.", "pmid_70": 84150.0, "pmid_date_70": 1979.0, "pmid_journal_70": "Lancet (London, England)"}]}, {"_id": "7473-OMIM:236270", "condition": {"condition_name": "HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE COMPLEMENTATION TYPE; HMAE", "freq_per_birth": "The most common form of homocystinuria affects at least 1 in 200,000 to 335,000 people worldwide. The disorder appears to be more common in some countries, such as Ireland (1 in 65,000), Germany (1 in 17,800), Norway (1 in 6,400), and Qatar (1 in 1,800). The rarer forms of homocystinuria each have a small number of cases reported in the scientific literature.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE COMPLEMENTATION TYPE; HMAE"]}, "gene information": {"db_hgnc_gene_id": 7473.0}, "interventions": [{"int_description_1": "Hydroxocobalamin"}, {"int_description_2": "Cyanocobalamin", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Pyridoxine"}, {"int_description_4": "Cobamamide"}, {"int_description_5": "Leucovorin", "timeframe_int5": "Hours", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Glycine betaine", "timeframe_int6": "Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Cohort study or studies", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Folic acid", "timeframe_int7": "Hours", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Methionine", "timeframe_int8": "Hours", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency.", "pmid_1": 27905001.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Journal of inherited metabolic disease"}, {"pmid_title_2": "Clinical onset and course, response to treatment and outcome in 24 patients with the cblE or cblG remethylation defect complemented by genetic and in vitro enzyme study data.", "pmid_2": 25526710.0, "pmid_date_2": 2015.0, "pmid_journal_2": "Journal of inherited metabolic disease"}, {"pmid_title_3": "CblE type of homocystinuria: mild clinical phenotype in two patients homozygous for a novel mutation in the MTRR gene.", "pmid_3": 12971424.0, "pmid_date_3": 2003.0, "pmid_journal_3": "Journal of inherited metabolic disease"}, {"pmid_title_4": "CblE type of homocystinuria due to methionine synthase reductase deficiency: clinical and molecular studies and prenatal diagnosis in two families.", "pmid_4": 12555939.0, "pmid_date_4": 2002.0, "pmid_journal_4": "Journal of inherited metabolic disease"}]}, {"_id": "7525-OMIM:616325", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 7525.0}, "interventions": [{"int_description_1": "Mechanical ventilation", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Ephedrine", "timeframe_int2": "Days or Weeks,Years", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Salbutamol"}, {"int_description_4": "Amifampridine"}, {"int_description_5": "Carbamazepine"}, {"int_description_6": "Pyridostigmine"}, {"int_description_7": "Quinidine", "timeframe_int7": "Days or Weeks", "age_use_int7": "Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Case report(s)", "rev1_eff_reclass_drug7": "Still in Trials / Unproven"}, {"int_description_8": "Fluoxetine"}], "references": [{"pmid_title_1": "Recessive variants of MuSK are associated with late onset CMS and predominant limb girdle weakness.", "pmid_1": 29704306.0, "pmid_date_1": 2018.0, "pmid_journal_1": "American journal of medical genetics. Part A"}, {"pmid_title_2": "Congenital Myasthenic Syndromes", "pmid_2": 20301347.0, "pmid_date_2": 2016.0, "pmid_journal_2": "GeneReviews\u00ae"}, {"pmid_title_3": "Limb-girdle congenital myasthenic syndrome in a Chinese family with novel mutations in MUSK gene and literature review.", "pmid_3": 27588369.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Clinical neurology and neurosurgery"}, {"pmid_title_4": "Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK.", "pmid_4": 24183479.0, "pmid_date_4": 2014.0, "pmid_journal_4": "Neuromuscul Disord"}, {"pmid_title_5": "Marked phenotypic variability in two siblings with congenital myasthenic syndrome due to mutations in MUSK.", "pmid_5": 24122059.0, "pmid_date_5": 2013.0, "pmid_journal_5": "J Neurol"}, {"pmid_title_6": "A mutation causes MuSK reduced sensitivity to agrin and congenital myasthenia.", "pmid_6": 23326516.0, "pmid_date_6": 2013.0, "pmid_journal_6": "PLoS One"}]}, {"_id": "7526-OMIM:251000", "condition": {"condition_name": "METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY", "freq_per_birth": "This condition occurs in an estimated 1 in 50,000 to 100,000 people.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 7526.0}, "interventions": [{"int_description_1": "Protein-restricted diet", "timeframe_int1": "Days or Weeks", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Hydroxocobalamin", "timeframe_int2": "Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Metronidazole"}, {"int_description_4": "Benzoic acid", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Levocarnitine", "timeframe_int5": "Hours", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Carglumic acid", "timeframe_int6": "Hours", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Modified mRNA encoding human methylmalonyl-coenzyme A mutase encapsulated into lipid nanoparticles"}, {"int_description_8": "Kidney-liver transplantation", "timeframe_int8": "Years", "age_use_int8": "Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Isolated Methylmalonic Acidemia", "pmid_1": 20301409.0, "pmid_date_1": 2016.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia.", "pmid_2": 25205257.0, "pmid_date_2": 2014.0, "pmid_journal_2": "Orphanet journal of rare diseases"}, {"pmid_title_3": "Renal transplant in methylmalonic acidemia: could it be the best option? Report on a case at 10 years and review of the literature.", "pmid_3": 17401587.0, "pmid_date_3": 2007.0, "pmid_journal_3": "Pediatric nephrology (Berlin, Germany)"}]}, {"_id": "7530-OMIM:610377", "condition": {"condition_name": "MEVALONIC ACIDURIA", "freq_per_birth": "More than 200 people with mevalonate kinase deficiency have been reported worldwide; the majority of these individuals have HIDS.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MEVALONIC ACIDURIA", "HYPER-IgD SYNDROME"]}, "gene information": {"db_hgnc_gene_id": 7530.0}, "interventions": [{"int_description_1": "Anakinra", "timeframe_int1": "Days or Weeks", "age_use_int1": "Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Corticotherapy", "timeframe_int2": "Days or Weeks,Years", "age_use_int2": "Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency.", "pmid_1": 31474985.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Frontiers in immunology"}, {"pmid_title_2": "Efficacy of Continuous Interleukin 1 Blockade in Mevalonate Kinase Deficiency: A Multicenter Retrospective Study in 13 Adult Patients and Literature Review.", "pmid_2": 29335349.0, "pmid_date_2": 2018.0, "pmid_journal_2": "The Journal of rheumatology"}, {"pmid_title_3": "The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry.", "pmid_3": 27213830.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Arthritis & rheumatology (Hoboken, N.J.)"}, {"pmid_title_4": "Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum.", "pmid_4": 12563048.0, "pmid_date_4": 2003.0, "pmid_journal_4": "Pediatrics"}]}, {"_id": "7577-OMIM:160500", "condition": {"condition_name": "MYOPATHY, DISTAL, 1; MPD1", "freq_per_birth": "Although Laing distal myopathy is thought to be rare, its prevalence is unknown.  Several families with the condition have been identified worldwide.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1", "MYOPATHY, DISTAL, 1; MPD1", "MYOPATHY, MYOSIN STORAGE, AUTOSOMAL DOMINANT; MSMA", "MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB", "SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM", "CARDIOMYOPATHY, DILATED, 1S; CMD1S"]}, "gene information": {"db_hgnc_gene_id": 7577.0}, "interventions": [{"int_description_1": "Lightweight splinting of the ankle", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Child", "contra_int1": "No", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "ACE inhibitors"}, {"int_description_3": "Physiotherapy", "timeframe_int3": "Days or Weeks,Years", "age_use_int3": "Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Surgical lengthening of the tendo Achilles"}, {"int_description_5": "Surgical stabilization of the spine"}], "references": [{"pmid_title_1": "Laing Distal Myopathy", "pmid_1": 20301606.0, "pmid_date_1": 2015.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Clinical utility gene card for: Laing distal myopathy.", "pmid_2": 21150886.0, "pmid_date_2": 2011.0, "pmid_journal_2": "European journal of human genetics : EJHG"}, {"pmid_title_3": "Autosomal dominant distal myopathy: further evidence of a chromosome 14 locus.", "pmid_3": 11166161.0, "pmid_date_3": 2001.0, "pmid_journal_3": "Neuromuscular disorders : NMD"}]}, {"_id": "7577-OMIM:192600", "condition": {"condition_name": "CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1", "freq_per_birth": "Familial hypertrophic cardiomyopathy affects an estimated 1 in 500 people worldwide. It is the most common genetic heart disease in the United States.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM", "CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1", "MYOPATHY, MYOSIN STORAGE, AUTOSOMAL DOMINANT; MSMA", "MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB", "MYOPATHY, DISTAL, 1; MPD1", "CARDIOMYOPATHY, DILATED, 1S; CMD1S"]}, "gene information": {"db_hgnc_gene_id": 7577.0}, "interventions": [{"int_description_1": "Propranolol"}, {"int_description_2": "Losartan"}, {"int_description_3": "Metoprolol"}, {"int_description_4": "Atenolol"}, {"int_description_5": "Nadolol"}, {"int_description_6": "Bisoprolol"}, {"int_description_7": "Amiodarone"}, {"int_description_8": "Sotalol", "timeframe_int8": "Days or Weeks", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Perhexiline", "timeframe_int9": "Days or Weeks", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Dofetilide"}, {"int_description_11": "Diltiazem"}, {"int_description_12": "Verapamil"}, {"int_description_13": "Mavacamten", "timeframe_int13": "Days or Weeks,Years", "age_use_int13": "Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Disopyramide", "timeframe_int14": "Days or Weeks,Years", "age_use_int14": "Child", "qualscale_reclass_drug14": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}, {"int_description_15": "Warfarin"}, {"int_description_16": "Alcohol Septal Ablation"}, {"int_description_17": "Dual-Chamber Pacing"}, {"int_description_18": "Surgical Myectomy"}], "references": [{"pmid_title_1": "Targeted Medical Therapies for Hypertrophic Cardiomyopathy.", "pmid_1": 31993794.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Current cardiology reports"}, {"pmid_title_2": "Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy.", "pmid_2": 32466879.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Journal of the American College of Cardiology"}, {"pmid_title_3": "Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.", "pmid_3": 32871100.0, "pmid_date_3": 2020.0, "pmid_journal_3": "Lancet (London, England)"}, {"pmid_title_4": "Novel Pharmacotherapy in Hypertrophic Cardiomyopathy.", "pmid_4": 29746257.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Cardiology in review"}, {"pmid_title_5": "Dofetilide for suppression of atrial fibrillation in hypertrophic cardiomyopathy: A case series and literature review.", "pmid_5": 29450893.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Pacing and clinical electrophysiology : PACE"}, {"pmid_title_6": "Drug Therapy for Hypertrophic Cardiomypathy: Physiology and Practice.", "pmid_6": 26818487.0, "pmid_date_6": 2016.0, "pmid_journal_6": "Current cardiology reviews"}, {"pmid_title_7": "Management of hypertrophic cardiomyopathy.", "pmid_7": 24751563.0, "pmid_date_7": 2014.0, "pmid_journal_7": "Annals of global health"}, {"pmid_title_8": "\u03b2 Blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy.", "pmid_8": 22633205.0, "pmid_date_8": 2012.0, "pmid_journal_8": "The American journal of cardiology"}, {"pmid_title_9": "Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy.", "pmid_9": 20921440.0, "pmid_date_9": 2010.0, "pmid_journal_9": "Circulation"}, {"pmid_title_10": "A new therapeutic strategy for hypertrophic nonobstructive cardiomyopathy in humans. A randomized and prospective study with an Angiotensin II receptor blocker.", "pmid_10": 18160763.0, "pmid_date_10": 2007.0, "pmid_journal_10": "International heart journal"}, {"pmid_title_11": "Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy.", "pmid_11": 15837258.0, "pmid_date_11": 2005.0, "pmid_journal_11": "Journal of the American College of Cardiology"}]}, {"_id": "7577-OMIM:255160", "condition": {"condition_name": "MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM", "MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB", "MYOPATHY, MYOSIN STORAGE, AUTOSOMAL DOMINANT; MSMA", "CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1", "MYOPATHY, DISTAL, 1; MPD1", "CARDIOMYOPATHY, DILATED, 1S; CMD1S"]}, "gene information": {"db_hgnc_gene_id": 7577.0}, "interventions": [{"int_description_1": "Wheelchairs or similar mobility devices"}, {"int_description_2": "Indapamide"}, {"int_description_3": "Occupational or speech therapy"}, {"int_description_4": "Physical therapy"}, {"int_description_5": "Respiratory support"}, {"int_description_6": "Stretching, bracing, and supportive care"}, {"int_description_7": "Scoliosis surgery"}, {"int_description_8": "Surgery for treatment of contractures, foot deformities"}], "references": [{"pmid_title_1": "Scoliosis surgery in a patient with de novo myosin storage myopathy.", "pmid_1": 21723124.0, "pmid_date_1": 2011.0, "pmid_journal_1": "Neuromuscular disorders : NMD"}, {"pmid_title_2": "Myosin storage (hyaline body) myopathy: a case report.", "pmid_2": 17118657.0, "pmid_date_2": 2006.0, "pmid_journal_2": "Neuromuscular disorders : NMD"}]}, {"_id": "7577-OMIM:608358", "condition": {"condition_name": "MYOPATHY, MYOSIN STORAGE, AUTOSOMAL DOMINANT; MSMA", "freq_per_birth": "Myosin storage myopathy is a rare condition. Its prevalence is unknown.", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM", "MYOPATHY, MYOSIN STORAGE, AUTOSOMAL DOMINANT; MSMA", "MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB", "CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1", "MYOPATHY, DISTAL, 1; MPD1", "CARDIOMYOPATHY, DILATED, 1S; CMD1S"]}, "gene information": {"db_hgnc_gene_id": 7577.0}, "interventions": [{"int_description_1": "Wheelchairs or similar mobility devices"}, {"int_description_2": "Indapamide"}, {"int_description_3": "Occupational or speech therapy"}, {"int_description_4": "Physical therapy"}, {"int_description_5": "Respiratory support"}, {"int_description_6": "Stretching, bracing, and supportive care"}, {"int_description_7": "Scoliosis surgery"}, {"int_description_8": "Surgery for treatment of contractures, foot deformities"}], "references": [{"pmid_title_1": "Scoliosis surgery in a patient with de novo myosin storage myopathy.", "pmid_1": 21723124.0, "pmid_date_1": 2011.0, "pmid_journal_1": "Neuromuscular disorders : NMD"}, {"pmid_title_2": "Myosin storage (hyaline body) myopathy: a case report.", "pmid_2": 17118657.0, "pmid_date_2": 2006.0, "pmid_journal_2": "Neuromuscular disorders : NMD"}]}, {"_id": "7577-OMIM:613426", "condition": {"condition_name": "CARDIOMYOPATHY, DILATED, 1S; CMD1S", "freq_per_birth": "It is estimated that 750,000 people in the United States have dilated cardiomyopathy; roughly half of these cases are familial.", "pattern_of_inheritance": "Autosomal dominant==X-linked dominant==Autosomal recessive==Autosomal dominant==X-linked recessive==Autosomal recessive", "alternate_names": ["SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM", "CARDIOMYOPATHY, DILATED, 1S; CMD1S", "MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB", "CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1", "MYOPATHY, DISTAL, 1; MPD1", "MYOPATHY, MYOSIN STORAGE, AUTOSOMAL DOMINANT; MSMA"]}, "gene information": {"db_hgnc_gene_id": 7577.0}, "interventions": [{"int_description_1": "Cardiac Assist Devices (Mechanical Hearts)"}, {"int_description_2": "Cardiac resynchronization therapy"}, {"int_description_3": "Implantable Cardiac Defibrillator (ICD)"}, {"int_description_4": "Pacemakers"}, {"int_description_5": "Wearable defibrillators"}, {"int_description_6": "Heparin"}, {"int_description_7": "Isosorbide dinitrate"}, {"int_description_8": "Norepinephrine"}, {"int_description_9": "Dopamine"}, {"int_description_10": "Carvedilol"}, {"int_description_11": "Spironolactone"}, {"int_description_12": "Losartan"}, {"int_description_13": "Metoprolol"}, {"int_description_14": "Eplerenone"}, {"int_description_15": "Candesartan"}, {"int_description_16": "Tolvaptan"}, {"int_description_17": "Bisoprolol"}, {"int_description_18": "Amiodarone"}, {"int_description_19": "Ivabradine"}, {"int_description_20": "Bumetanide"}, {"int_description_21": "Valsartan"}, {"int_description_22": "Digoxin"}, {"int_description_23": "Furosemide"}, {"int_description_24": "Hydralazine"}, {"int_description_25": "Ramipril"}, {"int_description_26": "Enalapril"}, {"int_description_27": "Lisinopril"}, {"int_description_28": "Perindopril"}, {"int_description_29": "Captopril"}, {"int_description_30": "Dofetilide"}, {"int_description_31": "Acetazolamide", "timeframe_int31": "Hours,Days or Weeks", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Enoxaparin"}, {"int_description_33": "Torasemide"}, {"int_description_34": "Etacrynic acid"}, {"int_description_35": "Rosuvastatin"}, {"int_description_36": "Sacubitril"}, {"int_description_37": "Milrinone"}, {"int_description_38": "Acetylsalicylic acid"}, {"int_description_39": "Metolazone"}, {"int_description_40": "Warfarin"}, {"int_description_41": "Beta-blockers"}, {"int_description_42": "Vitamin-K-antagonists"}, {"int_description_43": "Catheter ablation"}, {"int_description_44": "Implantable cardioverter/defibrillator"}, {"int_description_45": "Implantation of a left ventricular assist device"}, {"int_description_46": "Intramyocardial CD34+ stem cell injection"}, {"int_description_47": "Coronary bypass surgery"}, {"int_description_48": "Heart Transplantation"}], "references": [{"pmid_title_1": "Left Ventricular Noncompaction Syndrome: Genetic Insights and Therapeutic Perspectives.", "pmid_1": 32648009.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Current cardiology reports"}, {"pmid_title_2": "Different Manifestations in Familial Isolated Left Ventricular Non-compaction: Two Case Reports and Literature Review.", "pmid_2": 32775315.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Frontiers in pediatrics"}, {"pmid_title_3": "A New Diagnosis of Left Ventricular Non-Compaction in a Patient Presenting with Acute Heart Failure.", "pmid_3": 30651913.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Journal of radiology case reports"}, {"pmid_title_4": "Heart rate manipulation in dilated cardiomyopathy: Assessing the role of Ivabradine.", "pmid_4": 29716702.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Indian heart journal"}, {"pmid_title_5": "2017 ACC Expert Consensus Decision Pathway for Optimization of Heart\u00a0Failure Treatment: Answers to 10\u00a0Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.", "pmid_5": 29277252.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Journal of the American College of Cardiology"}, {"pmid_title_6": "Multifocal atrial and ventricular premature contractions with an increased risk of dilated cardiomyopathy caused by a Na<sub>v</sub>1.5 gain-of-function mutation (G213D).", "pmid_6": 29506689.0, "pmid_date_6": 2018.0, "pmid_journal_6": "International journal of cardiology"}, {"pmid_title_7": "Transendocardial CD34<sup>+</sup> Cell Transplantation in Noncompaction Cardiomyopathy: First-in-Man Case Study.", "pmid_7": 29974792.0, "pmid_date_7": 2018.0, "pmid_journal_7": "Cell transplantation"}, {"pmid_title_8": "Does Lowering Heart Rate Improve Outcomes in Children With Dilated\u00a0Cardiomyopathy and Chronic\u00a0Heart Failure?", "pmid_8": 28859791.0, "pmid_date_8": 2017.0, "pmid_journal_8": "Journal of the American College of Cardiology"}, {"pmid_title_9": "Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure.", "pmid_9": 28859790.0, "pmid_date_9": 2017.0, "pmid_journal_9": "Journal of the American College of Cardiology"}, {"pmid_title_10": "Left Ventricular Noncompaction Cardiomyopathy Presenting with Heart Failure in a 35-Year-Old Man.", "pmid_10": 28878579.0, "pmid_date_10": 2017.0, "pmid_journal_10": "Texas Heart Institute journal"}, {"pmid_title_11": "Tolvaptan: A Novel Diuretic in Heart Failure Management.", "pmid_11": 27403182.0, "pmid_date_11": 2016.0, "pmid_journal_11": "The journal of Tehran Heart Center"}, {"pmid_title_12": "Left ventricular noncompaction: A rare indication for pediatric heart transplantation.", "pmid_12": 26777414.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology"}, {"pmid_title_13": "2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.", "pmid_13": 27206819.0, "pmid_date_13": 2016.0, "pmid_journal_13": "European heart journal"}, {"pmid_title_14": "Effects of \u03b2-blocker therapy on electrocardiographic and echocardiographic characteristics of left ventricular noncompaction.", "pmid_14": 25331160.0, "pmid_date_14": 2015.0, "pmid_journal_14": "Clinical research in cardiology : official journal of the German Cardiac Society"}, {"pmid_title_15": "I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.", "pmid_15": 25179314.0, "pmid_date_15": 2015.0, "pmid_journal_15": "Cardiology journal"}, {"pmid_title_16": "Ivabradine might improve exercise capacity in dilated cardiomyopathy in comparison with bisoprolol: assessment with the ergospirometry test.", "pmid_16": 24774739.0, "pmid_date_16": 2014.0, "pmid_journal_16": "Revista espanola de cardiologia (English ed.)"}, {"pmid_title_17": "Angiotensin-neprilysin inhibition versus enalapril in heart failure.", "pmid_17": 25176015.0, "pmid_date_17": 2014.0, "pmid_journal_17": "The New England journal of medicine"}, {"pmid_title_18": "Ivabradine improves heart rate variability in patients with nonischemic dilated cardiomyopathy.", "pmid_18": 25119894.0, "pmid_date_18": 2014.0, "pmid_journal_18": "Arquivos brasileiros de cardiologia"}, {"pmid_title_19": "Isolated left ventricular noncompaction causing stroke in a 30-year-old woman: case report and literature review.", "pmid_19": 23914034.0, "pmid_date_19": 2013.0, "pmid_journal_19": "Texas Heart Institute journal"}, {"pmid_title_20": "2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.", "pmid_20": 23747642.0, "pmid_date_20": 2013.0, "pmid_journal_20": "Journal of the American College of Cardiology"}, {"pmid_title_21": "Mechanical circulatory support for advanced heart failure: patients and technology in evolution.", "pmid_21": 22412091.0, "pmid_date_21": 2012.0, "pmid_journal_21": "Circulation"}, {"pmid_title_22": "Eplerenone in patients with systolic heart failure and mild symptoms.", "pmid_22": 21073363.0, "pmid_date_22": 2011.0, "pmid_journal_22": "The New England journal of medicine"}, {"pmid_title_23": "Ivabradine, a novel heart rate slower: is it a sword of double blades in patients with idiopathic dilated cardiomyopathy?", "pmid_23": 21712169.0, "pmid_date_23": 2011.0, "pmid_journal_23": "Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology"}, {"pmid_title_24": "Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial.", "pmid_24": 21111980.0, "pmid_date_24": 2010.0, "pmid_journal_24": "Journal of cardiac failure"}, {"pmid_title_25": "Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.", "pmid_25": 20801500.0, "pmid_date_25": 2010.0, "pmid_journal_25": "Lancet (London, England)"}, {"pmid_title_26": "Comparison of dopamine and norepinephrine in the treatment of shock.", "pmid_26": 20200382.0, "pmid_date_26": 2010.0, "pmid_journal_26": "The New England journal of medicine"}, {"pmid_title_27": "Comparison of Dopamine and Norepinephrine in the treatment of shock.", "pmid_27": 21977124.0, "pmid_date_27": 2010.0, "pmid_journal_27": "Maedica"}, {"pmid_title_28": "Sleep apnoea in patients with heart failure: part II: therapy.", "pmid_28": 19913772.0, "pmid_date_28": 2009.0, "pmid_journal_28": "Archives of cardiovascular diseases"}, {"pmid_title_29": "The management of acute heart failure and diuretic therapy.", "pmid_29": 19142155.0, "pmid_date_29": 2009.0, "pmid_journal_29": "American journal of therapeutics"}, {"pmid_title_30": "Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial.", "pmid_30": 19922995.0, "pmid_date_30": 2009.0, "pmid_journal_30": "Lancet (London, England)"}, {"pmid_title_31": "Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.", "pmid_31": 19406272.0, "pmid_date_31": 2009.0, "pmid_journal_31": "The American journal of cardiology"}, {"pmid_title_32": "Long-term support with milrinone prior to cardiac transplantation in a neonate with left ventricular noncompaction cardiomyopathy.", "pmid_32": 17551772.0, "pmid_date_32": 2007.0, "pmid_journal_32": "Pediatric cardiology"}, {"pmid_title_33": "Rosuvastatin in older patients with systolic heart failure.", "pmid_33": 17984166.0, "pmid_date_33": 2007.0, "pmid_journal_33": "The New England journal of medicine"}, {"pmid_title_34": "Echocardiography in the diagnosis and management of isolated left ventricular noncompaction: case reports and review of the literature.", "pmid_34": 16944490.0, "pmid_date_34": 2006.0, "pmid_journal_34": "Journal of clinical ultrasound : JCU"}, {"pmid_title_35": "Cardiomyopathy, familial dilated.", "pmid_35": 16839424.0, "pmid_date_35": 2006.0, "pmid_journal_35": "Orphanet journal of rare diseases"}, {"pmid_title_36": "Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.", "pmid_36": 15659722.0, "pmid_date_36": 2005.0, "pmid_journal_36": "The New England journal of medicine"}, {"pmid_title_37": "Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.", "pmid_37": 15492298.0, "pmid_date_37": 2004.0, "pmid_journal_37": "Circulation"}, {"pmid_title_38": "Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.", "pmid_38": 15533851.0, "pmid_date_38": 2004.0, "pmid_journal_38": "The New England journal of medicine"}, {"pmid_title_39": "A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home.", "pmid_39": 15454175.0, "pmid_date_39": 2004.0, "pmid_journal_39": "The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation"}, {"pmid_title_40": "Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease.", "pmid_40": 12679756.0, "pmid_date_40": 2003.0, "pmid_journal_40": "American heart journal"}, {"pmid_title_41": "Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.", "pmid_41": 12595851.0, "pmid_date_41": 2003.0, "pmid_journal_41": "American heart journal"}, {"pmid_title_42": "Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.", "pmid_42": 12390947.0, "pmid_date_42": 2002.0, "pmid_journal_42": "Circulation"}, {"pmid_title_43": "Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors.", "pmid_43": 12392830.0, "pmid_date_43": 2002.0, "pmid_journal_43": "Journal of the American College of Cardiology"}, {"pmid_title_44": "Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in MEDical patients with ENOXaparin (MEDENOX) trial.", "pmid_44": 11206019.0, "pmid_date_44": 2000.0, "pmid_journal_44": "The American journal of cardiology"}, {"pmid_title_45": "Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.", "pmid_45": 10714728.0, "pmid_date_45": 2000.0, "pmid_journal_45": "JAMA"}, {"pmid_title_46": "The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.", "pmid_46": 10023943.0, "pmid_date_46": 1999.0, "pmid_journal_46": "Lancet (London, England)"}, {"pmid_title_47": "Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.", "pmid_47": 10486417.0, "pmid_date_47": 1999.0, "pmid_journal_47": "The New England journal of medicine"}, {"pmid_title_48": "Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction.", "pmid_48": 10091816.0, "pmid_date_48": 1999.0, "pmid_journal_48": "Journal of the American College of Cardiology"}, {"pmid_title_49": "Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.", "pmid_49": 10587334.0, "pmid_date_49": 1999.0, "pmid_journal_49": "Circulation"}, {"pmid_title_50": "The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.", "pmid_50": 10471456.0, "pmid_date_50": 1999.0, "pmid_journal_50": "The New England journal of medicine"}, {"pmid_title_51": "Diuretic therapy.", "pmid_51": 9691107.0, "pmid_date_51": 1998.0, "pmid_journal_51": "The New England journal of medicine"}, {"pmid_title_52": "Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction.", "pmid_52": 9525542.0, "pmid_date_52": 1998.0, "pmid_journal_52": "Journal of the American College of Cardiology"}, {"pmid_title_53": "Ventricular dysfunction and the risk of stroke after myocardial infarction.", "pmid_53": 8995087.0, "pmid_date_53": 1997.0, "pmid_journal_53": "The New England journal of medicine"}, {"pmid_title_54": "Effect of antithrombotic therapy on risk of sudden coronary death in patients with congestive heart failure.", "pmid_54": 9104905.0, "pmid_date_54": 1997.0, "pmid_journal_54": "The American journal of cardiology"}, {"pmid_title_55": "A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy.", "pmid_55": 8789442.0, "pmid_date_55": 1996.0, "pmid_journal_55": "Human molecular genetics"}, {"pmid_title_56": "Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.", "pmid_56": 7539890.0, "pmid_date_56": 1995.0, "pmid_journal_56": "The New England journal of medicine"}, {"pmid_title_57": "Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)", "pmid_57": 7914611.0, "pmid_date_57": 1994.0, "pmid_journal_57": "Lancet (London, England)"}, {"pmid_title_58": "Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial.", "pmid_58": 1545080.0, "pmid_date_58": 1992.0, "pmid_journal_58": "Journal of the American College of Cardiology"}, {"pmid_title_59": "Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.", "pmid_59": 2057034.0, "pmid_date_59": 1991.0, "pmid_journal_59": "The New England journal of medicine"}, {"pmid_title_60": "Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group.", "pmid_60": 2447297.0, "pmid_date_60": 1988.0, "pmid_journal_60": "JAMA"}, {"pmid_title_61": "Low dose heparin for prevention of deep vein thrombosis and pulmonary embolism in medical patients.", "pmid_61": 3306913.0, "pmid_date_61": 1987.0, "pmid_journal_61": "Scottish medical journal"}, {"pmid_title_62": "Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).", "pmid_62": 2883575.0, "pmid_date_62": 1987.0, "pmid_journal_62": "The New England journal of medicine"}, {"pmid_title_63": "Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.", "pmid_63": 3520315.0, "pmid_date_63": 1986.0, "pmid_journal_63": "The New England journal of medicine"}]}, {"_id": "758-OMIM:215700", "condition": {"condition_name": "CITRULLINEMIA, CLASSIC", "freq_per_birth": "Type I citrullinemia is the most common form of the disorder, affecting about 1 in 57,000 people worldwide. Type II citrullinemia is found primarily in the Japanese population, where it occurs in an estimated 1 in 100,000 to 230,000 individuals. Type II also has been reported in other populations, including other people from East Asia, the Middle East, the United States, and the United Kingdom.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["CITRULLINEMIA, CLASSIC"]}, "gene information": {"db_hgnc_gene_id": 758.0}, "interventions": [{"int_description_1": "Low protein diet and Essential amino acids (EAAs) supplementation", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Low protein diet and essential fatty acid (EFAs)/long-chain polyunsaturated fatty acid supplementation (EFAs/ (LCPUFAs)-enriched infant formulas)", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Vitamin and mineral supplementation"}, {"int_description_4": "Arginine", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Case report(s)", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Benzoic acid", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Phenylbutyric acid", "timeframe_int6": "Hours,Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Glycerol phenylbutyrate"}, {"int_description_8": "Phenylacetic acid"}, {"int_description_9": "Carglumic acid"}, {"int_description_10": "D-glucose"}, {"int_description_11": "Heterologous human adult liver-derived progenitor cells", "timeframe_int11": "Hours,Days or Weeks", "age_use_int11": "Neonate,Infant,Child", "contra_int11": "No", "qualscale_reclass_drug11": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "Human heterologous liver cells (for infusion)"}, {"int_description_13": "Therapeutic hypothermia", "timeframe_int13": "Hours", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Hemodialysis"}, {"int_description_15": "\u0421ontinuous veno-venous haemofiltration", "timeframe_int15": "Days or Weeks,Years", "age_use_int15": "Infant,Child", "contra_int15": "No", "qualscale_reclass_drug15": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug15": "Curative"}, {"int_description_16": "Orthotopic liver transplantation (OLT)"}], "references": [{"pmid_title_1": "Progress and challenges in development of new therapies for urea cycle disorders.", "pmid_1": 31227828.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Human molecular genetics"}, {"pmid_title_2": "Early prediction of phenotypic severity in Citrullinemia Type 1.", "pmid_2": 31469252.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Annals of clinical and translational neurology"}, {"pmid_title_3": "Phase I/II Trial of Liver-derived Mesenchymal Stem Cells in Pediatric Liver-based Metabolic Disorders: A Prospective, Open Label, Multicenter, Partially Randomized, Safety Study of One Cycle of Heterologous Human Adult Liver-derived Progenitor Cells (HepaStem) in Urea Cycle Disorders and Crigler-Najjar Syndrome Patients.", "pmid_3": 30801523.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Transplantation"}, {"pmid_title_4": "Citrullinemia Type 1: Behavioral Improvement with Late Liver Transplantation.", "pmid_4": 30848473.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Indian journal of pediatrics"}, {"pmid_title_5": "First report of carglumic acid in a patient with citrullinemia type 1 (argininosuccinate synthetase deficiency).", "pmid_5": 28741715.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Journal of clinical pharmacy and therapeutics"}, {"pmid_title_6": "Liver transplantation for neonatal-onset citrullinemia.", "pmid_6": 29726081.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Pediatric transplantation"}, {"pmid_title_7": "Citrullinemia Type I", "pmid_7": 20301631.0, "pmid_date_7": 2016.0, "pmid_journal_7": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_8": "Report of 3 Patients With Urea Cycle Defects Treated With Related Living-Donor Liver Transplant.", "pmid_8": 26640932.0, "pmid_date_8": 2015.0, "pmid_journal_8": "Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation"}, {"pmid_title_9": "Urea cycle disorders in Spain: an observational, cross-sectional and multicentric study of 104 cases.", "pmid_9": 25433810.0, "pmid_date_9": 2014.0, "pmid_journal_9": "Orphanet J Rare Dis"}, {"pmid_title_10": "Dietary management of urea cycle disorders: European practice.", "pmid_10": 24113687.0, "pmid_date_10": 2013.0, "pmid_journal_10": "Molecular genetics and metabolism"}, {"pmid_title_11": "Liver transplantation for urea cycle disorders in pediatric patients: a single-center experience.", "pmid_11": 23347504.0, "pmid_date_11": 2013.0, "pmid_journal_11": "Pediatric transplantation"}, {"pmid_title_12": "Suggested guidelines for the diagnosis and management of urea cycle disorders.", "pmid_12": 22642880.0, "pmid_date_12": 2012.0, "pmid_journal_12": "Orphanet journal of rare diseases"}, {"pmid_title_13": "The implementation of neonatal peritoneal dialysis in a clinical setting.", "pmid_13": 22420616.0, "pmid_date_13": 2012.0, "pmid_journal_13": "The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians"}, {"pmid_title_14": "Dietary management of urea cycle disorders: UK practice.", "pmid_14": 22594780.0, "pmid_date_14": 2012.0, "pmid_journal_14": "Journal of human nutrition and dietetics : the official journal of the British Dietetic Association"}, {"pmid_title_15": "Successful prospective management of neonatal citrullinemia.", "pmid_15": 22768672.0, "pmid_date_15": 2012.0, "pmid_journal_15": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_16": "30-year follow-up of a patient with classic citrullinemia.", "pmid_16": 22494546.0, "pmid_date_16": 2012.0, "pmid_journal_16": "Molecular genetics and metabolism"}, {"pmid_title_17": "Long-chain polyunsaturated fatty acids in inborn errors of metabolism.", "pmid_17": 22254065.0, "pmid_date_17": 2010.0, "pmid_journal_17": "Nutrients"}, {"pmid_title_18": "New insights in nutritional management and amino acid supplementation in urea cycle disorders.", "pmid_18": 20299258.0, "pmid_date_18": 2010.0, "pmid_journal_18": "Mol Genet Metab"}, {"pmid_title_19": "Metabolic investigations prevent liver transplantation in two young children with citrullinemia type I.", "pmid_19": 20852933.0, "pmid_date_19": 2010.0, "pmid_journal_19": "Journal of inherited metabolic disease"}, {"pmid_title_20": "Prenatal benzoate treatment in urea cycle defects.", "pmid_20": 19000997.0, "pmid_date_20": 2009.0, "pmid_journal_20": "Archives of disease in childhood. Fetal and neonatal edition"}, {"pmid_title_21": "The role of molecular testing and enzyme analysis in the management of hypomorphic citrullinemia.", "pmid_21": 18925679.0, "pmid_date_21": 2008.0, "pmid_journal_21": "American journal of medical genetics. Part A"}, {"pmid_title_22": "Cross-sectional multicenter study of patients with urea cycle disorders in the United States.", "pmid_22": 18562231.0, "pmid_date_22": 2008.0, "pmid_journal_22": "Mol Genet Metab"}, {"pmid_title_23": "Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.", "pmid_23": 17538087.0, "pmid_date_23": 2007.0, "pmid_journal_23": "The New England journal of medicine"}, {"pmid_title_24": "Essential polyunsaturated fatty acids in plasma and erythrocytes of children with inborn errors of amino acid metabolism.", "pmid_24": 16530443.0, "pmid_date_24": 2006.0, "pmid_journal_24": "Molecular genetics and metabolism"}, {"pmid_title_25": "Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University.", "pmid_25": 16237708.0, "pmid_date_25": 2005.0, "pmid_journal_25": "Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society"}, {"pmid_title_26": "Clearance of amino acids by hemodialysis in argininosuccinate synthetase deficiency.", "pmid_26": 15069407.0, "pmid_date_26": 2004.0, "pmid_journal_26": "The Journal of pediatrics"}, {"pmid_title_27": "Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.", "pmid_27": 15050979.0, "pmid_date_27": 2004.0, "pmid_journal_27": "Molecular genetics and metabolism"}, {"pmid_title_28": "[Severe fulminant form of neonatal citrullinemia. Report of a case].", "pmid_28": 12666042.0, "pmid_date_28": 2003.0, "pmid_journal_28": "Revista de neurologia"}, {"pmid_title_29": "Long-term survival after liver transplantation in children with metabolic disorders.", "pmid_29": 12234269.0, "pmid_date_29": 2002.0, "pmid_journal_29": "Pediatric transplantation"}, {"pmid_title_30": "A pediatric patient with classical citrullinemia who underwent living-related partial liver transplantation.", "pmid_30": 11391244.0, "pmid_date_30": 2001.0, "pmid_journal_30": "Transplantation"}, {"pmid_title_31": "Living-related liver transplantation in inherited metabolic liver disease: feasibility and cautions.", "pmid_31": 11794242.0, "pmid_date_31": 2001.0, "pmid_journal_31": "Journal of pediatric gastroenterology and nutrition"}, {"pmid_title_32": "Liver transplantation for citrullinaemia improves intellectual function.", "pmid_32": 10399089.0, "pmid_date_32": 1999.0, "pmid_journal_32": "Journal of inherited metabolic disease"}, {"pmid_title_33": "Liver transplantation in urea cycle disorders.", "pmid_33": 10603100.0, "pmid_date_33": 1999.0, "pmid_journal_33": "European journal of pediatrics"}, {"pmid_title_34": "Inborn errors of metabolism with a protein-restricted diet: effect on polyunsaturated fatty acids.", "pmid_34": 9427146.0, "pmid_date_34": 1997.0, "pmid_journal_34": "Journal of inherited metabolic disease"}, {"pmid_title_35": "Prospective management of a child with neonatal citrullinemia.", "pmid_35": 8419623.0, "pmid_date_35": 1993.0, "pmid_journal_35": "The Journal of pediatrics"}]}, {"_id": "7608-OMIM:618198", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24"]}, "gene information": {"db_hgnc_gene_id": 7608.0}, "interventions": [{"int_description_1": "Mechanical ventilation", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Amifampridine"}, {"int_description_3": "Procaine", "timeframe_int3": "Days or Weeks,Years", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Procainamide"}, {"int_description_5": "Pyridostigmine"}, {"int_description_6": "Ciprofloxacin"}, {"int_description_7": "Quinidine"}, {"int_description_8": "Chloroquine"}, {"int_description_9": "Fluoxetine"}, {"int_description_10": "Phenytoin"}, {"int_description_11": "Beta-blockers"}, {"int_description_12": "Lithium"}, {"int_description_13": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "Congenital Myasthenic Syndromes", "pmid_1": 20301347.0, "pmid_date_1": 2016.0, "pmid_journal_1": "GeneReviews\u00ae"}, {"pmid_title_2": "Identification of mutations in the MYO9A gene in patients with congenital myasthenic syndrome.", "pmid_2": 27259756.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Brain"}]}, {"_id": "7652-OMIM:251260", "condition": {"condition_name": "NIJMEGEN BREAKAGE SYNDROME; NBS", "freq_per_birth": "The exact prevalence of Nijmegen breakage syndrome is unknown. This condition is estimated to affect one in 100,000 newborns worldwide, but is thought to be most common in the Slavic populations of Eastern Europe.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL", "NIJMEGEN BREAKAGE SYNDROME; NBS", "Hereditary breast and ovarian cancer syndrome", "Familial prostate cancer", "APLASTIC ANEMIA"]}, "gene information": {"db_hgnc_gene_id": 7652.0}, "interventions": [{"int_description_1": "Prednisone"}, {"int_description_2": "Dexamethasone"}, {"int_description_3": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_4": "Rituximab"}, {"int_description_5": "Alemtuzumab"}, {"int_description_6": "Cyclosporine"}, {"int_description_7": "Muromonab"}, {"int_description_8": "Cyclophosphamide"}, {"int_description_9": "Busulfan"}, {"int_description_10": "Melphalan"}, {"int_description_11": "Ifosfamide"}, {"int_description_12": "Thiotepa"}, {"int_description_13": "Doxycycline"}, {"int_description_14": "Doxorubicin"}, {"int_description_15": "Mercaptopurine"}, {"int_description_16": "Trimethoprim"}, {"int_description_17": "Sulfamethoxazole"}, {"int_description_18": "Vincristine"}, {"int_description_19": "Posaconazole"}, {"int_description_20": "Methotrexate"}, {"int_description_21": "Fludarabine", "timeframe_int21": "Days or Weeks", "age_use_int21": "Neonate,Infant,Child", "contra_int21": "No", "qualscale_reclass_drug21": "Authoritative published clinical practice guideline"}, {"int_description_22": "Cytarabine"}, {"int_description_23": "Daunorubicin"}, {"int_description_24": "Etoposide", "timeframe_int24": "Days or Weeks", "age_use_int24": "Neonate,Infant,Child", "contra_int24": "No", "qualscale_reclass_drug24": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug24": "Effective / Ameliorative"}, {"int_description_25": "Mycophenolate mofetil"}, {"int_description_26": "Vitamin E"}, {"int_description_27": "Methylprednisolone"}, {"int_description_28": "Antiseptic compresses"}, {"int_description_29": "Asparaginase Escherichia coli"}, {"int_description_30": "Silver sulfadiazine"}, {"int_description_31": "Fluoroquinolone  antibiotics", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Hormone replacement therapy"}, {"int_description_33": "Filgrastim"}, {"int_description_34": "Folic acid"}, {"int_description_35": "Gamma-globulin replacement therapy"}, {"int_description_36": "Speech therapy"}, {"int_description_37": "Thoracoabdominal irradiation"}, {"int_description_38": "Total body irradiation"}, {"int_description_39": "Hematopoietic stem cells transplantation", "timeframe_int39": "Days or Weeks,Years", "age_use_int39": "Neonate,Infant,Child", "contra_int39": "No", "qualscale_reclass_drug39": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug39": "Effective / Ameliorative"}, {"int_description_40": "Necrectomy"}], "references": [{"pmid_title_1": "Nijmegen breakage syndrome: case report and review of literature.", "pmid_1": 32537088.0, "pmid_date_1": 2020.0, "pmid_journal_1": "The Pan African medical journal"}, {"pmid_title_2": "Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders.", "pmid_2": 28392333.0, "pmid_date_2": 2018.0, "pmid_journal_2": "The Journal of allergy and clinical immunology"}, {"pmid_title_3": "Nijmegen Breakage Syndrome", "pmid_3": 20301355.0, "pmid_date_3": 2017.0, "pmid_journal_3": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_4": "Clinical course and therapeutic implications for lymphoid malignancies in Nijmegen breakage syndrome.", "pmid_4": 26826318.0, "pmid_date_4": 2016.0, "pmid_journal_4": "European journal of medical genetics"}, {"pmid_title_5": "Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options - a Retrospective Analysis.", "pmid_5": 26271390.0, "pmid_date_5": 2015.0, "pmid_journal_5": "Journal of clinical immunology"}, {"pmid_title_6": "Nijmegen breakage syndrome (NBS).", "pmid_6": 22373003.0, "pmid_date_6": 2012.0, "pmid_journal_6": "Orphanet journal of rare diseases"}, {"pmid_title_7": "Necrobiotic cutaneous granulomas in Nijmegen breakage syndrome.", "pmid_7": 22533239.0, "pmid_date_7": 2012.0, "pmid_journal_7": "Journal of investigational allergology & clinical immunology"}, {"pmid_title_8": "Promising therapy results for lymphoid malignancies in children with chromosomal breakage syndromes (Ataxia teleangiectasia or Nijmegen-breakage syndrome): a retrospective survey.", "pmid_8": 21923652.0, "pmid_date_8": 2011.0, "pmid_journal_8": "British journal of haematology"}, {"pmid_title_9": "High prevalence of primary ovarian insufficiency in girls and young women with Nijmegen breakage syndrome: evidence from a longitudinal study.", "pmid_9": 20444919.0, "pmid_date_9": 2010.0, "pmid_journal_9": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_10": "Successful SCT for Nijmegen breakage syndrome.", "pmid_10": 19684627.0, "pmid_date_10": 2010.0, "pmid_journal_10": "Bone marrow transplantation"}, {"pmid_title_11": "Non-Hodgkin lymphoma (NHL) in children with Nijmegen Breakage syndrome (NBS).", "pmid_11": 18937313.0, "pmid_date_11": 2009.0, "pmid_journal_11": "Pediatric blood & cancer"}, {"pmid_title_12": "Long-term remission of children with relapsed and secondary anaplastic large cell non-Hodgkin lymphoma (ALCL) following treatment with pulsed dexamethasone and low dose etoposide.", "pmid_12": 16609950.0, "pmid_date_12": 2008.0, "pmid_journal_12": "Pediatric blood & cancer"}, {"pmid_title_13": "Successful treatment of diffuse large B-cell non-hodgkin lymphoma with modified CHOP (cyclophosphamide/doxorubicin/vincristine/prednisone) chemotherapy and rituximab in a patient with Nijmegen syndrome.", "pmid_13": 18186968.0, "pmid_date_13": 2007.0, "pmid_journal_13": "Clinical lymphoma & myeloma"}, {"pmid_title_14": "T-cell lymphoblastic leukemia/lymphoma in Nijmegen breakage syndrome.", "pmid_14": 15339696.0, "pmid_date_14": 2004.0, "pmid_journal_14": "Haematologica"}, {"pmid_title_15": "Nijmegen breakage syndrome. The International Nijmegen Breakage Syndrome Study Group.", "pmid_15": 10799436.0, "pmid_date_15": 2000.0, "pmid_journal_15": "Archives of disease in childhood"}, {"pmid_title_16": "Non-Hodgkin's lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): experience from the BFM trials.", "pmid_16": 10707797.0, "pmid_date_16": 2000.0, "pmid_journal_16": "Annals of oncology : official journal of the European Society for Medical Oncology"}]}, {"_id": "7660-OMIM:233700", "condition": {"condition_name": "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 1; CGD1", "freq_per_birth": "Chronic granulomatous disease is estimated to occur in 1 in 200,000 to 250,000 people worldwide.", "pattern_of_inheritance": "X-linked recessive==Autosomal recessive", "alternate_names": ["GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 1; CGD1"]}, "gene information": {"db_hgnc_gene_id": 7660.0}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Prednisone"}, {"int_description_3": "Lenograstim"}, {"int_description_4": "Pioglitazone"}, {"int_description_5": "Anakinra"}, {"int_description_6": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_7": "Hydroxychloroquine"}, {"int_description_8": "Alemtuzumab"}, {"int_description_9": "Cyclosporine"}, {"int_description_10": "Metronidazole"}, {"int_description_11": "Amphotericin B"}, {"int_description_12": "Sirolimus"}, {"int_description_13": "Interferon gamma-1b", "timeframe_int13": "Days or Weeks", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Case report(s)", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Piperacillin"}, {"int_description_15": "Cyclophosphamide"}, {"int_description_16": "Busulfan"}, {"int_description_17": "Melphalan"}, {"int_description_18": "Caspofungin"}, {"int_description_19": "Linezolid"}, {"int_description_20": "Mercaptopurine"}, {"int_description_21": "Mesalazine"}, {"int_description_22": "Sulfasalazine"}, {"int_description_23": "Clindamycin"}, {"int_description_24": "Tazobactam"}, {"int_description_25": "Trimethoprim"}, {"int_description_26": "Sulfamethoxazole"}, {"int_description_27": "Ciprofloxacin"}, {"int_description_28": "Meropenem"}, {"int_description_29": "Cefuroxime"}, {"int_description_30": "Thalidomide"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks,Years", "age_use_int31": "Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Itraconazole", "timeframe_int32": "Hours,Days or Weeks", "age_use_int32": "Neonate,Infant,Child", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Posaconazole"}, {"int_description_34": "Methotrexate"}, {"int_description_35": "Fludarabine"}, {"int_description_36": "Cytarabine"}, {"int_description_37": "Tacrolimus"}, {"int_description_38": "Azathioprine"}, {"int_description_39": "Mycophenolic acid"}, {"int_description_40": "Ustekinumab"}, {"int_description_41": "Isavuconazole"}, {"int_description_42": "Ceftazidime"}, {"int_description_43": "Methylprednisolone"}, {"int_description_44": "Infliximab"}, {"int_description_45": "antimicrobial therapy", "timeframe_int45": "Hours", "age_use_int45": "Neonate,Infant,Child", "contra_int45": "No", "qualscale_reclass_drug45": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug45": "Effective / Ameliorative"}, {"int_description_46": "corticosteroids", "timeframe_int46": "Hours,Days or Weeks", "age_use_int46": "Neonate,Infant,Child", "contra_int46": "No", "qualscale_reclass_drug46": "Case report(s)", "rev1_eff_reclass_drug46": "Effective / Ameliorative"}, {"int_description_47": "Teicoplanin"}, {"int_description_48": "Gene editing: autologous CD34+ cells transduced ex vivo with a recombinant retrovirus encoding normal p47(phox)"}, {"int_description_49": "granulocyte transfusions", "timeframe_int49": "Hours,Days or Weeks", "age_use_int49": "Neonate,Infant,Child", "qualscale_reclass_drug49": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug49": "Effective / Ameliorative"}, {"int_description_50": "sun protection", "age_use_int50": "Neonate,Infant,Child"}, {"int_description_51": "Total body irradiation"}, {"int_description_52": "Bone marrow transplantation", "timeframe_int52": "Days or Weeks,Years", "contra_int52": "No", "qualscale_reclass_drug52": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug52": "Curative"}, {"int_description_53": "Hematopoietic stem cell transplantation"}, {"int_description_54": "surgery"}], "references": [{"pmid_title_1": "Chronic Granulomatous Disease: a Comprehensive Review.", "pmid_1": 32524254.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Clinical reviews in allergy & immunology"}, {"pmid_title_2": "Recent advances in chronic granulomatous disease.", "pmid_2": 32181279.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Genes & diseases"}, {"pmid_title_3": "Hemophagocytic lymphohistiocytosis resulting from a cytokine storm triggered by septicemia in a child with chronic granuloma disease: a case report and literature review.", "pmid_3": 32126983.0, "pmid_date_3": 2020.0, "pmid_journal_3": "BMC pediatrics"}, {"pmid_title_4": "Chronic Granulomatous Disease.", "pmid_4": 31172494.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Methods in molecular biology (Clifton, N.J.)"}, {"pmid_title_5": "[A clinical study of haploid hematopoietic stem cells combined with third-party umbilical cord blood transplantation in the treatment of chronic granulomatous disease].", "pmid_5": 31208508.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics"}, {"pmid_title_6": "Macrophage activation syndrome/haemophagocytic lymphohistiocytosis secondary to <i>Burkholderia cepacia</i> complex septicaemia in an elderly female carrier of X-linked chronic granulomatous disease with extreme lyonisation: 'cepacia syndrome' revisited.", "pmid_6": 31473638.0, "pmid_date_6": 2019.0, "pmid_journal_6": "BMJ case reports"}, {"pmid_title_7": "A novel mutation in <i>NCF2</i> resulting in very-early-onset colitis and juvenile idiopathic arthritis in a patient with chronic granulomatous disease.", "pmid_7": 31832070.0, "pmid_date_7": 2019.0, "pmid_journal_7": "Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology"}, {"pmid_title_8": "Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.", "pmid_8": 29746680.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Journal of the Pediatric Infectious Diseases Society"}, {"pmid_title_9": "Seven chronic granulomatous disease cases in a single-center experience and a review of the literature.", "pmid_9": 28577521.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Asian Pacific journal of allergy and immunology"}, {"pmid_title_10": "Successful transcatheter arterial antimicrobial and steroid therapy for refractory liver abscess in chronic granulomatous disease: A case report and review of literature.", "pmid_10": 29132925.0, "pmid_date_10": 2018.0, "pmid_journal_10": "Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy"}, {"pmid_title_11": "Prevention of Infectious Complications in Patients With Chronic Granulomatous Disease.", "pmid_11": 29746681.0, "pmid_date_11": 2018.0, "pmid_journal_11": "Journal of the Pediatric Infectious Diseases Society"}, {"pmid_title_12": "Infectious Complications in Patients With Chronic Granulomatous Disease.", "pmid_12": 29746678.0, "pmid_date_12": 2018.0, "pmid_journal_12": "Journal of the Pediatric Infectious Diseases Society"}, {"pmid_title_13": "Chronic Granulomatous Disease in children: a single center experience.", "pmid_13": 29223406.0, "pmid_date_13": 2018.0, "pmid_journal_13": "Clinical immunology (Orlando, Fla.)"}, {"pmid_title_14": "New onset colitis in an adult patient with chronic granulomatous disease treated with hematopoietic stem cell transplantation: a diagnostic dilemma.", "pmid_14": 29755533.0, "pmid_date_14": 2018.0, "pmid_journal_14": "Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology"}, {"pmid_title_15": "An Update on the Use of Immunomodulators in Primary Immunodeficiencies.", "pmid_15": 27873163.0, "pmid_date_15": 2017.0, "pmid_journal_15": "Clinical reviews in allergy & immunology"}, {"pmid_title_16": "Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial.", "pmid_16": 28752258.0, "pmid_date_16": 2017.0, "pmid_journal_16": "Journal of clinical immunology"}, {"pmid_title_17": "Inflammatory bowel disease in chronic granulomatous disease: An emerging problem over a twenty years' experience.", "pmid_17": 28981976.0, "pmid_date_17": 2017.0, "pmid_journal_17": "Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology"}, {"pmid_title_18": "<i>Chromobacterium violaceum</i> infection in chronic granulomatous disease: a case report and review of the literature.", "pmid_18": 28348801.0, "pmid_date_18": 2017.0, "pmid_journal_18": "JMM case reports"}, {"pmid_title_19": "A rare complication of chronic granulomatous disease in a child: constrictive aspergillus pericarditis.", "pmid_19": 28990950.0, "pmid_date_19": 2017.0, "pmid_journal_19": "Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir"}, {"pmid_title_20": "Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD).", "pmid_20": 26951230.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Current gastroenterology reports"}, {"pmid_title_21": "Aspergillosis in Chronic Granulomatous Disease.", "pmid_21": 29376932.0, "pmid_date_21": 2016.0, "pmid_journal_21": "Journal of fungi (Basel, Switzerland)"}, {"pmid_title_22": "Association Between Discoid Lupus Erythematosus and Chronic Granulomatous Disease--Report of Two Cases and Review of the Literature.", "pmid_22": 27001332.0, "pmid_date_22": 2016.0, "pmid_journal_22": "Pediatric dermatology"}, {"pmid_title_23": "Chronic Granulomatous Disease.", "pmid_23": 26865172.0, "pmid_date_23": 2016.0, "pmid_journal_23": "Indian journal of pediatrics"}, {"pmid_title_24": "Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.", "pmid_24": 26680691.0, "pmid_date_24": 2016.0, "pmid_journal_24": "Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology"}, {"pmid_title_25": "Treatment of CGD-associated Colitis with the IL-23 Blocker Ustekinumab.", "pmid_25": 27465505.0, "pmid_date_25": 2016.0, "pmid_journal_25": "Journal of clinical immunology"}, {"pmid_title_26": "Pioglitazone as a novel therapeutic approach in chronic granulomatous disease.", "pmid_26": 27056268.0, "pmid_date_26": 2016.0, "pmid_journal_26": "The Journal of allergy and clinical immunology"}, {"pmid_title_27": "Low-dose total-body irradiation and alemtuzumab-based reduced-intensity conditioning regimen results in durable engraftment and correction of clinical disease among children with chronic granulomatous disease.", "pmid_27": 25845644.0, "pmid_date_27": 2015.0, "pmid_journal_27": "Pediatric transplantation"}, {"pmid_title_28": "Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis.", "pmid_28": 26052777.0, "pmid_date_28": 2015.0, "pmid_journal_28": "The American journal of gastroenterology"}, {"pmid_title_29": "Mobilization characteristics and strategies to improve hematopoietic progenitor cell mobilization and collection in patients with chronic granulomatous disease and severe combined immunodeficiency.", "pmid_29": 25143186.0, "pmid_date_29": 2015.0, "pmid_journal_29": "Transfusion"}, {"pmid_title_30": "Severe and Rapid Progression in Very Early-Onset Chronic Granulomatous Disease-Associated Colitis.", "pmid_30": 26233238.0, "pmid_date_30": 2015.0, "pmid_journal_30": "Journal of clinical immunology"}, {"pmid_title_31": "Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment.", "pmid_31": 26386811.0, "pmid_date_31": 2015.0, "pmid_journal_31": "The Journal of allergy and clinical immunology"}, {"pmid_title_32": "Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.", "pmid_32": 24161820.0, "pmid_date_32": 2014.0, "pmid_journal_32": "Lancet (London, England)"}, {"pmid_title_33": "IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans.", "pmid_33": 24550444.0, "pmid_date_33": 2014.0, "pmid_journal_33": "Proceedings of the National Academy of Sciences of the United States of America"}, {"pmid_title_34": "Assessment of atherosclerosis in chronic granulomatous disease.", "pmid_34": 25239440.0, "pmid_date_34": 2014.0, "pmid_journal_34": "Circulation"}, {"pmid_title_35": "Resistant invasive aspergillosis in an autosomal recessive chronic granulomatous disease.", "pmid_35": 23002911.0, "pmid_date_35": 2013.0, "pmid_journal_35": "Fetal and pediatric pathology"}, {"pmid_title_36": "Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison of those managed conservatively with those that have undergone haematopoietic stem cell transplant.", "pmid_36": 23011479.0, "pmid_date_36": 2013.0, "pmid_journal_36": "Journal of clinical immunology"}, {"pmid_title_37": "Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease.", "pmid_37": 22078471.0, "pmid_date_37": 2012.0, "pmid_journal_37": "The Journal of allergy and clinical immunology"}, {"pmid_title_38": "Corticosteroid therapy for liver abscess in chronic granulomatous disease.", "pmid_38": 22157170.0, "pmid_date_38": 2012.0, "pmid_journal_38": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_39": "Gene therapy of chronic granulomatous disease: the engraftment dilemma.", "pmid_39": 21045810.0, "pmid_date_39": 2011.0, "pmid_journal_39": "Molecular therapy : the journal of the American Society of Gene Therapy"}, {"pmid_title_40": "Anakinra for the inflammatory complications of chronic granulomatous disease.", "pmid_40": 21411850.0, "pmid_date_40": 2011.0, "pmid_journal_40": "The Netherlands journal of medicine"}, {"pmid_title_41": "A twice daily posaconazole dosing algorithm for children with chronic granulomatous disease.", "pmid_41": 21772229.0, "pmid_date_41": 2011.0, "pmid_journal_41": "The Pediatric infectious disease journal"}, {"pmid_title_42": "Allogeneic haematopoietic stem cell transplantation as therapy for chronic granulomatous disease--single centre experience.", "pmid_42": 21384251.0, "pmid_date_42": 2011.0, "pmid_journal_42": "Journal of clinical immunology"}, {"pmid_title_43": "The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort.", "pmid_43": 21175646.0, "pmid_date_43": 2011.0, "pmid_journal_43": "Transfusion"}, {"pmid_title_44": "Chronic granulomatous disease: recent advances in pathophysiology and treatment.", "pmid_44": 21116026.0, "pmid_date_44": 2010.0, "pmid_journal_44": "The Netherlands journal of medicine"}, {"pmid_title_45": "Chronic granulomatous disease.", "pmid_45": 19504359.0, "pmid_date_45": 2010.0, "pmid_journal_45": "Clinical reviews in allergy & immunology"}, {"pmid_title_46": "Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease.", "pmid_46": 20495074.0, "pmid_date_46": 2010.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils.", "pmid_47": 19965657.0, "pmid_date_47": 2010.0, "pmid_journal_47": "Blood"}, {"pmid_title_48": "Residual NADPH oxidase and survival in chronic granulomatous disease.", "pmid_48": 21190454.0, "pmid_date_48": 2010.0, "pmid_journal_48": "The New England journal of medicine"}, {"pmid_title_49": "Complications of tumor necrosis factor-\u03b1 blockade in chronic granulomatous disease-related colitis.", "pmid_49": 21058909.0, "pmid_date_49": 2010.0, "pmid_journal_49": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_50": "Linezolid an oral treatment option for staphylococcal liver abscess in chronic granulomatous disease.", "pmid_50": 19859022.0, "pmid_date_50": 2009.0, "pmid_journal_50": "The Pediatric infectious disease journal"}, {"pmid_title_51": "Modern management of chronic granulomatous disease.", "pmid_51": 18217895.0, "pmid_date_51": 2008.0, "pmid_journal_51": "British journal of haematology"}, {"pmid_title_52": "Gastrointestinal manifestations of chronic granulomatous disease.", "pmid_52": 16970572.0, "pmid_date_52": 2006.0, "pmid_journal_52": "Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland"}, {"pmid_title_53": "Corticosteroid therapy for refractory infections in chronic granulomatous disease: case reports and review of the literature.", "pmid_53": 16937761.0, "pmid_date_53": 2006.0, "pmid_journal_53": "Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology"}, {"pmid_title_54": "Nonmyeloablative stem cell transplantation for nonmalignant diseases in children with severe organ dysfunction.", "pmid_54": 17013427.0, "pmid_date_54": 2006.0, "pmid_journal_54": "Bone marrow transplantation"}, {"pmid_title_55": "Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients.", "pmid_55": 15940051.0, "pmid_date_55": 2005.0, "pmid_journal_55": "Transplantation"}, {"pmid_title_56": "Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection.", "pmid_56": 15889369.0, "pmid_date_56": 2005.0, "pmid_journal_56": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_57": "Granulocyte transfusions in children with chronic granulomatous disease and invasive aspergillosis.", "pmid_57": 15828925.0, "pmid_date_57": 2005.0, "pmid_journal_57": "Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy"}, {"pmid_title_58": "Gastrointestinal involvement in chronic granulomatous disease.", "pmid_58": 15286231.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatrics"}, {"pmid_title_59": "Long-term interferon-gamma therapy for patients with chronic granulomatous disease.", "pmid_59": 15356785.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_60": "Itraconazole to prevent fungal infections in chronic granulomatous disease.", "pmid_60": 12802027.0, "pmid_date_60": 2003.0, "pmid_journal_60": "The New England journal of medicine"}, {"pmid_title_61": "Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.", "pmid_61": 12393596.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Blood"}, {"pmid_title_62": "Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.", "pmid_62": 11259721.0, "pmid_date_62": 2001.0, "pmid_journal_62": "The New England journal of medicine"}, {"pmid_title_63": "Colitis in chronic granulomatous disease.", "pmid_63": 11159292.0, "pmid_date_63": 2001.0, "pmid_journal_63": "Archives of disease in childhood"}, {"pmid_title_64": "Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.", "pmid_64": 11100285.0, "pmid_date_64": 2000.0, "pmid_journal_64": "Bone marrow transplantation"}, {"pmid_title_65": "Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B.", "pmid_65": 9763555.0, "pmid_date_65": 1998.0, "pmid_journal_65": "Blood"}, {"pmid_title_66": "Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor.", "pmid_66": 9505898.0, "pmid_date_66": 1998.0, "pmid_journal_66": "Gut"}, {"pmid_title_67": "Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease.", "pmid_67": 9342375.0, "pmid_date_67": 1997.0, "pmid_journal_67": "Proceedings of the National Academy of Sciences of the United States of America"}, {"pmid_title_68": "Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine.", "pmid_68": 7815206.0, "pmid_date_68": 1995.0, "pmid_journal_68": "The Journal of pediatrics"}, {"pmid_title_69": "Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease.", "pmid_69": 8673477.0, "pmid_date_69": 1995.0, "pmid_journal_69": "Blood cells, molecules & diseases"}, {"pmid_title_70": "Chronic granulomatous disease presenting in childhood with Pseudomonas cepacia septicaemia.", "pmid_70": 7508484.0, "pmid_date_70": 1993.0, "pmid_journal_70": "The Journal of infection"}, {"pmid_title_71": "A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group.", "pmid_71": 1846940.0, "pmid_date_71": 1991.0, "pmid_journal_71": "The New England journal of medicine"}, {"pmid_title_72": "The effect of teicoplanin on leukocytic activity and intraleukocytic micro-organisms.", "pmid_72": 2871098.0, "pmid_date_72": 1986.0, "pmid_journal_72": "The Journal of hospital infection"}, {"pmid_title_73": "Bone marrow transplantation in chronic granulomatous disease.", "pmid_73": 6376746.0, "pmid_date_73": 1984.0, "pmid_journal_73": "The Journal of pediatrics"}, {"pmid_title_74": "Colitis in chronic granulomatous disease.", "pmid_74": 6119271.0, "pmid_date_74": 1982.0, "pmid_journal_74": "Gastroenterology"}]}, {"_id": "7661-OMIM:233710", "condition": {"condition_name": "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 2; CGD2", "freq_per_birth": "Chronic granulomatous disease is estimated to occur in 1 in 200,000 to 250,000 people worldwide.", "pattern_of_inheritance": "X-linked recessive==Autosomal recessive", "alternate_names": ["GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 2; CGD2"]}, "gene information": {"db_hgnc_gene_id": 7661.0}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Prednisone"}, {"int_description_3": "Lenograstim"}, {"int_description_4": "Pioglitazone"}, {"int_description_5": "Anakinra"}, {"int_description_6": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_7": "Hydroxychloroquine"}, {"int_description_8": "Alemtuzumab"}, {"int_description_9": "Cyclosporine"}, {"int_description_10": "Metronidazole", "timeframe_int10": "Days or Weeks,Years", "age_use_int10": "Neonate,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Case report(s)", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Amphotericin B"}, {"int_description_12": "Sirolimus"}, {"int_description_13": "Interferon gamma-1b", "timeframe_int13": "Days or Weeks", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Case report(s)", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Piperacillin"}, {"int_description_15": "Cyclophosphamide"}, {"int_description_16": "Busulfan"}, {"int_description_17": "Melphalan"}, {"int_description_18": "Caspofungin", "timeframe_int18": "Days or Weeks,Years", "age_use_int18": "Neonate,Infant,Child", "contra_int18": "No", "qualscale_reclass_drug18": "Case report(s)", "rev1_eff_reclass_drug18": "Effective / Ameliorative"}, {"int_description_19": "Linezolid", "timeframe_int19": "Days or Weeks,Years", "age_use_int19": "Neonate,Infant,Child", "contra_int19": "No", "qualscale_reclass_drug19": "Case report(s)", "rev1_eff_reclass_drug19": "Effective / Ameliorative"}, {"int_description_20": "Mercaptopurine"}, {"int_description_21": "Mesalazine"}, {"int_description_22": "Sulfasalazine"}, {"int_description_23": "Clindamycin"}, {"int_description_24": "Tazobactam"}, {"int_description_25": "Trimethoprim"}, {"int_description_26": "Sulfamethoxazole"}, {"int_description_27": "Ciprofloxacin"}, {"int_description_28": "Meropenem"}, {"int_description_29": "Cefuroxime"}, {"int_description_30": "Thalidomide", "timeframe_int30": "Days or Weeks,Years", "age_use_int30": "Neonate,Infant,Child", "contra_int30": "No", "qualscale_reclass_drug30": "Case report(s)", "rev1_eff_reclass_drug30": "Effective / Ameliorative"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Itraconazole"}, {"int_description_33": "Posaconazole"}, {"int_description_34": "Methotrexate"}, {"int_description_35": "Fludarabine"}, {"int_description_36": "Cytarabine"}, {"int_description_37": "Tacrolimus", "timeframe_int37": "Days or Weeks,Years", "age_use_int37": "Neonate,Infant,Child", "contra_int37": "No", "qualscale_reclass_drug37": "Case report(s)", "rev1_eff_reclass_drug37": "Effective / Ameliorative"}, {"int_description_38": "Azathioprine"}, {"int_description_39": "Mycophenolic acid"}, {"int_description_40": "Ustekinumab"}, {"int_description_41": "Isavuconazole"}, {"int_description_42": "Ceftazidime"}, {"int_description_43": "Methylprednisolone"}, {"int_description_44": "Infliximab"}, {"int_description_45": "antimicrobial therapy", "timeframe_int45": "Hours,Days or Weeks,Years", "age_use_int45": "Neonate,Infant,Child", "contra_int45": "No", "qualscale_reclass_drug45": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug45": "Effective / Ameliorative"}, {"int_description_46": "corticosteroids", "timeframe_int46": "Hours,Days or Weeks", "age_use_int46": "Neonate,Infant,Child", "contra_int46": "No", "qualscale_reclass_drug46": "Case report(s)", "rev1_eff_reclass_drug46": "Effective / Ameliorative"}, {"int_description_47": "Teicoplanin"}, {"int_description_48": "granulocyte transfusions", "timeframe_int48": "Days or Weeks", "age_use_int48": "Neonate,Infant,Child", "contra_int48": "No", "qualscale_reclass_drug48": "Case report(s)", "rev1_eff_reclass_drug48": "Effective / Ameliorative"}, {"int_description_49": "sun protection"}, {"int_description_50": "Total body irradiation"}, {"int_description_51": "Bone marrow transplantation", "timeframe_int51": "Days or Weeks,Years", "contra_int51": "No", "qualscale_reclass_drug51": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug51": "Curative"}, {"int_description_52": "Hematopoietic stem cell transplantation"}, {"int_description_53": "surgery"}], "references": [{"pmid_title_1": "Chronic Granulomatous Disease: a Comprehensive Review.", "pmid_1": 32524254.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Clinical reviews in allergy & immunology"}, {"pmid_title_2": "Recent advances in chronic granulomatous disease.", "pmid_2": 32181279.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Genes & diseases"}, {"pmid_title_3": "Hemophagocytic lymphohistiocytosis resulting from a cytokine storm triggered by septicemia in a child with chronic granuloma disease: a case report and literature review.", "pmid_3": 32126983.0, "pmid_date_3": 2020.0, "pmid_journal_3": "BMC pediatrics"}, {"pmid_title_4": "Chronic Granulomatous Disease.", "pmid_4": 31172494.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Methods in molecular biology (Clifton, N.J.)"}, {"pmid_title_5": "[A clinical study of haploid hematopoietic stem cells combined with third-party umbilical cord blood transplantation in the treatment of chronic granulomatous disease].", "pmid_5": 31208508.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics"}, {"pmid_title_6": "Macrophage activation syndrome/haemophagocytic lymphohistiocytosis secondary to <i>Burkholderia cepacia</i> complex septicaemia in an elderly female carrier of X-linked chronic granulomatous disease with extreme lyonisation: 'cepacia syndrome' revisited.", "pmid_6": 31473638.0, "pmid_date_6": 2019.0, "pmid_journal_6": "BMJ case reports"}, {"pmid_title_7": "A novel mutation in <i>NCF2</i> resulting in very-early-onset colitis and juvenile idiopathic arthritis in a patient with chronic granulomatous disease.", "pmid_7": 31832070.0, "pmid_date_7": 2019.0, "pmid_journal_7": "Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology"}, {"pmid_title_8": "Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.", "pmid_8": 29746680.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Journal of the Pediatric Infectious Diseases Society"}, {"pmid_title_9": "Seven chronic granulomatous disease cases in a single-center experience and a review of the literature.", "pmid_9": 28577521.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Asian Pacific journal of allergy and immunology"}, {"pmid_title_10": "Successful transcatheter arterial antimicrobial and steroid therapy for refractory liver abscess in chronic granulomatous disease: A case report and review of literature.", "pmid_10": 29132925.0, "pmid_date_10": 2018.0, "pmid_journal_10": "Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy"}, {"pmid_title_11": "Prevention of Infectious Complications in Patients With Chronic Granulomatous Disease.", "pmid_11": 29746681.0, "pmid_date_11": 2018.0, "pmid_journal_11": "Journal of the Pediatric Infectious Diseases Society"}, {"pmid_title_12": "Infectious Complications in Patients With Chronic Granulomatous Disease.", "pmid_12": 29746678.0, "pmid_date_12": 2018.0, "pmid_journal_12": "Journal of the Pediatric Infectious Diseases Society"}, {"pmid_title_13": "Chronic Granulomatous Disease in children: a single center experience.", "pmid_13": 29223406.0, "pmid_date_13": 2018.0, "pmid_journal_13": "Clinical immunology (Orlando, Fla.)"}, {"pmid_title_14": "New onset colitis in an adult patient with chronic granulomatous disease treated with hematopoietic stem cell transplantation: a diagnostic dilemma.", "pmid_14": 29755533.0, "pmid_date_14": 2018.0, "pmid_journal_14": "Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology"}, {"pmid_title_15": "An Update on the Use of Immunomodulators in Primary Immunodeficiencies.", "pmid_15": 27873163.0, "pmid_date_15": 2017.0, "pmid_journal_15": "Clinical reviews in allergy & immunology"}, {"pmid_title_16": "Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial.", "pmid_16": 28752258.0, "pmid_date_16": 2017.0, "pmid_journal_16": "Journal of clinical immunology"}, {"pmid_title_17": "Inflammatory bowel disease in chronic granulomatous disease: An emerging problem over a twenty years' experience.", "pmid_17": 28981976.0, "pmid_date_17": 2017.0, "pmid_journal_17": "Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology"}, {"pmid_title_18": "<i>Chromobacterium violaceum</i> infection in chronic granulomatous disease: a case report and review of the literature.", "pmid_18": 28348801.0, "pmid_date_18": 2017.0, "pmid_journal_18": "JMM case reports"}, {"pmid_title_19": "A rare complication of chronic granulomatous disease in a child: constrictive aspergillus pericarditis.", "pmid_19": 28990950.0, "pmid_date_19": 2017.0, "pmid_journal_19": "Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir"}, {"pmid_title_20": "Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD).", "pmid_20": 26951230.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Current gastroenterology reports"}, {"pmid_title_21": "Aspergillosis in Chronic Granulomatous Disease.", "pmid_21": 29376932.0, "pmid_date_21": 2016.0, "pmid_journal_21": "Journal of fungi (Basel, Switzerland)"}, {"pmid_title_22": "Association Between Discoid Lupus Erythematosus and Chronic Granulomatous Disease--Report of Two Cases and Review of the Literature.", "pmid_22": 27001332.0, "pmid_date_22": 2016.0, "pmid_journal_22": "Pediatric dermatology"}, {"pmid_title_23": "Chronic Granulomatous Disease.", "pmid_23": 26865172.0, "pmid_date_23": 2016.0, "pmid_journal_23": "Indian journal of pediatrics"}, {"pmid_title_24": "Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.", "pmid_24": 26680691.0, "pmid_date_24": 2016.0, "pmid_journal_24": "Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology"}, {"pmid_title_25": "Treatment of CGD-associated Colitis with the IL-23 Blocker Ustekinumab.", "pmid_25": 27465505.0, "pmid_date_25": 2016.0, "pmid_journal_25": "Journal of clinical immunology"}, {"pmid_title_26": "Pioglitazone as a novel therapeutic approach in chronic granulomatous disease.", "pmid_26": 27056268.0, "pmid_date_26": 2016.0, "pmid_journal_26": "The Journal of allergy and clinical immunology"}, {"pmid_title_27": "Low-dose total-body irradiation and alemtuzumab-based reduced-intensity conditioning regimen results in durable engraftment and correction of clinical disease among children with chronic granulomatous disease.", "pmid_27": 25845644.0, "pmid_date_27": 2015.0, "pmid_journal_27": "Pediatric transplantation"}, {"pmid_title_28": "Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis.", "pmid_28": 26052777.0, "pmid_date_28": 2015.0, "pmid_journal_28": "The American journal of gastroenterology"}, {"pmid_title_29": "Mobilization characteristics and strategies to improve hematopoietic progenitor cell mobilization and collection in patients with chronic granulomatous disease and severe combined immunodeficiency.", "pmid_29": 25143186.0, "pmid_date_29": 2015.0, "pmid_journal_29": "Transfusion"}, {"pmid_title_30": "Severe and Rapid Progression in Very Early-Onset Chronic Granulomatous Disease-Associated Colitis.", "pmid_30": 26233238.0, "pmid_date_30": 2015.0, "pmid_journal_30": "Journal of clinical immunology"}, {"pmid_title_31": "Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment.", "pmid_31": 26386811.0, "pmid_date_31": 2015.0, "pmid_journal_31": "The Journal of allergy and clinical immunology"}, {"pmid_title_32": "Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.", "pmid_32": 24161820.0, "pmid_date_32": 2014.0, "pmid_journal_32": "Lancet (London, England)"}, {"pmid_title_33": "IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans.", "pmid_33": 24550444.0, "pmid_date_33": 2014.0, "pmid_journal_33": "Proceedings of the National Academy of Sciences of the United States of America"}, {"pmid_title_34": "Assessment of atherosclerosis in chronic granulomatous disease.", "pmid_34": 25239440.0, "pmid_date_34": 2014.0, "pmid_journal_34": "Circulation"}, {"pmid_title_35": "Resistant invasive aspergillosis in an autosomal recessive chronic granulomatous disease.", "pmid_35": 23002911.0, "pmid_date_35": 2013.0, "pmid_journal_35": "Fetal and pediatric pathology"}, {"pmid_title_36": "Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison of those managed conservatively with those that have undergone haematopoietic stem cell transplant.", "pmid_36": 23011479.0, "pmid_date_36": 2013.0, "pmid_journal_36": "Journal of clinical immunology"}, {"pmid_title_37": "Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease.", "pmid_37": 22078471.0, "pmid_date_37": 2012.0, "pmid_journal_37": "The Journal of allergy and clinical immunology"}, {"pmid_title_38": "Corticosteroid therapy for liver abscess in chronic granulomatous disease.", "pmid_38": 22157170.0, "pmid_date_38": 2012.0, "pmid_journal_38": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_39": "Gene therapy of chronic granulomatous disease: the engraftment dilemma.", "pmid_39": 21045810.0, "pmid_date_39": 2011.0, "pmid_journal_39": "Molecular therapy : the journal of the American Society of Gene Therapy"}, {"pmid_title_40": "Anakinra for the inflammatory complications of chronic granulomatous disease.", "pmid_40": 21411850.0, "pmid_date_40": 2011.0, "pmid_journal_40": "The Netherlands journal of medicine"}, {"pmid_title_41": "A twice daily posaconazole dosing algorithm for children with chronic granulomatous disease.", "pmid_41": 21772229.0, "pmid_date_41": 2011.0, "pmid_journal_41": "The Pediatric infectious disease journal"}, {"pmid_title_42": "Allogeneic haematopoietic stem cell transplantation as therapy for chronic granulomatous disease--single centre experience.", "pmid_42": 21384251.0, "pmid_date_42": 2011.0, "pmid_journal_42": "Journal of clinical immunology"}, {"pmid_title_43": "The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort.", "pmid_43": 21175646.0, "pmid_date_43": 2011.0, "pmid_journal_43": "Transfusion"}, {"pmid_title_44": "Chronic granulomatous disease: recent advances in pathophysiology and treatment.", "pmid_44": 21116026.0, "pmid_date_44": 2010.0, "pmid_journal_44": "The Netherlands journal of medicine"}, {"pmid_title_45": "Chronic granulomatous disease.", "pmid_45": 19504359.0, "pmid_date_45": 2010.0, "pmid_journal_45": "Clinical reviews in allergy & immunology"}, {"pmid_title_46": "Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease.", "pmid_46": 20495074.0, "pmid_date_46": 2010.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils.", "pmid_47": 19965657.0, "pmid_date_47": 2010.0, "pmid_journal_47": "Blood"}, {"pmid_title_48": "Residual NADPH oxidase and survival in chronic granulomatous disease.", "pmid_48": 21190454.0, "pmid_date_48": 2010.0, "pmid_journal_48": "The New England journal of medicine"}, {"pmid_title_49": "Complications of tumor necrosis factor-\u03b1 blockade in chronic granulomatous disease-related colitis.", "pmid_49": 21058909.0, "pmid_date_49": 2010.0, "pmid_journal_49": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_50": "Linezolid an oral treatment option for staphylococcal liver abscess in chronic granulomatous disease.", "pmid_50": 19859022.0, "pmid_date_50": 2009.0, "pmid_journal_50": "The Pediatric infectious disease journal"}, {"pmid_title_51": "Modern management of chronic granulomatous disease.", "pmid_51": 18217895.0, "pmid_date_51": 2008.0, "pmid_journal_51": "British journal of haematology"}, {"pmid_title_52": "Gastrointestinal manifestations of chronic granulomatous disease.", "pmid_52": 16970572.0, "pmid_date_52": 2006.0, "pmid_journal_52": "Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland"}, {"pmid_title_53": "Corticosteroid therapy for refractory infections in chronic granulomatous disease: case reports and review of the literature.", "pmid_53": 16937761.0, "pmid_date_53": 2006.0, "pmid_journal_53": "Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology"}, {"pmid_title_54": "Nonmyeloablative stem cell transplantation for nonmalignant diseases in children with severe organ dysfunction.", "pmid_54": 17013427.0, "pmid_date_54": 2006.0, "pmid_journal_54": "Bone marrow transplantation"}, {"pmid_title_55": "Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients.", "pmid_55": 15940051.0, "pmid_date_55": 2005.0, "pmid_journal_55": "Transplantation"}, {"pmid_title_56": "Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection.", "pmid_56": 15889369.0, "pmid_date_56": 2005.0, "pmid_journal_56": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_57": "Granulocyte transfusions in children with chronic granulomatous disease and invasive aspergillosis.", "pmid_57": 15828925.0, "pmid_date_57": 2005.0, "pmid_journal_57": "Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy"}, {"pmid_title_58": "Gastrointestinal involvement in chronic granulomatous disease.", "pmid_58": 15286231.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatrics"}, {"pmid_title_59": "Long-term interferon-gamma therapy for patients with chronic granulomatous disease.", "pmid_59": 15356785.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_60": "Itraconazole to prevent fungal infections in chronic granulomatous disease.", "pmid_60": 12802027.0, "pmid_date_60": 2003.0, "pmid_journal_60": "The New England journal of medicine"}, {"pmid_title_61": "Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.", "pmid_61": 12393596.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Blood"}, {"pmid_title_62": "Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.", "pmid_62": 11259721.0, "pmid_date_62": 2001.0, "pmid_journal_62": "The New England journal of medicine"}, {"pmid_title_63": "Colitis in chronic granulomatous disease.", "pmid_63": 11159292.0, "pmid_date_63": 2001.0, "pmid_journal_63": "Archives of disease in childhood"}, {"pmid_title_64": "Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.", "pmid_64": 11100285.0, "pmid_date_64": 2000.0, "pmid_journal_64": "Bone marrow transplantation"}, {"pmid_title_65": "Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B.", "pmid_65": 9763555.0, "pmid_date_65": 1998.0, "pmid_journal_65": "Blood"}, {"pmid_title_66": "Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor.", "pmid_66": 9505898.0, "pmid_date_66": 1998.0, "pmid_journal_66": "Gut"}, {"pmid_title_67": "Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine.", "pmid_67": 7815206.0, "pmid_date_67": 1995.0, "pmid_journal_67": "The Journal of pediatrics"}, {"pmid_title_68": "Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease.", "pmid_68": 8673477.0, "pmid_date_68": 1995.0, "pmid_journal_68": "Blood cells, molecules & diseases"}, {"pmid_title_69": "Chronic granulomatous disease presenting in childhood with Pseudomonas cepacia septicaemia.", "pmid_69": 7508484.0, "pmid_date_69": 1993.0, "pmid_journal_69": "The Journal of infection"}, {"pmid_title_70": "A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group.", "pmid_70": 1846940.0, "pmid_date_70": 1991.0, "pmid_journal_70": "The New England journal of medicine"}, {"pmid_title_71": "The effect of teicoplanin on leukocytic activity and intraleukocytic micro-organisms.", "pmid_71": 2871098.0, "pmid_date_71": 1986.0, "pmid_journal_71": "The Journal of hospital infection"}, {"pmid_title_72": "Bone marrow transplantation in chronic granulomatous disease.", "pmid_72": 6376746.0, "pmid_date_72": 1984.0, "pmid_journal_72": "The Journal of pediatrics"}, {"pmid_title_73": "Colitis in chronic granulomatous disease.", "pmid_73": 6119271.0, "pmid_date_73": 1982.0, "pmid_journal_73": "Gastroenterology"}]}, {"_id": "7662-OMIM:613960", "condition": {"condition_name": "GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 3; CGD3", "freq_per_birth": "Chronic granulomatous disease is estimated to occur in 1 in 200,000 to 250,000 people worldwide.", "pattern_of_inheritance": "X-linked recessive==Autosomal recessive", "alternate_names": ["GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 3; CGD3"]}, "gene information": {"db_hgnc_gene_id": 7662.0}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Prednisone"}, {"int_description_3": "Lenograstim"}, {"int_description_4": "Pioglitazone"}, {"int_description_5": "Anakinra"}, {"int_description_6": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_7": "Hydroxychloroquine", "timeframe_int7": "Days or Weeks,Years", "age_use_int7": "Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Case report(s)", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Alemtuzumab"}, {"int_description_9": "Cyclosporine"}, {"int_description_10": "Metronidazole", "timeframe_int10": "Days or Weeks,Years", "age_use_int10": "Infant,Child", "contra_int10": "No", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Amphotericin B"}, {"int_description_12": "Sirolimus"}, {"int_description_13": "Interferon gamma-1b", "timeframe_int13": "Days or Weeks,Years", "age_use_int13": "Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Cohort study or studies", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Piperacillin"}, {"int_description_15": "Cyclophosphamide"}, {"int_description_16": "Busulfan"}, {"int_description_17": "Melphalan"}, {"int_description_18": "Caspofungin"}, {"int_description_19": "Linezolid", "timeframe_int19": "Days or Weeks,Years", "age_use_int19": "Infant,Child", "contra_int19": "No", "qualscale_reclass_drug19": "Case report(s)", "rev1_eff_reclass_drug19": "Effective / Ameliorative"}, {"int_description_20": "Mercaptopurine"}, {"int_description_21": "Mesalazine"}, {"int_description_22": "Sulfasalazine"}, {"int_description_23": "Clindamycin"}, {"int_description_24": "Tazobactam"}, {"int_description_25": "Trimethoprim"}, {"int_description_26": "Sulfamethoxazole"}, {"int_description_27": "Ciprofloxacin"}, {"int_description_28": "Meropenem"}, {"int_description_29": "Cefuroxime"}, {"int_description_30": "Thalidomide", "timeframe_int30": "Days or Weeks,Years", "age_use_int30": "Infant,Child", "rev1_eff_reclass_drug30": "Effective / Ameliorative"}, {"int_description_31": "Voriconazole", "timeframe_int31": "Days or Weeks", "age_use_int31": "Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Case report(s)", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Itraconazole", "timeframe_int32": "Days or Weeks,Years", "age_use_int32": "Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Case report(s)", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Posaconazole"}, {"int_description_34": "Methotrexate"}, {"int_description_35": "Fludarabine"}, {"int_description_36": "Cytarabine"}, {"int_description_37": "Tacrolimus", "timeframe_int37": "Days or Weeks", "age_use_int37": "Infant,Child", "contra_int37": "No", "qualscale_reclass_drug37": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug37": "Effective / Ameliorative"}, {"int_description_38": "Azathioprine"}, {"int_description_39": "Mycophenolic acid"}, {"int_description_40": "Ustekinumab"}, {"int_description_41": "Isavuconazole"}, {"int_description_42": "Ceftazidime"}, {"int_description_43": "Methylprednisolone"}, {"int_description_44": "Infliximab"}, {"int_description_45": "antimicrobial therapy", "timeframe_int45": "Hours", "age_use_int45": "Infant,Child", "contra_int45": "No", "qualscale_reclass_drug45": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug45": "Effective / Ameliorative"}, {"int_description_46": "corticosteroids", "timeframe_int46": "Days or Weeks", "age_use_int46": "Infant,Child", "contra_int46": "No", "qualscale_reclass_drug46": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug46": "Effective / Ameliorative"}, {"int_description_47": "Teicoplanin"}, {"int_description_48": "granulocyte transfusions"}, {"int_description_49": "sun protection"}, {"int_description_50": "Total body irradiation"}, {"int_description_51": "Bone marrow transplantation", "timeframe_int51": "Days or Weeks,Years", "contra_int51": "No", "qualscale_reclass_drug51": "Case report(s)", "rev1_eff_reclass_drug51": "Curative"}, {"int_description_52": "Hematopoietic stem cell transplantation"}, {"int_description_53": "surgery"}], "references": [{"pmid_title_1": "Chronic Granulomatous Disease: a Comprehensive Review.", "pmid_1": 32524254.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Clinical reviews in allergy & immunology"}, {"pmid_title_2": "Recent advances in chronic granulomatous disease.", "pmid_2": 32181279.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Genes & diseases"}, {"pmid_title_3": "Hemophagocytic lymphohistiocytosis resulting from a cytokine storm triggered by septicemia in a child with chronic granuloma disease: a case report and literature review.", "pmid_3": 32126983.0, "pmid_date_3": 2020.0, "pmid_journal_3": "BMC pediatrics"}, {"pmid_title_4": "Chronic Granulomatous Disease.", "pmid_4": 31172494.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Methods in molecular biology (Clifton, N.J.)"}, {"pmid_title_5": "[A clinical study of haploid hematopoietic stem cells combined with third-party umbilical cord blood transplantation in the treatment of chronic granulomatous disease].", "pmid_5": 31208508.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics"}, {"pmid_title_6": "Macrophage activation syndrome/haemophagocytic lymphohistiocytosis secondary to <i>Burkholderia cepacia</i> complex septicaemia in an elderly female carrier of X-linked chronic granulomatous disease with extreme lyonisation: 'cepacia syndrome' revisited.", "pmid_6": 31473638.0, "pmid_date_6": 2019.0, "pmid_journal_6": "BMJ case reports"}, {"pmid_title_7": "A novel mutation in <i>NCF2</i> resulting in very-early-onset colitis and juvenile idiopathic arthritis in a patient with chronic granulomatous disease.", "pmid_7": 31832070.0, "pmid_date_7": 2019.0, "pmid_journal_7": "Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology"}, {"pmid_title_8": "Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.", "pmid_8": 29746680.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Journal of the Pediatric Infectious Diseases Society"}, {"pmid_title_9": "Seven chronic granulomatous disease cases in a single-center experience and a review of the literature.", "pmid_9": 28577521.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Asian Pacific journal of allergy and immunology"}, {"pmid_title_10": "Successful transcatheter arterial antimicrobial and steroid therapy for refractory liver abscess in chronic granulomatous disease: A case report and review of literature.", "pmid_10": 29132925.0, "pmid_date_10": 2018.0, "pmid_journal_10": "Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy"}, {"pmid_title_11": "Prevention of Infectious Complications in Patients With Chronic Granulomatous Disease.", "pmid_11": 29746681.0, "pmid_date_11": 2018.0, "pmid_journal_11": "Journal of the Pediatric Infectious Diseases Society"}, {"pmid_title_12": "Infectious Complications in Patients With Chronic Granulomatous Disease.", "pmid_12": 29746678.0, "pmid_date_12": 2018.0, "pmid_journal_12": "Journal of the Pediatric Infectious Diseases Society"}, {"pmid_title_13": "Chronic Granulomatous Disease in children: a single center experience.", "pmid_13": 29223406.0, "pmid_date_13": 2018.0, "pmid_journal_13": "Clinical immunology (Orlando, Fla.)"}, {"pmid_title_14": "New onset colitis in an adult patient with chronic granulomatous disease treated with hematopoietic stem cell transplantation: a diagnostic dilemma.", "pmid_14": 29755533.0, "pmid_date_14": 2018.0, "pmid_journal_14": "Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology"}, {"pmid_title_15": "An Update on the Use of Immunomodulators in Primary Immunodeficiencies.", "pmid_15": 27873163.0, "pmid_date_15": 2017.0, "pmid_journal_15": "Clinical reviews in allergy & immunology"}, {"pmid_title_16": "Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial.", "pmid_16": 28752258.0, "pmid_date_16": 2017.0, "pmid_journal_16": "Journal of clinical immunology"}, {"pmid_title_17": "Inflammatory bowel disease in chronic granulomatous disease: An emerging problem over a twenty years' experience.", "pmid_17": 28981976.0, "pmid_date_17": 2017.0, "pmid_journal_17": "Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology"}, {"pmid_title_18": "<i>Chromobacterium violaceum</i> infection in chronic granulomatous disease: a case report and review of the literature.", "pmid_18": 28348801.0, "pmid_date_18": 2017.0, "pmid_journal_18": "JMM case reports"}, {"pmid_title_19": "A rare complication of chronic granulomatous disease in a child: constrictive aspergillus pericarditis.", "pmid_19": 28990950.0, "pmid_date_19": 2017.0, "pmid_journal_19": "Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir"}, {"pmid_title_20": "Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD).", "pmid_20": 26951230.0, "pmid_date_20": 2016.0, "pmid_journal_20": "Current gastroenterology reports"}, {"pmid_title_21": "Aspergillosis in Chronic Granulomatous Disease.", "pmid_21": 29376932.0, "pmid_date_21": 2016.0, "pmid_journal_21": "Journal of fungi (Basel, Switzerland)"}, {"pmid_title_22": "Association Between Discoid Lupus Erythematosus and Chronic Granulomatous Disease--Report of Two Cases and Review of the Literature.", "pmid_22": 27001332.0, "pmid_date_22": 2016.0, "pmid_journal_22": "Pediatric dermatology"}, {"pmid_title_23": "Chronic Granulomatous Disease.", "pmid_23": 26865172.0, "pmid_date_23": 2016.0, "pmid_journal_23": "Indian journal of pediatrics"}, {"pmid_title_24": "Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.", "pmid_24": 26680691.0, "pmid_date_24": 2016.0, "pmid_journal_24": "Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology"}, {"pmid_title_25": "Treatment of CGD-associated Colitis with the IL-23 Blocker Ustekinumab.", "pmid_25": 27465505.0, "pmid_date_25": 2016.0, "pmid_journal_25": "Journal of clinical immunology"}, {"pmid_title_26": "Pioglitazone as a novel therapeutic approach in chronic granulomatous disease.", "pmid_26": 27056268.0, "pmid_date_26": 2016.0, "pmid_journal_26": "The Journal of allergy and clinical immunology"}, {"pmid_title_27": "Low-dose total-body irradiation and alemtuzumab-based reduced-intensity conditioning regimen results in durable engraftment and correction of clinical disease among children with chronic granulomatous disease.", "pmid_27": 25845644.0, "pmid_date_27": 2015.0, "pmid_journal_27": "Pediatric transplantation"}, {"pmid_title_28": "Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis.", "pmid_28": 26052777.0, "pmid_date_28": 2015.0, "pmid_journal_28": "The American journal of gastroenterology"}, {"pmid_title_29": "Mobilization characteristics and strategies to improve hematopoietic progenitor cell mobilization and collection in patients with chronic granulomatous disease and severe combined immunodeficiency.", "pmid_29": 25143186.0, "pmid_date_29": 2015.0, "pmid_journal_29": "Transfusion"}, {"pmid_title_30": "Severe and Rapid Progression in Very Early-Onset Chronic Granulomatous Disease-Associated Colitis.", "pmid_30": 26233238.0, "pmid_date_30": 2015.0, "pmid_journal_30": "Journal of clinical immunology"}, {"pmid_title_31": "Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment.", "pmid_31": 26386811.0, "pmid_date_31": 2015.0, "pmid_journal_31": "The Journal of allergy and clinical immunology"}, {"pmid_title_32": "Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.", "pmid_32": 24161820.0, "pmid_date_32": 2014.0, "pmid_journal_32": "Lancet (London, England)"}, {"pmid_title_33": "IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans.", "pmid_33": 24550444.0, "pmid_date_33": 2014.0, "pmid_journal_33": "Proceedings of the National Academy of Sciences of the United States of America"}, {"pmid_title_34": "Assessment of atherosclerosis in chronic granulomatous disease.", "pmid_34": 25239440.0, "pmid_date_34": 2014.0, "pmid_journal_34": "Circulation"}, {"pmid_title_35": "Resistant invasive aspergillosis in an autosomal recessive chronic granulomatous disease.", "pmid_35": 23002911.0, "pmid_date_35": 2013.0, "pmid_journal_35": "Fetal and pediatric pathology"}, {"pmid_title_36": "Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison of those managed conservatively with those that have undergone haematopoietic stem cell transplant.", "pmid_36": 23011479.0, "pmid_date_36": 2013.0, "pmid_journal_36": "Journal of clinical immunology"}, {"pmid_title_37": "Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease.", "pmid_37": 22078471.0, "pmid_date_37": 2012.0, "pmid_journal_37": "The Journal of allergy and clinical immunology"}, {"pmid_title_38": "Corticosteroid therapy for liver abscess in chronic granulomatous disease.", "pmid_38": 22157170.0, "pmid_date_38": 2012.0, "pmid_journal_38": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_39": "Gene therapy of chronic granulomatous disease: the engraftment dilemma.", "pmid_39": 21045810.0, "pmid_date_39": 2011.0, "pmid_journal_39": "Molecular therapy : the journal of the American Society of Gene Therapy"}, {"pmid_title_40": "Anakinra for the inflammatory complications of chronic granulomatous disease.", "pmid_40": 21411850.0, "pmid_date_40": 2011.0, "pmid_journal_40": "The Netherlands journal of medicine"}, {"pmid_title_41": "A twice daily posaconazole dosing algorithm for children with chronic granulomatous disease.", "pmid_41": 21772229.0, "pmid_date_41": 2011.0, "pmid_journal_41": "The Pediatric infectious disease journal"}, {"pmid_title_42": "Allogeneic haematopoietic stem cell transplantation as therapy for chronic granulomatous disease--single centre experience.", "pmid_42": 21384251.0, "pmid_date_42": 2011.0, "pmid_journal_42": "Journal of clinical immunology"}, {"pmid_title_43": "The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort.", "pmid_43": 21175646.0, "pmid_date_43": 2011.0, "pmid_journal_43": "Transfusion"}, {"pmid_title_44": "Chronic granulomatous disease: recent advances in pathophysiology and treatment.", "pmid_44": 21116026.0, "pmid_date_44": 2010.0, "pmid_journal_44": "The Netherlands journal of medicine"}, {"pmid_title_45": "Chronic granulomatous disease.", "pmid_45": 19504359.0, "pmid_date_45": 2010.0, "pmid_journal_45": "Clinical reviews in allergy & immunology"}, {"pmid_title_46": "Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease.", "pmid_46": 20495074.0, "pmid_date_46": 2010.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils.", "pmid_47": 19965657.0, "pmid_date_47": 2010.0, "pmid_journal_47": "Blood"}, {"pmid_title_48": "Residual NADPH oxidase and survival in chronic granulomatous disease.", "pmid_48": 21190454.0, "pmid_date_48": 2010.0, "pmid_journal_48": "The New England journal of medicine"}, {"pmid_title_49": "Complications of tumor necrosis factor-\u03b1 blockade in chronic granulomatous disease-related colitis.", "pmid_49": 21058909.0, "pmid_date_49": 2010.0, "pmid_journal_49": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_50": "Linezolid an oral treatment option for staphylococcal liver abscess in chronic granulomatous disease.", "pmid_50": 19859022.0, "pmid_date_50": 2009.0, "pmid_journal_50": "The Pediatric infectious disease journal"}, {"pmid_title_51": "Modern management of chronic granulomatous disease.", "pmid_51": 18217895.0, "pmid_date_51": 2008.0, "pmid_journal_51": "British journal of haematology"}, {"pmid_title_52": "Gastrointestinal manifestations of chronic granulomatous disease.", "pmid_52": 16970572.0, "pmid_date_52": 2006.0, "pmid_journal_52": "Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland"}, {"pmid_title_53": "Corticosteroid therapy for refractory infections in chronic granulomatous disease: case reports and review of the literature.", "pmid_53": 16937761.0, "pmid_date_53": 2006.0, "pmid_journal_53": "Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology"}, {"pmid_title_54": "Nonmyeloablative stem cell transplantation for nonmalignant diseases in children with severe organ dysfunction.", "pmid_54": 17013427.0, "pmid_date_54": 2006.0, "pmid_journal_54": "Bone marrow transplantation"}, {"pmid_title_55": "Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients.", "pmid_55": 15940051.0, "pmid_date_55": 2005.0, "pmid_journal_55": "Transplantation"}, {"pmid_title_56": "Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection.", "pmid_56": 15889369.0, "pmid_date_56": 2005.0, "pmid_journal_56": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_57": "Granulocyte transfusions in children with chronic granulomatous disease and invasive aspergillosis.", "pmid_57": 15828925.0, "pmid_date_57": 2005.0, "pmid_journal_57": "Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy"}, {"pmid_title_58": "Gastrointestinal involvement in chronic granulomatous disease.", "pmid_58": 15286231.0, "pmid_date_58": 2004.0, "pmid_journal_58": "Pediatrics"}, {"pmid_title_59": "Long-term interferon-gamma therapy for patients with chronic granulomatous disease.", "pmid_59": 15356785.0, "pmid_date_59": 2004.0, "pmid_journal_59": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"}, {"pmid_title_60": "Itraconazole to prevent fungal infections in chronic granulomatous disease.", "pmid_60": 12802027.0, "pmid_date_60": 2003.0, "pmid_journal_60": "The New England journal of medicine"}, {"pmid_title_61": "Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.", "pmid_61": 12393596.0, "pmid_date_61": 2002.0, "pmid_journal_61": "Blood"}, {"pmid_title_62": "Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.", "pmid_62": 11259721.0, "pmid_date_62": 2001.0, "pmid_journal_62": "The New England journal of medicine"}, {"pmid_title_63": "Colitis in chronic granulomatous disease.", "pmid_63": 11159292.0, "pmid_date_63": 2001.0, "pmid_journal_63": "Archives of disease in childhood"}, {"pmid_title_64": "Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.", "pmid_64": 11100285.0, "pmid_date_64": 2000.0, "pmid_journal_64": "Bone marrow transplantation"}, {"pmid_title_65": "Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B.", "pmid_65": 9763555.0, "pmid_date_65": 1998.0, "pmid_journal_65": "Blood"}, {"pmid_title_66": "Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor.", "pmid_66": 9505898.0, "pmid_date_66": 1998.0, "pmid_journal_66": "Gut"}, {"pmid_title_67": "Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine.", "pmid_67": 7815206.0, "pmid_date_67": 1995.0, "pmid_journal_67": "The Journal of pediatrics"}, {"pmid_title_68": "Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease.", "pmid_68": 8673477.0, "pmid_date_68": 1995.0, "pmid_journal_68": "Blood cells, molecules & diseases"}, {"pmid_title_69": "Chronic granulomatous disease presenting in childhood with Pseudomonas cepacia septicaemia.", "pmid_69": 7508484.0, "pmid_date_69": 1993.0, "pmid_journal_69": "The Journal of infection"}, {"pmid_title_70": "A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group.", "pmid_70": 1846940.0, "pmid_date_70": 1991.0, "pmid_journal_70": "The New England journal of medicine"}, {"pmid_title_71": "The effect of teicoplanin on leukocytic activity and intraleukocytic micro-organisms.", "pmid_71": 2871098.0, "pmid_date_71": 1986.0, "pmid_journal_71": "The Journal of hospital infection"}, {"pmid_title_72": "Bone marrow transplantation in chronic granulomatous disease.", "pmid_72": 6376746.0, "pmid_date_72": 1984.0, "pmid_journal_72": "The Journal of pediatrics"}, {"pmid_title_73": "Colitis in chronic granulomatous disease.", "pmid_73": 6119271.0, "pmid_date_73": 1982.0, "pmid_journal_73": "Gastroenterology"}]}, {"_id": "7863-OMIM:614736", "condition": {"condition_name": "GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 7863.0}, "interventions": [{"int_description_1": "Hydrocortisone"}, {"int_description_2": "Glucocorticoid therapy", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Cohort study or studies", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "NNT mutations: a cause of primary adrenal insufficiency, oxidative stress and extra-adrenal defects.", "pmid_1": 27129361.0, "pmid_date_1": 2016.0, "pmid_journal_1": "Eur J Endocrinol"}, {"pmid_title_2": "A novel homozygous insertion and review of published mutations in the NNT gene causing familial glucocorticoid deficiency (FGD).", "pmid_2": 26548497.0, "pmid_date_2": 2015.0, "pmid_journal_2": "Eur J Med Genet"}, {"pmid_title_3": "A novel homozygous mutation of the nicotinamide nucleotide transhydrogenase gene in a Japanese patient with familial glucocorticoid deficiency.", "pmid_3": 23474776.0, "pmid_date_3": 2013.0, "pmid_journal_3": "Endocr J"}]}, {"_id": "7897-OMIM:257220", "condition": {"condition_name": "NIEMANN-PICK DISEASE, TYPE C1; NPC1", "freq_per_birth": "Niemann-Pick disease types A and B is estimated to affect 1 in 250,000 individuals. Niemann-Pick disease type A occurs more frequently among individuals of Ashkenazi (eastern and central European) Jewish descent than in the general population. The incidence within the Ashkenazi population is approximately 1 in 40,000 individuals.Combined, Niemann-Pick disease types C1 and C2 are estimated to affect 1 in 150,000 individuals; however, type C1 is by far the more common type, accounting for 95 percent of cases. The disease occurs more frequently in people of French-Acadian descent in Nova Scotia. In Nova Scotia, a population of affected French-Acadians were previously designated as having Niemann-Pick disease type D, however, it was shown that these individuals have mutations in the gene associated with Niemann-Pick disease type C1.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["NIEMANN-PICK DISEASE, TYPE C1; NPC1"]}, "gene information": {"db_hgnc_gene_id": 7897.0}, "interventions": [{"int_description_1": "Plant stanol esters"}, {"int_description_2": "Baclofen", "timeframe_int2": "Days or Weeks,Years", "age_use_int2": "Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Still in Trials / Unproven"}, {"int_description_3": "Miglustat"}, {"int_description_4": "Hydroxypropyl betadex"}, {"int_description_5": "Synthetic high-density lipoprotein nanoparticles"}, {"int_description_6": "Thioperamide maleate"}, {"int_description_7": "Palliative care"}, {"int_description_8": "Liver transplant"}], "references": [{"pmid_title_1": "Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry.", "pmid_1": 32334605.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Orphanet journal of rare diseases"}, {"pmid_title_2": "Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann-Pick disease Type C: an international, multicenter, retrospective chart review.", "pmid_2": 30732631.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Orphanet journal of rare diseases"}, {"pmid_title_3": "Expanded access with intravenous hydroxypropyl-\u03b2-cyclodextrin to treat children and young adults with Niemann-Pick disease type C1: a case report analysis.", "pmid_3": 31639011.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Orphanet journal of rare diseases"}, {"pmid_title_4": "The Palliative Use of Intrathecal Baclofen in Niemann-Pick Disease Type C.", "pmid_4": 31649137.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Pediatrics"}, {"pmid_title_5": "Pediatric liver transplantation for neonatal-onset Niemann-Pick disease type C: Japanese multicenter experience.", "pmid_5": 31081242.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Pediatric transplantation"}, {"pmid_title_6": "Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann-Pick diseases.", "pmid_6": 31711490.0, "pmid_date_6": 2019.0, "pmid_journal_6": "BMC medicine"}, {"pmid_title_7": "Drug-induced increase in lysobisphosphatidic acid reduces the cholesterol overload in Niemann-Pick type C cells and mice.", "pmid_7": 31267706.0, "pmid_date_7": 2019.0, "pmid_journal_7": "EMBO reports"}, {"pmid_title_8": "The clinical spectrum of fetal Niemann-Pick type C.", "pmid_8": 19206179.0, "pmid_date_8": 2009.0, "pmid_journal_8": "American journal of medical genetics. Part A"}, {"pmid_title_9": "Niemann-Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group.", "pmid_9": 11567215.0, "pmid_date_9": 2001.0, "pmid_journal_9": "American journal of human genetics"}]}, {"_id": "7979-OMIM:177735", "condition": {"condition_name": "PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT", "freq_per_birth": "PHA1 is a rare condition that has been estimated to affect 1 in 80,000 newborns.", "pattern_of_inheritance": "Autosomal recessive, Autosomal dominant", "alternate_names": ["PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT"]}, "gene information": {"db_hgnc_gene_id": 7979.0}, "interventions": [{"int_description_1": "Peritoneal dialysis"}, {"int_description_2": "Dietary potassium restriction"}, {"int_description_3": "Salbutamol"}, {"int_description_4": "Beclomethasone dipropionate"}, {"int_description_5": "Fludrocortisone"}, {"int_description_6": "Hydroxyprogesterone"}, {"int_description_7": "Montelukast"}, {"int_description_8": "Domperidone"}, {"int_description_9": "Ranitidine"}, {"int_description_10": "Cromoglicic acid"}, {"int_description_11": "Carbenoxolone"}, {"int_description_12": "Indomethacin"}, {"int_description_13": "Hydrochlorothiazide"}, {"int_description_14": "Phenoxymethylpenicillin"}, {"int_description_15": "Hydrocortisone"}, {"int_description_16": "Flucloxacillin"}, {"int_description_17": "Omeprazole"}, {"int_description_18": "Sodium citrate"}, {"int_description_19": "Sevelamer", "timeframe_int19": "Hours,Days or Weeks,Years", "age_use_int19": "Neonate,Infant,Child", "contra_int19": "No", "qualscale_reclass_drug19": "Case report(s)", "rev1_eff_reclass_drug19": "Effective / Ameliorative"}, {"int_description_20": "Tolevamer"}, {"int_description_21": "Calcium carbonate"}, {"int_description_22": "Sodium chloride"}, {"int_description_23": "Calcium gluconate"}, {"int_description_24": "Gaviscon", "timeframe_int24": "Hours", "age_use_int24": "Neonate,Infant,Child", "contra_int24": "No", "qualscale_reclass_drug24": "Case report(s)", "rev1_eff_reclass_drug24": "Effective / Ameliorative"}, {"int_description_25": "Insulin"}, {"int_description_26": "Sodium bicarbonate"}, {"int_description_27": "D-glucose", "timeframe_int27": "Hours,Days or Weeks", "age_use_int27": "Neonate,Infant,Child", "contra_int27": "No", "rev1_eff_reclass_drug27": "Effective / Ameliorative"}, {"int_description_28": "Ion exchange resins"}], "references": [{"pmid_title_1": "Pseudohypoaldosteronism type 1: clinical features and management in infancy.", "pmid_1": 24616761.0, "pmid_date_1": 2013.0, "pmid_journal_1": "Endocrinol Diabetes Metab Case Rep"}, {"pmid_title_2": "Pseudohypoaldosteronism type 1: management issues.", "pmid_2": 23680607.0, "pmid_date_2": 2013.0, "pmid_journal_2": "Indian Pediatr"}, {"pmid_title_3": "Life threatening hyperkalemia in a neonate with pseudo-hypoaldosteronism.", "pmid_3": 22764468.0, "pmid_date_3": 2012.0, "pmid_journal_3": "J Pak Med Assoc"}, {"pmid_title_4": "A homozygous missense mutation in SCNN1A is responsible for a transient neonatal form of pseudohypoaldosteronism type 1.", "pmid_4": 21653223.0, "pmid_date_4": 2011.0, "pmid_journal_4": "Am J Physiol Endocrinol Metab"}, {"pmid_title_5": "Critical points in the management of pseudohypoaldosteronism type 1.", "pmid_5": 21750640.0, "pmid_date_5": 2011.0, "pmid_journal_5": "J Clin Res Pediatr Endocrinol"}, {"pmid_title_6": "Pseudohypoaldosteronism type 1 in an infant.", "pmid_6": 21789870.0, "pmid_date_6": 2011.0, "pmid_journal_6": "Ceylon Med J"}, {"pmid_title_7": "Autosomal dominant pseudohypoaldosteronism type 1 with a novel splice site mutation in MR gene.", "pmid_7": 19912655.0, "pmid_date_7": 2009.0, "pmid_journal_7": "BMC Nephrol"}, {"pmid_title_8": "Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.", "pmid_8": 16972228.0, "pmid_date_8": 2007.0, "pmid_journal_8": "Hum Mutat"}, {"pmid_title_9": "Recurrence of the R947X mutation in unrelated families with autosomal dominant pseudohypoaldosteronism type 1: evidence for a mutational hot spot in the mineralocorticoid receptor gene.", "pmid_9": 16757525.0, "pmid_date_9": 2006.0, "pmid_journal_9": "J Clin Endocrinol Metab"}, {"pmid_title_10": "Identification of a novel mutation in the human mineralocorticoid receptor gene in a german family with autosomal-dominant pseudohypoaldosteronism type 1: further evidence for marked interindividual clinical heterogeneity.", "pmid_10": 12679457.0, "pmid_date_10": 2003.0, "pmid_journal_10": "J Clin Endocrinol Metab"}, {"pmid_title_11": "Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism.", "pmid_11": 12788847.0, "pmid_date_11": 2003.0, "pmid_journal_11": "J Clin Endocrinol Metab"}, {"pmid_title_12": "Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds.", "pmid_12": 11344206.0, "pmid_date_12": 2001.0, "pmid_journal_12": "J Clin Endocrinol Metab"}, {"pmid_title_13": "Compound heterozygous mutations in the gamma subunit gene of ENaC (1627delG and 1570-1G-->A) in one sporadic Japanese patient with a systemic form of pseudohypoaldosteronism type 1.", "pmid_13": 11231969.0, "pmid_date_13": 2001.0, "pmid_journal_13": "J Clin Endocrinol Metab"}, {"pmid_title_14": "A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.", "pmid_14": 11134129.0, "pmid_date_14": 2000.0, "pmid_journal_14": "J Clin Endocrinol Metab"}, {"pmid_title_15": "Lung symptoms in pseudohypoaldosteronism type 1 are associated with deficiency of the alpha-subunit of the epithelial sodium channel.", "pmid_15": 10586178.0, "pmid_date_15": 1999.0, "pmid_journal_15": "J Pediatr"}]}, {"_id": "7983-OMIM:612965", "condition": {"condition_name": "46,XY SEX REVERSAL 3; SRXY3", "freq_per_birth": "Swyer syndrome occurs in approximately 1 in 80,000 people.", "pattern_of_inheritance": "Y-linked==Autosomal dominant==Autosomal recessive==Not inherited", "alternate_names": ["46,XY SEX REVERSAL 3; SRXY3", "46,XX SEX REVERSAL 4; SRXX4"]}, "gene information": {"db_hgnc_gene_id": 7983.0}, "interventions": [{"int_description_1": "Gonadorelin"}, {"int_description_2": "Estradiol"}, {"int_description_3": "Progesterone"}, {"int_description_4": "Chorionic Gonadotropin (Human)"}], "references": [{"pmid_title_1": "A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans.", "pmid_1": 10369247.0, "pmid_date_1": 1999.0, "pmid_journal_1": "Nature genetics"}]}, {"_id": "7983-OMIM:617480", "condition": {"condition_name": "46,XX SEX REVERSAL 4; SRXX4", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["46,XX SEX REVERSAL 4; SRXX4", "46,XY SEX REVERSAL 3; SRXY3"]}, "gene information": {"db_hgnc_gene_id": 7983.0}, "interventions": [{"int_description_1": "Gonadectomy", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans.", "pmid_1": 10369247.0, "pmid_date_1": 1999.0, "pmid_journal_1": "Nature genetics"}]}, {"_id": "8512-OMIM:311250", "condition": {"condition_name": "ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO", "freq_per_birth": "Estimates of the prevalence of ornithine transcarbamylase deficiency have ranged from 1 in 14,000 to 1 in 77,000 people. Individuals with the neonatal-onset form of the disorder are more likely to be counted in these estimates, because people with the late-onset form are less likely to come to medical attention.", "pattern_of_inheritance": "X-linked recessive", "alternate_names": ["ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO"]}, "gene information": {"db_hgnc_gene_id": 8512.0}, "interventions": [{"int_description_1": "Low protein diet and arginine supplementation"}, {"int_description_2": "Low protein diet and citrulline supplementation", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Low protein diet and Essential amino acids (EAAs) supplementation", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Soybean oil"}, {"int_description_5": "Arginine", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Still in Trials / Unproven"}, {"int_description_6": "Benzoic acid", "timeframe_int6": "Hours", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Phenylbutyric acid", "timeframe_int7": "Hours,Days or Weeks", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Glycerol phenylbutyrate"}, {"int_description_9": "Citrulline"}, {"int_description_10": "Phenylacetic acid"}, {"int_description_11": "KB195 glycan"}, {"int_description_12": "Carglumic acid"}, {"int_description_13": "D-glucose"}, {"int_description_14": "Heterologous human adult liver-derived stem cells"}, {"int_description_15": "Human heterologous liver cells (for infusion)"}, {"int_description_16": "Therapeutic hypothermia", "timeframe_int16": "Hours,Days or Weeks", "age_use_int16": "Neonate,Infant,Child", "contra_int16": "No", "qualscale_reclass_drug16": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug16": "Effective / Ameliorative"}, {"int_description_17": "Adeno-associated viral vector serotype 8 encoding human ornithine transcarbamylase (DTX301)"}, {"int_description_18": "Adeno-associated viral vector serotype LK03 encoding human ornithine transcarbamylase", "timeframe_int18": "Hours,Days or Weeks", "age_use_int18": "Neonate,Infant,Child", "contra_int18": "No", "qualscale_reclass_drug18": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug18": "Effective / Ameliorative"}, {"int_description_19": "Codon-optimised human ornithine transcarbamylase mRNA complexed with lipid -based nanoparticle(MRT5201)", "timeframe_int19": "Hours", "age_use_int19": "Neonate", "contra_int19": "No", "qualscale_reclass_drug19": "Case report(s)", "rev1_eff_reclass_drug19": "Still in Trials / Unproven"}, {"int_description_20": "Modified messenger ribonucleic acid encoding human ornithine transcarbamylase enzyme encapsulated into lipid nanoparticles(PRX -OTC)", "timeframe_int20": "Hours", "age_use_int20": "Neonate,Infant,Child", "contra_int20": "No", "qualscale_reclass_drug20": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug20": "Effective / Ameliorative"}, {"int_description_21": "Hemodialysis", "timeframe_int21": "Hours", "age_use_int21": "Neonate,Infant,Child", "contra_int21": "No", "qualscale_reclass_drug21": "Case report(s)", "rev1_eff_reclass_drug21": "Effective / Ameliorative"}, {"int_description_22": "\u0421ontinuous veno-venous haemofiltration", "timeframe_int22": "Days or Weeks,Years", "age_use_int22": "Neonate,Infant,Child", "contra_int22": "No", "qualscale_reclass_drug22": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug22": "Curative"}, {"int_description_23": "Orthotopic liver transplantation (OLT)"}], "references": [{"pmid_title_1": "Management of Ornithine Carbamoyltransferase Deficiency with Underlying Hyperammonia Hyperinsulinemia Syndrome.", "pmid_1": 31337745.0, "pmid_date_1": 2019.0, "pmid_journal_1": "The American journal of case reports"}, {"pmid_title_2": "Curative Treatment of Ornithine Transcarbamylase Deficiency With a Liver Transplant: A Case Report.", "pmid_2": 27447480.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation"}, {"pmid_title_3": "Cognitive and Behavioural Outcomes of Paediatric Liver Transplantation for Ornithine Transcarbamylase Deficiency.", "pmid_3": 29524203.0, "pmid_date_3": 2019.0, "pmid_journal_3": "JIMD reports"}, {"pmid_title_4": "Glycerol Phenylbutyrate (Ravicti)", "pmid_4": 29381293.0, "pmid_date_4": 2018.0, "pmid_journal_4": "CADTH Common Drug Reviews"}, {"pmid_title_5": "Prenatal treatment of ornithine transcarbamylase deficiency.", "pmid_5": 29396029.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Molecular genetics and metabolism"}, {"pmid_title_6": "Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013.", "pmid_6": 27538463.0, "pmid_date_6": 2016.0, "pmid_journal_6": "Orphanet journal of rare diseases"}, {"pmid_title_7": "Report of 3 Patients With Urea Cycle Defects Treated With Related Living-Donor Liver Transplant.", "pmid_7": 26640932.0, "pmid_date_7": 2015.0, "pmid_journal_7": "Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation"}, {"pmid_title_8": "Urea cycle disorders in Spain: an observational, cross-sectional and multicentric study of 104 cases.", "pmid_8": 25433810.0, "pmid_date_8": 2014.0, "pmid_journal_8": "Orphanet J Rare Dis"}, {"pmid_title_9": "Hepatocyte transplantation using a living donor reduced graft in a baby with ornithine transcarbamylase deficiency: a novel source of hepatocytes.", "pmid_9": 24273015.0, "pmid_date_9": 2014.0, "pmid_journal_9": "Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society"}, {"pmid_title_10": "Dietary management of urea cycle disorders: European practice.", "pmid_10": 24113687.0, "pmid_date_10": 2013.0, "pmid_journal_10": "Molecular genetics and metabolism"}, {"pmid_title_11": "Recurrent somnolence in a 17-month-old infant: late-onset ornithine transcarbamylase (OTC) deficiency due to the novel hemizygous mutation c.535C > T (p.Leu179Phe).", "pmid_11": 22727265.0, "pmid_date_11": 2013.0, "pmid_journal_11": "European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society"}, {"pmid_title_12": "Successful continuous venovenous hemofiltration in a neonate with hyperammonemia from ornithine transcabamylase deficiency.", "pmid_12": 24428103.0, "pmid_date_12": 2013.0, "pmid_journal_12": "Journal of the Medical Association of Thailand = Chotmaihet thangphaet"}, {"pmid_title_13": "Suggested guidelines for the diagnosis and management of urea cycle disorders.", "pmid_13": 22642880.0, "pmid_date_13": 2012.0, "pmid_journal_13": "Orphanet journal of rare diseases"}, {"pmid_title_14": "Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London.", "pmid_14": 21457616.0, "pmid_date_14": 2012.0, "pmid_journal_14": "Cell transplantation"}, {"pmid_title_15": "Dietary management of urea cycle disorders: UK practice.", "pmid_15": 22594780.0, "pmid_date_15": 2012.0, "pmid_journal_15": "Journal of human nutrition and dietetics : the official journal of the British Dietetic Association"}, {"pmid_title_16": "Impact of enzyme activity assay on indication in liver transplantation for ornithine transcarbamylase deficiency.", "pmid_16": 22264779.0, "pmid_date_16": 2012.0, "pmid_journal_16": "Molecular genetics and metabolism"}, {"pmid_title_17": "Living donor liver transplantation from an asymptomatic mother who was a carrier for ornithine transcarbamylase deficiency.", "pmid_17": 22583334.0, "pmid_date_17": 2012.0, "pmid_journal_17": "Pediatric transplantation"}, {"pmid_title_18": "Venovenous hemodiafiltration and hypothermia for treatment of cerebral edema associated with hyperammonemia.", "pmid_18": 22318103.0, "pmid_date_18": 2012.0, "pmid_journal_18": "Indian pediatrics"}, {"pmid_title_19": "Modeling and therapy of human liver diseases using induced pluripotent stem cells: how far have we come?", "pmid_19": 21274892.0, "pmid_date_19": 2011.0, "pmid_journal_19": "Hepatology (Baltimore, Md.)"}, {"pmid_title_20": "Hepatocyte transplantation.", "pmid_20": 25755322.0, "pmid_date_20": 2011.0, "pmid_journal_20": "Journal of clinical and experimental hepatology"}, {"pmid_title_21": "Living donor liver transplantation for ornithine transcarbamylase deficiency.", "pmid_21": 21585627.0, "pmid_date_21": 2011.0, "pmid_journal_21": "Pediatric transplantation"}, {"pmid_title_22": "Phenylbutyrate improves nitrogen disposal via an alternative pathway without eliciting an increase in protein breakdown and catabolism in control and ornithine transcarbamylase-deficient patients.", "pmid_22": 21490144.0, "pmid_date_22": 2011.0, "pmid_journal_22": "The American journal of clinical nutrition"}, {"pmid_title_23": "Successful management of refractory intracranial hypertension from acute hyperammonemic encephalopathy in a woman with ornithine transcarbamylase deficiency.", "pmid_23": 20422467.0, "pmid_date_23": 2010.0, "pmid_journal_23": "Neurocritical care"}, {"pmid_title_24": "Prenatal benzoate treatment in urea cycle defects.", "pmid_24": 19000997.0, "pmid_date_24": 2009.0, "pmid_journal_24": "Archives of disease in childhood. Fetal and neonatal edition"}, {"pmid_title_25": "[A newborn infant with hyperventilation].", "pmid_25": 18604903.0, "pmid_date_25": 2008.0, "pmid_journal_25": "Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke"}, {"pmid_title_26": "Hemodialysis for hyperammonemia associated with ornithine transcarbamylase deficiency.", "pmid_26": 23776342.0, "pmid_date_26": 2008.0, "pmid_journal_26": "The application of clinical genetics"}, {"pmid_title_27": "Hepatocyte transplantation followed by auxiliary liver transplantation--a novel treatment for ornithine transcarbamylase deficiency.", "pmid_27": 18211511.0, "pmid_date_27": 2008.0, "pmid_journal_27": "American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"}, {"pmid_title_28": "Cross-sectional multicenter study of patients with urea cycle disorders in the United States.", "pmid_28": 18562231.0, "pmid_date_28": 2008.0, "pmid_journal_28": "Mol Genet Metab"}, {"pmid_title_29": "Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.", "pmid_29": 17538087.0, "pmid_date_29": 2007.0, "pmid_journal_29": "The New England journal of medicine"}, {"pmid_title_30": "Mild hypothermia for the treatment of acute liver failure--what are we waiting for?", "pmid_30": 17909531.0, "pmid_date_30": 2007.0, "pmid_journal_30": "Nature clinical practice. Gastroenterology & hepatology"}, {"pmid_title_31": "High-volume continuous venovenous hemofiltration as an effective therapy for acute management of inborn errors of metabolism in young children.", "pmid_31": 17643056.0, "pmid_date_31": 2007.0, "pmid_journal_31": "Blood purification"}, {"pmid_title_32": "Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University.", "pmid_32": 16237708.0, "pmid_date_32": 2005.0, "pmid_journal_32": "Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society"}, {"pmid_title_33": "Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while awaiting liver transplantation.", "pmid_33": 15996260.0, "pmid_date_33": 2005.0, "pmid_journal_33": "American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"}, {"pmid_title_34": "Management and outcome of neonatal-onset ornithine transcarbamylase deficiency following liver transplantation at 60 days of life.", "pmid_34": 15781198.0, "pmid_date_34": 2005.0, "pmid_journal_34": "Molecular genetics and metabolism"}, {"pmid_title_35": "Ornithine transcarbamylase deficiency: a urea cycle defect.", "pmid_35": 12788037.0, "pmid_date_35": 2003.0, "pmid_journal_35": "European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society"}, {"pmid_title_36": "Experience of continuous haemodiafiltration in a male neonate with ornithine transcarbamylase deficiency.", "pmid_36": 12898242.0, "pmid_date_36": 2003.0, "pmid_journal_36": "European journal of pediatrics"}, {"pmid_title_37": "Alternative pathway therapy for urea cycle disorders: twenty years later.", "pmid_37": 11148549.0, "pmid_date_37": 2001.0, "pmid_journal_37": "The Journal of pediatrics"}, {"pmid_title_38": "[Interdisciplinary treatment of early-onset ornithine transcarbamylase (OTC) deficiency. Two case reports and a review].", "pmid_38": 11745010.0, "pmid_date_38": 2001.0, "pmid_journal_38": "Zeitschrift fur Geburtshilfe und Neonatologie"}, {"pmid_title_39": "Long-term management of patients with urea cycle disorders.", "pmid_39": 11148550.0, "pmid_date_39": 2001.0, "pmid_journal_39": "The Journal of pediatrics"}, {"pmid_title_40": "Long-term treatment with sodium phenylbutyrate in ornithine transcarbamylase-deficient patients.", "pmid_40": 11286510.0, "pmid_date_40": 2001.0, "pmid_journal_40": "Molecular genetics and metabolism"}, {"pmid_title_41": "Emergency treatment of neonatal hyperammonaemic coma with mild systemic hypothermia.", "pmid_41": 11454378.0, "pmid_date_41": 2001.0, "pmid_journal_41": "Lancet (London, England)"}, {"pmid_title_42": "Continuous arteriovenous hemodiafiltration in the acute treatment of hyperammonaemia due to ornithine transcarbamylase deficiency.", "pmid_42": 11104170.0, "pmid_date_42": 2000.0, "pmid_journal_42": "Renal failure"}]}, {"_id": "8527-OMIM:245050", "condition": {"condition_name": "SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY", "freq_per_birth": "The prevalence of SCOT deficiency is unknown. More than 20 cases of this condition have been reported in the scientific literature.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 8527.0}, "interventions": [{"int_description_1": "High-carbohydrate and low-protein diet"}, {"int_description_2": "Low-fat diet", "timeframe_int2": "Days or Weeks,Years", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Insulin human"}, {"int_description_4": "Levocarnitine"}, {"int_description_5": "Phenytoin"}, {"int_description_6": "Albumin human", "timeframe_int6": "Hours", "age_use_int6": "Neonate,Infant,Child", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Sodium chloride", "timeframe_int7": "Hours,Days or Weeks", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Starch, corn"}, {"int_description_9": "Phenobarbital"}, {"int_description_10": "Sodium bicarbonate"}, {"int_description_11": "D-glucose"}, {"int_description_12": "Assisted respiration"}, {"int_description_13": "Frequent feeding"}, {"int_description_14": "Fresh frozen plasma transfusion"}, {"int_description_15": "Hemodialysis"}, {"int_description_16": "Red cell blood transfusion"}], "references": [{"pmid_title_1": "A Rare Cause of Life-Threatening Ketoacidosis: Novel Compound Heterozygous <i>OXCT1</i> Mutations Causing Succinyl-CoA:3-Ketoacid CoA Transferase Deficiency.", "pmid_1": 30799594.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Yonsei medical journal"}, {"pmid_title_2": "A Case of Succinyl-CoA:3-Oxoacid CoA Transferase Deficiency Presenting with Severe Acidosis in a 14-Month-Old Female: Evidence for Pathogenicity of a Point Mutation in the <i>OXCT1</i> Gene.", "pmid_2": 31073471.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Journal of pediatric intensive care"}, {"pmid_title_3": "When one disease is not enough: succinyl-CoA: 3-oxoacid coenzyme A transferase (SCOT) deficiency due to a novel mutation in OXCT1 in an infant with known phenylketonuria.", "pmid_3": 28820737.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_4": "Inborn errors of ketone body utilization.", "pmid_4": 25559898.0, "pmid_date_4": 2015.0, "pmid_journal_4": "Pediatrics international : official journal of the Japan Pediatric Society"}, {"pmid_title_5": "Clinical and molecular characterization of five patients with succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency.", "pmid_5": 21296660.0, "pmid_date_5": 2011.0, "pmid_journal_5": "Biochimica et biophysica acta"}, {"pmid_title_6": "Neonatal hypoglycaemia in severe succinyl-CoA: 3-oxoacid CoA-transferase deficiency.", "pmid_6": 11757586.0, "pmid_date_6": 2001.0, "pmid_journal_6": "Journal of inherited metabolic disease"}]}, {"_id": "853-OMIM:267300", "condition": {"condition_name": "RENAL TUBULAR ACIDOSIS, DISTAL, 2, WITH PROGRESSIVE SENSORINEURAL HEARING LOSS", "freq_per_birth": "Renal tubular acidosis with deafness is a rare disorder; its prevalence is unknown.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["RENAL TUBULAR ACIDOSIS, DISTAL, 2, WITH PROGRESSIVE SENSORINEURAL HEARING LOSS"]}, "gene information": {"db_hgnc_gene_id": 853.0}, "interventions": [{"int_description_1": "Cochlear implant", "timeframe_int1": "Days or Weeks", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Hearing aids"}, {"int_description_3": "Hearing devices", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Indomethacin", "timeframe_int4": "Hours", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Pyridoxine"}, {"int_description_6": "Potassium citrate"}, {"int_description_7": "Sodium citrate"}, {"int_description_8": "ADV7103"}, {"int_description_9": "Alkali"}, {"int_description_10": "Alkaline therapy"}, {"int_description_11": "Potassium chloride"}, {"int_description_12": "Potassium", "timeframe_int12": "Hours", "age_use_int12": "Neonate,Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Potassium sodium citrate", "timeframe_int13": "Hours", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Thiazides"}, {"int_description_15": "Sodium bicarbonate"}, {"int_description_16": "Ureteric stenting"}], "references": [{"pmid_title_1": "ATP6V1B1 recurrent mutations in Algerian deaf patients associated with renal tubular acidosis.", "pmid_1": 31733597.0, "pmid_date_1": 2020.0, "pmid_journal_1": "International journal of pediatric otorhinolaryngology"}, {"pmid_title_2": "Hereditary Distal Renal Tubular Acidosis", "pmid_2": 31600044.0, "pmid_date_2": 2019.0, "pmid_journal_2": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_3": "Pathophysiology, diagnosis and treatment of inherited distal renal tubular acidosis.", "pmid_3": 28994037.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Journal of nephrology"}, {"pmid_title_4": "Novel compound heterozygous ATP6V1B1 mutations in a Chinese child patient with primary distal renal tubular acidosis: a case report.", "pmid_4": 30558562.0, "pmid_date_4": 2018.0, "pmid_journal_4": "BMC nephrology"}, {"pmid_title_5": "Clinical and molecular aspects of distal renal tubular acidosis in children.", "pmid_5": 28188436.0, "pmid_date_5": 2017.0, "pmid_journal_5": "Pediatric nephrology (Berlin, Germany)"}, {"pmid_title_6": "Complicated pregnancies in inherited distal renal tubular acidosis: importance of acid-base balance.", "pmid_6": 28005240.0, "pmid_date_6": 2017.0, "pmid_journal_6": "Journal of nephrology"}, {"pmid_title_7": "Mutation analysis and audiologic assessment in six Chinese children with primary distal renal tubular acidosis.", "pmid_7": 24975934.0, "pmid_date_7": 2014.0, "pmid_journal_7": "Renal failure"}, {"pmid_title_8": "Homozygous and compound heterozygous mutations in the ATP6V1B1 gene in patients with renal tubular acidosis and sensorineural hearing loss.", "pmid_8": 22509993.0, "pmid_date_8": 2013.0, "pmid_journal_8": "Clinical genetics"}, {"pmid_title_9": "An expanded syndrome of dRTA with hearing loss, hyperoxaluria and beta2-microglobulinuria.", "pmid_9": 25984047.0, "pmid_date_9": 2010.0, "pmid_journal_9": "NDT plus"}, {"pmid_title_10": "Inner ear abnormalities in four patients with dRTA and SNHL: clinical and genetic heterogeneity.", "pmid_10": 19639346.0, "pmid_date_10": 2009.0, "pmid_journal_10": "Pediatric nephrology (Berlin, Germany)"}, {"pmid_title_11": "Atypical presentation of distal renal tubular acidosis in two siblings.", "pmid_11": 18386070.0, "pmid_date_11": 2008.0, "pmid_journal_11": "Pediatric nephrology (Berlin, Germany)"}, {"pmid_title_12": "Inherited renal acidoses.", "pmid_12": 17557941.0, "pmid_date_12": 2007.0, "pmid_journal_12": "Physiology (Bethesda, Md.)"}]}, {"_id": "8582-OMIM:261600", "condition": {"condition_name": "PHENYLKETONURIA; PKU", "freq_per_birth": "The occurrence of PKU varies among ethnic groups and geographic regions worldwide.  In the United States, PKU occurs in 1 in 10,000 to 15,000 newborns.  Most cases of PKU are detected shortly after birth by newborn screening, and treatment is started promptly.  As a result, the severe signs and symptoms of classic PKU are rarely seen.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["PHENYLKETONURIA; PKU"]}, "gene information": {"db_hgnc_gene_id": 8582.0}, "interventions": [{"int_description_1": "Phenylalanine (Phe)-free medical food"}, {"int_description_2": "Phenylalanine (Phe)-restricted diet combination therapy with Phe-free L-amino acid supplements or/and protein", "timeframe_int2": "Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Phenylalanine (Phe)-restricted diet monotherapy", "timeframe_int3": "Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Sapropterin (tetrahydrobiopterin, BH4) combination therapy with Phenylalanine (Phe)-restricted diet", "timeframe_int4": "Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Sapropterin"}], "references": [{"pmid_title_1": "Phenylketonuria: Current Treatments and Future Developments.", "pmid_1": 30864096.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Drugs"}, {"pmid_title_2": "Nutritional management of phenylalanine hydroxylase (PAH) deficiency in pediatric patients in Canada: a survey of dietitians' current practices.", "pmid_2": 30621767.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Orphanet J Rare Dis"}, {"pmid_title_3": "Allelic phenotype values: a model for genotype-based phenotype prediction in phenylketonuria.", "pmid_3": 29997390.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Genetics in medicine : official journal of the American College of Medical Genetics"}, {"pmid_title_4": "Phenylketonuria", "pmid_4": 30570999.0, "pmid_date_4": 2019.0, "pmid_journal_4": "StatPearls"}, {"pmid_title_5": "International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria.", "pmid_5": 31103398.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Molecular genetics and metabolism"}, {"pmid_title_6": "Phenylketonuria Dietary Management and an Emerging Development.", "pmid_6": 28754201.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Journal of the Academy of Nutrition and Dietetics"}, {"pmid_title_7": "Key European guidelines for the diagnosis and management of patients with phenylketonuria.", "pmid_7": 28082082.0, "pmid_date_7": 2017.0, "pmid_journal_7": "The lancet. Diabetes & endocrinology"}, {"pmid_title_8": "The relationship between dietary intake, growth and body composition in Phenylketonuria.", "pmid_8": 28739202.0, "pmid_date_8": 2017.0, "pmid_journal_8": "Molecular genetics and metabolism"}, {"pmid_title_9": "The complete European guidelines on phenylketonuria: diagnosis and treatment.", "pmid_9": 29025426.0, "pmid_date_9": 2017.0, "pmid_journal_9": "Orphanet J Rare Dis"}, {"pmid_title_10": "Hyperphenylalaninaemias in Estonia: Genotype-Phenotype Correlation and Comparative Overview of the Patient Cohort Before and After Nation-Wide Neonatal Screening.", "pmid_10": 28956315.0, "pmid_date_10": 2017.0, "pmid_journal_10": "JIMD Rep"}, {"pmid_11": 30462435.0, "pmid_date_11": 2017.0}, {"pmid_title_12": "Improved metabolic control in tetrahydrobiopterin (BH4), responsive phenylketonuria with sapropterin administered in two divided doses vs. a single daily dose.", "pmid_12": 28593914.0, "pmid_date_12": 2017.0, "pmid_journal_12": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_13": "Long-term BH4 (sapropterin) treatment of children with hyperphenylalaninemia - effect on median Phe/Tyr ratios.", "pmid_13": 26910740.0, "pmid_date_13": 2016.0, "pmid_journal_13": "Journal of pediatric endocrinology & metabolism : JPEM"}, {"pmid_title_14": "Individualized long-term outcomes in blood phenylalanine concentrations and dietary phenylalanine tolerance in 11 patients with primary phenylalanine hydroxylase (PAH) deficiency treated with Sapropterin-dihydrochloride.", "pmid_14": 25497838.0, "pmid_date_14": 2015.0, "pmid_journal_14": "Molecular genetics and metabolism"}, {"pmid_title_15": "Alternative therapies to address the unmet medical needs of patients with phenylketonuria.", "pmid_15": 25660215.0, "pmid_date_15": 2015.0, "pmid_journal_15": "Expert opinion on pharmacotherapy"}, {"pmid_title_16": "6R-tetrahydrobiopterin treated PKU patients below 4 years of age: Physical outcomes, nutrition and genotype.", "pmid_16": 25882749.0, "pmid_date_16": 2015.0, "pmid_journal_16": "Molecular genetics and metabolism"}, {"pmid_title_17": "Sapropterin dihydrochloride treatment in Turkish hyperphenylalaninemic patients under age four.", "pmid_17": 26701937.0, "pmid_date_17": 2015.0, "pmid_journal_17": "The Turkish journal of pediatrics"}, {"pmid_title_18": "Long-term developmental progression in infants and young children taking sapropterin for phenylketonuria: a two-year analysis of safety and efficacy.", "pmid_18": 25232857.0, "pmid_date_18": 2015.0, "pmid_journal_18": "Genetics in medicine : official journal of the American College of Medical Genetics"}, {"pmid_title_19": "Phenylalanine hydroxylase deficiency: diagnosis and management guideline.", "pmid_19": 24385074.0, "pmid_date_19": 2014.0, "pmid_journal_19": "Genetics in medicine : official journal of the American College of Medical Genetics"}, {"pmid_title_20": "Sapropterin is safe and effective in patients less than 4-years-old with BH4-responsive phenylalanine hydrolase deficiency.", "pmid_20": 25223838.0, "pmid_date_20": 2014.0, "pmid_journal_20": "The Journal of pediatrics"}, {"pmid_title_21": "Recommendations for the nutrition management of phenylalanine hydroxylase deficiency.", "pmid_21": 24385075.0, "pmid_date_21": 2014.0, "pmid_journal_21": "Genet Med"}, {"pmid_title_22": "Sapropterin dihydrochloride for the treatment of hyperphenylalaninemias.", "pmid_22": 23705856.0, "pmid_date_22": 2013.0, "pmid_journal_22": "Expert opinion on drug metabolism & toxicology"}, {"pmid_title_23": "Risk factors for developing mineral bone disease in phenylketonuric patients.", "pmid_23": 23352389.0, "pmid_date_23": 2013.0, "pmid_journal_23": "Molecular genetics and metabolism"}, {"pmid_title_24": "Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study.", "pmid_24": 23690520.0, "pmid_date_24": 2013.0, "pmid_journal_24": "Pediatrics"}, {"pmid_25": 23678512.0, "pmid_date_25": 2012.0}, {"pmid_title_26": "Positive effect of a simplified diet on blood phenylalanine control in different phenylketonuria variants, characterized by newborn BH4 loading test and PAH analysis.", "pmid_26": 22607939.0, "pmid_date_26": 2012.0, "pmid_journal_26": "Molecular genetics and metabolism"}, {"pmid_title_27": "Efficacy and safety of BH4 before the age of 4 years in patients with mild phenylketonuria.", "pmid_27": 22388642.0, "pmid_date_27": 2012.0, "pmid_journal_27": "Journal of inherited metabolic disease"}, {"pmid_title_28": "Physical development in patients with phenylketonuria on dietary treatment: a retrospective study.", "pmid_28": 21878401.0, "pmid_date_28": 2011.0, "pmid_journal_28": "Molecular genetics and metabolism"}, {"pmid_title_29": "Neurological complications and behavioral problems in patients with phenylketonuria in a follow-up unit.", "pmid_29": 21821452.0, "pmid_date_29": 2011.0, "pmid_journal_29": "Molecular genetics and metabolism"}, {"pmid_title_30": "Phenylketonuria: an inborn error of phenylalanine metabolism.", "pmid_30": 18566668.0, "pmid_date_30": 2008.0, "pmid_journal_30": "The Clinical biochemist. Reviews"}, {"pmid_title_31": "The tetrahydrobiopterin loading test in 36 patients with hyperphenylalaninaemia: evaluation of response and subsequent treatment.", "pmid_31": 17603758.0, "pmid_date_31": 2007.0, "pmid_journal_31": "Journal of inherited metabolic disease"}, {"pmid_title_32": "Biopterin responsive phenylalanine hydroxylase deficiency.", "pmid_32": 14726806.0, "pmid_date_32": 2004.0, "pmid_journal_32": "Genetics in medicine : official journal of the American College of Medical Genetics"}, {"pmid_title_33": "Efficiency of long-term tetrahydrobiopterin monotherapy in phenylketonuria.", "pmid_33": 15303001.0, "pmid_date_33": 2004.0, "pmid_journal_33": "Journal of inherited metabolic disease"}, {"pmid_title_34": "Tetrahydrobiopterin-responsive hyperphenylalaninaemia due to homozygous mutations in the phenylalanine hydroxylase gene.", "pmid_34": 12659094.0, "pmid_date_34": 2003.0, "pmid_journal_34": "European journal of pediatrics"}, {"pmid_title_35": "Phenylketonuria in adulthood: a collaborative study.", "pmid_35": 12408183.0, "pmid_date_35": 2002.0, "pmid_journal_35": "Journal of inherited metabolic disease"}, {"pmid_title_36": "Tetrahydrobiopterin responsiveness in phenylketonuria. Two new cases and a review of molecular genetic findings.", "pmid_36": 11999982.0, "pmid_date_36": 2002.0, "pmid_journal_36": "Journal of inherited metabolic disease"}, {"pmid_title_37": "Tetrahydrobiopterin monotherapy for phenylketonuria patients with common mild mutations.", "pmid_37": 12174822.0, "pmid_date_37": 2002.0, "pmid_journal_37": "European journal of pediatrics"}, {"pmid_title_38": "Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria.", "pmid_38": 12501224.0, "pmid_date_38": 2002.0, "pmid_journal_38": "The New England journal of medicine"}, {"pmid_title_39": "Two novel genetic lesions and a common BH4-responsive mutation of the PAH gene in Italian patients with hyperphenylalaninemia.", "pmid_39": 12409276.0, "pmid_date_39": 2002.0, "pmid_journal_39": "Molecular genetics and metabolism"}]}, {"_id": "8646-OMIM:264070", "condition": {"condition_name": "HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D"]}, "gene information": {"db_hgnc_gene_id": 8646.0}, "interventions": [{"int_description_1": "Phe-restricted diet"}, {"int_description_2": "Insulin human"}, {"int_description_3": "Magnesium"}, {"int_description_4": "Gliclazide", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Sapropterin", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Mutations in PCBD1 cause hypomagnesemia and renal magnesium wasting.", "pmid_1": 24204001.0, "pmid_date_1": 2014.0, "pmid_journal_1": "J Am Soc Nephrol"}, {"pmid_title_2": "Hyperphenylalaninemia with high levels of 7-biopterin is associated with mutations in the PCBD gene encoding the bifunctional protein pterin-4a-carbinolamine dehydratase and transcriptional coactivator (DCoH).", "pmid_2": 9585615.0, "pmid_date_2": 1998.0, "pmid_journal_2": "Am J Hum Genet"}]}, {"_id": "8653-OMIM:606054", "condition": {"condition_name": "PROPIONIC ACIDEMIA", "freq_per_birth": "Propionic acidemia affects about 1 in 100,000 people in the United States. The condition appears to be more common in several populations worldwide, including the Inuit population of Greenland, some Amish communities, and Saudi Arabians.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["PROPIONIC ACIDEMIA"]}, "gene information": {"db_hgnc_gene_id": 8653.0}, "interventions": [{"int_description_1": "Low-isoleucine,\u2212methionine,\u2212threonine,-valine diet"}, {"int_description_2": "Protein-restricted diet", "timeframe_int2": "Days or Weeks,Years", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Still in Trials / Unproven"}, {"int_description_3": "Soybean oil", "timeframe_int3": "Hours", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Ubidecarenone"}, {"int_description_5": "Arginine"}, {"int_description_6": "Clonazepam", "timeframe_int6": "Hours", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Cohort study or studies", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Baclofen"}, {"int_description_8": "gamma-Hydroxybutyric acid"}, {"int_description_9": "Insulin human"}, {"int_description_10": "Trihexyphenidyl"}, {"int_description_11": "Hydroxocobalamin"}, {"int_description_12": "Metronidazole"}, {"int_description_13": "Somatotropin"}, {"int_description_14": "Vitamin D"}, {"int_description_15": "Levetiracetam"}, {"int_description_16": "Carbamazepine", "timeframe_int16": "Hours,Days or Weeks,Years", "age_use_int16": "Neonate,Infant,Child", "contra_int16": "No", "qualscale_reclass_drug16": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug16": "Effective / Ameliorative"}, {"int_description_17": "Benzoic acid", "timeframe_int17": "Hours,Days or Weeks", "age_use_int17": "Neonate,Infant,Child", "contra_int17": "No", "qualscale_reclass_drug17": "Case report(s)", "rev1_eff_reclass_drug17": "Still in Trials / Unproven"}, {"int_description_18": "Phenylbutyric acid"}, {"int_description_19": "Levocarnitine", "timeframe_int19": "Hours,Days or Weeks", "age_use_int19": "Neonate,Infant,Child", "contra_int19": "No", "qualscale_reclass_drug19": "Cohort study or studies", "rev1_eff_reclass_drug19": "Effective / Ameliorative"}, {"int_description_20": "Sodium citrate"}, {"int_description_21": "Riboflavin", "timeframe_int21": "Hours", "age_use_int21": "Neonate,Infant,Child", "contra_int21": "No", "qualscale_reclass_drug21": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug21": "Effective / Ameliorative"}, {"int_description_22": "Modified messenger ribonucleic acid encoding human propionyl-coenzyme A carboxylase alpha and beta subunits encapsulated into lipid nanoparticle (mRNA-3927)", "timeframe_int22": "Hours,Days or Weeks", "age_use_int22": "Neonate,Infant,Child", "contra_int22": "No", "qualscale_reclass_drug22": "Case report(s)", "rev1_eff_reclass_drug22": "Still in Trials / Unproven"}, {"int_description_23": "Carglumic acid", "timeframe_int23": "Hours,Days or Weeks", "age_use_int23": "Neonate,Infant,Child", "contra_int23": "No", "qualscale_reclass_drug23": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug23": "Effective / Ameliorative"}, {"int_description_24": "Phenobarbital", "timeframe_int24": "Hours,Days or Weeks", "age_use_int24": "Neonate,Infant,Child", "contra_int24": "No", "qualscale_reclass_drug24": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug24": "Effective / Ameliorative"}, {"int_description_25": "D-glucose"}, {"int_description_26": "Thiamine"}, {"int_description_27": "Heterologous human adult liver-derived progenitor cells"}, {"int_description_28": "Assisted respiration"}, {"int_description_29": "Feeding per gastrostomy tube", "timeframe_int29": "Hours,Days or Weeks", "age_use_int29": "Neonate,Infant,Child", "contra_int29": "No", "qualscale_reclass_drug29": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug29": "Effective / Ameliorative"}, {"int_description_30": "Feeding per nasogastric tube", "timeframe_int30": "Hours,Days or Weeks", "age_use_int30": "Neonate,Infant,Child", "contra_int30": "No", "qualscale_reclass_drug30": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug30": "Effective / Ameliorative"}, {"int_description_31": "Hemodialysis", "timeframe_int31": "Hours,Days or Weeks", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Peritoneal dialysis"}, {"int_description_33": "Strict avoidance of fasting (fed every 3-6 hours)"}, {"int_description_34": "\u0421ontinuous veno-venous haemofiltration"}, {"int_description_35": "Orthotopic liver transplantation (OLT)"}], "references": [{"pmid_title_1": "Case reports: three novel variants in PCCA and PCCB genes in Chinese patients with propionic acidemia.", "pmid_1": 32252659.0, "pmid_date_1": 2020.0, "pmid_journal_1": "BMC medical genetics"}, {"pmid_title_2": "Nutrition management guideline for propionic acidemia: An evidence- and consensus-based approach.", "pmid_2": 30879957.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Molecular genetics and metabolism"}, {"pmid_title_3": "Evaluation of long-term effectiveness of the use of carglumic acid in patients with propionic acidemia (PA) or methylmalonic acidemia (MMA): study protocol for a randomized controlled trial.", "pmid_3": 31196016.0, "pmid_date_3": 2019.0, "pmid_journal_3": "BMC pediatrics"}, {"pmid_title_4": "Epilepsy in Propionic Acidemia: Case Series of 14 Saudi Patients.", "pmid_4": 30014764.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Journal of child neurology"}, {"pmid_title_5": "Long-term continuous N-carbamylglutamate treatment in frequently decompensated propionic acidemia: a case report.", "pmid_5": 29679984.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Journal of medical case reports"}, {"pmid_title_6": "Liver Transplantation for Propionic Acidemia and Methylmalonic Acidemia: Perioperative Management and Clinical Outcomes.", "pmid_6": 30080956.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society"}, {"pmid_title_7": "Propionyl-CoA carboxylase - A review.", "pmid_7": 29033250.0, "pmid_date_7": 2017.0, "pmid_journal_7": "Molecular genetics and metabolism"}, {"pmid_title_8": "Anaplerotic therapy in propionic acidemia.", "pmid_8": 28712602.0, "pmid_date_8": 2017.0, "pmid_journal_8": "Molecular genetics and metabolism"}, {"pmid_title_9": "Liver Transplantation for Propionic Acidemia.", "pmid_9": 26881497.0, "pmid_date_9": 2017.0, "pmid_journal_9": "Journal of pediatric gastroenterology and nutrition"}, {"pmid_title_10": "Propionic Acidemia", "pmid_10": 22593918.0, "pmid_date_10": 2016.0, "pmid_journal_10": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_11": "Methylmalonic and propionic acidemias: clinical management update.", "pmid_11": 27653704.0, "pmid_date_11": 2016.0, "pmid_journal_11": "Current opinion in pediatrics"}, {"pmid_title_12": "Carglumic acid enhances rapid ammonia detoxification in classical organic acidurias with a favourable risk-benefit profile: a retrospective observational study.", "pmid_12": 27030250.0, "pmid_date_12": 2016.0, "pmid_journal_12": "Orphanet journal of rare diseases"}, {"pmid_title_13": "Reversal of cardiomyopathy in propionic acidemia after liver transplantation: a 10-year follow-up.", "pmid_13": 26358860.0, "pmid_date_13": 2015.0, "pmid_journal_13": "Transplant international : official journal of the European Society for Organ Transplantation"}, {"pmid_title_14": "Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia.", "pmid_14": 25205257.0, "pmid_date_14": 2014.0, "pmid_journal_14": "Orphanet journal of rare diseases"}, {"pmid_title_15": "Severe renal failure and hyperammonemia in a newborn with propionic acidemia: effects of treatment on the clinical course.", "pmid_15": 24329397.0, "pmid_date_15": 2014.0, "pmid_journal_15": "Renal failure"}, {"pmid_title_16": "Successful reversal of propionic acidaemia associated cardiomyopathy: evidence for low myocardial coenzyme Q10 status and secondary mitochondrial dysfunction as an underlying pathophysiological mechanism.", "pmid_16": 25010387.0, "pmid_date_16": 2014.0, "pmid_journal_16": "Mitochondrion"}, {"pmid_title_17": "Improved neurologic prognosis for a patient with propionic acidemia who received early living donor liver transplantation.", "pmid_17": 23151386.0, "pmid_date_17": 2013.0, "pmid_journal_17": "Molecular genetics and metabolism"}, {"pmid_title_18": "Propionic acidemia associated with visual hallucinations.", "pmid_18": 22156789.0, "pmid_date_18": 2012.0, "pmid_journal_18": "Journal of child neurology"}, {"pmid_title_19": "Short-term outcome of propionic aciduria treated at presentation with N-carbamylglutamate: a retrospective review of four patients.", "pmid_19": 23430860.0, "pmid_date_19": 2012.0, "pmid_journal_19": "JIMD reports"}, {"pmid_title_20": "Living-donor liver transplantation for propionic acidemia.", "pmid_20": 22151065.0, "pmid_date_20": 2012.0, "pmid_journal_20": "Pediatric transplantation"}, {"pmid_title_21": "N-carbamylglutamate augments ureagenesis and reduces ammonia and glutamine in propionic acidemia.", "pmid_21": 20566609.0, "pmid_date_21": 2010.0, "pmid_journal_21": "Pediatrics"}, {"pmid_title_22": "Evaluation and management of patients with propionic acidemia undergoing liver transplantation: a comprehensive review.", "pmid_22": 17032422.0, "pmid_date_22": 2006.0, "pmid_journal_22": "Pediatric transplantation"}]}, {"_id": "866-OMIM:602722", "condition": {"condition_name": "RENAL TUBULAR ACIDOSIS, DISTAL, 3, WITH OR WITHOUT SENSORINEURAL HEARING LOSS", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["RENAL TUBULAR ACIDOSIS, DISTAL, 3, WITH OR WITHOUT SENSORINEURAL HEARING LOSS"]}, "gene information": {"db_hgnc_gene_id": 866.0}, "interventions": [{"int_description_1": "Alkali treatment with potassium citrate and sodium bicarbonate", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Oral alkali (1-3 mEq/kg/day bicarbonate)"}, {"int_description_3": "Oral alkali (5 mmol/kg per day)"}, {"int_description_4": "Sodium bicarbonate", "timeframe_int4": "Hours", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Pathophysiology, diagnosis and treatment of inherited distal renal tubular acidosis.", "pmid_1": 28994037.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Journal of nephrology"}, {"pmid_title_2": "Genotype-Phenotype Analysis in Pediatric Patients with Distal Renal Tubular Acidosis.", "pmid_2": 29627839.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Kidney & blood pressure research"}, {"pmid_title_3": "Mutational analyses of the ATP6V1B1 and ATP6V0A4 genes in patients with primary distal renal tubular acidosis.", "pmid_3": 23729491.0, "pmid_date_3": 2013.0, "pmid_journal_3": "Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"}, {"pmid_title_4": "Inner ear abnormalities in four patients with dRTA and SNHL: clinical and genetic heterogeneity.", "pmid_4": 19639346.0, "pmid_date_4": 2009.0, "pmid_journal_4": "Pediatric nephrology (Berlin, Germany)"}, {"pmid_title_5": "Medullary sponge kidney associated with primary distal renal tubular acidosis and mutations of the H+-ATPase genes.", "pmid_5": 19364879.0, "pmid_date_5": 2009.0, "pmid_journal_5": "Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"}, {"pmid_title_6": "Inherited renal acidoses.", "pmid_6": 17557941.0, "pmid_date_6": 2007.0, "pmid_journal_6": "Physiology (Bethesda, Md.)"}]}, {"_id": "877-OMIM:266100", "condition": {"condition_name": "EPILEPSY, PYRIDOXINE-DEPENDENT; EPD", "freq_per_birth": "Pyridoxine-dependent epilepsy occurs in 1 in 100,000 to 700,000 individuals.  At least 100 cases have been reported worldwide.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["EPILEPSY, PYRIDOXINE-DEPENDENT; EPD"]}, "gene information": {"db_hgnc_gene_id": 877.0}, "interventions": [{"int_description_1": "Lysine restricted diet", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Arginine", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Pyridoxine"}, {"int_description_4": "Tryptophan", "timeframe_int4": "Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Cohort study or studies", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Novel homozygous missense mutation in ALDH7A1 causes neonatal pyridoxine dependent epilepsy.", "pmid_1": 27856333.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Molecular and cellular probes"}, {"pmid_title_2": "Pyridoxine-dependent epilepsy: A novel mutation in a Tunisian child.", "pmid_2": 28131559.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Archives de pediatrie : organe officiel de la Societe francaise de pediatrie"}, {"pmid_title_3": "A Prospective Case Study of the Safety and Efficacy of Lysine-Restricted Diet and Arginine Supplementation Therapy in a Patient With Pyridoxine-Dependent Epilepsy Caused by Mutations in ALDH7A1.", "pmid_3": 27212567.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Pediatric neurology"}, {"pmid_title_4": "Triple therapy with pyridoxine, arginine supplementation and dietary lysine restriction in pyridoxine-dependent epilepsy: Neurodevelopmental outcome.", "pmid_4": 26026794.0, "pmid_date_4": 2015.0, "pmid_journal_4": "Molecular genetics and metabolism"}, {"pmid_title_5": "Long-term treatment outcome of two patients with pyridoxine-dependent epilepsy caused by ALDH7A1 mutations: normal neurocognitive outcome.", "pmid_5": 24789515.0, "pmid_date_5": 2015.0, "pmid_journal_5": "Journal of child neurology"}, {"pmid_title_6": "First cases of pyridoxine-dependent epilepsy in Bulgaria: novel mutation in the ALDH7A1 gene.", "pmid_6": 26232297.0, "pmid_date_6": 2015.0, "pmid_journal_6": "Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"}, {"pmid_title_7": "Lysine-restricted diet and mild cerebral serotonin deficiency in a patient with pyridoxine-dependent epilepsy caused by <i>ALDH7A1</i> genetic defect.", "pmid_7": 27896080.0, "pmid_date_7": 2014.0, "pmid_journal_7": "Molecular genetics and metabolism reports"}, {"pmid_title_8": "Fetal onset ventriculomegaly and subependymal cysts in a pyridoxine dependent epilepsy patient.", "pmid_8": 24664088.0, "pmid_date_8": 2014.0, "pmid_journal_8": "Pediatrics"}, {"pmid_title_9": "Clinical diagnosis, treatment, and ALDH7A1 mutations in pyridoxine-dependent epilepsy in three Chinese infants.", "pmid_9": 24664145.0, "pmid_date_9": 2014.0, "pmid_journal_9": "PloS one"}, {"pmid_title_10": "Clinical, biochemical, and molecular studies in pyridoxine-dependent epilepsy. Antisense therapy as possible new therapeutic option.", "pmid_10": 23350806.0, "pmid_date_10": 2013.0, "pmid_journal_10": "Epilepsia"}, {"pmid_title_11": "Pyridoxine-dependent epilepsy in Tunisia is caused by a founder missense mutation of the ALDH7A1 gene.", "pmid_11": 23376216.0, "pmid_date_11": 2013.0, "pmid_journal_11": "Gene"}, {"pmid_title_12": "The genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy due to mutations in ALDH7A1.", "pmid_12": 20814824.0, "pmid_date_12": 2010.0, "pmid_journal_12": "Journal of inherited metabolic disease"}]}, {"_id": "8864-OMIM:312060", "condition": {"condition_name": "PROPERDIN DEFICIENCY, X-LINKED; CFPD", "pattern_of_inheritance": "X-linked recessive", "alternate_names": ["PROPERDIN DEFICIENCY, X-LINKED; CFPD"]}, "gene information": {"db_hgnc_gene_id": 8864.0}, "interventions": [{"int_description_1": "Amoxicillin"}, {"int_description_2": "Hydrocortisone"}, {"int_description_3": "Quadrivalent polysaccharide meningococcal vaccine", "timeframe_int3": "Days or Weeks", "age_use_int3": "Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "A novel mutation W388X underlying properdin deficiency in a Finnish family.", "pmid_1": 22229731.0, "pmid_date_1": 2012.0, "pmid_journal_1": "Scandinavian journal of immunology"}, {"pmid_title_2": "Properdin deficiency in a family with fulminant meningococcal infections.", "pmid_2": 7151327.0, "pmid_date_2": 1982.0, "pmid_journal_2": "Clinical and experimental immunology"}]}, {"_id": "8905-OMIM:614921", "condition": {"condition_name": "CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It"]}, "gene information": {"db_hgnc_gene_id": 8905.0}, "interventions": [{"int_description_1": "Lactose-rich diet"}, {"int_description_2": "Galactose", "timeframe_int2": "Days or Weeks,Years", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Frequent feeding"}], "references": [{"pmid_title_1": "Intact transferrin and total plasma glycoprofiling for diagnosis and therapy monitoring in phosphoglucomutase-I deficiency.", "pmid_1": 30048639.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Transl Res"}, {"pmid_title_2": "Clinical and molecular genetic characterization of two patients with mutations in the phosphoglucomutase 1 (PGM1) gene.", "pmid_2": 29858906.0, "pmid_date_2": 2018.0, "pmid_journal_2": "J Pediatr Endocrinol Metab"}, {"pmid_title_3": "PGM1 deficiency: Substrate use during exercise and effect of treatment with galactose.", "pmid_3": 28190645.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Neuromuscul Disord"}, {"pmid_title_4": "Oral D-galactose supplementation in PGM1-CDG.", "pmid_4": 28617415.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Genet Med"}, {"pmid_title_5": "News on Clinical Details and Treatment in PGM1-CDG.", "pmid_5": 26303607.0, "pmid_date_5": 2016.0, "pmid_journal_5": "JIMD Rep"}, {"pmid_title_6": "Glycogen storage disease-like phenotype with central nervous system involvement in a PGM1-CDG patient.", "pmid_6": 24878975.0, "pmid_date_6": 2014.0, "pmid_journal_6": "Neuro Endocrinol Lett"}, {"pmid_title_7": "Multiple phenotypes in phosphoglucomutase 1 deficiency.", "pmid_7": 24499211.0, "pmid_date_7": 2014.0, "pmid_journal_7": "N Engl J Med"}]}, {"_id": "8907-OMIM:615816", "condition": {"condition_name": "IMMUNODEFICIENCY 23", "freq_per_birth": "PGM3-CDG is a rare disorder, although its prevalence is unknown. Approximately 40 people with the condition have been described worldwide.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["IMMUNODEFICIENCY 23"]}, "gene information": {"db_hgnc_gene_id": 8907.0}, "interventions": [{"int_description_1": "Gastrostomy tube"}, {"int_description_2": "Hemodialysis"}, {"int_description_3": "Nasogastric tube"}, {"int_description_4": "Ventilatory and circulatory support"}, {"int_description_5": "Exclusion of milk, cereals and eggs"}, {"int_description_6": "Doxorubicin"}, {"int_description_7": "Bleomycin"}, {"int_description_8": "Dacarbazine"}, {"int_description_9": "Vinblastine"}, {"int_description_10": "Antimicrobial therapy", "timeframe_int10": "Hours,Days or Weeks", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Cohort study or studies", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Corticosteroids"}, {"int_description_12": "Emollients"}, {"int_description_13": "Lasix"}, {"int_description_14": "Filgrastim"}, {"int_description_15": "Occupational therapy, physical therapy, and speech therapy"}, {"int_description_16": "Orthopedic and physical medicine management (well-supported wheel chairs, appropriate transfer devices for the home, and physical therapy)"}, {"int_description_17": "Platelets transfusions"}, {"int_description_18": "Red blood cells transfusions"}, {"int_description_19": "Bilateral lung transplantation", "timeframe_int19": "Days or Weeks,Years", "age_use_int19": "Infant,Child", "contra_int19": "No", "qualscale_reclass_drug19": "Case report(s)", "rev1_eff_reclass_drug19": "Effective / Ameliorative"}, {"int_description_20": "Hematopoietic stem cell transplantation"}, {"int_description_21": "Renal transplantation"}, {"int_description_22": "Surgery for skeletal malformations."}], "references": [{"pmid_title_1": "Eleven percent intact PGM3 in a severely immunodeficient patient with a novel splice-site mutation, a case report.", "pmid_1": 30157810.0, "pmid_date_1": 2018.0, "pmid_journal_1": "BMC pediatrics"}, {"pmid_title_2": "Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview", "pmid_2": 20301507.0, "pmid_date_2": 2017.0, "pmid_journal_2": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_3": "A Novel PGM3 Mutation Is Associated With a Severe Phenotype of Bone Marrow Failure, Severe Combined Immunodeficiency, Skeletal Dysplasia, and Congenital Malformations.", "pmid_3": 28543917.0, "pmid_date_3": 2017.0, "pmid_journal_3": "Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research"}, {"pmid_title_4": "PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia.", "pmid_4": 24931394.0, "pmid_date_4": 2014.0, "pmid_journal_4": "American journal of human genetics"}, {"pmid_title_5": "Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment.", "pmid_5": 24589341.0, "pmid_date_5": 2014.0, "pmid_journal_5": "The Journal of allergy and clinical immunology"}]}, {"_id": "8918-OMIM:307800", "condition": {"condition_name": "HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT", "pattern_of_inheritance": "X-linked dominant, Autosomal dominant, Autosomal recessive, X-linked recessive", "alternate_names": ["HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT"]}, "gene information": {"db_hgnc_gene_id": 8918.0}, "interventions": [{"int_description_1": "Hearing aids"}, {"int_description_2": "Ergocalciferol", "timeframe_int2": "Days or Weeks", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Alfacalcidol"}, {"int_description_4": "Burosumab"}, {"int_description_5": "Somatotropin"}, {"int_description_6": "Cholecalciferol"}, {"int_description_7": "Vitamin D"}, {"int_description_8": "Calcitriol", "timeframe_int8": "Days or Weeks", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Phosphate ion"}, {"int_description_10": "Cinacalcet"}, {"int_description_11": "Physiotherapy"}, {"int_description_12": "Orthodontic implant surgery"}, {"int_description_13": "Orthopedic surgery"}, {"int_description_14": "Osteotomy"}, {"int_description_15": "Parathyroidectomy"}, {"int_description_16": "Total  knee arthroplasty"}, {"int_description_17": "Total hip arthroplasty"}], "references": [{"pmid_title_1": "X-linked hypophosphatemic rickets: an Italian experts' opinion survey.", "pmid_1": 31151476.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Ital J Pediatr"}, {"pmid_title_2": "Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.", "pmid_2": 31068690.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Nat Rev Nephrol"}, {"pmid_title_3": "X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.", "pmid_3": 29381780.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Endocr Rev"}, {"pmid_title_4": "Analysis of 2 novel mutations of PHEX gene inducing X-linked dominant hypophosphatemia rickets in 2 families: Two case reports.", "pmid_4": 30075510.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Medicine (Baltimore)"}, {"pmid_title_5": "Two novel variants of the PHEX gene in patients with X\u2011linked dominant hypophosphatemic rickets and prenatal diagnosis for fetuses in these families.", "pmid_5": 29393334.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Int J Mol Med"}, {"pmid_title_6": "Contemporary Medical and Surgical Management of X-linked Hypophosphatemic Rickets.", "pmid_6": 26040953.0, "pmid_date_6": 2015.0, "pmid_journal_6": "J Am Acad Orthop Surg"}, {"pmid_title_7": "X-linked hypophosphatemic rickets: case report.", "pmid_7": 24684036.0, "pmid_date_7": 2014.0, "pmid_journal_7": "Srp Arh Celok Lek"}, {"pmid_title_8": "A clinical and molecular genetic study of hypophosphatemic rickets in children.", "pmid_8": 16055933.0, "pmid_date_8": 2005.0, "pmid_journal_8": "Pediatr Res"}, {"pmid_title_9": "Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets.", "pmid_9": 12915641.0, "pmid_date_9": 2003.0, "pmid_journal_9": "J Clin Endocrinol Metab"}, {"pmid_title_10": "X-linked hypophosphatemia in Polish patients. 2. Analysis of clinical features and genotype-phenotype correlation.", "pmid_10": 14564066.0, "pmid_date_10": 2001.0, "pmid_journal_10": "J Appl Genet"}]}, {"_id": "8923-OMIM:601815", "condition": {"condition_name": "PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY; PHGDHD", "freq_per_birth": "This condition is likely a rare disorder, but its prevalence is unknown. At least 15 cases have been described in the scientific literature.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY; PHGDHD"]}, "gene information": {"db_hgnc_gene_id": 8923.0}, "interventions": [{"int_description_1": "Glycine", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Serine", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Infantile Serine Biosynthesis Defect Due to Phosphoglycerate Dehydrogenase Deficiency: Variability in Phenotype and Treatment Response, Novel Mutations, and Diagnostic Challenges.", "pmid_1": 28135894.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Journal of child neurology"}, {"pmid_title_2": "Abstracts of the Annual Symposium of the Society for the Study of Inborn Errors of Metabolism. Birmingham, United Kingdom. September 4-7, 2012.", "pmid_2": 22886422.0, "pmid_date_2": 2012.0, "pmid_journal_2": "Journal of inherited metabolic disease"}, {"pmid_title_3": "Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency.", "pmid_3": 15610810.0, "pmid_date_3": 2004.0, "pmid_journal_3": "Lancet (London, England)"}]}, {"_id": "8941-OMIM:613490", "condition": {"condition_name": "ALPHA-1-ANTITRYPSIN DEFICIENCY", "freq_per_birth": "Alpha-1 antitrypsin deficiency occurs worldwide, but its prevalence varies by population. This disorder affects about 1 in 1,500 to 3,500 individuals with European ancestry. It is uncommon in people of Asian descent. Many individuals with alpha-1 antitrypsin deficiency are likely undiagnosed, particularly people with a lung condition called chronic obstructive pulmonary disease (COPD). COPD can be caused by alpha-1 antitrypsin deficiency; however, the alpha-1 antitrypsin deficiency is often never diagnosed. Some people with alpha-1 antitrypsin deficiency are misdiagnosed with asthma.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ALPHA-1-ANTITRYPSIN DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 8941.0}, "interventions": [{"int_description_1": "Alpha-1-proteinase inhibitor"}, {"int_description_2": "Cyclo[L-alanyl-L-seryl-L-isoleucyl-L-prolyl-L-prolyl-L-glutaminyl-L-lysyl-L-tyrosyl-D-prolyl-L-prolyl-(2S)-2-aminodecanoyl-L-alpha-glutamyl-L-threonyl] acetate salt"}, {"int_description_3": "Recombinant alpha 1-antitrypsin"}, {"int_description_4": "Factor IX Complex (Human)"}, {"int_description_5": "Gene therapy"}, {"int_description_6": "N-acetylgalactosamine-conjugated synthetic double-stranded oligomer specific to serpin family A member 1 gene"}, {"int_description_7": "Recombinant adeno-associated viral vector containing human alpha-1 antitrypsin gene"}, {"int_description_8": "Synthetic double-stranded oligomer specific to the SERPINA1 gene and containing a cholesterol-conjugated, acyclic nucleobase analogue"}, {"int_description_9": "Synthetic double-stranded siRNA oligonucleotide directed against SERPINA1 mRNA and containing four modified nucleosides which form a ligand cluster of four N-acetylgalactosamine residues"}, {"int_description_10": "Continuus plasma exchange transfusion"}, {"int_description_11": "RNAi therapy"}, {"int_description_12": "Liver transplant"}, {"int_description_13": "Lung transplant"}], "references": [{"pmid_title_1": "Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease.", "pmid_1": 32379724.0, "pmid_date_1": 2020.0, "pmid_journal_1": "JCI insight"}, {"pmid_title_2": "Greater survival despite increased complication rates following lung transplant for alpha-1-antitrypsin deficiency compared to chronic obstructive pulmonary disease.", "pmid_2": 31179055.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Journal of thoracic disease"}, {"pmid_title_3": "American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.", "pmid_3": 14522813.0, "pmid_date_3": 2003.0, "pmid_journal_3": "American journal of respiratory and critical care medicine"}, {"pmid_title_4": "The alpha 1-antitrypsin gene and its deficiency states.", "pmid_4": 2696185.0, "pmid_date_4": 1989.0, "pmid_journal_4": "Trends in genetics : TIG"}, {"pmid_title_5": "Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder.", "pmid_5": 6604220.0, "pmid_date_5": 1983.0, "pmid_journal_5": "The New England journal of medicine"}]}, {"_id": "8979-OMIM:269880", "condition": {"condition_name": "SHORT SYNDROME", "pattern_of_inheritance": "Autosomal dominant", "alternate_names": ["IMMUNODEFICIENCY 36", "SHORT SYNDROME", "AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE"]}, "gene information": {"db_hgnc_gene_id": 8979.0}, "interventions": [{"int_description_1": "Low carbohidrate diet"}, {"int_description_2": "Insulin human"}, {"int_description_3": "Metformin"}, {"int_description_4": "Dapagliflozin"}, {"int_description_5": "Dental prostheses"}], "references": [{"pmid_title_1": "SHORT Syndrome", "pmid_1": 24830046.0, "pmid_date_1": 2020.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "SHORT syndrome in two Chinese girls: A case report and review of the literature.", "pmid_2": 32602265.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Mol Genet Genomic Med"}, {"pmid_title_3": "Metformin paradoxically worsens insulin resistance in SHORT syndrome.", "pmid_3": 31583022.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Diabetol Metab Syndr"}, {"pmid_title_4": "Treatment of a case of severe insulin resistance as a result of a PIK3R1 mutation with a sodium-glucose cotransporter\u00a02 inhibitor.", "pmid_4": 29476696.0, "pmid_date_4": 2018.0, "pmid_journal_4": "J Diabetes Investig"}, {"pmid_title_5": "Clinical reappraisal of SHORT syndrome with PIK3R1 mutations: toward recommendation for molecular testing and management.", "pmid_5": 26497935.0, "pmid_date_5": 2016.0, "pmid_journal_5": "Clin Genet"}, {"pmid_title_6": "Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations.", "pmid_6": 27766312.0, "pmid_date_6": 2016.0, "pmid_journal_6": "JCI Insight"}, {"pmid_title_7": "SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling.", "pmid_7": 23810379.0, "pmid_date_7": 2013.0, "pmid_journal_7": "Am J Hum Genet"}]}, {"_id": "8979-OMIM:615214", "condition": {"condition_name": "AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE", "alternate_names": ["IMMUNODEFICIENCY 36", "AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE", "SHORT SYNDROME"]}, "gene information": {"db_hgnc_gene_id": 8979.0}, "interventions": [{"int_description_1": "Human immunoglobulin G", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Aggressive antibiotic therapy", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Vorhyaluronidase alfa"}], "references": [{"pmid_title_1": "Agammaglobulinemia", "pmid_1": 32310401.0, "pmid_date_1": 2020.0}, {"pmid_title_2": "Autosomal Recessive Agammaglobulinemia Due to a Homozygous Mutation in PIK3R1.", "pmid_2": 29178053.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Journal of clinical immunology"}, {"pmid_title_3": "Agammaglobulinemia and absent B lineage cells in a patient lacking the p85\u03b1 subunit of PI3K.", "pmid_3": 22351933.0, "pmid_date_3": 2012.0, "pmid_journal_3": "The Journal of experimental medicine"}]}, {"_id": "8979-OMIM:616005", "condition": {"condition_name": "IMMUNODEFICIENCY 36", "alternate_names": ["AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE", "IMMUNODEFICIENCY 36", "SHORT SYNDROME"]}, "gene information": {"db_hgnc_gene_id": 8979.0}, "interventions": [{"int_description_1": "Insulin human"}, {"int_description_2": "Human immunoglobulin G", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Cohort study or studies", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Sirolimus", "timeframe_int3": "Days or Weeks", "age_use_int3": "Infant,Child", "contra_int3": "Yes", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Still in Trials / Unproven"}, {"int_description_4": "Seletalisib"}, {"int_description_5": "Antibiotic therapy", "timeframe_int5": "Hours", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Cohort study or studies", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Vorhyaluronidase alfa"}, {"int_description_7": "Leniolisib (CDZ173)", "timeframe_int7": "Years", "age_use_int7": "Child", "contra_int7": "No", "qualscale_reclass_drug7": "Expert Opinion", "rev1_eff_reclass_drug7": "Still in Trials / Unproven"}, {"int_description_8": "Nemiralisib (GSK2269557)"}, {"int_description_9": "Adenoidectomy"}, {"int_description_10": "Bone marrow transplantation"}, {"int_description_11": "Haematopoietic stem cell transplantation", "timeframe_int11": "Days or Weeks,Years", "age_use_int11": "Child", "contra_int11": "No", "qualscale_reclass_drug11": "Case report(s)", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "Spleenectomy"}, {"int_description_13": "Tonsillectomy"}], "references": [{"pmid_title_1": "APDS2 and SHORT Syndrome in a Teenager with PIK3R1 Pathogenic Variant.", "pmid_1": 32778990.0, "pmid_date_1": 2020.0, "pmid_journal_1": "J Clin Immunol"}, {"pmid_title_2": "Activated phosphoinositide 3-kinase delta syndrome 1 and 2 (APDS 1 and APDS 2): similarities and differences based on clinical presentation in two boys.", "pmid_2": 32265996.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Allergy Asthma Clin Immunol"}, {"pmid_title_3": "Seletalisib for Activated PI3K\u03b4 Syndromes: Open-Label Phase 1b and Extension Studies.", "pmid_3": 33115853.0, "pmid_date_3": 2020.0, "pmid_journal_3": "J Immunol"}, {"pmid_title_4": "PIK3R1 Mutation Associated with Hyper IgM (APDS2 Syndrome): A Case Report and Review of the Literature.", "pmid_4": 30799802.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Endocr Metab Immune Disord Drug Targets"}, {"pmid_title_5": "Disseminated and Congenital Toxoplasmosis in a Mother and Child With Activated PI3-Kinase \u03b4 Syndrome Type 2 (APDS2): Case Report and a Literature Review of Toxoplasma Infections in Primary Immunodeficiencies.", "pmid_5": 30891027.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Front Immunol"}, {"pmid_title_6": "PI3K pathway defects leading to immunodeficiency and immune dysregulation.", "pmid_6": 31060715.0, "pmid_date_6": 2019.0, "pmid_journal_6": "J Allergy Clin Immunol"}, {"pmid_title_7": "Secondary C1q Deficiency in Activated PI3K\u03b4 Syndrome Type 2.", "pmid_7": 31781101.0, "pmid_date_7": 2019.0, "pmid_journal_7": "Front Immunol"}, {"pmid_title_8": "Hematopoietic cell transplantation in primary immunodeficiency - conventional and emerging indications.", "pmid_8": 29300535.0, "pmid_date_8": 2018.0, "pmid_journal_8": "Expert Rev Clin Immunol"}, {"pmid_title_9": "Respiratory Manifestations of the Activated Phosphoinositide 3-Kinase Delta Syndrome.", "pmid_9": 29556229.0, "pmid_date_9": 2018.0, "pmid_journal_9": "Front Immunol"}, {"pmid_title_10": "The Treatment of Activated PI3K\u03b4 Syndrome.", "pmid_10": 30245694.0, "pmid_date_10": 2018.0, "pmid_journal_10": "Front Immunol"}, {"pmid_title_11": "Activated PI3 Kinase Delta Syndrome: From Genetics to Therapy.", "pmid_11": 29535736.0, "pmid_date_11": 2018.0, "pmid_journal_11": "Front Immunol"}, {"pmid_title_12": "Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-\u03b4 Syndrome.", "pmid_12": 29599765.0, "pmid_date_12": 2018.0, "pmid_journal_12": "Front Immunol"}, {"pmid_title_13": "Long-term follow-up of an activated PI3K-\u03b4 syndrome 2 in patient presenting with an agammaglobulinemia phenotype.", "pmid_13": 30081089.0, "pmid_date_13": 2018.0, "pmid_journal_13": "Ann Allergy Asthma Immunol"}, {"pmid_title_14": "Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase \u03b4 Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase \u03b4 Syndrome Registry.", "pmid_14": 29599784.0, "pmid_date_14": 2018.0, "pmid_journal_14": "Front Immunol"}, {"pmid_title_15": "Type 1 diabetes mellitus associated with activated phosphatidylinositol 3-kinase delta syndrome, type 2.", "pmid_15": 29280567.0, "pmid_date_15": 2018.0, "pmid_journal_15": "J Diabetes"}, {"pmid_title_16": "Hematopoietic stem cell transplant in patients with activated PI3K delta syndrome.", "pmid_16": 27847301.0, "pmid_date_16": 2017.0, "pmid_journal_16": "J Allergy Clin Immunol"}, {"pmid_title_17": "Genetic defects in PI3K\u03b4 affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections.", "pmid_17": 28104464.0, "pmid_date_17": 2017.0, "pmid_journal_17": "Clin Immunol"}, {"pmid_title_18": "Variant PIK3R1 Hypermorphic Mutation and Clinical Phenotypes in a Family with Short Statures, Mild Immunodeficiency and Lymphoma.", "pmid_18": 28561224.0, "pmid_date_18": 2017.0, "pmid_journal_18": "Klin Padiatr"}, {"pmid_title_19": "Successful bone marrow transplantation in two sisters with activated phosphoinositide 3-kinase \u03b4 syndrome 2.", "pmid_19": 28869616.0, "pmid_date_19": 2017.0, "pmid_journal_19": "Bone Marrow Transplant"}, {"pmid_title_20": "Effective activated PI3K\u03b4 syndrome-targeted therapy with the PI3K\u03b4 inhibitor leniolisib.", "pmid_20": 28972011.0, "pmid_date_20": 2017.0, "pmid_journal_20": "Blood"}, {"pmid_title_21": "First-in-human studies of seletalisib, an orally bioavailable small-molecule PI3K\u03b4 inhibitor for the treatment of immune and inflammatory diseases.", "pmid_21": 28160012.0, "pmid_date_21": 2017.0, "pmid_journal_21": "Eur J Clin Pharmacol"}, {"pmid_title_22": "Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3K<i>\u03b4</i>.", "pmid_22": 28442583.0, "pmid_date_22": 2017.0, "pmid_journal_22": "J Pharmacol Exp Ther"}, {"pmid_title_23": "Activated PI3K\u03b4 syndrome type 2: Two patients, a novel mutation, and review of the literature.", "pmid_23": 27116393.0, "pmid_date_23": 2016.0, "pmid_journal_23": "Pediatr Allergy Immunol"}, {"pmid_title_24": "PI3K\u03b4 and primary immunodeficiencies.", "pmid_24": 27616589.0, "pmid_date_24": 2016.0, "pmid_journal_24": "Nat Rev Immunol"}, {"pmid_title_25": "Dominant Splice Site Mutations in PIK3R1 Cause Hyper IgM Syndrome, Lymphadenopathy and Short Stature.", "pmid_25": 27076228.0, "pmid_date_25": 2016.0, "pmid_journal_25": "J Clin Immunol"}, {"pmid_title_26": "Gain-of-function mutation in PIK3R1 in a patient with a narrow clinical phenotype of respiratory infections.", "pmid_26": 27693481.0, "pmid_date_26": 2016.0, "pmid_journal_26": "Clin Immunol"}, {"pmid_title_27": "De novo PIK3R1 gain-of-function with recurrent sinopulmonary infections, long-lasting chronic CMV-lymphadenitis and microcephaly.", "pmid_27": 26529633.0, "pmid_date_27": 2016.0, "pmid_journal_27": "Clin Immunol"}, {"pmid_title_28": "Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase \u03b4 syndrome 2: A\u00a0cohort study.", "pmid_28": 27221134.0, "pmid_date_28": 2016.0, "pmid_journal_28": "J Allergy Clin Immunol"}, {"pmid_title_29": "A new subcutaneous immune globulin (HyQvia) for primary immunodeficiency.", "pmid_29": 26305523.0, "pmid_date_29": 2015.0, "pmid_journal_29": "Med Lett Drugs Ther"}, {"pmid_title_30": "A human immunodeficiency caused by mutations in the PIK3R1 gene.", "pmid_30": 25133428.0, "pmid_date_30": 2014.0, "pmid_journal_30": "J Clin Invest"}, {"pmid_title_31": "Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K.", "pmid_31": 25488983.0, "pmid_date_31": 2014.0, "pmid_journal_31": "J Exp Med"}, {"pmid_title_32": "Safety and pharmacokinetics of subcutaneous ceftriaxone administered with or without recombinant human hyaluronidase (rHuPH20) versus intravenous ceftriaxone administration in adult volunteers.", "pmid_32": 19947907.0, "pmid_date_32": 2010.0, "pmid_journal_32": "Curr Med Res Opin"}]}, {"_id": "897-OMIM:300539", "condition": {"condition_name": "NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS", "pattern_of_inheritance": "X-linked recessive", "alternate_names": ["NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS", "DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED"]}, "gene information": {"db_hgnc_gene_id": 897.0}, "interventions": [{"int_description_1": "Desmopressin"}, {"int_description_2": "Tolvaptan", "timeframe_int2": "Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Cohort study or studies", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Demeclocycline"}, {"int_description_4": "Urea", "timeframe_int4": "Days or Weeks,Years", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Cohort study or studies", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "SR 121463"}, {"int_description_6": "Satavaptan", "timeframe_int6": "Days or Weeks,Years", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Cohort study or studies", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Sodium supplementation", "timeframe_int7": "Hours", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Cohort study or studies", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "AVP"}, {"int_description_9": "Fluid restriction", "timeframe_int9": "Hours,Days or Weeks", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Cohort study or studies", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Focus on neonatal and infantile onset of nephrogenic syndrome of inappropriate antidiuresis: 12\u00a0years later.", "pmid_1": 29546600.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Pediatr Nephrol"}, {"pmid_title_2": "Adult female with symptomatic AVPR2-related nephrogenic syndrome of inappropriate antidiuresis (NSIAD).", "pmid_2": 29472987.0, "pmid_date_2": 2018.0, "pmid_journal_2": "Endocrinol Diabetes Metab Case Rep"}, {"pmid_title_3": "Lack of responsiveness to 1-desamino-D arginin vasopressin (desmopressin) in male patients with nephrogenic syndrome of inappropriate antidiuresis: from bench to bedside.", "pmid_3": 21834801.0, "pmid_date_3": 2012.0, "pmid_journal_3": "Eur J Clin Invest"}, {"pmid_title_4": "Nephrogenic syndrome of inappropriate antidiuresis.", "pmid_4": 22518188.0, "pmid_date_4": 2012.0, "pmid_journal_4": "Int J Pediatr"}, {"pmid_title_5": "Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments.", "pmid_5": 20159941.0, "pmid_date_5": 2010.0, "pmid_journal_5": "Mol Pharmacol"}, {"pmid_title_6": "Thirst perception and arginine vasopressin production in a kindred with an activating mutation of the type 2 vasopressin receptor: the pathophysiology of nephrogenic syndrome of inappropriate antidiuresis.", "pmid_6": 19542240.0, "pmid_date_6": 2009.0, "pmid_journal_6": "Eur J Endocrinol"}, {"pmid_title_7": "Agonist-independent interactions between beta-arrestins and mutant vasopressin type II receptors associated with nephrogenic syndrome of inappropriate antidiuresis.", "pmid_7": 19179480.0, "pmid_date_7": 2009.0, "pmid_journal_7": "Mol Endocrinol"}, {"pmid_title_8": "Long-term outcomes in a family with nephrogenic syndrome of inappropriate antidiuresis.", "pmid_8": 20148077.0, "pmid_date_8": 2009.0, "pmid_journal_8": "Int J Pediatr Endocrinol"}, {"pmid_title_9": "Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree.", "pmid_9": 17229917.0, "pmid_date_9": 2007.0, "pmid_journal_9": "J Am Soc Nephrol"}, {"pmid_title_10": "Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children.", "pmid_10": 16423613.0, "pmid_date_10": 2006.0, "pmid_journal_10": "J Pediatr"}]}, {"_id": "897-OMIM:304800", "condition": {"condition_name": "DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED", "freq_per_birth": "The prevalence of nephrogenic diabetes insipidus is unknown, although the condition is thought to be rare. The acquired form occurs more frequently than the hereditary form.", "pattern_of_inheritance": "Autosomal dominant, X-linked recessive, Autosomal recessive", "alternate_names": ["DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED", "NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS"]}, "gene information": {"db_hgnc_gene_id": 897.0}, "interventions": [{"int_description_1": "5% dextrose in water"}, {"int_description_2": "Abundant water intake"}, {"int_description_3": "Dietary restriction of sodium (1 mmol/kg/day)"}, {"int_description_4": "Low sodium diet"}, {"int_description_5": "Low-salt, normal protein diet (2 - 2.5 mg of protein per kilogram daily)", "timeframe_int5": "Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Salt restricted, low protein diet", "timeframe_int6": "Hours", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Desmopressin", "timeframe_int7": "Hours", "age_use_int7": "Neonate,Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Vasopressin"}, {"int_description_9": "Conivaptan"}, {"int_description_10": "Lixivaptan"}, {"int_description_11": "Relcovaptan", "timeframe_int11": "Hours", "age_use_int11": "Neonate,Infant,Child", "contra_int11": "No", "qualscale_reclass_drug11": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "Tolvaptan"}, {"int_description_13": "Indomethacin", "timeframe_int13": "Days or Weeks", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Amiloride"}, {"int_description_15": "Hydrochlorothiazide"}, {"int_description_16": "Celecoxib"}, {"int_description_17": "Geneticin"}, {"int_description_18": "Valproic acid"}, {"int_description_19": "100 mmol/L trimethylamine oxide"}, {"int_description_20": "2% dimethyl sulfoxide"}, {"int_description_21": "Aldosterone antagonists"}, {"int_description_22": "SR 121463"}, {"int_description_23": "OPC-51803", "timeframe_int23": "Days or Weeks", "age_use_int23": "Neonate,Infant,Child", "contra_int23": "No", "qualscale_reclass_drug23": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug23": "Effective / Ameliorative"}, {"int_description_24": "Potassium"}, {"int_description_25": "MCF14 (OPC23h)"}, {"int_description_26": "MCF18 (VNA932)"}, {"int_description_27": "MCF57"}, {"int_description_28": "NSAIDs"}, {"int_description_29": "OPC23h"}, {"int_description_30": "OPC31260 (Mozavaptan)"}, {"int_description_31": "OPC41061"}, {"int_description_32": "Potassium-sparing diuretic"}, {"int_description_33": "Thiazide diuretic"}, {"int_description_34": "VA999088 (VA88)"}, {"int_description_35": "VA999089 (VA89)"}, {"int_description_36": "WAY-VNA-932"}, {"int_description_37": "Adenovirus-mediated gene transfer"}, {"int_description_38": "Bladder catheterization"}], "references": [{"pmid_title_1": "Hereditary Nephrogenic Diabetes Insipidus", "pmid_1": 20301356.0, "pmid_date_1": 2020.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "A female with X-linked Nephrogenic diabetes insipidus in a family with inherited central diabetes Insipidus: Case report and review of the literature.", "pmid_2": 32073219.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Am J Med Genet A"}, {"pmid_title_3": "Pharmacological Chaperones as Potential Therapeutic Strategies for Misfolded Mutant Vasopressin Receptors.", "pmid_3": 28939971.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Handb Exp Pharmacol"}, {"pmid_title_4": "Pharmacoperone rescue of vasopressin 2 receptor mutants reveals unexpected constitutive activity and coupling bias.", "pmid_4": 28767678.0, "pmid_date_4": 2017.0, "pmid_journal_4": "PLoS One"}, {"pmid_title_5": "Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).", "pmid_5": 27156763.0, "pmid_date_5": 2016.0, "pmid_journal_5": "Best Pract Res Clin Endocrinol Metab"}, {"pmid_title_6": "Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R Agonist.", "pmid_6": 27601473.0, "pmid_date_6": 2016.0, "pmid_journal_6": "J Biol Chem"}, {"pmid_title_7": "Mutations of Vasopressin Receptor 2 Including Novel L312S Have Differential Effects on Trafficking.", "pmid_7": 27355191.0, "pmid_date_7": 2016.0, "pmid_journal_7": "Mol Endocrinol"}, {"pmid_title_8": "Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.", "pmid_8": 25902753.0, "pmid_date_8": 2015.0, "pmid_journal_8": "Eur J Pediatr"}, {"pmid_title_9": "Vasopressin receptors and pharmacological chaperones: from functional rescue to promising therapeutic strategies.", "pmid_9": 24239889.0, "pmid_date_9": 2014.0, "pmid_journal_9": "Pharmacol Res"}, {"pmid_title_10": "Genetic analysis of a congenital nephrogenic diabetes insipidus pedigree.", "pmid_10": 24622440.0, "pmid_date_10": 2014.0, "pmid_journal_10": "Chin Med J (Engl)"}, {"pmid_title_11": "A novel deletion mutation of the arginine vasopressin receptor 2 gene in a Japanese infant with nephrogenic diabetes insipidus.", "pmid_11": 25374441.0, "pmid_date_11": 2014.0, "pmid_journal_11": "Clin Pediatr Endocrinol"}, {"pmid_title_12": "X-linked recessive nephrogenic diabetes insipidus: a clinico-genetic study.", "pmid_12": 24030030.0, "pmid_date_12": 2014.0, "pmid_journal_12": "J Pediatr Endocrinol Metab"}, {"pmid_title_13": "Clinical overview of nephrogenic diabetes insipidus based on a nationwide survey in Japan.", "pmid_13": 25324589.0, "pmid_date_13": 2014.0, "pmid_journal_13": "Yonago Acta Med"}, {"pmid_title_14": "Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.", "pmid_14": 23360744.0, "pmid_date_14": 2013.0, "pmid_journal_14": "Endocr Rev"}, {"pmid_title_15": "Use of Kikume green-red fusions to study the influence of pharmacological chaperones on trafficking of G protein-coupled receptors.", "pmid_15": 22306118.0, "pmid_date_15": 2012.0, "pmid_journal_15": "FEBS Lett"}, {"pmid_title_16": "V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists.", "pmid_16": 22144672.0, "pmid_date_16": 2012.0, "pmid_journal_16": "J Biol Chem"}, {"pmid_title_17": "Nephrogenic diabetes insipidus : Old deletion, new effect. A case report of a family from Greece.", "pmid_17": 24391420.0, "pmid_date_17": 2011.0, "pmid_journal_17": "Hippokratia"}, {"pmid_title_18": "Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus.", "pmid_18": 19729439.0, "pmid_date_18": 2009.0, "pmid_journal_18": "J Am Soc Nephrol"}, {"pmid_title_19": "Nephrogenic diabetes insipidus (NDI): clinical, laboratory and genetic characterization of five Brazilian patients.", "pmid_19": 19488606.0, "pmid_date_19": 2009.0, "pmid_journal_19": "Clinics (Sao Paulo)"}, {"pmid_title_20": "G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo.", "pmid_20": 17878512.0, "pmid_date_20": 2007.0, "pmid_journal_20": "Pharmacol Rev"}, {"pmid_title_21": "Pharmacological chaperones in nephrogenic diabetes insipidus: possibilities for clinical application.", "pmid_21": 17516711.0, "pmid_date_21": 2007.0, "pmid_journal_21": "BioDrugs"}, {"pmid_title_22": "Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.", "pmid_22": 17371330.0, "pmid_date_22": 2007.0, "pmid_journal_22": "Nephrology (Carlton)"}, {"pmid_title_23": "Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus.", "pmid_23": 16926443.0, "pmid_date_23": 2007.0, "pmid_journal_23": "Am J Physiol Renal Physiol"}, {"pmid_title_24": "Relief of nocturnal enuresis by desmopressin is kidney and vasopressin type 2 receptor independent.", "pmid_24": 17389737.0, "pmid_date_24": 2007.0, "pmid_journal_24": "J Am Soc Nephrol"}, {"pmid_title_25": "Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus.", "pmid_25": 16319185.0, "pmid_date_25": 2006.0, "pmid_journal_25": "J Am Soc Nephrol"}, {"pmid_title_26": "Genetics of vasopressin receptors.", "pmid_26": 14972085.0, "pmid_date_26": 2004.0, "pmid_journal_26": "Curr Hypertens Rep"}, {"pmid_title_27": "Aminoglycoside-mediated rescue of a disease-causing nonsense mutation in the V2 vasopressin receptor gene in vitro and in vivo.", "pmid_27": 14998935.0, "pmid_date_27": 2004.0, "pmid_journal_27": "Hum Mol Genet"}, {"pmid_title_28": "Appropriate polarization following pharmacological rescue of V2 vasopressin receptors encoded by X-linked nephrogenic diabetes insipidus alleles involves a conformation of the receptor that also attains mature glycosylation.", "pmid_28": 12824183.0, "pmid_date_28": 2003.0, "pmid_journal_28": "J Biol Chem"}, {"pmid_title_29": "Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system.", "pmid_29": 12584270.0, "pmid_date_29": 2003.0, "pmid_journal_29": "Nephrol Dial Transplant"}, {"pmid_title_30": "Aminoglycoside pretreatment partially restores the function of truncated V(2) vasopressin receptors found in patients with nephrogenic diabetes insipidus.", "pmid_30": 12414899.0, "pmid_date_30": 2002.0, "pmid_journal_30": "J Clin Endocrinol Metab"}, {"pmid_title_31": "Nephrogenic diabetes insipidus.", "pmid_31": 11181969.0, "pmid_date_31": 2001.0, "pmid_journal_31": "Annu Rev Physiol"}, {"pmid_title_32": "Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants.", "pmid_32": 10749568.0, "pmid_date_32": 2000.0, "pmid_journal_32": "J Clin Invest"}, {"pmid_title_33": "Effect of DDAVP on nocturnal enuresis in a patient with nephrogenic diabetes insipidus.", "pmid_33": 10373137.0, "pmid_date_33": 1999.0, "pmid_journal_33": "Arch Dis Child"}, {"pmid_title_34": "Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus.", "pmid_34": 10477148.0, "pmid_date_34": 1999.0, "pmid_journal_34": "J Am Soc Nephrol"}, {"pmid_title_35": "AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus.", "pmid_35": 9853256.0, "pmid_date_35": 1998.0, "pmid_journal_35": "Kidney Int"}, {"pmid_title_36": "Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication.", "pmid_36": 9294123.0, "pmid_date_36": 1997.0, "pmid_journal_36": "J Clin Invest"}, {"pmid_title_37": "Molecular biology of diabetes insipidus.", "pmid_37": 7541187.0, "pmid_date_37": 1995.0, "pmid_journal_37": "Annu Rev Med"}, {"pmid_title_38": "Mutations in the vasopressin V2-receptor gene in three families of Italian descent with nephrogenic diabetes insipidus.", "pmid_38": 7833930.0, "pmid_date_38": 1994.0, "pmid_journal_38": "Hum Mol Genet"}]}, {"_id": "89-OMIM:201450", "condition": {"condition_name": "ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF; ACADMD", "freq_per_birth": "In the United States, the estimated incidence of MCAD deficiency is 1 in 17,000 people. The condition is more common in people of northern European ancestry than in other ethnic groups.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF; ACADMD"]}, "gene information": {"db_hgnc_gene_id": 89.0}, "interventions": [{"int_description_1": "Levocarnitine", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "Yes", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Starch, corn"}, {"int_description_3": "Sodium bicarbonate", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "D-glucose"}, {"int_description_5": "Extracorporeal membrane oxygenation"}, {"int_description_6": "Strict avoidance of fasting (fed every 3-6 hours)", "timeframe_int6": "Hours,Days or Weeks", "age_use_int6": "Neonate,Infant", "contra_int6": "No", "qualscale_reclass_drug6": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency", "pmid_1": 20301597.0, "pmid_date_1": 2019.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Medium-chain acyl-Coenzyme A dehydrogenase deficiency (MCADD): a cause of severe hypoglycaemia in an apparently well child.", "pmid_2": 27903579.0, "pmid_date_2": 2016.0, "pmid_journal_2": "BMJ case reports"}, {"pmid_title_3": "Medium-chain Acyl-CoA dehydrogenase deficiency presenting with neonatal pulmonary haemorrhage.", "pmid_3": 27057325.0, "pmid_date_3": 2015.0, "pmid_journal_3": "Maternal health, neonatology and perinatology"}, {"pmid_title_4": "Resuscitation of a neonate with medium chain acyl-coenzyme a dehydrogenase deficiency using extracorporeal life support.", "pmid_4": 24403369.0, "pmid_date_4": 2014.0, "pmid_journal_4": "World journal for pediatric & congenital heart surgery"}, {"pmid_title_5": "Experimental evidence for protein oxidative damage and altered antioxidant defense in patients with medium-chain acyl-CoA dehydrogenase deficiency.", "pmid_5": 24623196.0, "pmid_date_5": 2014.0, "pmid_journal_5": "Journal of inherited metabolic disease"}, {"pmid_title_6": "Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: regional experience and high incidence of carnitine deficiency.", "pmid_6": 23842438.0, "pmid_date_6": 2013.0, "pmid_journal_6": "Orphanet journal of rare diseases"}, {"pmid_title_7": "Clinical, biochemical and genetic analyses in two Korean patients with medium-chain acyl-CoA dehydrogenase deficiency.", "pmid_7": 21239873.0, "pmid_date_7": 2011.0, "pmid_journal_7": "The Korean journal of laboratory medicine"}, {"pmid_title_8": "Relevance of expanded neonatal screening of medium-chain acyl co-a dehydrogenase deficiency: outcome of a decade in galicia (Spain).", "pmid_8": 23430840.0, "pmid_date_8": 2011.0, "pmid_journal_8": "JIMD reports"}, {"pmid_title_9": "Management of fatty acid oxidation disorders: a survey of current treatment strategies.", "pmid_9": 12487544.0, "pmid_date_9": 2002.0, "pmid_journal_9": "Journal of the American Dietetic Association"}, {"pmid_title_10": "Outcome of medium chain acyl-CoA dehydrogenase deficiency after diagnosis.", "pmid_10": 10208954.0, "pmid_date_10": 1999.0, "pmid_journal_10": "Archives of disease in childhood"}, {"pmid_title_11": "Early diagnosis and treatment of neonatal medium-chain acyl-CoA dehydrogenase deficiency: report of two siblings.", "pmid_11": 2347356.0, "pmid_date_11": 1990.0, "pmid_journal_11": "European journal of pediatrics"}, {"pmid_title_12": "Medium-chain acyl-CoA dehydrogenase deficiency: metabolic effects and therapeutic efficacy of long-term L-carnitine supplementation.", "pmid_12": 2502671.0, "pmid_date_12": 1989.0, "pmid_journal_12": "Journal of inherited metabolic disease"}]}, {"_id": "9008-OMIM:173900", "condition": {"condition_name": "POLYCYSTIC KIDNEY DISEASE 1 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE", "freq_per_birth": "Polycystic kidney disease is a fairly common genetic disorder. It affects about 500,000 people in the United States. The autosomal dominant form of the disease is much more common than the autosomal recessive form. Autosomal dominant polycystic kidney disease affects 1 in 500 to 1,000 people, while the autosomal recessive type occurs in an estimated 1 in 20,000 to 40,000 people.", "pattern_of_inheritance": "Autosomal dominant, Autosomal recessive", "alternate_names": ["POLYCYSTIC KIDNEY DISEASE 1 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE"]}, "gene information": {"db_hgnc_gene_id": 9008.0}, "interventions": [{"int_description_1": "Dialysis"}, {"int_description_2": "Extracorporeal shock-wave lithotripsy"}, {"int_description_3": "Face-mask continuous positive airway pressure"}, {"int_description_4": "Parenteral nutrition"}, {"int_description_5": "Ethanol"}, {"int_description_6": "Fenofibrate"}, {"int_description_7": "Pasireotide"}, {"int_description_8": "Lanreotide"}, {"int_description_9": "Octreotide"}, {"int_description_10": "Tolvaptan"}, {"int_description_11": "Metronidazole"}, {"int_description_12": "Sirolimus"}, {"int_description_13": "Furosemide"}, {"int_description_14": "Captopril"}, {"int_description_15": "Chloramphenicol"}, {"int_description_16": "Minocycline"}, {"int_description_17": "Clindamycin"}, {"int_description_18": "Trimethoprim"}, {"int_description_19": "Sulfamethoxazole"}, {"int_description_20": "Vancomycin"}, {"int_description_21": "Tranexamic acid"}, {"int_description_22": "Bosutinib"}, {"int_description_23": "Allopurinol"}, {"int_description_24": "Potassium citrate"}, {"int_description_25": "ACE inhibitors"}, {"int_description_26": "Angiotensin II receptor antagonists"}, {"int_description_27": "Sodium chloride"}, {"int_description_28": "Fluoroquinolones"}, {"int_description_29": "mTOR inhibitors"}, {"int_description_30": "Torin2"}, {"int_description_31": "Blood transfusions"}, {"int_description_32": "Supplementary oxygen"}, {"int_description_33": "Urine alkalinization"}, {"int_description_34": "Cyst aspiration"}, {"int_description_35": "Endovascular treatment with detachable platinum coils"}, {"int_description_36": "Hand-assisted laparoscopic nephrectomy"}, {"int_description_37": "Hepatic artery embolization"}, {"int_description_38": "Kidney transplant"}, {"int_description_39": "Laparoscopic and retroperitonoscopic nephrectomy and arterial embolization"}, {"int_description_40": "Laparoscopic fenestration of hepatic cysts"}, {"int_description_41": "Laparoscopic renal cyst fenestration"}, {"int_description_42": "Liver transplant"}, {"int_description_43": "Percutaneous nephrostolithotomy"}, {"int_description_44": "Renal denervation"}, {"int_description_45": "Replacement of the aorta"}, {"int_description_46": "Segmental arterial embolization"}, {"int_description_47": "Surgical clipping of ruptured aneurysm"}, {"int_description_48": "Surgical renal cyst fenestration"}], "references": [{"pmid_title_1": "A study of sirolimus and mTOR kinase inhibitor in a hypomorphic <i>Pkd1</i> mouse model of autosomal dominant polycystic kidney disease.", "pmid_1": 31042058.0, "pmid_date_1": 2019.0, "pmid_journal_1": "American journal of physiology. Renal physiology"}, {"pmid_title_2": "Polycystic Kidney Disease, Autosomal Dominant", "pmid_2": 20301424.0, "pmid_date_2": 2018.0, "pmid_journal_2": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_3": "PPAR\u03b1 agonist fenofibrate enhances fatty acid \u03b2-oxidation and attenuates polycystic kidney and liver disease in mice.", "pmid_3": 28903946.0, "pmid_date_3": 2018.0, "pmid_journal_3": "American journal of physiology. Renal physiology"}, {"pmid_title_4": "Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease.", "pmid_4": 28194574.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Pediatric nephrology (Berlin, Germany)"}, {"pmid_title_5": "Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model.", "pmid_5": 24994926.0, "pmid_date_5": 2015.0, "pmid_journal_5": "Journal of the American Society of Nephrology : JASN"}]}, {"_id": "9009-OMIM:613095", "condition": {"condition_name": "POLYCYSTIC KIDNEY DISEASE 2 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD2", "freq_per_birth": "Polycystic kidney disease is a fairly common genetic disorder. It affects about 500,000 people in the United States. The autosomal dominant form of the disease is much more common than the autosomal recessive form. Autosomal dominant polycystic kidney disease affects 1 in 500 to 1,000 people, while the autosomal recessive type occurs in an estimated 1 in 20,000 to 40,000 people.", "pattern_of_inheritance": "Autosomal dominant==Autosomal recessive", "alternate_names": ["POLYCYSTIC KIDNEY DISEASE 2 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD2"]}, "gene information": {"db_hgnc_gene_id": 9009.0}, "interventions": [{"int_description_1": "Dialysis"}, {"int_description_2": "Extracorporeal shock-wave lithotripsy"}, {"int_description_3": "Ethanol"}, {"int_description_4": "Pasireotide"}, {"int_description_5": "Lanreotide"}, {"int_description_6": "Octreotide"}, {"int_description_7": "Tolvaptan"}, {"int_description_8": "Metronidazole"}, {"int_description_9": "Chloramphenicol"}, {"int_description_10": "Minocycline"}, {"int_description_11": "Clindamycin"}, {"int_description_12": "Trimethoprim"}, {"int_description_13": "Sulfamethoxazole"}, {"int_description_14": "Vancomycin"}, {"int_description_15": "Chloroquine"}, {"int_description_16": "Tranexamic acid"}, {"int_description_17": "Bosutinib"}, {"int_description_18": "Allopurinol"}, {"int_description_19": "Potassium citrate"}, {"int_description_20": "ACE inhibitors"}, {"int_description_21": "Angiotensin II receptor antagonists"}, {"int_description_22": "Fluoroquinolones"}, {"int_description_23": "mTOR inhibitors"}, {"int_description_24": "Blood transfusions"}, {"int_description_25": "Urine alkalinization"}, {"int_description_26": "Cyst aspiration"}, {"int_description_27": "Endovascular treatment with detachable platinum coils"}, {"int_description_28": "Hand-assisted laparoscopic nephrectomy"}, {"int_description_29": "Hepatic artery embolization"}, {"int_description_30": "Kidney transplant"}, {"int_description_31": "Laparoscopic and retroperitonoscopic nephrectomy and arterial embolization"}, {"int_description_32": "Laparoscopic fenestration of hepatic cysts"}, {"int_description_33": "Laparoscopic renal cyst fenestration"}, {"int_description_34": "Liver transplant"}, {"int_description_35": "Percutaneous nephrostolithotomy"}, {"int_description_36": "Renal denervation"}, {"int_description_37": "Replacement of the aorta"}, {"int_description_38": "Segmental arterial embolization"}, {"int_description_39": "Surgical clipping of ruptured aneurysm"}, {"int_description_40": "Surgical renal cyst fenestration"}], "references": [{"pmid_title_1": "Polycystic Kidney Disease, Autosomal Dominant", "pmid_1": 20301424.0, "pmid_date_1": 2018.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Targeted rescue of a polycystic kidney disease mutation by lysosomal inhibition.", "pmid_2": 26924047.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Kidney international"}]}, {"_id": "9020-OMIM:266200", "condition": {"condition_name": "PYRUVATE KINASE DEFICIENCY OF RED CELLS", "freq_per_birth": "Pyruvate kinase deficiency is the most common inherited cause of nonspherocytic hemolytic anemia. More than 500 affected families have been identified, and studies suggest that the disorder may be underdiagnosed because mild cases may not be identified.Pyruvate kinase deficiency is found in all ethnic groups. Its prevalence has been estimated at 1 in 20,000 people of European descent. It is more common in the Old Order Amish population of Pennsylvania.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["PYRUVATE KINASE DEFICIENCY OF RED CELLS"]}, "gene information": {"db_hgnc_gene_id": 9020.0}, "interventions": [{"int_description_1": "Frequent transfusions"}, {"int_description_2": "Red blood cell transfusions", "timeframe_int2": "Hours,Days or Weeks,Years", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Hematopoietic stem cell transplantation", "timeframe_int3": "Days or Weeks,Years", "age_use_int3": "Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Splenectomy", "timeframe_int4": "Days or Weeks,Years", "age_use_int4": "Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "The variable manifestations of disease in pyruvate kinase deficiency and their management.", "pmid_1": 32165483.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Haematologica"}, {"pmid_title_2": "Novel mutations associated with pyruvate kinase deficiency in Brazil.", "pmid_2": 29519373.0, "pmid_date_2": 2017.0, "pmid_journal_2": "Hematol Transfus Cell Ther"}, {"pmid_title_3": "Molecular and clinical heterogeneity in pyruvate kinase deficiency in India.", "pmid_3": 23770304.0, "pmid_date_3": 2013.0, "pmid_journal_3": "Blood cells, molecules & diseases"}, {"pmid_title_4": "Molecular abnormality of erythrocyte pyruvate kinase deficiency in the Amish.", "pmid_4": 8161798.0, "pmid_date_4": 1994.0, "pmid_journal_4": "Blood"}]}, {"_id": "9115-OMIM:212065", "condition": {"condition_name": "CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A", "freq_per_birth": "More than 800 individuals with PMM2-CDG have been identified worldwide.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A"]}, "gene information": {"db_hgnc_gene_id": 9115.0}, "interventions": [{"int_description_1": "Human immunoglobulin G"}, {"int_description_2": "Midazolam"}, {"int_description_3": "Diazoxide"}, {"int_description_4": "Antibiotic infusion monotherapy", "timeframe_int4": "Hours", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "Lorazepam"}, {"int_description_6": "Physical Exercise Training"}, {"int_description_7": "Speech therapy"}, {"int_description_8": "Cervical spine stabilization"}], "references": [{"pmid_title_1": "International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up.", "pmid_1": 30740725.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Journal of inherited metabolic disease"}, {"pmid_title_2": "PMM2-CDG (<i>CDG-Ia</i>)", "pmid_2": 20301289.0, "pmid_date_2": 2015.0, "pmid_journal_2": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_3": "Congenital disorder of glycosylation type Ia: heterogeneity in the clinical presentation from multivisceral failure to hyperinsulinaemic hypoglycaemia as leading symptoms in three infants with phosphomannomutase deficiency.", "pmid_3": 19396570.0, "pmid_date_3": 2009.0, "pmid_journal_3": "Journal of inherited metabolic disease"}]}, {"_id": "9208-OMIM:201750", "condition": {"condition_name": "ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1", "freq_per_birth": "The prevalence of cytochrome P450 oxidoreductase deficiency is unknown. About 65 cases have been reported worldwide.Researchers suspect that cytochrome P450 oxidoreductase deficiency is underdiagnosed and that mild cases of this disorder may be relatively common. Because the signs and symptoms can be difficult to detect, people with mild cytochrome P450 oxidoreductase deficiency may never come to medical attention.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY", "ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1", "ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 9208.0}, "interventions": [{"int_description_1": "Testosterone enanthate"}, {"int_description_2": "Hormone replacement therapy"}, {"int_description_3": "Hypospadias surgical repair"}, {"int_description_4": "Ovariectomy"}], "references": [{"pmid_title_1": "Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients.", "pmid_1": 15483095.0, "pmid_date_1": 2005.0, "pmid_journal_1": "The Journal of clinical endocrinology and metabolism"}]}, {"_id": "9210-OMIM:613038", "condition": {"condition_name": "PITUITARY HORMONE DEFICIENCY, COMBINED, 1; CPHD1", "freq_per_birth": "The prevalence of combined pituitary hormone deficiency is estimated to be 1 in 8,000 individuals worldwide.", "pattern_of_inheritance": "Autosomal recessive==Autosomal dominant", "alternate_names": ["PITUITARY HORMONE DEFICIENCY, COMBINED, 1; CPHD1"]}, "gene information": {"db_hgnc_gene_id": 9210.0}, "interventions": [{"int_description_1": "Levothyroxine", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No"}, {"int_description_2": "Somatotropin", "rev1_eff_reclass_drug2": "Curative"}, {"int_description_3": "Hydrocortisone"}, {"int_description_4": "Sex steroid replacement therapy"}], "references": [{"pmid_title_1": "<i>PROP1</i>-Related Combined Pituitary Hormone Deficiency", "pmid_1": 20301521.0, "pmid_date_1": 2014.0, "pmid_journal_1": "GeneReviews\u00ae"}, {"pmid_title_2": "Auxological and endocrine phenotype in a population-based cohort of patients with PROP1 gene defects.", "pmid_2": 16131601.0, "pmid_date_2": 2005.0, "pmid_journal_2": "European journal of endocrinology"}, {"pmid_title_3": "Absent or delayed adrenarche in Pit-1/POU1F1 deficiency.", "pmid_3": 16210857.0, "pmid_date_3": 2005.0, "pmid_journal_3": "Hormone research"}, {"pmid_title_4": "Combined pituitary hormone deficiency in Australian children: clinical and genetic correlates.", "pmid_4": 12780757.0, "pmid_date_4": 2003.0, "pmid_journal_4": "Clinical endocrinology"}]}, {"_id": "92-OMIM:201475", "condition": {"condition_name": "ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF; ACADVLD", "freq_per_birth": "VLCAD deficiency is estimated to affect 1 in 40,000 to 120,000 people.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF; ACADVLD"]}, "gene information": {"db_hgnc_gene_id": 92.0}, "interventions": [{"int_description_1": "Low-fat diet with supplemental calories provided through medium-chain triglycerides (MCT)"}, {"int_description_2": "Ubidecarenone"}, {"int_description_3": "Bezafibrate"}, {"int_description_4": "Ascorbic acid", "timeframe_int4": "Hours,Days or Weeks", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "rev1_eff_reclass_drug4": "Still in Trials / Unproven"}, {"int_description_5": "Levocarnitine"}, {"int_description_6": "Gluconolactone"}, {"int_description_7": "Riboflavin"}, {"int_description_8": "Triheptanoin", "timeframe_int8": "Hours", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Starch, corn", "timeframe_int9": "Hours,Days or Weeks", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Medium-chain triglycerides"}, {"int_description_11": "Vitamin B complex", "timeframe_int11": "Hours,Days or Weeks", "age_use_int11": "Neonate,Infant,Child", "contra_int11": "No", "qualscale_reclass_drug11": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug11": "Effective / Ameliorative"}, {"int_description_12": "D-glucose"}, {"int_description_13": "Extracorporeal membrane oxygenation"}, {"int_description_14": "Strict avoidance of fasting (fed every 3-6 hours)", "timeframe_int14": "Hours,Days or Weeks", "age_use_int14": "Neonate,Infant", "contra_int14": "No", "qualscale_reclass_drug14": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "One potential hotspot ACADVL mutation in Chinese patients with very-long-chain acyl-coenzyme A dehydrogenase deficiency.", "pmid_1": 31794763.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Clinica chimica acta; international journal of clinical chemistry"}, {"pmid_title_2": "Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency", "pmid_2": 20301763.0, "pmid_date_2": 2019.0, "pmid_journal_2": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_3": "Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency.", "pmid_3": 30401918.0, "pmid_date_3": 2019.0, "pmid_journal_3": "Journal of human genetics"}, {"pmid_title_4": "Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan; 2nd report QOL survey.", "pmid_4": 31372341.0, "pmid_date_4": 2019.0, "pmid_journal_4": "Molecular genetics and metabolism reports"}, {"pmid_title_5": "Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan.", "pmid_5": 29552494.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Molecular genetics and metabolism reports"}, {"pmid_title_6": "Treatable massive pericardial effusion and hypertrophic cardiomyopathy in an infant with a novel homozygous ACADVL mutation: A case report.", "pmid_6": 29768383.0, "pmid_date_6": 2018.0, "pmid_journal_6": "Medicine"}, {"pmid_title_7": "Triheptanoin treatment in patients with pediatric cardiomyopathy associated with long chain-fatty acid oxidation disorders.", "pmid_7": 27590926.0, "pmid_date_7": 2016.0, "pmid_journal_7": "Molecular genetics and metabolism"}, {"pmid_title_8": "Very long-chain acyl-coenzyme A dehydrogenase deficiency in Chinese patients: eight case reports, including one case of prenatal diagnosis.", "pmid_8": 25652019.0, "pmid_date_8": 2015.0, "pmid_journal_8": "European journal of medical genetics"}, {"pmid_title_9": "Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop.", "pmid_9": 19399638.0, "pmid_date_9": 2009.0, "pmid_journal_9": "Journal of inherited metabolic disease"}, {"pmid_title_10": "Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency.", "pmid_10": 19327992.0, "pmid_date_10": 2009.0, "pmid_journal_10": "Neuromuscular disorders : NMD"}, {"pmid_title_11": "Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride.", "pmid_11": 12122118.0, "pmid_date_11": 2002.0, "pmid_journal_11": "The Journal of clinical investigation"}, {"pmid_title_12": "A severe genotype with favourable outcome in very long chain acyl-CoA dehydrogenase deficiency.", "pmid_12": 11124787.0, "pmid_date_12": 2001.0, "pmid_journal_12": "Archives of disease in childhood"}, {"pmid_title_13": "Acute, severe cardiomyopathy as main symptom of late-onset very long-chain acyl-coenzyme A dehydrogenase deficiency.", "pmid_13": 9877038.0, "pmid_date_13": 1998.0, "pmid_journal_13": "European journal of pediatrics"}, {"pmid_title_14": "Reversal of severe hypertrophic cardiomyopathy and excellent neuropsychologic outcome in very-long-chain acyl-coenzyme A dehydrogenase deficiency.", "pmid_14": 9709714.0, "pmid_date_14": 1998.0, "pmid_journal_14": "The Journal of pediatrics"}]}, {"_id": "9360-OMIM:603553", "condition": {"condition_name": "HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2; FHL2", "freq_per_birth": "Familial hemophagocytic lymphohistiocytosis occurs in approximately 1 in 50,000 individuals worldwide.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2; FHL2", "APLASTIC ANEMIA"]}, "gene information": {"db_hgnc_gene_id": 9360.0}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Dexamethasone"}, {"int_description_3": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_4": "Cyclosporine"}, {"int_description_5": "Methotrexate"}, {"int_description_6": "Etoposide"}, {"int_description_7": "HLH-2004 treatment protocol", "timeframe_int7": "Hours", "age_use_int7": "Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Hematopoietic stem cell transplantation", "timeframe_int8": "Days or Weeks,Years", "age_use_int8": "Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Curative"}, {"int_description_9": "Splenectomy"}], "references": [{"pmid_title_1": "Type 2 familial hemophagocytic lymphohistiocytosis in half brothers: A case report.", "pmid_1": 30045285.0, "pmid_date_1": 2018.0, "pmid_journal_1": "Medicine"}, {"pmid_title_2": "Spectrum of Atypical Clinical Presentations in Patients with Biallelic PRF1 Missense Mutations.", "pmid_2": 26184781.0, "pmid_date_2": 2015.0, "pmid_journal_2": "Pediatric blood & cancer"}, {"pmid_title_3": "Approach to hemophagocytic syndromes.", "pmid_3": 22160031.0, "pmid_date_3": 2011.0, "pmid_journal_3": "Hematology. American Society of Hematology. Education Program"}, {"pmid_title_4": "Neonatal primary hemophagocytic lymphohistiocytosis in Turkish children.", "pmid_4": 19131769.0, "pmid_date_4": 2008.0, "pmid_journal_4": "Journal of pediatric hematology/oncology"}]}, {"_id": "93-OMIM:203750", "condition": {"condition_name": "ALPHA-METHYLACETOACETIC ACIDURIA", "freq_per_birth": "Beta-ketothiolase deficiency appears to be very rare. Fewer than 250 affected individuals have been reported in the medical literature.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["ALPHA-METHYLACETOACETIC ACIDURIA"]}, "gene information": {"db_hgnc_gene_id": 93.0}, "interventions": [{"int_description_1": "Restricted animal proteins diet", "timeframe_int1": "Hours", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Cohort study or studies", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Insulin human", "timeframe_int2": "Hours", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Cohort study or studies", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Levocarnitine"}, {"int_description_4": "Sodium bicarbonate", "timeframe_int4": "Hours", "age_use_int4": "Neonate,Infant,Child", "contra_int4": "No", "qualscale_reclass_drug4": "Cohort study or studies", "rev1_eff_reclass_drug4": "Effective / Ameliorative"}, {"int_description_5": "D-glucose", "timeframe_int5": "Days or Weeks", "age_use_int5": "Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Cohort study or studies", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}], "references": [{"pmid_title_1": "Recent advances in understanding beta-ketothiolase (mitochondrial acetoacetyl-CoA thiolase, T2) deficiency.", "pmid_1": 30393371.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Journal of human genetics"}, {"pmid_title_2": "Beta-ketothiolase deficiency: A case with unusual presentation of nonketotic hypoglycemic episodes due to coexistent probable secondary carnitine deficiency.", "pmid_2": 31240151.0, "pmid_date_2": 2019.0, "pmid_journal_2": "JIMD reports"}, {"pmid_title_3": "Beta-Ketothiolase Deficiency Presenting with Metabolic Stroke After a Normal Newborn Screen in Two Individuals.", "pmid_3": 28726122.0, "pmid_date_3": 2018.0, "pmid_journal_3": "JIMD reports"}, {"pmid_title_4": "Characterization and outcome of 41 patients with beta-ketothiolase deficiency: 10\u00a0years' experience of a medical center in northern Vietnam.", "pmid_4": 28220263.0, "pmid_date_4": 2017.0, "pmid_journal_4": "Journal of inherited metabolic disease"}]}, {"_id": "9413-OMIM:615966", "condition": {"condition_name": "IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES"]}, "gene information": {"db_hgnc_gene_id": 9413.0}, "interventions": [{"int_description_1": "Mechanical ventilation"}, {"int_description_2": "Nasal continuous positive airway pressure treatment"}, {"int_description_3": "Transfer factor"}, {"int_description_4": "Testosterone"}, {"int_description_5": "Salmeterol"}, {"int_description_6": "Ursodeoxycholic acid"}, {"int_description_7": "Sargramostim"}, {"int_description_8": "Dopamine"}, {"int_description_9": "Prednisolone"}, {"int_description_10": "Prednisone", "timeframe_int10": "Days or Weeks", "age_use_int10": "Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Fluticasone"}, {"int_description_12": "Ketoconazole"}, {"int_description_13": "Ganciclovir"}, {"int_description_14": "Human immunoglobulin G"}, {"int_description_15": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_16": "Midazolam"}, {"int_description_17": "Rituximab"}, {"int_description_18": "Alemtuzumab"}, {"int_description_19": "Clarithromycin"}, {"int_description_20": "Cyclosporine"}, {"int_description_21": "Clofazimine"}, {"int_description_22": "Isoniazid"}, {"int_description_23": "Amphotericin B"}, {"int_description_24": "Budesonide"}, {"int_description_25": "Somatotropin"}, {"int_description_26": "Piperacillin"}, {"int_description_27": "Vitamin D"}, {"int_description_28": "Levetiracetam"}, {"int_description_29": "Cyclophosphamide"}, {"int_description_30": "Busulfan"}, {"int_description_31": "Melphalan", "timeframe_int31": "Days or Weeks", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Thiotepa"}, {"int_description_33": "Caspofungin"}, {"int_description_34": "Amikacin"}, {"int_description_35": "Pyrazinamide"}, {"int_description_36": "Linezolid"}, {"int_description_37": "Pyridoxine"}, {"int_description_38": "Ethambutol"}, {"int_description_39": "Azithromycin"}, {"int_description_40": "Trimethoprim"}, {"int_description_41": "Sulfamethoxazole"}, {"int_description_42": "Ciprofloxacin"}, {"int_description_43": "Ofloxacin"}, {"int_description_44": "Fusidic acid"}, {"int_description_45": "Ampicillin"}, {"int_description_46": "Cefotaxime"}, {"int_description_47": "Meropenem"}, {"int_description_48": "Amoxicillin"}, {"int_description_49": "Cefuroxime"}, {"int_description_50": "Ceftriaxone"}, {"int_description_51": "Cefazolin"}, {"int_description_52": "Cefoperazone"}, {"int_description_53": "Latamoxef"}, {"int_description_54": "Sulbactam"}, {"int_description_55": "Clavulanic acid"}, {"int_description_56": "Treosulfan"}, {"int_description_57": "Atovaquone"}, {"int_description_58": "Rifampicin"}, {"int_description_59": "Fluconazole"}, {"int_description_60": "Itraconazole"}, {"int_description_61": "Pyrimethamine"}, {"int_description_62": "Methotrexate"}, {"int_description_63": "Sulfadoxine"}, {"int_description_64": "Levofloxacin"}, {"int_description_65": "Fludarabine"}, {"int_description_66": "Pentamidine"}, {"int_description_67": "Vancomycin"}, {"int_description_68": "Tacrolimus"}, {"int_description_69": "Valproic acid"}, {"int_description_70": "Foscarnet"}, {"int_description_71": "Acyclovir"}, {"int_description_72": "Cidofovir"}, {"int_description_73": "Mycophenolate mofetil"}, {"int_description_74": "Ledipasvir"}, {"int_description_75": "Oxacillin"}, {"int_description_76": "Omeprazole"}, {"int_description_77": "Methylprednisolone"}, {"int_description_78": "Methimazole"}, {"int_description_79": "Infliximab"}, {"int_description_80": "Interferon alfa-2a, Recombinant"}, {"int_description_81": "Anti Thymocyte Globulin"}, {"int_description_82": "Anti-CD45 antibodies"}, {"int_description_83": "CMV hyperImmunoglobulin"}, {"int_description_84": "Nystatin"}, {"int_description_85": "Teicoplanin"}, {"int_description_86": "Sofosbuvir"}, {"int_description_87": "Antilymphocyte immunoglobulin (horse)", "timeframe_int87": "Days or Weeks", "age_use_int87": "Infant,Child", "contra_int87": "No", "qualscale_reclass_drug87": "Case report(s)", "rev1_eff_reclass_drug87": "Effective / Ameliorative"}, {"int_description_88": "Human interleukin-2"}, {"int_description_89": "Thymic hormone"}, {"int_description_90": "Thyroid hormone"}, {"int_description_91": "Thyroxin"}, {"int_description_92": "Phenobarbital"}, {"int_description_93": "Filgrastim"}, {"int_description_94": "2'-Deoxycytidine"}, {"int_description_95": "Irradiated blood transfusions"}, {"int_description_96": "Parenteral nutrition"}, {"int_description_97": "Platelet transfusions"}, {"int_description_98": "Total body irradiation"}, {"int_description_99": "Hematopoietic stem cell transplantation"}], "references": [{"pmid_title_1": "Severe Combined Immunodeficiency", "pmid_1": 30969584.0, "pmid_date_1": 2021.0, "pmid_journal_1": "statpearls"}, {"pmid_title_2": "Reticular dysgenesis caused by an intronic pathogenic variant in <i>AK2</i>.", "pmid_2": 32532877.0, "pmid_date_2": 2020.0, "pmid_journal_2": "Cold Spring Harb Mol Case Stud"}, {"pmid_title_3": "Biallelic Form of a Known CD3E Mutation in a Patient with Severe Combined Immunodeficiency.", "pmid_3": 32016651.0, "pmid_date_3": 2020.0, "pmid_journal_3": "J Clin Immunol"}, {"pmid_title_4": "Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.", "pmid_4": 30194989.0, "pmid_date_4": 2019.0, "pmid_journal_4": "J Allergy Clin Immunol"}, {"pmid_title_5": "Disseminated Bacille Calmette-Gu\u00e9rin infection in a patient with severe combined immunodeficiency caused by JAK3 gene mutation.", "pmid_5": 31309596.0, "pmid_date_5": 2019.0, "pmid_journal_5": "Pediatr Dermatol"}, {"pmid_title_6": "Prevention of transfusion-transmitted cytomegalovirus infection using leukoreduced blood components in patients receiving seronegative umbilical cord blood transplantation.", "pmid_6": 31322734.0, "pmid_date_6": 2019.0, "pmid_journal_6": "Transfusion"}, {"pmid_title_7": "Human interleukin-2 receptor \u03b2 mutations associated with defects in immunity and peripheral tolerance.", "pmid_7": 31040185.0, "pmid_date_7": 2019.0, "pmid_journal_7": "J Exp Med"}, {"pmid_title_8": "Combined Immunodeficiency With Late-Onset Progressive Hypogammaglobulinemia and Normal B Cell Count in a Patient With RAG2 Deficiency.", "pmid_8": 31058115.0, "pmid_date_8": 2019.0, "pmid_journal_8": "Front Pediatr"}, {"pmid_title_9": "Hematopoietic stem cell transplantation for cytidine triphosphate synthase 1 (CTPS1) deficiency.", "pmid_9": 29884857.0, "pmid_date_9": 2019.0, "pmid_journal_9": "Bone Marrow Transplant"}, {"pmid_title_10": "Severe combined immunodeficiency (SCID) presenting in childhood, with agammaglobulinemia, associated with novel compound heterozygous mutations in DCLRE1C.", "pmid_10": 30630113.0, "pmid_date_10": 2019.0, "pmid_journal_10": "Clin Immunol"}, {"pmid_title_11": "Recent advances in understanding the pathogenesis and management of reticular dysgenesis.", "pmid_11": 29270983.0, "pmid_date_11": 2018.0, "pmid_journal_11": "Br J Haematol"}, {"pmid_title_12": "Two siblings with PRKDC defect who presented with cutaneous granulomas and review of the literature.", "pmid_12": 30121298.0, "pmid_date_12": 2018.0, "pmid_journal_12": "Clin Immunol"}, {"pmid_title_13": "SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.", "pmid_13": 30154114.0, "pmid_date_13": 2018.0, "pmid_journal_13": "Blood"}, {"pmid_title_14": "A Novel Homozygous <i>JAK3</i> Mutation Leading to T-B+NK- SCID in Two Brazilian Patients.", "pmid_14": 30177960.0, "pmid_date_14": 2018.0, "pmid_journal_14": "Front Pediatr"}, {"pmid_title_15": "Co-appearance of OPV and BCG vaccine-derived complications in two infants with severe combined immunodeficiency.", "pmid_15": 29804197.0, "pmid_date_15": 2018.0, "pmid_journal_15": "Immunol Res"}, {"pmid_title_16": "Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis.", "pmid_16": 30014500.0, "pmid_date_16": 2018.0, "pmid_journal_16": "Hepatology"}, {"pmid_title_17": "JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long-known gene.", "pmid_17": 30032486.0, "pmid_date_17": 2018.0, "pmid_journal_17": "Mol Genet Genomic Med"}, {"pmid_title_18": "Chronic active Epstein-Barr virus infection as the initial symptom in a Janus kinase 3 deficiency child: Case report and literature review.", "pmid_18": 29049190.0, "pmid_date_18": 2017.0, "pmid_journal_18": "Medicine (Baltimore)"}, {"pmid_title_19": "Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome.", "pmid_19": 28331055.0, "pmid_date_19": 2017.0, "pmid_journal_19": "Blood"}, {"pmid_title_20": "A novel deletion mutation in IL2RG gene results in X-linked severe combined immunodeficiency with an atypical phenotype.", "pmid_20": 27566612.0, "pmid_date_20": 2017.0, "pmid_journal_20": "Immunogenetics"}, {"pmid_title_21": "Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency.", "pmid_21": 28346229.0, "pmid_date_21": 2017.0, "pmid_journal_21": "J Clin Invest"}, {"pmid_title_22": "Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report.", "pmid_22": 28209722.0, "pmid_date_22": 2017.0, "pmid_journal_22": "Blood"}, {"pmid_title_23": "A 24-Year Enzyme Replacement Therapy in an Adenosine-deaminase-Deficient Patient.", "pmid_23": 26684479.0, "pmid_date_23": 2016.0, "pmid_journal_23": "Pediatrics"}, {"pmid_title_24": "Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.", "pmid_24": 27129325.0, "pmid_date_24": 2016.0, "pmid_journal_24": "Blood"}, {"pmid_title_25": "Insufficient immune reconstitution after allogeneic cord blood transplantation without chemotherapy conditioning in patients with SCID caused by CD3\u03b4 deficiency.", "pmid_25": 26999462.0, "pmid_date_25": 2016.0, "pmid_journal_25": "Bone Marrow Transplant"}, {"pmid_title_26": "Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency.", "pmid_26": 27099176.0, "pmid_date_26": 2016.0, "pmid_journal_26": "Sci Transl Med"}, {"pmid_title_27": "Case Report: Whole exome sequencing identifies variation c.2308G>A p.E770K in <i>RAG1</i> associated with B- T- NK+ severe combined immunodeficiency.", "pmid_27": 29067161.0, "pmid_date_27": 2016.0, "pmid_journal_27": "F1000Res"}, {"pmid_title_28": "CTP Synthase 1 Deficiency in Successfully Transplanted Siblings with Combined Immune Deficiency and Chronic Active EBV Infection.", "pmid_28": 27638562.0, "pmid_date_28": 2016.0, "pmid_journal_28": "J Clin Immunol"}, {"pmid_title_29": "Mutation c.256_257delAA in RAG1 Gene in Polish Children with Severe Combined Immunodeficiency: Diversity of Clinical Manifestations.", "pmid_29": 28083621.0, "pmid_date_29": 2016.0, "pmid_journal_29": "Arch Immunol Ther Exp (Warsz)"}, {"pmid_title_30": "Persistent rotavirus diarrhea post-transplant in a novel JAK3-SCID patient after vaccination.", "pmid_30": 26248889.0, "pmid_date_30": 2016.0, "pmid_journal_30": "Pediatr Allergy Immunol"}, {"pmid_title_31": "Novel compound heterozygous mutations in a Japanese girl with Janus kinase 3 deficiency.", "pmid_31": 27593409.0, "pmid_date_31": 2016.0, "pmid_journal_31": "Pediatr Int"}, {"pmid_title_32": "Mutations in Recombination Activating Gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt.", "pmid_32": 25869295.0, "pmid_date_32": 2015.0, "pmid_journal_32": "Clin Immunol"}, {"pmid_title_33": "A 15-year-old boy with severe combined immunodeficiency, fungal infection, and weight gain.", "pmid_33": 26314823.0, "pmid_date_33": 2015.0, "pmid_journal_33": "Allergy Asthma Proc"}, {"pmid_title_34": "A novel common gamma chain mutation in a Chinese family with X-linked severe combined immunodeficiency (X-SCID; T(-)NK(-)B(+)).", "pmid_34": 26409833.0, "pmid_date_34": 2015.0, "pmid_journal_34": "Immunogenetics"}, {"pmid_title_35": "PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity.", "pmid_35": 25842288.0, "pmid_date_35": 2015.0, "pmid_journal_35": "J Allergy Clin Immunol"}, {"pmid_title_36": "Transplantation outcomes for severe combined immunodeficiency, 2000-2009.", "pmid_36": 25075835.0, "pmid_date_36": 2014.0, "pmid_journal_36": "N Engl J Med"}, {"pmid_title_37": "Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.", "pmid_37": 25109802.0, "pmid_date_37": 2014.0, "pmid_journal_37": "J Allergy Clin Immunol"}, {"pmid_title_38": "SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.", "pmid_38": 24144642.0, "pmid_date_38": 2014.0, "pmid_journal_38": "Blood"}, {"pmid_title_39": "Severe combined immunodeficiency caused by a new homozygous RAG1 mutation with progressive encephalopathy.", "pmid_39": 24333136.0, "pmid_date_39": 2014.0, "pmid_journal_39": "Hematol Oncol Stem Cell Ther"}, {"pmid_title_40": "The many faces of Artemis-deficient combined immunodeficiency - Two patients with DCLRE1C mutations and a systematic literature review of genotype-phenotype correlation.", "pmid_40": 24230999.0, "pmid_date_40": 2013.0, "pmid_journal_40": "Clin Immunol"}, {"pmid_title_41": "Successful bone marrow transplantation with reduced intensity conditioning in a patient with delayed-onset adenosine deaminase deficiency.", "pmid_41": 22805442.0, "pmid_date_41": 2013.0, "pmid_journal_41": "Pediatr Transplant"}, {"pmid_title_42": "Hemophagocytic bone marrow aplasia with plasma cells in a RAG2-deficient SCID case after a nonconditioned transplantation from a fully matched sibling.", "pmid_42": 23389499.0, "pmid_date_42": 2013.0, "pmid_journal_42": "J Pediatr Hematol Oncol"}, {"pmid_title_43": "Skeletal abnormalities and successful hematopoietic stem cell transplantation in patients with reticular dysgenesis.", "pmid_43": 23763981.0, "pmid_date_43": 2013.0, "pmid_journal_43": "J Allergy Clin Immunol"}, {"pmid_title_44": "Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency.", "pmid_44": 22409989.0, "pmid_date_44": 2012.0, "pmid_journal_44": "J Allergy Clin Immunol"}, {"pmid_title_45": "Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.", "pmid_45": 22791287.0, "pmid_date_45": 2012.0, "pmid_journal_45": "Blood"}, {"pmid_title_46": "Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.", "pmid_46": 22968453.0, "pmid_date_46": 2012.0, "pmid_journal_46": "Blood"}, {"pmid_title_47": "IL-21 is the primary common \u03b3 chain-binding cytokine required for human B-cell differentiation in vivo.", "pmid_47": 22039266.0, "pmid_date_47": 2011.0, "pmid_journal_47": "Blood"}, {"pmid_title_48": "Hematopoietic stem cell transplantation for CD3\u03b4 deficiency.", "pmid_48": 21757226.0, "pmid_date_48": 2011.0, "pmid_journal_48": "J Allergy Clin Immunol"}, {"pmid_title_49": "Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency.", "pmid_49": 21725047.0, "pmid_date_49": 2011.0, "pmid_journal_49": "Blood"}, {"pmid_title_50": "A leaky mutation in CD3D differentially affects \u03b1\u03b2 and \u03b3\u03b4 T cells and leads to a T\u03b1\u03b2-T\u03b3\u03b4+B+NK+ human SCID.", "pmid_50": 21926461.0, "pmid_date_50": 2011.0, "pmid_journal_50": "J Clin Invest"}, {"pmid_title_51": "Occurrence of myelodysplastic syndrome in 2 patients with reticular dysgenesis.", "pmid_51": 21458044.0, "pmid_date_51": 2011.0, "pmid_journal_51": "J Allergy Clin Immunol"}, {"pmid_title_52": "Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency.", "pmid_52": 20113887.0, "pmid_date_52": 2010.0, "pmid_journal_52": "Immunol Allergy Clin North Am"}, {"pmid_title_53": "Hemophagocytosis after bone marrow transplantation for JAK3-deficient severe combined immunodeficiency.", "pmid_53": 19659508.0, "pmid_date_53": 2010.0, "pmid_journal_53": "Pediatr Transplant"}, {"pmid_title_54": "A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining.", "pmid_54": 19075392.0, "pmid_date_54": 2009.0, "pmid_journal_54": "J Clin Invest"}, {"pmid_title_55": "Novel RAG2 mutation in a patient with T- B- severe combined immunodeficiency and disseminated BCG disease.", "pmid_55": 20128425.0, "pmid_date_55": 2009.0, "pmid_journal_55": "J Investig Allergol Clin Immunol"}, {"pmid_title_56": "A novel missense RAG-1 mutation results in T-B-NK+ SCID in Athabascan-speaking Dine Indians from the Canadian Northwest Territories.", "pmid_56": 18701881.0, "pmid_date_56": 2009.0, "pmid_journal_56": "Eur J Hum Genet"}, {"pmid_title_57": "Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID.", "pmid_57": 19458910.0, "pmid_date_57": 2009.0, "pmid_journal_57": "Clin Exp Med"}, {"pmid_title_58": "Gene therapy for immunodeficiency due to adenosine deaminase deficiency.", "pmid_58": 19179314.0, "pmid_date_58": 2009.0, "pmid_journal_58": "N Engl J Med"}, {"pmid_title_59": "Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency.", "pmid_59": 17825895.0, "pmid_date_59": 2007.0, "pmid_journal_59": "J Allergy Clin Immunol"}, {"pmid_title_60": "Novel RAG1 mutation in a case of severe combined immunodeficiency.", "pmid_60": 16061569.0, "pmid_date_60": 2005.0, "pmid_journal_60": "Pediatrics"}, {"pmid_title_61": "Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.", "pmid_61": 14615376.0, "pmid_date_61": 2004.0, "pmid_journal_61": "Blood"}, {"pmid_title_62": "Novel Artemis gene mutations of radiosensitive severe combined immunodeficiency in Japanese families.", "pmid_62": 12592555.0, "pmid_date_62": 2003.0, "pmid_journal_62": "Hum Genet"}, {"pmid_title_63": "Bone marrow transplantation for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans.", "pmid_63": 11360109.0, "pmid_date_63": 2001.0, "pmid_journal_63": "Bone Marrow Transplant"}, {"pmid_title_64": "Successful bone-marrow transplantation for reticular dysgenesis.", "pmid_64": 6132037.0, "pmid_date_64": 1983.0, "pmid_journal_64": "Lancet"}, {"pmid_title_65": "Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.", "pmid_65": 6983936.0, "pmid_date_65": 1982.0, "pmid_journal_65": "Clin Exp Immunol"}]}, {"_id": "9455-OMIM:262600", "condition": {"condition_name": "PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2", "freq_per_birth": "The prevalence of combined pituitary hormone deficiency is estimated to be 1 in 8,000 individuals worldwide.", "pattern_of_inheritance": "Autosomal recessive==Autosomal dominant", "alternate_names": ["PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2"]}, "gene information": {"db_hgnc_gene_id": 9455.0}, "interventions": [{"int_description_1": "Ventilation"}, {"int_description_2": "Testosterone"}, {"int_description_3": "Testosterone enanthate"}, {"int_description_4": "Calcium"}, {"int_description_5": "Quinagolide"}, {"int_description_6": "Bromocriptine"}, {"int_description_7": "Conjugated estrogens"}, {"int_description_8": "Ethinylestradiol"}, {"int_description_9": "Levothyroxine"}, {"int_description_10": "Estradiol"}, {"int_description_11": "Prasterone sulfate"}, {"int_description_12": "Menotropins"}, {"int_description_13": "Somatotropin"}, {"int_description_14": "Vitamin D"}, {"int_description_15": "Dydrogesterone"}, {"int_description_16": "Hydrocortisone"}, {"int_description_17": "Hydrocortisone acetate"}, {"int_description_18": "Chorionic Gonadotropin (Human)"}, {"int_description_19": "Androgens", "timeframe_int19": "Hours", "age_use_int19": "Neonate", "contra_int19": "No", "qualscale_reclass_drug19": "Case report(s)", "rev1_eff_reclass_drug19": "Effective / Ameliorative"}, {"int_description_20": "Birth control pills"}, {"int_description_21": "Glucocorticoid therapy"}, {"int_description_22": "Glucose, 5%"}, {"int_description_23": "Gonadotropin replacement"}, {"int_description_24": "Hypertonic saline"}, {"int_description_25": "Recombinant gonadotropin"}, {"int_description_26": "Sex steroid replacement therapy"}, {"int_description_27": "Iodine"}, {"int_description_28": "Transphenoidal operation"}], "references": [{"pmid_title_1": "Therapy-Induced Growth and Sexual Maturation in a Developmentally Infantile Adult Patient with a PROP1 Mutation.", "pmid_1": 29180983.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Frontiers in endocrinology"}, {"pmid_title_2": "Molecular screening of a large cohort of Moroccan patients with congenital hypopituitarism.", "pmid_2": 25557026.0, "pmid_date_2": 2015.0, "pmid_journal_2": "Clinical endocrinology"}, {"pmid_title_3": "<i>PROP1</i>-Related Combined Pituitary Hormone Deficiency", "pmid_3": 20301521.0, "pmid_date_3": 2014.0, "pmid_journal_3": "GeneReviews\u00ae"}, {"pmid_title_4": "Clinical Case Seminar. Peculiar prolactinomas in patients with pituitary developmental gene mutations: from an adult endocrinologist perspective.", "pmid_4": 22801565.0, "pmid_date_4": 2012.0, "pmid_journal_4": "Hormones (Athens, Greece)"}, {"pmid_title_5": "Detection of genetic hypopituitarism in an adult population of idiopathic pituitary insufficiency patients with growth hormone deficiency.", "pmid_5": 21132537.0, "pmid_date_5": 2011.0, "pmid_journal_5": "Pituitary"}, {"pmid_title_6": "Case seminar: a young female with acute hyponatremia and a sellar mass.", "pmid_6": 21863341.0, "pmid_date_6": 2011.0, "pmid_journal_6": "Endocrine"}, {"pmid_title_7": "The natural history of the R120C PROP1 mutation reveals a wide phenotypic variability in two untreated adult brothers with combined pituitary hormone deficiency.", "pmid_7": 17526949.0, "pmid_date_7": 2006.0, "pmid_journal_7": "Endocrine"}, {"pmid_title_8": "Auxological and endocrine phenotype in a population-based cohort of patients with PROP1 gene defects.", "pmid_8": 16131601.0, "pmid_date_8": 2005.0, "pmid_journal_8": "European journal of endocrinology"}, {"pmid_title_9": "A familial form of congenital hypopituitarism due to a PROP1 mutation in a large kindred: phenotypic and in vitro functional studies.", "pmid_9": 15531542.0, "pmid_date_9": 2004.0, "pmid_journal_9": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_10": "PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis.", "pmid_10": 15472232.0, "pmid_date_10": 2004.0, "pmid_journal_10": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_11": "A novel PROP1 gene mutation (157delA) in Japanese siblings with combined anterior pituitary hormone deficiency.", "pmid_11": 15521968.0, "pmid_date_11": 2004.0, "pmid_journal_11": "Clinical endocrinology"}, {"pmid_title_12": "PROP-1 gene mutation (R120C) causing combined pituitary hormone deficiencies with variable clinical course in eight siblings of one Jewish Moroccan family.", "pmid_12": 14614227.0, "pmid_date_12": 2003.0, "pmid_journal_12": "Hormone research"}, {"pmid_title_13": "A unique case of combined pituitary hormone deficiency caused by a PROP1 gene mutation (R120C) associated with normal height and absent puberty.", "pmid_13": 12153609.0, "pmid_date_13": 2002.0, "pmid_journal_13": "Clinical endocrinology"}, {"pmid_title_14": "PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency.", "pmid_14": 11549703.0, "pmid_date_14": 2001.0, "pmid_journal_14": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_15": "Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to PROP1 mutation.", "pmid_15": 11549674.0, "pmid_date_15": 2001.0, "pmid_journal_15": "The Journal of clinical endocrinology and metabolism"}, {"pmid_title_16": "Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg-->Cys at codon 120 (R120C).", "pmid_16": 9768691.0, "pmid_date_16": 1998.0, "pmid_journal_16": "The Journal of clinical endocrinology and metabolism"}]}, {"_id": "9457-OMIM:617290", "condition": {"condition_name": "EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D"]}, "gene information": {"db_hgnc_gene_id": 9457.0}, "interventions": [{"int_description_1": "Vagus nerve stimulation"}, {"int_description_2": "Lysine restricted diet"}, {"int_description_3": "Clobazam"}, {"int_description_4": "Corticotropin"}, {"int_description_5": "Arginine"}, {"int_description_6": "Nitrazepam", "timeframe_int6": "Hours", "age_use_int6": "Neonate,Infant,Child", "qualscale_reclass_drug6": "Case report(s)", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Topiramate"}, {"int_description_8": "Pyridoxal phosphate"}, {"int_description_9": "Midazolam"}, {"int_description_10": "Levetiracetam", "timeframe_int10": "Hours", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Case report(s)", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Carbamazepine"}, {"int_description_12": "Pyridoxine"}, {"int_description_13": "Valproic acid"}, {"int_description_14": "Lamotrigine"}, {"int_description_15": "Leucovorin"}, {"int_description_16": "Phenobarbital"}, {"int_description_17": "Aterotemporal lobectomy"}, {"int_description_18": "Hippocampal amygdala resection"}], "references": [{"pmid_title_1": "Nonketotic Hyperglycinemia", "pmid_1": 20301531.0, "pmid_date_1": 2019.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "PLPHP deficiency: clinical, genetic, biochemical, and mechanistic insights.", "pmid_2": 30668673.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Brain : a journal of neurology"}, {"pmid_title_3": "Insight into vitamin B<sub>6</sub> -dependent epilepsy due to PLPBP (previously PROSC) missense mutations.", "pmid_3": 29689137.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Human mutation"}, {"pmid_title_4": "<i>PLPBP</i> mutations cause variable phenotypes of developmental and epileptic encephalopathy.", "pmid_4": 30525118.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Epilepsia open"}, {"pmid_title_5": "Pyridoxine-Dependent Epilepsy", "pmid_5": 20301659.0, "pmid_date_5": 2017.0, "pmid_journal_5": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_6": "Confirmation of mutations in <i>PROSC</i> as a novel cause of vitamin B <sub><sub>6</sub></sub> -dependent epilepsy.", "pmid_6": 28391250.0, "pmid_date_6": 2017.0, "pmid_journal_6": "Journal of medical genetics"}, {"pmid_title_7": "Mutations in PROSC Disrupt Cellular Pyridoxal Phosphate Homeostasis and Cause Vitamin-B<sub>6</sub>-Dependent Epilepsy.", "pmid_7": 27912044.0, "pmid_date_7": 2016.0, "pmid_journal_7": "American journal of human genetics"}, {"pmid_title_8": "Current treatment and management of pyridoxine-dependent epilepsy.", "pmid_8": 25639976.0, "pmid_date_8": 2015.0, "pmid_journal_8": "Current treatment options in neurology"}]}, {"_id": "9577-OMIM:614023", "condition": {"condition_name": "PHOSPHOSERINE PHOSPHATASE DEFICIENCY", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["PHOSPHOSERINE PHOSPHATASE DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 9577.0}, "interventions": [{"int_description_1": "Serine", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Still in Trials / Unproven"}], "references": [{"pmid_title_1": "Phosphoserine phosphatase (PSPH) gene mutation in an intellectual disability family from Pakistan.", "pmid_1": 25080166.0, "pmid_date_1": 2015.0, "pmid_journal_1": "Clinical genetics"}, {"pmid_title_2": "An update on serine deficiency disorders.", "pmid_2": 23463425.0, "pmid_date_2": 2013.0, "pmid_journal_2": "Journal of inherited metabolic disease"}, {"pmid_title_3": "L-serine synthesis in the central nervous system: a review on serine deficiency disorders.", "pmid_3": 19963421.0, "pmid_date_3": 2010.0, "pmid_journal_3": "Molecular genetics and metabolism"}, {"pmid_title_4": "Treatment with amino acids in serine deficiency disorders.", "pmid_4": 16763900.0, "pmid_date_4": 2006.0, "pmid_journal_4": "Journal of inherited metabolic disease"}, {"pmid_title_5": "Phosphoserine phosphatase deficiency in a patient with Williams syndrome.", "pmid_5": 9222972.0, "pmid_date_5": 1997.0, "pmid_journal_5": "Journal of medical genetics"}]}, {"_id": "9689-OMIM:261640", "condition": {"condition_name": "HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A", "freq_per_birth": "This condition is rare, affecting an estimated 1 in 500,000 to 1 in 1 million newborns. In most parts of the world, tetrahydrobiopterin deficiency accounts for 1 to 3 percent of all cases of elevated phenylalanine levels. The remaining cases are caused by a similar condition called phenylketonuria (PKU). In certain countries, including Saudi Arabia, Taiwan, China, and Turkey, it is more common for elevated levels of phenylalanine to be caused by tetrahydrobiopterin deficiency than by PKU.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A"]}, "gene information": {"db_hgnc_gene_id": 9689.0}, "interventions": [{"int_description_1": "Levodopa", "timeframe_int1": "Days or Weeks", "age_use_int1": "Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Oxitriptan", "timeframe_int2": "Days or Weeks", "age_use_int2": "Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Pramipexole"}, {"int_description_4": "Entacapone"}, {"int_description_5": "Carbidopa", "timeframe_int5": "Days or Weeks", "age_use_int5": "Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Selegiline"}, {"int_description_7": "Neurotransmitter precursor replacement therapy", "timeframe_int7": "Days or Weeks", "age_use_int7": "Infant,Child", "contra_int7": "No", "qualscale_reclass_drug7": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug7": "Effective / Ameliorative"}, {"int_description_8": "Sapropterin"}], "references": [{"pmid_title_1": "Phenylalanine Hydroxylase Deficiency", "pmid_1": 20301677.0, "pmid_date_1": 2017.0, "pmid_journal_1": "GeneReviews<sup>\u00ae</sup>"}, {"pmid_title_2": "Long-term safety and effectiveness of pramipexole in tetrahydrobiopterin deficiency.", "pmid_2": 27562098.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Eur J Paediatr Neurol"}, {"pmid_title_3": "Demographics, diagnosis and treatment of 256 patients with tetrahydrobiopterin deficiency in mainland China: results of a retrospective, multicentre study.", "pmid_3": 23138986.0, "pmid_date_3": 2013.0, "pmid_journal_3": "J Inherit Metab Dis"}, {"pmid_title_4": "Phenotypic variability, neurological outcome and genetics background of 6-pyruvoyl-tetrahydropterin synthase deficiency.", "pmid_4": 20059486.0, "pmid_date_4": 2010.0, "pmid_journal_4": "Clin Genet"}, {"pmid_title_5": "Long-term follow-up of Taiwanese Chinese patients treated early for 6-pyruvoyl-tetrahydropterin synthase deficiency.", "pmid_5": 18332253.0, "pmid_date_5": 2008.0, "pmid_journal_5": "Arch Neurol"}, {"pmid_title_6": "Mutation analysis of the 6-pyruvoyl-tetrahydropterin synthase gene in Chinese hyperphenylalaninemia caused by tetrahydrobiopterin synthesis deficiency.", "pmid_6": 9450907.0, "pmid_date_6": 1998.0, "pmid_journal_6": "Hum Mutat"}]}, {"_id": "9752-OMIM:261630", "condition": {"condition_name": "HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C", "freq_per_birth": "This condition is rare, affecting an estimated 1 in 500,000 to 1 in 1 million newborns. In most parts of the world, tetrahydrobiopterin deficiency accounts for 1 to 3 percent of all cases of elevated phenylalanine levels. The remaining cases are caused by a similar condition called phenylketonuria (PKU). In certain countries, including Saudi Arabia, Taiwan, China, and Turkey, it is more common for elevated levels of phenylalanine to be caused by tetrahydrobiopterin deficiency than by PKU.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C"]}, "gene information": {"db_hgnc_gene_id": 9752.0}, "interventions": [{"int_description_1": "Phenylalanine-restricted diet"}, {"int_description_2": "Bromocriptine", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Levodopa"}, {"int_description_4": "Clonazepam"}, {"int_description_5": "Prednisone"}, {"int_description_6": "Oxitriptan"}, {"int_description_7": "Rotigotine"}, {"int_description_8": "Pramipexole", "timeframe_int8": "Hours,Days or Weeks", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Case report(s)", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Zonisamide", "timeframe_int9": "Hours,Days or Weeks", "age_use_int9": "Neonate,Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug9": "Effective / Ameliorative"}, {"int_description_10": "Entacapone", "timeframe_int10": "Hours,Days or Weeks", "age_use_int10": "Neonate,Infant,Child", "contra_int10": "No", "qualscale_reclass_drug10": "Cohort study or studies", "rev1_eff_reclass_drug10": "Effective / Ameliorative"}, {"int_description_11": "Carbidopa"}, {"int_description_12": "Selegiline", "timeframe_int12": "Hours,Days or Weeks", "age_use_int12": "Neonate,Infant,Child", "contra_int12": "No", "qualscale_reclass_drug12": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug12": "Effective / Ameliorative"}, {"int_description_13": "Fluoxetine", "timeframe_int13": "Hours,Days or Weeks", "age_use_int13": "Neonate,Infant,Child", "contra_int13": "No", "qualscale_reclass_drug13": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug13": "Effective / Ameliorative"}, {"int_description_14": "Leucovorin", "timeframe_int14": "Days or Weeks", "age_use_int14": "Neonate,Infant,Child", "contra_int14": "No", "rev1_eff_reclass_drug14": "Effective / Ameliorative"}, {"int_description_15": "Sapropterin"}], "references": [{"pmid_title_1": "Urinary sulphatoxymelatonin as a biomarker of serotonin status in biogenic amine-deficient patients.", "pmid_1": 29116116.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Sci Rep"}, {"pmid_title_2": "Long-term safety and effectiveness of pramipexole in tetrahydrobiopterin deficiency.", "pmid_2": 27562098.0, "pmid_date_2": 2016.0, "pmid_journal_2": "Eur J Paediatr Neurol"}, {"pmid_title_3": "Transdermal rotigotine in dihydropteridine reductase deficiency.", "pmid_3": 27423595.0, "pmid_date_3": 2016.0, "pmid_journal_3": "J Neurol Sci"}, {"pmid_title_4": "Short prolactin profile for monitoring treatment in BH4 deficiency.", "pmid_4": 25707872.0, "pmid_date_4": 2015.0, "pmid_journal_4": "Eur J Paediatr Neurol"}, {"pmid_title_5": "Fast clinical molecular diagnosis of hyperphenylalaninemia using next-generation sequencing-based on a custom AmpliSeq\u2122 panel and Ion Torrent PGM sequencing.", "pmid_5": 25456745.0, "pmid_date_5": 2014.0, "pmid_journal_5": "Mol Genet Metab"}, {"pmid_title_6": "Dopamine agonists in dihydropteridine reductase deficiency.", "pmid_6": 22325981.0, "pmid_date_6": 2012.0, "pmid_journal_6": "Mol Genet Metab"}, {"pmid_title_7": "Serum prolactin as a tool for the follow-up of treated DHPR-deficient patients.", "pmid_7": 18425437.0, "pmid_date_7": 2008.0, "pmid_journal_7": "J Inherit Metab Dis"}, {"pmid_title_8": "Outcome and long-term follow-up of 36 patients with tetrahydrobiopterin deficiency.", "pmid_8": 18060820.0, "pmid_date_8": 2008.0, "pmid_journal_8": "Mol Genet Metab"}, {"pmid_title_9": "Molecular genetics of tetrahydrobiopterin (BH4) deficiency in the Maltese population.", "pmid_9": 17188538.0, "pmid_date_9": 2007.0, "pmid_journal_9": "Mol Genet Metab"}, {"pmid_title_10": "Dihydropteridine reductase deficiency in man: from biology to treatment.", "pmid_10": 14705166.0, "pmid_date_10": 2004.0, "pmid_journal_10": "Med Res Rev"}, {"pmid_title_11": "Molecular analysis of 16 Turkish families with DHPR deficiency using denaturing gradient gel electrophoresis (DGGE).", "pmid_11": 11153907.0, "pmid_date_11": 2000.0, "pmid_journal_11": "Hum Genet"}, {"pmid_title_12": "Dihydropteridine reductase deficiency: physical structure of the QDPR gene, identification of two new mutations and genotype-phenotype correlations.", "pmid_12": 9744478.0, "pmid_date_12": 1998.0, "pmid_journal_12": "Hum Mutat"}]}, {"_id": "9766-OMIM:607624", "condition": {"condition_name": "GRISCELLI SYNDROME, TYPE 2", "freq_per_birth": "Griscelli syndrome is a rare condition; its prevalence is unknown. Type 2 appears to be the most common of the three known types.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["GRISCELLI SYNDROME, TYPE 2"]}, "gene information": {"db_hgnc_gene_id": 9766.0}, "interventions": [{"int_description_1": "Prednisolone"}, {"int_description_2": "Dexamethasone", "timeframe_int2": "Hours,Days or Weeks", "age_use_int2": "Neonate,Infant,Child", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Human immunoglobulin G", "timeframe_int3": "Hours,Days or Weeks", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_5": "Cyclosporine", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Methotrexate", "timeframe_int6": "Hours,Days or Weeks", "age_use_int6": "Neonate,Infant,Child", "contra_int6": "No", "qualscale_reclass_drug6": "Case report(s)", "rev1_eff_reclass_drug6": "Effective / Ameliorative"}, {"int_description_7": "Etoposide"}, {"int_description_8": "HLH-94 treatment protocol", "timeframe_int8": "Hours,Days or Weeks", "age_use_int8": "Neonate,Infant,Child", "contra_int8": "No", "qualscale_reclass_drug8": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug8": "Effective / Ameliorative"}, {"int_description_9": "Allogeneic bone marrow transplantation"}, {"int_description_10": "Allogeneic stem cell transplantation"}, {"int_description_11": "Hematopoietic stem cell transplantation", "timeframe_int11": "Days or Weeks", "age_use_int11": "Infant,Child", "contra_int11": "No", "qualscale_reclass_drug11": "Cohort study or studies", "rev1_eff_reclass_drug11": "Curative"}], "references": [{"pmid_title_1": "Congenital Neutropenia and Rare Functional Phagocyte Disorders in Children.", "pmid_1": 31030818.0, "pmid_date_1": 2019.0, "pmid_journal_1": "Hematology/oncology clinics of North America"}, {"pmid_title_2": "Late-onset hemophagocytic lymphohistiocytosis (HLH) in an adult female with Griscelli syndrome type 2 (GS2).", "pmid_2": 25544030.0, "pmid_date_2": 2015.0, "pmid_journal_2": "Annals of hematology"}, {"pmid_title_3": "Clinical presentation of Griscelli syndrome type 2 and spectrum of RAB27A mutations.", "pmid_3": 19953648.0, "pmid_date_3": 2010.0, "pmid_journal_3": "Pediatric blood & cancer"}, {"pmid_title_4": "Griscelli disease: genotype-phenotype correlation in an array of clinical heterogeneity.", "pmid_4": 12148598.0, "pmid_date_4": 2002.0, "pmid_journal_4": "Journal of clinical immunology"}]}, {"_id": "9831-OMIM:233650", "condition": {"condition_name": "COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["OMENN SYNDROME", "COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS", "ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY", "SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE"]}, "gene information": {"db_hgnc_gene_id": 9831.0}, "interventions": [{"int_description_1": "Ursodeoxycholic acid"}, {"int_description_2": "Prednisone"}, {"int_description_3": "Octreotide"}, {"int_description_4": "Eltrombopag"}, {"int_description_5": "Human immunoglobulin G"}, {"int_description_6": "Abatacept"}, {"int_description_7": "Rituximab"}, {"int_description_8": "Alemtuzumab"}, {"int_description_9": "Adalimumab"}, {"int_description_10": "Cyclosporine"}, {"int_description_11": "Isoniazid"}, {"int_description_12": "Sirolimus"}, {"int_description_13": "Somatotropin"}, {"int_description_14": "Cyclophosphamide"}, {"int_description_15": "Busulfan"}, {"int_description_16": "Melphalan"}, {"int_description_17": "Thiotepa"}, {"int_description_18": "Micafungin"}, {"int_description_19": "Pyrazinamide"}, {"int_description_20": "Ethambutol"}, {"int_description_21": "Azithromycin"}, {"int_description_22": "Trimethoprim"}, {"int_description_23": "Dapsone"}, {"int_description_24": "Sulfamethoxazole"}, {"int_description_25": "Treosulfan"}, {"int_description_26": "Rifampicin"}, {"int_description_27": "Fluconazole"}, {"int_description_28": "Methotrexate"}, {"int_description_29": "Fludarabine"}, {"int_description_30": "Tacrolimus"}, {"int_description_31": "Acyclovir"}, {"int_description_32": "Cidofovir"}, {"int_description_33": "Brincidofovir"}, {"int_description_34": "Mycophenolate mofetil"}, {"int_description_35": "Acetylsalicylic acid"}, {"int_description_36": "Probenecid"}, {"int_description_37": "Infliximab"}, {"int_description_38": "Anti-thymocyte globulin"}, {"int_description_39": "Corticosteroids"}, {"int_description_40": "Meglumine antimoniate"}, {"int_description_41": "Narcotic analgesics"}, {"int_description_42": "Steroids"}, {"int_description_43": "Parenteral nutrition"}, {"int_description_44": "Radioimmunotherapy"}, {"int_description_45": "Total body irradiation"}, {"int_description_46": "Hematopoietic stem cell transplantation", "timeframe_int46": "Days or Weeks", "age_use_int46": "Infant,Child", "qualscale_reclass_drug46": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug46": "Curative"}, {"int_description_47": "Thymectomy"}], "references": [{"pmid_title_1": "Unrelated Hematopoietic Cell Transplantation in a Patient with Combined Immunodeficiency with Granulomatous Disease and Autoimmunity Secondary to RAG Deficiency.", "pmid_1": 27539235.0, "pmid_date_1": 2016.0, "pmid_journal_1": "Journal of clinical immunology"}, {"pmid_title_2": "A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency.", "pmid_2": 24996264.0, "pmid_date_2": 2014.0, "pmid_journal_2": "The Journal of allergy and clinical immunology"}, {"pmid_title_3": "Exome sequencing reveals RAG1 mutations in a child with autoimmunity and sterile chronic multifocal osteomyelitis evolving into disseminated granulomatous disease.", "pmid_3": 24122031.0, "pmid_date_3": 2013.0, "pmid_journal_3": "Journal of clinical immunology"}, {"pmid_title_4": "An immunodeficiency disease with RAG mutations and granulomas.", "pmid_4": 18463379.0, "pmid_date_4": 2008.0, "pmid_journal_4": "The New England journal of medicine"}]}, {"_id": "9831-OMIM:603554", "condition": {"condition_name": "OMENN SYNDROME", "freq_per_birth": "Overall, the various forms of SCID are estimated to affect 1 in 75,000 to 100,000 newborns. The exact prevalence of Omenn syndrome is unknown.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE", "OMENN SYNDROME", "ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY", "COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS"]}, "gene information": {"db_hgnc_gene_id": 9831.0}, "interventions": [{"int_description_1": "Cardiopulmonary resuscitation"}, {"int_description_2": "Prednisolone"}, {"int_description_3": "Prednisone"}, {"int_description_4": "Dexamethasone"}, {"int_description_5": "Panthenol"}, {"int_description_6": "Ganciclovir"}, {"int_description_7": "Human immunoglobulin G"}, {"int_description_8": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_9": "Alemtuzumab"}, {"int_description_10": "Clarithromycin"}, {"int_description_11": "Cyclosporine"}, {"int_description_12": "Isoniazid"}, {"int_description_13": "Interferon gamma-1b"}, {"int_description_14": "Cyclophosphamide"}, {"int_description_15": "Busulfan"}, {"int_description_16": "Melphalan"}, {"int_description_17": "Thiotepa"}, {"int_description_18": "Caspofungin"}, {"int_description_19": "Ethambutol"}, {"int_description_20": "Azithromycin"}, {"int_description_21": "Trimethoprim"}, {"int_description_22": "Sulfamethoxazole"}, {"int_description_23": "Treosulfan"}, {"int_description_24": "Rifampicin"}, {"int_description_25": "Fluconazole"}, {"int_description_26": "Voriconazole"}, {"int_description_27": "Methotrexate"}, {"int_description_28": "Fludarabine"}, {"int_description_29": "Etoposide"}, {"int_description_30": "Tacrolimus"}, {"int_description_31": "Foscarnet", "timeframe_int31": "Days or Weeks", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Mycophenolate mofetil", "timeframe_int32": "Hours,Days or Weeks", "age_use_int32": "Neonate,Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Methylprednisolone", "timeframe_int33": "Days or Weeks", "age_use_int33": "Neonate,Infant,Child", "contra_int33": "No", "qualscale_reclass_drug33": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug33": "Curative"}, {"int_description_34": "Anti-thymocyte globulin"}, {"int_description_35": "Antibiotics"}, {"int_description_36": "Palivizumab"}, {"int_description_37": "Antilymphocyte immunoglobulin (horse)", "timeframe_int37": "Days or Weeks", "age_use_int37": "Neonate,Infant,Child", "contra_int37": "No", "qualscale_reclass_drug37": "Case report(s)", "rev1_eff_reclass_drug37": "Effective / Ameliorative"}, {"int_description_38": "Hypochlorite"}, {"int_description_39": "Low-pH emollient cream (CeraVe, New York, New York)", "timeframe_int39": "Days or Weeks", "age_use_int39": "Neonate,Infant,Child", "contra_int39": "No", "qualscale_reclass_drug39": "Case report(s)", "rev1_eff_reclass_drug39": "Effective / Ameliorative"}, {"int_description_40": "CD4-DLI"}, {"int_description_41": "Parenteral nutrition"}, {"int_description_42": "Red blood cells transfusion"}, {"int_description_43": "Hematopoietic stem cell transplantation"}, {"int_description_44": "Ileum resection"}, {"int_description_45": "Subtotal appendectomy"}, {"int_description_46": "Surgical removement of lymphadenitis"}], "references": [{"pmid_title_1": "Prominent dermal Langerhans cells in an Omenn syndrome patient with a novel mutation in the IL2RG gene.", "pmid_1": 31456262.0, "pmid_date_1": 2019.0, "pmid_journal_1": "J Dermatol"}, {"pmid_title_2": "Atypical Omenn Syndrome Due to RAG2 Gene Mutation, a Case Report.", "pmid_2": 31885011.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Iran J Immunol"}, {"pmid_title_3": "SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.", "pmid_3": 30154114.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Blood"}, {"pmid_title_4": "Topical Hypochlorite and Skin Acidification Improves Erythroderma of Omenn Syndrome.", "pmid_4": 29610161.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Pediatrics"}, {"pmid_title_5": "DNA recombination defects in Kuwait: Clinical, immunologic and genetic profile.", "pmid_5": 29051008.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Clin Immunol"}, {"pmid_title_6": "Characterization of T and B cell repertoire diversity in patients with RAG deficiency.", "pmid_6": 28783691.0, "pmid_date_6": 2016.0, "pmid_journal_6": "Sci Immunol"}, {"pmid_title_7": "Molecular Characteristics, Clinical and Immunologic Manifestations of 11 Children with Omenn Syndrome in East Slavs (Russia, Belarus, Ukraine).", "pmid_7": 26596586.0, "pmid_date_7": 2016.0, "pmid_journal_7": "J Clin Immunol"}, {"pmid_title_8": "Variable phenotype of severe immunodeficiencies associated with RMRP gene mutations.", "pmid_8": 25663137.0, "pmid_date_8": 2015.0, "pmid_journal_8": "J Clin Immunol"}, {"pmid_title_9": "Cyclosporin treatment improves skin findings in omenn syndrome.", "pmid_9": 25727345.0, "pmid_date_9": 2015.0, "pmid_journal_9": "Pediatr Dermatol"}, {"pmid_title_10": "SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.", "pmid_10": 24144642.0, "pmid_date_10": 2014.0, "pmid_journal_10": "Blood"}, {"pmid_title_11": "Atypical Omenn Syndrome due to Adenosine Deaminase Deficiency.", "pmid_11": 25954555.0, "pmid_date_11": 2012.0, "pmid_journal_11": "Case Reports Immunol"}, {"pmid_title_12": "Novel mutations in RAG1/2 and ADA genes in Israeli patients presenting with T-B-SCID or Omenn syndrome.", "pmid_12": 21624848.0, "pmid_date_12": 2011.0, "pmid_journal_12": "Clin Immunol"}, {"pmid_title_13": "Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation.", "pmid_13": 20375313.0, "pmid_date_13": 2010.0, "pmid_journal_13": "Blood"}, {"pmid_title_14": "Saving the red baby: successful allogeneic cord blood transplantation in Omenn syndrome.", "pmid_14": 19064334.0, "pmid_date_14": 2009.0, "pmid_journal_14": "Clin Immunol"}, {"pmid_title_15": "Rapid full engraftment and successful immune reconstitution after allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in Omenn syndrome.", "pmid_15": 18992055.0, "pmid_date_15": 2009.0, "pmid_journal_15": "Pediatr Transplant"}, {"pmid_title_16": "Variability of clinical and laboratory features among patients with ribonuclease mitochondrial RNA processing endoribonuclease gene mutations.", "pmid_16": 18804272.0, "pmid_date_16": 2008.0, "pmid_journal_16": "J Allergy Clin Immunol"}, {"pmid_title_17": "Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency.", "pmid_17": 17825895.0, "pmid_date_17": 2007.0, "pmid_journal_17": "J Allergy Clin Immunol"}, {"pmid_title_18": "Omenn syndrome--review of several phenotypes of Omenn syndrome and RAG1/RAG2 mutations in Japan.", "pmid_18": 17075247.0, "pmid_date_18": 2006.0, "pmid_journal_18": "Allergol Int"}, {"pmid_title_19": "Mutations in the RNA component of RNase mitochondrial RNA processing might cause Omenn syndrome.", "pmid_19": 16630949.0, "pmid_date_19": 2006.0, "pmid_journal_19": "J Allergy Clin Immunol"}, {"pmid_title_20": "Novel adopted immunotherapy for mixed chimerism after unrelated cord blood transplantation in Omenn syndrome.", "pmid_20": 16191096.0, "pmid_date_20": 2005.0, "pmid_journal_20": "Eur J Haematol"}, {"pmid_title_21": "Omenn syndrome due to ARTEMIS mutations.", "pmid_21": 15731174.0, "pmid_date_21": 2005.0, "pmid_journal_21": "Blood"}, {"pmid_title_22": "Reviewing Omenn syndrome.", "pmid_22": 11795679.0, "pmid_date_22": 2001.0, "pmid_journal_22": "Eur J Pediatr"}]}, {"_id": "9831-OMIM:609889", "condition": {"condition_name": "ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE", "ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY", "OMENN SYNDROME", "COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS"]}, "gene information": {"db_hgnc_gene_id": 9831.0}, "interventions": [{"int_description_1": "Ganciclovir", "timeframe_int1": "Hours,Days or Weeks", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Human immunoglobulin G"}, {"int_description_3": "Rituximab"}, {"int_description_4": "Foscarnet"}, {"int_description_5": "Anti-CD20 mAb"}, {"int_description_6": "Steroids"}, {"int_description_7": "Filgrastim"}, {"int_description_8": "Conditioning regimen"}, {"int_description_9": "Hematopoietic stem cell transplantation", "timeframe_int9": "Days or Weeks", "age_use_int9": "Infant,Child", "contra_int9": "No", "qualscale_reclass_drug9": "Case report(s)", "rev1_eff_reclass_drug9": "Curative"}], "references": [{"pmid_title_1": "Recombinase-activating gene 1 immunodeficiency: different immunological phenotypes in three siblings.", "pmid_1": 19243569.0, "pmid_date_1": 2009.0, "pmid_journal_1": "Acta Paediatr"}, {"pmid_title_2": "A variant of SCID with specific immune responses and predominance of gamma delta T cells.", "pmid_2": 16211094.0, "pmid_date_2": 2005.0, "pmid_journal_2": "J Clin Invest"}, {"pmid_title_3": "A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection.", "pmid_3": 16276422.0, "pmid_date_3": 2005.0, "pmid_journal_3": "J Clin Invest"}]}, {"_id": "9832-OMIM:233650", "condition": {"condition_name": "COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["OMENN SYNDROME", "COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS", "SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE"]}, "gene information": {"db_hgnc_gene_id": 9832.0}, "interventions": [{"int_description_1": "Ursodeoxycholic acid"}, {"int_description_2": "Prednisone"}, {"int_description_3": "Octreotide"}, {"int_description_4": "Eltrombopag"}, {"int_description_5": "Human immunoglobulin G"}, {"int_description_6": "Abatacept"}, {"int_description_7": "Rituximab"}, {"int_description_8": "Alemtuzumab"}, {"int_description_9": "Adalimumab"}, {"int_description_10": "Cyclosporine"}, {"int_description_11": "Isoniazid"}, {"int_description_12": "Sirolimus"}, {"int_description_13": "Somatotropin"}, {"int_description_14": "Cyclophosphamide"}, {"int_description_15": "Busulfan"}, {"int_description_16": "Melphalan"}, {"int_description_17": "Thiotepa"}, {"int_description_18": "Micafungin"}, {"int_description_19": "Pyrazinamide"}, {"int_description_20": "Ethambutol"}, {"int_description_21": "Azithromycin"}, {"int_description_22": "Trimethoprim"}, {"int_description_23": "Dapsone"}, {"int_description_24": "Sulfamethoxazole"}, {"int_description_25": "Treosulfan"}, {"int_description_26": "Rifampicin"}, {"int_description_27": "Fluconazole"}, {"int_description_28": "Methotrexate"}, {"int_description_29": "Fludarabine"}, {"int_description_30": "Tacrolimus"}, {"int_description_31": "Acyclovir"}, {"int_description_32": "Cidofovir"}, {"int_description_33": "Brincidofovir"}, {"int_description_34": "Mycophenolate mofetil"}, {"int_description_35": "Acetylsalicylic acid"}, {"int_description_36": "Probenecid"}, {"int_description_37": "Infliximab"}, {"int_description_38": "Anti-thymocyte globulin"}, {"int_description_39": "Corticosteroids"}, {"int_description_40": "Meglumine antimoniate"}, {"int_description_41": "Narcotic analgesics"}, {"int_description_42": "Steroids"}, {"int_description_43": "Parenteral nutrition"}, {"int_description_44": "Radioimmunotherapy"}, {"int_description_45": "Total body irradiation"}, {"int_description_46": "Hematopoietic stem cell transplantation", "timeframe_int46": "Days or Weeks", "age_use_int46": "Neonate,Infant,Child", "contra_int46": "No", "qualscale_reclass_drug46": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug46": "Curative"}, {"int_description_47": "Thymectomy"}], "references": [{"pmid_title_1": "Unrelated Hematopoietic Cell Transplantation in a Patient with Combined Immunodeficiency with Granulomatous Disease and Autoimmunity Secondary to RAG Deficiency.", "pmid_1": 27539235.0, "pmid_date_1": 2016.0, "pmid_journal_1": "Journal of clinical immunology"}, {"pmid_title_2": "A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency.", "pmid_2": 24996264.0, "pmid_date_2": 2014.0, "pmid_journal_2": "The Journal of allergy and clinical immunology"}, {"pmid_title_3": "Exome sequencing reveals RAG1 mutations in a child with autoimmunity and sterile chronic multifocal osteomyelitis evolving into disseminated granulomatous disease.", "pmid_3": 24122031.0, "pmid_date_3": 2013.0, "pmid_journal_3": "Journal of clinical immunology"}, {"pmid_title_4": "An immunodeficiency disease with RAG mutations and granulomas.", "pmid_4": 18463379.0, "pmid_date_4": 2008.0, "pmid_journal_4": "The New England journal of medicine"}]}, {"_id": "9832-OMIM:603554", "condition": {"condition_name": "OMENN SYNDROME", "freq_per_birth": "Overall, the various forms of SCID are estimated to affect 1 in 75,000 to 100,000 newborns. The exact prevalence of Omenn syndrome is unknown.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE", "OMENN SYNDROME", "COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS"]}, "gene information": {"db_hgnc_gene_id": 9832.0}, "interventions": [{"int_description_1": "Cardiopulmonary resuscitation"}, {"int_description_2": "Prednisolone"}, {"int_description_3": "Prednisone"}, {"int_description_4": "Dexamethasone"}, {"int_description_5": "Panthenol"}, {"int_description_6": "Ganciclovir"}, {"int_description_7": "Human immunoglobulin G"}, {"int_description_8": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_9": "Alemtuzumab"}, {"int_description_10": "Clarithromycin"}, {"int_description_11": "Cyclosporine"}, {"int_description_12": "Isoniazid"}, {"int_description_13": "Interferon gamma-1b"}, {"int_description_14": "Cyclophosphamide"}, {"int_description_15": "Busulfan"}, {"int_description_16": "Melphalan"}, {"int_description_17": "Thiotepa"}, {"int_description_18": "Caspofungin"}, {"int_description_19": "Ethambutol"}, {"int_description_20": "Azithromycin"}, {"int_description_21": "Trimethoprim"}, {"int_description_22": "Sulfamethoxazole"}, {"int_description_23": "Treosulfan"}, {"int_description_24": "Rifampicin"}, {"int_description_25": "Fluconazole"}, {"int_description_26": "Voriconazole"}, {"int_description_27": "Methotrexate"}, {"int_description_28": "Fludarabine"}, {"int_description_29": "Etoposide"}, {"int_description_30": "Tacrolimus"}, {"int_description_31": "Foscarnet", "timeframe_int31": "Days or Weeks", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug31": "Curative"}, {"int_description_32": "Mycophenolate mofetil", "timeframe_int32": "Hours,Days or Weeks", "age_use_int32": "Neonate,Infant,Child", "contra_int32": "No", "qualscale_reclass_drug32": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug32": "Effective / Ameliorative"}, {"int_description_33": "Methylprednisolone", "timeframe_int33": "Hours,Days or Weeks", "age_use_int33": "Neonate,Infant,Child", "contra_int33": "No", "qualscale_reclass_drug33": "Authoritative published clinical practice guideline", "rev1_eff_reclass_drug33": "Effective / Ameliorative"}, {"int_description_34": "Anti-thymocyte globulin"}, {"int_description_35": "Antibiotics"}, {"int_description_36": "Palivizumab"}, {"int_description_37": "Antilymphocyte immunoglobulin (horse)", "timeframe_int37": "Days or Weeks", "age_use_int37": "Neonate,Infant,Child", "contra_int37": "No", "qualscale_reclass_drug37": "Case report(s)", "rev1_eff_reclass_drug37": "Effective / Ameliorative"}, {"int_description_38": "Hypochlorite"}, {"int_description_39": "Low-pH emollient cream (CeraVe, New York, New York)", "timeframe_int39": "Days or Weeks", "age_use_int39": "Neonate,Infant,Child", "contra_int39": "No", "qualscale_reclass_drug39": "Case report(s)", "rev1_eff_reclass_drug39": "Effective / Ameliorative"}, {"int_description_40": "CD4-DLI"}, {"int_description_41": "Parenteral nutrition"}, {"int_description_42": "Red blood cells transfusion"}, {"int_description_43": "Hematopoietic stem cell transplantation"}, {"int_description_44": "Ileum resection"}, {"int_description_45": "Subtotal appendectomy"}, {"int_description_46": "Surgical removement of lymphadenitis"}], "references": [{"pmid_title_1": "Prominent dermal Langerhans cells in an Omenn syndrome patient with a novel mutation in the IL2RG gene.", "pmid_1": 31456262.0, "pmid_date_1": 2019.0, "pmid_journal_1": "J Dermatol"}, {"pmid_title_2": "Atypical Omenn Syndrome Due to RAG2 Gene Mutation, a Case Report.", "pmid_2": 31885011.0, "pmid_date_2": 2019.0, "pmid_journal_2": "Iran J Immunol"}, {"pmid_title_3": "SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.", "pmid_3": 30154114.0, "pmid_date_3": 2018.0, "pmid_journal_3": "Blood"}, {"pmid_title_4": "Topical Hypochlorite and Skin Acidification Improves Erythroderma of Omenn Syndrome.", "pmid_4": 29610161.0, "pmid_date_4": 2018.0, "pmid_journal_4": "Pediatrics"}, {"pmid_title_5": "DNA recombination defects in Kuwait: Clinical, immunologic and genetic profile.", "pmid_5": 29051008.0, "pmid_date_5": 2018.0, "pmid_journal_5": "Clin Immunol"}, {"pmid_title_6": "Characterization of T and B cell repertoire diversity in patients with RAG deficiency.", "pmid_6": 28783691.0, "pmid_date_6": 2016.0, "pmid_journal_6": "Sci Immunol"}, {"pmid_title_7": "Molecular Characteristics, Clinical and Immunologic Manifestations of 11 Children with Omenn Syndrome in East Slavs (Russia, Belarus, Ukraine).", "pmid_7": 26596586.0, "pmid_date_7": 2016.0, "pmid_journal_7": "J Clin Immunol"}, {"pmid_title_8": "Variable phenotype of severe immunodeficiencies associated with RMRP gene mutations.", "pmid_8": 25663137.0, "pmid_date_8": 2015.0, "pmid_journal_8": "J Clin Immunol"}, {"pmid_title_9": "Cyclosporin treatment improves skin findings in omenn syndrome.", "pmid_9": 25727345.0, "pmid_date_9": 2015.0, "pmid_journal_9": "Pediatr Dermatol"}, {"pmid_title_10": "SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.", "pmid_10": 24144642.0, "pmid_date_10": 2014.0, "pmid_journal_10": "Blood"}, {"pmid_title_11": "Atypical Omenn Syndrome due to Adenosine Deaminase Deficiency.", "pmid_11": 25954555.0, "pmid_date_11": 2012.0, "pmid_journal_11": "Case Reports Immunol"}, {"pmid_title_12": "Novel mutations in RAG1/2 and ADA genes in Israeli patients presenting with T-B-SCID or Omenn syndrome.", "pmid_12": 21624848.0, "pmid_date_12": 2011.0, "pmid_journal_12": "Clin Immunol"}, {"pmid_title_13": "Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation.", "pmid_13": 20375313.0, "pmid_date_13": 2010.0, "pmid_journal_13": "Blood"}, {"pmid_title_14": "Saving the red baby: successful allogeneic cord blood transplantation in Omenn syndrome.", "pmid_14": 19064334.0, "pmid_date_14": 2009.0, "pmid_journal_14": "Clin Immunol"}, {"pmid_title_15": "Rapid full engraftment and successful immune reconstitution after allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in Omenn syndrome.", "pmid_15": 18992055.0, "pmid_date_15": 2009.0, "pmid_journal_15": "Pediatr Transplant"}, {"pmid_title_16": "Variability of clinical and laboratory features among patients with ribonuclease mitochondrial RNA processing endoribonuclease gene mutations.", "pmid_16": 18804272.0, "pmid_date_16": 2008.0, "pmid_journal_16": "J Allergy Clin Immunol"}, {"pmid_title_17": "Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency.", "pmid_17": 17825895.0, "pmid_date_17": 2007.0, "pmid_journal_17": "J Allergy Clin Immunol"}, {"pmid_title_18": "Omenn syndrome--review of several phenotypes of Omenn syndrome and RAG1/RAG2 mutations in Japan.", "pmid_18": 17075247.0, "pmid_date_18": 2006.0, "pmid_journal_18": "Allergol Int"}, {"pmid_title_19": "Mutations in the RNA component of RNase mitochondrial RNA processing might cause Omenn syndrome.", "pmid_19": 16630949.0, "pmid_date_19": 2006.0, "pmid_journal_19": "J Allergy Clin Immunol"}, {"pmid_title_20": "Novel adopted immunotherapy for mixed chimerism after unrelated cord blood transplantation in Omenn syndrome.", "pmid_20": 16191096.0, "pmid_date_20": 2005.0, "pmid_journal_20": "Eur J Haematol"}, {"pmid_title_21": "Omenn syndrome due to ARTEMIS mutations.", "pmid_21": 15731174.0, "pmid_date_21": 2005.0, "pmid_journal_21": "Blood"}, {"pmid_title_22": "Reviewing Omenn syndrome.", "pmid_22": 11795679.0, "pmid_date_22": 2001.0, "pmid_journal_22": "Eur J Pediatr"}]}, {"_id": "9863-OMIM:616326", "condition": {"condition_name": "MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY"]}, "gene information": {"db_hgnc_gene_id": 9863.0}, "interventions": [{"int_description_1": "Mechanical ventilation", "timeframe_int1": "Days or Weeks,Years", "age_use_int1": "Neonate,Infant,Child", "contra_int1": "No", "qualscale_reclass_drug1": "Case report(s)", "rev1_eff_reclass_drug1": "Effective / Ameliorative"}, {"int_description_2": "Ephedrine", "timeframe_int2": "Days or Weeks,Years", "age_use_int2": "Neonate,Infant,Child", "contra_int2": "No", "qualscale_reclass_drug2": "Case report(s)", "rev1_eff_reclass_drug2": "Effective / Ameliorative"}, {"int_description_3": "Salbutamol", "timeframe_int3": "Days or Weeks,Years", "age_use_int3": "Neonate,Infant,Child", "contra_int3": "No", "qualscale_reclass_drug3": "Case report(s)", "rev1_eff_reclass_drug3": "Effective / Ameliorative"}, {"int_description_4": "Amifampridine"}, {"int_description_5": "Procaine", "timeframe_int5": "Hours,Days or Weeks", "age_use_int5": "Neonate,Infant,Child", "contra_int5": "No", "qualscale_reclass_drug5": "Case report(s)", "rev1_eff_reclass_drug5": "Effective / Ameliorative"}, {"int_description_6": "Procainamide"}, {"int_description_7": "Pyridostigmine"}, {"int_description_8": "Ambenonium"}, {"int_description_9": "Neostigmine"}, {"int_description_10": "Ciprofloxacin"}, {"int_description_11": "Quinidine"}, {"int_description_12": "Chloroquine"}, {"int_description_13": "Phenytoin"}, {"int_description_14": "Beta-blockers"}, {"int_description_15": "Lithium"}, {"int_description_16": "Prophylactic anticholinesterase therapy"}, {"int_description_17": "Percutaneous endoscopic gastrostomy"}], "references": [{"pmid_title_1": "Molecular characterization of congenital myasthenic syndromes in Spain.", "pmid_1": 29054425.0, "pmid_date_1": 2017.0, "pmid_journal_1": "Neuromuscular disorders : NMD"}, {"pmid_title_2": "Congenital Myasthenic Syndromes", "pmid_2": 20301347.0, "pmid_date_2": 2016.0, "pmid_journal_2": "GeneReviews\u00ae"}, {"pmid_title_3": "Potentially Treatable Disorder Diagnosed Post Mortem by Exome Analysis in a Boy with Respiratory Distress.", "pmid_3": 26927095.0, "pmid_date_3": 2016.0, "pmid_journal_3": "Int J Mol Sci"}, {"pmid_title_4": "Long-term follow-up in patients with congenital myasthenic syndrome due to RAPSN mutations.", "pmid_4": 26782015.0, "pmid_date_4": 2016.0, "pmid_journal_4": "Neuromuscular disorders : NMD"}, {"pmid_title_5": "Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients.", "pmid_5": 19620612.0, "pmid_date_5": 2009.0, "pmid_journal_5": "Neurology"}, {"pmid_title_6": "Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission.", "pmid_6": 17686188.0, "pmid_date_6": 2007.0, "pmid_journal_6": "Expert reviews in molecular medicine"}, {"pmid_title_7": "Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations.", "pmid_7": 16945936.0, "pmid_date_7": 2006.0, "pmid_journal_7": "Brain : a journal of neurology"}, {"pmid_title_8": "Possible founder effect of rapsyn N88K mutation and identification of novel rapsyn mutations in congenital myasthenic syndromes.", "pmid_8": 12807980.0, "pmid_date_8": 2003.0, "pmid_journal_8": "J Med Genet"}, {"pmid_title_9": "Rapsyn mutations in myasthenic syndrome due to impaired receptor clustering.", "pmid_9": 12929188.0, "pmid_date_9": 2003.0, "pmid_journal_9": "Muscle & nerve"}]}, {"_id": "9987-OMIM:209920", "condition": {"condition_name": "BARE LYMPHOCYTE SYNDROME, TYPE II", "freq_per_birth": "BLS II is a rare condition. At least 100 cases have been reported in the medical literature. While BLS II has been found in several populations throughout the world, it appears to be especially prevalent in the Mediterranean region and North Africa.", "pattern_of_inheritance": "Autosomal recessive", "alternate_names": ["BARE LYMPHOCYTE SYNDROME, TYPE II"]}, "gene information": {"db_hgnc_gene_id": 9987.0}, "interventions": [{"int_description_1": "Mechanical ventilation"}, {"int_description_2": "Nasogastric feeding"}, {"int_description_3": "Oxygen treatment"}, {"int_description_4": "Nutritional rehabilitation"}, {"int_description_5": "Ganciclovir"}, {"int_description_6": "Human immunoglobulin G"}, {"int_description_7": "Antithymocyte immunoglobulin (rabbit)"}, {"int_description_8": "Rituximab"}, {"int_description_9": "Alemtuzumab"}, {"int_description_10": "Cyclosporine"}, {"int_description_11": "Amphotericin B"}, {"int_description_12": "Cyclophosphamide"}, {"int_description_13": "Busulfan"}, {"int_description_14": "Thiotepa"}, {"int_description_15": "Azithromycin"}, {"int_description_16": "Clindamycin"}, {"int_description_17": "Trimethoprim"}, {"int_description_18": "Sulfamethoxazole"}, {"int_description_19": "Amoxicillin"}, {"int_description_20": "Ceftriaxone"}, {"int_description_21": "Treosulfan"}, {"int_description_22": "Fluconazole"}, {"int_description_23": "Fludarabine"}, {"int_description_24": "Vancomycin"}, {"int_description_25": "Acyclovir"}, {"int_description_26": "Methylprednisolone"}, {"int_description_27": "Anti-LFA1 with or without CD2"}, {"int_description_28": "Antibiotics"}, {"int_description_29": "Antithymocyte globulin"}, {"int_description_30": "Antiviral pharmacotherapy"}, {"int_description_31": "Corticosteroids", "timeframe_int31": "Days or Weeks", "age_use_int31": "Neonate,Infant,Child", "contra_int31": "No", "qualscale_reclass_drug31": "Cohort study or studies", "rev1_eff_reclass_drug31": "Effective / Ameliorative"}, {"int_description_32": "Steroids"}, {"int_description_33": "Physiotherapy"}, {"int_description_34": "Virus-specific, donor-derived T-cell infusion"}, {"int_description_35": "Hematopoietic stem cell transplantation"}, {"int_description_36": "Placement of a pericardial window", "timeframe_int36": "Days or Weeks", "age_use_int36": "Neonate,Infant,Child", "contra_int36": "No", "qualscale_reclass_drug36": "Cohort study or studies", "rev1_eff_reclass_drug36": "Curative"}, {"int_description_37": "Splenectomy"}, {"int_description_38": "Trans-tympanic drain"}], "references": [{"pmid_title_1": "A novel mutation in RFXANK gene and low B cell count in a patient with MHC class II deficiency: a case report.", "pmid_1": 32578129.0, "pmid_date_1": 2020.0, "pmid_journal_1": "Immunol Res"}, {"pmid_title_2": "Enterovirus-Related Immune Reconstitution Inflammatory Syndrome (IRIS) Following Haploidentical Stem Cell Transplantation in an MHC Class II-Deficient Child.", "pmid_2": 28508932.0, "pmid_date_2": 2017.0, "pmid_journal_2": "J Clin Immunol"}, {"pmid_title_3": "Major Histocompatibility Complex Class II Deficiency due to a Novel Mutation in RFXANK in a Child of Mexican Descent.", "pmid_3": 26634365.0, "pmid_date_3": 2016.0, "pmid_journal_3": "J Clin Immunol"}, {"pmid_title_4": "Clinical, immunological and genetic findings of a large tunisian series of major histocompatibility complex class II deficiency patients.", "pmid_4": 23314770.0, "pmid_date_4": 2013.0, "pmid_journal_4": "J Clin Immunol"}, {"pmid_title_5": "Clinical, immunological and genetic features in eleven Algerian patients with major histocompatibility complex class II expression deficiency.", "pmid_5": 22863278.0, "pmid_date_5": 2012.0, "pmid_journal_5": "Allergy Asthma Clin Immunol"}, {"pmid_title_6": "Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients.", "pmid_6": 21908431.0, "pmid_date_6": 2011.0, "pmid_journal_6": "Blood"}, {"pmid_title_7": "The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population.", "pmid_7": 20414676.0, "pmid_date_7": 2010.0, "pmid_journal_7": "Eur J Pediatr"}]}]}